PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cilleros-Mane, V; Just-Borras, L; Polishchuk, A; Duran, M; Tomas, M; Garcia, N; Tomas, JM; Lanuza, MA				Cilleros-Mane, V; Just-Borras, L.; Polishchuk, A.; Duran, M.; Tomas, M.; Garcia, N.; Tomas, J. M.; Lanuza, M. A.			M-1 and M-2 mAChRs activate PDK1 and regulate PKC beta I and epsilon and the exocytotic apparatus at the NMJ	FASEB JOURNAL			English	Article						muscarinic receptors; neuromuscular junction; PDK1; PKC; SNAP-25	PROTEIN-KINASE-C; SYNAPTOSOME-ASSOCIATED PROTEIN; EPIDERMAL-GROWTH-FACTOR; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; POSSIBLE INVOLVEMENT; DEPENDENT PHOSPHORYLATION; MUSCARINIC AUTORECEPTORS; TRANSMITTER RELEASE; SYNAPTIC ACTIVITY	Neuromuscular junctions (NMJ) regulate cholinergic exocytosis through the M-1 and M-2 muscarinic acetylcholine autoreceptors (mAChR), involving the crosstalk between receptors and downstream pathways. Protein kinase C (PKC) regulates neurotransmission but how it associates with the mAChRs remains unknown. Here, we investigate whether mAChRs recruit the classical PKC beta I and the novel PKC epsilon isoforms and modulate their priming by PDK1, translocation and activity on neurosecretion targets. We show that each M-1 and M-2 mAChR activates the master kinase PDK1 and promotes a particular priming of the presynaptic PKC beta I and epsilon isoforms. M-1 recruits both primed-PKCs to the membrane and promotes Munc18-1, SNAP-25, and MARCKS phosphorylation. In contrast, M-2 downregulates PKC epsilon through a PKA-dependent pathway, which inhibits Munc18-1 synthesis and PKC phosphorylation. In summary, our results discover a co-dependent balance between muscarinic autoreceptors which orchestrates the presynaptic PKC and their action on ACh release SNARE-SM mechanism. Altogether, this molecular signaling explains previous functional studies at the NMJ and guide toward potential therapeutic targets.	[Cilleros-Mane, V; Just-Borras, L.; Polishchuk, A.; Duran, M.; Tomas, M.; Garcia, N.; Tomas, J. M.; Lanuza, M. A.] Univ Rovira & Virgili, Fac Med & Ciencies Salut, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, Reus, Spain	Universitat Rovira i Virgili	Tomas, JM; Lanuza, MA (corresponding author), Univ Rovira & Virgili, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, C St Llorenc 21, Reus 43201, Spain.	josepmaria.tomas@urv.cat; mariaangel.lanuza@urv.cat	Cilleros-Mañé, Víctor/G-5251-2018	Cilleros-Mañé, Víctor/0000-0001-5690-9932; Tomas, Josep/0000-0002-0406-0006; Polishchuk, Aleksandra/0000-0001-6445-1538	Ministerio de Economia y Competitividad (MINECO); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF) [SAF2015-67143-P, PID2019-106332GB-I00]; Universitat Rovira i Virgili (URV) [2017PFR-URV-B2-85]; Catalan Government [2017SGR704]; European Social Fund (ESF); Iniciativa de Empleo Juvenil (IEJ) [LE1511314-2014PEJ-04, LE1911587-2019PEJ-04]; Spanish Ministerio de Ciencia Innovacion y Universidades [PID2019-106332GB-I00, PRE2020-092084]; Universitat Rovira i Virgili (URV); Contractes de personal investigador predoctoral en formacio [2018PMF-PIPF-18]	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF)(European Commission); Universitat Rovira i Virgili (URV); Catalan Government; European Social Fund (ESF)(European Social Fund (ESF)); Iniciativa de Empleo Juvenil (IEJ); Spanish Ministerio de Ciencia Innovacion y Universidades(Spanish Government); Universitat Rovira i Virgili (URV); Contractes de personal investigador predoctoral en formacio	Ministerio de Economia y Competitividad (MINECO); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF), Grant/Award Number: SAF2015-67143-P and PID2019-106332GB-I00; Universitat Rovira i Virgili (URV), Grant/Award Number: 2017PFR-URV-B2-85; Catalan Government, Grant/Award Number: 2017SGR704; European Social Fund (ESF); Iniciativa de Empleo Juvenil (IEJ), Grant/Award Number: LE1511314-2014PEJ-04 and LE1911587-2019PEJ-04; Spanish Ministerio de Ciencia Innovacion y Universidades, Grant/Award Number: PRE2020-092084 and PID2019-106332GB-I00; Universitat Rovira i Virgili (URV); Contractes de personal investigador predoctoral en formacio, Grant/Award Number: 2018PMF-PIPF-18	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Besalduch N, 2010, J COMP NEUROL, V518, P211, DOI 10.1002/cne.22220; Brazhnik E, 2004, J NEUROSCI, V24, P9313, DOI 10.1523/JNEUROSCI.1618-04.2004; Callaghan B, 2004, CIRC RES, V94, P626, DOI 10.1161/01.RES.0000118248.17466.B7; Caulfield MP, 1998, PHARMACOL REV, V50, P279; CAZAUBON SM, 1993, J BIOL CHEM, V268, P17559; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Cilleros-Mane V, 2020, FASEB J, V34, P4934, DOI 10.1096/fj.201902113R; de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x; Denning MF, 2012, PIGM CELL MELANOMA R, V25, P466, DOI 10.1111/j.1755-148X.2012.01015.x; Di-Capua N, 2003, J NEUROCHEM, V84, P409, DOI 10.1046/j.1471-4159.2003.01563.x; Disatnik MH, 2004, J CELL SCI, V117, P4469, DOI 10.1242/jcs.01309; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Ersvaer E, 2010, TOXINS, V2, P174, DOI 10.3390/toxins2010174; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Garcia N, 2005, HISTOL HISTOPATHOL, V20, P733, DOI 10.14670/HH-20.733; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; Heise C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00035; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Hurtado E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00270; Hurtado E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00147; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Just-Borras L, 2019, MOL NEUROBIOL, V56, P6856, DOI 10.1007/s12035-019-1550-1; Kang BS, 2000, ONCOGENE, V19, P4263, DOI 10.1038/sj.onc.1203779; Kataoka M, 2000, J NEUROCHEM, V74, P2058, DOI 10.1046/j.1471-4159.2000.0742058.x; Katayama N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08237-x; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Lanuza MA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121578; Lanuza MA, 2014, J ANAT, V224, P61, DOI 10.1111/joa.12106; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; Liu GS, 1999, J MOL CELL CARDIOL, V31, P1937, DOI 10.1006/jmcc.1999.1026; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Valenzuela IMPY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081311; Minic J, 2002, EUR J NEUROSCI, V15, P439, DOI 10.1046/j.0953-816x.2001.01875.x; Mochly-Rosen D, 1998, FASEB J, V12, P35; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Morgan A., 2004, CELL BIOL CHROMAFFIN, V1, P65; Nadal L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00024; Nadal L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0248-9; Nagy G, 2002, J NEUROSCI, V22, P9278; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; NAKANO S, 1992, MUSCLE NERVE, V15, P496, DOI 10.1002/mus.880150414; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0171-5; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0098-x; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; Osto E, 2008, CIRCULATION, V118, P2174, DOI 10.1161/CIRCULATIONAHA.108.789537; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Perkins GA, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-17; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; ROSS EM, 1993, LIFE SCI, V52, P413, DOI 10.1016/0024-3205(93)90296-F; Santafe MM, 2007, NEUROSCIENCE, V148, P432, DOI 10.1016/j.neuroscience.2007.06.017; Santafe MM, 2009, J NEUROSCI RES, V87, P683, DOI 10.1002/jnr.21885; Santafe MM, 2004, NEUROSCIENCE, V123, P61, DOI 10.1016/j.neuroscience.2003.09.012; Shen A, 1998, BIOCHEM PHARMACOL, V56, P1529, DOI 10.1016/S0006-2952(98)00242-1; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shirai Y, 1998, JPN J PHARMACOL, V78, P411, DOI 10.1254/jjp.78.411; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Simo A, 2019, MOL NEUROBIOL, V56, P5346, DOI 10.1007/s12035-018-1462-5; Simo A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00207; Slutsky I, 1999, J PHYSIOL-LONDON, V514, P769, DOI 10.1111/j.1469-7793.1999.769ad.x; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Sons MS, 2003, ANN NY ACAD SCI, V998, P404, DOI 10.1196/annals.1254.052; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Willets JM, 2007, J NEUROCHEM, V103, P2268, DOI 10.1111/j.1471-4159.2007.04931.x; Wright MC, 2009, J NEUROSCI, V29, P14942, DOI 10.1523/JNEUROSCI.2276-09.2009; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685; Zhang Y, 2015, J BIOL CHEM, V290, P8644, DOI 10.1074/jbc.M114.615021; Zhao LX, 2019, FASEB J, V33, P6622, DOI 10.1096/fj.201802351R; Zhou JZ, 2003, J BIOL CHEM, V278, P5388, DOI 10.1074/jbc.M209695200	90	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21724	10.1096/fj.202002213R	http://dx.doi.org/10.1096/fj.202002213R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34133802				2022-12-28	WOS:000667814100058
J	Nayak, AP; Lim, JM; Arbel, E; Wang, RP; Villalba, DR; Nguyen, TL; Schaible, N; Krishnan, R; Tang, DD; Penn, RB				Nayak, Ajay P.; Lim, John M.; Arbel, Eylon; Wang, Ruping; Villalba, Dominic R.; Nguyen, Tahn L.; Schaible, Niccole; Krishnan, Ramaswamy; Tang, Dale D.; Penn, Raymond B.			Cooperativity between beta-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation	FASEB JOURNAL			English	Article						actin cytoskeleton; airway smooth muscle; asthma; beta 2 adrenoceptor; c-abl tyrosine kinase	PROTEIN-KINASE-A; ACTIN DEPOLYMERIZATION; ASTHMA PHENOTYPE; ACTIVATION; CONTRACTION; CYTOKINES; CELLS; RHOA	Current therapeutic approaches to avoid or reverse bronchoconstriction rely primarily on beta 2 adrenoceptor agonists (beta-agonists) that regulate pharmacomechanical coupling/cross bridge cycling in airway smooth muscle (ASM). Targeting actin cytoskeleton polymerization in ASM represents an alternative means to regulate ASM contraction. Herein we report the cooperative effects of targeting these distinct pathways with beta-agonists and inhibitors of the mammalian Abelson tyrosine kinase (Abl1 or c-Abl). The cooperative effect of beta-agonists (isoproterenol) and c-Abl inhibitors (GNF-5, or imatinib) on contractile agonist (methacholine, or histamine) -induced ASM contraction was assessed in cultured human ASM cells (using Fourier Transfer Traction Microscopy), in murine precision cut lung slices, and in vivo (flexiVent in mice). Regulation of intracellular signaling that regulates contraction (pMLC20, pMYPT1, pHSP20), and actin polymerization state (F:G actin ratio) were assessed in cultured primary human ASM cells. In each (cell, tissue, in vivo) model, c-Abl inhibitors and beta-agonist exhibited additive effects in either preventing or reversing ASM contraction. Treatment of contracted ASM cells with c-Abl inhibitors and beta-agonist cooperatively increased actin disassembly as evidenced by a significant reduction in the F:G actin ratio. Mechanistic studies indicated that the inhibition of pharmacomechanical coupling by beta-agonists is near optimal and is not increased by c-Abl inhibitors, and the cooperative effect on ASM relaxation resides in further relaxation of ASM tension development caused by actin cytoskeleton depolymerization, which is regulated by both beta-agonists and c-Abl inhibitors. Thus, targeting actin cytoskeleton polymerization represents an untapped therapeutic reserve for managing airway resistance.	[Nayak, Ajay P.; Lim, John M.; Villalba, Dominic R.; Nguyen, Tahn L.; Penn, Raymond B.] Thomas Jefferson Univ, Ctr Translat Med, Korman Resp Inst, Dept Med Pulm & Crit Care Med, Philadelphia, PA 19107 USA; [Arbel, Eylon; Wang, Ruping; Tang, Dale D.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA; [Schaible, Niccole; Krishnan, Ramaswamy] Harvard Med Sch, Ctr Vasc Biol Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Jefferson University; Albany Medical College; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Penn, RB (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St, Philadelphia, PA 19107 USA.	Raymond.Penn@jefferson.edu		Arbel, Eylon/0000-0001-7040-3014	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL145392, HL110951, HL130304]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL145392, HL110951 and HL130304	Abe K, 2011, AM J RESP CELL MOL, V45, P804, DOI 10.1165/rcmb.2010-0371OC; Adcock Ian M., 2002, Journal of Allergy and Clinical Immunology, V110, pS261, DOI 10.1067/mai.2002.129705; Boterman M, 2005, EUR J PHARMACOL, V516, P85, DOI 10.1016/j.ejphar.2005.04.029; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Cleary RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-105; Fabbro D, 2010, BBA-PROTEINS PROTEOM, V1804, P454, DOI 10.1016/j.bbapap.2009.12.009; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hirshman CA, 2005, AM J PHYSIOL-LUNG C, V288, pL924, DOI 10.1152/ajplung.00463.2004; Hirshman CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1468, DOI 10.1152/ajpcell.2001.281.5.C1468; ITO A, 1994, CIRCULATION, V90, P2425, DOI 10.1161/01.CIR.90.5.2425; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; MacDonald JA, 2016, MOL PHARMACOL, V89, P105, DOI 10.1124/mol.115.100529; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; Nayak AP, 2019, AM J PHYSIOL-LUNG C, V316, pL894, DOI 10.1152/ajplung.00426.2018; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Pascual RM, 2001, AM J PHYSIOL-LUNG C, V281, pL1425, DOI 10.1152/ajplung.2001.281.6.L1425; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Pera T, 2019, METHODS MOL BIOL, V1957, P69, DOI 10.1007/978-1-4939-9158-7_4; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; Pera T, 2016, PHARMACOL THERAPEUT, V164, P82, DOI 10.1016/j.pharmthera.2016.04.002; Peters SP, 2007, J ALLERGY CLIN IMMUN, V119, P1454, DOI 10.1016/j.jaci.2007.03.022; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sarria B, 2002, AM J PHYSIOL-LUNG C, V283, pL1125, DOI 10.1152/ajplung.00084.2002; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Tang Dale D, 2018, Adv Pharmacol, V81, P1, DOI 10.1016/bs.apha.2017.06.001; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Usui T, 2014, APOPTOSIS, V19, P387, DOI 10.1007/s10495-013-0934-3; Wang YN, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0709-4; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798; Yoo EJ, 2017, BRIT J PHARMACOL, V174, P4383, DOI 10.1111/bph.14040; Yoshie H, 2018, BIOPHYS J, V114, P2194, DOI 10.1016/j.bpj.2018.02.045; Yu QF, 2018, BRIT J PHARMACOL, V175, P2077, DOI 10.1111/bph.14201; Zhang WW, 2016, J PHYSIOL-LONDON, V594, P4879, DOI 10.1113/JP272132; Zhang WW, 2010, AM J PHYSIOL-CELL PH, V299, pC298, DOI 10.1152/ajpcell.00118.2010; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200	43	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21674	10.1096/fj.202100154R	http://dx.doi.org/10.1096/fj.202100154R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34115899	Green Accepted			2022-12-28	WOS:000667814100031
J	Yokota, M; Haffner, N; Kassier, M; Brunner, M; Shambat, SM; Brennecke, F; Schniering, J; Maggio, EM; Distler, O; Zinkernagel, AS; Maurer, B				Yokota, Masaya; Haeffner, Nicola; Kassier, Matthew; Brunner, Matthias; Shambat, Srikanth Mairpady; Brennecke, Fabian; Schniering, Janine; Maggio, Ewerton Marques; Distler, Oliver; Zinkernagel, Annelies Sophie; Maurer, Britta			Staphylococcus aureus impairs dermal fibroblast functions with deleterious effects on wound healing	FASEB JOURNAL			English	Article						fibroblasts; staphyloccous aureus; wound healing	SYSTEMIC-SCLEROSIS; DIGITAL ULCERS; INVASION; INFLAMMASOME; MICROBIOME; EXPRESSION; INFECTION; KINASE; REPAIR; CELLS	Chronic wounds are a major disease burden worldwide. The breach of the epithelial barrier facilitates transition of skin commensals to invasive facultative pathogens. Therefore, we investigated the potential effects of Staphylococcus aureus (SA) on dermal fibroblasts as key cells for tissue repair. In co-culture systems combining live or heat-killed SA with dermal fibroblasts derived from the BJ-5ta cell line, healthy individuals, and patients with systemic sclerosis, we assessed tissue repair including pro-inflammatory cytokines, matrix metalloproteases (MMPs), myofibroblast functions, and host defense responses. Only live SA induced the upregulation of IL-1 beta/-6/-8 and MMP1/3 as co-factors of tissue degradation. Additionally, the increased cell death reduced collagen production, proliferation, migration, and contractility, prerequisite mechanisms for wound closure. Intracellular SA triggered inflammatory and type I IFN responses via intracellular dsDNA sensor molecules and MyD88 and STING signaling pathways. In conclusion, live SA affected various key tissue repair functions of dermal fibroblasts from different sources to a similar extent. Thus, SA infection of dermal fibroblasts should be taken into account for future wound management strategies.	[Yokota, Masaya; Kassier, Matthew; Brunner, Matthias; Brennecke, Fabian; Schniering, Janine; Distler, Oliver; Maurer, Britta] Univ Hosp Zurich, Ctr Expt Rheumatol, Dept Rheumatol, Zurich, Switzerland; [Yokota, Masaya] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan; [Haeffner, Nicola; Shambat, Srikanth Mairpady; Zinkernagel, Annelies Sophie] Univ Zurich, Univ Hosp Zurich, Dept Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Maggio, Ewerton Marques] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland; [Maurer, Britta] Univ Bern, Univ Hosp Bern, Dept Rheumatol & Immunol, Bern, Switzerland	University of Zurich; University Zurich Hospital; Chiba University; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Maurer, B (corresponding author), Ctr Expt Rheumatol, Dept Rheumatol, Gloriastr 25, CH-8091 Zurich, Switzerland.	Britta.Maurer@usz.ch		Mairpady Shambat, Srikanth/0000-0002-0527-3978	Prof. Max Cloetta Foundation; Abbvie \ AbbVie Deutschland (AbbVie Germany); Novartis Stiftung fur Medizinisch-Biologische Forschung (Novartis Foundation for Medical-Biological Research); Olga Mayenfisch Foundation; Vontobel-Stiftung (Vontobel Foundation); EMDO Stiftung (EMDO-Stiftung); Herzog Egli Foundation; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF) [31003A_176252]	Prof. Max Cloetta Foundation; Abbvie \ AbbVie Deutschland (AbbVie Germany); Novartis Stiftung fur Medizinisch-Biologische Forschung (Novartis Foundation for Medical-Biological Research); Olga Mayenfisch Foundation; Vontobel-Stiftung (Vontobel Foundation); EMDO Stiftung (EMDO-Stiftung); Herzog Egli Foundation; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF)	Prof. Max Cloetta Foundation; Abbvie vertical bar AbbVie Deutschland (AbbVie Germany); Novartis Stiftung fur Medizinisch-Biologische Forschung (Novartis Foundation for Medical-Biological Research); Olga Mayenfisch Foundation; Vontobel-Stiftung (Vontobel Foundation); EMDO Stiftung (EMDO-Stiftung); Herzog Egli Foundation; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 31003A_176252	Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bettenworth D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107317; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Denton CP, 2012, ANN RHEUM DIS, V71, P718, DOI 10.1136/annrheumdis-2011-200631; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Giuggioli D, 2018, AUTOIMMUN REV, V17, P155, DOI 10.1016/j.autrev.2017.11.020; Giuggioli D, 2013, CLIN RHEUMATOL, V32, P623, DOI 10.1007/s10067-012-2161-7; Giuggioli D, 2012, ARTHRIT CARE RES, V64, P295, DOI 10.1002/acr.20673; Grice EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3_4; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Horn J, 2018, INT J MED MICROBIOL, V308, P607, DOI 10.1016/j.ijmm.2017.11.009; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Josse J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02433; Leimer N, 2016, J INFECT DIS, V213, P305, DOI 10.1093/infdis/jiv388; Loffler B, 2014, INT J MED MICROBIOL, V304, P170, DOI 10.1016/j.ijmm.2013.11.011; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LURIA SE, 1946, P SOC EXP BIOL MED, V61, P46, DOI 10.3181/00379727-61-15222; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nunan R, 2014, DIS MODEL MECH, V7, P1205, DOI 10.1242/dmm.016782; Parker D, 2012, J IMMUNOL, V189, P4040, DOI 10.4049/jimmunol.1201055; Pei JW, 2019, CANCER LETT, V450, P110, DOI 10.1016/j.canlet.2019.02.029; Quiblier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063513; Rahim K, 2017, MICROB ECOL, V73, P710, DOI 10.1007/s00248-016-0867-9; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sayedyahossein S, 2015, FASEB J, V29, P711, DOI 10.1096/fj.14-262774; Scales BS, 2013, J PATHOL, V229, P323, DOI 10.1002/path.4118; Scumpia PO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006496; Seidl K, 2013, J MICROBIOL METH, V92, P307, DOI 10.1016/j.mimet.2012.12.018; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Smith RS, 1997, AM J PATHOL, V151, P317; Strobel M, 2016, CLIN MICROBIOL INFEC, V22, P799, DOI 10.1016/j.cmi.2016.06.020; Surewaard BGJ, 2016, J EXP MED, V213, P1141, DOI 10.1084/jem.20160334; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Wirz EG, 2016, ANN RHEUM DIS, V75, P1285, DOI 10.1136/annrheumdis-2015-207271; Xia YY, 1997, AM J PATHOL, V151, P375; Zhang XP, 2017, MICROBIOL RES, V205, P19, DOI 10.1016/j.micres.2017.08.006	47	3	3	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21695	10.1096/fj.201902836R	http://dx.doi.org/10.1096/fj.201902836R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160101	Green Published, hybrid			2022-12-28	WOS:000667814100069
J	Liu, ZQ; Lai, JC; Jiang, H; Ma, CY; Huang, HY				Liu, Ziqiang; Lai, Jiacheng; Jiang, Heng; Ma, Chengyuan; Huang, Haiyan			Collagen XI alpha 1 chain, a potential therapeutic target for cancer	FASEB JOURNAL			English	Review						cancer; collagen; extracellular matrix; invasion	GENE-EXPRESSION; EXTRACELLULAR-MATRIX; BREAST-CANCER; PROMOTES CHEMORESISTANCE; ANTIBODY FRAGMENT; 11A1 EXPRESSION; STROMAL CELLS; KEY GENES; COL11A1; CARCINOMA	Extracellular matrix (ECM) plays an important role in the progression of cancer. Collagen is the most abundant component in ECM, and it is involved in the biological formation of cancer. Although type XI collagen is a minor fibrillar collagen, collagen XI alpha 1 chain (COL11A1) has been found to be upregulated in a variety of cancers including ovarian cancer, breast cancer, thyroid cancer, pancreatic cancer, non-small-cell lung cancer, and transitional cell carcinoma of the bladder. High levels of COL11A1 usually predict poor prognosis, while COL11A1 is related to angiogenesis, invasion, and drug resistance of cancer. However, little is known about the specific mechanism by which COL11A1 regulates tumor progression. Here, we have organized and summarized the recent developments regarding elucidation of the relationship between COL11A1 and various cancers, as well as the interaction between COL11A1 and intracellular signaling pathways. In addition, we have selected therapeutic agents targeting COL11A1. All these indicate the possibility of using COL11A1 as a target for cancer treatment.	[Liu, Ziqiang; Lai, Jiacheng; Jiang, Heng; Ma, Chengyuan; Huang, Haiyan] First Hosp Jilin Univ, Dept Neurosurg, 71 Xinmin St, Changchun 130021, Peoples R China	Jilin University	Ma, CY; Huang, HY (corresponding author), First Hosp Jilin Univ, Dept Neurosurg, 71 Xinmin St, Changchun 130021, Peoples R China.	chengyuan@jlu.edu.cn; huanghy@jlu.edu.cn		Liu, Ziqiang/0000-0002-0150-6826	Natural Science Foundation of Jilin Province [20180101158JC]	Natural Science Foundation of Jilin Province	This work was supported by Natural Science Foundation of Jilin Province (20180101158JC).	Andriani F, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4772-0; Aquino PF, 2012, J PROTEOME RES, V11, P5836, DOI 10.1021/pr300612x; Arolt C, 2020, CANCERS, V12, DOI 10.3390/cancers12092466; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Boguslawska J, 2018, CANCER LETT, V412, P155, DOI 10.1016/j.canlet.2017.10.019; Boguslawska J, 2016, J UROLOGY, V195, P1892, DOI 10.1016/j.juro.2015.11.050; Brandes AA, 2016, NEURO-ONCOLOGY, V18, P1146, DOI 10.1093/neuonc/now009; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Bynigeri RR, 2017, WORLD J GASTROENTERO, V23, P382, DOI 10.3748/wjg.v23.i3.382; Castellana B, 2012, J CANCER, V3, P175, DOI 10.7150/jca.4120; Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; Chen SR, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1204082; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Chong IW, 2006, ONCOL REP, V16, P981; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Cun XL, 2016, ACTA BIOMATER, V31, P186, DOI 10.1016/j.actbio.2015.12.002; Dabiri Asma, 2017, Gastroenterol Hepatol Bed Bench, V10, pS62; Di Y, 2019, HEREDITAS, V156, DOI 10.1186/s41065-019-0083-y; Dong X, 2019, NANO LETT, V19, P997, DOI 10.1021/acs.nanolett.8b04236; Ediriweera MK, 2019, SEMIN CANCER BIOL, V59, P147, DOI 10.1016/j.semcancer.2019.05.012; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Ewald JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055414; Feldmann G, 2008, GUT, V57, P1420, DOI 10.1136/gut.2007.148189; Fischer H, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-17; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Freire J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/812027; Galvan JA, 2020, VIRCHOWS ARCH, V476, P725, DOI 10.1007/s00428-019-02714-6; Galvan JA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-867; Gao XY, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.152831; Garcia-Pravia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078327; Ge C, 2017, ONCOL LETT, V13, P2777, DOI 10.3892/ol.2017.5750; Giussani M, 2018, J CELL PHYSIOL, V233, P6280, DOI 10.1002/jcp.26513; Gu SQ, 2020, MATH BIOSCI ENG, V17, P1428, DOI 10.3934/mbe.2020073; Hao SH, 2019, MED SCI MONITOR, V25, P2488, DOI 10.12659/MSM.915382; He Y, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dow018; Ho XD, 2017, EXP BIOL MED, V242, P1802, DOI 10.1177/1535370217736512; Januchowski R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/365867; Jiang H, 2018, INT J MOL MED, V41, P2021, DOI 10.3892/ijmm.2018.3401; Jin YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18060860; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kleinert R, 2015, ANTICANCER RES, V35, P6153; Lai K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188272; Lee J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695534; Li AQ, 2017, ONCOL REP, V37, P333, DOI 10.3892/or.2016.5276; Li JL, 2019, PEERJ, V7, DOI 10.7717/peerj.7705; Li L, 2005, WORLD J GASTROENTERO, V11, P4478, DOI 10.3748/wjg.v11.i29.4478; Li S, 2017, ONCOL LETT, V14, P3967, DOI 10.3892/ol.2017.6707; Liang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18205; Liang H, 2015, J CONTROL RELEASE, V209, P101, DOI 10.1016/j.jconrel.2015.04.029; Liu JX, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317714899; Mohan V, 2020, SEMIN CANCER BIOL, V62, P192, DOI 10.1016/j.semcancer.2019.09.004; Nabavi S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2942-5; Nallanthighal S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2442-z; Nielsen CF, 2017, ONCOTARGET, V8, P44605, DOI 10.18632/oncotarget.17883; Nissen NI, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1110-6; Nizri E, 2019, PANCREAS, V48, P367, DOI 10.1097/MPA.0000000000001261; Pan AN, 2018, DRUG DELIV, V25, P1495, DOI 10.1080/10717544.2018.1474971; Park HJ, 2011, EXP THER MED, V2, P1111, DOI 10.3892/etm.2011.318; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Rada M, 2018, ONCOGENE, V37, P4809, DOI 10.1038/s41388-018-0297-x; Raglow Z, 2015, CANCER LETT, V357, P448, DOI 10.1016/j.canlet.2014.12.011; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Rice AJ, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.54; Ryan RE, 2015, CYTOKINE, V72, P71, DOI 10.1016/j.cyto.2014.11.007; Schultz S, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0403-5; Shen LH, 2016, ONCOL REP, V36, P877, DOI 10.3892/or.2016.4869; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Skuja E., 2019, Experimental Oncology, V41, P323, DOI 10.32471/exp-oncology.2312-8852.vol-41-no-4.13841; Su C, 2019, MOL MED REP, V20, P4202, DOI 10.3892/mmr.2019.10667; Sun DF, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0669-x; Sun H, 2016, ONCOL LETT, V11, P525, DOI 10.3892/ol.2015.3929; Sun QQ, 2018, THERANOSTICS, V8, P5072, DOI 10.7150/thno.26546; Sun Y, 2010, CELL BIOCHEM BIOPHYS, V56, P59, DOI 10.1007/s12013-009-9071-6; Tan GF, 2021, CANCER SCI, V112, P397, DOI 10.1111/cas.14726; Tang L, 2020, J DIGEST DIS, V21, P639, DOI 10.1111/1751-2980.12936; Teng PN, 2014, BRIT J CANCER, V110, P123, DOI 10.1038/bjc.2013.687; Todhunter RJ, 2019, J ORTHOP RES, V37, P313, DOI 10.1002/jor.24178; Toss MS, 2019, MODERN PATHOL, V32, P1460, DOI 10.1038/s41379-019-0286-9; Tu HB, 2021, J INVEST SURG, V34, P664, DOI 10.1080/08941939.2019.1672839; Turkowski K, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081755; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; Vazquez-Villa F, 2015, TUMOR BIOL, V36, P2213, DOI 10.1007/s13277-015-3295-4; Wang HB, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-019-1066-9; Wang H, 2021, J CANCER, V12, P1406, DOI 10.7150/jca.47032; Wang JX, 2015, INT J CLIN EXP PATHO, V8, P517; Weng TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161007; Wu YH, 2014, ONCOGENE, V33, P3432, DOI 10.1038/onc.2013.307; Wu YH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00206; Wu YH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1555-8; Wu YH, 2017, INT J CANCER, V141, P2305, DOI 10.1002/ijc.30932; Wu YH, 2015, ONCOTARGET, V6, P23748, DOI 10.18632/oncotarget.4250; Wu YH, 2015, J CANCER, V6, P1011, DOI 10.7150/jca.12738; Xia FD, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013802; Xu CJ, 2020, MOL MED REP, V22, P3677, DOI 10.3892/mmr.2020.11490; Xu SS, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2058-1; Yang CJ, 2020, CANCER BIOMARK, V27, P445, DOI 10.3233/CBM-191200; Yang HJ, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.588; Zhang BH, 2018, CANCER BIOL THER, V19, P364, DOI 10.1080/15384047.2018.1423915; Zhang Q, 2018, CANCERS, V10, DOI 10.3390/cancers10080260; Zhao Y, 2009, ANAT REC, V292, P692, DOI 10.1002/ar.20874; Zheng XY, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.106982	103	13	13	7	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21603	10.1096/fj.202100054RR	http://dx.doi.org/10.1096/fj.202100054RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33999448	hybrid			2022-12-28	WOS:000655695900009
J	Zhao, ZL; Zhao, YS; Zhang, YQ; Shi, WL; Li, XQ; Shyy, JYJ; He, M; Wang, LY				Zhao, Zunlan; Zhao, Yingshuai; Zhang, Yuqing; Shi, Weili; Li, Xiqing; Shyy, John Y. -J.; He, Ming; Wang, Liuyi			Gout-induced endothelial impairment: The role of SREBP2 transactivation of YAP	FASEB JOURNAL			English	Article						endothelial dysfunction; Gout; SREBP2; YAP	URIC-ACID; MONOSODIUM URATE; OXIDATIVE STRESS; HIPPO PATHWAY; BETULINIC ACID; ACTIVATION; ATHEROSCLEROSIS; INFLAMMASOME; CRYSTAL; TAZ	Gout is a multifaceted inflammatory disease involving vascular impairments induced by hyperuricemia. Experiments using human umbilical vein endothelial cells treated with uric acid (UA), monosodium urate (MSU), or serum from gout patients showed increased expression of pro-inflammatory genes (ie, VCAM1, ICAM1, CYR61, CCNA1, and E2F1) with attendant increase in monocyte adhesion. Mechanistically, UA- or MSU-induced SREBP2 expression and its transcriptional activity. RNA sequencing analysis and real-time PCR showed the induction of YAP signaling and pro-inflammatory pathways in HUVECs transfected with adenovirus-SREBP2. The SREBP2 knockdown by siRNA partially abolished UA- or MSU-induced YAP activity, pro-inflammatory gene expression, and monocytes adhesion. Vascular intima from transgenic mice overexpressing SREBP2 in endothelium or mice with hyperuricemia exhibited activated YAP signaling and increased expression of pro-inflammatory genes. Betulin, an SREBP pharmacological inhibitor, attenuated the UA-, MSU-, or gout serum-induced endothelial cell inflammation and dysfunction. In the human study, endothelial cell function, assessed by EndoPAT, was negatively correlated with serum UA level among gouty patients and healthy controls. Collectively, UA or MSU causes endothelial dysfunction via SREBP2 transactivation of YAP. Betulin inhibition of SREBP2 may restrain gout-induced endothelial dysfunction.	[Zhao, Zunlan; Zhao, Yingshuai; Shi, Weili; Wang, Liuyi] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Gen Med, Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China; [Zhao, Zunlan; Zhang, Yuqing; Shyy, John Y. -J.; He, Ming] Univ Calif San Diego, Dept Med, Div Cardiol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Li, Xiqing] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Oncol, Peoples Hosp, Zhengzhou, Henan, Peoples R China	Zhengzhou University; University of California System; University of California San Diego; Zhengzhou University	Wang, LY (corresponding author), Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Gen Med, Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.; He, M (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	m1he@health.ucsd.edu; wly2000@126.com			General project of Henan Medical Science and Technology Program [201602202]	General project of Henan Medical Science and Technology Program	This work was supported in part by General project of Henan Medical Science and Technology Program (201602202 to LW)	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chapman PT, 1997, ARTHRITIS RHEUM, V40, P955, DOI 10.1002/art.1780400525; Chen Z, 2015, CIRCULATION, V131, P805, DOI 10.1161/CIRCULATIONAHA.114.013675; Chen Z, 2014, CURR OPIN LIPIDOL, V25, P339, DOI 10.1097/MOL.0000000000000107; Choe JY, 2015, APOPTOSIS, V20, P38, DOI 10.1007/s10495-014-1057-1; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Gaubert M, 2018, PURINERG SIGNAL, V14, P191, DOI 10.1007/s11302-018-9604-9; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Gui YZ, 2016, ACTA PHARMACOL SIN, V37, P1337, DOI 10.1038/aps.2016.46; Hansildaar R, 2021, LANCET RHEUMATOL, V3, pE58, DOI 10.1016/S2665-9913(20)30221-6; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Karasawa T, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0050-9; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krol SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/584189; Li P, 2016, INT J MOL MED, V37, P989, DOI 10.3892/ijmm.2016.2491; Liang WY, 2015, NUTR METAB CARDIOVAS, V25, P187, DOI 10.1016/j.numecd.2014.08.006; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin TY, 2016, P NATL ACAD SCI USA, V113, P15078, DOI 10.1073/pnas.1618773114; Liu Y, 2014, CLIN REV ALLERG IMMU, V47, P136, DOI 10.1007/s12016-013-8402-y; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Maruhashi T, 2018, ATHEROSCLEROSIS, V278, P226, DOI 10.1016/j.atherosclerosis.2018.10.007; Neogi T, 2015, ARTHRITIS RHEUMATOL, V67, P2557, DOI 10.1002/art.39254; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Papezikova I, 2013, FREE RADICAL RES, V47, P82, DOI 10.3109/10715762.2012.747677; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Shu ZP, 2019, J CELL MOL MED, V23, P3616, DOI 10.1111/jcmm.14262; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Sousa JLC, 2019, MOLECULES, V24, DOI 10.3390/molecules24020355; Taher R, 2019, ATHEROSCLEROSIS, V290, P37, DOI 10.1016/j.atherosclerosis.2019.07.013; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Tasaki E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179426; Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Wang XP, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00200; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Xiao J, 2015, MOL IMMUNOL, V66, P310, DOI 10.1016/j.molimm.2015.03.250; Xiao J, 2015, INT J MOL MED, V35, P1347, DOI 10.3892/ijmm.2015.2148; Yang WH, 2019, CELL REP, V28, P2501, DOI 10.1016/j.celrep.2019.07.107; Yoon JJ, 2017, EUR J PHARMACOL, V796, P224, DOI 10.1016/j.ejphar.2016.11.044; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zamudio-Cuevas Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1012-3; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	46	2	2	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21613	10.1096/fj.202100337R	http://dx.doi.org/10.1096/fj.202100337R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33977576				2022-12-28	WOS:000655695900023
J	Davies, KL; Smith, DJ; El-Bacha, T; Stewart, ME; Easwaran, A; Wooding, PFP; Forhead, AJ; Murray, AJ; Fowden, AL; Camm, EJ				Davies, Katie L.; Smith, Danielle J.; El-Bacha, Tatiana; Stewart, Max E.; Easwaran, Akshay; Wooding, Peter F. P.; Forhead, Alison J.; Murray, Andrew J.; Fowden, Abigail L.; Camm, Emily J.			Development of cerebral mitochondrial respiratory function is impaired by thyroid hormone deficiency before birth in a region-specific manner	FASEB JOURNAL			English	Article						brain; fetus; mitochondria; thyroid hormones	MYELIN BASIC-PROTEIN; OXYGEN-CONSUMPTION; OXIDATIVE-PHOSPHORYLATION; FETAL THYROIDECTOMY; SKELETAL-MUSCLE; RAT; EXPRESSION; MATURATION; GENES; HYPOTHYROIDISM	Thyroid hormones regulate adult metabolism partly through actions on mitochondrial oxidative phosphorylation (OXPHOS). They also affect neurological development of the brain, but their role in cerebral OXPHOS before birth remains largely unknown, despite the increase in cerebral energy demand during the neonatal period. Thus, this study examined prepartum development of cerebral OXPHOS in hypothyroid fetal sheep. Using respirometry, Complex I (CI), Complex II (CII), and combined CI&CII OXPHOS capacity were measured in the fetal cerebellum and cortex at 128 and 142 days of gestational age (dGA) after surgical thyroidectomy or sham operation at 105 dGA (term similar to 145 dGA). Mitochondrial electron transfer system (ETS) complexes, mRNA transcripts related to mitochondrial biogenesis and ATP production, and mitochondrial density were quantified using molecular techniques. Cerebral morphology was assessed by immunohistochemistry and stereology. In the cortex, hypothyroidism reduced CI-linked respiration and CI abundance at 128 dGA and 142 dGA, respectively, and caused upregulation of PGC1 alpha (regulator of mitochondrial biogenesis) and thyroid hormone receptor beta at 128 dGA and 142 dGA, respectively. In contrast, in the cerebellum, hypothyroidism reduced CI&II-and CII-linked respiration at 128 dGA, with no significant effect on the ETS complexes. In addition, cerebellar glucocorticoid hormone receptor and adenine nucleotide translocase (ANT1) were downregulated at 128 dGA and 142 dGA, respectively. These alterations in mitochondrial function were accompanied by reduced myelination. The findings demonstrate the importance of thyroid hormones in the prepartum maturation of cerebral mitochondria and have implications for the etiology and treatment of the neurodevelopmental abnormalities associated with human prematurity and congenital hypothyroidism.	[Davies, Katie L.; Smith, Danielle J.; El-Bacha, Tatiana; Stewart, Max E.; Easwaran, Akshay; Wooding, Peter F. P.; Forhead, Alison J.; Murray, Andrew J.; Fowden, Abigail L.; Camm, Emily J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Forhead, Alison J.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford, England; [El-Bacha, Tatiana] Univ Fed Rio de Janeiro, Inst Nutr, Rio De Janeiro, Brazil; [Camm, Emily J.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia	University of Cambridge; Oxford Brookes University; Universidade Federal do Rio de Janeiro; Hudson Institute of Medical Research	Fowden, AL; Camm, EJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	alf1000@cam.ac.uk; ejc68@cam.ac.uk		WOODING, FBP/0000-0003-2471-7586; Murray, Andrew/0000-0002-0929-9315; Fowden, Abigail/0000-0002-3384-4467; Forhead, Alison/0000-0003-2125-4811; Smith, Danielle/0000-0002-6708-5470	Wellcome Trust [102357]; Biotechnology and Biological Sciences Research Council [BB/P019048/1]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded in whole, or in part, by the Wellcome Trust (102357, PhD Studentship awarded to K.L. Davies) and the Biotechnology and Biological Sciences Research Council (BB/P019048/1, awarded to A.L. Fowden and A.J. Murray). For the purpose of open access, the author has applied a CC BY public copyright licence	Back SA, 2006, J CHILD NEUROL, V21, P582, DOI 10.1177/08830738060210070101; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Batistuzzo A, 2020, ARCH ENDOCRIN METAB, V64, P89, DOI [10.20945/2359-39970-00000201, DOI 10.20945/2359-39970-00000201]; BERBEL P, 1994, BEHAV BRAIN RES, V64, P9, DOI 10.1016/0166-4328(94)90114-7; Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Bobyleva V, 1997, BIOCHEM MOL BIOL INT, V41, P469; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; BREALL JA, 1984, J CLIN INVEST, V73, P1418, DOI 10.1172/JCI111346; Burtscher J, 2015, MITOCHONDRION, V25, P104, DOI 10.1016/j.mito.2015.10.007; Byrne K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-378; Camm EJ, 2021, THYROID, V31, P861, DOI 10.1089/thy.2020.0534; Davies KL, 2020, J PHYSIOL-LONDON, V598, P2453, DOI 10.1113/JP279194; DAWES GS, 1959, J PHYSIOL-LONDON, V146, P295, DOI 10.1113/jphysiol.1959.sp006194; Dugas JC, 2012, MOL CELL NEUROSCI, V50, P45, DOI 10.1016/j.mcn.2012.03.007; Durand B, 2000, BIOESSAYS, V22, P64; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; Forhead AJ, 2014, J ENDOCRINOL, V221, pR87, DOI 10.1530/JOE-14-0025; Forhead AJ, 2006, ENDOCRINOLOGY, V147, P5988, DOI 10.1210/en.2006-0712; Freitas TP, 2010, MOL CELL BIOCHEM, V341, P245, DOI 10.1007/s11010-010-0455-0; GADALETA MN, 1985, NEUROCHEM RES, V10, P163, DOI 10.1007/BF00964565; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; GRAVEL C, 1990, J COMP NEUROL, V291, P147, DOI 10.1002/cne.902910110; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Harris SE, 2020, THYROID, V30, P794, DOI 10.1089/thy.2019.0749; Herpin P, 1996, REPROD FERT DEVELOP, V8, P147, DOI 10.1071/RD9960147; Jeannin E, 1998, J BIOL CHEM, V273, P24239, DOI 10.1074/jbc.273.37.24239; Jones SA, 2003, MOL CELL ENDOCRINOL, V199, P49, DOI 10.1016/S0303-7207(02)00296-4; Kelly AK, 2011, PHYSIOL GENOMICS, V43, P12, DOI 10.1152/physiolgenomics.00213.2009; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leger J, 2014, J CLIN ENDOCR METAB, V99, P363, DOI 10.1210/jc.2013-1891; Lombardi A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00237; Lopez M, 2013, TRENDS MOL MED, V19, P418, DOI 10.1016/j.molmed.2013.04.004; Mannisto T, 2013, AM J EPIDEMIOL, V178, P731, DOI 10.1093/aje/kwt031; Martinez B, 2001, J NEUROCHEM, V78, P1054, DOI 10.1046/j.1471-4159.2001.00487.x; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; MCINTOSH GH, 1982, J COMP PATHOL, V92, P599, DOI 10.1016/0021-9975(82)90012-3; Myers DA, 2008, AM J PHYSIOL-REG I, V294, pR1312, DOI 10.1152/ajpregu.00004.2008; Nakai A, 2002, AM J OBSTET GYNECOL, V186, P574, DOI 10.1067/mob.2002.121542; POLK DH, 1987, PEDIATR RES, V21, P453, DOI 10.1203/00006450-198705000-00006; Portman MA, 2000, CIRCULATION, V102, P1323, DOI 10.1161/01.CIR.102.11.1323; Prezioso G, 2018, HORM RES PAEDIAT, V90, P73, DOI 10.1159/000492129; Prieur B, 1998, EUR J BIOCHEM, V252, P194, DOI 10.1046/j.1432-1327.1998.2520194.x; RAJAN RR, 1982, EXPERIENTIA, V38, P1110, DOI 10.1007/BF01955395; Reddy PH, 2016, J INVEST MED, V64, P1220, DOI 10.1136/jim-2016-000240; STERLING K, 1995, METABOLISM, V44, P193, DOI 10.1016/0026-0495(95)90264-3; Tian Y. Z., 2013, Asian Journal of Animal and Veterinary Advances, V8, P473, DOI 10.3923/ajava.2013.473.482; TOSIC M, 1992, J NEUROCHEM, V59, P1770, DOI 10.1111/j.1471-4159.1992.tb11009.x; VegaNunez E, 1997, ENDOCRINOLOGY, V138, P3771, DOI 10.1210/en.138.9.3771; Wassner AJ, 2018, CLIN PERINATOL, V45, P1, DOI 10.1016/j.clp.2017.10.004	51	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21591	10.1096/fj.202100075R	http://dx.doi.org/10.1096/fj.202100075R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33891344	Green Published			2022-12-28	WOS:000645260100017
J	Nickerson, AJ; Rajendran, VM				Nickerson, Andrew J.; Rajendran, Vazhaikkurichi M.			Aldosterone up-regulates basolateral Na+-K+-2Cl(-) cotransporter-1 to support enhanced large-conductance K+ channel-mediated K+ secretion in rat distal colon	FASEB JOURNAL			English	Article						renal disease; hyperkalemia; pseudo-obstruction; short circuit current	POTASSIUM SECRETION; DIETARY POTASSIUM; EXPRESSION; LOCALIZATION; BK; ABSORPTION; TRANSPORT; SODIUM; PERMEABILITY; MUCOSA	Na+-K+-2Cl(-) cotransporter-1 (NKCC1) facilitates basolateral K+ and Cl- uptake, supporting their efflux across mucosal membranes of colonic epithelial cells. NKCC1 activity has also been shown to be critical for electrogenic K+ secretion induced by aldosterone, which is known to stimulate large-conductance K+ (BK) channel expression in mucosal membranes. This study was aimed to (1) identify whether aldosterone enhances NKCC1 expression specifically to support BK-mediated K+ secretion and (2) to determine whether increased NKCC1 supports electrogenic Cl- secretion in parallel to K+ secretion. Dietary Na+ depletion was used to induce secondary hyperaldosteronism in rats, or aldosterone was administered ex vivo to rat distal colonic mucosae. NKCC1-dependent electrogenic K+ or Cl- secretion was measured as a function of short circuit current (ISC). qRT-PCR, western blot, and immunofluorescence analyses were performed using standard techniques. Aldosterone enhanced NKCC1 and BKa expression and electrogenic K+ secretion in the distal colon, which was inhibited by either serosal bumetanide (NKCC1 inhibitor) or mucosal iberiotoxin (IbTX; BK channel blocker), but not TRAM-34 (IK channel blocker). Expression of NKCC1 and BKa proteins was enhanced in crypt cells of hyper-aldosterone rats. However, neither NKCC1-dependent Cl- secretion nor CFTR (apical Cl- channel) expression was enhanced by aldosterone. We conclude that aldosterone enhances NKCC1 to support BK-mediated K+ secretion independently of Cl- secretion in the distal colon. The regulation of NKCC1 expression/K+ secretion by aldosterone may be a therapeutic target in treating gastrointestinal disorders associated with alterations in colonic K+ transport, such as colonic pseudo-obstruction, and hyperkalemia associated with renal disease.	[Nickerson, Andrew J.] West Virginia Univ, Dept Physiol Pharmacol & Neurosci, Sch Med, Morgantown, WV 26506 USA; [Rajendran, Vazhaikkurichi M.] West Virginia Univ, Dept Biochem, Sch Med, 1 Med Ctr Dr, Morgantown, WV 26506 USA; [Rajendran, Vazhaikkurichi M.] West Virginia Univ, Dept Med, Sch Med, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Rajendran, VM (corresponding author), West Virginia Univ, Dept Biochem, Sch Med, 1 Med Ctr Dr, Morgantown, WV 26506 USA.	vrajendran@hsc.wvu.edu			National Institute of Health NIDDK [R01DK104791, DK112085]	National Institute of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Health NIDDK R01DK104791 and DK112085 grants to VMR.	Amasheh S, 2000, ANN NY ACAD SCI, V915, P92; ARCHAMPONG EQ, 1972, GUT, V13, P880, DOI 10.1136/gut.13.11.880; Bazard P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72450-4; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; COOKE HJ, 1989, FASEB J, V3, P127, DOI 10.1096/fasebj.3.2.2464517; Cuff MA, 2004, BIOCHEM SOC T, V32, P1100, DOI 10.1042/BST0321100; Ding B, 2014, AM J PHYSIOL-CELL PH, V306, pC66, DOI 10.1152/ajpcell.00096.2013; Edmonds CJ., 2019, J PHYSL, V53, P1689; Escoubet B, 1997, AM J PHYSIOL-CELL PH, V272, pC1482, DOI 10.1152/ajpcell.1997.272.5.C1482; FOSTER ES, 1984, AM J PHYSIOL, V246, pG611, DOI 10.1152/ajpgi.1984.246.5.G611; FOSTER ES, 1985, GASTROENTEROLOGY, V88, P41, DOI 10.1016/S0016-5085(85)80130-X; Greig ER, 2002, PFLUG ARCH EUR J PHY, V444, P476, DOI 10.1007/s00424-002-0828-7; Gross ER, 2012, GASTROENTEROLOGY, V143, P408, DOI 10.1053/j.gastro.2012.05.007; Grotjohann I, 1998, J PHYSIOL-LONDON, V507, P561, DOI 10.1111/j.1469-7793.1998.561bt.x; GUERRANT RL, 1972, GUT, V13, P197, DOI 10.1136/gut.13.3.197; HALEVY J, 1986, GASTROENTEROLOGY, V91, P1227, DOI 10.1016/S0016-5085(86)80021-X; Halm ST, 2006, AM J PHYSIOL-CELL PH, V291, pC636, DOI 10.1152/ajpcell.00557.2005; Hay-Schmidt A, 2003, PFLUG ARCH EUR J PHY, V446, P61, DOI 10.1007/S00424-002-0983-x; HAYSLETT JP, 1980, AM J PHYSIOL, V239, pF378, DOI 10.1152/ajprenal.1980.239.4.F378; HAYSLETT JP, 1982, AM J PHYSIOL, V243, pF103, DOI 10.1152/ajprenal.1982.243.2.F103; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Inagaki A, 2019, PFLUG ARCH EUR J PHY, V471, P313, DOI 10.1007/s00424-018-2208-y; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Jiang C, 2017, J BIOL CHEM, V292, P3137, DOI 10.1074/jbc.M116.770065; Jiang GR, 2003, HYPERTENSION, V41, P1131, DOI 10.1161/01.HYP.0000066128.04083.CA; Kanthesh BM, 2013, AM J PHYSIOL-CELL PH, V305, pC972, DOI 10.1152/ajpcell.00165.2013; KLIGER AS, 1981, J CLIN INVEST, V67, P1189, DOI 10.1172/JCI110134; LOMAX RB, 1994, AM J PHYSIOL, V266, pG71, DOI 10.1152/ajpgi.1994.266.1.G71; Martin KC., 2012, BONE, V23, P1, DOI [10.1002/cne.20931.Immunolocalization, DOI 10.1002/CNE.20931.IMMUNOLOCALIZATION]; MARTIN RS, 1983, KIDNEY INT, V24, P386, DOI 10.1038/ki.1983.171; Mathialahan T, 2005, J PATHOL, V206, P46, DOI 10.1002/path.1750; Mathialahan T, 2003, NEPHROL DIAL TRANSPL, V18, P341, DOI 10.1093/ndt/18.2.341; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Rajendran VM, 2018, COMPR PHYSIOL, V8, P1513, DOI 10.1002/cphy.c170030; Rajendran VM, 1998, AM J PHYSIOL-GASTR L, V274, pG424, DOI 10.1152/ajpgi.1998.274.2.G424; Ram P, 2016, CASE REP GASTROINTES, V2016, DOI 10.1155/2016/1207240; RECHKEMMER G, 1989, P NATL ACAD SCI USA, V86, P397, DOI 10.1073/pnas.86.1.397; Rehman S, 2020, AM J PHYSIOL-GASTR L, V319, pG142, DOI 10.1152/ajpgi.00011.2020; Sandle GI, 2007, J PATHOL, V212, P66, DOI 10.1002/path.2159; Sandle GI, 2012, AM J PHYSIOL-CELL PH, V303, pC328, DOI 10.1152/ajpcell.00099.2012; Sausbier M, 2006, J AM SOC NEPHROL, V17, P1275, DOI 10.1681/ASN.2005101111; Singh SK, 2012, AM J PHYSIOL-CELL PH, V302, pC1353, DOI 10.1152/ajpcell.00216.2011; Sorensen MV, 2008, J PHYSIOL-LONDON, V586, P4251, DOI 10.1113/jphysiol.2008.156968; Sorensen MV, 2011, PFLUG ARCH EUR J PHY, V462, P745, DOI 10.1007/s00424-011-1000-z; Sorensen MV, 2010, PFLUG ARCH EUR J PHY, V459, P645, DOI 10.1007/s00424-009-0781-9; Sunuwar L, 2017, BBA-MOL BASIS DIS, V1863, P947, DOI 10.1016/j.bbadis.2017.01.009; SWEIRY JH, 1989, J CLIN INVEST, V83, P844, DOI 10.1172/JCI113967; Tadros SF, 2005, HEARING RES, V209, P10, DOI 10.1016/j.heares.2005.05.009; TURNAMIAN SG, 1989, J CLIN INVEST, V84, P1924, DOI 10.1172/JCI114380; Van Dinter TG, 2005, GASTROENTEROLOGY, V129, P1268, DOI 10.1053/j.gastro.2005.07.029; Vivas L, 2015, PHYSIOL BEHAV, V152, P416, DOI 10.1016/j.physbeh.2015.08.010	53	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21606	10.1096/fj.202100203R	http://dx.doi.org/10.1096/fj.202100203R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908679				2022-12-28	WOS:000645260100064
J	Herman, L; Legois, B; Todeschini, AL; Veitia, RA				Herman, Laetitia; Legois, Berangere; Todeschini, Anne-Laure; Veitia, Reiner A.			Genomic exploration of the targets of FOXL2 and ESR2 unveils their implication in cell migration, invasion, and adhesion	FASEB JOURNAL			English	Article						cell movement; ESR2; forkhead box protein L2; gene expression regulation; granulosa cell		FOXL2 and ESR2 are key transcriptional regulators in ovarian granulosa cells. To explore their transcriptional roles and their interplay, we have depleted Foxl2 and Esr2 in mouse primary granulosa cells to assess their ability to bind their targets and/or to modulate gene expression and cellular functions. We show that FOXL2 is involved in a large number of regulatory actions essential for the maintenance of granulosa cell fate. A parallel ChIP-seq analysis showed that FOXL2 mainly binds to sites located in intergenic regions quite far from its targets. A bioinformatic analysis demonstrated that FOXL2-activated genes were enriched in peaks associated with the H3K27ac mark, whereas FOXL2-repressed genes were not, suggesting that FOXL2 can activate transcription through binding to enhancer sites. We also identified about 500 deregulated genes upon Esr2 silencing, of which one third are also targets of FOXL2. We provide evidence showing that both factors modulate, through a coherent feed-forward loop, a number of common targets. Many of the FOXL2/ESR2 targets are involved in cell motility and, consistently, granulosa cells depleted for either Foxl2 or Esr2 exhibit decreased migration, invasion and adhesion. This effect is paralleled by the depletion of their target Phactr1, involved in actin cytoskeleton dynamics. Our analysis expands the number of direct and indirect transcriptional targets of both FOXL2 and ESR2, which deserve investigation in the context of adult-type granulosa cell tumors whose molecular diagnostic hallmark is the presence of the C134W FOXL2 pathogenic variant.	[Herman, Laetitia; Legois, Berangere; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris, Fac Sci, Paris, France; [Herman, Laetitia; Legois, Berangere; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris, CNRS, Inst Jacques Monod, Paris, France; [Veitia, Reiner A.] Univ Paris Saclay, Commissariat Energie Atom, Inst Biol F Jacob, Fontenay Aux Roses, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Todeschini, AL (corresponding author), Univ Paris, CNRS UMR7592, Inst Jacques Monod, Reiner Veitia Team Oncol Mol & Pathol Ovariennes, 15 Rue Helene Brion, F-75205 Paris, France.	anne-laure.todeschini@ijm.fr		Legois, Berangere/0000-0002-3610-7593	Universite Paris Diderot; Agence National pour la Recherche, Sexmaintain projet	Universite Paris Diderot; Agence National pour la Recherche, Sexmaintain projet(French National Research Agency (ANR))	This study was supported by Universite Paris Diderot (LH, BL, ALT, RAV), and the Agence National pour la Recherche, Sexmaintain projet (LH, BL, ALT, RAV).	Anttonen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085545; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Benayoun BA, 2013, ONCOGENE, V32, P2739, DOI 10.1038/onc.2012.298; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Carles A, 2020, CANCER RES, V80, P3480, DOI 10.1158/0008-5472.CAN-20-0104; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dipietromaria A, 2009, HUM MOL GENET, V18, P3324, DOI 10.1093/hmg/ddp273; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dutertre M, 2001, ENDOCRINOLOGY, V142, P4040, DOI 10.1210/en.142.9.4040; Garcia-Moreno SA, 2019, DEV BIOL, V446, P168, DOI 10.1016/j.ydbio.2018.12.023; Georges A, 2014, ELIFE, V3, DOI 10.7554/eLife.04207; Grossman H, 2015, FASEB J, V29, P3206, DOI 10.1096/fj.14-269449; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Jin H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15748-1; Jing Y, 2019, MED SCI MONITOR, V25, P1291, DOI 10.12659/MSM.912586; Kakourou G, 2013, FERTIL STERIL, V99, P803, DOI 10.1016/j.fertnstert.2012.10.036; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khristi V, 2018, MOL CELL ENDOCRINOL, V474, P214, DOI 10.1016/j.mce.2018.03.012; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim JH, 2014, J REPROD DEVELOP, V60, P14, DOI 10.1262/jrd.2013-090; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Liu CY, 2019, BIOL REPROD, V100, P1057, DOI 10.1093/biolre/ioy246; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234795; Mouilleron S, 2012, STRUCTURE, V20, P1960, DOI 10.1016/j.str.2012.08.031; Nicol B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13060-1; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rolaki A, 2007, AM J PATHOL, V170, P1561, DOI 10.2353/ajpath.2007.060926; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Szabo Q, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1668; Todeschini AL, 2011, HUM MOL GENET, V20, P3376, DOI 10.1093/hmg/ddr244; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145	44	1	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21355	10.1096/fj.202002444R	http://dx.doi.org/10.1096/fj.202002444R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749886				2022-12-28	WOS:000635216100002
J	Zhou, GK; Wang, T; Zha, XM				Zhou, Guokun; Wang, Tao; Zha, Xiang-ming			RNA-Seq analysis of knocking out the neuroprotective proton-sensitive GPR68 on basal and acute ischemia-induced transcriptome changes and signaling in mouse brain	FASEB JOURNAL			English	Article						GPR68; ischemia; neuroprotection; OGR1; proton receptor; transcriptome	SYNAPTIC PLASTICITY; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; RECEPTOR; EXPRESSION; RAT; HEMOGLOBIN; CHANNEL; MICE; NEUROGLOBIN	Brain acid signaling plays important roles in both physiological and disease conditions. One key neuronal metabotropic proton receptor in the brain is GPR68, which contributes to hippocampal long-term potentiation (LTP) and mediates neuroprotection in acidotic and ischemic conditions. Here, to gain greater understanding of GPR68 function in the brain, we performed mRNA-Seq analysis in mice. First, we studied sham-operated animals to determine baseline expression. Compared to wild type (WT), GPR68-/- (KO) brain downregulated genes that are enriched in Gene Ontology (GO) terms of misfolding protein binding, response to organic cyclic compounds, and endoplasmic reticulum chaperone complex. Next, we examined the expression profile following transient middle cerebral artery occlusion (tMCAO). tMCAO-upregulated genes cluster to cytokine/chemokine-related functions and immune responses, while tMCAO-downregulated genes cluster to channel activities and synaptic signaling. For proton-sensitive receptors, tMCAO downregulated ASIC1a and upregulated GPR4 and GPR65, but had no effect on ASIC2, PAC, or GPR68. GPR68 deletion did not alter the expression of these proton receptors, either at baseline or after ischemia. Lastly, we performed GeneVenn analysis of differential genes at baseline and post-tMCAO. Ischemia upregulated the expression of three hemoglobin genes, along with H2-Aa, Ppbp, Siglece, and Tagln, in WT but not in KO. Immunostaining showed that tMCAO-induced hemoglobin localized to neurons. Western blot analysis further showed that hemoglobin induction is GPR68-dependent. Together, these data suggest that GPR68 deletion at baseline disrupts chaperone functions and cellular signaling responses and imply a contribution of hemoglobin-mediated antioxidant mechanism to GPR68-dependent neuroprotection in ischemia.	[Zhou, Guokun; Wang, Tao; Zha, Xiang-ming] Univ S Alabama, Dept Physiol & Cell Biol, Coll Med, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA; [Zhou, Guokun] Nantong Univ, Inst Special Environm Med, Nantong, Peoples R China	University of South Alabama; Nantong University	Zha, XM (corresponding author), Univ S Alabama, Dept Physiol & Cell Biol, Coll Med, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA.	zha@southalabama.edu	Wang, Tao/ABB-7736-2021	Wang, Tao/0000-0002-3725-4050; Zha, Xiangming/0000-0001-9490-2731; Zhou, Guokun/0000-0002-5755-507X	NIH/NINDS [R01NS102495]; University of South Alabama College of Medicine [1341]; NIH/ARRA [S10RR027535]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of South Alabama College of Medicine; NIH/ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by NIH/NINDS grant R01NS102495 and an intramural grant #1341 from University of South Alabama College of Medicine (to XMZ). The Nikon A1 microscope was funded by an NIH/ARRA equipment grant #S10RR027535.	Alcazar O, 2007, INVEST OPHTH VIS SCI, V48, P5662, DOI 10.1167/iovs.07-0392; Amri F, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00067; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Bot PTG, 2009, STROKE, V40, P439, DOI 10.1161/STROKEAHA.108.522284; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Buga AM, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00044, 10.3389/fnagi.2014.00130]; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Clarke J, 2014, J CEREBR BLOOD F MET, V34, P630, DOI 10.1038/jcbfm.2013.237; Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013; Codrich M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.458; Deng XT, 2017, COMPUT BIOL CHEM, V68, P1, DOI 10.1016/j.compbiolchem.2017.01.015; Dergunova LV, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5039-5; Devis-Jauregui L, 2021, AUTOPHAGY, V17, P1077, DOI 10.1080/15548627.2020.1752548; Du JY, 2017, ELIFE, V6, DOI 10.7554/eLife.22564; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035; Enogieru AB, 2019, ADV PHARMACOL SCI, V2019, DOI 10.1155/2019/2706783; Fischer M, 2005, J MOL DIAGN, V7, P89, DOI 10.1016/S1525-1578(10)60013-X; Fury W, 2020, STROKE, V51, P2514, DOI 10.1161/STROKEAHA.120.029440; Glitsch M, 2019, CELL CALCIUM, V80, P38, DOI 10.1016/j.ceca.2019.03.010; Guo SZ, 2018, J CEREBR BLOOD F MET, V38, P2236, DOI 10.1177/0271678X18795986; Hanafusa K, 2019, J BIOL CHEM, V294, P19335, DOI 10.1074/jbc.RA119.009603; He YD, 2010, TRANSL STROKE RES, V1, P48, DOI 10.1007/s12975-009-0004-x; He YD, 2009, J CEREBR BLOOD F MET, V29, P596, DOI 10.1038/jcbfm.2008.145; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Highstein SM, 2014, P NATL ACAD SCI USA, V111, P5421, DOI 10.1073/pnas.1319561111; Huang Y, 2015, NEUROPHARMACOLOGY, V94, P42, DOI 10.1016/j.neuropharm.2014.12.010; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jiang N, 2017, J CEREBR BLOOD F MET, V37, P528, DOI 10.1177/0271678X16630558; Kang PF, 2020, FREE RADICAL BIO MED, V146, P198, DOI 10.1016/j.freeradbiomed.2019.10.416; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; KILMARTIN JV, 1973, P NATL ACAD SCI USA, V70, P1246, DOI 10.1073/pnas.70.4.1246; Kopec AM, 2017, J NEUROSCI METH, V280, P64, DOI 10.1016/j.jneumeth.2017.02.002; Kori A, 2019, BRAIN DEV-JPN, V41, P803, DOI 10.1016/j.braindev.2019.05.006; Kosmachevskaya OV, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1575, DOI 10.1134/S0006297918120155; Kumar NN, 2015, SCIENCE, V348, P1255, DOI 10.1126/science.aaa0922; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Mezuki S, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-1001-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakano T, 2019, THROMB HAEMOSTASIS, V119, P467, DOI 10.1055/s-0038-1677532; Nestler EJ, 2015, EUR J PHARMACOL, V753, P66, DOI [10.1016/j.ejphar.2014.1.0.034, 10.1016/j.ejphar.2014.10.034]; Ouyang Yi-Bing, 2012, Int J Cell Biol, V2012, P493934, DOI 10.1155/2012/493934; Patterson JR, 2016, BRAIN RES, V1649, P53, DOI 10.1016/j.brainres.2016.08.030; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; PERUTZ MF, 1987, COLD SPRING HARB SYM, V52, P555, DOI 10.1101/SQB.1987.052.01.063; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rajdev S, 2000, ANN NEUROL, V47, P782, DOI 10.1002/1531-8249(200006)47:6<782::AID-ANA11>3.0.CO;2-3; Rajput PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024467; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; REISBERG PI, 1980, J BIOL CHEM, V255, P4159; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Sato K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74372-7; Schaffner A, 2004, J LEUKOCYTE BIOL, V76, P1010, DOI 10.1189/jlb.0404261; Scheich B, 2017, NEUROSCIENCE, V346, P320, DOI 10.1016/j.neuroscience.2017.01.039; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Secondo A, 2019, STROKE, V50, P1240, DOI 10.1161/STROKEAHA.118.024115; Siddiqui SS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101125; Siesjo B K, 1982, Ciba Found Symp, V87, P77, DOI 10.1002/9780470720691.ch5; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; Simoes AES, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-181; Singhal NK, 2018, MOL NEUROBIOL, V55, P8051, DOI 10.1007/s12035-018-0971-6; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Su YC, 2016, INT J NEUROSCI, V126, P681, DOI 10.3109/00207454.2015.1059836; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Ting SM, 2020, STROKE, V51, P958, DOI 10.1161/STROKEAHA.119.027315; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang P, 2015, J NEUROSCI RES, V93, P1756, DOI 10.1002/jnr.23637; Wang T., 2020, BRAIN HEMORRHAGES, V1, p185; Wang T, 2020, STROKE, V51, P3690, DOI 10.1161/STROKEAHA.120.031479; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Watanabe-Kusunoki K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.575890; Wei WC, 2018, CURR BIOL, V28, P3815, DOI 10.1016/j.cub.2018.10.046; Wei WC, 2015, P NATL ACAD SCI USA, V112, P10738, DOI 10.1073/pnas.1506085112; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wiley SZ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030559; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu YY, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00672-8; Xu YY, 2018, FASEB J, V32, P3832, DOI 10.1096/fj.201701367R; Yonetani T, 2008, BBA-PROTEINS PROTEOM, V1784, P1146, DOI 10.1016/j.bbapap.2008.04.025; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zhang CJ, 2018, AGING DIS, V9, P249, DOI 10.14336/AD.2017.0424; Zhang WT, 2019, CNS NEUROSCI THER, V25, P1329, DOI 10.1111/cns.13256; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009; Zhong WL, 2018, EBIOMEDICINE, V37, P246, DOI 10.1016/j.ebiom.2018.10.041	92	6	6	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21461	10.1096/fj.202002511R	http://dx.doi.org/10.1096/fj.202002511R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724568	Green Accepted			2022-12-28	WOS:000635216100093
J	de Torre-Minguela, C; Gomez, AI; Couillin, I; Pelegrin, P				de Torre-Minguela, Carlos; Gomez, Ana I.; Couillin, Isabelle; Pelegrin, Pablo			Gasdermins mediate cellular release of mitochondrial DNA during pyroptosis and apoptosis	FASEB JOURNAL			English	Article						GSDMD; GSDME; macrophages; mitochondrial DNA; pyroptosis	NLRP3 INFLAMMASOME ACTIVATION; CYTOCHROME-C; SUPEROXIDE; DEATH; FLUORESCENCE; MECHANISM; CLEAVAGE; TISSUES; PORES; GSDMD	Pyroptosis and intrinsic apoptosis are two forms of regulated cell death driven by active caspases where plasma membrane permeabilization is induced by gasdermin pores. Caspase-1 induces gasdermin D pore formation during pyroptosis, whereas caspase-3 promotes gasdermin E pore formation during apoptosis. These two types of cell death are accompanied by mitochondrial outer membrane permeabilization due to BAK/BAX pore formation in the external membrane of mitochondria, and to some extent, this complex also affects the inner mitochondrial membrane facilitating mitochondrial DNA relocalization from the matrix to the cytosol. However, the detailed mechanism responsible for this process has not been investigated. Herein, we reported that gasdermin processing is required to induce mitochondrial DNA release from cells during pyroptosis and apoptosis. Gasdermin targeted at the plasma membrane promotes a fast mitochondrial collapse along with the initial accumulation of mitochondrial DNA in the cytosol and then facilitates the DNA's release from the cell when the plasma membrane ruptures. These findings demonstrate that gasdermin action has a critical effect on the plasma membrane and facilitates the release of mitochondrial DNA as a damage-associated molecular pattern.	[de Torre-Minguela, Carlos; Gomez, Ana I.] Clin Univ Hosp Virgen Arrixaca, Biomed Res Inst Murcia IMIB Arrixaca, Murcia, Spain; [Couillin, Isabelle] Univ Orleans, CNRS, UMR7355, Expt & Mol Immunol & Neurogenet, Orleans, France; [Pelegrin, Pablo] Univ Murcia, Fac Med, Dept Biochem & Mol Biol & Immunol B, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Murcia	de Torre-Minguela, C; Pelegrin, P (corresponding author), Clin Univ Hosp Virgen Arrixaca, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Edificio LAIB 4 Plant, Carretera Buenavista S-N, Murcia 30120, Spain.	carlos.de3@um.es; pablo.pelegrin@imib.es	Pelegrin, Pablo/M-2007-2014	Pelegrin, Pablo/0000-0002-9688-1804; de Torre, Carlos/0000-0003-3314-3203	Fondo Europeo de Desarrollo Regional/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion [SAF2017-88276-R, PID2020-116709RB-I00]; Fundacion Seneca [20859/PI/18, 21081/PDC/19, 0003/COVI/20]; European Research Council [ERC-2013-CoG 614578, 899636]	Fondo Europeo de Desarrollo Regional/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion; Fundacion Seneca(Fundacion Seneca); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from Fondo Europeo de Desarrollo Regional/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion (grants SAF2017-88276-R, PID2020-116709RB-I00), Fundacion Seneca (grants 20859/PI/18, 21081/PDC/19 and 0003/COVI/20) and the European Research Council (grants ERC-2013-CoG 614578 and ERC-2019-PoC grant 899636)	ALTSCHULD RA, 1985, J BIOL CHEM, V260, P4325; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Bae JH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040328; Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Chauhan D, 2018, CELL REP, V25, P2354, DOI 10.1016/j.celrep.2018.10.087; Chen KW, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6676; de Torre-Minguela C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22586; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Hajizadeh S, 2003, ARTHRITIS RES THER, V5, pR234, DOI 10.1186/ar787; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Huang LS, 2020, IMMUNITY, V52, P475, DOI 10.1016/j.immuni.2020.02.002; Imo T, 2013, CELL DEATH DIFFER, V20, P343, DOI 10.1038/cdd.2012.149; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Karmakar M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16043-9; Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Loomis WP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1559-4; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Martin-Sanchez F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.390; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Nerlich A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18468-7; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Polster BM, 2014, METHOD ENZYMOL, V547, P225, DOI 10.1016/B978-0-12-801415-8.00013-8; Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	54	17	17	4	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21757	10.1096/fj.202100085R	http://dx.doi.org/10.1096/fj.202100085R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34233045				2022-12-28	WOS:000678975300009
J	Chen, H; Song, FF; Long, FX				Chen, Hong; Song, Fangfang; Long, Fanxin			WNT7B overexpression rescues bone loss caused by glucocorticoids in mice	FASEB JOURNAL			English	Article						bone; glucocorticoid; osteoblast; osteoporosis; WNT7B	SCLEROSTIN-ANTIBODY; GENE-EXPRESSION; OSTEOBLASTS; ACTIVATION; DIFFERENTIATION; TERIPARATIDE; ALENDRONATE; PREVALENCE; METABOLISM; DICKKOPF-1	Glucocorticoids, widely prescribed for anti-inflammatory and immunosuppressive purposes, are the most common secondary cause for osteoporosis and related fractures. Current anti-resorptive and anabolic therapies are insufficient for treating glucocorticoid-induced osteoporosis due to contraindications or concerns of side effects. Glucocorticoids have been shown to disrupt Wnt signaling in osteoblast-lineage cells, but the efficacy for Wnt proteins to restore bone mass after glucocorticoid therapy has not been examined. Here by using two mouse genetic models wherein WNT7B expression is temporally activated by either tamoxifen or doxycycline in osteoblast-lineage cells, we show that WNT7B recovers bone mass following glucocorticoid-induced bone loss, thanks to increased osteoblast number and function. However, WNT7B overexpression in bone either before or after glucocorticoid treatments does not ameliorate the abnormal accumulation of body fat. The study demonstrates a potent bone anabolic function for WNT7B in countering glucocorticoid-induced bone loss.	[Chen, Hong; Long, Fanxin] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Chen, Hong] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China; [Song, Fangfang; Long, Fanxin] Childrens Hosp Philadelphia, Dept Surg, Translat Res Program Pediat Orthoped, Philadelphia, PA 19146 USA; [Song, Fangfang] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan, Peoples R China	Washington University (WUSTL); Chongqing Medical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Wuhan University	Long, FX (corresponding author), Childrens Hosp Philadelphia, Dept Surg, Translat Res Program Pediat Orthoped, Philadelphia, PA 19146 USA.	longf1@chop.edu			HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR060456, P30 AR057235]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01 AR060456 and P30 AR057235	Achiou Z, 2015, BONE, V81, P691, DOI 10.1016/j.bone.2015.09.010; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Chen H, 2019, FASEB J, V33, P7810, DOI 10.1096/fj.201900201RR; Chen JQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004145; Colditz J, 2019, J BONE MINER RES, V34, P1314, DOI 10.1002/jbmr.3702; Compston J, 2018, ENDOCRINE, V61, P7, DOI 10.1007/s12020-018-1588-2; Dimitriadis G, 1997, BIOCHEM J, V321, P707, DOI 10.1042/bj3210707; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Fardet L, 2011, RHEUMATOLOGY, V50, P1982, DOI 10.1093/rheumatology/ker017; File Elizabeth, 2009, Curr Rheumatol Rep, V11, P169; Gasparini SJ, 2016, STEROIDS, V116, P76, DOI 10.1016/j.steroids.2016.10.008; Hildebrandt S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26300-z; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Joeng KS, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.4; Karner CM, 2017, CELL MOL LIFE SCI, V74, P1649, DOI 10.1007/s00018-016-2425-5; Karner CM, 2015, J CLIN INVEST, V125, P551, DOI 10.1172/JCI78470; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Ledford H, 2020, NATURE, V582, P469, DOI 10.1038/d41586-020-01824-5; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mak W, 2009, CALCIFIED TISSUE INT, V85, P538, DOI 10.1007/s00223-009-9303-1; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Overman RA, 2013, ARTHRIT CARE RES, V65, P294, DOI 10.1002/acr.21796; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Shen LX, 2009, J CELL BIOCHEM, V106, P337, DOI 10.1002/jcb.22010; Song DY, 2020, BONE RES, V8, DOI 10.1038/s41413-019-0081-8; Thiele Sylvia, 2014, Bonekey Rep, V3, P552, DOI 10.1038/bonekey.2014.47; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Wang FS, 2008, ENDOCRINOLOGY, V149, P1793, DOI 10.1210/en.2007-0910; Yao W, 2016, OSTEOPOROSIS INT, V27, P283, DOI 10.1007/s00198-015-3308-6; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Zheng DL, 2013, MOL CANCER RES, V11, P482, DOI 10.1158/1541-7786.MCR-12-0520; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	39	1	1	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21683	10.1096/fj.202100151RR	http://dx.doi.org/10.1096/fj.202100151RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118078				2022-12-28	WOS:000667814100048
J	Goroshchuk, O; Kolosenko, I; Kunold, E; Vidarsdottir, L; Pirmoradian, M; Azimi, A; Jafari, R; Palm-Apergi, C				Goroshchuk, Oksana; Kolosenko, Iryna; Kunold, Elena; Vidarsdottir, Linda; Pirmoradian, Mohammad; Azimi, Alireza; Jafari, Rozbeh; Palm-Apergi, Caroline			Thermal proteome profiling identifies PIP4K2A and ZADH2 as off-targets of Polo-like kinase 1 inhibitor volasertib	FASEB JOURNAL			English	Article						acute leukemia; CETSA; Polo-like kinase 1; thermal proteome profiling; volasertib; ZADH2	BI 6727; GENE; PLK1; EXPRESSION; NMS-P937; AURORA; GROWTH; POTENT; CELLS	Polo-like kinase 1 (PLK1) is an important cell cycle kinase and an attractive target for anticancer treatments. An ATP-competitive small molecular PLK1 inhibitor, volasertib, has reached phase III in clinical trials in patients with refractory acute myeloid leukemia as a combination treatment with cytarabine. However, severe side effects limited its use. The origin of the side effects is unclear and might be due to insufficient specificity of the drug. Thus, identifying potential off-targets to volasertib is important for future clinical trials and for the development of more specific drugs. In this study, we used thermal proteome profiling (TPP) to identify proteome-wide targets of volasertib. Apart from PLK1 and proteins regulated by PLK1, we identified about 200 potential volasertib off-targets. Comparison of this result with the mass-spectrometry analysis of volasertib-treated cells showed that phosphatidylinositol phosphate and prostaglandin metabolism pathways are affected by volasertib. We confirmed that PIP4K2A and ZADH2-marker proteins for these pathways-are, indeed, stabilized by volasertib. PIP4K2A, however, was not affected by another PLK1 inhibitor onvansertib, suggesting that PIP4K2A is a true off-target of volasertib. Inhibition of these proteins is known to impact both the immune response and fatty acid metabolism and could explain some of the side effects seen in volasertib-treated patients.	[Goroshchuk, Oksana; Kolosenko, Iryna; Vidarsdottir, Linda; Azimi, Alireza; Palm-Apergi, Caroline] Karolinska Inst, Dept Lab Med Biomol & Cellular Med, Solna, Sweden; [Kunold, Elena; Pirmoradian, Mohammad; Jafari, Rozbeh] Karolinska Inst, Dept Oncol Pathol, Clin Prote Mass Spectrometry, Solna, Sweden	Karolinska Institutet; Karolinska Institutet	Jafari, R (corresponding author), Karolinska Inst, Sci Life Lab, Clin Prote Mass Spectrometry, Dept Oncol Pathol, Tomtebodavagen 23A, S-17165 Solna, Sweden.; Palm-Apergi, C (corresponding author), Karolinska Inst, Dept Lab Med Biomol & Cellular Med, Halsovagen 7, S-14157 Huddinge, Sweden.; Palm-Apergi, C (corresponding author), Karolinska Univ Hosp, Huddinge, Sweden.	rozbeh.jafari@ki.se; caroline.palm.apergi@ki.se		Goroshchuk, Oksana/0000-0002-1585-1962; Palm Apergi, Caroline/0000-0003-2236-2099; Vidarsdottir, Linda/0000-0003-3082-1320; Jafari, Rozbeh/0000-0002-3396-4709	Stiftelsen for Strategisk Forskning (SSF); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Dr Ake Olssons Stiftelse for Haematologisk Forskning (Dr Ake Olsson Foundation); Karolinska Institutet (KI); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gunvor and Josef Aner's Foundation; Robert Lundbergs Minnesstiftelse (Robert Lundberg Memorial Foundation); Vetenskapsradet (VR); Cancerfonden (Swedish Cancer Society)	Stiftelsen for Strategisk Forskning (SSF)(Swedish Foundation for Strategic Research); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Dr Ake Olssons Stiftelse for Haematologisk Forskning (Dr Ake Olsson Foundation); Karolinska Institutet (KI); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gunvor and Josef Aner's Foundation; Robert Lundbergs Minnesstiftelse (Robert Lundberg Memorial Foundation); Vetenskapsradet (VR)(Swedish Research Council); Cancerfonden (Swedish Cancer Society)(Swedish Cancer Society)	Stiftelsen for Strategisk Forskning (SSF); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Dr Ake Olssons Stiftelse for Haematologisk Forskning (Dr Ake Olsson Foundation); Karolinska Institutet (KI); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gunvor and Josef Aner's Foundation; Robert Lundbergs Minnesstiftelse (Robert Lundberg Memorial Foundation); Vetenskapsradet (VR); Cancerfonden (Swedish Cancer Society)	ANDERSON RJ, 1976, KIDNEY INT, V10, P205, DOI 10.1038/ki.1976.99; [Anonymous], BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours-Full Text View; Benetatos L, 2011, ANN HEMATOL, V90, P1037, DOI 10.1007/s00277-011-1193-4; Beria I, 2011, BIOORG MED CHEM LETT, V21, P2969, DOI 10.1016/j.bmcl.2011.03.054; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Casolaro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058424; Chen IJ, 2018, FREE RADICAL BIO MED, V115, P113, DOI 10.1016/j.freeradbiomed.2017.11.016; Childs D, 2019, MOL CELL PROTEOMICS, V18, P2506, DOI 10.1074/mcp.TIR119.001481; Cholewa BD, 2014, J PROTEOME RES, V13, P5041, DOI 10.1021/pr5002516; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Farfsing A, 2009, LEUKEMIA, V23, P2018, DOI 10.1038/leu.2009.144; Fiume R, 2015, BBA-MOL CELL BIOL L, V1851, P898, DOI 10.1016/j.bbalip.2015.02.014; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Goroshchuk O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59653-5; Goroshchuk O, 2019, ONCOGENE, V38, P1, DOI 10.1038/s41388-018-0443-5; Granholm V, 2014, J PROTEOME RES, V13, P890, DOI 10.1021/pr400937n; Holman Jerry D, 2014, Curr Protoc Bioinformatics, V46, DOI 10.1002/0471250953.bi1324s46; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Kobayashi T, 2020, BLOOD, V136, P3004, DOI 10.1182/blood.2020005602; Kolosenko I, 2021, FASEB J, V35, DOI 10.1096/fj.202002454RR; Kolosenko I, 2020, FUTURE MED CHEM, V12, P1457, DOI 10.4155/fmc-2020-0128; Kolosenko I, 2017, J CONTROL RELEASE, V261, P199, DOI 10.1016/j.jconrel.2017.07.002; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lima K, 2019, CANCER GENET-NY, V233, P56, DOI 10.1016/j.cancergen.2019.04.002; Lima K, 2015, BLOOD CELL MOL DIS, V55, P228, DOI 10.1016/j.bcmd.2015.06.014; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Maffei R, 2013, HAEMATOLOGICA, V98, P1115, DOI 10.3324/haematol.2012.073080; Mathre S, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182210; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nagasawa I, 2020, CELL CHEM BIOL, V27, P186, DOI 10.1016/j.chembiol.2019.11.010; Oncoheroes Biosciences Inc, 2020, ONCOHEROES BIOSCI; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Rolf MG, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.175; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sharma S, 2019, CELL REP, V27, P1979, DOI 10.1016/j.celrep.2019.04.084; Shim H, 2016, P NATL ACAD SCI USA, V113, P7596, DOI 10.1073/pnas.1600934113; Shin YJ, 2019, J EXP MED, V216, P1120, DOI 10.1084/jem.20172170; Sivakumaren SC, 2020, CELL CHEM BIOL, V27, P525, DOI 10.1016/j.chembiol.2020.02.003; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Syed N, 2006, BLOOD, V107, P250, DOI 10.1182/blood-2005-03-1194; Valsasina B, 2012, MOL CANCER THER, V11, P1006, DOI 10.1158/1535-7163.MCT-11-0765; Wilson CL, 2015, CHILDREN-BASEL, V2, P1, DOI 10.3390/children2010001; Woo SH, 2015, CLIN J AM SOC NEPHRO, V10, P372, DOI 10.2215/CJN.02390314; Wu YH, 2008, STRUCTURE, V16, P1714, DOI 10.1016/j.str.2008.09.007; Yeung SLA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005619; Yu YH, 2013, J LIPID RES, V54, P2391, DOI 10.1194/jlr.M037556; Zhu YF, 2020, MOL CELL PROTEOMICS, V19, P1047, DOI 10.1074/mcp.TIR119.001646	62	2	2	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21741	10.1096/fj.202100457RR	http://dx.doi.org/10.1096/fj.202100457RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143546				2022-12-28	WOS:000667814100005
J	Tu, S; Jiang, YZ; Cheng, HH; Yuan, XN; He, Y; Peng, Y; Peng, XQ; Peng, ZZ; Tao, LJ; Yang, HX				Tu, Sha; Jiang, Yanzhi; Cheng, Haihua; Yuan, Xiangning; He, Ying; Peng, Yu; Peng, Xiongqun; Peng, Zhangzhe; Tao, Lijian; Yang, Huixiang			Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF-kappa B pathway	FASEB JOURNAL			English	Article						AKF-PD; inflammation; liver fibrosis; NF-kappa B	HEPATIC-FIBROSIS; NONALCOHOLIC STEATOHEPATITIS; EXPRESSION; INJURY; ALPHA; INHIBITION; LOSARTAN; CELLS	Despite the increasing understanding of the pathophysiology of hepatic fibrosis, the therapies to combat it remain inadequate. Fluorofenidone (AKF-PD) is a novel pyridone agent able to ameliorate hepatic fibrosis in an experimental hepatic fibrosis model induced by dimethylnitrosamine. However, the underlying mechanism remains to be further elucidated. In light of the critical role of the NF-kappa B pathway in inflammation and hepatic fibrosis, together with the preliminary finding that AKF-PD decreases the release of proinflammatory cytokines in the endotoxemia and unilateral ureteral occlusion model, the aim of this study was to explore whether AKF-PD exerts an antifibrotic effect in hepatic fibrosis by inhibiting inflammation and suppressing the activation of the NF-kappa B pathway in vivo and in vitro. To test this possibility, the effect of AKF-PD on hepatic fibrosis models induced by both carbon tetrachloride (CCL4) and porcine serum (PS) was investigated. Our results showed that AKF-PD treatment ameliorated hepatic injury and fibrosis in both models. Furthermore, the administration of AKF-PD induced a robust anti-inflammatory reaction revealed by the downregulation of the proinflammatory cytokines as well as the suppression of the infiltration of inflammatory cells in the fibrotic liver. The analysis of the mechanism of action demonstrated that the attenuation of the production of proinflammatory cytokines and chemokines mediated by AKF-PD in vivo and in vitro were accompanied by the suppression in the activation of the NF-kappa B signaling pathway. In conclusion, AKF-PD might be considered as an antifibrotic agent attenuating hepatic inflammation and fibrosis potentially through the suppression of the NF-kappa B pathway.	[Tu, Sha; Jiang, Yanzhi; Cheng, Haihua; He, Ying; Peng, Yu; Yang, Huixiang] Cent South Univ, Xiangya Hosp, Dept Gastroenterol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China; [Tu, Sha; Yuan, Xiangning; Peng, Zhangzhe; Tao, Lijian; Yang, Huixiang] Cent South Univ, Hunan Key Lab Organ Fibrosis, Changsha, Peoples R China; [Peng, Xiongqun] Changsha Cent Hosp, Dept Gastroenterol, Changsha, Peoples R China; [Peng, Zhangzhe; Tao, Lijian] Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Peoples R China	Central South University; Central South University; Central South University	Yang, HX (corresponding author), Cent South Univ, Xiangya Hosp, Dept Gastroenterol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.	yang_hx430@163.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation of China [81370547, 81873585]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81370547 and 81873585	Armendariz-Borunda J, 2006, GUT, V55, P1663, DOI 10.1136/gut.2006.107136; Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhunchet E, 1996, HEPATOLOGY, V23, P811, DOI 10.1002/hep.510230423; Colmenero J, 2009, AM J PHYSIOL-GASTR L, V297, pG726, DOI 10.1152/ajpgi.00162.2009; Croquet V, 2002, J HEPATOL, V37, P773, DOI 10.1016/S0168-8278(02)00307-0; Di Pascoli M, 2013, J HEPATOL, V58, P904, DOI 10.1016/j.jhep.2012.12.012; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P8897, DOI 10.1073/pnas.151136298; Flores-Contreras L, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-131; Gao B, 2010, GASTROENTEROLOGY, V139, P27, DOI 10.1053/j.gastro.2010.05.018; Garcia L, 2002, J HEPATOL, V37, P797, DOI 10.1016/S0168-8278(02)00272-6; Huang L, 2014, AM J MED SCI, V348, P75, DOI 10.1097/MAJ.0000000000000187; Ibrahim SH, 2018, GUT, V67, P963, DOI 10.1136/gutjnl-2017-315691; Inao M, 2004, J HEPATOL, V41, P584, DOI 10.1016/j.jhep.2004.06.033; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Lancaster LH, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0057-2017; Liu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129283; Liu JJ, 2015, SHOCK, V43, P201, DOI 10.1097/SHK.0000000000000273; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Peng Y, 2014, AM J PHYSIOL-GASTR L, V306, pG253, DOI 10.1152/ajpgi.00471.2012; Peng Y, 2013, EUR J CLIN INVEST, V43, P358, DOI 10.1111/eci.12053; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Qin J, 2015, KIDNEY BLOOD PRESS R, V40, P89, DOI 10.1159/000368485; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Song C, 2016, J CELL MOL MED, V20, P2064, DOI 10.1111/jcmm.12898; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711; Tang YT, 2015, AM J MED SCI, V350, P195, DOI 10.1097/MAJ.0000000000000501; Tang YT, 2010, INT IMMUNOPHARMACOL, V10, P580, DOI 10.1016/j.intimp.2010.02.005; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Yuan QJ, 2011, AM J NEPHROL, V34, P181, DOI 10.1159/000329080	34	3	4	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21497	10.1096/fj.202002402R	http://dx.doi.org/10.1096/fj.202002402R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34152015				2022-12-28	WOS:000667814100068
J	Balestrini, PA; Sanchez-Cardenas, C; Luque, GM; Graf, CB; Sierra, JM; Hernandez-Cruz, A; Visconti, PE; Krapf, D; Darszon, A; Buffone, MG				Balestrini, Paula A.; Sanchez-Cardenas, Claudia; Luque, Guillermina M.; Baro Graf, Carolina; Sierra, Jessica M.; Hernandez-Cruz, Arturo; Visconti, Pablo E.; Krapf, Dario; Darszon, Alberto; Buffone, Mariano G.			Membrane hyperpolarization abolishes calcium oscillations that prevent induced acrosomal exocytosis in human sperm	FASEB JOURNAL			English	Article						acrosome reaction; capacitation; membrane potential; Valinomycin	CAPACITATION-ASSOCIATED HYPERPOLARIZATION; MOUSE SPERM; ACTIN CYTOSKELETON; SPERMATOZOA; CHANNELS; CA2+; FERTILIZATION; PROTEINS; BEHAVIOR; VESICLE	Sperm capacitation is essential to gain fertilizing capacity. During this process, a series of biochemical and physiological modifications occur that allow sperm to undergo acrosomal exocytosis (AE). At the molecular level, hyperpolarization of the sperm membrane potential (Em) takes place during capacitation. This study shows that human sperm incubated under conditions that do not support capacitation (NC) can become ready for an agonist stimulated AE by pharmacologically inducing Em hyperpolarization with Valinomycin or Amiloride. To investigate how Em hyperpolarization promotes human sperm's ability to undergo AE, live single-cell imaging experiments were performed to simultaneously monitor changes in [Ca2+](i) and the occurrence of AE. Em hyperpolarization turned [Ca2+](i) dynamics in NC sperm from spontaneously oscillating into a sustained slow [Ca2+](i) increase. The addition of progesterone (P4) or K+ to Valinomycin-treated sperm promoted that a significant number of cells displayed a transitory rise in [Ca2+](i) which then underwent AE. Altogether, our results demonstrate that Em hyperpolarization is necessary and sufficient to prepare human sperm for the AE. Furthermore, this Em change decreased Ca2+ oscillations that block the occurrence of AE, providing strong experimental evidence of the molecular mechanism that drives the acquisition of acrosomal responsiveness.	[Balestrini, Paula A.; Luque, Guillermina M.; Sierra, Jessica M.; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina; [Sanchez-Cardenas, Claudia; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico; [Baro Graf, Carolina; Hernandez-Cruz, Arturo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Ciudad Univ, Mexico City, DF, Mexico; [Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Paige Labs, Amherst, MA 01003 USA; [Krapf, Dario] Inst Biol Mol & Celular Rosario CONICET UNR, Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Massachusetts System; University of Massachusetts Amherst	Krapf, D (corresponding author), Inst Biol Mol & Celular Rosario IBR, 27 Febrero,S2000EZP, Rosario, Santa Fe, Argentina.; Buffone, MG (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	krapf@ibr-conicet.gov.ar; mgbuffone@ibyme.conicet.gov.ar	Luque, Guillermina/M-9237-2019	Luque, Guillermina/0000-0002-2745-8236; Balestrini, Paula Ania/0000-0002-9351-1226; Darszon, Alberto/0000-0002-2502-0505; Baro Graf, Carolina/0000-0003-4490-9083; Sierra, Jessica Mariel/0000-0001-7829-9207	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [RO1 HD38082]; Agencia Nacional de Promocion Cientifica y Tecnologica (PICT) [2015--2294, 2017--3047]; PAPIIT--UNAM [IN205516, IG200119]; Consejo Nacional de Ciencia y Tecnologia Fronteras de la Ciencia/71 [CB 2015/255914, 280478, 252969, 253952]	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agencia Nacional de Promocion Cientifica y Tecnologica (PICT)(ANPCyT); PAPIIT--UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia Fronteras de la Ciencia/71	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH (RO1 HD38082 to P.E.V), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2015--2294 and 2017--3047 to MGB), PAPIIT--UNAM, IN205516 and IG200119; Consejo Nacional de Ciencia y Tecnologia Fronteras de la Ciencia/71 (CB 2015/255914, 280478, 252969, 253952 to AD)	AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Graf CB, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00383; Graf CB, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00101; Bedu-Addo K, 2007, DEV BIOL, V302, P324, DOI 10.1016/j.ydbio.2006.09.040; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Buffone MG, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117911; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Charpentier M, 2016, SCIENCE, V352, P1102, DOI 10.1126/science.aae0109; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Brukman NG, 2019, J CELL PHYSIOL, V234, P5276, DOI 10.1002/jcp.27337; Harper CV, 2005, HUM REPROD, V20, P2675, DOI 10.1093/humrep/dei158; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hino T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140400; Hirohashi N, 2018, BIOL REPROD, V99, P127, DOI 10.1093/biolre/ioy045; Kelly MC, 2018, HUM REPROD, V33, P1023, DOI 10.1093/humrep/dey096; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kohn FM, 1997, HUM REPROD, V12, P714, DOI 10.1093/humrep/12.4.714; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; Lopez-Gonzalez I, 2014, MOL HUM REPROD, V20, P619, DOI 10.1093/molehr/gau029; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Luque GM, 2018, J CELL PHYSIOL, V233, P9685, DOI 10.1002/jcp.26883; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; Mannowetz N, 2013, ELIFE, V2, DOI 10.7554/eLife.01009; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Mata-Martinez E, 2018, BIOCHEM BIOPH RES CO, V497, P146, DOI 10.1016/j.bbrc.2018.02.042; McPartlin LA, 2011, BIOL REPROD, V85, P179, DOI 10.1095/biolreprod.110.085555; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Molina LCP, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00387; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Pelletier RM, 1999, BIOL REPROD, V60, P1128, DOI 10.1095/biolreprod60.5.1128; Puga Molina LC., 2018, J BIOL CHEM; Molina LCP, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00072; Molina LCP, 2017, J CELL PHYSIOL, V232, P1404, DOI 10.1002/jcp.25634; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Romarowski A, 2016, ADV ANAT EMBRYOL CEL, V220, P129, DOI 10.1007/978-3-319-30567-7_7; Romarowski A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136085; Sanchez-Cardenas C, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119768; Sanchez-Carranza O, 2015, BIOCHEM BIOPH RES CO, V466, P554, DOI 10.1016/j.bbrc.2015.09.073; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; Stival C, 2018, J BIOL CHEM, V293, P9435, DOI 10.1074/jbc.RA118.002286; Stival C, 2016, ADV ANAT EMBRYOL CEL, V220, P93, DOI 10.1007/978-3-319-30567-7_5; Suarez SS, 2003, CELL MOL BIOL, V49, P351; Torrezan-Nitao E., 2020, HUM REPROD; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wertheimer E, 2013, J BIOL CHEM, V288, P35307, DOI 10.1074/jbc.M113.489476; World Health Organization W. H, 2010, WHO LAB MAN EX PROC; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	61	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21478	10.1096/fj.202002333RR	http://dx.doi.org/10.1096/fj.202002333RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33991146				2022-12-28	WOS:000655695900066
J	Nakagawa, Y; Kumagai, K; Han, SI; Mizunoe, Y; Araki, M; Mizuno, S; Ohno, H; Matsuo, K; Yamada, Y; Kim, JD; Miyamoto, T; Sekiya, M; Konishi, M; Itoh, N; Matsuzaka, T; Takahashi, S; Sone, H; Shimano, H				Nakagawa, Yoshimi; Kumagai, Kae; Han, Song-iee; Mizunoe, Yuhei; Araki, Masaya; Mizuno, Seiya; Ohno, Hiroshi; Matsuo, Kazuya; Yamada, Yasunari; Kim, Jun-dal; Miyamoto, Takafumi; Sekiya, Motohiro; Konishi, Morichika; Itoh, Nobuyuki; Matsuzaka, Takashi; Takahashi, Satoru; Sone, Hirohito; Shimano, Hitoshi			Starvation-induced transcription factor CREBH negatively governs body growth by controlling GH signaling	FASEB JOURNAL			English	Article						CREBH; FGF21; GH resistance; GHR; growth delay; IGFBP1	FACTOR-BINDING PROTEIN-1; ACTIVATED RECEPTOR-ALPHA; FATTY-ACID OXIDATION; I IGF-I; GENE-EXPRESSION; PPAR-ALPHA; HORMONE RECEPTORS; TRANSGENIC MICE; NUTRITIONAL REGULATION; INSULIN-RESISTANCE	cAMP responsive element-binding protein H (CREBH) is a hepatic transcription factor to be activated during fasting. We generated CREBH knock-in flox mice, and then generated liver-specific CREBH transgenic (CREBH L-Tg) mice in an active form. CREBH L-Tg mice showed a delay in growth in the postnatal stage. Plasma growth hormone (GH) levels were significantly increased in CREBH L-Tg mice, but plasma insulin-like growth factor 1 (IGF1) levels were significantly decreased, indicating GH resistance. In addition, CREBH overexpression significantly increased hepatic mRNA and plasma levels of FGF21, which is thought to be as one of the causes of growth delay. However, the additional ablation of FGF21 in CREBH L-Tg mice could not correct GH resistance at all. CREBH L-Tg mice sustained GH receptor (GHR) reduction and the increase of IGF binding protein 1 (IGFBP1) in the liver regardless of FGF21. As GHR is a first step in GH signaling, the reduction of GHR leads to impairment of GH signaling. These data suggest that CREBH negatively regulates growth in the postnatal growth stage via various pathways as an abundant energy response by antagonizing GH signaling.	[Nakagawa, Yoshimi; Matsuo, Kazuya; Yamada, Yasunari; Kim, Jun-dal] Univ Toyama, Inst Nat Med, Div Complex Biosyst Res, Dept Res & Dev, Toyama 9300194, Japan; [Nakagawa, Yoshimi; Kumagai, Kae; Han, Song-iee; Mizunoe, Yuhei; Araki, Masaya; Ohno, Hiroshi; Miyamoto, Takafumi; Sekiya, Motohiro; Takahashi, Satoru; Shimano, Hitoshi] Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Nakagawa, Yoshimi; Han, Song-iee; Shimano, Hitoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Nakagawa, Yoshimi; Shimano, Hitoshi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Tokyo, Japan; [Mizuno, Seiya; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr LARC, Fac Med, Tsukuba, Ibaraki, Japan; [Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo, Japan; [Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Matsuzaka, Takashi; Takahashi, Satoru] Univ Tsukuba, Transborder Med Res Ctr TMRC, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan; [Sone, Hirohito] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan; [Shimano, Hitoshi] Univ Tsukuba, Life Sci Ctr Survival Dynam, Tsukuba Adv Res Alliance TARA, Tsukuba, Ibaraki, Japan	University of Toyama; University of Tsukuba; University of Tsukuba; University of Tsukuba; Kobe Pharmaceutical University; Kyoto University; University of Tsukuba; University of Tsukuba; Niigata University; University of Tsukuba	Nakagawa, Y (corresponding author), Univ Toyama, Inst Nat Med, Div Complex Biosyst Res, Dept Res & Dev, Toyama 9300194, Japan.; Shimano, H (corresponding author), Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Fac Med, Tsukuba, Ibaraki 3058575, Japan.	ynaka@inm.u-toyama.ac.jp; hshimano@md.tsukuba.ac.jp	Sone, Hirohito/ABC-9346-2021	Sone, Hirohito/0000-0003-1263-2817; Jun-Dal, Kim/0000-0002-7361-0999; Miyamoto, Takafumi/0000-0001-9363-2864; Mizunoe, Yuhei/0000-0001-6716-1544	JSPS KAKENHI [16H03253, 21H04861, 19H00449, 17H06395]; Japan Health Foundation; Tamura Foundation; Uehara Memorial Foundation; AMED-CREST [20gm1110008s0303, 16gm0910003h0002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Health Foundation(Japan Health Foundation); Tamura Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); AMED-CREST	This work was supported by JSPS KAKENHI (Grant Number 16H03253 and 21H04861 (to YN), 19H00449 (to KK), and 17H06395 (to H. Shimano)), the Japan Health Foundation (to YN), the Tamura Foundation (to YN), The Uehara Memorial Foundation (to YN), and AMED-CREST (Grant number 20gm1110008s0303 (to YN) and 16gm0910003h0002 (to H. Shimano)). The authors would like to thank Enago () for the English language review.	AMSELEM S, 1989, NEW ENGL J MED, V321, P989, DOI 10.1056/NEJM198910123211501; Araki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072148; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0; BAXTER RC, 1978, BIOCHEM BIOPH RES CO, V84, P350, DOI 10.1016/0006-291X(78)90177-8; Beauloye V, 2002, ENDOCRINOLOGY, V143, P792, DOI 10.1210/en.143.3.792; BORNFELDT KE, 1989, J ENDOCRINOL, V122, P651, DOI 10.1677/joe.0.1220651; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23938; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Crossey PA, 2000, DIABETES, V49, P457, DOI 10.2337/diabetes.49.3.457; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Davey HW, 2001, ENDOCRINOLOGY, V142, P3836, DOI 10.1210/en.142.9.3836; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; EMLER CA, 1987, ENDOCRINOLOGY, V120, P832, DOI 10.1210/endo-120-2-832; Fang F, 2019, P NATL ACAD SCI USA, V116, P7449, DOI 10.1073/pnas.1901867116; FLIESEN T, 1989, PEDIATR RES, V26, P415, DOI 10.1203/00006450-198911000-00010; Fujimoto Y, 2013, ENDOCRINOLOGY, V154, P3577, DOI 10.1210/en.2013-1203; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gan YJ, 2014, MOL ENDOCRINOL, V28, P1841, DOI 10.1210/me.2014-1174; Gay E, 1997, ENDOCRINOLOGY, V138, P2937, DOI 10.1210/en.138.7.2937; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GODOWSKI PJ, 1989, P NATL ACAD SCI USA, V86, P8083, DOI 10.1073/pnas.86.20.8083; Goto T, 2017, J BIOL CHEM, V292, P9175, DOI 10.1074/jbc.M116.767590; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Hasegawa Y, 2013, EXP ANIM TOKYO, V62, P295; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; Huang Y, 2004, MOL ENDOCRINOL, V18, P1471, DOI 10.1210/me.2003-0418; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Kim SH, 2017, ANN PEDIATR ENDOCRIN, V22, P145, DOI 10.6065/apem.2017.22.3.145; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; LeRoith D, 2005, J CLIN INVEST, V115, P233, DOI 10.1172/JCI200524228; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712; List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; LOWE WL, 1989, J CLIN INVEST, V84, P619, DOI 10.1172/JCI114207; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; MURPHY LJ, 1991, ENDOCRINOLOGY, V128, P689, DOI 10.1210/endo-128-2-689; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Nakagawa Y, 2021, CELL MOL GASTROENTER, V11, P949, DOI 10.1016/j.jcmgh.2020.11.004; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39182; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27857; Nakagawa Y, 2014, ENDOCRINOLOGY, V155, P4706, DOI 10.1210/en.2014-1113; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Ono M, 2007, MOL ENDOCRINOL, V21, P1443, DOI 10.1210/me.2006-0543; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Satoh A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100930; SENEVIRATNE C, 1990, MOL ENDOCRINOL, V4, P1199, DOI 10.1210/mend-4-8-1199; Silha JV, 2002, ENDOCRINOLOGY, V143, P3711, DOI 10.1210/en.2002-220116; STRAUS DS, 1990, MOL ENDOCRINOL, V4, P91, DOI 10.1210/mend-4-1-91; Takei K, 2017, J DIABETES INVEST, V8, P446, DOI 10.1111/jdi.12621; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; THISSEN JP, 1990, J ENDOCRINOL, V124, P159, DOI 10.1677/joe.0.1240159; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; UNDERWOOD LE, 1994, HORM RES, V42, P145, DOI 10.1159/000184187; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Wang XD, 2015, CELL METAB, V22, P811, DOI 10.1016/j.cmet.2015.09.010; Woelfle J, 2004, AM J PHYSIOL-ENDOC M, V286, pE393, DOI 10.1152/ajpendo.00389.2003; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	78	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21663	10.1096/fj.202002784RR	http://dx.doi.org/10.1096/fj.202002784RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042217				2022-12-28	WOS:000655695900015
J	Ali, AAH; Abdel-Hafiz, L; Tundo-Lavalle, F; Hassan, SA; von Gall, C				Ali, Amira A. H.; Abdel-Hafiz, Laila; Tundo-Lavalle, Federica; Hassan, Soha A.; von Gall, Charlotte			P2Y(2) deficiency impacts adult neurogenesis and related forebrain functions	FASEB JOURNAL			English	Article						adult neurogenesis; olfaction; p-Akt; purinergic receptors; working memory	INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; GUT MICROBIOTA; RHEUMATOID-ARTHRITIS; OXIDATIVE-METABOLISM; ULCERATIVE-COLITIS; EPITHELIAL BARRIER; TYROSYL RESIDUES; MYELOPEROXIDASE; NEUTROPHILS	Adult neurogenesis occurs particularly in the subgranular zone (SGZ) of the hippocampus and the subventricular zone (SVZ) of the lateral ventricle. This continuous addition of neurons to pre-existing neuronal networks is essential for intact cognitive and olfactory functions, respectively. Purinergic signaling modulates adult neurogenesis, however, the role of individual purinergic receptor subtypes in this dynamic process and related cognitive performance is poorly understood. In this study, we analyzed the role of P2Y(2) receptor in the neurogenic niches and in related forebrain functions such as spatial working memory and olfaction using mice with a targeted deletion of the P2Y(2) receptor (P2Y2(-/-)). Proliferation, migration, differentiation, and survival of neuronal precursor cells (NPCs) were analyzed by BrdU assay and immunohistochemistry; signal transduction pathway components were analyzed by immunoblot. In P2Y2(-/-) mice, proliferation of NPCs in the SGZ and the SVZ was reduced. However, migration, neuronal fate decision, and survival were not affected. Moreover, p-Akt expression was decreased in P2Y2(-/-) mice. P2Y2(-/-) mice showed an impaired performance in the Y-maze and a higher latency in the hidden food test. These data indicate that the P2Y(2) receptor plays an important role in NPC proliferation as well as in hippocampus-dependent working memory and olfactory function.	[Ali, Amira A. H.; Abdel-Hafiz, Laila; Tundo-Lavalle, Federica; Hassan, Soha A.; von Gall, Charlotte] Heinrich Heine Univ, Univ Hosp Dusseldorf, Inst Anat 2, Med Fac, Dusseldorf, Germany; [Hassan, Soha A.] Suez Univ, Zool Dept, Fac Sci, Suez, Egypt	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Egyptian Knowledge Bank (EKB); Suez University	von Gall, C (corresponding author), Heinrich Heine Univ, Med Fac, Inst Anat 2, Univ Str 1, D-40225 Dusseldorf, Germany.; von Gall, C (corresponding author), Heinrich Heine Univ, Univ Hosp Dusseldorf, Univ Str 1, D-40225 Dusseldorf, Germany.	charlotte.gall@uni-duesseldorf.de	Ali, Amira/AHB-8622-2022	Ali, Amira Amin Hassan/0000-0003-0058-0300; Hassan, Soha/0000-0001-8566-4727	Heinrich Heine University Duesseldorf	Heinrich Heine University Duesseldorf	The authors thank Hanna Bellert, Ralf Fassbender, Angelika Hallenberger, and Ursula Lammersen for excellent technical support. The authors also thank Prof. Joseph Huston for helpful discussions. The authors acknowledge support by the Heinrich Heine University Duesseldorf	Aherne CM, 2015, MUCOSAL IMMUNOL, V8, P1324, DOI 10.1038/mi.2015.22; Alexeev EE, 2018, AM J PATHOL, V188, P1183, DOI 10.1016/j.ajpath.2018.01.011; Arora AK, 2011, ADSORPT SCI TECHNOL, V29, P39, DOI 10.1260/0263-6174.29.1.39; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Barry R, 2020, MUCOSAL IMMUNOL, V13, P322, DOI 10.1038/s41385-019-0235-4; BEAN RC, 1968, J GEN PHYSIOL, V52, P495, DOI 10.1085/jgp.52.3.495; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bendheim PE, 2002, J MOL NEUROSCI, V19, P213, DOI 10.1007/s12031-002-0036-0; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Cartwright IM, 2020, MUCOSAL IMMUNOL, V13, P230, DOI 10.1038/s41385-019-0237-2; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chai WD, 2019, AM J PHYSIOL-ENDOC M, V317, pE1063, DOI 10.1152/ajpendo.00203.2019; Chami B, 2018, ARCH BIOCHEM BIOPHYS, V645, P61, DOI 10.1016/j.abb.2018.03.012; Chen MX, 2019, J FORMOS MED ASSOC, V118, pS10, DOI 10.1016/j.jfma.2018.09.007; Chen Y, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01339-3; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Churg A, 2012, AM J RESP CRIT CARE, V185, P34, DOI 10.1164/rccm.201103-0468OC; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Curtis VF, 2018, MOL BIOL CELL, V29, P2687, DOI 10.1091/mbc.E18-06-0377; Darkoh C, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00346-18; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; DECHATELET LR, 1976, BLOOD, V47, P545; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeRoche TC, 2014, GASTROENTEROL REP, V2, P178, DOI 10.1093/gastro/gou031; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Dowdell AS, 2020, MOL BIOL CELL, V31, P2249, DOI 10.1091/mbc.E20-05-0291; Ehrlich AM, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-02023-y; Elliott SN, 1998, CAN J GASTROENTEROL, V12, P559, DOI 10.1155/1998/398384; FLIGIEL SEG, 1984, AM J PATHOL, V115, P418; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Fu SL, 2000, J BIOL CHEM, V275, P10851, DOI 10.1074/jbc.275.15.10851; Gao RY, 2021, MUCOSAL IMMUNOL, V14, P479, DOI 10.1038/s41385-020-00347-6; Grigorieva DV, 2016, B EXP BIOL MED+, V161, P495, DOI 10.1007/s10517-016-3446-7; Haselhorst Thomas, 2009, V534, P375, DOI 10.1007/978-1-59745-022-5_26; Heinecke JW, 2014, DIABETES, V63, P4001, DOI 10.2337/db14-1273; Hendrikx T, 2019, J INTERN MED, V286, P32, DOI 10.1111/joim.12892; Herraiz T, 2004, FREE RADICAL RES, V38, P323, DOI 10.1080/10611860310001648167; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; Ilyasov IR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031131; Ji Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051579; Ji Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092062; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Kaur H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01365; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; Khan I, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030126; Kim CH, 2018, IMMUNOLOGY, V154, P220, DOI 10.1111/imm.12930; Krishnan S, 2018, CELL REP, V23, P1099, DOI 10.1016/j.celrep.2018.03.109; Kuenzig ME, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0054-z; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z; Lee JS, 2018, J BIOL CHEM, V293, P6039, DOI 10.1074/jbc.RA117.000269; Levy M, 2016, GENE DEV, V30, P1589, DOI 10.1101/gad.284091.116; LYMAR SV, 1995, CHEM RES TOXICOL, V8, P833, DOI 10.1021/tx00048a003; Manchanda K, 2018, ARTERIOSCL THROM VAS, V38, P1859, DOI 10.1161/ATVBAHA.118.311143; Matijasic M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082668; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Meddows-Taylor S, 1999, CLIN DIAGN LAB IMMUN, V6, P345, DOI 10.1128/CDLI.6.3.345-351.1999; Mor M, 2003, ADV EXP MED BIOL, V527, P567; Muthas D, 2017, SCAND J GASTROENTERO, V52, P125, DOI 10.1080/00365521.2016.1235224; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Onyiah JC, 2018, J INNATE IMMUN, V10, P228, DOI 10.1159/000488914; Paoliello-Paschoalato AB, 2014, J IMMUNOL METHODS, V412, P70, DOI 10.1016/j.jim.2014.07.001; Phillipson M, 2019, TRENDS IMMUNOL, V40, P635, DOI 10.1016/j.it.2019.05.001; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rosales C, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1469780; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Shurney D, 2019, AM J HEALTH PROMOT, V33, P821, DOI 10.1177/0890117119845711b; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Strzepa A, 2017, CELL IMMUNOL, V317, P1, DOI 10.1016/j.cellimm.2017.05.002; THOMAS EL, 1979, INFECT IMMUN, V25, P110, DOI 10.1128/IAI.25.1.110-116.1979; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Venkitakrishnan Rani Parvathy, 2012, Methods Mol Biol, V914, P47, DOI 10.1007/978-1-62703-023-6_4; Villanacci V, 2013, WORLD J GASTROENTERO, V19, P968, DOI 10.3748/wjg.v19.i7.968; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; Wang RX, 2020, P NATL ACAD SCI USA, V117, P11648, DOI 10.1073/pnas.1917597117; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wei ZL, 2003, J NEUROSCI RES, V73, P364, DOI 10.1002/jnr.10668; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Ximenes VF, 2005, BRAZ J MED BIOL RES, V38, P1575, DOI 10.1590/S0100-879X2005001100003; Yisireyili M, 2017, NAGOYA J MED SCI, V79, P477, DOI 10.18999/nagjms.79.4.477; Zhang DC, 2019, BLOOD, V133, P2168, DOI 10.1182/blood-2018-11-844555; Zhang N, 2018, NUTRITION, V51-52, P80, DOI 10.1016/j.nut.2017.12.005; Zhao ZH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0304-5; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	99	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21546	10.1096/fj.202002419RR	http://dx.doi.org/10.1096/fj.202002419RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817825	hybrid			2022-12-28	WOS:000645260100079
J	Camm, EJ; Cross, CM; Kane, AD; Tarry-Adkins, JL; Ozanne, SE; Giussani, DA				Camm, Emily J.; Cross, Christine M.; Kane, Andrew D.; Tarry-Adkins, Jane L.; Ozanne, Susan E.; Giussani, Dino A.			Maternal antioxidant treatment protects adult offspring against memory loss and hippocampal atrophy in a rodent model of developmental hypoxia	FASEB JOURNAL			English	Article						brain; fetal hypoxia; hippocampus; memory; programming	HIGH-ALTITUDE HYPOXIA; UMBILICAL BLOOD-FLOW; LOW-BIRTH-WEIGHT; VITAMIN-C; PRENATAL HYPOXIA; ESTROUS-CYCLE; FETAL-GROWTH; GESTATIONAL HYPOXIA; E SUPPLEMENTATION; OXIDATIVE STRESS	Chronic fetal hypoxia is one of the most common outcomes in complicated pregnancy in humans. Despite this, its effects on the long-term health of the brain in offspring are largely unknown. Here, we investigated in rats whether hypoxic pregnancy affects brain structure and function in the adult offspring and explored underlying mechanisms with maternal antioxidant intervention. Pregnant rats were randomly chosen for normoxic or hypoxic (13% oxygen) pregnancy with or without maternal supplementation with vitamin C in their drinking water. In one cohort, the placenta and fetal tissues were collected at the end of gestation. In another, dams were allowed to deliver naturally, and offspring were reared under normoxic conditions until 4 months of age (young adult). Between 3.5 and 4 months, the behavior, cognition and brains of the adult offspring were studied. We demonstrated that prenatal hypoxia reduced neuronal number, as well as vascular and synaptic density, in the hippocampus, significantly impairing memory function in the adult offspring. These adverse effects of prenatal hypoxia were independent of the hypoxic pregnancy inducing fetal growth restriction or elevations in maternal or fetal plasma glucocorticoid levels. Maternal vitamin C supplementation during hypoxic pregnancy protected against oxidative stress in the placenta and prevented the adverse effects of prenatal hypoxia on hippocampal atrophy and memory loss in the adult offspring. Therefore, these data provide a link between prenatal hypoxia, placental oxidative stress, and offspring brain health in later life, providing insight into mechanism and identifying a therapeutic strategy.	[Camm, Emily J.; Cross, Christine M.; Kane, Andrew D.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Tarry-Adkins, Jane L.; Ozanne, Susan E.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Ozanne, Susan E.; Giussani, Dino A.] Cambridge Strateg Initiat Reprod, Cambridge, England; [Camm, Emily J.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Hudson Institute of Medical Research	Camm, EJ; Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	ejc68@cam.ac.uk; dag26@cam.ac.uk	Kane, Andrew/C-5876-2013	Kane, Andrew/0000-0001-9488-4086; Giussani, Dino/0000-0002-1308-1204; Tarry-Adkins, Jane/0000-0001-9569-6132	British Heart Foundation (BHF) [PG/14/5/30547]; RCUK | Medical Research Council (MRC) [MC_UU_00014/4]	British Heart Foundation (BHF)(British Heart Foundation); RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	British Heart Foundation (BHF), Grant/Award Number: PG/14/5/30547; RCUK | Medical Research Council (MRC), Grant/Award Number: MC_UU_00014/4	Adler A, 2010, NEONATOLOGY, V98, P73, DOI 10.1159/000275561; Alkadhi KA, 2019, MOL NEUROBIOL, V56, P6566, DOI 10.1007/s12035-019-1541-2; Allison BJ, 2016, J PHYSIOL-LONDON, V594, P1247, DOI 10.1113/JP271091; Allison BJ, 2020, HYPERTENSION, V76, P1195, DOI 10.1161/HYPERTENSIONAHA.120.15384; Antonow-Schlorke I, 2001, NEUROSCI LETT, V297, P147, DOI 10.1016/S0304-3940(00)01605-0; BAKER PT, 1969, SCIENCE, V163, P1149, DOI 10.1126/science.163.3872.1149; Basaran A, 2010, OBSTET GYNECOL SURV, V65, P653, DOI 10.1097/OGX.0b013e3182095366; Beazley D, 2005, AM J OBSTET GYNECOL, V192, P520, DOI 10.1016/j.ajog.2004.09.005; Bender D E, 1994, Int J Rehabil Res, V17, P75, DOI 10.1097/00004356-199403000-00009; Botting KJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb1929; Brain KL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006552; Brain KL, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12614; Cai ZW, 1999, BRAIN RES BULL, V49, P359, DOI 10.1016/S0361-9230(99)00076-3; Camm EJ, 2011, FASEB J, V25, P420, DOI 10.1096/fj.10-158188; Camm EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021142; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Cook JD, 2005, BLOOD, V106, P1441, DOI 10.1182/blood-2004-12-4782; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Derks JB, 2010, PEDIATR RES, V68, P374, DOI 10.1203/PDR.0b013e3181ef7780; Dubrovskaya N M, 2010, Neurosci Behav Physiol, V40, P231, DOI 10.1007/s11055-009-9235-2; Ducsay CA, 2018, PHYSIOL REV, V98, P1241, DOI 10.1152/physrev.00043.2017; ELLINGTON SKL, 1987, J ANAT, V150, P247; Eskenazi B, 2007, HUM REPROD, V22, P3013, DOI 10.1093/humrep/dem301; Fernandez-Twinn DS, 2012, ENDOCRINOLOGY, V153, P5961, DOI 10.1210/en.2012-1508; Foley AG, 2005, J NEUROSCI RES, V82, P245, DOI 10.1002/jnr.20641; Frick KM, 2001, BEHAV NEUROSCI, V115, P229, DOI 10.1037//0735-7044.115.1.229; Ganguly E, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104836; Ganguly E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00562; Gardner DS, 2003, CIRCULATION, V108, P331, DOI 10.1161/01.CIR.0000080323.40820.A1; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; GIUSSANI DA, 1994, J PHYSIOL-LONDON, V477, P75, DOI 10.1113/jphysiol.1994.sp020172; Giussani DA, 2016, J PHYSIOL-LONDON, V594, P1215, DOI 10.1113/JP271099; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Golan H, 2004, J NEUROSCI RES, V78, P430, DOI 10.1002/jnr.20269; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HECHER K, 1995, AM J OBSTET GYNECOL, V173, P10, DOI 10.1016/0002-9378(95)90161-2; Hogan AM, 2010, DEVELOPMENTAL SCI, V13, P533, DOI 10.1111/j.1467-7687.2009.00909.x; JANICKE B, 1994, PHARMACOL BIOCHEM BE, V48, P863, DOI 10.1016/0091-3057(94)90193-7; Joels M, 2001, J NEUROENDOCRINOL, V13, P657, DOI 10.1046/j.1365-2826.2001.00688.x; Kane AD, 2013, CIRC J, V77, P2604, DOI 10.1253/circj.CJ-13-0311; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Koo JW, 2003, FASEB J, V17, P1556, DOI 10.1096/fj.02-1032fje; Lovick TA, 2012, BRAZ J MED BIOL RES, V45, P314, DOI 10.1590/S0100-879X2012007500044; MCCULLOUGH ML, 1976, DEV PSYCHOBIOL, V9, P335, DOI 10.1002/dev.420090406; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; Miller SL, 2012, NEUROENDOCRINOLOGY, V96, P13, DOI 10.1159/000336378; Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402; Miller SL, 2014, J PINEAL RES, V56, P283, DOI 10.1111/jpi.12121; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nakamura H, 1999, J NEUROSCI RES, V56, P307; Niermeyer S, 2009, ARCH DIS CHILD, V94, P806, DOI 10.1136/adc.2008.141838; Nuzzo AM, 2018, AM J PATHOL, V188, P2704, DOI 10.1016/j.ajpath.2018.07.027; Palanisamy A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133172; Pan S, 2020, NAT NEUROSCI, V23, P487, DOI 10.1038/s41593-019-0582-1; Phillips TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06300-1; Pompili A, 2010, BEHAV BRAIN RES, V213, P10, DOI 10.1016/j.bbr.2010.04.018; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; SACOPOLLITT C, 1981, CHILD DEV, V52, P839, DOI 10.2307/1129085; Schwartz JE, 1998, BIOL NEONATE, V73, P313, DOI 10.1159/000013990; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shaw CJ, 2018, J PHYSIOL-LONDON, V596, P6105, DOI 10.1113/JP275659; Soria R, 2013, PEDIATR RES, V74, P633, DOI 10.1038/pr.2013.150; Spencer JL, 2008, FRONT NEUROENDOCRIN, V29, P219, DOI 10.1016/j.yfrne.2007.08.006; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Steadman PE, 2020, NEURON, V105, P150, DOI 10.1016/j.neuron.2019.10.013; Thakor AS, 2010, J PHYSIOL-LONDON, V588, P4235, DOI 10.1113/jphysiol.2010.196402; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Thomas LDK, 2013, JAMA INTERN MED, V173, P386, DOI 10.1001/jamainternmed.2013.2296; Tijsseling D, 2013, PEDIATR RES, V74, P639, DOI 10.1038/pr.2013.152; UNGER C, 1988, JAMA-J AM MED ASSOC, V259, P3427, DOI 10.1001/jama.259.23.3427; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WALAAS SI, 1988, SYNAPSE, V2, P516, DOI 10.1002/syn.890020507; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wehby GL, 2013, J PEDIATR-US, V162, P606, DOI 10.1016/j.jpeds.2012.09.011; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004; Zamudio S, 2007, FRONT BIOSCI-LANDMRK, V12, P2967, DOI 10.2741/2286; Zhuravin IA, 2019, NEUROBIOL LEARN MEM, V164, DOI 10.1016/j.nlm.2019.107066	89	4	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21477	10.1096/fj.202002557RR	http://dx.doi.org/10.1096/fj.202002557RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33891326	Green Published, hybrid			2022-12-28	WOS:000645260100020
J	Cui, YX; Yang, MM; Wang, YL; Ren, JN; Lin, P; Cui, C; Song, J; He, Q; Hu, HQ; Wang, KX; Sun, Y				Cui, Yixin; Yang, Mengmeng; Wang, Yilin; Ren, Jianmin; Lin, Peng; Cui, Chen; Song, Jia; He, Qin; Hu, Huiqing; Wang, Kexin; Sun, Yu			Melatonin prevents diabetes-associated cognitive dysfunction from microglia-mediated neuroinflammation by activating autophagy via TLR4/Akt/mTOR pathway	FASEB JOURNAL			English	Article						apoptosis; autophagy; cognition; melatonin; neuroinflammation	NF-KAPPA-B; METABOLIC-DISORDERS; OXIDATIVE STRESS; INFLAMMATION; IMPAIRMENT; EXPRESSION; APOPTOSIS; HIPPOCAMPUS; SEX	Cognitive dysfunction often occurs in diabetes mellitus patients. This study aimed to investigate the efficacy of melatonin (MLT) in improving diabetes-associated cognitive decline and the underlying mechanism involved. Type 2 diabetic mice and palmitic acid (PA)-stimulated BV-2 cells were treated by MLT, and the potential mechanisms among MLT, cognition, and autophagy were explored. The results showed that type 2 diabetic mice showed obvious learning and memory impairments in the Morris water maze test compared with normal controls, which could be ameliorated by MLT treatment. Meanwhile, MLT administration significantly improved neuroinflammation and regulated microglial apoptosis. Furthermore, autophagy inhibitor 3-methyladenine (3-MA) increased the microglial inflammation and apoptosis, indicating that the treatment effect of MLT was mediated by autophagy. Lastly, MLT treatment significantly decreased the levels of toll-like receptors 4 (TLR4), phosphorylated-protein kinase B (Akt), and phosphorylated-mechanistic target of rapamycin (mTOR), indicating that blocking TLR4/Akt/mTOR pathway might be an underlying basis for the anti-inflammatory and anti-apoptosis effects of MLT. Collectively, our study suggested that MLT could improve learning and memory in type 2 diabetic mice by activating autophagy via the TLR4/Akt/mTOR pathway, thereby inhibiting neuroinflammation and microglial apoptosis.	[Cui, Yixin; Yang, Mengmeng; Ren, Jianmin; Lin, Peng; Cui, Chen; Song, Jia; He, Qin; Hu, Huiqing; Sun, Yu] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Peoples R China; [Cui, Yixin; Yang, Mengmeng; Ren, Jianmin; Lin, Peng; Cui, Chen; Song, Jia; He, Qin; Hu, Huiqing; Sun, Yu] Shandong Univ, Inst Endocrine & Metab Dis, Jinan, Peoples R China; [Wang, Yilin] Peking Univ, Dept Traumat Orthoped, Peoples Hosp, Beijing, Peoples R China; [Ren, Jianmin; Lin, Peng; He, Qin; Sun, Yu] Shandong Prov Med & Hlth, Key Lab Endocrine & Metab Dis, Jinan, Peoples R China; [Ren, Jianmin; Lin, Peng; He, Qin; Sun, Yu] Jinan Clin Res Ctr Endocrine & Metab Dis, Jinan, Peoples R China; [Wang, Kexin] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Peking University; Shandong University	Wang, KX (corresponding author), Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China.; Sun, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, Inst Endocrinol & Metab, Jinan 250012, Shandong, Peoples R China.	wkx3726@163.com; 18560083995@163.com			National Natural Science Foundation of China [82070852, 81873650, 82070799]; Natural Science Foundation of Shandong Province [ZR2020MH105]; Fundamental research funds of Shandong University [2018JC015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Fundamental research funds of Shandong University	National Natural Science Foundation of China, Grant/Award Number: 82070852, 81873650 and 82070799; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2020MH105; Fundamental research funds of Shandong University, Grant/Award Number: 2018JC015	Baydas G, 2002, NEUROSCI LETT, V326, P109, DOI 10.1016/S0304-3940(02)00328-2; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Chang CP, 2013, CELL DEATH DIFFER, V20, P515, DOI 10.1038/cdd.2012.146; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Corpas R, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12515; Espeland MA, 2018, ALZHEIMERS DEMENT, V14, P1184, DOI 10.1016/j.jalz.2018.05.015; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fernandez-Gil BI, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7187128; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Han HE, 2013, BIOMOL THER, V21, P21, DOI 10.4062/biomolther.2012.089; Hu Y, 2016, AUTOPHAGY, V12, P2286, DOI 10.1080/15548627.2016.1230584; Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kim J, 2011, BRAIN RES, V1418, P42, DOI 10.1016/j.brainres.2011.08.059; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Lee JW, 2019, AUTOPHAGY, V15, P753, DOI 10.1080/15548627.2018.1556946; Lo CC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111187; Luengo E, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12578; Machado I, 2015, BRAIN BEHAV IMMUN, V46, P137, DOI 10.1016/j.bbi.2015.01.012; Matsuzawa-Ishimoto Y, 2018, ANNU REV IMMUNOL, V36, P73, DOI 10.1146/annurev-immunol-042617-053253; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Obayashi K, 2018, CLIN ENDOCRINOL, V89, P750, DOI 10.1111/cen.13842; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Qiao JT, 2018, METABOLISM, V81, P13, DOI 10.1016/j.metabol.2017.09.010; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Rawlings AM, 2019, DIABETES CARE, V42, P1248, DOI 10.2337/dc19-0120; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Robert G, 2012, AUTOPHAGY, V8, P637, DOI 10.4161/auto.19084; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanchez A, 2015, INT J MOL SCI, V16, P16981, DOI 10.3390/ijms160816981; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685; Wang KX, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1567179; Wang SJ, 2018, J CELL MOL MED, V22, P5132, DOI 10.1111/jcmm.13802; Wei J, 2020, AM J TRANSL RES, V12, P1584; Wu X, 2018, BRAIN BEHAV IMMUN, V73, P533, DOI 10.1016/j.bbi.2018.06.018; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu JQ, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12584; Yang L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190225; Yang L, 2018, CELL STRESS CHAPERON, V23, P1283, DOI 10.1007/s12192-018-0936-8; Yang YJ, 2019, NEUROPSYCHOPHARMACOL, V44, P2054, DOI 10.1038/s41386-019-0437-1; Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759; Zemdegs J, 2016, BRIT J PHARMACOL, V173, P2095, DOI 10.1111/bph.13343; Zhai ME, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12419; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhao LC, 2018, MOL CELL PROTEOMICS, V17, P2335, DOI 10.1074/mcp.RA118.000690; Zonis S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0281-0	49	9	9	4	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21485	10.1096/fj.202002247RR	http://dx.doi.org/10.1096/fj.202002247RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33709562	hybrid			2022-12-28	WOS:000635216100025
J	Almeida, CF; Bitoun, M; Vainzof, M				F. Almeida, Camila; Bitoun, Marc; Vainzof, Mariz			Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy	FASEB JOURNAL			English	Article						congenital; GTPase; injury; muscle; stem cell		Dynamin 2 (DNM2) is a ubiquitously expressed protein involved in many functions related to trafficking and remodeling of membranes and cytoskeleton dynamics. Mutations in the DNM2 gene cause the autosomal dominant centronuclear myopathy (AD-CNM), characterized mainly by muscle weakness and central nuclei. Several defects have been identified in the KI-Dnm2(R465W/+) mouse model of the disease to explain the muscle phenotype, including reduction of the satellite cell pool in muscle, but the functional consequences of this depletion have not been characterized until now. Satellite cells (SC) are the main source for muscle growth and regeneration of mature tissue. Here, we investigated muscle regeneration in the KI-Dnm2(R465W/+) mouse model for AD-CNM. We found a reduced number of Pax7-positive SCs, which were also less activated after induced muscle injury. The muscles of the KI-Dnm2(R465W/+) mouse regenerated more slowly and less efficiently than wild-type ones, formed fewer new myofibers, and did not recover its normal mass 15 days after injury. Altogether, our data provide evidence that the muscle regeneration is impaired in the KI-Dnm2(R465W/+) mouse and contribute with one more layer to the comprehension of the disease, by identifying a new pathomechanism linked to DNM2 mutations which may be involved in the muscle-specific impact occurring in AD-CNM.	[F. Almeida, Camila; Vainzof, Mariz] Univ Sao Paulo, Lab Muscle Prot & Comparat Histopathol, Human Genome & Stem Cell Res Ctr, Biosci Inst, Sao Paulo, Brazil; [F. Almeida, Camila; Bitoun, Marc] Sorbonne Univ, INSERM, Inst Myol, Ctr Res Myol,UMRS 974, Paris, France; [F. Almeida, Camila] Ohio State Univ, Dept Pediat, Ctr Gene Therapy, Nationwide Childrens Hosp, Columbus, OH 43210 USA	Universidade de Sao Paulo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Vainzof, M (corresponding author), IBUSP, Human Genome & Stem Cell Res Ctr, Rua Matao,106 Cidade Univ, BR-05508900 Sao Paulo, SP, Brazil.	mvainzof@usp.br	Vainzof, Mariz/J-7150-2012; Bitoun, Marc/M-4720-2017; de Freitas Almeida, Camila/L-6601-2013	Vainzof, Mariz/0000-0002-2797-0782; Bitoun, Marc/0000-0002-4188-7918; de Freitas Almeida, Camila/0000-0003-2652-2205	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID) [2013/08028-1, 2015/18914-4, 2017/07376-7]; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [456522/2014-0]; MCTI | Financiadora de Estudos e Projetos (FINEP) [01.08.0579.00]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTI | Financiadora de Estudos e Projetos (FINEP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID grants 2013/08028-1, 2015/18914-4, and 2017/07376-7); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 456522/2014-0; MCTI | Financiadora de Estudos e Projetos (FINEP), Grant/Award Number: 01.08.0579.00	Abou-Khalil R, 2010, CELL CYCLE, V9, P2575, DOI 10.4161/cc.9.13.12149; Almeida CF, 2020, METHODS MOL BIOL, V2063, P157, DOI 10.1007/978-1-0716-0138-9_12; Almeida CF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1078686; Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; Bohm J, 2012, HUM MUTAT, V33, P949, DOI 10.1002/humu.22067; Castets P, 2011, HUM MOL GENET, V20, P694, DOI 10.1093/hmg/ddq515; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Feichtinger RG, 2019, GENET MED, V21, P2521, DOI 10.1038/s41436-019-0532-z; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fischer D, 2006, BRAIN, V129, P1463, DOI 10.1093/brain/awl071; Fongy A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38184-0; Franck A, 2019, MOL BIOL CELL, V30, P579, DOI 10.1091/mbc.E18-11-0718; Fraysse B, 2016, BIOL OPEN, V5, P1691, DOI 10.1242/bio.020263; Garry GA, 2016, METHODS MOL BIOL, V1460, P61, DOI 10.1007/978-1-4939-3810-0_6; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gonzalez-Jamett AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04418-w; Hanisch F, 2011, J NEUROL, V258, P1085, DOI 10.1007/s00415-010-5889-5; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Heslop L, 2000, J CELL SCI, V113, P2299; Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Kutchukian C, 2017, J PHYSIOL-LONDON, V595, P7369, DOI 10.1113/JP274990; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lawlor MW, 2012, AM J PATHOL, V181, P961, DOI 10.1016/j.ajpath.2012.05.016; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Ribeiro AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48156-7; Romero NB, 2011, SEMIN PEDIATR NEUROL, V18, P250, DOI 10.1016/j.spen.2011.10.006; ROSE DSC, 1994, J CLIN PATHOL, V47, P1010, DOI 10.1136/jcp.47.11.1010; Ross J, 2012, STEM CELLS, V30, P2330, DOI 10.1002/stem.1197; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sambuughin N, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0481-3; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Sewry CA, 2017, NEUROPATH APPL NEURO, V43, P5, DOI 10.1111/nan.12369; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sidiropoulos PNM, 2012, BRAIN, V135, P1395, DOI 10.1093/brain/aws061; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Zammit PS, 2017, SEMIN CELL DEV BIOL, V72, P19, DOI 10.1016/j.semcdb.2017.11.011	51	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21346	10.1096/fj.202001313RRR	http://dx.doi.org/10.1096/fj.202001313RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715228	Green Submitted			2022-12-28	WOS:000635216100090
J	Brito, FMJD; Butcher, A; Pisconti, A; Poulet, B; Prior, A; Charlesworth, G; Sperinck, C; di Mase, MS; Liu, K; Bou-Gharios, G; van 't Hof, RJ; Daroszewska, A				Johnson de Sousa Brito, Francesca Manuela; Butcher, Andrew; Pisconti, Addolorata; Poulet, Blandine; Prior, Amanda; Charlesworth, Gemma; Sperinck, Catherine; Scotto di Mase, Michele; Liu, Ke; Bou-Gharios, George; Jurgen van 't Hof, Robert; Daroszewska, Anna			Syndecan-3 enhances anabolic bone formation through WNT signaling	FASEB JOURNAL			English	Article						bone; frizzled; osteoblast; Syndecan&#8208; 3; WNT		Osteoporosis is the most common age-related metabolic bone disorder, which is characterized by low bone mass and deterioration in bone architecture, with a propensity to fragility fractures. The best treatment for osteoporosis relies on stimulation of osteoblasts to form new bone and restore bone structure, however, anabolic therapeutics are few and their use is time restricted. Here, we report that Syndecan-3 increases new bone formation through enhancement of WNT signaling in osteoblasts. Young adult Sdc3(-/-) mice have low bone volume, reduced bone formation, increased bone marrow adipose tissue, increased bone fragility, and a blunted anabolic bone formation response to mechanical loading. This premature osteoporosis-like phenotype of Sdc3(-/-) mice is due to delayed osteoblast maturation and impaired osteoblast function, with contributing increased osteoclast-mediated bone resorption. Indeed, overexpressing Sdc3 in osteoblasts using the Col1a1 promoter rescues the low bone volume phenotype of the Sdc3(-/-) mice, and also increases bone volume in WT mice. Mechanistically, SDC3 enhances canonical WNT signaling in osteoblasts through stabilization of Frizzled 1, making SDC3 an attractive target for novel bone anabolic drug development.	[Johnson de Sousa Brito, Francesca Manuela; Butcher, Andrew; Poulet, Blandine; Prior, Amanda; Charlesworth, Gemma; Sperinck, Catherine; Scotto di Mase, Michele; Liu, Ke; Bou-Gharios, George; Jurgen van 't Hof, Robert; Daroszewska, Anna] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal & Ageing Sci, Dept Musculoskeletal Biol,Inst Life Course & Med, Liverpool, Merseyside, England; [Pisconti, Addolorata] Univ Liverpool, Dept Biochem, IIB, Liverpool, Merseyside, England; [Pisconti, Addolorata] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Daroszewska, Anna] Liverpool Univ Hosp NHS Fdn Trust, Dept Clin Biochem & Metab Med, Liverpool, Merseyside, England; [Daroszewska, Anna] Liverpool Univ Hosp NHS Fdn Trust, Dept Rheumatol, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	van 't Hof, RJ; Daroszewska, A (corresponding author), Univ Liverpool, Inst Life Course & Med Sci, Dept Musculoskeletal & Ageing Sci, 6 West Derby St, Liverpool L7 8TX, Merseyside, England.	r.vanthof@liverpool.ac.uk; a.daroszewska@liverpool.ac.uk		Pisconti, Addolorata/0000-0002-9631-8720; Daroszewska, Anna/0000-0002-6692-6610; Johnson de Sousa Brito, Francesca/0000-0001-9376-0487	Medical Research Council [MR/R002819/1]; Institute of Ageing and Chronic Disease, University of Liverpool, UK	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Ageing and Chronic Disease, University of Liverpool, UK	This project was financially supported by the Medical Research Council (grant MR/R002819/1) and funding from the Institute of Ageing and Chronic Disease, University of Liverpool, UK. We would like to thank Andy Houghton and Euan Owen, Institute of Life Course and Medical Sciences (formerly Institute of Ageing and Chronic Disease), University of Liverpool, for their help with animal work.	Abdallah BM, 2015, BONE, V70, P28, DOI 10.1016/j.bone.2014.07.028; Afratis NA, 2017, FEBS J, V284, P27, DOI 10.1111/febs.13940; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bhat V, 2016, STEM CELLS DEV, V25, P522, DOI 10.1089/scd.2015.0315; Canalis E, 2018, EUR J ENDOCRINOL, V178, pR33, DOI 10.1530/EJE-17-0920; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Eastell R, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.69, 10.1038/nrdp.2016.70]; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Fisher MC, 2006, MATRIX BIOL, V25, P27, DOI 10.1016/j.matbio.2005.07.008; Ghali O, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0056-6; GOULD SE, 1995, DEV BIOL, V168, P438, DOI 10.1006/dbio.1995.1093; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Idris AI, 2009, ENDOCRINOLOGY, V150, P5, DOI 10.1210/en.2008-0998; Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113; Imai S, 2009, BONE, V44, P785, DOI 10.1016/j.bone.2009.01.004; Itzstein C, 2012, METHODS MOL BIOL, V816, P177, DOI 10.1007/978-1-61779-415-5_12; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kaksonen M, 2002, MOL CELL NEUROSCI, V21, P158, DOI 10.1006/mcne.2002.1167; Katoh M, 2007, INT J MOL MED, V19, P529; Kim JM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1167-8; Koyama E, 1996, J ORTHOPAED RES, V14, P403, DOI 10.1002/jor.1100140310; KOYAMA E, 1995, DEV DYNAM, V203, P152, DOI 10.1002/aja.1002030204; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Lehoczky JA, 2018, NATURE, V557, P495, DOI 10.1038/d41586-018-04820-y; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mansouri R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.287; Newton PT, 2019, NATURE, V567, P234, DOI 10.1038/s41586-019-0989-6; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Pacifici M, 2005, J BONE MINER METAB, V23, P191, DOI 10.1007/s00774-004-0584-1; Pataki CA, 2015, J HISTOCHEM CYTOCHEM, V63, P465, DOI 10.1369/0022155415586961; Pisconti A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0104-8; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; RAULO E, 1994, J BIOL CHEM, V269, P12999; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Shimazu A, 1996, EXP CELL RES, V229, P126, DOI 10.1006/excr.1996.0350; Shimo T, 2004, DEV DYNAM, V229, P607, DOI 10.1002/dvdy.20009; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Simmons GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098861; Szenker-Ravi E, 2018, NATURE, V557, P564, DOI 10.1038/s41586-018-0118-y; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van't Hof RJ, 2017, BONE, V99, P69, DOI 10.1016/j.bone.2017.03.051; van't Hof RJ, 2012, METHODS MOL BIOL, V816, P461, DOI 10.1007/978-1-61779-415-5_27; Varanasi SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010692; Wang XD, 2018, JBMR PLUS, V2, P164, DOI 10.1002/jbm4.10030; Weivoda MM, 2016, J BONE MINER RES, V31, P65, DOI 10.1002/jbmr.2599; Wuelling M, 2019, NATURE, V567, P178, DOI 10.1038/d41586-019-00527-w; Yu SB, 2013, BONE, V56, P234, DOI 10.1016/j.bone.2013.06.019	61	1	1	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21246	10.1096/fj.202002024R	http://dx.doi.org/10.1096/fj.202002024R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769615	Green Published, hybrid			2022-12-28	WOS:000635216100022
J	Ohsawa, I; Kawano, F				Ohsawa, Ikumi; Kawano, Fuminori			Chronic exercise training activates histone turnover in mouse skeletal muscle fibers	FASEB JOURNAL			English	Article						exercise training; H2B&#8208; GFP; histone modification; myonucleus; skeletal muscle	PGC-1-ALPHA MESSENGER-RNA; METHYLATION; DYNAMICS; EXCHANGE	Epigenetic regulation of skeletal muscle adaptation to exercise is a recent topic for which there is limited information. This study investigated whether exercise training activates histone turnover in the skeletal muscle fibers of mice. Experiments using a tetracycline-inducible H2B-GFP expression model demonstrated that 4 weeks of running training, but not 2 weeks of training, significantly promoted the incorporation of H2B-GFP into nucleosomes and the dissociation of histone H3.3 at both transcriptionally upregulated and nonresponsive loci. Muscle-specific PGC-1 alpha-b-overexpressing mice crossed with H2B-GFP mice showed a slight increase in H2B-GFP incorporation at transcriptionally active loci, but not in the dissociation of H3.3 from nucleosomes. Gene expression responses to a single bout of running were significantly enhanced in 4-week trained mice when compared with those in 2-week trained mice. The most drastic increase in the gene response was found in the expression of Hspa1a and Hspa1b, in which the magnitude of upregulation in response to running was significantly enhanced from 8-fold in 2 week trained mice to 97- and 121-fold in 4 week trained mice, respectively. It was also found that the HSP70 level increased during the training period. In a myonuclear immunohistochemical analysis of chromatin remodelers, we further found that the level of SPT16, an H2A-H2B-specific chaperone, was upregulated after running training. These results revealed that 4 weeks of running training activated histone turnover in skeletal muscle fibers. They also suggested that histone turnover led to loosening of the nucleosomes and enhanced gene responses to exercise.	[Ohsawa, Ikumi; Kawano, Fuminori] Matsumoto Univ, Grad Sch Hlth Sci, 2095-1 Niimura, Matsumoto, Nagano 3901295, Japan		Kawano, F (corresponding author), Matsumoto Univ, Grad Sch Hlth Sci, 2095-1 Niimura, Matsumoto, Nagano 3901295, Japan.	kawano@t.matsu.ac.jp		Kawano, Fuminori/0000-0002-3714-0360	MEXT | Japan Society for the Promotion of Science (JSPS) [19K22824]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16H03263; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19K22824	ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Barone R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19781; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Boonsanay V, 2016, CELL STEM CELL, V18, P229, DOI 10.1016/j.stem.2015.11.002; Cho Y, 2019, MOL METAB, V23, P88, DOI 10.1016/j.molmet.2019.02.009; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; Gates LA, 2017, J BIOL CHEM, V292, P14456, DOI 10.1074/jbc.M117.802074; Goh Q, 2019, ELIFE, V8, DOI 10.7554/eLife.44876; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Le HQ, 2016, NAT CELL BIOL, V18, P864, DOI 10.1038/ncb3387; Jamai A, 2007, MOL CELL, V25, P345, DOI 10.1016/j.molcel.2007.01.019; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kawano F, 2015, J APPL PHYSIOL, V119, P1042, DOI 10.1152/japplphysiol.00289.2015; Koya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077788; Lim C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231321; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Lolis AA, 2013, J BIOL CHEM, V288, P7676, DOI 10.1074/jbc.M112.426718; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Nakamura K, 2017, J APPL PHYSIOL, V123, P902, DOI 10.1152/japplphysiol.00289.2017; Ohsawa I, 2018, J APPL PHYSIOL, V125, P1097, DOI 10.1152/japplphysiol.00074.2018; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Safina A, 2013, CELL CYCLE, V12, P2423, DOI 10.4161/cc.25452; Seaborne RA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20287-3; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Svensson JP, 2015, GENOME RES, V25, P872, DOI 10.1101/gr.188870.114; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Turner DC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40787-0; Tvardovskiy A, 2017, NUCLEIC ACIDS RES, V45, P9272, DOI 10.1093/nar/gkx696; Valenzuela N, 2017, J CELL SCI, V130, P2551, DOI 10.1242/jcs.200642; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wenderski W, 2016, BIOESSAYS, V38, P410, DOI 10.1002/bies.201500171; White Z, 2017, SKELET MUSCLE, V7, DOI [10.1186/s13395-017-0120-3, 10.1186/s13395-016-0117-3]; Winje IM, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13034; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Zhou JJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12996	39	7	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21453	10.1096/fj.202002027RR	http://dx.doi.org/10.1096/fj.202002027RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749947				2022-12-28	WOS:000635216100075
J	Zapata-Perez, R; Tammaro, A; Schomakers, BV; Scantlebery, AML; Denis, S; Elfrink, HL; Giroud-Gerbetant, J; Canto, C; Lopez-Leonardo, C; McIntyre, RL; van Weeghel, M; Sanchez-Ferrer, A; Houtkooper, RH				Zapata-Perez, Ruben; Tammaro, Alessandra; Schomakers, Bauke V.; Scantlebery, Angelique M. L.; Denis, Simone; Elfrink, Hyung L.; Giroud-Gerbetant, Judith; Canto, Carles; Lopez-Leonardo, Carmen; McIntyre, Rebecca L.; van Weeghel, Michel; Sanchez-Ferrer, Alvaro; Houtkooper, Riekelt H.			Reduced nicotinamide mononucleotide is a new and potent NAD(+) precursor in mammalian cells and mice	FASEB JOURNAL			English	Article						metabolism; NAD(+); NMNH; nicotinamide mononucleotide		Nicotinamide adenine dinucleotide (NAD(+)) homeostasis is constantly compromised due to degradation by NAD(+)-dependent enzymes. NAD(+) replenishment by supplementation with the NAD(+) precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can alleviate this imbalance. However, NMN and NR are limited by their mild effect on the cellular NAD(+) pool and the need of high doses. Here, we report a synthesis method of a reduced form of NMN (NMNH), and identify this molecule as a new NAD(+) precursor for the first time. We show that NMNH increases NAD(+) levels to a much higher extent and faster than NMN or NR, and that it is metabolized through a different, NRK and NAMPT-independent, pathway. We also demonstrate that NMNH reduces damage and accelerates repair in renal tubular epithelial cells upon hypoxia/reoxygenation injury. Finally, we find that NMNH administration in mice causes a rapid and sustained NAD(+) surge in whole blood, which is accompanied by increased NAD(+) levels in liver, kidney, muscle, brain, brown adipose tissue, and heart, but not in white adipose tissue. Together, our data highlight NMNH as a new NAD(+) precursor with therapeutic potential for acute kidney injury, confirm the existence of a novel pathway for the recycling of reduced NAD(+) precursors and establish NMNH as a member of the new family of reduced NAD(+) precursors.	[Zapata-Perez, Ruben; Schomakers, Bauke V.; Scantlebery, Angelique M. L.; Denis, Simone; Elfrink, Hyung L.; McIntyre, Rebecca L.; van Weeghel, Michel; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam UMC, Amsterdam Gastroenterol Endocrinol & Metab, Lab Genet Metab Dis,Amsterdam Cardiovasc Sci, Meibergdreef 9, Amsterdam, Netherlands; [Tammaro, Alessandra] Univ Amsterdam, Amsterdam UMC, Pathol Dept, Amsterdam, Netherlands; [Schomakers, Bauke V.; Elfrink, Hyung L.; van Weeghel, Michel] Univ Amsterdam, Amsterdam UMC, Core Facil Metabol, Amsterdam, Netherlands; [Giroud-Gerbetant, Judith; Canto, Carles] Nestle Res, Nestle Inst Hlth Sci, Lausanne, Switzerland; [Lopez-Leonardo, Carmen] Univ Murcia, Dept Organ Chem, Murcia, Spain; [Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Murcia, Spain	University of Amsterdam; University of Amsterdam; University of Amsterdam; Nestle SA; University of Murcia; University of Murcia	Zapata-Perez, R; Houtkooper, RH (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Gastroenterol Endocrinol & Metab, Lab Genet Metab Dis,Amsterdam Cardiovasc Sci, Meibergdreef 9, Amsterdam, Netherlands.	r.zapataperez@amsterdamumc.nl; r.h.houtkooper@amsterdamumc.nl	Houtkooper, Riekelt/P-5001-2019; Zapata-Perez, Ruben/AAA-9782-2020; Sanchez-Ferrer, Alvaro/M-1631-2014	Zapata-Perez, Ruben/0000-0003-4432-9652; Canto, Carles/0000-0002-5167-7922; Giroud-Gerbetant, Judith/0000-0001-6847-5721; Tammaro, Alessandra/0000-0003-3128-5259; Sanchez-Ferrer, Alvaro/0000-0001-7266-4402; Houtkooper, Riekelt/0000-0001-9961-0842	NWO-FAPESP [457002002]; European Union's Horizon 2020; ERC Starting grant [638290]; ZonMw [91715305]; Velux Stiftung [1063]; MINECO-FEDER [BIO2013-45336-R]; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia; Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia [19893/GERM/15];  [840110]	NWO-FAPESP; European Union's Horizon 2020; ERC Starting grant(European Research Council (ERC)); ZonMw(Netherlands Organization for Health Research and Development); Velux Stiftung; MINECO-FEDER; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia; Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia(Fundacion Seneca); 	NWO-FAPESP, Grant/Award Number: 457002002; European Union's Horizon 2020; Marie Sklodowska-Curie, Grant/Award Number: 840110; ERC Starting grant, Grant/Award Number: 638290; ZonMw, Grant/Award Number: 91715305; Velux Stiftung, Grant/Award Number: 1063; MINECO-FEDER, Grant/Award Number: BIO2013-45336-R; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia, Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia, Grant/Award Number: 19893/GERM/15	Abdelraheim SR, 2017, PROTEIN J, V36, P425, DOI 10.1007/s10930-017-9734-x; Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Airhart SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186459; Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; ASH SR, 1970, AM J PATHOL, V60, P385; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bonventre Joseph V, 2014, Trans Am Clin Climatol Assoc, V125, P293; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cao LJ, 2017, FREE RADICAL BIO MED, V112, P433, DOI 10.1016/j.freeradbiomed.2017.08.011; Chung KW, 2019, CELL METAB, V30, P784, DOI 10.1016/j.cmet.2019.08.003; Connell NJ, 2019, DIABETOLOGIA, V62, P888, DOI 10.1007/s00125-019-4831-3; Conze D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46120-z; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Dollerup OL, 2018, AM J CLIN NUTR, V108, P343, DOI 10.1093/ajcn/nqy132; Elena-Real CA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0408-1; Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043; FRICK DN, 1995, J BIOL CHEM, V270, P1529, DOI 10.1074/jbc.270.4.1529; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Giroud-Gerbetant J, 2019, MOL METAB, V30, P192, DOI 10.1016/j.molmet.2019.09.013; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Goodman RP, 2020, NATURE, V583, P122, DOI 10.1038/s41586-020-2337-2; Grozio A, 2019, NAT METAB, V1, P47, DOI 10.1038/s42255-018-0009-4; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Guan Y, 2017, J AM SOC NEPHROL, V28, P2337, DOI 10.1681/ASN.2016040385; Hosios AM, 2018, J BIOL CHEM, V293, P7490, DOI 10.1074/jbc.TM117.000239; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang SZ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005233; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ishibashi N, 1999, J IMMUNOL, V163, P5666; KATO T, 1973, ANAL BIOCHEM, V53, P86, DOI 10.1016/0003-2697(73)90409-0; Khamchun S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0123-9; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kim J, 2015, AM J PHYSIOL-RENAL, V308, pF298, DOI 10.1152/ajprenal.00459.2014; Lan RP, 2016, J AM SOC NEPHROL, V27, P3356, DOI 10.1681/ASN.2015020177; Langley B, 2013, NEUROTHERAPEUTICS, V10, P605, DOI 10.1007/s13311-013-0214-5; Leung AKL, 2017, CURR BIOL, V27, pR1256, DOI 10.1016/j.cub.2017.09.054; Love NR, 2015, P NATL ACAD SCI USA, V112, P1386, DOI 10.1073/pnas.1417290112; MANDEL LJ, 1990, J CLIN INVEST, V85, P316, DOI 10.1172/JCI114440; Martens CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03421-7; Martin DR, 2000, AM J PHYSIOL-REG I, V279, pR1834, DOI 10.1152/ajpregu.2000.279.5.R1834; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; PALLER MS, 1992, J AM SOC NEPHROL, V2, P1338; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Ralto KM, 2020, NAT REV NEPHROL, V16, P99, DOI 10.1038/s41581-019-0216-6; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Remie CME, 2020, AM J CLIN NUTR, V112, P413, DOI 10.1093/ajcn/nqaa072; Ren HL, 2018, MED SCI MONITOR, V24, P1132, DOI 10.12659/MSM.908954; Riss TL, 2004, CELL VIABILITY ASSAY; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Scantlebery AML, 2021, J PATHOL, V253, P404, DOI 10.1002/path.5605; Stokman G, 2011, J AM SOC NEPHROL, V22, P859, DOI 10.1681/ASN.2010040423; Stokman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014386; Tammaro A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01346; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Wei Wenjie, 2014, World J Biol Chem, V5, P58, DOI 10.4331/wjbc.v5.i1.58; Xiao WS, 2018, ANTIOXID REDOX SIGN, V28, P251, DOI 10.1089/ars.2017.7216; Yang B, 2001, J AM SOC NEPHROL, V12, P275, DOI 10.1681/ASN.V122275; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang Y, 2019, J BIOL CHEM, V294, P9295, DOI 10.1074/jbc.RA118.005772; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhou HL, 2019, NATURE, V565, P96, DOI 10.1038/s41586-018-0749-z	73	20	21	8	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21456	10.1096/fj.202001826R	http://dx.doi.org/10.1096/fj.202001826R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724555	hybrid			2022-12-28	WOS:000635216100078
J	Chiu, LY; Wu, NL; Hung, CF; Bai, P; Dai, YS; Lin, WW				Chiu, Ling-Ya; Wu, Nan-Lin; Hung, Chi-Feng; Bai, Peter; Dai, Yang-Shia; Lin, Wan-Wan			PARP-1 involves in UVB-induced inflammatory response in keratinocytes and skin injury via regulation of ROS-dependent EGFR transactivation and p38 signaling	FASEB JOURNAL			English	Article						EGFR; inflammation; keratinocyte; PARP&#8208; 1; UVB	GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; KINASE ACTIVATION; OXIDATIVE STRESS; I INTERFERON; EXPRESSION; IRRADIATION; INHIBITION; APOPTOSIS	UV irradiation can injure the epidermis, resulting in sunburn, inflammation, and cutaneous tissue disorders. Previous studies demonstrate that EGFR in keratinocytes can be activated by UVB and contributes to inflammation. Poly (ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme and plays an essential role in DNA repair under moderate stress. In this study, we set out to understand how PARP-1 regulates UVB irradiation-induced skin injury and interplays with EGFR to mediate the inflammation response. We found that PARP-1 deficiency exacerbated the UVB-induced inflammation, water loss, and back skin damage in mice. In human primary keratinocytes, UVB can activate PARP-1 and enhance DNA damage upon PARP-1 gene silencing. Moreover, PARP-1 silencing and PARP inhibitor olaparib can suppress UVB-induced COX-2 and MMP-1 expression, but enhance TNF-alpha and IL-8 expression. In addition, EGFR silencing or EGFR inhibition by gefitinib can decrease UVB-induced COX-2, TNF-alpha, and IL-8 expression, suggesting EGFR activation via paracrine action can mediate UVB-induced inflammation responses. Immunoblotting data revealed that PARP-1 inhibition decreases UVB-induced EGFR and p38 activation. Pharmacological inhibition of p38 also dramatically led to the attenuation of UVB-induced inflammatory gene expression. Of note, genetic ablation of PARP-1 or EGFR can attenuate UVB-induced ROS production, and antioxidant NAC can attenuate UVB-induced EGFR-p38 signaling axis and PARP-1 activation. These data suggest the regulatory loops among EGFR, PARP-1, and ROS upon UVB stress. PARP-1 not only serves DNA repair function but also orchestrates interactions to EGFR transactivation and ROS production, leading to p38 signaling for inflammatory gene expression in keratinocytes.	[Chiu, Ling-Ya; Lin, Wan-Wan] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Rm 1119,11F,1,Sec 1,Renai Rd, Taipei 100, Taiwan; [Chiu, Ling-Ya] MacKay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wu, Nan-Lin] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Wu, Nan-Lin] MacKay Mem Hosp, Dept Dermatol, Taipei, Taiwan; [Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Bai, Peter] Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary; [Bai, Peter] MTA DE Lendulet Lab Cellular Metab, Debrecen, Hungary; [Bai, Peter] Univ Debrecen, Res Ctr Mol Med, Debrecen, Hungary; [Dai, Yang-Shia] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Lin, Wan-Wan] Natl Def Med Ctr, Dept & Grad Inst Pharmacol, Taipei, Taiwan; [Lin, Wan-Wan] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital; Fu Jen Catholic University; University of Debrecen; University of Debrecen; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Taipei Medical University	Lin, WW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pharmacol, Rm 1119,11F,1,Sec 1,Renai Rd, Taipei 100, Taiwan.	wwllaura1119@ntu.edu.tw	Hung, Chi-Feng/AAL-4977-2021	Hung, Chi-Feng/0000-0003-3478-5451; Lin, Wan Wan/0000-0002-3207-734X	Ministry of Science and Technology, Taiwan (MOST) [MOST 108-2911-I-002-513, MOST 107-2911-I-002-544]; Hungarian Academy of Sciences [NKM-26/2019]; Academia Sinica [AS-TP-106-L11]; NTU | College of Medicine, National Taiwan University (NTUCM) [NSCCMOH-94-51, NSCCMOH-131-21]; National Taiwan University Hospital (NTUH) [109-M4754]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Academia Sinica(Academia Sinica - Taiwan); NTU | College of Medicine, National Taiwan University (NTUCM); National Taiwan University Hospital (NTUH)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 107-2911-I-002-544; Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 108-2911-I-002-513; Hungarian Academy of Sciences, Grant/Award Number: NKM-26/2019; Academia Sinica, Grant/Award Number: AS-TP-106-L11; NTU | College of Medicine, National Taiwan University (NTUCM), Grant/Award Number: NSCCMOH-94-51; NTU | College of Medicine, National Taiwan University (NTUCM), Grant/Award Number: NSCCMOH-131-21; National Taiwan University Hospital (NTUH), Grant/Award Number: 109-M4754	Brand RM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00920; Burian M, 2018, J INVEST DERMATOL, V138, P2507, DOI 10.1016/j.jid.2018.08.004; Byun S, 2013, CARCINOGENESIS, V34, P397, DOI 10.1093/carcin/bgs358; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Cimino F, 2006, J AGR FOOD CHEM, V54, P4041, DOI 10.1021/jf060253x; El-Abaseri Taghrid Bahig, 2013, ISRN Dermatol, V2013, P848705, DOI 10.1155/2013/848705; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Ghodgaonkar MM, 2008, DNA REPAIR, V7, P617, DOI 10.1016/j.dnarep.2008.01.001; Gruber JV, 2019, J INFLAMM RES, V12, P219, DOI 10.2147/JIR.S215776; Gu YP, 2020, AGEING RES REV, V59, DOI 10.1016/j.arr.2020.101036; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Han WN, 2009, PHOTOCHEM PHOTOBIOL, V85, P997, DOI 10.1111/j.1751-1097.2008.00531.x; He Y, 2017, J PHOTOCH PHOTOBIO B, V177, P24, DOI 10.1016/j.jphotobiol.2017.10.006; Hegedus C, 2020, CANCERS, V12, DOI 10.3390/cancers12010005; Hegedus C, 2014, REDOX BIOL, V2, P978, DOI 10.1016/j.redox.2014.08.003; Hocsak E, 2017, FREE RADICAL BIO MED, V108, P770, DOI 10.1016/j.freeradbiomed.2017.04.018; Huang CC, 2010, INT J MOL SCI, V11, P4782, DOI 10.3390/ijms11124782; Jiao J, 2014, CARCINOGENESIS, V35, P1310, DOI 10.1093/carcin/bgu020; Kammeyer A, 2015, AGEING RES REV, V21, P16, DOI 10.1016/j.arr.2015.01.001; Kang JS, 2007, J INVEST DERMATOL, V127, P698, DOI 10.1038/sj.jid.5700572; Kim I, 2014, GENES DIS, V1, P188, DOI 10.1016/j.gendis.2014.08.005; Kim KM, 2019, BIOL PHARM BULL, V42, P1524, DOI 10.1248/bpb.b19-00222; Kiss B, 2020, EXP DERMATOL, V29, P79, DOI 10.1111/exd.14061; Langelier MF, 2018, CURR OPIN STRUC BIOL, V53, P187, DOI 10.1016/j.sbi.2018.11.002; Lee JW, 2020, PHOTOCHEM PHOTOBIOL, V96, P478, DOI 10.1111/php.13245; Li N, 2016, CELL REP, V15, P843, DOI 10.1016/j.celrep.2016.03.070; Li YL, 2018, CARCINOGENESIS, V39, P700, DOI 10.1093/carcin/bgy039; Lin P, 2019, CYTOTECHNOLOGY, V71, P1003, DOI 10.1007/s10616-019-00342-1; Liu Q, 2018, ONCOGENE, V37, P2793, DOI 10.1038/s41388-018-0130-6; MILLER CC, 1994, J BIOL CHEM, V269, P3529; Mohania D, 2017, ADV EXP MED BIOL, V996, P71, DOI 10.1007/978-3-319-56017-5_7; Mortadza SAS, 2018, GLIA, V66, P562, DOI 10.1002/glia.23265; Nanba D, 2013, J DERMATOL SCI, V72, P81, DOI 10.1016/j.jdermsci.2013.05.009; Park M, 2013, EXP DERMATOL, V22, P336, DOI 10.1111/exd.12138; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pastore S, 2014, ARCH TOXICOL, V88, P1189, DOI 10.1007/s00204-014-1244-4; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; Peus D, 2001, CURR PROBL DERMATOL, V29, P114; Pines A, 2013, TRENDS BIOCHEM SCI, V38, P321, DOI 10.1016/j.tibs.2013.03.002; Piskunova T S, 2007, Adv Gerontol, V20, P82; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Prasad R, 2017, PHOTOCHEM PHOTOBIOL, V93, P930, DOI 10.1111/php.12687; Raad H, 2017, J INVEST DERMATOL, V137, P1311, DOI 10.1016/j.jid.2016.12.027; Robaszkiewicz A, 2014, FREE RADICAL BIO MED, V76, P69, DOI 10.1016/j.freeradbiomed.2014.07.027; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Seo M, 2010, BIOCHEM BIOPH RES CO, V393, P190, DOI 10.1016/j.bbrc.2010.01.085; Sontheimer C, 2017, ARTHRITIS RHEUMATOL, V69, P826, DOI 10.1002/art.39987; Tan TC, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00703; Van Laethem A, 2006, FREE RADICAL BIO MED, V41, P1361, DOI 10.1016/j.freeradbiomed.2006.07.007; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Wan YS, 2001, INT J MOL MED, V7, P329; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Wang JY, 2020, J DERMATOL SCI, V98, P119, DOI 10.1016/j.jdermsci.2020.03.007; Wang Q, 2005, INT J MOL MED, V15, P633; Wu NL, 2016, J INVEST DERMATOL, V136, P192, DOI 10.1038/JID.2015.381; Wu SL, 2008, MOL IMMUNOL, V45, P2288, DOI 10.1016/j.molimm.2007.11.019; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yin ZX, 2018, ONCOTARGET, V9, P1885, DOI 10.18632/oncotarget.21277; Zhuang LH, 1999, J IMMUNOL, V162, P1440	62	10	11	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21393	10.1096/fj.202002285RR	http://dx.doi.org/10.1096/fj.202002285RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570794	Bronze			2022-12-28	WOS:000629576700042
J	Koch, L; Kespohl, B; Agthe, M; Schumertl, T; Dusterhoft, S; Lemberg, MK; Lokau, J; Garbers, C				Koch, Lydia; Kespohl, Birte; Agthe, Maria; Schumertl, Tim; Dusterhoft, Stefan; Lemberg, Marius K.; Lokau, Juliane; Garbers, Christoph			Interleukin-11 (IL-11) receptor cleavage by the rhomboid protease RHBDL2 induces IL-11 trans-signaling	FASEB JOURNAL			English	Article						cytokine; interleukin&#8208; 11; protease; RHBDL2; rhomboid		Interleukin-11 (IL-11) is a pleiotropic cytokine with both pro- and anti-inflammatory properties. It activates its target cells via binding to the membrane-bound IL-11 receptor (IL-11R), which then recruits a homodimer of the ubiquitously expressed, signal-transducing receptor gp130. Besides this classic signaling pathway, IL-11 can also bind to soluble forms of the IL-11R (sIL-11R), and IL-11/sIL-11R complexes activate cells via the induction of gp130 homodimerization (trans-signaling). We have previously reported that the metalloprotease ADAM10 cleaves the membrane-bound IL-11R and thereby generates sIL-11R. In this study, we identify the rhomboid intramembrane protease RHBDL2 as a so far unrecognized alternative sheddase that can efficiently trigger IL-11R secretion. We determine the cleavage site used by RHBDL2, which is located in the extracellular part of the receptor in close proximity to the plasma membrane, between Ala-370 and Ser-371. Furthermore, we identify critical amino acid residues within the transmembrane helix that are required for IL-11R proteolysis. We also show that ectopically expressed RHBDL2 is able to cleave the IL-11R within the early secretory pathway and not only at the plasma membrane, indicating that its subcellular localization plays a central role in controlling its activity. Moreover, RHBDL2-derived sIL-11R is biologically active and able to perform IL-11 trans-signaling. Finally, we show that the human mutation IL-11R-A370V does not impede IL-11 classic signaling, but prevents RHBDL2-mediated IL-11R cleavage.	[Koch, Lydia; Agthe, Maria] Univ Kiel, Inst Biochem, Kiel, Germany; [Kespohl, Birte; Schumertl, Tim; Lokau, Juliane; Garbers, Christoph] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany; [Dusterhoft, Stefan] Rhein Westfal TH Aachen, Inst Mol Pharmacol, Aachen, Germany; [Lemberg, Marius K.] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany	University of Kiel; Otto von Guericke University; RWTH Aachen University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Garbers, C (corresponding author), Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany.	christoph.garbers@med.ovgu.de	Garbers, Christoph/D-9932-2015; Lemberg, Marius K/B-8881-2016	Garbers, Christoph/0000-0003-4939-6950; Lemberg, Marius K/0000-0002-0996-1268; Dusterhoft, Stefan/0000-0002-6926-136X	Deutsche Forschungsgemeinschaft (DFG) [125440785 -A10]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 125440785 -A10	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Agthe M, 2018, CELL REP, V25, P10, DOI 10.1016/j.celrep.2018.09.005; Agthe M, 2017, PLACENTA, V57, P13, DOI 10.1016/j.placenta.2017.05.015; Balic JJ, 2017, CYTOKINE, V92, P118, DOI 10.1016/j.cyto.2017.01.015; Battistini C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235958; Bilinski P, 1998, GENE DEV, V12, P2234, DOI 10.1101/gad.12.14.2234; Brischoux-Boucher E, 2018, CLIN GENET, V94, P373, DOI 10.1111/cge.13409; Clarke CM, 2018, AM J MED GENET A, V176, P290, DOI 10.1002/ajmg.a.38540; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Johnson N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07556-3; Johnstone CN, 2015, CYTOKINE GROWTH F R, V26, P489, DOI 10.1016/j.cytogfr.2015.07.015; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Keupp K, 2013, MOL GENET GENOM MED, V1, P223, DOI 10.1002/mgg3.28; Korakavi N, 2019, AM J MED GENET A, V179, P668, DOI 10.1002/ajmg.a.61070; Lastun VL, 2016, SEMIN CELL DEV BIOL, V60, P10, DOI 10.1016/j.semcdb.2016.07.033; Lei XJ, 2009, J MOL BIOL, V394, P815, DOI 10.1016/j.jmb.2009.10.025; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Liao HJ, 2012, TRAFFIC, V13, P1106, DOI 10.1111/j.1600-0854.2012.01371.x; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Lokau J, 2018, J BIOL CHEM, V293, P6398, DOI 10.1074/jbc.RA118.001879; Lokau J, 2017, BBA-MOL CELL RES, V1864, P2105, DOI 10.1016/j.bbamcr.2017.06.008; Lokau J, 2017, BIOCHEM BIOPH RES CO, V491, P296, DOI 10.1016/j.bbrc.2017.07.106; Lokau J, 2017, INT J BIOCHEM CELL B, V85, P6, DOI 10.1016/j.biocel.2017.01.014; Lokau J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1785021; Lokau J, 2016, CELL REP, V14, P1761, DOI 10.1016/j.celrep.2016.01.053; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Nitz R, 2015, BIOCHIMIE, V119, P175, DOI 10.1016/j.biochi.2015.11.005; Noy PJ, 2016, FASEB J, V30, P2311, DOI 10.1096/fj.201500122R; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Putoczki TL, 2015, IMMUNOTHERAPY-UK, V7, P441, DOI [10.2217/IMT.15.17, 10.2217/imt.15.17]; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Riethmueller S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000080; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sammel M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153677; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schumacher N, 2015, J BIOL CHEM, V290, P26059, DOI 10.1074/jbc.M115.649509; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; SUEN Y, 1994, BLOOD, V84, P4125, DOI 10.1182/blood.V84.12.4125.bloodjournal84124125; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wilde MI, 1998, BIODRUGS, V10, P159, DOI 10.2165/00063030-199810020-00006; Winship AL, 2016, MOL CANCER THER, V15, P720, DOI 10.1158/1535-7163.MCT-15-0677; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342	55	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21380	10.1096/fj.202002087R	http://dx.doi.org/10.1096/fj.202002087R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566379	Green Published			2022-12-28	WOS:000629576700001
J	Young, GH; Lin, JT; Cheng, YF; Ho, CF; Kuok, QY; Hsu, RC; Liao, WR; Chen, CC; Chen, HM				Young, Guang-Huar; Lin, Jiun-Tsai; Cheng, Yi-Fang; Ho, Chia-Fang; Kuok, Qian-Yu; Hsu, Ru-Chun; Liao, Wan-Rou; Chen, Chin-Chen; Chen, Han-Min			Modulation of adenine phosphoribosyltransferase-mediated salvage pathway to accelerate diabetic wound healing	FASEB JOURNAL			English	Article						adenine; adenylate energy charge; AMPK; APRT; diabetic wound healing		Adenine phosphoribosyltransferase (APRT) is the key enzyme involved in purine salvage by the incorporation of adenine and phosphoribosyl pyrophosphate to provide adenylate nucleotides. To evaluate the role of APRT in the repair processes of cutaneous wounds in healthy skin and in diabetic patients, a diabetic mouse model (db/db) and age-matched wild-type mice were used. Moreover, the topical application of adenine was assessed. In vitro studies, analytical, histological, and immunohistochemical methods were used. Diabetic mice treated with adenine exhibited elevated ATP levels in organismic skin and accelerated wound healing. In vitro studies showed that APRT utilized adenine to rescue cellular ATP levels and proliferation from hydrogen peroxide-induced oxidative damage. HPLC-ESI-MS/MS-based analysis of total adenylate nucleotides in NIH-3T3 fibroblasts demonstrated that adenine addition enlarged the cellular adenylate pool, reduced the adenylate energy charge, and provided additional AMP for the further generation of ATP. These data indicate an upregulation of APRT in skin wounds, highlighting its role during the healing of diabetic wounds through regulation of the nucleotide pool after injury. Furthermore, topical adenine supplementation resulted in an enlargement of the adenylate pool needed for the generation of ATP, an important molecule for wound repair.	[Young, Guang-Huar; Lin, Jiun-Tsai; Cheng, Yi-Fang; Ho, Chia-Fang; Kuok, Qian-Yu; Hsu, Ru-Chun; Liao, Wan-Rou; Chen, Chin-Chen; Chen, Han-Min] Energenesis Biomed Co Ltd, Taipei, Taiwan; [Chen, Han-Min] Catholic Fu Jen Univ, Inst Appl Sci & Engn, Dept Life Sci, 510 Zhongzheng Rd, New Taipei 24205, Taiwan	Fu Jen Catholic University	Chen, HM (corresponding author), Catholic Fu Jen Univ, Inst Appl Sci & Engn, Dept Life Sci, 510 Zhongzheng Rd, New Taipei 24205, Taiwan.	steven@energenesis-biomedical.com			Energenesis-Biomedical	Energenesis-Biomedical	Energenesis-Biomedical	Andreea SI, 2008, EXP DIABETES RES, DOI 10.1155/2008/473603; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Baranowska-Bosiacka I, 2009, TOXICOLOGY, V259, P77, DOI 10.1016/j.tox.2009.02.005; Bhagavan NV., 2011, NUCLEOTIDE METABOLIS, pCH25; Burnstock G, 2012, J INVEST DERMATOL, V132, P526, DOI 10.1038/jid.2011.344; Sanchez MC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080098; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; CARTIER PH, 1980, J BIOL CHEM, V255, P4574; Chen Y, 2017, INT J CLIN EXP MED, V10, P14904; Cheng YF, 2016, EXP DERMATOL, V25, P162, DOI 10.1111/exd.12881; Cheng YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142283; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Foker JE., 1988, GOOGLE PATENTS; Frenguelli BG, 2019, NEUROCHEM RES, V44, P661, DOI 10.1007/s11064-017-2386-6; Gassmann MG, 1999, ONCOGENE, V18, P6667, DOI 10.1038/sj.onc.1203120; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Gupta A, 2005, MOL CELL BIOCHEM, V270, P71, DOI 10.1007/s11010-005-5258-3; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2014, J INTERN MED, V276, P543, DOI 10.1111/joim.12268; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Howard JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091787; IM MJC, 1970, J SURG RES, V10, P459, DOI 10.1016/0022-4804(70)90070-3; IM MJC, 1970, J SURG RES, V10, P173; Jin CE, 2015, GENET MOL RES, V14, P8883, DOI 10.4238/2015.August.3.11; KAMATANI N, 1981, BIOCHIM BIOPHYS ACTA, V675, P344, DOI 10.1016/0304-4165(81)90024-6; Kiernan J.A., 2015, HISTOLOGICAL HISTOCH, P454; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Lee DH, 2014, INT J MOL MED, V33, P1147, DOI 10.3892/ijmm.2014.1698; Lelli JL, 1998, FREE RADICAL BIO MED, V25, P694, DOI 10.1016/S0891-5849(98)00107-5; Leu JG, 2018, EUR J PHARMACOL, V818, P569, DOI 10.1016/j.ejphar.2017.11.027; Li HC, 2015, J BIOL CHEM, V290, P24592, DOI 10.1074/jbc.M115.680074; Liao WR, 2020, J FOOD DRUG ANAL, V28, P365, DOI 10.38212/2224-6614.1007; Lin JT, 2014, EXPERT OPIN INV DRUG, V23, P1253, DOI 10.1517/13543784.2014.922951; Mansbridge JN, 1999, DIABETES OBES METAB, V1, P265, DOI 10.1046/j.1463-1326.1999.00032.x; MAZOR D, 1994, VOX SANG, V66, P264, DOI 10.1111/j.1423-0410.1994.tb00327.x; Muller WEG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188977; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; Nouvong A, 2016, PHYSIOL GENOMICS, V48, P889, DOI 10.1152/physiolgenomics.00066.2016; Paglia G, 2016, TRANSFUSION, V56, P2538, DOI 10.1111/trf.13740; PAKKENBERG H, 1965, ACTA NEUROL SCAND, V41, P497, DOI 10.1111/j.1600-0404.1965.tb04740.x; Papanas N, 2010, DRUG SAFETY, V33, P455, DOI 10.2165/11534570-000000000-00000; Park SA, 2014, WOUND REPAIR REGEN, V22, P368, DOI 10.1111/wrr.12172; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; ROSSOMANDO EF, 1983, J SURG RES, V35, P259, DOI 10.1016/S0022-4804(83)80012-2; Sarojini H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174899; Smith DG, 1999, FOOT ANKLE INT, V20, P258, DOI 10.1177/107110079902000409; STUART MJ, 1977, AM J HEMATOL, V2, P53, DOI 10.1002/ajh.2830020108; Sun CY, 2015, J AM SOC NEPHROL, V26, P281, DOI 10.1681/ASN.2014010021; Thimm D, 2015, ACTA PHYSIOL, V213, P808, DOI 10.1111/apha.12452; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vande Berg JS, 2003, SURG CLIN N AM, V83, P509, DOI 10.1016/S0039-6109(02)00195-0; Wang JP, 2010, AM J SURG, V199, P823, DOI 10.1016/j.amjsurg.2009.05.040; Wang XY, 2016, J BIOTECHNOL, V231, P115, DOI 10.1016/j.jbiotec.2016.05.032; Wojtowicz AM, 2014, WOUND REPAIR REGEN, V22, P246, DOI 10.1111/wrr.12154; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Young G-H., 2015, HONG KONG J NEPHROL, V2, pS19; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Young GH, 2020, J CEREBR BLOOD F MET, V40, P1316, DOI 10.1177/0271678X19861448; Young GH, 2015, J PROTEOMICS, V120, P204, DOI 10.1016/j.jprot.2015.03.012; Young GH, 2014, ANTIOXID REDOX SIGN, V20, P1181, DOI 10.1089/ars.2013.5366	64	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21296	10.1096/fj.202001736RR	http://dx.doi.org/10.1096/fj.202001736RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33675115				2022-12-28	WOS:000629576700019
J	Zhong, YX; Yu, JS; Wang, XQ; Binas, B; Yoo, HH				Zhong, Yixiang; Yu, Jun Sang; Wang, Xiaoqiong; Binas, Bert; Yoo, Hye Hyun			Chemical-based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: Comparison with the spheroid model	FASEB JOURNAL			English	Article						drug&#8208; induced liver injury; drug metabolism; hepatotoxicity; long&#8208; term cell culture; primary human hepatocyte		Traditionally cultured monolayers of primary human hepatocytes (PHHs) deteriorate within days and thereby become unsuitable for drug-related studies. PHH spheroids (3D PHHs) maintain liver functions for weeks, but are considerably more demanding. Recently, a chemical-based approach (5C PHHs) succeeded in long-term culture of hepatocyte monolayers, but it remains unclear whether the drug-related functions are preserved. To clarify this, we compared the 5C and 3D PHHs in terms of gene expression analysis, proteomic analysis, functionality (basal and induced activities of representative CYP450 enzymes and urea and albumin secretions), survival in culture, and sensitivity to representative drugs. In all comparisons, which spanned culture durations of up to 4 weeks, the 5C PHHs performed at least as well as the 3D PHHs. Hence, the novel 5C PHH monolayer format combines the convenience of the traditional monolayer format with the functionality and maintainability of the spheroid format. Our results suggest that 5C PHH monolayers can be used more conveniently and efficiently for high-throughput drug screening, preclinical drug safety evaluations, and mechanistic studies.	[Zhong, Yixiang; Yu, Jun Sang; Yoo, Hye Hyun] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan, Gyeonggi Do, South Korea; [Zhong, Yixiang; Yu, Jun Sang; Yoo, Hye Hyun] Hanyang Univ, Coll Pharm, Ansan, Gyeonggi Do, South Korea; [Zhong, Yixiang; Wang, Xiaoqiong; Binas, Bert] Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea	Hanyang University; Hanyang University; Hanyang University	Yoo, HH (corresponding author), Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan, Gyeonggi Do, South Korea.; Yoo, HH (corresponding author), Hanyang Univ, Coll Pharm, Ansan, Gyeonggi Do, South Korea.	yoohh@hanyang.ac.kr			National Research Foundation of Korea (NRF) [2017R1A2B4001814]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2017R1A2B4001814	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Baze A, 2018, TISSUE ENG PART C-ME, V24, P534, DOI [10.1089/ten.tec.2018.0134, 10.1089/ten.TEC.2018.0134]; Bell CC, 2018, TOXICOL SCI, V162, P655, DOI 10.1093/toxsci/kfx289; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Bjornsson ES, 2015, ARCH TOXICOL, V89, P327, DOI 10.1007/s00204-015-1456-2; Boteon YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201419; Chapman KL, 2013, REGUL TOXICOL PHARM, V66, P88, DOI 10.1016/j.yrtph.2013.03.001; Esposti DD, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/387626; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Germano D, 2015, TOXICOL IN VITRO, V30, P79, DOI 10.1016/j.tiv.2014.05.009; Gu XL, 2018, ARCH TOXICOL, V92, P3505, DOI 10.1007/s00204-018-2302-0; HAUSSINGER D, 1990, KLIN WOCHENSCHR, V68, P1096, DOI 10.1007/BF01798059; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Jang KJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax5516; Gomez-Lechon MJ, 2014, EXPERT OPIN DRUG MET, V10, P1553, DOI 10.1517/17425255.2014.967680; Katsuda T, 2020, FEBS LETT, V594, P114, DOI 10.1002/1873-3468.13582; Lauschke VM, 2016, CHEM RES TOXICOL, V29, P1936, DOI 10.1021/acs.chemrestox.6b00150; LEE CH, 1993, J CELL PHYSIOL, V157, P392, DOI 10.1002/jcp.1041570223; Lewis DFV, 1998, ENVIRON HEALTH PERSP, V106, P633; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; McMillian MK, 2001, IN VITRO MOL TOXICOL, V14, P177, DOI 10.1089/109793301753407948; Oorts M, 2016, TOXICOL IN VITRO, V34, P179, DOI 10.1016/j.tiv.2016.03.008; Oorts M, 2015, J PHARMACOL TOX MET, V73, P63, DOI 10.1016/j.vascn.2015.03.002; Prieur X, 2005, J BIOL CHEM, V280, P27533, DOI 10.1074/jbc.M503139200; Regenthal R, 1999, J CLIN MONITOR COMP, V15, P529, DOI 10.1023/A:1009935116877; Shen T, 2019, GASTROENTEROLOGY, V156, P2230, DOI 10.1053/j.gastro.2019.02.002; Shiga T, 2011, HEART VESSELS, V26, P274, DOI 10.1007/s00380-010-0047-7; Suk KT, 2012, AM J GASTROENTEROL, V107, P1380, DOI 10.1038/ajg.2012.138; Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; Tang D, 2020, BIOCHEM BIOPH RES CO, V525, P238, DOI 10.1016/j.bbrc.2020.02.041; Tetsuka K, 2017, J PHARM SCI-US, V106, P2302, DOI 10.1016/j.xphs.2017.05.010; van Giersbergen PLM, 2005, J CLIN PHARMACOL, V45, P42, DOI 10.1177/0091270004270833; Vildhede A, 2015, J PROTEOME RES, V14, P3305, DOI 10.1021/acs.jproteome.5b00334; Vorrink SU, 2017, FASEB J, V31, P2696, DOI 10.1096/fj.201601375R; Xiang CG, 2019, SCIENCE, V364, P399, DOI 10.1126/science.aau7307; Xu JHJ, 2008, TOXICOL SCI, V105, P97, DOI 10.1093/toxsci/kfn109; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zeilinger K, 2016, EXP BIOL MED, V241, P1684, DOI 10.1177/1535370216657448; Zhong Y., 2021, FASEB J, V35; Zhong Y, 2019, GENES CELLS, V24, P324, DOI 10.1111/gtc.12678	43	1	1	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21379	10.1096/fj.202001629RR	http://dx.doi.org/10.1096/fj.202001629RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566373				2022-12-28	WOS:000629576700025
J	Zhou, RM; Liao, JS; Cai, DP; Tian, Q; Huang, EP; Lu, TM; Chen, SY; Xie, WB				Zhou, Ruimei; Liao, Jiashun; Cai, Dunpeng; Tian, Qin; Huang, Enping; Lu, Tianming; Chen, Shi-You; Xie, Wei-Bing			Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						epithelial&#8208; mesenchymal transition; fibroblast activation; Nupr1; renal fibrosis	NUCLEAR-PROTEIN; STRESS-RESPONSE; EMERGING ROLE; EXPRESSION; P8; GENE; CONTRIBUTES; CLONING; ORIGIN; CELLS	Renal interstitial fibrosis (RIF) is a pathological process that fibrotic components are excessively deposited in the renal interstitial space due to kidney injury, resulting in impaired renal function and chronic kidney disease. The molecular mechanisms controlling renal fibrosis are not fully understood. In this present study, we identified Nuclear protein 1 (Nupr1), a transcription factor also called p8, as a novel regulator promoting renal fibrosis. Unilateral ureteral obstruction (UUO) time-dependently induced Nupr1 mRNA and protein expression in mouse kidneys while causing renal damage and fibrosis. Nupr1 deficiency (Nupr1(-/-)) attenuated the renal tubule dilatation, tubular epithelial cell atrophy, and interstitial collagen accumulation caused by UUO. Consistently, Nupr1(-/-) significantly decreased the expression of type I collagen, myofibroblast markers smooth muscle alpha-actin (alpha-SMA), fibroblast-specific protein 1 (FSP-1), and vimentin in mouse kidney that were upregulated by UUO. These results suggest that Nupr1 protein was essential for fibroblast activation and/or epithelial-mesenchymal transition (EMT) during renal fibrogenesis. Indeed, Nupr1 was indispensable for TGF-beta-induced myofibroblast activation of kidney interstitial NRK-49F fibroblasts, multipotent mesenchymal C3H10T1/2 cells, and the EMT of kidney epithelial NRK-52E cells. It appears that Nupr1 mediated TGF-beta-induced alpha-SMA expression and collagen synthesis by initiating Smad3 signaling pathway. Importantly, trifluoperazine (TFP), a Nupr1 inhibitor, alleviated UUO-induced renal fibrosis. Taken together, our results demonstrate that Nupr1 promotes renal fibrosis by activating myofibroblast transformation from both fibroblasts and tubular epithelial cells.	[Zhou, Ruimei; Liao, Jiashun; Tian, Qin; Huang, Enping; Xie, Wei-Bing] Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China; [Zhou, Ruimei; Cai, Dunpeng; Chen, Shi-You] Univ Missouri, Dept Surg, Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Lu, Tianming] Southern Med Univ, Dept Neurol, Affiliated Hosp 3, Guangzhou, Peoples R China	Southern Medical University - China; University of Missouri System; University of Missouri Columbia; Southern Medical University - China	Xie, WB (corresponding author), Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China.; Chen, SY (corresponding author), Univ Missouri, Sch Med, Dept Surg, Columbia, MO 65212 USA.	scqvd@missouri.edu; xieweib@126.com			Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2019A1515010271]	Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2019A1515010271	Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Brannon KM, 2007, CANCER LETT, V254, P146, DOI 10.1016/j.canlet.2007.03.011; Bulow RD, 2019, J HISTOCHEM CYTOCHEM, V67, P643, DOI 10.1369/0022155419849388; Chowdhury U, 2009, CANCER METAST REV, V28, P225, DOI 10.1007/s10555-009-9183-x; Galichon P, 2017, J AM SOC NEPHROL, V28, P545, DOI 10.1681/ASN.2015080936; Garcia-Montero AC, 2001, BIOCHEM J, V357, P249, DOI 10.1042/0264-6021:3570249; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kramann Rafael, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0026-7; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Malicet C, 2006, P NATL ACAD SCI USA, V103, P2671, DOI 10.1073/pnas.0508955103; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Mohammad HP, 2004, MOL ENDOCRINOL, V18, P2583, DOI 10.1210/me.2004-0163; MuchanetaKubara EC, 1997, NEPHROL DIAL TRANSPL, V12, P904, DOI 10.1093/ndt/12.5.904; Narzt MS, 2019, REDOX BIOL, V20, P467, DOI 10.1016/j.redox.2018.11.006; Neira JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39732; Ning XX, 2018, J CELL MOL MED, V22, P1383, DOI 10.1111/jcmm.13465; Pommier RM, 2012, BIOCHEM J, V445, P285, DOI 10.1042/BJ20120368; Ree AH, 1999, CANCER RES, V59, P4675; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Rossini M, 2005, KIDNEY INT, V68, P2621, DOI 10.1111/j.1523-1755.2005.00734.x; Santofimia-Castano P, 2019, J CLIN INVEST, V129, P2500, DOI 10.1172/JCI127223; Sharma S, 2011, CURR OPIN NEPHROL HY, V20, P56, DOI 10.1097/MNH.0b013e3283414c88; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Wang BD, 2018, INT J MOL MED, V41, P3278, DOI 10.3892/ijmm.2018.3562; Wang YP, 2018, PROG MOL BIOL TRANSL, V153, P181, DOI 10.1016/bs.pmbts.2017.11.019; Wu YR, 2018, INT UROL NEPHROL, V50, P1347, DOI 10.1007/s11255-018-1820-2; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Xu LL, 2020, AGING-US, V12, P5209, DOI 10.18632/aging.102942; Zhou D, 2016, SCI CHINA LIFE SCI, V59, P920, DOI 10.1007/s11427-016-0020-y	33	3	3	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21381	10.1096/fj.202000926RR	http://dx.doi.org/10.1096/fj.202000926RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33617091				2022-12-28	WOS:000629576700002
J	He, HY; Luo, HW; Liu, L; Shangguan, YF; Xie, XK; Wen, YX; Wang, H; Chen, LB				He, Hangyuan; Luo, Hanwen; Liu, Liang; Shangguan, Yangfan; Xie, Xingkui; Wen, Yinxian; Wang, Hui; Chen, Liaobin			Prenatal caffeine exposure caused H-type blood vessel-related long bone dysplasia via miR375/CTGF signaling	FASEB JOURNAL			English	Article						bone dysplasia; connective tissue growth factor; H&#8208; type blood vessel; microRNA375; prenatal caffeine exposure	GROWTH-FACTOR CTGF/CCN2; LATE-STAGE; ANGIOGENESIS; TISSUE; EXPRESSION; DIFFERENTIATION; OSTEOGENESIS; OSTEOPOROSIS; MICRORNAS; MECHANISM	Caffeine has developmental toxicity. Prenatal caffeine exposure (PCE) caused intrauterine growth retardation (IUGR) and multiple organ dysplasia. This study intended to explore the effect and mechanism of PCE on long bone development in female fetal rats. In vivo, the PCE group pregnant rats were given different concentrations of caffeine during the gestational Day 9-20. The mRNA expression of osteogenesis-related genes were significantly reduced in PCE group. In the PCE group (120 mg/kg center dot d), the length and primary center of fetal femur were shorter, and accompanied by H-type blood vessel abundance reducing. Meanwhile, connective tissue growth factor (CTGF) expression decreased in the growth plate of the PCE group (120 mg/kg center dot d). In contrast, the miR375 expression increased. In vitro, caffeine decreased CTGF and increased miR375 expression in fetal growth plate chondrocytes. After co-culture with caffeine-treated chondrocytes, the tube formation ability for the H-type endothelial cells was decreased. Furthermore, CTGF overexpression or miR375 inhibitor reversed caffeine-induced reduction of tube formation ability, and miR375 inhibitor reversed caffeine-induced CTGF expression inhibition. In summary, PCE decreased the expression of CTGF by miR375, ultimately resulting in H-type blood vessel-related long bone dysplasia.	[He, Hangyuan; Liu, Liang; Shangguan, Yangfan; Xie, Xingkui; Wen, Yinxian; Wang, Hui; Chen, Liaobin] Wuhan Univ, Dept Joint Surg & Sports Med, Zhongnan Hosp, Wuhan, Peoples R China; [Luo, Hanwen; Wen, Yinxian] Guangxi Med Univ, Affiliated Hosp 4, Dept Orthoped Surg, Liuzhou, Peoples R China; [Shangguan, Yangfan; Xie, Xingkui; Wang, Hui; Chen, Liaobin] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China; [Wang, Hui] Wuhan Univ, Dept Pharmacol, Basic Med Sch, Wuhan, Peoples R China	Wuhan University; Guangxi Medical University; Wuhan University	Chen, LB (corresponding author), Wuhan Univ, Dept Joint Surg & Sports Med, Zhongnan Hosp, Wuhan, Peoples R China.; Wang, H (corresponding author), Wuhan Univ, Dept Pharmacol, Med Sch, Wuhan, Peoples R China.	wanghui19@whu.edu.cn; lbchen@whu.edu.cn						Alam KJ, 2017, INT J CANCER, V141, P1614, DOI 10.1002/ijc.30861; Available N., 2003, ED HLTH ABINGDON, V16, P2; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Berglundh S, 2021, EUR J NUTR, V60, P791, DOI 10.1007/s00394-020-02280-7; Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332; Chen LW, 2018, EXP THER MED, V15, P4318, DOI 10.3892/etm.2018.5952; Cheung WH, 2001, CANCER LETT, V163, P25, DOI 10.1016/S0304-3835(00)00653-4; Choi S, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800254; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; Gillette R, 2017, HORM BEHAV, V87, P8, DOI 10.1016/j.yhbeh.2016.10.011; Gkiatas Ioannis, 2015, Am J Orthop (Belle Mead NJ), V44, P61; He Z, 2019, TOXICOL LETT, V302, P7, DOI 10.1016/j.toxlet.2018.12.001; Herberth G, 2014, J ALLERGY CLIN IMMUN, V133, P543, DOI 10.1016/j.jaci.2013.06.036; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; Kuczkowski K M, 2003, Med J Malaysia, V58, P147; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lee SH, 2018, MOL REPROD DEV, V85, P336, DOI 10.1002/mrd.22969; Lei NB, 2019, EUR REV MED PHARMACO, V23, P11043, DOI 10.26355/eurrev_201912_19812; Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3; Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002; Li QX, 2020, PHARMACOL RES, V151, DOI 10.1016/j.phrs.2019.104555; Lun WJ, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0575-2; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Ma LM, 2013, J GENET GENOMICS, V40, P143, DOI 10.1016/j.jgg.2013.03.002; Mehta RR, 2011, ANGIOGENESIS, V14, P355, DOI 10.1007/s10456-011-9220-6; Melton LJ, 2001, CALCIFIED TISSUE INT, V69, P179, DOI 10.1007/s00223-001-1043-9; Modzelewska D, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2215-9; Mu SZ, 2016, MOL CELL BIOCHEM, V416, P99, DOI 10.1007/s11010-016-2699-9; Mujahid S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-13; Ojeda NB, 2014, ACTA PHYSIOL, V210, P307, DOI 10.1111/apha.12206; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reddi HV, 2013, CANCER GENE THER, V20, P267, DOI 10.1038/cgt.2013.16; Sakai N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05624-2; Shangguan YF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.546; Sun T., 2017, PLOS ONE, V12, P171; Wang FQ, 2012, ENVIRON SCI TECHNOL, V46, P6822, DOI 10.1021/es3008547; Wang L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.36; Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007; Wu ZX, 2020, FOOD CHEM TOXICOL, V136, DOI 10.1016/j.fct.2019.111083; Xiao H, 2020, BRIT J PHARMACOL, V177, P4683, DOI 10.1111/bph.15225; Xiao H, 2019, FASEB J, V33, P12972, DOI 10.1096/fj.201901145RR; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yamaai T, 2005, J BONE MINER METAB, V23, P280, DOI 10.1007/s00774-004-0600-5; Zhang W, 2012, CELL BIOCHEM FUNCT, V30, P297, DOI 10.1002/cbf.2801; Zhou JZ, 2014, INT J MOL MED, V33, P1250, DOI 10.3892/ijmm.2014.1691	51	1	1	11	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21370	10.1096/fj.202002230R	http://dx.doi.org/10.1096/fj.202002230R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33734471				2022-12-28	WOS:000647789600086
J	Li, S; Liu, J; Zhang, H; Sun, ZP; Ying, Z; Wu, YH; Xu, JH; Liu, Q				Li, Shuang; Liu, Jing; Zhang, Heng; Sun, Zhepeng; Ying, Zhu; Wu, Yihan; Xu, Jianhai; Liu, Qun			Toxoplasma gondii glutathione S-transferase 2 plays an important role in partial secretory protein transport	FASEB JOURNAL			English	Article						GSTs; protein trafficking; Toxoplasma gondii; vesicle	ORGANELLE BIOGENESIS; TRAFFICKING; MECHANISMS; COMPLEXES; PATHWAYS; INVASION; BINDING; TGSUB1	Toxoplasma gondii is an apicomplexan parasite, which has three unique secretory organelles: micronemes, rhoptries, and dense granules. Almost all the secreted proteins are transported through the endoplasmic reticulum (ER) and Golgi system to function in their respective destination by accurate targeting and packaging. Glutathione S-transferase (GST) is a supergene family enzyme that has multiple functions, which include regulation of cell proliferation and death signaling pathways, and participation in transportation and metabolism in mammal cells. However, the role of GST in Toxoplasma gondii has not been explained. In this study, we identified three GST proteins in T gondii, of which GST2 acts as a membrane protein that localizes to the Golgi-endosomal system and colocalizes with proteins involved in vesicle transport as well, including synaptobrevin, putative sortilin (VPS10), Rab5 and Rab6, which function as vesicle transport factors. Moreover, the loss of TgGST2 leads to Rab5 and Rab6 distribution of discrete puncta, and incorrect localization and decreased expression of several secretory proteins, and to significantly reduced invasion capacity and virulence to mice. Consistent with its relation to vesicle transport proteins, the distribution of TgGST2 relies on post-Golgi trafficking. Overall, our findings demonstrated that TgGST2 contributes to vesicle trafficking and plays a critical role in parasite lytic cycle.	[Li, Shuang; Liu, Jing; Zhang, Heng; Sun, Zhepeng; Ying, Zhu; Wu, Yihan; Xu, Jianhai; Liu, Qun] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Beijing, Peoples R China; [Li, Shuang; Liu, Jing; Zhang, Heng; Sun, Zhepeng; Ying, Zhu; Wu, Yihan; Xu, Jianhai; Liu, Qun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol, Minist Agr, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, Q (corresponding author), China Agr Univ, Acad Vet Med, Lab Natl Anim Protozoa, Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	qunliu@cau.edu.cn	ZHU, YING/HHC-8921-2022					Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Aksoy M, 2016, J ENZYM INHIB MED CH, V31, P546, DOI 10.3109/14756366.2015.1046063; [Anonymous], 2009, TOXOPLASMOSIS ANIMAL; Biddau M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006836; Binder EM, 2008, TRAFFIC, V9, P1485, DOI 10.1111/j.1600-0854.2008.00774.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14; Dixon DP, 2010, J BIOL CHEM, V285, P36322, DOI 10.1074/jbc.M110.164806; Dybas JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003899; Gomez C, 2011, PLANT J, V67, P960, DOI 10.1111/j.1365-313X.2011.04648.x; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; Kemp LE, 2013, FEMS MICROBIOL REV, V37, P607, DOI 10.1111/1574-6976.12013; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Langsley G, 2008, MICROBES INFECT, V10, P462, DOI 10.1016/j.micinf.2008.01.017; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; McGovern OL, 2018, TRAFFIC, V19, P336, DOI 10.1111/tra.12556; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Morlon-Guyot J, 2015, CELL MICROBIOL, V17, P1157, DOI 10.1111/cmi.12426; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Ngo HM, 2000, TRENDS CELL BIOL, V10, P67, DOI 10.1016/S0962-8924(99)01698-0; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Remoue F, 2002, INFECT IMMUN, V70, P601, DOI 10.1128/IAI.70.2.601-605.2002; Roiko MS, 2009, CELL MICROBIOL, V11, P1444, DOI 10.1111/j.1462-5822.2009.01357.x; Saadatnia G, 2012, SCAND J INFECT DIS, V44, P805, DOI 10.3109/00365548.2012.693197; Sakura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38842; Sheiner L, 2008, TRAFFIC, V9, P636, DOI 10.1111/j.1600-0854.2008.00713.x; Shitan N, 2013, INT REV CEL MOL BIO, V305, P383, DOI 10.1016/B978-0-12-407695-2.00009-3; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Sreenath AS, 2005, CLIN BIOCHEM, V38, P436, DOI 10.1016/j.clinbiochem.2005.01.009; Stedman TT, 2003, J BIOL CHEM, V278, P5433, DOI 10.1074/jbc.M209390200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tomavo S, 2014, INT J PARASITOL, V44, P133, DOI 10.1016/j.ijpara.2013.10.003; Tomavo S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003629; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Venugopal K, 2018, INT J MED MICROBIOL, V308, P751, DOI 10.1016/j.ijmm.2018.07.007; Wang SA, 2015, RES VET SCI, V99, P157, DOI 10.1016/j.rvsc.2014.12.006; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Zhang Y, 2019, MICROBIOL RES, V227, DOI 10.1016/j.micres.2019.06.003; Zhao J, 2015, TRENDS PLANT SCI, V20, P576, DOI 10.1016/j.tplants.2015.06.007; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006	47	1	1	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21352	10.1096/fj.202001987RR	http://dx.doi.org/10.1096/fj.202001987RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33543805				2022-12-28	WOS:000647789600096
J	Benwell, CJ; Taylor, JAGE; Robinson, SD				Benwell, Christopher J.; Taylor, James A. G. E.; Robinson, Stephen D.			Endothelial neuropilin-2 influences angiogenesis by regulating actin pattern development and alpha 5-integrin-p-FAK complex recruitment to assembling adhesion sites	FASEB JOURNAL			English	Article						angiogenesis; endothelium; integrins; neuropilin-2; protein trafficking	ARP2/3 COMPLEX; CELL-MIGRATION; GROWTH-FACTOR; INTEGRIN; FAK; ACTIVATION; VEGF; EXPRESSION; BINDING; DYNAMICS	The ability to form a variety of cell-matrix connections is crucial for angiogenesis to take place. Without stable anchorage to the extracellular matrix (ECM), endothelial cells (ECs) are unable to sense, integrate and disseminate growth factor stimulated responses that drive growth of a vascular bed. Neuropilin-2 (NRP2) is a widely expressed membrane-bound multifunctional non-tyrosine kinase receptor, which has previously been implicated in influencing cell adhesion and migration by interacting with alpha 5-integrin and regulating adhesion turnover. alpha 5-integrin, and its ECM ligand fibronectin (FN) are both known to be upregulated during the formation of neo-vasculature. Despite being descriptively annotated as a candidate biomarker for aggressive cancer phenotypes, the EC-specific roles for NRP2 during developmental and pathological angiogenesis remain unexplored. The data reported here support a model whereby NRP2 actively promotes EC adhesion and migration by regulating dynamic cytoskeletal remodeling and by stimulating Rab11-dependent recycling of alpha 5-integrin-p-FAK complexes to newly assembling adhesion sites. Furthermore, temporal depletion of EC-NRP2 in vivo impairs primary tumor growth by disrupting vessel formation. We also demonstrate that EC-NRP2 is required for normal postnatal retinal vascular development, specifically by regulating cell-matrix adhesion. Upon loss of endothelial NRP2, vascular outgrowth from the optic nerve during superficial plexus formation is disrupted, likely due to reduced FAK phosphorylation within sprouting tip cells.	[Benwell, Christopher J.; Taylor, James A. G. E.; Robinson, Stephen D.] Norwich Res Pk, Gut Microbes & Hlth, Quadram Inst Biosci, Norwich, Norfolk, England; [Robinson, Stephen D.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Robinson, SD (corresponding author), Norwich Res Pk, Gut Microbes & Hlth, Quadram Inst Biosci, Norwich, Norfolk, England.	Stephen.Robinson@quadram.ac.uk		Benwell, Christopher/0000-0003-0579-7920; Robinson, Stephen/0000-0002-6606-7588	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R012490/1]; British Heart Foundation (BHF) [PG/15/25/31369]	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation (BHF)(British Heart Foundation)	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/M011216/1; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/R012490/1; British Heart Foundation (BHF), Grant/Award Number: PG/15/25/31369	Ajeian JN, 2016, PROTEOM CLIN APPL, V10, P51, DOI 10.1002/prca.201500033; Alarcon-Martinez L, 2018, ELIFE, V7, DOI 10.7554/eLife.34861; Alghamdi AAA, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00395; Bachelder RE, 2001, CANCER RES, V61, P5736; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Bernusso VA, 2015, BBA-MOL CELL RES, V1853, P388, DOI 10.1016/j.bbamcr.2014.11.008; Bielenberg DR, 2012, AM J PATHOL, V181, P548, DOI 10.1016/j.ajpath.2012.04.013; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Borkowetz A, 2020, INT J CANCER, V146, P2619, DOI 10.1002/ijc.32679; Brash JT, 2020, CIRC RES, V127, P849, DOI 10.1161/CIRCRESAHA.120.317025; Buskermolen ABC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195201; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; De Pascalis C, 2017, MOL BIOL CELL, V28, P1833, DOI 10.1091/mbc.E17-03-0134; Deshpande PP, 2013, NANOMEDICINE-UK, V8, P1509, DOI [10.2217/NNM.13.118, 10.2217/nnm.13.118]; Fakhari M, 2002, CANCER-AM CANCER SOC, V94, P258, DOI 10.1002/cncr.10177; Fantin A, 2015, CELL REP, V11, P1577, DOI 10.1016/j.celrep.2015.05.018; Fantin A, 2011, DEVELOPMENT, V138, P4185, DOI 10.1242/dev.070037; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Fukahi K, 2004, CLIN CANCER RES, V10, P581, DOI 10.1158/1078-0432.CCR-0930-03; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Ghosh Dastidar D. Ghosh, 2020, VESSEL PLUS, V14, DOI [10.20517/2574-1209.2019.36, DOI 10.20517/2574-1209.2019.36]; Goel HL, 2012, J CELL SCI, V125, P497, DOI 10.1242/jcs.094433; Goel HL, 2011, DEVELOPMENT, V138, P2969, DOI 10.1242/dev.051318; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Golubovskaya VM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-280; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Holt MR, 1998, INT J BIOCHEM CELL B, V30, P307, DOI 10.1016/S1357-2725(97)00101-5; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Jalal S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.220780; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Lambert J, 2020, J CELL SCI, V133, DOI 10.1242/jcs.235762; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Lenzo FL, 2017, TRANSL CANCER RES, V6, pS957, DOI 10.21037/tcr.2017.06.05; Luo X, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00472-6; Mana G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13546; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Nader GPF, 2016, NAT CELL BIOL, V18, P491, DOI 10.1038/ncb3333; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Pan L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2502-0; Plein A, 2014, MICROCIRCULATION, V21, P315, DOI 10.1111/micc.12124; Raimondi C, 2014, J EXP MED, V211, P1167, DOI 10.1084/jem.20132330; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Robinson SD, 2011, CURR OPIN CELL BIOL, V23, P630, DOI 10.1016/j.ceb.2011.03.014; Robinson SD, 2009, J BIOL CHEM, V284, P33966, DOI 10.1074/jbc.M109.030700; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schimmel L, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.185405; Srichai M., 2010, INTEGRIN STRUCTURE F; Sundararaman A, 2020, CURR BIOL, V30, P2146, DOI 10.1016/j.cub.2020.03.042; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Vales A, 2007, LEUKEMIA LYMPHOMA, V48, P1997, DOI 10.1080/10428190701534424; WOO MK, 1994, J CELL SCI, V107, P1359; Woodside DG, 2001, THROMB HAEMOSTASIS, V86, P316, DOI 10.1055/s-0037-1616229; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zhang JL, 2014, PHARMACOL THERAPEUT, V142, P154, DOI 10.1016/j.pharmthera.2013.12.003	70	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21679	10.1096/fj.202100286R	http://dx.doi.org/10.1096/fj.202100286R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314542	Green Accepted, Green Submitted			2022-12-28	WOS:000678975300008
J	Lv, MZ; Zhang, SM; Jiang, B; Cao, SR; Dong, YQ; Cao, L; Guo, S				Lv, Mengzhu; Zhang, Simeng; Jiang, Bo; Cao, Sunrun; Dong, Yuqing; Cao, Liu; Guo, Shu			Adipose-derived stem cells regulate metabolic homeostasis and delay aging by promoting mitophagy	FASEB JOURNAL			English	Article						adipose-derived mesenchymal stem cells; aging; metabolism; mitophagy; stem cell transplantation	MITOCHONDRIA; THERAPIES; FRAILTY	Tissues undergo a process of degeneration as the body ages. Mesenchymal stem cells (MSCs) have been found to have major potential in delaying the aging process in tissues and organs. However, the mechanism underlying the anti-aging effects of MSC is not clear which limits clinical applications. In this study, we used adipose-derived mesenchymal stem cells (ADSCs) to perform anti-aging treatments on senescent cells and progeroid animal models. Following intervention with ADSCs, replicative senescence was delayed and metabolic homeostasis was transformed from catabolism to anabolism. Metabolomic tests were used to analyze different metabolites. We found that ADSCs acted to accelerate mitophagy which eliminated intracellular ROS and improved the quality of mitochondria. These processes acted to regulate the cellular metabolic homeostasis and ultimately delayed the process of aging. Allogeneic stem cell therapy in a Progeria animal model (DNA polymerase gamma (POLG) knockin, mitochondrial dysfunction) also showed that ADSC therapy can improve alopecia and kyphosis by promoting mitophagy. Our research confirms for the first time that allogeneic stem cell therapy can improve aging-related symbols and phenotypes through mitochondrial quality control. These results are highly significant for the future applications of stem cells in aging-related diseases.	[Lv, Mengzhu; Dong, Yuqing; Guo, Shu] China Med Univ, Dept Plast Surg, Hosp 1, 155 Nan Jing St, Shenyang 110001, Liaoning, Peoples R China; [Zhang, Simeng] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China; [Jiang, Bo; Cao, Sunrun; Cao, Liu] Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Jiang, Bo; Cao, Sunrun; Cao, Liu] China Med Univ, Inst Translat Med, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Jiang, Bo; Cao, Sunrun; Cao, Liu] Liaoning Prov Collaborat Innovat Ctr Aging Relate, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Guo, S (corresponding author), China Med Univ, Dept Plast Surg, Hosp 1, 155 Nan Jing St, Shenyang 110001, Liaoning, Peoples R China.; Cao, L (corresponding author), China Med Univ, Inst Translat Med, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	1021815514@qq.com; sguo@cmu.edu.cn		Guo, Shu/0000-0001-9094-1602; Mengzhu, Lv/0000-0002-7804-2636	National Natural Science Foundation of China (NSFC) [51872332]; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation) [20170541040]; China Medical University (CMU) [111/1210519020]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation); China Medical University (CMU)(China Medical University)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 51872332; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation), Grant/Award Number: 20170541040; China Medical University (CMU), Grant/Award Number: 111/1210519020	Bakula D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00239; Bateman ME, 2018, STEM CELLS, V36, P1311, DOI 10.1002/stem.2847; Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Golpanian S, 2016, ONCOTARGET, V7, P11899, DOI 10.18632/oncotarget.7727; Goradel NH, 2018, J CELL BIOCHEM, V119, P95, DOI 10.1002/jcb.26169; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Huang L, 2020, STEM CELLS DEV, V29, P555, DOI 10.1089/scd.2019.0237; Hur W, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0520-7; Jankowski M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081783; Jung WY, 2015, TISSUE CELL, V47, P86, DOI 10.1016/j.tice.2014.12.001; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; Pourakbari R, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118181; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Shi RY, 2018, TRENDS CARDIOVAS MED, V28, P246, DOI 10.1016/j.tcm.2017.11.008; Sneddon JB, 2018, CELL STEM CELL, V22, P810, DOI 10.1016/j.stem.2018.05.016; Stepien A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5302120; Sugaya K, 2018, ADV EXP MED BIOL, V1056, P61, DOI 10.1007/978-3-319-74470-4_5; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Tompkins BA, 2017, J GERONTOL A-BIOL, V72, P1513, DOI 10.1093/gerona/glx137; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Yang SD, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/1351860; Yi X, 2020, J CELL PHYSIOL, V235, P349, DOI 10.1002/jcp.28974; Zhao LF, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1893-4; Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287	31	8	8	5	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21709	10.1096/fj.202100332R	http://dx.doi.org/10.1096/fj.202100332R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143518				2022-12-28	WOS:000667814100024
J	Chan, JY; Bensellam, M; Lin, RCY; Liang, CD; Lee, KL; Jonas, JC; Laybutt, DR				Chan, Jeng Yie; Bensellam, Mohammed; Lin, Ruby C. Y.; Liang, Cassandra; Lee, Kailun; Jonas, Jean-Christophe; Laybutt, D. Ross			Transcriptome analysis of islets from diabetes-resistant and diabetes-prone obese mice reveals novel gene regulatory networks involved in beta-cell compensation and failure	FASEB JOURNAL			English	Article						beta&#8208; cell compensation; beta&#8208; cell failure; islets; obesity; type 2 diabetes	UNFOLDED PROTEIN RESPONSE; HUMAN PANCREATIC-ISLETS; HIGH-FAT DIET; INSULIN-SECRETION; MOUSE ISLETS; MICROARRAY ANALYSIS; GLUCOSE-METABOLISM; ENDOCRINE PANCREAS; COUPLED RECEPTORS; OXIDATIVE STRESS	The mechanisms underpinning beta-cell compensation for obesity-associated insulin resistance and beta-cell failure in type 2 diabetes remain poorly understood. We used a large-scale strategy to determine the time-dependent transcriptomic changes in islets of diabetes-prone db/db and diabetes-resistant ob/ob mice at 6 and 16 weeks of age. Differentially expressed genes were subjected to cluster, gene ontology, pathway and gene set enrichment analyses. A distinctive gene expression pattern was observed in 16 week db/db islets in comparison to the other groups with alterations in transcriptional regulators of islet cell identity, upregulation of glucose/lipid metabolism, and various stress response genes, and downregulation of specific amino acid transport and metabolism genes. In contrast, ob/ob islets displayed a coordinated downregulation of metabolic and stress response genes at 6 weeks of age, suggestive of a preemptive reconfiguration in these islets to lower the threshold of metabolic activation in response to increased insulin demand thereby preserving beta-cell function and preventing cellular stress. In addition, amino acid transport and metabolism genes were upregulated in ob/ob islets, suggesting an important role of glutamate metabolism in beta-cell compensation. Gene set enrichment analysis of differentially expressed genes identified the enrichment of binding motifs for transcription factors, FOXO4, NFATC1, and MAZ. siRNA-mediated knockdown of these genes in MIN6 cells altered cell death, insulin secretion, and stress gene expression. In conclusion, these data revealed novel gene regulatory networks involved in beta-cell compensation and failure. Preemptive metabolic reconfiguration in diabetes-resistant islets may dampen metabolic activation and cellular stress during obesity.	[Chan, Jeng Yie; Bensellam, Mohammed; Liang, Cassandra; Lee, Kailun; Laybutt, D. Ross] Garvan Inst Med Res, Sydney, NSW, Australia; [Chan, Jeng Yie; Lin, Ruby C. Y.; Laybutt, D. Ross] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Bensellam, Mohammed; Jonas, Jean-Christophe] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Dendocrinol Diabet & Nutr, Brussels, Belgium; [Lin, Ruby C. Y.] Westmead Inst Med Res, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia; [Lin, Ruby C. Y.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Universite Catholique Louvain; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Laybutt, DR (corresponding author), Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	r.laybutt@garvan.org.au	Lin, Ruby CY/A-1636-2009	Lin, Ruby CY/0000-0003-4163-511X; Bensellam, Mohammed/0000-0002-1641-1694	Department of Health \ National Health and Medical Research Council (NHMRC)	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Department of Health vertical bar National Health and Medical Research Council (NHMRC)	Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Atanes P, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154394; Baraille F, 2015, DIABETES, V64, P2744, DOI 10.2337/db14-0993; Bartolome A, 2019, J CLIN INVEST, V129, P268, DOI 10.1172/JCI98098; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Bensellam M, 2018, J ENDOCRINOL, V236, pR109, DOI 10.1530/JOE-17-0516; Bensellam M, 2016, DIABETOLOGIA, V59, P1492, DOI 10.1007/s00125-016-3947-y; Bensellam M, 2015, DIABETOLOGIA, V58, P758, DOI 10.1007/s00125-015-3503-1; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Boni-Schnetzler M, 2019, SEMIN IMMUNOPATHOL, V41, P501, DOI 10.1007/s00281-019-00745-4; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bowen A, 2016, BIOCHEM BIOPH RES CO, V479, P793, DOI 10.1016/j.bbrc.2016.09.130; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Brun T, 2008, HUM MOL GENET, V17, P478, DOI 10.1093/hmg/ddm325; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Cartland SP, 2020, FASEB J, V34, P9547, DOI 10.1096/fj.201902785R; Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660; Chan JY, 2011, DIABETOLOGIA, V54, P1766, DOI 10.1007/s00125-011-2139-z; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Cheng Q, 2016, J MOL ENDOCRINOL, V56, P175, DOI 10.1530/JME-15-0212; Cheng YY, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0529-z; Collins SC, 2016, DIABETES, V65, P1952, DOI 10.2337/db15-1489; Cunha DA, 2014, CELL DEATH DIFFER, V21, P1313, DOI 10.1038/cdd.2014.53; Dai CH, 2016, J CLIN INVEST, V126, P1857, DOI 10.1172/JCI83657; Dos Santos RS, 2017, ENDOCRINOLOGY, V158, P2503, DOI 10.1210/en.2017-00104; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Ebrahimi AG, 2020, MOL METAB, V35, DOI 10.1016/j.molmet.2020.02.002; Fazio EN, 2005, J ENDOCRINOL, V187, P407, DOI 10.1677/joe.1.06376; Frigerio S, 2002, HORM RES, V57, P94, DOI 10.1159/000057959; Fu A, 2020, NAT METAB, V2, P432, DOI 10.1038/s42255-020-0199-4; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Gerst F, 2018, J CLIN ENDOCR METAB, V103, P4373, DOI 10.1210/jc.2018-00791; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Glauser DA, 2009, J RECEPT SIG TRANSD, V29, P293, DOI 10.3109/10799890903241824; Gosmain Y, 2011, DIABETES OBES METAB, V13, P31, DOI 10.1111/j.1463-1326.2011.01445.x; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Gupta MK, 2019, COMPUT BIOL CHEM, V79, P24, DOI 10.1016/j.compbiolchem.2019.01.010; Hayashi T, 2020, VET QUART, V40, P243, DOI 10.1080/01652176.2020.1823522; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Herbert TP, 2016, DIABETES, V65, P1472, DOI 10.2337/db15-1633; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hulman A, 2017, DIABETOLOGIA, V60, P1252, DOI 10.1007/s00125-017-4275-6; Jennings RE, 2015, DEVELOPMENT, V142, P3126, DOI 10.1242/dev.120063; Jung DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077851; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; Kanno A, 2019, J DIABETES INVEST, V10, P577, DOI 10.1111/jdi.12945; Kawamura Y, 2006, MOL ENDOCRINOL, V20, P844, DOI 10.1210/me.2005-0138; Keller MP, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006466; KENNEDY GC, 1992, P NATL ACAD SCI USA, V89, P11498, DOI 10.1073/pnas.89.23.11498; Khan S, 2018, BIOCHEM BIOPH RES CO, V495, P2221, DOI 10.1016/j.bbrc.2017.12.111; Kharroubi I, 2006, DIABETOLOGIA, V49, P2350, DOI 10.1007/s00125-006-0366-5; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755; Klochendler A, 2016, DIABETES, V65, P2081, DOI 10.2337/db16-0003; Kluth O, 2014, DIABETES, V63, P4230, DOI 10.2337/db14-0425; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Kozinski K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31553; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Lavine JA, 2010, ENDOCRINOLOGY, V151, P3577, DOI 10.1210/en.2010-0233; Lee H, 2020, CELL METAB, V31, P822, DOI 10.1016/j.cmet.2020.03.002; Lee SH, 2008, EXP DIABETES RES, DOI 10.1155/2008/728763; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Leem J, 2018, BIOCHEM BIOPH RES CO, V503, P278, DOI 10.1016/j.bbrc.2018.06.015; Lehtihet M, 2005, BIOCHEM BIOPH RES CO, V328, P601, DOI 10.1016/j.bbrc.2005.01.024; Li N, 2017, REDOX BIOL, V13, P541, DOI 10.1016/j.redox.2017.07.012; Lo CM, 2011, DIABETES, V60, P2000, DOI 10.2337/db10-0789; Lou JM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01151-w; Lytrivi M, 2020, J MOL BIOL, V432, P1514, DOI 10.1016/j.jmb.2019.09.016; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; Maschio DA, 2019, J CELL PHYSIOL, V234, P19852, DOI 10.1002/jcp.28584; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Munakata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19765-5; Nakamura M, 1995, DIABETES RES CLIN PR, V30, P89, DOI 10.1016/0168-8227(95)01155-2; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Noushmehr H, 2005, DIABETES, V54, P472, DOI 10.2337/diabetes.54.2.472; Omikorede O, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.35; Ooi JYY, 2017, RNA BIOL, V14, P500, DOI 10.1080/15476286.2016.1181251; Perelis M, 2016, J BIOL RHYTHM, V31, P323, DOI 10.1177/0748730416656949; Persaud SJ, 2017, CURR OPIN PHARMACOL, V37, P24, DOI 10.1016/j.coph.2017.08.001; Petrenko V, 2020, P NATL ACAD SCI USA, V117, P2484, DOI 10.1073/pnas.1916539117; Pratley Richard E, 2002, Curr Diab Rep, V2, P242, DOI 10.1007/s11892-002-0090-6; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Roma LP, 2020, J MOL BIOL, V432, P1461, DOI 10.1016/j.jmb.2019.10.012; Sampieri L, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00123; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Shafrir E, 1999, ANN NY ACAD SCI, V892, P223, DOI 10.1111/j.1749-6632.1999.tb07798.x; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Solini A, 2017, DIABETES METAB, V43, P512, DOI 10.1016/j.diabet.2017.04.002; Stanojevic V, 2015, BEST PRACT RES CL EN, V29, P859, DOI 10.1016/j.beem.2015.10.002; Suga T, 2019, MOL METAB, V19, P1, DOI 10.1016/j.molmet.2018.10.009; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thielen L, 2018, CURR OPIN ENDOCRINOL, V25, P75, DOI 10.1097/MED.0000000000000391; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; Tong X, 2020, DIABETES, V69, P342, DOI 10.2337/db19-0281; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Vernier S, 2012, ISLETS, V4, P379, DOI 10.4161/isl.22720; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wali Jibran A, 2013, Cells, V2, P266, DOI 10.3390/cells2020266; Xin Y, 2018, DIABETES, V67, P1783, DOI 10.2337/db18-0365; Yada T, 2014, DIABETES OBES METAB, V16, P111, DOI 10.1111/dom.12344; Ye RS, 2018, J CLIN INVEST, V128, P1178, DOI [10.1172/JCI97702, 10.1172/jci97702]; Zaiko M, 2004, EUR J ENDOCRINOL, V150, P389, DOI 10.1530/eje.0.1500389; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang JT, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1552-y	117	2	2	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21608	10.1096/fj.202100009R	http://dx.doi.org/10.1096/fj.202100009R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33977593				2022-12-28	WOS:000655695900005
J	Deng, JZ; Yang, YS; He, JY; Xie, Z; Luo, F; Xu, JZ; Zhang, ZH				Deng, Jiezhong; Yang, Yusheng; He, Jinyue; Xie, Zhao; Luo, Fei; Xu, Jianzhong; Zhang, Zehua			Vitamin D receptor activated by vitamin D administration alleviates Mycobacterium tuberculosis-induced bone destruction by inhibiting NF kappa B-mediated aberrant osteoclastogenesis	FASEB JOURNAL			English	Article						Mycobacterium tuberculosis; osteoclastogenesis; vitamin D; VDR	SPINAL TUBERCULOSIS; IN-VITRO; EXPRESSION; RESORPTION; CELLS; MODEL	Clinically, bone destruction caused by Mycobacterium tuberculosis was serious especially in patients with vitamin D (VD) deficiency. However, the role of VD in M. tuberculosis-induced bone destruction remains clear. In this context, we investigate the role of VD and vitamin D receptor (VDR) in the M. tuberculosis-induced bone destruction. First, we infected RAW264.7 and bone marrow-derived macrophages (BMMs) with Mycobacterium bovis Bacillus Calmette-Guerin (M. bovis BCG) in vitro. Then, we activated VDR through VD administration. TRAP and FAK staining, bone resorption assays, immunofluorescence staining, qPCR, and western blot were carried out. In vivo, the M. tuberculosis-induced osteolytic model on the murine skull was established and the mu CT and histological analyses were performed. We found that VDR and TRAP were upregulated in bone tuberculosis tissue and proved that M. tuberculosis infection promoted osteoclastogenesis in RAW264.7 and BMMs. VD could inhibit osteoclasts differentiation, fusion, and bone resorption dose-dependently. However, when VDR was knocked down, the inhibitory effect of VD on osteoclasts disappeared. In mechanism, activation of VDR inhibits the phosphorylation of I kappa B alpha, thereby inhibiting NF kappa B signaling pathway and alleviating osteoclastogenesis. Furthermore, in the skull osteolysis model, VD administration reduced osteolysis, but not in VDR-/- mice. Our study, for the first time, demonstrates that activation of VDR by VD administration inhibits M. tuberculosis-induced bone destruction. Our results reveal that VD and VDR are potential therapeutic targets for M. tuberculosis-induced bone destruction, and are of great clinical significance for the development of new therapeutic strategies.	[Deng, Jiezhong; Yang, Yusheng; He, Jinyue; Xie, Zhao; Luo, Fei; Xu, Jianzhong; Zhang, Zehua] Army Med Univ, Dept Orthoped Surg, Southwest Hosp, Third Mil Med Univ, Chongqing, Peoples R China	Army Medical University	Zhang, ZH (corresponding author), Army Med Univ, Dept Orthoped Surg, Southwest Hosp, Affiliated Hosp 1, 30 Gaotanyan Zhengjie, Chongqing 400038, Peoples R China.	zhangzehuatmmu@163.com			National Natural Science Foundation of China [81772365, 81972082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (81772365, 81972082)	Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Amarasekara DS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e8; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bernardor J, 2020, J BONE MINER RES, V35, P2265, DOI 10.1002/jbmr.4122; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen Y, 2013, J BIOL CHEM, V288, P19450, DOI 10.1074/jbc.M113.467670; Chiu YH, 2012, J BONE MINER RES, V27, P79, DOI 10.1002/jbmr.531; Christophe T, 2010, FUTURE MED CHEM, V2, P1283, DOI 10.4155/FMC.10.223; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Dou C, 2014, BBA-GENE REGUL MECH, V1839, P1084, DOI 10.1016/j.bbagrm.2014.08.002; Gu JH, 2015, J STEROID BIOCHEM, V152, P25, DOI 10.1016/j.jsbmb.2015.04.003; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hu JX, 2020, J CELL MOL MED, V24, P1893, DOI 10.1111/jcmm.14885; Jain AK, 2020, J BONE JOINT SURG AM, V102, P617, DOI 10.2106/JBJS.19.00001; Jimi E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121636; Krishnan AV, 2010, ENDOCR-RELAT CANCER, V17, pR19, DOI 10.1677/ERC-09-0139; Li LT, 2012, INT ORTHOP, V36, P277, DOI 10.1007/s00264-011-1398-0; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu XC, 2015, JPN J INFECT DIS, V68, P89, DOI 10.7883/yoken.JJID.2014.147; Meghji S, 1997, J EXP MED, V186, P1241, DOI 10.1084/jem.186.8.1241; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakamichi Y, 2018, J STEROID BIOCHEM, V177, P70, DOI 10.1016/j.jsbmb.2017.11.005; Nakamichi Y, 2017, J BONE MINER RES, V32, P1297, DOI 10.1002/jbmr.3096; Ono T, 2018, HISTOCHEM CELL BIOL, V149, P325, DOI 10.1007/s00418-018-1636-2; Schwarz EM, 2019, J ORTHOP RES, V37, P997, DOI 10.1002/jor.24293; Starczak Y, 2018, J STEROID BIOCHEM, V177, P77, DOI 10.1016/j.jsbmb.2017.10.022; Trochoutsou AI, 2015, MINI-REV MED CHEM, V15, P953, DOI 10.2174/1389557515666150519110830; Ufimtseva E, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4325646; Verlinden L, 2019, J STEROID BIOCHEM, V195, DOI 10.1016/j.jsbmb.2019.105478; Wang XW, 2017, LIFE SCI, V188, P198, DOI 10.1016/j.lfs.2017.07.022; Zarei A, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.30	32	3	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21543	10.1096/fj.202100135R	http://dx.doi.org/10.1096/fj.202100135R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046950				2022-12-28	WOS:000655695900050
J	Chacon, P; Vega-Rioja, A; Doukkali, B; Rodriguez, AD; Bellido, V; Puente, Y; Alcaniz, L; Rodriguez, D; Palacios, R; Cornejo-Garcia, JA; Monteseirin, J; Rivas-Perez, D				Chacon, Pedro; Vega-Rioja, Antonio; Doukkali, Bouchra; del Valle Rodriguez, Alberto; Bellido, Virginia; Puente, Yolanda; Alcaniz, Lorena; Rodriguez, David; Palacios, Ricardo; Antonio Cornejo-Garcia, Jose; Monteseirin, Javier; Rivas-Perez, David			Targeted inhibition of allergen-induced histamine production by neutrophils	FASEB JOURNAL			English	Article						allergen immunotherapy; asthma; diamine oxidase; histamine; histidine decarboxylase	ACTIVATED PROTEIN-KINASE; LUNG MAST-CELLS; DIAMINE OXIDASE; CYCLOSPORINE-A; THERAPEUTIC VACCINES; ASTHMATIC-PATIENTS; MEDIATOR RELEASE; HUMAN BASOPHILS; IN-VITRO; IMMUNOTHERAPY	Histamine is a critical inflammatory mediator in allergic diseases. We showed in a previous work that neutrophils from allergic patients produce histamine in response to allergens to which the patients were sensitized. Here, we investigate the molecular mechanisms involved in this process using peripheral blood neutrophils. We challenged these cells in vitro with allergens and analyzed histamine release in the culture supernatants. We also explored the effect of common therapeutic drugs that ameliorate allergic symptoms, as well as allergen-specific immunotherapy. Additionally, we examined the expression of histidine decarboxylase and diamine oxidase, critical enzymes in the metabolism of histamine, under allergen challenge. We show that allergen-induced histamine release is dependent on the activation of the phosphoinositide 3-kinase, mitogen-activated protein kinase p38, and extracellular signal-regulated kinase 1/2 signaling pathways. We also found a contribution of the phosphatase calcineurin to lesser extent. Anti-histamines, glucocorticoids, anti-M3-muscarinic receptor antagonists, and mainly beta(2)-receptor agonists abolished the allergen-dependent histamine release. Interestingly, allergen-specific immunotherapy canceled the histamine release through the downregulation of histidine decarboxylase expression. Our observations describe novel molecular mechanisms involved in the allergen-dependent histamine release by human neutrophils and provide new targets to inhibit histamine production.	[Chacon, Pedro; Vega-Rioja, Antonio; Doukkali, Bouchra; del Valle Rodriguez, Alberto; Bellido, Virginia; Puente, Yolanda; Monteseirin, Javier] Hosp Univ Virgen Macarena, UGC Alergol, Edificio Policlin 1a Planta,Ave Dr Fedriani 3, Seville 41009, Spain; [Alcaniz, Lorena] Hosp Univ Virgen Macarena, UGC Dermatol, Seville, Spain; [Rodriguez, David; Palacios, Ricardo] Labs Diater, Madrid, Spain; [Antonio Cornejo-Garcia, Jose] IBIMA Hosp Univ Reg Malaga UMA, Lab Invest, Malaga, Spain; [Monteseirin, Javier] Univ Seville, Fac Med, Dept Med, Seville, Spain; [Rivas-Perez, David] Univ Seville, Fac Odontol, Seville, Spain; [Monteseirin, Javier] Calle Asuncion 27,3 Izqda, Seville 41011, Spain; [Monteseirin, Javier] Hosp Quiron Infanta Luisa, Seville 41010, Spain	Hospital Universitario Virgen Macarena; Hospital Universitario Virgen Macarena; University of Sevilla; University of Sevilla	Vega-Rioja, A (corresponding author), Hosp Univ Virgen Macarena, UGC Alergol, Edificio Policlin 1a Planta,Ave Dr Fedriani 3, Seville 41009, Spain.	macrofago@us.es; fmonteseirin@us.es	RIBAS PEREZ, DAVID/GZA-6697-2022; Cornejo-Garcia, Jose Antonio/S-7726-2016	RIBAS PEREZ, DAVID/0000-0001-6123-9216; Vega Rioja, Antonio/0000-0003-4698-9697; Chacon Fernandez, Pedro Jose/0000-0003-0925-814X; Cornejo-Garcia, Jose Antonio/0000-0003-3465-8735	EC vertical bar European Regional Development Fund (ERDF); MINECO vertical bar Instituto de Salud Carlos III (ISCIII) [RD16/0006/0035]; MINECO vertical bar Agencia Estatal de Investigacion (AEI) [SAF2014-60649-JIN]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia) [PC--0217--2017]	EC vertical bar European Regional Development Fund (ERDF); MINECO vertical bar Instituto de Salud Carlos III (ISCIII); MINECO vertical bar Agencia Estatal de Investigacion (AEI); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia)	EC broken vertical bar European Regional Development Fund (ERDF); MINECO broken vertical bar Instituto de Salud Carlos III (ISCIII), Grant/Award Number: RD16/0006/0035; MINECO broken vertical bar Agencia Estatal de Investigacion (AEI), Grant/Award Number: SAF2014-60649-JIN; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia), Grant/Award Number: PC--0217--2017	Akabane Hirotomo, 2006, Allergol Int, V55, P387, DOI 10.2332/allergolint.55.387; Akdis CA, 2006, EUR J PHARMACOL, V533, P69; Alagha K, 2014, THER ADV CHRONIC DIS, V5, P85, DOI 10.1177/2040622313518227; Alcaniz L, 2013, FASEB J, V27, P2902; Aroca R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094558; Barcik W, 2017, CURR OPIN IMMUNOL, V48, P108, DOI 10.1016/j.coi.2017.08.011; Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; BERGSTRAND H, 1984, ALLERGY, V39, P217, DOI 10.1111/j.1398-9995.1984.tb02627.x; Bergstrand H, 1986, ALLERGY, V41, P319; BERTHON B, 1994, BIOCHEM PHARMACOL, V47, P789, DOI 10.1016/0006-2952(94)90478-2; Billington CK, 2017, HANDB EXP PHARMACOL, V237, P23, DOI 10.1007/164_2016_64; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Carballo M, 1999, J BIOL CHEM, V274, P93; Chong LK, 1998, BRIT J PHARMACOL, V123, P1009, DOI 10.1038/sj.bjp.0701703; Ciepiela O, 2015, RESP PHYSIOL NEUROBI, V209, P13, DOI 10.1016/j.resp.2014.12.004; Ciz M, 2013, BRIT J PHARMACOL, V170, P17, DOI 10.1111/bph.12107; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DVORAK AM, 1993, J HISTOCHEM CYTOCHEM, V41, P787, DOI 10.1177/41.6.8315271; El Bekay R, 2003, BLOOD, V102, P662, DOI 10.1182/blood-2002-09-2785; GALANT SP, 1980, J CLIN INVEST, V65, P577, DOI 10.1172/JCI109702; Gibbs BF, 2005, INT ARCH ALLERGY IMM, V136, P329, DOI 10.1159/000084226; HOLGATE ST, 1985, INT ARCH ALLER A IMM, V77, P47, DOI 10.1159/000233752; Hosoki K, 2016, CURR OPIN ALLERGY CL, V16, P45, DOI 10.1097/ACI.0000000000000231; Ibarrola I, 2004, ANN ALLERG ASTHMA IM, V93, P589, DOI 10.1016/S1081-1206(10)61268-9; Jutel A, 2006, CHEM IMMUNOL ALLERGY, V91, P174; Kips JC, 2001, AM J RESP CRIT CARE, V164, P923, DOI 10.1164/ajrccm.164.6.2010107; Koprak S, 2003, CELL IMMUNOL, V223, P1, DOI 10.1016/S0008-8749(03)00130-8; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Matera MG, 2017, HANDB EXP PHARMACOL, V237, P41, DOI 10.1007/164_2016_68; Milara J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210188; Miyamoto M, 2004, EUR RESPIR J, V24, P231, DOI 10.1183/09031936.04.00035204; Monteseirin J, 2005, CLIN EXP ALLERGY, V35, P1204, DOI 10.1111/j.1365-2222.2005.02320.x; Monteseirin J, 2002, J ASTHMA, V39, P619, DOI 10.1081/JAS-120014926; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Monteseirin J, 2001, J ALLERGY CLIN IMMUN, V107, P623, DOI 10.1067/mai.2001.113566; Monteseirin J, 2004, J LEUKOCYTE BIOL, V76, P692, DOI 10.1189/jlb.0903441; Moote W, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0282-5; Profita M, 2005, ALLERGY, V60, P1361, DOI 10.1111/j.1398-9995.2005.00892.x; Ronchetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124090; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Schwelberger HG, 1998, INFLAMM RES, V47, pS60; Shamji MH, 2015, J ALLERGY CLIN IMMUN, V135, P913, DOI 10.1016/j.jaci.2014.09.049; Sheikh A, 2013, CURR OPIN ALLERGY CL, V13, P263, DOI 10.1097/ACI.0b013e32836097f4; Shim JY, 2003, CLIN EXP ALLERGY, V33, P52, DOI 10.1046/j.1365-2222.2003.01567.x; Shiraishi M, 2000, BRIT J PHARMACOL, V129, P515, DOI 10.1038/sj.bjp.0703085; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Smolinska S, 2014, ALLERGY, V69, P273, DOI 10.1111/all.12330; Smuda C, 2011, IMMUNOL LETT, V141, P102, DOI 10.1016/j.imlet.2011.08.002; Sperr WR, 1997, INT ARCH ALLERGY IMM, V114, P68, DOI 10.1159/000237645; Sperr WR, 1996, J ALLERGY CLIN IMMUN, V98, P389, DOI 10.1016/S0091-6749(96)70163-X; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; Tedeschi A, 2000, INT J IMMUNOPHARMACO, V22, P797, DOI 10.1016/S0192-0561(00)00041-2; Thangam EB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01873; Tsang F, 1998, BRIT J PHARMACOL, V125, P61, DOI 10.1038/sj.bjp.0702049; Vega A, 2007, J CELL SCI, V120, P2328, DOI 10.1242/jcs.000331; Vega A, 2006, J LEUKOCYTE BIOL, V80, P152, DOI 10.1189/jlb.0705411; Ventura I, 2014, ALLERGY, V69, P898, DOI 10.1111/all.12414; Ventura I, 2014, PEDIAT ALLERG IMM-UK, V25, P129, DOI 10.1111/pai.12145; Virchow JC, 2019, LANCET, V394, P1737, DOI 10.1016/S0140-6736(19)32215-9; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232	63	0	0	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21483	10.1096/fj.202001912R	http://dx.doi.org/10.1096/fj.202001912R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788304				2022-12-28	WOS:000645260100001
J	Figueiredo, AB; Castro, RADE; Nogueira-Paiva, NC; Moreira, F; Goncalves, FQ; Soares, RP; Castro-Borges, W; Silva, GG; Cunha, RA; Goncalves, T; Afonso, LCC				Figueiredo, Amanda Braga; de Oliveira e Castro, Renata Alves; Nogueira-Paiva, Nivia Carolina; Moreira, Filipa; Goncalves, Francisco Queiroz; Soares, Rodrigo Pedro; Castro-Borges, William; Silva, Gustavo Goncalves; Cunha, Rodrigo Antunes; Goncalves, Teresa; Crocco Afonso, Luis Carlos			Clustering of adenosine A(2B) receptors with ectonucleotidases in caveolin-rich lipid rafts underlies immunomodulation by Leishmania amazonensis	FASEB JOURNAL			English	Article						adenosine receptor; caveolin; cAMP; dendritic cell; Leishmania; lipid raft	IMMUNE-RESPONSE; PLASMA-MEMBRANE; EXPRESSION; INFLAMMATION; IL-10; COLOCALIZATION; ESTABLISHMENT; COMPARTMENTS; NUCLEOTIDES; MACROPHAGES	Extracellular adenosine plays important roles in modulating the immune responses. We have previously demonstrated that infection of dendritic cells (DC) by Leishmania amazonensis leads to increased expression of CD39 and CD73 and to the selective activation of the low affinity A(2B) receptors (A(2B)R), which contributes to DC inhibition, without involvement of the high affinity A(2A)R. To understand this apparent paradox, we now characterized the alterations of both adenosine receptors in infected cells. With this aim, bone marrow-derived DC from C57BL/6J mice were infected with metacyclic promastigotes of L. amazonensis. Fluorescence microscopy revealed that L. amazonensis infection stimulates the recruitment of A(2B)R, but not of A(2A)R, to the surface of infected DC, without altering the amount of mRNA or the total A(2B)R density, an effect dependent on lipophosphoglycan (LPG). Log-phase promastigotes or axenic amastigotes of L. amazonensis do not stimulate A(2B)R recruitment. A2BR clusters are localized in caveolin-rich lipid rafts and the disruption of these membrane domains impairs A(2B)R recruitment and activation. More importantly, our results show that A(2B)R co-localize with CD39 and CD73 forming a "purinergic cluster" that allows for the production of extracellular adenosine in close proximity with these receptors. We conclude that A(2B)R activation by locally produced adenosine constitutes an elegant and powerful evasion mechanism used by L. amazonensis to down-modulate the DC activation.	[Figueiredo, Amanda Braga; de Oliveira e Castro, Renata Alves; Crocco Afonso, Luis Carlos] Univ Fed Ouro Preto, Lab Imunoparasitol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, Brazil; [Nogueira-Paiva, Nivia Carolina] Univ Fed Ouro Preto, Lab Multiusuario Microscopia, Nucleo Pesquisas Ciencias Biol, Ouro Preto, Brazil; [Moreira, Filipa; Goncalves, Francisco Queiroz; Cunha, Rodrigo Antunes; Goncalves, Teresa] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Soares, Rodrigo Pedro] Fundacao Oswaldo Cruz, Inst Rene Rachou, Rio De Janeiro, Brazil; [Castro-Borges, William; Silva, Gustavo Goncalves] Univ Fed Ouro Preto, Lab Enzimol & Proteom, Nucleo Pesquisas Ciencias Biol, Ouro Preto, Brazil; [Cunha, Rodrigo Antunes; Goncalves, Teresa] Univ Coimbra, Fac Med, Coimbra, Portugal; [Figueiredo, Amanda Braga] Ctr Int Pesquisa & Ensino CIPE, AC Camargo Canc Ctr, Grp Imunooncol Translac, Sao Paulo, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade de Coimbra; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto; Universidade de Coimbra; A.C.Camargo Cancer Center	Afonso, LCC (corresponding author), Univ Fed Ouro Preto, ICEB NUPEB, Dept Ciencias Biol, Lab Imunoparasitol, Campus Morro Cruzeiro, BR-35400000 Ouro Preto, MG, Brazil.	afonso@ufop.edu.br	Gonçalves, Teresa/F-5146-2011; Cunha, Rodrigo A/E-7475-2015; Castro-Borges, William/GLR-8712-2022	Gonçalves, Teresa/0000-0001-9347-0535; Cunha, Rodrigo A/0000-0003-2550-6422; Goncalves Silva, Gustavo/0000-0002-6151-2320	FAPEMIG [CBB-APQ-00617-13, PRONEX-CBB-APQ-01419-14]; CNPq [444092/2014-5, 307695/2017-4]; CAPES [BEX-7462/14-0]; Rede de Pesquisa em Doencas Infecciosas Humanas e Animais no Estado de Minas Gerais/FAPEMIG [RED-00313-16]; FEDER (QREN), through Programa Mais Centro [CENTRO-01-0246-FEDER-000010, CENTRO-07-ST24-FEDER-002006]; Fundacao para a Ciencia e Tecnologia [POCI-01-0145-FEDER-03127, UIDB/04539/2020]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rede de Pesquisa em Doencas Infecciosas Humanas e Animais no Estado de Minas Gerais/FAPEMIG; FEDER (QREN), through Programa Mais Centro; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	FAPEMIG, Grant/Award Number: CBB-APQ-00617-13 and PRONEX-CBB-APQ-01419-14; CNPq, Grant/Award Number: 444092/2014-5 and 307695/2017-4; CAPES, Grant/Award Number: BEX-7462/14-0; Rede de Pesquisa em Doencas Infecciosas Humanas e Animais no Estado de Minas Gerais/FAPEMIG, Grant/Award Number: RED-00313-16; FEDER (QREN), through Programa Mais Centro, Grant/Award Number: CENTRO-01-0246-FEDER-000010 and CENTRO-07-ST24-FEDER-002006; Fundacao para a Ciencia e Tecnologia, Grant/Award Number: POCI-01-0145-FEDER-03127 and UIDB/04539/2020	Aaron JS, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211847; Allard B, 2016, CURR OPIN PHARMACOL, V29, P7, DOI 10.1016/j.coph.2016.04.001; Antonioli L, 2014, DRUG DISCOV TODAY, V19, P1051, DOI 10.1016/j.drudis.2014.02.010; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Savio LEB, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237560; Becher A, 2005, BIOCHEM SOC SYMP, V72, P151, DOI 10.1042/bss0720151; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P3093, DOI 10.1128/IAI.61.7.3093-3097.1993; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Cekic C, 2014, CANCER RES, V74, P7250, DOI 10.1158/0008-5472.CAN-13-3583; Chaves MM, 2014, J IMMUNOL, V192, P4765, DOI 10.4049/jimmunol.1301058; Cunha RA, 1998, J NEUROSCI, V18, P1987; D' Ambrosi N, 2013, CURR MED CHEM, V20, P56; de Assis RR, 2012, BBA-GEN SUBJECTS, V1820, P1354, DOI 10.1016/j.bbagen.2011.11.001; Figueiredo AB, 2012, EUR J IMMUNOL, V42, P1203, DOI 10.1002/eji.201141926; Figueiredo AB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00849; Fortin A, 2006, J LEUKOCYTE BIOL, V79, P574, DOI 10.1189/jlb.0505249; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Garcia-Marcos M, 2009, FEBS J, V276, P330, DOI 10.1111/j.1742-4658.2008.06794.x; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Goncalves R, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-39; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; He X, 2013, CELL SIGNAL, V25, P1913, DOI 10.1016/j.cellsig.2013.05.024; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Inoue Y, 2017, ONCOTARGET, V8, P8738, DOI 10.18632/oncotarget.14434; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Koziak K, 2000, J BIOL CHEM, V275, P2057, DOI 10.1074/jbc.275.3.2057; Lasley RD, 2011, BBA-BIOMEMBRANES, V1808, P1284, DOI 10.1016/j.bbamem.2010.09.019; Lima MHF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00815; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marques-da-Silva ED, 2008, MICROBES INFECT, V10, P850, DOI 10.1016/j.micinf.2008.04.016; Mello PD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01526; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; Nogueira PM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2568-8; Ohta A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00109; OSWALD IP, 1992, J IMMUNOL, V148, P3578; Papanikolaou A, 2005, J BIOL CHEM, V280, P26406, DOI 10.1074/jbc.M413927200; Schicker K, 2009, BBA-MOL CELL RES, V1793, P325, DOI 10.1016/j.bbamcr.2008.09.014; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Shamri R, 2002, J BIOL CHEM, V277, P40027, DOI 10.1074/jbc.M206806200; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; STEHLE JH, 1992, MOL ENDOCRINOL, V6, P384, DOI 10.1210/me.6.3.384; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; vanSteensel B, 1996, J CELL SCI, V109, P787; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Vijayan D, 2017, NAT REV CANCER, V17, P709, DOI 10.1038/nrc.2017.86; Wei Q, 2013, PURINERG SIGNAL, V9, P271, DOI 10.1007/s11302-012-9350-3; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Young A, 2017, CANCER RES, V77, P4684, DOI 10.1158/0008-5472.CAN-17-0393; Zhang W, 2018, PURINERG SIGNAL, V14, P443, DOI 10.1007/s11302-018-9628-1; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	57	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21509	10.1096/fj.202002396RR	http://dx.doi.org/10.1096/fj.202002396RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813781				2022-12-28	WOS:000645260100025
J	McGlade, EA; Herrera, GG; Stephens, KK; Olsen, SLW; Winuthayanon, S; Guner, J; Hewitt, SC; Korach, KS; DeMayo, FJ; Lydon, JP; Monsivais, D; Winuthayanon, W				McGlade, Emily A.; Herrera, Gerardo G.; Stephens, Kalli K.; Olsen, Sierra L. W.; Winuthayanon, Sarayut; Guner, Joie; Hewitt, Sylvia C.; Korach, Kenneth S.; DeMayo, Francesco J.; Lydon, John P.; Monsivais, Diana; Winuthayanon, Wipawee			Cell-type specific analysis of physiological action of estrogen in mouse oviducts	FASEB JOURNAL			English	Article						embryo development; embryo transport; estrogen; insulin-like growth factor 1; oviduct; scRNA-seq	ENDURANCE EXERCISE PERFORMANCE; RUNNING PERFORMANCE; SPLENIC CONTRACTION; GENDER-DIFFERENCES; SEX-DIFFERENCES; MUSCLE; WOMEN; MEN; MARATHON; ECONOMY	One of the endogenous estrogens, 17 beta-estradiol (E-2) is a female steroid hormone secreted from the ovary. It is well established that E-2 causes biochemical and histological changes in the uterus. However, it is not completely understood how E-2 regulates the oviductal environment in vivo. In this study, we assessed the effect of E-2 on each oviductal cell type, using an ovariectomized-hormone-replacement mouse model, single-cell RNA-sequencing (scRNA-seq), in situ hybridization, and cell-type-specific deletion in mice. We found that each cell type in the oviduct responded to E-2 distinctively, especially ciliated and secretory epithelial cells. The treatment of exogenous E-2 did not drastically alter the transcriptomic profile from that of endogenous E-2 produced during estrus. Moreover, we have identified and validated genes of interest in our datasets that may be used as cell-and region-specific markers in the oviduct. Insulin-like growth factor 1 (Igf1) was characterized as an E-2-target gene in the mouse oviduct and was also expressed in human fallopian tubes. Deletion of Igf1 in progesterone receptor (Pgr)-expressing cells resulted in female subfertility, partially due to an embryo developmental defect and embryo retention within the oviduct. In summary, we have shown that oviductal cell types, including epithelial, stromal, and muscle cells, are differentially regulated by E-2 and support gene expression changes, such as growth factors that are required for normal embryo development and transport in mouse models. Furthermore, we have identified cell-specific and region-specific gene markers for targeted studies and functional analysis in vivo.	[McGlade, Emily A.; Herrera, Gerardo G.; Stephens, Kalli K.; Olsen, Sierra L. W.; Winuthayanon, Sarayut; Winuthayanon, Wipawee] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Ctr Reprod Biol, Biotechnol Life Sci Bldg,1770 Stadium Way, Pullman, WA 99164 USA; [Guner, Joie; Monsivais, Diana] Baylor Coll Med, Dept Pathol & Immunol, Ctr Reprod Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Hewitt, Sylvia C.; Korach, Kenneth S.; DeMayo, Francesco J.] Natl Inst Environm Hlth Sci, Dept Hlth & Human Serv, Reprod & Dev Biol Lab, Natl Inst Hlth NIH NIEHS, Res Triangle Pk, NC USA; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Washington State University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	Winuthayanon, W (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Ctr Reprod Biol, Biotechnol Life Sci Bldg,1770 Stadium Way, Pullman, WA 99164 USA.	w.winuthayanon@wsu.edu		Korach, Kenneth/0000-0002-7765-418X; McGlade, Emily/0000-0003-4979-9979; Hewitt, Sylvia/0000-0001-7713-0805; /0000-0002-9323-3764; Winuthayanon, Sarayut/0000-0002-8439-0389	Burroughs Wellcome Fund (BWF); Louis Stokes Alliance for Minority Participation (LSAMP) Research Award; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [1ZIAES103311, 1ZIAES070065]; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD042311, R01HD097087, R01HD097087-01S1, R01HD097087-02S1, R00HD096057]	Burroughs Wellcome Fund (BWF)(Burroughs Wellcome Fund); Louis Stokes Alliance for Minority Participation (LSAMP) Research Award; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Burroughs Wellcome Fund (BWF); Louis Stokes Alliance for Minority Participation (LSAMP) Research Award; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: 1ZIAES103311 and 1ZIAES070065; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD042311, R01HD097087, R01HD097087-01S1, R01HD097087-02S1 and R00HD096057	ARMSTRONG RB, 1992, J APPL PHYSIOL, V73, P2274, DOI 10.1152/jappl.1992.73.6.2274; ASTRAND PO, 1964, J APPL PHYSIOL, V19, P268, DOI 10.1152/jappl.1964.19.2.268; Bakovic D, 2005, CLIN EXP PHARMACOL P, V32, P944, DOI 10.1111/j.1440-1681.2005.04289.x; Bower MA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1644; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; Costa AM, 2012, SPORTS MED, V42, P449, DOI 10.2165/11650560-000000000-00000; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; Entin P., 2007, Equine and Comparative Exercise Physiology, V4, P135; Fletcher JR, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.178; Gagnon CM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0684; GUILHERME João Paulo Limongi França, 2014, Rev. bras. educ. fís. esporte, V28, P177, DOI 10.1590/S1807-55092014000100177; Guth LM, 2013, CURR OPIN PEDIATR, V25, P653, DOI 10.1097/MOP.0b013e3283659087; Handelsman DJ, 2018, ENDOCR REV, V39, P803, DOI 10.1210/er.2018-00020; Harper J., 2015, J SPORT CULT IDENTIT, V6, P1, DOI [DOI 10.18848/2381-6678/CGP/V06I01/54079, 10.18848/2381-6678/CGP/v06i01/54079]; Haugen T, 2018, INT J SPORT PHYSIOL, V13, P678, DOI 10.1123/ijspp.2017-0441; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; HELGERUD J, 1990, EUR J APPL PHYSIOL O, V61, P433, DOI 10.1007/BF00236064; Hilton EN, 2021, SPORTS MED, V51, P199, DOI 10.1007/s40279-020-01389-3; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Howden EJ, 2015, J APPL PHYSIOL, V119, P37, DOI 10.1152/japplphysiol.00092.2015; Hunter SK, 2015, J APPL PHYSIOL, V118, P1321, DOI 10.1152/japplphysiol.00852.2014; Ingham SA, 2008, MED SCI SPORT EXER, V40, P345, DOI 10.1249/mss.0b013e31815a83dc; Jeon Y, 2019, J EXERC REHABIL, V15, P537, DOI 10.12965/jer.1938336.168; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; Joyner MJ, 2011, J APPL PHYSIOL, V110, P275, DOI 10.1152/japplphysiol.00563.2010; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Joyner MJ, 2020, J APPL PHYSIOL, V128, P1065, DOI 10.1152/japplphysiol.00793.2019; Joyner MJ, 2019, SPORTS MED, V49, P199, DOI 10.1007/s40279-019-01164-z; Joyner MJ, 2017, J PHYSIOL-LONDON, V595, P2949, DOI 10.1113/JP272268; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Keenan KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191504; Kim J, 2018, P NATL ACAD SCI USA, V115, pE7212, DOI 10.1073/pnas.1800455115; Kipp S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00079; Kubo K, 2003, EUR J APPL PHYSIOL, V88, P520, DOI 10.1007/s00421-002-0744-8; Lauderdale M A, 1999, Equine Vet J Suppl, P586; Liebenberg L, 2008, J HUM EVOL, V55, P1156, DOI 10.1016/j.jhevol.2008.07.004; LONGHURST JC, 1986, AM J PHYSIOL, V251, pH502, DOI 10.1152/ajpheart.1986.251.3.H502; Lund RJ, 1995, J S AFR VET ASSOC, V66, P239; McKeever K H, 2006, Equine Vet J Suppl, P233; Miller VM, 2015, J WOMENS HEALTH, V24, P969, DOI 10.1089/jwh.2015.5498; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Pate RR, 2007, SPORTS MED, V37, P294, DOI 10.2165/00007256-200737040-00006; Porter MM, 2002, J APPL PHYSIOL, V92, P1451, DOI 10.1152/japplphysiol.00744.2001; Roberts TA, 2020, BR J SPORTS MED; Rooney MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205664; Schagatay E, 2020, EUR J APPL PHYSIOL, V120, P2693, DOI 10.1007/s00421-020-04471-w; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Senefeld J, 2016, SCAND J MED SCI SPOR, V26, P17, DOI 10.1111/sms.12412; Senefeld JW, 2020, JAMA-J AM MED ASSOC, V324, P99, DOI 10.1001/jama.2020.5655; Senefeld JW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225724; Shave Rob, 2017, Vet Sci, V4, DOI 10.3390/vetsci4010009; Staaden R., 1984, THESIS MURDOCH U MUR; Thibault V, 2010, J SPORT SCI MED, V9, P214; Trachsel DS, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0846-x; VAHLQUIST B, 1950, BLOOD, V5, P874, DOI 10.1182/blood.V5.9.874.874; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; Wiik A., 2020, J CLIN ENDOCR METAB, V105, P805; Yilmaz DC, 2013, INDIAN J MED RES, V137, P1111; Young LE, 2003, EXP PHYSIOL, V88, P659, DOI 10.1113/eph8802615; Zaldivar-Lopez S, 2011, VET CLIN PATH, V40, P414, DOI 10.1111/j.1939-165X.2011.00360.x	65	6	6	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21563	10.1096/fj.202002747R	http://dx.doi.org/10.1096/fj.202002747R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33818810	Green Submitted, Green Accepted			2022-12-28	WOS:000645260100070
J	Uda, Y; Spatz, JM; Hussein, A; Garcia, JH; Lai, F; Dedic, C; Fulzele, K; Dougherty, S; Eberle, M; Adamson, C; Misener, L; Gerstenfeld, L; Pajevic, PD				Uda, Yuhei; Spatz, Jordan M.; Hussein, Amira; Garcia, Joseph H.; Lai, Forest; Dedic, Chris; Fulzele, Keertik; Dougherty, Sean; Eberle, Margaret; Adamson, Chris; Misener, Lowell; Gerstenfeld, Louis; Pajevic, Paola Divieti			Global transcriptomic analysis of a murine osteocytic cell line subjected to spaceflight	FASEB JOURNAL			English	Article						bone cells; bone loss; gene expression; International Space Station; microgravity	PPAR-GAMMA; INHIBITOR SCLEROSTIN; NITRIC-OXIDE; BONE; GENE; INVOLVEMENT; EXPRESSION; OSTEOCLASTOGENESIS; DIFFERENTIATION; IDENTIFICATION	Bone loss is a major health concern for astronauts during long-term spaceflight and for patients during prolonged bed rest or paralysis. Growing evidence suggests that osteocytes, the most abundant cells in the mineralized bone matrix, play a key role in sensing mechanical forces applied to the skeleton and integrating the orchestrated response into subcellular biochemical signals to modulate bone homeostasis. However, the precise molecular mechanisms underlying both mechanosensation and mechanotransduction in late-osteoblast-to-osteocyte cells under microgravity (mu G) have yet to be elucidated. To unravel the mechanisms by which late osteoblasts and osteocytes sense and respond to mechanical unloading, we exposed the osteocytic cell line, Ocy454, to 2, 4, or 6 days of mu G on the SpaceX Dragon-6 resupply mission to the International Space Station. Our results showed that mu G impairs the differentiation of osteocytes, consistent with prior osteoblast spaceflight experiments, which resulted in the downregulation of key osteocytic genes. Importantly, we demonstrate the modulation of critical glycolysis pathways in osteocytes subjected to microgravity and discovered a set of mechanical sensitive genes that are consistently regulated in multiple cell types exposed to microgravity suggesting a common, yet to be fully elucidated, genome-wide response to microgravity. Ground-based simulated microgravity experiments utilizing the NASA rotating-wall-vessel were unable to adequately replicate the changes in microgravity exposure highlighting the importance of spaceflight missions to understand the unique environmental stress that microgravity presents to diverse cell types. In summary, our findings demonstrate that osteocytes respond to mu G with an increase in glucose metabolism and oxygen consumption.	[Uda, Yuhei; Lai, Forest; Dedic, Chris; Fulzele, Keertik; Pajevic, Paola Divieti] Boston Univ, Henry M Goldman Sch Dent Med, Dept Translat Dent Med, 700 Albany St,W201E, Boston, MA 02118 USA; [Spatz, Jordan M.; Pajevic, Paola Divieti] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Spatz, Jordan M.; Pajevic, Paola Divieti] Harvard Med Sch, Boston, MA 02115 USA; [Spatz, Jordan M.; Garcia, Joseph H.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Hussein, Amira; Gerstenfeld, Louis] Boston Univ, Sch Med, Dept Orthopaed Surg, Boston, MA 02118 USA; [Dougherty, Sean; Eberle, Margaret; Adamson, Chris; Misener, Lowell] CALM Technol Inc, Kingston, ON, Canada	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Boston University	Pajevic, PD (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Translat Dent Med, 700 Albany St,W201E, Boston, MA 02118 USA.	pdivieti@bu.edu	Uda, Yuhei/AAZ-4978-2021	Uda, Yuhei/0000-0003-4705-6215	Canadian Space Agency; NIH [NIAMS AR059655]; CASIS [GA2015-209]; Boston University Microarray Core Facility (CTSA grant) [U54-TR001012]	Canadian Space Agency(Canadian Space Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CASIS; Boston University Microarray Core Facility (CTSA grant)	The authors wish to thank Dr Lisa E. Freed for her invaluable advice and contribution in the developing this project, all staff and members of the Kennedy Space Center ISS processing facility and NASA mission support team for their help and support for the ISS mission, with a particular thanks to Derek Duflo (Jacobs--TOSC), Gerard Newsham (Jacobs--TOSC), Larry Cotton (NASA/JSC PIM), Henry Orosco (NASA/JSC RIM), and Brienne Shkedi (NASA/JSC ISS liaison). The authors also would like to thank Jenna Aronson and Dr Chao Shi for their contribution to this work and Dr Faye Chen (NIH--NIAMS) for her advice and continuous support. The authors also thank Luc Lefebvre and the Canadian Space Agency for the support and loaning of the eOSTEO payload hardware. This work was supported by grants from NIH (NIAMS AR059655 to PDP), CASIS (grant GA2015-209 to PDP), and the Boston University Microarray Core Facility (CTSA grant U54-TR001012).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Camirand A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160034; Cardinaux JR, 1996, J NEUROSCI, V16, P919; Chakraborty N, 2020, J BONE MINER RES, V35, P2049, DOI 10.1002/jbmr.4102; Cho YE, 2007, NEUROSCI LETT, V416, P144, DOI 10.1016/j.neulet.2007.01.073; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Cuzzocrea S, 2003, ENDOCRINOLOGY, V144, P1098, DOI 10.1210/en.2002-220597; Delgado-Calle J, 2015, CURR MOL BIOL REP, V1, P157; Dobrosak Cale, 2017, Bone Rep, V7, P114, DOI 10.1016/j.bonr.2017.10.002; Frings-Meuthen P, 2013, J MUSCULOSKEL NEURON, V13, P45; Fritton SP, 2009, ANNU REV FLUID MECH, V41, P347, DOI 10.1146/annurev.fluid.010908.165136; Fulzele K, 2017, J BONE MINER RES, V32, P373, DOI 10.1002/jbmr.3001; Gabel LA-O, 2021, BRIT J SPORT MED, DOI [10.1136/bjsports-2020-103602, DOI 10.1136/BJSP0RTS-2020-103602]; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalaitzoglou E, 2016, CURR OSTEOPOROS REP, V14, P310, DOI 10.1007/s11914-016-0329-9; Kanai Y, 2017, J CLIN INVEST, V127, P4136, DOI 10.1172/JCI94912; Khoury-Haddad H, 2014, P NATL ACAD SCI USA, V111, pE728, DOI 10.1073/pnas.1317585111; Kuang HB, 2009, ENDOCRINOLOGY, V150, P5596, DOI 10.1210/en.2009-0570; KUKITA A, 1990, P NATL ACAD SCI USA, V87, P3023, DOI 10.1073/pnas.87.8.3023; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; Lee MJ, 2004, MOL CELL BIOL, V24, P3918, DOI 10.1128/MCB.24.9.3918-3927.2004; Lee NJ, 2018, MOL METAB, V13, P30, DOI 10.1016/j.molmet.2018.05.004; Meakin LB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00154; Michaletti A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15612-1; Moeller LC, 2005, J CLIN ENDOCR METAB, V90, P936, DOI 10.1210/jc.2004-1768; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Ortega MT, 2012, ADV SPACE RES, V49, P1441, DOI 10.1016/j.asr.2012.02.021; Pajevic PD, 2020, CURR OSTEOPOROS REP, V18, P551, DOI 10.1007/s11914-020-00613-3; Pajevic Paola Divieti, 2013, Curr Biotechnol, V2, P179; Pajevic PD, 2009, IBMS BONEKEY, V6, P63, DOI DOI 10.1138/20090363; Patel MJ, 2007, J CELL BIOCHEM, V101, P587, DOI 10.1002/jcb.21218; Pino E, 2012, J BIOL CHEM, V287, P18351, DOI 10.1074/jbc.M112.350918; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Qusous A, 2011, J MEMBRANE BIOL, V243, P25, DOI 10.1007/s00232-011-9389-z; RAMBAUT PC, 1979, ACTA ASTRONAUT, V6, P1113, DOI 10.1016/0094-5765(79)90059-6; Robling AG, 2020, ANNU REV PHYSIOL, V82, P485, DOI 10.1146/annurev-physiol-021119-034332; Rodionova NV, 2002, ADV SPACE RES, V30, P765, DOI 10.1016/S0273-1177(02)00393-9; SHOWS TB, 1969, BIOCHEM GENET, V3, P525, DOI 10.1007/BF00485474; Smith SM, 2015, BONE, V81, P712, DOI 10.1016/j.bone.2015.10.002; Smith SM, 2012, NUTRIENTS, V4, P2047, DOI 10.3390/nu4122047; Smith SM, 2012, J BONE MINER RES, V27, P1896, DOI 10.1002/jbmr.1647; Spatz JM, 2012, J CLIN ENDOCR METAB, V97, pE1736, DOI 10.1210/jc.2012-1579; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takiguchi S, 2014, INT J ONCOL, V44, P1316, DOI 10.3892/ijo.2014.2293; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Uda Y, 2017, CURR OSTEOPOROS REP, V15, P318, DOI 10.1007/s11914-017-0373-0; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Wu C, 2015, GENE DEV, V29, P817, DOI 10.1101/gad.255000.114; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Xu LCH, 2019, J ORTHOP RES, V37, P1681, DOI 10.1002/jor.24302; Yamada T, 2004, J BONE MINER RES, V19, P1452, DOI 10.1359/JBMR.040515	72	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21578	10.1096/fj.202100059R	http://dx.doi.org/10.1096/fj.202100059R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835498				2022-12-28	WOS:000645260100042
J	Britton, C; Poznansky, MC; Reeves, P				Britton, C.; Poznansky, M. C.; Reeves, P.			Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune-mediated diseases	FASEB JOURNAL			English	Review						chemokine; GPCR; therapeutics	MIGRATION-INHIBITORY FACTOR; CHEMOKINE RECEPTOR CXCR4; CELL-DERIVED FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; FACTOR-I CXCL12; T-CELL; BONE-MARROW; FACTOR MIF; PROGENITOR CELLS; SIGNAL-TRANSDUCTION	Historically the chemokine receptor CXCR4 and its canonical ligand CXCL12 are associated with the bone marrow niche and hematopoiesis. However, CXCL12 exhibits broad tissue expression including brain, thymus, heart, lung, liver, kidney, spleen, and bone marrow. CXCR4 can be considered as a node which is integrating and transducing inputs from a range of ligand-receptor interactions into a responsive and divergent network of intracellular signaling pathways that impact multiple cellular processes such as proliferation, migration, and stress resistance. Dysregulation of the CXCR4/CXCL12 axis and consequent fundamental cellular processes, are associated with a panoply of disease. This review frames the polyfunctionality of the receptor at a molecular, physiological, and pathophysiological levels. Transitioning our perspective of this axis from a single gene/protein:single function model to a polyfunctional signaling cascade highlights the potential for finer therapeutic intervention and cautions against a reductionist approach.	[Britton, C.; Poznansky, M. C.; Reeves, P.] Vaccine & Immunotherapy Ctr, Boston, MA 02215 USA; [Reeves, P.] Imperial Coll Sch Med, Dept Med, London, England	Imperial College London	Poznansky, MC (corresponding author), Vaccine & Immunotherapy Ctr, Boston, MA 02215 USA.; Britton, C (corresponding author), Imperial Coll Sch Med, Dept Med, London, England.	cb5415@ic.ac.uk; mpoznansky@mgh.harvard.edu	Reeves, Patrick/I-1066-2018	Reeves, Patrick/0000-0001-8202-0723; Britton, Clemency/0000-0001-6820-8674				Abe P, 2014, DEVELOPMENT, V141, P1857, DOI 10.1242/dev.104224; Aboumrad E, 2007, CLIN EXP IMMUNOL, V148, P432, DOI 10.1111/j.1365-2249.2007.03370.x; Alagpulinsa DA, 2019, PHARMACOL THERAPEUT, V193, P63, DOI 10.1016/j.pharmthera.2018.08.011; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Arisawa T, 2008, ONCOL REP, V19, P223; Bachelerie F, 2010, DIS MARKERS, V29, P189, DOI [10.3233/DMA-2010-0736, 10.1155/2010/475104]; Bamidele AO, 2015, J CELL BIOL, V210, P257, DOI 10.1083/jcb.201411045; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; Barbolina MV, 2010, MOL CANCER RES, V8, P653, DOI 10.1158/1541-7786.MCR-09-0463; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Brainard DM, 2004, J VIROL, V78, P5184, DOI 10.1128/JVI.78.10.5184-5193.2004; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burger JA, 2010, SEMIN CANCER BIOL, V20, P424, DOI 10.1016/j.semcancer.2010.09.005; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Cao Y, 2015, LEUKEMIA, V29, P169, DOI 10.1038/leu.2014.187; Chalichem NSS, 2018, J DRUG TARGET, V26, P670, DOI 10.1080/1061186X.2018.1433682; Chang S.-W.L., 2015, MECH STAT MODELS UND; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chen JY, 2015, ONCOTARGET, V6, P5597, DOI 10.18632/oncotarget.3343; Chen T, 2015, AM J TRANSPLANT, V15, P618, DOI 10.1111/ajt.13049; Chen YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44123; Cheng M, 2015, J MOL CELL CARDIOL, V81, P49, DOI 10.1016/j.yjmcc.2015.01.024; Cheng M, 2012, PROG MOL BIOL TRANSL, V111, P243, DOI 10.1016/B978-0-12-398459-3.00011-3; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Chung SH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3158; Collins PJ, 2017, FASEB J, V31, P3084, DOI 10.1096/fj.201700013R; Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; de Bock CE, 2015, CANCER CELL, V27, P745, DOI 10.1016/j.ccell.2015.05.011; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeNies MS, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00077; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Doring Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00212; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Doring Y, 2017, CIRCULATION, V136, P388, DOI 10.1161/CIRCULATIONAHA.117.027646; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Dubois-Laforgue D, 2001, DIABETES, V50, P1211, DOI 10.2337/diabetes.50.5.1211; Duquenne C, 2014, J IMMUNOL, V193, P4188, DOI 10.4049/jimmunol.1303298; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Esencay M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-347; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Fujita M, 2018, BIOCHEM J, V475, P723, DOI 10.1042/BCJ20170867; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Ge BS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16802-7; Giger RJ, 2001, CELL, V105, P1, DOI 10.1016/S0092-8674(01)00290-2; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Goshima Y, 2002, J CLIN INVEST, V109, P993, DOI 10.1172/JCI200215467; Nobre CCG, 2017, PATHOL ONCOL RES, V23, P235, DOI 10.1007/s12253-016-0138-6; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hagemann T, 2007, MOL CANCER THER, V6, P1993, DOI 10.1158/1535-7163.MCT-07-0118; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hampton HR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8139; Hashimoto I, 2008, EUR J CANCER, V44, P1022, DOI 10.1016/j.ejca.2008.02.043; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Heesen M, 1997, J IMMUNOL, V158, P3561; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Hoffmann F, 2012, J BIOL CHEM, V287, P28362, DOI 10.1074/jbc.M111.335679; Hsu W, 2005, AUTOIMMUN REV, V4, P429, DOI 10.1016/j.autrev.2005.03.004; Huang Z, 2014, GUT, V63, P1247, DOI 10.1136/gutjnl-2012-304213; Ide A, 2003, HUM IMMUNOL, V64, P973, DOI 10.1016/S0198-8859(03)00176-9; Iwanaga Tomohiro, 2007, Gan To Kagaku Ryoho, V34, P1917; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Karpova D, 2015, STEM CELLS, V33, P2391, DOI 10.1002/stem.2054; Kijima T, 2002, CANCER RES, V62, P6304; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Kim SY, 2008, CLIN EXP METASTAS, V25, P201, DOI 10.1007/s10585-007-9133-3; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Konoplev S, 2007, CANCER, V109, P1152, DOI 10.1002/cncr.22510; Kraemer BF, 2010, J MOL MED, V88, P1277, DOI 10.1007/s00109-010-0680-8; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; Krockenberger M, 2008, J IMMUNOL, V180, P7338, DOI 10.4049/jimmunol.180.11.7338; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Kucia M, 2004, J MOL HISTOL, V35, P233; Kumar A, 2011, J IMMUNOL, V186, P951, DOI 10.4049/jimmunol.1002019; Lacy M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23554-5; Lao J, 2017, J PHYS CHEM B, V121, P1466, DOI 10.1021/acs.jpcb.6b10969; Leng QB, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-51; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Li BH, 2018, CANCER IMMUNOL RES, V6, P539, DOI 10.1158/2326-6066.CIR-17-0530; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liberman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043665; Liebick M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157502; Liu L, 2013, MOL MED REP, V8, P140, DOI 10.3892/mmr.2013.1477; Lourenco S, 2015, J IMMUNOL, V194, P3463, DOI 10.4049/jimmunol.1402097; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martinez-Munoz L, 2014, P NATL ACAD SCI USA, V111, pE1960, DOI 10.1073/pnas.1322887111; Matin K, 2002, IMMUNOLOGY, V107, P222, DOI 10.1046/j.1365-2567.2002.01478.x; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Meng WF, 2018, GENE, V641, P105, DOI 10.1016/j.gene.2017.10.015; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mo W, 2013, CELL, V152, P1077, DOI 10.1016/j.cell.2013.01.053; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Montresor A, 2015, ONCOTARGET, V6, P34245, DOI 10.18632/oncotarget.5196; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Murphy PM, 2018, CYTOKINE, V109, P2, DOI 10.1016/j.cyto.2017.12.022; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Papeta N, 2007, TRANSPLANTATION, V83, P174, DOI 10.1097/01.tp.0000250658.00925.c8; Patel B, 2014, BLOOD, V124, P96, DOI 10.1182/blood-2014-01-549352; Pawig L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00429; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pelus LM, 2005, EXP HEMATOL, V33, P295, DOI 10.1016/j.exphem.2004.11.008; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Perez-Martinez M, 2010, J CELL SCI, V123, P1160, DOI 10.1242/jcs.064238; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Pozzobon T, 2016, IMMUNOL LETT, V177, P6, DOI 10.1016/j.imlet.2016.06.006; Puddinu V, 2017, ONCOTARGET, V8, P85068, DOI 10.18632/oncotarget.18844; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rajasekaran D, 2016, J BIOL CHEM, V291, P15881, DOI 10.1074/jbc.M116.717751; Ray P, 2015, ONCOGENE, V34, P2043, DOI 10.1038/onc.2014.157; Redpath AN, 2017, BLOOD ADV, V1, P1934, DOI 10.1182/bloodadvances.2017006064; Reeves P., 2018, COMPOSITIONS TREATME; Reeves PM, 2017, ANTI-CANCER DRUG, V28, P935, DOI 10.1097/CAD.0000000000000518; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Ryan LK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060153; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Sand LGL, 2015, BIOCHEM BIOPH RES CO, V466, P89, DOI 10.1016/j.bbrc.2015.08.113; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Scofield SLC, 2018, LIFE SCI, V211, P8, DOI 10.1016/j.lfs.2018.09.012; Scotton CJ, 2001, CANCER RES, V61, P4961; Shin HN, 2012, INT J MOL MED, V30, P1537, DOI 10.3892/ijmm.2012.1141; Siders W, 2009, BLOOD, V114, P1064; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Signoret N, 1998, J CELL SCI, V111, P2819; Sinitski D, 2019, THROMB HAEMOSTASIS, V119, P553, DOI 10.1055/s-0039-1677803; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takahashi N, 1998, MOL MED, V4, P707, DOI 10.1007/BF03401765; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Tas F, 2008, MED ONCOL, V25, P431, DOI 10.1007/s12032-008-9058-y; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Teixido J, 2018, INT J BIOCHEM CELL B, V95, P121, DOI 10.1016/j.biocel.2017.12.018; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tong X, 2015, INT J CLIN EXP MED, V8, P15949; Torres R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007570; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Vianello F, 2005, J IMMUNOL, V175, P5115, DOI 10.4049/jimmunol.175.8.5115; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; von Hundelshausen P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6650; Walenkamp AME, 2017, J NUCL MED, V58, p77S, DOI 10.2967/jnumed.116.186874; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00641; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Wang YG, 2012, PROG MOL BIOL TRANSL, V111, P265, DOI 10.1016/B978-0-12-398459-3.00012-5; Wang YT, 2012, CURR DRUG TARGETS, V13, P166, DOI 10.2174/138945012799201603; Ward SG, 2006, TRENDS IMMUNOL, V27, P80, DOI 10.1016/j.it.2005.12.004; Welschinger R, 2013, EXP HEMATOL, V41, P293, DOI 10.1016/j.exphem.2012.11.004; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu L, 2013, MOL BIOSYST, V9, P2107, DOI 10.1039/c3mb70120d; Xue YB, 2017, BIOMED PHARMACOTHER, V86, P426, DOI 10.1016/j.biopha.2016.12.051; Yang B, 2004, CYTOKINE, V26, P114, DOI 10.1016/j.cyto.2004.01.005; Yang QL, 2017, INT J ONCOL, V50, P1160, DOI 10.3892/ijo.2017.3906; Yang QL, 2011, J HUAZHONG U SCI-MED, V31, P497, DOI 10.1007/s11596-011-0479-z; Yi YJ, 1999, J VIROL, V73, P7117, DOI 10.1128/JVI.73.9.7117-7125.1999; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zeng Y., 2016, INT J CANC CLIN RES, V3, P51; Zeng Y, 2019, FASEB J, V33, P6596, DOI 10.1096/fj.201802067RR; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhao HL, 2015, ONCOTARGET, V6, P5022, DOI 10.18632/oncotarget.3217; Zheng HC, 2006, ANTICANCER RES, V26, P3579; Zheng JH, 2013, CLIN CANCER RES, V19, P1400, DOI 10.1158/1078-0432.CCR-12-2888; Zhong JX, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00477; Zhu B, 2012, STEM CELLS, V30, P2571, DOI 10.1002/stem.1239; Ziarek JJ, 2013, ACS CHEM BIOL, V8, P1955, DOI 10.1021/cb400274z; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064; Zlatopolskiy A, 2001, IMMUNOL CELL BIOL, V79, P340, DOI 10.1046/j.1440-1711.2001.01015.x; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	230	19	19	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21260	10.1096/fj.202001273R	http://dx.doi.org/10.1096/fj.202001273R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715207				2022-12-28	WOS:000635216100043
J	Borrello, MT; Emma, MR; Listi, A; Rubis, M; Coslet, S; Augello, G; Cusimano, A; Cabibi, D; Porcasi, R; Giannitrapani, L; Soresi, M; Pantuso, G; Blyth, K; Montalto, G; Pin, C; Cervello, M; Iovanna, J				Borrello, Maria Teresa; Emma, Maria Rita; Listi, Angela; Rubis, Marion; Coslet, Sergiu; Augello, Giuseppa; Cusimano, Antonella; Cabibi, Daniela; Porcasi, Rossana; Giannitrapani, Lydia; Soresi, Maurizio; Pantuso, Gianni; Blyth, Karen; Montalto, Giuseppe; Pin, Christopher; Cervello, Melchiorre; Iovanna, Juan			NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response	FASEB JOURNAL			English	Article						lipotoxicity; NAFL; NASH; NUPR1; PPAR&#8208; a signalling; UPR	ER-STRESS; HEPATIC STEATOSIS; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; NUCLEAR-PROTEIN; CELL-DEATH; P8; MICE; DYSFUNCTION	Non-alcoholic fatty liver (NAFL) and related syndromes affect one-third of the adult population in industrialized and developing countries. Lifestyle and caloric oversupply are the main causes of such array of disorders, but the molecular mechanisms underlying their etiology remain elusive. Nuclear Protein 1 (NUPR1) expression increases upon cell injury in all organs including liver. Recently, we reported NUPR1 actively participates in the activation of the Unfolded Protein Response (UPR). The UPR typically maintains protein homeostasis, but downstream mediators of the pathway regulate metabolic functions including lipid metabolism. As increases in UPR and NUPR1 in obesity and liver disease have been well documented, the goal of this study was to investigate the roles of NUPR1 in this context. To establish whether NUPR1 is involved in these liver conditions we used patient-derived liver biopsies and in vitro and in vivo NUPR1 loss of functions models. First, we analyzed NUPR1 expression in a cohort of morbidly obese patients (MOPs), with simple fatty liver (NAFL) or more severe steatohepatitis (NASH). Next, we explored the metabolic roles of NUPR1 in wild-type (Nupr1(+/+)) or Nupr1 knockout mice (Nupr1(-/-)) fed with a high-fat diet (HFD) for 15 weeks. Immunohistochemical and mRNA analysis revealed NUPR1 expression is inversely correlated to hepatic steatosis progression. Mechanistically, we found NUPR1 participates in the activation of PPAR-alpha signaling via UPR. As PPAR-alpha signaling is controlled by UPR, collectively, these findings suggest a novel function for NUPR1 in protecting liver from metabolic distress by controlling lipid homeostasis, possibly through the UPR.	[Borrello, Maria Teresa; Listi, Angela; Rubis, Marion; Iovanna, Juan] Aix Marseille Univ, Ctr Rech Cancerol Marseille, INSERM, CNRS,UMR 7258,U1068, Parc Sci & Technol Luminy, Marseille, France; [Borrello, Maria Teresa; Listi, Angela; Rubis, Marion; Iovanna, Juan] Inst Paoli Calmettes, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France; [Emma, Maria Rita; Augello, Giuseppa; Cusimano, Antonella; Cervello, Melchiorre] CNR, Ist Ric & Innovaz Biomed IRIB, Via Ugo La Malfa 153, I-90144 Palermo, Italy; [Coslet, Sergiu] Aix Marseille Univ, MI mAbs, Parc Sci & Technol Luminy, Marseille, France; [Cabibi, Daniela; Porcasi, Rossana; Giannitrapani, Lydia; Soresi, Maurizio; Montalto, Giuseppe] Univ Palermo, Dipartimento Promoz Salute Maternoinfantile Med I, Palermo, Italy; [Pantuso, Gianni] Univ Palermo, Dept Surg Oncol & Oral Sci, Div Gen & Oncol Surg, Palermo, Italy; [Blyth, Karen] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Pin, Christopher] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Consiglio Nazionale delle Ricerche (CNR); Istituto Ricerca l'Innovazione Biomedica (IRIB-CNR); UDICE-French Research Universities; Aix-Marseille Universite; University of Palermo; University of Palermo; Beatson Institute; Western University (University of Western Ontario)	Iovanna, J (corresponding author), Inst Paoli Calmettes, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France.; Cervello, M (corresponding author), CNR, Ist Ric & Innovaz Biomed IRIB, Via Ugo La Malfa 153, I-90144 Palermo, Italy.; Iovanna, J (corresponding author), Aix Marseille Univ, Ctr Rech Cancerol Marseille CRCM, INSERM, CNRS,UMR 7258,U1068, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France.	melchiorre.cervello@irib.cnr.it; juan.iovanna@inserm.fr	Borrello, Maria Teresa/AAD-6227-2021; cabibi, daniela/D-7438-2013	Borrello, Maria Teresa/0000-0003-1365-1358; cabibi, daniela/0000-0001-6571-6577; Giannitrapani, Lydia/0000-0003-2845-5296	La Ligue Contre le Cancer; Canceropole PACA; INSERM; Associazione Italiana per la Ricerca sul Cancro (AIRC) [18394]; Associazione Italiana per la Ricerca sul Cancro (AIRC)	La Ligue Contre le Cancer(Ligue nationale contre le cancer); Canceropole PACA(Region Grand-Est); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by La Ligue Contre le Cancer, to MTB INCa, Canceropole PACA and INSERM to JI; MC was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC project number 18394). MRE was supported by a post-doctoral fellowship from Associazione Italiana per la Ricerca sul Cancro (AIRC)	Allen-Jennings AE, 2002, J BIOL CHEM, V277, P20020, DOI 10.1074/jbc.M200727200; Arora S, 2016, CLIN CHIM ACTA, V452, P66, DOI 10.1016/j.cca.2015.10.021; Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Chen XQ, 2016, DIABETES, V65, P1904, DOI 10.2337/db15-1637; Chowdhury U, 2009, CANCER METAST REV, V28, P225, DOI 10.1007/s10555-009-9183-x; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Garcia-Montero A, 2001, EUR J CELL BIOL, V80, P720, DOI 10.1078/0171-9335-00209; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Herrema H, 2016, J BIOL CHEM, V291, P17394, DOI 10.1074/jbc.M116.728949; Huang C, 2019, CANCERS, V11, DOI 10.3390/cancers11121869; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KRAMER R, 1995, BRIT J CANCER, V71, P670, DOI 10.1038/bjc.1995.133; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, TOXICOL LETT, V211, P29, DOI 10.1016/j.toxlet.2012.02.017; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mueller Fabrice A., 2019, Current Opinion in Toxicology, V16, P9, DOI 10.1016/j.cotox.2019.03.001; Nagahara R, 2019, YONAGO ACTA MED, V62, P36, DOI 10.33160/yam.2019.03.006; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Path G, 2020, AM J PHYSIOL-ENDOC M, V319, pE338, DOI 10.1152/ajpendo.00088.2020; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Santofimia-Castano P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35020-3; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Taieb D, 2005, HEPATOLOGY, V42, P176, DOI 10.1002/hep.20759; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Zhu XH, 2018, FOOD CHEM TOXICOL, V114, P52, DOI 10.1016/j.fct.2018.02.019	46	6	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21395	10.1096/fj.202002413RR	http://dx.doi.org/10.1096/fj.202002413RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566371	Bronze, Green Submitted			2022-12-28	WOS:000629576700045
J	Elzi, DJ; Bauta, WE; Sanchez, JR; Das, T; Mogare, S; Fatland, PZ; Iza, M; Pertsemlidis, A; Rebel, VI				Elzi, David J.; Bauta, William E.; Sanchez, Jamila R.; Das, Trisha; Mogare, Shweta; Fatland, Peter Zannes; Iza, Moises; Pertsemlidis, Alexander; Rebel, Vivienne, I			Identification of a novel mechanism for meso-tetra (4-carboxyphenyl) porphyrin (TCPP) uptake in cancer cells	FASEB JOURNAL			English	Article						clathrin&#8208; dependent endocytosis; CD320; cell biology		Porphyrins are used for cancer diagnostic and therapeutic applications, but the mechanism of how porphyrins accumulate in cancer cells remains elusive. Knowledge of how porphyrins enter cancer cells can aid the development of more accurate cancer diagnostics and therapeutics. To gain insight into porphyrin uptake mechanisms in cancer cells, we developed a flow cytometry assay to quantify cellular uptake of meso-tetra (4-carboxyphenyl) porphyrin (TCPP), a porphyrin that is currently being developed for cancer diagnostics. We found that TCPP enters cancer cells through clathrin-mediated endocytosis. The LDL receptor, previously implicated in the cellular uptake of other porphyrins, only contributes modestly to uptake. We report that TCPP instead binds strongly (KD=42nM) to CD320, the cellular receptor for cobalamin/transcobalamin II (Cbl/TCN2). Additionally, TCPP competes with Cbl/TCN2 for CD320 binding, suggesting that CD320 is a novel receptor for TCPP. Knockdown of CD320 inhibits TCPP uptake by up to 40% in multiple cancer cell lines, including lung, breast, and prostate cell lines, which supports our hypothesis that CD320 both binds to and transports TCPP into cancer cells. Our findings provide some novel insights into why porphyrins concentrate in cancer cells. Additionally, our study describes a novel function for the CD320 receptor which has been reported to transport only Cbl/TCN2 complexes.	[Elzi, David J.; Bauta, William E.; Sanchez, Jamila R.; Das, Trisha; Mogare, Shweta; Fatland, Peter Zannes; Iza, Moises; Rebel, Vivienne, I] BioAffin Technol Inc, 22211 West I-10,Suite 1206, San Antonio, TX 78257 USA; [Pertsemlidis, Alexander] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Pertsemlidis, Alexander; Rebel, Vivienne, I] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Pertsemlidis, Alexander] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Pertsemlidis, Alexander] UT Hlth San Antonio MD Anderson, Mays Canc Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Rebel, VI (corresponding author), BioAffin Technol Inc, 22211 West I-10,Suite 1206, San Antonio, TX 78257 USA.	vr@bioaffinitytech.com						Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; ALLISON BA, 1994, BRIT J CANCER, V69, P833, DOI 10.1038/bjc.1994.162; AMAGASAKI T, 1990, BLOOD, V76, P1380; An WT, 2009, DYES PIGMENTS, V81, P1, DOI 10.1016/j.dyepig.2008.08.004; Anand S, 2012, CANCER LETT, V326, P8, DOI 10.1016/j.canlet.2012.07.026; Andrade SM, 2002, BIOPHYS J, V82, P1607, DOI 10.1016/S0006-3495(02)75512-4; AVELINE BM, 1995, J PHOTOCH PHOTOBIO B, V30, P161, DOI 10.1016/1011-1344(95)07174-Z; Azzouzi AR, 2017, LANCET ONCOL, V18, P181, DOI 10.1016/S1470-2045(16)30661-1; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Bonneau S, 2004, BIOCHEM PHARMACOL, V68, P1443, DOI 10.1016/j.bcp.2004.06.014; Bonneau S, 2002, BIOPHYS J, V83, P3470, DOI 10.1016/S0006-3495(02)75346-0; Boswell-Casteel RC, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0165-6; Bredell MG, 2010, J PHOTOCH PHOTOBIO B, V101, P185, DOI 10.1016/j.jphotobiol.2010.07.002; Cameron MC, 2019, J AM ACAD DERMATOL, V80, P321, DOI 10.1016/j.jaad.2018.02.083; CANDIDE C, 1986, FEBS LETT, V207, P133, DOI 10.1016/0014-5793(86)80026-6; Cole DA., U.S. Patent, Patent No. [3 : 597-875, 3597875]; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cuenca RE, 2004, ANN SURG ONCOL, V11, P322, DOI 10.1245/ASO.2004.03.025; Dabrowski JM, 2016, COORDIN CHEM REV, V325, P67, DOI 10.1016/j.ccr.2016.06.007; Daniel JA, 2015, TRAFFIC, V16, P635, DOI 10.1111/tra.12272; DAVILA J, 1990, J AM CHEM SOC, V112, P2686, DOI 10.1021/ja00163a032; DIGIROLAMO PM, 1975, ARCH BIOCHEM BIOPHYS, V168, P386, DOI 10.1016/0003-9861(75)90267-2; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dutta Dipannita, 2012, Cell Logist, V2, P203; El-Far M, 1984, Prog Clin Biol Res, V170, P661; Elkin SR, 2015, CANCER RES, V75, P4640, DOI 10.1158/0008-5472.CAN-15-0939; Elzi DJ., 2021, FASEB J, V35; Fogarty FM, 2014, ONCOGENE, V33, P4653, DOI 10.1038/onc.2013.403; HARRISON SM, 1987, BIOCHIM BIOPHYS ACTA, V925, P133, DOI 10.1016/0304-4165(87)90102-4; Hiyama K, 2013, J PORPHYR PHTHALOCYA, V17, P36, DOI 10.1142/S1088424612501192; Hooda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063402; Hu ZY, 2009, BIOMED PHARMACOTHER, V63, P155, DOI 10.1016/j.biopha.2008.07.087; Huang H, 2017, BIOMACROMOLECULES, V18, P562, DOI 10.1021/acs.biomac.6b01715; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Jiang WX, 2013, FASEB J, V27, P2988, DOI 10.1096/fj.13-230185; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; KESSEL D, 1986, CANCER LETT, V33, P183, DOI 10.1016/0304-3835(86)90023-6; Kessel D, 2012, ISR J CHEM, V52, P674, DOI 10.1002/ijch.201100059; Khot MI, 2020, PHOTODIAGN PHOTODYN, V29, DOI 10.1016/j.pdpdt.2019.10.014; Kiesslich T, 2010, FUTURE ONCOL, V6, P1925, DOI [10.2217/fon.10.147, 10.2217/FON.10.147]; Kim JH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1514-4; Kirsch SH, 2013, CLIN CHEM LAB MED, V51, P139, DOI 10.1515/cclm-2012-0673; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; KONGSHAUG M, 1989, BRIT J CANCER, V59, P184, DOI 10.1038/bjc.1989.38; KORBELIK M, 1991, CANCER RES, V51, P2251; KORBELIK M, 1991, BRIT J CANCER, V64, P508, DOI 10.1038/bjc.1991.339; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; Kurokawa H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38460-z; Lange N, 1999, BRIT J CANCER, V80, P185, DOI 10.1038/sj.bjc.6690338; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; Mang TS, 1998, CANCER J SCI AM, V4, P378; Martinez-Olivan J, 2015, FEBS LETT, V589, P3534, DOI 10.1016/j.febslet.2015.10.014; Martinez-Olivan J, 2014, FEBS J, V281, P2638, DOI 10.1111/febs.12811; MATSUDA S, 1980, J BIOCHEM-TOKYO, V88, P1515, DOI 10.1093/oxfordjournals.jbchem.a133122; Mazor O, 2005, PHOTOCHEM PHOTOBIOL, V81, P342, DOI 10.1562/2004-06-14-RA-199.1; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mittal S, 2013, CANCER BIOTHER RADIO, V28, P651, DOI 10.1089/cbr.2013.1512; MORGAN WT, 1988, J BIOL CHEM, V263, P8226; MORGAN WT, 1980, BIOCHIM BIOPHYS ACTA, V624, P271, DOI 10.1016/0005-2795(80)90246-9; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; NAKAJIMA S, 1995, CANCER LETT, V92, P113, DOI 10.1016/0304-3835(95)03762-L; Nakayama T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36478; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Park Hyo Jin, 2009, Immune Netw, V9, P138, DOI 10.4110/in.2009.9.4.138; PASTERNA.RF, 1972, J AM CHEM SOC, V94, P4511, DOI 10.1021/ja00768a016; Patriquin L, 2015, J THORAC ONCOL, V10, P1311, DOI 10.1097/JTO.0000000000000627; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Piffaretti D, 2019, J PHOTOCH PHOTOBIO B, V201, DOI 10.1016/j.jphotobiol.2019.111640; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Quadros Edward V, 2013, J Cancer Ther, V4, P1074; Quadros EV, 2013, BIOCHIMIE, V95, P1008, DOI 10.1016/j.biochi.2013.02.004; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Radulescu AE, 2007, MOL BIOL CELL, V18, P94, DOI 10.1091/mbc.E06-06-0532; RASSMUSSENTAXDAL DS, 1955, CANCER, V8, P78, DOI 10.1002/1097-0142(1955)8:1<78::AID-CNCR2820080109>3.0.CO;2-L; RAVIKANT M, 1991, J CHEM SOC DALTON, P2103, DOI 10.1039/dt9910002103; ROBERTS WG, 1992, CANCER RES, V52, P924; Royle SJ, 2010, TRAFFIC, V11, P1489, DOI 10.1111/j.1600-0854.2010.01104.x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Schmitt F, 2009, J BIOL INORG CHEM, V14, P693, DOI 10.1007/s00775-009-0482-z; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; Shafirstein G, 2016, ANN AM THORAC SOC, V13, P265, DOI 10.1513/AnnalsATS.201509-650FR; Shi JY, 2011, THERANOSTICS, V1, P363, DOI 10.7150/thno/v01p0363; Shibata Y, 2001, CANCER LETT, V166, P79, DOI 10.1016/S0304-3835(00)00717-5; Silva JN, 2006, BIO-MED MATER ENG, V16, pS147; Stenzl A, 2010, J UROLOGY, V184, P1907, DOI 10.1016/j.juro.2010.06.148; Strauss WSL., SPIE 1994, V2078, P515; Takada T, 2014, J CLIN BIOCHEM NUTR, V54, P26, DOI 10.3164/jcbn.13-87; Usuda J, 2006, J THORAC ONCOL, V1, P489, DOI 10.1097/01243894-200606000-00018; VITOLS S, 1992, CANCER RES, V52, P6244; Weimer S, 2006, ANAL BIOCHEM, V352, P110, DOI 10.1016/j.ab.2006.02.029; Wyss P, 2001, INT J CANCER, V93, P720, DOI 10.1002/ijc.1400; Xu M, 2008, MOL CELL BIOL, V28, P4819, DOI 10.1128/MCB.01969-07; Zhao SG, 2013, ANN SURG ONCOL, V20, P4379, DOI 10.1245/s10434-011-2201-6; Zimmer SN, 2011, BLOOD, V118, P69, DOI 10.1182/blood-2010-09-307942	101	1	1	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21427	10.1096/fj.202000197R	http://dx.doi.org/10.1096/fj.202000197R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33629776				2022-12-28	WOS:000629576700053
J	Furlan, AG; Spanou, CES; Godwin, ARF; Wohl, AP; Zimmermann, LMA; Imhof, T; Koch, M; Baldock, C; Sengle, G				Furlan, Ariane G.; Spanou, Chara E. S.; Godwin, Alan R. F.; Wohl, Alexander P.; Zimmermann, Laura-Marie A.; Imhof, Thomas; Koch, Manuel; Baldock, Clair; Sengle, Gerhard			A new MMP-mediated prodomain cleavage mechanism to activate bone morphogenetic proteins from the extracellular matrix	FASEB JOURNAL			English	Article						bone morphogenetic protein (BMP); extracellular matrix (ECM); fibrillin; matrix metalloproteinase (MMP); single particle transmission electron microscopy	GROWTH-FACTOR-BETA; TGF-BETA; CRYSTAL-STRUCTURE; BINDING-PROTEINS; GENE-EXPRESSION; COMPLEX; METALLOPROTEINASES; DIFFERENTIATION; FIBRILLIN-1; TGF-BETA-1	Since their discovery as pluripotent cytokines extractable from bone matrix, it has been speculated how bone morphogenetic proteins (BMPs) become released and activated from the extracellular matrix (ECM). In contrast to TGF-beta s, most investigated BMPs are secreted as bioactive prodomain (PD)-growth factor (GF) complexes (CPLXs). Recently, we demonstrated that PD-dependent targeting of BMP-7 CPLXs to the extracellular fibrillin microfibril (FMF) components fibrillin-1 and -2 represents a BMP sequestration mechanism by rendering the GF latent. Understanding how BMPs become activated from ECM scaffolds such as FMF is crucial to elucidate pathomechanisms characterized by aberrant BMP activation and ECM destruction. Here, we describe a new MMP-dependent BMP-7 activation mechanism from ECM-targeted pools via specific PD degradation. Using Edman sequencing and mutagenesis, we identified a new and conserved MMP-13 cleavage site within the BMP-7 PD. A degradation screen with different BMP family PDs and representative MMP family members suggested utilization of the identified site in a general MMP-driven BMP activation mechanism. Furthermore, sandwich ELISA and solid phase cleavage studies in combination with bioactivity assays, single particle TEM, and in silico molecular docking experiments provided evidence that PD cleavage by MMP-13 leads to BMP-7 CPLX disintegration and bioactive GF release.	[Furlan, Ariane G.; Spanou, Chara E. S.; Wohl, Alexander P.; Zimmermann, Laura-Marie A.; Sengle, Gerhard] Univ Cologne Cologne, Univ Hosp Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann St 52, D-50931 Cologne, Germany; [Spanou, Chara E. S.; Zimmermann, Laura-Marie A.; Sengle, Gerhard] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Pediat & Adolescent Med, Cologne, Germany; [Godwin, Alan R. F.; Baldock, Clair] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Trust Ctr Cell Matrix Res,Sch Biol Sci, Manchester, Lancs, England; [Godwin, Alan R. F.; Baldock, Clair] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Imhof, Thomas; Koch, Manuel] Univ Cologne, Univ Hosp Cologne, Fac Med, Inst Dent Res & Oral Musculoskeletal Biol, Cologne, Germany; [Koch, Manuel; Sengle, Gerhard] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany; [Sengle, Gerhard] Cologne Ctr Musculoskeletal Biomech CCMB, Cologne, Germany	University of Cologne; University of Cologne; University of Manchester; University of Manchester; University of Cologne; University of Cologne	Sengle, G (corresponding author), Univ Cologne Cologne, Univ Hosp Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann St 52, D-50931 Cologne, Germany.	gsengle@uni-koeln.de	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814; Zimmermann, Laura-Marie A./0000-0003-2126-9191	Deutsche Forschungsgemeinschaft (DFG) [73111208 SFB829/B12, 397484323 TRR259/B09, FOR2722/C2, FOR2722/B2]; MCTI | CNPq | Instituto Nacional de Ciencia e Tecnologia da Criosfera (INCT da Criosfera) [231369/2013-1]; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/S015779/1]; Wellcome Trust (Wellcome) [203128/Z/16/Z]; BBSRC [BB/N015398/1, BB/S015779/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MCTI | CNPq | Instituto Nacional de Ciencia e Tecnologia da Criosfera (INCT da Criosfera); RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust (Wellcome); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 73111208 SFB829/B12, 397484323 TRR259/B09, FOR2722/C2 and FOR2722/B2; MCTI | CNPq | Instituto Nacional de Ciencia e Tecnologia da Criosfera (INCT da Criosfera), Grant/Award Number: 231369/2013-1; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/S015779/1; Wellcome Trust (Wellcome), Grant/Award Number: 203128/Z/16/Z	Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Almalki SG, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0393-1; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Assis-Ribas T, 2018, DEV BIOL, V437, P63, DOI 10.1016/j.ydbio.2018.03.002; Bach DH, 2018, MOL THER-ONCOLYTICS, V8, P1, DOI 10.1016/j.omto.2017.10.002; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Cyr-Depauw C, 2016, MOL CELL BIOL, V36, P1509, DOI 10.1128/MCB.00600-15; D'Angelo M, 2001, J BONE MINER RES, V16, P2339, DOI 10.1359/jbmr.2001.16.12.2339; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Hiepen C, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000557; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Jiang H, 2016, J BIOL CHEM, V291, P2954, DOI 10.1074/jbc.M115.683292; Kienast Y, 2016, J BIOL CHEM, V291, P3395, DOI 10.1074/jbc.M115.680009; Kim HK, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.40; Kim HK, 2012, BIOMATERIALS, V33, P7057, DOI 10.1016/j.biomaterials.2012.06.036; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kumar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127877; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le VQ, 2018, EMBO J, V37, P384, DOI 10.15252/embj.201797931; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32231; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeys BL, 2003, ACTA CLIN BELG, V58, P3, DOI 10.1179/acb.2003.58.1.001; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakashima A, 2006, FRONT BIOSCI-LANDMRK, V11, P1667, DOI 10.2741/1912; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721; Park HI, 2010, ANAL BIOCHEM, V396, P262, DOI 10.1016/j.ab.2009.10.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Rothhammer T, 2008, EUR J CANCER, V44, P2526, DOI 10.1016/j.ejca.2008.07.029; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Sakai H, 2012, CLIN EXP METASTAS, V29, P327, DOI 10.1007/s10585-012-9453-9; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakai LY, 2016, GENE, V591, P279, DOI 10.1016/j.gene.2016.07.033; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Sengle G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005340; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sieron AL, 2002, CYTOKINE, V18, P214, DOI 10.1006/cyto.2002.1035; Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601; Suzawa M, 1999, ENDOCRINOLOGY, V140, P2125, DOI 10.1210/en.140.5.2125; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tillet E, 2018, J BIOL CHEM, V293, P10963, DOI 10.1074/jbc.RA118.002968; Troilo H, 2014, P NATL ACAD SCI USA, V111, P13063, DOI 10.1073/pnas.1404166111; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Unsold C, 2001, J CELL SCI, V114, P187; van der Kraan PM, 2010, OSTEOARTHR CARTILAGE, V18, P735, DOI 10.1016/j.joca.2010.03.001; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yu Q, 2000, GENE DEV, V14, P163	80	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21353	10.1096/fj.202001264R	http://dx.doi.org/10.1096/fj.202001264R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33629769				2022-12-28	WOS:000629576700048
J	Zheng, JX; Yang, T; Gao, SH; Cheng, MR; Shao, Y; Xi, YF; Guo, LZ; Zhang, D; Gao, W; Zhang, GZ; Yang, LJ; Yang, T				Zheng, Jinxiu; Yang, Ting; Gao, Shuhua; Cheng, Minrong; Shao, Ying; Xi, Yanfeng; Guo, Linzhi; Zhang, Dong; Gao, Wei; Zhang, Guozhen; Yang, Lijun; Yang, Tao			miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8(+) T cell-mediated immune attack in colorectal cancer	FASEB JOURNAL			English	Article						calnexin (CANX); colorectal cancer (CRC); immune system; major histocompatibility complex class I (MHC-I); miR-148a-3p	ANTIGEN-PROCESSING MACHINERY; DENDRITIC CELLS; CALNEXIN; EXPRESSION; RESISTANCE; DEFECTS	Nonresponse, or acquired resistance to immune checkpoint inhibitors in colorectal cancer (CRC) highlight the importance of finding potential tolerance mechanisms. Low expression of major histocompatibility complex, class I (MHC-I) on the cell surface of the tumor is one of the main mechanisms of tumor escape from T-cell recognition and destruction. In this study, we demonstrated that a high level of calnexin (CANX) in the tumors is positively correlated with the overall survival in colorectal cancer patients. CANX is a chaperone protein involved in the folding and assembly of MHC-I molecules. Using miRNA target prediction databases and luciferase assays, we identified miR-148a-3p as a potential regulator of CANX. Inhibition of miR-148a-3p restores surface levels of MHC-I and significantly enhanced the effects of CD8(+) T-cell-mediated immune attack in vitro and in vivo by promoting CANX expression. These results reveal that miR-148a-3p can function as a tumor promotor in CRC by targeting the CANX/MHC-I axis, which provides a rationale for immunotherapy through targeting the miR-148a-3p/CANX/MHC-I pathway in patients with CRC.	[Zheng, Jinxiu; Yang, Lijun] Shanxi Med Univ, Dept Pharmacol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China; [Yang, Ting; Gao, Shuhua; Cheng, Minrong; Zhang, Dong; Yang, Tao] Shanxi Med Univ, Dept Biochem & Mol Biol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China; [Shao, Ying] Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China; [Zheng, Jinxiu; Yang, Ting; Shao, Ying; Yang, Lijun; Yang, Tao] Shanxi Med Univ, Key Lab Cellular Physiol, Minist Educ, Taiyuan, Peoples R China; [Xi, Yanfeng] Shanxi Prov Canc Hosp, Dept Pathol, Taiyuan, Peoples R China; [Guo, Linzhi] Shanxi Med Univ, Lab Morphol, Taiyuan, Peoples R China; [Gao, Wei] Shanxi Med Univ, Hosp 1, Shanxi Key Lab Otorhinolaryngol Head & Neck Canc, Taiyuan, Peoples R China; [Zhang, Guozhen] Shanxi Med Univ, Hosp 2, Dept Pathol, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Yang, LJ (corresponding author), Shanxi Med Univ, Dept Pharmacol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China.; Yang, T (corresponding author), Shanxi Med Univ, Dept Biochem & Mol Biol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China.	yanglijunmm@sxmu.edu.cn; yangtao056cn@sxmu.edu.cn	Gao, Wei/E-8505-2013	Gao, Wei/0000-0001-7836-2851	National Natural Science Foundation of China [81972325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant/Award Number: 81972325	Afferni C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02601; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alles J, 2017, ONCOTARGET, V8, P56417, DOI 10.18632/oncotarget.17662; [Anonymous], 2018, N Engl J Med, V379, P2185, DOI 10.1056/NEJMx180040; Ashizawa M, 2019, MOL CANCER RES, V17, P1403, DOI 10.1158/1541-7786.MCR-18-0831; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Burr ML, 2019, CANCER CELL, V36, P385, DOI 10.1016/j.ccell.2019.08.008; Carosella ED, 2015, EUR UROL, V68, P267, DOI 10.1016/j.eururo.2015.02.032; Chen YC, 2019, CANCER IMMUNOL RES, V7, P123, DOI 10.1158/2326-6066.CIR-18-0124; Cheng NL, 2015, AGING CELL, V14, P200, DOI 10.1111/acel.12294; Ciardiello D, 2019, CANCER TREAT REV, V76, P22, DOI 10.1016/j.ctrv.2019.04.003; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Dissemond J, 2004, CANCER LETT, V203, P225, DOI 10.1016/j.canlet.2003.09.036; Dong PX, 2018, ONCOGENE, V37, P5257, DOI 10.1038/s41388-018-0347-4; Donia M, 2017, CANCER RES, V77, P4562, DOI 10.1158/0008-5472.CAN-16-3172; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; Franke AJ, 2019, JNCI-J NATL CANCER I, V111, P1131, DOI 10.1093/jnci/djz093; Hasim A, 2011, CHINESE MED J-PEKING, V124, P341, DOI 10.3760/cma.j.issn.0366-6999.2011.03.004; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65; Lakkaraju AKK, 2013, MOL CELL, V51, P386, DOI 10.1016/j.molcel.2013.07.009; Lee CH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236101; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Liston A, 2010, J CLIN IMMUNOL, V30, P339, DOI 10.1007/s10875-010-9378-5; Liu RH, 2018, GASTROENTEROLOGY, V154, P637, DOI 10.1053/j.gastro.2017.09.045; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Liu Y, 2012, CANCER IMMUNOL IMMUN, V61, P789, DOI 10.1007/s00262-011-1137-9; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Mari L, 2018, GASTROENTEROLOGY, V155, P784, DOI 10.1053/j.gastro.2018.06.030; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Strauss J, 2018, CLIN CANCER RES, V24, P1287, DOI 10.1158/1078-0432.CCR-17-2653; Ugurel S, 2019, CANCER IMMUNOL IMMUN, V68, P983, DOI 10.1007/s00262-019-02341-9; Wang B, 2009, IMMUNOLOGY, V128, P43, DOI 10.1111/j.1365-2567.2009.03067.x; Wang XH, 2017, CANCER RES, V77, P839, DOI 10.1158/0008-5472.CAN-15-3142; Wang Y, 2020, AM J TRANSL RES, V12, P541; Wiersma VR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00007; Wu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00745; Xu SH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11406; Xu SJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101140; Yang W, 2020, ONCOGENE, V39, P1098, DOI 10.1038/s41388-019-1045-6; Zhu XP, 2005, J IMMUNOL, V175, P967, DOI 10.4049/jimmunol.175.2.967	45	14	16	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21776	10.1096/fj.202100235R	http://dx.doi.org/10.1096/fj.202100235R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324740				2022-12-28	WOS:000678975300034
J	Linares, R; Fernandez, MF; Gutierrez, A; Garcia-Villalba, R; Suarez, B; Zapater, P; Martinez-Blazquez, JA; Caparros, E; Tomas-Barberan, FA; Frances, R				Linares, Raquel; Fernandez, Mariana F.; Gutierrez, Ana; Garcia-Villalba, Rocio; Suarez, Beatriz; Zapater, Pedro; Alberto Martinez-Blazquez, Jose; Caparros, Esther; Tomas-Barberan, Francisco A.; Frances, Ruben			Endocrine disruption in Crohn's disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products	FASEB JOURNAL			English	Article						bacterial DNA; bisphenol A; Crohn's disease; cytokine; short-chain fatty acids	BOWEL-DISEASE; BACTERIAL-DNA; CHEMICALS; IBD; METABOLISM; ASSOCIATION; STATEMENT; EXPOSURE; PROGRESS; HEALTH	The relevance of environmental triggers in Crohn's disease remains poorly explored, despite the well-known association between industrialization and disease onset/progression. We have aimed at evaluating the influence of endocrine disrupting chemicals in CD patients. We performed a prospective observational study on consecutive patients diagnosed of CD. Serum levels of endocrine disruptors, short-chain fatty acids, tryptophan and cytokines were measured. Bacterial-DNA and serum endotoxin levels were also evaluated. Gene expression of ER-alpha, ER-beta and GPER was measured in PBMCs. All patients were genotyped for NOD2 and ATG16L1 polymorphisms. A series of 200 CD patients (140 in remission, 60 with active disease) was included in the study. Bisphenol A was significantly higher in patients with active disease versus remission and in colonic versus ileal disease. GPER was significantly increased in active patients and correlated with BPA levels. BPA was significantly increased in patients with bacterial-DNA and correlated with serum endotoxin levels, (r = 0.417; P = .003). Serum butyrate and tryptophan levels were significantly lower in patients with bacterial-DNA and an inverse relationship was present between them and BPA levels (r = -0.491; P = .001) (r = -0.611; P = .001). Serum BPA levels correlated with IL-23 (r = 0.807; P = .001) and IL-17A (r = 0.743; P = .001). The multivariate analysis revealed an independent significant contribution of BPA and bacterial-DNA to serum levels of IL-23 and IL-17A. In conclusion, bisphenol A significantly affects systemic inflammatory response in CD patients with gut barrier disruption and dysbiotic microbiota secretory products in blood. These results provide evidence of an endocrine disruptor playing an actual pathogenic role on CD.	[Linares, Raquel; Caparros, Esther; Frances, Ruben] Univ Miguel Hernandez, Dept Med Clin, Alacant, Spain; [Fernandez, Mariana F.; Suarez, Beatriz] Univ Granada, Ctr Invest Biomed CIBM, Granada, Spain; [Fernandez, Mariana F.; Suarez, Beatriz] Inst Invest Biosanitaria Ibs GRANADA, Granada, Spain; [Fernandez, Mariana F.; Suarez, Beatriz] Inst Salud Carlos III, CIBEResp, Madrid, Spain; [Gutierrez, Ana; Zapater, Pedro; Caparros, Esther; Frances, Ruben] Hosp Gen Univ Alicante, IIS ISABIAL, Alicante, Spain; [Gutierrez, Ana; Zapater, Pedro; Frances, Ruben] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Garcia-Villalba, Rocio; Alberto Martinez-Blazquez, Jose; Tomas-Barberan, Francisco A.] Univ Murcia, CEBAS CSIC, Murcia, Spain; [Zapater, Pedro] Univ Miguel Hernandez, Dept Farmacol, Alacant, Spain	Universidad Miguel Hernandez de Elche; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia; Universidad Miguel Hernandez de Elche	Frances, R (corresponding author), Univ Miguel Hernandez Elche, Dept Med Clin, Hepat & Intestinal Irnmunobiol Grp, Carretera Alicante Valencia,Km 8,7, Alacant 03550, Spain.	rfrances@umh.es	Fernandez, Mariana F./C-9877-2012; Caparrós, Esther/AHD-3233-2022; Zapater, Pedro/H-8450-2019; Frances, Ruben/V-4120-2019	Fernandez, Mariana F./0000-0001-6417-8914; Caparrós, Esther/0000-0002-9681-0408; Zapater, Pedro/0000-0001-7927-858X; Frances, Ruben/0000-0001-5105-1201	Ministerio de Ciencia, Innovacion y Universidades, Madrid, Spain [PID2019-107036RB-I00, FPU 18/00063]; IIS ISABIAL, Hospital General Universitario, Alicante, Spain [2020-0287]	Ministerio de Ciencia, Innovacion y Universidades, Madrid, Spain(Spanish Government); IIS ISABIAL, Hospital General Universitario, Alicante, Spain	This study has been partially funded by PID2019-107036RB-I00, from Ministerio de Ciencia, Innovacion y Universidades, Madrid, Spain, and 2020-0287, from IIS ISABIAL, Hospital General Universitario, Alicante, Spain. RL is recipient of a grant (FPU 18/00063) by Ministerio de Ciencia, Innovacion y Universidades, Madrid, Spain.	Acconcia F, 2015, DOSE-RESPONSE, V13, DOI 10.1177/1559325815610582; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136; Benchimol EI, 2015, AM J GASTROENTEROL, V110, P553, DOI 10.1038/ajg.2015.52; Braun JM, 2017, NAT REV ENDOCRINOL, V13, P161, DOI 10.1038/nrendo.2016.186; Cave M, 2010, HEPATOLOGY, V51, P474, DOI 10.1002/hep.23321; Chang JT, 2020, NEW ENGL J MED, V383, P2652, DOI 10.1056/NEJMra2002697; Chen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34055; Choy MC, 2017, INFLAMM BOWEL DIS, V23, P2, DOI 10.1097/MIB.0000000000000955; Cimmino I, 2019, J MOL ENDOCRINOL, V63, P273, DOI 10.1530/JME-18-0265; de Silva PS, 2017, ENVIRON POLLUT, V229, P621, DOI 10.1016/j.envpol.2017.06.023; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; DeLuca JAA, 2018, EXP BIOL MED, V243, P864, DOI 10.1177/1535370218782139; Feng D, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114880; Frances R, 2004, HEPATOLOGY, V39, P484, DOI 10.1002/hep.20055; Galvez-Ontiveros Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041158; Garcia-Villalba R, 2012, J SEP SCI, V35, P1906, DOI 10.1002/jssc.201101121; Gomez-Hurtado I, 2020, LIVER INT, V40, P2182, DOI 10.1111/liv.14571; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Gutierrez A, 2016, AM J GASTROENTEROL, V111, P529, DOI 10.1038/ajg.2016.8; Gutierrez A, 2014, GUT, V63, P272, DOI 10.1136/gutjnl-2012-303557; Gutierrez A, 2009, INFLAMM BOWEL DIS, V15, P508, DOI 10.1002/ibd.20806; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Hammer T, 2017, ALIMENT PHARM THER, V45, P1107, DOI 10.1111/apt.13975; Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001; Heindel JJ, 2015, NAT REV ENDOCRINOL, V11, P653, DOI 10.1038/nrendo.2015.163; Ho SM, 2019, INFLAMM BOWEL DIS, V25, pS13, DOI 10.1093/ibd/izz076; Jacenik D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43233-3; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juanola O, 2018, HEPATOL COMMUN, V2, P1610, DOI 10.1002/hep4.1268; Kedia Saurabh, 2017, Inflamm Intest Dis, V2, P102, DOI 10.1159/000465522; Kuo CC, 2013, CURR DIABETES REP, V13, P831, DOI 10.1007/s11892-013-0432-6; Lai KP, 2016, ENVIRON POLLUT, V218, P923, DOI 10.1016/j.envpol.2016.08.039; Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Li XJ, 2011, INFLAMM BOWEL DIS, V17, P1784, DOI 10.1002/ibd.21535; Linares PM, 2017, DIGEST DIS SCI, V62, P2744, DOI 10.1007/s10620-017-4717-5; Michalowicz J, 2014, ENVIRON TOXICOL PHAR, V37, P738, DOI 10.1016/j.etap.2014.02.003; Mondot S, 2016, GUT, V65, P954, DOI 10.1136/gutjnl-2015-309184; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Nikolaus S, 2017, GASTROENTEROLOGY, V153, P1504, DOI 10.1053/j.gastro.2017.08.028; Park JH, 2017, AUTOIMMUN REV, V16, P416, DOI 10.1016/j.autrev.2017.02.013; Pierdominici M, 2015, ONCOTARGET, V6, P40443, DOI 10.18632/oncotarget.6217; Roda G, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0156-2; Salamanca-Fernandez E, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.109012; Sands BE, 2004, GASTROENTEROLOGY, V126, P1518, DOI 10.1053/j.gastro.2004.02.072; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Savastano S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0532-y; Tenailleau QM, 2020, ENVIRON POLLUT, V263, DOI 10.1016/j.envpol.2020.114599; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Vela-Soria F, 2014, TALANTA, V129, P209, DOI 10.1016/j.talanta.2014.05.016; Vernet C, 2019, EPIDEMIOLOGY, V30, P756, DOI 10.1097/EDE.0000000000001056; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014; Yilmaz B, 2019, NAT MED, V25, P323, DOI 10.1038/s41591-018-0308-z; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	60	6	6	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21697	10.1096/fj.202100481R	http://dx.doi.org/10.1096/fj.202100481R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085740	Green Published			2022-12-28	WOS:000667814100078
J	Nguyen, H; Koh, JY; Li, HN; Islas-Robles, A; Venkata, SPM; Wang, JM; Monks, TJ				Nguyen, Huong; Koh, Jia Yi; Li, Hainan; Islas-Robles, Argel; Venkata, Sai Pranathi Meda; Wang, Jie-Mei; Monks, Terrence J.			A novel imidazolinone metformin-methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF-1 alpha pathway	FASEB JOURNAL			English	Article						angiogenesis; endothelial nitric oxide synthase; hypoxia-inducible factor-1 alpha; methylglyoxal; metformin	PERIPHERAL ARTERIAL-DISEASE; HYPOXIA-INDUCIBLE FACTOR-1; NITRIC-OXIDE SYNTHASE; THERAPEUTIC ANGIOGENESIS; IN-VIVO; HIF-1-ALPHA; ACTIVATION; INHIBITION; GROWTH; PHOSPHORYLATION	Peripheral arterial disease (PAD) is one of the major complications of diabetes due to an impairment in angiogenesis. Since there is currently no drug with satisfactory efficacy to enhance blood vessel formation, discovering therapies to improve angiogenesis is critical. An imidazolinone metabolite of the metformin-methylglyoxal scavenging reaction, (E)-1,1-dimethyl-2-(5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl) guanidine (IMZ), was recently characterized and identified in the urine of type-2 diabetic patients. Here, we report the pro-angiogenesis effect of IMZ (increased aortic sprouting, cell migration, network formation, and upregulated multiple pro-angiogenic factors) in human umbilical vein endothelial cells. Using genetic and pharmacological approaches, we showed that IMZ augmented angiogenesis by activating the endothelial nitric oxide synthase (eNOS)/hypoxia-inducible factor-1 alpha (HIF-1 alpha) pathway. Furthermore, IMZ significantly promoted capillary density in the in vivo Matrigel plug angiogenesis model. Finally, the role of IMZ in post-ischemic angiogenesis was examined in a chronic hyperglycemia mouse model subjected to hind limb ischemia. We observed improved blood perfusion, increased capillary density, and reduced tissue necrosis in mice receiving IMZ compared to control mice. Our data demonstrate the pro-angiogenic effects of IMZ, its underlying mechanism, and provides a structural basis for the development of potential pro-angiogenic agents for the treatment of PAD.	[Nguyen, Huong; Koh, Jia Yi; Li, Hainan; Venkata, Sai Pranathi Meda; Wang, Jie-Mei; Monks, Terrence J.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 259 Mack Ave,5146 Applebaum Bldg, Detroit, MI 48201 USA; [Islas-Robles, Argel] Inst In Vitro Sci Inc, Gaithersburg, MD USA; [Wang, Jie-Mei] Wayne State Univ, Ctr Mol Med, Detroit, MI USA	Wayne State University; Wayne State University	Wang, JM; Monks, TJ (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 259 Mack Ave,5146 Applebaum Bldg, Detroit, MI 48201 USA.	jiemei.wang@wayne.edu; terrence.monks@wayne.edu	Meda Venkata, Sai Pranathi/GNP-8412-2022; WANG, JIEMEI/D-6317-2012	Meda Venkata, Sai Pranathi/0000-0002-1771-4806; WANG, JIEMEI/0000-0002-8723-4410	NIH/NIDDK [R01 DK109036, R01 DK119222]; Wayne State University new faculty startup funding in the Department of Pharmaceutical Sciences	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wayne State University new faculty startup funding in the Department of Pharmaceutical Sciences	This work was supported in part by NIH/NIDDK R01 DK109036 (To JMW), R01 DK119222 (To TJM and JMW) and Wayne State University new faculty startup funding in the Department of Pharmaceutical Sciences (To TJM)	Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Bandyopadhyay A, 2002, ONCOGENE, V21, P3541, DOI 10.1038/sj.onc.1205439; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; BOGLE RG, 1994, BRIT J PHARMACOL, V111, P1257, DOI 10.1111/j.1476-5381.1994.tb14881.x; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Clark N, 2003, DIABETES CARE, V26, P3333; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cui HQ, 2018, FOOD CHEM, V265, P227, DOI 10.1016/j.foodchem.2018.04.045; Davies Sean S, 2017, Curr Pharmacol Rep, V3, P51, DOI 10.1007/s40495-017-0081-6; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Edmonds M, 2006, DRUGS, V66, P913, DOI 10.2165/00003495-200666070-00003; El-Awady MS, 2014, J PHARM PHARMACOL, V66, P835, DOI 10.1111/jphp.12204; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Fenton C, 2006, DRUGS, V66, P477, DOI 10.2165/00003495-200666040-00006; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Iyer Sunil R, 2017, JACC Basic Transl Sci, V2, P503, DOI 10.1016/j.jacbts.2017.07.012; Joshi MS, 2007, P NATL ACAD SCI USA, V104, P9982, DOI 10.1073/pnas.0506824104; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kinsky OR, 2016, CHEM RES TOXICOL, V29, P227, DOI 10.1021/acs.chemrestox.5b00497; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Lekakis JP, 2002, INT J CARDIOL, V86, P317, DOI 10.1016/S0167-5273(02)00413-8; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li HN, 2017, AM J PHYSIOL-ENDOC M, V313, pE391, DOI 10.1152/ajpendo.00073.2017; Marso SP, 2006, J AM COLL CARDIOL, V47, P921, DOI 10.1016/j.jacc.2005.09.065; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Mohler ER, 2007, NAT CLIN PRACT CARD, V4, P151, DOI 10.1038/ncpcardio0823; Nigro C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010188; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Park YK, 2008, MOL PHARMACOL, V74, P236, DOI 10.1124/mol.108.045278; Raasch W, 2001, BRIT J PHARMACOL, V133, P755, DOI 10.1038/sj.bjp.0704153; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Ripa RS, 2006, EUR HEART J, V27, P1785, DOI 10.1093/eurheartj/ehl117; Ruggiero-Lopez D, 1999, BIOCHEM PHARMACOL, V58, P1765, DOI 10.1016/S0006-2952(99)00263-4; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Thiruvoipati T, 2015, WORLD J DIABETES, V6, P961, DOI 10.4239/wjd.v6.i7.961; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Uccioli L, 2018, VASC HEALTH RISK MAN, V14, P63, DOI 10.2147/VHRM.S125065; Ucuzian AA, 2010, J BURN CARE RES, V31, P158, DOI 10.1097/BCR.0b013e3181c7ed82; Wang F, 2002, BIOCHEM BIOPH RES CO, V295, P657, DOI 10.1016/S0006-291X(02)00729-5; Wang JM, 2014, ARTERIOSCL THROM VAS, V34, P99, DOI 10.1161/ATVBAHA.113.302104; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X; Yu JW, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0408-3; Zhou Q, 2019, FOOD CHEM TOXICOL, V129, P291, DOI 10.1016/j.fct.2019.05.004; Zhu ZW, 2015, AM J PHYSIOL-ENDOC M, V308, pE518, DOI 10.1152/ajpendo.00469.2014	56	3	3	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21645	10.1096/fj.202002674RR	http://dx.doi.org/10.1096/fj.202002674RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105824	Green Published			2022-12-28	WOS:000667814100062
J	You, HM; Wang, L; Bu, FT; Meng, HW; Pan, XY; Li, JJ; Zhang, YF; Wang, A; Yin, NN; Huang, C; Li, J				You, Hongmei; Wang, Ling; Bu, Fangtian; Meng, Hongwu; Pan, Xueyin; Li, Juanjuan; Zhang, Yafei; Wang, Ao; Yin, Nana; Huang, Cheng; Li, Jun			The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics	FASEB JOURNAL			English	Article						epigenetics; HDAC2; HSCs; liver fibrosis; miR-455-3p	HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; HISTONE DEACETYLASES; DNA METHYLATION; ACTIVATION; MICRORNA; REGRESSION; HYPERMETHYLATION; ACETYLATION; APOPTOSIS	Histone deacetylases (HDACs), especially HDAC2, play a role in alleviating liver fibrosis; however, the specific upstream regulation mechanism is unknown. Herein, TargetScan was used to predict the potential upstream targets of HDAC2, and the role of miR-455-3p was explored. The dual luciferase reporter assay showed that miR-455-3p binds to the 3MODIFIER LETTER PRIME UTR of HDAC2 mRNA. Additionally, miR-455-3p was downregulated in the liver tissues of patients with cirrhosis and mice with liver fibrosis, as well as in primary HSCs isolated from fibrotic mouse livers and TGF-beta-treated LX-2 cells. In contrast, it is highly expressed in the reversal stage of hepatic fibrosis and MDI-cultured LX-2 cells. Our functional analyses showed that miR-455-3p overexpression facilitated apoptosis and reduced the expression of pro-fibrotic markers and the proliferation of activated LX-2 cells. On the contrary, miR-455-3p inhibition converted inactivated LX-2 cells into activated, proliferative, fibrogenic cells. Interestingly, restoration of HDAC2 expression partially blocked the function of miR-455-3p. Downregulated miR-455-3p expression can be restored by DNA methyltransferases in activated LX-2 cells. Methylation-specific PCR, bisulfite sequencing PCR, and chromatin immunoprecipitation assays indicated that the methylation level of miR-455-3p promoter CpG islands was elevated in TGF-beta-treated LX-2 cells and that miR-455-3p was downregulated in activated LX-2 cells by DNA hypermethylation, which is mediated by DNMT3b and DNMT1. In conclusion, miR-455-3p acts as a liver fibrosis suppressor by targeting HDAC2, and its deficiency further aggravates the reversal phase of fibrosis. Thus, the epigenetics mediated miR-455-3p/HDAC2 axis may serve as a novel potential therapeutic target for clinical treatment of hepatic fibrosis.	[You, Hongmei; Wang, Ling; Bu, Fangtian; Meng, Hongwu; Pan, Xueyin; Li, Juanjuan; Zhang, Yafei; Wang, Ao; Yin, Nana; Huang, Cheng; Li, Jun] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Huang, C; Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Anhui, Peoples R China.	huangcheng@ahmu.edu.cn; lj@ahmu.edu.cn			National Natural Science Foundation of China [81770609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This Study was supported by the National Natural Science Foundation of China (No. 81770609).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calvente CJ, 2020, MOL THER, V28, P653, DOI 10.1016/j.ymthe.2019.09.013; Calvente CJ, 2019, J CLIN INVEST, V129, P4091, DOI 10.1172/JCI122258; Chen PJ, 2016, TOXICOL APPL PHARM, V292, P8, DOI 10.1016/j.taap.2015.12.021; Chen WS, 2016, BBA-MOL CELL RES, V1863, P2881, DOI 10.1016/j.bbamcr.2016.09.010; Chen X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1032-9; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Feng LF, 2019, METHODS MOL BIOL, V1894, P181, DOI 10.1007/978-1-4939-8916-4_12; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2012, P NATL ACAD SCI USA, V109, P9230, DOI 10.1073/pnas.1206645109; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guo SW, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116819; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Huang ZW, 2017, DNA CELL BIOL, V36, P759, DOI 10.1089/dna.2017.3799; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Jackaman C, 2017, AGEING RES REV, V36, P105, DOI 10.1016/j.arr.2017.03.008; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kirpich I, 2012, ALCOHOL CLIN EXP RES, V36, P1578, DOI 10.1111/j.1530-0277.2012.01751.x; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kumar P, 2017, AM J PHYSIOL-RENAL, V313, pF781, DOI 10.1152/ajprenal.00166.2017; Kumar S, 2017, HUM MOL GENET, V26, P3808, DOI 10.1093/hmg/ddx267; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lan T, 2018, HEPATOLOGY, V68, P1070, DOI 10.1002/hep.29885; Li MW, 2017, INT IMMUNOPHARMACOL, V52, P272, DOI 10.1016/j.intimp.2017.09.020; Li X, 2016, TOXICOL APPL PHARM, V306, P58, DOI 10.1016/j.taap.2016.07.003; Livyatan I, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.33; Long XR, 2014, INT J ONCOL, V44, P1915, DOI 10.3892/ijo.2014.2373; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Mao QD, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431x20176103, 10.1590/1414-431X20176103]; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Pan XY, 2019, THERANOSTICS, V9, P4308, DOI 10.7150/thno.32710; Pan XY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00553; Proshkina EN, 2015, AGEING RES REV, V24, P218, DOI 10.1016/j.arr.2015.08.005; Ramalho-Carvalho J, 2018, METHODS MOL BIOL, V1708, P447, DOI 10.1007/978-1-4939-7481-8_23; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sarnow P, 2016, ANNU REV VIROL, V3, P309, DOI 10.1146/annurev-virology-110615-042409; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shao MY, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-1550-0; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Su QZ, 2018, ADV DRUG DELIVER REV, V129, P54, DOI 10.1016/j.addr.2018.01.009; Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523; Tang JH, 2013, CLIN SCI, V124, P651, DOI 10.1042/CS20120504; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tsay HC, 2019, J HEPATOL, V70, P722, DOI 10.1016/j.jhep.2018.12.016; Tu XL, 2014, J PATHOL, V234, P46, DOI 10.1002/path.4373; Valente S, 2014, J MED CHEM, V57, P701, DOI 10.1021/jm4012627; WANG KK, 1988, HEPATOLOGY, V8, P1679, DOI 10.1002/hep.1840080635; Wang XL, 2021, GUT, V70, P784, DOI 10.1136/gutjnl-2020-322526; Wei S, 2019, MOL THER-NUCL ACIDS, V16, P758, DOI 10.1016/j.omtn.2019.05.001; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wu J, 2018, BIOCHEM BIOPH RES CO, V503, P977, DOI 10.1016/j.bbrc.2018.06.105; Wu Y, 2018, KOREAN J PHYSIOL PHA, V22, P607, DOI 10.4196/kjpp.2018.22.6.607; Wu YT, 2017, TOXICOL APPL PHARM, V315, P35, DOI 10.1016/j.taap.2016.12.002; Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yao Q, 2019, CURR OPIN CHEM BIOL, V51, P11, DOI 10.1016/j.cbpa.2019.01.024; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yu HX, 2019, MOL IMMUNOL, V107, P29, DOI 10.1016/j.molimm.2019.01.004; Zhang HY, 2014, PROTEOMICS, V14, P1977, DOI 10.1002/pmic.201300539; Zhang L, 2020, J AM SOC NEPHROL, V31, P337, DOI 10.1681/ASN.2019070739; Zhou Y, 2020, J CELL BIOCHEM, V121, P651, DOI 10.1002/jcb.29310	79	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21700	10.1096/fj.202002319RRR	http://dx.doi.org/10.1096/fj.202002319RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105828				2022-12-28	WOS:000667814100017
J	Fu, G; Scarbrough, C; Song, KK; Phan, N; Wirschell, M; Nicastro, D				Fu, Gang; Scarbrough, Chasity; Song, Kangkang; Phan, Nhan; Wirschell, Maureen; Nicastro, Daniela			Structural organization of the intermediate and light chain complex of Chlamydomonas ciliary I1 dynein	FASEB JOURNAL			English	Article						cryo&#8208; electron tomography; flagella; IC140; ICLC complex; TCTEX2B	INNER ARM DYNEIN; FLAGELLAR DYNEIN; NUCLEAR TRANSFORMATION; REGULATORY COMPLEX; CENTRAL APPARATUS; RADIAL SPOKES; PROTEIN; MICROTUBULES; MOTILITY; REVEALS	Axonemal I1 dynein (dynein f) is the largest inner dynein arm in cilia and a key regulator of ciliary beating. It consists of two dynein heavy chains, and an intermediate chain/light chain (ICLC) complex. However, the structural organization of the nine ICLC subunits remains largely unknown. Here, we used biochemical and genetic approaches, and cryo-electron tomography imaging in Chlamydomonas to dissect the molecular architecture of the I1 dynein ICLC complex. Using a strain expressing SNAP-tagged IC140, tomography revealed the location of the IC140 N-terminus at the proximal apex of the ICLC structure. Mass spectrometry of a tctex2b mutant showed that TCTEX2B dynein light chain is required for the stable assembly of TCTEX1 and inner dynein arm interacting proteins IC97 and FAP120. The structural defects observed in tctex2b located these 4 subunits in the center and bottom regions of the ICLC structure, which overlaps with the location of the IC138 regulatory subcomplex, which contains IC138, IC97, FAP120, and LC7b. These results reveal the three-dimensional organization of the native ICLC complex and indicate potential protein-protein interactions that are involved in the pathway by which I1 regulates ciliary motility.	[Fu, Gang; Song, Kangkang; Phan, Nhan; Nicastro, Daniela] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Fu, Gang] Fudan Univ, Multiscale Res Inst Complex Syst, Shanghai, Peoples R China; [Scarbrough, Chasity; Wirschell, Maureen] Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, Jackson, MS 39216 USA; [Song, Kangkang] Univ Massachusetts, Sch Med, Cryo Core Facil, Worcester, MA 01655 USA; [Wirschell, Maureen] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Fudan University; University of Mississippi; University of Mississippi Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Donald Danforth Plant Science Center	Nicastro, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	daniela.nicastro@utsouthwestern.edu		Nicastro, Daniela/0000-0002-0122-7173	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R01GM083122]; Emory University [T735204]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR140082, RP170644]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); Emory University; Cancer Prevention and Research Institute of Texas (CPRIT)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01GM083122; Emory University, Grant/Award Number: T735204; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/Award Number: RR140082; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/Award Number: RP170644	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; DiBella LM, 2004, J BIOL CHEM, V279, P21666, DOI 10.1074/jbc.M313540200; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; Dymek EE, 2019, MOL BIOL CELL, V30, P1805, DOI 10.1091/mbc.E19-01-0063; Elam CA, 2011, CYTOSKELETON, V68, P363, DOI 10.1002/cm.20519; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fu G, 2018, MOL BIOL CELL, V29, P1048, DOI 10.1091/mbc.E18-02-0142; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gokhale A, 2009, J CELL BIOL, V186, P817, DOI 10.1083/jcb.200906168; GOODENOUGH UW, 1985, CELL, V41, P341, DOI 10.1016/S0092-8674(85)80003-9; Gui L, 2019, P NATL ACAD SCI USA, V116, P23152, DOI 10.1073/pnas.1910960116; Habermacher G, 1997, J CELL BIOL, V136, P167, DOI 10.1083/jcb.136.1.167; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Heumann JM, 2011, J STRUCT BIOL, V175, P288, DOI 10.1016/j.jsb.2011.05.011; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Hunter EL, 2018, MOL BIOL CELL, V29, P886, DOI 10.1091/mbc.E17-12-0729; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Iomini C, 2009, METHOD CELL BIOL, V93, P121, DOI 10.1016/S0091-679X(08)93007-7; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; King SJ, 1997, J CELL BIOL, V136, P177, DOI 10.1083/jcb.136.1.177; King SM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028100; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kubo S, 2020, REMODELING ACTIVATIO, DOI [10.1101/2020.11.30.404319, DOI 10.1101/2020.11.30.404319]; Kubo T, 2018, MOL BIOL CELL, V29, P1060, DOI 10.1091/mbc.E17-11-0689; Lin JF, 2018, SCIENCE, V360, DOI 10.1126/science.aar1968; Lin JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6727; Lin JF, 2014, NAT CELL BIOL, V16, P479, DOI 10.1038/ncb2939; Loreng TD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028118; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mitchell DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028290; Myster SH, 1999, J CELL BIOL, V146, P801, DOI 10.1083/jcb.146.4.801; Myster SH, 1997, MOL BIOL CELL, V8, P607, DOI 10.1091/mbc.8.4.607; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Osinka A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070730; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Perrone CA, 2000, MOL BIOL CELL, V11, P2297, DOI 10.1091/mbc.11.7.2297; Perrone CA, 1998, MOL BIOL CELL, V9, P3351, DOI 10.1091/mbc.9.12.3351; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Rao Q., 2020, CRYO EM STRUCTURES O, DOI [10.1101/2020.12.08.415687, DOI 10.1101/2020.12.08.415687]; SALE WS, 1977, P NATL ACAD SCI USA, V74, P2045, DOI 10.1073/pnas.74.5.2045; Schmidts M, 2015, NAT COMMS, V6, P1; Sizova IA, 1996, GENE, V181, P13, DOI 10.1016/S0378-1119(96)00384-8; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Song KK, 2015, J BIOL CHEM, V290, P5341, DOI 10.1074/jbc.M114.626556; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Toropova K, 2019, NAT STRUCT MOL BIOL, P1; Trudgian DC, 2012, J PROTEOME RES, V11, P6282, DOI 10.1021/pr300694b; Trudgian DC, 2011, PROTEOMICS, V11, P2790, DOI 10.1002/pmic.201000800; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; VanderWaal KE, 2011, MOL BIOL CELL, V22, P2862, DOI 10.1091/mbc.E11-03-0270; Viswanadha R, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018325; Viswanadha R, 2014, CYTOSKELETON, V71, P573, DOI 10.1002/cm.21192; Walton T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20735-7; Wirschell M, 2007, CELL MOTIL CYTOSKEL, V64, P569, DOI 10.1002/cm.20211; Wirschell M, 2011, ARCH BIOCHEM BIOPHYS, V510, P93, DOI 10.1016/j.abb.2011.04.003; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; Woolley DM, 1997, J CELL SCI, V110, P85; Yamamoto R, 2013, J CELL BIOL, V201, P263, DOI 10.1083/jcb.201211048; Yang F, 2015, AM J PHYSIOL-LUNG C, V308, pL569, DOI 10.1152/ajplung.00257.2014; Yang PF, 2000, J BIOL CHEM, V275, P18905, DOI 10.1074/jbc.M002134200; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025	72	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21646	10.1096/fj.202001857R	http://dx.doi.org/10.1096/fj.202001857R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33993568	Green Accepted			2022-12-28	WOS:000655695900007
J	Hamano, F; Matoba, K; Hashidate-Yoshida, T; Suzuki, T; Miura, K; Hishikawa, D; Harayama, T; Yuki, K; Kita, Y; Noda, NN; Shimizu, T; Shindou, H				Hamano, Fumie; Matoba, Kazuaki; Hashidate-Yoshida, Tomomi; Suzuki, Tomoyuki; Miura, Kiyotake; Hishikawa, Daisuke; Harayama, Takeshi; Yuki, Koichi; Kita, Yoshihiro; Noda, Nobuo N.; Shimizu, Takao; Shindou, Hideo			Mutagenesis and homology modeling reveal a predicted pocket of lysophosphatidylcholine acyltransferase 2 to catch Acyl-CoA	FASEB JOURNAL			English	Article						AGPAT family; LPCAT1; LPCAT2; platelet activating factor; protein structure	PLATELET-ACTIVATING-FACTOR; CRYSTAL-STRUCTURE; PHOSPHORYLATION; IDENTIFICATION; CLONING; MOTIFS; CELLS; SITE	Platelet-activating factor (PAF) is a potent proinflammatory phospholipid mediator that elicits various cellular functions and promotes several pathological events, including anaphylaxis and neuropathic pain. PAF is biosynthesized by two types of lyso-PAF acetyltransferases: lysophosphatidylcholine acyltransferase 1 (LPCAT1) and LPCAT2, which are constitutive and inducible forms of lyso-PAF acetyltransferase, respectively. Because LPCAT2 mainly produces PAF under inflammatory stimuli, understanding the structure of LPCAT2 is important for developing specific drugs against PAF-related inflammatory diseases. Although the structure of LPCAT2 has not been determined, the crystal structure was reported for Thermotoga maritima PlsC, an enzyme in the same gene family as LPCAT2. Here, we identified residues in mouse LPCAT2 essential for its enzymatic activity and a potential acyl-coenzyme A (CoA)-binding pocket, based on homology modeling of mouse LPCAT2 with PlsC. We also found that Ala115 of mouse LPCAT2 was important for acyl-CoA selectivity. In conclusion, these results predict the three-dimensional (3D) structure of mouse LPCAT2. Our findings have implications for the future development of new drugs against PAF-related diseases.	[Hamano, Fumie; Hashidate-Yoshida, Tomomi; Suzuki, Tomoyuki; Hishikawa, Daisuke; Harayama, Takeshi; Shimizu, Takao; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Hamano, Fumie; Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Tokyo, Japan; [Matoba, Kazuaki; Noda, Nobuo N.; Shimizu, Takao] Inst Microbial Chem BIKAKEN, Tokyo, Japan; [Suzuki, Tomoyuki] Univ Tokyo, Dept Resp Med, Tokyo, Japan; [Miura, Kiyotake; Yuki, Koichi] Univ Tokyo, Dept Biochem & Mol Biol, Tokyo, Japan; [Hishikawa, Daisuke] Tokyo Med & Dent Univ TMDU, Inst Res, Tokyo, Japan; [Harayama, Takeshi] Univ Cote Azur, CNRS, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Yuki, Koichi] Harvard Med Sch, Dept Anesthesia & Immunol, Boston, MA 02115 USA; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Med Lipid Sci, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Tokyo	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Med Lipid Signaling, Tokyo 1628655, Japan.	hshindou@ri.ncgm.go.jp	Shimizu, Takao/AAV-7052-2021; Harayama, Takeshi/AAD-8852-2022; Noda, Nobuo/P-1397-2015	Harayama, Takeshi/0000-0003-2255-4197; Noda, Nobuo/0000-0002-6940-8069	AMED-CREST [JP20gm0910011]; AMED-P-CREATE [JP20cm0106116]; AMED GAPFREE Program [19ak0101043h0005]; Takeda Science Foundation; French Government (National Research Agency, ANR) through the "Investments for the Future" program LABEX SIGNALIFE [ANR-11-LABX-0028]; French Government (National Research Agency, ANR) through the "Investments for the Future" program IDEX UCAJedi [ANR-15-IDEX-01]; ATIP-Avenir program (CNRS/Inserm)	AMED-CREST; AMED-P-CREATE; AMED GAPFREE Program; Takeda Science Foundation(Takeda Science Foundation (TSF)); French Government (National Research Agency, ANR) through the "Investments for the Future" program LABEX SIGNALIFE(French National Research Agency (ANR)); French Government (National Research Agency, ANR) through the "Investments for the Future" program IDEX UCAJedi(French National Research Agency (ANR)); ATIP-Avenir program (CNRS/Inserm)	This work was supported by AMED-CREST (grant number JP20gm0910011 to HS), AMED-P-CREATE (grant number JP20cm0106116 to HS), and the AMED Program for Basic and Clinical Research on Hepatitis (grant number JP20fk0210041 to HS). TS was supported by AMED GAPFREE Program (19ak0101043h0005) and the Takeda Science Foundation. TH was supported by the French Government (National Research Agency, ANR) through the "Investments for the Future" programs LABEX SIGNALIFE ANR-11-LABX-0028 an IDEX UCAJedi ANR-15-IDEX-01, and the ATIP-Avenir program (CNRS/Inserm)	Albesa-Jove D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10906; Allen KN, 2019, TRENDS BIOCHEM SCI, V44, P7, DOI 10.1016/j.tibs.2018.09.013; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cotte AK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02732-5; Dircks LK, 1999, J BIOL CHEM, V274, P34728, DOI 10.1074/jbc.274.49.34728; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsiao YS, 2006, BIOCHEM BIOPH RES CO, V346, P974, DOI 10.1016/j.bbrc.2006.06.006; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Morimoto R, 2014, J BIOL CHEM, V289, P15566, DOI 10.1074/jbc.M114.558874; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Robertson RM, 2017, NAT STRUCT MOL BIOL, V24, P666, DOI 10.1038/nsmb.3436; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2017, FASEB J, V31, P2973, DOI 10.1096/fj.201601183R; Sun P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku201; Tarui M, 2014, J LIPID RES, V55, P1386, DOI 10.1194/jlr.M049205; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WYKLE RL, 1980, J BIOL CHEM, V255, P256; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002	31	1	1	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21501	10.1096/fj.202002591R	http://dx.doi.org/10.1096/fj.202002591R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33956375	hybrid, Green Submitted			2022-12-28	WOS:000655695900048
J	Jaswal, S; Anand, V; Ali, SA; Jena, MK; Kumar, S; Kaushik, JK; Mohanty, AK				Jaswal, Shalini; Anand, Vijay; Ali, Syed Azmal; Jena, Manoj K.; Kumar, Sudarshan; Kaushik, Jai K.; Mohanty, Ashok K.			TMT based deep proteome analysis of buffalo mammary epithelial cells and identification of novel protein signatures during lactogenic differentiation	FASEB JOURNAL			English	Article						buffalo; differentiation; lactogenesis; mammary epithelial cells; nanoLC-MS/MS; signaling pathways	GENE-EXPRESSION; IN-VITRO; CHOLESTEROL SULFATE; LACTATION; GLAND; MILK; PROLACTIN; KERATINOCYTES; MORPHOGENESIS; TRANSCRIPTION	The lactating mammary gland harbours numerous matured alveoli with their lumen surrounded by differentiated mammary epithelial cells (MECs), which are exclusively involved in milk synthesis and secretion. Buffalo (Bubalus bubalis) is the second major milk-producing animal, and its physiology is different from cattle. The complete protein machinery involved in MECs differentiation is still not defined in ruminants, in particular, buffalo. Therefore, we have studied the differential expression of regulated proteins in the in vitro grown buffalo MECs (BuMECs) at different time points (on 3, 6, 12, and 15 days) of their differentiation in the presence of lactogenic hormones. TMT-based MS analysis identified 4,934 proteins; of them, 681 were differentially expressed proteins (DEPs). The principal component analysis suggested a highly heterogeneous expression of DEPs at the four-time points of hormone treatment, with most of them (307) attained the highest expression on 12 days. Bioinformatics analysis revealed the association of DEPs with 24 KEGG pathways. We observed few new proteins, namely ABCA13, IVL, VPS37, CZIB, RFX7, Rab5, TTLL12, SMEK1, GDI2, and TMEM131 in BuMECs. The function of one of the highly upregulated proteins, namely involucrin in the differentiation of BuMECs was confirmed based on biochemical inhibition assay. The results further conclude that the proteins with higher abundance can be considered as the potential biomarkers for differentiation, and they may have a significant association with the lactation process in buffalo too. The proteome dataset obtained can be used to understand the species-specific variations among other lactating animals.	[Jaswal, Shalini; Ali, Syed Azmal; Kumar, Sudarshan; Kaushik, Jai K.; Mohanty, Ashok K.] Natl Dairy Res Inst NDRI, Prote & Cell Biol Lab, Anim Biotechnol Ctr, Karnal 132001, Haryana, India; [Anand, Vijay] Vet Coll & Res Inst TANUVAS, Dept Vet Physiol & Biochem, Orathanadu, India; [Jena, Manoj K.] Lovely Profess Univ, Sch Bioengn & Biosci, Dept Biotechnol, Phagwara, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Tamil Nadu Veterinary & Animal Sciences University; Lovely Professional University	Mohanty, AK (corresponding author), Natl Dairy Res Inst NDRI, Prote & Cell Biol Lab, Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	ashokmohanty1@gmail.com	Ali, Syed Azmal/AAM-9532-2021; Jena, M/AGM-1989-2022; Anand, Vijay/GLT-5411-2022	Ali, Syed Azmal/0000-0003-3024-9379; Anand, Vijay/0000-0002-4061-9946	National Innovation Agriculture Project (NAIP) [4136_C4]; University Grants Commission	National Innovation Agriculture Project (NAIP); University Grants Commission(University Grants Commission, India)	National Innovation Agriculture Project (NAIP), Grant/Award Number: 4136_C4; University Grants Commission	Akers RM, 2006, LIVEST SCI, V105, P44, DOI 10.1016/j.livsci.2006.04.026; Alhussien MN, 2018, VET WORLD, V11, P562, DOI 10.14202/vetworld.2018.562-577; Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; Arora R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42513-2; Bambhroliya A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192689; Bionaz M, 2012, MILK PROTEIN, P285, DOI 10.5772/46054; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bissonnette N, 2018, J DAIRY SCI, V101, P456, DOI 10.3168/jds.2017-13129; Blanchard AA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-268; Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x; Bridgewater RE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04783-6; Bruckmaier RM, 1998, J DAIRY SCI, V81, P939, DOI 10.3168/jds.S0022-0302(98)75654-1; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41552-z; Dai WT, 2018, FUNCT INTEGR GENOMIC, V18, P125, DOI 10.1007/s10142-017-0580-x; de Koning PJA, 2009, INT J CANCER, V125, P1542, DOI 10.1002/ijc.24507; Desrivieres S, 2003, MOL CELL PROTEOMICS, V2, P1039, DOI 10.1074/mcp.M300032-MCP200; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; Dziegelewska Z, 2018, STROMAL CELLS STRUCT, P87; Fu Mei, 2014, PLoS One, V9, pe113669, DOI 10.1371/journal.pone.0113669; Furukawa Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204355; Geletu M, 2020, JOVE-J VIS EXP, DOI 10.3791/60147; Gillespie MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-169; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Haaksma CJ, 2011, BIOL REPROD, V85, P13, DOI 10.1095/biolreprod.110.090639; Han X, 2012, FUNCT FOODS HEALTH D, V2, P86, DOI 10.31989/ffhd.v2i4.96; Han Y, 2020, METALLOMICS, V12, P346, DOI 10.1039/c9mt00301k; Hanley K, 2001, J LIPID RES, V42, P390; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q; Itoh M, 2003, J MAMMARY GLAND BIOL, V8, P449, DOI 10.1023/B:JOMG.0000017431.45314.07; Janjanam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102515; Janjanam J, 2013, PROTEOMICS, V13, P3189, DOI 10.1002/pmic.201300031; Jaswal S., 2020, SCI REP-UK, V10, P1; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kapila Neha, 2013, ISRN Biotechnol, V2013, P735053, DOI 10.5402/2013/735053; Kashwa M, 2016, DEGREE PROJ ANIM SCI, V548, P1; Kim BR, 2015, ONCOTARGET, V6, P31830, DOI 10.18632/oncotarget.5570; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; LEVINE JF, 1985, J CELL BIOL, V100, P1415, DOI 10.1083/jcb.100.5.1415; Liao LQ, 2017, CANCER RES, V77, P2090, DOI 10.1158/0008-5472.CAN-16-2409; Liu FM, 2015, STEM CELL RES, V15, P376, DOI 10.1016/j.scr.2015.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowdon RF., 2014, NAT COMMUN, V5, P1; Ly Tony, 2018, Wellcome Open Res, V3, P51, DOI 10.12688/wellcomeopenres.14392.1; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Mani O, 2009, J DAIRY SCI, V92, P3744, DOI 10.3168/jds.2009-2063; Mattissek C, 2014, MOL MEMBR BIOL, V31, P111, DOI 10.3109/09687688.2014.894210; MCGRATH CM, 1975, AM ZOOL, V15, P231; Meng H, 2011, CELL CYCLE, V10, P73, DOI 10.4161/cc.10.1.14243; Minozzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080219; Modregger J, 2000, J CELL SCI, V113, P4511; Mohammad MA, 2012, AM J PHYSIOL-ENDOC M, V303, pE365, DOI 10.1152/ajpendo.00175.2012; Montevil M, 2016, PROG BIOPHYS MOL BIO, V122, P58, DOI 10.1016/j.pbiomolbio.2016.08.004; Muroya S, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0068-x; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Pauloin A, 2012, BBA-MOL CELL RES, V1823, P987, DOI 10.1016/j.bbamcr.2012.02.016; Perisic P., 2015, Biotechnology in Animal Husbandry, V31, P255, DOI 10.2298/BAH1502255P; Prinz E, 2018, MOL BIOL CELL, V29, P2470, DOI 10.1091/mbc.E17-08-0504; Rahaman SNA, 2018, PEERJ, V6, DOI 10.7717/peerj.5377; Rhoads RE, 2007, J MAMMARY GLAND BIOL, V12, P283, DOI 10.1007/s10911-007-9058-0; Riddle O, 1933, AM J PHYSIOL, V105, P191, DOI 10.1152/ajplegacy.1933.105.1.191; Rios AC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11400; Roth L, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan0949; Simoes AES, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-181; SOULE HD, 1990, CANCER RES, V50, P6075; Srivastava, 2003, CURR PROTOC IMMUNOL, V58, DOI [10.1002/0471142735.ima01ts58, DOI 10.1002/0471142735.IMA01TS58]; Tanjore H, 2006, AM J PATHOL, V168, P715, DOI 10.2353/ajpath.2006.051321; Theerawatanasirikul S, 2012, RES VET SCI, V93, P1287, DOI 10.1016/j.rvsc.2012.06.005; Townson SM, 2003, J BIOL CHEM, V278, P20059, DOI 10.1074/jbc.M212988200; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; WILLIAMS ML, 1987, J LIPID RES, V28, P955; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Yan QX, 2015, J AGR FOOD CHEM, V63, P7388, DOI 10.1021/acs.jafc.5b02231; Zhang HL, 2017, J REPROD DEVELOP, V63, P325, DOI 10.1262/jrd.2016-157	78	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21621	10.1096/fj.202002476RR	http://dx.doi.org/10.1096/fj.202002476RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33977573				2022-12-28	WOS:000655695900053
J	Kida, M; Nakamura, T; Fujiwara, Y; Nakamura, M; Murata, T				Kida, Misato; Nakamura, Tatsuro; Fujiwara, Yuki; Nakamura, Masataka; Murata, Takahisa			PGD(2)/CRTH2 signaling promotes acquired immunity against bee venom by enhancing IgE production	FASEB JOURNAL			English	Article						biological defense; IgE production; lipid mediator	ALLERGIC INFLAMMATION; CRTH2; RECEPTOR; CELLS; ACTIVATION; RAT	IgE-dependent/independent activation of mast cell (MC) has been assumed to play a host defensive role against venom injection in skin. However, its detailed mechanisms remain unknown. We aimed to investigate the contribution of MC-derived prostaglandin D-2 (PGD(2))-mediated signaling in host defense against bee venom (BV). To achieve this, we utilized gene-deficient mice of a PGD(2) receptor, chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). We first confirmed that subcutaneous injection of BV produced PGD(2) equally in wild-type (WT) and CRTH2-deficient (Crth2(-/-)) mice skins. The BV injection dropped body temperature and impaired kidney equally in both lines of mice. In WT mice, pre-injection of BV (3 weeks) significantly inhibited the hypothermia and kidney impairment caused by second BV injection. In contrast, this pre-injection was not effective for the second BV injection in Crth2(-/-) mice. We also found that BV injections increased serum BV-specific IgE levels in WT mice, and its serum transfused mice improved the BV-induced hypothermia in naive WT mice. In contrast, serum BV-specific IgE level was significantly lower in Crth2(-/-) mice. FACS analysis showed the BV injection stimulate migration of dendritic cells (DCs) into regional lymph nodes in WT mice. In Crth2(-/-) mice, its number was significantly smaller than that of WT mice. In conclusion, PGD(2)/CRTH2 signaling plays defensive role against second BV injection. This signaling promotes BV-specific IgE production at least partially by promoting DCs migration into regional lymph node.	[Kida, Misato; Nakamura, Tatsuro; Fujiwara, Yuki; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Radiol, Tokyo, Japan; [Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU)	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Anim Radiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	MEXT | Japan Society for the Promotion of Science (JSPS) [18K14603, 20H05678]; Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18K14603 and 20H05678; Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation	ARGIOLAS A, 1983, J BIOL CHEM, V258, P3697; dosReis MA, 1997, KIDNEY BLOOD PRESS R, V20, P271, DOI 10.1159/000174157; FUJIMOTO I, 1991, FEBS LETT, V287, P15, DOI 10.1016/0014-5793(91)80005-N; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Gosset P, 2003, J IMMUNOL, V170, P4943, DOI 10.4049/jimmunol.170.10.4943; Grisotto LSD, 2006, TOXICON, V48, P44, DOI 10.1016/j.toxicon.2006.04.016; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; SCHMIDT JO, 1995, TOXICON, V33, P917, DOI 10.1016/0041-0101(95)00011-A; SCHUMACHER MJ, 1992, J ALLERGY CLIN IMMUN, V90, P59, DOI 10.1016/S0091-6749(06)80011-4; SCHUMACHER MJ, 1994, J ALLERGY CLIN IMMUN, V93, P831, DOI 10.1016/0091-6749(94)90373-5; Singh PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120346; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Tsubosaka Y, 2014, J IMMUNOL, V193, P5835, DOI 10.4049/jimmunol.1303478	20	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21616	10.1096/fj.202002748RR	http://dx.doi.org/10.1096/fj.202002748RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33978990				2022-12-28	WOS:000655695900022
J	Mancek-Keber, M; Hafner-Bratkovic, I; Lainscek, D; Bencina, M; Govednik, T; Orehek, S; Plaper, T; Jazbec, V; Bergant, V; Grass, V; Pichlmair, A; Jerala, R				Mancek-Keber, Mateja; Hafner-Bratkovic, Iva; Lainscek, Dusko; Bencina, Mojca; Govednik, Tea; Orehek, Sara; Plaper, Tjasa; Jazbec, Vid; Bergant, Valter; Grass, Vincent; Pichlmair, Andreas; Jerala, Roman			Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs	FASEB JOURNAL			English	Article						ACE2; disulfides; SARS-CoV-2; spike; thiol-reacting compounds	CELL ENTRY; GLYCOPROTEIN; INFECTION; HIV	The SARS-CoV-2 pandemic imposed a large burden on health and society. Therapeutics targeting different components and processes of the viral infection replication cycle are being investigated, particularly to repurpose already approved drugs. Spike protein is an important target for both vaccines and therapeutics. Insights into the mechanisms of spike-ACE2 binding and cell fusion could support the identification of compounds with inhibitory effects. Here, we demonstrate that the integrity of disulfide bonds within the receptor-binding domain (RBD) plays an important role in the membrane fusion process although their disruption does not prevent binding of spike protein to ACE2. Several reducing agents and thiol-reactive compounds are able to inhibit viral entry. N-acetyl cysteine amide, L-ascorbic acid, JTT-705, and auranofin prevented syncytia formation, viral entry into cells, and infection in a mouse model, supporting disulfides of the RBD as a therapeutically relevant target.	[Mancek-Keber, Mateja; Hafner-Bratkovic, Iva; Lainscek, Dusko; Bencina, Mojca; Govednik, Tea; Orehek, Sara; Plaper, Tjasa; Jazbec, Vid; Jerala, Roman] Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia; [Mancek-Keber, Mateja; Hafner-Bratkovic, Iva; Lainscek, Dusko; Bencina, Mojca; Jerala, Roman] Ctr Excellence EN FIST, Ljubljana, Slovenia; [Govednik, Tea; Orehek, Sara; Plaper, Tjasa; Jazbec, Vid] Univ Ljubljana, Grad Sch Biomed, Ljubljana, Slovenia; [Bergant, Valter; Grass, Vincent; Pichlmair, Andreas] Tech Univ Munich, Inst Virol, Immunopathol Virus Infect Lab, Munich, Germany	National Institute of Chemistry - Slovenia; University of Ljubljana; Technical University of Munich	Jerala, R (corresponding author), Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si		Orehek, Sara/0000-0003-3002-6175; Hafner Bratkovic, Iva/0000-0001-5635-931X	Slovenian Research Agency [V4-2038, P4-0176, J3-9257]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	Slovenian Research Agency, Grant/Award Number: V4-2038, P4-0176 and J3-9257	Andreou A, 2020, IN VIVO, V34, P1567, DOI 10.21873/invivo.11946; Arslan B., 2020, SSRN, DOI DOI 10.2139/SSRN.3682517; Ates B, 2008, FREE RADICAL RES, V42, P372, DOI 10.1080/10715760801998638; Bagheri M, 2022, J BIOMOL STRUCT DYN, V40, P1597, DOI 10.1080/07391102.2020.1830854; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cecchini R, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110102; Biancatelli RMLC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01451; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Gallagher TM, 1996, J VIROL, V70, P4683, DOI 10.1128/JVI.70.7.4683-4690.1996; Garcia-Murria MJ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030229; Gur M, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0011141; Hati S, 2020, ACS OMEGA, V5, P16292, DOI 10.1021/acsomega.0c02125; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Ibrahim H, 2020, CLIN IMMUNOL, V219, DOI 10.1016/j.clim.2020.108544; Joshi S, 2021, INT J INFECT DIS, V102, P501, DOI 10.1016/j.ijid.2020.10.069; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kaur U, 2021, CURR DRUG TARGETS, V22, P192, DOI 10.2174/1389450121666200924113243; Lainscek D, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050431; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lavillette D, 2006, J BIOL CHEM, V281, P9200, DOI 10.1074/jbc.M512529200; Mancek-Keber M, 2009, J BIOL CHEM, V284, P19493, DOI 10.1074/jbc.M109.003756; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Meirson T, 2021, BIOINFORMATICS, V37, P929, DOI 10.1093/bioinformatics/btaa744; Mesko M, 2020, ACS SYNTH BIOL, V9, P2055, DOI 10.1021/acssynbio.0c00133; Mohammadpour AH, 2013, CLIN PHARMACOKINET, V52, P615, DOI 10.1007/s40262-013-0071-8; Papa G, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009246; Plaper T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88315-3; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Roder C, 2015, DRUGS R&D, V15, P13, DOI 10.1007/s40268-015-0083-y; Rothan HA, 2020, VIROLOGY, V547, P7, DOI 10.1016/j.virol.2020.05.002; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Seif F, 2020, INT ARCH ALLERGY IMM, V181, P467, DOI 10.1159/000508247; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Stukalov A, 2021, NATURE, V594, P246, DOI 10.1038/s41586-021-03493-4; Suhail S, 2020, PROTEIN J, V39, P644, DOI 10.1007/s10930-020-09935-8; Thomas S, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0369; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Xia S, 2020, CELL MOL IMMUNOL, V17, P765, DOI 10.1038/s41423-020-0374-2; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054	40	20	20	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21651	10.1096/fj.202100560R	http://dx.doi.org/10.1096/fj.202100560R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34004056	Green Published			2022-12-28	WOS:000655695900001
J	Lamus, ERB; Carotti, V; de Vries, CRS; Witsel, F; Arntz, OJ; van de Loo, FAJ; Carvajal, CA; Bindels, RJM; Hoenderop, JGJ; Rigalli, JP				Lamus, Eric R. Barros; Carotti, Valentina; de Vries, Christine R. S.; Witsel, Femke; Arntz, Onno J.; van de Loo, Fons A. J.; Carvajal, Cristian A.; Bindels, Rene J. M.; Hoenderop, Joost G. J.; Rigalli, Juan P.			Extracellular vesicles regulate purinergic signaling and epithelial sodium channel expression in renal collecting duct cells	FASEB JOURNAL			English	Article						aldosterone; epithelial sodium channel; exosomes; extracellular vesicles; purinergic signaling	PROTEOMIC ANALYSIS; ADENYLYL-CYCLASE; NA+ CHANNELS; T-CELLS; EXOSOMES; RECEPTORS; CD39; IDENTIFICATION; SECRETION; PROTEINS	Purinergic signaling regulates several renal physiological and pathophysiological processes. Extracellular vesicles (EVs) are nanoparticles released by most cell types, which, in non-renal tissues, modulate purinergic signaling. The aim of this study was to investigate the effect of EVs from renal proximal tubule (HK2) and collecting duct cells (HCD) on intra-and intersegment modulation of extracellular ATP levels, the underlying molecular mechanisms, and the impact on the expression of the alpha subunit of the epithelial sodium channel (alpha ENaC). HK2 cells were exposed to HK2 EVs, while HCD cells were exposed to HK2 and HCD EVs. Extracellular ATP levels and alpha ENaC expression were measured by chemiluminescence and -qRT-PCR, respectively. ATPases in EV populations were identified by mass spectrometry. The effect of aldosterone was assessed using EVs from aldosterone-treated cells and urinary EVs (uEVs) from primary aldosteronism (PA) patients. HK2 EVs downregulated ectonucleoside-triphosphate-diphosphohydrolase-1 (ENTPD1) expression, increased extracellular ATP and downregulated alpha ENaC expression in HCD cells. ENTPD1 downregulation could be attributed to increased miR-205-3p and miR-505 levels. Conversely, HCD EVs decreased extracellular ATP levels and upregulated alpha ENaC expression in HCD cells, probably due to enrichment of 14-3-3 isoforms with ATPase activity. Pretreatment of donor cells with aldosterone or exposure to uEVs from PA patients enhanced the effects on extracellular ATP and alpha ENaC expression. We demonstrated inter-and intrasegment modulation of renal purinergic signaling by EVs. Our findings postulate EVs as carriers of information along the renal tubules, whereby processes affecting EV release and/or cargo may impact on purinergically regulated processes.	[Lamus, Eric R. Barros; Carotti, Valentina; de Vries, Christine R. S.; Witsel, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.; Rigalli, Juan P.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Lamus, Eric R. Barros; Carvajal, Cristian A.] Pontificia Univ Catolica Chile, Sch Med, Dept Endocrinol, Santiago, Chile; [Arntz, Onno J.; van de Loo, Fons A. J.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Rheumatol, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Pontificia Universidad Catolica de Chile; Radboud University Nijmegen	Hoenderop, JGJ; Rigalli, JP (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl; juanpablo.rigalli@radboudumc.nl	Barros, Eric/P-5504-2018	Barros, Eric/0000-0001-6613-4181	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [VICI 016.130.668]; Radboud Universiteit (RU); MINEDUC \ Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [1150437, EQM-150023, 21171092]; MINEDUC \ CONICYT \ Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [1160695]; ICM-MINECON [IMII P09/16-F]; Pontificia Universidad Catolica de Chile (UC); SOCHED; DIDEMUC	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Radboud Universiteit (RU); MINEDUC \ Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); MINEDUC \ CONICYT \ Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF); ICM-MINECON; Pontificia Universidad Catolica de Chile (UC); SOCHED; DIDEMUC	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: VICI 016.130.668; Radboud Universiteit (RU), Grant/Award Number: Radboud Excellence Initiative; MINEDUC vertical bar Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Grant/Award Number: 1150437, EQM-150023 and 21171092; MINEDUC vertical bar CONICYT vertical bar Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF), Grant/Award Number: 1160695; ICM--MINECON, Grant/Award Number: IMII P09/16-F; Pontificia Universidad Catolica de Chile (UC), Grant/Award Number: PhD grant; SOCHED, Grant/Award Number: PhD grant; DIDEMUC, Grant/Award Number: PhD grant	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Arkhipov SN, 2019, BIOCHEM BIOPH RES CO, V513, P166, DOI 10.1016/j.bbrc.2019.03.177; Bai AP, 2014, J IMMUNOL, V193, P3366, DOI 10.4049/jimmunol.1400346; Berenguer J, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1446660; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Burnstock G, 2014, PURINERG SIGNAL, V10, P71, DOI 10.1007/s11302-013-9400-5; Burrello J., 2019, HYPERTENSION, V74, p359; Buzzi N, 2009, BBA-GEN SUBJECTS, V1790, P1651, DOI 10.1016/j.bbagen.2009.10.005; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czekalski S, 1996, KIDNEY INT, V50, P1125, DOI 10.1038/ki.1996.419; D'Souza-Schorey C, 2018, ESSAYS BIOCHEM, V62, P125, DOI 10.1042/EBC20170078; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Dang VD, 2017, FASEB J, V31, P5399, DOI 10.1096/fj.201700417R; DEMBINSKI TC, 1985, CANCER RES, V45, P3083; Deng J, 2012, RESP PHYSIOL NEUROBI, V181, P53, DOI 10.1016/j.resp.2011.11.009; Drumm K, 2006, CELL PHYSIOL BIOCHEM, V17, P21, DOI 10.1159/000091456; Erozenci LA, 2019, FEBS LETT, V593, P1580, DOI 10.1002/1873-3468.13487; Fang FQ, 2016, CELL REP, V14, P1218, DOI 10.1016/j.celrep.2016.01.002; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Gerlach JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074801; Gildea JJ, 2014, CLIN BIOCHEM, V47, P89, DOI 10.1016/j.clinbiochem.2014.06.018; Gohar EY, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00329-0; Gonzalez DA, 2020, MOL CELL BIOCHEM, V463, P1, DOI 10.1007/s11010-019-03624-6; Gorelik J, 2005, P NATL ACAD SCI USA, V102, P15000, DOI 10.1073/pnas.0507008102; Gracia T, 2017, SCI REP-UK, V7, DOI 10.1038/srep40601; Hanner F, 2012, AM J PHYSIOL-RENAL, V303, pF1454, DOI 10.1152/ajprenal.00206.2011; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jella KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165763; Jerez S, 2017, J CELL BIOCHEM, V118, P351, DOI 10.1002/jcb.25642; Kemp BA, 2013, KIDNEY INT, V84, P501, DOI 10.1038/ki.2013.187; Liu ZN, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105915; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Mironova E, 2011, J BIOL CHEM, V286, P1054, DOI 10.1074/jbc.M110.176552; Moriguchi-Mori K, 2016, BIOMED RES-TOKYO, V37, P37, DOI 10.2220/biomedres.37.37; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muller L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20254; Muratsu-Ikeda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041462; Mustafa SB, 2008, J CELL PHYSIOL, V215, P101, DOI 10.1002/jcp.21291; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Orriss IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069057; Pathan M, 2019, NUCLEIC ACIDS RES, V47, pD516, DOI 10.1093/nar/gky1029; Patni H, 2007, AM J PHYSIOL-RENAL, V293, pF1065, DOI 10.1152/ajprenal.00147.2007; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Post SR, 1998, J BIOL CHEM, V273, P23093, DOI 10.1074/jbc.273.36.23093; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Ramteke MP, 2014, FEBS LETT, V588, P71, DOI 10.1016/j.febslet.2013.11.008; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rigalli JP, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00244; Robertson S, 2015, HYPERTENSION, V66, pAP002; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Salimu J, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1368823; Salomon C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00175; Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061; Sheller-Miller S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00432; Shirley DG, 2009, PURINERG SIGNAL, V5, P501, DOI 10.1007/s11302-009-9152-4; Simpson RJ., 2008, COLD SPRING HARB PRO, V3; Sinha Ankit, 2017, Curr Protoc Protein Sci, V87, DOI 10.1002/cpps.23; Street JM, 2017, ADV CLIN CHEM, V78, P103, DOI 10.1016/bs.acc.2016.07.003; Street JM, 2011, J PHYSIOL-LONDON, V589, P6119, DOI 10.1113/jphysiol.2011.220277; Svenningsen P, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13346; Svenningsen P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00292; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toney GM, 2012, CURR OPIN NEPHROL HY, V21, P52, DOI 10.1097/MNH.0b013e32834db4a0; Torres B, 2002, J BIOL CHEM, V277, P7761, DOI 10.1074/jbc.M110352200; Tutakhel OAZ, 2016, AM J PHYSIOL-RENAL, V310, pF204, DOI 10.1152/ajprenal.00429.2015; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Vekaria RM, 2006, AM J PHYSIOL-RENAL, V290, pF550, DOI 10.1152/ajprenal.00151.2005; Verschuren EHJ, 2020, FASEB J, V34, P6382, DOI 10.1096/fj.201902901R; Visovatti SH, 2016, AM J PHYSIOL-HEART C, V311, pH286, DOI 10.1152/ajpheart.00572.2015; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zhong B, 2019, J CELL PHYSIOL, V234, P15025, DOI 10.1002/jcp.28142	80	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21506	10.1096/fj.202002559R	http://dx.doi.org/10.1096/fj.202002559R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811695	hybrid			2022-12-28	WOS:000645260100031
J	Wang, ZZ; Zheng, P; Xie, YY; Chen, X; Solowij, N; Green, K; Chew, YL; Huang, XF				Wang, Zhizhen; Zheng, Peng; Xie, Yuanyi; Chen, Xi; Solowij, Nadia; Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng			Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of A beta pathology models	FASEB JOURNAL			English	Article						amyloid-beta; Alzheimer's disease; cannabidiol; cannabinoid receptor 1; Caenorhabditis elegans; neurite degeneration	ALZHEIMERS-DISEASE; RECEPTOR TRAFFICKING; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; INDUCED TOXICITY; HYDROLASE FAAH; NEURONAL LOSS; SYNAPTIC LOSS; CANNABINOIDS; PEPTIDE	Cannabidiol (CBD), a phytocannabinoid from the Cannabis sativa plant, exhibits a broad spectrum of potential therapeutic properties for neurodegenerative diseases. An accumulation of amyloid-beta (A beta) protein is one of the most important neuropathology in neurodegenerative diseases like Alzheimer's disease (AD). Data on the effect of CBD on the amelioration of A beta-induced neurite degeneration and its consequences of life and health spans is sparse. This study aimed to investigate the effects of CBD on neurite outgrowth in cells and lifespan and health span in Caenorhabditis elegans (C. elegans). In human SH-SY5Y neuronal cells, CBD prevented neurite lesion induced by A beta(1-42) and increased the expression of fatty acid amide hydrolase (FAAH) and cannabinoid receptor 1 (CB1R). Furthermore, CBD both protected the reduction of dendritic spine density and rescued the activity of synaptic Ca2+/calmodulin-dependent protein kinase II (CaMKII) from A beta(1-42) toxicity in primary hippocampal neurons. In C. elegans, we used the transgenic CL2355 strain of C. elegans, which expresses the human A beta peptide throughout the nervous system and found that CBD treatment extended lifespan and improved health span. The neuroprotective effect of CBD was further explored by observing the dopaminergic neurons using transgenic dat-1: GFP strains using the confocal microscope. This study shows that CBD prevents the neurite degeneration induced by A beta, by a mechanism involving CB1R activation, and extends lifespan and improves health span in A beta-overexpressing worms. Our findings support the potential therapeutic approach of CBD for the treatment of AD patients.	[Wang, Zhizhen; Solowij, Nadia; Green, Katrina; Huang, Xu-Feng] Australian Ctr Cannabinoid Clin & Res Excellence, New Lambton Hts, NSW, Australia; [Wang, Zhizhen; Zheng, Peng; Xie, Yuanyi; Chen, Xi; Solowij, Nadia; Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng] Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia; [Wang, Zhizhen; Zheng, Peng; Xie, Yuanyi; Chen, Xi; Solowij, Nadia; Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng] Univ Wollongong, Sch Med, Wollongong, NSW 2522, Australia; [Solowij, Nadia] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng] Univ Wollongong, Sch Chem & Mol Biosci, Mol Horizons, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong; University of Wollongong; University of Wollongong	Huang, XF (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia.; Huang, XF (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW 2522, Australia.; Chew, YL (corresponding author), Univ Wollongong, Sch Chem & Mol Biosci, Mol Horizons, Wollongong, NSW 2522, Australia.	ylchew@uow.edu.au; xhuang@uow.edu.au	Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Zheng, Peng/0000-0002-8248-1826	Australian Centre for Cannabinoid Clinical and Research Excellence [APP1176503]; Research Committee of the University of Wollongong, Australia	Australian Centre for Cannabinoid Clinical and Research Excellence; Research Committee of the University of Wollongong, Australia	This work was funded by Australian Centre for Cannabinoid Clinical and Research Excellence APP1176503 and Research Committee of the University of Wollongong, Australia	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alexander AG, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00279; Androuin A, 2018, ACTA NEUROPATHOL, V135, P839, DOI 10.1007/s00401-018-1847-6; Aso E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00037; Attems J, 2007, ACTA NEUROPATHOL, V113, P53, DOI 10.1007/s00401-006-0146-9; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Beltramo M, 2000, J NEUROSCI, V20, P3401, DOI 10.1523/JNEUROSCI.20-09-03401.2000; Benito C, 2003, J NEUROSCI, V23, P11136; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Borlikova GG, 2013, NEUROBIOL AGING, V34, P1315, DOI 10.1016/j.neurobiolaging.2012.10.028; Branca JJV, 2019, INT J ENV RES PUB HE, V16; BRENNER S, 1974, GENETICS, V77, P71; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Burns JM, 2005, NEUROLOGY, V64, P1397, DOI 10.1212/01.WNL.0000158423.05224.7F; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Campos AC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00269; Campos AC, 2016, PHARMACOL RES, V112, P119, DOI 10.1016/j.phrs.2016.01.033; Chege PM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00089; Cheng D, 2014, PSYCHOPHARMACOLOGY, V231, P3009, DOI 10.1007/s00213-014-3478-5; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Currais A, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.12; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Deutsch DG, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.7016.00370; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Elmes MW, 2015, J BIOL CHEM, V290, P8711, DOI 10.1074/jbc.M114.618447; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; GIBB WRG, 1989, J NEUROL NEUROSUR PS, V52, P193, DOI 10.1136/jnnp.52.2.193; Glass M, 2001, PROG NEURO-PSYCHOPH, V25, P743, DOI 10.1016/S0278-5846(01)00162-2; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Santos NAG, 2015, TOXICOL IN VITRO, V30, P231, DOI 10.1016/j.tiv.2015.11.004; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Harvey BS, 2012, NEUROTOXICOLOGY, V33, P138, DOI 10.1016/j.neuro.2011.12.015; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Land MH, 2020, CANNABIS CANNABINOID, DOI 10.1089/can.2020.0103; Lee JH, 2010, NEUROCHEM INT, V57, P985, DOI 10.1016/j.neuint.2010.10.010; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Margie O, 2013, JOVE-J VIS EXP, DOI 10.3791/50069; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Maulik Malabika, 2017, Front Genet, V8, P77, DOI 10.3389/fgene.2017.00077; McCollum L, 2007, J PHARMACOL EXP THER, V321, P930, DOI 10.1124/jpet.106.117549; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Murakami H, 2008, NEUROBIOL AGING, V29, P1093, DOI 10.1016/j.neurobiolaging.2007.01.013; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Ng LF, 2014, FREE RADICAL BIO MED, V71, P390, DOI 10.1016/j.freeradbiomed.2014.03.003; Nobili A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14727; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Oakes MD, 2017, J NEUROSCI, V37, P2859, DOI 10.1523/JNEUROSCI.3151-16.2017; Ofengeim D, 2012, J BIOL CHEM, V287, P8714, DOI 10.1074/jbc.M111.290957; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pandelides Z, 2020, GEROSCIENCE, V42, P785, DOI 10.1007/s11357-020-00182-4; Popugaeva E, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0034-7; Prenderville JA, 2015, BRIT J PHARMACOL, V172, P3950, DOI 10.1111/bph.13186; Price TJ, 2005, NEUROPHARMACOLOGY, V49, P25, DOI 10.1016/j.neuropharm.2005.01.031; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; STAMPANONI BM, 2017, CANNABIS CANNABINOID, V2, P21, DOI DOI 10.1089/CAN.2017.0002; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Takuma H, 2004, J NEUROPATH EXP NEUR, V63, P255, DOI 10.1093/jnen/63.3.255; Tejeda-Benitez L, 2016, REV ENVIRON CONTAM T, V237, P1, DOI 10.1007/978-3-319-23573-8_1; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Thomas A, 2004, EUR J PHARMACOL, V487, P213, DOI 10.1016/j.ejphar.2004.01.023; Wang CY, 2018, NEUROBIOL DIS, V109, P88, DOI 10.1016/j.nbd.2017.10.003; Watt G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00020; Williams EJ, 2003, J CELL BIOL, V160, P481, DOI 10.1083/jcb.200210164; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yang ZZ, 2018, FREE RADICAL BIO MED, V129, P310, DOI 10.1016/j.freeradbiomed.2018.09.035; Zheng MG, 2013, AMYLOID, V20, P13, DOI 10.3109/13506129.2012.755122	83	11	11	2	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21537	10.1096/fj.202002724R	http://dx.doi.org/10.1096/fj.202002724R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817834				2022-12-28	WOS:000645260100091
J	Zhang, JY; Liu, CC; Liang, Q; Zheng, F; Guan, YF; Yang, GR; Chen, LH				Zhang, Jiayang; Liu, Chengcheng; Liang, Qing; Zheng, Feng; Guan, Youfei; Yang, Guangrui; Chen, Lihong			Postnatal deletion of Bmal1 in mice protects against obstructive renal fibrosis via suppressing Gli2 transcription	FASEB JOURNAL			English	Article						Bmal1; circadian clock; Gli2; renal fibrosis	CIRCADIAN CLOCK; BLOOD-PRESSURE; INTERSTITIAL FIBROSIS; HYPERTENSION; MECHANISMS; DEFICIENT; COMPONENT; RHYTHMS; MODEL; NOTCH	Circadian clock is involved in regulating most renal physiological functions, including water and electrolyte balance and blood pressure homeostasis, however, the role of circadian clock in renal pathophysiology remains largely unknown. Here we aimed to investigate the role of Bmal1, a core clock component, in the development of renal fibrosis, the hallmark of pathological features in many renal diseases. The inducible Bmal1 knockout mice (iKO) whose gene deletion occurred in adulthood were used in the study. Analysis of the urinary water, sodium and potassium excretion showed that the iKO mice exhibit abolished diurnal variations. In the model of renal fibrosis induced by unilateral ureteral obstruction, the iKO mice displayed significantly decreased tubulointerstitial fibrosis reflected by attenuated collagen deposition and mitigated expression of fibrotic markers alpha-SMA and fibronectin. The hedgehog pathway transcriptional effectors Gli1 and Gli2, which have been reported to be involved in the pathogenesis of renal fibrosis, were significantly decreased in the iKO mice. Mechanistically, ChIP assay and luciferase reporter assay revealed that BMAL1 bound to the promoter of and activate the transcription of Gli2, but not Gli1, suggesting that the involvement of Bmal1 in renal fibrosis was possibly mediated via Gli2-dependent mechanisms. Furthermore, treatment with TGF-beta increased Bmal1 in cultured murine proximal tubular cells. Knockdown of Bmal1 abolished, while overexpression of Bmal1 increased, Gli2 and the expression of fibrosis-related genes. Collectively, these results revealed a prominent role of the core clock gene Bmal1 in tubulointerstitial fibrosis. Moreover, we identified Gli2 as a novel target of Bmal1, which may mediate the adverse effect of Bmal1 in obstructive nephropathy.	[Zhang, Jiayang; Liu, Chengcheng; Liang, Qing; Zheng, Feng; Guan, Youfei; Chen, Lihong] Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Liaoning, Peoples R China; [Yang, Guangrui] Dalian Univ Technol, Sch Bioengn, Dalian, Peoples R China	Dalian Medical University; Dalian University of Technology	Chen, LH (corresponding author), Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Liaoning, Peoples R China.	lihong@dmu.edu.cn			National Key R&D Program of China [2019YFA0802400]; National Natural Science Foundation of China [32071157, 81570643, 81670242]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: #2019YFA0802400; National Natural Science Foundation of China, Grant/Award Number: 32071157, 81570643 and 81670242	Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P1258, DOI 10.2215/CJN.10581110; Ansermet C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52682-9; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang L, 2018, CIRCULATION, V138, P67, DOI 10.1161/CIRCULATIONAHA.117.029972; Chen WD, 2015, AM J PATHOL, V185, P3152, DOI 10.1016/j.ajpath.2015.08.003; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ST., 2018, JCI INSIGHT, V3; Crislip GR, 2020, AM J PHYSIOL-RENAL, V318, pF1463, DOI 10.1152/ajprenal.00014.2020; Crislip GR, 2018, CURR OPIN PHYSIOL, V5, P38, DOI 10.1016/j.cophys.2018.06.002; Crosby P, 2019, CELL, V177, P896, DOI 10.1016/j.cell.2019.02.017; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dan H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107661; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Hara M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07767-8; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Honma S, 2016, EUR J PHARMACOL, V780, P136, DOI 10.1016/j.ejphar.2016.03.041; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Jiang SL, 2021, PHYTOMEDICINE, V80, DOI 10.1016/j.phymed.2020.153393; Johnston JG, 2020, HYPERTENSION, V75, P1624, DOI 10.1161/HYPERTENSIONAHA.119.13908; Johnston JG, 2018, FREE RADICAL BIO MED, V119, P93, DOI 10.1016/j.freeradbiomed.2018.01.018; Kim H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020305; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kramann R, 2016, NEPHROL DIAL TRANSPL, V31, P1989, DOI 10.1093/ndt/gfw102; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Motohashi H, 2020, KIDNEY INT, V97, P728, DOI 10.1016/j.kint.2019.09.032; Nikolaeva S, 2016, J AM SOC NEPHROL, V27, P2997, DOI 10.1681/ASN.2015091055; Nikolaeva S, 2012, J AM SOC NEPHROL, V23, P1019, DOI 10.1681/ASN.2011080842; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; Solocinski K, 2017, ACTA PHYSIOL, V220, P72, DOI 10.1111/apha.12804; Solocinski K, 2015, J BIOL RHYTHM, V30, P470, DOI 10.1177/0748730415610879; Tokonami N, 2014, J AM SOC NEPHROL, V25, P1430, DOI 10.1681/ASN.2013060641; Townsend RR, 2015, NAT REV NEPHROL, V11, P555, DOI 10.1038/nrneph.2015.114; Xie ZW, 2015, J CLIN INVEST, V125, P324, DOI 10.1172/JCI76881; Yang GR, 2020, ARTERIOSCL THROM VAS, V40, P1523, DOI 10.1161/ATVBAHA.120.314318; Yang GR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125133; Yang GR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007225; Yang ZT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3006; Zha M, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2655-1; Zhang DG, 2020, AM J PHYSIOL-RENAL, V318, pF710, DOI 10.1152/ajprenal.00364.2019; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	49	7	7	5	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21530	10.1096/fj.202002452R	http://dx.doi.org/10.1096/fj.202002452R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813752				2022-12-28	WOS:000645260100102
J	Hariharan, VN; Yadav, R; Thakur, C; Singh, A; Gopinathan, R; Singh, DP; Sankhe, G; Malhotra, V; Chandra, N; Bhatt, A; Saini, DK				Hariharan, Vignesh Narayan; Yadav, Rahul; Thakur, Chandrani; Singh, Albel; Gopinathan, Renu; Singh, Devendra Pratap; Sankhe, Gaurav; Malhotra, Vandana; Chandra, Nagasuma; Bhatt, Apoorva; Saini, Deepak Kumar			Cyclic di-GMP sensing histidine kinase PdtaS controls mycobacterial adaptation to carbon sources	FASEB JOURNAL			English	Article						c&#8208; di&#8208; GMP; nutrient starvation; two&#8208; component system		Cell signaling relies on second messengers to transduce signals from the sensory apparatus to downstream signaling pathway components. In bacteria, one of the most important and ubiquitous second messenger is the small molecule cyclic diguanosine monophosphate (c-di-GMP). While the biosynthesis, degradation, and regulatory pathways controlled by c-di-GMP are well characterized, the mechanisms through which c-di-GMP controls these processes are not entirely understood. Herein we present the report of a c-di-GMP sensing sensor histidine kinase PdtaS (Rv3220c), which binds to c-di-GMP at submicromolar concentrations, subsequently perturbing signaling of the PdtaS-PdtaR (Rv1626) two-component system. Aided by biochemical analysis, genetics, molecular docking, FRET microscopy, and structural modelling, we have characterized the binding of c-di-GMP in the GAF domain of PdtaS. We show that a pdtaS knockout in Mycobacterium smegmatis is severely compromised in growth on amino acid deficient media and exhibits global transcriptional dysregulation. The perturbation of the c-di-GMP-PdtaS-PdtaR axis results in a cascade of cellular changes recorded by a multiparametric systems' approach of transcriptomics, unbiased metabolomics, and lipid analyses.	[Hariharan, Vignesh Narayan; Yadav, Rahul; Gopinathan, Renu; Singh, Devendra Pratap; Saini, Deepak Kumar] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Thakur, Chandrani; Chandra, Nagasuma] Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India; [Singh, Albel; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Singh, Albel; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Sankhe, Gaurav; Saini, Deepak Kumar] Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore, Karnataka, India; [Malhotra, Vandana] Delhi Univ, Sri Venkateswara Coll, Dept Biochem, Delhi, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; University of Birmingham; University of Birmingham; Indian Institute of Science (IISC) - Bangalore; University of Delhi	Saini, DK (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	deepaksaini@iisc.ac.in		Yadav, Rahul/0000-0002-8537-6896; Hariharan, Vignesh Narayan/0000-0001-9624-1244	Council of Scientific & Industrial Research [37(1663)15/EMR-II)]; Department of Biotechnology, India [BT/PR17357/MED/29/1019/2016]; DBT partnership program [DBT/BF/PRIns/2011-12]; Infosys Foundation; DST [SR/FST/LSII-036/2016]; Newton-Bhabha fellowship; BIRAC-BMGF [BIRAC/PMU/2019/SENTINELS-001]	Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); DBT partnership program; Infosys Foundation; DST(Department of Science & Technology (India)); Newton-Bhabha fellowship; BIRAC-BMGF	This work was supported by the Council of Scientific & Industrial Research (Grant No. 37(1663)15/EMR-II) and Department of Biotechnology, India (Grant No. BT/PR17357/MED/29/1019/2016) to DKS. The study is also supported by the DBT partnership program to the Indian Institute of Science (DBT/BF/PRIns/2011-12) and Infosys Foundation; Equipment support by DST-Funds for Infrastructure in Science and Technology program (SR/FST/LSII-036/2016). Part of the work was also supported by the Newton-Bhabha fellowship to VNH and Sentinels grant from BIRAC-BMGF (BIRAC/PMU/2019/SENTINELS-001) to DKS	Agrawal R., 2013, DYNAMIC MODELS INFEC, P79, DOI [10.1007/978-1-4614-9224-5_4, DOI 10.1007/978-1-4614-9224-5_4]; Agrawal R, 2015, BIOCHEM J, V469, P121, DOI 10.1042/BJ20150268; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bharati BK, 2013, GENE, V528, P99, DOI 10.1016/j.gene.2013.07.043; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Dadura K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02145; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Dobson G., 1985, CHEM METHODS BACTERI, P237; Dubey BN, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600823; Gordhan BG, 2002, INFECT IMMUN, V70, P3080, DOI 10.1128/IAI.70.6.3080-3084.2002; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Gupta KR, 2016, J BACTERIOL, V198, P1414, DOI 10.1128/JB.00126-16; Gupta KR, 2015, APPL ENVIRON MICROB, V81, P2571, DOI 10.1128/AEM.03999-14; Hayashi M, 2010, FEMS MICROBIOL LETT, V304, P12, DOI 10.1111/j.1574-6968.2009.01879.x; Haydel SE, 2004, FEMS MICROBIOL LETT, V236, P341, DOI 10.1016/j.femsle.2004.06.010; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hong YZ, 2013, TUBERCULOSIS, V93, P625, DOI 10.1016/j.tube.2013.09.002; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mdluli K, 2006, CURR OPIN PHARMACOL, V6, P459, DOI 10.1016/j.coph.2006.06.004; Morth JP, 2005, FEBS LETT, V579, P4145, DOI 10.1016/j.febslet.2005.06.043; Morth JP, 2004, STRUCTURE, V12, P1595, DOI 10.1016/j.str.2004.06.018; Perry J, 2011, MOL BIOSYST, V7, P1388, DOI 10.1039/c0mb00329h; Preu J, 2012, J STRUCT BIOL, V177, P498, DOI 10.1016/j.jsb.2011.11.012; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Sambarey A, 2017, EBIOMEDICINE, V15, P112, DOI 10.1016/j.ebiom.2016.12.009; Sharma IM, 2014, IUBMB LIFE, V66, P823, DOI 10.1002/iub.1339; Sousa EHS, 2017, J INORG BIOCHEM, V167, P12, DOI 10.1016/j.jinorgbio.2016.11.022; Singh A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164253; Singh N, 2015, ANTIOXID REDOX SIGN, V22, P603, DOI 10.1089/ars.2014.6020; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tiwari S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01878; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Zhang HN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06289-7	41	5	5	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21475	10.1096/fj.202002537RR	http://dx.doi.org/10.1096/fj.202002537RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33772870				2022-12-28	WOS:000635216100004
J	Liu, LX; Zhang, YY; Liu, T; Ke, CR; Huang, JZ; Fu, YJ; Lin, Z; Chen, FJ; Wu, XQ; Chen, Q				Liu, Lixia; Zhang, Yingyong; Liu, Tao; Ke, Chongrong; Huang, Jianzhong; Fu, Yajuan; Lin, Zhang; Chen, Fengjuan; Wu, Xiuqin; Chen, Qi			Pyrroloquinoline quinone protects against exercise-induced fatigue and oxidative damage via improving mitochondrial function in mice	FASEB JOURNAL			English	Article						damage; exercise; fatigue; mitochondria; PQQ		Pyrroloquinoline quinone (PQQ) has a variety of biological functions. However, rare attention has been paid to its effects on exercise-induced damage. Here, we assessed the potential protective effects of PQQ against the fatigue and oxidative damage caused by repeated exhaustive exercise, and studied the underlying mechanism. The models for exercise-induced fatigue were established, and the parameters were measured, including the time to exhaustion (TTE), biochemical indicators, the expression of nuclear factor kappa B (NF-kappa B) and inflammatory cytokines and so on. Besides, the mitochondrial function was evaluated by the morphology, membrane potential, respiratory function, adenosine triphosphate (ATP) levels, and the application of the mitochondrial complex I inhibitor. The results demonstrate that PQQ prolongs TTE, causes the decrease in the activity of serum creatine kinase and lactate dehydrogenase, increases the activity of antioxidant enzymes, inhibits the production of reactive oxygen species (ROS) and malondialdehyde (MDA), and diminishes the over expression of NF-kappa B (p65) and inflammatory mediators. Furthermore, PQQ preserves normal mitochondrial function. Particularly, PQQ reduces the accumulation of ROS triggered by the mitochondrial complex I inhibitor. These data suggest that PQQ can significantly protect mice from exercise-induced fatigue and oxidative damage by improving mitochondrial function. These data also suggest that PQQ controls mitochondrial activity through directly affecting the NADH dehydrogenase.	[Liu, Lixia; Fu, Yajuan; Lin, Zhang; Chen, Qi] Fujian Normal Univ, Biomed Res Ctr South China, Fujian Key Lab Innate Immune Biol, Fuzhou, Funjian, Peoples R China; [Liu, Lixia; Zhang, Yingyong; Liu, Tao; Chen, Fengjuan; Wu, Xiuqin] Fujian Normal Univ, Sch Phys Educ & Sport Sci, Fuzhou, Fujian, Peoples R China; [Liu, Lixia; Wu, Xiuqin] Fujian Normal Univ, Key Lab Gen Adm Sport China, Fuzhou, Fujian, Peoples R China; [Liu, Lixia] Fujian Normal Univ, Fujian Key Lab Sports & Hlth, Fuzhou, Fujian, Peoples R China; [Ke, Chongrong; Huang, Jianzhong; Fu, Yajuan; Lin, Zhang; Chen, Qi] Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Ke, Chongrong; Huang, Jianzhong] Fujian Normal Univ, Natl Engn Res Ctr Ind Microbiol & Fermentat Techn, Fuzhou, Fujian, Peoples R China	Fujian Normal University; Fujian Normal University; Fujian Normal University; Fujian Normal University; Fujian Normal University; Fujian Normal University	Wu, XQ (corresponding author), Fujian Normal Univ, Sch Phys Educ & Sport Sci, Fuzhou, Fujian, Peoples R China.; Chen, Q (corresponding author), Fujian Normal Univ, Biomed Res Ctr South China, Qishan Campus,Keji Rd 1, Fuzhou 350117, Fujian, Peoples R China.	616331350@qq.com; chenqi@fjnu.edu.cn		Ke, ChongRong/0000-0002-2111-4627	Fujian Provincial Health and Education Alliance Funds [WKJ-FJ-28]; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	Fujian Provincial Health and Education Alliance Funds; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	Fujian Provincial Health and Education Alliance Funds, Grant/Award Number: WKJ-FJ-28; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship to QC	Aydin C, 2007, CELL BIOCHEM FUNCT, V25, P129, DOI 10.1002/cbf.1279; Basham SA, 2020, J DIET SUPPL, V17, P401, DOI 10.1080/19390211.2019.1604604; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bishop A, 1998, NUTR REV, V56, P287, DOI 10.1111/j.1753-4887.1998.tb01661.x; Breuer ME, 2013, NEUROBIOL DIS, V51, P27, DOI 10.1016/j.nbd.2012.03.007; Das S, 2008, PHARM RES-DORDR, V25, P2593, DOI 10.1007/s11095-008-9677-1; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Feldkamp T, 2005, AM J PHYSIOL-RENAL, V288, pF1092, DOI 10.1152/ajprenal.00443.2004; Fu X, 2010, J MED FOOD, V13, P211, DOI 10.1089/jmf.2009.0049; Hamidie RDR, 2017, IOP CONF SER-MAT SCI, V180, DOI 10.1088/1757-899X/180/1/012202; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Hou LJ, 2017, J AM COLL CARDIOL, V70, pC64, DOI 10.1016/j.jacc.2017.07.218; Huang WC, 2015, NUTRIENTS, V7, P905, DOI 10.3390/nu7020905; Jonscher KR, 2017, FASEB J, V31, P1434, DOI 10.1096/fj.201600906R; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; Kinoshita S, 2003, ACTA PHYSIOL SCAND, V178, P225, DOI 10.1046/j.1365-201X.2003.01135.x; Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007; Liu LX, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1333390; Liu ZG, 2016, J SPORT HEALTH SCI, V5, P424, DOI 10.1016/j.jshs.2015.09.005; Liu ZB, 2016, INFLAMMATION, V39, P248, DOI 10.1007/s10753-015-0245-7; Mankowski RT, 2015, MED SCI SPORT EXER, V47, P1857, DOI 10.1249/MSS.0000000000000620; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; McFarlin BK, 2016, BBA CLIN, V5, P72, DOI 10.1016/j.bbacli.2016.02.003; Nieman DC, 2018, INT J SPORT NUTR EXE, V28, P266, DOI 10.1123/ijsnem.2017-0272; Nybo L, 2003, MED SCI SPORT EXER, V35, P589, DOI 10.1249/01.MSS.0000058433.85789.66; Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005; Pan HY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/145418; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Singh AK, 2015, EXP GERONTOL, V66, P1, DOI 10.1016/j.exger.2015.04.001; SMIDT CR, 1991, BIOFACTORS, V3, P53; Steckling FM, 2020, SCAND J MED SCI SPOR, V30, P264, DOI 10.1111/sms.13579; Stevanovic J, 2020, MOL METAB, V32, P1, DOI 10.1016/j.molmet.2019.11.015; Suhett LG, 2021, CRIT REV FOOD SCI, V61, P946, DOI 10.1080/10408398.2020.1749025; Sun M, 2012, SCAND J MED SCI SPOR, V22, P764, DOI 10.1111/j.1600-0838.2011.01314.x; THOMAS DP, 1988, INT J SPORTS MED, V9, P257, DOI 10.1055/s-2007-1025017; Tsukakoshi K, 2018, ACS CHEM NEUROSCI, V9, P2898, DOI 10.1021/acschemneuro.8b00355; Wan JJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.194; Xu MH, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1334485; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111; Zhu BQ, 2006, J CARDIOVASC PHARM T, V11, P119, DOI 10.1177/1074248406288757	41	6	7	11	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21394	10.1096/fj.202001977RR	http://dx.doi.org/10.1096/fj.202001977RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710654				2022-12-28	WOS:000635216100056
J	Qian, Y; Li, Y; Liu, XX; Yuan, N; Ma, JJ; Zheng, QW; Liu, F				Qian, Yu; Li, Yi; Liu, Xinxuan; Yuan, Na; Ma, Jinjie; Zheng, Qiwen; Liu, Fan			Evidence for CAT gene being functionally involved in the susceptibility of COVID-19	FASEB JOURNAL			English	Article						COVID-19; bioinformatics; protein interaction; candidate gene; eQTL	CATALASE; IDENTIFICATION; BLOOD	Novel coronary pneumonia (COVID-19) is a respiratory distress syndrome caused by a new type of coronavirus. Understanding the genetic basis of susceptibility and prognosis to COVID-19 is of great significance to disease prevention, molecular typing, prognosis, and treatment. However, so far, there have been only two genome-wide association studies (GWASs) on the susceptibility of COVID-19. Starting with these reported DNA variants, we found the genes regulated by these variants through cis-eQTL and cis-meQTL acting. We further did a series of bioinformatics analysis on these potential risk genes. The analysis shows that the genetic variants on EHF regulate the expression of its neighbor CAT gene via cis-eQTL. There was significant evidence that CAT and the SARS-CoV-2-related S protein binding protein ACE2 interact with each other. Intracellular localization results showed that CAT and ACE2 proteins both exists in the cell membrane and extracellular area and their interaction could have an impact on the cell invasion ability of S protein. In addition, the expression of these three genes showed a significant positive correlation in the lungs. Based on these results, we propose that CAT plays a crucial intermediary role in binding effectiveness of ACE2, thereby affecting the susceptibility to COVID-19.	[Qian, Yu; Li, Yi; Liu, Xinxuan; Yuan, Na; Ma, Jinjie; Zheng, Qiwen; Liu, Fan] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China; [Qian, Yu; Li, Yi; Liu, Xinxuan; Yuan, Na; Ma, Jinjie; Zheng, Qiwen; Liu, Fan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Fan] China Natl Ctr Bioinformat, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, F (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genom & Precis Med, Beichen West Rd 1-104, Beijing 100101, Peoples R China.	liufan@big.ac.cn		Li, Yi/0000-0002-2448-9176; Xinxuan, Liu/0000-0002-1653-1434	Strategic Priority Research Program of Chinese Academy of Sciences [XDB38010400]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	Strategic Priority Research Program of Chinese Academy of Sciences, Grant/Award Number: XDB38010400	[Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arita Y, 2006, AM J PHYSIOL-LUNG C, V290, pL978, DOI 10.1152/ajplung.00296.2005; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Coursin DB, 1996, HISTOL HISTOPATHOL, V11, P851; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Gong J, 2019, NUCLEIC ACIDS RES, V47, pD1066, DOI 10.1093/nar/gky814; Huan TX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12228-z; Kachuri Linda, 2020, Genome Med, V12, P93, DOI [10.1101/2020.05.01.20088054, 10.1186/s13073-020-00790-x]; Latz CA, 2020, ANN HEMATOL, V99, P2113, DOI 10.1007/s00277-020-04169-1; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McClay JL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0842-7; Odajima N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-183; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Qin M, 2020, ADV MATER, V32, DOI 10.1002/adma.202004901; Rungtabnapa P, 2011, AM J PHYSIOL-CELL PH, V300, pC235, DOI 10.1152/ajpcell.00249.2010; Shi Y, 2020, J ZHEJIANG UNIV-SC B, V21, P343, DOI 10.1631/jzus.B2000083; Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	22	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21384	10.1096/fj.202100008	http://dx.doi.org/10.1096/fj.202100008			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710662	Green Published			2022-12-28	WOS:000635216100046
J	Canals, D; Salamone, S; Santacreu, BJ; Aguilar, D; Hernandez-Corbacho, MJ; Ostermeyer-Fay, AG; Greene, M; Nemeth, E; Haley, JD; Obeid, LM; Hannun, YA				Canals, Daniel; Salamone, Silvia; Jaime Santacreu, Bruno; Aguilar, Daniel; Hernandez-Corbacho, Maria Jose; Ostermeyer-Fay, Anne G.; Greene, Meaghan; Nemeth, Erika; Haley, John D.; Obeid, Lina M.; Hannun, Yusuf A.			The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha	FASEB JOURNAL			English	Article						ceramide; doxorubicin; migration; phosphatase; sphingomyelinase		We have recently reported that a specific pool of ceramide, located in the plasma membrane, mediated the effects of sublethal doses of the chemotherapeutic compound doxorubicin on enhancing cancer cell migration. We identified neutral sphingomyelinase 2 (nSMase2) as the enzyme responsible to generate this bioactive pool of ceramide. In this work, we explored the role of members of the protein phosphatases 1 family (PP1), and we identified protein phosphatase 1 alpha isoform (PP1 alpha) as the specific PP1 isoform to mediate this phenotype. Using a bioinformatics approach, we build a functional interaction network based on phosphoproteomics data on plasma membrane ceramide. This led to the identification of several ceramide-PP1 alpha downstream substrates. Studies on phospho mutants of ezrin (T567) and Scrib (S1378/S1508) demonstrated that their dephosphorylation is sufficient to enhance cell migration. In summary, we identified a mechanism where reduced doses of doxorubicin result in the dysregulation of cytoskeletal proteins and enhanced cell migration. This mechanism could explain the reported effects of doxorubicin worsening cancer metastasis in animal models.	[Canals, Daniel; Salamone, Silvia; Jaime Santacreu, Bruno; Hernandez-Corbacho, Maria Jose; Ostermeyer-Fay, Anne G.; Greene, Meaghan; Nemeth, Erika; Haley, John D.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Jaime Santacreu, Bruno] Catedra Biol Celular & Mol, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Aguilar, Daniel] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Barcelona, Spain; [Haley, John D.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport VA Hosp, Northport, NY USA; [Obeid, Lina M.; Hannun, Yusuf A.] Stony Brook Canc Ctr, Stony Brook, NY USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Buenos Aires; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123; Haley, John/0000-0002-0283-6413; Santacreu, Bruno/0000-0003-2506-5006	National Cancer Institute (NCI) [CA218678]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute (NCI), Grant/Award Number: CA218678	Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Canals D., 2021, FASEB J, V35; Canals D, 2020, FASEB J, V34, P7610, DOI 10.1096/fj.202000205R; Canals D, 2018, CHEM PHYS LIPIDS, V216, P142, DOI 10.1016/j.chemphyslip.2018.09.013; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Elliott A, 2018, BIOINFORMATICS, V34, P64, DOI 10.1093/bioinformatics/btx419; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harvey RF, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw6763; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Karagiannis GS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0026; Khasraw M, 2012, BREAST, V21, P142, DOI 10.1016/j.breast.2011.12.012; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim Y, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2856-8; Liu CL, 2019, J BREAST CANCER, V22, P185, DOI 10.4048/jbc.2019.22.e22; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Piccolo SR, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156506; Sakamoto W, 2019, J LIPID RES, V60, P1841, DOI 10.1194/jlr.M094722; Shamseddine AA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.268; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih YK, 2012, BIOINFORMATICS, V28, pI473, DOI 10.1093/bioinformatics/bts370; Siddiqui RA, 2003, BIOCHEM J, V371, P621, DOI 10.1042/BJ20021667; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05467-z	39	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21396	10.1096/fj.202002427R	http://dx.doi.org/10.1096/fj.202002427R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583073	Green Accepted			2022-12-28	WOS:000629576700046
J	Doni, D; Rigoni, G; Palumbo, E; Baschiera, E; Peruzzo, R; De Rosa, E; Caicci, F; Passerini, L; Bettio, D; Russo, A; Szabo, I; Soriano, ME; Salviati, L; Costantini, P				Doni, Davide; Rigoni, Giovanni; Palumbo, Elisa; Baschiera, Elisa; Peruzzo, Roberta; De Rosa, Edith; Caicci, Federico; Passerini, Leonardo; Bettio, Daniela; Russo, Antonella; Szabo, Ildiko; Soriano, Maria Eugenia; Salviati, Leonardo; Costantini, Paola			The displacement of frataxin from the mitochondrial cristae correlates with abnormal respiratory supercomplexes formation and bioenergetic defects in cells of Friedreich ataxia patients	FASEB JOURNAL			English	Article						FeS&#8208; cluster assembly; mitochondria; mitochondrial morphology; respiration	FE/S CLUSTER SYNTHESIS; POINT MUTATIONS; SULFUR TRANSFER; COMPLEXES I; MATURATION; DEFICIENCY; BIOSYNTHESIS; MECHANISMS; STABILITY; PHENOTYPE	Friedreich ataxia (FRDA) is a neurodegenerative disease resulting from a severe decrease of frataxin (FXN). Most patients carry a GAA repeat expansion in both alleles of the FXN gene, whereas a small fraction of them are compound heterozygous for the expansion and a point mutation in the other allele. FXN is involved in the mitochondrial biogenesis of the FeS-clusters. Distinctive feature of FRDA patient cells is an impaired cellular respiration, likely due to a deficit of key redox cofactors working as electrons shuttles through the respiratory chain. However, a definite relationship between FXN levels, FeS-clusters assembly dysregulation and bioenergetics failure has not been established. In this work, we performed a comparative analysis of the mitochondrial phenotype of cell lines from FRDA patients, either homozygous for the expansion or compound heterozygotes for the G130V mutation. We found that, in healthy cells, FXN and two key proteins of the FeS-cluster assembly machinery are enriched in mitochondrial cristae, the dynamic subcompartment housing the respiratory chain. On the contrary, FXN widely redistributes to the matrix in FRDA cells with defects in respiratory supercomplexes assembly and altered respiratory function. We propose that this could be relevant for the early mitochondrial defects afflicting FRDA cells and that perturbation of mitochondrial morphodynamics could in turn be critical in terms of disease mechanisms.	[Doni, Davide; Rigoni, Giovanni; Peruzzo, Roberta; De Rosa, Edith; Caicci, Federico; Passerini, Leonardo; Szabo, Ildiko; Soriano, Maria Eugenia; Costantini, Paola] Univ Padua, Dept Biol, Viale G Colombo 3, I-35131 Padua, Italy; [Palumbo, Elisa; Russo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Baschiera, Elisa; Bettio, Daniela; Salviati, Leonardo] Univ Padua, Dept Womens & Childrens Hlth, Clin Genet Unit, Padua, Italy; [Baschiera, Elisa; Bettio, Daniela; Salviati, Leonardo] Ist Ric Pediat IRP Citta Speranza, Padua, Italy; [Salviati, Leonardo] Univ Padua, Myol Ctr, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Costantini, P (corresponding author), Univ Padua, Dept Biol, Viale G Colombo 3, I-35131 Padua, Italy.	paola.costantini@unipd.it	Russo, Antonella/K-8970-2016; Peruzzo, Roberta/ABC-6936-2021	Russo, Antonella/0000-0001-6691-257X; Peruzzo, Roberta/0000-0001-9209-9068; Szabo, Ildiko/0000-0002-3637-3947	Department of Biology, University of Padova [COST_FINA_P14_02, BIRD179997/17]; Department of Molecular Medicine, University of Padova [PRID/SID 2019, PRID/SID 2017]; MIUR [PRIN 20155795S5W]; Fondazione Citta della Speranza, Padova	Department of Biology, University of Padova; Department of Molecular Medicine, University of Padova; MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Citta della Speranza, Padova	Department of Biology, University of Padova: COST_FINA_P14_02 to P.C. and BIRD179997/17 to M.E.S.; Department of Molecular Medicine, University of Padova: PRID/SID 2019 to A.R. and PRID/SID 2017 to E.P.; MIUR: PRIN 20155795S5W to I.S.; Fondazione Citta della Speranza, Padova to L.S.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Bellanda M, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2019.07.007; Boniecki MT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01497-1; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711; Chiang S, 2018, NEUROCHEM INT, V117, P35, DOI 10.1016/j.neuint.2017.08.002; Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016; Clark E., 2018, NEURONAL SIGNALLING, V2; Clark E, 2017, ANN CLIN TRANSL NEUR, V4, P575, DOI 10.1002/acn3.433; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Correia AR, 2008, FEBS J, V275, P3680, DOI 10.1111/j.1742-4658.2008.06512.x; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Castro M, 2000, HUM GENET, V106, P86, DOI 10.1007/s004399900201; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Erwin GS, 2017, SCIENCE, V358, P1617, DOI 10.1126/science.aan6414; Faggianelli N, 2015, FRONT MOL NEUROSCI, V8, DOI [10.3385/fnmol.2015.00066, 10.3389/fnmol.2015.00066]; Fox NG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09989-y; Galea CA, 2016, ANN NEUROL, V79, P485, DOI 10.1002/ana.24595; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463; Jasoliya M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217776; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Lazaropoulos M, 2015, ANN CLIN TRANSL NEUR, V2, P831, DOI 10.1002/acn3.225; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lin H, 2017, DIS MODEL MECH, V10, P1343, DOI 10.1242/dmm.030502; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Ly Y., 2015, MOL THER, V23; Lynch DR, 2002, MUSCLE NERVE, V25, P664, DOI 10.1002/mus.10077; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Nachbauer W, 2011, MOVEMENT DISORD, V26, P1935, DOI 10.1002/mds.23789; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Salehi MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094069; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Stevanoni M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006201; Telot L, 2018, BBA-MOL BASIS DIS, V1864, P997, DOI 10.1016/j.bbadis.2018.01.010; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhao HT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10320-2; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	76	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21362	10.1096/fj.202000524RR	http://dx.doi.org/10.1096/fj.202000524RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33629768				2022-12-28	WOS:000629576700034
J	Yu, H; Zhong, HM; Li, N; Chen, KZ; Chen, JJ; Sun, J; Xu, LL; Wang, J; Zhang, MG; Liu, XH; Deng, LF; Huang, P; Huang, SY; Shen, X; Zhong, YS				Yu, Huan; Zhong, Huimin; Li, Na; Chen, Kaizhe; Chen, Junjue; Sun, Jun; Xu, Lili; Wang, Jing; Zhang, Mingui; Liu, Xiaohong; Deng, Lianfu; Huang, Ping; Huang, Shouyue; Shen, Xi; Zhong, Yisheng			Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma	FASEB JOURNAL			English	Article						glaucoma; microglia; osteopontin; p38 MAPK signaling pathway; rat	OPTIC-NERVE HEAD; CYTOKINE EXPRESSION; IMMUNE-MECHANISMS; MOUSE MODEL; RAT MODEL; RECEPTOR; COMPRESSION; INHIBITION; APOPTOSIS; AUTOPHAGY	Microglia activation and release of pro-inflammatory cytokines have been closely linked to glaucoma. However, the mechanisms that initiate these pathways remain unclear. Here, we investigated the role of a pro-inflammatory cytokine--osteopontin (OPN), in retinal microglia activation process along with the underlying mechanisms in glaucoma. A rat chronic ocular hypertension (COH) model was established presenting an increase in retinal OPN level and activation of microglia. Primary microglia cells were isolated and cultured under a pressure culture system showing heightened expressions of microglia-derived OPN with changes in inflammatory factors (TNF-alpha, IL-1 beta, and IL-6). OPN and OPN neutralizing antibody (Anti-OPN) interventions were both applied systems for comparison, and cross-referenced with OPN knockdown in vitro. JAK/STAT, NF-kappa B, ERK1/2, and p38 MAPK, recognized as the primary signaling pathways related to microglia activation, were then screened on whether they can facilitate OPN to act on microglia and their impact on specific inhibitors. Thereafter, retrograde labeling of retinal ganglion cells (RGCs) and flash visual evoked potentials (F-VEP) were used to investigate neuron protection in context of each blockade. Results suggest that OPN is able to enhance the proliferation and activation of retinal microglia in experimental glaucoma which may play a role in the glaucomatous optic neuropathy, and contribute to the eventual RGCs loss and vision function impairment. Such effect may be mediated through the regulation of p38 MAPK signaling pathway.	[Yu, Huan; Zhong, Huimin; Li, Na; Chen, Junjue; Sun, Jun; Wang, Jing; Zhang, Mingui; Liu, Xiaohong; Huang, Shouyue; Shen, Xi; Zhong, Yisheng] Shanghai Jiao Tong Univ, Affiliated Med Sch, Dept Ophthalmol, Ruijin Hosp, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China; [Chen, Kaizhe; Deng, Lianfu; Huang, Ping] Shanghai Jiao Tong Univ, Affiliated Med Sch, Shanghai Inst Traumatol & Orthopaed, Shanghai Key Lab Bone & Joint Dis,Ruijin Hosp, Shanghai, Peoples R China; [Xu, Lili] Shanghai Jiao Tong Univ, Affiliated Med Sch, Ruijin Hosp, Dept Emergency, Shanghai, Peoples R China; [Zhong, Yisheng] Shanghai Jiao Tong Univ, Affiliated Med Sch, Ruijin Hosp, Dept Ophthalmol,Zhoushan Branch, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, X; Zhong, YS (corresponding author), Shanghai Jiao Tong Univ, Affiliated Med Sch, Dept Ophthalmol, Ruijin Hosp, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.	carl_shen2005@126.com; yszhong68@126.com			National Natural Science Foundation of China (NSFC) [81870652, 82070953, 82000885]; Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation) [2020LP034, 2018JP008]; Ruijin Youth NSFC Cultivation Foundation [2019QNPY01026]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation); Ruijin Youth NSFC Cultivation Foundation	National Natural Science Foundation of China (NSFC), Grant/Award Number: NO. 81870652, NO. 82070953 and NO. 82000885; Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation), Grant/Award Number: NO. 2020LP034 and NO. 2018JP008; Ruijin Youth NSFC Cultivation Foundation, Grant/Award Number: NO. 2019QNPY01026	Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Birke MT, 2010, INVEST OPHTH VIS SCI, V51, P5759, DOI 10.1167/iovs.10-5558; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Broom L, 2015, EXP NEUROL, V263, P1, DOI 10.1016/j.expneurol.2014.09.005; Chan KC, 2019, ACTA BIOMATER, V94, P219, DOI 10.1016/j.actbio.2019.06.005; Chang SW, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00058; Chen X, 2017, MOL MED REP, V15, P2890, DOI 10.3892/mmr.2017.6327; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6443, DOI 10.1167/iovs.11-7409; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Dong LD, 2015, J NEUROSCI, V35, P5409, DOI 10.1523/JNEUROSCI.4376-14.2015; Dong N, 2014, MOL VIS, V20, P616; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Esposito E, 2018, J NEUROCHEM, V146, P160, DOI 10.1111/jnc.14337; Gramlich OW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0542-6; Hazenbiller O, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0148-6; Huang RH, 2017, CELL PHYSIOL BIOCHEM, V41, P1851, DOI 10.1159/000471933; Huang SY, 2017, NEUROSCIENCE, V341, P27, DOI 10.1016/j.neuroscience.2016.11.019; Jo AO, 2017, J PHYSIOL-LONDON, V595, P6499, DOI 10.1113/JP274562; Kamat SS, 2016, SEMIN OPHTHALMOL, V31, P147, DOI 10.3109/08820538.2015.1114858; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kong YXG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.026; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Kupenova P, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000128; Kurtenbach S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00263; Lavery WJ, 2012, INVEST OPHTH VIS SCI, V53, P560, DOI 10.1167/iovs.11-8429; Liu XH, 2016, INVEST OPHTH VIS SCI, V57, P776, DOI 10.1167/iovs.15-18024; Lo JY, 2015, FOOD FUNCT, V6, P3550, DOI 10.1039/c5fo00607d; Lozano DC, 2019, INVEST OPHTH VIS SCI, V60, P921, DOI 10.1167/iovs.18-25700; Mac Nair CE, 2015, PROG MOL BIOL TRANSL, V134, P343, DOI 10.1016/bs.pmbts.2015.06.010; Moreno M, 2014, Arch Soc Esp Oftalmol, V89, P471, DOI 10.1016/j.oftal.2014.05.011; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Nettelhoff L, 2016, CLIN ORAL INVEST, V20, P621, DOI 10.1007/s00784-015-1542-0; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Rabenstein M, 2016, J NEUROIMMUNOL, V299, P130, DOI 10.1016/j.jneuroim.2016.09.009; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Song FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149991; Swiatkowski P, 2016, NEUROSCIENCE, V318, P22, DOI 10.1016/j.neuroscience.2016.01.008; Tambuyzer BR, 2012, CELL BIOL INT, V36, P1233, DOI 10.1042/CBI20120172; Tan HB, 2012, EXP THER MED, V4, P401, DOI 10.3892/etm.2012.619; Vargas JLC, 2015, J NEUROSCI, V35, P12088, DOI 10.1523/JNEUROSCI.1273-15.2015; Wang AYM, 2020, CLIN EXP OPTOM, V103, P562, DOI 10.1111/cxo.13031; Wang JW, 2016, J GLAUCOMA, V25, P459, DOI 10.1097/IJG.0000000000000200; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Wen XY, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00162; Wu JH, 2015, NEUROBIOL DIS, V74, P167, DOI 10.1016/j.nbd.2014.11.014; Xu YF, 2012, J INT MED RES, V40, P1438, DOI 10.1177/147323001204000422; Yang WL, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00008; Yu H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925852; Yu H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1879437; Zhen PY, 2017, EXP EYE RES, V162, P97, DOI 10.1016/j.exer.2017.06.014; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zhu SH, 2017, INFLAMMATION, V40, P1475, DOI 10.1007/s10753-017-0571-z; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	58	12	12	7	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21405	10.1096/fj.202002218R	http://dx.doi.org/10.1096/fj.202002218R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559950				2022-12-28	WOS:000629576700029
J	Ramirez-Sagredo, A; Quiroga, C; Garrido-Moreno, V; Lopez-Crisosto, C; Leiva-Navarrete, S; Norambuena-Soto, I; Ortiz-Quintero, J; Diaz-Vesga, MC; Perez, W; Hendrickson, T; Parra, V; Pedrozo, Z; Altamirano, F; Chiong, M; Lavandero, S				Ramirez-Sagredo, Andrea; Quiroga, Clara; Garrido-Moreno, Valeria; Lopez-Crisosto, Camila; Leiva-Navarrete, Sebastian; Norambuena-Soto, Ignacio; Ortiz-Quintero, Jafet; Diaz-Vesga, Magda C.; Perez, William; Hendrickson, Troy; Parra, Valentina; Pedrozo, Zully; Altamirano, Francisco; Chiong, Mario; Lavandero, Sergio			Polycystin-1 regulates cardiomyocyte mitophagy	FASEB JOURNAL			English	Article						cardiomyocyte; FoxO1; mitochondrial dynamics; mitochondrial metabolism; mitophagy; polycystin-1	FOXO TRANSCRIPTION FACTORS; MITOCHONDRIAL DYNAMICS; OXIDATIVE STRESS; HEART; FISSION; AKT; PHOSPHORYLATION; DYSFUNCTION; PATHWAYS; SURVIVAL	Polycystin-1 (PC1) is a transmembrane protein found in different cell types, including cardiomyocytes. Alterations in PC1 expression have been linked to mitochondrial damage in renal tubule cells and in patients with autosomal dominant polycystic kidney disease. However, to date, the regulatory role of PC1 in cardiomyocyte mitochondria is not well understood. The analysis of mitochondrial morphology from cardiomyocytes of heterozygous PC1 mice (PDK1(+/-)) using transmission electron microscopy showed that cardiomyocyte mitochondria were smaller with increased mitochondria density and circularity. These parameters were consistent with mitochondrial fission. We knocked-down PC1 in cultured rat cardiomyocytes and human-induced pluripotent stem cells (iPSC)-derived cardiomyocytes to evaluate mitochondrial function and morphology. The results showed that downregulation of PC1 expression results in reduced protein levels of sub-units of the OXPHOS complexes and less functional mitochondria (reduction of mitochondrial membrane potential, mitochondrial respiration, and ATP production). This mitochondrial dysfunction activates the elimination of defective mitochondria by mitophagy, assessed by an increase of autophagosome adapter protein LC3B and the recruitment of the Parkin protein to the mitochondria. siRNA-mediated PC1 knockdown leads to a loss of the connectivity of the mitochondrial network and a greater number of mitochondria per cell, but of smaller sizes, which characterizes mitochondrial fission. PC1 silencing also deregulates the AKT-FoxO1 signaling pathway, which is involved in the regulation of mitochondrial metabolism, mitochondrial morphology, and processes that are part of cell quality control, such as mitophagy. Together, these data provide new insights about the controls that PC1 exerts on mitochondrial morphology and function in cultured cardiomyocytes dependent on the AKT-FoxO1 signaling pathway.	[Ramirez-Sagredo, Andrea; Garrido-Moreno, Valeria; Lopez-Crisosto, Camila; Leiva-Navarrete, Sebastian; Norambuena-Soto, Ignacio; Ortiz-Quintero, Jafet; Diaz-Vesga, Magda C.; Parra, Valentina; Pedrozo, Zully; Chiong, Mario; Lavandero, Sergio] Univ Chile, Adv Ctr Chron Dis ACCDiS, Fac Ciencias Quim & Farmaceut, Olivos 1007, Santiago 8380492, Chile; [Ramirez-Sagredo, Andrea; Garrido-Moreno, Valeria; Lopez-Crisosto, Camila; Leiva-Navarrete, Sebastian; Norambuena-Soto, Ignacio; Ortiz-Quintero, Jafet; Diaz-Vesga, Magda C.; Parra, Valentina; Pedrozo, Zully; Chiong, Mario; Lavandero, Sergio] Univ Chile, Fac Med, Olivos 1007, Santiago 8380492, Chile; [Quiroga, Clara; Lopez-Crisosto, Camila] Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Leiva-Navarrete, Sebastian; Parra, Valentina] Univ Chile, Autophagy Res Ctr, Santiago, Chile; [Leiva-Navarrete, Sebastian; Parra, Valentina; Pedrozo, Zully] Univ Chile, Network Study High Lethal Cardiopulm Dis REECPAL, Santiago, Chile; [Ortiz-Quintero, Jafet] Univ Nacl Autonoma Honduras, Dept Bioanal & Inmunol, Escuela Microbiol, Fac Ciencias, Tegucigalpa, Honduras; [Diaz-Vesga, Magda C.; Pedrozo, Zully] Univ Chile, Fac Med, Programa Fisiol & Biofis, ICBM, Santiago, Chile; [Diaz-Vesga, Magda C.] Pontificia Univ Javeriana Cali, Grp Invest Ciencias Basicas & Clin Salud, Cali, Colombia; [Perez, William; Hendrickson, Troy; Altamirano, Francisco] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Hendrickson, Troy] Texas A&M Hlth Sci Ctr, Texas A&M MD PhD Program, College Stn, TX USA; [Altamirano, Francisco] Cornell Univ, Dept Cardiothorac Surg, Weill Cornell Med Coll, Ithaca, NY USA; [Lavandero, Sergio] Corp Ctr Estudios Cient Enfermedades Cron CECEC, Santiago, Chile; [Lavandero, Sergio] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX USA	Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Universidad Nacional Autonoma de Honduras; Universidad de Chile; Pontificia Universidad Javeriana; The Methodist Hospital System; The Methodist Hospital - Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lavandero, S (corresponding author), Univ Chile, Adv Ctr Chron Dis ACCDiS, Fac Ciencias Quim & Farmaceut, Olivos 1007, Santiago 8380492, Chile.; Lavandero, S (corresponding author), Univ Chile, Fac Med, Olivos 1007, Santiago 8380492, Chile.	slavander@uchile.cl	Chiong, Mario/I-1043-2013; Parra, Valentina/N-3972-2018	Chiong, Mario/0000-0002-5174-6545; Quiroga, Clara/0000-0002-0251-4772; Perez, William/0000-0003-0344-4160; Ramirez Sagredo, Andrea/0000-0003-1081-0704; Norambuena, Ignacio/0000-0002-2676-2674; Ortiz-Quintero, Jafet/0000-0001-7656-6367; Garrido Moreno, Valeria Soraya/0000-0002-3298-2622; Diaz Vesga, Magda Carolina/0000-0002-7807-2050; Parra, Valentina/0000-0002-0080-6472; Lopez-Crisosto, Camila/0000-0003-1055-099X	Agencia Nacional de Investigacion y Desarrollo (ANID), Chile [FONDECYT 3190546, 1190743, 1200490, 1180613, 3210443, 3210496, FONDAP 15130011, 21191341, 21171588]; International Centre for Genetic Engineering and Biotechnology (ICGEB) [CRP/CHL18-04]; University of Chile grant U-Redes Generacion [VID G_2018-35]; Houston Methodist Start-Up funds	Agencia Nacional de Investigacion y Desarrollo (ANID), Chile; International Centre for Genetic Engineering and Biotechnology (ICGEB); University of Chile grant U-Redes Generacion; Houston Methodist Start-Up funds	The authors thank Gindra Latorre and Fidel Albornoz for their excellent technical support. This work was supported by the Agencia Nacional de Investigacion y Desarrollo (ANID), Chile, Grant/Award Numbers: FONDECYT 3190546, 1190743, 1200490, 1180613, 3210443, 3210496, FONDAP 15130011, and PhD fellowships 21191341 and 21171588; International Centre for Genetic Engineering and Biotechnology (ICGEB), Grant/Award Number: CRP/CHL18-04; University of Chile grant U-Redes Generacion, Grant/Award Number: VID G_2018-35, Houston Methodist Start-Up funds.	Altamirano F, 2019, CIRCULATION, V140, P921, DOI 10.1161/CIRCULATIONAHA.118.034731; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chebib FT, 2017, KIDNEY INT REP, V2, P913, DOI 10.1016/j.ekir.2017.05.014; Chiong M, 2010, APOPTOSIS, V15, P887, DOI 10.1007/s10495-010-0505-9; Cordova-Casanova A, 2018, BBA-MOL CELL RES, V1865, P289, DOI 10.1016/j.bbamcr.2017.11.001; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Galvez A, 2001, CELL TISSUE RES, V304, P279, DOI 10.1007/s004410100358; Hong TT, 2014, NAT MED, V20, P624, DOI 10.1038/nm.3543; Huang CY, 2018, J MOL CELL CARDIOL, V122, P58, DOI 10.1016/j.yjmcc.2018.08.006; Ishimoto Y, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00337-17; Jasova M, 2017, J BIOENERG BIOMEMBR, V49, P357, DOI 10.1007/s10863-017-9720-1; Klawitter J, 2014, AM J PHYSIOL-RENAL, V307, pF1198, DOI 10.1152/ajprenal.00327.2014; Kubli DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130707; Li W, 2017, ENDOCRINOLOGY, V158, P2155, DOI 10.1210/en.2016-1970; Lin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20856-6; MANGOOKARIM R, 1989, FASEB J, V3, P2629, DOI 10.1096/fasebj.3.14.2480260; Marin-Garcia J, 2016, HEART FAIL REV, V21, P123, DOI 10.1007/s10741-016-9530-2; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027; Menezes LF, 2019, NAT REV NEPHROL, V15, P736, DOI 10.1038/s41581-019-0183-y; Menon V, 2011, CLIN J AM SOC NEPHRO, V6, P7, DOI 10.2215/CJN.04140510; Morales PE, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.09.006; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Ning YZ, 2015, J TOXICOL SCI, V40, P637, DOI 10.2131/jts.40.637; Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597; Parra V, 2018, CIRC RES, V122, pE20, DOI 10.1161/CIRCRESAHA.117.311522; Parra V, 2014, DIABETES, V63, P75, DOI 10.2337/db13-0340; Pedrozo Z, 2015, CIRCULATION, V131, P2131, DOI 10.1161/CIRCULATIONAHA.114.013537; Pennanen C, 2014, J CELL SCI, V127, P2659, DOI 10.1242/jcs.139394; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003; Puri R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11636-5; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shi YD, 2018, BBA-MOL BASIS DIS, V1864, P2481, DOI 10.1016/j.bbadis.2018.04.005; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Trotta AP, 2017, CELL MOL LIFE SCI, V74, P1999, DOI 10.1007/s00018-016-2451-3; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wallace DP, 2011, BBA-MOL BASIS DIS, V1812, P1291, DOI 10.1016/j.bbadis.2010.11.005; Wang D, 2020, BRIT J PHARMACOL, V177, P432, DOI 10.1111/bph.14878; Yang MJ, 2019, BBA-MOL BASIS DIS, V1865, P2293, DOI 10.1016/j.bbadis.2019.05.007; Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	55	6	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21796	10.1096/fj.202002598R	http://dx.doi.org/10.1096/fj.202002598R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324238	hybrid			2022-12-28	WOS:000678975300004
J	Tsinman, TK; Jiang, X; Han, L; Koyama, E; Mauck, RL; Dyment, NA				Tsinman, Tonia K.; Jiang, Xi; Han, Lin; Koyama, Eiki; Mauck, Robert L.; Dyment, Nathaniel A.			Intrinsic and growth-mediated cell and matrix specialization during murine meniscus tissue assembly	FASEB JOURNAL			English	Article						extracellular matrix; growth; mechanobiology; meniscus	HUMAN KNEE MENISCI; GENE-EXPRESSION; OSTEOARTHRITIS DEVELOPMENT; REGIONAL-VARIATIONS; LAPINE MENISCI; COLLAGEN; JOINT; MATURATION; AGGRECAN; FIBROCARTILAGE	The incredible mechanical strength and durability of mature fibrous tissues and their extremely limited turnover and regenerative capacity underscores the importance of proper matrix assembly during early postnatal growth. In tissues with composite extracellular matrix (ECM) structures, such as the adult knee meniscus, fibrous (Collagen-I rich), and cartilaginous (Collagen-II, proteoglycan-rich) matrix components are regionally segregated to the outer and inner portions of the tissue, respectively. While this spatial variation in composition is appreciated to be functionally important for resisting complex mechanical loads associated with gait, the establishment of these specialized zones is poorly understood. To address this issue, the following study tracked the growth of the murine meniscus from its embryonic formation through its first month of growth, encompassing the critical time-window during which animals begin to ambulate and weight bear. Using histological analysis, region specific high-throughput qPCR, and Col-1, and Col-2 fluorescent reporter mice, we found that matrix and cellular features defining specific tissue zones were already present at birth, before continuous weight-bearing had occurred. These differences in meniscus zones were further refined with postnatal growth and maturation, resulting in specialization of mature tissue regions. Taken together, this work establishes a detailed timeline of the concurrent spatiotemporal changes that occur at both the cellular and matrix level throughout meniscus maturation. The findings of this study provide a framework for investigating the reciprocal feedback between cells and their evolving microenvironments during assembly of a mechanically robust fibrocartilage tissue, thus providing insight into mechanisms of tissue degeneration and effective regenerative strategies.	[Tsinman, Tonia K.; Jiang, Xi; Mauck, Robert L.; Dyment, Nathaniel A.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, 371 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA; [Tsinman, Tonia K.; Jiang, Xi; Mauck, Robert L.; Dyment, Nathaniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Tsinman, Tonia K.; Mauck, Robert L.] Corporal Michael Crescenz VA Med Ctr, Translat Musculoskeletal Res Ctr, Philadelphia, PA USA; [Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Koyama, Eiki] Childrens Hosp Philadelphia, Translat Res Program Pediat Orthopaed, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Drexel University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mauck, RL; Dyment, NA (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, 371 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	lemauck@pennmedicine.upenn.edu; dyment@pennmedicine.upenn.edu	Han, Lin/D-2602-2014	Han, Lin/0000-0003-4180-1288; Tsinman, Tonia/0000-0002-9150-4321	U.S. Department of Veterans Affairs (VA) [IK6 RX003416]; National Science Foundation (NSF) [CMMI-1548571]; HHS \ National Institutes of Health (NIH) [R01 AR075418, R00 AR067283, P30 AR069619]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); National Science Foundation (NSF)(National Science Foundation (NSF)); HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	U.S. Department of Veterans Affairs (VA), Grant/Award Number: IK6 RX003416; National Science Foundation (NSF), Grant/Award Number: CMMI--1548571; HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R01 AR075418, R00 AR067283 and P30 AR069619	Llacua LA, 2018, DIABETOLOGIA, V61, P1261, DOI 10.1007/s00125-017-4524-8; Andrews SHJ, 2017, CONNECT TISSUE RES, V58, P271, DOI 10.1080/03008207.2017.1303489; Andrews SHJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-21; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Caceres MD, 2018, STEM CELLS DEV, V27, P1161, DOI 10.1089/scd.2018.0121; Chevrier A, 2009, J ORTHOP RES, V27, P1197, DOI 10.1002/jor.20869; Chokalingam K, 2009, TISSUE ENG PT A, V15, P2807, DOI 10.1089/ten.TEA.2008.0560; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Di Giancamillo A, 2014, J CELL MOL MED, V18, P1964, DOI 10.1111/jcmm.12367; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Dyment NA, 2016, JOVE-J VIS EXP, DOI 10.3791/54468; Dyment NA, 2015, DEV BIOL, V405, P96, DOI 10.1016/j.ydbio.2015.06.020; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fox AJS, 2012, SPORTS HEALTH, V4, P340, DOI 10.1177/1941738111429419; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Gamer LW, 2018, J BONE MINER RES, V33, P1708, DOI 10.1002/jbmr.3441; Gamer LW, 2017, J ORTHOP RES, V35, P1683, DOI 10.1002/jor.23446; Gamer LW, 2017, CONNECT TISSUE RES, V58, P238, DOI 10.1080/03008207.2016.1271797; Grinstein M, 2019, ELIFE, V8, DOI 10.7554/eLife.48689; Han WM, 2016, NAT MATER, V15, P477, DOI [10.1038/NMAT4520, 10.1038/nmat4520]; Hyde G, 2008, J ANAT, V213, P531, DOI 10.1111/j.1469-7580.2008.00966.x; Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kambic HE, 2005, J ORTHOP RES, V23, P142, DOI 10.1016/j.orthres.2004.06.016; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Killian ML, 2010, ANAT REC, V293, P1991, DOI 10.1002/ar.21296; Koyama E, 2021, J BONE MINER RES, V36, P1387, DOI 10.1002/jbmr.4291; Kumar A, 2017, DEVELOPMENT, V144, P4261, DOI 10.1242/dev.158469; Kwok J, 2016, OSTEOARTHR CARTILAGE, V24, P709, DOI 10.1016/j.joca.2015.11.006; Le Graverand MPH, 2001, J ANAT, V198, P525, DOI 10.1046/j.1469-7580.2000.19850525.x; Le Graverand MPH, 2001, OSTEOARTHR CARTILAGE, V9, P56, DOI 10.1053/joca.2000.0350; Le Graverand MPH, 2001, ARTHRITIS RHEUM, V44, P1808, DOI 10.1002/1529-0131(200108)44:8<1808::AID-ART318>3.0.CO;2-B; Le Graverand MPH, 2001, OSTEOARTHR CARTILAGE, V9, P65, DOI 10.1053/joca.2000.0351; Li Q, 2017, ACTA BIOMATER, V54, P356, DOI 10.1016/j.actbio.2017.02.043; Li Q, 2015, J BIOMECH, V48, P1364, DOI 10.1016/j.jbiomech.2015.02.064; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; McNulty AL, 2015, J BIOMECH, V48, P1469, DOI 10.1016/j.jbiomech.2015.02.008; Melrose J, 2005, HISTOCHEM CELL BIOL, V124, P225, DOI 10.1007/s00418-005-0005-0; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mikic B, 2000, J REHABIL RES DEV, V37, P127; Pauli C, 2011, OSTEOARTHR CARTILAGE, V19, P1132, DOI 10.1016/j.joca.2011.05.008; Pazin DE, 2014, J ORTHOP RES, V32, P46, DOI 10.1002/jor.22490; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Qu FN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21212-4; Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7; Sanchez-Adams J, 2013, J ORTHOP RES, V31, P1218, DOI 10.1002/jor.22362; Sanchez-Adams J, 2012, BIOMECH MODEL MECHAN, V11, P1047, DOI 10.1007/s10237-012-0372-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Screen HRC, 2015, J ORTHOP RES, V33, P793, DOI 10.1002/jor.22818; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Shwartz Y, 2016, CELL REP, V15, P2577, DOI 10.1016/j.celrep.2016.05.055; Smith SM, 2010, HISTOCHEM CELL BIOL, V134, P251, DOI 10.1007/s00418-010-0730-x; Son M, 2012, EUR CELLS MATER, V23, P195, DOI 10.22203/eCM.v023a15; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Utreja A, 2016, OSTEOARTHR CARTILAGE, V24, P335, DOI 10.1016/j.joca.2015.08.010; Valiyaveettil M, 2005, CONNECT TISSUE RES, V46, P83, DOI 10.1080/03008200590954113; Vanderploeg EJ, 2012, J ANAT, V221, P174, DOI 10.1111/j.1469-7580.2012.01523.x; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009	65	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21779	10.1096/fj.202100499R	http://dx.doi.org/10.1096/fj.202100499R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314047	Green Accepted			2022-12-28	WOS:000678975300035
J	Aladhami, AK; Unger, CA; Ennis, SL; Altomare, D; Ji, H; Hope, MC; Velazquez, KT; Enos, RT				Aladhami, Ahmed K.; Unger, Christian A.; Ennis, Shannon L.; Altomare, Diego; Ji, Hao; Hope, Marion C., III; Velazquez, Kandy T.; Enos, Reilly T.			Macrophage tumor necrosis factor-alpha deletion does not protect against obesity-associated metabolic dysfunction	FASEB JOURNAL			English	Article						insulin resistance; macrophage; metabolism; obesity; TNF-alpha	DIETARY SATURATED FAT; INSULIN-RESISTANCE; ADIPOCYTE INFLAMMATION; SKELETAL-MUSCLE; RECEPTOR; CELLS; GENE; SENSITIVITY; EXPRESSION; LIVER	The pro-inflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha), has been suggested to be a key factor in the induction of obesity-associated metabolic dysfunction. However, the role that macrophage-derived TNF-alpha has on regulating metabolic perturbations in obesity is not completely understood. Therefore, we utilized the TNF-alpha(Flox/Flox) ((F/F)), LyzMcre(+/-) mouse model to determine the impact that macrophage TNF-alpha deletion has on the development of high-fat diet (HFD)-induced obesity. At 10 weeks of age, male littermates were randomly assigned to 1 of 4 groups: TNF-alpha(F/F) low-fat diet (TNF-alpha(F/F) LFD), TNF-alpha(F/F,) (LyzMCre) LFD, TNF-alpha(F/F) HFD, or TNF-alpha(F/F,) (LyzMCre) HFD (n = 16-28/group) and were fed their respective diets for 18 weeks. Body weight was assessed throughout the course of the experiment. Body composition, hepatic lipid accumulation, and metabolic outcomes were also examined. A microarray gene expression experiment was performed from RNA isolated from epididymal adipose tissue of the HFD-fed groups (n = 10/group) and results were verified via qRT-PCR for all groups. Macrophage-derived TNF-alpha deletion significantly reduced adipose tissue TNF-alpha gene expression and circulating TNF-alpha and downregulated genes linked to the toll-like receptor (TLR) and NF kappa B signaling pathways. However, macrophage TNF-alpha deletion had no effect on hindering the development of obesity, hepatic lipid accumulation, or improving glucose metabolism or insulin sensitivity. In conclusion, macrophage-derived TNF-alpha is not a causative factor for the induction of obesity-associated metabolic dysfunction.	[Aladhami, Ahmed K.; Unger, Christian A.; Ennis, Shannon L.; Hope, Marion C., III; Velazquez, Kandy T.; Enos, Reilly T.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, 6439 Garners Ferry Rd, Columbia, SC 29209 USA; [Altomare, Diego; Ji, Hao] Univ South Carolina, Dept Drug Discovery & Biomed Sci, Coll Pharm, Columbia, SC 29209 USA; [Aladhami, Ahmed K.] Univ Baghdad, Nursing Coll, Baghdad, Iraq	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University of Baghdad	Enos, RT (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	enosr@email.sc.edu	Enos, Reilly/AFO-4814-2022	Enos, Reilly/0000-0001-5571-4586; Aladhami, Ahmed/0000-0002-9072-551X; Hope, Marion/0000-0002-4855-5764	NIH-NCCIH [K01-AT010348, R00-AT009206]; University of South Carolina Advanced Support for Innovative Research Excellence (ASPIRE)	NIH-NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina Advanced Support for Innovative Research Excellence (ASPIRE)	This work was supported by grants K01-AT010348 (NIH-NCCIH) and the University of South Carolina Advanced Support for Innovative Research Excellence (ASPIRE) to RTE. KTV is supported by R00-AT009206 (NIH-NCCIH)	Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bader Jackie, 2020, Oncotarget, V11, P4554, DOI 10.18632/oncotarget.27832; Bader JE, 2019, AM J PHYSIOL-ENDOC M, V316, pE358, DOI 10.1152/ajpendo.00438.2018; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Charkoftaki G, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0191-9; Chen X, 2016, J INTERF CYTOK RES, V36, P580, DOI 10.1089/jir.2016.0022; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cranford TL, 2016, INT J OBESITY, V40, P844, DOI 10.1038/ijo.2015.244; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Enos RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167979; Enos RT, 2016, AM J PHYSIOL-GASTR L, V310, pG906, DOI 10.1152/ajpgi.00345.2015; Enos RT, 2015, NUTR RES, V35, P449, DOI 10.1016/j.nutres.2015.04.003; Enos RT, 2014, J NUTR BIOCHEM, V25, P600, DOI 10.1016/j.jnutbio.2014.01.011; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jager J, 2016, J INTERN MED, V280, P209, DOI 10.1111/joim.12483; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Paquot N, 2000, J CLIN ENDOCR METAB, V85, P1316, DOI 10.1210/jc.85.3.1316; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Salles J, 2012, J NUTR BIOCHEM, V23, P1685, DOI 10.1016/j.jnutbio.2011.12.001; Schreyer SA, 1998, J CLIN INVEST, V102, P402, DOI 10.1172/JCI2849; Skurski J, 2020, METABOLISM, V106, DOI 10.1016/j.metabol.2020.154194; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; SZOKA PR, 1980, J BIOL CHEM, V255, P1367; Tencerova M, 2015, FASEB J, V29, P2959, DOI 10.1096/fj.15-270496; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Uysal KT, 1998, ENDOCRINOLOGY, V139, P4832, DOI 10.1210/en.139.12.4832; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velazquez KT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13412; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang WS, 2016, CELL PHYSIOL BIOCHEM, V38, P2139, DOI 10.1159/000445570; Zhu QZ, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101010	46	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21665	10.1096/fj.202100543RR	http://dx.doi.org/10.1096/fj.202100543RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34131955	Green Accepted			2022-12-28	WOS:000667814100004
J	Schiff, T				Schiff, Tamar			The 2021 FASEB virtual Catalyst Conference on Transplantation Genomics: Ethics of Research and Clinical Applications, January 27, 2021	FASEB JOURNAL			English	Editorial Material									[Schiff, Tamar] NYU, Grossman Sch Med, Div Med Eth, 550 1st Ave, New York, NY 10016 USA	New York University	Schiff, T (corresponding author), NYU, Grossman Sch Med, Div Med Eth, 550 1st Ave, New York, NY 10016 USA.	tamar.schiff2@nyulangone.org							0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21589	10.1096/fj.202100524	http://dx.doi.org/10.1096/fj.202100524			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34131960	Bronze			2022-12-28	WOS:000667814100001
J	Felix-Soriano, E; Sainz, N; Gil-Iturbe, E; Collantes, M; Fernandez-Galilea, M; Castilla-Madrigal, R; Ly, L; Dalli, J; Moreno-Aliaga, MJ				Felix-Soriano, Elisa; Sainz, Neira; Gil-Iturbe, Eva; Collantes, Maria; Fernandez-Galilea, Marta; Castilla-Madrigal, Rosa; Ly, Lucy; Dalli, Jesmond; Moreno-Aliaga, Maria J.			Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice	FASEB JOURNAL			English	Article						aging; brown adipose tissue; DHA; lipidomic; obesity; proresolving lipid mediators	PRO-RESOLVING MEDIATORS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; INSULIN SENSITIVITY; ARACHIDONIC-ACID; UP-REGULATION; EXPRESSION; ADIPOCYTE; GLUCOSE; SEX	Brown adipose tissue (BAT) dysfunction in aging and obesity has been related to chronic unresolved inflammation, which could be mediated by an impaired production of specialized proresolving lipid mediators (SPMs), such as Lipoxins-LXs, Resolvins-Rvs, Protectins-PDs, and Maresins-MaRs. Our aim was to characterize the changes in BAT SPMs signatures and their association with BAT dysfunction during aging, especially under obesogenic conditions, and their modulation by a docosahexaenoic acid (DHA)-rich diet. Lipidomic, functional, and molecular studies were performed in BAT of 2- and 18-month-old lean (CT) female mice and in 18-month-old diet-induced obese (DIO) mice fed with a high-fat diet (HFD), or a DHA-enriched HFD. Aging downregulated Prdm16 and UCP1 levels, especially in DIO mice, while DHA partially restored them. Arachidonic acid (AA)-derived LXs and DHA-derived MaRs and PDs were the most abundant SPMs in BAT of young CT mice. Interestingly, the sum of LXs and of PDs were significantly lower in aged DIO mice compared to young CT mice. Some of the SPMs most significantly reduced in obese-aged mice included LXB4, MaR2, 4S,14S-diHDHA, 10S,17S-diHDHA (a.k.a. PDX), and RvD6. In contrast, DHA increased DHA-derived SPMs, without modifying LXs. However, MicroPET studies showed that DHA was not able to counteract the impaired cold exposure response in BAT of obese-aged mice. Our data suggest that a defective SPMs production could underlie the decrease of BAT activity observed in obese-aged mice, and highlight the relevance to further characterize the physiological role and therapeutic potential of specific SPMs on BAT development and function.	[Felix-Soriano, Elisa; Sainz, Neira; Gil-Iturbe, Eva; Fernandez-Galilea, Marta; Castilla-Madrigal, Rosa; Moreno-Aliaga, Maria J.] Univ Navarra, Sch Pharm & Nutr, Ctr Nutr Res, Pamplona, Spain; [Felix-Soriano, Elisa; Sainz, Neira; Gil-Iturbe, Eva; Fernandez-Galilea, Marta; Castilla-Madrigal, Rosa; Moreno-Aliaga, Maria J.] Univ Navarra, Sch Pharm & Nutr, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Collantes, Maria] Clin Univ Navarra, Radiopharm Radionanopharmacol & Translat Mol Imag, Pamplona, Spain; [Collantes, Maria; Fernandez-Galilea, Marta; Moreno-Aliaga, Maria J.] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Ly, Lucy; Dalli, Jesmond] Queen Mary Univ London, William Harvey Res Inst, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Moreno-Aliaga, Maria J.] Inst Salud Carlos III ISCIII, CIBER Physiopathol Obes & Nutr CIBERobn, Madrid, Spain	University of Navarra; University of Navarra; University of Navarra; University of London; Queen Mary University London; University of London; Queen Mary University London; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Moreno-Aliaga, MJ (corresponding author), Univ Navarra, Ctr Nutr Res, Dept Nutr Food Sci & Physiol, Sch Pharm & Nutr, C Irunlarrea 1, Pamplona 31008, Spain.	mjmoreno@unav.es	Moreno-Aliaga, Maria J/M-7015-2018; Collantes, María/A-4641-2015; Gil-Iturbe, Eva/C-4387-2018	Moreno-Aliaga, Maria J/0000-0002-2018-6434; Collantes, María/0000-0003-1162-1470; Felix Soriano, Elisa/0000-0003-4633-1289; Gil-Iturbe, Eva/0000-0002-4046-5756; Dalli, Jesmond/0000-0001-6328-3640; Sainz, Neira/0000-0003-0298-3031	Government of Spain (MINECO-FEDER) [BFU2015-65937-R]; CIBER Physiopathology of Obesity and Nutrition (CIBERobn) [CB12/03/30002]; "Juan de la Cierva" grant [IJCI-2016-30025]; Center for Nutrition Research (University of Navarra); Wellcome Trust [107613/Z/15/Z]; Royal Society [107613/Z/15/Z]	Government of Spain (MINECO-FEDER); CIBER Physiopathology of Obesity and Nutrition (CIBERobn); "Juan de la Cierva" grant; Center for Nutrition Research (University of Navarra); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This research was funded by the Government of Spain (MINECO-FEDER, BFU2015-65937-R). CIBER Physiopathology of Obesity and Nutrition (CIBERobn, CB12/03/30002) is also acknowledged. "Juan de la Cierva" grant was provided to M. F.-G. (IJCI-2016-30025). E.F-S. and E.G-I received a grant from the Center for Nutrition Research (University of Navarra). JD is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 107613/Z/15/Z)	Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Becerril S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010962; Calder PC, 2020, BIOCHIMIE, V178, P105, DOI 10.1016/j.biochi.2020.08.015; Chan PC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133115; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Colson C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020438; Corrales P, 2019, AGING CELL, V18, DOI 10.1111/acel.12948; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Darcy J, 2020, GEROSCIENCE, V42, P1527, DOI 10.1007/s11357-020-00221-0; Deng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102362; Dieckmann S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00073; Elias I, 2016, DIABETES, V65, P2139, DOI 10.2337/db16-0040; Fernandez-Galilea M, 2020, J PHYSIOL BIOCHEM, V76, P251, DOI 10.1007/s13105-019-00720-5; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Fleckenstein-Elsen M, 2016, MOL NUTR FOOD RES, V60, P2065, DOI 10.1002/mnfr.201500892; Fuse S, 2020, INT J OBESITY, V44, P1387, DOI 10.1038/s41366-020-0558-y; Fuse S, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.6.065002; Gangemi S, 2005, EXP GERONTOL, V40, P612, DOI 10.1016/j.exger.2005.04.004; Garcia-Alonso V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153751; Garcia-Alonso V, 2013, J BIOL CHEM, V288, P28230, DOI 10.1074/jbc.M113.468603; Ghandour RA, 2018, J LIPID RES, V59, P452, DOI 10.1194/jlr.M081091; Gil-Iturbe E, 2020, APPL PHYSIOL NUTR ME, V45, P957, DOI 10.1139/apnm-2019-0721; Gomez EA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19176-z; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Graja A, 2015, GERONTOLOGY, V61, P211, DOI 10.1159/000366557; Grzybek M, 2019, MOL METAB, V22, P12, DOI 10.1016/j.molmet.2019.01.009; Hanssen MJW, 2015, DIABETOLOGIA, V58, P586, DOI 10.1007/s00125-014-3465-8; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Hoene M, 2014, BBA-MOL CELL BIOL L, V1841, P1563, DOI 10.1016/j.bbalip.2014.08.003; Huang R, 2020, FASEB J, V34, P13521, DOI 10.1096/fj.202001145R; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Jove M, 2016, J GERONTOL A-BIOL, V71, P578, DOI 10.1093/gerona/glv074; Kim J, 2016, J BIOL CHEM, V291, P20551, DOI 10.1074/jbc.M116.721480; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Kulterer OC, 2020, J CLIN ENDOCR METAB, V105, P2203, DOI 10.1210/clinem/dgaa183; Laiglesia LM, 2018, INT J OBESITY, V42, P572, DOI 10.1038/ijo.2017.226; Laiglesia LM, 2018, J CELL PHYSIOL, V233, P2238, DOI 10.1002/jcp.26096; Leiria LO, 2019, CELL METAB, V30, P768, DOI 10.1016/j.cmet.2019.07.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livshits G, 2019, AGEING RES REV, V56, DOI 10.1016/j.arr.2019.100980; Loh RKC, 2017, OBES REV, V18, P1227, DOI 10.1111/obr.12584; Bargut TCL, 2019, MOL CELL ENDOCRINOL, V482, P18, DOI 10.1016/j.mce.2018.12.003; Bargut TCL, 2016, EUR J NUTR, V55, P159, DOI 10.1007/s00394-015-0834-0; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Martinez-Fernandez L, 2017, FASEB J, V31, P2135, DOI 10.1096/fj.201600859R; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; Minkina N.I., 2022, RES SQUARE, DOI [10.21203/rs.3.rs-1243247/v1, DOI 10.21203/RS.3.RS-1243247/V1, 10.21203/rs.3.pex-1147/v1, DOI 10.21203/RS.3.PEX-1147/V1]; Moreno-Aliaga MJ, 2020, J PHYSIOL BIOCHEM, V76, P181, DOI 10.1007/s13105-020-00745-1; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Ostermann AI, 2019, AM J CLIN NUTR, V109, P1251, DOI 10.1093/ajcn/nqz016; Pascoal LB, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0777-2; Perez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691; Pisani DF, 2014, MOL METAB, V3, P834, DOI 10.1016/j.molmet.2014.09.003; Quesada-Lopez T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13479; Roca P, 1999, PFLUG ARCH EUR J PHY, V438, P628, DOI 10.1007/s004240051086; Rouger L, 2013, J ENDOCRINOL, V219, P279, DOI 10.1530/JOE-13-0106; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sakamoto T, 2016, AM J PHYSIOL-ENDOC M, V310, pE676, DOI 10.1152/ajpendo.00028.2015; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Soundarrajan M, 2020, ADIPOCYTE, V9, P87, DOI 10.1080/21623945.2020.1724740; Titos E, 2016, J IMMUNOL, V197, P3360, DOI 10.4049/jimmunol.1502522; Tourki B, 2020, MOL METAB, V31, P138, DOI 10.1016/j.molmet.2019.10.008; Valencak TG, 2017, REDOX BIOL, V12, P806, DOI 10.1016/j.redox.2017.04.012; Valle A, 2007, CELL PHYSIOL BIOCHEM, V19, P195, DOI 10.1159/000099207; Villarroya F, 2018, J INTERN MED, V284, P492, DOI 10.1111/joim.12803; Villarroya F, 2018, CELL METAB, V27, P954, DOI 10.1016/j.cmet.2018.04.006; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; White PJ, 2015, METABOLISM, V64, P666, DOI 10.1016/j.metabol.2015.01.017; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829; Xiang AS, 2020, METABOLITES, V10, DOI 10.3390/metabo10100388; Yang J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020501	83	11	11	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21592	10.1096/fj.202002531R	http://dx.doi.org/10.1096/fj.202002531R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33960028	hybrid, Green Published			2022-12-28	WOS:000655695900039
J	Mordhorst, A; Dhandapani, P; Matthes, S; Mosienko, V; Rothe, M; Todiras, M; Self, J; Schunck, WH; Schutz, A; Bader, M; Alenina, N				Mordhorst, Alexander; Dhandapani, Priyavathi; Matthes, Susann; Mosienko, Valentina; Rothe, Michael; Todiras, Mihail; Self, Julie; Schunck, Wolf-Hagen; Schutz, Anja; Bader, Michael; Alenina, Natalia			Phenylalanine hydroxylase contributes to serotonin synthesis in mice	FASEB JOURNAL			English	Article						phenylalanine hydroxylase; serotonin; tryptophan hydroxylase	TRYPTOPHAN-HYDROXYLASE; INTESTINAL-MUCOSA; ACID; SUBSTRATE; MASS; TRANSPORTER; TRYPTAMINE; DISRUPTION; PLATELETS; DOMAINS	Serotonin is an important signaling molecule in the periphery and in the brain. The hydroxylation of tryptophan is the first and rate-limiting step of its synthesis. In most vertebrates, two enzymes have been described to catalyze this step, tryptophan hydroxylase (TPH) 1 and 2, with expression localized to peripheral and neuronal cells, respectively. However, animals lacking both TPH isoforms still exhibit about 10% of normal serotonin levels in the blood demanding an additional source of the monoamine. In this study, we provide evidence by the gain and loss of function approaches in in vitro and in vivo systems, including stable-isotope tracing in mice, that phenylalanine hydroxylase (PAH) is a third TPH in mammals. PAH contributes to serotonin levels in the blood, and may be important as a local source of serotonin in organs in which no other TPHs are expressed, such as liver and kidney.	[Mordhorst, Alexander; Dhandapani, Priyavathi; Matthes, Susann; Mosienko, Valentina; Todiras, Mihail; Self, Julie; Schunck, Wolf-Hagen; Schutz, Anja; Bader, Michael; Alenina, Natalia] Max Delbruck Ctr Mol Med, Helmholtz Assoc MDC, Berlin, Germany; [Mordhorst, Alexander; Bader, Michael; Alenina, Natalia] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany; [Mordhorst, Alexander; Bader, Michael] Charite, Berlin, Germany; [Rothe, Michael] Lipidomix, Berlin, Germany; [Todiras, Mihail] Nicolae Testemitanu State Univ Med & Pharm, Kishinev, Moldova; [Bader, Michael] Univ Lubeck, Inst Biol, Lubeck, Germany; [Alenina, Natalia] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia; [Alenina, Natalia] Russian Acad Sci, Inst Cytol, St Petersburg, Russia; [Matthes, Susann] German Fed Inst Risk Assessment, Unit Toxicol Prod & Safe Use, Berlin, Germany; [Mosienko, Valentina] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England; [Self, Julie] Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA; [Self, Julie] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Nicolae Testemitanu State University of Medicine & Pharmacy; University of Lubeck; Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Federal Institute for Risk Assessment; University of Exeter; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Alenina, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	alenina@mdc-berlin.de	Todiras, Mihail/AAT-4426-2020; Bader, Michael/K-2124-2013	Todiras, Mihail/0000-0002-9373-4753; Schutz, Anja/0000-0002-0606-2574; Bader, Michael/0000-0003-4780-4164	Saint Petersburg State University (SPbU) [51143531]; Bundesministerium fur Bildung und Forschung (BMBF); Deutsches Zentrum fur Herz-Kreislaufforschung (DZHK); Volkswagen Foundation (VolkswagenStiftung)	Saint Petersburg State University (SPbU); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsches Zentrum fur Herz-Kreislaufforschung (DZHK); Volkswagen Foundation (VolkswagenStiftung)(Volkswagen)	Saint Petersburg State University (SPbU), Grant/Award Number: 51143531; Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: ERA-NET RESPOND; Deutsches Zentrum fur Herz-Kreislaufforschung (DZHK), Grant/Award Number: Partner Site Berlin; Volkswagen Foundation (VolkswagenStiftung), Grant/Award Number: trilateral cooperation grant	Alcaniz S, 1997, COMP BIOCHEM PHYS C, V116, P205, DOI 10.1016/S0742-8413(96)00148-X; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Andersen OA, 2003, J MOL BIOL, V333, P747, DOI 10.1016/j.jmb.2003.09.004; AXELROD J, 1963, J PHARMACOL EXP THER, V141, P161; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; CURTIUS HC, 1980, J CHROMATOGR, V199, P171, DOI 10.1016/S0021-9673(01)91370-6; Daubner SC, 1997, BIOCHEMISTRY-US, V36, P11574, DOI 10.1021/bi9711137; EMANUEL DA, 1959, AM J PHYSIOL, V196, P1122, DOI 10.1152/ajplegacy.1959.196.5.1122; ERSPAMER V, 1952, NATURE, V169, P800, DOI 10.1038/169800b0; Erspamer V., 1937, ARCH FISIOL, V37, P156; FELDMAN JM, 1985, AM J CLIN NUTR, V42, P639, DOI 10.1093/ajcn/42.4.639; FREEDLAND RA, 1964, AM J PHYSIOL, V206, P341, DOI 10.1152/ajplegacy.1964.206.2.341; Fujiwara T, 2010, J BIOL CHEM, V285, P11308, DOI 10.1074/jbc.M109.091371; Gehin M, 2018, CLIN PHARMACOL THER, V104, P1260, DOI 10.1002/cpt.1087; GERSHON MD, 1965, SCIENCE, V149, P197, DOI 10.1126/science.149.3680.197; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; GREENGARD O, 1976, SCIENCE, V192, P1007, DOI 10.1126/science.944951; GRENETT HE, 1987, P NATL ACAD SCI USA, V84, P5530, DOI 10.1073/pnas.84.16.5530; Gross ER, 2012, GASTROENTEROLOGY, V143, P408, DOI 10.1053/j.gastro.2012.05.007; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Kaplan K, 2016, J APPL PHYSIOL, V120, P1070, DOI 10.1152/japplphysiol.01015.2015; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kowlessur D, 1996, ARCH BIOCHEM BIOPHYS, V333, P85, DOI 10.1006/abbi.1996.0367; Kumar A, 2020, CELL HOST MICROBE, V28, P41, DOI 10.1016/j.chom.2020.05.004; Lancellotti P, 2015, INT J CARDIOL, V197, P72, DOI 10.1016/j.ijcard.2015.06.035; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Li Z, 2017, J BIOMED RES, V31, P445, DOI 10.7555/JBR.31.20170026; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Matthes S, 2019, ACS CHEM NEUROSCI, V10, P3207, DOI 10.1021/acschemneuro.8b00635; McKinney J, 2001, BIOCHEMISTRY-US, V40, P15591, DOI 10.1021/bi015722x; MELMON K, 1963, LANCET, V2, P316; Nakatani Y, 2008, EUR J NEUROSCI, V27, P2466, DOI 10.1111/j.1460-9568.2008.06201.x; Neal KB, 2009, J PHYSIOL-LONDON, V587, P567, DOI 10.1113/jphysiol.2008.160416; Nocito A, 2007, HEPATOLOGY, V45, P369, DOI 10.1002/hep.21516; Oleskin AV, 2016, MICROBIOLOGY+, V85, P1, DOI [10.7868/S0026365616010080, 10.1134/S0026261716010082]; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; RAPPORT MM, 1948, SCIENCE, V108, P329, DOI 10.1126/science.108.2804.329; RENSON J, 1962, J BIOL CHEM, V237, P2261; Sano M, 2014, J MASS SPECTROM, V49, P128, DOI 10.1002/jms.3313; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Siltberg-Liberles J, 2008, GENE, V427, P86, DOI 10.1016/j.gene.2008.09.005; Soares-da-Silva P, 2016, EXP PHYSIOL, V101, P459, DOI 10.1113/EP085284; SOLE MJ, 1986, KIDNEY INT, V29, P689, DOI 10.1038/ki.1986.53; TWAROG BM, 1953, AM J PHYSIOL, V175, P157, DOI 10.1152/ajplegacy.1953.175.1.157; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Watts SW, 2012, PHARMACOL REV, V64, P359, DOI 10.1124/pr.111.004697; Welford RWD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30059; Windahl MS, 2008, BIOCHEMISTRY-US, V47, P12087, DOI 10.1021/bi8015263; Winn SR, 2018, MOL GENET METAB, V123, P6, DOI 10.1016/j.ymgme.2017.10.009; Yabut JM, 2019, ENDOCR REV, V40, P1092, DOI 10.1210/er.2018-00283; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	58	6	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21648	10.1096/fj.202100366R	http://dx.doi.org/10.1096/fj.202100366R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33993565	Green Published, Green Accepted			2022-12-28	WOS:000655695900006
J	Chu, YY; Zhu, YR; Zhang, YJ; Liu, XJ; Guo, YL; Chang, L; Yun, XM; Wei, ZF; Xia, YF; Dai, Y				Chu, Yuyao; Zhu, Yanrong; Zhang, Yajing; Liu, Xiaojing; Guo, Yilei; Chang, Lan; Yun, Xinming; Wei, Zhifeng; Xia, Yufeng; Dai, Yue			Tetrandrine attenuates intestinal epithelial barrier defects caused by colitis through promoting the expression of Occludin via the AhR-miR-429 pathway	FASEB JOURNAL			English	Article						aryl hydrocarbon receptor; colitis; intestinal epithelial barrier; Occludin; tetrandrine	TIGHT JUNCTIONS; MICE; PERMEABILITY; CELLS	The elevated intestinal permeability due to mucosal barrier defects is not only secondary to inflammatory bowel disease but also precedes enteritis. Tetrandrine, a bisbenzyl isoquinoline alkaloid isolated from the dried roots of Stephamis tetlandra S. Moor, was previously demonstrated to ameliorate colitis induced by dextran sulfate sodium (DSS) in mice. Here, we investigate whether and how tetrandrine protects against the disruption of the intestinal epithelial barrier under colitis condition. The data show that oral administration of tetrandrine significantly counteracted the increase of intestinal permeability in DSS-treated mice, enhanced the mRNA and protein expression of Occludin and Claudin1 in the colon, but hardly affected the expression of ZO-1 and Mucin2. In vitro, tetrandrine treatment rescued the decrease of monolayer transmembrane resistance and the increase of epithelial cell permeability induced by TNF-a, upregulated the expression of Occludin, and downregulated the expression of Claudin1 but did not affect the expression of ZO-1. The siRNA of Occludin largely weakened the protective effect of tetrandrine on the epithelial barrier function in Caco-2 cells. MiR-429 mimic obviously counteracted the upregulation of tetrandrine on the expression of Occludin and the amelioration on epithelial barrier defects, in contrast, miR-429 inhibitor showed the opposite effects. The antagonist (CH223191) and siAhR of aryl hydrocarbon receptor (AhR) nearly completely diminished the effects of tetrandrine, including inhibition of the miR429 expression, the upregulation of Occludin expression, and amelioration of intestinal epithelial barrier defects in Caco-2 cells. In colitis mice, CH223191 significantly weakened the protective effect of tetrandrine on colitis and intestinal mucosal barrier and diminished the downregulation on miR-429 expression and the promotion on Occludin expression in the colon. In summary, tetrandrine can attenuate the intestinal epithelial barrier defects in colitis through promoting Occludin expression via the AhR/miR-429 pathway, and it might be used to treat colitis as a barrier protector.	[Chu, Yuyao; Zhu, Yanrong; Zhang, Yajing; Liu, Xiaojing; Guo, Yilei; Chang, Lan; Yun, Xinming; Wei, Zhifeng; Xia, Yufeng; Dai, Yue] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing, Peoples R China	China Pharmaceutical University	Xia, YF; Dai, Y (corresponding author), China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.	yfxiacpu@126.com; yuedaicpu@cpu.edu.cn			"Double First-Class" University project [CPU2018GY10]; China National Natural Science Foundation [81673666]	"Double First-Class" University project; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	"Double First-Class" University project, Grant/Award Number: CPU2018GY10; China National Natural Science Foundation, Grant/Award Number: 81673666	Bauer H, 2016, CNS NEUROL DISORD-DR, V15, P1016, DOI 10.2174/1871527315666160915142244; Camilleri M, 2019, GUT, V68, P1516, DOI 10.1136/gutjnl-2019-318427; Chen LY, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00035; Chinen I, 2015, INT IMMUNOL, V27, P405, DOI 10.1093/intimm/dxv015; Dong CY, 2020, J MOL NEUROSCI, V70, P56, DOI 10.1007/s12031-019-01400-1; Feng Y, 2019, BIOORG MED CHEM LETT, V29, P2051, DOI 10.1016/j.bmcl.2019.06.013; Hecht E, 2014, TOXICOL APPL PHARM, V280, P511, DOI 10.1016/j.taap.2014.08.023; Heinemann U, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236020; Hou QK, 2017, CELL PHYSIOL BIOCHEM, V44, P2256, DOI 10.1159/000486059; Jia YG, 2018, FASEB J, V32, P3398, DOI 10.1096/fj.201701148RR; Kumar V, 2018, J IMMUNOL, V200, P2677, DOI 10.4049/jimmunol.1701148; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Li GX, 2019, J CELL BIOCHEM, V120, P18995, DOI 10.1002/jcb.29222; Li J-X., 2015, EVID BASED COMPLEMEN, V2015, P1; Liu ZZ, 2018, INT J MOL MED, V41, P1560, DOI 10.3892/ijmm.2017.3341; Meng D., 1999, J 3 MIL MED U, V2, P78; Merga Y, 2014, DIGEST DIS, V32, P475, DOI 10.1159/000358156; Miner-Williams WM, 2016, NUTR RES REV, V29, P40, DOI 10.1017/S0954422416000019; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Oh-oka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098016; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rogers S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40539; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Sun L, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0146-0; Tan B, 2019, SCAND J GASTROENTERO, V54, P432, DOI 10.1080/00365521.2019.1595708; Tao Y, 2020, FASEB J, V34, P3069, DOI 10.1096/fj.201901638RR; Van Itallie CM, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1382671; Wang K, 2018, BIOCHEM PHARMACOL, V155, P494, DOI 10.1016/j.bcp.2018.07.039; Wu XX, 2019, INFLAMMATION, V42, P2215, DOI 10.1007/s10753-019-01085-z; Yang H, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28320; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Yu T, 2016, CELL TISSUE RES, V366, P341, DOI 10.1007/s00441-016-2435-5; Yuan XS, 2016, BIOCHEM PHARMACOL, V101, P87, DOI 10.1016/j.bcp.2015.11.025; Zhang D, 2009, INT J COLORECTAL DIS, V24, P5, DOI 10.1007/s00384-008-0544-7; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548; Zhang Y., 2017, MED INFORM, V30, P56	38	8	8	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21502	10.1096/fj.202002086RR	http://dx.doi.org/10.1096/fj.202002086RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811696				2022-12-28	WOS:000645260100027
J	Gu, TY; Shen, B; Li, BH; Guo, YC; Li, F; Ma, ZZ; Chen, LY; Zhang, QD; Qu, Y; Dong, H; Cai, XB; Lu, LG				Gu, Tianyi; Shen, Bo; Li, Binghang; Guo, Yuecheng; Li, Fei; Ma, Zhenzeng; Chen, Liuying; Zhang, Qidi; Qu, Ying; Dong, Hui; Cai, Xiaobo; Lu, Lungen			miR-30c inhibits angiogenesis by targeting delta-like ligand 4 in liver sinusoidal endothelial cell to attenuate liver fibrosis	FASEB JOURNAL			English	Article						delta-like ligand 4; liver fibrosis; liver sinusoidal endothelial cell; miR-30c	HEPATIC STELLATE CELLS; INTERFERING RNA; UP-REGULATION; FIBROGENESIS; MICRORNAS; DELIVERY	Liver fibrosis is a common feature of liver dysfunction during chronic liver diseases and is frequently associated with angiogenesis, a dynamic process that forms new blood vessels from preexisting vasculature. MicroRNAs (miRNAs), which act as posttranscriptional regulators of gene expression, have been shown to regulate liver fibrosis; however, how miRNAs regulate angiogenesis and its mechanism in fibrosis are not well understood. We aimed to elucidate the role and mechanism of miR-30c in attenuating liver fibrosis. Using miRNA profiling of fibrotic murine livers, we identified differentially regulated miRNAs and discovered that miR-30c is aberrantly expressed and targets endothelial delta-like ligand 4 (DLL4) in either carbon tetrachloride-treated or bile duct ligated fibrotic mice, as well as in patients with liver fibrosis. Using CCK-8, wound healing and Matrigel tube formation assays, we found that miR-30c inhibited liver sinusoidal endothelial cell (LSEC) proliferation, migration, and angiogenesis capacity by targeting DLL4 in vitro. Importantly, nanoparticle-based delivery of miR-30c to LSECs inhibited the DLL4/Notch pathway and angiogenesis, thereby ameliorating liver fibrosis in vivo. Collectively, our findings demonstrate a protective role of miR-30c in liver fibrosis by regulating DLL4/Notch signaling and angiogenesis. Thus, miR-30c may serve as a potential treatment for chronic liver diseases.	[Gu, Tianyi; Shen, Bo; Li, Binghang; Guo, Yuecheng; Li, Fei; Zhang, Qidi; Qu, Ying; Dong, Hui; Cai, Xiaobo; Lu, Lungen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai 201620, Peoples R China; [Gu, Tianyi; Shen, Bo; Li, Binghang; Guo, Yuecheng; Li, Fei; Zhang, Qidi; Qu, Ying; Dong, Hui; Cai, Xiaobo; Lu, Lungen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China; [Ma, Zhenzeng] Bengbu Med Coll, Affiliated Hosp 1, Dept Gastroenterol, Bengbu, Peoples R China; [Chen, Liuying] Huazhong Univ Sci & Technol, Union Hosp, Div Gastroenterol, Tongji Med Coll, Wuhan, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Bengbu Medical College; Huazhong University of Science & Technology	Cai, XB; Lu, LG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai 201620, Peoples R China.	caixiaobo19790719@126.com; lungenlu1965@163.com	Guo, Yuecheng/GNP-6792-2022		National Natural Science Foundation of China (NSFC) [81670548, 81470858, 81970528]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670548, 81470858 and 81970528	Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bocca C, 2015, CELL MOL GASTROENTER, V1, P477, DOI 10.1016/j.jcmgh.2015.06.011; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen LY, 2019, BBA-MOL CELL RES, V1866, P1663, DOI 10.1016/j.bbamcr.2019.06.011; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; DeLeve LD, 2017, SEMIN LIVER DIS, V37, P377, DOI 10.1055/s-0037-1617455; Elpek GO, 2015, WORLD J HEPATOL, V7, P377, DOI 10.4254/wjh.v7.i3.377; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Farra R, 2015, WORLD J GASTROENTERO, V21, P8994, DOI 10.3748/wjg.v21.i30.8994; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; FRASER JRE, 1985, CELL TISSUE RES, V242, P505; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; GARCIAMONZON C, 1995, GASTROENTEROLOGY, V108, P231, DOI 10.1016/0016-5085(95)90029-2; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Greuter T, 2016, J GASTROENTEROL, V51, P511, DOI 10.1007/s00535-016-1190-4; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Huang JW, 2013, CANCER SCI, V104, P1609, DOI 10.1111/cas.12291; Huang QB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067294; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lin LT, 2017, NANOMED-NANOTECHNOL, V13, P2329, DOI 10.1016/j.nano.2017.06.019; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Ma RQ, 2016, INTERDISCIP SCI, V8, P209, DOI 10.1007/s12539-015-0117-8; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; Menakuru SR, 2008, BRIT J CANCER, V99, P1961, DOI 10.1038/sj.bjc.6604733; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Park HJ, 2016, ADV HEALTHC MATER, V5, P2931, DOI 10.1002/adhm.201600416; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shen Z, 2016, AM J PATHOL, V186, P1874, DOI 10.1016/j.ajpath.2016.03.010; Shi ZG, 2012, J ONCOL, V2012, DOI 10.1155/2012/903581; SHIMIZU H, 1994, HEPATOLOGY, V20, P1323, DOI 10.1002/hep.1840200533; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Thomas H., 2017, NAT REV GASTRO HEPAT, V15, P6; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	44	4	4	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21571	10.1096/fj.202002694R	http://dx.doi.org/10.1096/fj.202002694R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33861889				2022-12-28	WOS:000645260100045
J	Li, QX; Liu, YY; Xia, X; Sun, HC; Gao, JH; Ren, QX; Zhou, T; Ma, C; Xia, JG; Yin, CL				Li, Qinxue; Liu, Yayun; Xia, Xin; Sun, Haichen; Gao, Jinhuan; Ren, Quanxin; Zhou, Tian; Ma, Chang; Xia, Jinggang; Yin, Chunlin			Activation of macrophage TBK1-HIF-1 alpha-mediated IL-17/IL-10 signaling by hyperglycemia aggravates the complexity of coronary atherosclerosis: An in vivo and in vitro study	FASEB JOURNAL			English	Article						amlexanox; HIF-1 alpha; hyperglycemia; intimal hyperplasia; SYNTAXscore; TBK1	SYNTAX SCORE; IMMUNOMETABOLISM	Our purpose was to study the effect of hyperglycemia on macrophage TBK-HIF-1 alpha-mediated IL-17/IL-10 signaling and its correlation with coronary atherosclerosis. A total of 135 patients with coronary heart disease (CHD) were divided into a stable CHD (SCHD) group (n = 30) and an acute myocardial infarction (AMI) group (n = 105) [nondiabetes mellitus (non-DM)-AMI, n = 60; DM-AMI, n = 45] from January to September 2020. The SYNTAX score and metabolic and inflammatory markers were quantified and compared. THP-1 cell studies and an animal study of coronary intimal hyperplasia were also carried out. We found that the DM-AMI group showed a higher SYNTAX score than the non-DM-AMI group (P<.05). The DM-AMI group showed the highest expression levels of TANK-binding kinase 1 (TBK1), hypoxia-inducible factor 1 alpha (HIF-1 alpha), and interleukin (IL)-17 and the lowest expression level of IL-10, followed by the non-DM-AMI group and the SCHD group (P<.05). THP-1 cell studies showed that BAY87-2243 (a HIF-1 alpha inhibitor) reversed the increase in IL-17 and decrease in IL-10 expression induced by hyperglycemia. Amlexanox (a TBK1 inhibitor) reversed the increase in HIF-1 alpha expression induced by hyperglycemia. Amlexanox treatment resulted in lower coronary artery intimal hyperplasia and a larger lumen area in a diabetic swine model. We conclude that hyperglycemia might aggravate the complexity of coronary atherosclerosis through activation of TBK1-HIF-1 alpha-mediated IL-17/IL-10 signaling. Thus, TBK1 may be a novel drug therapy target for CHD complicated with DM.	[Li, Qinxue; Liu, Yayun; Gao, Jinhuan; Zhou, Tian; Ma, Chang; Xia, Jinggang; Yin, Chunlin] Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Dept Cardiol, Beijing 100053, Peoples R China; [Xia, Xin] Capital Med Univ, Tiantan Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Sun, Haichen] Capital Med Univ, Xuanwu Hosp, Surg Lab, Beijing, Peoples R China; [Ren, Quanxin] Beijing Fangshan Dist Liangxiang Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Xia, JG; Yin, CL (corresponding author), Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Dept Cardiol, Beijing 100053, Peoples R China.	xiajinggang@sina.cn; yinclmaill@163.com		Xia, Jinggang/0000-0002-3543-0014	National Natural Science Foundation of China (NSFC) [81770344]; National Clinical Research Centre for Geriatric Diseases; Beijing Key Clinical Speciality Development Project; China Young and Middle-aged Clinical Research VG fund [2017-CCA-VG-043]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Clinical Research Centre for Geriatric Diseases; Beijing Key Clinical Speciality Development Project; China Young and Middle-aged Clinical Research VG fund	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770344; National Clinical Research Centre for Geriatric Diseases; Beijing Key Clinical Speciality Development Project; China Young and Middle-aged Clinical Research VG fund, Grant/Award Number: 2017-CCA-VG-043	Chen Z, 2018, J CELL PHYSIOL, V233, P2839, DOI 10.1002/jcp.25998; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Cruz VH, 2018, MOL METAB, V16, P139, DOI 10.1016/j.molmet.2018.06.007; Esper RB, 2018, J AM COLL CARDIOL, V72, P2826, DOI 10.1016/j.jacc.2018.09.046; Karakoyun S, 2016, ANGIOLOGY, V67, P384, DOI 10.1177/0003319715591752; Koelwyn GJ, 2018, NAT IMMUNOL, V19, P526, DOI 10.1038/s41590-018-0113-3; Li QX, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154231; Morici Nuccia, 2020, CJC Open, V2, P236, DOI 10.1016/j.cjco.2020.03.005; Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Perrin-Cocon L, 2018, J IMMUNOL, V201, P1510, DOI 10.4049/jimmunol.1701522; Quan MY, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1438-z; Shen HX, 2019, MOL IMMUNOL, V109, P81, DOI 10.1016/j.molimm.2019.03.005; Shi J, 2020, AM J PHYSIOL-HEART C, V319, pH613, DOI 10.1152/ajpheart.00220.2020; Tabas I, 2020, CIRC RES, V126, P1209, DOI 10.1161/CIRCRESAHA.119.315939; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tang CY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00837; Viola A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01462; Wade SM, 2019, EBIOMEDICINE, V47, P402, DOI 10.1016/j.ebiom.2019.08.043; Wang SJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz8521; Wu JY, 2020, MOL CELL, V77, P213, DOI 10.1016/j.molcel.2019.10.023; Xia JG, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00372; Yanes Bowden GJ, 2021, CORONARY ARTERY DIS, V32, P231; Zentsova I, 2019, J AUTOIMMUN, V105, DOI 10.1016/j.jaut.2019.06.005; Zhou Z, 2020, TOXICOLOGY, V444, DOI 10.1016/j.tox.2020.152579	25	1	1	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21609	10.1096/fj.202100086RR	http://dx.doi.org/10.1096/fj.202100086RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908659				2022-12-28	WOS:000645260100053
J	Lin, LTW; Razzaq, A; Di Gregorio, SE; Hong, S; Charles, B; Lopes, MH; Beraldo, F; Prado, VF; Prado, MAM; Duennwald, ML				Lin, Lilian Tsai-Wei; Razzaq, Abdul; Di Gregorio, Sonja E.; Hong, Soojie; Charles, Brendan; Lopes, Marilene H.; Beraldo, Flavio; Prado, Vania F.; Prado, Marco A. M.; Duennwald, Martin L.			Hsp90 and its co-chaperone Sti1 control TDP-43 misfolding and toxicity	FASEB JOURNAL			English	Article						ALS; Hsp90; protein aggregation; Sti1; TDP-43; yeast	INDUCIBLE PHOSPHOPROTEIN 1; FRONTOTEMPORAL LOBAR DEGENERATION; HEAT-SHOCK; QUALITY-CONTROL; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHAPERONES; ATPASE ACTIVITY; YEAST MODELS; PROTEIN; STRESS	Protein misfolding is a central feature of most neurodegenerative diseases. Molecular chaperones can modulate the toxicity associated with protein misfolding, but it remains elusive which molecular chaperones and co-chaperones interact with specific misfolded proteins. TDP-43 misfolding and inclusion formation are a hallmark of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Using yeast and mammalian neuronal cells we find that Hsp90 and its co-chaperone Sti1 have the capacity to alter TDP-43 misfolding, inclusion formation, aggregation, and cellular toxicity. Our data also demonstrate that impaired Hsp90 function sensitizes cells to TDP-43 toxicity and that Sti1 specifically interacts with and strongly modulates TDP-43 toxicity in a dose-dependent manner. Our study thus uncovers a previously unrecognized tie between Hsp90, Sti1, TDP-43 misfolding, and cellular toxicity.	[Lin, Lilian Tsai-Wei; Di Gregorio, Sonja E.; Hong, Soojie; Charles, Brendan; Duennwald, Martin L.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada; [Razzaq, Abdul; Lopes, Marilene H.; Beraldo, Flavio; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [Lopes, Marilene H.; Prado, Vania F.; Prado, Marco A. M.; Duennwald, Martin L.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, MSB 414,1151 Richmond St, London, ON N6A 5C1, Canada; [Lopes, Marilene H.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Beraldo, Flavio; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade de Sao Paulo; Western University (University of Western Ontario)	Duennwald, ML (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, MSB 414,1151 Richmond St, London, ON N6A 5C1, Canada.	mduennwa@uwo.ca	Lopes, Marilene/GLV-4734-2022	Lopes, Marilene/0000-0003-2496-0674	ALS Canada Research Grants; CIHR [MOP 136930, PJT 159781, PJT 162431]; NSERC; SPRINT FAPESP [2019/00341-9, 2016/00440-9]	ALS Canada Research Grants; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); SPRINT FAPESP	ALS Canada Research Grants to MLD, FHB, and MAMP, CIHR grants to MLD, VFP, and MAMP (MOP 136930, PJT 159781, PJT 162431), NSERC Discovery Grant to MLD MAMP is a Tier 1 Canada Research Chair. Research Grant and scholarship to MHL (SPRINT FAPESP#2019/00341--9 and SPRINT FAPESP#2016/00440--9)	Ambegaokar SS, 2011, HUM MOL GENET, V20, P4947, DOI 10.1093/hmg/ddr432; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armakola M, 2011, METHODS, V53, P238, DOI 10.1016/j.ymeth.2010.11.006; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bastow EL, 2011, BIOCHEM SOC T, V39, P1482, DOI 10.1042/BST0391482; Beraldo FH, 2013, FASEB J, V27, P3594, DOI 10.1096/fj.13-232280; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Biebl MM, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a034017; BLUSZTAJN JK, 1992, J NEUROSCI, V12, P793; Bohush A, 2019, J PARKINSON DIS, V9, P97, DOI 10.3233/JPD-181443; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Carlomagno Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090452; da Fonseca ACC, 2021, CYTOKINE GROWTH F R, V57, P73, DOI 10.1016/j.cytogfr.2020.06.003; Chafekar SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037929; Chang HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3757; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Csermely P, 1998, CURR SCI INDIA, V74, P442; Di Gregorio SE, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00394; Di Gregorio SE, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy054; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Farkas Z, 2018, ELIFE, V7, DOI 10.7554/eLife.29845; Flom G, 2005, CURR GENET, V47, P368, DOI 10.1007/s00294-005-0580-6; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gorkovskiy A, 2017, P NATL ACAD SCI USA, V114, pE4193, DOI 10.1073/pnas.1704016114; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Inda MC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14082-5; Jinwal UK, 2012, J BIOL CHEM, V287, P24814, DOI 10.1074/jbc.M112.367268; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Karam JA, 2017, J BIOL CHEM, V292, P6039, DOI 10.1074/jbc.C117.777730; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kryndushkin DS, 2002, J BIOL CHEM, V277, P23702, DOI 10.1074/jbc.M111547200; Lackie RE, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01013-5; Lackie RE, 2020, J NEUROCHEM, V153, P727, DOI 10.1111/jnc.14882; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Nelson PT, 2019, BRAIN, V142, P1503, DOI 10.1093/brain/awz099; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Ostapchenko VG, 2013, J NEUROSCI, V33, P16552, DOI 10.1523/JNEUROSCI.3214-13.2013; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Park SK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006805; PESIRIDIS G, 2009, SCIENCE, V18, pR156; Petropavlovskiy Andrey A, 2020, STAR Protoc, V1, P100182, DOI 10.1016/j.xpro.2020.100182; Prasad A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00025; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Rehn Alexandra Beatrice, 2015, Subcell Biochem, V78, P113, DOI 10.1007/978-3-319-11731-7_6; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Scotter EL, 2015, NEUROTHERAPEUTICS, V12, P515, DOI 10.1007/s13311-015-0351-0; Shenouda M, 2018, ADV NEUROBIOL, V20, P239, DOI 10.1007/978-3-319-89689-2_9; Shiber A, 2013, MOL BIOL CELL, V24, P2076, DOI 10.1091/mbc.E13-01-0010; Soares IN, 2013, MOL CELL PROTEOMICS, V12, P3253, DOI 10.1074/mcp.M113.031005; Soti C, 2000, BIOGERONTOLOGY, V1, P225, DOI 10.1023/A:1010082129022; Soto C, 2018, NAT NEUROSCI, V21, P1332, DOI 10.1038/s41593-018-0235-9; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Tripathi V, 2014, J BIOL CHEM, V289, P36220, DOI 10.1074/jbc.M114.590141; Truman AW, 2007, EUKARYOT CELL, V6, P744, DOI 10.1128/EC.00009-07; Wang SH, 2008, CHEM BIOL, V15, P1328, DOI 10.1016/j.chembiol.2008.10.006; Wayne N, 2010, J MOL BIOL, V401, P931, DOI 10.1016/j.jmb.2010.06.066; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Wilson RS, 2019, NEUROLOGY, V92, pE831, DOI 10.1212/WNL.0000000000006949; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolfe KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095914; Wolfe KJ, 2013, MOL BIOL CELL, V24, P3588, DOI 10.1091/mbc.E13-06-0315; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	79	10	10	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21594	10.1096/fj.202002645R	http://dx.doi.org/10.1096/fj.202002645R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908654	Green Submitted			2022-12-28	WOS:000645260100015
J	Luo, ZT; Luo, ST; Ju, YC; Ding, P; Xu, J; Gu, Q; Zhou, HH				Luo, Zhiteng; Luo, Siting; Ju, Yingchen; Ding, Peng; Xu, Jun; Gu, Qiong; Zhou, Huihao			Structural insights into the ligand recognition and catalysis of the key aminobutanoyltransferase CntL in staphylopine biosynthesis	FASEB JOURNAL			English	Article						biosynthesis; metallophore; Staphylococcus aureus; substrate selectivity; X-ray crystallography	STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; SIDEROPHORE BIOSYNTHESIS; TRANSITION-METALS; ABC-TRANSPORTER; NICKEL IMPORT; METALLOPHORE; GROWTH; IDENTIFICATION; CONTRIBUTES	Staphylopine (StP) and other nicotianamine-like metallophores are crucial for many pathogens to acquire the transition metals from hosts during invasion. CntL from Staphylococcus aureus (SaCntL) catalyzes the condensation of the 2-aminobutyrate (Ab) moiety of S-adenosylmethionine (SAM) with D-histidine in the biosynthesis of StP. Here, we report the crystal structures of SaCntL in complex with either SAM or two products. The structure of SaCntL consists of an N-terminal four-helix bundle (holding catalytic residue E84) and a C-terminal Rossmann fold (binding the substrates). The sequence connecting the N-and C-terminal domains (N-C linker) in SaCntL was found to undergo conformational alternation between open and closed states. Our structural and biochemical analyses suggested that this intrinsically dynamic interdomain linker forms an additional structural module that plays essential roles in ligand diffusion, recognition, and catalysis. We confirmed that SaCntL stereoselectively carries out the catalysis of D-His but not its enantiomer, L-His, and we found that the N-C linker and active site of SaCntL could accommodate both enantiomers. SaCntL is likely able to bind L-His without catalysis, and as a result, L-His could show inhibitory effects toward SaCntL. These findings provide critical structural and mechanistic insights into CntL, which facilitates a better understanding of the biosynthesis of nicotianamine-like metallophores and the discovery of inhibitors of this process.	[Luo, Zhiteng; Luo, Siting; Ju, Yingchen; Ding, Peng; Xu, Jun; Gu, Qiong; Zhou, Huihao] Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, Guangzhou 510006, Peoples R China; [Luo, Zhiteng; Luo, Siting; Ju, Yingchen; Ding, Peng; Xu, Jun; Gu, Qiong; Zhou, Huihao] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Chiral Mol & Drug Discover, Guangzhou 510006, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, Guangzhou 510006, Peoples R China.; Zhou, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Chiral Mol & Drug Discover, Guangzhou 510006, Peoples R China.	zhuihao@mail.sysu.edu.cn	ZHOU, HUIHAO/L-6133-2016	ZHOU, HUIHAO/0000-0002-9675-5007	National Key Research and Development Program [2017YFE0109900]; National Natural Science Foundation of China [81773636]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2016ZT06Y337]; Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery [2019B030301005]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery	This research was supported by National Key Research and Development Program (No. 2017YFE0109900), National Natural Science Foundation of China (No. 81773636), Program for Guangdong Introducing Innovative and Entrepreneurial Teams (No. 2016ZT06Y337), and Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery (No. 2019B030301005)	Andreini C, 2004, BIOINFORMATICS, V20, P1373, DOI 10.1093/bioinformatics/bth095; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Begg SL, 2019, BIOCHEM SOC T, V47, P77, DOI 10.1042/BST20180275; Bielecki P, 2013, ENVIRON MICROBIOL, V15, P570, DOI 10.1111/1462-2920.12024; Chen CH, 2019, FEBS LETT, V593, P1213, DOI 10.1002/1873-3468.13396; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Dawadi S, 2018, ACS MED CHEM LETT, V9, P386, DOI 10.1021/acsmedchemlett.8b00090; del Campo JSM, 2016, ACS CHEM BIOL, V11, P3035, DOI 10.1021/acschembio.6b00666; Ding YP, 2012, J BACTERIOL, V194, P6586, DOI 10.1128/JB.01414-12; Dreyfus C, 2009, P NATL ACAD SCI USA, V106, P16180, DOI 10.1073/pnas.0904439106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14644; Grim KP, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00014-20; Grim KP, 2017, MBIO, V8, DOI [10.1128/mbio.01281-17, 10.1128/mBio.01281-17]; Hajjar C, 2019, J AM CHEM SOC, V141, P5555, DOI 10.1021/jacs.9b01676; Hiron A, 2010, MOL MICROBIOL, V77, P1246, DOI 10.1111/j.1365-2958.2010.07287.x; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Laffont C, 2020, METALLOMICS, V12, P1480, DOI 10.1039/d0mt00150c; Laffont C, 2019, BIOCHEM J, V476, P2221, DOI 10.1042/BCJ20190384; Lebrette H, 2015, METALLOMICS, V7, P613, DOI 10.1039/c4mt00295d; Lebrette H, 2014, STRUCTURE, V22, P1421, DOI 10.1016/j.str.2014.07.012; Lebrette H, 2013, J INORG BIOCHEM, V121, P16, DOI 10.1016/j.jinorgbio.2012.12.010; Lhospice S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16765-9; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Luo ST, 2019, INT J BIOL MACROMOL, V135, P725, DOI 10.1016/j.ijbiomac.2019.05.169; Mastropasqua MC, 2017, MOL MICROBIOL, V106, P543, DOI 10.1111/mmi.13834; McFarlane JS, 2019, J BIOL CHEM, V294, P17988, DOI 10.1074/jbc.RA119.011059; McFarlane JS, 2018, J BIOL CHEM, V293, P8009, DOI 10.1074/jbc.RA118.002007; McFarlane JS, 2017, BIOCHEMISTRY-US, V56, P5967, DOI 10.1021/acs.biochem.7b00804; McFarlane JS, 2020, CHEM BIOL, V5, P395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neres J, 2013, J MED CHEM, V56, P2385, DOI 10.1021/jm301709s; Palmer LD, 2016, ANNU REV GENET, V50, P67, DOI 10.1146/annurev-genet-120215-035146; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sassone-Corsi M, 2016, P NATL ACAD SCI USA, V113, P13462, DOI 10.1073/pnas.1606290113; Song LQ, 2018, P NATL ACAD SCI USA, V115, P3942, DOI 10.1073/pnas.1718382115; Tang JY, 2019, J MOL BIOL, V431, P4868, DOI 10.1016/j.jmb.2019.10.009; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tripathi A, 2014, J AM CHEM SOC, V136, P1579, DOI 10.1021/ja4115924; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zhang J, 2019, CHEM SCI, V10, P6635, DOI 10.1039/c9sc01405e; Zhang J, 2017, J ORG CHEM, V82, P13643, DOI 10.1021/acs.joc.7b02342	48	1	1	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21575	10.1096/fj.202002287RR	http://dx.doi.org/10.1096/fj.202002287RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826776				2022-12-28	WOS:000645260100048
J	Ohata, K; Kondo, M; Ozono, Y; Hanada, Y; Sato, T; Inohara, H; Shimada, S				Ohata, Kazuya; Kondo, Makoto; Ozono, Yoshiyuki; Hanada, Yukiko; Sato, Takashi; Inohara, Hidenori; Shimada, Shoichi			Cochlear protection against noise exposure requires serotonin type 3A receptor via the medial olivocochlear system	FASEB JOURNAL			English	Article						HT3A receptor; acoustic trauma; noise-induced hearing loss	ACETYLCHOLINE-RELEASE; 5-HT3 RECEPTOR; HEARING-LOSS; NEURONS; PROJECTIONS; MODULATION; PATHWAYS; DAMAGE; INNERVATION; STEREOCILIA	The cochlear efferent feedback system plays important roles in auditory processing, including regulation of the dynamic range of hearing, and provides protection against acoustic trauma. These functions are performed through medial olivocochlear (MOC) neurons. However, the underlying cellular and molecular mechanisms are not fully understood. The serotonin type 3A (5-HT3A) receptor is widely expressed throughout the nervous system, which suggests important roles in various neural functions. However, involvement of the 5-HT3A receptor in the MOC system remains unclear. We used mice in this study and found that the 5-HT3A receptor was expressed in MOC neurons that innervated outer hair cells in the cochlea and was involved in the activation of MOC neurons by noise exposure. 5-HT3A receptor knockout impaired MOC functions, potentiated noise-induced hearing loss, and increased loss of ribbon synapses following noise exposure. Furthermore, 5-HT3 receptor agonist treatment alleviated the noise-induced hearing loss and loss of ribbon synapses, which enhanced cochlear protection provided by the MOC system. Our findings demonstrate that the 5-HT3A receptor plays fundamental roles in the MOC system and critically contributes to protection from noise-induced hearing impairment.	[Ohata, Kazuya; Kondo, Makoto; Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Ohata, Kazuya; Ozono, Yoshiyuki; Hanada, Yukiko; Sato, Takashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan; [Kondo, Makoto; Shimada, Shoichi] Osaka Psychiat Med Ctr, Osaka Psychiat Res Ctr, Addict Res Unit, Osaka, Japan	Osaka University; Osaka University	Kondo, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mkondo@anat1.med.osaka-u.ac.jp			MEXT vertical bar Japan Society for the Promotion of Science (JSPS) [17K16912, 19K18729, 19K11440]	MEXT vertical bar Japan Society for the Promotion of Science (JSPS)	MEXT broken vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 17K16912, 19K18729 and 19K11440	Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Boero LE, 2018, J NEUROSCI, V38, P7440, DOI 10.1523/JNEUROSCI.0363-18.2018; Brown MC, 2008, NEUROSCIENCE, V154, P147, DOI 10.1016/j.neuroscience.2007.12.045; Brown MC, 2003, EXP BRAIN RES, V153, P491, DOI 10.1007/s00221-003-1679-y; BROWN MC, 1993, J COMP NEUROL, V337, P600, DOI 10.1002/cne.903370406; Chittajallu R, 2013, NAT NEUROSCI, V16, P1598, DOI 10.1038/nn.3538; CONSOLO S, 1994, J NEUROCHEM, V62, P2254; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; Dean C, 2012, OTOL NEUROTOL, V33, P1085, DOI 10.1097/MAO.0b013e31825e7e12; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Franklin K., 2007, MOUSE BRAIN STEREOTA; Giovannini MG, 1998, J PHARMACOL EXP THER, V285, P1219; Grose JH, 2006, J ACOUST SOC AM, V119, P2305, DOI 10.1121/1.2172169; Guinan JJ, 1996, J ACOUST SOC AM, V100, P1680, DOI 10.1121/1.416066; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Hanada Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28618-0; HENRY KR, 1980, AUDIOLOGY, V19, P369; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Horvath M, 2003, EUR J NEUROSCI, V18, P1439, DOI 10.1046/j.1460-9568.2003.02870.x; KIANG NYS, 1982, SCIENCE, V217, P175, DOI 10.1126/science.7089553; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kondo M, 2018, MOL PSYCHIATR, V23, P833, DOI 10.1038/mp.2017.87; Kondo M, 2015, MOL PSYCHIATR, V20, P1428, DOI 10.1038/mp.2014.153; Kondo M, 2017, ANAT SCI INT, V92, P1, DOI 10.1007/s12565-016-0358-6; Kondo M, 2014, LEARN MEMORY, V21, P1, DOI 10.1101/lm.032193.113; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Koyama Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42884; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; LIBERMAN MC, 1987, HEARING RES, V26, P65, DOI 10.1016/0378-5955(87)90036-0; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; LIBERMAN MC, 1986, HEARING RES, V24, P17, DOI 10.1016/0378-5955(86)90003-1; Maison SF, 2013, J NEUROSCI, V33, P5542, DOI 10.1523/JNEUROSCI.5027-12.2013; Manzoor NF, 2013, BRAIN RES, V1523, P28, DOI 10.1016/j.brainres.2013.05.025; Morales M, 2002, J NEUROSCI, V22, P6732; Ofsie MS, 1997, HEARING RES, V113, P207, DOI 10.1016/S0378-5955(97)00150-0; Pilz PKD, 1997, HEARING RES, V105, P171, DOI 10.1016/S0378-5955(96)00206-7; Rajan R, 2000, J NEUROSCI, V20, P6684, DOI 10.1523/JNEUROSCI.20-17-06684.2000; Rothlin CV, 2003, MOL PHARMACOL, V63, P1067, DOI 10.1124/mol.63.5.1067; Smith DW, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00012; Snell KB, 2000, J ACOUST SOC AM, V107, P1615, DOI 10.1121/1.428446; Takimoto Y, 2014, BRAIN RES, V1557, P74, DOI 10.1016/j.brainres.2014.02.016; Taranda J, 2009, PLOS BIOL, V7, P71, DOI 10.1371/journal.pbio.1000018; Terreros G, 2016, J NEUROSCI, V36, P7198, DOI 10.1523/JNEUROSCI.4031-15.2016; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; THOMPSON AM, 1995, BRAIN RES, V695, P263, DOI 10.1016/0006-8993(95)00863-L; Ueda N, 2018, BIOCHEM BIOPH RES CO, V506, P498, DOI 10.1016/j.bbrc.2018.10.106; Wersinger E, 2011, HEARING RES, V279, P1, DOI 10.1016/j.heares.2010.12.018; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; WINSLOW RL, 1988, HEARING RES, V35, P165, DOI 10.1016/0378-5955(88)90116-5; Woods CI, 1999, BRAIN RES, V836, P9, DOI 10.1016/S0006-8993(99)01541-3; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; Zhu XX, 2007, J COMP NEUROL, V503, P593, DOI 10.1002/cne.21402	56	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21486	10.1096/fj.202002383R	http://dx.doi.org/10.1096/fj.202002383R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811700	hybrid			2022-12-28	WOS:000645260100006
J	Pavlik, V; Sobotka, L; Pejchal, J; Cepa, M; Nesporova, K; Arenbergerova, M; Mrozkova, A; Velebny, V				Pavlik, Vojtech; Sobotka, Lubos; Pejchal, Jaroslav; Cepa, Martin; Nesporova, Kristina; Arenbergerova, Monika; Mrozkova, Adela; Velebny, Vladimir			Silver distribution in chronic wounds and the healing dynamics of chronic wounds treated with dressings containing silver and octenidine	FASEB JOURNAL			English	Article						distribution of silver; hyaluronic acid; octenidine; silver; wound	VENOUS LEG ULCERS; 2-PERCENT 2-PHENOXYETHANOL; 0.1-PERCENT OCTENIDINE; NANOCRYSTALLINE SILVER; SKIN; NANOPARTICLES; TOXICITY; DIHYDROCHLORIDE; MECHANISM; MICE	Although silver is an efficient antimicrobial and is a widely used antiseptic in wound healing, previous studies have reported the cytotoxic in vitro effects of silver dressings. Moreover, few studies have addressed the distribution of silver in chronic wounds. The study compares the healing of chronic wounds treated with a standard-of-care silver dressing (Ag-CMC) and a dressing containing antiseptic octenidine (OCT-HA). Biopsies were taken from two wound areas before the commencement of treatment (baseline), after 2 weeks and after 6 weeks (the end of the study). We analyzed the histopathologic wound-healing score, silver distribution, and expression of selected genes. The wound-healing score improved significantly in the wounded area treated with OCT-HA after 2 weeks compared to the baseline and the Ag-CMC. The Ag-CMC wound areas improved after 6 weeks compared to the baseline. Moreover, collagen maturation and decreases in the granulocyte and macrophage counts were faster in the OCT-HA parts. Treatment with OCT-HA resulted in less wound slough. The silver, visualized via autometallography, penetrated approximately 2 mm into the wound tissue and associated around capillaries and ECM fibers, and was detected in phagocytes. The metallothionein gene expression was elevated in the Ag-CMC wound parts. This exploratory study determined the penetration of silver into human chronic wounds and changes in the distribution thereof during treatment. We observed that silver directly affects the cells in the wound and elevates the metallothionein gene expression. Octenidine and hyaluronan dressings provide a suitable alternative to silver and carboxymethyl cellulose dressings without supplying silver to the wound.	[Pavlik, Vojtech; Cepa, Martin; Nesporova, Kristina; Velebny, Vladimir] Contipro AS, Cell Physiol Res Grp, Dolni Dobrouc, Czech Republic; [Pavlik, Vojtech; Arenbergerova, Monika] Charles Univ Prague, Third Fac Med, Dept Dermatovenereol, Prague, Czech Republic; [Sobotka, Lubos] Charles Univ Prague, Dept Med 3, Fac Hosp & Med Fac, Hradec Kralove, Czech Republic; [Pejchal, Jaroslav] Univ Def Brno, Fac Mil Hlth Sci, Dept Toxicol & Mil Pharm, Hradec Kralove, Czech Republic; [Mrozkova, Adela] Charles Univ Prague, Med Fac, Dept Hyg & Prevent Med, Hradec Kralove, Czech Republic	Contipro; Charles University Prague; Charles University Prague; University Hospital Hradec Kralove; University of Defence - Czech Republic; Charles University Prague; University Hospital Hradec Kralove	Pavlik, V (corresponding author), Contipro AS, Dolni Dobrouc 401, Dolni Dobrouc 56201, Czech Republic.	vojtech.pavlik@contipro.com	Nesporova, Kristina/AFP-1069-2022; Pejchal, Jaroslav/AAJ-1177-2020	Nesporova, Kristina/0000-0001-7864-7689; Pejchal, Jaroslav/0000-0003-2228-7922; Pavlik, Vojtech/0000-0002-6575-9726	PROGRES [Q40/12]	PROGRES	We are grateful for the technical assistance provided by Sarka Duskova, Lenka Nespechalova, and Sarka Pruchova. This study was supported by PROGRES Q40/12.	Barillo DJ, 2020, TOXICOL LETT, V319, P111, DOI 10.1016/j.toxlet.2019.10.023; Barillo DJ, 2017, J BURN CARE RES, V38, pE818, DOI 10.1097/BCR.0000000000000493; Bisson JF, 2013, J DERMATOL, V40, P463, DOI 10.1111/1346-8138.12149; Brouillard C, 2018, J EUR ACAD DERMATOL, V32, P2295, DOI 10.1111/jdv.15055; Brzicova T, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9050687; Buhrer C, 2002, J HOSP INFECT, V51, P305, DOI 10.1053/jhin.2002.1249; Catanzano O, 2015, CARBOHYD POLYM, V131, P407, DOI 10.1016/j.carbpol.2015.05.081; Chen ZL, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0070-9; CONSTABLE JD, 1967, PLAST RECONSTR SURG, V39, P342, DOI 10.1097/00006534-196704000-00002; COOMBS CJ, 1992, BURNS, V18, P179, DOI 10.1016/0305-4179(92)90067-5; Cyphert Jaime M, 2015, Int J Cell Biol, V2015, P563818, DOI 10.1155/2015/563818; Dalzon B, 2020, ENVIRON SCI-NANO, V7, P2032, DOI 10.1039/c9en01329f; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; Djokic SS, 1998, J ELECTROCHEM SOC, V145, P1426, DOI 10.1149/1.1838499; Djokic S, 2010, ECS TRANSACTIONS, V25, P7, DOI 10.1149/1.3298945; Fredriksson C, 2009, WOUNDS, V21, P116; Fumal I, 2002, DERMATOLOGY, V204, P70, DOI 10.1159/000057729; Ghatak Shibnath, 2015, Int J Cell Biol, V2015, P834893, DOI 10.1155/2015/834893; Gunther F, 2021, J INFECT PREVENT, V22, P12, DOI 10.1177/1757177420963829; Hadrup N, 2018, REGUL TOXICOL PHARM, V98, P257, DOI 10.1016/j.yrtph.2018.08.007; Hammerle G, 2016, INT WOUND J, V13, P182, DOI 10.1111/iwj.12250; Hartmann CA, 2016, INT WOUND J, V13, P1344, DOI 10.1111/iwj.12525; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P244, DOI 10.1159/000314699; Hwang IS, 2012, FEBS J, V279, P1327, DOI 10.1111/j.1742-4658.2012.08527.x; Kaewamatawong T, 2014, J ENVIRON PATHOL TOX, V33, P59, DOI 10.1615/JEnvironPatholToxicolOncol.2014010179; Klein P, 2018, BIOFOULING, V34, P226, DOI 10.1080/08927014.2018.1425684; Kodedova M, 2011, BIOTECHNIQUES, V50, P58, DOI 10.2144/000113568; Krasowski G, 2015, WOUND REPAIR REGEN, V23, P525, DOI 10.1111/wrr.12301; Lansdown ABG, 1997, BRIT J DERMATOL, V137, P728; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003; Mahedia M, 2016, PRS-GLOB OPEN, V4, DOI 10.1097/GOX.0000000000000747; Malanovic N, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106146; Mijnendonckx K, 2013, BIOMETALS, V26, P609, DOI 10.1007/s10534-013-9645-z; Monavarian M, 2019, TISSUE ENG PART B-RE, V25, P294, DOI [10.1089/ten.TEB.2018.0350, 10.1089/ten.teb.2018.0350]; Mulley G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094409; Nadworny PL, 2010, WOUND REPAIR REGEN, V18, P254, DOI 10.1111/j.1524-475X.2010.00579.x; Nadworny PL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-13; Nesporova K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72249-3; Nikolic N, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/5143635; Olsson M, 2019, WOUND REPAIR REGEN, V27, P114, DOI 10.1111/wrr.12683; Panuncialman J, 2010, WOUND REPAIR REGEN, V18, P21, DOI 10.1111/j.1524-475X.2009.00559.x; Paul A, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0848-9; Pavlik V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211055; Petrey AC, 2019, MATRIX BIOL, V78-79, P314, DOI 10.1016/j.matbio.2018.03.011; Pfurtscheller K, 2014, WOUND REPAIR REGEN, V22, P654, DOI 10.1111/wrr.12209; Rahim K, 2017, MICROB ECOL, V73, P710, DOI 10.1007/s00248-016-0867-9; Rigo C, 2013, INT J MOL SCI, V14, P4817, DOI 10.3390/ijms14034817; Roman M, 2020, ANALYST, V145, P6456, DOI 10.1039/d0an00607f; Rosen J, 2015, J INVEST DERMATOL, V135, P1459, DOI 10.1038/jid.2015.21; Satoh M., 2009, MEDIATORS INFLAMM, V2009, P1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seiser S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79378-9; Shatirishvili M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.342; Shim I, 2017, J APPL TOXICOL, V37, P471, DOI 10.1002/jat.3382; Souza HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173417; Stahl J, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-44; Sultana J., 2009, BANGLADESH J PATHOL, V24, P3, DOI DOI 10.3329/BJPATH.V24I1.2874; Tak YK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16908; Team RC., 2013, R LANG ENV STAT COMP; Thomason HA, 2018, WOUND REPAIR REGEN, V26, P144, DOI 10.1111/wrr.12627; Trop M, 2006, J TRAUMA, V60, P648, DOI 10.1097/01.ta.0000208126.22089.b6; Vanscheidt W, 2012, INT WOUND J, V9, P316, DOI 10.1111/j.1742-481X.2011.00886.x; Vimbela GV, 2017, INT J NANOMED, V12, P3941, DOI 10.2147/IJN.S134526; Voigt J, 2012, WOUND REPAIR REGEN, V20, P317, DOI 10.1111/j.1524-475X.2012.00777.x; Winter H, 2000, DERMATOL SURG, V26, P829, DOI 10.1046/j.1524-4725.2000.99291.x; You CG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10481-0; Zhang XF, 2016, INT J MOL SCI, V17, DOI [10.3390/ijms17081354, 10.3390/ijms17101603]	68	2	2	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21580	10.1096/fj.202100065R	http://dx.doi.org/10.1096/fj.202100065R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908652				2022-12-28	WOS:000645260100035
J	Radadiya, PS; Thornton, MM; Daniel, EA; Idowu, JY; Wang, W; Magenheimer, B; Subramaniam, D; Tran, PV; Calvet, JP; Wallace, DP; Sharma, M				Radadiya, Priyanka S.; Thornton, Mackenzie M.; Daniel, Emily A.; Idowu, Jessica Y.; Wang, Wei; Magenheimer, Brenda; Subramaniam, Dharmalingam; Tran, Pamela, V; Calvet, James P.; Wallace, Darren P.; Sharma, Madhulika			Quinomycin A reduces cyst progression in polycystic kidney disease	FASEB JOURNAL			English	Article						Quinomycin A; proliferation; Notch; polycystic kidney	MONOCYTE CHEMOATTRACTANT PROTEIN-1; ELEVATED AROMATASE EXPRESSION; ADIPOSE STROMAL CELLS; BREAST-CANCER; CORTISOL METABOLISM; SIGNALING PATHWAYS; MMP-9 EXPRESSION; OBESE WOMEN; WEIGHT-GAIN; CYP19 GENE	Polycystic kidney disease (PKD) is a genetic disorder characterized by aberrant renal epithelial cell proliferation and formation and progressive growth of numerous fluid-filled cysts within the kidneys. Previously, we showed that there is elevated Notch signaling compared to normal renal epithelial cells and that Notch signaling contributes to the proliferation of cystic cells. Quinomycin A, a bis-intercalator peptide, has previously been shown to target the Notch signaling pathway and inhibit tumor growth in cancer. Here, we show that Quinomycin A decreased cell proliferation and cyst growth of human ADPKD cyst epithelial cells cultured within a 3D collagen gel. Treatment with Quinomycin A reduced kidney weight to body weight ratio and decreased renal cystic area and fibrosis in Pkd1(RC/RC); Pkd2(+/-) mice, an orthologous PKD mouse model. This was accompanied by reduced expression of Notch pathway proteins, RBPjk and HeyL and cell proliferation in kidneys of PKD mice. Quinomycin A treatments also normalized cilia length of cyst epithelial cells derived from the collecting ducts. This is the first study to demonstrate that Quinomycin A effectively inhibits PKD progression and suggests that Quinomycin A has potential therapeutic value for PKD patients.	[Radadiya, Priyanka S.; Thornton, Mackenzie M.; Daniel, Emily A.; Idowu, Jessica Y.; Wallace, Darren P.; Sharma, Madhulika] Univ Kansas, Dept Internal Med, Med Ctr, Kansas City, KS 66160 USA; [Magenheimer, Brenda; Calvet, James P.] Univ Kansas, Biochem & Mol Biol, Med Ctr, Kansas City, KS 66160 USA; [Wang, Wei; Tran, Pamela, V] Univ Kansas, Med Ctr, Anat & Cell Biol, Kansas City, KS 66160 USA; [Radadiya, Priyanka S.; Thornton, Mackenzie M.; Daniel, Emily A.; Idowu, Jessica Y.; Wang, Wei; Magenheimer, Brenda; Tran, Pamela, V; Calvet, James P.; Wallace, Darren P.] Univ Kansas, Med Ctr, Jared Grantham Kidney Inst, Kansas City, KS 66160 USA; [Subramaniam, Dharmalingam] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Sharma, M (corresponding author), Univ Kansas, Dept Internal Med, Med Ctr, Kansas City, KS 66160 USA.	msharma3@kumc.edu		Subramaniam, Dharmalingam/0000-0002-2710-485X; Calvet, James/0000-0001-5928-9820; Tran, Pamela/0000-0003-4619-4376	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103418]; PKD Biomarkers, Biomaterials, and Cellular Models Core in the Kansas PKD Research and Translational Core Center part of the national PKD Research Resource Consortium [U54 DK126126];  [R01DK103033];  [R01DK108433]	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); PKD Biomarkers, Biomaterials, and Cellular Models Core in the Kansas PKD Research and Translational Core Center part of the national PKD Research Resource Consortium; ; 	This project was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103418--summer scholarship award to PR, PKD Biomarkers, Biomaterials, and Cellular Models Core in the Kansas PKD Research and Translational Core Center (U54 DK126126), which is part of the national PKD Research Resource Consortium; R01DK103033 to PVT, Lied pilot award and R01DK108433 to MS	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; An J, 2017, ONCOTARGET, V8, P39230, DOI 10.18632/oncotarget.16837; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Basurto L, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.05.013; Bezemer ID, 2005, CANCER CAUSE CONTROL, V16, P561, DOI 10.1007/s10552-004-7472-9; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Brown KA, 2017, J CLIN ENDOCR METAB, V102, P1692, DOI 10.1210/jc.2016-3606; Brown KA, 2014, J MAMMARY GLAND BIOL, V19, P183, DOI 10.1007/s10911-014-9321-0; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P428, DOI 10.1210/jc.78.2.428; Bulun SE, 2007, J STEROID BIOCHEM, V106, P81, DOI 10.1016/j.jsbmb.2007.05.027; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Burkhard K, 2010, METHODS MOL BIOL, V661, P107, DOI 10.1007/978-1-60761-795-2_6; Chen D, 2012, MOL CELL ENDOCRINOL, V355, P114, DOI 10.1016/j.mce.2012.01.027; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dutta P, 2018, BREAST CANCER RES TR, V170, P477, DOI 10.1007/s10549-018-4760-8; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; Han R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27810-6; Hao QY, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00589-8; Hetemaki N, 2017, J CLIN ENDOCR METAB, V102, P4588, DOI 10.1210/jc.2017-01474; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Ignacio RMC, 2016, IMMUNE NETW, V16, P189, DOI 10.4110/in.2016.16.3.189; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; Iyengar NM, 2015, CANCER PREV RES, V8, P349, DOI 10.1158/1940-6207.CAPR-14-0243; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kulendran M, 2009, ANTICANCER RES, V29, P1095; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; Lim SY, 2016, ONCOTARGET, V7, P28697, DOI 10.18632/oncotarget.7376; Lubowicka E, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2124390; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Martinez-Chacon G, 2018, FASEB J, V32, P3361, DOI 10.1096/fj.201700938RRR; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P1327, DOI 10.1210/jc.87.3.1327; McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Nascimento-Sales M, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13271; NEWTON CJ, 1986, J STEROID BIOCHEM, V24, P1033, DOI 10.1016/0022-4731(86)90356-0; Park KS, 2009, CLIN CHIM ACTA, V403, P92, DOI 10.1016/j.cca.2009.01.025; Peuhu E, 2017, EMBO J, V36, P165, DOI 10.15252/embj.201694387; Polari L, 2015, MOL CELL ENDOCRINOL, V412, P123, DOI 10.1016/j.mce.2015.06.002; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rice S, 2012, FERTIL STERIL, V97, P1460, DOI 10.1016/j.fertnstert.2012.03.008; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 1997, RECENT PROG HORM RES, V52, P185; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Stingl John, 2005, Methods Mol Biol, V290, P249; Strauss L, 2013, FASEB J, V27, P1342, DOI 10.1096/fj.12-219048; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Svensson S, 2015, CLIN CANCER RES, V21, P3794, DOI 10.1158/1078-0432.CCR-15-0204; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Thijssen JHH., 1976, CONSENSUS MENOPAUSE, P25; To SQ, 2015, J STEROID BIOCHEM, V145, P179, DOI 10.1016/j.jsbmb.2014.05.004; To SQ, 2013, BIOCHEM BIOPH RES CO, V433, P96, DOI 10.1016/j.bbrc.2013.02.058; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; Vrieling A, 2010, BREAST CANCER RES TR, V123, P641, DOI 10.1007/s10549-010-1116-4; Westerbacka J, 2008, AM J PHYSIOL-ENDOC M, V294, pE841, DOI 10.1152/ajpendo.00653.2006; Zhao Y, 1997, J STEROID BIOCHEM, V61, P203, DOI 10.1016/S0960-0760(97)80013-1; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350	73	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21533	10.1096/fj.202002490R	http://dx.doi.org/10.1096/fj.202002490R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826787	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000645260100088
J	Yuan, CF; Li, Z; Zhao, Y; Wang, X; Chen, L; Zhao, ZJ; Cao, MS; Chen, T; Iqbal, T; Zhang, BQ; Fan, WJ; Wei, YM; Li, CJ; Zhou, X				Yuan, Chenfeng; Li, Zheng; Zhao, Yun; Wang, Xin; Chen, Lu; Zhao, Zijiao; Cao, Maosheng; Chen, Tong; Iqbal, Tariq; Zhang, Boqi; Fan, Wenjing; Wei, Yameng; Li, Chunjin; Zhou, Xu			Follicular fluid exosomes: Important modulator in proliferation and steroid synthesis of porcine granulosa cells	FASEB JOURNAL			English	Article						exosome; granulosa cell; proliferation; steroid	EXTRACELLULAR VESICLES; TRANSFERRIN RECEPTOR; MICRORNAS; MATURATION; EXTERNALIZATION; RETICULOCYTES; SECRETION; MECHANISM; EXPANSION; PATHWAY	Granulosa cells (GCs) are regulated by various factors during ovarian development. However, there are few reports on the role of follicular fluid exosomes in ovarian GCs. In this study, porcine ovarian GCs were used to explore the effects of follicular fluid exosomes on GCs. GCs were treated with in vitro, and the changes in cell proliferation, steroid synthesis, and associated signal pathways were detected. The results showed that exosomes increased cell viability and altered the gene expression profile of GCs. Exosomes also increased the level of gene expression associated with both proliferation and progesterone synthesis, in which the MAPK/ERK and WNT/B-CATENIN pathways were involved. In addition, exosome-carried microRNAs were identified by high-throughput sequencing, and exosomal miR-31-5p was found to promote the proliferation of GCs and progesterone synthesis via the WNT/B-CATENIN pathway by targeting the SFRP4 follicle growth inhibitor. In conclusion, this study has demonstrated that exosomes are essential substances involved in regulating the physiological function of GCs.	[Yuan, Chenfeng; Li, Zheng; Zhao, Yun; Wang, Xin; Chen, Lu; Zhao, Zijiao; Cao, Maosheng; Chen, Tong; Iqbal, Tariq; Zhang, Boqi; Fan, Wenjing; Wei, Yameng; Li, Chunjin; Zhou, Xu] Jilin Univ, Coll Anim Sci, Changchun 130062, Peoples R China	Jilin University	Li, CJ; Zhou, X (corresponding author), Jilin Univ, Coll Anim Sci, Changchun 130062, Peoples R China.	llcjj158@163.com; xzhou65@vip.sina.com	LI, CHUNJIN/GWC-7561-2022	Iqbal, Tariq/0000-0002-4984-8518; Cao, Maosheng/0000-0002-4296-3046	National Natural Science Foundation of China (NSFC) [31772596, 31672417, 31872983]; Jilin Key Programs for Science and Technology Development [20190301008NY]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jilin Key Programs for Science and Technology Development	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31772596, 31672417 and 31872983; Jilin Key Programs for Science and Technology Development, Grant/Award Number: 20190301008NY	Abedini A, 2016, FASEB J, V30, P1534, DOI 10.1096/fj.15-280313; [Anonymous], 2018, PROCEEDINGS; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baumgarten SC, 2015, J CLIN ENDOCR METAB, V100, pE1046, DOI 10.1210/jc.2015-1504; Bebelman MP, 2018, PHARMACOL THERAPEUT, V188, P1, DOI 10.1016/j.pharmthera.2018.02.013; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Bukhari SA, 2019, IUBMB LIFE, V71, P1701, DOI 10.1002/iub.2123; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen SX, 2019, J CELL PHYSIOL, V234, P8776, DOI 10.1002/jcp.27536; Choi H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197385; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Crescitelli R, 2021, NAT PROTOC, V16, P1548, DOI 10.1038/s41596-020-00466-1; da Silveira JC, 2015, REPROD FERT DEVELOP, V27, P897, DOI 10.1071/RD14452; da Silveira JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093252; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; HARDING C, 1984, EUR J CELL BIOL, V35, P256; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Hung WT, 2017, BIOL REPROD, V97, P644, DOI 10.1093/biolre/iox106; Hung WT, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132977; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jiao X, 2018, TRENDS ENDOCRIN MET, V29, P795, DOI 10.1016/j.tem.2018.07.002; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lapointe Evelyne, 2011, Front Biosci (Schol Ed), V3, P276, DOI 10.2741/s151; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Li L, 2011, BIOSCI BIOTECH BIOCH, V75, P434, DOI 10.1271/bbb.100606; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Li Z, 2020, BIOCHEM BIOPH RES CO, V523, P506, DOI 10.1016/j.bbrc.2019.12.065; Li Z, 2018, AM J TRANSL RES, V10, P1490; Liu Y, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12546; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Lv C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01059-5; Mahdi T, 2012, CELL METAB, V16, P625, DOI 10.1016/j.cmet.2012.10.009; Manabe N, 2004, J REPROD DEVELOP, V50, P493, DOI 10.1262/jrd.50.493; Matsuno Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217760; Matsuno Y, 2017, J REPROD DEVELOP, V63, P51, DOI 10.1262/jrd.2016-124; Ni J, 2020, MOL THER-NUCL ACIDS, V22, P948, DOI 10.1016/j.omtn.2020.10.014; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Ragusa M, 2015, CELL CYCLE, V14, P289, DOI 10.1080/15384101.2015.1006535; Reverchon M, 2012, HUM REPROD, V27, P1790, DOI 10.1093/humrep/des089; Santarpia L, 2010, ENDOCR-RELAT CANCER, V17, pF51, DOI 10.1677/ERC-09-0222; Santonocito M, 2014, FERTIL STERIL, V102, P1751, DOI 10.1016/j.fertnstert.2014.08.005; Shi ZG, 2019, EUR REV MED PHARMACO, V23, P5432, DOI 10.26355/eurrev_201906_18212; Sohel MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078505; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Xie M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00203-x; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang ML, 2020, LAB INVEST, V100, P342, DOI 10.1038/s41374-019-0321-y; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Yu CL, 2017, REPRODUCTION, V153, P63, DOI [10.1530/REP-16-0323, 10.1530/rep-16-0323]; Zamberlam G, 2019, ENDOCRINOLOGY, V160, P1561, DOI 10.1210/en.2019-00212	56	6	6	7	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21610	10.1096/fj.202100030RR	http://dx.doi.org/10.1096/fj.202100030RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908671				2022-12-28	WOS:000645260100040
J	Bivona, JJ; Crymble, HM; Guigni, BA; Stapleton, RD; Files, DC; Toth, MJ; Poynter, ME; Suratt, BT				Bivona, Joseph J., III; Crymble, Hanna M.; Guigni, Blas A.; Stapleton, Renee D.; Files, D. Clark; Toth, Michael J.; Poynter, Matthew E.; Suratt, Benjamin T.			Macrophages augment the skeletal muscle proinflammatory response through TNF alpha following LPS-induced acute lung injury	FASEB JOURNAL			English	Article						acute lung injury; cytokines; inflammation; macrophage; skeletal muscle		Muscle may contribute to the systemic inflammatory environment during critical illness, but leukocyte interaction and cytokine influence on muscle and its response has not been fully explored in this context. Using an in vivo model of intratracheal lipopolysaccharide (IT LPS)-induced acute lung injury, we show that skeletal muscle rapidly responds with expression of proinflammatory genes, which may be explained by migration of LPS into the circulation. Treatment of mature C2C12 myotubes with LPS at a level achieved in the circulation following IT LPS elicited a proinflammatory cytokine expression profile similar to that of in vivo murine muscle following IT LPS. Stimulation with toll-like receptor (TLR) 2 and 3 agonists provoked comparable responses in C2C12 myotubes. Additionally, co-cultures of C2C12 myotubes and bone marrow-derived macrophages (BMDM) identified the capacity of macrophages to increase myotube proinflammatory gene expression, with tumor necrosis factor-alpha (TNF alpha) gene and protein expression largely attributable to BMDM. To investigate the contribution of TNF alpha in the synergy of the co-culture environment, C2C12 myotubes were treated with recombinant TNF alpha, co-cultures were established using TNF-deficient BMDM, and co-cultures were also depleted of TNF alpha using antibodies. To determine whether the in vitro observations were relevant in vivo, mice received intramuscular administration of LPS +/- TNF alpha or TNF alpha-neutralizing antibodies and showed that TNF alpha is both sufficient and necessary to induce synergistic cytokine release from muscle. Taken together, these data demonstrate how skeletal muscle tissue may contribute proinflammatory cytokines following acute endotoxin injury and the potential of leukocytes to augment this response via TNF alpha secretion.	[Bivona, Joseph J., III; Crymble, Hanna M.; Stapleton, Renee D.; Toth, Michael J.; Poynter, Matthew E.; Suratt, Benjamin T.] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA; [Bivona, Joseph J., III; Guigni, Blas A.] Univ Vermont, Cellular Mol & Biomed Sci Doctoral Program, Burlington, VT USA; [Guigni, Blas A.; Toth, Michael J.] Univ Vermont, Dept Mol Physiol & Biophys, Larner Coll Med, Burlington, VT USA; [Files, D. Clark] Wake Forest Sch Med, Dept Internal Med, Sect Pulm Crit Care Allergy & Immunol, Winston Salem, NC 27101 USA	University of Vermont; University of Vermont; University of Vermont; Wake Forest University	Poynter, ME (corresponding author), Univ Vermont, Pulm Dis & Crit Care Med, Given E410A,89 Beaumont Ave, Burlington, VT 05405 USA.	matthew.poynter@uvm.edu		Files, Daniel Clark/0000-0002-1595-4080	NIH NHLBI [R01HL143452, T32HL076122]	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded through NIH NHLBI R01HL143452 and T32HL076122.	Armstrong Lawrence E, 2018, J Sports Med (Hindawi Publ Corp), V2018, P5724575, DOI 10.1155/2018/5724575; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bercker S, 2005, CRIT CARE MED, V33, P711, DOI 10.1097/01.CCM.0000157969.46388.A2; Borge BAS, 2009, AM J PHYSIOL-HEART C, V296, pH735, DOI 10.1152/ajpheart.01309.2008; Brown SM, 2019, ANN AM THORAC SOC, V16, P947, DOI 10.1513/AnnalsATS.201812-913FR; De Letter MACJ, 2000, J NEUROIMMUNOL, V106, P206, DOI 10.1016/S0165-5728(99)00252-0; De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329; DEITCH EA, 1990, SURGERY, V107, P411; Dirajlal-Fargo S, 2020, CLIN INFECT DIS, V70, P2413, DOI 10.1093/cid/ciz561; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Dort J, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4761427; Dumont NA, 2013, AM J PATHOL, V182, P505, DOI 10.1016/j.ajpath.2012.10.010; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Files DC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010283; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Gong WY, 2016, J PAIN, V17, P1081, DOI 10.1016/j.jpain.2016.06.010; Guigni BA, 2019, AM J PHYSIOL-CELL PH, V317, pC1213, DOI 10.1152/ajpcell.00148.2019; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Jin RM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121549; Kompan L, 1999, INTENS CARE MED, V25, P157, DOI 10.1007/s001340050809; Laitano O, 2021, SHOCK, V55, P676, DOI 10.1097/SHK.0000000000001641; Langen RCJ, 2012, AM J RESP CELL MOL, V47, P288, DOI 10.1165/rcmb.2011-0119OC; Latroche C, 2017, STEM CELL REP, V9, P2018, DOI 10.1016/j.stemcr.2017.10.027; Lee C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00077; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; LIM SG, 1993, SCAND J GASTROENTERO, V28, P573, DOI 10.3109/00365529309096090; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; McNicol FJ, 2010, BRIT J SURG, V97, P434, DOI 10.1002/bjs.6868; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Puthucheary ZA, 2018, THORAX, V73, P926, DOI 10.1136/thoraxjnl-2017-211073; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Raza A, 2017, J LEUKOCYTE BIOL, V102, P1219, DOI 10.1189/jlb.2AB0116-009RR; Reidy PT, 2019, AM J PHYSIOL-ENDOC M, V317, pE85, DOI 10.1152/ajpendo.00422.2018; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Scheler M, 2013, AM J PHYSIOL-CELL PH, V305, pC877, DOI 10.1152/ajpcell.00043.2013; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Suzuki K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010017; Pham T, 2017, AM J RESP CRIT CARE, V195, P860, DOI 10.1164/rccm.201609-1773CP; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Tkalcevic VI, 2006, EUR J PHARMACOL, V539, P131, DOI 10.1016/j.ejphar.2006.03.074; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wilairatana P, 1997, CLIN INFECT DIS, V24, P430, DOI 10.1093/clinids/24.3.430	51	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21462	10.1096/fj.202002275RR	http://dx.doi.org/10.1096/fj.202002275RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724561	Green Accepted			2022-12-28	WOS:000635216100096
J	Buisseret, B; Guillemot-Legris, O; Ben Kouidar, Y; Paquot, A; Muccioli, GG; Alhouayek, M				Buisseret, Baptiste; Guillemot-Legris, Owein; Ben Kouidar, Youssef; Paquot, Adrien; Muccioli, Giulio G.; Alhouayek, Mireille			Effects of R-flurbiprofen and the oxygenated metabolites of endocannabinoids in inflammatory pain mice models	FASEB JOURNAL			English	Article						analgesia; capsaicin; eicosanoid; lipid mediator; prostanoid; PGD(2)&#8208; G		Pain is one of the cardinal signs accompanying inflammation. The prostaglandins (PGs), synthetized from arachidonic acid by cyclooxygenase (COX)-2, are major bioactive lipids implicated in inflammation and pain. However, COX-2 is also able to metabolize other lipids, including the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide (AEA), to give glycerol ester (PG-G) and ethanolamide (PG-EA) derivatives of the PGs. Consequently, COX-2 can be considered as a hub not only controlling PG synthesis, but also PG-G and PG-EA synthesis. As they were more recently characterized, these endocannabinoid metabolites are less studied in nociception compared to PGs. Interestingly R-profens, previously considered as inactive enantiomers of nonsteroidal anti-inflammatory drugs (NSAIDs), are substrate-selective COX inhibitors. Indeed, R-flurbiprofen can selectively block PG-G and PG-EA production, without affecting PG synthesis from COX-2. Therefore, we compared the effect of R-flurbiprofen and S-flurbiprofen in models of inflammatory pain triggered by local administration of lipopolysaccharides (LPS) and carrageenan in mice. Remarkably, the effects of flurbiprofen enantiomers on mechanical hyperalgesia seem to depend on (i) the inflammatory stimuli, (ii) the route of administration, and (iii) the timing of administration. We also assessed the effect of administration of the PG-Gs, PG-EAs, and PGs on LPS-induced mechanical hyperalgesia. Our data support the interest of studying the nonhydrolytic endocannabinoid metabolism in the context of inflammatory pain.	[Buisseret, Baptiste; Guillemot-Legris, Owein; Ben Kouidar, Youssef; Paquot, Adrien; Muccioli, Giulio G.; Alhouayek, Mireille] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG; Alhouayek, M (corresponding author), Univ Catholique Louvain UCL, Louvain Drug Res Inst LDRI, Bioanal & Pharmacol Bioact Lipids Res Grp BPBL, Ave E Mounier,72 B1-72-01, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be; mireille.alhouayek@uclouvain.be	Alhouayek, Mireille/R-5058-2018	Alhouayek, Mireille/0000-0002-9193-0718; Guillemot-Legris, Owein/0000-0003-3738-3423; Muccioli, Giulio/0000-0002-1600-9259	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Alhouayek M, 2018, FASEB J, V32, P5000, DOI 10.1096/fj.201701205R; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; ANSEL JC, 1993, J IMMUNOL, V150, P4478; Ates M, 2003, EUR J NEUROSCI, V17, P597, DOI 10.1046/j.1460-9568.2003.02470.x; Ayoub SS, 2010, METHODS MOL BIOL, V644, P117, DOI 10.1007/978-1-59745-364-6_9; Bang SS, 2018, J CLIN INVEST, V128, P3568, DOI 10.1172/JCI99888; Bennett DL, 2019, PHYSIOL REV, V99, P1079, DOI 10.1152/physrev.00052.2017; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Booker L, 2012, BRIT J PHARMACOL, V165, P2485, DOI 10.1111/j.1476-5381.2011.01445.x; Bottemanne P, 2019, FASEB J, V33, P7635, DOI 10.1096/fj.201802259R; Buisseret B, 2019, TRENDS MOL MED, V25, P882, DOI 10.1016/j.molmed.2019.04.009; Buisseret B, 2019, BBA-MOL CELL BIOL L, V1864, P609, DOI 10.1016/j.bbalip.2019.01.009; Buritova J, 1998, BRIT J PHARMACOL, V125, P87, DOI 10.1038/sj.bjp.0702053; Calil IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090013; CATANZARO PJ, 1971, AM J PATHOL, V64, P387; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Clapper JR, 2018, J PHARMACOL EXP THER, V367, P494, DOI 10.1124/jpet.118.252296; de Bruin N, 2018, CHIRALITY, V30, P632, DOI 10.1002/chir.22826; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Donvito G, 2018, NEUROPSYCHOPHARMACOL, V43, P52, DOI 10.1038/npp.2017.204; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Edwards SR, 2007, CLIN EXP PHARMACOL P, V34, P414, DOI 10.1111/j.1440-1681.2007.04581.x; Fowler CJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P191, DOI 10.1006/abbi.1998.1025; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; JAMALI F, 1988, J PHARM SCI, V77, P666, DOI 10.1002/jps.2600770805; KALGUTKAR AS, 1994, BIOCHEMISTRY-US, V33, P8625, DOI 10.1021/bi00195a002; Khasabova IA, 2019, BLOOD, V133, P1989, DOI 10.1182/blood-2018-11-884346; Kim SG, 2003, CELL MOL NEUROBIOL, V23, P401, DOI 10.1023/A:1023696806609; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Leipold DD, 2004, CHIRALITY, V16, P379, DOI 10.1002/chir.20053; Matsuda M, 2019, J ANESTH, V33, P131, DOI 10.1007/s00540-018-2579-4; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Myers MJ, 2019, MOL IMMUNOL, V109, P38, DOI 10.1016/j.molimm.2019.02.020; NEUGEBAUER V, 1995, J PHARMACOL EXP THER, V275, P618; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Piomelli D, 2014, J NEUROSCI, V34, P15184, DOI 10.1523/JNEUROSCI.3475-14.2014; Rose TM, 2014, BIOORG MED CHEM LETT, V24, P5695, DOI 10.1016/j.bmcl.2014.10.064; SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V; Sala A, 2018, BIOCHEM PHARMACOL, V158, P161, DOI 10.1016/j.bcp.2018.10.007; Sasso O, 2015, PHARMACOL RES, V97, P7, DOI 10.1016/j.phrs.2015.04.001; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Watanabe M, 2015, NEUROREPORT, V26, P173, DOI 10.1097/WNR.0000000000000322; Woodhams SG, 2017, NEUROPHARMACOLOGY, V124, P105, DOI 10.1016/j.neuropharm.2017.06.015; Woodhams SG, 2015, HANDB EXP PHARMACOL, V227, P119, DOI 10.1007/978-3-662-46450-2_7; Yang F, 2017, PROTEIN CELL, V8, P169, DOI 10.1007/s13238-016-0353-7	54	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21411	10.1096/fj.202002468R	http://dx.doi.org/10.1096/fj.202002468R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749884				2022-12-28	WOS:000635216100035
J	Farzi, A; Ip, CK; Reed, F; Enriquez, R; Zenz, G; Durdevic, M; Zhang, L; Holzer, P; Herzog, H				Farzi, Aitak; Ip, Chi Kin; Reed, Felicia; Enriquez, Ronaldo; Zenz, Geraldine; Durdevic, Marija; Zhang, Lei; Holzer, Peter; Herzog, Herbert			Lack of peptide YY signaling in mice disturbs gut microbiome composition in response to high-fat diet	FASEB JOURNAL			English	Article						food intake; gut hormones; intestinal barrier; intestinal microbiota; obesity		Peptide YY (PYY), produced by endocrine L cells in the gut, is known for its critical role in regulating gastrointestinal functions as well as satiety. However, how these processes are integrated with maintaining a healthy gut microbiome composition is unknown. Here, we show that lack of PYY in mice leads to distinct changes in gut microbiome composition that are diet-dependent. While under chow diet only slight differences in gut microbiome composition could be observed, high-fat diet (HFD) aggravated these differences. Specifically an increased abundance of the Bacteroidetes phylum with a corresponding decrease of the Firmicutes/Bacteroidetes ratio could be detected in Pyy-knockout (KO) mice in response to HFD. Detailed analysis of the Bacteroidetes phylum further revealed that the Alistipes genus belonging to the Rikenellaceae family, the Parabacteroides belonging to the Tannerellaceae family, as well as Muribaculum were increased in Pyy-KO mice. In order to investigate whether these changes are associated with changed markers of gut barrier and immunity, we analyzed the colonic expression of various pro-inflammatory cytokines, as well as tight junction proteins and mucin 2, and identified increased mRNA expression of the tight junction proteins Cldn2 and Ocel1 in Pyy-KO mice, while pro-inflammatory cytokine expression was not significantly altered. Together these results highlight a critical gene-environment interaction between diet and the gut microbiome and its impact on homeostasis of the intestinal epithelium under conditions of reduced PYY signaling which is commonly seen under obese conditions.	[Farzi, Aitak; Ip, Chi Kin; Reed, Felicia; Enriquez, Ronaldo; Zhang, Lei; Herzog, Herbert] St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Farzi, Aitak; Zenz, Geraldine; Holzer, Peter] Med Univ Graz, Otto Loewi Res Ctr, Div Pharmacol, Univ Pl 4, A-8010 Graz, Austria; [Ip, Chi Kin; Zhang, Lei; Herzog, Herbert] Univ NSW, Fac Med, Sydney, NSW, Australia; [Durdevic, Marija] Med Univ Graz, Ctr Med Res, Graz, Austria; [Durdevic, Marija] Med Univ Graz, Diagnost & Res Inst Pathol, Graz, Austria; [Durdevic, Marija] Med Univ Graz, Theodor Escherich Lab Med Microbiome Res, Graz, Austria	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Medical University of Graz; University of New South Wales Sydney; Medical University of Graz; Medical University of Graz; Medical University of Graz	Herzog, H (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia.; Farzi, A (corresponding author), Med Univ Graz, Otto Loewi Res Ctr, Div Pharmacol, Univ Pl 4, A-8010 Graz, Austria.	aitak.farzi@medunigraz.at; h.herzog@garvan.org.au	Holzer, Peter/F-7578-2011	Holzer, Peter/0000-0002-5754-395X; Zhang, Lei/0000-0002-3927-8881; , Herbert/0000-0002-1713-1029; IP, CHI KIN/0000-0002-0464-4706; Zenz, Geraldine/0000-0003-3611-8724; Farzi, Aitak/0000-0001-9606-3871	Austrian Science Fund (FWF) [J-3814]; Department of Health | National Health and Medical Research Council (NHMRC) [1124723, 118775]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Austrian Science Fund (FWF), Grant/Award Number: J-3814; Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: 1124723 and 118775	Adam CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140392; Ahn DH, 2005, CELL PHYSIOL BIOCHEM, V15, P29, DOI 10.1159/000083636; Al Mushref M, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.11.01; Allaire JM, 2018, AM J PHYSIOL-GASTR L, V314, pG360, DOI 10.1152/ajpgi.00181.2017; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Brennan IM, 2011, INT J OBESITY, V35, P448, DOI 10.1038/ijo.2010.153; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chung YW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227886; Colosimo DA, 2019, CELL HOST MICROBE, V26, P273, DOI 10.1016/j.chom.2019.07.002; Cox HM, 2007, PEPTIDES, V28, P345, DOI 10.1016/j.peptides.2006.07.023; Cox HM, 2007, AUTON NEUROSCI-BASIC, V133, P76, DOI 10.1016/j.autneu.2006.10.005; Cox HM, 2010, CELL METAB, V11, P532, DOI 10.1016/j.cmet.2010.04.014; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Fernandes SP, 2020, J PEDIATR ENDOCR MET, V33, P873, DOI 10.1515/jpem-2020-0033; Forbes SC, 2014, NEUROGASTROENT MOTIL, V26, P1605, DOI 10.1111/nmo.12428; Ip CK, 2019, CELL METAB, V30, P111, DOI 10.1016/j.cmet.2019.04.001; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Kang M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42658; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Kuo WT, 2019, GASTROENTEROLOGY, V157, P1323, DOI 10.1053/j.gastro.2019.07.058; L'Huillier C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061348; Lapebie P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10068-5; Lean MEJ, 2016, INT J OBESITY, V40, P622, DOI 10.1038/ijo.2015.220; Leon-Coria A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007466; Liu DL, 2017, RSC ADV, V7, P48136, DOI 10.1039/c7ra07651g; Marion S, 2020, J LIPID RES, V61, P1450, DOI [10.1194/jlr.RA120001021, 10.1194/jlr.RA120001021.]; Nagpal R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02897; Parker BJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00906; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Robertson SJ, 2019, CELL REP, V27, P1910, DOI 10.1016/j.celrep.2019.04.023; Rodriguez-Pineiro AM, 2015, GUT MICROBES, V6, P326, DOI 10.1080/19490976.2015.1086057; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shobar RM, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.54; Smith BJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1494-7; Souli A, 1997, PEPTIDES, V18, P551, DOI 10.1016/S0196-9781(97)00069-7; Svane MS, 2016, INT J OBESITY, V40, P1699, DOI 10.1038/ijo.2016.121; Trivedi PG, 2001, PEPTIDES, V22, P395, DOI 10.1016/S0196-9781(01)00349-7; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Webb CR, 2018, INFLAMM BOWEL DIS, V24, P361, DOI 10.1093/ibd/izx014; Ye LH, 2019, ELIFE, V8, DOI 10.7554/eLife.48479; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang L, 2012, DIABETES OBES METAB, V14, P727, DOI 10.1111/j.1463-1326.2012.01592.x	51	4	4	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21435	10.1096/fj.202002215R	http://dx.doi.org/10.1096/fj.202002215R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749879	Green Published			2022-12-28	WOS:000635216100071
J	Goulding, J; Kondrashov, A; Mistry, SJ; Melarangi, T; Vo, NTN; Hoang, DM; White, CW; Denning, C; Briddon, SJ; Hill, SJ				Goulding, Joelle; Kondrashov, Alexander; Mistry, Sarah J.; Melarangi, Tony; Vo, Nguyen T. N.; Hoang, Duc M.; White, Carl W.; Denning, Chris; Briddon, Stephen J.; Hill, Stephen J.			The use of fluorescence correlation spectroscopy to monitor cell surface beta 2-adrenoceptors at low expression levels in human embryonic stem cell-derived cardiomyocytes and fibroblasts	FASEB JOURNAL			English	Article						cardiomyocytes; differentiation; embryonic stem cells; fibroblasts; fluorescence correlation spectroscopy; haplotype; receptor internalization; single&#8208; nucleotide polymorphisms; &#946; 2&#8208; adrenoceptors		The importance of cell phenotype in determining the molecular mechanisms underlying beta(2)-adrenoceptor (beta 2AR) function has been noted previously when comparing responses in primary cells and recombinant model cell lines. Here, we have generated haplotype-specific SNAP-tagged beta 2AR human embryonic stem (ES) cell lines and applied fluorescence correlation spectroscopy (FCS) to study cell surface receptors in progenitor cells and in differentiated fibroblasts and cardiomyocytes. FCS was able to quantify SNAP-tagged beta 2AR number and diffusion in both ES-derived cardiomyocytes and CRISPR/Cas9 genome-edited HEK293T cells, where the expression level was too low to detect using standard confocal microscopy. These studies demonstrate the power of FCS in investigating cell surface beta 2ARs at the very low expression levels often seen in endogenously expressing cells. Furthermore, the use of ES cell technology in combination with FCS allowed us to demonstrate that cell surface beta 2ARs internalize in response to formoterol-stimulation in ES progenitor cells but not following their differentiation into ES-derived fibroblasts. This indicates that the process of agonist-induced receptor internalization is strongly influenced by cell phenotype and this may have important implications for drug treatment with long-acting beta 2AR agonists.	[Goulding, Joelle; Kondrashov, Alexander; Mistry, Sarah J.; White, Carl W.; Denning, Chris; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Ctr Membrane Proteins & Receptors COMPARE, Nottingham, England; [Goulding, Joelle; White, Carl W.; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Nottingham, England; [Kondrashov, Alexander; Melarangi, Tony; Vo, Nguyen T. N.; Hoang, Duc M.; Denning, Chris] Univ Nottingham, Div Canc & Stem Cells, Biodiscovery Inst, Univ Pk, Nottingham, England; [Mistry, Sarah J.] Univ Nottingham, Sch Pharm, Nottingham, England; [Hoang, Duc M.] Vinmec Res Inst Stem Cell & Gene Technol, Dept Cellular Mfg, Hanoi, Vietnam; [White, Carl W.] Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Nedlands, WA, Australia; [White, Carl W.] Univ Western Australia, Ctr Med Res, QEII Med Ctr, Nedlands, WA, Australia; [White, Carl W.] Australian Res Council, Ctr Personalised Therapeut Technol, Melbourne, Vic, Australia	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Briddon, SJ; Hill, SJ (corresponding author), Univ Nottingham, Ctr Membrane Proteins & Receptors COMPARE, Nottingham, England.	stephen.briddon@nottingham.ac.uk; stephen.hill@nottingham.ac.uk	Goulding, Joelle/AAI-1362-2021; Hill, Stephen/N-6753-2013	Goulding, Joelle/0000-0002-6227-4483; Hill, Stephen/0000-0002-4424-239X; Mistry, Sarah Jane/0000-0003-1409-0097; Hoang, Duc M./0000-0001-5444-561X; Kondrashov, Alexander/0000-0003-3428-5975; White, Carl/0000-0002-4975-6189	RCUK | Medical Research Council (MRC) [MR/N020081/1]; British Heart Foundation (BHF) [RG/14/1/30588]; Department of Health | National Health and Medical Research Council (NHMRC) [1088334]	RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation (BHF)(British Heart Foundation); Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N020081/1; British Heart Foundation (BHF), Grant/Award Number: RG/14/1/30588; Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: 1088334	Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Briddon SJ, 2004, P NATL ACAD SCI USA, V101, P4673, DOI 10.1073/pnas.0400420101; Briddon SJ, 2018, TRENDS PHARMACOL SCI, V39, P158, DOI 10.1016/j.tips.2017.11.004; Bruck H, 2005, CLIN PHARMACOL THER, V78, P232, DOI 10.1016/j.clpt.2005.06.002; Bruck H, 2003, PHARMACOGENETICS, V13, P59, DOI 10.1097/00008571-200302000-00001; Calebiro D, 2020, ANNU REV PHARMACOL, V60, P73, DOI 10.1146/annurev-pharmtox-010919-023348; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chiantia S, 2009, BBA-BIOMEMBRANES, V1788, P225, DOI 10.1016/j.bbamem.2008.08.013; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; Dewar JC, 1998, CLIN EXP ALLERGY, V28, P442; Dick E, 2011, STEM CELL RES, V6, P158, DOI 10.1016/j.scr.2010.10.002; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Gherbi K, 2015, FASEB J, V29, P2859, DOI 10.1096/fj.14-265199; Ghosh E, 2019, CELL REP, V28, P3287, DOI 10.1016/j.celrep.2019.08.053; Gondin AB, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00104; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Gregorio GG, 2017, NATURE, V547, P68, DOI 10.1038/nature22354; Grime RL, 2020, NANOSCALE, V12, P11518, DOI 10.1039/d0nr01060j; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Huang B, 2004, CHEMPHYSCHEM, V5, P1523, DOI 10.1002/cphc.200400176; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Isbilir A, 2020, P NATL ACAD SCI USA, V117, P29144, DOI 10.1073/pnas.2013319117; Jacobson GA, 2018, DRUG SAFETY, V41, P441, DOI 10.1007/s40264-017-0631-1; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kilpatrick LE, 2019, CELL CHEM BIOL, V26, P830, DOI 10.1016/j.chembiol.2019.02.014; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Kondrashov A, 2018, STEM CELLS DEV, V27, P391, DOI 10.1089/scd.2017.0268; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Koryakina Y, 2012, CELL BIOL INT, V36, P1171, DOI 10.1042/CBI20120134; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Masureel M, 2018, NAT CHEM BIOL, V14, P1059, DOI 10.1038/s41589-018-0145-x; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; MOORE RH, 1995, J CELL SCI, V108, P2983; Murphy L, 2014, DRUGS, V74, P1635, DOI 10.1007/s40265-014-0284-7; Nesbeth D, 2006, MOL THER, V13, P814, DOI 10.1016/j.ymthe.2005.09.016; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rose RH, 2012, BRIT J PHARMACOL, V165, P1789, DOI 10.1111/j.1476-5381.2011.01640.x; Rosethorne EM, 2010, N-S ARCH PHARMACOL, V382, P255, DOI 10.1007/s00210-010-0533-6; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Sun YH, 2016, CHEM COMMUN, V52, P7086, DOI 10.1039/c6cc00628k; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; White CW, 2020, CELL CHEM BIOL, V27, P499, DOI 10.1016/j.chembiol.2020.01.010; White CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03486-2; Wingler LM, 2020, TRENDS CELL BIOL, V30, P736, DOI 10.1016/j.tcb.2020.06.002	64	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21398	10.1096/fj.202002268R	http://dx.doi.org/10.1096/fj.202002268R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710675	Green Published			2022-12-28	WOS:000635216100052
J	Liu, XY; Lin, L; Tang, LC; Xie, HH; Gu, LK; Lv, XJ; Liu, CB; Zhao, JZ; Deng, RZ; Liu, Y; Qu, J; Gu, F				Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Liu, Changbao; Zhao, Junzhao; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng			Lb2Cas12a and its engineered variants mediate genome editing in human cells	FASEB JOURNAL			English	Article						PAM; activity; fidelity; RS1		Cas12a-mediated targeted genome engineering strategies have enabled a broad range of research and clinical applications. However, the limited target-selection spectrum and low activity/fidelity remain a bottleneck for its widespread application in precision site-specific human genome editing. Therefore, there exists an acute need to identify novel Cas12a nucleases with improved features for genome editing. By screening a range of candidate Cas12a nucleases, here we demonstrate that Lb2Cas12a possesses genome editing activity in human cells and it has greater flexibility in PAM (5MODIFIER LETTER PRIME-BYYV-3MODIFIER LETTER PRIME) selection. Furthermore, we engineered Lb2Cas12a to generate variants (Lb2Cas12a-RVR and Lb2Cas12a-RR), which greatly expands the target-selection spectrum. Our study illustrated that Lb2Cas12a could be harnessed as additional genome editing tool for the manipulation of human genome.	[Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Eye Hosp, State Key Lab, Wenzhou, Peoples R China; [Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Key Lab Vis Sci, Minist Hlth, Wenzhou, Peoples R China; [Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Gu, F (corresponding author), Wenzhou Med Univ, 270 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China.	gufenguw@gmail.com		Gu, Feng/0000-0002-9600-8407; Gu, Feng/0000-0002-9019-2960	National Natural Science Foundation of China [81201181, 82000861]; National Key R&D Program of China [2018YFA0107304]; Natural Science Foundation of Zhejiang Province [2017C37176]; Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences [WKJ-ZJ-1828]; Zhejiang Provincial Fund for Collegiate Technological Innovation Program [2017R413001]; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University [J01-20190201]; Wenzhou City Grant [C20170007]; Lin He's Academician Workstation of New Medicine and Clinical Translation [17331209, 18331105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences; Zhejiang Provincial Fund for Collegiate Technological Innovation Program; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University; Wenzhou City Grant; Lin He's Academician Workstation of New Medicine and Clinical Translation	National Natural Science Foundation of China, Grant/Award Number: 81201181 and 82000861; National Key R&D Program of China, Grant/Award Number: 2018YFA0107304; Natural Science Foundation of Zhejiang Province, Grant/Award Number: 2017C37176; Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences, Grant/Award Number: WKJ-ZJ-1828; Zhejiang Provincial Fund for Collegiate Technological Innovation Program, Grant/Award Number: 2017R413001; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University, Grant/Award Number: J01-20190201; Wenzhou City Grant, Grant/Award Number: C20170007; Lin He's Academician Workstation of New Medicine and Clinical Translation, Grant/Award Number: 17331209 and 18331105	Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen D, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00453; Chen P, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01989-2; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; He XB, 2019, J BIOL CHEM, V294, P9308, DOI 10.1074/jbc.RA119.007791; Hong W, 2018, ACS SYNTH BIOL, V7, P1588, DOI 10.1021/acssynbio.8b00087; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Li XS, 2018, NAT BIOTECHNOL, V36, P324, DOI 10.1038/nbt.4102; Lin L, 2018, MOL THER, V26, P2650, DOI 10.1016/j.ymthe.2018.08.021; Liu YC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02265-x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Sun HH, 2018, MOL THER, V26, P2070, DOI 10.1016/j.ymthe.2018.05.021; Tang Lianchao, 2019, Cell Regen, V8, P44, DOI 10.1016/j.cr.2019.08.002; Teng F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1620-8; Teng F, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0069-3; Toth E, 2018, NUCLEIC ACIDS RES, V46, P10272, DOI 10.1093/nar/gky815; Tu MJ, 2017, NUCLEIC ACIDS RES, V45, P11295, DOI 10.1093/nar/gkx783; Walton RT, 2020, SCIENCE, V368, P290, DOI 10.1126/science.aba8853; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814	30	4	4	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21270	10.1096/fj.202001013RR	http://dx.doi.org/10.1096/fj.202001013RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715215				2022-12-28	WOS:000635216100049
J	Guerrina, N; Traboulsi, H; de Souza, AR; Bosse, Y; Thatcher, TH; Robichaud, A; Ding, J; Li, PZ; Simon, L; Pareek, S; Bourbeau, J; Tan, WC; Benedetti, A; Obeidat, M; Sin, DD; Brandsma, CA; Nickle, DC; Sime, PJ; Phipps, RP; Nair, P; Zago, M; Hamid, Q; Smith, BM; Eidelman, DH; Baglole, CJ				Guerrina, Necola; Traboulsi, Hussein; de Souza, Angela Rico; Bosse, Yohan; Thatcher, Thomas H.; Robichaud, Annette; Ding, Jun; Li, Pei Z.; Simon, Leora; Pareek, Swati; Bourbeau, Jean; Tan, Wan C.; Benedetti, Andrea; Obeidat, Ma'en; Sin, Don D.; Brandsma, Corry-Anke; Nickle, David C.; Sime, Patricia J.; Phipps, Richard P.; Nair, Parameswaran; Zago, Michela; Hamid, Qutayba; Smith, Benjamin M.; Eidelman, David H.; Baglole, Carolyn J.			Aryl hydrocarbon receptor deficiency causes the development of chronic obstructive pulmonary disease through the integration of multiple pathogenic mechanisms	FASEB JOURNAL			English	Article								Emphysema, a component of chronic obstructive pulmonary disease (COPD), is characterized by irreversible alveolar destruction that results in a progressive decline in lung function. This alveolar destruction is caused by cigarette smoke, the most important risk factor for COPD. Only 15%-20% of smokers develop COPD, suggesting that unknown factors contribute to disease pathogenesis. We postulate that the aryl hydrocarbon receptor (AHR), a receptor/transcription factor highly expressed in the lungs, may be a new susceptibility factor whose expression protects against COPD. Here, we report that Ahr-deficient mice chronically exposed to cigarette smoke develop airspace enlargement concomitant with a decline in lung function. Chronic cigarette smoke exposure also increased cleaved caspase-3, lowered SOD2 expression, and altered MMP9 and TIMP-1 levels in Ahr-deficient mice. We also show that people with COPD have reduced expression of pulmonary and systemic AHR, with systemic AHR mRNA levels positively correlating with lung function. Systemic AHR was also lower in never-smokers with COPD. Thus, AHR expression protects against the development of COPD by controlling interrelated mechanisms involved in the pathogenesis of this disease. This study identifies the AHR as a new, central player in the homeostatic maintenance of lung health, providing a foundation for the AHR as a novel therapeutic target and/or predictive biomarker in chronic lung disease.	[Guerrina, Necola; Traboulsi, Hussein; de Souza, Angela Rico; Ding, Jun; Pareek, Swati; Bourbeau, Jean; Benedetti, Andrea; Hamid, Qutayba; Smith, Benjamin M.; Baglole, Carolyn J.] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Guerrina, Necola; Pareek, Swati; Baglole, Carolyn J.] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Bosse, Yohan] Laval Univ, Inst Univ Cardiol & Pneumol Quebec, Dept Mol Med, Quebec City, PQ, Canada; [Thatcher, Thomas H.; Sime, Patricia J.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Robichaud, Annette] SCIREQ Sci Resp Equipment Inc, Montreal, PQ, Canada; [Ding, Jun; Simon, Leora; Bourbeau, Jean; Benedetti, Andrea; Hamid, Qutayba; Smith, Benjamin M.; Eidelman, David H.; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Li, Pei Z.; Bourbeau, Jean; Benedetti, Andrea; Smith, Benjamin M.] McGill Univ, Resp Epidemiol & Clin Res Unit, Hlth Ctr, Montreal, PQ, Canada; [Tan, Wan C.] Univ British Columbia UBC, UBC, James Hogg Res Ctr, Vancouver, BC, Canada; [Benedetti, Andrea] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Benedetti, Andrea] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Benedetti, Andrea] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada; [Obeidat, Ma'en; Sin, Don D.] Univ British Columbia, Ctr Heart Lung Innovat, St Pauls Hosp, Vancouver, BC, Canada; [Obeidat, Ma'en; Sin, Don D.] Univ British Columbia, Div Resp Med, Vancouver, BC, Canada; [Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nickle, David C.] Merck & Co Inc, Rahway, NJ 07065 USA; [Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; [Nair, Parameswaran] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Nair, Parameswaran] St Josephs Healthcare, Hamilton, ON, Canada; [Zago, Michela] Klox Technol, Laval, PQ, Canada; [Hamid, Qutayba] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [Baglole, Carolyn J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University; Laval University; Virginia Commonwealth University; McGill University; McGill University; University of British Columbia; McGill University; McGill University; McGill University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of Groningen; Merck & Company; University of Rochester; McMaster University; University of Sharjah; McGill University	Baglole, CJ (corresponding author), MUHC, Res Inst, Ctr Translat Biol CTB, Block E,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	carolyn.baglole@mcgill.ca	Sin, Don/AAC-2219-2021; Ding, Jun/ABH-1012-2021	Ding, Jun/0000-0001-5183-6885	Canada Foundation for Innovation (CFI); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Gouvernement du Canada \ CIHR \ Institute of Circulatory and Respiratory Health (ICRH) [PJT-168836]; Canada Research Chairs (Chaires de recherche du Canada); Fonds de Recherche du Quebec - Sante (FRQS); HHS \ National Institutes of Health (NIH) [HL075432, HL120908]	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Gouvernement du Canada \ CIHR \ Institute of Circulatory and Respiratory Health (ICRH); Canada Research Chairs (Chaires de recherche du Canada)(Canada Research Chairs); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Canada Foundation for Innovation (CFI); Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC); Gouvernement du Canada vertical bar CIHR vertical bar Institute of Circulatory and Respiratory Health (ICRH), Grant/Award Number: PJT-168836; Canada Research Chairs (Chaires de recherche du Canada); Fonds de Recherche du Quebec - Sante (FRQS); Fonds de Recherche du Quebec - Sante (FRQS); HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: HL075432; HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: HL120908	Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Angelis N, 2014, J THORAC DIS, V6, pS167, DOI 10.3978/j.issn.2072-1439.2014.03.07; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Baglole CJ, 2018, PEDIATR RES, V83, P1165, DOI 10.1038/pr.2018.36; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Boschetto P, 2006, THORAX, V61, P1037, DOI 10.1136/thx.2006.058321; Bourbeau J, 2014, COPD, V11, P125, DOI 10.3109/15412555.2012.665520; Busch R, 2017, AM J RESP CELL MOL, V57, P35, DOI 10.1165/rcmb.2016-0331OC; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; de Souza AR, 2014, TOXICOL SCI, V140, P204, DOI 10.1093/toxsci/kfu068; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Ghio AJ, 2014, INFECTION, V42, P459, DOI 10.1007/s15010-014-0592-6; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Guerrina N., 2021, FASEB J, V35; Guerrina N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123882; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hecht E, 2014, TOXICOL APPL PHARM, V280, P511, DOI 10.1016/j.taap.2014.08.023; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; National Research Council, REV DEP DEF ENH PART, P85; Nemmar A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/279371; Viet NN, 2015, RESPIROLOGY, V20, P602, DOI 10.1111/resp.12507; Papandrinopoulou D, 2012, PULM MED, V2012, DOI 10.1155/2012/542769; POLAND A, 1976, J BIOL CHEM, V251, P4936; Robichaud A, 2017, J APPL PHYSIOL, V123, P746, DOI 10.1152/japplphysiol.00856.2016; Rogers S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40539; Sarill M, 2015, FREE RADICAL BIO MED, V89, P342, DOI 10.1016/j.freeradbiomed.2015.08.007; Sharafkhaneh Amir, 2008, Proc Am Thorac Soc, V5, P475, DOI 10.1513/pats.200708-126ET; Sheridan JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0214-6; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Stejskalova L, 2013, TOXICOL LETT, V223, P183, DOI 10.1016/j.toxlet.2013.09.014; Tammemagi MC, 2011, CANCER PREV RES, V4, P552, DOI 10.1158/1940-6207.CAPR-10-0183; Tan WC, 2015, THORAX, V70, P822, DOI 10.1136/thoraxjnl-2015-206938; Taylor SC, 2015, J VIROL METHODS, V224, P58, DOI 10.1016/j.jviromet.2015.08.014; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; van der Vaart H, 2005, AM J RESP CRIT CARE, V172, P465, DOI 10.1164/rccm.200501-147OC; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035; Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787; Wang CK, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/195094; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wu R, 2007, J PHARMACOL EXP THER, V320, P448, DOI 10.1124/jpet.106.111773; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020; Zago M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074953	59	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21376	10.1096/fj.202002350R	http://dx.doi.org/10.1096/fj.202002350R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33605487	Green Published			2022-12-28	WOS:000629576700022
J	Tang, Q; Liu, QH; Yang, XP; Wu, T; Huang, CY; Zhang, JH; Zhang, ZJ; Zhang, GR; Zhao, YN; Zhou, J; Huang, H; Xia, Y; Yan, JM; Li, YP; He, JH				Tang, Qin; Liu, Qinhui; Yang, Xuping; Wu, Tong; Huang, Cuiyuan; Zhang, Jinhang; Zhang, Zijing; Zhang, Guorong; Zhao, Yingnan; Zhou, Jian; Huang, Hui; Xia, Yan; Yan, Jiamin; Li, Yanping; He, Jinhan			Sirtuin 6 supra-physiological overexpression in hypothalamic pro-opiomelanocortin neurons promotes obesity via the hypothalamus-adipose axis	FASEB JOURNAL			English	Article						obesity; overexpression; POMC neurons; Sirt6; sympathetic nervous system	POMC NEURONS; LEPTIN; WHITE; MICE; PREDISPOSES; HOMEOSTASIS; DELETION; TISSUE; BROWN	Sirtuin 6 (Sirt6), a member of the Sirtuin family, has important roles in maintaining glucose and lipid metabolism. Our previous studies demonstrated that the deletion of Sirt6 in pro-opiomelanocortin (POMC)-expressing cells by the loxP-Cre system resulted in severe obesity and hepatic steatosis. However, whether overexpression of Sirt6 in hypothalamic POMC neurons could ameliorate diet-induced obesity is still unknown. Thus, we generated mice specifically overexpressing Sirt6 in hypothalamic POMC neurons (PSOE) by stereotaxic injection of Cre-dependent adeno-associated viruses into the arcuate nucleus of Pomc-Cre mice. PSOE mice showed increased adiposity and decreased energy expenditure. Furthermore, thermogenesis of BAT and lipolysis of WAT were both impaired, caused by reduced sympathetic nerve innervation and activity in adipose tissues. Mechanistically, Sirt6 overexpression decreasing STAT3 acetylation, thus lowering POMC expression in the hypothalamus underlined the observed phenotypes in PSOE mice. These results demonstrate that Sirt6 overexpression specifically in the hypothalamic POMC neurons exacerbates diet-induced obesity and metabolic disorders via the hypothalamus-adipose axis.	[Tang, Qin; Liu, Qinhui; Yang, Xuping; Wu, Tong; Huang, Cuiyuan; Zhang, Jinhang; Zhang, Zijing; Zhang, Guorong; Zhao, Yingnan; Zhou, Jian; Huang, Hui; Xia, Yan; Yan, Jiamin; Li, Yanping; He, Jinhan] Sichuan Univ, Lab Clin Pharm & Adverse Drug React, West China Hosp, Chengdu, Peoples R China; [Yang, Xuping; Wu, Tong; Huang, Cuiyuan; Zhang, Jinhang; Zhang, Zijing; Zhang, Guorong; Zhao, Yingnan; Zhou, Jian; Huang, Hui; Xia, Yan; Yan, Jiamin; He, Jinhan] Sichuan Univ, Dept Pharm, West China Hosp, Chengdu, Peoples R China	Sichuan University; Sichuan University	He, JH (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy,Lab Clin Pharm & Adverse, Chengdu 610041, Sichuan, Peoples R China.; He, JH (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.	jinhanhe@scu.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China (NSFC) [81930020, 81873662, 81870599, 82025007]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81930020, 81873662, 81870599 and 82025007	Anderson JG, 2015, MOL METAB, V4, P846, DOI 10.1016/j.molmet.2015.09.003; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Cakir I, 2019, TRENDS ENDOCRIN MET, V30, P163, DOI 10.1016/j.tem.2019.01.002; Chang AR, 2020, PHYSIOL REV, V100, P145, DOI 10.1152/physrev.00030.2018; Chen L, 2019, J BIOL CHEM, V294, P1579, DOI 10.1074/jbc.RA118.005309; Chen Y, 2015, DIABETES, V64, P2069, DOI 10.2337/db14-1206; Cui XN, 2017, AM J PHYSIOL-ENDOC M, V313, pE493, DOI 10.1152/ajpendo.00122.2017; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Dorfman MD, 2017, DIABETES, V66, P920, DOI 10.2337/db16-0482; Favero G, 2014, ACTA HISTOCHEM, V116, P272, DOI 10.1016/j.acthis.2013.08.006; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.12519; Guo DF, 2019, DIABETES, V68, P1591, DOI 10.2337/db18-1088; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Ka SO, 2017, FASEB J, V31, P3999, DOI 10.1096/fj.201700098RR; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kuang JY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00135; Kuang JY, 2017, DIABETES, V66, P1159, DOI 10.2337/db16-1225; Mark AL, 2009, HYPERTENSION, V53, P375, DOI 10.1161/HYPERTENSIONAHA.108.124255; Messina G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00137; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nadal A, 2017, NAT REV ENDOCRINOL, V13, P536, DOI 10.1038/nrendo.2017.51; Nguyen NLT, 2017, AM J PHYSIOL-REG I, V312, pR132, DOI 10.1152/ajpregu.00344.2016; Nguyen NLT, 2014, AM J PHYSIOL-REG I, V306, pR375, DOI 10.1152/ajpregu.00552.2013; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Padilla SL, 2012, ENDOCRINOLOGY, V153, P1219, DOI 10.1210/en.2011-1665; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Petridou A, 2019, METABOLISM, V92, P163, DOI 10.1016/j.metabol.2018.10.009; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Scherer PE, 2016, DIABETES, V65, P1452, DOI 10.2337/db16-0339; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Shen KL, 2020, WORLD J PEDIATR, V16, P219, DOI 10.1007/s12519-020-00344-6; Sociali G, 2017, FASEB J, V31, P3138, DOI 10.1096/fj.201601294R; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tang CF, 2019, J CELL PHYSIOL, V234, P18615, DOI 10.1002/jcp.28500; Tang Q, 2020, MOL METAB, V37, DOI 10.1016/j.molmet.2020.100994; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Timper K, 2017, DIS MODEL MECH, V10, P679, DOI 10.1242/dmm.026609; Toda C, 2017, ANNU REV PHYSIOL, V79, P209, DOI 10.1146/annurev-physiol-022516-034110; Tupone D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00014; Villarroya F, 2018, J INTERN MED, V284, P492, DOI 10.1111/joim.12803; Wang DQ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00040; Wang PTQ, 2020, NATURE, V583, P839, DOI 10.1038/s41586-020-2527-y; Wen S, 2019, SCI CHINA LIFE SCI, V62, P771, DOI 10.1007/s11427-018-9371-4; Xiao YZ, 2017, DIABETES, V66, P1146, DOI 10.2337/db16-1546; Xiong XW, 2016, DIABETOLOGIA, V59, P151, DOI 10.1007/s00125-015-3778-2; Yao L, 2017, CELL REP, V20, P641, DOI 10.1016/j.celrep.2017.06.069; Yuan FX, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101084; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055	49	3	3	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21408	10.1096/fj.202002607	http://dx.doi.org/10.1096/fj.202002607			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583107	Bronze			2022-12-28	WOS:000629576700031
J	Verzele, NAJ; Chua, BY; Law, CW; Zhang, A; Ritchie, ME; Wightman, O; Edwards, IN; Hulme, KD; Bloxham, CJ; Bielefeldt-Ohmann, H; Trewella, MW; Moe, AAK; Chew, KY; Mazzone, SB; Short, KR; McGovern, AE				Verzele, Nathalie A. J.; Chua, Brendon Y.; Law, Charity W.; Zhang, Albert; Ritchie, Matthew E.; Wightman, Oliver; Edwards, Isaac N.; Hulme, Katina D.; Bloxham, Conor J.; Bielefeldt-Ohmann, Helle; Trewella, Matthew W.; Moe, Aung Aung Kywe; Chew, Keng Yih; Mazzone, Stuart B.; Short, Kirsty R.; McGovern, Alice E.			The impact of influenza pulmonary infection and inflammation on vagal bronchopulmonary sensory neurons	FASEB JOURNAL			English	Article						neuroinflammation; respiratory disease; sensory neuron; vagal ganglia; vagus nerve	DIFFERENTIAL EXPRESSION ANALYSIS; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; AFFERENT NEURONS; GENE-EXPRESSION; VIRUS; MACROPHAGES; AIRWAYS; COUGH; CELLS	Influenza A virus (IAV) is rapidly detected in the airways by the immune system, with resident parenchymal cells and leukocytes orchestrating viral sensing and the induction of antiviral inflammatory responses. The airways are innervated by heterogeneous populations of vagal sensory neurons which also play an important role in pulmonary defense. How these neurons respond to IAV respiratory infection remains unclear. Here, we use a murine model to provide the first evidence that vagal sensory neurons undergo significant transcriptional changes following a respiratory IAV infection. RNA sequencing on vagal sensory ganglia showed that IAV infection induced the expression of many genes associated with an antiviral and pro-inflammatory response and this was accompanied by a significant increase in inflammatory cell recruitment into the vagal ganglia. Assessment of gene expression in single-vagal sensory neurons confirmed that IAV infection induced a neuronal inflammatory phenotype, which was most prominent in bronchopulmonary neurons, and also evident in some neurons innervating other organs. The altered transcriptome could be mimicked by intranasal treatment with cytokines and the lung homogenates of infected mice, in the absence of infectious virus. These data argue that IAV pulmonary infection and subsequent inflammation induces vagal sensory ganglia neuroinflammation and this may have important implications for IAV-induced morbidity.	[Verzele, Nathalie A. J.; Wightman, Oliver; Edwards, Isaac N.; Hulme, Katina D.; Bloxham, Conor J.; Bielefeldt-Ohmann, Helle; Chew, Keng Yih; Short, Kirsty R.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Chua, Brendon Y.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Law, Charity W.; Zhang, Albert; Ritchie, Matthew E.] Walter & Eliza Hall Inst Med Res, Epigenet & Dev Div, Parkville, Vic, Australia; [Bielefeldt-Ohmann, Helle; Short, Kirsty R.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Trewella, Matthew W.; Moe, Aung Aung Kywe; Mazzone, Stuart B.; McGovern, Alice E.] Univ Melbourne, Dept Anat & Neurosci, Med Bldg 181, Parkville, Vic 3010, Australia	University of Queensland; University of Melbourne; Walter & Eliza Hall Institute; University of Queensland; University of Melbourne	McGovern, AE (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Med Bldg 181, Parkville, Vic 3010, Australia.		Moe, Aung Aung Kywe ./O-7248-2015; Moe, Aung Aung Kywe/AAX-9746-2021; Chua, Brendon/A-9755-2012	Moe, Aung Aung Kywe ./0000-0002-9629-7923; Chua, Brendon/0000-0001-5654-1293; Verzele, Nathalie/0000-0001-8048-5578; Law, Charity W/0000-0001-6082-6814; Hulme, Katina/0000-0003-1322-0136; BLOXHAM, Conor/0000-0003-1469-8174; Ritchie, Matthew/0000-0002-7383-0609	National Health and Medical Research Council of Australia [1121376, 1161029]; Australian Research Council [DE180100512]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	National Health and Medical Research Council of Australia, Grant/Award Number: 1121376 and 1161029; Australian Research Council, Grant/Award Number: DE180100512	Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Carr MJ, 2002, AM J RESP CRIT CARE, V165, P1071, DOI 10.1164/ajrccm.165.8.2108065; Chung KF, 2013, LANCET RESP MED, V1, P414, DOI 10.1016/S2213-2600(13)70043-2; Cobos EJ, 2018, CELL REP, V22, P1301, DOI 10.1016/j.celrep.2018.01.006; Deng Z, 2018, AM J RESP CRIT CARE, V198, P868, DOI 10.1164/rccm.201709-1813OC; Dinh QT, 2005, CLIN EXP ALLERGY, V35, P820, DOI 10.1111/j.1365-2222.2005.02264.x; Le DD, 2016, NEUROIMMUNOMODULAT, V23, P18, DOI 10.1159/000440622; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischer A, 1996, J CLIN INVEST, V98, P2284, DOI 10.1172/JCI119039; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kaelberer MM, 2020, AM J PHYSIOL-LUNG C, V318, pL953, DOI 10.1152/ajplung.00403.2019; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kupari J, 2019, CELL REP, V27, P2508, DOI 10.1016/j.celrep.2019.04.096; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Le DD, 2016, NEUROIMMUNOMODULAT, V23, P261, DOI 10.1159/000453068; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lin RL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00411; Lin RL, 2013, J APPL PHYSIOL, V114, P1536, DOI 10.1152/japplphysiol.01301.2012; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Liu YR, 2009, J VIROL, V83, P6837, DOI 10.1128/JVI.00379-09; Lucas TM, 2016, J VIROL, V90, P2600, DOI 10.1128/JVI.02463-15; Matsuda K, 2004, VET PATHOL, V41, P101, DOI 10.1354/vp.41-2-101; Mazzone SB, 2020, MOL NEUROBIOL, V57, P949, DOI 10.1007/s12035-019-01782-8; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; McGovern AE, 2012, NEUROSCIENCE, V207, P148, DOI 10.1016/j.neuroscience.2012.01.029; McGovern AE, 2018, J ALLERGY CLIN IMMUN, V142, P1392, DOI 10.1016/j.jaci.2018.09.004; McGovern AE, 2015, BRAIN STRUCT FUNCT, V220, P3683, DOI 10.1007/s00429-014-0883-9; McGovern Alice E, 2010, Front Neurol, V1, P153, DOI 10.3389/fneur.2010.00153; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Patil MJ, 2020, J PHYSIOL-LONDON, V598, P5541, DOI 10.1113/JP280276; Plato M, 2006, NEUROSCI LETT, V395, P215, DOI 10.1016/j.neulet.2005.10.078; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shinya K, 2000, ARCH VIROL, V145, P187, DOI 10.1007/s007050050016; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Short KR, 2011, JOVE-J VIS EXP, DOI 10.3791/2357; Spronken MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133888; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Wang JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181699; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043436; Xing Y., 2020, J INVEST DERMATOL; Yu XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13839-2; Zaccone EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155526	51	5	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21320	10.1096/fj.202001509R	http://dx.doi.org/10.1096/fj.202001509R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33660333	Bronze			2022-12-28	WOS:000629576700035
J	Amador-Martinez, I; Garcia-Ballhaus, J; Buelna-Chontal, M; Cortes-Gonzalez, C; Masso, F; Jaisser, F; Barrera-Chimal, J				Amador-Martinez, Isabel; Garcia-Ballhaus, Johannes; Buelna-Chontal, Mabel; Cortes-Gonzalez, Cesar; Masso, Felipe; Jaisser, Frederic; Barrera-Chimal, Jonatan			Early inflammatory changes and CC chemokine ligand-8 upregulation in the heart contribute to uremic cardiomyopathy	FASEB JOURNAL			English	Article						cardiorenal; chemokines; chronic kidney disease; fibrosis	CHRONIC KIDNEY-DISEASE; CARDIORENAL SYNDROME; OXIDATIVE STRESS; CARDIAC FIBROSIS; TOXINS; LINK	Uremic cardiomyopathy is a common complication in chronic kidney disease (CKD) patients, accounting for a high mortality rate. Several mechanisms have been proposed to link CKD and cardiac alterations; however, the early cardiac modifications that occur in CKD that may trigger cardiac remodeling and dysfunction remain largely unexplored. Here, in a mouse model of CKD induced by 5/6 nephrectomy, we first analyzed the early transcriptional and inflammatory changes that occur in the heart. Five days after 5/6 nephrectomy, RNA-sequencing showed the upregulation of 54 genes in the cardiac tissue of CKD mice and the enrichment of biological processes related to immune system processes. Increased cardiac infiltration of T-CD4(+) lymphocytes, myeloid cells, and macrophages during early CKD was observed. Next, since CC chemokine ligand-8 (CCL8) was one of the most upregulated genes in the heart of mice with early CKD, we investigated the effect of acute and transient CCL8 inhibition on uremic cardiomyopathy severity. An increase in CCL8 protein levels was confirmed in the heart of early CKD mice. CCL8 inhibition attenuated the early infiltration of T-CD4(+) lymphocytes and macrophages to the cardiac tissue, leading to a protection against chronic cardiac fibrotic remodeling, inflammation and cardiac dysfunction induced by CKD. Altogether, our data show the occurrence of transcriptional and inflammatory changes in the heart during the early phases of CKD and identify CCL8 as a key contributor to the early cardiac inflammatory state that triggers further cardiac remodeling and dysfunction in uremic cardiomyopathy.	[Amador-Martinez, Isabel; Garcia-Ballhaus, Johannes; Barrera-Chimal, Jonatan] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Ciudad Univ, Mexico City, DF, Mexico; [Amador-Martinez, Isabel; Garcia-Ballhaus, Johannes; Barrera-Chimal, Jonatan] Inst Nacl Cardiol Ignacio Chavez, Lab Fisiol Cardiovasc & Trasplante Renal, Unidad Invest UNAM INC, Mexico City, DF, Mexico; [Buelna-Chontal, Mabel] Inst Nacl Cardiol Ignacio Chavez, Dept Biomed Cardiovasc, Mexico City, DF, Mexico; [Cortes-Gonzalez, Cesar] Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City, Mexico; [Masso, Felipe] Inst Nacl Cardiol Ignacio Chavez, Lab Med Traslac, Unidad Invest UNAM INC, Mexico City, DF, Mexico; [Jaisser, Frederic] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, INSERM,UMRS 1138, Paris, France; [Jaisser, Frederic] Univ Lorraine, CHRU Nancy, UMR 1116,French Clin Res Infrastruct Network F CO, Ctr Invest Clin Plurithemat 1433,INSERM,INI CRCT, Nancy, France; Univ Nacl Autonoma Mexico, Unidad Invest UNAM INC, Lah Fisiol Cardiovasc & Trasplante Renal, Inst Invest Biomed, Juan Badiano 1,Secc 16 Belisario Dominguez, Mexico City 14080, DF, Mexico	Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico; National Institute of Cardiology - Mexico; Instituto Nacional de Cancerologia (INCAN); National Institute of Cardiology - Mexico; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universidad Nacional Autonoma de Mexico	Barrera-Chimal, J (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Juan Badiano 1,Secc 16 Belisario Dominguez, Mexico City 14080, DF, Mexico.	jonatanbc@hotmail.com	Buelna-Chontal, Mabel/AAZ-9298-2021	Barrera-Chimal, JONATAN/0000-0002-0711-5092	National Autonomous University of Mexico-DGAPA-PAPIIT [IN202919]; Fundacion Miguel Aleman AC; Consejo Nacional de Ciencia y Tecnologia (Conacyt-Mexico) - Ciencia de Frontera [1768]; Agence Nationale de la Recherche [ANR-16-CE14-0021-01]; Fight-HF Avenir Investment Program [ANR-15-RHUS-0004]; Fondation de France [Cardio 00086498]; Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico [SECTEI/276/2019]	National Autonomous University of Mexico-DGAPA-PAPIIT; Fundacion Miguel Aleman AC; Consejo Nacional de Ciencia y Tecnologia (Conacyt-Mexico) - Ciencia de Frontera; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fight-HF Avenir Investment Program; Fondation de France(Fondation de France); Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico	This research was supported by grants from the National Autonomous University of Mexico-DGAPA-PAPIIT (IN202919), Fundacion Miguel Aleman AC and Consejo Nacional de Ciencia y Tecnologia (Conacyt-Mexico) - Ciencia de Frontera No. 1768 to JBC, the Agence Nationale de la Recherche (ANR-16-CE14-0021-01), the Fight-HF Avenir Investment Program (ANR-15-RHUS-0004), the Fondation de France (Cardio 00086498) to FJ, and the Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico (SECTEI/276/2019) to CCG	Amador-Martinez I, 2019, AM J PHYSIOL-RENAL, V317, pF275, DOI 10.1152/ajprenal.00020.2019; Amdur RL, 2016, CLIN J AM SOC NEPHRO, V11, P1546, DOI 10.2215/CJN.13121215; Amdur RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148189; Asano K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8802; Bacmeister L, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0722-5; Bogdanova EA, 2011, METHODS MOL BIOL, V729, P85, DOI 10.1007/978-1-61779-065-2_6; Bonan NB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46724-5; Bradshaw AD, 2020, MATRIX BIOL, V91-92, P167, DOI 10.1016/j.matbio.2020.04.001; Bugyei-Twum A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39551; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Cazana-Perez V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00089; Chang D, 2015, BIOMATERIALS, V68, P67, DOI 10.1016/j.biomaterials.2015.07.050; Chin LH, 2017, ONCOTARGET, V8, P113303, DOI 10.18632/oncotarget.22964; Claro LM, 2018, TOXINS, V10, DOI 10.3390/toxins10100384; Clementi A, 2013, BLOOD PURIFICAT, V36, P200, DOI 10.1159/000356369; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Felisbino MB, 2018, JACC-BASIC TRANSL SC, V3, P704, DOI 10.1016/j.jacbts.2018.05.003; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Granata A, 2016, EUR J INTERN MED, V30, P1, DOI 10.1016/j.ejim.2016.02.019; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Jager KJ, 2019, NEPHROL DIAL TRANSPL, V34, P1803, DOI 10.1093/ndt/gfz174; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kumar Shankar, 2014, World J Nephrol, V3, P143, DOI 10.5527/wjn.v3.i4.143; Lindsey ML, 2020, J CARD FAIL, V26, P876, DOI 10.1016/j.cardfail.2020.05.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025920; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Moradi H, 2013, AM J NEPHROL, V38, P136, DOI 10.1159/000351758; Patel B, 2018, JACC-BASIC TRANSL SC, V3, P230, DOI 10.1016/j.jacbts.2017.12.006; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Rossi M, 2014, ARCH MED RES, V45, P309, DOI 10.1016/j.arcmed.2014.04.002; Santoro A, 2002, NEPHROL DIAL TRANSPL, V17, P10, DOI 10.1093/ndt/17.suppl_8.10; Sosinska-Zawierucha P, 2021, RENAL FAILURE, V43, P401, DOI 10.1080/0886022X.2021.1890617; Unudurthi SD, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2020.117440; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wang L, 2014, CARDIOVASC RES, V101, P383, DOI 10.1093/cvr/cvt258; Wang XL, 2019, NAT REV NEPHROL, V15, P159, DOI 10.1038/s41581-018-0101-8; Wang XL, 2017, JOVE-J VIS EXP, DOI 10.3791/55825; Winterberg PD, 2019, J AM SOC NEPHROL, V30, P407, DOI 10.1681/ASN.2017101138; Zhang JB, 2010, NEPHROLOGY, V15, P33, DOI 10.1111/j.1440-1797.2009.01172.x	43	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21761	10.1096/fj.202100746R	http://dx.doi.org/10.1096/fj.202100746R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245616				2022-12-28	WOS:000678975300042
J	Kanack, AJ; Aoki, K; Tiemeyer, M; Dahms, NM				Kanack, Adam J.; Aoki, Kazuhiro; Tiemeyer, Michael; Dahms, Nancy M.			Platelet and myeloid cell phenotypes in a rat model of Fabry disease	FASEB JOURNAL			English	Article						animal model; glycobiology; glycosphingolipids; lysosomal storage disease	CORONARY MICROVASCULAR DYSFUNCTION; CLINICAL-MANIFESTATIONS; ACTIVATION; INVOLVEMENT; DISORDER; IMPACT; ENZYME; SKIN	Fabry disease results from a deficiency of the lysosomal enzyme alpha-Galactosidase-A (alpha-Gal A) and is estimated to occur in approximately 1:4100 live births. Characteristic of the disease is the accumulation of alpha-Gal-A substrates, primarily the glycosphingolipids (GSLs) globotriaosylceramide and glohotriaosylsphingosine. Thrombotic events are a significant concern for Fabry patients, with strokes contributing to a. significant decrease in overall lifespan. Currently, the mechanisms underlying the increased risk of thrombotic events experienced by Fabry patients are incompletely defined. Using a rat model of Fabry disease, we provide an improved understanding of the mechanisms linking GSL, accumulation to thrombotic risk. We found that alpha-Gal A-deficient rats accumulate myeloid-derived leukocytes at sites of GST, accumulation, including in the hone marrow and circulation, and that myeloid-derived leukocyte and megakaryocyte populations were prominent among cell types that accumulated GSLs. In the circulation, alpha-Gal A-deficient rats had increases in cytokine-producing cell types and a corresponding elevation of pro-inflammatory cytokines. Lastly, circulating platelets from alpha-Gal A-deficient rats accumulated a similar set of alpha-Galactosidase-A substrates as was observed in megakaryocytes in the bone marrow, and exhibited increased platelet binding to fibrinogen in microfluidic and flow cytometric assays.	[Kanack, Adam J.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Medical College of Wisconsin; University System of Georgia; University of Georgia	Dahms, NM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	ndahms@mcw.edu			HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [K12HL141954, R24HL114474]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK042667]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [P41GM103490]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID) [R21AI129873]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K12HL141954, K12HL141954 and R24HL114474; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK042667; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P41GM103490; Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID), Grant/Award Number: R21AI129873	Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Biancini GB, 2012, BBA-MOL BASIS DIS, V1822, P226, DOI 10.1016/j.bbadis.2011.11.001; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Branton M, 2002, J AM SOC NEPHROL, V13, pS139, DOI 10.1097/01.ASN.0000016683.73778.78; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; De Francesco PN, 2013, MOL GENET METAB, V109, P93, DOI 10.1016/j.ymgme.2013.02.003; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; del Pino MD, 2018, KIDNEY BLOOD PRESS R, V43, P406, DOI 10.1159/000488121; Elliott PM, 2006, HEART, V92, P357, DOI 10.1136/hrt.2004.054015; Estevez B, 2017, PHYSIOLOGY, V32, P162, DOI 10.1152/physiol.00020.2016; Fabry J., 1898, ARCH DERMATOL SYPHIL, V43, P187; FELISTE R, 1987, THROMB RES, V48, P403, DOI 10.1016/0049-3848(87)90398-7; Ferreira CR, 2017, METABOLIC DISEASES: FOUNDATIONS OF CLINICAL MANAGEMENT, GENETICS, AND PATHOLOGY, 2ND EDITION, P367, DOI 10.3233/978-1-61499-718-4-367; Fitzgerald DJ, 2013, CIRC RES, V112, P174, DOI 10.1161/CIRCRESAHA.111.300271; FLYNN DM, 1972, ARCH DIS CHILD, V47, P26, DOI 10.1136/adc.47.251.26; Forstenpointner J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00448; Germain DP, 2019, MOL GENET METAB REP, V19, DOI 10.1016/j.ymgmr.2019.100454; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hofmann L, 2018, ELIFE, V7, DOI 10.7554/eLife.39300; Hopkins PV, 2015, J PEDIATR-US, V166, P172, DOI 10.1016/j.jpeds.2014.09.023; IGARASHI T, 1986, AM J HEMATOL, V22, P63, DOI 10.1002/ajh.2830220110; Inoue T, 2013, J HUM GENET, V58, P548, DOI 10.1038/jhg.2013.48; Junttila IS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00888; Koping M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0882-7; Kolodny E, 2015, STROKE, V46, P302, DOI 10.1161/STROKEAHA.114.006283; Korver S, 2018, MOL GENET METAB, V125, P205, DOI 10.1016/j.ymgme.2018.08.014; Lanfranca MP, 2016, J MOL MED, V94, P523, DOI 10.1007/s00109-016-1391-6; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; Lorenzen JM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0311-3; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Manz XD, 2020, JOVE-J VIS EXP, DOI 10.3791/61068; MARGUERIE GA, 1979, J BIOL CHEM, V254, P5357; Mehta N, 2016, J PROTEOME RES, V15, P2969, DOI 10.1021/acs.jproteome.6b00132; MEUWISSEN SGM, 1982, HEPATOLOGY, V2, P263; Miller JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45837-1; Miller JJ, 2019, FASEB J, V33, P418, DOI 10.1096/fj.201800771R; Miller JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99171; Mosevoll KA, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00147; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; Navarro C, 2006, ACTA NEUROPATHOL, V111, P178, DOI 10.1007/s00401-005-0026-8; Neelamegham S, 2019, GLYCOBIOLOGY, V29, P620, DOI 10.1093/glycob/cwz045; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Nylander S, 2006, THROMB RES, V117, P543, DOI 10.1016/j.thromres.2005.04.026; Orteu CH, 2007, BRIT J DERMATOL, V157, P331, DOI 10.1111/j.1365-2133.2007.08002.x; Ortiz A, 2017, MED CLIN-BARCELONA, V148, P132, DOI 10.1016/j.medcli.2016.09.047; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Parks OB, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00085; Ries M, 2003, EUR J PEDIATR, V162, P767, DOI 10.1007/s00431-003-1299-3; Rombach SM, 2012, HYPERTENSION, V60, P998, DOI 10.1161/HYPERTENSIONAHA.112.195685; de Morales JMGR, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102429; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott CR, 2013, J PEDIATR-US, V163, P498, DOI 10.1016/j.jpeds.2013.01.031; SHER NA, 1979, ARCH OPHTHALMOL-CHIC, V97, P671; Shu LM, 2014, KIDNEY INT, V86, P58, DOI 10.1038/ki.2013.520; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; SPAETH GL, 1965, ARCH OPHTHALMOL-CHIC, V74, P760, DOI 10.1001/archopht.1965.00970040762005; SUGIYAMA T, 1987, BLOOD, V69, P1712; Tomberli B, 2013, EUR J HEART FAIL, V15, P1363, DOI 10.1093/eurjhf/hft104; Uceyler N, 2014, CLIN J PAIN, V30, P915, DOI 10.1097/AJP.0000000000000041; Utsumi K, 2009, J NEUROL SCI, V283, P83, DOI 10.1016/j.jns.2009.02.319; Vedder AC, 2009, NEPHROL DIAL TRANSPL, V24, P3074, DOI 10.1093/ndt/gfp263; Vukelic Z, 2005, J AM SOC MASS SPECTR, V16, P571, DOI 10.1016/j.jasms.2005.01.013; Waldek S, 2009, GENET MED, V11, P790, DOI 10.1097/GIM.0b013e3181bb05bb; Wells L, 2013, MOL CELL PROTEOMICS, V12, P833, DOI 10.1074/mcp.E113.027904; Yazdanfard PD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225071; Yogasundaram H, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009098; York WS, 2014, GLYCOBIOLOGY, V24, P402, DOI 10.1093/glycob/cwu018	73	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21818	10.1096/fj.202001727RR	http://dx.doi.org/10.1096/fj.202001727RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320241	Green Accepted			2022-12-28	WOS:000678975300029
J	Meng, L; Du, CP; Lu, CY; Zhang, K; Li, L; Yan, JZ; Hou, XY				Meng, Li; Du, Cai-Ping; Lu, Chun-Yuan; Zhang, Kun; Li, Lin; Yan, Jing-Zhi; Hou, Xiao-Yu			Neuronal activity-induced SUMOylation of Akt1 by PIAS3 is required for long-term potentiation of synaptic transmission	FASEB JOURNAL			English	Article						Akt1; brain-derived neurotrophic factor; ERK1; 2 signaling; SUMO1 conjugation; synaptic plasticity	E3 LIGASE; PLASTICITY; PROTEIN; ACTIVATION; PHOSPHORYLATION; KINASE; LTP; TRANSCRIPTION; CONJUGATION; INHIBITION	Neuronal activity regulates spatial distribution of the SUMOylation system in cytosolic and dendritic sites, which has been implicated in learning, memory, and underlying synaptic structural and functional remodeling in the hippocampus. However, the functional target proteins for activated small ubiquitin-like modifiers (SUMOs) and downstream molecular consequences behind long-term potentiation (LTP) of synaptic plasticity remain to be elucidated. In this study, we showed that N-methyl-D-aspartate receptor-mediated neuronal activity induced the covalent modification of cytosolic Akt1 by small ubiquitin-like modifier 1 (SUMO1) in rat cortical and hippocampal CA1 neurons. Protein inhibitor of activated STAT3 (PIAS3) was involved in the activity-induced Akt1 SUMO1-ylation, and K64 and K276 residues were major SUMOylated sites. Importantly, Akt1 SUMOylation at K64 and K276 enhanced its enzymatic activity and facilitated T308 phosphorylation. Furthermore, the N-terminal SAP domain of PIAS3 bound Akt1 directly. The disruption of Akt1-PIAS3 interaction by Tat-SAP, a synthetic Tat-fused cell-permeable peptide containing PIAS3 SAP domain, inhibited neuronal activity-induced Akt1 SUMOylation and impaired LTP expression and late phase LTP maintenance in the hippocampus. Correlatedly, Tat-SAP not only blocked the LTP-related extracellular signal-regulated kinase (ERK)1/2-Elk-1-brain-derived neurotrophic factor (BDNF)/Arc signaling, but also disrupted mammalian target of rapamycin (mTOR)-eIF4E-binding protein 1 (4E-BP1) pathway. These findings reveal an activity-induced Akt1 SUMOylation by PIAS3 that contributes to ERK1/2-BDNF/Arc and mTOR-4E-BP1 cascades, and in turn, long-lasting excitatory synaptic responses.	[Meng, Li; Du, Cai-Ping; Lu, Chun-Yuan; Zhang, Kun; Li, Lin; Yan, Jing-Zhi; Hou, Xiao-Yu] Xuzhou Med Univ, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221004, Jiangsu, Peoples R China; [Hou, Xiao-Yu] China Pharmaceut Univ, Sch Life Sci Technol, State Key Lab Nat Med, Nanjing 211198, Peoples R China	Xuzhou Medical University; China Pharmaceutical University	Yan, JZ; Hou, XY (corresponding author), Xuzhou Med Univ, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221004, Jiangsu, Peoples R China.; Hou, XY (corresponding author), China Pharmaceut Univ, Sch Life Sci Technol, State Key Lab Nat Med, Nanjing 211198, Peoples R China.	yanjingzhi@xzhmu.edu.cn; xyhou@cpu.edu.cn		Hou, Xiao-Yu/0000-0001-5409-8785	National Natural Science Foundation of China [81673418, 81473185]; Natural Science Foundation of the Jiangsu Higher Education Institutions [18KJA310007, 20KJA310010]; Jiangsu 333 Program [BRA2018059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions; Jiangsu 333 Program	The National Natural Science Foundation of China, Grant/Award Number: 81673418 and 81473185; The Natural Science Foundation of the Jiangsu Higher Education Institutions, Grant/Award Number: 18KJA310007 and 20KJA310010; Jiangsu 333 Program, Grant/Award Number: BRA2018059	Ahmad F, 2017, ANTIOXID REDOX SIGN, V27, P1269, DOI 10.1089/ars.2016.6860; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Balasuriya N, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090450; Balasuriya N, 2018, J BIOL CHEM, V293, P10744, DOI 10.1074/jbc.RA118.002357; Balu DT, 2012, HIPPOCAMPUS, V22, P230, DOI 10.1002/hipo.20887; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chen YC, 2014, J NEUROSCI, V34, P9574, DOI 10.1523/JNEUROSCI.4302-13.2014; Chotiner JK, 2010, LEARN MEMORY, V17, P117, DOI 10.1101/lm.1585910; Chowdhury D, 2019, CELL STRESS CHAPERON, V24, P393, DOI 10.1007/s12192-019-00974-4; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; de la Cruz-Herrera CF, 2015, ONCOGENE, V34, P1442, DOI 10.1038/onc.2014.48; Du CP, 2020, ANTIOXID REDOX SIGN, V32, P18, DOI 10.1089/ars.2018.7669; Gallo EF, 2011, J NEUROSCI, V31, P6947, DOI 10.1523/JNEUROSCI.0374-11.2011; Ghosh H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13365; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Jaafari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052345; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kantamneni S, 2011, BIOCHEM BIOPH RES CO, V409, P657, DOI 10.1016/j.bbrc.2011.05.060; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Khayachi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03222-y; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Levenga J, 2017, ELIFE, V6, DOI 10.7554/eLife.30640; Li R, 2013, CANCER RES, V73, P5742, DOI 10.1158/0008-5472.CAN-13-0538; Lin C, 2016, ONCOGENE, V35, P595, DOI 10.1038/onc.2015.115; Liu J, 2013, STROKE, V44, DOI 10.1161/STROKEAHA.113.680181; Liu SY, 2019, BRIT J PHARMACOL, V176, P1793, DOI 10.1111/bph.14656; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nair Rajeevkumar R, 2017, Front Synaptic Neurosci, V9, P8, DOI 10.3389/fnsyn.2017.00008; Panja D, 2014, CELL REP, V9, P1430, DOI 10.1016/j.celrep.2014.10.016; Panja D, 2014, NEUROPHARMACOLOGY, V76, P664, DOI 10.1016/j.neuropharm.2013.06.024; Racaniello M, 2010, NEUROCHEM RES, V35, P239, DOI 10.1007/s11064-009-0047-0; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schorova Lenka, 2016, Front Synaptic Neurosci, V8, P9, DOI 10.3389/fnsyn.2016.00009; Sun JD, 2016, CELL MOL LIFE SCI, V73, P4303, DOI 10.1007/s00018-016-2269-z; Tai DJC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10552; Tai DJC, 2011, EMBO J, V30, P205, DOI 10.1038/emboj.2010.290; Volianskis A, 2015, BRAIN RES, V1621, P5, DOI 10.1016/j.brainres.2015.01.016; Wang LL, 2014, J PSYCHIATR NEUROSCI, V39, P259, DOI 10.1503/jpn.130148; Wang ZJ, 2020, HORM BEHAV, V118, DOI 10.1016/j.yhbeh.2019.104640; Wu R, 2020, J BIOL CHEM, V295, P6741, DOI 10.1074/jbc.RA119.012338; Zhao C, 2015, MOL NEUROBIOL, V51, P500, DOI 10.1007/s12035-014-8796-4	50	3	3	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21769	10.1096/fj.202002728R	http://dx.doi.org/10.1096/fj.202002728R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34288124				2022-12-28	WOS:000678975300039
J	Rotgers, E; Nicol, B; Rodriguez, K; Rattan, S; Flaws, JA; Yao, HHC				Rotgers, Emmi; Nicol, Barbara; Rodriguez, Karina; Rattan, Saniya; Flaws, Jodi A.; Yao, Humphrey Hung-Chang			Constitutive expression of Steroidogenic factor-1 (NR5A1) disrupts ovarian functions, fertility, and metabolic homeostasis in female mice	FASEB JOURNAL			English	Article						hyperandrogenism; infertility; metabolism; ovary	NUCLEAR RECEPTOR; SEX REVERSAL; PHENOTYPES; CRITERIA; INFERTILITY; PREVALENCE; REGULATOR; KNOCKOUT; PROTEIN; CELLS	Steroid hormones regulate various aspects of physiology, from reproductive functions to metabolic homeostasis. Steroidogenic factor-1 (NR5A1) plays a central role in the development of steroidogenic tissues and their ability to produce steroid hormones. Inactivation of Nr5a1 in the mouse results in a complete gonadal and adrenal agenesis, absence of gonadotropes in the pituitary and impaired development of ventromedial hypothalamus, which controls glucose and energy metabolism. In this study, we set out to examine the consequences of NR5A1 overexpression (NR5A1+) in the NR5A1-positive cell populations in female mice. Ovaries of NR5A1+ females presented defects such as multi-oocyte follicles and an accumulation of corpora lutea. These females were hyperandrogenic, had irregular estrous cycles with persistent metestrus and became prematurely infertile. Furthermore, the decline in fertility coincided with weight gain, increased adiposity, hypertriglyceridemia, hyperinsulinemia, and impaired glucose tolerance, indicating defects in metabolic functions. In summary, excess NR5A1 expression causes hyperandrogenism, disruption of ovarian functions, premature infertility, and disorders of metabolic homeostasis. This NR5A1 overexpression mouse provides a novel model for studying not only the molecular actions of NR5A1, but also the crosstalk between endocrine, reproductive, and metabolic systems.	[Rotgers, Emmi; Nicol, Barbara; Rodriguez, Karina; Yao, Humphrey Hung-Chang] NIEHS, Reprod Dev Biol Grp, POB 12233, Res Triangle Pk, NC 27709 USA; [Rattan, Saniya; Flaws, Jodi A.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL 61801 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Illinois System; University of Illinois Urbana-Champaign	Yao, HHC (corresponding author), NIEHS, Reprod Dev Biol Grp, NIH, 111 TW Alexander Dr,Mail Drop C4-10, Res Triangle Pk, NC 27709 USA.	humphrey.yao@nih.gov	; Yao, Hung-Chang Humphrey/B-4795-2010	Nicol, Barbara/0000-0002-3434-0658; Rodriguez, Karina/0000-0002-8465-1972; Yao, Hung-Chang Humphrey/0000-0003-2944-8469	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [Z01ES102965, T32 ES007326]	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: Z01ES102965 and T32 ES007326	Aflatounian A, 2020, J ENDOCRINOL, V245, P381, DOI 10.1530/JOE-19-0530; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16058, DOI 10.1038/nrdp.2016.58; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Baetens D, 2017, GENET MED, V19, P367, DOI 10.1038/gim.2016.118; Bashamboo A, 2016, HUM MOL GENET, V25, P3446, DOI 10.1093/hmg/ddw186; Benrick A, 2017, P NATL ACAD SCI USA, V114, pE7187, DOI 10.1073/pnas.1708854114; Bingham NC, 2006, GENESIS, V44, P419, DOI 10.1002/dvg.20231; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Buaas FW, 2012, DEVELOPMENT, V139, P4561, DOI 10.1242/dev.087247; Caldwell ASL, 2017, P NATL ACAD SCI USA, V114, pE3334, DOI 10.1073/pnas.1616467114; Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339; Couse JF, 2006, ENDOCRINOLOGY, V147, P3666, DOI 10.1210/en.2006-0276; Davis AM, 2004, J NEUROBIOL, V60, P424, DOI 10.1002/neu.20030; Domenice S, 2016, BIRTH DEFECTS RES C, V108, P309, DOI 10.1002/bdrc.21145; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Hakkinen MR, 2018, J PHARMACEUT BIOMED, V152, P165, DOI 10.1016/j.jpba.2018.01.034; Hinshelwood MM, 2003, MOL CELL ENDOCRINOL, V207, P39, DOI 10.1016/S0303-7207(03)00257-0; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Jin H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159112; Kim KW, 2011, P NATL ACAD SCI USA, V108, P10673, DOI 10.1073/pnas.1102364108; Kim KW, 2010, MOL ENDOCRINOL, V24, P1240, DOI 10.1210/me.2009-0206; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; Lavery R, 2011, DEV BIOL, V354, P111, DOI 10.1016/j.ydbio.2011.03.029; Livadas S, 2014, ENDOCRINE, V47, P631, DOI 10.1007/s12020-014-0200-7; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Luo XR, 1995, PHILOS T R SOC B, V350, P279, DOI 10.1098/rstb.1995.0162; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Nicol B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13060-1; Nicol B, 2018, HUM MOL GENET, V27, P4273, DOI 10.1093/hmg/ddy312; Nicol B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131276; Nomura R, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223768; Pangas SA, 2007, MOL ENDOCRINOL, V21, P2458, DOI 10.1210/me.2007-0146; Paradisi R, 2013, GYNECOL ENDOCRINOL, V29, P391, DOI 10.3109/09513590.2012.754876; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Rattan S, 2018, BIOL REPROD, V98, P130, DOI 10.1093/biolre/iox154; Ryan GE, 2018, ENDOCRINOLOGY, V159, P1734, DOI 10.1210/en.2017-03218; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Stener-Victorin E, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa010; Sugawara T, 1997, STEROIDS, V62, P5, DOI 10.1016/S0039-128X(96)00152-3; Teede HJ, 2018, CLIN ENDOCRINOL, V89, P251, DOI 10.1111/cen.13795; Vasquez YM, 2016, MOL ENDOCRINOL, V30, P518, DOI 10.1210/me.2015-1215; Walters KA, 2019, J ENDOCRINOL, V242, pR23, DOI 10.1530/JOE-19-0096; Walters KA, 2018, TRENDS ENDOCRIN MET, V29, P842, DOI 10.1016/j.tem.2018.08.005; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Wu S, 2014, DIABETES, V63, P1270, DOI 10.2337/db13-1514; Zeng X, 2020, CLIN CHIM ACTA, V502, P214, DOI 10.1016/j.cca.2019.11.003; Zhao L, 2015, DEVELOPMENT, V142, P1083, DOI 10.1242/dev.122184	53	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21770	10.1096/fj.202100304R	http://dx.doi.org/10.1096/fj.202100304R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34288113	Green Accepted			2022-12-28	WOS:000678975300051
J	Zhou, W; Menkhorst, E; Dimitriadis, E				Zhou, Wei; Menkhorst, Ellen; Dimitriadis, Evdokia			Jagged1 regulates endometrial receptivity in both humans and mice	FASEB JOURNAL			English	Article						blastocyst implantation; endometrial epithelial cell; endometrial receptivity; JAG1; Notch pathway	EMBRYONIC LETHALITY; NOTCH; IMPLANTATION; EXPRESSION; DECIDUALIZATION; PROGESTERONE; RECEPTOR; UTERUS; TIGHT; DIFFERENTIATION	The human endometrium undergoes cycle-dependent changes and is only receptive to an implanting blastocyst within a narrow window of 2-4 days in the mid-secretory phase. Such functional changes require delicate interplay between a diversity of factors including cytokines and signaling pathways. The Notch signaling pathway members are expressed in human endometrium. We have previously demonstrated that Notch ligand Jagged1 (JAG1) localizes in the endometrial luminal epithelium (LE) and is abnormally reduced in infertile women during receptivity. However, the functional consequences of reduced JAG1 production on endometrial receptivity to implantation of the blastocyst are unknown. This study aimed to determine the role of JAG1 in regulating endometrial receptivity in humans and mice. Knockdown of JAG1 in both primary human endometrial epithelial cells and Ishikawa cells significantly reduced their adhesive capacity to HTR8/SVneo (trophoblast cell line) spheroids. We confirmed that in human endometrial epithelial cells, JAG1 interacted with Notch Receptor 3 (NOTCH3) and knockdown of JAG1 significantly reduced the expression of Notch signaling downstream target HEY1 and classical receptivity markers. Knockdown of Jag1 in mouse LE significantly impaired blastocyst implantation. We identified ten genes (related to tight junction, infertility, and cell adhesion) that were differentially expressed by Jag1 knockdown in LE in mice. Further analysis of the tight junction family members in both species revealed that JAG1 altered the expression of tight junction components only in mice. Together, our data demonstrated that JAG1 altered endometrial epithelial cell adhesive capacity and regulated endometrial receptivity in both humans and mice likely via different mechanisms.	[Zhou, Wei; Menkhorst, Ellen; Dimitriadis, Evdokia] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Zhou, Wei; Menkhorst, Ellen; Dimitriadis, Evdokia] Royal Womens Hosp, Gynaecol Res Ctr, Level 7,20 Flemington Rd, Parkville, Vic 3052, Australia	University of Melbourne	Dimitriadis, E (corresponding author), Royal Womens Hosp, Gynaecol Res Ctr, Level 7,20 Flemington Rd, Parkville, Vic 3052, Australia.	eva.dimitriadis@unimelb.edu.au		Zhou, Wei/0000-0001-9636-7963	Department of Health | National Health and Medical Research Council (NHMRC) [APP1120689, 550905]	Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1120689 and #550905	Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashary N, 2018, ENDOCRINOLOGY, V159, P1188, DOI 10.1210/en.2017-03082; BIGSBY RM, 1986, AM J PHYSIOL, V251, pE630, DOI 10.1152/ajpendo.1986.251.5.E630; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Campbell EA, 2006, HUM REPROD, V21, P2495, DOI 10.1093/humrep/del195; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Cobellis L, 2008, J ANAT, V213, P464, DOI 10.1111/j.1469-7580.2008.00963.x; Craciunas L, 2019, HUM REPROD UPDATE, V25, P202, DOI 10.1093/humupd/dmy044; Cuman C, 2013, HUM REPROD, V28, P1161, DOI 10.1093/humrep/det058; Cuman C, 2014, REPRODUCTION, V147, pR75, DOI 10.1530/REP-13-0474; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Evans J, 2016, NAT REV ENDOCRINOL, V12, P654, DOI 10.1038/nrendo.2016.116; Fatemi HM, 2013, REPROD BIOMED ONLINE, V27, P530, DOI 10.1016/j.rbmo.2013.05.018; FINN CA, 1965, J REPROD FERTIL, V9, P301; George L, 2020, BIOCHEM BIOPH RES CO, V531, P459, DOI 10.1016/j.bbrc.2020.07.123; GLASSER SR, 1987, DIFFERENTIATION, V35, P132, DOI 10.1111/j.1432-0436.1987.tb00161.x; Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kopan R, 2014, PEDIATR NEPHROL, V29, P651, DOI 10.1007/s00467-013-2661-y; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2000, GENE DEV, V14, P1343; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Liu H, 2017, J CANCER, V8, P65, DOI 10.7150/jca.16739; Luu KC, 2004, P NATL ACAD SCI USA, V101, P8028, DOI 10.1073/pnas.0401069101; Matsuo I, 2017, MECH DEVELOP, V144, P62, DOI 10.1016/j.mod.2016.09.002; Mazella J, 2008, ENDOCRINOLOGY, V149, P15, DOI 10.1210/en.2007-0477; Menkhorst E, 2018, ONCOL LETT, V16, P4721, DOI 10.3892/ol.2018.9193; Mote PA, 1999, J CLIN ENDOCR METAB, V84, P2963, DOI 10.1210/jc.84.8.2963; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Satterfield MC, 2007, ENDOCRINOLOGY, V148, P3922, DOI 10.1210/en.2007-0321; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Someya M, 2013, CELL TISSUE RES, V354, P481, DOI 10.1007/s00441-013-1676-9; Su RW, 2016, P NATL ACAD SCI USA, V113, P2300, DOI 10.1073/pnas.1520441113; Takamura M, 2020, BIOL REPROD, V102, P53, DOI 10.1093/biolre/ioz173; Van Sinderen M, 2014, J MOL HISTOL, V45, P697, DOI 10.1007/s10735-014-9587-y; Vasquez YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007787; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Wang WX, 2020, NAT MED, V26, P1644, DOI 10.1038/s41591-020-1040-z; Wang XH, 2004, J CELL SCI, V117, P53, DOI 10.1242/jcs.00826; Whitby S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.596324; Winship AL, 2015, P NATL ACAD SCI USA, V112, P15928, DOI 10.1073/pnas.1515076112; Wu Y, 2021, BIOL REPROD, V104, P539, DOI 10.1093/biolre/ioaa222; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Zafir Sadaf, 2021, Fertil Res Pract, V7, P8, DOI 10.1186/s40738-021-00100-y; Zhang S, 2014, CELL RES, V24, P925, DOI 10.1038/cr.2014.82; Zhou W, 2020, REPROD BIOL ENDOCRIN, V18, DOI 10.1186/s12958-020-00624-w; Zhou W, 2017, MOL HUM REPROD, V23, P657, DOI 10.1093/molehr/gax044	53	4	4	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21784	10.1096/fj.202100590R	http://dx.doi.org/10.1096/fj.202100590R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34252231	Green Published			2022-12-28	WOS:000678975300015
J	Ye, YY; Xu, LL; Ding, H; Wang, X; Luo, J; Zhang, Y; Zen, K; Fang, Y; Dai, CS; Wang, YW; Zhou, Y; Jiang, L; Yang, JW				Ye, Yinyin; Xu, Lingling; Ding, Hao; Wang, Xiao; Luo, Jing; Zhang, Yu; Zen, Ke; Fang, Yi; Dai, Chunsun; Wang, Yuwei; Zhou, Yang; Jiang, Lei; Yang, Junwei			Pyruvate kinase M2 mediates fibroblast proliferation to promote tubular epithelial cell survival in acute kidney injury	FASEB JOURNAL			English	Article						acute kidney injury; fibroblast; PKM2; tubular epithelial cell	HEPATOCYTE GROWTH-FACTOR; METABOLIC REQUIREMENTS; PROXIMAL TUBULE; FACTOR RECEPTOR; ACTIVATION; MECHANISMS; REPAIR; TISSUE; MYOFIBROBLAST; FIBROSIS	Acute kidney injury (AKI) is a devastating condition with high morbidity and mortality rates. The pathological features of AKI are tubular injury, infiltration of inflammatory cells, and impaired vascular integrity. Pyruvate kinase is the final rate-limiting enzyme in the glycolysis pathway. We previously showed that pyruvate kinase M2 (PKM2) plays an important role in regulating the glycolytic reprogramming of fibroblasts in renal interstitial fibrosis. The present study aimed to determine the role of PKM2 in fibroblast activation during the pathogenesis of AKI. We found increased numbers of S100A4 positive cells expressing PKM2 in renal tissues from mice with AKI induced via folic acid or ischemia/reperfusion (I/R). The loss of PKM2 in fibroblasts impaired fibroblast proliferation and promoted tubular epithelial cell death including apoptosis, necroptosis, and ferroptosis. Mechanistically, fibroblasts produced less hepatocyte growth factor (HGF) in response to a loss of PKM2. Moreover, in two AKI mouse models, fibroblast-specific deletion of PKM2 blocked HGF signal activation and aggravated AKI after it was induced in mice via ischemia or folic acid. Fibroblast proliferation mediated by PKM2 elicits pro-survival signals that repress tubular cell death and may help to prevent AKI progression. Fibroblast activation mediated by PKM2 in AKI suggests that targeting PKM2 expression could be a novel strategy for treating AKI.	[Ye, Yinyin; Xu, Lingling; Ding, Hao; Wang, Xiao; Luo, Jing; Zhang, Yu; Fang, Yi; Dai, Chunsun; Zhou, Yang; Jiang, Lei; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 N Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China; [Ye, Yinyin; Wang, Yuwei] Wannan Med Coll, Yijishan Hosp, Dept Nephrol, Wuhu, Peoples R China; [Zen, Ke] Nanjing Univ, Adv Inst Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China	Nanjing Medical University; Wannan Medical College; Nanjing University	Jiang, L; Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 N Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	jianglei@njmu.eu.cn; jwyang@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [81870502, 81873618, 81800651]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870502, 81873618 and 81800651	Al-Jaghbeer M, 2018, J AM SOC NEPHROL, V29, P654, DOI 10.1681/ASN.2017070765; Belavgeni A, 2020, CELL CHEM BIOL, V27, P448, DOI 10.1016/j.chembiol.2020.03.016; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Boor P, 2012, NEPHROL DIAL TRANSPL, V27, P3027, DOI 10.1093/ndt/gfs296; Chen JC, 2018, J AM SOC NEPHROL, V29, P2372, DOI 10.1681/ASN.2017121272; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Ding H, 2017, AM J PHYSIOL-RENAL, V313, pF561, DOI 10.1152/ajprenal.00036.2017; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Gerarduzzi C, 2017, INFLAMM RES, V66, P451, DOI 10.1007/s00011-016-1019-x; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Gui Y, 2019, CELL DEATH DIFFER, V26, P2774, DOI 10.1038/s41418-019-0336-3; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; He F, 2008, COLLOID SURFACE B, V61, P290, DOI 10.1016/j.colsurfb.2007.09.009; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Karihaloo A, 2001, J BIOL CHEM, V276, P9166, DOI 10.1074/jbc.M009963200; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; KURTZ A, 1989, CONTRIB NEPHROL, V76, P14; Kurtz A, 2011, ANNU REV PHYSIOL, V73, P377, DOI 10.1146/annurev-physiol-012110-142238; Liu YH, 2004, AM J PHYSIOL-RENAL, V287, pF7, DOI 10.1152/ajprenal.00451.2003; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Maddaluno L, 2017, DEVELOPMENT, V144, P4047, DOI 10.1242/dev.152587; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Muller T, 2017, CELL MOL LIFE SCI, V74, P3631, DOI 10.1007/s00018-017-2547-4; Neto MM, 2004, CLIN TRANSPLANT, V18, P156, DOI 10.1046/j.1399-0012.2003.00140.x; Otto AM, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0145-9; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Priante G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143598; Qin N, 2019, J PATHOL, V247, P392, DOI 10.1002/path.5198; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Schiessl IM, 2018, J AM SOC NEPHROL, V29, P1383, DOI 10.1681/ASN.2017101069; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shen Y, 2020, AM J PHYSIOL-RENAL, V318, pF689, DOI 10.1152/ajprenal.00229.2019; TAKAHASHIIWANAGA H, 1991, CELL TISSUE RES, V264, P269, DOI 10.1007/BF00313964; Tan RJ, 2016, KIDNEY DIS-BASEL, V2, P136, DOI 10.1159/000446336; Tanimura S, 2002, J BIOL CHEM, V277, P28256, DOI 10.1074/jbc.M202866200; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; Vincent IS, 2014, NEPHRON CLIN PRACT, V127, P10, DOI 10.1159/000363714; Yang WW, 2015, J CELL SCI, V128, P1655, DOI 10.1242/jcs.166629; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Zeisberg M, 2015, CLIN J AM SOC NEPHRO, V10, P1831, DOI 10.2215/CJN.00640114; Zhou D, 2019, FASEB J, V33, P12576, DOI 10.1096/fj.201900651RR; Zhou D, 2018, J AM SOC NEPHROL, V29, P1257, DOI 10.1681/ASN.2017080903; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102	56	4	4	6	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21706	10.1096/fj.202100040R	http://dx.doi.org/10.1096/fj.202100040R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160104				2022-12-28	WOS:000667814100019
J	Kim, J; Kang, J; Kim, YW; Kim, A				Kim, Jiwook; Kang, Jin; Kim, Yea Woon; Kim, AeRi			The human beta-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites	FASEB JOURNAL			English	Article						CTCF sites; enhancer; LCR HS2; TAD; beta-globin	LOCUS-CONTROL REGION; HYPERSENSITIVE SITES; GENE-EXPRESSION; SPECIFICITY; COOPERATE; SEQUENCE; GATA-1; TARGET	The human beta-globin locus control region (LCR) hypersensitive site 2 (HS2) is one of enhancers for transcription of the beta-like globin genes in erythroid cells. Our previous study showed that the LCR HS2 has active chromatin structure before transcriptional induction of the beta-globin gene, while another enhancer LCR HS3 is activated by the induction. To compare functional difference between them, we deleted each HS (Delta HS2 and Delta HS3) from the human beta-globin locus in hybrid MEL/ch11 cells. Deletion of either HS2 or HS3 dramatically diminished the beta-globin transcription and disrupted locus-wide histone H3K27ac and chromatin interaction between LCR HSs and gene. Surprisingly, Delta HS2 weakened interactions between CTCF sites forming the beta-globin topologically associating domain (TAD), while Delta HS3 did not. CTCF occupancy and chromatin accessibility were reduced at the CTCF sites in the Delta HS2 locus. To further characterize the HS2, we deleted the maf-recognition elements for erythroid activator NF-E2 at HS2. This deletion decreased the beta-globin transcription and enhancer-promoter interaction, but did not affect interactions between CTCF sites for the TAD. In light of these results, we propose that the HS2 has a role in forming a beta-globin TAD by activating neighboring CTCF sites and this role is beyond typical enhancer activity.	[Kim, Jiwook; Kang, Jin; Kim, Yea Woon; Kim, AeRi] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea	Pusan National University	Kim, A (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea.	kimaeri@pusan.ac.kr			National Research Foundation of Korea (NRF) [NRF-2017R1A2B4008947]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1A2B4008947	Amid A, 2015, HAEMATOLOGICA, V100, DOI 10.3324/haematol.2014.117408; Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bottardi S, 2005, HUM MOL GENET, V14, P493, DOI 10.1093/hmg/ddi046; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Cho Y, 2008, NUCLEIC ACIDS RES, V36, P4521, DOI 10.1093/nar/gkn368; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Joly P, 2011, HEMOGLOBIN, V35, P316, DOI 10.3109/03630269.2011.571331; Kang J, 2018, BBA-GENE REGUL MECH, V1861, P637, DOI 10.1016/j.bbagrm.2018.05.005; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kim A, 2003, MOL CELL BIOL, V23, P8099, DOI 10.1128/MCB.23.22.8099-8109.2003; Kim K, 2010, INT J BIOCHEM CELL B, V42, P1517, DOI 10.1016/j.biocel.2010.05.009; Kim S, 2012, INT J BIOCHEM CELL B, V44, P505, DOI 10.1016/j.biocel.2011.12.001; Kim YW, 2020, FASEB J, V34, P14736, DOI 10.1096/fj.202001526R; Kim YW, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170976; Krivega I, 2016, ANN NY ACAD SCI, V1368, P31, DOI 10.1111/nyas.13012; Kukreti R, 2002, AM J HEMATOL, V69, P77, DOI 10.1002/ajh.10026; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Li GL, 1998, GENES CELLS, V3, P415, DOI 10.1046/j.1365-2443.1998.00200.x; Majumder P, 2020, J EXP MED, V217, DOI 10.1084/jem.20190668; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; Paliou C, 2019, P NATL ACAD SCI USA, V116, P12390, DOI 10.1073/pnas.1900672116; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Peterson KR, 2012, NUCLEIC ACIDS RES, V40, P11256, DOI 10.1093/nar/gks900; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reik A, 1998, MOL CELL BIOL, V18, P5992, DOI 10.1128/MCB.18.10.5992; Ross J, 2009, NUCLEIC ACIDS RES, V37, P5295, DOI 10.1093/nar/gkp545; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Stees JR, 2016, MOL CELL BIOL, V36, P238, DOI 10.1128/MCB.00723-15; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358	44	3	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21669	10.1096/fj.202002337R	http://dx.doi.org/10.1096/fj.202002337R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34033138				2022-12-28	WOS:000655695900046
J	Nguyen-Lefebvre, AT; Selzner, N; Wrana, JL; Bhat, M				Anh Thu Nguyen-Lefebvre; Selzner, Nazia; Wrana, Jeffrey L.; Bhat, Mamatha			The hippo pathway: A master regulator of liver metabolism, regeneration, and disease	FASEB JOURNAL			English	Review						Hippo signaling pathway; liver cancer; liver metabolism; liver regeneration	YES-ASSOCIATED PROTEIN; HEPATIC STELLATE CELLS; HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; EPITHELIAL-MESENCHYMAL TRANSITION; AMPK-MEDIATED REGULATION; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; STEM-CELL; SIGNALING-PATHWAY; YAP PATHWAY	The liver is the only visceral organ in the body with a tremendous capacity to regenerate in response to insults that induce inflammation, cell death, and injury. Liver regeneration is a complicated process involving a well-orchestrated activation of non-parenchymal cells in the injured area and proliferation of undamaged hepatocytes. Furthermore, the liver has a Hepatostat, defined as adjustment of its volume to that required for homeostasis. Understanding the mechanisms that control different steps of liver regeneration is critical to informing therapies for liver repair, to help patients with liver disease. The Hippo signaling pathway is well known for playing an essential role in the control and regulation of liver size, regeneration, stem cell self-renewal, and liver cancer. Thus, the Hippo pathway regulates dynamic cell fates in liver, and in absence of its downstream effectors YAP and TAZ, liver regeneration is severely impaired, and the proliferative expansion of liver cells blocked. We will mainly review upstream mechanisms activating the Hippo signaling pathway following partial hepatectomy in mouse model and patients, its roles during different steps of liver regeneration, metabolism, and cancer. We will also discuss how targeting the Hippo signaling cascade might improve liver regeneration and suppress liver tumorigenesis.	[Anh Thu Nguyen-Lefebvre; Selzner, Nazia; Bhat, Mamatha] Toronto Gen Hosp, Multiorgan Transplant Program, Dept Med, Toronto, ON, Canada; [Anh Thu Nguyen-Lefebvre; Wrana, Jeffrey L.] Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bhat, M (corresponding author), Univ Toronto, Univ Hlth Network, Multiorgan Transplant Program, 585 Univ Ave,11 PMB-183, Toronto, ON, Canada.	mamatha.bhat@uhn.ca		Bhat, Mamatha/0000-0003-1960-8449; Nguyen-Lefebvre, Anh Thu/0000-0001-6247-7101	Canadian Liver Foundation; American Society of Transplantation; Canadian Donation and Transplant Research Program; Toronto General and Western Hospital Foundation	Canadian Liver Foundation; American Society of Transplantation; Canadian Donation and Transplant Research Program; Toronto General and Western Hospital Foundation	Canadian Liver Foundation; American Society of Transplantation; Canadian Donation and Transplant Research Program; Toronto General and Western Hospital Foundation	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Alder O, 2014, CELL REP, V9, P261, DOI 10.1016/j.celrep.2014.08.046; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Ardestani A, 2018, TRENDS ENDOCRIN MET, V29, P492, DOI 10.1016/j.tem.2018.04.006; Armengol C, 2011, INT J BIOCHEM CELL B, V43, P265, DOI 10.1016/j.biocel.2009.07.012; Attisano Liliana, 2013, F1000Prime Rep, V5, P17, DOI 10.12703/P5-17; Aylon Y, 2016, GENE DEV, V30, P786, DOI 10.1101/gad.274167.115; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Basu D, 2014, MOL CANCER THER, V13, P1457; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Benhammou Jihane N, 2020, Hepatoma Res, V6, DOI 10.20517/2394-5079.2020.16; Bergquist A, 2015, BEST PRACT RES CL GA, V29, P221, DOI 10.1016/j.bpg.2015.02.003; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Buckarma EH, 2020, MOL CANCER RES, V18, P1574, DOI 10.1158/1541-7786.MCR-20-0165; Cai WY, 2017, HEPATOLOGY, V65, P1206, DOI 10.1002/hep.28911; Caliari SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21387; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chan SW, 2013, J BIOL CHEM, V288, P37296; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Ege N, 2018, CELL SYST, V6, P692, DOI 10.1016/j.cels.2018.05.006; Ellison C, 2015, CURR BIOL, V25, pR113, DOI 10.1016/j.cub.2014.12.026; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Farshidfar F, 2017, CELL REP, V18, P2780, DOI 10.1016/j.celrep.2017.02.033; Fausti Francesca, 2012, Mol Biol Int, V2012, P307628, DOI 10.1155/2012/307628; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Fitamant J, 2015, CELL REP, V10, P1692, DOI 10.1016/j.celrep.2015.02.027; Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491; Geng C, 2016, BIOCHEM BIOPH RES CO, V471, P444, DOI 10.1016/j.bbrc.2016.02.059; Ghouri Yezaz Ahmed, 2015, J Carcinog, V14, P1, DOI 10.4103/1477-3163.151940; Gilgenkrantz H, 2018, AM J PATHOL, V188, P1316, DOI 10.1016/j.ajpath.2018.03.008; Gill MK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05939-2; Gong R, 2015, CELL RES, V25, P985, DOI 10.1038/cr.2015.88; Grijalva JL, 2014, AM J PHYSIOL-GASTR L, V307, pG196, DOI 10.1152/ajpgi.00077.2014; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Hagenbeek TJ, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaj1757; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hasuike S, 2005, J GASTROEN HEPATOL, V20, P1753, DOI 10.1111/j.1440-1746.2005.03922.x; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Hibi Taizo, 2017, Clin Liver Dis (Hoboken), V10, P93, DOI 10.1002/cld.666; Higashi T, 2015, BRIT J CANCER, V113, P252, DOI 10.1038/bjc.2015.170; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; Ichikawa T, 2001, HEPATOLOGY, V34, P918, DOI 10.1053/jhep.2001.29132; Irvine KD, 2012, SEMIN CELL DEV BIOL, V23, P812, DOI 10.1016/j.semcdb.2012.04.006; Jagannathan R, 2016, MOL CELL BIOL, V36, P2526, DOI 10.1128/MCB.00136-16; Jiang X, 2020, EXP CELL RES, V399; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Johnson K, 2003, NAT CELL BIOL, V5, P12, DOI 10.1038/ncb0103-12; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Juan WC, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090055; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kaneko K, 2014, BIOCHEM BIOPH RES CO, V447, P352, DOI 10.1016/j.bbrc.2014.04.006; Kanellos G, 2015, CELL REP, V13, P1949, DOI 10.1016/j.celrep.2015.10.056; Kanwal F, 2018, GASTROENTEROLOGY, V155, P1828, DOI 10.1053/j.gastro.2018.08.024; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Khandelwal M, 2020, MOL CELL BIOCHEM, V464, P51, DOI 10.1007/s11010-019-03648-y; Kim AR, 2019, FASEB J, V33, P5914, DOI 10.1096/fj.201801256RR; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kim JM, 2011, HUM PATHOL, V42, P315, DOI 10.1016/j.humpath.2010.08.003; Kim KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092427; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kohjima M, 2013, J HEPATOL, V59, P1246, DOI 10.1016/j.jhep.2013.07.025; Konishi T, 2018, AM J PHYSIOL-GASTR L, V314, pG471, DOI 10.1152/ajpgi.00153.2017; Koo JH, 2018, CELL METAB, V28, P196, DOI 10.1016/j.cmet.2018.07.010; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lawrence MC, 2019, LIVER TRANSPLANT, V25, P1541, DOI 10.1002/lt.25608; Lee DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11961; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Li JX, 2000, GENE DEV, V14, P464; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Li Q, 2014, DEV CELL, V31, P291, DOI 10.1016/j.devcel.2014.09.012; Li XJ, 2013, INT J ONCOL, V43, P1992, DOI 10.3892/ijo.2013.2121; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Liu Y, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/7652359; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Luo M, 2020, NAT CELL BIOL, V22, P1447, DOI 10.1038/s41556-020-00602-9; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Maruyama T, 2017, CURR OPIN CELL BIOL, V48, P106, DOI 10.1016/j.ceb.2017.06.007; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Meyer K, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20198985; Meyer K, 2017, CELL SYST, V4, P277, DOI 10.1016/j.cels.2017.02.008; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mitamura T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-97; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Moslehi A, 2018, J CLIN TRANSL HEPATO, V6, P332, DOI 10.14218/JCTH.2017.00061; Moya IM, 2019, SCIENCE, V366, P1029, DOI 10.1126/science.aaw9886; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; NAGASUE N, 1987, ANN SURG, V206, P30, DOI 10.1097/00000658-198707000-00005; Nagata R, 2018, DEV GROWTH DIFFER, V60, P522, DOI 10.1111/dgd.12575; Nakajima H, 2017, DEV CELL, V40, P523, DOI 10.1016/j.devcel.2017.02.019; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Nelson N, 2016, ONCOTARGET, V7, P33821, DOI 10.18632/oncotarget.8447; Nguyen HB, 2013, ONCOGENE, V32, P4100, DOI 10.1038/onc.2012.431; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Oertel M, 2008, BBA-MOL BASIS DIS, V1782, P61, DOI 10.1016/j.bbadis.2007.12.004; Oh SH, 2002, SEMIN CELL DEV BIOL, V13, P405, DOI 10.1016/S1084952102001271; Ohashi K, 2017, J BIOCHEM, V161, P245, DOI 10.1093/jb/mvw082; Oikawa H, 2002, J GASTROEN HEPATOL, V17, P861, DOI 10.1046/j.1440-1746.2002.02831.x; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Park YY, 2016, HEPATOLOGY, V63, P159, DOI 10.1002/hep.28223; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Pei TM, 2015, ONCOTARGET, V6, P17206, DOI 10.18632/oncotarget.4043; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Perra A, 2014, J HEPATOL, V61, P1088, DOI 10.1016/j.jhep.2014.06.033; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Pinzani M, 2015, DIGEST DIS, V33, P492, DOI 10.1159/000374096; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Ray Katrina, 2015, Nat Rev Gastroenterol Hepatol, V12, P549, DOI 10.1038/nrgastro.2015.147; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Regue L, 2013, BIOESSAYS, V35, P430, DOI 10.1002/bies.201200163; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Riddiough GE, 2020, HPB, V22, P487, DOI 10.1016/j.hpb.2019.10.2445; Rizvi S, 2016, J BIOL CHEM, V291, P8031, DOI 10.1074/jbc.M115.698472; Robinson BS, 2011, CURR BIOL, V21, pR890, DOI 10.1016/j.cub.2011.09.019; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Roglic G., 2016, INT J NONCOMMUN DIS, V1, P3, DOI [DOI 10.4103/2468-8827.184853, 10.4103/2468-8827.184853]; Rudnick DA, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/549241; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Sato Y, 1997, SURG TODAY, V27, P518, DOI 10.1007/BF02385805; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379; Sciarretta S, 2015, CELL REP, V11, P125, DOI 10.1016/j.celrep.2015.03.010; Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7; Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; Shu ZP, 2019, J CELL MOL MED, V23, P3616, DOI 10.1111/jcmm.14262; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Smoot RL, 2018, J CELL BIOCHEM, V119, P824, DOI 10.1002/jcb.26246; Sohn BH, 2016, CLIN CANCER RES, V22, P1256, DOI 10.1158/1078-0432.CCR-15-1447; Sonam S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20415; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song ZW, 2017, SEMIN CELL DEV BIOL, V71, P153, DOI 10.1016/j.semcdb.2017.07.041; Soon RK, 2008, CLIN LIVER DIS, V12, P791, DOI 10.1016/j.cld.2008.07.004; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Suarez-Causado A, 2015, BBA-MOL CELL RES, V1853, P2453, DOI 10.1016/j.bbamcr.2015.05.017; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; Sugihara T, 2018, MOL CANCER RES, V16, P1556, DOI 10.1158/1541-7786.MCR-18-0158; Sugimachi K, 2017, ONCOLOGY-BASEL, V93, P67, DOI 10.1159/000463390; Swiderska-Syn M, 2014, GUT, V63, P1333, DOI 10.1136/gutjnl-2013-305962; Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tang Y, 2020, CANCER CELL, V38, P115, DOI 10.1016/j.ccell.2020.05.019; Tanimizu N, 2014, ORGANOGENESIS, V10, P208, DOI 10.4161/org.27591; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Tao YC, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4256352; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thimgan MS, 1999, AM J PHYSIOL-GASTR L, V277, pG137, DOI 10.1152/ajpgi.1999.277.1.G137; Titchenell PM, 2017, TRENDS ENDOCRIN MET, V28, P497, DOI 10.1016/j.tem.2017.03.003; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Tschuor C, 2019, FASEB BIOADV, V1, P51, DOI 10.1096/fba.1023; Tucker ON, 2005, CURR OPIN CRIT CARE, V11, P150, DOI 10.1097/01.ccx.0000157080.11117.45; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vos TA, 1999, HEPATOLOGY, V29, P1833, DOI 10.1002/hep.510290638; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang C, 2012, MOL MED REP, V5, P410, DOI 10.3892/mmr.2011.640; Wang DY, 2020, AM J CANCER RES, V10, P610; Wang EY, 2018, BBA-GENE REGUL MECH, V1861, P854, DOI 10.1016/j.bbagrm.2018.07.004; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wang Y, 2017, PROTEIN CELL, V8, P349, DOI 10.1007/s13238-017-0371-0; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; WATANABE N, 1991, J CELL BIOL, V113, P1069, DOI 10.1083/jcb.113.5.1069; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wu H, 2016, TUMOR BIOL, V37, P13499, DOI 10.1007/s13277-016-5211-y; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xiao Yang, 2016, Curr Treat Options Cardiovasc Med, V18, P38, DOI 10.1007/s11936-016-0461-y; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; XU TA, 1995, DEVELOPMENT, V121, P1053; Yamada D, 2015, HEPATOLOGY, V61, P1627, DOI 10.1002/hep.27687; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182; Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yokoyama Y, 2007, J HEPATO-BILIARY-PAN, V14, P159, DOI 10.1007/s00534-006-1125-1; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan WC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07394-5; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhang X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15280; Zhang XD, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0892-2; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340; Zhang Y, 2017, J MOL MED, V95, P465, DOI 10.1007/s00109-017-1525-5; Zhang ZW, 2013, CELL PHYSIOL BIOCHEM, V32, P1808, DOI 10.1159/000356614; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng X, 2017, EMBO J, V36, P3325, DOI 10.15252/embj.201797609; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zoller H, 2016, METABOLISM, V65, P1151, DOI 10.1016/j.metabol.2016.01.010	280	18	18	7	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21570	10.1096/fj.202002284RR	http://dx.doi.org/10.1096/fj.202002284RR			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33831275	hybrid			2022-12-28	WOS:000645260100047
J	Barayan, D; Abdullahi, A; Vinaik, R; Knuth, CM; Auger, C; Jeschke, MG				Barayan, Dalia; Abdullahi, Abdikarim; Vinaik, Roohi; Knuth, Carly M.; Auger, Christopher; Jeschke, Marc G.			Interleukin-6 blockade, a potential adjunct therapy for post-burn hypermetabolism	FASEB JOURNAL			English	Article						anti-IL-6 mAb; burn; effectiveness; hypermetabolism; interleukin-6; safety	WHITE ADIPOSE-TISSUE; RECEPTOR ANTIBODY; INJURY; SKIN; TOCILIZUMAB; CYTOKINES; MARKER; IL-6	Severe burns remain a leading cause of death and disability worldwide. Despite advances in patient care, the excessive and uncontrolled hypermetabolic stress response induced by this trauma inevitably affects every organ system causing substantial morbidity and mortality. Recent evidence suggests interleukin-6 (IL-6) is a major culprit underlying post-burn hypermetabolism. Indeed, genetic deletion of IL-6 alleviates various complications associated with poor clinical outcomes including the adverse remodeling of adipose tissue, cachexia and hepatic steatosis. Thus, pharmacological blockade of IL-6 may be a more favorable treatment option to fully restore metabolic function after injury. To test this, we investigated the safety and effectiveness of blocking IL-6 for post-burn hypermetabolism using a validated anti-IL-6 monoclonal antibody (mAb) in our experimental murine model. Here, we show daily anti-IL-6 mAb administration protects against burn-induced weight loss (P < .0001) without any adverse effect on mortality. At the organ level, post-burn treatment with the IL-6 blocker suppressed the thermogenic activation of adipose tissue (P < .01) and its associated wasting (P < .05). The reduction of browning-induced lipolysis (P < .0001) indirectly decreased hepatic lipotoxicity (P < .01) which improved liver dysfunction (P < .05). Importantly, the beneficial effects of this anti-IL-6 agent extended to the skin, reflected by the decrease in excessive collagen deposition (P < .001) and genes involved in pathologic fibrosis and scarring (P < .05). Together, our results indicate that post-burn IL-6 blockade leads to significant improvements in systemic hypermetabolism by inhibiting pathological alterations in key immunometabolic organs. These findings support the therapeutic potential of anti-IL-6 interventions to improve care, quality of life, and survival in burned patients.	[Barayan, Dalia; Abdullahi, Abdikarim; Vinaik, Roohi; Knuth, Carly M.; Auger, Christopher; Jeschke, Marc G.] Sunnybrook Res Inst, Toronto, ON, Canada; [Jeschke, Marc G.] Univ Toronto, Dept Surg, Div Plast Surg, Toronto, ON, Canada; [Jeschke, Marc G.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Jeschke, Marc G.] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Jeschke, MG (corresponding author), Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada.	marc.jeschke@sunnybrook.ca	Jeschke, Marc/D-3501-2019	Jeschke, Marc/0000-0003-0870-1664	Canadian Institutes of Health Research [123336]; CFI Leaders Opportunity Fund [25407]; NIH [R01GM087285, 5R01GM133961-02]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CFI Leaders Opportunity Fund(Canada Foundation for Innovation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Canadian Institutes of Health Research: #123336; CFI Leaders Opportunity Fund: Project #25407; NIH: R01GM087285, 5R01GM133961-02	Abdullahi A, 2014, CELL MOL LIFE SCI, V71, P3241, DOI 10.1007/s00018-014-1612-5; Abdullahi A, 2020, J CELL MOL MED, V24, P9764, DOI 10.1111/jcmm.15548; Abdullahi A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2103-2; Abdullahi A, 2019, ANN SURG, V269, P554, DOI 10.1097/SLA.0000000000002465; Abdullahi A, 2017, SHOCK, V47, P33, DOI 10.1097/SHK.0000000000000749; Abdullahi A, 2016, TRENDS ENDOCRIN MET, V27, P542, DOI 10.1016/j.tem.2016.06.006; Ando K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102436; Barayan D, 2020, SHOCK, V53, P137, DOI 10.1097/SHK.0000000000001439; Biffl WL, 1996, ANN SURG, V224, P647, DOI 10.1097/00000658-199611000-00009; Brigham Peter A., 1996, Journal of Burn Care and Rehabilitation, V17, P95, DOI 10.1097/00004630-199603000-00003; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971; Finnerty CC, 2016, LANCET, V388, P1427, DOI 10.1016/S0140-6736(16)31406-4; Gallucci RM, 2001, J INTERF CYTOK RES, V21, P603, DOI 10.1089/10799900152547867; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Guzik TJ, 2017, CARDIOVASC RES, V113, P1009, DOI 10.1093/cvr/cvx108; Hager S, 2018, J BURN CARE RES, V39, P379, DOI 10.1097/BCR.0000000000000604; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Jeschke MG, 2009, MOL MED, V15, P337, DOI 10.2119/molmed.2009.00005; KOCH AE, 1993, PATHOBIOLOGY, V61, P239, DOI 10.1159/000163802; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Mihara M, 2011, OPEN ACCESS RHEUMATO, V3, P19, DOI 10.2147/OARRR.S17118; Narsale AA, 2014, CURR OPIN SUPPORT PA, V8, P321, DOI 10.1097/SPC.0000000000000091; Ohsugi Y, 2007, BIOL PHARM BULL, V30, P2001, DOI 10.1248/bpb.30.2001; Peters HPF, 2000, MED SCI SPORT EXER, V32, P134; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Price LA., 2007, J BURNS WOUNDS, V12; Rose-John S, 2017, NAT REV RHEUMATOL, V13, P399, DOI 10.1038/nrrheum.2017.83; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Villarroya F, 2018, J INTERN MED, V284, P492, DOI 10.1111/joim.12803; Yeh FL, 1999, BURNS, V25, P131, DOI 10.1016/S0305-4179(98)00150-8	34	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21596	10.1096/fj.202100388R	http://dx.doi.org/10.1096/fj.202100388R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871073	Green Accepted			2022-12-28	WOS:000645260100023
J	McMillan, H; Lundy, FT; Dunne, OM; Al-Natour, B; Jeanneau, C; About, I; Curtis, TM; El Karim, I				McMillan, Hayley; Lundy, Fionnuala T.; Dunne, Orla M.; Al-Natour, Banan; Jeanneau, Charlotte; About, Imad; Curtis, Tim M.; El Karim, Ikhlas			Endogenous Mas-related G-protein-coupled receptor X1 activates and sensitizes TRPA1 in a human model of peripheral nerves	FASEB JOURNAL			English	Article						dental pulp; human; MrgprX1; nociception; peripheral neurons	GENE FAMILY; CHANNEL; CELLS; ANTAGONISTS; EXPRESSION; NEURONS; ITCH; PAIN; MRG	Mas-related G-protein-coupled receptor X1 (MrgprX1) is a human-specific Mrgpr and its expression is restricted to primary sensory neurons. However, its role in nociception and pain signaling pathways is largely unknown. This study aims to investigate a role for MrgprX1 in nociception via interaction with the pain receptor, Transient Receptor Potential Ankyrin 1 (TRPA1), using in-vitro and in-vivo human neuronal models. MrgprX1 protein expression in human trigeminal nociceptors was investigated by the immunolabeling of the dental pulp and cultured peripheral neuronal equivalent (PNE) cells. MrgprX1 receptor signaling was monitored by Fura-2-based Ca2+ imaging using PNEs and membrane potential responses were measured using FluoVolt (TM). Immunofluorescent staining revealed MrgprX1 expression in-vivo in dental afferents, which was more intense in inflamed compared to healthy dental pulps. Endogenous MrgprX1 protein expression was confirmed in the in-vitro human PNE model. MrgprX1 receptor signaling and the mechanisms through which it couples to TRPA1 were studied by Ca2+ imaging. Results showed that MrgprX1 activates TRPA1 and induces membrane depolarization in a TRPA1 dependent manner. In addition, MrgprX1 sensitizes TRPA1 to agonist stimulation via Protein Kinase C (PKC). The activation and sensitization of TRPA1 by MrgprX1 in a model of human nerves suggests an important role for this receptor in the modulation of nociception.	[McMillan, Hayley; Lundy, Fionnuala T.; Dunne, Orla M.; Al-Natour, Banan; Curtis, Tim M.; El Karim, Ikhlas] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Al-Natour, Banan] Jordan Univ Sci & Technol, Fac Dent, Dept Oral Med & Oral Surg, Irbid, Jordan; [Jeanneau, Charlotte; About, Imad] Aix Marseille Univ, Inst Movement Sci, ISM, CNRS, Marseille, France	Queens University Belfast; Jordan University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	El Karim, I (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	i.elkarim@qub.ac.uk	Curtis, Tim/AEU-9750-2022	El karim, Ikhlas/0000-0002-5314-7378; Curtis, Tim/0000-0003-1543-2781; Lundy, Fionnuala/0000-0003-3150-1150	Animal Free Research UK	Animal Free Research UK	This study was funded by Animal Free Research UK.	Albarran L, 2013, BBA-MOL CELL RES, V1833, P3025, DOI 10.1016/j.bbamcr.2013.08.014; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bayrakdarian M, 2011, BIOORG MED CHEM LETT, V21, P2102, DOI 10.1016/j.bmcl.2011.01.138; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bonnamain V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00357; Brackley AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01999-4; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Castro J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131712; [陈华鑫 Chen Huaxin], 2004, [长安大学学报. 自然科学版, Journal of Chang'An University Natural Science Edition], V24, P1; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Clarke R, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00995-2017; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; El Karim IA, 2016, J ENDODONT, V42, P589, DOI 10.1016/j.joen.2015.12.017; Fehrenbacher JC, 2009, PAIN, V144, P253, DOI 10.1016/j.pain.2009.03.027; Flegel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128951; Gervois P, 2015, STEM CELLS DEV, V24, P296, DOI 10.1089/scd.2014.0117; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Guan Y, 2010, P NATL ACAD SCI USA, V107, P15933, DOI 10.1073/pnas.1011221107; Guan Y, 2010, NEUROSCI LETT, V471, P43, DOI 10.1016/j.neulet.2010.01.006; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; He SQ, 2014, NEUROSCIENCE, V261, P43, DOI 10.1016/j.neuroscience.2013.12.041; He SQ, 2014, PAIN, V155, P534, DOI 10.1016/j.pain.2013.12.008; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P456, DOI 10.1016/S0165-6147(97)90683-0; Kenakin T, 2006, EXPERT OPIN DRUG DIS, V1, P635, DOI 10.1517/17460441.1.7.635; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kunapuli P, 2006, ANAL BIOCHEM, V351, P50, DOI 10.1016/j.ab.2006.01.014; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li D, 2019, STEM CELL REV REP, V15, P67, DOI 10.1007/s12015-018-9854-5; Li Z, 2017, P NATL ACAD SCI USA, V114, pE1996, DOI 10.1073/pnas.1615255114; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; MATTHEWS B, 1994, ARCH ORAL BIOL, V39, pS87, DOI 10.1016/0003-9969(94)90193-7; Meents JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170097; Meixiong J, 2017, ANNU REV GENET, V51, P103, DOI 10.1146/annurev-genet-120116-024723; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Reddy VB, 2018, J INVEST DERMATOL, V138, P461, DOI 10.1016/j.jid.2017.05.042; Schmidt R, 2009, ADV EXP MED BIOL, V611, P111, DOI 10.1007/978-0-387-73657-0_49; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Solinski HJ, 2014, PHARMACOL REV, V66, P570, DOI 10.1124/pr.113.008425; Solinski HJ, 2012, J BIOL CHEM, V287, P40956, DOI 10.1074/jbc.M112.408617; Solinski HJ, 2010, MOL PHARMACOL, V78, P249, DOI 10.1124/mol.110.063867; SOWUNMI A, 1989, LANCET, V2, P213; Tecles O, 2005, ARCH ORAL BIOL, V50, P103, DOI 10.1016/j.archoralbio.2004.11.009; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yekkirala AS, 2013, LIFE SCI, V92, P438, DOI 10.1016/j.lfs.2012.06.021; Young FI, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1290561; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	57	2	2	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21492	10.1096/fj.202001667RR	http://dx.doi.org/10.1096/fj.202001667RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788969	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000645260100094
J	Mizera, J; Kazek, G; Niedzielska-Andres, E; Pomierny-Chamiolo, L				Mizera, Jozef; Kazek, Grzegorz; Niedzielska-Andres, Ewa; Pomierny-Chamiolo, Lucyna			Maternal high-sugar diet results in NMDA receptors abnormalities and cognitive impairment in rat offspring	FASEB JOURNAL			English	Article						maternal high-sugar diet; memory impairment; miRNA; NMDA receptor; proximity ligation assay	NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; ECTO-ATPASE NTPDASE2; PURINERGIC RECEPTORS; OLFACTORY-BULB; PROGENITOR CELLS; NUCLEOTIDE RECEPTORS; SIGNALING PATHWAY; EXPRESSION LEVELS; P2Y(2) RECEPTORS	Cognitive impairment affects patients suffering from various neuropsychiatric diseases, which are often accompanied by changes in the glutamatergic system. Epidemiological studies indicate that predispositions to the development of neuropsychiatric diseases may be programmed prenatally. Mother's improper diet during pregnancy and lactation may cause fetal abnormalities and, consequently, predispose to diseases in childhood and even adulthood. Considering the prevalence of obesity in developed countries, it seems important to examine the effects of diet on the behavior and physiology of future generations. We hypothesized that exposure to sugar excess in a maternal diet during pregnancy and lactation would affect memory as the NMDA receptor-related processes. Through the manipulation of the sugar amount in the maternal diet in rats, we assessed its effect on offspring's memory. Then, we evaluated if memory alterations were paralleled by molecular changes in NMDA receptors and related modulatory pathways in the prefrontal cortex and the hippocampus of adolescent and young adult female and male offspring. Behavioral studies have shown sex-related changes like impaired recognition memory in adolescent males and spatial memory in females. Molecular results confirmed an NMDA receptor hypofunction along with subunit composition abnormalities in the medial prefrontal cortex of adolescent offspring. In young adults, GluN2A-containing receptors were dominant in the medial prefrontal cortex, while in the hippocampus the GluN2B subunit contribution was elevated. In conclusion, we demonstrated that a maternal high-sugar diet can affect the memory processes in the offspring by disrupting the NMDA receptor composition and regulation in the medial prefrontal cortex and the hippocampus.	[Mizera, Jozef; Niedzielska-Andres, Ewa; Pomierny-Chamiolo, Lucyna] Jagiellonian Univ Med Coll, Dept Toxicol, Med 9, PL-30688 Krakow, Poland; [Kazek, Grzegorz] Jagiellonian Univ Med Coll, Dept Pharmacodynam, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Niedzielska-Andres, E; Pomierny-Chamiolo, L (corresponding author), Jagiellonian Univ Med Coll, Dept Toxicol, Med 9, PL-30688 Krakow, Poland.	ewa.niedzielska@uj.edu.pl; lucyna.pomierny-chamiolo@uj.edu.pl		Pomierny-Chamiolo, Lucyna/0000-0002-8308-8030	National Science Center, Poland [2015/19/D/NZ7/00082]; Statutory Funds of the Department of Toxicology, Jagiellonian University Medical College, Poland [N42/DBS/000145, N42/DBS/000146]	National Science Center, Poland(National Science Centre, Poland); Statutory Funds of the Department of Toxicology, Jagiellonian University Medical College, Poland	National Science Center, Poland, Grant/Award Number: 2015/19/D/NZ7/00082; Statutory Funds of the Department of Toxicology, Jagiellonian University Medical College, Poland, Grant/Award Number: N42/DBS/000145 and N42/DBS/000146	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Adeosun SO, 2014, J BIOL CHEM, V289, P2946, DOI 10.1074/jbc.M113.497909; Agresti C, 2005, GLIA, V50, P132, DOI 10.1002/glia.20160; Ali AAH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103423; Ali AAH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041394; Ali AAH, 2019, BRAIN STRUCT FUNCT, V224, P373, DOI 10.1007/s00429-018-1775-1; Ali AAH, 2015, AGING-US, V7, P435, DOI 10.18632/aging.100764; Anders JJ, 2008, IEEE J SEL TOP QUANT, V14, P118, DOI 10.1109/JSTQE.2008.916181; Arthur DB, 2006, J NEUROSCI, V26, P3798, DOI 10.1523/JNEUROSCI.5338-05.2006; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Bassani TB, 2018, MOL NEUROBIOL, V55, P4280, DOI 10.1007/s12035-017-0645-9; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Braun N, 2003, EUR J NEUROSCI, V17, P1355, DOI 10.1046/j.1460-9568.2003.02567.x; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2018, BIOCHEM PHARMACOL, V151, P157, DOI 10.1016/j.bcp.2017.07.016; Burnstock G, 2016, NEUROPHARMACOLOGY, V104, P4, DOI 10.1016/j.neuropharm.2015.05.031; Burnstock G, 2013, ADV EXP MED BIOL, V986, P1, DOI 10.1007/978-94-007-4719-7_1; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Cao L, 2013, EMBO REP, V14, P184, DOI 10.1038/embor.2012.215; Cao X, 2013, STEM CELLS, V31, P1633, DOI 10.1002/stem.1408; Chen JZ, 2014, CELLS TISSUES ORGANS, V199, P131, DOI 10.1159/000365654; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cronin C, 2011, BEHAV BRAIN RES, V223, P417, DOI 10.1016/j.bbr.2011.05.002; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Fischer T, 2012, PURINERG SIGNAL, V8, P191, DOI 10.1007/s11302-011-9286-z; Fischer W, 2009, NEUROSCIENCE, V160, P767, DOI 10.1016/j.neuroscience.2009.02.026; Fujita T, 2009, GLIA, V57, P244, DOI 10.1002/glia.20749; Gampe K, 2015, STEM CELLS, V33, P253, DOI 10.1002/stem.1846; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; Grimm I, 2009, J CELL SCI, V122, P2524, DOI 10.1242/jcs.044891; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754; Jacobson KA, 2020, BRIT J PHARMACOL, V177, P2413, DOI [10.1111/bph.15005, 10.1111/bph.1500510.1111/bph.15005]; Jacobson KA, 2009, PURINERG SIGNAL, V5, P75, DOI 10.1007/s11302-008-9106-2; Jia CH, 2010, NEUROBIOL DIS, V38, P405, DOI 10.1016/j.nbd.2010.02.013; Katz S, 2011, ARCH BIOCHEM BIOPHYS, V513, P144, DOI 10.1016/j.abb.2011.06.013; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Kim HJ, 2012, J NEUROCHEM, V121, P228, DOI 10.1111/j.1471-4159.2012.07700.x; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; Lipp HP, 2016, BRAIN BEHAV EVOLUT, V87, P205, DOI 10.1159/000446905; Lommen J, 2017, CELL TISSUE RES, V369, P579, DOI 10.1007/s00441-017-2634-8; Malin SA, 2008, PAIN, V138, P484, DOI 10.1016/j.pain.2008.01.026; Messemer N, 2013, NEUROPHARMACOLOGY, V73, P122, DOI 10.1016/j.neuropharm.2013.05.017; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Neary Joseph T, 2005, Purinergic Signal, V1, P329, DOI 10.1007/s11302-005-8075-y; Neary JT, 2009, TRENDS NEUROSCI, V32, P189, DOI 10.1016/j.tins.2009.01.002; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Pannangrong W, 2019, J ZHEJIANG UNIV-SC B, V20, P253, DOI 10.1631/jzus.B1800340; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Potthoff SA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00234; Prieur EAK, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3162; Rakai BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099527; Ralevic V, 1998, PHARMACOL REV, V50, P413; Recinto P, 2012, NEUROPSYCHOPHARMACOL, V37, P1275, DOI 10.1038/npp.2011.315; Rotermund N, 2018, J PHYSIOL-LONDON, V596, P717, DOI 10.1113/JP275503; Sakamoto M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00121; Schnell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099883; Schulz K, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00435; SCOTT JW, 1993, MICROSC RES TECHNIQ, V24, P142, DOI 10.1002/jemt.1070240206; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shukla V, 2005, J NEUROSCI RES, V80, P600, DOI 10.1002/jnr.20508; Stefani J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00134; Suadicani SO, 2003, GLIA, V42, P160, DOI 10.1002/glia.10197; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Suyama S, 2012, J NEUROSCI, V32, P9238, DOI 10.1523/JNEUROSCI.4001-11.2012; Takahashi H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00229; Tang Y, 2017, GLIA, V65, P213, DOI 10.1002/glia.23056; Toda T, 2019, MOL PSYCHIATR, V24, P67, DOI 10.1038/s41380-018-0036-2; von Kugelgen I, 2016, NEUROPHARMACOLOGY, V104, P50, DOI 10.1016/j.neuropharm.2015.10.030; von Kugelgen I, 2019, BRAIN RES BULL, V151, P12, DOI 10.1016/j.brainresbull.2019.03.010; Walter J, 2011, NEUROBIOL AGING, V32, P1906, DOI 10.1016/j.neurobiolaging.2009.11.011; Weisman GA, 2005, MOL NEUROBIOL, V31, P169, DOI 10.1385/MN:31:1-3:169; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Weisman GA, 2012, PURINERG SIGNAL, V8, P559, DOI 10.1007/s11302-012-9307-6; Whitman MC, 2007, J NEUROSCI, V27, P9951, DOI 10.1523/JNEUROSCI.1633-07.2007; Xu PF, 2018, BIOORGAN MED CHEM, V26, P366, DOI 10.1016/j.bmc.2017.11.043; Zarrinmayeh H, 2020, MOL IMAGING, V19, DOI 10.1177/1536012120927609; Zheng F, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12458; Zlomuzica A, 2008, EUR J NEUROSCI, V27, P1461, DOI 10.1111/j.1460-9568.2008.06115.x	96	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21547	10.1096/fj.202002691R	http://dx.doi.org/10.1096/fj.202002691R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855764				2022-12-28	WOS:000645260100080
J	van Rosmalen, L; van Dalum, J; Appenroth, D; Roodenrijs, RTM; de Wit, L; Hazlerigg, DG; Hut, RA				van Rosmalen, Laura; van Dalum, Jayme; Appenroth, Daniel; Roodenrijs, Renzo T. M.; de Wit, Lauren; Hazlerigg, David G.; Hut, Roelof A.			Mechanisms of temperature modulation in mammalian seasonal timing	FASEB JOURNAL			English	Article						ambient temperature; maternal photoperiodic programming; Microtus arvalis; photoperiodic neuroendocrine system; seasonal reproduction	FOLLICLE-STIMULATING-HORMONE; VOLE MICROTUS-ARVALIS; AMBIENT-TEMPERATURE; PHOTOPERIODIC INFORMATION; REPRODUCTIVE DEVELOPMENT; DJUNGARIAN HAMSTER; SIBERIAN HAMSTERS; MATERNAL TRANSFER; THYROID-HORMONE; PARS TUBERALIS	Global warming is predicted to have major effects on the annual time windows during which species may successfully reproduce. At the organismal level, climatic shifts engage with the control mechanism for reproductive seasonality. In mammals, laboratory studies on neuroendocrine mechanism emphasize photoperiod as a predictive cue, but this is based on a restricted group of species. In contrast, field-oriented comparative analyses demonstrate that proximate bioenergetic effects on the reproductive axis are a major determinant of seasonal reproductive timing. The interaction between proximate energetic and predictive photoperiodic cues is neglected. Here, we focused on photoperiodic modulation of postnatal reproductive development in common voles (Microtus arvalis), a herbivorous species in which a plastic timing of breeding is well documented. We demonstrate that temperature-dependent modulation of photoperiodic responses manifest in the thyrotrophin-sensitive tanycytes of the mediobasal hypothalamus. Here, the photoperiod-dependent expression of type 2 deiodinase expression, associated with the summer phenotype was enhanced by 21 degrees C, whereas the photoperiod-dependent expression of type 3 deiodinase expression, associated with the winter phenotype, was enhanced by 10 degrees C in spring voles. Increased levels of testosterone were found at 21 degrees C, whereas somatic and gonadal growth were oppositely affected by temperature. The magnitude of these temperature effects was similar in voles photoperiodical programmed for accelerated maturation (ie, born early in the breeding season) and in voles photoperiodical programmed for delayed maturation (ie, born late in the breeding season). The melatonin-sensitive pars tuberalis was relatively insensitive to temperature. These data define a mechanistic hierarchy for the integration of predictive temporal cues and proximate thermo-energetic effects in mammalian reproduction.	[van Rosmalen, Laura; Roodenrijs, Renzo T. M.; de Wit, Lauren; Hut, Roelof A.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Chronobiol Unit, Bldg 5171,Room 0344,Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [van Dalum, Jayme; Appenroth, Daniel; Hazlerigg, David G.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Seasonal Timekeeping Initiat ASTI, Tromso, Norway	University of Groningen; UiT The Arctic University of Tromso	van Rosmalen, L (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Chronobiol Unit, Bldg 5171,Room 0344,Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	Lauravanrosmalen@hotmail.com	van Rosmalen, Laura/ABG-5228-2021	Appenroth, Daniel/0000-0003-0197-3739; van Rosmalen, Laura/0000-0003-1273-1225	Adaptive Life program of the University of Groningen [B050216]; Arctic University of Norway (Universitetet i Tromso)	Adaptive Life program of the University of Groningen; Arctic University of Norway (Universitetet i Tromso)	We thank R. Schepers for his valuable help in tissue collections and animal care, Dr. H. Dardente for providing the probes for in situ hybridization and Prof. Dr. M.P. Gerkema for establishing the common vole colony at the University of Groningen. This work was funded by the Adaptive Life program of the University of Groningen (B050216 to LvR, RTMR, and LdW and RAH), and by the Arctic University of Norway (Universitetet i Tromso to JvD, DA, and DGH).	Appenroth D, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.220699; Baker JR, 1932, P R SOC LOND B-CONTA, V112, P39, DOI 10.1098/rspb.1932.0076; Bakker ES, 2004, OECOLOGIA, V138, P91, DOI 10.1007/s00442-003-1402-5; Bronson, 1989, MAMMALIAN REPROD BIO, V15, P313, DOI [10.1016/0306-4530(90)90082-K, DOI 10.1016/0306-4530(90)90082-K]; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; BRONSON FH, 1983, BIOL REPROD, V29, P72, DOI 10.1095/biolreprod29.1.72; Bunn A., 2008, IND COMMER TRAIN, V10, P11, DOI [10.1108/eb003648, DOI 10.1108/EB003648]; Caro SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001517; COOPER J. P., 1964, J APPL ECOL, V1, P45, DOI 10.2307/2401588; Dardente H, 2003, J NEUROENDOCRINOL, V15, P778, DOI 10.1046/j.1365-2826.2003.01060.x; Dardente H, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12775; Dardente H, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12729; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; de Miera CS, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12679; de Miera CS, 2017, P NATL ACAD SCI USA, V114, P8408, DOI 10.1073/pnas.1702943114; de Miera CS, 2014, CURR BIOL, V24, P1500, DOI 10.1016/j.cub.2014.05.024; Denver RJ, 2013, CURR TOP DEV BIOL, V103, P195, DOI 10.1016/B978-0-12-385979-2.00007-1; ELLIOTT JA, 1976, FED PROC, V35, P2339; GASTON S, 1967, SCIENCE, V158, P925, DOI 10.1126/science.158.3803.925; GERKEMA MP, 1993, J BIOL RHYTHM, V8, P151, DOI 10.1177/074873049300800205; Goldman SL, 2000, J BIOL RHYTHM, V15, P417, DOI 10.1177/074873000129001503; Guerra M, 2010, CELL TISSUE RES, V339, P359, DOI 10.1007/s00441-009-0885-8; Gupta D, 1977, Padiatr Padol Suppl, P83; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Hazlerigg D, 2008, CURR BIOL, V18, pR795, DOI 10.1016/j.cub.2008.07.040; Hazlerigg D, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12631; HEIDEMAN PD, 1991, BIOL REPROD, V44, P1189, DOI 10.1095/biolreprod44.6.1189; Hoffmann K., 1982, P297; HOFFMANN K, 1978, J REPROD FERTIL, V54, P29, DOI 10.1530/jrf.0.0540029; HORTON TH, 1985, BIOL REPROD, V33, P934, DOI 10.1095/biolreprod33.4.934; HORTON TH, 1984, BIOL REPROD, V31, P499, DOI 10.1095/biolreprod31.3.499; HORTON TH, 1992, ANIM REPROD SCI, V30, P29, DOI 10.1016/0378-4320(92)90004-W; Hut RA, 2014, CURR BIOL, V24, pR602, DOI 10.1016/j.cub.2014.05.061; Hut RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0433; Hut RA, 2011, CURR BIOL, V21, pR22, DOI 10.1016/j.cub.2010.11.060; Ikegami K, 2015, ENDOCRINOLOGY, V156, P647, DOI 10.1210/en.2014-1741; KLEIN DC, 1970, SCIENCE, V169, P1093, DOI 10.1126/science.169.3950.1093; KLIMAN RM, 1992, J BIOL RHYTHM, V7, P161, DOI 10.1177/074873049200700207; Kriegsfeld LJ, 2000, J NEUROENDOCRINOL, V12, P553, DOI 10.1046/j.1365-2826.2000.00485.x; Krol E, 2012, GEN COMP ENDOCR, V179, P289, DOI 10.1016/j.ygcen.2012.09.004; Larkin JE, 2001, J BIOL RHYTHM, V16, P76, DOI 10.1177/074873040101600109; LERCHL A, 1993, BIOL REPROD, V49, P1108, DOI 10.1095/biolreprod49.5.1108; Lomet D, 2018, CELL MOL LIFE SCI, V75, P905, DOI 10.1007/s00018-017-2667-x; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MAGNER JA, 1990, ENDOCR REV, V11, P354, DOI 10.1210/edrv-11-2-354; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Meachem SJ, 1996, BIOL REPROD, V54, P36, DOI 10.1095/biolreprod54.1.36; MORGAN PJ, 1994, NEUROCHEM INT, V24, P101, DOI 10.1016/0197-0186(94)90100-7; Nakane Y, 2019, ANNU REV ANIM BIOSCI, V7, P173, DOI 10.1146/annurev-animal-020518-115216; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; NEGUS NC, 1986, CAN J ZOOL, V64, P785, DOI 10.1139/z86-117; NEGUS NC, 1977, J MAMMAL, V58, P347, DOI 10.2307/1379333; NEGUS NC, 1992, CAN J ZOOL, V70, P2121, DOI 10.1139/z92-285; NEGUS NC, 1977, SCIENCE, V196, P1230, DOI 10.1126/science.323977; NELSON RJ, 1989, BIOL REPROD, V40, P481, DOI 10.1095/biolreprod40.3.481; NELSON RJ, 1987, AM NAT, V130, P350, DOI 10.1086/284715; NELSON RJ, 1983, J REPROD FERTIL, V69, P473, DOI 10.1530/jrf.0.0690473; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; PEACOCK JM, 1976, J APPL ECOL, V13, P225, DOI 10.2307/2401942; PEACOCK JM, 1975, J APPL ECOL, V12, P115, DOI 10.2307/2401721; Prendergast BJ, 2000, P NATL ACAD SCI USA, V97, P5586, DOI 10.1073/pnas.100098597; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; SANDERS EH, 1981, SCIENCE, V214, P67, DOI 10.1126/science.7025209; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; Simonneaux V, 2020, EUR J NEUROSCI, V51, P509, DOI 10.1111/ejn.14287; Simons MJP, 2011, J EXP BIOL, V214, P38, DOI 10.1242/jeb.044230; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; SPEARS N, 1988, J ANIM ECOL, V57, P61, DOI 10.2307/4763; STEINLECHNER S, 1991, NATO ADV SCI I A-LIF, V204, P159; Steinlechner S., 2003, MECH SEASONAL CONTRO; STETSON MH, 1986, BIOL REPROD, V34, P664, DOI 10.1095/biolreprod34.4.664; van Dalum J, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00901; van Rosmalen L, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.230987; Wagner GC, 2008, ENDOCRINOLOGY, V149, P32, DOI 10.1210/en.2007-0658; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Walker William H, 2011, Spermatogenesis, V1, P116; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMS LM, 1988, J ENDOCRINOL, V119, pR1, DOI 10.1677/joe.0.119R001; Wood SH, 2015, CURR BIOL, V25, P2651, DOI 10.1016/j.cub.2015.09.014; Yasuo S, 2009, J NEUROSCI, V29, P2885, DOI 10.1523/JNEUROSCI.0145-09.2009; YELLON SM, 1984, ENDOCRINOLOGY, V114, P664, DOI 10.1210/endo-114-2-664; Zhang Q, 2015, INT J BIOMETEOROL, V59, P679, DOI 10.1007/s00484-014-0879-4	83	10	10	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21605	10.1096/fj.202100162R	http://dx.doi.org/10.1096/fj.202100162R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913553	Green Published, hybrid			2022-12-28	WOS:000645260100063
J	Zhang, RM; Zeyer, KA; Odenthal, N; Zhang, YY; Reinhardt, DP				Zhang, Rong-Mo; Zeyer, Karina A.; Odenthal, Nadine; Zhang, Yiyun; Reinhardt, Dieter P.			The fibrillin-1 RGD motif posttranscriptionally regulates ERK1/2 signaling and fibroblast proliferation via miR-1208	FASEB JOURNAL			English	Article						ERK1/2 signaling; fibrillin-1; fibroblasts; miR-1208; proliferation; RGD	CELL-ADHESION; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; AORTIC-ANEURYSM; MICRORNAS; MICROFIBRILS; ACTIVATION; BINDING; INTEGRINS; RECEPTOR	Fibrillin-1 is an extracellular matrix protein which contains one conserved RGD integrin-binding motif. It constitutes the backbone of microfibrils in many tissues, and mutations in fibrillin-1 cause various connective tissue disorders. Although it is well established that fibrillin-1 interacts with several RGD-dependent integrins, very little is known about the associated intracellular signaling pathways. Recent published evidence identified a subset of miRNAs regulated by fibrillin-1 RGD-cell adhesion, with miR-1208 among the most downregulated. The present study shows that the downregulated miR-1208 controls fibroblast proliferation. Inhibitor experiments revealed that fibrillin-1 RGD suppressed miR-1208 expression via c-Src kinase and the downstream JNK signaling. Bioinformatic prediction and experimental target sequence validation demonstrated four miR-1208 binding sites on the ERK2 mRNA and one on the MEK1 mRNA. ERK2 and MEK1 are critical proliferation-promoting kinases. Decreased miR-1208 levels elevated the total and phosphorylated ERK1/2 and MEK1/2 protein levels and the phosphorylated to total ERK1/2 ratio. Together, the data demonstrate a novel outside-in signaling mechanism explaining how fibrillin-1 RGD-cell binding regulates fibroblast proliferation.	[Zhang, Rong-Mo; Zeyer, Karina A.; Zhang, Yiyun; Reinhardt, Dieter P.] McGill Univ, Fac Med & Hlth Sci, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 0C7, Canada; [Odenthal, Nadine] Univ Lubeck, Dept Nat Sci, Lubeck, Germany; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada	McGill University; University of Lubeck; McGill University	Reinhardt, DP (corresponding author), McGill Univ, Fac Med & Hlth Sci, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 0C7, Canada.	dieter.reinhardt@mcgill.ca	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872	Canadian Institutes of Health Research [PJT-162099]; Marfan Foundation; Genetic Aortic Disorders Association Canada; China Scholarship Council; Hector and Ada Ma Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Marfan Foundation; Genetic Aortic Disorders Association Canada; China Scholarship Council(China Scholarship Council); Hector and Ada Ma Fellowship	Canadian Institutes of Health Research, Grant/Award Number: PJT-162099; Marfan Foundation; Genetic Aortic Disorders Association Canada; China Scholarship Council; Hector and Ada Ma Fellowship	AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arihiro K, 2000, Breast Cancer, V7, P19, DOI 10.1007/BF02967183; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; BITTERMAN PB, 1983, J CELL BIOL, V97, P1925, DOI 10.1083/jcb.97.6.1925; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brandt R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10954-y; Breuksch I, 2017, ONCOTARGET, V8; Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Gerber EE, 2013, NATURE, V503, P126, DOI 10.1038/nature12614; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hubmacher D, 2014, BIOMACROMOLECULES, V15, P1456, DOI 10.1021/bm5000696; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin Yi, 2013, Methods Mol Biol, V936, P117; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Juliano RL, 1993, CURR OPIN CELL BIOL, V5, P812, DOI 10.1016/0955-0674(93)90030-T; Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4; Kim EA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143540; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Lefloch R, 2009, CELL CYCLE, V8, P705, DOI 10.4161/cc.8.5.7734; Li B, 2006, J BIOMED MATER RES A, V79A, P989, DOI 10.1002/jbm.a.30847; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Loeys B. L., 2010, SCI TRANSL MED, V2, P20, DOI 10.1126/scitranslmed.3000488; Mariko B, 2010, AM J PHYSIOL-CELL PH, V299, pC977, DOI 10.1152/ajpcell.00377.2009; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Merk DR, 2012, CIRC RES, V110, P312, DOI 10.1161/CIRCRESAHA.111.253740; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; MORGAN TL, 1991, EXP CELL RES, V197, P125, DOI 10.1016/0014-4827(91)90489-H; Nissan MH, 2013, CANCER DISCOV, V3, P719, DOI 10.1158/2159-8290.CD-13-0245; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Piha-Gossack A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033560; Polioudakis D, 2013, NUCLEIC ACIDS RES, V41, P2239, DOI 10.1093/nar/gks1452; Porst M, 2006, KIDNEY INT, V69, P450, DOI 10.1038/sj.ki.5000030; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; Skarpen E, 2008, FASEB J, V22, P466, DOI 10.1096/fj.07-8650com; Suh EJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r121; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zeyer KA, 2019, J MOL BIOL, V431, P401, DOI 10.1016/j.jmb.2018.11.021; Zhang RM, 2020, METHODS MOL BIOL, V2043, P237, DOI 10.1007/978-1-4939-9698-8_19	78	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21598	10.1096/fj.202100282R	http://dx.doi.org/10.1096/fj.202100282R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871068				2022-12-28	WOS:000645260100021
J	Ayuso, M; Irwin, R; Walsh, C; Van Cruchten, S; Van Ginneken, C				Ayuso, Miriam; Irwin, Rachelle; Walsh, Colum; Van Cruchten, Steven; Van Ginneken, Chris			Low birth weight female piglets show altered intestinal development, gene expression, and epigenetic changes at key developmental loci	FASEB JOURNAL			English	Article						gene expression; gene methylation; intestinal development; LBW; piglet	INTRAUTERINE GROWTH RESTRICTION; DNA METHYLATION; MESSENGER-RNA; ALKALINE-PHOSPHATASE; NEONATAL PIGLETS; BARRIER FUNCTION; GUT DEVELOPMENT; MODEL; MORPHOLOGY; IMMUNITY	Intestinal development is compromised in low birth weight (LBW) pigs, negatively impacting their growth, health, and resilience. We investigated the molecular mechanisms of the altered intestinal maturation observed in neonatal and juvenile LBW female piglets by comparing the changes in intestinal morphology, gene expression, and methylation in LBW versus normal birth weight (NBW) female piglets. A total of 16 LBW/NBW sibling pairs were sacrificed at 0 hours, 8 hours, 10 days, and 8 weeks of age. The gastrointestinal tract was weighed, measured, and the small intestine was sampled for histomorphology, gene expression, and methylation analyses. Impaired intestinal development, with shorter villi and shallower crypts, was observed in LBW female piglets. The expression of intestinal development markers (ALPI and OLFM) rapidly peaked after birth in NBW but not in LBW female piglets. The lower expression of genes involved in nutrient digestion (ANPEP and SI) and barrier function (OCLN and CLDN4) in LBW, together with their delayed development of intestinal villi and crypts could help to explain the compromised health and growth potential of LBW female piglets. The changes in methylation observed in LBW in key regulators of intestinal development (OLFM4 and FZD5) suggest long-term effects of BW on intestinal gene expression, development, and function. Accordingly, experimental demethylation induced in IPEC-J2 cells led to increased expression of intestinal genes (MGA, DPP4, and GLUT2). Overall, we have identified the alterations in transcription or epigenetic marking at a number of genes critical to intestinal development, which may contribute to both the short- and long-term failure of LBW female piglets to thrive.	[Ayuso, Miriam; Van Cruchten, Steven; Van Ginneken, Chris] Univ Antwerp, Dept Vet Sci, Comparat Perinatal Dev, Antwerp, Belgium; [Irwin, Rachelle; Walsh, Colum] Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland	University of Antwerp; Ulster University	Ayuso, M (corresponding author), Univ Antwerp, Dept Vet Sci, Campus CDE U016,Univ Pl 1, B-2610 Antwerp, Belgium.	Miriam.AyusoHernando@uantwerpen.be	ayuso, miriam/GPX-8386-2022	ayuso, miriam/0000-0001-6045-394X; Van Ginneken, Chris/0000-0002-1622-9120	University of Antwerp Bijzonder Onderzoeksfonds (BOF) [34479]; STSM under the COST Action "Sharing Advances on Large Animal Models (SALAAM)" [BM1308]	University of Antwerp Bijzonder Onderzoeksfonds (BOF); STSM under the COST Action "Sharing Advances on Large Animal Models (SALAAM)"	This research was funded by the special research fund of the University of Antwerp Bijzonder Onderzoeksfonds (BOF) under grant no 34479. The research stay abroad that allowed MA to perform gene expression and methylation analyses in the lab of CW was funded by an STSM under the COST Action BM1308 "Sharing Advances on Large Animal Models (SALAAM)."	Ashworth CJ, 2001, J REP FER S, P233; Ayuso M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197263; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Biesterveld BE, 2015, J SURG RES, V196, P235, DOI 10.1016/j.jss.2015.02.030; Buddington RK, 2012, J ANIM SCI, V90, P290, DOI 10.2527/jas.54604; Burrin DG, 2000, AM J CLIN NUTR, V71, P1603; Butler JE, 2013, IMMUNOLOGY, V138, P134, DOI 10.1111/imm.12018; Che LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157314; Cui XL, 2003, BBA-BIOMEMBRANES, V1612, P178, DOI 10.1016/S0005-2736(03)00129-9; Dehmer JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027070; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dong L, 2014, J HISTOCHEM CYTOCHEM, V62, P510, DOI 10.1369/0022155414532655; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Gao F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-716; GODA T, 1985, J PEDIATR GASTR NUTR, V4, P998, DOI 10.1097/00005176-198512000-00024; Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004; Gonzalez-Bulnes A, 2016, THERIOGENOLOGY, V86, P110, DOI 10.1016/j.theriogenology.2016.03.024; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Gunadi, 2014, J PEDIATR SURG, V49, P1614, DOI 10.1016/j.jpedsurg.2014.04.011; Hamard A, 2010, J NUTR BIOCHEM, V21, P914, DOI 10.1016/j.jnutbio.2009.07.004; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hoch M, 1996, MECH DEVELOP, V58, P3, DOI 10.1016/S0925-4773(96)00541-2; Hu Y, 2018, MOL GENET GENOMICS, V293, P807, DOI 10.1007/s00438-018-1422-9; Huygelen V, 2014, J ANIM SCI, V92, P3398, DOI 10.2527/jas.2014-7742; Irwin RE, 2014, GENOMICS, V104, P383, DOI 10.1016/j.ygeno.2014.08.013; Ivanova E, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00857-x; Jorgensen BG, 2019, J NEUROGASTROENTEROL, V25, P377, DOI 10.5056/jnm19077; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Lackeyram D, 2010, J NUTR, V140, P461, DOI 10.3945/jn.109.117267; Leedham SJ, 2005, J CELL MOL MED, V9, P11, DOI 10.1111/j.1582-4934.2005.tb00333.x; Lengyel J A, 1998, Cell Res, V8, P273; Lickert H, 2001, MECH DEVELOP, V105, P181, DOI 10.1016/S0925-4773(01)00390-2; Liu X, 2020, SIGNAL IMAGE VIDEO P, V14, P1227, DOI 10.1007/s11760-020-01644-0; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; Niinikoski H, 2004, J NUTR, V134, P1467, DOI 10.1093/jn/134.6.1467; Ovilo C, 2014, BRIT J NUTR, V111, P735, DOI 10.1017/S0007114513002948; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; Rasmussen SO, 2016, AM J PHYSIOL-GASTR L, V311, pG480, DOI 10.1152/ajpgi.00139.2016; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Rutledge CE., 2014, DEVELOPMENT, V141, p1313; Rutledge CE, 2014, DEVELOPMENT, V141, P1313, DOI 10.1242/dev.104646; Sangild PT, 2007, AM J PHYSIOL-REG I, V293, pR2179, DOI 10.1152/ajpregu.00395.2007; Sarr O., BIORXIV; SCHREIBER RA, 1988, ANN ALLERGY, V61, P3; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Stoy A.C.F., 2013, ISRN GENOMICS, V2013, P1, DOI [10.1155/2013/980651, DOI 10.1155/2013/980651]; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Tsukahara T, 2013, ANIM SCI J, V84, P54, DOI 10.1111/j.1740-0929.2012.01039.x; Umar Shahid, 2010, Curr Gastroenterol Rep, V12, P340, DOI 10.1007/s11894-010-0130-3; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Vanden Hole C, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02510; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergauwen H, 2015, IMPACT FOOD BIOACTIV, P125, DOI DOI 10.1007/978-3-319-16104-4_12; Vergauwen H, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5040041; Vergauwen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120485; Wadley GD, 2013, PHYSIOL GENOMICS, V45, P99, DOI 10.1152/physiolgenomics.00095.2012; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang W, 2016, FASEB J, V30, P863, DOI 10.1096/fj.15-274779; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Xu S, 2015, J APPL MICROBIOL, V119, P225, DOI 10.1111/jam.12833; Yang H, 2009, ANN NY ACAD SCI, V1165, P338, DOI 10.1111/j.1749-6632.2009.04026.x; Yeruva L, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0456-x; Zhang H, 2018, POULTRY SCI, V97, P628, DOI 10.3382/ps/pex328	68	4	4	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21522	10.1096/fj.202002587R	http://dx.doi.org/10.1096/fj.202002587R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734504	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000635216100021
J	Ilic, N; Tao, YL; Boutros-Suleiman, S; Kadali, VN; Emanuelli, A; Levy-Cohen, G; Blank, M				Ilic, Natasa; Tao, Yulei; Boutros-Suleiman, Sandy; Kadali, Venkata Narasimha; Emanuelli, Andrea; Levy-Cohen, Gal; Blank, Michael			SMURF2-mediated ubiquitin signaling plays an essential role in the regulation of PARP1 PARylating activity, molecular interactions, and functions in mammalian cells	FASEB JOURNAL			English	Article						interactome; PARP1; PARylation; SMURF2; ubiquitinome	PROTEOME-WIDE IDENTIFICATION; POLY(ADP-RIBOSE) POLYMERASE; DNA-REPAIR; ADP-RIBOSYLATION; ASSOCIATION; DOMAINS	Poly(ADP-ribose) polymerase 1 (PARP1) is a key molecular stress sensor and response mediator implicated in multiple cellular functions in health and diseases. Despite its importance and intrinsic involvement in pivotal molecular and cellular processes, including DNA repair, transcription regulation, chromatin organization, and cell death, the regulatory mechanisms of PARP1 are poorly understood. In this study, we show that SMURF2, a HECT-type E3 ubiquitin ligase and suggested tumor suppressor, physically interacts with PARP1 in different cellular settings, directly ubiquitinates it in vitro and stimulates its PARylation activity in cells, the phenomenon that required SMURF2 E3 ubiquitin ligase function. Intriguingly, in the cellular environment SMURF2 was found to regulate the dynamic exchange of ubiquitin moieties on PARP1, mostly decreasing its monoubiquitination. Through the set of systematic mass spectrometry analyses conducted on SMURF2-modified cells, we identified on PARP1 18 lysine residues (out of 126 present in PARP1) as sites which ubiquitination was considerably affected by SMURF2. Subsequent site-directed mutagenesis coupled with in cellula ubiquitination and PARylation assays unveiled K222 as a critical site enabling a cross talk between SMURF2-modulated monoubiquitination of PARP1 and its activity, and pointed to K498, S507, and a KTR triad (K498/K521/K524) as the main auto-PARylation sites affected by SMURF2. The results also uncovered that SMURF2 controls PARP1 interactome, influencing its functions and expression in a context-dependent manner. Taken together, these findings suggest that SMURF2-mediated ubiquitin signaling plays an essential role in PARP1 regulation, beyond the regulation of its protein expression.	[Ilic, Natasa; Tao, Yulei; Boutros-Suleiman, Sandy; Kadali, Venkata Narasimha; Emanuelli, Andrea; Levy-Cohen, Gal; Blank, Michael] Bar Ilan Univ, Lab Mol & Cellular Canc Biol, Azrieli Fac Med, IL-1311502 Safed, Israel; [Emanuelli, Andrea] Univ Bordeaux, Lab Angiogenese & Microenvironm Canc LAMC ACML, Inserm U1029, Campus Talence Allee Geoffroy St Hilaire, F-33615 Pessac, France	Bar Ilan University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Blank, M (corresponding author), Bar Ilan Univ, Lab Mol & Cellular Canc Biol, Azrieli Fac Med, IL-1311502 Safed, Israel.	michael.blank@biu.ac.il	Emanuelli, Andrea/AAJ-8175-2020; Kadali, Venkata Narasimha/AGR-3560-2022; Ilic, Natasa/AAR-2491-2021	Kadali, Venkata Narasimha/0000-0003-2041-7092; Ilic, Natasa/0000-0001-5987-2805; Boutros-Suleiman, Sandy/0000-0003-4216-0371	Israel Science Foundation [422/20]; Marie-Curie FP-7 CIG [612816]	Israel Science Foundation(Israel Science Foundation); Marie-Curie FP-7 CIG	Israel Science Foundation, Grant/Award Number: #422/20; Marie-Curie FP-7 CIG, Grant/Award Number: #612816	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Alemasova EE, 2019, NUCLEIC ACIDS RES, V47, P3811, DOI 10.1093/nar/gkz120; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Borroni AP, 2018, AGING CELL, V17, DOI 10.1111/acel.12732; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Ciccarone F, 2017, SEMIN CELL DEV BIOL, V63, P123, DOI 10.1016/j.semcdb.2016.11.010; Dawicki-McKenna JM, 2015, MOL CELL, V60, P755, DOI 10.1016/j.molcel.2015.10.013; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Emanuelli A, 2019, CANCERS, V11, DOI 10.3390/cancers11040556; Emanuelli A, 2017, CANCER RES, V77, P4217, DOI 10.1158/0008-5472.CAN-16-2828; Franzese E, 2019, CANCER TREAT REV, V73, P1, DOI 10.1016/j.ctrv.2018.12.002; Fu L, 2020, SEMIN CANCER BIOL, V67, P102, DOI 10.1016/j.semcancer.2019.12.023; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kashima L, 2012, J BIOL CHEM, V287, P12975, DOI 10.1074/jbc.M111.321828; Kim JJ, 2018, MOL CELLS, V41, P799, DOI 10.14348/molcells.2018.0078; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Koganti P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00295; Langelier MF, 2011, METHODS MOL BIOL, V780, P209, DOI 10.1007/978-1-61779-270-0_13; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Levy-Cohen G, 2015, ANAL BIOCHEM, V484, P37, DOI 10.1016/j.ab.2015.04.040; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Ayyathan DM, 2020, ONCOGENE, V39, P3396, DOI 10.1038/s41388-020-1226-3; Martello R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12917; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Qian H, 2020, J CELL MOL MED, V24, P4600, DOI 10.1111/jcmm.15121; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Sun CY, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5148; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Zhang NJ, 2020, CELL DEATH DIFFER, V27, P2605, DOI 10.1038/s41418-020-0523-2; Zhang Y, 2017, ONCOTARGET, V8, P94505, DOI 10.18632/oncotarget.21784; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	47	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21436	10.1096/fj.202001759R	http://dx.doi.org/10.1096/fj.202001759R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734501				2022-12-28	WOS:000635216100070
J	Ito, M; Kudo, K; Higuchi, H; Otsuka, H; Tanaka, M; Fukunishi, N; Araki, T; Takamatsu, M; Ino, Y; Kimura, Y; Kotani, A				Ito, Masatoshi; Kudo, Kai; Higuchi, Hiroshi; Otsuka, Hiroko; Tanaka, Masayuki; Fukunishi, Nahoko; Araki, Takuma; Takamatsu, Masako; Ino, Yoko; Kimura, Yayoi; Kotani, Ai			Proteomic and phospholipidomic characterization of extracellular vesicles inducing tumor microenvironment in Epstein-Barr virus-associated lymphomas	FASEB JOURNAL			English	Article						Epstein&#8208; Barr virus; extracellular vesicle; tumor microenvironment; proteomics; phospholipids		Epstein-Barr virus (EBV) causes malignant carcinomas including B cell lymphomas accompanied by the systemic inflammation. Previously, we observed that phosphatidylserine (PS)-exposing subset of extracellular vesicles (EVs) secreted from an EBV strain Akata-transformed lymphoma (Akata EVs) convert surrounding phagocytes into tumor-associated macrophages (TAMs) via induction of inflammatory response, which is in part mediated by EBV-derived micro RNAs. However, it is still unclear about EV-carried other potential inflammatory factors associated with TAM formation in EBV lymphomas. To this end, we sought to explore proteomic and phospholipidomic profiles of PS-exposing EVs derived from EBV-transformed lymphomas. Mass spectrometric analysis revealed that several immunomodulatory proteins including integrin alpha L beta 2 and fibroblast growth factor 2 (FGF2) were highly expressed in PS-exposing Akata EVs compared with another EBV strain B95-8-transformed lymphoma-derived counterparts which significantly lack TAM-inducing ability. Pharmacological inhibition of either integrin alpha L beta 2 or FGF2 hampered cytokine induction in monocytic cultured cells elicited by PS-exposing Akata EVs, suggesting the involvement of these proteins in EV-mediated TAM induction in EBV lymphomas. In addition, phospholipids containing precursors of immunomodulatory lipid mediators were also enriched in PS-exposing Akata EVs compared with B95-8 counterparts. Phospholipidomic analysis of fractionated Akata EVs by density gradient centrifugation further demonstrated that PS-exposing Akata EVs might be identical to certain Akata EVs in low density fractions containing exosomes. Therefore, we concluded that a variety of immunomodulatory cargo molecules in a certain EV subtype are presumably conducive to the development of EBV lymphomas.	[Ito, Masatoshi; Tanaka, Masayuki; Fukunishi, Nahoko; Araki, Takuma] Tokai Univ, Support Ctr Med Res & Educ, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Kudo, Kai; Higuchi, Hiroshi; Otsuka, Hiroko; Takamatsu, Masako; Kotani, Ai] Tokai Univ, Dept Hematol Malignancy, Isehara, Kanagawa, Japan; [Kudo, Kai; Takamatsu, Masako; Kotani, Ai] Tokai Univ, Inst Med Sci, Dept Innovat Med Sci, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Ino, Yoko; Kimura, Yayoi] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan; [Kotani, Ai] Japan Agcy Med Res & Dev, AMED PRIME, Tokyo, Japan	Tokai University; Tokai University; Tokai University; Yokohama City University	Ito, M (corresponding author), Tokai Univ, Support Ctr Med Res & Educ, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.; Kotani, A (corresponding author), Tokai Univ, Inst Med Sci, Dept Innovat Med Sci, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	masa104-ito@tokai-u.jp; aikotani@k-lab.jp		Ito, Masatoshi/0000-0003-2665-0020; Kudo, Kai/0000-0002-5410-3334; Tanaka, Masayuki/0000-0002-8682-8719	Japan Agency for Medical Research and Development (AMED); MEXT | JST | Core Research for Evolutional Science and Technology (CREST); Research Program on Hepatitis from Japan Agency for Medical Research and Development [16fk0210114h0001]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | JST | Core Research for Evolutional Science and Technology (CREST); Research Program on Hepatitis from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: AMED--PRIME; MEXT | JST | Core Research for Evolutional Science and Technology (CREST); Research Program on Hepatitis from Japan Agency for Medical Research and Development, Grant/Award Number: 16fk0210114h0001	Ariza ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069827; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Chen ZZ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0863-7; Cianciaruso C, 2019, CELL REP, V27, P3062, DOI 10.1016/j.celrep.2019.05.008; Dang VD, 2017, FASEB J, V31, P5399, DOI 10.1096/fj.201700417R; De Re V, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101596; Duchez AC, 2015, P NATL ACAD SCI USA, V112, pE3564, DOI 10.1073/pnas.1507905112; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Hamidi H, 2018, NAT REV CANCER, V18, P532, DOI 10.1038/s41568-018-0038-z; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Higuchi H, 2018, BLOOD, V131, P2552, DOI 10.1182/blood-2017-07-794529; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Jiao YJ, 2019, J CELL BIOCHEM, V120, P988, DOI 10.1002/jcb.27465; Kakizaki M, 2020, J BIOL CHEM, V295, P12449, DOI 10.1074/jbc.RA120.014317; Kakizaki M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205886; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Lai RC, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29828; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; Ludwig S, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1593808; Lydic TA, 2015, METHODS, V87, P83, DOI 10.1016/j.ymeth.2015.04.014; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Masoodi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076532; Matsumura S, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1579541; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Nakamura S, 2008, WHO CLASSIFICATION T, V94, P243; Nishiumi S, 2018, DIGEST DIS SCI, V63, P1485, DOI 10.1007/s10620-018-5025-4; Onodi Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01479; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sato H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107579; Shannon-Lowe C, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00713; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Takase N, 2016, CANCER LETT, V380, P47, DOI 10.1016/j.canlet.2016.06.009; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Teow SY, 2017, INT J BIOL SCI, V13, P1276, DOI 10.7150/ijbs.19531; Triebl A, 2014, J CHROMATOGR A, V1347, P104, DOI 10.1016/j.chroma.2014.04.070; Valkonen S, 2019, BBA-MOL CELL BIOL L, V1864, P1168, DOI 10.1016/j.bbalip.2019.03.011; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Witwer KW, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1648167; Wortzel I, 2019, DEV CELL, V49, P347, DOI 10.1016/j.devcel.2019.04.011; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	47	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21505	10.1096/fj.202002730R	http://dx.doi.org/10.1096/fj.202002730R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33723887				2022-12-28	WOS:000635216100011
J	Xiang, JN; Zhang, SY; Xu, RY; Chu, HS; Biswas, S; Yu, SX; Miao, DS; Li, WD; Li, ST; Brown, AJ; Yang, HY; Xu, YH; Li, BJ; Liu, HJ				Xiang, Jinnan; Zhang, Shaoyang; Xu, Ruiyao; Chu, Hongshang; Biswas, Soma; Yu, Shuxiang; Miao, Dengshun; Li, Weidong; Li, Shentian; Brown, Andrew J.; Yang, Hongyuan; Xu, Yuhong; Li, Baojie; Liu, Huijuan			Elevated HB-EGF expression in neural stem cells causes middle age obesity by suppressing Hypocretin/Orexin expression	FASEB JOURNAL			English	Article						HB&#8208; EGF; midlife obesity; Nestin; neuron; Orexin		Obesity is common in the middle aged population and it increases the risks of diabetes, cardiovascular diseases, certain cancers, and dementia. Yet, its etiology remains incompletely understood. Here, we show that ectopic expression of HB-EGF, an important regulator of neurogenesis, in Nestin(+) neuroepithelial progenitors with the Cre-LoxP system leads to development of spontaneous middle age obesity in male mice accompanied by hyperglycemia and insulin resistance. The Nestin-HB-EGF mice show decreases in food uptake, energy expenditure, and physical activity, suggesting that reduced energy expenditure underlies the pathogenesis of this obesity model. However, HB-EGF expression in appetite-controlling POMC or AgRP neurons or adipocytes fails to induce obesity. Mechanistically, HB-EGF suppresses expression of Hypocretin/Orexin, an orexigenic neuropeptide hormone, in the hypothalamus of middle aged Nestin-HB-EGF mice. Hypothalamus Orexin administration alleviates the obese and hyperglycemic phenotypes in Nestin-HB-EGF mice. This study uncovers an important role for HB-EGF in regulating Orexin expression and energy expenditure and establishes a midlife obesity model whose pathogenesis involves age-dependent changes in hypothalamus neurons.	[Xiang, Jinnan; Li, Baojie] Shanghai Jiao Tong Univ, Sch Med, Bio X Renji Hosp Res Ctr, Renji Hosp, Shanghai, Peoples R China; [Xiang, Jinnan; Zhang, Shaoyang; Xu, Ruiyao; Chu, Hongshang; Biswas, Soma; Yu, Shuxiang; Li, Weidong; Li, Shentian; Li, Baojie; Liu, Huijuan] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai, Peoples R China; [Miao, Dengshun] Nanjing Med Univ, State Key Lab Reprod Med, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China; [Brown, Andrew J.; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Xu, Yuhong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Li, Baojie] Chengdu Univ Tradit Chinese Med, Ctr Tradit Chinese Med & Stem Cell Res, Chengdu, Sichuan, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University; University of New South Wales Sydney; Shanghai Jiao Tong University; Chengdu University of Traditional Chinese Medicine	Li, BJ; Liu, HJ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai, Peoples R China.	libj@sjtu.edu.cn; liuhj@sjtu.edu.cn	zhang, shaoyang/GPX-2651-2022	Li, Weidong/0000-0001-5384-4838	National Key Research and Development Program of China [2018YFA0800803]; NSFC | National Natural Science Foundation of ChinaYunnan Joint Fund (NSFC-Yunnan Joint Fund) [81520108012, 91749201]	National Key Research and Development Program of China; NSFC | National Natural Science Foundation of ChinaYunnan Joint Fund (NSFC-Yunnan Joint Fund)	National Key Research and Development Program of China, Grant/Award Number: 2018YFA0800803; NSFC | National Natural Science Foundation of ChinaYunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81520108012 and 91749201	Adam JA, 2002, INT J OBESITY, V26, P274, DOI 10.1038/sj.ijo.0801868; Adeghate E, 2012, VITAM HORM, V89, P111, DOI 10.1016/B978-0-12-394623-2.00007-X; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cavalcanti-de-Albuquerque JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08239-x; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Deng Q, 2019, ELIFE, V8, DOI 10.7554/eLife.50208; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gao XB, 2014, ANNU REV NEUROSCI, V37, P101, DOI 10.1146/annurev-neuro-071013-013855; Goodarzi MO, 2018, LANCET DIABETES ENDO, V6, P223, DOI 10.1016/S2213-8587(17)30200-0; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hirano A, 2018, P NATL ACAD SCI USA, V115, P3434, DOI 10.1073/pnas.1801693115; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; Hunt NJ, 2015, NEUROBIOL AGING, V36, P292, DOI 10.1016/j.neurobiolaging.2014.08.010; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2002, J NEUROSCI, V22, P5365; Johren O, 2001, ENDOCRINOLOGY, V142, P3324, DOI 10.1210/en.142.8.3324; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lemus MB, 2015, ENDOCRINOLOGY, V156, P1701, DOI 10.1210/en.2014-1961; Li P, 2019, J BONE MINER RES, V34, P295, DOI 10.1002/jbmr.3596; Mahler SV, 2014, NAT NEUROSCI, V17, P1298, DOI 10.1038/nn.3810; Manceau R, 2020, DIABETOLOGIA, V63, P673, DOI 10.1007/s00125-020-05104-9; Martins LB, 2019, NUTRITION, V66, P16, DOI 10.1016/j.nut.2019.03.017; Matsumoto S, 2002, BIOCHEM BIOPH RES CO, V292, P781, DOI 10.1006/bbrc.2002.6720; Morello G, 2016, P NATL ACAD SCI USA, V113, P4759, DOI 10.1073/pnas.1521304113; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1; Nevarez N, 2018, F1000RESEARCH, V7; Opanashuk LA, 1999, J NEUROSCI, V19, P133, DOI 10.1523/JNEUROSCI.19-01-00133.1999; Oyagi A, 2011, NEUROSCIENCE, V185, P116, DOI 10.1016/j.neuroscience.2011.04.034; Oyagi A, 2012, CNS NEUROSCI THER, V18, P803, DOI 10.1111/j.1755-5949.2012.00371.x; Oyagi A, 2011, BRAIN RES, V1419, P97, DOI 10.1016/j.brainres.2011.09.003; Pulver A, 2020, BRAIN RES, V1746, DOI 10.1016/j.brainres.2020.147013; Ronan L, 2016, NEUROBIOL AGING, V47, P63, DOI 10.1016/j.neurobiolaging.2016.07.010; Sanchez-Gurmaches J, 2015, STEM CELL REP, V4, P541, DOI 10.1016/j.stemcr.2015.02.008; Sasaki K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0176-0; Sawai N, 2010, NEUROSCI LETT, V468, P51, DOI 10.1016/j.neulet.2009.10.061; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Sternson SM, 2017, ANNU REV PHYSIOL, V79, P401, DOI 10.1146/annurev-physiol-021115-104948; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Taylor SR, 2014, SEMIN CELL DEV BIOL, V28, P22, DOI 10.1016/j.semcdb.2014.03.004; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Yang LY, 2013, J NEUROSCI, V33, P5275, DOI 10.1523/JNEUROSCI.3200-12.2013; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yelin-Bekerman L, 2015, ELIFE, V4, DOI [10.7554/eLife.08633, 10.7554/eLife.08638]	59	0	0	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21345	10.1096/fj.202001945R	http://dx.doi.org/10.1096/fj.202001945R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715219				2022-12-28	WOS:000635216100091
J	Chen, ZF; Dong, D; Zhu, YJ; Pang, NN; Ding, JB				Chen, Zhifang; Dong, Di; Zhu, Yuejie; Pang, Nannan; Ding, Jianbing			The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma	FASEB JOURNAL			English	Article						cervical cancer; human papilloma virus; prognosis; Tim-3/Galectin-9	IMMUNOGLOBULIN MUCIN-3; TIM-3 EXPRESSION; POOR-PROGNOSIS; CANCER; PHENOTYPE; CD4; HPV	The interaction between Tim-3 on T cell and its ligand, Galectin-9, negatively regulates cellular immune responses. However, the role of Tim-3/Galectin-9 pathway in the immune evasion of cervical cancer remains unknown. This study is to investigate the expression, function, and regulation of Tim-3/Galectin-9 signaling pathway in human papilloma virus (HPV) positive cervical cancer. Flow cytometry showed that Tim-3 expression on T cell and Galectin-9 expression on monocytes in HPV positive cervical cancer patients were significantly higher compared to cervical intraepithelial neoplasia and benign uterine fibroids Tim-3 + CD4+ Th1 cells and Tim-3 + CD8+ T cells in HPV positive cervical cancer patients were significantly reduced after surgery. Serum TGF-beta and IL-10 levels were positively correlated with Tim-3 + Treg cells, while IFN-gamma and IL-2 were negatively correlated with Tim-3 + Th1 cells. Additionally, Tim-3 + CD4+ T cells were positively correlated with Galectin-9 + monocytes. Survival curve analysis showed that Tim-3 + CD4+ T cells were negatively correlated with patient survival, and closely related to FIGO stage, degree of differentiation, and lymph node metastasis of HPV positive cervical cancer. In vitro experiments showed that by blocking the Tim-3/Galectin-9 pathway, the proliferation of T cells and their ability to express IFN-gamma, IL-2, perforin, and granzyme B was significantly restored. In conclusion, high levels of Tim-3 and Galectin-9 in HPV positive cervical cancer patients play roles in the progression of disease by promoting Treg cells to inhibit the cytotoxic function of Th1 and CD8+ T cells. Tim-3/Galectin-9 may serve as a new immunotherapy target for patients with HPV positive cervical cancer.	[Chen, Zhifang; Dong, Di; Pang, Nannan; Ding, Jianbing] Affiliated Hosp 1, State Key Lab Pathogenesis Prevent Treatment Cent, Xinjiang Med Univ, 393 Xinyi Rd, Urumqi 830011, Peoples R China; [Chen, Zhifang; Zhu, Yuejie] Xinjiang Med Univ, Dept Gynecol, Affiliated Hosp 1, Urumqi, Peoples R China; [Ding, Jianbing] Xinjiang Med Univ, Dept Immunol, Coll Basic Med, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Ding, JB (corresponding author), Affiliated Hosp 1, State Key Lab Pathogenesis Prevent Treatment Cent, Xinjiang Med Univ, 393 Xinyi Rd, Urumqi 830011, Peoples R China.	1601379937@qq.com		Ding, Jianbing/0000-0001-5506-7665	State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian [SKL-HIDCA-2019-8]; National Natural Science Foundation of China (NSFC) [81660475]	State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian, Grant/Award Number: SKL--HIDCA--2019--8; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81660475	Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]; Chen ZF, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/6519427; Chen ZF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6891482; Chen ZF, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-61; Chibwesha CJ, 2019, JAMA-J AM MED ASSOC, V322, P1558, DOI 10.1001/jama.2019.16176; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; Dutta A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7374; Golden-Mason L, 2015, CLIN IMMUNOL, V158, P114, DOI 10.1016/j.clim.2015.03.008; Han JF, 2020, CANCER IMMUNOL RES, V8, P146, DOI 10.1158/2326-6066.CIR-19-0398; Ji J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0528-7; Ji XJ, 2013, EUR J IMMUNOL, V43, P458, DOI 10.1002/eji.201242768; Ju Y, 2014, MOL IMMUNOL, V58, P85, DOI 10.1016/j.molimm.2013.11.001; Kang CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15659; Kim BH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49928-x; Laheurte C, 2019, BRIT J CANCER, V121, P405, DOI 10.1038/s41416-019-0531-5; Lan Y, 2017, J BUON, V22, P1017; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Li L, 2018, INT IMMUNOPHARMACOL, V57, P139, DOI 10.1016/j.intimp.2018.02.016; Liu YX, 2015, J HEPATOL, V62, P563, DOI 10.1016/j.jhep.2014.10.034; Lu X, 2017, CELL IMMUNOL, V313, P43, DOI 10.1016/j.cellimm.2017.01.001; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Markwick LJL, 2015, GASTROENTEROLOGY, V148, P590, DOI 10.1053/j.gastro.2014.11.041; Maskey N, 2019, CANCER MANAG RES, V11, P7647, DOI 10.2147/CMAR.S217264; Ostroumov D, 2018, CELL MOL LIFE SCI, V75, P689, DOI 10.1007/s00018-017-2686-7; Piao YR, 2013, ASIAN PAC J CANCER P, V14, P3897, DOI 10.7314/APJCP.2013.14.6.3897; Sada-Ovalle I, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20078; Saresella M, 2014, FASEB J, V28, P5000, DOI 10.1096/fj.14-258194; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Su H, 2018, LUNG CANCER, V121, P18, DOI 10.1016/j.lungcan.2018.04.009; Telli TA, 2020, CANCER LETT, V469, P142, DOI 10.1016/j.canlet.2019.10.036; Wang XX, 2018, INT IMMUNOPHARMACOL, V56, P249, DOI 10.1016/j.intimp.2018.01.037; Wu JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09484-8; Yang M, 2015, J SURG ONCOL, V112, P430, DOI 10.1002/jso.24012; Yang SF, 2017, INFLAMMATION, V40, P1062, DOI 10.1007/s10753-017-0549-x; Yasinska IM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01594; Yuan J, 2014, NEOPLASMA, V61, P35, DOI 10.4149/neo_2014_006; Zhang R, 2019, SMALL, V15, DOI 10.1002/smll.201903881; Zhao FH, 2019, LANCET, V393, P969, DOI 10.1016/S0140-6736(18)32849-6; Zhou EC, 2015, INT J CLIN EXP PATHO, V8, P8018	39	8	8	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21401	10.1096/fj.202000528RR	http://dx.doi.org/10.1096/fj.202000528RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559190	hybrid			2022-12-28	WOS:000629576700036
J	Ivanoff, AE; Einstein, GP; Tulp, OL				Ivanoff, Athena; Einstein, George; Tulp, Orien			A Review for Medical Students and Student Doctors on Detecting and Reporting Suspected Child Abuse and Neglect (SCAN) from Clinical and Forensic Observations	FASEB JOURNAL			English	Meeting Abstract	Annual Meeting on Experimental Biology	APR 04-07, 2020	San Diego, CA	Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut					[Ivanoff, Athena; Einstein, George; Tulp, Orien] USAT Montserrat, Arvada, CO USA						University of Science Arts & Technology, Montserrat, British West Indies	University of Science Arts & Technology, Montserrat, British West Indies	Supported by Institutional Resources of the University of Science Arts & Technology, Montserrat, British West Indies		0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34			1						10.1096/fasebj.2020.34.s1.07600	http://dx.doi.org/10.1096/fasebj.2020.34.s1.07600			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG5YS	34081801				2022-12-28	WOS:000546107901171
J	Ferreira, JC; Fadl, S; Ilter, M; Pekel, H; Rezgui, R; Sensoy, O; Rabeh, WM				Ferreira, Juliana C.; Fadl, Samar; Ilter, Metehan; Pekel, Hanife; Rezgui, Rachid; Sensoy, Ozge; Rabeh, Wael M.			Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro	FASEB JOURNAL			English	Article						3-chymotrypsin-like protease (3CLpro); COVID-19; DMSO; initial velocity; SARS-CoV-2; thermodynamic stability	RESPIRATORY-SYNDROME-CORONAVIRUS; SARS-CORONAVIRUS; INHIBITORS; IDENTIFICATION; DIMERIZATION; HYDROLYSIS; PROTEINASE; PARAMETERS; ASSAYS; GUI	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19), one of the most challenging global pandemics of the modern era. Potential treatment strategies against COVID-19 are yet to be devised. It is crucial that antivirals that interfere with the SARS-CoV-2 life cycle be identified and developed. 3-Chymotrypsin-like protease (3CLpro) is an attractive antiviral drug target against SARS-CoV-2, and coronaviruses in general, because of its role in the processing of viral polyproteins. Inhibitors of 3CLpro activity are screened in enzyme assays before further development of the most promising leads. Dimethyl sulfoxide (DMSO) is a common additive used in such assays and enhances the solubility of assay components. However, it may also potentially affect the stability and efficiency of 3CLpro but, to date, this effect had not been analyzed in detail. Here, we investigated the effect of DMSO on 3CLpro-catalyzed reaction. While DMSO (5%-20%) decreased the optimum temperature of catalysis and thermodynamic stability of 3CLpro, it only marginally affected the kinetic stability of the enzyme. Increasing the DMSO concentration up to 20% improved the catalytic efficiency and peptide-binding affinity of 3CLpro. At such high DMSO concentration, the solubility and stability of peptide substrate were improved because of reduced aggregation. In conclusion, we recommend 20% DMSO as the minimum concentration to be used in screens of 3CLpro inhibitors as lead compounds for the development of antiviral drugs against COVID-19.	[Ferreira, Juliana C.; Fadl, Samar; Rabeh, Wael M.] New York Univ Abu Dhabi, Sci Div, POB 129188, Abu Dhabi, U Arab Emirates; [Ilter, Metehan] Istanbul Medipol Univ, Grad Sch Engn & Nat Sci, Istanbul, Turkey; [Pekel, Hanife] Istanbul Medipol Univ, Vocat Sch Hlth Serv, Dept Pharm Serv, Istanbul, Turkey; [Pekel, Hanife; Sensoy, Ozge] Istanbul Medipol Univ, Res Inst Hlth Sci & Technol SABITA, Regenerat & Restorat Med Res Ctr REMER, Istanbul, Turkey; [Rezgui, Rachid] New York Univ Abu Dhabi, Core Technol Platforms, Abu Dhabi, U Arab Emirates; [Sensoy, Ozge] Istanbul Medipol Univ, Sch Engn & Nat Sci, Dept Comp Engn, Istanbul, Turkey	Istanbul Medipol University; Istanbul Medipol University; Istanbul Medipol University; Istanbul Medipol University	Rabeh, WM (corresponding author), New York Univ Abu Dhabi, Sci Div, POB 129188, Abu Dhabi, U Arab Emirates.	wael.rabeh@nyu.edu		rabeh, wael/0000-0001-6071-8581; ILTER, Metehan/0000-0003-3579-4552	New York University Abu Dhabi [ADC05]	New York University Abu Dhabi	New York University Abu Dhabi, Grant/Award Number: COVID--19 Facilitator Research Fund (grant number: ADC05)	Abian O, 2020, INT J BIOL MACROMOL, V164, P1693, DOI 10.1016/j.ijbiomac.2020.07.235; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Acter T, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138996; Aggarwal M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14753; Ahn DG, 2020, J MICROBIOL BIOTECHN, V30, P313, DOI 10.4014/jmb.2003.03011; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Arakawa T, 2007, BIOPHYS CHEM, V131, P62, DOI 10.1016/j.bpc.2007.09.004; ARNTFIELD SD, 1981, CAN I FOOD SC TECH J, V14, P289, DOI 10.1016/S0315-5463(81)72929-8; Bacha U, 2008, CHEM BIOL DRUG DES, V72, P34, DOI 10.1111/j.1747-0285.2008.00679.x; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Bereau T, 2015, J CHEM THEORY COMPUT, V11, P2783, DOI 10.1021/acs.jctc.5b00056; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Ferreira JC., 2020, J BIOL CHEM, V296, P1; Ferreira JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79357-0; Gioia M, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114225; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACKSON M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P231, DOI 10.1016/0167-4838(91)90563-F; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60; Kao RY, 2004, FEBS LETT, V576, P325, DOI 10.1016/j.febslet.2004.09.026; Khan S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00187-20; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lee H, 2014, BIOORGAN MED CHEM, V22, P167, DOI 10.1016/j.bmc.2013.11.041; Lee J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19662-4; Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0; Guo LY, 2020, APMIS, V128, P423, DOI 10.1111/apm.13047; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; McCartney CSE, 2019, METHODS MOL BIOL, V1915, P39, DOI 10.1007/978-1-4939-8988-1_4; Mody V, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01577-x; Nawaz MH., 2018, BIOSCIENCE REP, V38, P1; Needle D, 2015, ACTA CRYSTALLOGR D, V71, P1102, DOI 10.1107/S1399004715003521; Ortiz SEM, 2001, J THERM ANAL CALORIM, V66, P489; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Rathnayake AD, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc5332; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Ye G, 2016, VIROLOGY, V494, P225, DOI 10.1016/j.virol.2016.04.018; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	59	4	4	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21774	10.1096/fj.202100994	http://dx.doi.org/10.1096/fj.202100994			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324734	Green Published			2022-12-28	WOS:000678975300032
J	Qiao, AJ; Ma, WX; Deng, JX; Zhou, JL; Han, CS; Zhang, E; Boriboun, C; Xu, SY; Zhang, CX; Jie, CF; Kim, JA; Habegger, KM; Qiu, HY; Zhao, TC; Zhang, JY; Qin, GJ				Qiao, Aijun; Ma, Wenxia; Deng, Jianxin; Zhou, Junlan; Han, Chaoshan; Zhang, Eric; Boriboun, Chan; Xu, Shiyue; Zhang, Chunxiang; Jie, Chunfa; Kim, Jeong-a; Habegger, Kirk M.; Qiu, Hongyu; Zhao, Ting C.; Zhang, Jianyi; Qin, Gangjian			Ablation of Sam68 in adult mice increases thermogenesis and energy expenditure	FASEB JOURNAL			English	Article						adipocytes; adipose; browning; energy metabolism; obesity; Sam68; thermogenesis; UCP1	BROWN ADIPOSE-TISSUE; FAT; BEIGE; SRC	Genetic deletion of Src associated in mitosis of 68kDa (Sam68), a pleiotropic adaptor protein prevents high-fat diet-induced weight gain and insulin resistance. To clarify the role of Sam68 in energy metabolism in the adult stage, we generated an inducible Sam68 knockout mice. Knockout of Sam68 was induced at the age of 7-10 weeks, and then we examined the metabolic profiles of the mice. Sam68 knockout mice gained less body weight over time and at 34 or 36 weeks old, had smaller fat mass without changes in food intake and absorption efficiency. Deletion of Sam68 in mice elevated thermogenesis, increased energy expenditure, and attenuated core-temperature drop during acute cold exposure. Furthermore, we examined younger Sam68 knockout mice at 11 weeks old before their body weights deviate, and confirmed increased energy expenditure and thermogenic gene program. Thus, Sam68 is essential for the control of adipose thermogenesis and energy homeostasis in the adult.	[Qiao, Aijun; Ma, Wenxia; Deng, Jianxin; Han, Chaoshan; Zhang, Eric; Boriboun, Chan; Xu, Shiyue; Zhang, Chunxiang; Zhang, Jianyi; Qin, Gangjian] Univ Alabama Birmingham, Sch Med & Sch Engn, Dept Biomed Engn, 1720 2nd Ave South,VH G094N, Birmingham, AL 35294 USA; [Zhou, Junlan; Qin, Gangjian] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Jie, Chunfa] Des Moines Univ, Dept Biochem & Nutr, Coll Osteopath Med, Des Moines, IA USA; [Kim, Jeong-a; Habegger, Kirk M.] Univ Alabama Birmingham, Dept Med Endocrinol Diabet & Metab, Comprehens Diabet Ctr, Sch Med, Birmingham, AL USA; [Qiu, Hongyu] Georgia State Univ, Ctr Mol & Translat Med, Inst Biomed Sci, Atlanta, GA 30303 USA; [Zhao, Ting C.] Boston Univ, Med Sch, Dept Surg, Roger Williams Med Ctr, Providence, RI USA	University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; University of Alabama System; University of Alabama Birmingham; University System of Georgia; Georgia State University; Boston University; Roger Williams Medical Center	Qiao, AJ; Qin, GJ (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, Sch Med & Sch Engn, Sch Engn, 1720 2nd Ave South,VH G094N,VH G094R, Birmingham, AL 35294 USA.	aqiao@uab.edu; gqin@uab.edu	Qiao, Aijun/AAO-4277-2020	Habegger, Kirk/0000-0002-0342-5480	National Institute of Health [HL138990, HL131110, HL130052, HL113541, HL142291, R01DK112934]; American Diabetes Association [1-15-BS-148]; American Heart Association [19TPA34910227, 19CDA34630052, 18POST34070088, 18PRE34080358]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association)	This work was supported by the National Institute of Health (R01 Grants#HL138990, HL131110, HL130052, and HL113541 to GQ; HL142291 to H.Q & GQ; R01DK112934 to KMH); American Diabetes Association (Grant# 1-15-BS-148 to GQ); American Heart Association (Grant#19TPA34910227 to GQ; 19CDA34630052 to A.Q; 18POST34070088 to S.X; and 18PRE34080358 to EZ)	Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Bielli P, 2014, EMBO REP, V15, P419, DOI 10.1002/embr.201338241; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Brown RJ, 2016, J CLIN ENDOCR METAB, V101, P4500, DOI 10.1210/jc.2016-2466; Caron A, 2018, NAT REV NEUROSCI, V19, P153, DOI 10.1038/nrn.2018.7; Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Darcy J, 2019, GEROSCIENCE, V41, P285, DOI 10.1007/s11357-019-00076-0; Fu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2916; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Huot ME, 2012, MOL CELL, V46, P187, DOI 10.1016/j.molcel.2012.02.007; Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Iwen KA, 2017, J CLIN ENDOCR METAB, V102, P4226, DOI 10.1210/jc.2017-01250; Kahn CR, 2019, J CLIN INVEST, V129, P3990, DOI 10.1172/JCI129187; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kooijman S, 2015, TRENDS ENDOCRIN MET, V26, P657, DOI 10.1016/j.tem.2015.09.008; Li LJ, 2014, FERTIL STERIL, V102, P61, DOI 10.1016/j.fertnstert.2014.03.036; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lim J, 2020, INT J OBESITY, V44, P697, DOI 10.1038/s41366-020-0528-4; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Paronetto MP, 2011, NUCLEIC ACIDS RES, V39, P4961, DOI 10.1093/nar/gkr085; Ramakrishnan P, 2011, MOL CELL, V43, P167, DOI 10.1016/j.molcel.2011.05.007; Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tam CS, 2012, CIRCULATION, V125, P2782, DOI 10.1161/CIRCULATIONAHA.111.042929; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Trayhurn P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01672; Wang SM, 2017, CELL MOL LIFE SCI, V74, P1765, DOI 10.1007/s00018-016-2420-x; Wang WS, 2019, CELL METAB, V30, P174, DOI 10.1016/j.cmet.2019.05.005; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Zhou JL, 2015, J ENDOCRINOL, V225, P181, DOI 10.1530/JOE-14-0727; Zhou JL, 2009, CIRCULATION, V120, P1213, DOI 10.1161/CIRCULATIONAHA.109.859207	42	2	2	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21772	10.1096/fj.202100021R	http://dx.doi.org/10.1096/fj.202100021R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34252225	Green Accepted			2022-12-28	WOS:000678975300030
J	Fuente, R; Gehring, N; Bettoni, C; Gil-Pena, H; Alonso-Duran, L; Michalke, B; Santos, F; Wagner, CA; Rubio-Aliaga, I				Fuente, Rocio; Gehring, Nicole; Bettoni, Carla; Gil-Pena, Helena; Alonso-Duran, Laura; Michalke, Bernhard; Santos, Fernando; Wagner, Carsten A.; Rubio-Aliaga, Isabel			Systemic Jak1 activation causes extrarenal calcitriol production and skeletal alterations provoking stunted growth	FASEB JOURNAL			English	Article						bone mass density; calcitriol; growth plate; Jak; Stat signaling	VITAMIN-D METABOLISM; 1,25-DIHYDROXYVITAMIN D-3; MARKED ALTERATIONS; D-RECEPTOR; PLATE; EXPRESSION; DISEASE; 1-ALPHA-HYDROXYLASE; MUTATION; PATHWAY	Mineral homeostasis is regulated by a complex network involving endocrine actions by calcitriol, parathyroid hormone (PTH), and FGF23 on several organs including kidney, intestine, and bone. Alterations of mineral homeostasis are found in chronic kidney disease and other systemic disorders. The interplay between the immune system and the skeletal system is not fully understood, but cytokines play a major role in modulating calcitriol production and function. One of the main cellular signaling pathways mediating cytokine function is the Janus kinase (JAK)--signal transducer and activator of transcription (STAT) pathway. Here, we used a mouse model (Jak1(S645P+/-)) that resembles a constitutive activating mutation of the Jak1/Stat3 signaling pathway in humans, and shows altered mineral metabolism, with higher fibroblast growth factor 23 (FGF23) levels, lower PTH levels, and higher calcitriol levels. The higher calcitriol levels are probably due to extrarenal calcitriol production. Furthermore, systemic Jak1/Stat3 activation led to growth impairment and skeletal alterations. The growth plate in long bones showed decreased chondrocyte proliferation rates and reduced height of terminal chondrocytes. Furthermore, we demonstrate that Jak1 is also involved in bone remodeling early in life. Jak1(S645P+/-) animals have decreased bone and cortical volume, imbalanced bone remodeling, reduced MAP kinase signaling, and local inflammation. In conclusion, Jak1 plays a major role in bone health probably both, directly and systemically by regulating mineral homeostasis. Understanding the role of this signaling pathway will contribute to a better knowledge in bone growth and in mineral physiology, and to the development of selective Jak inhibitors as osteoprotective agents.	[Fuente, Rocio; Gehring, Nicole; Bettoni, Carla; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Fuente, Rocio; Gehring, Nicole; Bettoni, Carla; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Natl Ctr Competence Res NCCR Kidney, Zurich, Switzerland; [Fuente, Rocio; Gil-Pena, Helena; Alonso-Duran, Laura; Santos, Fernando] Univ Oviedo, Div Pediat, Oviedo, Spain; [Michalke, Bernhard] German Res Ctr Environm Hlth GmbH, Dept Environm Sci, Res Unit Analyt, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Santos, Fernando] Hosp Univ Cent Asturias, Dept Pediat, Oviedo, Spain	University of Zurich; University of Oviedo; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Central University Hospital Asturias	Wagner, CA; Rubio-Aliaga, I (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Wagnerca@access.uzh.ch; isabel.rubioaliaga@uzh.ch		FUENTE, ROCIO/0000-0002-2311-2836; Rubio-Aliaga, Isabel/0000-0003-1051-9511; Wagner, Carsten/0000-0002-9874-8898	Swiss National Science Foundation (Schweizerische Nationalfonds) [176125]; Instituto Salud Carlos III [PI15/02122]; Marie Sklodowska--Curie Global Fellowship [853717]	Swiss National Science Foundation (Schweizerische Nationalfonds); Instituto Salud Carlos III(Instituto de Salud Carlos III); Marie Sklodowska--Curie Global Fellowship	The project was supported by a grant of the Swiss National Science Foundation (Schweizerische Nationalfonds) to Carsten A Wagner (176125) and a grant of the Instituto Salud Carlos III to Fernando Santos (PI15/02122). Rocio Fuente holds a UMarie Sklodowska--Curie Global Fellowship (Number Grant agreement No 853717)	Abreu MT, 2004, GUT, V53, P1129, DOI 10.1136/gut.2003.036657; Adam S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay4447; Alvarez-Garcia O, 2007, PEDIATR NEPHROL, V22, P954, DOI 10.1007/s00467-007-0456-8; Bikle D, 2020, NAT REV ENDOCRINOL, V16, P234, DOI 10.1038/s41574-019-0312-5; Bikle Daniel D, 2018, Bone Rep, V8, P255, DOI 10.1016/j.bonr.2018.02.004; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Christakos S, 2019, METABOLISM, V98, P112, DOI 10.1016/j.metabol.2019.06.010; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Daryadel A, 2021, FASEB J, V35, DOI 10.1096/fj.202002113R; Fernandez-Iglesias A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124519; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fuente R, 2019, FASEB J, V33, P8349, DOI 10.1096/fj.201802007R; Fuente R, 2018, BONE, V116, P187, DOI 10.1016/j.bone.2018.08.004; Gadina M, 2019, RHEUMATOLOGY, V58, P4, DOI 10.1093/rheumatology/key432; Giustina A, 2020, JBMR PLUS, V4, DOI 10.1002/jbm4.10417; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hernando N, 2021, J PHYSIOL-LONDON, V599, P1131, DOI 10.1113/JP280345; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hutchison MR, 2012, MOL ENDOCRINOL, V26, P1406, DOI 10.1210/me.2012-1063; Kagi L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195427; Levi M, 2019, NAT REV NEPHROL, V15, P482, DOI 10.1038/s41581-019-0159-y; Li Jiliang, 2013, JAKSTAT, V2, pe23930, DOI 10.4161/jkst.23930; Li Q, 2017, ONCOTARGET, V8, P34687, DOI 10.18632/oncotarget.16670; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Maruotti N, 2020, J CELL PHYSIOL, V235, P1915, DOI 10.1002/jcp.29149; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; Meyer MB, 2019, J BIOL CHEM, V294, P14467, DOI 10.1074/jbc.RA119.010173; Meyer MB, 2017, J BIOL CHEM, V292, P17541, DOI 10.1074/jbc.M117.806901; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Molinos I, 2006, KIDNEY INT, V70, P1955, DOI 10.1038/sj.ki.5001949; Mornet E, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-40; Murakami K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181126; Naja RP, 2009, ENDOCRINOLOGY, V150, P4024, DOI 10.1210/en.2008-1410; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pastor-Arroyo EM, 2020, ACTA PHYSIOL, V230, DOI 10.1111/apha.13526; Pastor-Arroyo EM, 2018, KIDNEY INT, V94, P49, DOI 10.1016/j.kint.2018.02.017; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rutherford C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf8566; Sabrautzki S, 2013, AM J PATHOL, V183, P352, DOI 10.1016/j.ajpath.2013.04.027; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Sims NA, 2020, EXP MOL MED, V52, P1185, DOI 10.1038/s12276-020-0445-6; Stocker A, 2005, J TRACE ELEM MED BIO, V19, P183, DOI 10.1016/j.jtemb.2005.08.004; Umbach AT, 2015, KIDNEY INT, V87, P728, DOI 10.1038/ki.2014.371; Vervloet M, 2019, NAT REV NEPHROL, V15, P109, DOI 10.1038/s41581-018-0087-2; VIETH R, 1979, J BIOL CHEM, V254, P2455; Wakahashi K, 2020, J BONE MINER METAB, V38, P145, DOI 10.1007/s00774-019-01075-z; Zhu JG, 2013, P NATL ACAD SCI USA, V110, P15650, DOI 10.1073/pnas.1315006110	57	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21721	10.1096/fj.202100587R	http://dx.doi.org/10.1096/fj.202100587R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118090				2022-12-28	WOS:000667814100049
J	Griesel, BA; Matsuzaki, S; Batushansky, A; Griffin, TM; Humphries, KM; Olson, AL				Griesel, Beth A.; Matsuzaki, Satoshi; Batushansky, Albert; Griffin, Timothy M.; Humphries, Kenneth M.; Olson, Ann Louise			PFKFB3-dependent glucose metabolism regulates 3T3-L1 adipocyte development	FASEB JOURNAL			English	Article						adipogenesis; adiponectin; glucose metabolism; glucose transport; glucose transporter 4 (GLUT4); phosphofructokinase fructose bisphosphatase 3 (PFKFB3)	INDUCED INSULIN-RESISTANCE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; DIFFERENTIATION; EXPRESSION; PATHWAY; PREF-1; PFKFB3; GROWTH	Proliferation and differentiation of preadipocytes, and other cell types, is accompanied by an increase in glucose uptake. Previous work showed that a pulse of high glucose was required during the first 3 days of differentiation in vitro, but was not required after that. The specific glucose metabolism pathways required for adipocyte differentiation are unknown. Herein, we used 3T3-L1 adipocytes as a model system to study glucose metabolism and expansion of the adipocyte metabolome during the first 3 days of differentiation. Our primary outcome measures were GLUT4 and adiponectin, key proteins associated with healthy adipocytes. Using complete media with 0 or 5 mM glucose, we distinguished between developmental features that were dependent on the differentiation cocktail of dexamethasone, insulin, and isobutylmethylxanthine alone or the cocktail plus glucose. Cocktail alone was sufficient to activate the capacity for 2-deoxglucose uptake and glycolysis, but was unable to support the expression of GLUT4 and adiponectin in mature adipocytes. In contrast, 5 mM glucose in the media promoted a transient increase in glucose uptake and glycolysis as well as a significant expansion of the adipocyte metabolome and proteome. Using genetic and pharmacologic approaches, we found that the positive effects of 5 mM glucose on adipocyte differentiation were specifically due to increased expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), a key regulator of glycolysis and the ancillary glucose metabolic pathways. Our data reveal a critical role for PFKFB3 activity in regulating the cellular metabolic remodeling required for adipocyte differentiation and maturation.	[Griesel, Beth A.; Griffin, Timothy M.; Humphries, Kenneth M.; Olson, Ann Louise] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 940 Stanton L Young BLVD,Rm 964 BMSB, Oklahoma City, OK 73104 USA; [Matsuzaki, Satoshi; Batushansky, Albert; Griffin, Timothy M.; Humphries, Kenneth M.] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Olson, AL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 940 Stanton L Young BLVD,Rm 964 BMSB, Oklahoma City, OK 73104 USA.	ann-olson@ouhsc.edu		Olson, Ann Louise/0000-0001-9401-2317	Oklahoma Center for Adult Stem Cell Research; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR17-018]	Oklahoma Center for Adult Stem Cell Research; Oklahoma Center for the Advancement of Science and Technology (OCAST)	Oklahoma Center for Adult Stem Cell Research; Oklahoma Center for the Advancement of Science and Technology (OCAST), Grant/Award Number: HR17-018	Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Batushansky A, 2019, OSTEOARTHR CARTILAGE, V27, P1361, DOI 10.1016/j.joca.2019.05.010; Beckermann KE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138729; Bockus LB, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007159; Burmistrova O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48196-z; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Holtrup B, 2017, ADIPOCYTE, V6, P224, DOI 10.1080/21623945.2017.1349042; Hudak CS, 2014, CELL REP, V8, P678, DOI 10.1016/j.celrep.2014.06.060; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Jackson RM, 2017, J BIOL CHEM, V292, P18556, DOI 10.1074/jbc.M117.791970; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Krycer JR, 2020, J BIOL CHEM, V295, P13250, DOI 10.1074/jbc.RA120.014907; Liu L, 2016, NAT CHEM BIOL, V12, P345, DOI [10.1038/NCHEMBIO.2047, 10.1038/nchembio.2047]; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; O'Neal J, 2016, BREAST CANCER RES TR, V160, P29, DOI 10.1007/s10549-016-3968-8; OLSON AL, 1990, PEDIATR RES, V28, P183, DOI 10.1203/00006450-199009000-00001; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rotondo F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09450-4; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Shi LL, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.44; Simon-Molas H, 2018, MOL CELL BIOCHEM, V448, P187, DOI 10.1007/s11010-018-3325-9; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM., 1998, J BIOL CHEM, V48, P31751; Tanner LB, 2018, CELL SYST, V7, P49, DOI 10.1016/j.cels.2018.06.003; Trefely S, 2015, J BIOL CHEM, V290, P25834, DOI 10.1074/jbc.M115.658815; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Ye JM, 2004, DIABETOLOGIA, V47, P1306, DOI 10.1007/s00125-004-1436-1; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Yi M, 2019, MOL METAB, V20, P1, DOI 10.1016/j.molmet.2018.11.013	39	1	1	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21728	10.1096/fj.202100381RR	http://dx.doi.org/10.1096/fj.202100381RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110658	Green Accepted			2022-12-28	WOS:000667814100064
J	Soni, H; Kumar, R; Kanthakumar, P; Adebiyi, A				Soni, Hitesh; Kumar, Ravi; Kanthakumar, Praghalathan; Adebiyi, Adebowale			Interleukin 1 beta-induced calcium signaling via TRPA1 channels promotes mitogen-activated protein kinase-dependent mesangial cell proliferation	FASEB JOURNAL			English	Article						calcium entry; interleukin 1 beta; mesangial cell proliferation; mitogen-activated protein kinase; TRPA1 channels	MAJOR SOURCE; A1 TRPA1; RECEPTOR; CA2+; IL-1-BETA; ALPHA; GLOMERULONEPHRITIS; FIBRONECTIN; EXPRESSION; MACROPHAGES	Glomerular mesangial cell (GMC)-derived pleiotropic cytokine, interleukin-1 (IL-1), contributes to hypercellularity in human and experimental proliferative glomerulonephritis. IL-1 promotes mesangial proliferation and may stimulate extracellular matrix accumulation, mechanisms of which are unclear. The present study shows that the beta isoform of IL-1 (IL-1 beta) is a potent inducer of IL-1 type I receptor-dependent Ca2+ entry in mouse GMCs. We also demonstrate that the transient receptor potential ankyrin 1 (TRPA1) is an intracellular store-independent diacylglycerol-sensitive Ca2+ channel in the cells. IL-1 beta-induced Ca2+ and Ba2+ influxes in the cells were negated by pharmacological inhibition and siRNA-mediated knockdown of TRPA1 channels. IL-1 beta did not stimulate fibronectin production in cultured mouse GMCs and glomerular explants but promoted Ca2+-dependent cell proliferation. IL-1 beta also stimulated TRPA1-dependent ERK mitogen-activated protein kinase (MAPK) phosphorylation in the cells. Concomitantly, IL-1 beta-induced GMC proliferation was attenuated by TRPA1 and RAF1/ MEK/ERK inhibitors. These findings suggest that IL-1 beta-induced Ca2+ entry via TRPA1 channels engenders MAPK-dependent mesangial cell proliferation. Hence, TRPA1-mediated Ca2+ signaling could be of pathological significance in proliferative glomerulonephritis.	[Soni, Hitesh; Kumar, Ravi; Kanthakumar, Praghalathan; Adebiyi, Adebowale] Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Adebiyi, A (corresponding author), Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA.	aadebiyi@uthsc.edu		Kanthakumar, Praghalathan/0000-0002-7610-8945; Kumar, Ravi/0000-0002-2514-257X; Adebiyi, Adebowale/0000-0002-7033-1871	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01 HL151735]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01 HL151735	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Adebiyi A, 2014, EXP CELL RES, V324, P92, DOI 10.1016/j.yexcr.2014.03.011; Adebiyi A, 2014, J CELL PHYSIOL, V229, P502, DOI 10.1002/jcp.24470; Afsar B, 2018, DRUGS, V78, P1073, DOI 10.1007/s40265-018-0942-2; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; ALLISON MEM, 1974, J CLIN INVEST, V53, P1402, DOI 10.1172/JCI107689; Anders HJ, 2016, J AM SOC NEPHROL, V27, P2564, DOI 10.1681/ASN.2016020177; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; BHASIN HK, 1978, LAB INVEST, V39, P21; BRADFIELD JWB, 1977, LAB INVEST, V36, P481; Braicu C, 2019, CANCERS, V11, DOI 10.3390/cancers11101618; Chuderland Dana, 2008, Commun Integr Biol, V1, P4; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guimaraes Marilia Z. P., 2007, P151; Humeau J, 2018, CELL CALCIUM, V70, P3, DOI 10.1016/j.ceca.2017.07.006; IKEDA M, 1991, CLIN EXP IMMUNOL, V83, P149; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma R, 2006, EXP BIOL MED, V231, P145; Ma ST, 2021, AM J HYPERTENS, V34, P110, DOI 10.1093/ajh/hpaa162; Ma ST, 2019, AM J PHYSIOL-RENAL, V317, pE623, DOI 10.1152/ajprenal.00069.2019; MARTIN J, 1986, J IMMUNOL, V137, P525; Masola V, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1770-1; MATSUMOTO K, 1988, AM J NEPHROL, V8, P463, DOI 10.1159/000167656; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; MOSQUERA JA, 1993, LAB INVEST, V68, P406; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; NORONHA IL, 1993, KIDNEY INT, V43, P682, DOI 10.1038/ki.1993.98; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pawluczyk IZA, 1998, KIDNEY INT, V54, P62, DOI 10.1046/j.1523-1755.1998.00965.x; Pohoczky K, 2016, J MOL ENDOCRINOL, V56, P135, DOI 10.1530/JME-15-0184; Prandini P, 2016, AM J RESP CELL MOL, V55, P645, DOI 10.1165/rcmb.2016-0089OC; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Radeke H H, 1991, Eur Cytokine Netw, V2, P51; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rush BM, 2018, JOVE-J VIS EXP, DOI 10.3791/58162; Sachdeva R, 2019, CELL CALCIUM, V78, P66, DOI 10.1016/j.ceca.2019.01.002; Salmon MD, 2011, INT IMMUNOPHARMACOL, V11, P145, DOI 10.1016/j.intimp.2010.11.006; SEDOR JR, 1992, KIDNEY INT, V41, P595, DOI 10.1038/ki.1992.89; Silverman HA., 822734 BIORXIV; Soni H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18143-x; STAHL RAK, 1990, AM J PHYSIOL, V259, pF419, DOI 10.1152/ajprenal.1990.259.3.F419; Stockand JD, 1998, PHYSIOL REV, V78, P723, DOI 10.1152/physrev.1998.78.3.723; TANG WW, 1994, J CLIN INVEST, V93, P273, DOI 10.1172/JCI116956; Tesch GH, 1997, NEPHROL DIAL TRANSPL, V12, P1109, DOI 10.1093/ndt/12.6.1109; Tesch GH, 1997, AM J PATHOL, V151, P141; Timoshanko JR, 2004, J AM SOC NEPHROL, V15, P910, DOI 10.1097/01.ASN.0000115704.86897.F4; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Vesey DA, 2002, KIDNEY INT, V62, P31, DOI 10.1046/j.1523-1755.2002.00401.x; Wang R, 2007, LIFE SCI, V80, P2481, DOI 10.1016/j.lfs.2007.04.010; Wang Z, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5179468; Wu CK, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073415; Wu CK, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052309; Wu CK., 2019, J CLIN MED, V8; Yin SJ, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0204-9; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Zhai WW, 2004, BRIT J PHARMACOL, V143, P1042, DOI 10.1038/sj.bjp.0705971	67	4	4	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21729	10.1096/fj.202100367R	http://dx.doi.org/10.1096/fj.202100367R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143493	Green Accepted			2022-12-28	WOS:000667814100063
J	Zhang, Y; Guo, XY; Guo, LJ; Chang, HM; Shu, J; Leung, PCK				Zhang, Yu; Guo, Xiaoyan; Guo, Linjiang; Chang, Hsun-Ming; Shu, Jing; Leung, Peter C. K.			Outcomes comparison of IVF/ICSI among different trigger methods for final oocyte maturation: A systematic review and meta-analysis	FASEB JOURNAL			English	Review						dual trigger; FSH co-trigger; FSH surge; GnRH agonist; pregnancy outcome	HUMAN CHORIONIC-GONADOTROPIN; FOLLICLE-STIMULATING-HORMONE; IN-VITRO FERTILIZATION; OVARIAN HYPERSTIMULATION SYNDROME; GNRH ANTAGONIST CYCLES; DUAL TRIGGER; NORMAL RESPONDERS; PREGNANCY RATE; SYNDROME OHSS; AGONIST	During the in vitro fertilization treatment, human chorionic gonadotrophin (hCG) is routinely used as a substitute for the natural endogenous LH surge during the final stage of oocyte maturation. However, it does not provide the FSH surge observed in the mid-cycle of the natural cycle. To date, whether the FSH surge can improve oocyte quality and pregnancy outcomes remains unknown. Randomized controlled trials comparing the following four trigger methods to conventional hCG were examined: GnRH agonist (GnRHa), kisspeptin, GnRHa plus hCG (dual trigger), and FSH plus hCG (FSH co-trigger). The results showed that the use of dual triggers was associated with a significantly higher number of retrieved cumulus-oocyte complexes (COCs) (weighted mean difference [WMD] 1.625, 95% CI 0.684-2.565), retrieved mature oocytes (WMD 0.986, 95% CI 0.426-1.545) and fertilized (2PN) oocytes (WMD 0.792, 95% CI 0.083-1.501), compared with the use of hCG. However, there was no significant difference between the two groups in terms of pregnancy rate. The FSH co-trigger resulted in significantly higher rates of 2PN oocytes retrieved than the hCG trigger (WMD 0.077, 95% CI 0.028-0.126). Notably, the risk of OHSS did not differ among the three treatment groups compared to that of the hCG group. This review protocol was registered with PROSPERO (CRD 42020194201).	[Zhang, Yu; Guo, Xiaoyan; Shu, Jing] Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Reprod Endocrinol, 158 Shangtang Rd, Hangzhou 310014, Peoples R China; [Zhang, Yu; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp, Res Inst, Dept Obstet & Gynaecol, 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Guo, Linjiang] Zhejiang Univ, Publ Policy Res Inst, Hangzhou, Peoples R China	Hangzhou Medical College; Zhejiang Provincial People's Hospital; BC Childrens Hospital; University of British Columbia; Zhejiang University	Shu, J (corresponding author), Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Reprod Endocrinol, 158 Shangtang Rd, Hangzhou 310014, Peoples R China.; Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp, Res Inst, Dept Obstet & Gynaecol, 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	shujing@hmc.edu.cn; peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	State Scholarship Fund of China Scholarship Council [201808330731]; Program for Medical New Talent in Zhejiang Province; Canadian Institutes of Health Research Foundation Scheme [143317]	State Scholarship Fund of China Scholarship Council(China Scholarship Council); Program for Medical New Talent in Zhejiang Province; Canadian Institutes of Health Research Foundation Scheme(Canadian Institutes of Health Research (CIHR))	This study was supported by the State Scholarship Fund of China Scholarship Council (201808330731) and the Program for Medical New Talent in Zhejiang Province. This work was also supported by the Canadian Institutes of Health Research Foundation Scheme Grant (#143317)	Abbara A, 2017, HUM REPROD, V32, P53; Abbara A, 2018, ENDOCR REV, V39, P593, DOI 10.1210/er.2017-00236; Abbara A, 2015, J CLIN ENDOCR METAB, V100, P3322, DOI 10.1210/jc.2015-2332; Ali SS, 2020, J GYNECOL OBSTET HUM, V49, DOI 10.1016/j.jogoh.2020.101728; Alleyassin A, 2018, MIDDLE EAST FERTIL S, V23, P199, DOI 10.1016/j.mefs.2018.01.001; Andersen CY, 1999, MOL HUM REPROD, V5, P726, DOI 10.1093/molehr/5.8.726; Bianchi V, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.07.998; Borm G, 2000, HUM REPROD, V15, P1490; Chamani IJ, 2019, FERTIL STERIL, V112, pE193, DOI 10.1016/j.fertnstert.2019.07.625; Chen CH, 2018, ARCH GYNECOL OBSTET, V298, P17, DOI 10.1007/s00404-018-4751-3; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Dashti S, 2019, INT J FERTIL STERIL, V13, P102, DOI 10.22074/ijfs.2019.5701; Decleer W, 2014, FACTS VIEWS VIS OBGY, V6, P203; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Dhillo WS, 2007, J CLIN ENDOCR METAB, V92, P3958, DOI 10.1210/jc.2007-1116; Ding N, 2017, EUR J OBSTET GYN R B, V218, P92, DOI 10.1016/j.ejogrb.2017.09.004; Dosouto C, 2019, PANMINERVA MED, V61, P42, DOI 10.23736/S0031-0808.18.03537-1; Eftekhar M, 2017, INT J REPROD BIOMED, V15, P429; Fauser BC, 2002, J CLIN ENDOCR METAB, V87, P709, DOI 10.1210/jc.87.2.709; Haas J, 2020, HUM REPROD, V35, P1648, DOI 10.1093/humrep/deaa107; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Humaidan P, 2005, HUM REPROD, V20, P1213, DOI 10.1093/humrep/deh765; Humaidan P, 2011, HUM REPROD UPDATE, V17, P510, DOI 10.1093/humupd/dmr008; Humaidan P, 2010, FERTIL STERIL, V93, P847, DOI 10.1016/j.fertnstert.2008.12.042; ITSKOVITZ J, 1991, FERTIL STERIL, V56, P213; Itskovitz-Eldor J, 2000, HUM REPROD, V15, P1965, DOI 10.1093/humrep/15.9.1965; Jayasena CN, 2014, J CLIN INVEST, V124, P3667, DOI 10.1172/JCI75730; Juneau CR, 2016, FERTIL STERIL, V106, pE189, DOI 10.1016/j.fertnstert.2016.07.542; Kim CH, 2014, J REPROD MED, V59, P63; Kol S, 2004, FERTIL STERIL, V81, P1, DOI 10.1016/j.fertnstert.2003.05.032; Kolibianakis EM, 2005, HUM REPROD, V20, P2887, DOI 10.1093/humrep/dei150; Lamb JD, 2011, FERTIL STERIL, V95, P1655, DOI 10.1016/j.fertnstert.2011.01.019; Legro RS, 2014, FERTIL STERIL, V102, P952, DOI 10.1016/j.fertnstert.2014.08.002; Lin MH, 2013, FERTIL STERIL, V100, P1296, DOI 10.1016/j.fertnstert.2013.07.1976; Lok F, 2003, HUM REPROD, V18, P2079, DOI 10.1093/humrep/deg421; Mahajan Nalini, 2016, J Hum Reprod Sci, V9, P101, DOI 10.4103/0974-1208.183506; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; NAKANO R, 1973, ACTA OBSTET GYN SCAN, V52, P269, DOI 10.3109/00016347309158325; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oktay K, 2010, REPROD BIOMED ONLINE, V20, P783, DOI 10.1016/j.rbmo.2010.03.004; Pereira N, 2016, REPROD BIOMED ONLINE, V33, P568, DOI 10.1016/j.rbmo.2016.08.009; Pirard C, 2006, HUM REPROD, V21, P1894, DOI 10.1093/humrep/del072; Qiu Q, 2020, HUM REPROD, V35, P1411, DOI 10.1093/humrep/deaa087; Schachter M, 2008, FERTIL STERIL, V90, P1087, DOI 10.1016/j.fertnstert.2007.07.1316; SEGAL S, 1992, FERTIL STERIL, V57, P1254; Seval MM, 2016, J OBSTET GYNAECOL RE, V42, P1146, DOI 10.1111/jog.13021; Shapiro BS, 2008, FERTIL STERIL, V90, P231, DOI 10.1016/j.fertnstert.2007.06.030; Skorupskaite K, 2014, HUM REPROD UPDATE, V20, P485, DOI 10.1093/humupd/dmu009; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tesarik J, 2006, HUM REPROD, V21, P2572, DOI 10.1093/humrep/del173; Youssef MAFM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008046.pub4; ZELINSKIWOOTEN MB, 1995, HUM REPROD, V10, P1658, DOI 10.1093/oxfordjournals.humrep.a136151; ZelinskiWooten MB, 1997, HUM REPROD, V12, P1877, DOI 10.1093/humrep/12.9.1877	53	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21696	10.1096/fj.202100406R	http://dx.doi.org/10.1096/fj.202100406R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085322	Bronze			2022-12-28	WOS:000667814100079
J	Zhang, Y; Du, XM; Chen, XM; Tang, HY; Zhou, Q; He, JL; Ding, YB; Wang, YX; Liu, XQ; Geng, YQ				Zhang, Yue; Du, Xinman; Chen, Xuemei; Tang, Hongyu; Zhou, Qin; He, Junlin; Ding, Yubin; Wang, Yingxiong; Liu, Xueqing; Geng, Yanqing			Rictor/mTORC2 is involved in endometrial receptivity by regulating epithelial remodeling	FASEB JOURNAL			English	Article						endometrial receptivity; epithelium remodeling; infertility; Na+ channel function; Rictor	ION CHANNELS; EMBRYO IMPLANTATION; UTERINE RECEPTIVITY; MTOR; RICTOR; RAC1; MICE; ENAC; PROGESTERONE; MECHANISMS	Successful embryo implantation requires well-functioning endometrial luminal epithelial cells to establish uterine receptivity. Inadequate uterine receptivity is responsible for approximately two thirds of implantation failures in humans. However, the regulatory mechanism governing this functional process remains largely unexplored. A previous study revealed that the expression of Rictor, the main member of mTORC2, in mouse epithelial cells is increased on the fourth day of gestation (D4). Here, we provide the first report of the involvement of Rictor in the regulation of endometrial receptivity. Rictor was conditionally ablated in the mouse endometrium using a progesterone receptor cre (PRcre) mouse model. Loss of Rictor altered polarity remodeling and the Na+ channel protein of endometrial cells by mediating Rac-1/PAK1(pPAK1)/ERM(pERM) and Sgk1/pSgk1 signaling, respectively, ultimately resulting in impaired fertility. In the endometrium of women with infertility, the expression of Rictor was changed, along with the morphological transformation and Na+ channel protein of epithelial cells. Our findings demonstrate that Rictor is crucial for the establishment of uterine receptivity in both mice and humans. The present study may help improve the molecular regulatory network of endometrial receptivity and provide new diagnostic and treatment strategies for infertility.	[Zhang, Yue; Du, Xinman; Chen, Xuemei; Tang, Hongyu; He, Junlin; Ding, Yubin; Wang, Yingxiong; Liu, Xueqing; Geng, Yanqing] Chongqing Med Univ, Sch Publ Hlth & Management, Joint Int Res Lab Reprod & Dev, Chongqing 400016, Peoples R China; [Zhou, Qin] Chongqing Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Chongqing, Peoples R China; [Wang, Yingxiong; Geng, Yanqing] Chongqing Med Univ, Coll Basic Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Liu, XQ; Geng, YQ (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Joint Int Res Lab Reprod & Dev, Chongqing 400016, Peoples R China.	100097@cqmu.edu.cn; 102813@cqmu.edu.cn	ZHOU, QIN/GWC-1900-2022	ZHOU, QIN/0000-0001-6306-6419; Geng, Yanqing/0000-0002-5744-8872	National Natural Science Foundation of China (NSFC) [31801247]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31801247	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Ahmed SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14867; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chan HC, 2013, ADV EXP MED BIOL, V763, P193; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Ekizceli G, 2017, BIOTECH HISTOCHEM, V92, P450, DOI 10.1080/10520295.2017.1350749; Enuka Y, 2012, HISTOCHEM CELL BIOL, V137, P339, DOI 10.1007/s00418-011-0904-1; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harris Thurl E, 2003, Sci STKE, V2003, pre15; He J, 2015, EXP CELL RES, V331, P164, DOI 10.1016/j.yexcr.2014.09.024; HILLE B, 1988, HARVEY LECT, V82, P47; Huang L, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001750; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Joly MM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0868-8; Kalam SN, 2018, CELL TISSUE RES, V374, P667, DOI 10.1007/s00441-018-2887-x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Lam EWF, 2012, J ENDOCRINOL, V212, P13, DOI 10.1530/JOE-10-0480; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Maddala R, 2011, DEV BIOL, V360, P30, DOI 10.1016/j.ydbio.2011.09.004; Messinis IE, 2016, EUR J OBSTET GYN R B, V207, P200, DOI 10.1016/j.ejogrb.2016.10.004; Mok KW, 2013, FASEB J, V27, P1137, DOI 10.1096/fj.12-212977; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Murphy CR, 2000, HUM REPROD, V15, P2451, DOI 10.1093/humrep/15.12.2451; Naftalin RJ, 2002, REPRODUCTION, V123, P633, DOI 10.1530/rep.0.1230633; NILSSON O, 1974, J REPROD FERTIL, V39, P187, DOI 10.1530/jrf.0.0390187; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Ruan YC, 2014, HUM REPROD UPDATE, V20, P517, DOI 10.1093/humupd/dmu006; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Salker MS, 2016, CELL PHYSIOL BIOCHEM, V39, P1295, DOI 10.1159/000447834; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt KM, 2017, ONCOTARGET, V8, P24491, DOI 10.18632/oncotarget.15524; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Shukla V, 2019, REPRODUCTION, V158, P47, DOI 10.1530/REP-18-0611; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Tu Z, 2016, CELL DEATH DIFFER, V23, P169, DOI 10.1038/cdd.2015.98; Vasquez YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007787; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; [文乙先 Wen Yixian], 2019, [重庆医科大学学报, Jounral of Chongqing Medical University], V44, P722; Xin QL, 2018, J CLIN INVEST, V128, P175, DOI 10.1172/JCI92862; Xu H, 2016, REPROD BIOMED ONLINE, V32, P207, DOI 10.1016/j.rbmo.2015.11.007; Yang JZ, 2004, CELL BIOL INT, V28, P433, DOI 10.1016/j.cellbi.2004.03.011; Ye XQ, 2020, TRENDS ENDOCRIN MET, V31, P165, DOI 10.1016/j.tem.2019.11.008; Zhang Y, 2018, J HAZARD MATER, V358, P101, DOI 10.1016/j.jhazmat.2018.06.042; Zhang Y, 2015, CELL RES, V25, P139, DOI 10.1038/cr.2014.139	52	3	3	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21731	10.1096/fj.202100529RR	http://dx.doi.org/10.1096/fj.202100529RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34131963				2022-12-28	WOS:000667814100075
J	Gupta, S; Wang, LQ; Slifker, MJ; Cai, KQ; Maclean, KN; Wasek, B; Bottiglieri, T; Kruger, WD				Gupta, Sapna; Wang, Liqun; Slifker, Michael J.; Cai, Kathy Q.; Maclean, Kenneth N.; Wasek, Brandi; Bottiglieri, Teodoro; Kruger, Warren D.			Analysis of differential neonatal lethality in cystathionine beta-synthase deficient mouse models using metabolic profiling	FASEB JOURNAL			English	Article						Homocysteine; inborn error; methionine; metabolomics; mouse models	HOMOCYSTINURIA; MICE; SERUM; HYPERHOMOCYSTEINEMIA; HOMOCYSTEINE; HEPATITIS; APOPTOSIS; FAILURE; INJURY	Cystathionine beta-synthase (CBS) is a key enzyme of the trans-sulfuration pathway that converts homocysteine to cystathionine. Loss of CBS activity due to mutation results in CBS deficiency, an inborn error of metabolism characterized by extreme elevation of plasma total homocysteine (tHcy). C57BL6 mice containing either a homozygous null mutation in the cystathionine beta-synthase (Cbs(-/-)) gene or an inactive human CBS protein (Tg-G307S Cbs(-/-)) are born in mendelian numbers, but the vast majority die between 18 and 21 days of age due to liver failure. However, adult Cbs null mice that express a hypomorphic allele of human CBS as a transgene (Tg-I278T Cbs(-/-)) show almost no neonatal lethality despite having serum tHcy levels similar to mice with no CBS activity. Here, we characterize liver and serum metabolites in neonatal Cbs(+/-), Tg-G307S Cbs(-/-), and Tg-I278T Cbs(-/-) mice at 6, 10, and 17 days of age to understand this difference. In serum, we observe similar elevations in tHcy in both Tg-G307S Cbs(-/-) and Tg-I278T Cbs(-/-) compared to control animals, but methionine is much more severely elevated in Tg-G307S Cbs(-/-) mice. Large scale metabolomic analysis of liver tissue confirms that both methionine and methionine-sulfoxide are significantly more elevated in Tg-G307S Cbs(-/-) animals, along with significant differences in several other metabolites including hexoses, amino acids, other amines, lipids, and carboxylic acids. Our data are consistent with a model that the neonatal lethality observed in CBS-null mice is driven by excess methionine resulting in increased stress on a variety of related pathways including the urea cycle, TCA cycle, gluconeogenesis, and phosphatidylcholine biosynthesis.	[Gupta, Sapna; Wang, Liqun; Cai, Kathy Q.; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Slifker, Michael J.] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Maclean, Kenneth N.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Wasek, Brandi; Bottiglieri, Teodoro] Baylor Scott & White Res Inst, Inst Metab Dis, Ctr Metabol, Dallas, TX USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor Health Care System; Baylor University Medical Center	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	Kruger, Warren/Y-2541-2018	Bottiglieri, Teodoro/0000-0002-4199-7551; kruger, warren/0000-0002-4990-3695	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK101404]; HHS \ NIH \ National Cancer Institute (NCI) [CA006927]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK101404; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA006927	Al-Dewik N, 2019, J INHERIT METAB DIS, V42, P818, DOI 10.1002/jimd.12099; Arning E, 2016, METHODS MOL BIOL, V1378, P255, DOI 10.1007/978-1-4939-3182-8_27; Chen X, 2006, HUM MUTAT, V27, P474, DOI 10.1002/humu.20320; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; FINKELSTEIN JD, 1988, J BIOL CHEM, V263, P11750; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; Gupta S, 2008, HUM MUTAT, V29, P1048, DOI 10.1002/humu.20773; Gupta S, 2018, J BIOL CHEM, V293, P13921, DOI 10.1074/jbc.RA118.002164; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Gupta S, 2013, HUM MUTAT, V34, P1085, DOI 10.1002/humu.22335; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Jacobs RL, 2017, MOL GENET METAB, V120, P325, DOI 10.1016/j.ymgme.2017.02.010; KALDOR J, 1986, MED J AUSTRALIA, V145, P76, DOI 10.5694/j.1326-5377.1986.tb101081.x; Maclean KN, 2019, FASEB J, V33, P6339, DOI 10.1096/fj.201802069RR; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Majtan T, 2018, MOL THER, V26, P834, DOI 10.1016/j.ymthe.2017.12.014; Majtan T, 2017, FASEB J, V31, P5495, DOI 10.1096/fj.201700565R; Mudd S., 2001, METABOLIC MOL BASES, P2007; MUDD SH, 1985, AM J HUM GENET, V37, P1; Mulvihill A, 2001, J AAPOS, V5, P311, DOI 10.1067/mpa.2001.118219; Park I, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8080244; QUASH G, 1995, BIOCHEM J, V305, P1017, DOI 10.1042/bj3051017; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Rooney M, 2020, BIOCHIMIE, V173, P91, DOI 10.1016/j.biochi.2020.04.004; Sato K, 2013, TRANSPL P, V45, P1904, DOI 10.1016/j.transproceed.2012.11.028; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Singh LR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000807; Skovby F, 2010, MOL GENET METAB, V99, P1, DOI 10.1016/j.ymgme.2009.09.009; Stabler SP, 2013, JIMD REP, V11, P149, DOI 10.1007/8904_2013_235; Tang BQ, 2006, BIOCHEM PHARMACOL, V72, P806, DOI 10.1016/j.bcp.2006.06.018; Ueki I, 2011, AM J PHYSIOL-ENDOC M, V301, pE668, DOI 10.1152/ajpendo.00151.2011; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WILLIAMS W. LANE, 1959, YALE JOUR BIOL AND MED, V31, P263; Yamada H, 2012, FREE RADICAL BIO MED, V52, P1716, DOI 10.1016/j.freeradbiomed.2012.02.033; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225; Yap S, 2001, J INHERIT METAB DIS, V24, P437, DOI 10.1023/A:1010525528842; Yoon KC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66947-1	39	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21629	10.1096/fj.202100302R	http://dx.doi.org/10.1096/fj.202100302R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33949005	Green Accepted			2022-12-28	WOS:000655695900042
J	Yang, F; Ma, HW; Butler, MR; Ding, XQ				Yang, Fan; Ma, Hongwei; Butler, Michael R.; Ding, Xi-Qin			Preservation of endoplasmic reticulum (ER) Ca2+ stores by deletion of inositol-1,4,5-trisphosphate receptor type 1 promotes ER retrotranslocation, proteostasis, and protein outer segment localization in cyclic nucleotide-gated channel-deficient cone photoreceptors	FASEB JOURNAL			English	Article						CNG channel; cone photoreceptors; ER Ca2+ stores; ER stress; inositol-1,4,5-trisphosphate receptor; retinal degeneration	STRESS-INDUCED APOPTOSIS; MULLER CELLS; RETINAL DEGENERATION; DOWN-REGULATION; CALCIUM INFLUX; MICE LACKING; HUMAN HRD1; HOMEOSTASIS; DEGRADATION; EXPRESSION	Endoplasmic reticulum (ER) Ca2+ homeostasis relies on an appropriate balance between efflux- and influx-channel activity responding to dynamic changes of intracellular Ca2+ levels. Dysregulation of this complex signaling network has been shown to contribute to neuronal and photoreceptor death in neuro- and retinal degenerative diseases, respectively. In mice with cone cyclic nucleotide-gated (CNG) channel deficiency, a model of achromatopsia/cone dystrophy, cones display early-onset ER stress-associated apoptosis and protein mislocalization. Cones in these mice also show reduced cytosolic Ca2+ level and subsequent elevation in the ER Ca2+-efflux-channel activity, specifically the inositol-1,4,5-trisphosphate receptor type 1 (IP(3)R1), and deletion of IP(3)R1 results in preservation of cones. This work investigated how preservation of ER Ca2+ stores leads to cone protection. We examined the effects of cone specific deletion of IP(3)R1 on ER stress responses/cone death, protein localization, and ER proteostasis/ER-associated degradation. We demonstrated that deletion of IP(3)R1 improves trafficking of cone-specific proteins M-/S-opsin and phosphodiesterase 6C to cone outer segments and reduces localization to cone inner segments. Consistent with the improved protein localization, deletion of IP(3)R1 results in increased ER retrotranslocation protein expression, reduced proteasome subunit expression, reduced ER stress/cone death, and reduced retinal remodeling. We also observed the enhanced ER retrotranslocation in mice that have been treated with a chemical chaperone, supporting the connection between improved ER retrotranslocation/proteostasis and alleviation of ER stress. Findings from this work demonstrate the importance of ER Ca2+ stores in ER proteostasis and protein trafficking/localization in photoreceptors, strengthen the link between dysregulation of ER Ca2+ homeostasis and ER stress/cone degeneration, and support an involvement of improved ER proteostasis in ER Ca2+ preservation-induced cone protection; thereby identifying IP(3)R1 as a critical mediator of ER stress and protein mislocalization and as a potential target to preserve cones in CNG channel deficiency.	[Yang, Fan; Ma, Hongwei; Butler, Michael R.; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu			National Eye Institute [R01EY027754, P30EY021725]; Oklahoma Center for the Advancement of Science and Technology	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology	National Eye Institute, Grant/Award Number: R01EY027754 and P30EY021725; Oklahoma Center for the Advancement of Science and Technology	Baehr W, 2009, EXP EYE RES, V89, P2, DOI 10.1016/j.exer.2008.12.016; Baldridge WH, 1998, J NEUROPHYSIOL, V79, P3012, DOI 10.1152/jn.1998.79.6.3012; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Bringmann A, 2001, FRONT BIOSCI-LANDMRK, V6, pE77, DOI 10.2741/Bringman; Butler MR, 2017, J BIOL CHEM, V292, P11189, DOI 10.1074/jbc.M117.782326; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; deRaad S, 1996, OPHTHALMIC RES, V28, P99, DOI 10.1159/000267881; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Hackos DH, 1999, J GEN PHYSIOL, V113, P799, DOI 10.1085/jgp.113.6.799; Huang CH, 2014, J BIOL CHEM, V289, P4444, DOI 10.1074/jbc.M113.519561; Kadowaki H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25724-x; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kikuchi D, 2016, BIOCHEM BIOPH RES CO, V469, P243, DOI 10.1016/j.bbrc.2015.11.113; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lobanova ES, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04117-8; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Ma HW, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0119-19.2019; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Mantopoulos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024245; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Olshevskaya EV, 2002, MOL CELL BIOCHEM, V230, P139, DOI 10.1023/A:1014248208584; Paredes F, 2016, FREE RADICAL BIO MED, V90, P206, DOI 10.1016/j.freeradbiomed.2015.11.024; Qi ZH, 2019, ADV EXP MED BIOL, V1206, P167, DOI 10.1007/978-981-15-0602-4_8; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Smith M, 2017, ESSAYS BIOCHEM, V61, P625, DOI 10.1042/EBC20170092; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; Sun SY, 2014, P NATL ACAD SCI USA, V111, pE582, DOI 10.1073/pnas.1318114111; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szikra T, 2008, J PHYSIOL-LONDON, V586, P4859, DOI 10.1113/jphysiol.2008.160051; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yang F, 2020, FASEB J, V34, P6335, DOI 10.1096/fj.201901951RR; Yang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14036; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851; Zhao TT, 2010, ADV EXP MED BIOL, V664, P575, DOI 10.1007/978-1-4419-1399-9_66	53	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21579	10.1096/fj.202002711R	http://dx.doi.org/10.1096/fj.202002711R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33960001	Green Accepted			2022-12-28	WOS:000655695900029
J	Fiorelli, S; Anesi, A; Porro, B; Cosentino, N; Werba, JP; Di Minno, A; Manega, CM; Barbieri, S; Colombo, GI; Marenzi, G; Cavalca, V; Tremoli, E; Eligini, S				Fiorelli, Susanna; Anesi, Andrea; Porro, Benedetta; Cosentino, Nicola; Werba, Jose P.; Di Minno, Alessandro; Manega, Chiara Maria; Barbieri, Simone; Colombo, Gualtiero, I; Marenzi, Giancarlo; Cavalca, Viviana; Tremoli, Elena; Eligini, Sonia			Lipidomics analysis of monocytes from patients with acute myocardial infarction reveals lactosylceramide as a new player in monocyte migration	FASEB JOURNAL			English	Article						cell migration; lipidomics; monocytes; myocardial infarction	AMYLOID-BETA PEPTIDE; ACID AMIDE HYDROLASE; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; RECEPTOR TRAFFICKING; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; INDUCED TOXICITY; NEURONAL LOSS	Monocyte recruitment after vascular injury and their migration through the vessel wall represent crucial events in the initiation, progression, and destabilization of atherosclerotic plaque. Circulating monocytes are exposed to stimuli that alter their physiological state, and among them, lipids play a key role. Several studies investigated the mechanisms by which lipids affect monocyte functions promoting coronary atherosclerotic plaque initiation, but information on the relationship between lipid composition and function of monocyte is scant. We aimed at studying the migration of circulating monocytes isolated from patients with acute myocardial infarction (AMI) at hospital presentation and investigating its correlation with cellular lipid profile. The migration of monocytes was tested using both fetal bovine serum (FBS) and autologous serum as chemoattractant stimuli. Monocyte lipid profile was evaluated through an untargeted lipidomics approach, using a liquid chromatography/time-of-flight mass spectrometry platform. We observed that AMI patients' monocytes showed a significant increase in FBS and autologous serum-mediated migration compared to controls. Moreover, a different monocyte lipidomic profile between the two study groups was detected. In particular, AMI patients' monocytes showed an altered composition in ceramides, with an increase in lactosylceramide and in phospholipids (ie, phosphatidylethanolamine and lisophosphatidylethanolamine). Of note, a positive correlation between lactosylceramide levels and monocyte migration was observed. Furthermore, the lactosylceramide synthase inhibition significantly reduced FBS-induced monocyte migration. Our results highlight the influence of lactosylceramide on the monocyte migration capacity, pointing out a new possible mechanism of lipids in the onset of atherothrombosis and, hence, in AMI.	[Fiorelli, Susanna; Anesi, Andrea; Porro, Benedetta; Cosentino, Nicola; Werba, Jose P.; Manega, Chiara Maria; Barbieri, Simone; Colombo, Gualtiero, I; Marenzi, Giancarlo; Cavalca, Viviana; Tremoli, Elena; Eligini, Sonia] IRCCS, Ctr Cardiol Monzino, Via C Parea 4, I-20138 Milan, Italy; [Di Minno, Alessandro] Univ Naples Federico II, Dept Pharm, Naples, Italy	IRCCS Centro Cardiologico Monzino; University of Naples Federico II	Cavalca, V (corresponding author), IRCCS, Ctr Cardiol Monzino, Via C Parea 4, I-20138 Milan, Italy.	viviana.cavalca@ccfm.it	Anesi, Andrea/ACJ-6729-2022; Colombo, Gualtiero I./B-4737-2010; Porro, Benedetta/K-1390-2016; Eligini, Sonia/F-3846-2018	Anesi, Andrea/0000-0002-9334-2610; Colombo, Gualtiero I./0000-0002-7348-1939; Porro, Benedetta/0000-0002-4019-4618; Eligini, Sonia/0000-0002-5507-6737	Ministero della Salute (Ministry of Health, Italy)	Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy)	Ministero della Salute (Ministry of Health, Italy)	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alexander AG, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00279; Androuin A, 2018, ACTA NEUROPATHOL, V135, P839, DOI 10.1007/s00401-018-1847-6; Aso E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00037; Attems J, 2007, ACTA NEUROPATHOL, V113, P53, DOI 10.1007/s00401-006-0146-9; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Beltramo M, 2000, J NEUROSCI, V20, P3401, DOI 10.1523/JNEUROSCI.20-09-03401.2000; Benito C, 2003, J NEUROSCI, V23, P11136; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Borlikova GG, 2013, NEUROBIOL AGING, V34, P1315, DOI 10.1016/j.neurobiolaging.2012.10.028; Branca JJV, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224420; BRENNER S, 1974, GENETICS, V77, P71; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Burns JM, 2005, NEUROLOGY, V64, P1397, DOI 10.1212/01.WNL.0000158423.05224.7F; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Campos AC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00269; Campos AC, 2016, PHARMACOL RES, V112, P119, DOI 10.1016/j.phrs.2016.01.033; Chege PM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00089; Cheng D, 2014, PSYCHOPHARMACOLOGY, V231, P3009, DOI 10.1007/s00213-014-3478-5; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Currais A, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.12; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Deutsch DG, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.7016.00370; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Elmes MW, 2015, J BIOL CHEM, V290, P8711, DOI 10.1074/jbc.M114.618447; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; GIBB WRG, 1989, J NEUROL NEUROSUR PS, V52, P193, DOI 10.1136/jnnp.52.2.193; Glass M, 2001, PROG NEURO-PSYCHOPH, V25, P743, DOI 10.1016/S0278-5846(01)00162-2; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Santos NAG, 2015, TOXICOL IN VITRO, V30, P231, DOI 10.1016/j.tiv.2015.11.004; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Harvey BS, 2012, NEUROTOXICOLOGY, V33, P138, DOI 10.1016/j.neuro.2011.12.015; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Land MH, 2020, CANNABIS CANNABINOID, DOI 10.1089/can.2020.0103; Lee JH, 2010, NEUROCHEM INT, V57, P985, DOI 10.1016/j.neuint.2010.10.010; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Margie O, 2013, JOVE-J VIS EXP, DOI 10.3791/50069; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Maulik Malabika, 2017, Front Genet, V8, P77, DOI 10.3389/fgene.2017.00077; McCollum L, 2007, J PHARMACOL EXP THER, V321, P930, DOI 10.1124/jpet.106.117549; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Murakami H, 2008, NEUROBIOL AGING, V29, P1093, DOI 10.1016/j.neurobiolaging.2007.01.013; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Ng LF, 2014, FREE RADICAL BIO MED, V71, P390, DOI 10.1016/j.freeradbiomed.2014.03.003; Nobili A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14727; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Oakes MD, 2017, J NEUROSCI, V37, P2859, DOI 10.1523/JNEUROSCI.3151-16.2017; Ofengeim D, 2012, J BIOL CHEM, V287, P8714, DOI 10.1074/jbc.M111.290957; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pandelides Z, 2020, GEROSCIENCE, V42, P785, DOI 10.1007/s11357-020-00182-4; Popugaeva E, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0034-7; Prenderville JA, 2015, BRIT J PHARMACOL, V172, P3950, DOI 10.1111/bph.13186; Price TJ, 2005, NEUROPHARMACOLOGY, V49, P25, DOI 10.1016/j.neuropharm.2005.01.031; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; Bassi MS, 2017, CANNABIS CANNABINOID, V2, P21, DOI 10.1089/can.2017.0002; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Takuma H, 2004, J NEUROPATH EXP NEUR, V63, P255, DOI 10.1093/jnen/63.3.255; Tejeda-Benitez L, 2016, REV ENVIRON CONTAM T, V237, P1, DOI 10.1007/978-3-319-23573-8_1; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Thomas A, 2004, EUR J PHARMACOL, V487, P213, DOI 10.1016/j.ejphar.2004.01.023; Wang CY, 2018, NEUROBIOL DIS, V109, P88, DOI 10.1016/j.nbd.2017.10.003; Watt G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00020; Williams EJ, 2003, J CELL BIOL, V160, P481, DOI 10.1083/jcb.200210164; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yang ZZ, 2018, FREE RADICAL BIO MED, V129, P310, DOI 10.1016/j.freeradbiomed.2018.09.035; Zheng MG, 2013, AMYLOID, V20, P13, DOI 10.3109/13506129.2012.755122	83	1	1	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21494	10.1096/fj.202001872RRR	http://dx.doi.org/10.1096/fj.202001872RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33856696				2022-12-28	WOS:000645260100092
J	Guo, W; Tang, ZY; Cai, ZY; Zhao, WE; Yang, J; Wang, XP; Ji, J; Huang, XX; Sun, XL				Guo, Wei; Tang, Zi-Yang; Cai, Zhen-Yu; Zhao, Wen-E; Yang, Jin; Wang, Xi-Peng; Ji, Juan; Huang, Xin-Xin; Sun, Xiu-Lan			Iptakalim alleviates synaptic damages via targeting mitochondrial ATP-sensitive potassium channel in depression	FASEB JOURNAL			English	Article						depression; Iptakalim; mitochondrial fission and fusion; mitochondrial KATP-channels; synaptic plasticity	RAT SUPRACHIASMATIC NUCLEUS; STRESS; FISSION; OPENER; DYSFUNCTION; PLASTICITY; VOLUME; INFLAMMATION; APOPTOSIS; PROTECTS	Synaptic plasticity damages play a crucial role in the onset and development of depression, especially in the hippocampus, which is more susceptible to stress and the most frequently studied brain region in depression. And, mitochondria have a major function in executing the complex processes of neurotransmission and plasticity. We have previously demonstrated that Iptakalim (Ipt), a new ATP-sensitive potassium (K-ATP) channel opener, could improve the depressive-like behavior in mice. But the underlying mechanisms are not well understood. The present study demonstrated that Ipt reversed depressive-like phenotype in vivo (chronic mild stress-induced mice model of depression) and in vitro (corticosterone-induced cellular model). Further study showed that Ipt could upregulate the synaptic-related proteins postsynaptic density 95 (PSD 95) and synaptophysin (SYN), and alleviated the synaptic structure damage. Moreover, Ipt could reverse the abnormal mitochondrial fission and fusion, as well as the reduced mitochondrial ATP production and collapse of mitochondrial membrane potential in depressive models. Knocking down the mitochondrial ATP-sensitive potassium (Mito-KATP) channel subunit MitoK partly blocked the above effects of Ipt. Therefore, our results reveal that Ipt can alleviate the abnormal mitochondrial dynamics and function depending on MitoK, contributing to improve synaptic plasticity and exert antidepressive effects. These findings provide a candidate compound and a novel target for antidepressive therapy.	[Guo, Wei; Tang, Zi-Yang; Cai, Zhen-Yu; Yang, Jin; Wang, Xi-Peng; Ji, Juan; Huang, Xin-Xin; Sun, Xiu-Lan] Nanjing Med Univ, Ctr Global Hlth, Neuroprotect Drug Discovery Key Lab, Jiangsu Key Lab Neurodegenerat, Nanjing, Peoples R China; [Zhao, Wen-E] Nanjing Med Univ, Anal Ctr, Nanjing, Peoples R China; [Sun, Xiu-Lan] Nanjing Univ Chinese Med, Affiliated Hosp, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine	Sun, XL (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Neurodegenerat, Dept Pharmacol, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China.	xiulans@njmu.edu.cn	Sun, Xiu-Lan/AAW-5376-2021	Sun, Xiu-Lan/0000-0001-8741-3833	National Natural Science Foundation of China [81973301, 81773701]; Medical Research Project of Jiangsu Commission of Health [ZDA2020006]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [18KJA310004]; Major Project of Nanjing Medical University [NMUD2018008]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX19_1121, KYCX20_1417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Research Project of Jiangsu Commission of Health; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Major Project of Nanjing Medical University; Postgraduate Research and Practice Innovation Program of Jiangsu Province	National Natural Science Foundation of China, Grant/Award Number: 81973301 and 81773701; Medical Research Project of Jiangsu Commission of Health, Grant/Award Number: ZDA2020006; Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Grant/Award Number: 18KJA310004; Major Project of Nanjing Medical University, Grant/Award Number: NMUD2018008; Postgraduate Research and Practice Innovation Program of Jiangsu Province, Grant/Award Number: KYCX19_1121 and KYCX20_1417	Anastacio MM, 2013, CIRCULATION, V128, pS130, DOI 10.1161/CIRCULATIONAHA.112.000128; Ballmaier M, 2008, AM J PSYCHIAT, V165, P229, DOI 10.1176/appi.ajp.2007.07030506; Balog J, 2016, J CEREBR BLOOD F MET, V36, P2022, DOI 10.1177/0271678X16671528; Bansal Y, 2016, CURR NEUROPHARMACOL, V14, P610, DOI 10.2174/1570159X14666160229114755; Berthet A, 2014, J NEUROSCI, V34, P14304, DOI 10.1523/JNEUROSCI.0930-14.2014; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen H, 2006, ACTA PHARMACOL SIN, V27, P665, DOI 10.1111/j.1745-7254.2006.00356.x; Cohen JW, 2011, SYNAPSE, V65, P763, DOI 10.1002/syn.20900; David DJ, 2016, ENCEPHALE, V42, P255, DOI 10.1016/j.encep.2016.03.012; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Fan Y, 2016, BRAIN STRUCT FUNCT, V221, P3111, DOI 10.1007/s00429-015-1090-z; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gong Y, 2011, NEUROSCI LETT, V488, P76, DOI 10.1016/j.neulet.2010.11.006; GULDNER FH, 1980, NEUROSCI LETT, V17, P27, DOI 10.1016/0304-3940(80)90056-7; Guldner FH, 1997, CELL TISSUE RES, V287, P43; Hei MF, 2019, BEHAV BRAIN RES, V365, P26, DOI 10.1016/j.bbr.2019.02.044; Holmes SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09562-7; Hu LF, 2005, J NEUROCHEM, V94, P1570, DOI 10.1111/j.1471-4159.2005.03306.x; Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758; JONES DG, 1978, BRAIN RES, V147, P47, DOI 10.1016/0006-8993(78)90771-0; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P99, DOI 10.1007/978-1-4939-8994-2_9; Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8; Lim GY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21243-x; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Lu M, 2014, INT J NEUROPSYCHOPH, V17, P1501, DOI 10.1017/S1461145714000285; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Manczak M, 2016, HUM MOL GENET, V25, P5148, DOI 10.1093/hmg/ddw330; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; Onukwufor JO, 2016, J EXP BIOL, V219, P2743, DOI 10.1242/jeb.140186; Paggio A, 2019, NATURE, V572, P609, DOI 10.1038/s41586-019-1498-3; Peng KG, 2018, BBA-MOL BASIS DIS, V1864, P1086, DOI 10.1016/j.bbadis.2018.01.013; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Price JB, 2018, NEUROSCI BIOBEHAV R, V90, P212, DOI 10.1016/j.neubiorev.2018.04.002; Ran YH, 2011, J ZHEJIANG UNIV-SC B, V12, P835, DOI 10.1631/jzus.B1100067; Shan H, 2016, NEUROPHARMACOLOGY, V107, P68, DOI 10.1016/j.neuropharm.2016.03.019; Streck EL, 2014, REV BRAS PSIQUIATR, V36, P156, DOI 10.1590/1516-4446-2013-1224; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Thomzig A, 2005, J COMP NEUROL, V484, P313, DOI 10.1002/cne.20469; Todorova V, 2017, CURR NEUROPHARMACOL, V15, P166, DOI 10.2174/1570159X14666160414111821; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wu J, 2006, J PHARMACOL EXP THER, V319, P155, DOI 10.1124/jpet.106.106286; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang FF, 2018, CNS NEUROSCI THER, V24, P994, DOI 10.1111/cns.12835; Zhang S, 2007, J NEUROCHEM, V103, P569, DOI 10.1111/j.1471-4159.2007.04775.x; Zhao XJ, 2017, BRAIN RES BULL, V130, P146, DOI 10.1016/j.brainresbull.2017.01.026; Zhao Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00293	53	2	3	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21581	10.1096/fj.202100124RR	http://dx.doi.org/10.1096/fj.202100124RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871072				2022-12-28	WOS:000645260100036
J	Li, J; Song, J; Yan, BX; Weiss, HL; Weiss, LT; Gao, TY; Evers, BM				Li, Jing; Song, Jun; Yan, Baoxiang; Weiss, Heidi L.; Weiss, L. Todd; Gao, Tianyan; Evers, B. Mark			Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance	FASEB JOURNAL			English	Article						cancer; gut hormones; high-fat diet; metabolism; obesity	RECEPTOR; FAT; RELEASE; MICE; CELL	Studies demonstrate a role for neurotensin (NT) in obesity and related comorbidities. Bile acid (BA) homeostasis alterations are associated with obesity. We determined the effect of NT on BA metabolism in obese and non-obese conditions. Plasma and fecal BA profiles were analyzed by LC-MS/MS in male and female NT+/+ and NT-/- mice fed low-fat (LFD) or high-fat diet (HFD) for 6 weeks (early stage of obesity) or greater than 20 weeks (late stage of obesity). The nuclear farnesoid X receptor (FXR) and BA transporter mRNA expression were assessed in ileum, mouse enteroids, and human cell lines. HFD decreased plasma primary and secondary BAs in NT+/+ mice; HFD-induced decrease of plasma BAs was improved in NT-deficient mice. In NT+/+ mice, HFD inhibited ileal FXR and BA transporter expression; HFD-decreased expression of FXR and BA transporters was prevented in NT-/- mice. Compared with LFD-fed NT+/+ mice, LFD-fed NT-/- mice had relatively lower levels of ileal FXR and BA transporter expression. Moreover, NT stimulates the expression of FXR and BA transporters in Caco-2 cells; however, stimulated expression of BA transporters was attenuated in NT-/- enteroids. Therefore, we demonstrate that HFD disrupts the BA metabolism and ileal FXR and BA transporter axis which are improved in the absence of NT, suggesting that NT contributes to HFD-induced disruption of BA metabolism and plays an inhibitory role in the regulation of ileal FXR and BA transporter signaling under obese conditions. Conversely, NT positively regulates the expression of ileal FXR and BA transporters under non-obese conditions. Therefore, NT plays a dual role in obese and non-obese conditions, suggesting possible therapeutic strategies for obesity control.	[Li, Jing; Song, Jun; Evers, B. Mark] Univ Kentucky, Med Ctr, Lexington, KY 40536 USA; [Li, Jing; Song, Jun; Yan, Baoxiang; Weiss, Heidi L.; Weiss, L. Todd; Gao, Tianyan; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Weiss, Heidi L.] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Evers, BM (corresponding author), Univ Kentucky, Markey Canc Ctr, H181 UK Chandler Hosp, 800 Rose St, Lexington, KY 40536 USA.	mark.evers@uky.edu			HHS vertical bar National Institutes of Health (NIH) [R01 DK112034, R01 DK48489]	HHS vertical bar National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS broken vertical bar National Institutes of Health (NIH), Grant/Award Number: R01 DK112034 and R01 DK48489	ANDERSSON S, 1977, ACTA PHYSIOL SCAND, V100, P231, DOI 10.1111/j.1748-1716.1977.tb05941.x; ARMSTRONG MJ, 1986, AM J PHYSIOL, V251, pG823, DOI 10.1152/ajpgi.1986.251.6.G823; BACA I, 1983, GASTROENTEROLOGY, V84, P556; BARBER DL, 1991, AM J PHYSIOL, V261, pG497, DOI 10.1152/ajpgi.1991.261.3.G497; Besserer-Offroy E, 2017, EUR J PHARMACOL, V805, P1, DOI 10.1016/j.ejphar.2017.03.046; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Bird JL, 2017, EUR J PHARM BIOPHARM, V119, P300, DOI 10.1016/j.ejpb.2017.06.027; BLACKBURN AM, 1981, J PHYSIOL-LONDON, V314, P11, DOI 10.1113/jphysiol.1981.sp013686; Browning MG, 2019, CURR OBES REP, V8, P175, DOI 10.1007/s13679-019-00334-4; Cariou B, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-48; Chen LM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108212; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Dobner PR, 2001, P NATL ACAD SCI USA, V98, P8048, DOI 10.1073/pnas.141042198; EVERS BM, 1992, ANN SURG, V216, P423, DOI 10.1097/00000658-199210000-00005; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Gonzalez FJ, 2017, DIGEST DIS, V35, P178, DOI 10.1159/000450908; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Gui XY, 2004, AM J PHYSIOL-GASTR L, V287, pG408, DOI 10.1152/ajpgi.00178.2003; Haeusler RA, 2016, J CLIN ENDOCR METAB, V101, P1935, DOI 10.1210/jc.2015-2583; Hofmann AF, 2009, HEPATOLOGY, V49, P1403, DOI 10.1002/hep.22789; Ippagunta SM, 2018, J NUTR, V148, P510, DOI 10.1093/jn/nxy022; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; La Merrill M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103337; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Li J, 2020, FASEB J, V34, P8596, DOI 10.1096/fj.201902374RR; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Molinaro A, 2018, TRENDS ENDOCRIN MET, V29, P31, DOI 10.1016/j.tem.2017.11.002; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; POLAK JM, 1977, NATURE, V270, P183, DOI 10.1038/270183a0; Prinz P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00199; ROSELL S, 1979, ACTA PHYSIOL SCAND, V107, P263, DOI 10.1111/j.1748-1716.1979.tb06472.x; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sundaram S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101197; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Xiao YT, 2018, EBIOMEDICINE, V35, P133, DOI 10.1016/j.ebiom.2018.08.006	43	2	2	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21371	10.1096/fj.202001692R	http://dx.doi.org/10.1096/fj.202001692R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811694	Green Accepted			2022-12-28	WOS:000645260100093
J	Pontifex, MG; Martinsen, A; Saleh, RNM; Harden, G; Tejera, N; Muller, M; Fox, C; Vauzour, D; Minihane, AM				Pontifex, Matthew G.; Martinsen, Anneloes; Saleh, Rasha Noureldin M.; Harden, Glenn; Tejera, Noemi; Mueller, Michael; Fox, Chris; Vauzour, David; Minihane, Anne-Marie			APOE4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in APOE-TR mice	FASEB JOURNAL			English	Article						Alzheimer's disease; docosahexaenoic acid; recognition memory; 4-vinylcyclohexene diepoxide	POLYUNSATURATED FATTY-ACIDS; IMPENDING OVARIAN FAILURE; APOLIPOPROTEIN-E GENOTYPE; TARGETED-REPLACEMENT; ALZHEIMERS-DISEASE; DOCOSAHEXAENOIC ACID; SPATIAL MEMORY; 4-VINYLCYCLOHEXENE DIEPOXIDE; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION	The impact of sex and menopausal status in Alzheimer's disease remains understudied despite increasing evidence of greater female risk, particularly in APOE4 carriers. Utilizing female APOE-TR mice maintained on a highfat diet background we induced ovarian failure through repeated VCD injections, to mimic human menopause. At 12 months of age, recognition memory and spatial memory were assessed using object recognition, Y-maze spontaneous alternation, and Barnes maze. A VCD*genotype interaction reduced the recognition memory (P < .05), with APOE4 VCD-treated animals unable to distinguish between novel and familiar objects. APOE4 mice displayed an additional 37% and 12% reduction in Barnes (P < .01) and Y-maze (P < .01) performance, indicative of genotype-specific spatial memory impairment. Molecular analysis indicated both VCD and genotype-related deficits in synaptic plasticity with BDNF, Akt, mTOR, and ERK signaling compromised. Subsequent reductions in the transcription factors Creb1 and Atf4 were also evident. Furthermore, the VCD*genotype interaction specifically diminished Ephb2 expression, while Fos, and Cnr1 expression reduced as a consequence of APOE4 genotype. Brain DHA levels were 13% lower in VCD-treated animals independent of genotype. Consistent with this, we detected alterations in the expression of the DHA transporters Acsl6 and Fatp4. Our results indicate that the combination of ovarian failure and APOE4 leads to an exacerbation of cognitive and neurological deficits.	[Pontifex, Matthew G.; Martinsen, Anneloes; Saleh, Rasha Noureldin M.; Harden, Glenn; Tejera, Noemi; Mueller, Michael; Fox, Chris; Vauzour, David; Minihane, Anne-Marie] Univ East Anglia, Norwich Med Sch, Norwich NR4 7UQ, Norfolk, England	University of East Anglia	Pontifex, MG (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich NR4 7UQ, Norfolk, England.	M.Pontifex@uea.ac.uk	Vauzour, Dr David/C-2245-2008	Vauzour, Dr David/0000-0001-5952-8756; Minihane, Anne Marie/0000-0001-9042-4226; Tejera, Noemi/0000-0001-8100-6022	Alzheimer's Society [AS-PhD-2015-023]; RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC); Alzheimer's Research Trust (ARUK); Centre for nutrition learning and memory	Alzheimer's Society; RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer's Research Trust (ARUK); Centre for nutrition learning and memory	Alzheimer's Society, Grant/Award Number: (AS-PhD-2015-023); RCUK vertical bar Biotechnology and Biological Sciences Research Council (BBSRC); Alzheimer's Research Trust (ARUK); Centre for nutrition learning and memory	Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Agarwal P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11123060; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Alemany R, 2010, LIPIDS, V45, P53, DOI 10.1007/s11745-009-3370-y; Alessandri JM, 2011, J NUTR BIOCHEM, V22, P820, DOI 10.1016/j.jnutbio.2010.07.005; Arevalo MA, 2015, HORM BEHAV, V74, P19, DOI 10.1016/j.yhbeh.2015.04.016; Bachmeier C, 2014, NEUROMOL MED, V16, P686, DOI 10.1007/s12017-014-8318-6; Bang OY, 2003, YONSEI MED J, V44, P401; Bastos CP, 2015, PSYCHONEUROENDOCRINO, V57, P14, DOI 10.1016/j.psyneuen.2015.03.020; Bathina S, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0809-2; Bimonte-Nelson HA, 2003, BEHAV NEUROSCI, V117, P1395, DOI 10.1037/0735-7044.117.6.1395; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Bradbury J, 2011, NUTRIENTS, V3, P529, DOI 10.3390/nu3050529; Brooks HL, 2016, PHYSIOLOGY, V31, P250, DOI 10.1152/physiol.00057.2014; Bryan KJ, 2010, J NEUROCHEM, V112, P870; Caffino L, 2020, CNS DRUGS, V34, DOI 10.1007/s40263-020-00705-9; Chamniansawat S, 2009, NEUROSCI LETT, V452, P130, DOI 10.1016/j.neulet.2009.01.010; Chen H, 2014, JOVE-J VIS EXP, DOI 10.3791/51083; Chen ZG, 2015, J BIOL CHEM, V290, P6387, DOI 10.1074/jbc.M114.605261; Chouinard-Watkins R, 2013, BRIT J NUTR, V110, P1751, DOI 10.1017/S0007114513001268; Chouinard-Watkins R, 2018, P NATL ACAD SCI USA, V115, P12343, DOI 10.1073/pnas.1817557115; Chouinard-Watkins R, 2014, NUTRIENTS, V6, P4452, DOI 10.3390/nu6104452; Christie WW, 2010, LIPID ANAL ISOLATION, P1; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corona C, 2018, J NEUROSCI, V38, P6102, DOI 10.1523/JNEUROSCI.3350-17.2018; Davis KE, 2013, BEHAV BRAIN RES, V254, P73, DOI 10.1016/j.bbr.2013.03.009; Denninger JK, 2018, JOVE-J VIS EXP, DOI 10.3791/58593; Dose J, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0288-2; Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fernandes MF, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030298; Fernandez RF, 2018, P NATL ACAD SCI USA, V115, P12525, DOI 10.1073/pnas.1807958115; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Giri M, 2016, CLIN INTERV AGING, V11, P665, DOI 10.2147/CIA.S105769; Gonzalez-Garcia I, 2018, J ENDOCRINOL, V238, P177, DOI 10.1530/JOE-18-0190; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Haas JR, 2007, COMPARATIVE MED, V57, P443; Hara Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.014; Hayward GC, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00129; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Herrera JL, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00103; Herrera MCA, 2017, CURR OBES REP, V6, P405, DOI 10.1007/s13679-017-0284-5; Hestiantoro A, 2017, CLIMACTERIC, V20, P577, DOI 10.1080/13697137.2017.1377696; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Horton KKA, 2019, CANNABIS CANNABINOID, V4, P33, DOI 10.1089/can.2018.0061; Huang CQ, 2021, J NEUROIMMUNE PHARM, V16, P609, DOI 10.1007/s11481-020-09953-4; Jones NS, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0267-19.2019; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kappeler CJ, 2012, SYST BIOL REPROD MED, V58, P57, DOI 10.3109/19396368.2011.648820; Kim D, 2019, BIOL PHARM BULL, V42, P1471, DOI 10.1248/bpb.b19-00056; Kim J, 2014, MOL CELLS, V37, P767, DOI 10.14348/molcells.2014.0248; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Koebele SV, 2020, HORM BEHAV, V126, DOI 10.1016/j.yhbeh.2020.104854; Koebele SV, 2017, HORM BEHAV, V87, P96, DOI 10.1016/j.yhbeh.2016.10.010; Konhilas JP, 2020, AM J PHYSIOL-HEART C, V318, pH1461, DOI 10.1152/ajpheart.00555.2019; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Li RN, 2014, MOL CELL ENDOCRINOL, V389, P13, DOI 10.1016/j.mce.2013.12.018; Liew SH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116947; Lo Van A, 2016, BIOCHIMIE, V130, P163, DOI 10.1016/j.biochi.2016.07.011; Locke C, 2017, BIOL OPEN, V6, P1820, DOI 10.1242/bio.029900; Lohff JC, 2005, COMPARATIVE MED, V55, P523; LOPEZ GH, 1995, COMP BIOCHEM PHYS B, V112, P331, DOI 10.1016/0305-0491(95)00079-8; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Maioli S, 2012, J ALZHEIMERS DIS, V32, P341, DOI 10.3233/JAD-2012-120697; Marin R, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00128; Marongiu R, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00242; Martinsen A, 2019, FASEB J, V33, P10315, DOI 10.1096/fj.201900423R; Mitchell RW, 2011, J NEUROCHEM, V117, P735, DOI 10.1111/j.1471-4159.2011.07245.x; Naqvi AZ, 2011, J AM GERIATR SOC, V59, P837, DOI 10.1111/j.1532-5415.2011.03402.x; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Nikolaienko O, 2018, SEMIN CELL DEV BIOL, V77, P33, DOI 10.1016/j.semcdb.2017.09.006; Nolt MJ, 2011, J NEUROSCI, V31, P5353, DOI 10.1523/JNEUROSCI.0282-11.2011; Pandey R, 2020, J ENDOCRINOL, V244, P53, DOI 10.1530/JOE-19-0197; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Patricio-Martinez A, 2019, NEUROSCIENCE, V416, P239, DOI 10.1016/j.neuroscience.2019.08.001; Pelerin H, 2014, PROSTAG LEUKOTR ESS, V91, P213, DOI 10.1016/j.plefa.2014.07.004; Peng S, 2010, INT J MOL SCI, V11, P222, DOI 10.3390/ijms11010222; Pinto LH, 2000, MAMM GENOME, V11, P531, DOI 10.1007/s003350010102; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Pontifex M, 2018, NEUROBIOL AGING, V69, P209, DOI 10.1016/j.neurobiolaging.2018.05.017; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Ryan J, 2014, BJOG-INT J OBSTET GY, V121, P1729, DOI 10.1111/1471-0528.12828; Saravi SSS, 2017, BIOMED PHARMACOTHER, V89, P591, DOI 10.1016/j.biopha.2017.02.078; Scarante FF, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00411; Sen A, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0301-3; Sinclair AJ, 2019, ASIA PAC J CLIN NUTR, V28, P675, DOI 10.6133/apjcn.201912_28(4).0002; Slim KE, 2017, FASEB J, V31, P989, DOI 10.1096/fj.201600921RR; Snyder HM, 2016, ALZHEIMERS DEMENT, V12, P1186, DOI 10.1016/j.jalz.2016.08.004; Sona C, 2018, NEUROBIOL DIS, V118, P94, DOI 10.1016/j.nbd.2018.07.002; Song YP, 2019, EBIOMEDICINE, V39, P409, DOI 10.1016/j.ebiom.2018.11.059; SU XS, 2020, J ETHNOPHARMACOL, V269, DOI DOI 10.1016/J.APCATB.2020.118800; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tan ZS, 2012, NEUROLOGY, V78, P658, DOI 10.1212/WNL.0b013e318249f6a9; Theriault P, 2016, ONCOTARGET, V7, P67808, DOI 10.18632/oncotarget.12179; Thomas R, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00319; Vandal M, 2014, J NEUROCHEM, V129, P516, DOI 10.1111/jnc.12640; Vauzour D, 2018, ARCH BIOCHEM BIOPHYS, V650, P14, DOI 10.1016/j.abb.2018.04.020; Vauzour D, 2018, BBA-MOL BASIS DIS, V1864, P69, DOI 10.1016/j.bbadis.2017.10.002; Wang ZJ, 2020, NEUROSCIENCE, V424, P24, DOI 10.1016/j.neuroscience.2019.10.050; Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099; Wright LE, 2008, J BONE MINER RES, V23, P1296, DOI 10.1359/JBMR.080309; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yassine HN, 2020, NEUROBIOL AGING, V92, P61, DOI 10.1016/j.neurobiolaging.2020.03.020; Yi JH, 2018, NEUROPHARMACOLOGY, V128, P282, DOI 10.1016/j.neuropharm.2017.10.028; Yong SM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06580; Zarate R, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0153-6; Zhang Y, 2016, AM J CLIN NUTR, V103, P330, DOI 10.3945/ajcn.115.124081	115	12	12	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21583	10.1096/fj.202002621RR	http://dx.doi.org/10.1096/fj.202002621RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33891334	Green Accepted			2022-12-28	WOS:000645260100034
J	Wang, X; Guan, RJ; Zhao, XM; Chen, J; Zhu, DN; Shen, LL; Song, NN				Wang, Xia; Guan, Ruijuan; Zhao, Xiaomei; Chen, Jun; Zhu, Danian; Shen, Linlin; Song, Nana			TASK1 and TASK3 in orexin neuron of lateral hypothalamus contribute to respiratory chemoreflex by projecting to nucleus tractus solitarius	FASEB JOURNAL			English	Article						chemoreflex; lateral hypothalamus; nucleus tractus solitarius; orexin; TASK1; TASK3	LYMPHATIC ENDOTHELIAL-CELLS; VESSEL FORMATION; HYALURONAN; HYDROGELS; RECEPTOR; LYMPHANGIOGENESIS; ANGIOGENESIS; INDUCTION; MT1-MMP; BINDING	TWIK-related acid-sensitive potassium channels (TASKs)-like current was recorded in orexin neurons in the lateral hypothalamus (LH), which are essential in respiratory chemoreflex. However, the specific mechanism responsible for the pH-sensitivity remains elusive. Thus, we hypothesized that TASKs contribute to respiratory chemoreflex. In the present study, we found that TASK1 and TASK3 were expressed in orexin neurons. Blocking TASKs or microinjecting acid artificial cerebrospinal fluid (ACSF) in the LH stimulated breathing. In contrast, alkaline ACSF inhibited breathing, which was attenuated by blocking TASK1. Damage of orexin neurons attenuated the stimulatory effect on respiration caused by microinjection of acid ACSF (at a pH of 6.5) or TASKs antagonists. The orexinA-positive fiber and orexin type 1 receptor (OX1R) neurons were located in the nucleus tractus solitarius (NTS). The exciting effect of acidosis in the LH on respiration was inhibited by blocking OX1R of the NTS. Taken together, we conclude that orexin neurons sense the extracellular pH change through TASKs and regulate respiration by projecting to the NTS.	[Wang, Xia; Guan, Ruijuan; Zhao, Xiaomei; Zhu, Danian; Shen, Linlin] Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai, Peoples R China; [Wang, Xia] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China; [Chen, Jun] Naval Mil Med Univ, Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China; [Shen, Linlin] Fudan Univ, Shanghai Key Lab Med Imaging Comp & Comp Assisted, Shanghai 200032, Peoples R China; [Song, Nana] Fudan Univ, Zhongshan Hosp, Div Nephrol, Shanghai 200032, Peoples R China	Fudan University; Shanghai Jiao Tong University; Naval Medical University; Fudan University; Fudan University	Shen, LL (corresponding author), Fudan Univ, Shanghai Key Lab Med Imaging Comp & Comp Assisted, Shanghai 200032, Peoples R China.; Song, NN (corresponding author), Fudan Univ, Zhongshan Hosp, Div Nephrol, Shanghai 200032, Peoples R China.	shenll@shmu.edu.cn; song.nana@zs-hospital.sh.cn			NSFC vertical bar Major Research Plan [81470203]; NSFC vertical bar Young Scientists Fund [81500048]	NSFC vertical bar Major Research Plan; NSFC vertical bar Young Scientists Fund	NSFC broken vertical bar Major Research Plan, Grant/Award Number: 81470203; NSFC broken vertical bar Young Scientists Fund, Grant/Award Number: 81500048	BANERJEE SD, 1992, J CELL BIOL, V119, P643, DOI 10.1083/jcb.119.3.643; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Campbell KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181484; Cho H, 2019, CIRC RES, V124, P225, DOI 10.1161/CIRCRESAHA.118.313707; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Detry B, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-29; Dixon JB, 2009, BIOTECHNOL BIOENG, V103, P1224, DOI 10.1002/bit.22337; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Faust HJ, 2018, BIOMATERIALS, V183, P93, DOI 10.1016/j.biomaterials.2018.08.045; Frye M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03959-6; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Gramolelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27739-w; Grimm L, 2019, ELIFE, V8, DOI 10.7554/eLife.42881; Guc E, 2017, BIOMATERIALS, V131, P160, DOI 10.1016/j.biomaterials.2017.03.033; Hanjaya-Putra D, 2012, BIOMATERIALS, V33, P6123, DOI 10.1016/j.biomaterials.2012.05.027; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; Hanjaya-Putra D, 2009, BIOTECHNOL PROGR, V25, P2, DOI 10.1002/btpr.129; Helm CLE, 2007, BIOTECHNOL BIOENG, V96, P167, DOI 10.1002/bit.21185; Hillel AT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002331; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kazenwadel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040497; Kim J, 2017, J CLIN INVEST, V127, P3447, DOI 10.1172/JCI93825; Knezevic Lea, 2017, Front Bioeng Biotechnol, V5, P25, DOI 10.3389/fbioe.2017.00025; Kono T, 2006, ARTERIOSCL THROM VAS, V26, P2070, DOI 10.1161/01.ATV.0000225770.57219.b0; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Liao S, 2013, LYMPHAT RES BIOL, V11, P136, DOI 10.1089/lrb.2013.0012; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Marino D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006894; Mason DE, 2019, J CELL BIOL, V218, P1369, DOI 10.1083/jcb.201806065; Muylaert DEP, 2014, HEART, V100, P1825, DOI 10.1136/heartjnl-2014-306092; Nguyen EH, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0096; Oliver G, 2020, CELL, V182, P270, DOI 10.1016/j.cell.2020.06.039; Park KM, 2014, DEVELOPMENT, V141, P2760, DOI 10.1242/dev.102194; Petrova TV, 2020, SCIENCE, V369, P157, DOI 10.1126/science.aax4063; Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Schaupper M, 2016, TISSUE ENG PART B-RE, V22, P395, DOI 10.1089/ten.teb.2016.0034; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Sweat RS, 2014, MICROCIRCULATION, V21, P532, DOI 10.1111/micc.12132; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141; Varberg KM, 2018, JOVE-J VIS EXP, DOI 10.3791/57044; Varberg KM, 2017, AM J PHYSIOL-CELL PH, V312, pC446, DOI 10.1152/ajpcell.00367.2016; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wolf KJ, 2019, ACS BIOMATER SCI ENG, V5, P3753, DOI 10.1021/acsbiomaterials.8b01268; Wong HLX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10824; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d; Yao GY, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-98; Yee D, 2011, TISSUE ENG PT A, V17, P1351, DOI [10.1089/ten.TEA.2010.0481, 10.1089/ten.tea.2010.0481]; Zhang L, 2014, ARTERIOSCL THROM VAS, V34, P1114, DOI 10.1161/ATVBAHA.114.303809	60	4	4	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21532	10.1096/fj.202002189R	http://dx.doi.org/10.1096/fj.202002189R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817828	hybrid			2022-12-28	WOS:000645260100100
J	Kido, K; Egawa, T; Fujiyoshi, H; Suzuki, H; Kawanaka, K; Hayashi, T				Kido, Kohei; Egawa, Tatsuro; Fujiyoshi, Haruna; Suzuki, Hikari; Kawanaka, Kentaro; Hayashi, Tatsuya			AMPK is indispensable for overload-induced muscle glucose uptake and glycogenesis but dispensable for inducing hypertrophy in mice	FASEB JOURNAL			English	Article						AMP-activated protein kinase; functional overload; glucose uptake; hypertrophy; skeletal muscle		Chronic muscle loading (overload) induces skeletal muscles to undergo hypertrophy and to increase glucose uptake. Although AMP-activated protein kinase (AMPK) reportedly serves as a negative regulator of hypertrophy and a positive regulator of glucose uptake, its role in overload-induced skeletal muscle hypertrophy and glucose uptake is unclear. This study aimed to determine whether AMPK regulates overload-induced hypertrophy and glucose uptake in skeletal muscles. To this end, skeletal muscle overload was induced through unilateral synergist ablations in wild-type (WT) and transgenic mice, expressing the dominant-negative mutation of AMPK (AMPK-DN). After 14 days, parameters, including muscle fiber cross-sectional area (CSA), glycogen level, and in vivo CHJ-2-deoxy-D-glucose uptake, were assessed. No significant difference was observed in body weight or blood glucose level between the WT and AMPK-DN mice. However, the 14-day muscle overload activated the AMPK pathway in WT mice skeletal muscle, whereas this response was impaired in the AMPK-DN mice. Despite a normal CSA gain in each fiber type, the AMPK-DN mice demonstrated a significant impairment of overload-induced muscle glucose uptake and glycogenesis, compared to WT mice. Moreover, 14-day overload-induced changes in GLUT4 and HKII expression levels were reduced in AMPK-DN mice, compared to WT mice. This study demonstrated that AMPK activation is indispensable for overload-induced muscle glucose uptake and glycogenesis; however, it is dispensable for the induction of hypertrophy in AMPK-DN mice. Furthermore, the AMPK/GLUT4 and HKII axes may regulate overload-induced muscle glucose uptake and glycogenesis.	[Kido, Kohei; Egawa, Tatsuro; Fujiyoshi, Haruna; Suzuki, Hikari; Hayashi, Tatsuya] Kyoto Univ, Grad Sch Human & Environm Studies, Lab Sports & Exercise Med, Kyoto, Japan; [Kido, Kohei; Kawanaka, Kentaro] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka, Japan; [Kido, Kohei; Kawanaka, Kentaro] Fukuoka Univ, Inst Phys Act, Fukuoka, Japan	Kyoto University; Fukuoka University; Fukuoka University	Kido, K (corresponding author), Grad Sch Human & Environm Studies, Lab Sports & Exercise Med, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	kohei.kido110@gmail.com		hayashi, Tatsuya/0000-0001-7600-4735; Kido, Kohei/0000-0003-0665-6572	MEXT \ Japan Society for the Promotion of Science (JSPS) [18J01392, 19K20007, 18H03148, 19K22806, 19K11520]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18J01392, 19K20007, 18H03148, 19K22806 and 19K11520	Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; AUGERT G, 1985, DIABETOLOGIA, V28, P295, DOI 10.1007/BF00271689; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; BALDWIN KM, 1981, J APPL PHYSIOL, V50, P1272, DOI 10.1152/jappl.1981.50.6.1272; Bodine SC, 2012, METHODS MOL BIOL, V798, P213, DOI 10.1007/978-1-61779-343-1_12; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Croymans DM, 2013, J APPL PHYSIOL, V115, P1245, DOI 10.1152/japplphysiol.00485.2013; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Egawa T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102954; Egawa T, 2015, AM J PHYSIOL-ENDOC M, V309, pE651, DOI 10.1152/ajpendo.00165.2015; Fang SH, 2011, MOL CELL BIOCHEM, V347, P175, DOI 10.1007/s11010-010-0626-z; Fentz J, 2015, AM J PHYSIOL-ENDOC M, V309, pE900, DOI 10.1152/ajpendo.00157.2015; Fryer LGD, 2002, BIOCHEM J, V363, P167, DOI 10.1042/0264-6021:3630167; Fu X, 2013, AM J PHYSIOL-CELL PH, V305, pC887, DOI 10.1152/ajpcell.00124.2013; Fueger PT, 2004, J BIOL CHEM, V279, P50956, DOI 10.1074/jbc.M408312200; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hingst JR, 2020, MOL METAB, V40, DOI 10.1016/j.molmet.2020.101028; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kido K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65397-z; Kjobsted R, 2019, DIABETES, V68, P1427, DOI 10.2337/db19-0050; Kjobsted R, 2017, DIABETES, V66, P598, DOI 10.2337/db16-0530; KONG XM, 1994, J BIOL CHEM, V269, P12963; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Larkin LM, 2000, J APPL PHYSIOL, V89, P1469, DOI 10.1152/jappl.2000.89.4.1469; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McMillin SL, 2017, DIABETES, V66, P1491, DOI 10.2337/db16-1075; MEGENEY LA, 1993, AM J PHYSIOL, V264, pE583, DOI 10.1152/ajpendo.1993.264.4.E583; Miura S, 2009, AM J PHYSIOL-ENDOC M, V296, pE47, DOI 10.1152/ajpendo.90690.2008; Moller LLV, 2020, J PHYSIOL-LONDON, V598, P5351, DOI 10.1113/JP280294; Moller LLV, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14460; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Nakano M, 2006, METABOLISM, V55, P300, DOI 10.1016/j.metabol.2005.09.003; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Riedl I, 2016, AM J PHYSIOL-ENDOC M, V310, pE461, DOI 10.1152/ajpendo.00387.2015; Ryder JW, 1999, FASEB J, V13, P2246, DOI 10.1096/fasebj.13.15.2246; Schwingshackl L, 2014, DIABETOLOGIA, V57, P1789, DOI 10.1007/s00125-014-3303-z; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; You JS, 2019, FASEB J, V33, P4021, DOI 10.1096/fj.201801653RR; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073	50	2	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21459	10.1096/fj.202002164R	http://dx.doi.org/10.1096/fj.202002164R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710687	Green Submitted			2022-12-28	WOS:000635216100103
J	Kirkwood, PM; Gibson, DA; Smith, JR; Wilson-Kanamori, JR; Kelepouri, O; Esnal-Zufiaurre, A; Dobie, R; Henderson, NC; Saunders, PTK				Kirkwood, Phoebe M.; Gibson, Douglas A.; Smith, James R.; Wilson-Kanamori, John R.; Kelepouri, Olympia; Esnal-Zufiaurre, Arantza; Dobie, Ross; Henderson, Neil C.; Saunders, Philippa T. K.			Single-cell RNA sequencing redefines the mesenchymal cell landscape of mouse endometrium	FASEB JOURNAL			English	Article						CD146; chondroitin sulfate proteoglycan 4; endometrium; fibroblast; pericyte; platelet&#8208; derived growth factor beta	STEM-CELLS; PERIVASCULAR CELLS; STROMAL CELLS; KIDNEY INJURY; R PACKAGE; EXPRESSION; IDENTIFICATION; DECIDUALIZATION; PERICYTES; MARKERS	The endometrium is a dynamic tissue that exhibits remarkable resilience to repeated episodes of differentiation, breakdown, regeneration, and remodeling. Endometrial physiology relies on a complex interplay between the stromal and epithelial compartments with the former containing a mixture of fibroblasts, vascular, and immune cells. There is evidence for rare populations of putative mesenchymal progenitor cells located in the perivascular niche of human endometrium, but the existence of an equivalent cell population in mouse is unclear. We used the Pdgfrb-BAC-eGFP transgenic reporter mouse in combination with bulk and single-cell RNA sequencing to redefine the endometrial mesenchyme. In contrast to previous reports we show that CD146 is expressed in both PDGFR beta + perivascular cells and CD31 + endothelial cells. Bulk RNAseq revealed cells in the perivascular niche which express the high levels of Pdgfrb as well as genes previously identified in pericytes and/or vascular smooth muscle cells (Acta2, Myh11, Olfr78, Cspg4, Rgs4, Rgs5, Kcnj8, and Abcc9). scRNA-seq identified five subpopulations of cells including closely related pericytes/vascular smooth muscle cells and three subpopulations of fibroblasts. All three fibroblast populations were PDGFR alpha+/CD34 + but were distinct in their expression of Ngfr/Spon2/Angptl7 (F1), Cxcl14/Smoc2/Rgs2 (F2), and Clec3b/Col14a1/Mmp3 (F3), with potential functions in the regulation of immune responses, response to wounding, and organization of extracellular matrix, respectively. Immunohistochemistry was used to investigate the spatial distribution of these populations revealing F1/NGFR + cells in most abundance beside epithelial cells. We provide the first definitive analysis of mesenchymal cells in the adult mouse endometrium identifying five subpopulations providing a platform for comparisons between mesenchymal cells in endometrium and other adult tissues which are prone to fibrosis.	[Kirkwood, Phoebe M.; Gibson, Douglas A.; Smith, James R.; Wilson-Kanamori, John R.; Kelepouri, Olympia; Esnal-Zufiaurre, Arantza; Dobie, Ross; Henderson, Neil C.; Saunders, Philippa T. K.] Univ Edinburgh, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Henderson, Neil C.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Saunders, PTK (corresponding author), Univ Edinburgh, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	p.saunders@ed.ac.uk	Saunders, Philippa/C-7489-2013	Saunders, Philippa/0000-0001-9051-9380; Gibson, Douglas/0000-0002-9949-1983; Smith, James/0000-0002-8120-8289	RCUK | Medical Research Council (MRC) [MR/N024524/1]; RCUK | MRC | Medical Research Foundation [MR/N013166/1]; Wellcome Trust (Wellcome) [219542/Z/19/Z]	RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK | MRC | Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Wellcome)	RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N024524/1; RCUK | MRC | Medical Research Foundation, Grant/Award Number: MR/N013166/1; Wellcome Trust (Wellcome), Grant/Award Number: 219542/Z/19/Z	Andersson E, 2015, INT J MOL MED, V35, P433, DOI 10.3892/ijmm.2014.2035; Ansell DM, 2015, EXP DERMATOL, V24, P833, DOI 10.1111/exd.12782; Bellofiore N, 2018, HUM REPROD, V33, P1715, DOI 10.1093/humrep/dey247; Bellofiore N, 2018, J MOL ENDOCRINOL, V61, pR25, DOI 10.1530/JME-17-0278; Bodnar RJ, 2016, WOUND REPAIR REGEN, V24, P204, DOI 10.1111/wrr.12415; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Cheng Y, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4794827; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Cousins FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36748; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dobie R, 2019, CELL REP, V29, P1832, DOI 10.1016/j.celrep.2019.10.024; Gaafar T, 2014, MOL CELL BIOCHEM, V395, P29, DOI 10.1007/s11010-014-2109-0; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Garry R, 2009, HUM REPROD, V24, P1393, DOI 10.1093/humrep/dep036; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Guimaraes-Camboa N, 2017, CELL STEM CELL, V20, P345, DOI 10.1016/j.stem.2016.12.006; Han XP, 2018, CELL, V173, P1307, DOI 10.1016/j.cell.2018.05.012; He LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35108; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Kaitu'u-Lino TJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099309; Kirita Y, 2020, P NATL ACAD SCI USA, V117, P15874, DOI 10.1073/pnas.2005477117; Kirita Y, 2019, NEPHRON, V143, P162, DOI 10.1159/000500638; Kitaya K, 2005, J CLIN ENDOCR METAB, V90, P2932, DOI 10.1210/jc.2004-2447; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; Krjutskov K, 2016, HUM REPROD, V31, P844, DOI 10.1093/humrep/dew008; Letouzey V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127531; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Matsumoto H, 2017, J REPROD DEVELOP, V63, P445, DOI 10.1262/jrd.2017-047; Maybin JA, 2015, HUM REPROD UPDATE, V21, P748, DOI 10.1093/humupd/dmv038; Mills Stuart J, 2013, Cells, V2, P621, DOI 10.3390/cells2030621; Papatheodorou I, 2020, NUCLEIC ACIDS RES, V48, pD77, DOI 10.1093/nar/gkz947; Parasar P, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0273-2; Peyser R, 2019, AM J RESP CELL MOL, V61, P74, DOI 10.1165/rcmb.2018-0313OC; Queckborner S, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-019-1496-2; Ramachandran P, 2020, NAT REV GASTRO HEPAT, V17, P457, DOI 10.1038/s41575-020-0304-x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saatcioglu HD, 2019, ELIFE, V8, DOI 10.7554/eLife.46349; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Spitzer TLB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095885; Tempest N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103240; Wang WX, 2020, NAT MED, V26, P1644, DOI 10.1038/s41591-020-1040-z; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	52	18	18	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21285	10.1096/fj.202002123R	http://dx.doi.org/10.1096/fj.202002123R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710643	Green Published, Green Submitted			2022-12-28	WOS:000635216100067
J	Lu, P; Li, M; Zhang, DH; Jiang, W				Lu, Pei; Li, Mao; Zhang, Donghui; Jiang, Wei			Lnc-ing pluripotency maintenance and early differentiation in human pluripotent stem cells	FASEB JOURNAL			English	Review						early differentiation; human embryonic stem cell; induced pluripotent stem cell; lncRNA; pluripotency	LONG NONCODING RNA; ENDODERM DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; LINCRNAS; ROLES	Pluripotency maintenance and lineage differentiation are two major characteristics of human embryonic and induced pluripotent stem cells. The determination of self-renewal or differentiation is under the exquisite control of the gene regulatory network, which is composed of transcription factors, signaling pathways, metabolic factors, chromatin or histone modifiers, miRNAs, and lncRNAs. Growing evidence has shown that long noncoding RNAs (lncRNAs) play important roles in epigenetic, transcriptional, and posttranscriptional gene regulation during the cell fate determination of pluripotent stem cells. Here, we summarize recent reports of lncRNA functions in pluripotency maintenance/exit and the early germ layer specification of human pluripotent stem cells. We also illustrate four major lncRNA functional mechanisms according to different types of cofactors: chromatin or histone modifiers, transcription factors, canonical and noncanonical RNA-binding proteins, and miRNAs. Further understanding of lncRNA-based regulation will provide more insights into the drivers manipulating cell fate and promote the therapeutic and research potential of human embryonic and induced pluripotent stem cells.	[Lu, Pei; Li, Mao; Jiang, Wei] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Frontier Sci Ctr Immunol & Metab,Med Res Inst, 116 East Lake Rd, Wuhan 430071, Hubei, Peoples R China; [Zhang, Donghui] Hubei Univ, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, 368 Youyi Rd, Wuhan 430062, Hubei, Peoples R China; [Jiang, Wei] Wuhan Univ, Human Genet Resource Preservat Ctr, Wuhan, Peoples R China; [Jiang, Wei] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China	Wuhan University; Hubei University; Wuhan University	Jiang, W (corresponding author), Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Frontier Sci Ctr Immunol & Metab,Med Res Inst, 116 East Lake Rd, Wuhan 430071, Hubei, Peoples R China.; Zhang, DH (corresponding author), Hubei Univ, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, 368 Youyi Rd, Wuhan 430062, Hubei, Peoples R China.	dongh.zhang@hubu.edu.cn; jiangw.mri@whu.edu.cn	zhang, donghui/AAY-4690-2021; Jiang, Wei/J-7993-2012	zhang, donghui/0000-0001-7258-8577; Jiang, Wei/0000-0002-6463-7356	National Natural Science Foundation of China (NSFC) [91740102]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 91740102	Banerjee P, 2018, STEM CELLS, V36, P218, DOI 10.1002/stem.2740; Bar S, 2019, CELL REP, V27, P20, DOI 10.1016/j.celrep.2019.03.019; Chen YF, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay0264; Daneshvar K, 2020, NAT CELL BIOL, V22, P1211, DOI 10.1038/s41556-020-0572-2; Daneshvar K, 2016, CELL REP, V17, P353, DOI 10.1016/j.celrep.2016.09.017; Durruthy-Durruthy J, 2016, NAT GENET, V48, P44, DOI 10.1038/ng.3449; Frank S, 2019, CELL STEM CELL, V24, P318, DOI 10.1016/j.stem.2018.11.005; Gaertner B, 2020, ELIFE, V9, DOI 10.7554/eLife.58659; Gao XF, 2019, NAT CELL BIOL, V21, P687, DOI 10.1038/s41556-019-0333-2; Geng T, 2019, STEM CELLS, V37, P1372, DOI 10.1002/stem.3064; Gokbuget D, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.164772; Guo CJ, 2020, CELL, V181, P621, DOI 10.1016/j.cell.2020.03.006; Han J, 2020, SCIENCE, V370, P1432, DOI 10.1126/science.abc9546; Jain AK, 2016, MOL CELL, V64, P967, DOI 10.1016/j.molcel.2016.10.039; Jha R, 2020, FASEB J, V34, P14336, DOI 10.1096/fj.202000206R; Jiang W, 2015, CELL REP, V11, P137, DOI 10.1016/j.celrep.2015.03.008; Jiapaer Z, 2018, STEM CELL REP, V11, P395, DOI 10.1016/j.stemcr.2018.06.010; Kleaveland B, 2018, CELL, V174, P350, DOI 10.1016/j.cell.2018.05.022; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Liu JL, 2017, DEV CELL, V42, P333, DOI 10.1016/j.devcel.2017.07.023; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu W, 2015, STEM CELLS DEV, V24, P1133, DOI 10.1089/scd.2014.0353; Ma ZL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234628; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Percharde M, 2018, CELL, V174, P391, DOI 10.1016/j.cell.2018.05.043; Sahakyan A, 2017, CELL STEM CELL, V20, P87, DOI 10.1016/j.stem.2016.10.006; Scarola M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8631; Shi CY, 2020, SCIENCE, V370, P1431, DOI 10.1126/science.abc9359; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Smith KN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34864-z; Smith KN, 2017, STEM CELL REP, V9, P108, DOI 10.1016/j.stemcr.2017.05.005; Sun L, 2019, NAT STRUCT MOL BIOL, V26, P322, DOI 10.1038/s41594-019-0200-7; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vallot C, 2017, CELL STEM CELL, V20, P102, DOI 10.1016/j.stem.2016.10.014; Wang JQ, 2018, CELL, V175, P1887, DOI 10.1016/j.cell.2018.11.039; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wang YY, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1323-9; Wilson KD, 2020, DEV CELL, V54, P694, DOI 10.1016/j.devcel.2020.07.006; Wu CS, 2014, GENOME RES, V24, P25, DOI 10.1101/gr.159483.113; Xu C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13287; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Yang J, 2020, STEM CELL REP, V15, P694, DOI 10.1016/j.stemcr.2020.07.014; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Yu CY, 2016, STEM CELLS, V34, P2052, DOI 10.1002/stem.2386; Zhang XX, 2021, INT J NEUROSCI, V131, P641, DOI 10.1080/00207454.2020.1797722	47	4	4	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21438	10.1096/fj.202002278R	http://dx.doi.org/10.1096/fj.202002278R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749897				2022-12-28	WOS:000635216100072
J	Stoddart, LA; Kilpatrick, LE; Corriden, R; Kellam, B; Briddon, SJ; Hill, SJ				Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Kellam, Barrie; Briddon, Stephen J.; Hill, Stephen J.			Efficient G protein coupling is not required for agonist-mediated internalization and membrane reorganization of the adenosine A(3) receptor	FASEB JOURNAL			English	Article						&#946; &#8208; arrestin; adenosine A(3) receptor; fluorescence correlation spectroscopy; G protein&#8208; coupled receptor; internalization; membrane organization	BETA(2)-ADRENERGIC RECEPTOR; TERNARY COMPLEX; IONIC LOCK; DRY MOTIF; CONSTITUTIVE ACTIVATION; MICRODOMAINS; ARRESTIN; BINDING; PHOSPHORYLATION; DESENSITIZATION	Organization of G protein-coupled receptors at the plasma membrane has been the focus of much recent attention. Advanced microscopy techniques have shown that these receptors can be localized to discrete microdomains and reorganization upon ligand activation is crucial in orchestrating their signaling. Here, we have compared the membrane organization and downstream signaling of a mutant (R108A, R3.50A) of the adenosine A(3) receptor (A(3)AR) to that of the wild-type receptor. Fluorescence Correlation Spectroscopy (FCS) studies with a fluorescent agonist (ABEA-X-BY630) demonstrated that both wild-type and mutant receptors bind agonist with high affinity but in subsequent downstream signaling assays the R108A mutation abolished agonist-mediated inhibition of cAMP production and ERK phosphorylation. In further FCS studies, both A(3)AR and A(3)AR R108A underwent similar agonist-induced increases in receptor density and molecular brightness which were accompanied by a decrease in membrane diffusion after agonist treatment. Using bimolecular fluorescence complementation, experiments showed that the R108A mutant retained the ability to recruit beta-arrestin and these receptor/arrestin complexes displayed similar membrane diffusion and organization to that observed with wild-type receptors. These data demonstrate that effective G protein signaling is not a prerequisite for agonist-stimulated beta-arrestin recruitment and membrane reorganization of the A(3)AR.	[Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Cell Signalling & Pharmacol Res Grp, Div Physiol Pharmacol & Neurosci, Sch Life Sci, Nottingham, England; [Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Kellam, Barrie; Briddon, Stephen J.; Hill, Stephen J.] Univ Birmingham, Ctr Membrane Prot & Receptors COMPARE, Birmingham, Midlands, England; [Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Kellam, Barrie; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Nottingham, England; [Kilpatrick, Laura E.; Kellam, Barrie] Biodiscovery Inst, Sch Pharm, Univ Pk Nottingham, Nottingham, England	University of Nottingham; University of Birmingham; University of Nottingham; University of Nottingham	Briddon, SJ; Hill, SJ (corresponding author), Univ Nottingham, Cell Signalling & Pharmacol Res Grp, Div Physiol Pharmacol & Neurosci, Sch Life Sci, Nottingham, England.	stephen.briddon@nottingham.ac.uk; Stephen.hill@nottingham.ac.uk	Hill, Stephen/N-6753-2013	Hill, Stephen/0000-0002-4424-239X; Stoddart, Leigh/0000-0002-4469-0600; Kilpatrick, Laura/0000-0001-6331-5606	Medical Research Council (MRC) [G0800006, MR/N020081/1]	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council (MRC), Grant/Award Number: G0800006 and MR/N020081/1	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Borea PA, 2015, PHARMACOL REV, V67, P74, DOI 10.1124/pr.113.008540; Briddon SJ, 2018, TRENDS PHARMACOL SCI, V39, P158, DOI 10.1016/j.tips.2017.11.004; Burnstock G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00661; Calebiro D, 2019, CURR OPIN CELL BIOL, V57, P57, DOI 10.1016/j.ceb.2018.11.003; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chen A, 2001, BIOCHEM BIOPH RES CO, V284, P596, DOI 10.1006/bbrc.2001.5027; Cordeaux Y, 2008, FASEB J, V22, P850, DOI 10.1096/fj.07-8180com; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; DONALDSON J, 1988, BIOCHEM PHARMACOL, V37, P715, DOI 10.1016/0006-2952(88)90146-3; Feng WK, 2003, BIOCHEM PHARMACOL, V65, P1077, DOI 10.1016/S0006-2952(03)00005-4; Ferguson G, 2002, BIOCHEMISTRY-US, V41, P14748, DOI 10.1021/bi0262911; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Ganguly S, 2010, BIOPHYS J, V99, P1397, DOI 10.1016/j.bpj.2010.06.031; Gondin AB, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00104; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kazemi MH, 2018, J CELL PHYSIOL, V233, P2032, DOI 10.1002/jcp.25873; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; Leschner J, 2013, J PHARMACOL EXP THER, V344, P85, DOI 10.1124/jpet.112.199190; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Middleton RJ, 2007, J MED CHEM, V50, P782, DOI 10.1021/jm061279i; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALMER TM, 1995, J BIOL CHEM, V270, P29607, DOI 10.1074/jbc.270.49.29607; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Perkovska S, 2018, TRAFFIC, V19, P58, DOI 10.1111/tra.12535; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Stoddart LA, 2014, BRIT J PHARMACOL, V171, P3827, DOI 10.1111/bph.12739; Sungkaworn T, 2017, NATURE, V550, P543, DOI 10.1038/nature24264; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P31973, DOI 10.1074/jbc.M112.348565; Yanagawa M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1917	45	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21211	10.1096/fj.202001729RR	http://dx.doi.org/10.1096/fj.202001729RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710641	Green Published			2022-12-28	WOS:000635216100076
J	Rodriguez, AG; Schroeder, ME; Grim, JC; Walker, CJ; Speckl, KF; Weiss, RM; Anseth, KS				Rodriguez, Andrea Gonzalez; Schroeder, Megan E.; Grim, Joseph C.; Walker, Cierra J.; Speckl, Kelly F.; Weiss, Robert M.; Anseth, Kristi S.			Tumor necrosis factor-alpha promotes and exacerbates calcification in heart valve myofibroblast populations	FASEB JOURNAL			English	Article						3D hydrogel; aortic valve disease; calcification; fibrosis; TNF&#8208; a; VIC	GROWTH-FACTOR-BETA; VALVULAR INTERSTITIAL-CELLS; TNF-ALPHA; IN-VITRO; HEMORRHAGIC-FEVER; DISEASE; STENOSIS; SELUMETINIB; ACTIVATION; FAILURE	Pro-inflammatory cytokines play critical roles in regulating valvular interstitial cell (VIC) phenotypic changes that can cause heart valve fibrosis and calcification. Tumor necrosis factor alpha (TNF-alpha) is a cytokine known to influence VIC behavior and has been reported at high levels in calcified valves ex vivo. We sought to understand the specific effects of TNF-alpha on VIC phenotypes (eg, fibroblast, profibrotic activated myofibroblasts) and its link with heart valve disorders. We characterize human aortic valve tissue from patients with valve disorders and identify a high variability of fibrotic and calcific markers between tissues. These results motivated in vitro studies to explore the effects of TNF-alpha on defined VIC fibroblasts and profibrotic activated myofibroblasts, induced via FGF-2 and TGF-beta 1 treatment. Using 3D hydrogels to culture VICs, we measure the effect of TNF-alpha (0.1-10 ng/mL) on key markers of fibrosis (eg, alpha SMA, COL1A1) and calcification (eg, RUNX2, BMP2, and calcium deposits). We observe calcification in TNF-alpha-treated VIC activated myofibroblasts and identify the MAPK/ERK signaling cascade as a potential pathway for TNF-alpha mediated calcification. Conversely, VIC fibroblasts respond to TNF-alpha with decreased calcification. Treatment of VIC profibrotic activated myofibroblast populations with TNF-alpha leads to increased calcification. Our in vitro findings correlate with findings in diseased human valves and highlight the importance of understanding the effect of cytokines and signaling pathways on specific VIC phenotypes. Finally, we reveal MAPK/ERK as a potential pathway involved in VIC-mediated matrix calcification with TNF-alpha treatment, suggesting this pathway as a potential pharmaceutical target for aortic valve disease.	[Rodriguez, Andrea Gonzalez; Grim, Joseph C.; Speckl, Kelly F.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Rodriguez, Andrea Gonzalez; Schroeder, Megan E.; Grim, Joseph C.; Walker, Cierra J.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Schroeder, Megan E.; Walker, Cierra J.; Anseth, Kristi S.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA; [Weiss, Robert M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Iowa	Anseth, KS (corresponding author), JSC Biotechnol Bldg,Campus Box 596, Boulder, CO 80309 USA.	kristi.anseth@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019; rodriguez, andrea/GRO-4054-2022		NIH [RO1HL132353, RO1HL142935, T32 HL007822]; American Heart Association [18IPA34170040]; Biological Sciences Initiative Fellowship;  [F31HL142223]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Biological Sciences Initiative Fellowship; 	The authors would like to thank the NIH for funding research through grants RO1HL132353 and RO1HL142935. JCG acknowledges funding from the NIH (T32 HL007822). CJW acknowledges funding from F31HL142223. KFS acknowledges funding from the Biological Sciences Initiative Fellowship. RMW acknowledges fund from American Heart Association Grant #18IPA34170040.	Aguado BA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav3233; Antoni C, 2002, CLIN EXP RHEUMATOL, V20, pS152; Benton JA, 2009, ARTERIOSCL THROM VAS, V29, P1950, DOI 10.1161/ATVBAHA.109.195271; Blaser MC., 2015, CARDIAC FIBROSIS HEA, DOI [10.1007/978-3-319-17437-2_3, DOI 10.1007/978-3-319-17437-2_3]; Bowler MA, 2015, CARDIOVASC PATHOL, V24, P1, DOI 10.1016/j.carpath.2014.08.003; Bradham WS, 2002, AM J PHYSIOL-HEART C, V282, pH1288, DOI 10.1152/ajpheart.00526.2001; Calin MV, 2009, CELL TISSUE RES, V336, P237, DOI 10.1007/s00441-009-0765-2; Casaluce F, 2017, EXPERT OPIN INV DRUG, V26, P973, DOI 10.1080/13543784.2017.1351543; Chen Y, 2016, J THORAC DIS, V8, pE1701, DOI 10.21037/jtd.2016.12.23; Colucci S., SCI WORLD J; Cush JJ, 2004, CLIN EXP RHEUMATOL, V22, pS141; Cushing MC, 2005, MATRIX BIOL, V24, P428, DOI 10.1016/j.matbio.2005.06.007; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Distler JHW, 2008, ARTHRITIS RHEUM, V58, P2228, DOI 10.1002/art.23645; Dolivo DM, 2017, CYTOKINE GROWTH F R, V38, P49, DOI 10.1016/j.cytogfr.2017.09.003; Dombi E, 2016, NEW ENGL J MED, V375, P2550, DOI 10.1056/NEJMoa1605943; Duan B, 2016, ACTA BIOMATER, V36, P42, DOI 10.1016/j.actbio.2016.03.007; DUTKA DP, 1993, BRIT HEART J, V70, P141; Fahey T J 3rd, 1990, Cytokine, V2, P92, DOI 10.1016/1043-4666(90)90002-B; Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Fujita M, 2003, AM J RESP CELL MOL, V29, P669, DOI 10.1165/rcmb.2002-0046OC; Galeone A, 2013, INT J CARDIOL, V169, P296, DOI 10.1016/j.ijcard.2013.09.012; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; Goody PR, 2020, ARTERIOSCL THROM VAS, V40, P885, DOI 10.1161/ATVBAHA.119.313067; He CM, 2017, AMINO ACIDS, V49, P1981, DOI 10.1007/s00726-017-2432-3; HERSHKOVIZ R, 1993, SCAND J IMMUNOL, V37, P111, DOI 10.1111/j.1365-3083.1993.tb01672.x; Hjortnaes J, 2016, J MOL CELL CARDIOL, V94, P13, DOI 10.1016/j.yjmcc.2016.03.004; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002; Do K, 2015, INVEST NEW DRUG, V33, P720, DOI 10.1007/s10637-015-0212-z; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Lehmkuhl L, 2013, INT J CARDIOVAS IMAG, V29, P693, DOI 10.1007/s10554-012-0123-4; Li C, 2011, AM J PATHOL, V179, P1746, DOI 10.1016/j.ajpath.2011.06.007; Li G, 2017, J THORAC CARDIOV SUR, V153, P1318, DOI 10.1016/j.jtcvs.2017.01.052; Lim J, 2016, AM J PATHOL, V186, P2378, DOI 10.1016/j.ajpath.2016.05.003; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Lindman BR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.6; Liu AC, 2008, AM J PATHOL, V173, P1275, DOI 10.2353/ajpath.2008.080365; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035; Masjedi S, 2017, HEART VESSELS, V32, P217, DOI 10.1007/s00380-016-0909-8; MAUVIEL A, 1988, FEBS LETT, V236, P47, DOI 10.1016/0014-5793(88)80283-7; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Minners J, 2008, EUR HEART J, V29, P1043, DOI 10.1093/eurheartj/ehm543; Mizutani H, 1997, J DERMATOL SCI, V14, P145, DOI 10.1016/S0923-1811(96)00562-2; Moreno PR, 2011, J THORAC CARDIOV SUR, V142, P895, DOI 10.1016/j.jtcvs.2011.03.002; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; O'Brien KD, 2006, ARTERIOSCL THROM VAS, V26, P1721, DOI 10.1161/01.ATV.0000227513.13697.ac; Orgaz JL, 2020, CANCER CELL, V37, P85, DOI 10.1016/j.ccell.2019.12.003; Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875; Parhami F, 2002, CIRC RES, V91, P570, DOI 10.1161/01.RES.0000036607.05037.DA; Quinlan AMT, 2012, J BIOMED MATER RES A, V100A, P2474, DOI 10.1002/jbm.a.34162; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rodriguez AG, 2018, APL BIOENG, V2, DOI 10.1063/1.5042430; Rutkovskiy A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006339; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sarzi-Puttini P, 2005, AUTOIMMUN REV, V4, P153, DOI 10.1016/j.autrev.2004.09.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Segura A, 2014, HEART FAIL REV, V19, P173, DOI 10.1007/s10741-012-9365-4; Sinagra E, 2013, EUR J INTERN MED, V24, P385, DOI 10.1016/j.ejim.2012.12.015; Sorimachi K, 1997, BIOCHEM MOL BIOL INT, V43, P79; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Wang B, 2017, CLIN SCI, V131, P411, DOI 10.1042/CS20160571; Wang R, 2014, EXP THER MED, V7, P935, DOI 10.3892/etm.2014.1529; Weiss RM, 2013, CIRC RES, V113, P209, DOI 10.1161/CIRCRESAHA.113.300153; Wypasek E, 2013, INFLAMMATION, V36, P449, DOI 10.1007/s10753-012-9565-z; YADAV M, 1991, FEMS MICROBIOL IMMUN, V89, P45, DOI 10.1016/0378-1097(91)90062-F; Yamane K, 2003, J IMMUNOL, V171, P3855, DOI 10.4049/jimmunol.171.7.3855; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; Yip CYY, 2011, CARDIOVASC PATHOL, V20, P177, DOI 10.1016/j.carpath.2010.12.001; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Yu ZQ, 2011, J PHARMACOL EXP THER, V337, P16, DOI 10.1124/jpet.110.177915; Yutzey KE, 2014, ARTERIOSCL THROM VAS, V34, P2387, DOI 10.1161/ATVBAHA.114.302523; Zeng QC, 2013, ARTERIOSCL THROM VAS, V33, P1580, DOI 10.1161/ATVBAHA.112.300912; Zhan Qiong, 2015, Int J Biol Sci, V11, P482, DOI 10.7150/ijbs.10905	79	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21382	10.1096/fj.202002013RR	http://dx.doi.org/10.1096/fj.202002013RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33554387	Bronze, Green Accepted			2022-12-28	WOS:000629576700003
J	Hu, LJ; Xu, XQ; Li, QJ; Chen, XJ; Yuan, XF; Qiu, S; Yao, CS; Zhang, DP; Wang, F				Hu, Lijuan; Xu, Xiaoqing; Li, Qiuju; Chen, Xijuan; Yuan, Xiangfei; Qiu, Shuai; Yao, Chuanshan; Zhang, Dapeng; Wang, Feng			Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states	FASEB JOURNAL			English	Article						cancer cachexia; caveolin-1; glycolysis; pancreatic cancer	MESENCHYMAL TRANSITION; GLUCOSE-METABOLISM; AEROBIC GLYCOLYSIS; INSULIN-RECEPTOR; DOWN-REGULATION; BREAST-CANCER; EXPRESSION; OVEREXPRESSION; PROGRESSION; MECHANISMS	In pancreatic cancer, autocrine insulin-like growth factor-1 (IGF-1) and paracrine insulin stimulate both IGF-1 receptor (IGF1R) and insulin receptor (IR) to increase tumor growth and glycolysis. In pancreatic cancer patients, cancer-induced glycolysis increases hepatic gluconeogenesis, skeletal muscle proteolysis, and fat lipolysis and, thereby, causes cancer cachexia. As a protein coexisting with IGF1R and IR, caveolin-1 (cav-1) may be involved in pancreatic cancer-induced cachexia. We undertook the present study to test this hypothesis. Out of wild-type MiaPaCa2 and AsPC1 human pancreatic cancer cell lines, we created their stable sub-lines whose cav-1 expression was diminished with RNA interference or increased with transgene expression. When these cells were studied in vitro, we found that cav-1 regulated IGF1R/IR expression and activation and also regulated cellular glycolysis. We transplanted the different types of MiaPaCa2 cells in growing athymic mice for 8 weeks, using intact athymic mice as tumor-free controls. We found that cav-1 levels in tumor grafts were correlated with expression levels of the enzymes that regulated hepatic gluconeogenesis, skeletal muscle proteolysis, and fat lipolysis in the respective tissues. When the tumors had original or increased cav-1, their carriers' body weight gain was less than the tumor-free reference. When cav-1 was diminished in tumors, the tumor carriers' body weight gain was not changed significantly, compared to the tumor-free reference. In conclusion, cav-1 in pancreatic cancer cells stimulated IGF1R/IR and glycolysis in the cancer cells and triggered cachectic states in the tumor carrier.	[Hu, Lijuan; Yuan, Xiangfei; Zhang, Dapeng; Wang, Feng] Nankai Univ, Nankai Hosp Affiliated, Lab Acute Abdomen Dis Associated Organ Injury & R, 6 Changjiang Rd, Tianjin 300100, Peoples R China; [Xu, Xiaoqing; Li, Qiuju; Chen, Xijuan; Qiu, Shuai] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China; [Yao, Chuanshan] Nankai Univ, Sch Med, Tianjin, Peoples R China	Nankai University; Tianjin Medical University; Nankai University	Wang, F (corresponding author), Nankai Univ, Nankai Hosp Affiliated, Lab Acute Abdomen Dis Associated Organ Injury & R, 6 Changjiang Rd, Tianjin 300100, Peoples R China.	fengwangpi@163.com			National Natural Science Foundation of China (NSFC) [81572318]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81572318	BURT ME, 1981, CANCER-AM CANCER SOC, V47, P2138, DOI 10.1002/1097-0142(19810501)47:9<2138::AID-CNCR2820470906>3.0.CO;2-#; Chai F, 2019, J CELL PHYSIOL, V234, P1937, DOI 10.1002/jcp.27074; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; Duxbury MS, 2004, J BIOL CHEM, V279, P23176, DOI 10.1074/jbc.M402051200; Ha TK, 2012, CANCER RES, V72, P4097, DOI 10.1158/0008-5472.CAN-12-0448; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hotz Hubert G, 2003, Pancreas, V26, pe89, DOI 10.1097/00006676-200305000-00020; Hu LJ, 2020, AM J CHINESE MED, V48, P1005, DOI 10.1142/S0192415X20500482; Jung AC, 2015, ONCOTARGET, V6, P41884, DOI 10.18632/oncotarget.6099; Kang F, 2014, J NUCL MED, V55, P439, DOI 10.2967/jnumed.113.121327; Kannan A, 2014, EUR J CANCER, V50, P204, DOI 10.1016/j.ejca.2013.08.016; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Liu ZW, 2013, CANCER BIOL THER, V14, P428, DOI 10.4161/cbt.23786; LUNDHOLM K, 1982, CANCER-AM CANCER SOC, V50, P1142, DOI 10.1002/1097-0142(19820915)50:6<1142::AID-CNCR2820500618>3.0.CO;2-I; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Parton RG, 2016, P NATL ACAD SCI USA, V113, P14170, DOI 10.1073/pnas.1617954113; PERMERT J, 1993, EUR J SURG, V159, P101; Raikar LS, 2006, J CELL BIOCHEM, V98, P861, DOI 10.1002/jcb.20732; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Shi Y, 2015, AUTOPHAGY, V11, P769, DOI 10.1080/15548627.2015.1034411; Simon L, 2020, CANCER METAST REV, V39, P435, DOI 10.1007/s10555-020-09890-x; Suzuoki M, 2002, BRIT J CANCER, V87, P1140, DOI 10.1038/sj.bjc.6600619; Tahir SA, 2013, CANCER RES, V73, P1900, DOI 10.1158/0008-5472.CAN-12-3040; Talbert EE, 2019, CELL REP, V28, P1612, DOI 10.1016/j.celrep.2019.07.016; Tanase CP, 2009, J MOL HISTOL, V40, P23, DOI 10.1007/s10735-008-9209-7; Tanno S, 2001, CANCER RES, V61, P589; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Trajkovic-Arsic M, 2013, J MOL ENDOCRINOL, V50, pR67, DOI 10.1530/JME-12-0259; Vallejo J, 2005, FASEB J, V19, P586, DOI 10.1096/fj.04-2380fje; Varewijck AJ, 2012, ENDOCR-RELAT CANCER, V19, pF63, DOI 10.1530/ERC-12-0026; Wang F, 2007, AM J PATHOL, V170, P469, DOI 10.2353/ajpath.2007.060489; Wang F, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4271-3; Wang XM, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0418-4; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang J, 2019, AM J CHINESE MED, V47, P675, DOI 10.1142/S0192415X19500356; Yim S, 2003, J BIOL CHEM, V278, P38260, DOI 10.1074/jbc.M306016200; Yu M, 2015, CANCER LETT, V360, P187, DOI 10.1016/j.canlet.2015.02.002; Zhang C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1703-1; Zhang DP, 2015, ONCOL LETT, V10, P1545, DOI 10.3892/ol.2015.3384	40	8	8	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21826	10.1096/fj.202100121RRR	http://dx.doi.org/10.1096/fj.202100121RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320244				2022-12-28	WOS:000678975300012
J	Kang, Y; Kim, YW; Kang, J; Kim, A				Kang, Yujin; Kim, Yea Woon; Kang, Jin; Kim, AeRi			Histone H3K4me1 and H3K27ac play roles in nucleosome eviction and eRNA transcription, respectively, at enhancers	FASEB JOURNAL			English	Article						enhancers; eRNA transcription; nucleosome eviction	LOCUS-CONTROL REGION; GLOBIN LOCUS; CHROMATIN; GENE; RNAS; MONOMETHYLATION; ACETYLATION; PROMOTERS; PROTEINS; GATA-1	Histone H3K4me1 and H3K27ac are enhancer-specific modifications and are required for enhancers to activate transcription of target genes. However, the reciprocal effects of these histone modifications on each other and their roles in enhancers are not clear. Here to comparatively analyze the role of these modifications, we inhibited H3K4me1 and H3K27ac by deleting the SET domains of histone methyltransferases MLL3 and MLL4 and the HAT domain of histone acetyltransferase p300, respectively, in erythroid K562 cells. The loss of H3K4me1 reduced H3K27ac at the beta-globin enhancer LCR HSs, but H3K27ac reduction did not affect H3K4me1. This unequal relationship between two modifications was revealed in putative enhancers by genome-wide analysis using ChIP-seq. Histone H3 eviction at putative enhancers was weakened by the loss of H3K4me1 but not by the loss of H3K27ac. Chromatin remodeling complexes were recruited into the beta-globin LCR HSs in a H3K4me1-dependent manner. In contrast, H3K27ac was required for enhancer RNA (eRNA) transcription, and H3K4me1 was not enough for it. Forced H3K27ac-induced eRNA transcription without affecting H3K4me1 at the beta-globin LCR HSs. These results indicate that H3K4me1 and H3K27ac affect each other in different ways and play more direct roles in nucleosome eviction and eRNA transcription, respectively, at enhancers.	[Kang, Yujin; Kim, Yea Woon; Kang, Jin; Kim, AeRi] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Busan 46241, South Korea	Pusan National University	Kim, A (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Busan 46241, South Korea.	kimaeri@pusan.ac.kr			National Research Foundation of Korea (NRF); Ministry of Science, ICT, and Future Planning [NRF--2014R1A2A1A11051702]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning	National Research Foundation of Korea (NRF); Ministry of Science, ICT, and Future Planning, Grant/Award Number: NRF--2014R1A2A1A11051702	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cho Y, 2008, NUCLEIC ACIDS RES, V36, P4521, DOI 10.1093/nar/gkn368; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Ebrahimi A, 2019, NAT CHEM BIOL, V15, P519, DOI 10.1038/s41589-019-0264-z; Fang XD, 2009, J MOL BIOL, V394, P197, DOI 10.1016/j.jmb.2009.09.046; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Grossman SR, 2018, P NATL ACAD SCI USA, V115, pE7222, DOI 10.1073/pnas.1804663115; Guertin MJ, 2013, CURR OPIN GENET DEV, V23, P116, DOI 10.1016/j.gde.2012.11.008; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Inukai S, 2017, CURR OPIN GENET DEV, V43, P110, DOI 10.1016/j.gde.2017.02.007; Jang Y, 2019, NUCLEIC ACIDS RES, V47, P607, DOI 10.1093/nar/gky982; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Johnson TA, 2018, NUCLEIC ACIDS RES, V46, P203, DOI 10.1093/nar/gkx1044; Kang J, 2018, BBA-GENE REGUL MECH, V1861, P637, DOI 10.1016/j.bbagrm.2018.05.005; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kang Y, 2015, BBA-GENE REGUL MECH, V1849, P282, DOI 10.1016/j.bbagrm.2014.12.010; Kim A, 2007, NUCLEIC ACIDS RES, V35, P5831, DOI 10.1093/nar/gkm620; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim YW, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170976; Kim YW, 2013, BBA-GENE REGUL MECH, V1829, P963, DOI 10.1016/j.bbagrm.2013.04.006; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02403-5; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Local A, 2018, NAT GENET, V50, P73, DOI 10.1038/s41588-017-0015-6; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Maruyama A, 2014, NUCLEIC ACIDS RES, V42, P13599, DOI 10.1093/nar/gku1169; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Rahnamoun H, 2018, J BIOL CHEM, V293, P13234, DOI 10.1074/jbc.RA118.003387; Raisner R, 2018, CELL REP, V24, P1722, DOI 10.1016/j.celrep.2018.07.041; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rickels R, 2017, NAT GENET, V49, P1647, DOI 10.1038/ng.3965; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Wang CC, 2016, P NATL ACAD SCI USA, V113, P11871, DOI 10.1073/pnas.1606857113; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhu Y, 2018, TOXICOL APPL PHARM, V357, P70, DOI 10.1016/j.taap.2018.08.011; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	58	10	10	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21781	10.1096/fj.202100488R	http://dx.doi.org/10.1096/fj.202100488R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34309923				2022-12-28	WOS:000678975300037
J	Yang, SR; Hua, KF; Yang, CY; Chen, A; Weng, JC; Tsai, YL; Wan, CJ; Wu, CY; Lee, CC; Chan, JF; Hsieh, CY; Hsu, YJ; Wu, CC; Mukhopadhyay, D; Huang, HS; Liu, FC; Ka, SM				Yang, Shin-Ruen; Hua, Kuo-Feng; Yang, Chih-Yu; Chen, Ann; Weng, Jui-Chun; Tsai, Yu-Ling; Wan, Chih-Jun; Wu, Chung-Yao; Lee, Chia-Chung; Chan, Jia-Feng; Hsieh, Chih-Yu; Hsu, Yu-Juei; Wu, Chia-Chao; Mukhopadhyay, Debabrata; Huang, Hsu-Shan; Liu, Feng-Cheng; Ka, Shuk-Man			Cf-02, a novel benzamide-linked small molecule, blunts NF-kappa B activation and NLRP3 inflammasome assembly and improves acute onset of accelerated and severe lupus nephritis in mice	FASEB JOURNAL			English	Article						severe lupus nephritis; autophagy; benzamide-linked small molecule; NF-kappa B/NLRP3; inflammasome axis	DENDRITIC CELLS; T-CELLS; ERYTHEMATOSUS; INHIBITORS; CD14; INTERLEUKIN-18; THERAPIES; MECHANISM; AUTOPHAGY; DISEASE	In the present study, acute onset of severe lupus nephritis was successfully treated in mice using a new, benzamide-linked, small molecule that targets immune modulation and the NLRP3 inflammasome. Specifically, 6-(2,4-difluorophenyl)-3-(3-(trifluoromethyl)phenyl)-2H-benzo[e][1,3]oxazine-2,4(3H)-dione (Cf-02) (a) reduced serum levels of IgG anti-dsDNA, IL-1 beta, IL-6, and TNF-alpha, (b) inhibited activation of dendritic cells and differentially regulated T cell functions, and (c) suppressed the NF-kappa B/NLRP3 inflammasome axis, targeting priming and activating signals of the inflammasome. Moreover, treatment with Cf-02 significantly inhibited secretion of IL-1 beta in lipopolysaccharide-stimulated macrophages, but this effect was abolished by autophagy induction. These results recommend Cf-02 as a promising drug candidate for the serious renal conditions associated with systemic lupus erythematosus. Future investigations should examine whether Cf-02 may also be therapeutic in other types of chronic kidney disease involving NLRP3 inflammasome-driven signaling.	[Yang, Shin-Ruen; Wan, Chih-Jun] Natl Def Med Ctr, Med Acad, Grad Inst Aerosp & Undersea Med, Dept Med, Taipei, Taiwan; [Yang, Shin-Ruen; Chen, Ann; Tsai, Yu-Ling; Wu, Chung-Yao] Triserv Gen Hosp, Dept Pathol, Natl Def Med Ctr, Taipei, Taiwan; [Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Hua, Kuo-Feng] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Chih-Yu] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Yang, Chih-Yu] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Weng, Jui-Chun; Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lee, Chia-Chung; Huang, Hsu-Shan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chan, Jia-Feng; Hsieh, Chih-Yu] Chu Kong Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan; [Hsieh, Chih-Yu] Taipei Med Univ, Coll Biomed Engn, Taipei, Taiwan; [Hsu, Yu-Juei; Wu, Chia-Chao] Triserv Gen Hosp, Dept Med, Natl Def Med Ctr, Div Nephrol, Taipei, Taiwan; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Huang, Hsu-Shan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Liu, Feng-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Dept Rheumatol Immunol & Allergy, 325,Sec 2,Cheng Gung Rd, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Ilan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; Mayo Clinic; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Liu, FC (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Dept Rheumatol Immunol & Allergy, 325,Sec 2,Cheng Gung Rd, Taipei, Taiwan.; Ka, SM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Dept Med, 161,Sec 6,Min Quan E Rd, Taipei, Taiwan.	lfc10399@yahoo.com.tw; shukmanka@gmail.com	Hsieh, Chih-Yu/GWQ-8343-2022	Yang, Chih-Yu/0000-0001-9899-3159; Huang, Hsu-Shan/0000-0001-8162-5608	Ministry of Science and Technology [MOST 109-2320-B-016-008, MOST 109-2314-B-016-034-MY3]; National Defense Medical Center [MAB-109-028]; Tri-Service General Hospital, Taipei, Taiwan [TSGH-D-109090]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Defense Medical Center; Tri-Service General Hospital, Taipei, Taiwan	This work was supported by grants MOST 109--2320--B--016--008, MOST 109--2314--B--016--034--MY3 from the Ministry of Science and Technology, MAB-109--028 from the National Defense Medical Center, and TSGH--D--109090 from the Tri--Service General Hospital, Taipei, Taiwan.	Akhtar S, 2011, MOL MED, V17, P88, DOI 10.2119/molmed.2010.00080; Alessandri C, 2012, FASEB J, V26, P4722, DOI 10.1096/fj.12-206060; Almaani S, 2017, CLIN J AM SOC NEPHRO, V12, P825, DOI 10.2215/CJN.05780616; Ayyappan P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00658; Bickert T, 2007, MED MICROBIOL IMMUN, V196, P31, DOI 10.1007/s00430-006-0026-x; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Bruschi M, 2020, J RHEUMATOL, V47, P377, DOI 10.3899/jrheum.181232; Chi HH, 2017, J AM SOC NEPHROL, V28, P2022, DOI 10.1681/ASN.2016080840; Chiu HW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42130-z; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; El-Ghoneimy DH, 2019, CLIN RHEUMATOL, V38, P2585, DOI 10.1007/s10067-019-04547-9; Flanc RS, 2004, AM J KIDNEY DIS, V43, P197, DOI 10.1053/j.ajkd.2003.10.012; Fu R, 2017, ARTHRITIS RHEUMATOL, V69, P1636, DOI 10.1002/art.40155; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hsieh CY, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020279; Hsieh CY, 2019, J CELL PHYSIOL, V234, P4081, DOI 10.1002/jcp.27204; Hsu WH, 2020, NEPHROL DIAL TRANSPL, V35, P74, DOI 10.1093/ndt/gfz073; Hung YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46299; Illei GG, 2001, ANN INTERN MED, V135, P248, DOI 10.7326/0003-4819-135-4-200108210-00009; Ka SM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0844-6; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Kronbichler A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/858027; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Lawal B, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010092; Lee CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149317; Lee CC, 2015, BIOORGAN MED CHEM, V23, P4522, DOI 10.1016/j.bmc.2015.06.007; Lee CC, 2015, EUR J MED CHEM, V98, P115, DOI 10.1016/j.ejmech.2015.05.015; Lin TJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01951; Liou JT, 2014, EUR J PHARMACOL, V726, P124, DOI 10.1016/j.ejphar.2014.01.049; Liphaus BL, 2013, LUPUS, V22, P940, DOI 10.1177/0961203313496300; Liu FC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051453; Liu FC, 2011, J CLIN IMMUNOL, V31, P1131, DOI 10.1007/s10875-011-9576-9; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mokgautsi N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052464; Molino C, 2009, EUR J INTERN MED, V20, P447, DOI 10.1016/j.ejim.2008.12.018; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V96, P15; Parikh SV, 2016, J AM SOC NEPHROL, V27, P2929, DOI 10.1681/ASN.2016040415; Ponticelli C, 2006, CLIN J AM SOC NEPHRO, V1, P863, DOI 10.2215/CJN.00880306; Rother N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01136; Shui HA, 2007, RHEUMATOLOGY, V46, P1277, DOI 10.1093/rheumatology/kem136; Silliman CC, 2010, AM J PHYSIOL-CELL PH, V298, pC714, DOI 10.1152/ajpcell.00011.2009; Takahama M, 2018, IMMUNOL REV, V281, P62, DOI 10.1111/imr.12613; Tam LS, 2003, LUPUS, V12, P665, DOI 10.1191/0961203303lu446oa; Tsai YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41123; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Whittall-Garcia LP, 2019, LUPUS, V28, P1549, DOI 10.1177/0961203319883936; Wong WT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01920; Wu CY, 2020, J IMMUNOL, V204, P1448, DOI 10.4049/jimmunol.1801610; Yang SR, 2020, KIDNEY INT, V98, P378, DOI 10.1016/j.kint.2020.02.033; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024; Zanoni I, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00032; Zhou XJ, 2019, AUTOPHAGY, V15, P908, DOI 10.1080/15548627.2019.1580512	55	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21785	10.1096/fj.202100047R	http://dx.doi.org/10.1096/fj.202100047R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314075				2022-12-28	WOS:000678975300016
J	Aragon-Herrera, A; Feijoo-Bandin, S; Morana-Fernandez, S; Anido-Varela, L; Rosello-Lleti, E; Portoles, M; Tarazon, E; Lage, R; Moscoso, I; Barral, L; Bani, D; Bigazzi, M; Gualillo, O; Gonzalez-Juanatey, JR; Lago, F				Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Morana-Fernandez, Sandra; Anido-Varela, Laura; Rosello-Lleti, Esther; Portoles, Manuel; Tarazon, Estefania; Lage, Ricardo; Moscoso, Isabel; Barral, Luis; Bani, Daniele; Bigazzi, Mario; Gualillo, Oreste; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca			Relaxin has beneficial effects on liver lipidome and metabolic enzymes	FASEB JOURNAL			English	Article						desaturases; liver; lysoglycerophospholipids; metabolomics; relaxin	FATTY LIVER; FIBROSIS; PHOSPHATIDYLCHOLINE; DISEASE; AXIS; LIPOTOXICITY; DECREASES; INSULIN; DELTA-5; AKT	Relaxin is an insulin-like hormone with pleiotropic protective effects in several organs, including the liver. We aimed to characterize its role in the control of hepatic metabolism in healthy rats. Sprague-Dawley rats were treated with human recombinant relaxin-2 for 2 weeks. The hepatic metabolic profile was analyzed using UHPLC-MS platforms. Hepatic gene expression of key enzymes of desaturation (Fads1/Fads2) of n-6 and n-3 polyunsaturated fatty acids (PUFAs), of phosphatidylethanolamine (PE) N-methyltransferase (Pemt), of fatty acid translocase Cd36, and of glucose-6-phosphate isomerase (Gpi) were quantified by Real Time-PCR. Activation of 5 ' AMP-activated protein kinase (AMPK) was analyzed by Western Blot. Relaxin-2 significantly modified the hepatic levels of 19 glycerophospholipids, 2 saturated (SFA) and 1 monounsaturated (MUFA) fatty acids (FA), 3 diglycerides, 1 sphingomyelin, 2 aminoacids, 5 nucleosides, 2 nucleotides, 1 carboxylic acid, 1 redox electron carrier, and 1 vitamin. The most noteworthy changes corresponded to the substantially decreased lysoglycerophospholipids, and to the clearly increased FA (16:1n-7/16:0) and MUFA + PUFA/SFA ratios, suggesting enhanced desaturase activity. Hepatic gene expression of Fads1, Fads2, and Pemt, which mediates lipid balance and liver health, was increased by relaxin-2, while mRNA levels of the main regulator of hepatic FA uptake Cd36, and of the essential glycolysis enzyme Gpi, were decreased. Relaxin-2 augmented the hepatic activation of the hepatoprotector and master regulator of energy homeostasis AMPK. Relaxin-2 treatment also rised FADS1, FADS2, and PEMT gene expression in cultured Hep G2 cells. Our results bring to light the hepatic metabolic features stimulated by relaxin, a promising hepatoprotective molecule.	[Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Morana-Fernandez, Sandra; Anido-Varela, Laura; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Inst Biomed Res Santiago de Compostela IDIS SERGA, Cellular & Mol Cardiol Unit, Santiago De Compostela, Spain; [Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Morana-Fernandez, Sandra; Anido-Varela, Laura; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Inst Biomed Res Santiago de Compostela IDIS SERGA, Dept Cardiol, Santiago De Compostela, Spain; [Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Rosello-Lleti, Esther; Portoles, Manuel; Tarazon, Estefania; Lage, Ricardo; Moscoso, Isabel; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Inst Hlth Carlos III, CIBERCV, Madrid, Spain; [Morana-Fernandez, Sandra; Lage, Ricardo; Moscoso, Isabel] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Cardiol Grp, Santiago De Compostela, Spain; [Morana-Fernandez, Sandra; Lage, Ricardo; Moscoso, Isabel] Univ Clin Hosp Santiago de Compostela, Hlth Res Inst, Santiago De Compostela, Spain; [Rosello-Lleti, Esther; Portoles, Manuel; Tarazon, Estefania] La Fe Univ Hosp IIS La Fe, Cardiocirculatory Unit, Hlth Inst, Valencia, Spain; [Barral, Luis] Univ A Coruna, Polytech Univ, Dept Phys & Earth Sci, Polymers Res Grp,Sch Serantes, Ferrol, Spain; [Bani, Daniele] Univ Florence, Dept Expt & Clin Med, Res Unit Histol & Embryol, Florence, Italy; [Bigazzi, Mario] Prosperius Inst, Endocrine Sect, Florence, Italy; [Gualillo, Oreste] Santiago Univ Clin Hosp, SERGAS Serv Galego Saude, NEIRID Lab Neuroendocrine Interact Rheumatol & In, Res Lab 9, Santiago De Compostela, Spain; [Gualillo, Oreste] Santiago Univ Clin Hosp, IDIS Inst Invest Sanitaria Santiago, NEIRID Lab Neuroendocrine Interact Rheumatol & In, Res Lab 9, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade da Coruna; Universidad Politecnica de Madrid; University of Florence; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Feijoo-Bandin, S (corresponding author), Hosp Clin Univ Santiago de Compostela, Unidad Invest Cardiol Celular & Mol 7, Inst Invest Sanitarias Santiago de Compostela IDI, Planta 2,Edificio Consultas Externas, Santiago De Compostela 15706, Spain.	Sandra.Feijoo.Bandin@sergas.es	Moscoso, Isabel/GXZ-9513-2022; Tarazón, Estefanía/D-6950-2017; Roselló Lletí, Esther/ABG-8503-2020; Aragon Herrera, Alana/GRE-9069-2022; PORTOLES, MANUEL/B-4789-2009; barral, luis/L-8737-2015	Moscoso, Isabel/0000-0002-6078-4666; Tarazón, Estefanía/0000-0003-3466-2558; Roselló Lletí, Esther/0000-0003-2627-6104; PORTOLES, MANUEL/0000-0002-4415-7160; barral, luis/0000-0002-3421-0239; Feijoo-Bandin, Sandra/0000-0002-3739-5806; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Aragon Herrera, Alana/0000-0003-3089-0684	Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Fondo de Investigaciones Sanitarias Instituto de Salud Carlos III [PI15/00681, PI17/00409, PI18/00821]; RETICS Programme [RD16/0012/0014]; CIBERCV; EC | European Regional Development Fund (ERDF); European Union Framework MSCA-RISE-H2020 Programme [734899]; GAIN-Xunta de Galicia; FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain); Spanish PFIS Program of the Instituto de Salud Carlos III (ISCIII) (Spain)	Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Fondo de Investigaciones Sanitarias Instituto de Salud Carlos III(Instituto de Salud Carlos III); RETICS Programme; CIBERCV; EC | European Regional Development Fund (ERDF); European Union Framework MSCA-RISE-H2020 Programme; GAIN-Xunta de Galicia; FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain); Spanish PFIS Program of the Instituto de Salud Carlos III (ISCIII) (Spain)	Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III, Grant/Award Number: PI15/00681, PI17/00409, PI18/00821, RETICS Programme RD16/0012/0014 and CIBERCV; EC | European Regional Development Fund (ERDF); European Union Framework MSCA-RISE-H2020 Programme, Grant/Award Number: Project number 734899; Predoctoral research grants from GAIN-Xunta de Galicia and FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain); Predoctoral research grant from Spanish PFIS Program of the Instituto de Salud Carlos III (ISCIII) (Spain); Predoctoral research grant from GAIN-Xunta de Galicia	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Akazawa Y, 2018, J GASTROENTEROL, V53, P893, DOI 10.1007/s00535-018-1451-5; Aragon-Herrera A, 2018, ENDOCRINE, V60, P103, DOI 10.1007/s12020-018-1534-3; Aragon-Herrera A, 2019, PHARMACOL RES, V144, P51, DOI 10.1016/j.phrs.2019.04.009; Araya J, 2010, OBESITY, V18, P1460, DOI 10.1038/oby.2009.379; Arendt BM, 2013, APPL PHYSIOL NUTR ME, V38, P334, DOI 10.1139/apnm-2012-0261; Bani D, 2001, HORM METAB RES, V33, P175, DOI 10.1055/s-2001-14935; Bani D, 2020, DRUG DISCOV TODAY, V25, P1239, DOI 10.1016/j.drudis.2020.04.014; Bani D, 2012, CURR DIABETES REV, V8, P329, DOI 10.2174/157339912802083487; Barr J, 2012, J PROTEOME RES, V11, P2521, DOI 10.1021/pr201223p; Bartrons R, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00331; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Bennett RG, 2014, LIVER INT, V34, P416, DOI 10.1111/liv.12247; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Chiappini F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46658; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Clarke JD, 2014, DIGEST DIS SCI, V59, P365, DOI 10.1007/s10620-013-2873-9; Coliva G, 2020, MOLECULES, V25, DOI 10.3390/molecules25081925; Delgado GE, 2017, J CLIN LIPIDOL, V11, P126, DOI 10.1016/j.jacl.2016.10.015; Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Fausther M, 2018, AM J PHYSIOL-GASTR L, V315, pG12, DOI 10.1152/ajpgi.00006.2018; Feijoo-Bandin S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00599; Fondevila MF, 2021, HEPATOLOGY, V73, P606, DOI 10.1002/hep.31290; Greenhill C, 2015, NAT REV ENDOCRINOL, V13, P249, DOI [10.1038/nrendo.2017.38, 10.1038/nrendo.2015.40]; Gromovsky AD, 2018, ARTERIOSCL THROM VAS, V38, P218, DOI 10.1161/ATVBAHA.117.309660; Halls ML, 2007, BRIT J PHARMACOL, V150, P677, DOI 10.1038/sj.bjp.0707140; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; Hirsova P, 2016, J LIPID RES, V57, P1758, DOI 10.1194/jlr.R066357; Hu MY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10893-8; Huang X, 2019, AUTOPHAGY, V15, P1258, DOI 10.1080/15548627.2019.1580105; Ichiba M, 2003, LIVER INT, V23, P338, DOI 10.1034/j.1478-3231.2003.00868.x; Jiang S, 2017, AGEING RES REV, V38, P18, DOI 10.1016/j.arr.2017.07.001; Jimenez-Castro MB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071785; Ju CH, 2019, BIOCHEM BIOPH RES CO, V511, P531, DOI 10.1016/j.bbrc.2019.02.091; Key CCC, 2020, J LIPID RES, V61, P1075, DOI 10.1194/jlr.RA120000760; Ko SH, 2014, BIOCHEM BIOPH RES CO, V443, P610, DOI 10.1016/j.bbrc.2013.12.018; Lee KC, 2019, LAB INVEST, V99, P1203, DOI 10.1038/s41374-019-0240-y; Li Lei O, 2010, Mol Endocrinol, V24, P657, DOI 10.1210/me.2009-0152; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lin HY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101298; Marra F, 2018, J HEPATOL, V68, P280, DOI 10.1016/j.jhep.2017.11.014; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Martinez-Arranz I, 2015, J PROTEOMICS, V127, P275, DOI 10.1016/j.jprot.2015.01.019; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Musso G, 2018, GASTROENTEROLOGY, V155, P282, DOI 10.1053/j.gastro.2018.06.031; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nazeer SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29370-1; Parikh A, 2013, CIRC RES, V113, P313, DOI 10.1161/CIRCRESAHA.113.301646; Patel DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177953; Qi SW, 2017, CLIN CHIM ACTA, V473, P89, DOI 10.1016/j.cca.2017.08.022; Rey E, 2020, LIVER INT, V40, P2553, DOI 10.1111/liv.14519; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Simon J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010040; Summers RJ, 2017, BRIT J PHARMACOL, V174, P915, DOI 10.1111/bph.13778; Svegliati-Baroni G, 2019, FREE RADICAL BIO MED, V144, P293, DOI 10.1016/j.freeradbiomed.2019.05.029; Tessari P, 2010, CURR OPIN CLIN NUTR, V13, P81, DOI 10.1097/MCO.0b013e32833383af; Unemori E, 2017, BRIT J PHARMACOL, V174, P921, DOI 10.1111/bph.13695; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wan S, 2019, FASEB J, V33, P10986, DOI 10.1096/fj.201900679R; Williams EJ, 2001, GUT, V49, P577, DOI 10.1136/gut.49.4.577; Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866; Zdralevic M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00313; Zhang Y, 2019, BIOANALYSIS, V11, P1003, DOI 10.4155/bio-2018-0319; Zhao P, 2020, SCIENCE, V367, P652, DOI 10.1126/science.aay0542	67	0	0	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21737	10.1096/fj.202002620RR	http://dx.doi.org/10.1096/fj.202002620RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143495				2022-12-28	WOS:000667814100087
J	Hernandez-Gonzalez, T; Gonzalez-Barrio, R; Escobar, C; Madrid, JA; Periago, MJ; Collado, MC; Scheer, FAJL; Garaulet, M				Hernandez-Gonzalez, Teresa; Gonzalez-Barrio, Rocio; Escobar, Carolina; Antonio Madrid, Juan; Jesus Periago, Maria; Carmen Collado, Maria; Scheer, Frank A. J. L.; Garaulet, Marta			Timing of chocolate intake affects hunger, substrate oxidation, and microbiota: A randomized controlled trial	FASEB JOURNAL			English	Article						circadian; chocolate; energy balance; glucose control; microbiota	DARK-CHOCOLATE; BLOOD-PRESSURE; WEIGHT-LOSS; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; COCOA CONSUMPTION; GLUCOSE-TOLERANCE; BODY-WEIGHT; FATTY-ACID; OBESITY	Eating chocolate in the morning or in the evening/at night, may differentially affect energy balance and impact body weight due to changes in energy intake, substrate oxidation, microbiota (composition/function), and circadian-related variables. In a randomized controlled trial, postmenopausal females (n = 19) had 100 g of chocolate in the morning (MC), in the evening/at night (EC), or no chocolate (N) for 2 weeks and ate any other food ad libitum. Our results show that 14 days of chocolate intake did not increase body weight. Chocolate consumption decreased hunger and desire for sweets (P < .005), and reduced ad libitum energy intake by similar to 300 kcal/day during MC and similar to 150 kcal/day during EC (P = .01), but did not fully compensate for the extra energy contribution of chocolate (542 kcal/day). EC increased physical activity by +6.9%, heat dissipation after meals +1.3%, and carbohydrate oxidation by +35.3% (P < .05). MC reduced fasting glucose (4.4%) and waist circumference (-1.7%) and increased lipid oxidation (+25.6%). Principal component analyses showed that both timings of chocolate intake resulted in differential microbiota profiles and function (P < .05). Heat map of wrist temperature and sleep records showed that EC induced more regular timing of sleep episodes with lower variability of sleep onset among days than MC (60 min vs 78 min; P = .028). In conclusion, having chocolate in the morning or in the evening/night results in differential effects on hunger and appetite, substrate oxidation, fasting glucose, microbiota (composition and function), and sleep and temperature rhythms. Results highlight that the "when" we eat is a relevant factor to consider in energy balance and metabolism.	[Hernandez-Gonzalez, Teresa; Antonio Madrid, Juan; Garaulet, Marta] Univ Murcia, Dept Physiol, Reg Campus Int Excellence, Murcia, Spain; [Hernandez-Gonzalez, Teresa; Gonzalez-Barrio, Rocio; Antonio Madrid, Juan; Jesus Periago, Maria; Garaulet, Marta] Univ Clin Hosp, Biomed Res Inst Murcia, IMIB Arrixaca UMU, Murcia, Spain; [Gonzalez-Barrio, Rocio; Jesus Periago, Maria] Univ Murcia, Fac Vet Sci, Dept Food Technol Food Sci & Nutr, Reg Campus Int Excellence, Murcia, Spain; [Escobar, Carolina] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Mexico City, DF, Mexico; [Carmen Collado, Maria] Inst Agrochem & Food Technol Natl Res Council IAT, Paterna, Spain; [Scheer, Frank A. J. L.; Garaulet, Marta] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Scheer, Frank A. J. L.; Garaulet, Marta] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA	University of Murcia; University of Murcia; Universidad Nacional Autonoma de Mexico; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Scheer, FAJL (corresponding author), Harvard Med Sch, Dept Med, Div Sleep Med, Boston, MA 02115 USA.; Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Campus Espinardo S-N, Murcia 30100, Spain.	fscheer@bwh.harvard.edu; garaulet@um.es	COLLADO, MARIA CARMEN/H-4924-2012; Periago, María Jesús/K-5251-2017; Scheer, Frank A.J.L./C-2795-2012; Gonzalez-Barrio, Rocio/F-2180-2018	COLLADO, MARIA CARMEN/0000-0002-6204-4864; Scheer, Frank A.J.L./0000-0002-2014-7582; Garaulet, Marta/0000-0002-4066-3509; Gonzalez-Barrio, Rocio/0000-0002-6648-5229	Ministry of Science, Innovation and Universities (MICINN) [SAF2017-84135-R, RTI2018-097982-B-I00]; FEDER; Autonomous Community of the Region of Murcia through the Seneca Foundation [20795/PI/18]; NIDDK [R01DK105072]; NIH [R01DK105072, R01HL094806, R01HL118601, R01DK099512, R01DK102696]	Ministry of Science, Innovation and Universities (MICINN)(Spanish Government); FEDER(European Commission); Autonomous Community of the Region of Murcia through the Seneca Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Ministry of Science, Innovation and Universities (MICINN) (SAF2017-84135--R) including FEDER co--funding; The Autonomous Community of the Region of Murcia through the Seneca Foundation (20795/PI/18) and NIDDK R01DK105072 granted to M.G.; M.C.C. acknowledges the support from the Ministry of Science, Innovation and Universities (MICINN) (RTI2018--097982--B--I00); F.A.J.L.S. was supported in part by NIH grants R01HL094806, R01HL118601, R01DK099512, R01DK102696, and R01DK105072 (to F.A.J.L.S.)	Ali F, 2016, EUR J LIPID SCI TECH, V118, P564, DOI 10.1002/ejlt.201400581; AMELINK GJ, 1990, ACTA PHYSIOL SCAND, V138, P115, DOI 10.1111/j.1748-1716.1990.tb08823.x; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709; Bandin C, 2015, INT J OBESITY, V39, P828, DOI 10.1038/ijo.2014.182; Blancas A, 2014, NEUROSCIENCE, V281, P44, DOI 10.1016/j.neuroscience.2014.09.036; Bonmati-Carrion MA, 2015, CHRONOBIOL INT, V32, P701, DOI 10.3109/07420528.2015.1016613; Canfora EE, 2015, CURR OPIN CLIN NUTR, V18, P395, DOI 10.1097/MCO.0000000000000184; Collado MC, 2018, FASEB J, V32, P2060, DOI 10.1096/fj.201700697RR; Chaudhary PP, 2018, APPL MICROBIOL BIOT, V102, P3095, DOI 10.1007/s00253-018-8871-2; Corbalan-Tutau MD, 2015, CLIN NUTR, V34, P477, DOI 10.1016/j.clnu.2014.05.007; Dashti HS, 2019, ADV NUTR, V10, P606, DOI 10.1093/advances/nmy131; Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Di Renzo GC, 2012, J MATERN-FETAL NEO M, V25, P1860, DOI 10.3109/14767058.2012.683085; DULLOO AG, 1986, INT J OBESITY, V10, P467; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Escobar C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63227-w; FROIDEVAUX F, 1993, AM J CLIN NUTR, V57, P35, DOI 10.1093/ajcn/57.1.35; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Garcia-Alonso FJ, 2017, FOOD FUNCT, V8, P3542, DOI [10.1039/c7fo00393e, 10.1039/C7FO00393E]; Garcia-Mantrana I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00890; Grassi D, 2005, AM J CLIN NUTR, V81, P611; Greenberg JA, 2016, AM J CLIN NUTR, V104, P613, DOI 10.3945/ajcn.115.129783; Greenberg JA, 2015, OBESITY, V23, P677, DOI 10.1002/oby.20983; Greenberg JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070271; Guerrero-Vargas NN, 2018, P NUTR SOC, V77, P199, DOI 10.1017/S0029665117004128; Harper A, 2007, BRIT J NUTR, V97, P579, DOI 10.1017/S0007114507339846; Hatayama H, 2007, BIOCHEM BIOPH RES CO, V356, P599, DOI 10.1016/j.bbrc.2007.03.025; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Ibero-Baraibar I, 2014, NUTR METAB CARDIOVAS, V24, P416, DOI 10.1016/j.numecd.2013.09.017; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Kord-Varkaneh H, 2019, CRIT REV FOOD SCI, V59, P2349, DOI 10.1080/10408398.2018.1451820; Kuijer RG, 2015, PSYCHOL HEALTH, V30, P203, DOI 10.1080/08870446.2014.960414; Latif R, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00011; LELO A, 1986, BRIT J CLIN PHARMACO, V22, P177, DOI 10.1111/j.1365-2125.1986.tb05246.x; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Lopez-Minguez J, 2015, CHRONOBIOL INT, V32, P71, DOI 10.3109/07420528.2014.955186; Lunsford-Avery JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32402-5; Magrone T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00677; Marsh CE, 2017, APPETITE, V116, P544, DOI 10.1016/j.appet.2017.05.050; Mellor DD, 2015, J AGR FOOD CHEM, V63, P9910, DOI 10.1021/acs.jafc.5b00776; Muller KE., 1988, APPL REGRESSION ANAL, P718; Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457; Nickols-Richardson SM, 2014, NUTR RES PRACT, V8, P695, DOI 10.4162/nrp.2014.8.6.695; Njike VY, 2011, INT J CARDIOL, V149, P83, DOI 10.1016/j.ijcard.2009.12.010; Oliveira D, 2017, J FUNCT FOODS, V37, P390, DOI 10.1016/j.jff.2017.08.010; Ormsbee MJ, 2016, APPL PHYSIOL NUTR ME, V41, P719, DOI 10.1139/apnm-2015-0526; Purdom T, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0207-1; Qian, 2020, AM J CLIN NUTR, V113, P154; Ramos S, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040084; Ruiz-Lozano T, 2016, CLIN NUTR, V35, P1308, DOI 10.1016/j.clnu.2016.02.007; Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848; Sayon-Orea C, 2013, OBESITY FACTS, V6, P337, DOI 10.1159/000354746; Shostak A, 2013, ADIPOCYTE, V2, P201, DOI 10.4161/adip.26007; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Strat KM, 2016, J NUTR BIOCHEM, V35, P1, DOI 10.1016/j.jnutbio.2015.12.008; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; TARKA SM, 1983, CLIN PHARMACOL THER, V34, P546, DOI 10.1038/clpt.1983.212; Taubert D, 2007, JAMA-J AM MED ASSOC, V298, P49, DOI 10.1001/jama.298.1.49; TRICHOPOULOS D, 1987, LANCET, V2, P269; Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075; VALLERAND AL, 1993, INT J OBESITY, V17, pS53; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; Varela Moreiras G, 2008, VALORACION DIETA ESP; Wehrens SMT, 2017, CURR BIOL, V27, P1768, DOI 10.1016/j.cub.2017.04.059; West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912; WISHNOFSKY M, 1958, AM J CLIN NUTR, V6, P542, DOI 10.1093/ajcn/6.5.542; Yamashita Y, 2018, J NUTR SCI VITAMINOL, V64, P151, DOI 10.3177/jnsv.64.151; Yoon HS, 2016, J NUTR, V146, P46, DOI 10.3945/jn.115.217711; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	74	4	4	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21649	10.1096/fj.202002770RR	http://dx.doi.org/10.1096/fj.202002770RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34164846	Green Published, hybrid			2022-12-28	WOS:000667814100066
J	Jin, XD; Liu, WY; Miao, J; Tai, ZP; Li, LY; Guan, PP; Liu, JX				Jin, XiaoDong; Liu, WenYe; Miao, Jing; Tai, ZhiPeng; Li, LingYa; Guan, PengPeng; Liu, Jing-Xia			Copper ions impair zebrafish skeletal myofibrillogenesis via epigenetic regulation	FASEB JOURNAL			English	Article						Cu2+; histone protein; methylation; myofibrillogenesis; smyd1b; smyd5	TRANSCRIPTIONAL RESPONSES; HISTONE METHYLTRANSFERASE; MUSCLE; DEFICIENCY; MECHANISMS; SMYD1	Unbalanced copper (Cu2+) homeostasis is associated with the developmental defects of vertebrate myogenesis, but the underlying molecular mechanisms remain elusive. In this study, it was found that Cu2+ stressed zebrafish embryos and larvae showed reduced locomotor speed as well as loose and decreased myofibrils in skeletal muscle, coupled with the downregulated expression of muscle fiber markers mylpfa and smyhc1l and the irregular arrangement of myofibril and sarcomere. Meanwhile, the Cu2+ stressed zebrafish embryos and larvae also showed significant reduction in the expression of H3K4 methyltransferase smyd1b transcripts and H3K4me3 protein as well as in the binding enrichment of H3K4me3 on gene mylpfa promoter in skeletal muscle cells, suggesting that smyd1b-H3K4me3 axis mediates the Cu2+-induced myofibrils specification defects. Additionally, whole genome DNA methylation sequencing unveiled that the gene smyd5 exhibited significant promoter hyper-methylation and increased expression in Cu2+ stressed embryos, and the ectopic expression of smyd5 in zebrafish embryos also induced the myofibrils specification defects as those observed in Cu2+ stressed embryos. Moreover, Cu2+ was shown to suppress myofibrils specification and smyd1b promoter transcriptional activity directly independent of the integral function of copper transporter cox17 and atp7b. All these data may shed light on the linkage of unbalanced copper homeostasis with specific gene promoter methylation and epigenetic histone protein modification as well as the resultant signaling transduction and the myofibrillogenesis defects.	[Jin, XiaoDong; Liu, WenYe; Miao, Jing; Tai, ZhiPeng; Li, LingYa; Liu, Jing-Xia] Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan 430070, Peoples R China; [Guan, PengPeng] Huazhong Agr Univ, Coll Informat, Hubei Engn Technol Res Ctr Agr Big Data, Agr Bioinformat Key Lab Hubei Prov, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Liu, JX (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan 430070, Peoples R China.	ichliu@mail.hzau.edu.cn			National Natural Science Foundation of China [32070807]; National Key R&D Program of China [2018YFD0900101, 2662018JC024]; Fundamental Research Funds for the Central University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Fundamental Research Funds for the Central University	This work was supported by the National Natural Science Foundation of China (Program No. 32070807 to J.--X. L.), by the National Key R&D Program of China (2018YFD0900101), and by the project 2662018JC024 of the Fundamental Research Funds for the Central University (to J.--X. L.)	Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Attar N, 2020, SCIENCE, V369, P59, DOI 10.1126/science.aba8740; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P217, DOI 10.1081/CLT-100102421; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Brero A, 2009, CLONING STEM CELLS, V11, P319, DOI 10.1089/clo.2008.0083; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cai MX, 2019, FASEB J, V33, P6209, DOI 10.1096/fj.201801578R; Chen MY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02599; Coda DM, 2015, CELL CYCLE, V14, P1389, DOI 10.1080/15384101.2015.1005993; Coughlin DJ, 1999, BIOL BULL, V196, P145, DOI 10.2307/1542560; Fanni D, 2014, CURR MED CHEM, V21, P3768, DOI 10.2174/0929867321666140601163244; Fujii T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29157; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kidder BL, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0115-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar N, 2006, MAYO CLIN PROC, V81, P1371, DOI 10.4065/81.10.1371; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Liu JX, 2017, BBA-GENE REGUL MECH, V1860, P1103, DOI 10.1016/j.bbagrm.2017.09.001; Liu JX, 2013, DEVELOPMENT, V140, P1067, DOI 10.1242/dev.086157; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Marques JP., 2007, APPL STAT USING SPSS; Molitor AM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004091; Myhre JL, 2014, DEV BIOL, V390, P26, DOI 10.1016/j.ydbio.2014.02.022; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Prohaska JR, 2014, ANN NY ACAD SCI, V1314, P1, DOI 10.1111/nyas.12354; ROME LC, 1990, J EXP BIOL, V154, P163; ROME LC, 1984, AM J PHYSIOL, V247, pR272, DOI 10.1152/ajpregu.1984.247.2.R272; Sadeghifar F, 2015, NUCLEIC ACIDS RES, V43, P4477, DOI 10.1093/nar/gkv312; Schmidt K, 2018, J BIOL CHEM, V293, P20085, DOI 10.1074/jbc.RA118.004889; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Sun HJ, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113364; Tai ZP, 2019, METALLOMICS, V11, P1452, DOI 10.1039/c9mt00125e; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tilton FA, 2011, COMP BIOCHEM PHYS C, V153, P9, DOI 10.1016/j.cbpc.2010.07.008; Tracy CM, 2018, CURR OPIN PHYSIOL, V1, P140, DOI 10.1016/j.cophys.2017.10.001; Wang ZY, 2019, CHEMOSPHERE, V222, P991, DOI 10.1016/j.chemosphere.2019.01.177; Wolman M, 2012, DEV NEUROBIOL, V72, P366, DOI 10.1002/dneu.20872; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang T, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194612; Zhang T, 2015, TOXICOL SCI, V148, P299, DOI 10.1093/toxsci/kfv184; Zhang YJ, 2018, AQUAT TOXICOL, V205, P156, DOI 10.1016/j.aquatox.2018.10.015; Zhang YJ, 2018, J HAZARD MATER, V344, P1057, DOI 10.1016/j.jhazmat.2017.11.039; Zhao G, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00548-3; Zhao G, 2020, METALLOMICS, V12, P12, DOI 10.1039/c9mt00210c	46	4	4	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21686	10.1096/fj.202100183R	http://dx.doi.org/10.1096/fj.202100183R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34101239				2022-12-28	WOS:000667814100054
J	Schnoder, L; Tomic, I; Schwindt, L; Helm, D; Rettel, M; Schulz-Schaeffer, W; Krause, E; Rettig, J; Fassbender, K; Liu, Y				Schnoeder, Laura; Tomic, Inge; Schwindt, Laura; Helm, Dominic; Rettel, Mandy; Schulz-Schaeffer, Walter; Krause, Elmar; Rettig, Jens; Fassbender, Klaus; Liu, Yang			P38 alpha-MAPK phosphorylates Snapin and reduces Snapin-mediated BACE1 transportation in APP-transgenic mice	FASEB JOURNAL			English	Article						Alzheimer's disease; BACE1; mapk14; phosphorylation; Snapin; trafficking	AMYLOID PRECURSOR PROTEIN; RETROGRADE TRANSPORT; BETA-SECRETASE; AXONAL-TRANSPORT; P38 KINASE; TAU; MOUSE; DEGRADATION; INHIBITION; CALCIUM	Amyloid beta peptide (A beta) is the major pathogenic molecule in Alzheimer's disease (AD). BACE1 enzyme is essential for the generation of A beta. Deficiency of p38 alpha-MAPK in neurons increases lysosomal degradation of BACE1 and decreases A beta deposition in the brain of APP-transgenic mice. However, the mechanisms mediating effects of p38 alpha-MAPK are largely unknown. In this study, we used APP-transgenic mice and cultured neurons and observed that deletion of p38 alpha-MAPK specifically in neurons decreased phosphorylation of Snapin at serine, increased retrograde transportation of BACE1 in axons and reduced BACE1 at synaptic terminals, which suggests that p38 alpha-MAPK deficiency promotes axonal transportation of BACE1 from its predominant locations, axonal terminals, to lysosomes in the cell body. In vitro kinase assay revealed that p38 alpha-MAPK directly phosphorylates Snapin. By further performing mass spectrometry analysis and site-directed mutagenic experiments in SH-SY5Y cell lines, we identified serine residue 112 as a p38 alpha-MAPK-phosphorylating site on Snapin. Replacement of serine 112 with alanine did abolish p38 alpha-MAPK knockdown-induced reduction of BACE1 activity and protein level, and transportation to lysosomes in SH-SY5Y cells. Taken together, our study suggests that activation of p38 alpha-MAPK phosphorylates Snapin and inhibits the retrograde transportation of BACE1 in axons, which might exaggerate amyloid pathology in AD brain.	[Schnoeder, Laura; Tomic, Inge; Schwindt, Laura; Fassbender, Klaus; Liu, Yang] Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany; [Schnoeder, Laura; Tomic, Inge; Schwindt, Laura; Fassbender, Klaus; Liu, Yang] Saarland Univ, German Inst Dementia Prevent DIDP, Homburg, Germany; [Helm, Dominic; Rettel, Mandy] European Mol Biol Lab, Prote Core Facil, Heidelberg, Germany; [Schulz-Schaeffer, Walter] Saarland Univ, Dept Neuropathol, Homburg, Germany; [Krause, Elmar; Rettig, Jens] Saarland Univ, Ctr Integrat Physiol & Mol Med CIPMM, Cellular Neurophysiol, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; European Molecular Biology Laboratory (EMBL); Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Schnoder, L; Liu, Y (corresponding author), Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany.	Laura.Schnoeder@uks.eu; a.liu@mx.uni-saarland.de	Liu, Yang/GSD-5476-2022	Liu, Yang/0000-0002-7614-4233; Fassbender, Klaus/0000-0003-3596-868X	Alzheimer Forschung Initiative e.V. [17046]; Deutsche Forschungsgemeinschaft (DFG) [LI1725/2--1]	Alzheimer Forschung Initiative e.V.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Alzheimer Forschung Initiative e.V. (#17046; to LS) and Deutsche Forschungsgemeinschaft (DFG) (LI1725/2--1; to Y. L.)	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Butzlaff M, 2015, HUM MOL GENET, V24, P3623, DOI 10.1093/hmg/ddv107; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Cai QA, 2010, NEURON, V68, P73, DOI 10.1016/j.neuron.2010.09.022; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Decker Y, 2018, BRAIN STRUCT FUNCT, V223, P1001, DOI 10.1007/s00429-017-1595-8; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Feng TC, 2017, J BIOL CHEM, V292, P1679, DOI 10.1074/jbc.M116.766584; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Ruan QT, 2020, J NEUROSCI, V40, P107, DOI 10.1523/JNEUROSCI.1808-19.2019; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Schmidt T, 2013, CELL CALCIUM, V54, P105, DOI 10.1016/j.ceca.2013.05.003; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Schnoder ML, 2020, FASEB J, V34, P9628, DOI 10.1096/fj.201902731RR; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tammineni P, 2017, AUTOPHAGY, V13, P982, DOI 10.1080/15548627.2017.1291114; Tammineni P, 2017, ELIFE, V6, DOI 10.7554/eLife.21776; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wolff S, 2006, FEBS LETT, V580, P6477, DOI 10.1016/j.febslet.2006.10.068; Xie K, 2013, NEUROBIOL AGING, V34, P2389, DOI 10.1016/j.neurobiolaging.2013.04.013; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Ye X, 2017, J NEUROSCI, V37, P2639, DOI 10.1523/JNEUROSCI.2851-16.2017; Ye X, 2014, CELL REP, V6, P24, DOI 10.1016/j.celrep.2013.12.008; Yun HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.68; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880	48	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21691	10.1096/fj.202100017R	http://dx.doi.org/10.1096/fj.202100017R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118085	Green Published, hybrid			2022-12-28	WOS:000667814100067
J	Krishnathas, GM; Strodke, B; Mittmann, L; Zech, T; Berger, LM; Reichel, CA; Rosser, S; Schmid, T; Knapp, S; Muller, S; Bracher, F; Furst, R; Bischoff-Kont, I				Krishnathas, G. Melissa; Stroedke, Benjamin; Mittmann, Laura; Zech, Thomas; Berger, Lena M.; Reichel, Christoph A.; Rosser, Silvia; Schmid, Tobias; Knapp, Stefan; Muller, Susanne; Bracher, Franz; Furst, Robert; Bischoff-Kont, Iris			C81-evoked inhibition of the TNFR1-NF kappa B pathway during inflammatory processes for stabilization of the impaired vascular endothelial barrier for leukocytes	FASEB JOURNAL			English	Article						carbazole derivative C81; endothelial cells; inflammation; protein translation; ubiquitination	NF-KAPPA-B; ADHESION MOLECULES; CELL-INTERACTIONS; ANNOMONTINE; SELECTIVITY; ACTIVATION; MECHANISMS; ALPHA	Chronic inflammation-related diseases are characterized by persistent leukocyte infiltration into the underlying tissue. The vascular endothelium plays a major role in this pathophysiological condition. Only few therapeutic strategies focus on the vascular endothelium as a major target for an anti-inflammatory approach. In this study, we present the natural compound-derived carbazole derivative C81 as chemical modulator interfering with leukocyte-endothelial cell interactions. An in vivo assay employing intravital microscopy to monitor leukocyte trafficking after C81 treatment in postcapillary venules of a murine cremaster muscle was performed. Moreover, in vitro assays using HUVECs and monocytes were implemented. The impact of C81 on cell adhesion molecules and the NF kappa B signaling cascade was analyzed in vitro in endothelial cells. Effects of C81 on protein translation were determined by incorporation of a puromycin analog-based approach and polysome profiling. We found that C81 significantly reduced TNF-activated leukocyte trafficking in postcapillary venules. Similar results were obtained in vitro when C81 reduced leukocyte-endothelial cell interactions by down-regulating cell adhesion molecules. Focusing on the NF kappa B signaling cascade, we found that C81 reduced the activation on multiple levels of the cascade through promoted I kappa B alpha recovery by attenuation of I kappa B alpha ubiquitination and through reduced protein levels of TNFR1 caused by protein translation inhibition. We suggest that C81 might represent a promising lead compound for interfering with inflammation-related processes in endothelial cells by down-regulation of I kappa B alpha ubiquitination on the one hand and inhibition of translation on the other hand without exerting cytotoxic effects.	[Krishnathas, G. Melissa; Zech, Thomas; Furst, Robert; Bischoff-Kont, Iris] Goethe Univ, Inst Pharmaceut Biol, Frankfurt, Germany; [Stroedke, Benjamin; Bracher, Franz] Ludwig Maximilians Univ Munchen, Dept Pharm, Ctr Drug Res, Munich, Germany; [Mittmann, Laura; Reichel, Christoph A.] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol, Munich, Germany; [Mittmann, Laura; Reichel, Christoph A.] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med, Munich, Germany; [Berger, Lena M.; Knapp, Stefan; Muller, Susanne] Goethe Univ, Inst Pharmaceut Chem, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Rosser, Silvia; Schmid, Tobias] Goethe Univ, Inst Biochem, Fac Med, Frankfurt, Germany	Goethe University Frankfurt; University of Munich; University of Munich; University of Munich; Goethe University Frankfurt; Goethe University Frankfurt	Bischoff-Kont, I (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Biol, Max von Laue Str 9, D-60438 Frankfurt, Germany.	i.bischoff@em.uni-frankfurt.de	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Schmid, Tobias/0000-0002-1952-5259; Berger, Lena Marie/0000-0002-7835-8067; Furst, Robert/0000-0002-9926-7578	Deutsche Forschungsgemeinschaft (DFG) [GRK 2336]; Innovative Medicines Initiative 2 Joint Undertaking [875510]; Sonderforschungsbereich (SFB) 914 of DFG; Structural Genomics Consortium at the Goethe University Frankfurt (SGC Frankfurt)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Innovative Medicines Initiative 2 Joint Undertaking; Sonderforschungsbereich (SFB) 914 of DFG(German Research Foundation (DFG)); Structural Genomics Consortium at the Goethe University Frankfurt (SGC Frankfurt)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: GRK 2336; Structural Genomics Consortium at the Goethe University Frankfurt (SGC Frankfurt); Innovative Medicines Initiative 2 Joint Undertaking, Grant/Award Number: 875510; Sonderforschungsbereich (SFB) 914 of DFG, Grant/Award Number: project B03 to C.A.R.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Azab A, 2016, MOLECULES, V21, DOI 10.3390/molecules21101321; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Blees JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046567; Brautigam J, 2019, J MOL CELL CARDIOL, V135, P97, DOI 10.1016/j.yjmcc.2019.08.001; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Rejon-Orantes JDC, 2011, PLANTA MED, V77, P322, DOI 10.1055/s-0030-1250406; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Frampton JE, 2018, BIODRUGS, V32, P507, DOI 10.1007/s40259-018-0307-0; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Giridharan S, 2018, J INFLAMM RES, V11, P407, DOI 10.2147/JIR.S140188; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hoffman AM, 2019, J BIOL CHEM, V294, P8942, DOI 10.1074/jbc.RA119.007996; Huang HL, 2015, ONCOTARGET, V6, P995, DOI 10.18632/oncotarget.2739; Huang MT., 1975, MOL PHARMACOL, V11, p511; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jagannath S, 2004, BRIT J HAEMATOL, V127, P165, DOI 10.1111/j.1365-2141.2004.05188.x; Jain J, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0147-4; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Laham-Karam N, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00276; Lamb YN, 2017, BIODRUGS, V31, P461, DOI 10.1007/s40259-017-0240-7; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li YYY, 2008, CLIN DERMATOL, V26, P527, DOI 10.1016/j.clindermatol.2007.11.002; Mateus A, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20199232; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Picado A, 2020, J MED CHEM, V63, P14626, DOI 10.1021/acs.jmedchem.0c01174; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Ramos GP, 2019, MAYO CLIN PROC, V94, P155, DOI 10.1016/j.mayocp.2018.09.013; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Scholz A, 2020, CELL MOL LIFE SCI, V77, P2017, DOI 10.1007/s00018-019-03265-4; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Stark A, 2019, FASEB J, V33, P8771, DOI 10.1096/fj.201802440R; Strodke B, 2015, ARCH PHARM, V348, P125, DOI 10.1002/ardp.201400328; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Totzke J, 2017, CELL CHEM BIOL, V24, P1029, DOI 10.1016/j.chembiol.2017.07.011; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Vasta JD, 2018, CELL CHEM BIOL, V25, P206, DOI 10.1016/j.chembiol.2017.10.010; Verhamme P, 2006, ACTA CLIN BELG, V61, P213, DOI 10.1179/acb.2006.036; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200; Yung R L, 2001, Curr Opin Investig Drugs, V2, P216; Zhang W, 2014, FEBS LETT, V588, P356, DOI 10.1016/j.febslet.2013.11.003	53	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21656	10.1096/fj.202100037R	http://dx.doi.org/10.1096/fj.202100037R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042211				2022-12-28	WOS:000655695900028
J	Rendina, DN; Lubach, GR; Lyte, M; Phillips, GJ; Gosain, A; Pierre, JF; Vlasova, RM; Styner, MA; Coe, CL				Rendina, Danielle N.; Lubach, Gabriele R.; Lyte, Mark; Phillips, Gregory J.; Gosain, Ankush; Pierre, Joseph F.; Vlasova, Roza M.; Styner, Martin A.; Coe, Christopher L.			Proteobacteria abundance during nursing predicts physical growth and brain volume at one year of age in young rhesus monkeys	FASEB JOURNAL			English	Article						breast feeding; gut microbiome; infant development; neuroimaging; Proteobacteria	INTESTINAL MICROBIOTA; GUT MICROBIOTA; HUMAN-MILK; VAGINAL MICROBIOME; DELIVERY MODE; INFANT; OLIGOSACCHARIDES; TRANSMISSION; ASSOCIATION; DISCOVERY	Over the last decade, multiple studies have highlighted the essential role of gut microbiota in normal infant development. However, the sensitive periods during which gut bacteria are established and become associated with physical growth and maturation of the brain are still poorly defined. This study tracked the assembly of the intestinal microbiota during the initial nursing period, and changes in community structure after transitioning to solid food in infant rhesus monkeys (Macaca mulatta). Anthropometric measures and rectal swabs were obtained at 2-month intervals across the first year of life and bacterial taxa identified by 16S rRNA gene sequencing. At 12 months of age, total brain and cortical regions volumes were quantified through structural magnetic resonance imaging. The bacterial community structure was dynamic and characterized by discrete maturational phases, reflecting an early influence of breast milk and the later transition to solid foods. Commensal microbial taxa varied with diet similar to findings in other animals and human infants; however, monkeys differ in the relative abundances of Lactobacilli and Bifidobacteria, two taxa predominant in breastfed human infants. Higher abundances of taxa in the phylum Proteobacteria during nursing were predictive of slower growth trajectories and smaller brain volumes at one year of age. Our findings define discrete phases of microbial succession in infant monkeys and suggest there may be a critical period during nursing when endogenous differences in certain taxa can shift the community structure and influence the pace of physical growth and the maturational trajectory of the brain.	[Rendina, Danielle N.; Lubach, Gabriele R.; Coe, Christopher L.] Univ Wisconsin, Harlow Ctr, Madison, WI USA; [Rendina, Danielle N.] Duke Univ, Dept Psychol & Neurosci, 210 Res Dr,3015 GSRB II, Durham, NC 27710 USA; [Lyte, Mark; Phillips, Gregory J.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Gosain, Ankush] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Gosain, Ankush; Pierre, Joseph F.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Pierre, Joseph F.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Vlasova, Roza M.; Styner, Martin A.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Vlasova, Roza M.; Styner, Martin A.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA	University of Wisconsin System; University of Wisconsin Madison; Duke University; Iowa State University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rendina, DN (corresponding author), Duke Univ, Dept Psychol & Neurosci, 210 Res Dr,3015 GSRB II, Durham, NC 27710 USA.	danielle.rendina@duke.edu	Pierre, Joseph/HCH-3993-2022; VLasova, Roza/AFQ-7077-2022	VLasova, Roza/0000-0002-6455-8949; Styner, Martin/0000-0002-8747-5118; Coe, Christopher/0000-0001-9335-9060; Lyte, Mark/0000-0001-8512-2581; Rendina, Danielle/0000-0003-0150-0886; Gosain, Ankush/0000-0002-0428-1503	HHS | NIH | National Institute of Mental Health (NIMH) [MH104198]	HHS | NIH | National Institute of Mental Health (NIMH)	HHS | NIH | National Institute of Mental Health (NIMH), Grant/Award Number: MH104198	Aakko J, 2017, BENEF MICROBES, V8, P563, DOI 10.3920/BM2016.0185; Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Amaral WZ, 2017, PSYCHOSOM MED, V79, P888, DOI 10.1097/PSY.0000000000000454; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Bokulich NA, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00219-18; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Browne HP, 2017, NAT REV MICROBIOL, V15, P531, DOI 10.1038/nrmicro.2017.50; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chen Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35262-1; Cherel M, 2015, PROC SPIE, V9413, DOI 10.1117/12.2082209; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cunnane SC, 2003, COMP BIOCHEM PHYS A, V136, P17, DOI 10.1016/S1095-6433(03)00048-5; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Leoz MLA, 2015, J PROTEOME RES, V14, P491, DOI 10.1021/pr500759e; Dettmer AM, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.22969; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Goto K, 2010, GLYCOCONJUGATE J, V27, P703, DOI 10.1007/s10719-010-9315-0; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Jasarevic E, 2015, ENDOCRINOLOGY, V156, P3265, DOI 10.1210/en.2015-1177; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057535; Knickmeyer RC, 2010, CEREB CORTEX, V20, P1053, DOI 10.1093/cercor/bhp166; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Luczynski P, 2016, EUR J NEUROSCI, V44, P2654, DOI 10.1111/ejn.13291; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Ma Y, 2017, SAUDI J BIOL SCI, V24, P114, DOI 10.1016/j.sjbs.2016.09.004; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; Madan JC, 2016, JAMA PEDIATR, V170, P212, DOI 10.1001/jamapediatrics.2015.3732; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Martin R, 2007, J APPL MICROBIOL, V103, P2638, DOI 10.1111/j.1365-2672.2007.03497.x; Martin R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158498; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Moossavi S, 2019, CELL HOST MICROBE, V25, P324, DOI 10.1016/j.chom.2019.01.011; Murphy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40597; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Ogbonnaya ES, 2015, BIOL PSYCHIAT, V78, pE7, DOI 10.1016/j.biopsych.2014.12.023; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rendina DN, 2019, J PEDIATR GASTR NUTR, V69, P363, DOI 10.1097/MPG.0000000000002394; Rhoades N, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1789-x; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Scott JA, 2016, BRAIN STRUCT FUNCT, V221, P2847, DOI 10.1007/s00429-015-1076-x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shi YD, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00617; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Shirtcliff EA, 2013, DEV PSYCHOL, V49, P2005, DOI 10.1037/a0032050; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Stilling RM, 2015, BRAIN BEHAV IMMUN, V50, P209, DOI 10.1016/j.bbi.2015.07.009; Stumpf RM, 2013, AM J PHYS ANTHROPOL, V152, P119, DOI 10.1002/ajpa.22395; Tao NA, 2011, J PROTEOME RES, V10, P1548, DOI 10.1021/pr1009367; Thongaram T, 2017, J DAIRY SCI, V100, P7825, DOI 10.3168/jds.2017-12753; Timmerman HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08268-4; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Wright CM, 2004, ARCH DIS CHILD-FETAL, V89, pF254, DOI 10.1136/adc.2003.026906; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang MY, 2019, ANN CLIN MICROB ANTI, V18, DOI 10.1186/s12941-019-0318-9; Zou ZH, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0264-y	74	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21682	10.1096/fj.202002162R	http://dx.doi.org/10.1096/fj.202002162R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042210				2022-12-28	WOS:000655695900056
J	Alexeev, EE; Dowdell, AS; Henen, MA; Lanis, JM; Lee, JS; Cartwright, IM; Schaefer, REM; Ornelas, A; Onyiah, JC; Vogeli, B; Colgan, SP				Alexeev, Erica E.; Dowdell, Alexander S.; Henen, Morkos A.; Lanis, Jordi M.; Lee, J. Scott; Cartwright, Ian M.; Schaefer, Rachel E. M.; Ornelas, Alfredo; Onyiah, Joseph C.; Vogeli, Beat; Colgan, Sean P.			Microbial--derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damage	FASEB JOURNAL			English	Article						colitis; inflammation; microbiota; mucosa; polymorphonuclear leukocyte; tryptophan metabolism	INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; ULCERATIVE-COLITIS; EPITHELIAL BARRIER; OXIDATIVE STRESS; TYROSYL RESIDUES; GUT MICROBIOTA; SYSTEM; ASSOCIATION; RESISTANCE	During episodes of acute inflammation, polymorphonuclear leukocytes (PMNs) are actively recruited to sites of inflammation or injury where they provide anti-microbial and wound-healing functions. One enzyme crucial for fulfilling these functions is myeloperoxidase (MPO), which generates hypochlorous acid from Cl- and hydrogen peroxide. The potential exists, however, that uncontrolled the extracellular generation of hypochlorous acid by MPO can cause bystander tissue damage and inhibit the healing response. Previous work suggests that the microbiota-derived tryptophan metabolites 1H-indole and related molecules ("indoles") are protective during intestinal inflammation, although their precise mechanism of action is unclear. In the present work, we serendipitously discovered that indoles are potent and selective inhibitors of MPO. Using both primary human PMNs and recombinant human MPO in a cell-free system, we revealed that indoles inhibit MPO at physiologic concentrations. Particularly, indoles block the chlorinating activity of MPO, a reliable marker for MPO-associated tissue damage, as measured by coulometric-coupled HPLC. Further, we observed direct interaction between indoles and MPO using the established biochemical techniques microscale thermophoresis and STD-NMR. Utilizing a murine colitis model, we demonstrate that indoles inhibit bystander tissue damage, reflected in decreased colon 3-chlorotyrosine and pro-inflammatory chemokine expression in vivo. Taken together, these results identify microbiota-derived indoles that acts as endogenous immunomodulatory compounds through their actions on MPO, suggesting a symbiotic association between the gut microbiota and host innate immune system. Such findings offer exciting new targets for future pharmacological intervention.	[Alexeev, Erica E.; Dowdell, Alexander S.; Lanis, Jordi M.; Lee, J. Scott; Cartwright, Ian M.; Schaefer, Rachel E. M.; Ornelas, Alfredo; Onyiah, Joseph C.; Colgan, Sean P.] Univ Colorado, Dept Med, Mucosal Inflammat Program, Anschutz Med Campus,12700 East 19th Ave MS B-146, Aurora, CO 80045 USA; [Alexeev, Erica E.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Henen, Morkos A.; Vogeli, Beat] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Henen, Morkos A.] Mansoura Univ, Dept Pharmaceut Organ Chem, Mansoura, Egypt	University of Colorado System; University of Colorado Anschutz Medical Campus; Cedars Sinai Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Egyptian Knowledge Bank (EKB); Mansoura University	Colgan, SP (corresponding author), Univ Colorado, Dept Med, Mucosal Inflammat Program, Anschutz Med Campus,12700 East 19th Ave MS B-146, Aurora, CO 80045 USA.	Sean.Colgan@CUAnschutz.edu	Henen, Morkos/M-5995-2018	Henen, Morkos/0000-0003-4835-5583; Vogeli, Beat/0000-0003-1176-3137; Lee, J. Scott/0000-0001-7151-9828; DOWDELL, ALEXANDER/0000-0002-0513-6623	NIH [DK1047893, DK50189, DK095491, DK103639]; VA Merit [BX002182]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit(US Department of Veterans Affairs)	NIH, Grant/Award Number: DK1047893, DK50189, DK095491 and DK103639; VA Merit, Grant/Award Number: BX002182	Aherne CM, 2015, MUCOSAL IMMUNOL, V8, P1324, DOI 10.1038/mi.2015.22; Alexeev EE, 2018, AM J PATHOL, V188, P1183, DOI 10.1016/j.ajpath.2018.01.011; Arora AK, 2011, ADSORPT SCI TECHNOL, V29, P39, DOI 10.1260/0263-6174.29.1.39; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Barry R, 2020, MUCOSAL IMMUNOL, V13, P322, DOI 10.1038/s41385-019-0235-4; BEAN RC, 1968, J GEN PHYSIOL, V52, P495, DOI 10.1085/jgp.52.3.495; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bendheim PE, 2002, J MOL NEUROSCI, V19, P213, DOI 10.1007/s12031-002-0036-0; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Cartwright IM, 2020, MUCOSAL IMMUNOL, V13, P230, DOI 10.1038/s41385-019-0237-2; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chai WD, 2019, AM J PHYSIOL-ENDOC M, V317, pE1063, DOI 10.1152/ajpendo.00203.2019; Chami B, 2018, ARCH BIOCHEM BIOPHYS, V645, P61, DOI 10.1016/j.abb.2018.03.012; Chen MX, 2019, J FORMOS MED ASSOC, V118, pS10, DOI 10.1016/j.jfma.2018.09.007; Chen Y, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01339-3; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Churg A, 2012, AM J RESP CRIT CARE, V185, P34, DOI 10.1164/rccm.201103-0468OC; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Curtis VF, 2018, MOL BIOL CELL, V29, P2687, DOI 10.1091/mbc.E18-06-0377; Darkoh C, 2019, MSYSTEMS, P4; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; DECHATELET LR, 1976, BLOOD, V47, P545; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeRoche TC, 2014, GASTROENTEROL REP, V2, P178, DOI 10.1093/gastro/gou031; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Dowdell AS, 2020, MOL BIOL CELL, V31, P2249, DOI 10.1091/mbc.E20-05-0291; Ehrlich AM, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-02023-y; Elliott SN, 1998, CAN J GASTROENTEROL, V12, P559, DOI 10.1155/1998/398384; FLIGIEL SEG, 1984, AM J PATHOL, V115, P418; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Fu SL, 2000, J BIOL CHEM, V275, P10851, DOI 10.1074/jbc.275.15.10851; Gao RY, 2021, MUCOSAL IMMUNOL, V14, P479, DOI 10.1038/s41385-020-00347-6; Grigorieva DV, 2016, B EXP BIOL MED+, V161, P495, DOI 10.1007/s10517-016-3446-7; Haselhorst Thomas, 2009, V534, P375, DOI 10.1007/978-1-59745-022-5_26; Heinecke JW, 2014, DIABETES, V63, P4001, DOI 10.2337/db14-1273; Hendrikx T, 2019, J INTERN MED, V286, P32, DOI 10.1111/joim.12892; Herraiz T, 2004, FREE RADICAL RES, V38, P323, DOI 10.1080/10611860310001648167; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; Ilyasov IR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031131; Ji Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051579; Ji Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092062; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Kaur H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01365; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; Khan I, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030126; Kim CH, 2018, IMMUNOLOGY, V154, P220, DOI 10.1111/imm.12930; Krishnan S, 2018, CELL REP, V23, P1099, DOI 10.1016/j.celrep.2018.03.109; Kuenzig ME, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0054-z; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z; Lee JS, 2018, J BIOL CHEM, V293, P6039, DOI 10.1074/jbc.RA117.000269; Levy M, 2016, GENE DEV, V30, P1589, DOI 10.1101/gad.284091.116; LYMAR SV, 1995, CHEM RES TOXICOL, V8, P833, DOI 10.1021/tx00048a003; Manchanda K, 2018, ARTERIOSCL THROM VAS, V38, P1859, DOI 10.1161/ATVBAHA.118.311143; Matijasic M, 2020, INT J MOL SCI, P21; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Meddows-Taylor S, 1999, CLIN DIAGN LAB IMMUN, V6, P345, DOI 10.1128/CDLI.6.3.345-351.1999; Mor M, 2003, ADV EXP MED BIOL, V527, P567; Muthas D, 2017, SCAND J GASTROENTERO, V52, P125, DOI 10.1080/00365521.2016.1235224; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Onyiah JC, 2018, J INNATE IMMUN, V10, P228, DOI 10.1159/000488914; Paoliello-Paschoalato AB, 2014, J IMMUNOL METHODS, V412, P70, DOI 10.1016/j.jim.2014.07.001; Phillipson M, 2019, TRENDS IMMUNOL, V40, P635, DOI 10.1016/j.it.2019.05.001; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rosales C, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1469780; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Shurney D, 2019, AM J HEALTH PROMOT, V33, P821, DOI 10.1177/0890117119845711b; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Strzepa A, 2017, CELL IMMUNOL, V317, P1, DOI 10.1016/j.cellimm.2017.05.002; THOMAS EL, 1979, INFECT IMMUN, V25, P110, DOI 10.1128/IAI.25.1.110-116.1979; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Venkitakrishnan Rani Parvathy, 2012, Methods Mol Biol, V914, P47, DOI 10.1007/978-1-62703-023-6_4; Villanacci V, 2013, WORLD J GASTROENTERO, V19, P968, DOI 10.3748/wjg.v19.i7.968; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; Wang RX, 2020, P NATL ACAD SCI USA, V117, P11648, DOI 10.1073/pnas.1917597117; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wei ZL, 2003, J NEUROSCI RES, V73, P364, DOI 10.1002/jnr.10668; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Ximenes VF, 2005, BRAZ J MED BIOL RES, V38, P1575, DOI 10.1590/S0100-879X2005001100003; Yisireyili M, 2017, NAGOYA J MED SCI, V79, P477, DOI 10.18999/nagjms.79.4.477; Zhang DC, 2019, BLOOD, V133, P2168, DOI 10.1182/blood-2018-11-844555; Zhang N, 2018, NUTRITION, V51-52, P80, DOI 10.1016/j.nut.2017.12.005; Zhao ZH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0304-5; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	99	9	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21552	10.1096/fj.202100027R	http://dx.doi.org/10.1096/fj.202100027R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826788	Green Accepted			2022-12-28	WOS:000645260100078
J	Lee, HN; Choi, YS; Kim, SH; Zhong, X; Kim, W; Park, JS; Saeidi, S; Han, BW; Kim, N; Lee, HS; Choi, YJ; Baek, JH; Na, HK; Surh, YJ				Lee, Ha-Na; Choi, Yeon-Seo; Kim, Seong Hoon; Zhong, Xiancai; Kim, Wonki; Park, Joon Sung; Saeidi, Soma; Han, Byung Woo; Kim, Nayoung; Lee, Hye Seung; Choi, Yoon Jin; Baek, Jeong-Heum; Na, Hye-Kyung; Surh, Young-Joon			Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality	FASEB JOURNAL			English	Article						cyclin D1; IL-6; IL-6R antagonist; inflammation-associated colorectal cancer; mitotic spindle abnormality; RvD1; STAT3	SMALL-MOLECULE INHIBITOR; SODIUM-INDUCED COLITIS; CRYO-EM STRUCTURE; NLRP3 INFLAMMASOME; BOWEL-DISEASE; PYRIN INFLAMMASOME; INTESTINAL INFLAMMATION; CROHNS-DISEASE; GUT MICROBIOTA; GASDERMIN D	While failure in resolution of inflammation is considered to increase the risk of tumorigenesis, there is paucity of experimental as well as clinical evidence supporting this association. Resolvin D1 (RvD1) is a representative pro-resolving lipid mediator that is endogenously generated from docosahexaenoic acid for the resolution of inflammation. Here, we report a decreased level of RvD1 in the blood from colorectal cancer patients and mice having inflammation-induced colon cancer, suggesting plasma RvD1 as a potential biomarker for monitoring colorectal cancer. Administration of RvD1 attenuated dextran sodium sulfate (DSS)-induced colitis and azoxymethane (AOM) plus DSS-induced colorectal carcinogenesis by suppressing the production of interleukin-6 (IL-6) and IL-6-mediated chromosomal instability. The protective effect of RvD1 against chromosomal instability is associated with downregulation of IL-6-induced Cyclin D1 expression, which appears to be mediated by blocking the Janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) axis. RvD1 inhibited the STAT3 signaling pathway by interfering with the binding of IL-6 to its receptor (IL-6R), suggesting the novel function of RvD1 as a putative IL-6R antagonist. Together, our findings suggest that RvD1-mediated blockade of IL-6 signal transmission may contribute to inhibition of chromosomal instability and tumorigenesis.	[Lee, Ha-Na; Choi, Yeon-Seo; Kim, Seong Hoon; Zhong, Xiancai; Kim, Wonki; Park, Joon Sung; Saeidi, Soma; Han, Byung Woo; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 08826, South Korea; [Choi, Yeon-Seo; Saeidi, Soma; Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Nayoung; Choi, Yoon Jin] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Baek, Jeong-Heum] Gachon Univ, Coll Med, Gil Med Ctr, Dept Surg,Div Colon & Rectal Surg, Incheon, South Korea; [Na, Hye-Kyung] Sungshin Womens Univ, Coll Human Ecol, Dept Food & Nutr, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gachon University; Sungshin Women's University; Seoul National University (SNU)	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 08826, South Korea.	surh@snu.ac.kr	Zhong, Xiancai/AAM-3069-2020; Zhong, Xiancai/AAV-2761-2020; Lee, Hye Seung/G-6419-2011	Zhong, Xiancai/0000-0001-8312-4057; Zhong, Xiancai/0000-0001-8312-4057; Lee, Hye Seung/0000-0002-1667-7986; Park, Joon Sung/0000-0002-1575-1849	National Research Foundation of Korea (NRF) [2011-0030001]; BK21 FOUR Program [5120200513755]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); BK21 FOUR Program	National Research Foundation of Korea (NRF), Grant/Award Number: GCRC Grant (no. 2011-0030001) and BK21 FOUR Program (5120200513755)	Alatab S, 2020, LANCET GASTROENTEROL, V5, P17, DOI 10.1016/S2468-1253(19)30333-4; Alimov I, 2019, J BIOL CHEM, V294, P3359, DOI 10.1074/jbc.RA118.005103; Allam O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194185; Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P1089, DOI 10.1097/MIB.0000000000000338; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Amarante-Mendes GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02379; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Balakrishnan A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0068-z; Bank S, 2019, ALIMENT PHARM THER, V49, P890, DOI 10.1111/apt.15187; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauer R, 2020, MOL ASPECTS MED, V76, DOI 10.1016/j.mam.2020.100863; Blazejewski AJ, 2017, CELL REP, V19, P2319, DOI 10.1016/j.celrep.2017.05.058; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Bulek K, 2020, J CLIN INVEST, V130, P4218, DOI 10.1172/JCI138103; Cao F, 2019, AUTOIMMUN REV, V18, P767, DOI 10.1016/j.autrev.2019.06.009; Cao J, 2019, EUR J PHARM BIOPHARM, V137, P112, DOI 10.1016/j.ejpb.2019.02.011; Caseley EA, 2020, GENES IMMUN, V21, P211, DOI 10.1038/s41435-020-0104-x; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Chen L, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01910; Chen XL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2157-1; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Dai GL, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00721; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Silva EFD, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021686; De Vroey B, 2011, NAT REV GASTRO HEPAT, V8, P74, DOI 10.1038/nrgastro.2010.218; de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287; Demon D, 2014, MUCOSAL IMMUNOL, V7, P1480, DOI 10.1038/mi.2014.36; Deng ZB, 2017, MOL THER, V25, P1641, DOI 10.1016/j.ymthe.2017.01.025; Dhimolea E, 2010, MABS-AUSTIN, V2, P3, DOI 10.4161/mabs.2.1.10328; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Duncan JA, 2018, IMMUNOL REV, V281, P115, DOI 10.1111/imr.12607; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Eren E, 2020, EMBO REP, V21, DOI 10.15252/embr.202050829; Fan TJ, 2018, INFLAMM BOWEL DIS, V24, P2394, DOI 10.1093/ibd/izy244; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Feuerstein JD, 2019, MAYO CLIN PROC, V94, P1357, DOI 10.1016/j.mayocp.2019.01.018; Finethy R, 2020, EMBO REP, V21, DOI 10.15252/embr.202050830; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Flood B, 2019, ONCOGENE, V38, P2658, DOI 10.1038/s41388-018-0613-5; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Gai K, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1817-5; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; Giacomelli R., 2020, CLIN EXP RHEUMATOL, P1; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Gomes MTR, 2019, J LEUKOCYTE BIOL, V106, P553, DOI 10.1002/JLB.4MR0119-013R; Gong ZZ, 2018, MOL IMMUNOL, V104, P11, DOI 10.1016/j.molimm.2018.09.004; Gram AM, 2021, J IMMUNOL, V206, P631, DOI 10.4049/jimmunol.2000382; Grammatikopoulou MG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111737; Hara H, 2018, CELL, V175, P1651, DOI 10.1016/j.cell.2018.09.047; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; Heilig R, 2018, EUR J IMMUNOL, V48, P230, DOI 10.1002/eji.201746947; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Huang Y, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708689; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039; Iqbal U, 2018, AM J MED SCI, V356, P350, DOI 10.1016/j.amjms.2018.06.023; Itani S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39075; Jamilloux Y, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty020; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jin TC, 2013, PROTEINS, V81, P1266, DOI 10.1002/prot.24287; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jing WD, 2021, CELL MICROBIOL, V23, DOI 10.1111/cmi.13309; Martinez-Garcia JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10626-x; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Khatri V, 2015, J DIGEST DIS, V16, P585, DOI 10.1111/1751-2980.12290; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kim ML, 2015, J EXP MED, V212, P927, DOI 10.1084/jem.20142384; Kirsner JB, 2001, WORLD J GASTROENTERO, V7, P175; Lazaridis LD, 2017, DIGEST DIS SCI, V62, P2348, DOI 10.1007/s10620-017-4609-8; Leach ST, 2008, INFLAMM BOWEL DIS, V14, P68, DOI 10.1002/ibd.20272; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Lemire P, 2017, CELL REP, V21, P3653, DOI 10.1016/j.celrep.2017.12.026; Leng FW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57043-0; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Levy M, 2017, TRENDS IMMUNOL, V38, P248, DOI 10.1016/j.it.2017.01.001; Li MS, 2020, BIOL RES, V53, DOI 10.1186/s40659-020-00279-2; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040354; Li YY, 2020, EXP CELL RES, V389, DOI 10.1016/j.yexcr.2020.111847; Liu L, 2017, J CROHNS COLITIS, V11, P737, DOI 10.1093/ecco-jcc/jjw219; Liu QQ, 2016, J DIGEST DIS, V17, P104, DOI 10.1111/1751-2980.12314; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Liu ZH, 2020, IMMUNITY, V53, P106, DOI 10.1016/j.immuni.2020.06.007; Loeven NA, 2020, CURR OPIN MICROBIOL, V54, P77, DOI 10.1016/j.mib.2020.01.005; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Lu A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.13; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Ludwiczek O, 2005, EUR CYTOKINE NETW, V16, P27; Ma CM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6717; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Mak WY, 2020, J GASTROEN HEPATOL, V35, P380, DOI 10.1111/jgh.14872; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; Man SM, 2018, NAT REV GASTRO HEPAT, V15, P721, DOI 10.1038/s41575-018-0054-1; Mao LM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02566; Mao LM, 2018, J CLIN INVEST, V128, P1793, DOI 10.1172/JCI98642; Marchetti C, 2018, P NATL ACAD SCI USA, V115, pE1530, DOI 10.1073/pnas.1716095115; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Maruzuru Y, 2021, J VIROL, V95, DOI 10.1128/JVI.02172-20; Mazarakis N, 2020, CLIN NUTR, V39, P664, DOI 10.1016/j.clnu.2019.03.022; Mazgaeen L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020379; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Mehto S, 2019, MOL CELL, V73, P429, DOI 10.1016/j.molcel.2018.11.018; Melmed GY, 2006, AM J GASTROENTEROL, V101, P1834, DOI 10.1111/j.1572-0241.2006.00646.x; Mezzasoma L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010024; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mishra R, 2020, WORLD J STEM CELLS, V12, P1050, DOI 10.4252/wjsc.v12.i10.1050; Morrison G, 2009, AUST FAM PHYSICIAN, V38, P956; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Mu J, 2019, J MED GENET, V56, P471, DOI 10.1136/jmedgenet-2018-105936; Mukherjee S, 2020, NAT IMMUNOL, V21, P626, DOI 10.1038/s41590-020-0681-x; Mullins B., 2020, IMMUNOLOGY, V162, P1; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Nie H, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6182464; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Oficjalska K, 2015, J IMMUNOL, V194, P1252, DOI 10.4049/jimmunol.1400501; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Onoufriadis A, 2018, J CROHNS COLITIS, V12, P321, DOI 10.1093/ecco-jcc/jjx157; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Perera AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26775-w; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Prochnicki Tomasz, 2016, F1000Res, V5, DOI 10.12688/f1000research.8614.1; Ranson N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010057; Ranson N, 2018, CELL MOL GASTROENTER, V6, P110, DOI 10.1016/j.jcmgh.2018.03.001; Ranson N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112379; Rapa SF, 2020, FASEB J, V34, P1576, DOI 10.1096/fj.201902040R; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Ruiz VMR, 2017, P NATL ACAD SCI USA, V114, P13242, DOI 10.1073/pnas.1710433114; Saber S., 2020, INFLAMMOPHARMACOLOGY, V28, P1; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Santos JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16889-z; Schnappauf O, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01745; Seregin SS, 2017, MUCOSAL IMMUNOL, V10, P434, DOI 10.1038/mi.2016.55; Seregin SS, 2017, CELL REP, V19, P733, DOI 10.1016/j.celrep.2017.03.080; Shao BZ, 2019, INFLAMMATION, V42, P1147, DOI 10.1007/s10753-019-01008-y; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Sharma D, 2018, GASTROENTEROLOGY, V154, P948, DOI 10.1053/j.gastro.2017.11.276; Shen C, 2019, P NATL ACAD SCI USA, V116, P2052, DOI 10.1073/pnas.1817221116; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Song-Zhao GX, 2014, MUCOSAL IMMUNOL, V7, P763, DOI 10.1038/mi.2013.94; Standing ASI, 2017, J EXP MED, V214, P59, DOI 10.1084/jem.20161228; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Taabazuing CY, 2020, IMMUNOL REV, V297, P13, DOI 10.1111/imr.12884; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Tatiya-aphiradee Nitima, 2019, Journal of Basic and Clinical Physiology and Pharmacology, V30, P1, DOI 10.1515/jbcpp-2018-0036; Thomas MG, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023765; Tian XQ, 2020, INT J RADIAT BIOL, V96, P740, DOI 10.1080/09553002.2020.1694188; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Toubai T, 2019, NAT MICROBIOL, V4, P800, DOI 10.1038/s41564-019-0373-1; Umiker B, 2019, INNATE IMMUN-LONDON, V25, P132, DOI 10.1177/1753425919826367; Valmiki S, 2017, WORLD J GASTROENTERO, V23, P5324, DOI 10.3748/wjg.v23.i29.5324; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Vande Walle L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000354; Verma D., 2020, J INVEST DERMATOL, P1; Verstockt B, 2018, J GASTROENTEROL, V53, P585, DOI 10.1007/s00535-018-1449-z; Volk JK, 2019, J EXP MED, V216, P2602, DOI 10.1084/jem.20190679; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2; Wang B, 2020, MOL ASPECTS MED, V76, DOI 10.1016/j.mam.2020.100869; Wang HL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0901-8; Wang LF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01487; Wang SB, 2015, J GASTROEN HEPATOL, V30, P504, DOI 10.1111/jgh.12710; Wang YQ, 2018, IMMUNOPHARM IMMUNOT, V40, P476, DOI 10.1080/08923973.2018.1469145; Wani S, 2020, AM J PHYSIOL-GASTR L, V319, pG646, DOI 10.1152/ajpgi.00295.2020; Wasan SK, 2011, INFLAMM BOWEL DIS, V17, P2536, DOI 10.1002/ibd.21667; Wera O, 2016, J CLIN MED, V5, DOI 10.3390/jcm5120118; Wilks S., 1859, LONDON MED GAZETT, V2, P264; Williams MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01091; Williams TM, 2015, AM J PHYSIOL-GASTR L, V308, pG139, DOI 10.1152/ajpgi.00234.2014; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wu DC, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3048532; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang XR, 2018, CELL RES, V28, P35, DOI 10.1038/cr.2017.148; Yao XM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01917-2; Yin JH, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12555; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhang HB, 2017, J IMMUNOL, V198, P4383, DOI 10.4049/jimmunol.1600714; Zhang J, 2014, MUCOSAL IMMUNOL, V7, P1139, DOI 10.1038/mi.2014.1; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2019, MUCOSAL IMMUNOL, V12, P1150, DOI 10.1038/s41385-019-0177-x; Zheng DP, 2021, IMMUNOLOGY, V162, P281, DOI 10.1111/imm.13293; Zheng DP, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0167-x; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhou HB, 2015, CELL REP, V13, P1149, DOI 10.1016/j.celrep.2015.09.073	214	3	3	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21432	10.1096/fj.202002392R	http://dx.doi.org/10.1096/fj.202002392R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33794029				2022-12-28	WOS:000645260100077
J	Qin, WH; Crestani, B; Spek, CA; Scicluna, BP; van der Poll, T; Duitman, J				Qin, Wanhai; Crestani, Bruno; Spek, C. Arnold; Scicluna, Brendon P.; van der Poll, Tom; Duitman, JanWillem			Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis	FASEB JOURNAL			English	Article						AEC2; DNA methylation; pulmonary fibrosis; stemness; TET2	DNA METHYLATION DYNAMICS; GENE-EXPRESSION; SELF-RENEWAL; STEM-CELLS; REPAIR; MECHANISMS; DIFFERENTIATION; REGENERATION; FIBROBLASTS; MACROPHAGES	Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown etiology with minimal treatment options. Repetitive alveolar epithelial injury has been suggested as one of the causative mechanisms of this disease. Type 2 alveolar epithelial cells (AEC2) play a crucial role during fibrosis by functioning as stem cells able to repair epithelial damage. The DNA demethylase Tet methylcytosine dioxygenase 2 (TET2) regulates the stemness of multiple types of stem cells, but whether it also affects the stemness of AEC2 during fibrosis remains elusive. To study the role of TET2 in AEC2 during fibrosis, we first determined TET2 protein levels in the lungs of IPF patients and compared TET2 expression in AEC2 of IPF patients and controls using publicly available data sets. Subsequently, pulmonary fibrosis was induced by the intranasal administration of bleomycin to wild-type and AEC2-specific TET2 knockout mice to determine the role of TET2 in vivo. Fibrosis was assessed by hydroxyproline analysis and fibrotic gene expression. Additionally, macrophage recruitment and activation, and epithelial injury were analyzed. TET2 protein levels and gene expression were downregulated in IPF lungs and AEC2, respectively. Bleomycin inoculation induced a robust fibrotic response as indicated by increased hydroxyproline levels and increased expression of pro-fibrotic genes. Additionally, increased macrophage recruitment and both M1 and M2 activation were observed. None of these parameters were, however, affected by AEC2-specific TET2 deficiency. TET2 expression is reduced in IPF, but the absence of TET2 in AEC2 cells does not affect the development of bleomycin-induced pulmonary fibrosis.	[Qin, Wanhai; Spek, C. Arnold; Scicluna, Brendon P.; van der Poll, Tom; Duitman, JanWillem] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Amsterdam UMC, Meibergdreef 9,Room G2-130, NL-1105 AZ Amsterdam, Netherlands; [Crestani, Bruno] Med Sch Xavier Bichat, INSERM, UMR1152, Paris, France; [Crestani, Bruno] Univ Paris Diderot, Dept Hosp Univ FIRE Fibrosis Inflammat & Remodeli, Paris, France; [Crestani, Bruno] Univ Paris Diderot, LabEx Inflamex, Paris, France; [Scicluna, Brendon P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam UMC, Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Amsterdam UMC, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Qin, WH (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Amsterdam UMC, Meibergdreef 9,Room G2-130, NL-1105 AZ Amsterdam, Netherlands.	W.Qin@amsterdamumc.nl	Spek, Arnold/AAC-5866-2019; qin, wanhai/M-1773-2019; Duitman, JanWillem/AFX-7298-2022; Qin, Wanhai/R-8266-2016; Scicluna, Brendon/T-8112-2018	Spek, Arnold/0000-0002-2149-4068; qin, wanhai/0000-0002-7776-5007; Duitman, JanWillem/0000-0003-4254-3380; Qin, Wanhai/0000-0002-7776-5007; Scicluna, Brendon/0000-0003-2826-0341	China Scholarship Council (CSC) [20160617115]; Netherlands Organization for Scientific Research [016.186.046]	China Scholarship Council (CSC)(China Scholarship Council); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	China Scholarship Council (CSC), Grant/Award Number: 20160617115; Netherlands Organization for Scientific Research, Grant/Award Number: 016.186.046	Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; Anas AA, 2017, AM J RESP CELL MOL, V56, P648, DOI 10.1165/rcmb.2016-0190OC; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Cakouros D, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-018-0247-4; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Chanda D, 2019, MOL ASPECTS MED, V65, P56, DOI 10.1016/j.mam.2018.08.004; Chapman CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17568; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chrysanthou S, 2018, STEM CELL REP, V10, P1355, DOI 10.1016/j.stemcr.2018.02.014; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Du YN, 2017, THORAX, V72, P481, DOI 10.1136/thoraxjnl-2016-209598; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Huang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107055; JanWillem Duitman, 2018, J Clin Transl Res, V3, P358; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Joshi N, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00646-2019; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Kolb P, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01105-2019; Kulkarni T, 2016, AM J PHYSIOL-LUNG C, V311, pL185, DOI 10.1152/ajplung.00115.2016; Lin C, 2014, THORAX, V69, P152, DOI 10.1136/thoraxjnl-2013-203877; Marchand-Adam S, 2006, AM J RESP CRIT CARE, V174, P58, DOI 10.1164/rccm.200507-1074OC; Martinez FJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.74; Matute-Bello G, 2007, AM J RESP CELL MOL, V37, P210, DOI 10.1165/rcmb.2006-0471OC; Melboucy-Belkhir S, 2014, AM J PHYSIOL-LUNG C, V307, pL838, DOI 10.1152/ajplung.00012.2014; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Okuma T, 2004, J PATHOL, V204, P594, DOI 10.1002/path.1667; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Qin Wanhai, 2020, Infect Immun, V89, DOI 10.1128/IAI.00603-20; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Spagnolo P, 2014, LANCET RESP MED, V2, P416, DOI 10.1016/S2213-2600(14)70047-5; Thannickal VJ, 2013, BIOGERONTOLOGY, V14, P609, DOI 10.1007/s10522-013-9451-6; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wang YP, 2015, MOL CELL, V57, P662, DOI 10.1016/j.molcel.2014.12.023; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yang IV, 2014, AM J RESP CRIT CARE, V190, P1263, DOI 10.1164/rccm.201408-1452OC; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034; Zhang L, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0864-2; Zhang XY, 2017, BBA-MOL BASIS DIS, V1863, P2389, DOI 10.1016/j.bbadis.2017.05.010	55	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21599	10.1096/fj.202002686RR	http://dx.doi.org/10.1096/fj.202002686RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913570	Green Published, hybrid			2022-12-28	WOS:000645260100009
J	Zhang, SM; Xiao, X; Kong, JW; Lu, K; Dou, SX; Wang, PY; Ma, L; Liu, YR; Li, GH; Li, W; Zhang, HD				Zhang, Shuming; Xiao, Xue; Kong, Jingwei; Lu, Ke; Dou, Shuo-Xing; Wang, Peng-Ye; Ma, Lu; Liu, Yuru; Li, Guohong; Li, Wei; Zhang, Huidong			DNA polymerase Gp90 activities and regulations on strand displacement DNA synthesis revealed at single-molecule level	FASEB JOURNAL			English	Article						DNA polymerase; exonuclease; magnetic tweezers; strand displacement DNA synthesis	REVERSE-TRANSCRIPTASE; MAGNETIC TWEEZERS; REPLICATION; HELICASE; DELTA; YEAST; RNA; NUCLEOSOME; KINETICS; BINDING	Strand displacement DNA synthesis (SDDS) is an essential step in DNA replication. With magnetic tweezers, we investigated SDDS kinetics of wild-type gp90 and its exonuclease-deficient polymerase gp90 exo-at single-molecule level. A novel binding state of gp90 to the fork flap was confirmed prior to SDDS, suggesting an intermediate in the initiation of SDDS. The rate and processivity of SDDS by gp90 exo-or wt-gp90 are increased with force and dNTP concentration. The rate and processivity of exonuclease by wt-gp90 are decreased with force. High GC content decreases SDDS and exonuclease processivity but increases exonuclease rate for wt-gp90. The high force and dNTP concentration and low GC content facilitate the successive SDDS but retard the successive exonuclease for wt-gp90. Furthermore, increasing GC content accelerates the transition from SDDS or exonuclease to exonuclease. This work reveals the kinetics of SDDS in detail and offers a broader cognition on the regulation of various factors on SDDS at single-polymerase level.	[Zhang, Shuming; Zhang, Huidong] Sichuan Univ, West China Sch Publ Hlth, Key Lab Environm & Female Reprod Hlth, Chengdu 610041, Peoples R China; [Zhang, Shuming; Zhang, Huidong] Sichuan Univ, West China Fourth Hosp, Chengdu 610041, Peoples R China; [Zhang, Shuming; Xiao, Xue; Kong, Jingwei; Lu, Ke; Dou, Shuo-Xing; Wang, Peng-Ye; Ma, Lu; Liu, Yuru; Li, Wei] Chinese Acad Sci, Inst Phys, Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Zhang, Shuming; Xiao, Xue; Kong, Jingwei; Lu, Ke; Dou, Shuo-Xing; Wang, Peng-Ye; Ma, Lu; Liu, Yuru; Li, Wei] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100190, Peoples R China; [Xiao, Xue; Kong, Jingwei; Lu, Ke; Dou, Shuo-Xing; Wang, Peng-Ye] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Peng-Ye; Li, Wei] Songshan Lake Mat Lab, Dongguan, Peoples R China; [Li, Guohong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China; [Zhang, Huidong] Sun Yat Sen Univ, Affiliated Hosp 8, Res Ctr Environm & Female Reprod Hlth, Shenzhen, Peoples R China	Sichuan University; Sichuan University; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Songshan Lake Materials Laboratory; Chinese Academy of Sciences; Institute of Biophysics, CAS; Sun Yat Sen University	Zhang, HD (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Key Lab Environm & Female Reprod Hlth, Chengdu 610041, Peoples R China.; Zhang, HD (corresponding author), Sichuan Univ, West China Fourth Hosp, Chengdu 610041, Peoples R China.; Li, W (corresponding author), Chinese Acad Sci, Inst Phys, Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China.; Li, W (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100190, Peoples R China.	weili007@iphy.ac.cn; zhanghd29@mail.sysu.edu.cn		Dou, Shuo-Xing/0000-0002-7201-2081	Ministry of Science and Technology of China [2018YFE0203302, 2017YFC1002002, 2017YFA0504202]; National Natural Science Foundation of China [21991133, 31871290, 82073589, 11874414, 31770812, 11774407, 11874415, 31991161, 31525013, 31630041]; Key Research Program on Frontier Science [QYZDB-SSW-SLH045]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB37000000]; National Key Research and Development Program [2016YFA0301500]; National Laboratory of Biomacromolecules [2020kf02]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program on Frontier Science; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Research and Development Program; National Laboratory of Biomacromolecules	This work was supported by grants from the Ministry of Science and Technology of China (2018YFE0203302, 2017YFC1002002, and 2017YFA0504202), the National Natural Science Foundation of China (21991133, 31871290, 82073589, 11874414, 31770812, 11774407, 11874415, 31991161, 31525013, and 31630041), the Key Research Program on Frontier Science (QYZDB--SSW--SLH045), the Strategic Priority Research Program of Chinese Academy of Sciences (XDB37000000) and the National Key Research and Development Program (2016YFA0301500), the National Laboratory of Biomacromolecules (2020kf02)	Ahmadian L, 2020, INFECT DRUG RESIST, V13, P2773, DOI 10.2147/IDR.S263759; Bartlett EJ, 2016, NUCLEIC ACIDS RES, V44, P2173, DOI 10.1093/nar/gkv965; Berezhna SY, 2012, J AM CHEM SOC, V134, P11261, DOI 10.1021/ja3038273; Carter AR, 2016, NUCLEIC ACIDS RES, V44, P5849, DOI 10.1093/nar/gkw445; Chen P, 2018, MOL CELL, V71, P284, DOI 10.1016/j.molcel.2018.06.020; Coggins SA, 2020, J BIOL CHEM, V295, P13432, DOI 10.1074/jbc.REV120.013746; da Silva EF, 2000, J BIOL CHEM, V275, P31528, DOI 10.1074/jbc.M004594200; Ganai RA, 2016, NUCLEIC ACIDS RES, V44, P8229, DOI 10.1093/nar/gkw556; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Garzon-Coral C, 2016, SCIENCE, V352, P1124, DOI 10.1126/science.aad9745; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Gu SL, 2017, DNA REPAIR, V57, P35, DOI 10.1016/j.dnarep.2017.06.021; Hodeib S, 2016, METHODS, V105, P3, DOI 10.1016/j.ymeth.2016.06.019; Hoekstra TP, 2017, BIOPHYS J, V112, P575, DOI 10.1016/j.bpj.2016.12.044; Hu KH, 2016, J CELL BIOL, V213, P535, DOI 10.1083/jcb.201511053; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Huguet JM, 2010, P NATL ACAD SCI USA, V107, P15431, DOI 10.1073/pnas.1001454107; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kim S, 2010, J MOL BIOL, V395, P995, DOI 10.1016/j.jmb.2009.11.072; Koc KN, 2015, NUCLEIC ACIDS RES, V43, P4179, DOI 10.1093/nar/gkv260; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; Lee M, 2018, NUCLEIC ACIDS RES, V46, P4689, DOI 10.1093/nar/gky272; Li W, 2016, MOL CELL, V64, P120, DOI 10.1016/j.molcel.2016.08.024; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Lionnet Timothee, 2012, Cold Spring Harb Protoc, V2012, P34, DOI 10.1101/pdb.top067488; Liu BY, 2016, VIRUS GENES, V52, P538, DOI 10.1007/s11262-016-1329-7; Liu XY, 2018, CHEM RES TOXICOL, V31, P58, DOI 10.1021/acs.chemrestox.7b00287; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Maier B, 2000, P NATL ACAD SCI USA, V97, P12002, DOI 10.1073/pnas.97.22.12002; Malik O, 2017, NUCLEIC ACIDS RES, V45, P10190, DOI 10.1093/nar/gkx720; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6174, DOI 10.1093/nar/gks253; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6187, DOI 10.1093/nar/gks254; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Marzahn MR, 2013, ENCY BIOL CHEM, VSecond edn, P236; Mi CY, 2020, BIOCHIMIE, V170, P73, DOI 10.1016/j.biochi.2019.12.013; Mills M, 2017, NUCLEIC ACIDS RES, V45, P11878, DOI 10.1093/nar/gkx939; Monge AM, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.032146; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Seol Y, 2016, METHODS, V105, P119, DOI 10.1016/j.ymeth.2016.04.030; Singh A, 2020, EMBO J, V39, DOI 10.15252/embj.2019103367; Singh K, 2007, J BIOL CHEM, V282, P10594, DOI 10.1074/jbc.M611242200; Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012; Sun B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04702-x; Sun F, 2016, SCI CHINA LIFE SCI, V59, P709, DOI 10.1007/s11427-016-5076-8; Sun F, 2013, NUCLEIC ACIDS RES, V41, P8182, DOI 10.1093/nar/gkt588; Turowski TW, 2020, MOL CELL, V79, P488, DOI 10.1016/j.molcel.2020.06.002; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; Wang S, 2015, NUCLEIC ACIDS RES, V43, P3736, DOI 10.1093/nar/gkv209; Whiting SH, 1998, J MOL BIOL, V278, P559, DOI 10.1006/jmbi.1998.1720; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Xiao X, 2020, J AM CHEM SOC, V142, P3340, DOI 10.1021/jacs.9b12448; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905	54	0	0	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21607	10.1096/fj.202100033RR	http://dx.doi.org/10.1096/fj.202100033RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908664				2022-12-28	WOS:000645260100054
J	Li, F; Yin, C; Ma, ZW; Yang, KL; Sun, LJ; Duan, C; Wang, T; Hussein, A; Wang, LN; Zhu, XT; Gao, P; Xi, QY; Zhang, YL; Shu, G; Wang, SB; Jiang, QY				Li, Fan; Yin, Cong; Ma, Zewei; Yang, Kelin; Sun, Lijuan; Duan, Chen; Wang, Tao; Hussein, Abdelaziz; Wang, Lina; Zhu, Xiaotong; Gao, Ping; Xi, Qianyun; Zhang, Yongliang; Shu, Gang; Wang, Songbo; Jiang, Qingyan			PHD3 mediates denervation skeletal muscle atrophy through Nf-kappa B signal pathway	FASEB JOURNAL			English	Article						Inflammation; NF&#8208; kB; PHD3; protein turnover; skeletal muscle	PROMOTES NEOVASCULARIZATION; SATELLITE CELLS; MURINE MODEL; HYPOXIA; INHIBITION; HIF; EXPRESSION; PROTEIN; HYPERTROPHY; DYSFUNCTION	Skeletal muscle is the largest organ of the body, the development of skeletal muscle is very important for the health of the animal body. Prolyl hydroxylases (PHDs) are the classical regulator of the hypoxia inducible factor (HIF) signal pathway, many researchers found that PHDs are involved in the muscle fiber type transformation, muscle regeneration, and myocyte differentiation. However, whether PHDs can impact the protein turnover of skeletal muscle is poorly understood. In this study, we constructed denervated muscle atrophy mouse model and found PHD3 was highly expressed in the atrophic muscles and there was a significant correlation between the expression level of PHD3 and skeletal muscle weight which was distinct from PHD1 and PHD2. Then, the similar results were getting from the different weight muscles of normal mice. To further verify the relationship between PHD3 and skeletal muscle protein turnover, we established a PHD3 interference model by injecting PHD3 sgRNA virus into tibialis anterior muscle (TA) muscle of MCK-Cre-cas9 mice and transfecting PHD3 shRNA lentivirus into primary satellite cells. It was found that the Knock-out of PHD3 in vivo led to a significant increase in muscle weight and muscle fiber area (P < .05). Besides, the activity of protein synthesis signal pathway increased significantly, while the protein degradation pathway was inhibited evidently (P < .05). In vitro, the results of 5-ethynyl-2 '-deoxyuridine (EdU) and tetramethylrhodamine ethyl ester (TMRE) fluorescence detection showed that PHD3 interference could lead to a decrease in cell proliferation and an increase of cell apoptosis. After the differentiation of satellite cells, the production of puromycin in the interference group was higher than that in the control group, and the content of 3-methylhistidine in the interference group was lower than that in the control group (P < .05) which is consistent with the change of protein turnover signal pathway in the cell. Mechanistically, there is an interaction between PHD3, NF-kappa B, and IKB alpha which was detected by immunoprecipitation. With the interfering of PHD3, the expression of the inflammatory signal pathway also significantly decreased (P < .05). These results suggest that PHD3 may affect protein turnover in muscle tissue by mediating inflammatory signal pathway. Finally, we knocked out PHD3 in denervated muscle atrophy mice and LPS-induced myotubes atrophy model. Then, we found that the decrease of PHD3 protein level could alleviate the muscle weight and muscle fiber reduction induced by denervation in mice. Meanwhile, the protein level of the inflammatory signal pathway and the content of 3-methylhistidine in denervated atrophic muscle were also significantly reduced (P < .05). In vitro, PHD3 knock-out could alleviate the decrease of myotube diameter induced by LPS, and the expression of protein synthesis pathway was also significantly increased (P < .05). On the contrary, the expression level of protein degradation and inflammatory signal pathway was significantly decreased (P < .05). Through these series of studies, we found that the increased expression of PHD3 in denervated muscle might be an important regulator in inducing muscle atrophy, and this process is likely to be mediated by the inflammatory NF-kappa B signal pathway.	[Li, Fan; Yin, Cong; Ma, Zewei; Sun, Lijuan; Duan, Chen; Wang, Tao; Hussein, Abdelaziz; Wang, Lina; Zhu, Xiaotong; Gao, Ping; Xi, Qianyun; Zhang, Yongliang; Shu, Gang; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Guangdong Lab Lingnan Modern Agr, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci, Guangzhou 510642, Peoples R China; [Li, Fan; Yin, Cong; Ma, Zewei; Sun, Lijuan; Duan, Chen; Wang, Tao; Hussein, Abdelaziz; Wang, Lina; Zhu, Xiaotong; Gao, Ping; Xi, Qianyun; Zhang, Yongliang; Shu, Gang; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Regulat, Coll Anim Sci, Guangzhou 510642, Peoples R China; [Yang, Kelin] Foshan Univ, Sch Life Sci & Engn, Guangdong Prov Key Lab Anim Mol Design & Precise, Foshan, Peoples R China	South China Agricultural University; South China Agricultural University; Foshan University	Wang, SB; Jiang, QY (corresponding author), South China Agr Univ, Guangdong Lab Lingnan Modern Agr, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci, Guangzhou 510642, Peoples R China.; Wang, SB; Jiang, QY (corresponding author), South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Regulat, Coll Anim Sci, Guangzhou 510642, Peoples R China.	songbowang@scau.edu.cn; qyjiang@scau.edu.cn		Hussein, Abdelaziz/0000-0002-4620-8080	Major Program of the National Natural Science Foundation of China [31790411, 31972636]; Local Innovative and Research Teams Project of Guangdong Province [2019BT02N630]	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Local Innovative and Research Teams Project of Guangdong Province	This work was supported by the Major Program of the National Natural Science Foundation of China (Grant No. 31790411 to Q.Y.J, 31972636 to S.B.W). Local Innovative and Research Teams Project of Guangdong Province (Grant No. 2019BT02N630 to G.S.)	Aglan A, 2017, J MOL MED, V95, P257, DOI 10.1007/s00109-016-1503-3; Agrawal A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204283; Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Amicarelli F, 1999, BBA-MOL BASIS DIS, V1453, P105, DOI 10.1016/S0925-4439(98)00088-X; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; Baghdadi MB, 2018, DEV BIOL, V433, P200, DOI 10.1016/j.ydbio.2017.07.026; Baskin KK, 2015, CELL METAB, V21, P237, DOI 10.1016/j.cmet.2014.12.021; Batt JAE, 2013, JOVE-J VIS EXP, DOI 10.3791/50657; Beneke A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.375; Billin AN, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0179-5; BILMAZES C, 1978, METABOLISM, V27, P525, DOI 10.1016/0026-0495(78)90018-5; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Borisov AB, 2000, ANAT REC, V258, P292; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Buford TW, 2010, J GERONTOL A-BIOL, V65, P532, DOI 10.1093/gerona/glp196; Cai XC, 2018, FASEB J, V32, P488, DOI 10.1096/fj.201700670R; Cao RY, 2018, ADV EXP MED BIOL, V1088, P605, DOI 10.1007/978-981-13-1435-3_29; Chen R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7097580; Darby IA, 2016, CELL TISSUE RES, V365, P553, DOI 10.1007/s00441-016-2461-3; de Theije CC, 2013, AM J PHYSIOL-LUNG C, V305, pL82, DOI 10.1152/ajplung.00354.2012; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Dutt V, 2015, PHARMACOL RES, V99, P86, DOI 10.1016/j.phrs.2015.05.010; Egner IM, 2016, DEVELOPMENT, V143, P2898, DOI 10.1242/dev.134411; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Escribese MM, 2012, J IMMUNOL, V189, P1946, DOI 10.4049/jimmunol.1201064; Flandin P, 2005, FEBS LETT, V579, P3411, DOI 10.1016/j.febslet.2005.04.084; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Freeman RS, 2003, MOL CELLS, V16, P1; Fry C.S., 2016, PHYS REP, V4, DOI DOI 10.14814/PHY2.13014; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gumucio JP, 2013, ENDOCRINE, V43, P12, DOI 10.1007/s12020-012-9751-7; Hoffmann C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029793; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kuprash DV, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1237, DOI 10.1134/S0006297916110018; Lang F, 2017, DIS MODEL MECH, V10, P881, DOI 10.1242/dmm.028910; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Lee D, 2015, J BIOL CHEM, V290, P30269, DOI 10.1074/jbc.M115.685164; Li LF, 2016, TRANSL RES, V173, P131, DOI 10.1016/j.trsl.2016.03.011; Liu HM, 2019, AM J PHYSIOL-CELL PH, V316, pC456, DOI 10.1152/ajpcell.00441.2018; Loeffler JP, 2016, BRAIN PATHOL, V26, P227, DOI 10.1111/bpa.12350; MacDonald EM, 2014, DIS MODEL MECH, V7, P471, DOI 10.1242/dmm.014126; MacLauchlan SC, 2018, MATRIX BIOL, V65, P45, DOI 10.1016/j.matbio.2017.07.002; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin NRW, 2017, J CELL BIOCHEM, V118, P2599, DOI 10.1002/jcb.25982; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Musaro A, 2017, METHODS MOL BIOL, V1553, P155, DOI 10.1007/978-1-4939-6756-8_12; Nakagawa K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5695217; Norrby Marlene, 2012, J Mol Signal, V7, P7, DOI 10.1186/1750-2187-7-7; Okamoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03980-7; Ottenheijm CAC, 2006, AM J PHYSIOL-LUNG C, V290, pL127, DOI 10.1152/ajplung.00073.2005; Paudyal A, 2018, EXP GERONTOL, V106, P165, DOI 10.1016/j.exger.2018.03.008; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Place TL, 2013, HYPOXIA, V1, P13, DOI 10.2147/HP.S50091; Rishi MT, 2015, MICROVASC RES, V97, P181, DOI 10.1016/j.mvr.2014.10.009; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; Ross LF., 2019, NEOREVIEWS, V20, P437; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scalabrin M, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101294; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Settelmeier S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233261; Shen H, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20155124; Shin J, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0079-5; Shiotani A, 2001, GENE THER, V8, P1043, DOI 10.1038/sj.gt.3301486; Sinha I, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00153; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Slot IGM, 2014, CELL SIGNAL, V26, P1837, DOI 10.1016/j.cellsig.2014.04.016; Spendiff S, 2016, J PHYSIOL-LONDON, V594, P7361, DOI 10.1113/JP272487; Takeda K, 2014, AM J PATHOL, V184, P686, DOI 10.1016/j.ajpath.2013.11.032; Tang HB, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004809; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273; Wilkinson DJ, 2018, AGEING RES REV, V47, P123, DOI 10.1016/j.arr.2018.07.005; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yang J, 2018, ADV EXP MED BIOL, V1088, P329, DOI 10.1007/978-981-13-1435-3_15; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008; Yoon HJ, 2020, CELL METAB, V32, P215, DOI 10.1016/j.cmet.2020.06.017; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43935; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	94	2	4	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21444	10.1096/fj.202002049R	http://dx.doi.org/10.1096/fj.202002049R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749901				2022-12-28	WOS:000635216100065
J	Wang, XF; Chang, XY; He, CY; Fan, ZY; Yu, ZJ; Yu, BQ; Wu, XY; Hou, JY; Li, JF; Su, LP; Liu, BY; Zhu, ZG				Wang, Xufeng; Chang, Xinyu; He, Changyu; Fan, Zhiyuan; Yu, Zhenjia; Yu, Beiqin; Wu, Xiongyan; Hou, Junyi; Li, Jianfang; Su, Liping; Liu, Bingya; Zhu, Zhenggang			ATP5B promotes the metastasis and growth of gastric cancer by activating the FAK/AKT/MMP2 pathway	FASEB JOURNAL			English	Article						ATP5B; gastric cancer; metastasis; proliferation		Adenosine triphosphate (ATP) in the tumor microenvironment serves a vital role during tumor progression. ATP synthase F1 beta subunit (ATP5B) is one of the most important subunits of ATP synthase and increases cellular ATP levels. ATP5B reportedly participates in carcinogenesis in several tumors. However, the regulatory mechanisms of ATP5B remain poorly understood in gastric cancer (GC). Here, we determined that high ATP5B expression in tumor tissues of GC is positively correlated with age, the tumor size, the TNM stage, lymph node metastasis, and patients' poor prognosis. The overexpression of ATP5B in GC cells elevated the cellular ATP content and promoted migration, invasion and proliferation. The levels of MMP2 expression, phosphorylated FAK, and phosphorylated AKT were increased after ATP5B overexpression in GC cells. Additionally, ATP5B overexpression increased the extracellular ATP level through the secretion of intracellular ATP and activated the FAK/AKT/MMP2 signaling pathway. ATP5B-induced downstream pathway activation was induced through the plasma membrane P2X7 receptor. Inhibitors of P2X7, FAK, AKT, and MMP2 suppressed the proliferative, migratory, and invasive capabilities of GC cells. In conclusion, our experiments indicate that ATP5B contributes to tumor progression of GC via FAK/AKT/MMP2 pathway. ATP5B, therefore, may be a biomarker of poor prognosis and a potential therapeutic target for GC.	[Wang, Xufeng; Chang, Xinyu; He, Changyu; Fan, Zhiyuan; Yu, Zhenjia; Yu, Beiqin; Wu, Xiongyan; Hou, Junyi; Li, Jianfang; Su, Liping; Liu, Bingya; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Sch Med, Dept Surg,Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Shanghai Inst Di, Shanghai, Peoples R China	Shanghai Jiao Tong University	Liu, BY; Zhu, ZG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp, Shanghai 200025, Peoples R China.; Liu, BY; Zhu, ZG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Gastr Neoplasms, Ruijin Hosp, Shanghai 200025, Peoples R China.	liubingya@sjtu.edu.cn; zzg1954@hotmail.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China (NSFC) [81672822, 81871904, 81772509, 81871902, 81902393]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81672822, 81871904, 81772509, 81871902 and 81902393	Amoroso F, 2015, ONCOGENE, V34, P5240, DOI 10.1038/onc.2014.444; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2013, PURINERG SIGNAL, V9, P491, DOI 10.1007/s11302-013-9372-5; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chen HY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0837-9; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gilbert SM, 2019, ONCOGENE, V38, P194, DOI 10.1038/s41388-018-0426-6; Hu LP, 2019, CLIN CANCER RES, V25, P1318, DOI 10.1158/1078-0432.CCR-18-2297; Leon D, 2007, ANAL BIOCHEM, V367, P140, DOI 10.1016/j.ab.2007.03.038; Li W, 2017, INT J ONCOL, V50, P1312, DOI 10.3892/ijo.2017.3878; Lu YX, 2018, CANCER RES, V78, P1972, DOI 10.1158/0008-5472.CAN-17-3155; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; Mishra M, 2017, EXPERT REV PROTEOMIC, V14, P1037, DOI 10.1080/14789450.2017.1388167; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pan JM, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1049-7; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ren T, 2017, ONCOGENE, V36, P5897, DOI 10.1038/onc.2017.167; Robinson AJ, 2020, CANCER RES, V80, P937, DOI 10.1158/0008-5472.CAN-19-1920; Schulien I, 2020, CANCER RES, V80, P699, DOI 10.1158/0008-5472.CAN-19-1909; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang LL, 2019, EXP BIOL MED, V244, P734, DOI 10.1177/1535370219846492; Weber GF, 2016, INT J CANCER, V138, P2061, DOI 10.1002/ijc.29839; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Xu GY, 2016, J NEURO-ONCOL, V126, P405, DOI 10.1007/s11060-015-1984-x; Yang JC, 2006, DIABETES, V55, P193, DOI 10.2337/diabetes.55.01.06.db05-0938; Yang JC, 2004, J BIOL CHEM, V279, P53915, DOI 10.1074/jbc.M405309200; Zhang YC, 2019, INT J CANCER, V145, P1068, DOI 10.1002/ijc.32207	31	3	4	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e20649	10.1096/fj.202000608R	http://dx.doi.org/10.1096/fj.202000608R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715234	hybrid			2022-12-28	WOS:000635216100098
J	Kerr, M; Dennis, KMJH; Carr, CA; Fuller, W; Berridge, G; Rohling, S; Aitken, CL; Lopez, C; Fischer, R; Miller, JJ; Clarke, K; Tyler, DJ; Heather, LC				Kerr, M.; Dennis, K. M. J. H.; Carr, C. A.; Fuller, W.; Berridge, G.; Rohling, S.; Aitken, C. L.; Lopez, C.; Fischer, R.; Miller, J. J.; Clarke, K.; Tyler, D. J.; Heather, L. C.			Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischemia	FASEB JOURNAL			English	Article						diabetes; energetics; fatty acids; heart; ischemia; mitochondria	ADENINE-NUCLEOTIDE TRANSLOCASE; FATTY-ACID-METABOLISM; COENZYME-A; OXIDATIVE-PHOSPHORYLATION; KINETIC-PROPERTIES; CHAIN; CARRIER; SAFRANINE; CARNITINE; BINDING	The bioactive lipid intermediate palmitoyl CoA (PCoA) can inhibit mitochondrial ADP/ATP transport, though the physiological relevance of this regulation remains unclear. We questioned whether myocardial ischemia provides a pathological setting in which PCoA regulation of ADP/ATP transport would be beneficial, and secondly, whether the chronically elevated lipid content within the diabetic heart could make mitochondria less sensitive to the effects of PCoA. PCoA acutely decreased ADP-stimulated state 3 respiration and increased the apparent K-m for ADP twofold. The half maximal inhibitory concentration (IC50) of PCoA in control mitochondria was 22 mu M. This inhibitory effect of PCoA on respiration was blunted in diabetic mitochondria, with no significant difference in the K-m for ADP in the presence of PCoA, and an increase in the IC50 to 32 mu M PCoA. The competitive inhibition by PCoA was localised to the phosphorylation apparatus, particularly the ADP/ATP carrier (AAC). During ischemia, the AAC imports ATP into the mitochondria, where it is hydrolysed by reversal of the ATP synthase, regenerating the membrane potential. Addition of PCoA dose-dependently prevented this wasteful ATP hydrolysis for membrane repolarisation during ischemia, however, this beneficial effect was blunted in diabetic mitochondria. Finally, using P-31-magnetic resonance spectroscopy we demonstrated that diabetic hearts lose ATP more rapidly during ischemia, with a threefold higher ATP decay rate compared with control hearts. In conclusion, PCoA plays a role in protecting mitochondrial energetics during ischemia, by preventing wasteful ATP hydrolysis. However, this beneficial effect is blunted in diabetes, contributing to the impaired energy metabolism seen during myocardial ischemia in the diabetic heart.	[Kerr, M.; Dennis, K. M. J. H.; Carr, C. A.; Rohling, S.; Aitken, C. L.; Lopez, C.; Miller, J. J.; Clarke, K.; Tyler, D. J.; Heather, L. C.] Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England; [Fuller, W.] Univ Glasgow, Inst Cardiovas & Med Sci, Glasgow, Lanark, Scotland; [Berridge, G.; Fischer, R.] Univ Oxford, Target Discovery Inst, Oxford, England; [Miller, J. J.] Univ Oxford, Dept Phys, Oxford, England; [Miller, J. J.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Tyler, D. J.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England	University of Oxford; University of Glasgow; University of Oxford; University of Oxford; Aarhus University; University of Oxford	Heather, LC (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	lisa.heather@dpag.ox.ac.uk	Fischer, Roman/N-4408-2017	Fischer, Roman/0000-0002-9715-5951; Fuller, William/0000-0002-5883-4433	British Heart Foundation [FS/17/58/33072, FS/15/68/32042, FS/19/18/34252, FS/19/61/34900, FS/20/34132]; Oxford Novo Nordisk Fellowship	British Heart Foundation(British Heart Foundation); Oxford Novo Nordisk Fellowship	British Heart Foundation, Grant/Award Number: FS/17/58/33072, FS/15/68/32042, FS/19/18/34252, FS/19/61/34900 and FS/20/34132; Oxford Novo Nordisk Fellowship	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; BAYDOUN AR, 1988, BIOCHEM PHARMACOL, V37, P3103, DOI 10.1016/0006-2952(88)90307-3; Blachnio-Zabielska AU, 2012, LIPIDS, V47, P1131, DOI 10.1007/s11745-012-3722-x; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Ciapaite J, 2005, DIABETES, V54, P944, DOI 10.2337/diabetes.54.4.944; Ciapaite J, 2006, FEBS J, V273, P5288, DOI 10.1111/j.1742-4658.2006.05523.x; Davis S, 2017, J PROTEOME RES, V16, P1288, DOI 10.1021/acs.jproteome.6b00915; DEVILLIERS M, 1986, BIOCHIM BIOPHYS ACTA, V876, P309, DOI 10.1016/0005-2760(86)90289-4; Dorner A, 2006, EUR J HEART FAIL, V8, P81, DOI 10.1016/j.ejheart.2005.05.003; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Heather LC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0268-2; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Kerr M, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140326; Kerr M, 2017, CLIN SCI, V131, P2079, DOI [10.1042/cs20160671, 10.1042/CS20160671]; KHOLODENKO B, 1987, FEBS LETT, V223, P247, DOI 10.1016/0014-5793(87)80298-3; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kunji ERS, 2020, BIOCHEM SOC T, V48, P1419, DOI 10.1042/BST20190933; Liepinsh E, 2016, BIOCHEM J, V473, P1191, DOI 10.1042/BCJ20160164; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lynn EG, 2010, J MOL CELL CARDIOL, V49, P693, DOI 10.1016/j.yjmcc.2010.06.008; Mansor LS, 2017, CARDIOVASC RES, V113, P737, DOI 10.1093/cvr/cvx045; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Mielke C, 2014, BIOCHEMISTRY-US, V53, P3817, DOI 10.1021/bi401651e; Minkler PE, 2008, ANAL BIOCHEM, V376, P275, DOI 10.1016/j.ab.2008.02.022; Miotto PM, 2018, DIABETES, V67, P2199, DOI 10.2337/db18-0417; MOREL F, 1974, FEBS LETT, V39, P133, DOI 10.1016/0014-5793(74)80035-9; Mukamal KJ, 2001, DIABETES CARE, V24, P1422, DOI 10.2337/diacare.24.8.1422; PANDE SV, 1971, J BIOL CHEM, V246, P402; Pinkosky SL, 2020, NAT METAB, V2, P873, DOI 10.1038/s42255-020-0245-2; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Purvis LAB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185356; ROUSLIN W, 1987, J MOL CELL CARDIOL, V19, P661, DOI 10.1016/S0022-2828(87)80374-7; ROUSLIN W, 1986, AM J PHYSIOL, V250, pH503, DOI 10.1152/ajpheart.1986.250.3.H503; Ruprecht JJ, 2019, CELL, V176, P435, DOI 10.1016/j.cell.2018.11.025; Seifert EL, 2016, J BIOL CHEM, V291, P26126, DOI 10.1074/jbc.M116.744714; Seo JB, 2019, NAT METAB, V1, P86, DOI 10.1038/s42255-018-0003-x; Sharma V, 2009, EUR J PHARMACOL, V607, P156, DOI 10.1016/j.ejphar.2009.02.016; STUBBS M, 1979, PHARMACOL THERAPEUT, V7, P329, DOI 10.1016/0163-7258(79)90035-4; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003; Wang Y, 2009, EXP PHYSIOL, V94, P220, DOI 10.1113/expphysiol.2008.044800; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; WOLDEGIORGIS G, 1979, BIOCHEM BIOPH RES CO, V89, P837, DOI 10.1016/0006-291X(79)91854-0; WOLKOWICZ PE, 1980, BIOCHEM J, V186, P257, DOI 10.1042/bj1860257	49	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21765	10.1096/fj.202100394R	http://dx.doi.org/10.1096/fj.202100394R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34318967	Green Published, Green Accepted			2022-12-28	WOS:000678975300046
J	Pham, TL; Kakazu, AH; He, JC; Nshimiyimana, R; Petasis, NA; Jun, B; Bazan, NG; Bazan, HEP				Pham, Thang L.; Kakazu, Azucena H.; He, Jiucheng; Nshimiyimana, Robert; Petasis, Nicos A.; Jun, Bokkyoo; Bazan, Nicolas G.; Bazan, Haydee E. P.			Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome	FASEB JOURNAL			English	Article						corneal nerves; hgf; pain; Rictor; RvD6 stereoisomers; trigeminal ganglia transcriptome	HEPATOCYTE GROWTH-FACTOR; GENE-RELATED PEPTIDE; CORNEAL SENSITIVITY; DOCOSAHEXAENOIC ACID; COLD THERMORECEPTORS; IN-VIVO; INFLAMMATION; RECOVERY; LASIK; ARCHITECTURE	Innervation sustains cornea integrity. Pigment epithelium-derived factor (PEDF) plus docosahexaenoic acid (DHA) regenerated damaged nerves by stimulating the synthesis of a new stereoisomer of Resolvin D6 (RvD6si). Here, we resolved the structure of this lipid isolated from mouse tears after injured corneas were treated with PEDF + DHA. RvD6si synthesis was inhibited by fluvoxamine, a cytochrome P450 inhibitor, but not by 15- or 5-LOX inhibitors, suggesting that the 4- and 17-hydroxy of DHA have an RR- or SR-configuration. The two compounds were chemically synthesized. Using chiral phase HPLC, four peaks of RvD6si(1-4) from tears were resolved. The RR-RvD6 standard eluted as a single peak with RvD6(1) while pure SR-RvD6 eluted with RvD6(3). The addition of these pure mediators prompted a trigeminal ganglion transcriptome response in injured corneas and showed that RR-RvD6 was the more potent, increasing cornea sensitivity and nerve regeneration. RR-RvD6 stimulates Rictor and hepatocyte growth factor (hgf) genes specifically as upstream regulators and a gene network involved in axon growth and suppression of neuropathic pain, indicating a novel function of this lipid mediator to maintain cornea integrity and homeostasis after injury.	[Pham, Thang L.; Kakazu, Azucena H.; He, Jiucheng; Jun, Bokkyoo; Bazan, Nicolas G.; Bazan, Haydee E. P.] Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA; [Nshimiyimana, Robert; Petasis, Nicos A.] Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA; [Nshimiyimana, Robert; Petasis, Nicos A.] Univ Southern Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90007 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Southern California; University of Southern California	Bazan, HEP (corresponding author), Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	hbazan1@lsuhsc.edu		PHAM, Thang/0000-0001-7600-7450	National Institutes of Health [R01EY019465]; National Eye Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health, Grant/Award Number: R01EY019465; National Eye Institute	Belmonte C, 1999, INVEST OPHTH VIS SCI, V40, P513; Belmonte C, 2011, INVEST OPHTH VIS SCI, V52, P3888, DOI 10.1167/iovs.09-5119; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Chandrasekher G, 2014, MOL VIS, V20, P24; Chao C, 2014, OCUL SURF, V12, P32, DOI 10.1016/j.jtos.2013.09.001; Cortina MS, 2012, ARCH OPHTHALMOL-CHIC, V130, P76, DOI 10.1001/archophthalmol.2011.287; Cortina MS, 2010, INVEST OPHTH VIS SCI, V51, P804, DOI 10.1167/iovs.09-3641; Cortina MS, 2013, INVEST OPHTH VIS SCI, V54, P4109, DOI 10.1167/iovs.13-12075; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; Erie JC, 2005, AM J OPHTHALMOL, V140, P1059, DOI 10.1016/j.ajo.2005.07.027; Ferrari G, 2014, INVEST OPHTH VIS SCI, V55, P6289, DOI 10.1167/iovs.14-13984; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; He JC, 2019, INVEST OPHTH VIS SCI, V60, P2449, DOI 10.1167/iovs.18-26384; He JC, 2019, VET OPHTHALMOL, V22, P345, DOI 10.1111/vop.12600; He JC, 2017, DIABETES, V66, P2511, DOI 10.2337/db17-0249; He JC, 2017, EXP EYE RES, V161, P153, DOI 10.1016/j.exer.2017.06.015; He JC, 2016, INVEST OPHTH VIS SCI, V57, P664, DOI 10.1167/iovs.15-18019; He JC, 2015, INVEST OPHTH VIS SCI, V56, P3505, DOI 10.1167/iovs.15-16755; He JC, 2013, OPHTHALMIC RES, V49, P185, DOI 10.1159/000345766; He JC, 2012, OPHTHALMOLOGY, V119, P956, DOI 10.1016/j.ophtha.2011.10.036; He JC, 2010, EXP EYE RES, V91, P513, DOI 10.1016/j.exer.2010.07.007; Hovanesian JA, 2001, J CATARACT REFR SURG, V27, P577, DOI 10.1016/S0886-3350(00)00835-X; Hua J, 2014, INVEST OPHTH VIS SCI, V55, P5944, DOI 10.1167/iovs.14-14356; Iyengar S, 2017, PAIN, V158, P543, DOI 10.1097/j.pain.0000000000000831; Jin YP, 2009, INVEST OPHTH VIS SCI, V50, P4743, DOI 10.1167/iovs.08-2462; Ko KR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26704-x; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kymionis GD, 2009, SEMIN OPHTHALMOL, V24, P231, DOI 10.3109/08820530903388751; Lee BH, 2002, INVEST OPHTH VIS SCI, V43, P3660; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Linna TU, 2000, INVEST OPHTH VIS SCI, V41, P393; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Murphy PJ, 1998, OPHTHAL PHYSL OPT, V18, P532, DOI 10.1016/S0275-5408(98)00021-0; Obrosov Alexander, 2017, J Neurol Neurophysiol, V8, DOI 10.4172/2155-9562.1000453; Omoto M, 2017, MOL THER, V25, P1881, DOI 10.1016/j.ymthe.2017.04.020; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Pham TL, 2021, J LIPID RES, V62, DOI 10.1194/jlr.TR120000954; Pham TL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61390-8; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rosenthal P, 2016, BRIT J OPHTHALMOL, V100, P128, DOI 10.1136/bjophthalmol-2014-306280; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Pham TL, 2019, FASEB J, V33, P4598, DOI 10.1096/fj.201801957R; Pham TL, 2017, J BIOL CHEM, V292, P18486, DOI 10.1074/jbc.M117.801472; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang ZZ, 2018, MOL VIS, V24, P274; Zieglgansberger W, 2019, CELL TISSUE RES, V375, P227, DOI 10.1007/s00441-018-2922-y	53	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21775	10.1096/fj.202100686R	http://dx.doi.org/10.1096/fj.202100686R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245621	Green Published			2022-12-28	WOS:000678975300033
J	Srivastava, RK; Lee, ES; Sim, E; Sheng, NC; Ibanez, CF				Srivastava, Raj Kamal; Lee, Ee-Soo; Sim, Eunice; Sheng, New Chih; Ibanez, Carlos F.			Sustained anti-obesity effects of life-style change and anti-inflammatory interventions after conditional inactivation of the activin receptor ALK7	FASEB JOURNAL			English	Article						activin; adipose tissue; adrenergic signaling; C/EBP alpha; diet-induced obesity; Na-salicylate	ADIPOSE-TISSUE; SIGNALING PATHWAYS; WEIGHT-LOSS; KINASE 7; EXPRESSION; OBESITY; DIFFERENTIATION; SUPERFAMILY; FAT; PROLIFERATION	Life-style change and anti-inflammatory interventions have only transient effects in obesity. It is not clear how benefits obtained by these treatments can be maintained longer term, especially during sustained high caloric intake. Constitutive ablation of the activin receptor ALK7 in adipose tissue enhances catecholamine signaling and lipolysis in adipocytes, and protects mice from diet-induced obesity. Here, we investigated the consequences of conditional ALK7 ablation in adipocytes of adult mice with pre-existing obesity. Although ALK7 deletion had little effect on its own, it synergized strongly with a transient switch to low-fat diet (life-style change) or anti-inflammatory treatment (Na-salicylate), resulting in enhanced lipolysis, increased energy expenditure, and reduced adipose tissue mass and body weight gain, even under sustained high caloric intake. By themselves, diet-switch and salicylate had only a temporary effect on weight gain. Mechanistically, combination of ALK7 ablation with either treatment strongly enhanced the levels of beta 3-AR, the main adrenergic receptor for catecholamine stimulation of lipolysis, and C/EBP alpha, an upstream regulator of beta 3-AR expression. These results suggest that inhibition of ALK7 can be combined with simple interventions to produce longer-lasting benefits in obesity.	[Srivastava, Raj Kamal; Lee, Ee-Soo; Sim, Eunice; Sheng, New Chih; Ibanez, Carlos F.] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Srivastava, Raj Kamal; Lee, Ee-Soo; Sim, Eunice; Sheng, New Chih; Ibanez, Carlos F.] Natl Univ Singapore, Inst Life Sci, Singapore 117597, Singapore; [Ibanez, Carlos F.] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing, Peoples R China; [Ibanez, Carlos F.] Peking Univ, PKU IDG McGovern Inst Brain Res, Sch Life Sci, Beijing, Peoples R China; [Ibanez, Carlos F.] Chinese Inst Brain Res, Beijing, Peoples R China; [Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Srivastava, Raj Kamal] Indira Gandhi Natl Tribal Univ, Amarkantak 484887, MP, India	National University of Singapore; National University of Singapore; Peking University; Peking University; Karolinska Institutet; Indira Gandhi National Tribal University	Ibanez, CF (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore.; Ibanez, CF (corresponding author), Natl Univ Singapore, Inst Life Sci, Singapore 117597, Singapore.	phscfi@nus.edu.sg	Srivastava, Raj Kamal/G-4853-2011	Srivastava, Raj Kamal/0000-0001-9328-146X	Vetenskapsradet (VR) [2016-01538]; Singapore National Medical Research Council [NMRC/CBRG/0107/2016]	Vetenskapsradet (VR)(Swedish Research Council); Singapore National Medical Research Council(National Medical Research Council, Singapore)	Vetenskapsradet (VR), Grant/Award Number: 2016-01538; Singapore National Medical Research Council, Grant/Award Number: NMRC/CBRG/0107/2016	Adapala VJ, 2011, J INFLAMM-LOND, V8, DOI [10.1186/1476-9255-8-5, 10.1186/1476-9255-9-15]; Anderson K, 2014, AM HEALTH DRUG BENEF, V7, P231; Andersson O, 2008, P NATL ACAD SCI USA, V105, P7252, DOI 10.1073/pnas.0800272105; Arner P, 1999, INT J OBESITY, V23, P10, DOI 10.1038/sj.ijo.0800789; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dixon TM, 2001, J BIOL CHEM, V276, P722, DOI 10.1074/jbc.M008440200; Emdin CA, 2019, DIABETES, V68, P226, DOI 10.2337/db18-0857; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Guo TQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03245; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huynh LK, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110743; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jocken JWE, 2008, METABOLISM, V57, P326, DOI 10.1016/j.metabol.2007.10.006; Jornvall H, 2004, MOL CELL BIOL, V24, P9383, DOI 10.1128/MCB.24.21.9383-9389.2004; Jornvall H, 2001, J BIOL CHEM, V276, P5140, DOI 10.1074/jbc.M005200200; Justice AE, 2019, NAT GENET, V51, P452, DOI 10.1038/s41588-018-0334-2; Kang Y, 1996, BIOCHEM MOL BIOL INT, V40, P993; Kogame M, 2006, J MED INVESTIG, V53, P238, DOI 10.2152/jmi.53.238; Kruger K, 2016, AM J LIFESTYLE MED, V10, P268, DOI 10.1177/1559827614552986; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lusk G, 1924, J BIOL CHEM, V59, P41; Marmol-Carrasco P, 2020, ELIFE, V9, DOI 10.7554/eLife.54721; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; Muller MJ, 2013, OBESITY, V21, P218, DOI 10.1002/oby.20027; Murakami M, 2013, BIOCHEM GENET, V51, P202, DOI 10.1007/s10528-012-9555-8; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Ryden M, 1996, J BIOL CHEM, V271, P30603, DOI 10.1074/jbc.271.48.30603; Sassmann A, 2010, GENESIS, V48, P618, DOI 10.1002/dvg.20665; Sjoholm K, 2006, BIOCHEM BIOPH RES CO, V344, P1308, DOI 10.1016/j.bbrc.2006.04.030; Srivastava RK, 2020, J BIOL CHEM, V295, P2034, DOI 10.1074/jbc.AC119.011795; van Baak MA, 2019, NAT REV ENDOCRINOL, V15, P274, DOI 10.1038/s41574-018-0148-4; Witthuhn BA, 2001, CYTOKINE, V14, P129, DOI 10.1006/cyto.2001.0864; Ye RS, 2015, MOL METAB, V4, P771, DOI 10.1016/j.molmet.2015.08.004; Yogosawa S, 2013, DIABETES, V62, P115, DOI 10.2337/db12-0295; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013	44	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21759	10.1096/fj.202002785RR	http://dx.doi.org/10.1096/fj.202002785RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245608	Green Submitted			2022-12-28	WOS:000678975300002
J	Yan, YT; Liu, JL; Lawrence, A; Dykstra, MJ; Fannin, R; Gerrish, K; Tucker, CJ; Scappini, E; Dixon, D				Yan, Yitang; Liu, Jingli; Lawrence, Arianna; Dykstra, Michael J.; Fannin, Rick; Gerrish, Kevin; Tucker, Charles J.; Scappini, Erica; Dixon, Darlene			Prolonged cadmium exposure alters benign uterine fibroid cell behavior, extracellular matrix components, and TGFB signaling	FASEB JOURNAL			English	Article						cadmium; extracellular matrix; metallohormone; NanoString; proliferation; TGFB1 signaling; uterine fibroid cells; uterine leiomyoma	IN-VIVO; ESTROGEN; ACTIVATION; LEIOMYOMA; MICROENVIRONMENT; METABOLISM; PATHWAYS; TARGETS	The heavy metal Cadmium (Cd), a widespread environmental contaminant, poses serious hazards to human health and is considered a metallohormone and carcinogen. In women with uterine fibroids, there is a significant association between blood Cd levels and increased fibroid tumor size. The aim of this study was to determine if benign human uterine leiomyoma (fibroid) cells could be malignantly transformed in vitro by continuous Cd exposure and, if so, explore a molecular mechanism by which this could occur. We found when fibroid cells were exposed to 10 mu M CdCl2 for 8 weeks, a robust and fast-growing Cd-Resistant Leiomyoma (CR-LM) cell culture was established. The CR-LM cells formed viable colonies in soft agar and had increased cytoplasmic glycogen aggregates, enhanced cell motility, a higher percentage of cells in G2/M phase, and increased expression of the proliferation marker Ki-67. NanoString analysis showed downregulation of genes encoding for extracellular matrix (ECM) components, such as collagens, fibronectins, laminins, and SLRP family proteins, whereas genes involved in ECM degradation (MMP1, MMP3, and MMP10) were significantly upregulated. A volcano plot showed that the top differentially genes favored cancer progression. Functional analysis by ingenuity pathway analysis predicted a significant inhibition of TGFB1 signaling, leading to enhanced proliferation and attenuated fibrosis. Prolonged Cd exposure altered phenotypic characteristics and dysregulated genes in fibroid cells predicative of progression towards a cancer phenotype. Therefore, continuous Cd exposure alters the benign characteristics of fibroid cells in vitro, and Cd exposure could possibly pose a health hazard for women with uterine fibroids.	[Yan, Yitang; Liu, Jingli; Lawrence, Arianna; Dixon, Darlene] Natl Inst Environm Hlth Sci NIEHS, Mol Pathogenesis Group, Mech Toxicol Branch, Div Natl Toxicol Program DNTP,NIH, 111 TW Alexander Dr,POB 12233,Mail Drop B3-06, Res Triangle Pk, NC 27709 USA; [Dykstra, Michael J.] NIEHS, Cellular & Mol Pathogenesis Branch, DNTP, NIH, Res Triangle Pk, NC 27709 USA; [Fannin, Rick; Gerrish, Kevin] NIEHS, Signal Transduct Lab, Mol Genom Core Lab, NIH, Res Triangle Pk, NC 27709 USA; [Tucker, Charles J.; Scappini, Erica] NIEHS, Signal Transduct Lab, Fluorescence Microscopy & Imaging Ctr, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dixon, D (corresponding author), Natl Inst Environm Hlth Sci NIEHS, Mol Pathogenesis Group, Mech Toxicol Branch, Div Natl Toxicol Program DNTP,NIH, 111 TW Alexander Dr,POB 12233,Mail Drop B3-06, Res Triangle Pk, NC 27709 USA.	dixon@niehs.nih.gov	Liu, Jingli/ABU-8123-2022; Liu, Jingli/GQH-2490-2022		HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [ES021196-27]	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: ES021196-27	Ali I, 2010, ENVIRON HEALTH PERSP, V118, P1389, DOI 10.1289/ehp.1001967; Appunni S, 2019, CLIN CHIM ACTA, V491, P1, DOI 10.1016/j.cca.2019.01.003; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Castro Lysandra, 2016, Expert Opin Environ Biol, V5, DOI 10.4172/2325-9655.S1-003; Ciebiera M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112435; Dykstra MJ., 2010, MICROSCOPY TODAY, V18, P50; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elinder C-G, 1985, CADMIUM HLTH TOXICOL, P81; Furuta S, 2018, ELIFE, V7, DOI 10.7554/eLife.26148; Gao XH, 2015, ENVIRON HEALTH PERSP, V123, P331, DOI 10.1289/ehp.1408234; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Lai Jin-Ping, 2008, J Gastrointest Cancer, V39, P149, DOI 10.1007/s12029-009-9058-y; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Liu JL, 2019, ARCH TOXICOL, V93, P2773, DOI 10.1007/s00204-019-02544-0; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; Lu JR, 2019, CANCER METAST REV, V38, P157, DOI 10.1007/s10555-019-09794-5; Luevano J, 2014, J ENVIRON PATHOL TOX, V33, P183, DOI 10.1615/JEnvironPatholToxicolOncol.2014011075; Murphy-Ullrich JE, 2018, MATRIX BIOL, V68-69, P28, DOI 10.1016/j.matbio.2017.12.009; Naito Zenya, 2005, Journal of Nippon Medical School, V72, P137, DOI 10.1272/jnms.72.137; NOGAWA K, 1986, ENVIRON RES, V40, P251, DOI 10.1016/S0013-9351(86)80101-3; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Pollack Anna Z, 2014, Curr Environ Health Rep, V1, P172; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rahimzadeh MR, 2017, CASP J INTERN MED, V8, P135, DOI 10.22088/cjim.8.3.135; Satarug S, 2018, TOXICS, V6, DOI 10.3390/toxics6010015; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Tian R, 2018, INT J ONCOL, V52, P1198, DOI 10.3892/ijo.2018.4267; WAALKES MP, 1994, FUND APPL TOXICOL, V23, P21, DOI 10.1006/faat.1994.1074; Yan YT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186078; Ye S, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0178-8; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zois CE, 2016, J MOL MED, V94, P137, DOI 10.1007/s00109-015-1377-9	37	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21738	10.1096/fj.202100354R	http://dx.doi.org/10.1096/fj.202100354R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245615	Green Published			2022-12-28	WOS:000678975300026
J	Lian, CL; Huang, QZ; Zhong, XY; He, ZY; Liu, BY; Zeng, HJ; Xu, NB; Yang, Z; Liao, CX; Fu, Z; Guo, HB				Lian, Changlin; Huang, Qiongzhen; Zhong, Xiangyang; He, Zhenyan; Liu, Boyang; Zeng, Huijun; Xu, Ningbo; Yang, Zhao; Liao, Chenxin; Fu, Zhao; Guo, Hongbo			Pentraxin 3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis	FASEB JOURNAL			English	Article						apoptosis; dopaminergic neuron; human adipose-derived mesenchymal stem cells; Parkinson's disease; pentraxin 3	CONDITIONED MEDIUM; MODEL; INJURY; PTX3; NEUROGENESIS; RECEPTORS; PROTECTS; DEATH	Although adipose-derived human mesenchymal stem cell (hADSC) transplantation has recently emerged as a promising therapeutic modality for Parkinson's disease (PD), its underlying mechanism of action has not been fully elucidated. This study evaluated the therapeutic effects of stereotaxic injection of hADSCs in the striatum of the 6-OHDA-induced mouse model. Furthermore, an in vitro PD model was constructed using tissue-organized brain slices. The therapeutic effect was also evaluated using a co-culture of the hADSCs and 6-OHDA-treated brain slice. The analysis of hADSC exocrine proteins using RNA-sequencing, human protein cytokine arrays, and label-free quantitative proteomics identified key extracellular factors in the hADSC secretion environment. The degeneration and apoptosis of the dopaminergic neurons were measured in the PD samples in vivo and in vitro, and the beneficial effects were evaluated using quantitative reverse transcription-polymerase chain reaction, western blotting, Fluoro-Jade C, TUNEL assay, and immunofluorescence analysis. This study found that hADSCs protected the dopaminergic neurons in the in vivo and vitro models. We identified Pentraxin 3 (PTX3) as a key extracellular factor in the hADSC secretion environment. Moreover, we found that human recombinant PTX3 (rhPTX3) treatment could rescue the pathophysiological behavior of the PD mice in vivo, prevent dopaminergic neuronal death, and increase neuronal terminals in the ventral tegmental area + substantia nigra pars compacta and striatum in the PD brain slices in vitro. Furthermore, testing of the pro-apoptotic markers in the PD mouse brain following rhPTX3 treatment revealed that rhPTX3 can prevent apoptosis and degeneration of the dopaminergic neurons. This study discovered that PTX3, a hADSC-secreted protein, potentially protected the dopaminergic neurons against apoptosis and degeneration during PD progression and improved motor performance in PD mice, indicating the possible mechanism of action of hADSC replacement therapy for PD. Thus, our study discovered potential translational implications for the development of PTX3-based therapeutics for PD.	[Lian, Changlin; Huang, Qiongzhen; Zhong, Xiangyang; Liu, Boyang; Zeng, Huijun; Xu, Ningbo; Yang, Zhao; Liao, Chenxin; Fu, Zhao; Guo, Hongbo] Southern Med Univ, Zhujiang Hosp,Guangdong Prov Key Lab Brain Funct, Neurosurg Inst Guangdong Prov,Minist China Diag &, Neurosurg Ctr,Natl Key Clin Specialty,Engn Techno, 253 Gongye Middle Ave, Guangzhou 510280, Guangdong, Peoples R China; [He, Zhenyan] Zhengzhou Univ, Affiliated Tumor Hosp, Dept Neurosurg, Zhengzhou, Peoples R China	Southern Medical University - China; Zhengzhou University	Guo, HB (corresponding author), Southern Med Univ, Zhujiang Hosp,Guangdong Prov Key Lab Brain Funct, Neurosurg Inst Guangdong Prov,Minist China Diag &, Neurosurg Ctr,Natl Key Clin Specialty,Engn Techno, 253 Gongye Middle Ave, Guangzhou 510280, Guangdong, Peoples R China.	guohongbo911@126.com	Xu, Ningbo/Q-3820-2017	Xu, Ningbo/0000-0001-9055-3597	Natural Science Foundation of Guangdong Province-Major Basic Cultivation Project [2017A030308001]; National Natural Science Foundation of China [81874079, 81672477]; Guangdong Province Science and Technology Innovation Strategy Special Fund [2018A030310422]; Guangdong Medical Science and Technology Research Fund [A2018542]; Key development and promotion project of Henan province [212102310662]	Natural Science Foundation of Guangdong Province-Major Basic Cultivation Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Innovation Strategy Special Fund; Guangdong Medical Science and Technology Research Fund; Key development and promotion project of Henan province	This study was supported by the Natural Science Foundation of Guangdong Province-Major Basic Cultivation Project (Grant/Award Numbers: 2017A030308001), the National Natural Science Foundation of China, (Grant/Award Numbers: 81874079, 81672477), Guangdong Province Science and Technology Innovation Strategy Special Fund (2018A030310422), Guangdong Medical Science and Technology Research Fund (A2018542), and Key development and promotion project of Henan province (No. 212102310662)	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360; Bacakova L, 2018, BIOTECHNOL ADV, V36, P1111, DOI 10.1016/j.biotechadv.2018.03.011; Balestrino R, 2020, EUR J NEUROL, V27, P27; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Cai Y, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01831-3; Cappuzzello C, 2016, J INVEST DERMATOL, V136, P293, DOI 10.1038/JID.2015.346; Cavaliere F, 2010, J NEUROSCI METH, V188, P205, DOI 10.1016/j.jneumeth.2010.02.008; Croft CL, 2019, J EXP MED, V216, P539, DOI 10.1084/jem.20182184; Fang B, 2019, J CELL MOL MED, V23, P4244, DOI 10.1111/jcmm.14314; Garlanda C, 2018, PHYSIOL REV, V98, P623, DOI 10.1152/physrev.00016.2017; Glavaski-Joksimovic A, 2013, EXP NEUROL, V247, P25, DOI 10.1016/j.expneurol.2013.03.016; Hartmann A, 2002, NEUROLOGY, V58, P308, DOI 10.1212/WNL.58.2.308; Hernandez-Baltazar D, 2017, NEUROLOGIA, V32, P533, DOI 10.1016/j.nrl.2015.06.011; Humpel Christian, 2018, Curr Protoc Immunol, V123, pe59, DOI 10.1002/cpim.59; Kress GJ, 2005, NEUROBIOL DIS, V20, P639, DOI 10.1016/j.nbd.2005.04.019; Lee HW, 2011, MOVEMENT DISORD, V26, P2364, DOI 10.1002/mds.23871; Lee HH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195758; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Nakhaeifard M, 2018, CELL J, V20, P348, DOI 10.22074/cellj.2018.5343; Palomares T, 2018, MOL NEUROBIOL, V55, P13, DOI 10.1007/s12035-017-0714-0; Pan Q, 2015, J KOREAN NEUROSURG S, V57, P82, DOI 10.3340/jkns.2015.57.2.82; Park HJ, 2016, ACTA NEUROPATHOL, V132, P685, DOI 10.1007/s00401-016-1605-6; Park HJ, 2014, NEUROBIOL AGING, V35, P1920, DOI 10.1016/j.neurobiolaging.2014.01.028; Park HW, 2015, J NEUROSCI RES, V93, P1814, DOI 10.1002/jnr.23616; Pires AO, 2017, PROG NEUROBIOL, V156, P69, DOI 10.1016/j.pneurobio.2017.04.006; Pu CM, 2017, J INVEST DERMATOL, V137, P1353, DOI 10.1016/j.jid.2016.12.030; Rafat A, 2019, CELL J, V20, P450, DOI 10.22074/cellj.2019.5507; Rajkovic I, 2018, J MOL MED, V96, P1319, DOI 10.1007/s00109-018-1698-6; Schneider-Brachert W, 2013, INT J MOL SCI, V14, P14475, DOI 10.3390/ijms140714475; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Schwerk A, 2015, CYTOTHERAPY, V17, P199, DOI 10.1016/j.jcyt.2014.09.005; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Tran C, 2015, ADV DRUG DELIVER REV, V82-83, P1, DOI 10.1016/j.addr.2014.10.007; Tysnes OB, 2017, J NEURAL TRANSM, V124, P901, DOI 10.1007/s00702-017-1686-y; Venderova K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009365; Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Xue JH, 2019, MAT SCI ENG C-MATER, V100, P584, DOI 10.1016/j.msec.2019.03.024; Zhang C, 2017, REDOX BIOL, V11, P1, DOI 10.1016/j.redox.2016.10.019; Zhou C, 2020, NEURAL REGEN RES, V15, P2318, DOI 10.4103/1673-5374.285001	42	4	4	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21748	10.1096/fj.202100408RR	http://dx.doi.org/10.1096/fj.202100408RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34152016	hybrid			2022-12-28	WOS:000667814100023
J	Liu, LW; Yu, HS; Long, Y; You, ZF; Ogawa, R; Du, YN; Huang, CY				Liu, Longwei; Yu, Hongsheng; Long, Yi; You, Zhifeng; Ogawa, Rei; Du, Yanan; Huang, Chenyu			Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression	FASEB JOURNAL			English	Article						ASPN; fibroblast; fibrosis; intercellular mechanocommunication; keloid	EXTRACELLULAR-MATRIX; HYPERTROPHIC SCARS; GASTRIC-CANCER; GROWTH-FACTOR; EXPRESSION; PATTERN; TENSION; CD44; MECHANOTRANSDUCTION; MECHANOBIOLOGY	Keloids are fibrotic lesions that grow unceasingly and invasively and are driven by local mechanical stimuli. Unlike other fibrotic diseases and normal wound healing, keloids exhibit little transformation of dermal fibroblasts into alpha-SMA(+) myofibroblasts. This study showed that asporin is the most strongly expressed gene in keloids and its gene-ontology terms relate strongly to ECM metabolism/organization. Experiments with human dermal cells (HDFs) showed that asporin overexpression/treatment abrogated the HDF ability to adopt a perpendicular orientation when subjected to stretching tension. It also induced calcification of the surrounding 3D collagen matrix. Asporin overexpression/treatment also prevented the HDFs from remodeling the surrounding 3D collagen matrix, leading to a disorganized network of thick, wavy collagen fibers that resembled keloid collagen architecture. This in turn impaired the ability of the HDFs to contract the collagen matrix. Asporin treatment also made the fibroblasts impervious to the fibrous collagen contraction of alpha-SMA(+) myofibroblasts, which normally activates fibroblasts. Thus, by calcifying collagen, asporin prevents fibroblasts from linearly rearranging the surrounding collagen; this reduces both their mechanosensitivity and mechanosignaling to each other through the collagen network. This blocks fibroblast activation and differentiation into the mature myofibroblasts that efficiently remodel the extracellular matrix. Consequently, the fibroblasts remain immature, highly proliferative, and continue laying down abundant extracellular matrix, causing keloid growth and invasion. Notably, dermal injection of asporin-overexpressing HDFs into murine wounds recapitulated keloid collagen histopathological characteristics. Thus, disrupted interfibroblast mechanocommunication may promote keloid progression. Asporin may be a new diagnostic biomarker and therapeutic target for keloids.	[Liu, Longwei; Yu, Hongsheng; Long, Yi; You, Zhifeng; Du, Yanan] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Ogawa, Rei] Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Tokyo, Japan; [Huang, Chenyu] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Dermatol, Beijing 102218, Peoples R China	Tsinghua University; Nippon Medical School; Tsinghua University	Du, YN (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.; Huang, CY (corresponding author), Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Dermatol, Beijing 102218, Peoples R China.	duyanan@tsinghua.edu.cn; huangchenyu@tsinghua.edu.cn	You, zhifeng/GZH-2746-2022; Huang, Chenyu/I-4410-2018; HUANG, CHENYU/GVT-7299-2022; Liu, Longwei/GNP-0820-2022	You, zhifeng/0000-0002-8983-5041; Huang, Chenyu/0000-0001-9521-5650; Liu, Longwei/0000-0003-4229-9066; Yu, Hongsheng/0000-0001-7296-1538	Beijing Natural Science Foundation [JQ18022]; National Key R&D Program of China [2016YFC1000810]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Key R&D Program of China	Beijing Natural Science Foundation, Grant/Award Number: JQ18022; National Key R&D Program of China, Grant/Award Number: 2016YFC1000810	Akaishi S, 2008, ANN PLAS SURG, V60, P445, DOI 10.1097/SAP.0b013e3181238dd7; Amadeu T, 2003, PATHOL RES PRACT, V199, P469, DOI 10.1078/0344-0338-00447; Arjunan S, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01609-7; Arno AI, 2014, BURNS, V40, P1255, DOI 10.1016/j.burns.2014.02.011; Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/NMAT4444, 10.1038/nmat4444]; Bot PT, 2013, CURR VASC PHARMACOL, V11, P13; Boyce DE, 2001, BRIT J PLAST SURG, V54, P511, DOI 10.1054/bjps.2001.3638; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Chen L, 2020, FASEB J, V34, P13125, DOI 10.1096/fj.202000380RR; Coentro JQ, 2019, ADV DRUG DELIVER REV, V146, P37, DOI 10.1016/j.addr.2018.08.009; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Di Marco E, 2016, CLIN SCI, V130, P1363, DOI 10.1042/CS20160249; Ding Q, 2015, ONCOL REP, V33, P1783, DOI 10.3892/or.2015.3791; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Eckhardt A, 2019, J ORTHOP RES, V37, P769, DOI 10.1002/jor.24211; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Hsu CK, 2018, J INVEST DERMATOL, V138, P208, DOI 10.1016/j.jid.2017.05.041; Huang C, 2017, BRIT J DERMATOL, V177, P1248, DOI 10.1111/bjd.15576; Huang CY, 2020, FASEB J, V34, P13171, DOI 10.1096/fj.202001157R; Huang CY, 2019, INT WOUND J, V16, P852, DOI 10.1111/iwj.13104; Huang CY, 2017, INT WOUND J, V14, P764, DOI 10.1111/iwj.12693; Huang CY, 2013, J PLAST RECONSTR AES, V66, pE351, DOI 10.1016/j.bjps.2013.08.002; Huang CY, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0b013e31829c4597; Huang CY, 2013, TRENDS MOL MED, V19, P555, DOI 10.1016/j.molmed.2013.05.005; Huang CY, 2014, INT WOUND J, V11, P517, DOI 10.1111/j.1742-481X.2012.01118.x; Huang CY, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-60; Huang CY, 2012, ARCH DERMATOL RES, V304, P589, DOI 10.1007/s00403-012-1278-5; Huang CY, 2012, AESTHET PLAST SURG, V36, P387, DOI 10.1007/s00266-011-9821-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; KELLY AP, 1988, DERMATOL CLIN, V6, P413, DOI 10.1016/S0733-8635(18)30653-3; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Lee TY, 1999, ANN PLAS SURG, V43, P179; Lin HH, 2015, ONCOTARGET, V6, P20946, DOI 10.18632/oncotarget.4173; Liu LW, 2020, P NATL ACAD SCI USA, V117, P10832, DOI 10.1073/pnas.1910650117; Liu LW, 2017, NAT MATER, V16, P1252, DOI [10.1038/NMAT5024, 10.1038/nmat5024]; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Louw L, 2000, PROSTAG LEUKOTR ESS, V63, P237, DOI 10.1054/plef.2000.0207; Ma XY, 2013, BIOPHYS J, V104, P1410, DOI 10.1016/j.bpj.2013.02.017; Maris P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001871; Mochimaru H, 2009, INVEST OPHTH VIS SCI, V50, P4410, DOI 10.1167/iovs.08-3044; Ogawa R, 2011, J NIPPON MED SCH, V78, P68, DOI 10.1272/jnms.78.68; Ong CT, 2010, BRIT J DERMATOL, V162, P1302, DOI 10.1111/j.1365-2133.2010.09660.x; Osman OS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-260; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rochette A, 2017, BRIT J CANCER, V116, P775, DOI 10.1038/bjc.2017.15; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen WY, 1998, BRIT J OPHTHALMOL, V82, P1063, DOI 10.1136/bjo.82.9.1063; Shih Barbara, 2010, Eplasty, V10, pe24; Simkova D, 2016, ONCOTARGET, V7, P52045, DOI 10.18632/oncotarget.10471; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tan S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01810; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Wang HL, 2014, BIOPHYS J, V107, P2592, DOI 10.1016/j.bpj.2014.09.044; Wang LL, 2017, CANCER LETT, V398, P24, DOI 10.1016/j.canlet.2017.04.001; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang ZC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.603187; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yu MH, 2017, KOREAN J RADIOL, V18, P323, DOI 10.3348/kjr.2017.18.2.323; Ziyrek M, 2015, BALK MED J, V32, P377, DOI 10.5152/balkanmedj.2015.15707	70	8	8	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21705	10.1096/fj.202100111R	http://dx.doi.org/10.1096/fj.202100111R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105826				2022-12-28	WOS:000667814100020
J	Sanchez-Alegria, K; Bastian-Eugenio, CE; Vaca, L; Arias, C				Sanchez-Alegria, Karina; Ernesto Bastian-Eugenio, Carlos; Vaca, Luis; Arias, Clorinda			Palmitic acid induces insulin resistance by a mechanism associated with energy metabolism and calcium entry in neuronal cells	FASEB JOURNAL			English	Article						intraneuronal Ca2+; neuronal insulin resistance; neuronal beta-oxidation; palmitic acid; PKC activation	FREE FATTY-ACIDS; PANCREATIC BETA-CELLS; K-ATP CHANNELS; ENDOPLASMIC-RETICULUM; GLUCOSE-PRODUCTION; ACTIVATION; BRAIN; RECEPTOR; PHOSPHORYLATION; GPR40	Palmitic acid (PA) is a saturated fatty acid whose high consumption has been largely associated with the development of different metabolic alterations, such as insulin resistance, metabolic syndrome, and type 2 diabetes. Particularly in the brain, insulin signaling disruption has been linked to cognitive decline and is considered a risk factor for Alzheimer's disease. Cumulative evidence has demonstrated the participation of PA in the molecular cascade underlying cellular insulin resistance in peripheral tissues, but its role in the development of neuronal insulin resistance and the mechanisms involved are not fully understood. It has generally been accepted that the brain does not utilize fatty acids as a primary energy source, but recent evidence shows that neurons possess the machinery for fatty acid beta-oxidation. However, it is still unclear under what conditions neurons use fatty acids as energy substrates and the implications of their oxidative metabolism in modifying insulin-stimulated effects. In the present work, we have found that neurons differentiated from human neuroblastoma MSN exposed to high but nontoxic concentrations of PA generate ATP through mitochondrial metabolism, which is associated with an increase in the cytosolic Ca2+ and diminished insulin signaling in neurons. These findings reveal a novel mechanism by which saturated fatty acids produce Ca2+ entry and insulin resistance that may play a causal role in increasing neuronal vulnerability associated with metabolic diseases.	[Sanchez-Alegria, Karina; Arias, Clorinda] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, AP 70-228, Ciudad De Mexico 04510, Mexico; [Ernesto Bastian-Eugenio, Carlos; Vaca, Luis] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Arias, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, AP 70-228, Ciudad De Mexico 04510, Mexico.	carias@unam.mx		Vaca, Luis/0000-0003-2266-4847	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [A1-S9559]; UNAMDireccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM) [IN202318]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAMDireccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM)	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Grant/Award Number: A1-S9559; UNAMDireccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM), Grant/Award Number: IN202318	Alfonzo-Mendez MA, 2018, BBA-MOL CELL RES, V1865, P842, DOI 10.1016/j.bbamcr.2018.03.006; Ardestani A, 2018, TRENDS ENDOCRIN MET, V29, P737, DOI 10.1016/j.tem.2018.07.003; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Busquets O, 2017, MECH AGEING DEV, V162, P38, DOI 10.1016/j.mad.2016.11.002; Calvo-Ochoa E, 2017, NEUROCHEM INT, V110, P75, DOI 10.1016/j.neuint.2017.09.008; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Chudobaa C, 2019, BIOL CHEM, V400, P991, DOI 10.1515/hsz-2018-0477; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; Clore JN, 2002, METABOLISM, V51, P1471, DOI 10.1053/meta.2002.35202; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dhopeshwarkar G A, 1973, Adv Lipid Res, V11, P109; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Flores-Leon M, 2019, NEUROCHEM RES, V44, P1745, DOI 10.1007/s11064-019-02810-8; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Grant W B, 1999, J Alzheimers Dis, V1, P197; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Hromadkova L, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118737; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jo YH, 2009, J NEUROPHYSIOL, V101, P2305, DOI 10.1152/jn.91294.2008; Kim JY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04175-w; Kishore P, 2011, J CLIN INVEST, V121, P4916, DOI 10.1172/JCI58035; Kumar A, 2009, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.002.2009; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Lipp P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004556; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Liu ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184818; Liu ZG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05217-z; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McFadden JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115642; McLean FH, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0352-9; Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005; Melo HM, 2020, CELL REP, V30, P2180, DOI 10.1016/j.celrep.2020.01.072; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Panov A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472459; Hernandez-Caceres MP, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00176; Pearson-Leary J, 2018, BEHAV BRAIN RES, V338, P32, DOI 10.1016/j.bbr.2017.09.033; Pereira SS, 2014, CURR OBES REP, V3, P422, DOI 10.1007/s13679-014-0124-9; Pilitsis JG, 2001, NEUROCHEM RES, V26, P1265, DOI 10.1023/A:1014227231130; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Ribeiro MC, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00067; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Sanchez-Alegria K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123725; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Spinelli M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02221-9; Sun XL, 2010, J NEUROCHEM, V112, P377, DOI 10.1111/j.1471-4159.2009.06450.x; Choi E, 2007, MOL CELL ENDOCRINOL, V272, P50, DOI 10.1016/j.mce.2007.04.004; Takahashi S, 2014, ASN NEURO, V6, DOI 10.1177/1759091414550997; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	72	4	5	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21712	10.1096/fj.202100243R	http://dx.doi.org/10.1096/fj.202100243R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110637				2022-12-28	WOS:000667814100036
J	Li, MS; Li, XP; Wang, D; Gao, XL; Li, SY; Cheng, XJ; Shen, YM; Li, SH; Jia, Q; Liu, Q				Li, Minshu; Li, Xiuping; Wang, Dan; Gao, Xiaolin; Li, Shiyao; Cheng, Xiaojing; Shen, Yiming; Li, Shenghui; Jia, Qiang; Liu, Qiang			Inhibition of exosome release augments neuroinflammation following intracerebral hemorrhage	FASEB JOURNAL			English	Article						exosome; intracerebral hemorrhage; immunity; neuroinflammation	NERVOUS-SYSTEM; BRAIN-INJURY; MOUSE MODEL; NEUTROPHIL; CELL; POLARIZATION; MICRORNAS; VESICLES	Intracerebral hemorrhage (ICH) is a severe stroke subtype without effective pharmacological treatment. Following ICH, peripheral leukocytes infiltrate into the brain and contribute to neuroinflammation and brain edema. However, the intercellular machinery controlling the initiation and propagation of leukocyte infiltration remains elusive. Exosomes are small extracellular vesicles released from donor cells and bridge intercellular communication. In this study, we investigated the effects of inhibition of exosome release on neuroinflammation and ICH injury. Using a mouse model of ICH induced by collagenase injection, we found that ICH induced an increase of exosome level in the brain. Inhibition of exosome release using GW4869 augmented neurological deficits and brain edema after ICH. The exacerbation of ICH injury was accompanied by increased barrier disruption and brain infiltration of leukocytes. The detrimental effects of GW4869 were ablated in ICH mice receiving antibody depletion of Gr-1(+) myeloid cells. Extracted exosomes from the ICH brains suppressed the production of inflammatory factors by splenocytes. Additionally, exosomes extracted from brain tissues of donor ICH mice reduced ICH injury in recipient mice. These results demonstrate that inhibition of exosome release augments neuroinflammation and ICH injury. The impact of exosomes released from the ICH brain on the immune system deserves further investigation.	[Li, Minshu; Wang, Dan; Gao, Xiaolin; Li, Shiyao; Cheng, Xiaojing; Liu, Qiang] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Li, Minshu; Li, Shenghui; Liu, Qiang] Minist Educ, Tianjin Neurol Inst, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin, Peoples R China; [Li, Xiuping] Shanxi Med Univ, Dept Neurol, Hosp 1, Taiyuan, Peoples R China; [Shen, Yiming; Jia, Qiang] Tianjin Med Univ Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China; [Shen, Yiming; Li, Shenghui; Jia, Qiang; Liu, Qiang] Tianjin Med Univ Gen Hosp, Preclin Multimodal Mol Imaging Ctr, Tianjin, Peoples R China	Tianjin Medical University; Shanxi Medical University; Tianjin Medical University; Tianjin Medical University	Liu, Q (corresponding author), Tianjin Med Univ Gen Hosp, Preclin Multimodal Mol Imaging Ctr, Tianjin, Peoples R China.	qliu@tmu.edu.cn	Shen, Yi/GRS-3602-2022; Liu, Qiang/HHZ-3181-2022		Natural Science Foundation of Tianjin [18JCZDJC97600, 20JCYBJC00400]; National Natural Science Foundation of China [81701176, 82071327]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of Tianjin (18JCZDJC97600, 20JCYBJC00400) and the National Natural Science Foundation of China (81701176, 82071327).	Catalano M, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1703244; Chaput N, 2005, EXPERT OPIN BIOL TH, V5, P737, DOI 10.1517/14712598.5.6.737; Chauhan A, 2018, NEUROBIOL AGING, V61, P102, DOI 10.1016/j.neurobiolaging.2017.09.022; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Duan SR, 2020, DRUG DES DEV THER, V14, P3143, DOI [10.2147/DDDT.S255628, 10.2147/DDDT.S255828]; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gao G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00161; Ge XT, 2020, MOL THER, V28, P503, DOI 10.1016/j.ymthe.2019.11.017; Han YX, 2019, J NEUROSURG, V131, P290, DOI 10.3171/2018.2.JNS171475; Harrell CR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121605; Jiang DD, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00665-8; Jin WN, 2021, NAT NEUROSCI, V24, P61, DOI 10.1038/s41593-020-00745-w; Joya A, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/2483078; Kalani A, 2014, MOL NEUROBIOL, V49, P590, DOI 10.1007/s12035-013-8544-1; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Li H, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.116951; Li MS, 2017, FASEB J, V31, P3278, DOI 10.1096/fj.201601377RR; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Li XP, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00154; Li XP, 2019, INT IMMUNOPHARMACOL, V72, P473, DOI 10.1016/j.intimp.2019.04.029; Li ZG, 2020, J EXP MED, V217, DOI 10.1084/jem.20200213; Liu WY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00240; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Otero-Ortega L, 2018, J CEREBR BLOOD F MET, V38, P767, DOI 10.1177/0271678X17708917; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Ren HL, 2018, STROKE, V49, P184, DOI 10.1161/STROKEAHA.117.018904; Sansing LH, 2011, ACTA NEUROCHIR SUPPL, V111, P173, DOI 10.1007/978-3-7091-0693-8_29; Soria FN, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00026; Sun W, 2018, ACTA PHARMACOL SIN, V39, P534, DOI 10.1038/aps.2018.17; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Xi GH, 2012, TRANSL STROKE RES, V3, pS1, DOI 10.1007/s12975-012-0189-2; Zhang X, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0898-6; Zhao XR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00770-7; Zhao XR, 2014, TRANSL STROKE RES, V5, P554, DOI 10.1007/s12975-014-0341-2; Zhu HM, 2019, PROG NEUROBIOL, V178, P6, DOI 10.1016/j.pneurobio.2019.03.003; Zoller M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01279	42	2	2	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21617	10.1096/fj.202002766R	http://dx.doi.org/10.1096/fj.202002766R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33982343				2022-12-28	WOS:000655695900018
J	Gantert, T; Henkel, F; Wurmser, C; Oeckl, J; Fischer, L; Haid, M; Adamski, J; Esser-von Bieren, J; Klingenspor, M; Fromme, T				Gantert, Thomas; Henkel, Fiona; Wurmser, Christine; Oeckl, Josef; Fischer, Lena; Haid, Mark; Adamski, Jerzy; Esser-von Bieren, Julia; Klingenspor, Martin; Fromme, Tobias			Fibroblast growth factor induced Ucp1 expression in preadipocytes requires PGE2 biosynthesis and glycolytic flux	FASEB JOURNAL			English	Article						Fgf signaling; Fgf8; glucose metabolism; glycolysis; paracrine fibroblast growth factor; PGE(2); preadipocyte; prostaglandin; Ucp1; uncoupling protein 1	BROWN ADIPOSE-TISSUE; FAT; MOUSE; FGF21; MICE; EVOLUTION; ROLES; CELL	High uncoupling protein 1 (Ucp1) expression is a characteristic of differentiated brown adipocytes and is linked to adipogenic differentiation. Paracrine fibroblast growth factor 8b (FGF8b) strongly induces Ucp1 transcription in white adipocytes independent of adipogenesis. Here, we report that FGF8b and other paracrine FGFs act on brown and white preadipocytes to upregulate Ucp1 expression via a FGFR1-MEK1/2-ERK1/2 axis, independent of adipogenesis. Transcriptomic analysis revealed an upregulation of prostaglandin biosynthesis and glycolysis upon Fgf8b treatment of preadipocytes. Oxylipin measurement by LC-MS/MS in FGF8b conditioned media identified prostaglandin E2 as a putative mediator of FGF8b induced Ucp1 transcription. RNA interference and pharmacological inhibition of the prostaglandin E2 biosynthetic pathway confirmed that PGE2 is causally involved in the control over Ucp1 transcription. Importantly, impairment of or failure to induce glycolytic flux blunted the induction of Ucp1, even in the presence of PGE2. Lastly, a screening of transcription factors identified Nrf1 and Hes1 as required regulators of FGF8b induced Ucp1 expression. Thus, we conclude that paracrine FGFs co-regulate prostaglandin and glucose metabolism to induce Ucp1 expression in a Nrf1/Hes1-dependent manner in preadipocytes, revealing a novel regulatory network in control of Ucp1 expression in a formerly unrecognized cell type.	[Gantert, Thomas; Oeckl, Josef; Fischer, Lena; Klingenspor, Martin; Fromme, Tobias] Tech Univ Munich, TUM Sch Life Sci, Dept Mol Nutr Med, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany; [Henkel, Fiona; Esser-von Bieren, Julia] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Helmholtz Ctr Munich, Munich, Germany; [Wurmser, Christine] Tech Univ Munich, TUM Sch Life Sci, Dept Anim Breeding, Freising Weihenstephan, Germany; [Haid, Mark; Adamski, Jerzy] Helmholtz Ctr Munich, Res Unit Mol Endocrinol & Metab, German Res Ctr Environm Hlth, Neuherberg, Germany; [Adamski, Jerzy] German Ctr Diabet Res DZD, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Inst Expt Genet, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Adamski, Jerzy] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Klingenspor, Martin] Tech Univ Munich, EKFZ Else Kroner Fresenius Ctr Nutr Med, Freising Weihenstephan, Germany; [Klingenspor, Martin] Tech Univ Munich, ZIEL Inst Food Hlth, Freising Weihenstephan, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; National University of Singapore; Technical University of Munich; Technical University of Munich	Gantert, T; Fromme, T (corresponding author), Tech Univ Munich, TUM Sch Life Sci, Dept Mol Nutr Med, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany.	thomas.gantert@tum.de; fromme@tum.de	Haid, Mark/J-4304-2019; Fromme, Tobias/AAU-8982-2020; Klingenspor, Martin/D-6930-2011	Haid, Mark/0000-0001-6118-1333; Fromme, Tobias/0000-0001-9150-2513; Adamski, Jerzy/0000-0001-9259-0199; Gantert, Thomas/0000-0002-0945-3167; Klingenspor, Martin/0000-0002-4502-6664; Esser-von Bieren, Julia/0000-0003-1898-9382	German Research Foundation [FR 3628/2--1]	German Research Foundation(German Research Foundation (DFG))	German Research Foundation, Grant/Award Number: FR 3628/2--1	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fresco VM, 2016, J BIOL CHEM, V291, P18730, DOI 10.1074/jbc.M115.702761; Garcia-Alonso V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153751; Gaviraghi M, 2018, EMBO J, V37, DOI 10.15252/embj.201899179; Gemel J, 1996, GENOMICS, V35, P253, DOI 10.1006/geno.1996.0349; Hazebroek MK, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00389; Henkel FDR, 2019, ALLERGY, V74, P1090, DOI 10.1111/all.13700; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jezek P, 2019, BBA-BIOENERGETICS, V1860, P259, DOI 10.1016/j.bbabio.2018.11.007; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Lagarde D, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016303; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; Maddaluno L, 2017, DEVELOPMENT, V144, P4047, DOI 10.1242/dev.152587; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Maurer S, 2021, FEBS J, V288, P3628, DOI 10.1111/febs.15470; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464; Oelkrug R, 2014, FREE RADICAL BIO MED, V77, P210, DOI 10.1016/j.freeradbiomed.2014.09.004; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rulifson IC, 2017, J BIOL CHEM, V292, P1951, DOI 10.1074/jbc.M116.751404; Shamsi F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15055-9; Sun YK, 2019, J MOL ENDOCRINOL, V62, P79, DOI 10.1530/JME-18-0151; Sunmonu NA, 2011, J CELL PHYSIOL, V226, P1722, DOI 10.1002/jcp.22587; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; Uchii M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2474; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang H, 2019, MOL METAB, V20, P14, DOI 10.1016/j.molmet.2018.11.009; Westphal S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44878-w; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	43	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21572	10.1096/fj.202002795R	http://dx.doi.org/10.1096/fj.202002795R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826782	hybrid			2022-12-28	WOS:000645260100046
J	Ghosh, S; Lewis, KN; Tulsian, R; Astafev, AA; Buffenstein, R; Kondratov, RV				Ghosh, Soumyaditya; Lewis, Kaitlyn N.; Tulsian, Richa; Astafev, Artem A.; Buffenstein, Rochelle; Kondratov, Roman, V			It's about time; divergent circadian clocks in livers of mice and naked mole-rats	FASEB JOURNAL			English	Article						aging; circadian rhythms; clock; glucose metabolism; longevity; mTOR; naked mole-rat	RHYTHMS; METABOLISM; MTOR; COMPONENTS; GLYCOLYSIS; AKT	Light is the key regulator of circadian clock, the time-keeping system synchronizing organism physiology and behavior with environmental day and night conditions. In its natural habitat, the strictly subterranean naked mole-rat (Heterocephalus glaber) has lived in a light-free environment for millennia. We questioned if this species retains a circadian clock and if the patterns of this clock and concomitant rhythms differed in liver tissue from mice and naked mole-rats. As expected, in mice, the various circadian clock genes peaked at different times of the day; the Period gene (Per) group peaked in the evening, whereas Brain and Muscle ARNT-like1 (Bmal1) gene peaked in the morning; this phase shift is considered to be fundamental for circadian clock function. In sharp contrast, in the naked mole-rat both Per1 and Per2, as well as Bmal1, peaked at the same time in the morning-around ZT2-suggesting the organization of the molecular circadian oscillator was different. Moreover, gene expression rhythms associated with glucose metabolism and mTOR signaling also differed between the species. Although the activity of mTORC1 was lower, while that of mTORC2 was higher in naked mole-rat livers compared to mice, unlike that of mice where the expression profiles of glucose metabolism genes were not synchronized, these were highly synchronized in naked mole-rats and likely linked to their use of feeding times at zeitgebers.	[Ghosh, Soumyaditya; Tulsian, Richa; Astafev, Artem A.; Kondratov, Roman, V] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, BGES Dept, 2121 Euclid Ave,SR271, Cleveland, OH 44115 USA; [Lewis, Kaitlyn N.; Buffenstein, Rochelle] UTHSCSA, Barshop Inst Aging & Longev Studies, San Antonio, TX USA; [Buffenstein, Rochelle] Calico Life Sci LLC, San Francisco, CA USA	University System of Ohio; Cleveland State University; University of Texas System; University of Texas Health San Antonio	Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, BGES Dept, 2121 Euclid Ave,SR271, Cleveland, OH 44115 USA.	r.kondratov@csuohio.edu			HHS | National Institutes of Health (NIH) [R01AG039547]; HHS | NIH | National Institute on Aging (NIA) [T32AG021890, R01AG022891]; Cleveland State University (CSU)	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cleveland State University (CSU)	HHS | National Institutes of Health (NIH), Grant/Award Number: R01AG039547; HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: T32AG021890 and R01AG022891; Cleveland State University (CSU), Grant/Award Number: D.R.A.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bozek K, 2010, BIOSYSTEMS, V102, P61, DOI 10.1016/j.biosystems.2010.07.010; Brett R.A., 1991, P137; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R., 2021, ADV EXPT MED BIOL, V1319; Buffenstein R., 2000, LIFE UNDERGROUND BIO; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cribbet MR, 2016, ANN NY ACAD SCI, V1385, P21, DOI 10.1111/nyas.13188; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAVISWALTON J, 1994, NATURWISSENSCHAFTEN, V81, P272, DOI 10.1007/s001140050071; Dominick G, 2015, ENDOCRINOLOGY, V156, P565, DOI 10.1210/en.2014-1690; Fang XD, 2014, CELL REP, V8, P1354, DOI 10.1016/j.celrep.2014.07.030; Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9; Gaun A, 2021, J PROTEOME RES, V20, P1280, DOI 10.1021/acs.jproteome.0c00681; Giebultowicz J, 2010, CURR BIOL, V20, pR608, DOI 10.1016/j.cub.2010.05.052; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kim SM, 2018, FASEB J, V32, P3085, DOI 10.1096/fj.201700784R; Lavocat V., 2013, EVOLUTION AFRICAN MA, P69, DOI [10.4159/harvard.9780674431263.c6, DOI 10.4159/HARVARD.9780674431263.C6]; Lee BP, 2020, GEROSCIENCE, V42, P633, DOI 10.1007/s11357-019-00150-7; Li S, 2015, DIABETES OBES METAB, V17, P33, DOI 10.1111/dom.12520; Meyuhas O, 2015, INT REV CEL MOL BIO, V320, P41, DOI 10.1016/bs.ircmb.2015.07.006; Millius A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00025; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mukherji A, 2015, P NATL ACAD SCI USA, V112, pE6691, DOI 10.1073/pnas.1519807112; Nojima A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069178; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park TJ, 2017, SCIENCE, V356, P305, DOI 10.1126/science.aab3896; QUAY WB, 1981, J NEURAL TRANSM, V52, P107, DOI 10.1007/BF01253102; Riccio AP, 2000, PHYSIOL BEHAV, V71, P15, DOI 10.1016/S0031-9384(00)00280-8; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Ruby JG, 2018, ELIFE, V7, DOI 10.7554/eLife.31157; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Smith MRB., 2021, ADV EXPT MED BIOL, V1319; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wegrzyn LR, 2017, AM J EPIDEMIOL, V186, P532, DOI 10.1093/aje/kwx140; Xie J, 2014, TRANSLATION, V2, DOI 10.4161/trla.28174; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	48	3	3	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21590	10.1096/fj.202100116R	http://dx.doi.org/10.1096/fj.202100116R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871093	Green Accepted			2022-12-28	WOS:000645260100024
J	Bottemanne, P; Paquot, A; Ameraoui, H; Guillemot-Legris, O; Alhouayek, M; Muccioli, GG				Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Guillemot-Legris, Owein; Alhouayek, Mireille; Muccioli, Giulio G.			25-Hydroxycholesterol metabolism is altered by lung inflammation, and its local administration modulates lung inflammation in mice	FASEB JOURNAL			English	Article						25&#8208; HC; ARDS; cholesterol&#8208; 25&#8208; hydroxylase; corticosteroid; leukotrienes; pneumonia		Inflammation is a critical component of many lung diseases including asthma and acute lung injury (ALI). Using high-performance liquid chromatography-mass spectrometry, we quantified the levels of oxysterols in two different murine models of lung diseases. These are lipid mediators derived from cholesterol and known to modulate immunity and inflammation. Interestingly, 25-hydroxycholesterol (25-OHC) was the only oxysterol with altered levels during lung inflammation, and its levels were differently affected according to the model. Therefore, we sought to assess how this oxysterol would affect lung inflammatory responses. In a model of lipopolysaccharide (LPS)-induced acute lung inflammation, 25-OHC levels were increased, and most of the hallmarks of the model (eg, leukocyte recruitment, mRNA expression, and secretion of inflammatory cytokines) were decreased following its intratracheal administration. We also found that, when administered in the lung, 25-OHC is metabolized locally into 25-hydroxycholesterol-3-sulfate and 7 alpha,25-dihydroxycholesterol. Their administration in the lungs did not recapitulate all the effects of 25-OHC. Conversely, in a model of allergic asthma induced by intranasal administration of house dust mites (HDM), 25-OHC levels were decreased, and when intranasally administered, this oxysterol worsened the hallmarks of the model (eg, leukocyte recruitment, tissue remodeling [epithelium thickening and peribranchial fibrosis], and cytokine expression) and induced changes in leukotriene levels. Ex vivo, we found that 25-OHC decreases LPS-induced primary alveolar macrophage activation while having no effect on neutrophil activation. Its sulfated metabolite, 25-hydroxycholesterol-3-sulfate, decreased neutrophil, but not macrophage activation. Taken together, our data support a differential role of 25-OHC in ALI and allergic inflammation models.	[Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Guillemot-Legris, Owein; Alhouayek, Mireille; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Ave E Mounier,72 B1-72-01, B-1200 Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Ave E Mounier,72 B1-72-01, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	; Alhouayek, Mireille/R-5058-2018	Muccioli, Giulio/0000-0002-1600-9259; Alhouayek, Mireille/0000-0002-9193-0718; Paquot, Adrien/0000-0002-4784-3510; Guillemot-Legris, Owein/0000-0003-3738-3423	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Alhouayek M, 2017, BBA-MOL CELL BIOL L, V1862, P474, DOI 10.1016/j.bbalip.2017.01.001; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Alm AS, 2010, RESP PHYSIOL NEUROBI, V171, P157, DOI 10.1016/j.resp.2010.02.009; Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231; Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487; Birrell MA, 2008, J IMMUNOL, V181, P4265, DOI 10.4049/jimmunol.181.6.4265; Bleecker ER, 2018, CHEST, V154, P982, DOI 10.1016/j.chest.2018.08.1022; Bottemanne P, 2019, FASEB J, V33, P7635, DOI 10.1096/fj.201802259R; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Chen JX, 2015, INT IMMUNOPHARMACOL, V25, P43, DOI 10.1016/j.intimp.2015.01.013; Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Claar D, 2015, EXPERT REV RESP MED, V9, P55, DOI 10.1586/17476348.2015.992783; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Farina MG, 2007, REPRODUCTION, V134, P355, DOI 10.1530/REP-07-0078; FrankeUllmann G, 1996, J IMMUNOL, V157, P3097; Ganeshan K, 2013, J IMMUNOL, V190, P5731, DOI 10.4049/jimmunol.1203362; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Guillemot-Legris O, 2019, J CROHNS COLITIS, V13, P218, DOI 10.1093/ecco-jcc/jjy157; Hajek AR, 2008, J ALLERGY CLIN IMMUN, V122, P633, DOI 10.1016/j.jaci.2008.06.021; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hu X, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4652695; Ichikawa T, 2013, EXP CELL RES, V319, P1176, DOI 10.1016/j.yexcr.2013.02.014; Jia J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708349; Koarai A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-63; Kulig W, 2016, CHEM PHYS LIPIDS, V199, P144, DOI 10.1016/j.chemphyslip.2016.03.001; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Li N, 2010, P NATL ACAD SCI USA, V107, P3734, DOI 10.1073/pnas.0911377107; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Madenspacher JH, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137189; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Mutemberezi V, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1114-8; Mutemberezi V, 2016, PROG LIPID RES, V64, P152, DOI 10.1016/j.plipres.2016.09.002; Mutemberezi V, 2016, ANAL BIOANAL CHEM, V408, P733, DOI 10.1007/s00216-015-9150-z; Ning YX, 2017, METABOLISM, V71, P83, DOI 10.1016/j.metabol.2016.12.007; Ninomiya Y, 2007, J STEROID BIOCHEM, V103, P44, DOI 10.1016/j.jsbmb.2006.07.009; Ouyang W, 2018, J CELL MOL MED, V22, P5494, DOI 10.1111/jcmm.13820; Panini SR, 2001, J LIPID RES, V42, P1678; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Perucha E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08332-9; Pokharel SM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09453-x; Ragaller Maximillian, 2010, J Emerg Trauma Shock, V3, P43, DOI 10.4103/0974-2700.58663; Raselli T, 2019, J CROHNS COLITIS, V13, P1186, DOI 10.1093/ecco-jcc/jjz039; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Shen ZJ, 2017, AM J RESP CRIT CARE, V195, P1576, DOI [10.1164/rccm.201608-1580OC, 10.1164/rccm.201608-1580oc]; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092668; Smet M, 2016, IMMUN INFLAMM DIS, V4, P350, DOI 10.1002/iid3.118; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Verheijden KAT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02419; Verheijden KAT, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0171-0; Vigne S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01184; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao ZM, 2016, AM J PATHOL, V186, P2614, DOI 10.1016/j.ajpath.2016.06.018; Zou XL, 2018, THER CLIN RISK MANAG, V14, P1627, DOI 10.2147/TCRM.S172262; Zu SL, 2020, CELL RES, V30, P1043, DOI 10.1038/s41422-020-00398-1	64	9	10	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21514	10.1096/fj.202002555R	http://dx.doi.org/10.1096/fj.202002555R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734509				2022-12-28	WOS:000635216100032
J	Hung, CF; Holton, S; Chow, YH; Liles, WC; Gharib, SA; Altemeier, WA				Hung, Chi F.; Holton, Sarah; Chow, Yu-Hua; Liles, Wayne Conrad; Gharib, Sina A.; Altemeier, William A.			Pericyte-like cells undergo transcriptional reprogramming and distinct functional adaptations in acute lung injury	FASEB JOURNAL			English	Article						acute lung injury; angiogenesis; ANGPTL4; CCR2; lung; inflammation; lung immunity; pericytes; transcriptional profiling		We previously reported on the role of pericyte-like cells as functional sentinel immune cells in lung injury. However, much about the biological role of pericytes in lung injury remains unknown. Lung pericyte-like cells are well-positioned to sense disruption to the epithelial barrier and coordinate local inflammatory responses due to their anatomic niche within the alveoli. In this report, we characterized transcriptional responses and functional changes in pericyte-like cells following activation by alveolar components from injured and uninjured lungs in a mouse model of acute lung injury (ALI). Purified pericyte-like cells from lung digests using PDGFR beta as a selection marker were expanded in culture as previously described (1). We induced sterile acute lung injury in mice with recombinant human Fas ligand (rhFasL) instillation followed by mechanical ventilation (1). We then collected bronchoalveolar lavage fluid (BALF) from injured and uninjured mice. Purified pericyte-like cells in culture were exposed to growth media only (control), BALF from uninjured mice, and BALF from injured mice for 6 and 24 hours. RNA collected from these treatment conditions were processed for RNAseq. Targets of interest identified by pathway analysis were validated using in vitro and in vivo assays. We observed robust global transcriptional changes in pericyte-like cells following treatment with uninjured and injured BALF at 6 hours, but this response persisted for 24 hours only after exposure to injured BALF. Functional enrichment analysis of pericytes treated with injured BALF revealed the activation of pro-inflammatory, cell migration, and angiogenesis-related pathways, whereas processes associated with tissue development and cell differentiation were down-regulated. We validated select upregulated targets in the inflammatory, angiogenic, and cell migratory pathways using functional biological assays in vitro and in vivo. We conclude that lung pericyte-like cells are highly responsive to alveolar compartment content from both uninjured and injured lungs, but injured BALF elicits a more sustained response. The inflammatory, angiogenic, and migratory changes exhibited by activated pericyte-like cells underscore the phenotypic plasticity of these specialized stromal cells in the setting of acute lung injury.	[Hung, Chi F.; Holton, Sarah; Chow, Yu-Hua; Gharib, Sina A.; Altemeier, William A.] Univ Washington, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA USA; [Hung, Chi F.; Holton, Sarah; Chow, Yu-Hua; Liles, Wayne Conrad; Gharib, Sina A.; Altemeier, William A.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Liles, Wayne Conrad] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hung, CF (corresponding author), Univ Washington, Ctr Lung Biol, Div Pulm & Crit Care, Box 358052,850 Republican St, Seattle, WA 98109 USA.	cfhung@uw.edu		Holton, Sarah/0000-0002-6373-3768	National Heart, Lung, and Blood Institute (NHLBI) [K08HL127075, R01HL122895]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K08HL127075 and R01HL122895	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Babapoor-Farrokhran S, 2015, P NATL ACAD SCI USA, V112, pE3030, DOI 10.1073/pnas.1423765112; Coates BM, 2018, J IMMUNOL, V200, P2391, DOI 10.4049/jimmunol.1701543; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Hung CF, 2017, AM J PHYSIOL-LUNG C, V312, pL556, DOI 10.1152/ajplung.00349.2016; Hung CF, 2017, AM J RESP CELL MOL, V56, P160, DOI 10.1165/rcmb.2016-0083MA; Ito Y, 2003, CANCER RES, V63, P6651; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2019, MBIO, V10, DOI 10.1128/mBio.02469-18; Li L, 2015, CELL REP, V10, P654, DOI 10.1016/j.celrep.2015.01.011; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Perdiguero EG, 2016, J PATHOL, V240, P461, DOI 10.1002/path.4805; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Stapor PC, 2014, J VASC RES, V51, P163, DOI 10.1159/000362276; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Xiao YL, 2013, J PATHOL, V229, P535, DOI 10.1002/path.4145; Xin XB, 2013, P NATL ACAD SCI USA, V110, pE3425, DOI 10.1073/pnas.1217091110	31	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21323	10.1096/fj.201903192RR	http://dx.doi.org/10.1096/fj.201903192RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710674	Green Submitted			2022-12-28	WOS:000635216100064
J	Lu, XP; Xu, M; Zhu, Q; Zhang, J; Liu, G; Bao, YT; Gu, L; Tian, Y; Wen, H; Zhu, WG				Lu, Xiaopeng; Xu, Min; Zhu, Qian; Zhang, Jun; Liu, Ge; Bao, Yantao; Gu, Luo; Tian, Yuan; Wen, He; Zhu, Wei-Guo			RNF8-ubiquitinated KMT5A is required for RNF168-induced H2A ubiquitination in response to DNA damage	FASEB JOURNAL			English	Article						DNA double&#8208; strand breaks; histone ubiquitination; KMT5A; RNF8; RNF168		Histone modifications play critical roles in DNA damage repair to safeguard genome integrity. However, how different histone modifiers coordinate to build appropriate chromatin context for DNA damage repair is largely unknown. Here, we report a novel interplay between the histone methyltransferase KMT5A and two E3 ligases RNF8 and RNF168 in establishing the histone modification status for DNA damage repair. KMT5A is a newly identified substrate of RNF8 in vitro and in vivo. In response to DNA double-strand breaks (DSBs), RNF8 promotes KMT5A recruitment onto damaged chromatin in a ubiquitination-dependent manner. RNF8-induced KMT5A ubiquitination increases the binding capacity of KMT5A to RNF168. Interestingly, KMT5A not only drives a local increase in H4K20 monomethylation at DSBs, but also promotes RNF168's activity in catalyzing H2A ubiquitination. We proved that the interaction between the H2A acidic patch and KMT5A R188/R189 residues is critical for KMT5A-mediated regulation of H2A ubiquitination. Taken together, our results highlight a new role for KMT5A in linking H4K20 methylation and H2A ubiquitination and provide insight into the histone modification network during DNA damage repair.	[Lu, Xiaopeng; Xu, Min; Zhu, Qian; Zhang, Jun; Liu, Ge; Bao, Yantao; Tian, Yuan; Wen, He; Zhu, Wei-Guo] Shenzhen Univ Sch Med, Dept Biochem & Mol Biol, Guangdong Key Lab Genome Instabil & Human Dis Pre, Shenzhen 518055, Peoples R China; [Gu, Luo] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Tian, Yuan; Zhu, Wei-Guo] Shenzhen Univ Sch Med, Shenzhen Bay Lab, Shenzhen, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ Sch Med, Int Canc Ctr, Shenzhen, Peoples R China	Nanjing Medical University; Shenzhen Bay Laboratory	Zhu, WG (corresponding author), Shenzhen Univ Sch Med, Dept Biochem & Mol Biol, Guangdong Key Lab Genome Instabil & Human Dis Pre, Shenzhen 518055, Peoples R China.	zhuweiguo@szu.edu.cn	Wen, He/GZL-8825-2022; Zhu, Wei-Guo/ABF-8373-2021; ZHANG, Jun/V-5275-2018	Zhu, Wei-Guo/0000-0001-8385-6581; ZHANG, Jun/0000-0002-6523-7573	National Key R&D Program of China [2017YFA0503900]; National Natural Science Foundation of China [81720108027, 81530074, 32090030, 82002988]; Science and Technology Program of Guangdong Province in China [2017B030301016]; Shenzhen Municipal Commission of Science and Technology Innovation [JCYJ20170818092450901, JCYJ20200109114214463]; China Postdoctoral Science Foundation [2019M653054]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province in China; Shenzhen Municipal Commission of Science and Technology Innovation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Key R&D Program of China, Grant/Award Number: 2017YFA0503900; National Natural Science Foundation of China, Grant/Award Number: 81720108027, 81530074, 32090030 and 82002988; Science and Technology Program of Guangdong Province in China, Grant/Award Number: 2017B030301016; Shenzhen Municipal Commission of Science and Technology Innovation, Grant/Award Number: JCYJ20170818092450901, JCYJ20200109114214463; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653054	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Baldock RA, 2015, CELL REP, V13, P2081, DOI 10.1016/j.celrep.2015.10.074; Barbour H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19722-9; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campbell S, 2013, CELL CYCLE, V12, P2675, DOI 10.4161/cc.25795; Cao LL, 2016, SCI CHINA LIFE SCI, V59, P257, DOI 10.1007/s11427-016-5011-z; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen XS, 2020, SCI CHINA LIFE SCI, V63, P206, DOI 10.1007/s11427-019-1587-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dhami GK, 2013, MOL CELL, V50, P565, DOI 10.1016/j.molcel.2013.04.028; Dulev S, 2020, CELL CYCLE, V19, P15, DOI 10.1080/15384101.2019.1690231; Dulev S, 2014, EMBO REP, V15, P1163, DOI 10.15252/embr.201439434; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gieni RS, 2011, CELL CYCLE, V10, P883, DOI 10.4161/cc.10.6.14907; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Girish TS, 2016, J MOL BIOL, V428, P1531, DOI 10.1016/j.jmb.2016.02.025; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Gong FD, 2019, MUTAT RES-REV MUTAT, V780, P37, DOI 10.1016/j.mrrev.2017.09.003; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Han J., 2020, GENOME INSTAB DIS, V1, P10, DOI [DOI 10.1007/S42764-019-00002-W, 10.1007/s42764-019-00002-w]; Hou LJ, 2016, MOL MED REP, V13, P1681, DOI 10.3892/mmr.2015.4733; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Isono M, 2017, CELL REP, V18, P520, DOI 10.1016/j.celrep.2016.12.042; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kim JJ, 2019, CRIT REV BIOCHEM MOL, V54, P208, DOI 10.1080/10409238.2019.1620676; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Leung JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004178; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Liu B, 2016, CANCER LETT, V376, P259, DOI 10.1016/j.canlet.2016.04.008; Liu CH, 2020, THERANOSTICS, V10, P1758, DOI 10.7150/thno.39013; Lu CS, 2012, J BIOL CHEM, V287, P43984, DOI 10.1074/jbc.M112.421545; Lu XP, 2019, NUCLEIC ACIDS RES, V47, P10977, DOI 10.1093/nar/gkz897; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nowsheen S, 2018, NAT CELL BIOL, V20, P455, DOI 10.1038/s41556-018-0071-x; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Scully R, 2019, NAT REV MOL CELL BIO, V20, P698, DOI 10.1038/s41580-019-0152-0; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Sin HS, 2012, GENE DEV, V26, P2737, DOI 10.1101/gad.202713.112; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tamburri S, 2020, MOL CELL, V77, P840, DOI 10.1016/j.molcel.2019.11.021; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tuzon CT, 2014, CELL REP, V8, P429, DOI 10.1016/j.celrep.2014.06.013; Uckelmann M, 2017, DNA REPAIR, V56, P92, DOI 10.1016/j.dnarep.2017.06.011; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Vissers JHA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-8; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Zhang HF, 2019, NUCLEIC ACIDS RES, V47, P9053, DOI 10.1093/nar/gkz626; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	75	2	2	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21326	10.1096/fj.202002234R	http://dx.doi.org/10.1096/fj.202002234R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710666				2022-12-28	WOS:000635216100083
J	Christophersen, DV; Moller, P; Thomsen, MB; Lykkesfeldt, J; Loft, S; Wallin, H; Vogel, U; Jacobsen, NR				Christophersen, Daniel Vest; Moller, Peter; Thomsen, Morten Baekgaard; Lykkesfeldt, Jens; Loft, Steffen; Wallin, Hakan; Vogel, Ulla; Jacobsen, Nicklas Raun			Accelerated atherosclerosis caused by serum amyloid A response in lungs of ApoE(-/-) mice	FASEB JOURNAL			English	Article						acute phase response; Apolipoprotein E knockout (ApoE(-/-)) mice; ischemic heart disease; recombinant human apolipoprotein serum amyloid A (hApo-SAA); Western-type diet	ACUTE-PHASE RESPONSE; WALLED CARBON NANOTUBES; PHYSICOCHEMICAL PROPERTIES; PULMONARY EXPOSURE; INFLAMMATORY RESPONSES; GENE FAMILY; APOLIPOPROTEIN; NANOPARTICLES; EXPRESSION; INSTILLATION	Airway exposure to cg particulate matter is associated with cardiovascular disease including atherosclerosis. Acute phase genes, especially Serum Amyloid A3 (Saa3), are highly expressed in the lung following pulmonary exposure to particles. We aimed to investigate whether the human acute phase protein SAA (a homolog to mouse SAA3) accelerated atherosclerotic plaque progression in Apolipaprotein E knockout (ApoE(-/)(-)) mice. Mice were intratracheally (i.t.) instilled with vehicle (phosphate buffered saline) or 2 pg human SAA once a week for 10 weeks. Plaque progression was assessed in the aorta using noninvasive ultrasound imaging of the aorta arch as well as by en face analysis. Additionally, lipid peroxidation, SAA3, and cholesterol were measured in plasma, inflammation was determined in lung, and mRNA levels of the acute phase genes Saa1 and Saa3 were measured in the liver and lung, respectively. Repeated i.t. instillation with SAA caused a significant progression in the atherosclerotic plaques in the aorta (1.5-fold). Concomitantly, SAA caused a statistically significant increase in neutrophils in bronchoalveolar lavage fluid (625-fold), in pulmonary Saa3 (196-fold), in systemic SAA3 (1.8-fold) and malondialdehyde levels (1.14-fold), indicating acute phase response (APR), inflammation and oxidative stress. Finally, pulmonary exposure to SAA significantly decreased the plasma levels of very low-density lipoproteins - low-density lipoproteins and total cholesterol, possibly due to lipids being sequestered in macrophages or foam cells in the arterial wall. Combined these results indicate the importance of the pulmonary APR and SAA3 for plaque progression.	[Christophersen, Daniel Vest; Moller, Peter; Loft, Steffen; Wallin, Hakan] Univ Copenhagen, Fac Hlth Sci, Dept Publ Hlth, Sect Environm Hlth, Copenhagen K, Denmark; [Christophersen, Daniel Vest] Ambu AS, Ballerup, Denmark; [Christophersen, Daniel Vest; Wallin, Hakan; Vogel, Ulla; Jacobsen, Nicklas Raun] Natl Res Ctr Working Environm, Lerso Pk Alle 105, DK-2100 Copenhagen, Denmark; [Thomsen, Morten Baekgaard] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Heart & Circulatory Res Sect, Copenhagen N, Denmark; [Lykkesfeldt, Jens] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Wallin, Hakan] Natl Inst Occupat Hlth, Oslo, Norway; [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	University of Copenhagen; National Research Centre for the Working Environment; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Jacobsen, NR (corresponding author), Natl Res Ctr Working Environm, Lerso Pk Alle 105, DK-2100 Copenhagen, Denmark.	nrj@nrcwe.dk	Vogel, Ulla B/I-5048-2012; Thomsen, Morten B/B-5377-2009	Vogel, Ulla B/0000-0001-6807-1524; Thomsen, Morten B/0000-0002-2469-6458; Loft, Steffen/0000-0001-9552-8518; Jacobsen, Nicklas Raun/0000-0002-2504-2229	Danish Nanosafety Centre II; FFIKA, Focused Research Effort on Chemicals in the Working Environment, from the Danish Government	Danish Nanosafety Centre II; FFIKA, Focused Research Effort on Chemicals in the Working Environment, from the Danish Government	The work was supported by the Danish Nanosafety Centre II and FFIKA, Focused Research Effort on Chemicals in the Working Environment, from the Danish Government	Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Bengtson S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178355; Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119; Cantin AM, 2000, AM J RESP CRIT CARE, V162, P1539, DOI 10.1164/ajrccm.162.4.9910106; Cao Y, 2014, TOXICOL SCI, V138, P104, DOI 10.1093/toxsci/kft328; Christophersen DV, 2016, TOXICOLOGY, V371, P29, DOI 10.1016/j.tox.2016.10.003; Christophersen DV., 2021, FASEB J, V35; Danielsen PH, 2020, TOXICOL APPL PHARM, V386, DOI 10.1016/j.taap.2019.114830; De Beer MC, 2014, ARTERIOSCL THROM VAS, V34, P255, DOI 10.1161/ATVBAHA.113.302247; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hadrup N, 2019, ENVIRON TOXICOL PHAR, V66, P116, DOI 10.1016/j.etap.2019.01.003; Halappanavar S, 2015, ENVIRON MOL MUTAGEN, V56, P245, DOI 10.1002/em.21936; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V201, P1567, DOI 10.1006/bbrc.1994.1883; Husain M, 2015, TOXICOL APPL PHARM, V289, P573, DOI 10.1016/j.taap.2015.11.003; Husain M, 2015, NANOTOXICOLOGY, V9, P1013, DOI 10.3109/17435390.2014.996192; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jacobsen NR, 2015, FOOD CHEM TOXICOL, V85, P84, DOI 10.1016/j.fct.2015.08.008; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Kyjovska ZO, 2015, MUTAGENESIS, V30, P499, DOI 10.1093/mutage/gev009; Lee HY, 2013, BIOCHEM BIOPH RES CO, V433, P18, DOI 10.1016/j.bbrc.2013.02.077; Li RS, 2013, J LIPID RES, V54, P1608, DOI 10.1194/jlr.M035014; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lykkesfeldt J, 2001, CLIN CHEM, V47, P1725; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Miller MR, 2014, BIOCHEM SOC T, V42, P1006, DOI 10.1042/BST20140090; Miller MR, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-61; Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com; Moller P, 2016, CRIT REV TOXICOL, V46, P437, DOI 10.3109/10408444.2016.1149451; Moller P, 2011, CRIT REV TOXICOL, V41, P339, DOI 10.3109/10408444.2010.533152; Morgantini C, 2011, DIABETES, V60, P2617, DOI 10.2337/db11-0378; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Poulsen SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174167; Poulsen SS, 2016, NANOTOXICOLOGY, V10, P1263, DOI 10.1080/17435390.2016.1202351; Poulsen SS, 2015, TOXICOL APPL PHARM, V284, P16, DOI 10.1016/j.taap.2014.12.011; Poulsen SS, 2015, TOXICOL APPL PHARM, V283, P210, DOI 10.1016/j.taap.2015.01.011; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Saber AT, 2014, WIRES NANOMED NANOBI, V6, P517, DOI 10.1002/wnan.1279; Saber AT, 2012, NANOTOXICOLOGY, V6, P776, DOI 10.3109/17435390.2011.620745; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; SELLAR GC, 1994, GENOMICS, V23, P492, DOI 10.1006/geno.1994.1530; Stone V, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP424; Thompson JC, 2018, ATHEROSCLEROSIS, V268, P32, DOI 10.1016/j.atherosclerosis.2017.11.011; Thompson JC, 2015, J LIPID RES, V56, P286, DOI 10.1194/jlr.M054015; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; WHO, 2008, 10 LEAD CAUS DEATH B	56	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21307	10.1096/fj.202002017R	http://dx.doi.org/10.1096/fj.202002017R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33638910	Green Published			2022-12-28	WOS:000629576700054
J	Kruglov, AG; Kharechkina, ES; Nikiforova, AB; Odinokova, IV; Kruglova, SA				Kruglov, Alexey G.; Kharechkina, Ekaterina S.; Nikiforova, Anna B.; Odinokova, Irina V.; Kruglova, Svetlana A.			Dynamics of the permeability transition pore size in isolated mitochondria and mitoplasts	FASEB JOURNAL			English	Article						dynamics; method; permeability transition pore; plasticity; pore size	RAT-LIVER MITOCHONDRIA; F1FO ATP SYNTHASE; CYCLOSPORINE-A; INNER MEMBRANE; CONDUCTANCE CHANNEL; MEGACHANNEL; INHIBITION; MODULATION; RELEASE; CA-2+	The size of the permeability transition pore (PTP) is accepted to be <= 1.5 kDa. However, different authors reported values from 650 to 4000 Da. The present study is focused on the variability of the average PTP size in and between mitochondrial samples, its reasons and relations with PTP dynamics. Measurement of PTP size by the standard method revealed its 500 Da-range variability between mitochondrial samples. Sequential measurements in the same sample showed that the PTP size tends to grow with time and Ca2+ concentration. Selective damage to the mitochondrial outer membrane (MOM) reduced the apparent PTP size by similar to 200-300 Da. Hypotonic and hypertonic osmotic shock and partial removal of the MOM with the preservation of the mitochondrial inner membrane intactness decreased the apparent PTP size by similar to 50%. We developed an approach to continuous monitoring of the PTP size that revealed the existence of stable PTP states with different pore sizes (similar to 700, 900-1000, similar to 1350, 1700-1800, and 2100-2200 Da) and transitions between them. The transitions were accelerated by elevating the Ca2+ concentration, temperature, and osmotic pressure, which demonstrates an increased capability of PTP to accommodate to large molecules (plasticity). Cyclosporin A inhibited the transitions between states. The analysis of PTP size dynamics in osmotically shocked mitochondria and mitoplasts confirmed the importance of the MOM for the stabilization of PTP structure. Thus, this approach provides a new tool for PTP studies and the opportunity to reconcile data on the PTP size and mitochondrial megachannel conductance.	[Kruglov, Alexey G.; Kharechkina, Ekaterina S.; Nikiforova, Anna B.; Odinokova, Irina V.] Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya 3, Pushchino 142290, Moscow Region, Russia; [Kruglova, Svetlana A.] Russian Acad Sci, Inst Basic Biol Problems, Pushchino, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences	Kruglov, AG (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya 3, Pushchino 142290, Moscow Region, Russia.	krugalex@rambler.ru	Svetlana, Kruglova/ABG-3970-2021	Svetlana, Kruglova/0000-0002-1582-4737	Russian Foundation for Basic Research (RFBR) [19-04-00327a, 075-00381-21-00]	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	Russian Foundation for Basic Research (RFBR), Grant/Award Number: #19-04-00327a; State Assignment, Grant/Award Number: 075-00381-21-00	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Almofti MR, 2003, J BIOCHEM, V134, P43, DOI 10.1093/jb/mvg111; ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; Baev AY, 2018, ANAL BIOCHEM, V552, P38, DOI 10.1016/j.ab.2017.07.006; BERNARDI P, 1993, J BIOL CHEM, V268, P1005; Bernardi P, 2020, P NATL ACAD SCI USA, V117, P2743, DOI 10.1073/pnas.1921035117; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bonora M, 2017, EMBO REP, V18, P1077, DOI 10.15252/embr.201643602; Boyman L, 2019, ARCH BIOCHEM BIOPHYS, V666, P31, DOI 10.1016/j.abb.2019.03.016; Broekemeier KM, 1998, BIOCHEMISTRY-US, V37, P13059, DOI 10.1021/bi980820c; BROEKEMEIER KM, 1985, J BIOL CHEM, V260, P105; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Carraro M, 2020, METHOD CELL BIOL, V155, P369, DOI 10.1016/bs.mcb.2019.10.004; Carraro M, 2018, CELL PHYSIOL BIOCHEM, V50, P1840, DOI 10.1159/000494864; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; Carroll J, 2019, P NATL ACAD SCI USA, V116, P12816, DOI 10.1073/pnas.1904005116; Chinopoulos C, 2018, NEUROCHEM INT, V117, P49, DOI 10.1016/j.neuint.2017.06.010; CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x; CROMPTON M, 1990, BIOCHEM J, V266, P33, DOI 10.1042/bj2660033; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HAWORTH RA, 1980, J MEMBRANE BIOL, V54, P231, DOI 10.1007/BF01870239; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Kharechkina ES, 2019, BBA-GEN SUBJECTS, V1863, P771, DOI 10.1016/j.bbagen.2019.01.003; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kruglov AG, 2007, BIOCHEM PHARMACOL, V74, P545, DOI 10.1016/j.bcp.2007.05.012; Kushnareva YE, 2000, ARCH BIOCHEM BIOPHYS, V376, P377, DOI 10.1006/abbi.2000.1730; LEQUOC K, 1985, J BIOL CHEM, V260, P7422; Lohret TA, 1996, J BIOL CHEM, V271, P4846; Martinucci S, 2000, FEBS LETT, V480, P89, DOI 10.1016/S0014-5793(00)01911-6; Massari S, 1996, J BIOL CHEM, V271, P31942; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P23, DOI 10.1016/0005-2728(72)90094-1; Mikkola R, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090433; Mnatsakanyan N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13766-2; Neginskaya MA, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.202012631; Neginskaya MA, 2019, CELL REP, V26, P11, DOI 10.1016/j.celrep.2018.12.033; NIGHTINGALE ER, 1959, J PHYS CHEM-US, V63, P1381, DOI 10.1021/j150579a011; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; PFEIFFER DR, 1995, J BIOL CHEM, V270, P4923, DOI 10.1074/jbc.270.9.4923; SCHLEGEL J, 1992, BIOCHEM J, V285, P65, DOI 10.1042/bj2850065; Shibata T, 2019, ARCH BIOCHEM BIOPHYS, V663, P288, DOI 10.1016/j.abb.2019.01.016; Sokolove PM, 1996, ARCH BIOCHEM BIOPHYS, V336, P69, DOI 10.1006/abbi.1996.0533; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1993, FEBS LETT, V330, P206, DOI 10.1016/0014-5793(93)80274-X; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; Toninello A, 2004, FREE RADICAL BIO MED, V37, P1073, DOI 10.1016/j.freeradbiomed.2004.06.044; Urbani A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12331-1; VERCESI AE, 1984, ARCH BIOCHEM BIOPHYS, V232, P86, DOI 10.1016/0003-9861(84)90523-X; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Winquist RJ, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113995	62	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21764	10.1096/fj.202100596R	http://dx.doi.org/10.1096/fj.202100596R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245631				2022-12-28	WOS:000678975300045
J	Liu, QJ; Kong, YL; Guo, XD; Liang, BE; Xie, HX; Hu, S; Han, MK; Zhao, XD; Feng, PN; Lyu, QQ; Dong, W; Liang, XL; Wang, WD; Li, CL				Liu, Qiaojuan; Kong, Yonglun; Guo, Xiangdong; Liang, Baien; Xie, Haixia; Hu, Shan; Han, Mengke; Zhao, Xiaoduo; Feng, Pinning; Lyu, Qianqian; Dong, Wei; Liang, Xinling; Wang, Weidong; Li, Chunling			GSK-3 beta inhibitor TDZD-8 prevents reduction of aquaporin-1 expression via activating autophagy under renal ischemia reperfusion injury	FASEB JOURNAL			English	Article						AQP1; autophagy; GSK-3 beta; ischemia/reperfusion	NF-KAPPA-B; AQP2 EXPRESSION; DOWN-REGULATION; KIDNEY; INFLAMMASOME; PATHOPHYSIOLOGY; HYPERCALCEMIA; DEGRADATION; TUBULE; CELLS	Renal ischemia/reperfusion (I/R) injury is a main cause of acute kidney injury (AKI). Aquaporin (AQP)-1 water channel in the kidney is critical for the maintenance of water homeostasis and the urinary concentrating ability. Increasing evidence supports an important role of autophagy in the pathogenesis of AKI induced by renal I/R. The purpose of the present study is to investigate whether activation of autophagy prevents downregulation of AQP1 protein induced by renal I/R and potential molecular mechanisms. Renal I/R induced consistently reduced protein expression of AQP1, 2, and 3, as well as sodium cotransporters Na+-K+-2Cl(-) cotransporter and alpha-Na,K-ATPase, which was associated with increased urine output and decreased creatinine clearance in rats. Renal I/R also suppressed autophagy and increased inflammatory responses in the kidney. 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-di one (TDZD-8), the glycogen synthase kinase-3 beta inhibitor, ameliorated renal injury under I/R, activated autophagy and markedly increased expression of AQPs and sodium transporters in the kidney, which was associated with improved urine output and creatinine clearance in rats. Hypoxia/reoxygenation (H/R) induced suppression of autophagy and downregulation of AQP1 in murine inner medullary collecting duct 3 (IMCD3) cells, which was fully prevented by TDZD-8 treatment. Inhibition of autophagy by 3-methyladenine or Atg5 gene knockdown attenuated recovery of AQP1 protein expression induced by TDZD-8 in IMCD3 cells with H/R. Interleukin-1 beta (IL-1 beta) decreased the abundance of AQP1 protein in IMCD3 cells. H/R induced increases in protein expression of nod-like receptor pyrin domain-containing 3 and IL-1 beta, which was reversed by TDZD-8. In conclusion, TDZD-8 treatment prevented downregulation of AQP1 expression under renal I/R injury, likely via activating autophagy and decreasing IL-1 beta production.	[Liu, Qiaojuan; Kong, Yonglun; Guo, Xiangdong; Liang, Baien; Xie, Haixia; Hu, Shan; Han, Mengke; Zhao, Xiaoduo; Wang, Weidong; Li, Chunling] Sun Yat Sen Univ, Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Qiaojuan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou, Peoples R China; [Feng, Pinning] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Lab, Guangzhou, Peoples R China; [Lyu, Qianqian] Ocean Univ China, Coll Marine Life Sci, MOE Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Dong, Wei; Liang, Xinling] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Divis Nephrol, Guangzhou, Peoples R China; [Wang, Weidong] Sun Yat Ssen Univ, Affiliated Hosp 7, Dept Nephrol, Shenzhen, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Ocean University of China; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Wang, WD; Li, CL (corresponding author), Sun Yat Sen Univ, Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	wangwd6@mail.sysu.edu.cn; lichl3@mail.sysu.edu.cn		Wang, Weidong/0000-0003-2523-3145	National Natural Science Foundation of China [81870465, 81970623, 81570635, 81670646]; Natural Science Foundation of Guangzhou [201904010255]; Natural Science Foundation of Guangdong Province [2021A1515011482, 2016A020215034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangzhou; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China, Grant/Award Number: 81870465, 81970623, 81570635 and 81670646; Natural Science Foundation of Guangzhou, Grant/Award Number: 201904010255; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2021A1515011482 and 2016A020215034	Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chatauret N, 2014, PROG UROL, V24, pS4, DOI 10.1016/S1166-7087(14)70057-0; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Covington MD, 2005, AM J PHYSIOL-RENAL, V289, pF280, DOI 10.1152/ajprenal.00351.2004; Decuypere JP, 2015, AM J KIDNEY DIS, V66, P699, DOI 10.1053/j.ajkd.2015.05.021; Deretic V, 2018, AUTOPHAGY, V14, P179, DOI 10.1080/15548627.2017.1412229; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Devarajan P, 2015, NEPHRON, V131, P85, DOI 10.1159/000437237; Duann P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050662; Gong H, 2004, KIDNEY INT, V66, P683, DOI 10.1111/j.1523-1755.2004.00791.x; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Helbert MJF, 1997, KIDNEY INT, V52, P414, DOI 10.1038/ki.1997.348; Hu S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01157; Hua Y, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182303; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Khositseth S, 2017, KIDNEY INT, V91, P1070, DOI 10.1016/j.kint.2016.12.005; Khositseth S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18311; Kim WY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39702-4; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF413, DOI 10.1152/ajprenal.1999.277.3.F413; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Lempiainen J, 2013, ACTA PHYSIOL, V208, P410, DOI 10.1111/apha.12120; Li CL, 2003, AM J PHYSIOL-RENAL, V284, pF1066, DOI 10.1152/ajprenal.00090.2002; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma ZW, 2014, BBA-MOL BASIS DIS, V1842, P1088, DOI 10.1016/j.bbadis.2014.04.002; Mancinelli R, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4629495; Nakagawa S, 2012, EUR J PHARMACOL, V696, P143, DOI 10.1016/j.ejphar.2012.09.010; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Norregaard R, 2015, AM J PHYSIOL-RENAL, V308, pF650, DOI 10.1152/ajprenal.00516.2014; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shimura T, 2011, J RADIAT RES, V52, P539, DOI 10.1269/jrr.11098; Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Wang FF, 2018, AM J PHYSIOL-RENAL, V315, pF199, DOI 10.1152/ajprenal.00609.2017; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wang WD, 2002, AM J PHYSIOL-RENAL, V283, pF1313, DOI 10.1152/ajprenal.00040.2002; Wang WD, 2008, AM J PHYSIOL-RENAL, V294, pF1473, DOI 10.1152/ajprenal.00036.2008; Wang WD, 2015, AM J PHYSIOL-RENAL, V308, pF910, DOI 10.1152/ajprenal.00649.2014; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	49	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21809	10.1096/fj.202100549R	http://dx.doi.org/10.1096/fj.202100549R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314052				2022-12-28	WOS:000678975300041
J	Cardenas, A; Papadogiannis, A; Dimitrov, E				Cardenas, Andrea; Papadogiannis, Alexander; Dimitrov, Eugene			The role of medial prefrontal cortex projections to locus ceruleus in mediating the sex differences in behavior in mice with inflammatory pain	FASEB JOURNAL			English	Article						locus ceruleus; medial prefrontal cortex; pain; sex difference	NORADRENERGIC NEURONS; MEMORY PERFORMANCE; NEUROPATHIC PAIN; COERULEUS; RAT; NOREPINEPHRINE; ORGANIZATION; RESPONSES; SYSTEM; MODEL	We tested the hypothesis that the cognitive impairment associated with inflammatory pain may result from dysregulation of the top-down control of locus ceruleus's (LC) activity by the medial prefrontal cortex (mPFC). Injection of complete Freund's adjuvant (CFA) served as a model for inflammatory pain. The CFA injection decreased the thermal thresholds in both sexes but only the male mice showed increased anxiety-like behavior and diminished cognition, while the females were not affected. Increased calcium fluorescence, a marker for neuronal activity, was detected by photometry in the mPFC of males but not in females with CFA. Next, while chemogenetic inhibition of the projections from the mPFC to the LC improved the object recognition memory of males with pain, the inhibition of the mPFC to LC pathway in female mice produced anxiolysis and spatial memory deficits. The behavior results prompted us to compare the reciprocal innervation of mPFC and LC between the sexes. We used an anterograde transsynaptic tagging technique, which relies on postsynaptic cre transfer, to assess the innervation of LC by mPFC efferents. The males showed a higher rate of postsynaptic cre transfer into LC neurons from mPFC efferents than the females. And vice versa, a retrograde tracing experiment demonstrated that LC to mPFC projection neurons were more numerous in females when compared to males. In conclusion, we provide evidence that subtle differences in the reciprocal neuronal circuit between the LC and mPFC may contribute to sex differences associated with the adverse cognitive effects of inflammatory pain.	[Cardenas, Andrea; Dimitrov, Eugene] Rosalind Franklin Univ Med & Sci, Ctr Neurobiol Stress Resilience & Psychiat Disord, 3333 Green Bay Rd, N Chicago, IL 60064 USA; [Papadogiannis, Alexander] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	Dimitrov, E (corresponding author), Rosalind Franklin Univ Med & Sci, Ctr Neurobiol Stress Resilience & Psychiat Disord, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	eugene.dimitrov@rosalindfranklin.edu			NIH [R01MH105528]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by NIH grant R01MH105528 to ED	Alba-Delgado C, 2013, BIOL PSYCHIAT, V73, P54, DOI 10.1016/j.biopsych.2012.06.033; Andreoli M, 2017, EXP NEUROL, V298, P1, DOI 10.1016/j.expneurol.2017.08.010; Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Bangasser DA, 2019, NEUROPSYCHOPHARMACOL, V44, P129, DOI 10.1038/s41386-018-0137-2; Bangasser DA, 2016, BRAIN RES, V1641, P177, DOI 10.1016/j.brainres.2015.11.021; Bangasser DA, 2011, PHYSIOL BEHAV, V103, P342, DOI 10.1016/j.physbeh.2011.02.037; Ben Abdallah NMB, 2011, EXP NEUROL, V227, P42, DOI 10.1016/j.expneurol.2010.09.008; Berridge CW, 2016, BRAIN RES, V1641, P189, DOI 10.1016/j.brainres.2015.11.024; Cardenas A, 2020, PAIN, V161, P1861, DOI 10.1097/j.pain.0000000000001875; Cardoso-Cruz H, 2019, PAIN, V160, P805, DOI 10.1097/j.pain.0000000000001457; Cardoso-Cruz H, 2013, J NEUROSCI, V33, P2465, DOI 10.1523/JNEUROSCI.5197-12.2013; Chandler DJ, 2019, J NEUROSCI, V39, P8239, DOI 10.1523/JNEUROSCI.1164-19.2019; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; Clewett DV, 2018, J NEUROSCI, V38, P1558, DOI 10.1523/JNEUROSCI.2097-17.2017; Drake RAR, 2021, ELIFE, V10, DOI 10.7554/eLife.65156; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fan XC, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00085; Fehrenbacher JC., 2012, CURR PROTOC PHARM CH, V56, P5; Franowicz JS, 2002, J NEUROSCI, V22, P8771; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hayashida K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040822; Hayashida K, 2018, ADV EXP MED BIOL, V1099, P93, DOI 10.1007/978-981-13-1756-9_8; Hickey L, 2014, J NEUROSCI, V34, P4148, DOI 10.1523/JNEUROSCI.4835-13.2014; Howorth PW, 2009, J COMP NEUROL, V512, P141, DOI 10.1002/cne.21879; Huang JT, 2019, NAT NEUROSCI, V22, P1659, DOI 10.1038/s41593-019-0481-5; Hughes SW, 2013, PAIN, V154, P1680, DOI 10.1016/j.pain.2013.05.010; Jett JD, 2013, NEUROPSYCHOPHARMACOL, V38, P585, DOI 10.1038/npp.2012.216; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Kim Myung-A., 2003, Korean Journal of Biological Sciences, V7, P49; Kummer KK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103440; Llorca-Torralba M, 2016, NEUROSCIENCE, V338, P93, DOI 10.1016/j.neuroscience.2016.05.057; Loyd DR, 2006, J COMP NEUROL, V496, P723, DOI 10.1002/cne.20962; LUQUE JM, 1992, DEV BRAIN RES, V67, P211, DOI 10.1016/0165-3806(92)90221-H; Matos SC, 2018, BRAIN STRUCT FUNCT, V223, P1149, DOI 10.1007/s00429-017-1543-7; McKlveen JM, 2015, J NEUROENDOCRINOL, V27, P446, DOI 10.1111/jne.12272; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Moriarty O, 2016, SCAND J PAIN, V10, P61, DOI 10.1016/j.sjpain.2015.09.008; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Moriya S, 2019, IBRO REP, V7, P1, DOI 10.1016/j.ibror.2019.05.005; Mulvey B, 2018, CELL REP, V23, P2225, DOI 10.1016/j.celrep.2018.04.054; Ohtani S, 2018, J PHARMACOL SCI, V138, P76, DOI 10.1016/j.jphs.2018.09.005; Ong WY, 2019, MOL NEUROBIOL, V56, P1137, DOI 10.1007/s12035-018-1130-9; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Parent AJ, 2016, NEUROSCIENCE, V315, P70, DOI 10.1016/j.neuroscience.2015.11.065; Pinos H, 2001, BRAIN RES BULL, V56, P73, DOI 10.1016/S0361-9230(01)00540-8; Radley JJ, 2008, J NEUROSCI, V28, P5806, DOI 10.1523/JNEUROSCI.0552-08.2008; Reyes BAS, 2014, LIFE SCI, V112, P2, DOI 10.1016/j.lfs.2014.07.017; Sales AC, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006267; SARA SJ, 1995, P NATL ACAD SCI USA, V92, P6032, DOI 10.1073/pnas.92.13.6032; Saunders A., 2015, CURR PROTOC NEUROSCI, V72, P1; Shah AA, 2003, BRAIN RES, V969, P183, DOI 10.1016/S0006-8993(03)02299-6; Shepard R, 2017, DEV COGN NEUROS-NETH, V28, P29, DOI 10.1016/j.dcn.2017.10.009; Stone LS, 1997, J NEUROSCI, V17, P7157; Suto T, 2014, PAIN, V155, P1935, DOI 10.1016/j.pain.2014.05.014; Tuscher JJ, 2018, NEUROBIOL LEARN MEM, V156, P103, DOI 10.1016/j.nlm.2018.11.002; Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7; Uematsu A, 2017, NAT NEUROSCI, V20, P1602, DOI 10.1038/nn.4642; Uematsu A, 2015, LEARN MEMORY, V22, P444, DOI 10.1101/lm.037283.114; Usdin TB, 2016, NEUROSCIENTIST, V22, P521, DOI 10.1177/1073858416633104; van Eden CG, 2000, PROG BRAIN RES, V126, P49; Wagner M, 2016, NEUROSCIENCE, V324, P420, DOI 10.1016/j.neuroscience.2016.03.038; Wang GQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8660; Wu XB, 2016, NEUROSCI LETT, V611, P40, DOI 10.1016/j.neulet.2015.11.030; Zhang ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066122; Zingg B, 2020, J NEUROSCI, V40, P3250, DOI 10.1523/JNEUROSCI.2158-19.2020; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045	68	3	3	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21747	10.1096/fj.202100319RR	http://dx.doi.org/10.1096/fj.202100319RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34151467	Green Accepted			2022-12-28	WOS:000667814100010
J	Robert, P; Nguyen, PMC; Richard, A; Grenier, C; Chevrollier, A; Munier, M; Grimaud, L; Proux, C; Champin, T; Lelievre, E; Sarzi, E; Vessieres, E; Henni, S; Prunier, D; Reynier, P; Lenaers, G; Fassot, C; Henrion, D; Loufrani, L				Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Lelievre, Eric; Sarzi, Emmanuelle; Vessieres, Emilie; Henni, Samir; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent			Protective role of the mitochondrial fusion protein OPA1 in hypertension	FASEB JOURNAL			English	Article						hypertension; mitochondria; Opa1; oxidative stress; vascular function	NITRIC-OXIDE; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; RESISTANCE ARTERIES; MORPHOLOGY; CELLS; VASODILATION; BIOGENESIS; ACTIVATION; INHIBITION	Hypertension is associated with excessive reactive oxygen species (ROS) production in vascular cells. Mitochondria undergo fusion and fission, a process playing a role in mitochondrial function. OPA1 is essential for mitochondrial fusion. Loss of OPA1 is associated with ROS production and cell dysfunction. We hypothesized that mitochondria fusion could reduce oxidative stress that defect in fusion would exacerbate hypertension. Using (a) Opa1 haploinsufficiency in isolated resistance arteries from Opa1(+/-) mice, (b) primary vascular cells from Opa1(+/-) mice, and (c) RNA interference experiments with siRNA against Opa1 in vascular cells, we investigated the role of mitochondria fusion in hypertension. In hypertension, Opa1 haploinsufficiency induced altered mitochondrial cristae structure both in vascular smooth muscle and endothelial cells but did not modify protein level of long and short forms of OPA1. In addition, we demonstrated an increase of mitochondrial ROS production, associated with a decrease of superoxide dismutase 1 protein expression. We also observed an increase of apoptosis in vascular cells and a decreased VSMCs proliferation. Blood pressure, vascular contractility, as well as endothelium-dependent and -independent relaxation were similar in Opa1(+/-), WT, L-NAME-treated Opa1(+/-) and WT mice. Nevertheless, chronic NO-synthase inhibition with L-NAME induced a greater hypertension in Opa1(+/-) than in WT mice without compensatory arterial wall hypertrophy. This was associated with a stronger reduction in endothelium-dependent relaxation due to excessive ROS production. Our results highlight the protective role of mitochondria fusion in the vasculature during hypertension by limiting mitochondria ROS production.	[Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Lelievre, Eric; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] Univ Angers, MITOVASC Inst, Angers, France; [Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Lelievre, Eric; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] Univ Angers, CARFI Facil, Angers, France; [Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] UMR CNRS 6015, Angers, France; [Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] INSERM U1083, Angers, France; [Sarzi, Emmanuelle] INSERM, Inst Neurosci Montpellier, U1051, Montpellier, France; [Henni, Samir; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Henrion, Daniel] Univ Hosp CHU Angers, Angers, France	Universite d'Angers; Universite d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Loufrani, L (corresponding author), INSERM U1083, MITOVASC, CNRS UMR 6015, 3 Rue Roger Amsler, F-49045 Angers, France.	laurent.loufrani@inserm.fr	CHEVROLLIER, Arnaud/GSD-3887-2022; CHEVROLLIER, Arnaud/P-6630-2019; Munier, Mathilde/AAX-3770-2021; Munier, Mathilde/AAD-8239-2022; CHEVROLLIER, Arnaud/K-2853-2015	CHEVROLLIER, Arnaud/0000-0002-5135-6643; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Munier, Mathilde/0000-0001-7194-6846; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Grenier, Celine/0000-0003-4521-9404; Reynier, Pascal/0000-0003-0802-4608	Region Pays de la Loire (Mitovasc project); Foundation for Medical Research [FRM -DPC20171138957]; GRRC (Groupe de Reflexion sur la Recherche Cardiovasculaire, France)	Region Pays de la Loire (Mitovasc project)(Region Pays de la Loire); Foundation for Medical Research; GRRC (Groupe de Reflexion sur la Recherche Cardiovasculaire, France)	This work was supported by the Region Pays de la Loire (Mitovasc project), by the Foundation for Medical Research (FRM -DPC20171138957) and by GRRC (Groupe de Reflexion sur la Recherche Cardiovasculaire, France)	Bartolak-Suki E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57301-1; Bautista LE, 2003, J HUM HYPERTENS, V17, P223, DOI 10.1038/sj.jhh.1001537; Berger JM, 2015, ATHEROSCLEROSIS, V239, P252, DOI 10.1016/j.atherosclerosis.2015.01.012; Bertholet AM, 2013, BRAIN, V136, P1518, DOI 10.1093/brain/awt060; Bouvet C, 2007, HYPERTENSION, V50, P248, DOI 10.1161/HYPERTENSIONAHA.107.088716; Caffarra Malvezzi Cristina, 2020, Vasc Biol, V2, pR85, DOI 10.1530/VB-20-0002; Caffin F, 2013, J PHYSIOL-LONDON, V591, P6017, DOI 10.1113/jphysiol.2013.263079; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chevrollier A, 2012, INT J BIOCHEM CELL B, V44, P980, DOI 10.1016/j.biocel.2012.03.006; Codron P, 2018, AMYOTROPH LAT SCL FR, V19, P446, DOI 10.1080/21678421.2018.1431787; Cousin M, 2010, HYPERTENSION, V55, P109, DOI 10.1161/HYPERTENSIONAHA.108.127456; Dai Y, 2011, INVEST OPHTH VIS SCI, V52, P2468, DOI 10.1167/iovs.10-5873; de la Barca JMC, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-21116; Dowell FJ, 1996, BRIT J PHARMACOL, V117, P341, DOI 10.1111/j.1476-5381.1996.tb15196.x; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Formichi P, 2015, J NEUROL SCI, V351, P99, DOI 10.1016/j.jns.2015.02.047; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fulop L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025199; Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131; Kalliovalkama J, 1999, CARDIOVASC RES, V42, P773, DOI 10.1016/S0008-6363(98)00346-0; Kao SH, 2015, INVEST OPHTH VIS SCI, V56, P2269, DOI 10.1167/iovs.14-16288; Katakam PVG, 2013, ARTERIOSCL THROM VAS, V33, P752, DOI 10.1161/ATVBAHA.112.300560; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Lahera V, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0710-9; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Le Page S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164066; Lin YY, 2019, J APPL PHYSIOL, V126, P1661, DOI 10.1152/japplphysiol.00038.2019; Liu N, 2017, J CELL MOL MED, V21, P3190, DOI 10.1111/jcmm.13223; Liu YP, 2008, MED BIOL ENG COMPUT, V46, P469, DOI 10.1007/s11517-008-0331-1; Loufrani L, 2001, FASEB J, V15, P117, DOI 10.1096/fj.01-0505fje; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Preti SC, 2005, BASIC CLIN PHARMACOL, V97, P29, DOI 10.1111/j.1742-7843.2005.pto_97105.x; Puddu P, 2007, CLIN EXP HYPERTENS, V29, P427, DOI 10.1080/10641960701613852; Retailleau K, 2010, HYPERTENSION, V55, P339, DOI 10.1161/HYPERTENSIONAHA.109.140236; RIBEIRO MO, 1992, HYPERTENSION, V20, P298, DOI 10.1161/01.HYP.20.3.298; Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303; Sun Y, 2005, HYPERTENSION, V46, P1355, DOI 10.1161/01.HYP.0000192651.06674.3f; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Tang Y, 2014, CARDIOVASC PATHOL, V23, P101, DOI 10.1016/j.carpath.2013.11.002; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Vishnyakova PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32410; Wei BR, 2011, AM J HYPERTENS, V24, P976, DOI 10.1038/ajh.2011.88; Wilde E, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005204; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006	55	6	6	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21678	10.1096/fj.202000238RRR	http://dx.doi.org/10.1096/fj.202000238RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34133045	Green Published			2022-12-28	WOS:000667814100039
J	Du, MF; Yuan, L; Zhang, Z; Zhang, C; Zhu, ML; Zhang, Z; Li, RD; Zhao, XY; Liang, H; Li, YH; Jiang, H; Qiao, J; Yin, YX				Du, Mufeng; Yuan, Lin; Zhang, Zhong; Zhang, Cong; Zhu, Minglu; Zhang, Zhe; Li, Ridong; Zhao, Xuyang; Liang, Hui; Li, Yuhua; Jiang, Hui; Qiao, Jie; Yin, Yuxin			PPP2R1B is modulated by ubiquitination and is essential for spermatogenesis	FASEB JOURNAL			English	Article						DCAF6; meiotic arrest; meiotic recombination; spermatogenesis; USP5	MIXED LINEAGE KINASE; INDUCED CELL-DEATH; PROGRAMMED NECROSIS; MITOCHONDRIAL FRAGMENTATION; NLRP3 INFLAMMASOME; METHAMPHETAMINE; RIP3; NECROPTOSIS; APOPTOSIS; ACTIVATION	The serine-threonine protein phosphatase 2A (PP2A) is a heterotrimeric enzyme complex that regulates many fundamental cellular processes. PP2A is involved in tumorigenesis because mutations in the scaffold subunit, PPP2R1B, were found in several types of cancers. However, the biological function of PPP2R1B remains largely unknown. We report here that homozygous deletion of Ppp2r1b in Mus musculus impairs meiotic recombination and causes meiotic arrest in spermatocytes. Consistently, male mice lacking Ppp2r1b are characterized with infertility. Furthermore, heterozygous missense mutations in the Homo sapiens PPP2R1B gene, which encodes PPP2R1B, are identified in azoospermia patients with meiotic arrest. We found that PPP2R1B mutants are susceptible to degradation by an E3 ligase CRL4A(DCAF6), and resistant to de-polyubiquitylation by ubiquitin-specific protease 5 (USP5). In addition, heterozygous mutations in PPP2R1B reduce stability of the wild-type PPP2R1B. Our results demonstrate an essential role of PPP2R1B in spermatogenesis and identify upstream regulators of PPP2R1B.	[Du, Mufeng; Yuan, Lin; Zhang, Zhong; Zhang, Cong; Zhu, Minglu; Li, Ridong; Zhao, Xuyang; Liang, Hui; Li, Yuhua; Yin, Yuxin] Sch Basic Med Sci, Inst Syst Biomed, Dept Pathol, Beijing, Peoples R China; [Du, Mufeng; Yuan, Lin; Zhang, Zhong; Zhang, Cong; Zhu, Minglu; Li, Ridong; Zhao, Xuyang; Liang, Hui; Li, Yuhua; Yin, Yuxin] Peking Univ, Peking Tsinghua Ctr Life Sci, Hlth Sci Ctr, Beijing, Peoples R China; [Zhang, Zhe; Jiang, Hui] Peking Univ Third Hosp, Depatment Urol, Beijing, Peoples R China; [Qiao, Jie] Peking Univ Third Hosp, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing, Peoples R China; [Yuan, Lin; Yin, Yuxin] Peking Univ, Inst Precis Med, Shenzhen Hosp, Shenzhen, Peoples R China	Peking University; Peking University; Peking University	Yin, YX (corresponding author), Peking Univ, Inst Syst Biomed, Pathol, Hlth Sci Ctr, Beijing 100191, Peoples R China.	yinyuxin@hsc.pku.edu.cn	Ridong, Li/AFD-8942-2022; Li, yu/HHZ-5236-2022; Ridong, Li/AAE-9471-2022	ZHANG, ZHE/0000-0003-2365-2362	National Key Research and Development Program of China [2016YFA0500302]; National Natural Science Foundation of China [81430056, 31420103905, 81372491]; Beijing Natural Science Foundation [7161007]; PUHSC Key Scientific Research Program [BMU20150507]; Lam Chung Nin Foundation for Systems Biomedicine	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); PUHSC Key Scientific Research Program; Lam Chung Nin Foundation for Systems Biomedicine	We thank Dr X. Li for analysis of whole--exome sequencing data, Dr G. Wang for critical reading and discussion of this work, Dr J. Yang for guidance in mice breeding and experimental suggestion. We are also grateful to Dr L. Zhang for the gifts of USP5, USP13 and Ub related plasmids; This work was supported by grants to YY, including the National Key Research and Development Program of China (2016YFA0500302), the National Natural Science Foundation of China (81430056, 31420103905, and 81372491), the Beijing Natural Science Foundation (7161007), the PUHSC Key Scientific Research Program (BMU20150507) and the Lam Chung Nin Foundation for Systems Biomedicine.	Afonso MB, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.280; Alexiou A, 2019, MOL NEUROBIOL, V56, P4530, DOI 10.1007/s12035-018-1397-x; Bertholet AM, 2016, NEUROBIOL DIS, V90, P3, DOI 10.1016/j.nbd.2015.10.011; Breckenridge DG, 2008, MOL CELL, V31, P586, DOI 10.1016/j.molcel.2008.07.015; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Carvalho M, 2012, ARCH TOXICOL, V86, P1167, DOI 10.1007/s00204-012-0815-5; Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711; Chen JS, 2019, CELL TRANSPLANT, V28, P1358, DOI 10.1177/0963689719867285; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chomchai C, 2015, CURR OPIN PSYCHIATR, V28, P269, DOI 10.1097/YCO.0000000000000168; Chou J, 2008, NEUROSCIENCE, V151, P92, DOI 10.1016/j.neuroscience.2007.10.044; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dara L, 2016, J CLIN INVEST, V126, P4068, DOI 10.1172/JCI90830; Dionisio PA, 2020, INT REV CEL MOL BIO, V353, P31, DOI 10.1016/bs.ircmb.2019.12.006; Dionisio PA, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2078-z; Dowding JM, 2014, CELL DEATH DIFFER, V21, P1622, DOI 10.1038/cdd.2014.72; Du SH, 2017, FORENSIC SCI MED PAT, V13, P409, DOI 10.1007/s12024-017-9896-z; Fattoretti P, 2006, ANN NY ACAD SCI, V1090, P79, DOI 10.1196/annals.1378.008; Feng ST, 2020, PHARMACOL RES, V151, DOI 10.1016/j.phrs.2019.104553; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Guo LM, 2020, NEURAL REGEN RES, V15, P865, DOI 10.4103/1673-5374.268902; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ho EL, 2009, NEUROCRIT CARE, V10, P295, DOI 10.1007/s12028-008-9177-5; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hu H, 2021, CELL DEATH DIFFER, V28, P251, DOI 10.1038/s41418-020-0598-9; Huang WY, 2015, TOXICOL SCI, V145, P68, DOI 10.1093/toxsci/kfv014; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jeon J, 2020, ANN RHEUM DIS, V79, P1635, DOI 10.1136/annrheumdis-2020-217904; Kim JE, 2014, CELL DEATH DIFFER, V21, P1036, DOI 10.1038/cdd.2014.17; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Li B, 2017, MOL NEUROBIOL, V54, P1642, DOI 10.1007/s12035-015-9637-9; Lin QS, 2020, LAB INVEST, V100, P503, DOI 10.1038/s41374-019-0319-5; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Liu ZY, 2019, THERANOSTICS, V9, P3659, DOI 10.7150/thno.32126; Meng LJ, 2015, P NATL ACAD SCI USA, V112, P11007, DOI 10.1073/pnas.1514730112; Moratalla R, 2017, PROG NEUROBIOL, V155, P149, DOI 10.1016/j.pneurobio.2015.09.011; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Moszczynska A, 2017, J PHARMACOL EXP THER, V362, P474, DOI 10.1124/jpet.116.238501; Nakamura T, 2020, ANTIOXID REDOX SIGN, V32, P817, DOI 10.1089/ars.2019.7916; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Parameyong A, 2013, J PINEAL RES, V55, P313, DOI 10.1111/jpi.12078; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shi F, 2019, THERANOSTICS, V9, P2424, DOI 10.7150/thno.30941; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sun LM, 2014, TRENDS BIOCHEM SCI, V39, P587, DOI 10.1016/j.tibs.2014.10.003; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tang X, 2020, CIRCULATION, V141, P984, DOI 10.1161/CIRCULATIONAHA.119.042336; Teodorof-Diedrich C., 2020, J Virol, V94; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vearrier D, 2012, DM-DIS MON, V58, P38, DOI 10.1016/j.disamonth.2011.09.004; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang KJ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01720; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; Wei RL, 2020, NEUROSCIENCE, V437, P23, DOI 10.1016/j.neuroscience.2020.02.042; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Xie XL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00802; Xu Enquan, 2017, Int J Physiol Pathophysiol Pharmacol, V9, P84; Xu X, 2018, FASEB J, V32, P6737, DOI 10.1096/fj.201701460RRR; Yang CL, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00990; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.286; Zhang Y, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02770-w	69	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21564	10.1096/fj.202002810R	http://dx.doi.org/10.1096/fj.202002810R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913576	hybrid			2022-12-28	WOS:000645260100067
J	Lin, NH; Yang, AW; Chang, CH; Perng, MD				Lin, Ni-Hsuan; Yang, Ai-Wen; Chang, Chih-Hsuan; Perng, Ming-Der			Elevated GFAP isoform expression promotes protein aggregation and compromises astrocyte function	FASEB JOURNAL			English	Article						Alexander disease; alternative splicing; astrocyte; GFAP isoform; intermediate filaments	FIBRILLARY ACIDIC PROTEIN; ALPHA-B-CRYSTALLIN; CENTRAL-NERVOUS-SYSTEM; ALEXANDER-DISEASE; WHITE-MATTER; INTERMEDIATE-FILAMENTS; ASSEMBLY PROPERTIES; ROSENTHAL FIBERS; ACTIVATION; MUTATIONS	Alexander disease (AxD) caused by mutations in the coding region of GFAP is a neurodegenerative disease characterized by astrocyte dysfunction, GFAP aggregation, and Rosenthal fiber accumulation. Although how GFAP mutations cause disease is not fully understood, Rosenthal fibers could be induced by forced overexpression of human GFAP and this could be lethal in mice implicate that an increase in GFAP levels is central to AxD pathogenesis. Our recent studies demonstrated that intronic GFAP mutations cause disease by altering GFAP splicing, suggesting that an increase in GFAP isoform expression could lead to protein aggregation and astrocyte dysfunction that typify AxD. Here we test this hypothesis by establishing primary astrocyte cultures from transgenic mice overexpressing human GFAP. We found that GFAP-delta and GFAP-kappa were disproportionately increased in transgenic astrocytes and both were enriched in Rosenthal fibers of human AxD brains. In vitro assembly studies showed that while the major isoform GFAP-alpha self-assembled into typical 10-nm filaments, minor isoforms including GFAP-delta, -kappa, and -lambda were assembly-compromised and aggregation prone. Lentiviral transduction showed that expression of these minor GFAP isoforms decreased filament solubility and increased GFAP stability, leading to the formation of Rosenthal fibers-like aggregates that also disrupted the endogenous intermediate filament networks. The aggregate-bearing astrocytes lost their normal morphology and glutamate buffering capacity, which had a toxic effect on neighboring neurons. In conclusion, our findings provide evidence that links elevated GFAP isoform expression with GFAP aggregation and impaired glutamate transport, and suggest a potential non-cell-autonomous mechanism underlying neurodegeneration through astrocyte dysfunction.	[Lin, Ni-Hsuan; Yang, Ai-Wen; Chang, Chih-Hsuan; Perng, Ming-Der] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Perng, Ming-Der] Natl Tsing Hua Univ, Dept Med Sci, Coll Life Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Perng, MD (corresponding author), Natl Tsinghua Univ, Rm 208,Life Sci Bldg 1,101 Kwang Fu Rd,Sec 2, Hsinchu 30013, Taiwan.	mdperng@life.nthu.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [109--2320--B--007--002]; National Tsing Hua University (NTHU) [109A2008V6]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Tsing Hua University (NTHU)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 109--2320--B--007--002; National Tsing Hua University (NTHU), Grant/Award Number: 109A2008V6	Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Battaglia RA, 2019, ELIFE, V8, DOI 10.7554/eLife.47789; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Blechingberg J, 2007, GLIA, V55, P497; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; BRENNER M, 1990, MOL BRAIN RES, V7, P277, DOI 10.1016/0169-328X(90)90078-R; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Brenner Michael, 2009, P591, DOI 10.1007/978-0-387-79492-1_24; Bugiani M, 2018, BRAIN PATHOL, V28, P408, DOI 10.1111/bpa.12606; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; CHEN WJ, 1994, J CELL SCI, V107, P2299; Clairembault T, 2014, J NEUROCHEM, V130, P805, DOI 10.1111/jnc.12742; Condorelli DF, 1999, J NEUROSCI RES, V56, P219, DOI 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Eng LF, 1998, J NEUROSCI RES, V53, P353, DOI 10.1002/(SICI)1097-4547(19980801)53:3<353::AID-JNR9>3.0.CO;2-9; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Hayashi J, 2020, CELL STRESS CHAPERON, V25, P639, DOI 10.1007/s12192-020-01098-w; Heaven MR, 2016, J PROTEOME RES, V15, P2265, DOI 10.1021/acs.jproteome.6b00316; Helman G, 2020, HUM MUTAT, V41, P1131, DOI 10.1002/humu.24008; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719; Hesse M, 2001, J CELL SCI, V114, P2569; Hol EM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a021642; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Huyghe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038264; IWAKI T, 1993, AM J PATHOL, V143, P487; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kamphuis W, 2014, NEUROBIOL AGING, V35, P492, DOI 10.1016/j.neurobiolaging.2013.09.035; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kapinos LE, 2010, J MOL BIOL, V396, P719, DOI 10.1016/j.jmb.2009.12.001; KOUKLIS PD, 1993, J CELL SCI, V106, P919; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li LB, 2006, J NEUROCHEM, V97, P759, DOI 10.1111/j.1471-4159.2006.03743.x; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Liedtke W, 1998, AM J PATHOL, V152, P251; Lin NH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180694; Lin NH, 2016, MOL BIOL CELL, V27, P3980, DOI 10.1091/mbc.E16-06-0362; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2012, ARCH NEUROL-CHICAGO, V69, P208, DOI 10.1001/archneurol.2011.1181; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perng MD, 1999, J CELL SCI, V112, P2099; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Perng MD, 2016, METHOD ENZYMOL, V569, P155, DOI 10.1016/bs.mie.2015.07.025; QUINLAN RA, 1989, J CELL SCI, V93, P71; RALTON JE, 1994, J CELL SCI, V107, P1935; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Sussmuth SD, 2008, CURR MED CHEM, V15, P1788, DOI 10.2174/092986708785133031; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tarasiuk J, 2012, J NEURAL TRANSM, V119, P747, DOI 10.1007/s00702-012-0806-y; Thomsen R, 2013, GLIA, V61, P1922, DOI 10.1002/glia.22569; Toops Kimberly A, 2012, BMC Res Notes, V5, P693, DOI 10.1186/1756-0500-5-693; van Bodegraven EJ, 2021, FASEB J, V35, DOI 10.1096/fj.202001767R; Walker AK, 2014, J NEUROSCI, V34, P6448, DOI 10.1523/JNEUROSCI.0248-14.2014	78	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21614	10.1096/fj.202100087R	http://dx.doi.org/10.1096/fj.202100087R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908669				2022-12-28	WOS:000645260100043
J	Nord, A; Metcalfe, NB; Page, JL; Huxtable, A; McCafferty, DJ; Dawson, NJ				Nord, Andreas; Metcalfe, Neil B.; Page, Jennifer L.; Huxtable, Anna; McCafferty, Dominic J.; Dawson, Neal J.			Avian red blood cell mitochondria produce more heat in winter than in autumn	FASEB JOURNAL			English	Article						cellular metabolism; erythrocyte; overwintering; oxygen consumption; thermal biology	ACTIVATED PROTEIN-KINASE; SAURURUS-CHINENSIS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; FATTY-ACID; MANASSANTIN; LIGNANS; AMPK; COA; ATHEROSCLEROSIS	Endotherms in cold regions improve heat-producing capacity when preparing for winter. We know comparatively little about how this change is fueled by seasonal adaptation in cellular respiration. Thus, we studied the changes of mitochondrial function in red blood cells in sympatric Coal (Periparus ater), Blue (Cyanistes caeruleus), and Great (Parus major) tits between autumn and winter. These species differ more than twofold in body mass and in several aspects of their foraging ecology and social dominance, which could require differential seasonal adaptation of energy expenditure. Coal and Great tits in particular upregulated the mitochondrial respiration rate and mitochondrial volume in winter. This was not directed toward ATP synthesis, instead reflecting increased uncoupling of electron transport from ATP production. Because uncoupling is exothermic, this increased heat-producing capacity at the sub-cellular level in winter. This previously unexplored the route of thermogenesis in birds should be addressed in future work.	[Nord, Andreas] Lund Univ, Sect Evolutionary Ecol, Dept Biol, SE-22362 Lund, Sweden; [Nord, Andreas; Page, Jennifer L.; Huxtable, Anna; McCafferty, Dominic J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Scottish Ctr Ecol & Nat Environm, Rowardennan, Scotland; [Metcalfe, Neil B.; Dawson, Neal J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Graham Kerr Bldg, Glasgow, Lanark, Scotland	Lund University; University of Glasgow; University of Glasgow	Nord, A (corresponding author), Lund Univ, Sect Evolutionary Ecol, Dept Biol, SE-22362 Lund, Sweden.	andreas.nord@biol.lu.se		Dawson, Neal/0000-0001-5389-8692; Page, Jennifer/0000-0003-4967-4498; Nord, Andreas/0000-0001-6170-689X; McCafferty, Dominic/0000-0002-3079-3326; Metcalfe, Neil/0000-0002-1970-9349	Birgit and Hellmuth Hertz Foundation/The Royal Physiographic Society of Lund [2017-39034]; Carl Trygger Foundation for Scientific Research [18:280]; Stiftelsen Lunds Djurskyddsfond; NERC [NE/R001510/1]	Birgit and Hellmuth Hertz Foundation/The Royal Physiographic Society of Lund; Carl Trygger Foundation for Scientific Research; Stiftelsen Lunds Djurskyddsfond; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by funds from the Birgit and Hellmuth Hertz Foundation/The Royal Physiographic Society of Lund (grant 2017-39034), the Carl Trygger Foundation for Scientific Research (grant 18:280), and Stiftelsen Lunds Djurskyddsfond (to AN). NJD and NBM were funded by NERC (grant NE/R001510/1)	Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014; Choi HN, 2013, FASEB J, V27; Chow YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38129; Cui H, 2014, J NAT PROD, V77, P100, DOI 10.1021/np400757k; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hwang BY, 2003, PHYTOCHEMISTRY, V64, P765, DOI 10.1016/S0031-9422(03)00391-1; Hwang Ji-Yeon, 2007, Nutr Res Pract, V1, P100, DOI 10.4162/nrp.2007.1.2.100; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Joo HJ, 2006, FOOD SCI BIOTECHNOL, V15, P413; Jung YW, 2019, ARCH PHARM RES, V42, P332, DOI 10.1007/s12272-018-1093-4; Kahn CR, 2019, J CLIN INVEST, V129, P3990, DOI 10.1172/JCI129187; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim JI., 2012, FASEB J, V26; Kim SJ, 2009, BIOCHEM BIOPH RES CO, V389, P437, DOI 10.1016/j.bbrc.2009.08.161; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Kwon DY, 2015, J MED CHEM, V58, P7659, DOI 10.1021/acs.jmedchem.5b01220; Lai K, 2013, ACS CHEM BIOL, V8, P257, DOI 10.1021/cb300495e; Lang LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099584; Li J, 2018, METHODS MOL BIOL, V1773, P167, DOI 10.1007/978-1-4939-7799-4_14; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu ZJ, 2014, ONCOL REP, V32, P659, DOI 10.3892/or.2014.3244; Ma YB, 2017, J BIOL CHEM, V292, P20989, DOI 10.1074/jbc.M117.812925; Muller S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43624-6; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Seo CS, 2008, J NAT PROD, V71, P1771, DOI 10.1021/np8002723; Seo CS, 2009, PHYTOTHER RES, V23, P1531, DOI 10.1002/ptr.2791; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Steinbeck KS, 2018, NAT REV ENDOCRINOL, V14, P331, DOI 10.1038/s41574-018-0002-8; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Wang EC, 1996, HETEROCYCLES, V43, P969, DOI 10.3987/COM-95-7370; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Yang QY, 2016, CELL METAB, V24, P542, DOI 10.1016/j.cmet.2016.08.010; Yu H, 2018, METHODS MOL BIOL, V1773, P273, DOI 10.1007/978-1-4939-7799-4_21; Yun YR, 2007, J MED FOOD, V10, P316, DOI 10.1089/jmf.2006.149; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zeng XY, 2012, BIOCHEM PHARMACOL, V84, P830, DOI 10.1016/j.bcp.2012.07.003; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhou YP, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0268-9	51	11	11	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21490	10.1096/fj.202100107R	http://dx.doi.org/10.1096/fj.202100107R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33829547	Green Accepted, hybrid			2022-12-28	WOS:000645260100103
J	Schadel, P; Troisi, F; Czapka, A; Gebert, N; Pace, S; Ori, A; Werz, O				Schaedel, Patrick; Troisi, Fabiana; Czapka, Anna; Gebert, Nadja; Pace, Simona; Ori, Alessandro; Werz, Oliver			Aging drives organ-specific alterations of the inflammatory microenvironment guided by immunomodulatory mediators in mice	FASEB JOURNAL			English	Article						aging; cytokines; inflammation; lipid mediators; resolution	HEPATIC STELLATE CELLS; EXTRACELLULAR VESICLES; LIVER FIBROSIS; SIGNAL TRANSDUCER; TRANSCRIPTION 3; EXOSOMES; DELIVERY; ACTIVATION; MECHANISMS; STAT3	Aging is accompanied by chronic, low-grade systemic inflammation, termed inflammaging, a main driver of age-associated diseases. Such sterile inflammation is typically characterized by elevated levels of pro-inflammatory mediators, such as cytokines, chemokines and reactive oxygen species causing organ damage. Lipid mediators play important roles in the fine-tuning of both the promotion and the resolution of inflammation. Yet, it remains unclear how lipid mediators fit within the concept of inflammaging and how their biosynthesis and function is affected by aging. Here, we provide comprehensive signature profiles of inflammatory markers in organs afflicted with inflammation of young and old C57BL/6 mice. We reveal an organ-specific footprint of inflammation-related cytokines, chemokines and lipid mediators, which are distinctively affected by aging. While some organs are characterized by a pronounced pro-inflammatory microenvironment and impaired resolution during aging, others display elevated levels of pro-resolving mediators or an overall decrease in inflammatory signaling. Our results demonstrate that it proves difficult to establish a unifying concept for alterations of immunomodulatory mediators as consequence of aging and that organ specificity needs to be considered. Moreover, our data imply that inclusion of lipid mediators into the concept of inflammaging provides a comprehensive tool to characterize the inflammatory microenvironment during aging on a broader and yet, more detailed scope.	[Schaedel, Patrick; Troisi, Fabiana; Czapka, Anna; Pace, Simona; Werz, Oliver] Friedrich Schiller Univ, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany; [Troisi, Fabiana] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Munich, Germany; [Troisi, Fabiana] Helmholtz Ctr Munich, Munich, Germany; [Gebert, Nadja; Ori, Alessandro] Fritz Lipmann Inst FLI, Leibniz Inst Aging, Jena, Germany	Friedrich Schiller University of Jena; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Werz, O (corresponding author), Friedrich Schiller Univ Jena, Inst Pharm, Dept Pharmaceut Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	oliver.werz@uni-jena.de	Ori, Alessandro/M-8586-2019	Ori, Alessandro/0000-0002-3046-0871; Schadel, Patrick/0000-0002-9586-6653	Free State of Thuringia; ProExcellence Initiative 2 ("RegenerAging"); Deutsche Forschungsgemeinschaft; Europaischer Fonds fur regionale Entwicklung [2019FGR0095];  [SFB 1278/1 PolyTarget-316213987];  [C02];  [SFB 1127/2 ChemBioSys-239748522];  [A04]	Free State of Thuringia(European Commission); ProExcellence Initiative 2 ("RegenerAging"); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Europaischer Fonds fur regionale Entwicklung; ; ; ; 	Free State of Thuringia; ProExcellence Initiative 2 ("RegenerAging"); Deutsche Forschungsgemeinschaft; SFB 1278/1 PolyTarget-316213987, Grant/Award Number: C02; SFB 1127/2 ChemBioSys-239748522, Grant/Award Number: A04; Europaischer Fonds fur regionale Entwicklung, Grant/Award Number: 2019FGR0095	Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beebe JD, 2018, PHARMACOL THERAPEUT, V191, P74, DOI 10.1016/j.pharmthera.2018.06.006; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Breitkopf K, 2005, GUT, V54, P673, DOI 10.1136/gut.2004.042911; Busatto S, 2019, BIOMED MICRODEVICES, V21, DOI 10.1007/s10544-019-0396-7; Chakraborty D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01236-6; Choi S, 2019, BIOCHEM BIOPH RES CO, V513, P49, DOI 10.1016/j.bbrc.2019.03.156; Gong XH, 2014, CELL PHYSIOL BIOCHEM, V33, P97, DOI 10.1159/000356653; He WW, 2019, ONCOL LETT, V17, P5608, DOI 10.3892/ol.2019.10236; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krishna Murli, 2017, Clin Liver Dis (Hoboken), V10, P53, DOI 10.1002/cld.653; Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026; LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lou GH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1512-5; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00243; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y; Ogiso H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162183; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Su TH, 2015, P NATL ACAD SCI USA, V112, P7243, DOI 10.1073/pnas.1507499112; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Xiang DM, 2018, GUT, V67, P1704, DOI 10.1136/gutjnl-2016-313392; Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004; Zhai XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49287-7; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240	47	3	3	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21558	10.1096/fj.202002684R	http://dx.doi.org/10.1096/fj.202002684R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855766				2022-12-28	WOS:000645260100073
J	Patel, AB; Veeraiah, P; Shameem, M; Kumar, JM; Saba, K				Patel, Anant Bahadur; Veeraiah, Pandichelvam; Shameem, Mohammad; Kumar, Jerald Mahesh; Saba, Kamal			Impaired GABAergic and glutamatergic neurometabolic activity in aged mice brain as measured by H-1-[C-13]-NMR spectroscopy	FASEB JOURNAL			English	Article						H-1&#8208; [C-13]&#8208; NMR spectroscopy; ATP; brain energy metabolism; GABA; glutamate	MAGNETIC-RESONANCE-SPECTROSCOPY; ENERGY-METABOLISM; RAT-BRAIN; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; GLUCOSE-OXIDATION; MEMORY DEFICITS; GABA SYNTHESIS; AGING BRAIN; CORTEX	Healthy aging is associated with a decline in cognitive function, and is a major risk factor for many neurodegenerative diseases. Although, there are several evidence that brain mitochondrial function is altered with aging its significance at the cellular level is elusive. In this study, we have investigated mitochondrial TCA cycle and neurotransmitter cycle fluxes associated with glutamatergic, GABAergic neurons and astroglia in the cerebral cortex and hippocampus of young (6 months) and aged (24 months) C57BL6 mice by using H-1-[C-13]-NMR spectroscopy together with timed infusion of C-13-labeled glucose and acetate. The ratio V-Cyc/V-TCA was determined from a steady-state [2-C-13]acetate experiment. Metabolic fluxes were obtained by fitting a three-compartment metabolic model to C-13 turnover of amino acids from glucose. Levels of glutamate, aspartate and taurine were reduced in the cerebral cortex, while glutamine and choline were elevated in the hippocampus of aged mice. Interestingly, the rate of acetate oxidation increased in the cerebral cortex, while the flux of mitochondrial TCA cycle of glutamatergic neurons decreased in the cerebral cortex (P < .0001) and hippocampus (P = .025) of aged mice. The glutamate-glutamine neurotransmitter cycle flux was reduced in the cerebral cortex (P < .0001). The GABAergic TCA cycle flux was reduced in the cerebral cortex (P = .0008), while GABA-glutamine neurotransmitter cycling flux was also reduced in the cerebral cortex (P = .011) and hippocampus (P = .042) of aged brain. In conclusion, the reduction in excitatory and inhibitory neurotransmitter activity of glutamatergic and GABAergic neurons in the cerebral cortex and hippocampus correlates qualitatively with declined cognitive function in aged mice.	[Patel, Anant Bahadur; Veeraiah, Pandichelvam; Shameem, Mohammad; Kumar, Jerald Mahesh; Saba, Kamal] CSIR Ctr Cellular & Mol Biol, NMR Microimaging & Spect, Uppal Rd, Hyderabad 500007, India; [Patel, Anant Bahadur; Saba, Kamal] Acad Sci & Innovat Res AcSIR, Ghaziabad, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Academy of Scientific & Innovative Research (AcSIR)	Patel, AB (corresponding author), CSIR Ctr Cellular & Mol Biol, NMR Microimaging & Spect, Uppal Rd, Hyderabad 500007, India.	abpatel@ccmb.res.in	Shameem, Mohammad/K-1632-2019; Veeraiah, Pandichelvam/AAS-4134-2020	Shameem, Mohammad/0000-0003-0578-2622; Veeraiah, Pandichelvam/0000-0002-9149-7483				Aanerud J, 2012, J CEREBR BLOOD F MET, V32, P1177, DOI 10.1038/jcbfm.2012.18; Bagga P, 2013, J NEUROCHEM, V127, P365, DOI 10.1111/jnc.12407; Barreto G, 2010, J NEUROSURG ANESTH, V22, P214, DOI 10.1097/ANA.0b013e3181d56c98; BENEDETTI MS, 1990, J NEUR TR S, V29, P259; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; BURNS A, 1992, AGE AGEING, V21, P316, DOI 10.1093/ageing/21.5.316; Canas PM, 2009, NEUROBIOL AGING, V30, P1877, DOI 10.1016/j.neurobiolaging.2008.01.003; Chakravarty S, 2017, BBA-MOL BASIS DIS, V1863, P152, DOI 10.1016/j.bbadis.2016.09.014; Chang L, 2009, MAGN RESON IMAGING, V27, P142, DOI 10.1016/j.mri.2008.06.002; Chen LH, 2019, NEUROSCI LETT, V708, DOI 10.1016/j.neulet.2019.134341; de Graaf RA, 2003, MAGNET RESON MED, V49, P37, DOI 10.1002/mrm.10348; Duarte JMN, 2014, NEUROBIOL AGING, V35, P1660, DOI 10.1016/j.neurobiolaging.2014.01.135; Duarte JMN, 2013, J NEUROCHEM, V126, P579, DOI 10.1111/jnc.12333; Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006; FITZPATRICK SM, 1990, J CEREBR BLOOD F MET, V10, P170, DOI 10.1038/jcbfm.1990.32; Goodall EF, 2018, NEUROPATH APPL NEURO, V44, P328, DOI 10.1111/nan.12408; Haider S, 2014, AGE, V36, P1291, DOI 10.1007/s11357-014-9653-0; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Harris JL, 2014, NEUROBIOL AGING, V35, P1686, DOI 10.1016/j.neurobiolaging.2014.01.018; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; HOYER S, 1985, ARCH GERONTOL GERIAT, V4, P193, DOI 10.1016/0167-4943(85)90001-9; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Kalpouzos G, 2009, NEUROBIOL AGING, V30, P112, DOI 10.1016/j.neurobiolaging.2007.05.019; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kaur M, 2008, BIOGERONTOLOGY, V9, P441, DOI 10.1007/s10522-008-9168-0; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Legrand A, 1998, BRAIN RES, V802, P125, DOI 10.1016/S0006-8993(98)00580-0; Lin AL, 2014, J CEREBR BLOOD F MET, V34, P1440, DOI 10.1038/jcbfm.2014.114; Ling LL, 2005, NEUROSCIENCE, V132, P1103, DOI 10.1016/j.neuroscience.2004.12.043; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lores-Arnaiz S, 2011, NEUROSCIENCE, V188, P117, DOI 10.1016/j.neuroscience.2011.04.060; Lores-Arnaiz S, 2016, NEUROCHEM RES, V41, P353, DOI 10.1007/s11064-015-1817-5; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mahesh Kumar MJ., 2014, P INT SOC MAGN RESON, V22, P62; Mason GF, 2003, BRAIN RES PROTOC, V10, P181, DOI 10.1016/S1385-299X(02)00217-9; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Mishra PK, 2018, J NEUROCHEM, V146, P722, DOI 10.1111/jnc.14544; Mishra PK, 2020, NEUROCHEM INT, V137, DOI 10.1016/j.neuint.2020.104750; No HJ, 2019, REV ESP MED NUCL IMA, V38, P160, DOI 10.1016/j.remn.2018.12.001; Nozaki Y, 2020, P NATL ACAD SCI USA, V117, P8166, DOI 10.1073/pnas.1921694117; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Patel AB, 2004, J CEREBR BLOOD F MET, V24, P972, DOI 10.1097/01.WCB.0000126234.16188.71; Patel AB, 2001, BRAIN RES, V919, P207, DOI 10.1016/S0006-8993(01)03015-3; Patel AB., 2012, P INT SOC MAGN RESON, V20, P1823; Patel AB, 2018, J CEREBR BLOOD F MET, V38, P1213, DOI 10.1177/0271678X17709463; Patel AB, 2010, J CEREBR BLOOD F MET, V30, P1200, DOI 10.1038/jcbfm.2010.2; Pathaki SS, 2017, NEUROPSYCHOPHARMACOL, V42, P854, DOI 10.1038/npp.2016.231; Peng SL, 2014, NEUROIMAGE, V98, P176, DOI 10.1016/j.neuroimage.2014.04.078; Petit-Taboue MC, 1998, NEUROIMAGE, V7, P176, DOI 10.1006/nimg.1997.0318; Petrosillo G, 2008, NEUROCHEM INT, V53, P126, DOI 10.1016/j.neuint.2008.07.001; Pistell PJ, 2012, NEUROBIOL AGING, V33, P2431, DOI 10.1016/j.neurobiolaging.2011.12.004; Raininko R, 2010, ACTA RADIOL, V51, P309, DOI 10.3109/02841850903476564; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Reutzel M, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4060769; Sailasuta N, 2008, MAGN RESON IMAGING, V26, P667, DOI 10.1016/j.mri.2007.06.007; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; SARANSAARI P, 1995, MECH AGEING DEV, V81, P61, DOI 10.1016/0047-6374(95)01583-L; Schmitz B, 2018, J NEUROIMAGING, V28, P416, DOI 10.1111/jon.12514; Schuff N, 2006, ADV EXP MED BIOL, V576, P241; SCHULZ J, 1994, J IMMUNOL METHODS, V167, P1, DOI 10.1016/0022-1759(94)90069-8; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Shen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051517; Sure VN, 2018, GEROSCIENCE, V40, P365, DOI 10.1007/s11357-018-0037-8; Takanashi J, 2015, MAGN RESON MED SCI, V14, P85, DOI 10.2463/mrms.2014-0064; Tiwari V, 2014, J NEUROCHEM, V128, P628, DOI 10.1111/jnc.12508; Tiwari V, 2013, J CEREBR BLOOD F MET, V33, P1523, DOI 10.1038/jcbfm.2013.114; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116	71	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21321	10.1096/fj.202001704RR	http://dx.doi.org/10.1096/fj.202001704RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33543543				2022-12-28	WOS:000647789600067
J	Bhat, OM; Yuan, XX; Kukreja, RC; Li, PL				Bhat, Owais M.; Yuan, Xinxu; Kukreja, Rakesh C.; Li, Pin-Lan			Regulatory role of mammalian target of rapamycin signaling in exosome secretion and osteogenic changes in smooth muscle cells lacking acid ceramidase gene	FASEB JOURNAL			English	Article						arterial stiffness; exosome; mTOR; sphingolipids; vascular calcification	ARTERIAL MEDIAL CALCIFICATION; VASCULAR CALCIFICATION; OSTEOBLASTIC DIFFERENTIATION; UP-REGULATION; CD38 GENE; SPHINGOMYELINASE; INHIBITION; EXPRESSION; DEGRADATION; TRANSITION	Acid ceramidase (murine gene code: Asah1) (50 kDa) belongs to N-terminal nucleophile hydrolase family. This enzyme is located in the lysosome, which mediates conversion of ceramide (CER) into sphingosine and free fatty acids at acidic pH. CER plays an important role in intracellular sphingolipid metabolism and its increase causes inflammation. The mammalian target of rapamycin complex 1 (mTORC1) signaling on late endosomes (LEs)/lysosomes may control cargo selection, membrane biogenesis, and exosome secretion, which may be fine controlled by lysosomal sphingolipids such as CER. This lysosomal-CER-mTOR signaling may be a crucial molecular mechanism responsible for development of arterial medial calcification (AMC). Torin-1 (5 mg/kg/day), an mTOR inhibitor, significantly decreased aortic medial calcification accompanied with decreased expression of osteogenic markers like osteopontin (OSP) and runt-related transcription factor 2 (RUNX2) and upregulation of smooth muscle 22 alpha (SM22-alpha) in mice receiving high dose of Vitamin D (500 000 IU/kg/day). Asah1(fl/fl)/SMCre mice had markedly increased co-localization of mTORC1 with lysosome-associated membrane protein-1 (Lamp-1) (lysosome marker) and decreased co-localization of vacuolar protein sorting-associated protein 16 (VPS16) (a multivesicular bodies [MVBs] marker) with Lamp-1, suggesting mTOR activation caused reduced MVBs interaction with lysosomes. Torin-1 significantly reduced the co-localization of mTOR vs Lamp-1, increased lysosome-MVB interaction which was associated with reduced accumulation of CD63 and annexin 2 (exosome markers) in the coronary arterial wall of mice. Using coronary artery smooth muscle cells (CASMCs), P-i-stimulation significantly increased p-mTOR expression in Asah1(fl/fl)/SMCre CASMCs as compared to WT/WT cells associated with increased calcium deposition and mineralization. Torin-1 blocked P-i-induced calcium deposition and mineralization. siRNA mTOR and Torin-1 significantly reduce co-localization of mTORC1 with Lamp-1, increased VPS16 vs Lamp-1 co-localization in P-i-stimulated CASMCs, associated with decreased exosome release. Functionally, Torin-1 significantly reduces arterial stiffening as shown by restoration from increased pulse wave velocity and decreased elastin breaks. These results suggest that lysosomal CER-mTOR signaling may play a critical role for the control of lysosome-MVB interaction, exosome secretion and arterial stiffening during AMC.	[Bhat, Owais M.; Yuan, Xinxu; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Kukreja, Rakesh C.] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Div Cardiol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Li, PL (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll, Virginia Campus, Richmond, VA 23298 USA.	pin-lan.li@vcuhealth.org			National Institutes of Health [HL122937, HL057244, HL075316]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: HL122937, HL057244 and HL075316	Bao JX, 2017, FRONT BIOSCI-LANDMRK, V22, P558, DOI 10.2741/4502; Bao JX, 2017, CELL PHYSIOL BIOCHEM, V41, P555, DOI 10.1159/000457877; Bhat O, 2020, J CELL MOL MED, V24, P539, DOI 10.1111/jcmm.14761; Bhat OM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58568-5; Bhat OM, 2015, J CARDIOL, V66, P28, DOI 10.1016/j.jjcc.2014.10.012; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Boini KM, 2012, J CELL MOL MED, V16, P1674, DOI 10.1111/j.1582-4934.2011.01462.x; Cai YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17540-6; Cao JM, 2017, MOL MED REP, V16, P1911, DOI 10.3892/mmr.2017.6844; Chandrika G, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695921; Chatterjee S, 2014, CIRCULATION, V129, P2403, DOI 10.1161/CIRCULATIONAHA.113.007559; Chong ZZ, 2011, TRENDS CARDIOVAS MED, V21, P151, DOI 10.1016/j.tcm.2012.04.005; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Goettsch C, 2016, J CLIN INVEST, V126, P1323, DOI 10.1172/JCI80851; Guo Y, 2019, FUNCT INTEGR GENOMIC, V19, P633, DOI 10.1007/s10142-019-00669-0; Gurley JM, 2016, DIABETES, V65, P2911, DOI 10.2337/db16-0305; Hartley CJ, 1997, AM J PHYSIOL-HEART C, V273, pH494, DOI 10.1152/ajpheart.1997.273.1.H494; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hoenderop JGJ, 2004, KIDNEY INT, V66, P1082, DOI 10.1111/j.1523-1755.2004.00858.x; Huber LA, 2016, CURR OPIN CELL BIOL, V39, P8, DOI 10.1016/j.ceb.2016.01.006; Iijima Katsuya, 2011, Clin Calcium, V21, P53, DOI CliCa111218031810; Jiao Y, 2017, ARTERIOSCL THROM VAS, V37, P1657, DOI 10.1161/ATVBAHA.117.309653; Kapustin AN, 2016, J PHYSIOL-LONDON, V594, P2905, DOI 10.1113/JP271340; Kapustin AN, 2017, ARTERIOSCL THROM VAS, V37, pE22, DOI 10.1161/ATVBAHA.116.308886; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2012, TRENDS CARDIOVAS MED, V22, P133, DOI 10.1016/j.tcm.2012.07.009; Krohn JB, 2016, J PHYSIOL-LONDON, V594, P2895, DOI 10.1113/JP271338; Krohn JB, 2016, ARTERIOSCL THROM VAS, V36, P525, DOI 10.1161/ATVBAHA.115.307009; Kurdi A, 2016, BRIT J CLIN PHARMACO, V82, P1267, DOI 10.1111/bcp.12820; Lesniewski LA, 2017, AGING CELL, V16, P17, DOI 10.1111/acel.12524; Li ST, 2018, INT J MOL MED, V42, P1517, DOI 10.3892/ijmm.2018.3699; Li X, 2014, J MOL MED, V92, P473, DOI 10.1007/s00109-014-1120-y; Liao LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082379; Lin ME, 2015, AM J PATHOL, V185, P1958, DOI 10.1016/j.ajpath.2015.03.020; Lin X, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116582; Lu QB, 2018, BBA-MOL BASIS DIS, V1864, P2154, DOI 10.1016/j.bbadis.2018.04.002; Luong TTD, 2021, CLIN SCI, V135, P515, DOI 10.1042/CS20201122; Mackey RH, 2007, ADV CARDIOL, V44, P234, DOI 10.1159/000096744; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Mondal RK, 2009, INDIAN PEDIATR, V46, P175; Nakahara T, 2017, JACC-CARDIOVASC IMAG, V10, P582, DOI 10.1016/j.jcmg.2017.03.005; Nakano-Kurimoto R, 2009, AM J PHYSIOL-HEART C, V297, pH1673, DOI 10.1152/ajpheart.00455.2009; Ode T, 2017, EXP CELL RES, V350, P103, DOI 10.1016/j.yexcr.2016.11.011; Pai A, 2011, AM J PATHOL, V178, P764, DOI 10.1016/j.ajpath.2010.10.006; Pan SL, 2017, AM J TRANSL RES, V9, P1307; Price PA, 2001, J NUTR, V131, P2910, DOI 10.1093/jn/131.11.2910; Qin JD, 2012, J BIOL CHEM, V287, P13620, DOI 10.1074/jbc.M111.304857; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Quinn U, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012024; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rzucidlo EM, 2009, VASCULAR, V17, pS15, DOI 10.2310/6670.2008.00089; Schieder M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3151pl3; Serban KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31596; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Smith ER, 2016, METHODS MOL BIOL, V1397, P175, DOI 10.1007/978-1-4939-3353-2_13; Song Y, 2017, EUR J PHARMACOL, V794, P45, DOI 10.1016/j.ejphar.2016.11.029; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; TANIMURA A, 1983, P SOC EXP BIOL MED, V172, P173; Tassew NG, 2017, CELL REP, V20, P99, DOI 10.1016/j.celrep.2017.06.009; Tong XY, 2016, J MOL CELL CARDIOL, V92, P30, DOI 10.1016/j.yjmcc.2016.01.020; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vogel KR, 2015, ANN CLIN TRANSL NEUR, V2, P699, DOI 10.1002/acn3.200; Wang Y, 2018, Zhonghua Yi Xue Za Zhi, V98, P1446, DOI 10.3760/cma.j.issn.0376-2491.2018.18.016; Xu TH, 2019, J CELL PHYSIOL, V234, P14306, DOI 10.1002/jcp.28130; Xu Z, 2017, EUR J PHARMACOL, V813, P1, DOI 10.1016/j.ejphar.2017.06.038; Yuan XX, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158532; Yuan XX, 2019, AM J PHYSIOL-HEART C, V316, pH345, DOI 10.1152/ajpheart.00342.2018; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhan JK, 2015, INT J CARDIOL, V189, P188, DOI 10.1016/j.ijcard.2015.04.086; Zhan JK, 2014, EXP CELL RES, V323, P352, DOI 10.1016/j.yexcr.2014.02.016; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang MH, 2020, HISTOCHEM CELL BIOL, V153, P357, DOI 10.1007/s00418-020-01847-z; Zhang WY, 2019, INT J CLIN EXP PATHO, V12, P2474; Zhang Y, 2014, CARDIOVASC RES, V102, P68, DOI 10.1093/cvr/cvu011; Zhao J, 2019, MOL MED REP, V20, P5197, DOI 10.3892/mmr.2019.10747; Zhao Y, 2015, KIDNEY INT, V88, P711, DOI 10.1038/ki.2015.160; Zhou KC, 2018, ACS CENTRAL SCI, V4, P548, DOI 10.1021/acscentsci.7b00582; Zhu DX, 2015, J CELL MOL MED, V19, P165, DOI 10.1111/jcmm.12373	85	3	3	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21732	10.1096/fj.202100385R	http://dx.doi.org/10.1096/fj.202100385R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143450	Green Accepted			2022-12-28	WOS:000667814100074
J	Liu, LF; Ge, W; Zhang, ZW; Li, Y; Xie, MX; Zhao, CH; Yao, CL; Luo, C; Wu, ZJ; Wang, WB; Zhao, D; Zhang, J; Qiu, W; Wang, YW				Liu, Longfei; Ge, Wen; Zhang, Zhiwei; Li, Ya; Xie, Mengxiao; Zhao, Chenhui; Yao, Chunlei; Luo, Can; Wu, Zhijiao; Wang, Wenbo; Zhao, Dan; Zhang, Jing; Qiu, Wen; Wang, Yingwei			Sublytic C5b-9 triggers glomerular mesangial cell proliferation via enhancing FGF1 and PDGF alpha gene transcription mediated by GCN5-dependent SOX9 acetylation in rat Thy-1 nephritis	FASEB JOURNAL			English	Article						acetylation; GCN5; SOX9; sublytic C5b-9; Thy-1 nephritis	LYSINE ACETYLTRANSFERASE GCN5; DNA-BINDING; C/EBP-BETA; COMPLEMENT; EXPRESSION; COMPLEXES; APOPTOSIS; ACTIVATION; CANCER; THROMBOSPONDIN-1	Rat Thy-1 nephritis (Thy-1N) is an animal model of human mesangioproliferative glomerulonephritis (MsPGN), accompanied by glomerular mesangial cell (GMC) proliferation and extracellular matrix (ECM) deposition. Although sublytic C5b-9 formed on GMC membrane could induce cell proliferation, the mechanism is still unclear. In this study, we first demonstrated that the level of SRY related HMG-BOX gene 9 (SOX9), general control nonderepressible 5 (GCN5), fibroblast growth factor 1 (FGF1) and platelet-derived growth factor alpha (PDGF alpha) was all elevated both in the renal tissues of Thy-1N rats (in vivo) and in the GMCs (in vitro) with sublytic C5b-9 stimulation. Then, we not only discovered that sublytic C5b-9 caused GMC proliferation through increasing SOX9, GCN5, FGF1 and PDGF alpha expression, but also proved that SOX9 and GCN5 formed a complex and combined with FGF1 and PDGF alpha promoters, leading to FGF1 and PDGF alpha gene transcription. More importantly, GCN5 could mediate SOX9 acetylation at lysine 62 (K62) to enhance SOX9 binding to FGF1 or PDGF alpha promoter and promote FGF1 or PDGF alpha synthesis and GMC proliferation. Besides, the experiments in vivo also showed that FGF1 and PDGF alpha expression, GMC proliferation and urinary protein secretion in Thy-1N rats were greatly reduced by silencing renal SOX9, GCN5, FGF1 or PDGF alpha gene. Furthermore, the renal tissues of MsPGN patients also exhibited positive expression of these genes mentioned above. Collectively, our findings indicate that GCN5, SOX9 and FGF1/PDGF alpha can form an axis and play an essential role in sublytic C5b-9-triggered GMC proliferation, which might provide a novel insight into the pathogenesis of Thy-1N and MsPGN.	[Liu, Longfei; Ge, Wen; Zhang, Zhiwei; Li, Ya; Luo, Can; Wu, Zhijiao; Wang, Wenbo; Zhao, Dan; Zhang, Jing; Qiu, Wen; Wang, Yingwei] Nanjing Med Univ, Dept Immunol, Key Lab Immunol Environm & Dis, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China; [Liu, Longfei] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Dept Cent Lab, Huaian, Peoples R China; [Xie, Mengxiao] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Peoples R China; [Zhao, Chenhui] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Peoples R China; [Yao, Chunlei] Nanjing Med Univ, Dept Nephrol, Affiliated Hosp 1, Nanjing, Peoples R China; [Qiu, Wen; Wang, Yingwei] Nanjing Med Univ, Key Lab Antibody Technol, Minist Hlth, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Qiu, W; Wang, YW (corresponding author), Nanjing Med Univ, Dept Immunol, Key Lab Immunol Environm & Dis, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China.	qiuwen@njmu.edu.cn; wangyw1508@njmu.edu.cn			National Natural Science Foundations of China [31770934, 31470853, 81971468, NMUB2020138]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundations of China, Grant/Award Number: 31770934, 31470853 and 81971468 Nanjing Medical University Science and Technology Development Fund: Grant/Award Number: NMUB2020138	Ali I, 2018, CHEM REV, V118, P340, DOI 10.1021/acs.chemrev.7b00181; Bai JX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01982; Borkham-Kamphorst E, 2016, CYTOKINE GROWTH F R, V28, P53, DOI 10.1016/j.cytogfr.2015.10.002; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen L, 2013, J BIOL CHEM, V288, P14510, DOI 10.1074/jbc.M113.458737; Cheng PF, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0594-4; Couser WG, 2001, KIDNEY INT, V59, P905, DOI 10.1046/j.1523-1755.2001.059003905.x; Dutta R, 2016, MOL GENET METAB, V119, P37, DOI 10.1016/j.ymgme.2016.06.013; Fan L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01478; Fosbrink M, 2005, IMMUNOL RES, V31, P37, DOI 10.1385/IR:31:1:37; Gao L, 2006, CLIN EXP IMMUNOL, V144, P326, DOI 10.1111/j.1365-2249.2006.03069.x; Gao L, 2009, CELL PROLIFERAT, V42, P83, DOI 10.1111/j.1365-2184.2008.00575.x; Guo L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00834-8; Haseeb A, 2019, NUCLEIC ACIDS RES, V47, P6917, DOI 10.1093/nar/gkz523; He FX, 2016, J MOL CELL BIOL, V8, P477, DOI 10.1093/jmcb/mjw021; Holmlund T, 2013, LEUKEMIA, V27, P578, DOI 10.1038/leu.2012.265; Jana S, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2019.113789; Kang HM, 2016, CELL REP, V14, P861, DOI 10.1016/j.celrep.2015.12.071; Li TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0877-2; Liang G, 2018, KIDNEY INT, V93, P95, DOI 10.1016/j.kint.2017.05.013; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Liu K, 2015, INT J MOL SCI, V16, P21897, DOI 10.3390/ijms160921897; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Lu Y, 2019, CELL MOL IMMUNOL, V16, P735, DOI 10.1038/s41423-018-0020-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Maillard N, 2015, J AM SOC NEPHROL, V26, P1503, DOI 10.1681/ASN.2014101000; Mustachio LM, 2019, AM J CANCER RES, V9, P1830; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Qiao LJ, 2018, J CELL MOL MED, V22, P5333, DOI 10.1111/jcmm.13806; Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.153; Qiu W, 2012, J PATHOL, V226, P619, DOI 10.1002/path.3011; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Rivera-Gonzalez GC, 2016, CELL STEM CELL, V19, P738, DOI 10.1016/j.stem.2016.09.002; Santos JC, 2016, CANCER RES, V76, P6735, DOI 10.1158/0008-5472.CAN-16-1120; Song SM, 2014, CANCER RES, V74, P4170, DOI 10.1158/0008-5472.CAN-13-3569; Stangou M, 2008, SCAND J UROL NEPHROL, V42, P373, DOI 10.1080/00365590801943241; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; Sun J, 2018, P NATL ACAD SCI USA, V115, P10010, DOI 10.1073/pnas.1805343115; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Ud-Din AIMS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071018; Vainer R, 2016, J MOL BIOL, V428, P3013, DOI 10.1016/j.jmb.2016.06.009; Wang LH, 2020, CANCER LETT, V468, P14, DOI 10.1016/j.canlet.2019.10.004; Wang YJ, 2017, CELL REP, V20, P600, DOI 10.1016/j.celrep.2017.06.065; Wang YW, 2006, LIFE SCI, V79, P182, DOI 10.1016/j.lfs.2005.12.053; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Wu WF, 2020, PHYTOMEDICINE, V69, DOI 10.1016/j.phymed.2020.153202; Xu JH, 2006, CELL TISSUE RES, V326, P159, DOI 10.1007/s00441-006-0214-4; Yu TY, 2020, INT J BIOL SCI, V16, P2340, DOI 10.7150/ijbs.46573; Yu TY, 2019, J CELL MOL MED, V23, P5654, DOI 10.1111/jcmm.14473; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006; Zakrzewska M, 2008, CRIT REV CL LAB SCI, V45, P91, DOI 10.1080/10408360701713120 ; Zhang J, 2018, J IMMUNOL, V201, P3184, DOI 10.4049/jimmunol.1800719; Zhang J, 2014, FASEB J, V28, P1511, DOI 10.1096/fj.13-242693; Zhang W, 2019, MOL ONCOL, V13, P2194, DOI 10.1002/1878-0261.12560; Zhao CH, 2018, ONCOGENE, V37, P4821, DOI 10.1038/s41388-018-0298-9; Zhu GQ, 2017, J IMMUNOL, V198, P1104, DOI 10.4049/jimmunol.1600403	61	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21751	10.1096/fj.202002814RR	http://dx.doi.org/10.1096/fj.202002814RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34156114				2022-12-28	WOS:000667814100032
J	Lu, LY; Chen, XX; Liu, Y; Yu, XJ				Lu, Lingyun; Chen, Xiaoxuan; Liu, Yi; Yu, Xijie			Gut microbiota and bone metabolism	FASEB JOURNAL			English	Review						bacterial metabolites; bone metabolism; gut microbiota; osteoporosis; pathogen-associated molecular patterns	TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; HIGH-FAT DIET; MESENCHYMAL STEM-CELLS; GAMMA-AMINOBUTYRIC-ACID; ARYL-HYDROCARBON RECEPTOR; TRIMETHYLAMINE-N-OXIDE; OSTEOCLAST DIFFERENTIATION; INDOXYL SULFATE; BILE-ACID	Osteoporosis is the most common metabolic skeletal disease. It is characterized by the deterioration of the skeletal microarchitecture and bone loss, leading to ostealgia, and even bone fractures. Accumulating evidence has indicated that there is an inextricable relationship between the gut microbiota (GM) and bone homeostasis involving host-microbiota crosstalk. Any perturbation of the GM can play an initiating and reinforcing role in disrupting the bone remodeling balance during the development of osteoporosis. Although the GM is known to influence bone metabolism, the mechanisms associated with these effects remain unclear. Herein, we review the current knowledge of how the GM affects bone metabolism in health and disease, summarize the correlation between pathogen-associated molecular patterns of GM structural components and bone metabolism, and discuss the potential mechanisms underlying how GM metabolites regulate bone turnover. Deciphering the complicated relationship between the GM and bone health will provide new insights into the prevention and treatment of osteoporosis.	[Lu, Lingyun; Yu, Xijie] Sichuan Univ, West China Hosp, Rare Dis Ctr, Dept Endocrinol & Metab,Lab Endocrinol & Metabol, 37 Guoxue Alley, Chengdu 610041, Peoples R China; [Lu, Lingyun] Sichuan Univ, West China Hosp, Dept Integrated Tradit Chinese & Western Med, Chengdu, Peoples R China; [Chen, Xiaoxuan] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China; [Liu, Yi] Sichuan Univ, West China Hosp, Rare Dis Ctr, Dept Rheumatol & Immunol, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Yu, XJ (corresponding author), Sichuan Univ, West China Hosp, Rare Dis Ctr, Dept Endocrinol & Metab,Lab Endocrinol & Metabol, 37 Guoxue Alley, Chengdu 610041, Peoples R China.	xijieyu@hotmail.com	Yu, Xijie/H-4124-2011	Yu, Xijie/0000-0002-3504-7664	National Natural Science Foundation of China [81770875]; Post-Doctoral Research Project, West China Hospital, Sichuan University [19HXBH053]; Health and Family Planning Commission of Sichuan Province [19PJ096]; 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University [2020HXFH008, ZYJC18003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Post-Doctoral Research Project, West China Hospital, Sichuan University; Health and Family Planning Commission of Sichuan Province; 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University	This work was supported by the National Natural Science Foundation of China (No. 81770875), the Post-Doctoral Research Project, West China Hospital, Sichuan University (No. 19HXBH053), the Health and Family Planning Commission of Sichuan Province (No. 19PJ096), and the 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (2020HXFH008, ZYJC18003).	Abdelqader A, 2013, TROP ANIM HEALTH PRO, V45, P1017, DOI 10.1007/s11250-012-0326-7; Adachi R, 2005, J LIPID RES, V46, P46, DOI 10.1194/jlr.M400294-JLR200; Adamopoulos IE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2936; Aguirre M, 2016, RES MICROBIOL, V167, P114, DOI 10.1016/j.resmic.2015.09.006; Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Ahn TK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124274; Amcheslavsky A, 2006, J CELL PHYSIOL, V207, P244, DOI 10.1002/jcp.20563; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Avella MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045572; Axmann R, 2008, ANN RHEUM DIS, V67, P1603, DOI 10.1136/ard.2007.080713; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Barcik W, 2017, CURR OPIN IMMUNOL, V48, P108, DOI 10.1016/j.coi.2017.08.011; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Bedi B, 2012, P NATL ACAD SCI USA, V109, pE725, DOI 10.1073/pnas.1120735109; Behera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33149-9; Behera J, 2018, BONE, V114, P90, DOI 10.1016/j.bone.2018.06.009; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bier A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091154; Bozec A, 2017, CURR OSTEOPOROS REP, V15, P121, DOI 10.1007/s11914-017-0356-1; Bozec A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007764; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Britton GJ, 2020, P NATL ACAD SCI USA, V117, P21536, DOI 10.1073/pnas.1922189117; Britton RA, 2014, J CELL PHYSIOL, V229, P1822, DOI 10.1002/jcp.24636; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Callaway DA, 2015, J BONE MINER METAB, V33, P359, DOI 10.1007/s00774-015-0656-4; Cano A, 2020, MATURITAS, V139, P90, DOI 10.1016/j.maturitas.2020.07.001; Cantley MD, 2011, J CELL PHYSIOL, V226, P3233, DOI 10.1002/jcp.22684; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; Chen Q, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/917168; Chen TH, 2007, BIOCHEM BIOPH RES CO, V355, P913, DOI 10.1016/j.bbrc.2007.02.057; Chen X, 2020, AGING DIS, V11, P629, DOI 10.14336/AD.2019.0613; Chen X, 2014, J LEUKOCYTE BIOL, V95, P723, DOI 10.1189/jlb.1213633; Cheng TH, 2020, TOXINS, V12, DOI 10.3390/toxins12110684; Chevalier C, 2020, CELL METAB, V32, P575, DOI 10.1016/j.cmet.2020.08.012; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho SW, 2013, J BONE MINER RES, V28, P2109, DOI 10.1002/jbmr.1961; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; Dar HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20896-y; Das M, 2019, RHEUMATOLOGY, V58, P2295, DOI 10.1093/rheumatology/kez302; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; De Weirdt R, 2010, FEMS MICROBIOL ECOL, V74, P601, DOI 10.1111/j.1574-6941.2010.00974.x; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Doerner KC, 1997, APPL ENVIRON MICROB, V63, P1185, DOI 10.1128/AEM.63.3.1185-1188.1997; Donkor ON, 2012, CLIN EXP IMMUNOL, V167, P282, DOI 10.1111/j.1365-2249.2011.04496.x; Dubreuil M, 2013, LIVER INT, V33, P1029, DOI 10.1111/liv.12153; Eaimworawuthikul S, 2020, EUR J NUTR, V59, P1453, DOI 10.1007/s00394-019-02002-8; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eisa NH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217931; El Refaey M, 2017, J BONE MINER RES, V32, P2182, DOI 10.1002/jbmr.3224; Elmansi AM, 2020, BONE REP, V12, DOI 10.1016/j.bonr.2020.100270; Elshabrawy HA, 2017, AUTOIMMUN REV, V16, P103, DOI 10.1016/j.autrev.2016.12.003; Ericsson AC, 2015, ILAR J, V56, P205, DOI 10.1093/ilar/ilv021; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Estell EG, 2021, NAT REV ENDOCRINOL, V17, P31, DOI 10.1038/s41574-020-00426-5; Falany ML, 2001, BIOCHEM BIOPH RES CO, V281, P180, DOI 10.1006/bbrc.2001.4307; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Fujimori K, 2019, MOLECULES, V24, DOI 10.3390/molecules24224155; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Fumoto T, 2014, J BONE MINER RES, V29, P830, DOI 10.1002/jbmr.2096; Gao J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00013; Garcia-Mantrana I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00890; Gentile CL, 2018, SCIENCE, V362, P776, DOI 10.1126/science.aau5812; Gomez R, 2015, NAT REV RHEUMATOL, V11, P159, DOI 10.1038/nrrheum.2014.209; Goto H, 2011, CYTOKINE, V56, P662, DOI 10.1016/j.cyto.2011.09.005; Grassi F, 2016, J BONE MINER RES, V31, P949, DOI 10.1002/jbmr.2757; Guss JD, 2017, J BONE MINER RES, V32, P1343, DOI 10.1002/jbmr.3114; Gustafsson BI, 2006, J CELL BIOCHEM, V98, P139, DOI 10.1002/jcb.20734; Hanly R, 2013, NUCL MED COMMUN, V34, P597, DOI 10.1097/MNM.0b013e3283608993; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; Harrington M, 2003, NUTR REV, V61, P179, DOI 10.1301/nr.2003.may.179-183; Hathaway-Schrader JD, 2019, AM J PATHOL, V189, P370, DOI 10.1016/j.ajpath.2018.10.017; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Herberg S, 2013, TISSUE ENG PT A, V19, P1, DOI [10.1089/ten.tea.2012.0085, 10.1089/ten.TEA.2012.0085]; Hirai T, 2009, J PHARMACOL SCI, V109, P319, DOI 10.1254/jphs.08243SC; Hirata J, 2015, BONE, V79, P252, DOI 10.1016/j.bone.2015.06.010; Hsu E, 2018, CALCIFIED TISSUE INT, V102, P512, DOI 10.1007/s00223-017-0321-0; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hu L, 2020, J ALZHEIMERS DIS, V77, P629, DOI 10.3233/JAD-200035; Hubbard TD, 2015, DRUG METAB DISPOS, V43, P1522, DOI 10.1124/dmd.115.064246; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Irie K, 2014, J DENT RES, V93, P801, DOI 10.1177/0022034514540173; Irwin R, 2013, INFLAMM BOWEL DIS, V19, P1586, DOI 10.1097/MIB.0b013e318289e17b; Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jimenez-Dalmaroni MJ, 2016, AUTOIMMUN REV, V15, P1, DOI 10.1016/j.autrev.2015.08.009; Jha S, 2015, J BONE MINER RES, V30, P2179, DOI 10.1002/jbmr.2565; Jones RM, 2018, BONE, V115, P59, DOI 10.1016/j.bone.2017.04.009; Kamprom W, 2021, INT J MED SCI, V18, P744, DOI 10.7150/ijms.48492; Karner CM, 2017, CELL MOL LIFE SCI, V74, P1649, DOI 10.1007/s00018-016-2425-5; Ke DS, 2018, BIOCHEM BIOPH RES CO, V497, P890, DOI 10.1016/j.bbrc.2018.02.164; Ke YL, 2018, FREE RADICAL BIO MED, V116, P88, DOI 10.1016/j.freeradbiomed.2018.01.007; Nguyen KD, 2018, EXPERT OPIN DRUG SAF, V17, P1005, DOI 10.1080/14740338.2018.1524868; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; Kiernan K, 2020, TRENDS ENDOCRIN MET, V31, P1, DOI 10.1016/j.tem.2019.11.002; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kim BJ, 2019, J CLIN ENDOCR METAB, V104, P2334, DOI 10.1210/jc.2018-02481; Kim HY, 2004, FOOD CHEM TOXICOL, V42, P2009, DOI 10.1016/j.fct.2004.06.021; Kim JM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092073; Kim YG, 2007, BIOCHEM BIOPH RES CO, V357, P1046, DOI 10.1016/j.bbrc.2007.04.042; Kim YH, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-60; Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Kondrikov D, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110805; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Kwon YM, 2015, OSTEOPOROSIS INT, V26, P969, DOI 10.1007/s00198-014-2977-x; Lagier JC, 2018, NAT REV MICROBIOL, V16, P540, DOI 10.1038/s41579-018-0041-0; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Fernandez-Murga ML, 2020, BONE, V141, DOI 10.1016/j.bone.2020.115580; Li C, 2019, OSTEOPOROSIS INT, V30, P1003, DOI 10.1007/s00198-019-04855-5; Li HW, 2020, CURR GENE THER, V20, P152, DOI 10.2174/1566523220999200727122502; Li JY, 2016, J CLIN INVEST, V126, P2049, DOI 10.1172/JCI86062; Li JY, 2014, J BONE MINER RES, V29, P43, DOI 10.1002/jbmr.2044; Li JY, 2019, DIGESTION, V99, P267, DOI 10.1159/000493096; Li L, 2019, AGING-US, V11, P9348, DOI 10.18632/aging.102376; Li LS, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.810; Li Y., 2020, FRONT ENDOCRINOL LAU, V11; Li ZX, 2019, J BONE MINER RES, V34, P765, DOI 10.1002/jbmr.3652; Liu H, 2019, THER ADV CHRONIC DIS, V10, DOI 10.1177/2040622319860653; Liu WC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207483; Liu WC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103486; Liu YK, 2020, AGING-US, V12, P10633, DOI 10.18632/aging.103283; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; Lorenzo J, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146619; Lucas S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02490-4; Luo CY, 2011, CELL MOL IMMUNOL, V8, P50, DOI 10.1038/cmi.2010.54; Luo YB, 2015, CELL METAB, V22, P886, DOI 10.1016/j.cmet.2015.08.020; Ma J, 2019, AGING-US, V11, P7537, DOI 10.18632/aging.102269; Ma SC, 2020, AGING-US, V12, P10795, DOI 10.18632/aging.103293; Ma SC, 2020, AGING-US, V12, P10736, DOI 10.18632/aging.103290; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Marchionatti A, 2018, CURR MED CHEM, V25, P2122, DOI 10.2174/0929867324666171116125131; Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miranda PM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0433-4; Mirzaei-Damabi N, 2020, PFLUG ARCH EUR J PHY, V472, P1051, DOI 10.1007/s00424-020-02422-0; Mitsou EK, 2017, BRIT J NUTR, V117, P1645, DOI 10.1017/S0007114517001593; Miyamoto T, 2017, BONE, V95, P1, DOI 10.1016/j.bone.2016.10.027; Montalvany-Antonucci CC, 2018, J NUTR BIOCHEM, V59, P93, DOI 10.1016/j.jnutbio.2018.06.006; Morales P, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.20; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mozar A, 2012, NEPHROL DIAL TRANSPL, V27, P2176, DOI 10.1093/ndt/gfr647; Muhammad SI, 2013, CLIN INTERV AGING, V8, P1259, DOI 10.2147/CIA.S45943; Mutus R, 2006, POULTRY SCI, V85, P1621, DOI 10.1093/ps/85.9.1621; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Novince CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06126-x; Ohlsson C, 2018, CALCIFIED TISSUE INT, V102, P426, DOI 10.1007/s00223-017-0336-6; Ohlsson C, 2017, CELL IMMUNOL, V317, P55, DOI 10.1016/j.cellimm.2017.05.003; Ohlsson C, 2015, TRENDS ENDOCRIN MET, V26, P69, DOI 10.1016/j.tem.2014.11.004; Ohlsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092368; Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8; Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502; Ott SJ, 2008, J CLIN MICROBIOL, V46, P3510, DOI 10.1128/JCM.01512-08; Pacifici R, 2016, ANN NY ACAD SCI, V1364, P11, DOI 10.1111/nyas.12969; Palomeras-Vilches A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102508; Park KR, 2018, THERANOSTICS, V8, P3087, DOI 10.7150/thno.24426; Park R, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102294; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; Parvaneh K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/897639; Paschou SA, 2017, J CLIN ENDOCR METAB, V102, P3621, DOI 10.1210/jc.2017-00042; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Perez-Rey J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030555; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pierce JL, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110818; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Poesen R, 2016, CLIN J AM SOC NEPHRO, V11, P1136, DOI 10.2215/CJN.00160116; Pollanen R, 2009, J AUTOIMMUN, V32, P172, DOI 10.1016/j.jaut.2009.02.010; Prates TP, 2014, J DENT RES, V93, P1155, DOI 10.1177/0022034514551770; Qi HH, 2016, MOL BIOSYST, V12, P2265, DOI 10.1039/c6mb00181e; Qiao J, 2021, FOOD FUNCT, V12, P963, DOI [10.1039/d0fo02664f, 10.1039/D0FO02664F]; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quach D, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00545-17; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Rath S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0271-9; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rodeheffer MS, 2016, CELL STEM CELL, V18, P684, DOI 10.1016/j.stem.2016.05.006; Rodrigues FC, 2012, J MED FOOD, V15, P664, DOI 10.1089/jmf.2011.0296; Rodriguez VA, 2016, ARCH BIOCHEM BIOPHYS, V591, P28, DOI 10.1016/j.abb.2015.12.006; Rolig AS, 2015, CELL HOST MICROBE, V18, P613, DOI 10.1016/j.chom.2015.10.009; Roshchina VV, 2016, ADV EXP MED BIOL, V874, P25, DOI 10.1007/978-3-319-20215-0_2; Ross FP, 2006, ANN NY ACAD SCI, V1068, P110, DOI 10.1196/annals.1346.014; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Ruiz-Gaspa S, 2010, EUR J CLIN INVEST, V40, P25, DOI 10.1111/j.1365-2362.2009.02230.x; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanchez-Duffhues G, 2015, BONE, V80, P43, DOI 10.1016/j.bone.2015.05.025; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schepper JD, 2020, J BONE MINER RES, V35, P801, DOI 10.1002/jbmr.3947; Schepper JD, 2019, J BONE MINER RES, V34, P681, DOI 10.1002/jbmr.3635; Schousboe A, 2007, PROG BRAIN RES, V160, P9, DOI 10.1016/S0079-6123(06)60002-2; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Seeman E, 2019, NAT REV RHEUMATOL, V15, P225, DOI 10.1038/s41584-019-0172-3; Shirjang S, 2017, CELL IMMUNOL, V315, P1, DOI 10.1016/j.cellimm.2016.12.005; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Souza JAC, 2016, INNATE IMMUN-LONDON, V22, P598, DOI 10.1177/1753425916666652; Souza PPC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01663; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Srutkova D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134050; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Strandwitz P, 2019, NAT MICROBIOL, V4, P396, DOI 10.1038/s41564-018-0307-3; Su Y, 2019, BONE, V129, DOI 10.1016/j.bone.2019.115082; Subramaniam S, 2018, BRIT J PHARMACOL, V175, P1344, DOI 10.1111/bph.13959; Sun YP, 2019, ARTIF CELL NANOMED B, V47, P1281, DOI 10.1080/21691401.2019.1596924; Surana NK, 2014, J CLIN INVEST, V124, P4197, DOI 10.1172/JCI72332; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Tanabe K, 2019, J AGR FOOD CHEM, V67, P867, DOI 10.1021/acs.jafc.8b05164; Tanaka S, 2003, J BONE MINER METAB, V21, P123, DOI 10.1007/s007740300021; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tang MJ, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.625034; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Targownik LE, 2014, CURR OPIN GASTROEN, V30, P168, DOI 10.1097/MOG.0000000000000037; Targownik LE, 2013, MATURITAS, V76, P315, DOI 10.1016/j.maturitas.2013.09.009; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Titanji K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004497; Tsapakis EM, 2012, EUR PSYCHIAT, V27, P156, DOI 10.1016/j.eurpsy.2010.10.006; Tyagi AM, 2021, ELIFE, V10, DOI 10.7554/eLife.64237; Tyagi AM, 2018, IMMUNITY, V49, P1116, DOI 10.1016/j.immuni.2018.10.013; Uchida Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23071517; Uluckan O, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8996; Van Bezooijen RL, 1999, J BONE MINER RES, V14, P1513, DOI 10.1359/jbmr.1999.14.9.1513; van den Heuvel EGHM, 2000, J NUTR, V130, P2938, DOI 10.1093/jn/130.12.2938; van den Heuvel EGHM, 1999, J BONE MINER RES, V14, P1211, DOI 10.1359/jbmr.1999.14.7.1211; Vitale M, 2021, CLIN NUTR, V40, P428, DOI 10.1016/j.clnu.2020.05.025; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wang ZY, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0766-y; Watanabe K, 2017, FEBS OPEN BIO, V7, P1178, DOI 10.1002/2211-5463.12258; Weaver CM, 2011, J AGR FOOD CHEM, V59, P6501, DOI 10.1021/jf2009777; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Wen KC, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.535310; Whisner CM, 2018, CALCIFIED TISSUE INT, V102, P443, DOI 10.1007/s00223-017-0339-3; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xiao Y, 2011, NUTRITION, V27, P214, DOI 10.1016/j.nut.2009.11.012; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yamamoto S, 2017, J NEPHROL, V30, P623, DOI 10.1007/s40620-017-0406-x; Yamasaki M, 2016, BIOCHEM BIOPH RES CO, V473, P654, DOI 10.1016/j.bbrc.2016.03.115; Yan J, 2018, GUT MICROBES, V9, P84, DOI 10.1080/19490976.2017.1371893; Yan J, 2018, CALCIFIED TISSUE INT, V102, P406, DOI 10.1007/s00223-018-0395-3; Yan J, 2017, CURR OSTEOPOROS REP, V15, P376, DOI 10.1007/s11914-017-0382-z; Yan J, 2016, P NATL ACAD SCI USA, V113, pE7554, DOI 10.1073/pnas.1607235113; Yang SH, 2005, J IMMUNOL, V175, P1956, DOI 10.4049/jimmunol.175.3.1956; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yao CK, 2016, ALIMENT PHARM THER, V43, P181, DOI 10.1111/apt.13456; You YS, 2014, J BONE MINER RES, V29, P212, DOI 10.1002/jbmr.2018; Yu MC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14148-4; Yu TY, 2015, J PHARMACOL SCI, V127, P75, DOI 10.1016/j.jphs.2014.11.006; Yue R, 2016, CELL STEM CELL, V18, P782, DOI 10.1016/j.stem.2016.02.015; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zaiss MM, 2019, J CLIN INVEST, V129, P3018, DOI 10.1172/JCI128521; Zaiss MM, 2010, ARTHRITIS RHEUM-US, V62, P2328, DOI 10.1002/art.27535; Zaiss MM, 2010, J IMMUNOL, V184, P7238, DOI 10.4049/jimmunol.0903841; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zeng Q, 2019, J BONE MINER RES, V34, P1789, DOI 10.1002/jbmr.3757; Zhang J, 2015, ENDOCRINOLOGY, V156, P3169, DOI 10.1210/EN.2015-1308; Zhang YP, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.575102; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhao Q, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0296-5; Zhao YX, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1486; Zhou T, 2019, DIABETES CARE, V42, P1365, DOI 10.2337/dc19-0134; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	298	10	10	8	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21740	10.1096/fj.202100451R	http://dx.doi.org/10.1096/fj.202100451R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143911				2022-12-28	WOS:000667814100008
J	McDonald, TS; Kumar, V; Fung, JN; Woodruff, TM; Lee, JD				McDonald, Tanya S.; Kumar, Vinod; Fung, Jenny N.; Woodruff, Trent M.; Lee, John D.			Glucose clearance and uptake is increased in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis through an insulin-independent mechanism	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; glucagon; glucose tolerance; glycogen; insulin; liver metabolism	BODY-MASS INDEX; CARBOHYDRATE-METABOLISM; FDG-PET; ALS; MUSCLE; SIGNATURES; TOLERANCE; PATHOLOGY; GLUCAGON	Metabolic disturbances are associated with the progression of the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS). However, the molecular events that drive energy imbalances in ALS are not completely understood. In this study, we aimed to elucidate deficits in energy homeostasis in the SOD1(G93A) mouse model of ALS. SOD1(G93A) mice and their wild-type littermates underwent indirect calorimetry and intraperitoneal glucose/insulin tolerance tests at both the onset and mid-symptomatic stages of the disease. Glucose uptake and the plasma glucoregulatory hormone profiles were analyzed. Pancreatic islet cell mass and function were assessed by measuring hormone concentrations and secretion in isolated islets, and pancreatic alpha- and beta-cell immunoreactive areas. Finally, we profiled liver glycogen metabolism by measuring glucagon concentrations and liver metabolic gene expressions. We identified that mid-symptomatic SOD1(G93A) mice have increased oxygen consumption and faster exogenous glucose uptake, despite presenting with normal insulin tolerance. The capacity for pancreatic islets to secrete insulin appears intact, however, islet cell insulin concentrations and beta-cell mass were reduced. Fasting glucose homeostasis was also disturbed, along with increased liver glycogen stores, despite elevated circulating glucagon, suggesting that glucagon signaling is impaired. Metabolic gene expression profiling of livers indicated that glucose cannot be utilized efficiently in SOD1(G93A) mice. Overall, we demonstrate that glucose homeostasis and uptake are altered in SOD1(G93A) mice, which is linked to an increase in insulin-independent glucose uptake, and a loss of beta-cells, insulin production, and glucagon sensitivity. This suggests that the hormonal regulation of glucose concentrations may contribute to the progression of disease in this ALS mouse model.	[McDonald, Tanya S.; Kumar, Vinod; Fung, Jenny N.; Woodruff, Trent M.; Lee, John D.] Univ Queensland, Sch Biomed Sci, Skerman Bldg, Brisbane, Qld 4072, Australia; [Woodruff, Trent M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Lee, JD (corresponding author), Univ Queensland, Sch Biomed Sci, Skerman Bldg, Brisbane, Qld 4072, Australia.	j.lee9@uq.edu.au	Kumar, Vinod/ABC-4866-2020; Woodruff, Trent M/B-4861-2009; Lee, John/Y-2066-2018	Kumar, Vinod/0000-0002-2775-6049; Woodruff, Trent M/0000-0003-1382-911X; McDonald, Tanya/0000-0003-4325-3537; Lee, John/0000-0002-9976-7396	Motor Neuron Disease Research Australia (MNDRA) Postdoctoral Fellowship [PDF1604]; National Health and Medical Research Council (NHMRC) [APP1082271]; MNDRA [IG1930]	Motor Neuron Disease Research Australia (MNDRA) Postdoctoral Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); MNDRA	JDL was supported by Motor Neuron Disease Research Australia (MNDRA) Postdoctoral Fellowship (PDF1604), and the research was funded by grants from the National Health and Medical Research Council (NHMRC; Project grant APP1082271) and MNDRA (IG1930)	Ahmed RM, 2014, J NEUROL, V261, P1774, DOI 10.1007/s00415-014-7416-6; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4]; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Desseille C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00332; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2010, CURR DRUG TARGETS, V11, P1250, DOI 10.2174/1389450111007011250; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; GOTOH F, 1972, J NEUROL SCI, V16, P201, DOI 10.1016/0022-510X(72)90089-5; Grad LI, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024117; Graham KL, 2016, BIOPROTOC, V6, P1840, DOI [10.21769/BioProtoc.1840, DOI 10.21769/BIOPROTOC.1840, 10.21769/ BioProtoc.1840]; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; HARNO K, 1984, ACTA NEUROL SCAND, V70, P451; HARRIS MD, 1986, J CLIN ENDOCR METAB, V63, P41; HUBBARD RW, 1992, NEUROLOGY, V42, P1532, DOI 10.1212/WNL.42.8.1532; KARPATI G, 1979, CAN J NEUROL SCI, V6, P105, DOI 10.1017/S0317167100119481; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kioumourtzoglou MA, 2015, JAMA NEUROL, V72, P905, DOI 10.1001/jamaneurol.2015.0910; Lee JD, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1435-2; Lee JD, 2017, BRIT J PHARMACOL, V174, P689, DOI 10.1111/bph.13730; Lee JD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-119; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lutz C, 2018, BRAIN RES, V1693, P1, DOI 10.1016/j.brainres.2018.03.024; Mariosa D, 2015, EUR J NEUROL, V22, P1436, DOI 10.1111/ene.12632; Ngo ST, 2015, J NEUROL SCI, V357, P22, DOI 10.1016/j.jns.2015.06.053; Okuno T, 2015, BIOACTIVE LIPID MEDI, P331, DOI [10.1007/978-4-431-55669-5_23, DOI 10.1007/978-4-431-55669-5_23]; Pagani M, 2014, NEUROLOGY, V83, P1067, DOI 10.1212/WNL.0000000000000792; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Poulton K R, 1993, Funct Neurol, V8, P33; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; REYES ET, 1984, J NEUROL SCI, V63, P317, DOI 10.1016/0022-510X(84)90154-0; SAFFER D, 1977, J NEUROL NEUROSUR PS, V40, P533, DOI 10.1136/jnnp.40.6.533; Scaricamazza S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101087; Smittkamp SE, 2014, NEURODEGENER DIS, V13, P29, DOI 10.1159/000351606; Spiers JG, 2017, STRESS, V20, P59, DOI 10.1080/10253890.2016.1276898; Stallings NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071793; Sun Y, 2015, J EPIDEMIOL, V25, P445, DOI 10.2188/jea.JE20140176; Szelechowski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22318-5; Tefera TW, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00611; Valbuena GN, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01276; Vandoorne T, 2018, ACTA NEUROPATHOL, V135, P489, DOI 10.1007/s00401-018-1835-x; Wang HTA, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0128-8; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561; Zeng MF, 2018, J CHROMATOGR B, V1083, P137, DOI 10.1016/j.jchromb.2018.02.040	48	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21707	10.1096/fj.202002450R	http://dx.doi.org/10.1096/fj.202002450R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118098	Green Submitted			2022-12-28	WOS:000667814100018
J	Xie, X; Liang, JY; Huang, R; Luo, C; Yang, JL; Xing, HM; Zhou, L; Qiao, H; Ergu, E; Chen, H				Xie, Xiang; Liang, Jiayu; Huang, Run; Luo, Chuang; Yang, Jiali; Xing, Hongming; Zhou, Le; Qiao, Han; Ergu, Erti; Chen, Huan			Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis	FASEB JOURNAL			English	Review						bladder; bladder smooth muscle; fibrosis; inflammation; ketamine cystitis; lamina propria; microvascular; oxidative stress; urothelium	NITRIC-OXIDE SYNTHASE; INDUCED ULCERATIVE CYSTITIS; TUMOR-NECROSIS-FACTOR; TIGHT JUNCTION PROTEINS; NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; VASCULAR SMOOTH-MUSCLE; GROWTH-FACTOR; INDUCED APOPTOSIS; OXIDATIVE-STRESS	Ketamine cystitis (KC) is a chronic bladder inflammation leading to urinary urgency, frequency, and pain. The pathogenesis of KC is complicated and involves multiple tissue injuries in the bladder. Recent studies indicated that urothelium disruption, lamina propria fibrosis and inflammation, microvascular injury, neuropathological alterations, and bladder smooth muscle (BSM) abnormalities all contribute to the pathogenesis of KC. Ketamine has been shown to induce these tissue injuries by regulating different signaling pathways. Ketamine can stimulate antiproliferative factor, adenosine triphosphate, and oxidative stress to disrupt urothelium. Lamina propria fibrosis and inflammation are associated with the activation of cyclooxygenase-2, nitric oxide synthase, immunoglobulin E, and transforming growth factor beta 1. Ketamine contributes to microvascular injury via the N-methyl-D aspartic receptor (NMDAR), and multiple inflammatory and angiogenic factors such as tumor necrosis factor alpha and vascular endothelial growth factor. For BSM abnormalities, ketamine can depress the protein kinase B, extracellular signal-regulated kinase, Cav1.2, and muscarinic receptor signaling. Elevated purinergic signaling also plays a role in BSM abnormalities. In addition, ketamine affects neuropathological alterations in the bladder by regulating NMDAR- and brain-derived neurotrophic factor-dependent signaling. Inflammatory cells also contribute to neuropathological changes via the secretion of chemical mediators. Clarifying the role and function of these signaling underlying tissue injuries in the bladder with KC can contribute to a better understanding of the pathophysiology of this disease and to the design of effective treatments for KC.	[Xie, Xiang; Liang, Jiayu; Huang, Run; Luo, Chuang; Yang, Jiali; Xing, Hongming; Zhou, Le; Qiao, Han; Ergu, Erti; Chen, Huan] Southwest Med Univ, Publ Ctr Expt Technol, Luzhou 646000, Peoples R China; [Xie, Xiang; Liang, Jiayu; Huang, Run; Luo, Chuang; Yang, Jiali; Xing, Hongming; Zhou, Le; Qiao, Han; Ergu, Erti; Chen, Huan] Southwest Med Univ, Sch Basic Med Sci, Luzhou 646000, Peoples R China	Southwest Medical University; Southwest Medical University	Chen, H (corresponding author), Southwest Med Univ, Publ Ctr Expt Technol, Luzhou 646000, Peoples R China.; Chen, H (corresponding author), Southwest Med Univ, Sch Basic Med Sci, Luzhou 646000, Peoples R China.	huanchen@swmu.edu.cn		Chen, Huan/0000-0002-6487-7923	National Natural Science Foundation of China [81800670]; Luzhou City Bureau of Science and Technology [2020LZXNYDZ05]; Undergraduate Innovation and Entrepreneurship Training Program [202010632005, S201910703072, 2020360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Luzhou City Bureau of Science and Technology; Undergraduate Innovation and Entrepreneurship Training Program	This study was supported by grants from the National Natural Science Foundation of China (81800670), Luzhou City Bureau of Science and Technology (2020LZXNYDZ05), and Undergraduate Innovation and Entrepreneurship Training Program (202010632005, S201910703072, 2020360)	Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Adam RM, 2003, J UROLOGY, V169, P2388, DOI 10.1097/01.ju.0000063980.99368.35; Akata T, 2001, ANESTHESIOLOGY, V95, P452, DOI 10.1097/00000542-200108000-00030; ALTURA BM, 1980, BRIT J PHARMACOL, V70, P257, DOI 10.1111/j.1476-5381.1980.tb07931.x; Andersson KE, 2017, THER ADV UROL, V9, P11, DOI 10.1177/1756287216675778; Andersson KE, 2014, NEUROUROL URODYNAM, V33, P9, DOI 10.1002/nau.22465; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Aronsson P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/359179; Avelino A, 2006, N-S ARCH PHARMACOL, V373, P287, DOI 10.1007/s00210-006-0073-2; Azadzoi KM, 1999, J UROLOGY, V161, P1626, DOI 10.1016/S0022-5347(05)68995-1; Azadzoi KM, 1999, J UROLOGY, V162, P1768, DOI 10.1016/S0022-5347(05)68236-5; Bahar E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091558; Baker SC, 2016, AM J PATHOL, V186, P1267, DOI 10.1016/j.ajpath.2015.12.014; Baker SC, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-64; Bellucci CHS, 2017, PROSTATE INT, V5, P70, DOI 10.1016/j.prnil.2017.01.008; Bhattarai P, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000585; Birder LA, 2012, NEUROUROL URODYNAM, V31, P293, DOI 10.1002/nau.22195; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birder LA, 2006, VASC PHARMACOL, V45, P221, DOI 10.1016/j.vph.2005.08.027; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Birder LA, 2018, SEMIN IMMUNOPATHOL, V40, P261, DOI 10.1007/s00281-018-0674-0; Bjorling DE, 1999, J UROLOGY, V162, P231, DOI 10.1097/00005392-199907000-00073; Bokor Gyula, 2014, J Pharm Pract, V27, P582, DOI 10.1177/0897190014525754; Bylund William, 2017, Clin Pract Cases Emerg Med, V1, P323, DOI 10.5811/cpcem.2017.7.34405; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Ceran C, 2010, INDIAN J UROL, V26, P364, DOI 10.4103/0970-1591.70570; Chang Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122545; Chau BN, 2004, MOL CELL BIOL, V24, P4438, DOI 10.1128/MCB.24.10.4438-4447.2004; Chen CC, 2000, J IMMUNOL, V165, P2719, DOI 10.4049/jimmunol.165.5.2719; Chen CH, 2011, J FORMOS MED ASSOC, V110, P787, DOI 10.1016/j.jfma.2011.11.010; Chen H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18167-4; Chen RM, 2005, CRIT CARE MED, V33, P1044, DOI 10.1097/01.CCM.0000163246.33366.51; Chen XP, 2008, CURR HYPERTENS REV, V4, P245, DOI 10.2174/157340208786241336; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; CHENG CL, 1995, BRAIN RES, V678, P40, DOI 10.1016/0006-8993(95)00212-9; Cheng FZ, 2018, BIOMECH MODEL MECHAN, V17, P403, DOI 10.1007/s10237-017-0968-5; Cheng JK, 2008, NEUROCHEM RES, V33, P1970, DOI 10.1007/s11064-008-9711-z; Cheung TT, 2014, J GASTROEN HEPATOL, V29, P1663, DOI 10.1111/jgh.12682; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; CHRISTMAS TJ, 1990, VIRCHOWS ARCH A, V416, P447, DOI 10.1007/BF01605152; Chu PSK, 2008, BJU INT, V102, P1616, DOI 10.1111/j.1464-410X.2008.07920.x; Chuang SM, 2019, INT J MOL MED, V44, P797, DOI 10.3892/ijmm.2019.4252; Chuang SM, 2013, NEUROUROL URODYNAM, V32, P1137, DOI 10.1002/nau.22367; Congiu T., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P45; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; Costantini P, 2002, CELL DEATH DIFFER, V9, P82, DOI 10.1038/sj.cdd.4400932; Cruz CD, 2014, NEUROUROL URODYNAM, V33, P39, DOI 10.1002/nau.22438; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Cui LJ, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190595; Cuzzocrea S, 2007, KIDNEY INT, V71, P290, DOI 10.1038/sj.ki.5002058; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Dadlani H, 2008, J BIOL CHEM, V283, P7844, DOI 10.1074/jbc.M703125200; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; de Groat WC, 2006, PROG BRAIN RES, V152, P59, DOI 10.1016/S0079-6123(05)52005-3; de Groat WC, 2012, EXP NEUROL, V235, P123, DOI 10.1016/j.expneurol.2011.05.003; de Groat WC, 2010, NEUROUROL URODYNAM, V29, P63, DOI 10.1002/nau.20761; Ding HL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1704-0; Domino EF, 2010, ANESTHESIOLOGY, V113, P678, DOI 10.1097/ALN.0b013e3181ed09a2; Dong CX, 2014, BIRTH DEFECTS RES B, V101, P355, DOI 10.1002/bdrb.21119; Dong CX, 2012, CRIT CARE MED, V40, P2407, DOI 10.1097/CCM.0b013e318253563c; Duan QX, 2017, EXP THER MED, V14, P2757, DOI 10.3892/etm.2017.4913; DURIEUX ME, 1995, ANESTH ANALG, V81, P57, DOI 10.1097/00000539-199507000-00012; Elhebir ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066708; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fan GY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2329868; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Garcia-Aranda MI, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115427; Giglio D, 2005, AUTON NEUROSCI-BASIC, V122, P9, DOI 10.1016/j.autneu.2005.07.005; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Grundy L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18136-w; Gu D, 2014, MOL BIOL REP, V41, P7313, DOI 10.1007/s11033-014-3616-5; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Hao Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122112; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hayes MD, 2020, ELIFE, V9, DOI 10.7554/eLife.51862; Hills CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071819; HIROTA K, 1995, ACTA ANAESTH SCAND, V39, P174, DOI 10.1111/j.1399-6576.1995.tb04038.x; HIRSHMAN CA, 1979, BRIT J ANAESTH, V51, P713, DOI 10.1093/bja/51.8.713; Ho CCK, 2010, MALAYS J MED SCI, V17, P61; Honnegowda T.M., 2015, PLAST AESTHETIC RES, V2, P243, DOI [10.4103/2347, DOI 10.4103/2347-9264.165438, 10.4103/2347-9264.165438]; Hu M, 2008, J NEUROCHEM, V106, P1900, DOI 10.1111/j.1471-4159.2008.05554.x; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Huang CJ, 2018, INT J MOL MED, V41, P836, DOI 10.3892/ijmm.2017.3264; Huang LK, 2014, POSTGRAD MED J, V90, P185, DOI 10.1136/postgradmedj-2013-131776; Hurst RE, 1996, UROLOGY, V48, P817, DOI 10.1016/S0090-4295(96)00322-6; HURST RE, 1987, J UROLOGY, V138, P433, DOI 10.1016/S0022-5347(17)43180-6; HURST RE, 1994, J UROLOGY, V152, P1641, DOI 10.1016/S0022-5347(17)32495-3; HURST RE, 1997, INTERSTITIAL CYSTITI, P93; Hurst RE, 2015, TRANSL ANDROL UROL, V4, P563, DOI 10.3978/j.issn.2223-4683.2015.10.03; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Inui E, 1999, J UROLOGY, V161, P827, DOI 10.1016/S0022-5347(01)61783-X; Jhang JF, 2015, INT J UROL, V22, P816, DOI 10.1111/iju.12841; Jhang JF, 2014, J UROLOGY, V192, P1249, DOI 10.1016/j.juro.2014.05.084; Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189; Jonkman Kelly, 2017, F1000Res, V6, DOI 10.12688/f1000research.11372.1; Juan YS, 2015, AM J PATHOL, V185, P2269, DOI 10.1016/j.ajpath.2015.04.020; Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalsi Sarbjeet S, 2011, Emerg Health Threats J, V4, P7107, DOI 10.3402/ehtj.v4i0.7107; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Katnik-Prastowska I, 2014, GLYCOCONJUGATE J, V31, P623, DOI 10.1007/s10719-014-9564-4; Keay S, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-17; Keiser M, 2018, MOL PHARMACEUT, V15, P326, DOI 10.1021/acs.molpharmaceut.7b00627; Ki S, 2018, ASIAN PAC J ALLERGY, V36, P32, DOI 10.12932/AP0871; Kidger E, 2016, UROLOGY, V90, DOI 10.1016/j.urology.2015.12.015; Kim A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30881; Kim JY, 2009, BJU INT, V103, P541, DOI 10.1111/j.1464-410X.2008.08097.x; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Lai YQ, 2012, UROL INT, V89, P93, DOI 10.1159/000338098; LANDAU EH, 1994, J UROLOGY, V152, P702, DOI 10.1016/S0022-5347(17)32685-X; Lankenau SE, 2004, J URBAN HEALTH, V81, P232, DOI 10.1093/jurban/jth110; Lee CL, 2013, BJU INT, V112, P1156, DOI 10.1111/bju.12256; Lee JD, 2014, J FORMOS MED ASSOC, V113, P17, DOI 10.1016/j.jfma.2012.03.010; Lee YL, 2017, AM J PATHOL, V187, P1945, DOI 10.1016/j.ajpath.2017.06.004; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li J, 2015, AM J TRANSPLANT, V15, P3095, DOI 10.1111/ajt.13406; Li Y, 2012, BRIT J PHARMACOL, V165, P1748, DOI 10.1111/j.1476-5381.2011.01635.x; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lin CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160578; Lin HC, 2015, MOL MED REP, V11, P2421, DOI 10.3892/mmr.2014.3110; Lin Z, 2003, UROL RES, V31, P232, DOI 10.1007/s00240-003-0302-9; Liu KM, 2015, AM J PHYSIOL-RENAL, V309, pF318, DOI 10.1152/ajprenal.00607.2014; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; LUNDY PM, 1974, BRIT J ANAESTH, V46, P333, DOI 10.1093/bja/46.5.333; Luo CX, 2014, J NEUROSCI, V34, P13535, DOI 10.1523/JNEUROSCI.1305-14.2014; Luo HQ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00395; Ma MZ, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.001; MADARA JL, 1987, AM J PHYSIOL, V253, pC171, DOI 10.1152/ajpcell.1987.253.1.C171; Maihofner C, 2003, CARCINOGENESIS, V24, P665, DOI 10.1093/carcin/bgg006; Matuszewski MA, 2016, CENT EUR J UROL, V69, P252, DOI 10.5173/ceju.2016.638; McCarthy CJ, 2019, EXP PHYSIOL, V104, P1717, DOI 10.1113/EP087960; Meegan JE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228727; Meng E, 2013, UROL SCI, V24, P113, DOI 10.1016/j.urols.2013.09.001; Meng E, 2015, UROL SCI, V26, P158, DOI 10.1016/j.urols.2015.08.004; Meng E, 2011, J UROLOGY, V186, P1134, DOI 10.1016/j.juro.2011.04.102; Minutti CM, 2019, IMMUNITY, V50, P645, DOI 10.1016/j.immuni.2019.01.008; Miodonski AJ, 1999, ANAT REC, V254, P375, DOI 10.1002/(SICI)1097-0185(19990301)254:3<375::AID-AR8>3.3.CO;2-I; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Mu KW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071755; Murray Patrick S, 2011, Int J Pept, V2011, P654085, DOI 10.1155/2011/654085; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; Natura G, 2005, PAIN, V116, P194, DOI 10.1016/j.pain.2005.04.002; Navines-Ferrer A, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8163803; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; Ohnishi N, 1994, Hinyokika Kiyo, V40, P657; Olsen Jun Jun, 2017, Clin Biochem Rev, V38, P131; Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137; Oter S, 2004, UROL RES, V32, P185, DOI 10.1007/s00240-003-0398-y; Ou YL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011500; Ozcan J, 2016, PAIN PRACT, V16, pE94, DOI 10.1111/papr.12466; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pandita RK, 2002, J UROLOGY, V168, P1230, DOI 10.1016/S0022-5347(05)64631-9; PANG X, 1995, BRIT J UROL, V75, P744, DOI 10.1111/j.1464-410X.1995.tb07384.x; Park JM, 1997, AM J PHYSIOL-RENAL, V273, pF538, DOI 10.1152/ajprenal.1997.273.4.F538; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; Peerapen P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01041; Peng Y, 2002, NEUROSCIENCE, V109, P657, DOI 10.1016/S0306-4522(01)00526-7; Pinto R, 2010, NEUROSCIENCE, V166, P907, DOI 10.1016/j.neuroscience.2010.01.015; Rajandram R, 2016, AM J PHYSIOL-RENAL, V310, pF885, DOI 10.1152/ajprenal.00483.2015; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Rashid Hani H, 2004, BMC Urol, V4, P3, DOI 10.1186/1471-2490-4-3; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Ribatti D, 2009, J CELL MOL MED, V13, P2822, DOI 10.1111/j.1582-4934.2009.00810.x; Ricci V, 2011, PSYCHOPHARMACOLOGY, V215, P143, DOI 10.1007/s00213-010-2121-3; Rickard A, 2008, IN VITRO CELL DEV-AN, V44, P261, DOI 10.1007/s11626-008-9116-y; Ro SH, 2013, ARCH BIOCHEM BIOPHYS, V534, P55, DOI 10.1016/j.abb.2012.07.017; ROMARIS M, 1995, BIOCHEM J, V310, P73, DOI 10.1042/bj3100073; Rosa AC, 2013, BRIT J PHARMACOL, V170, P38, DOI 10.1111/bph.12266; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Rundhaug JE, 2003, CLIN CANCER RES, V9, P551; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Ryu CM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44631-3; Saban Ricardo, 2007, BMC Physiology, V7, P4, DOI 10.1186/1472-6793-7-4; Salman M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4269875; SANT GR, 1994, UROL CLIN N AM, V21, P41; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schulter A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4180-5; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Schwartz ES, 2016, J UROLOGY, V196, P892, DOI 10.1016/j.juro.2016.03.077; Shahani R, 2007, UROLOGY, V69, P810, DOI 10.1016/j.urology.2007.01.038; Shan ZF, 2019, J CELL PHYSIOL, V234, P2778, DOI 10.1002/jcp.27094; Shang HS, 2017, ONCOTARGET, V8, P73670, DOI 10.18632/oncotarget.10727; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; Shen CH, 2019, MOL MED REP, V19, P2716, DOI 10.3892/mmr.2019.9907; Shen CH, 2016, MOL MED REP, V14, P1880, DOI 10.3892/mmr.2016.5482; Shochina M, 2001, J CLIN PATHOL-MOL PA, V54, P248, DOI 10.1136/mp.54.4.248; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; SMITH RE, 1994, J IMMUNOL, V153, P4704; SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782, DOI 10.1002/jlb.57.5.782; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Sun TT, 1999, ADV EXP MED BIOL, V462, P7; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Sun Y, 2001, J UROLOGY, V166, P1951, DOI 10.1016/S0022-5347(05)65726-6; Szade A, 2015, IUBMB LIFE, V67, P145, DOI 10.1002/iub.1358; Takadera T, 2006, TOXICOL APPL PHARM, V210, P100, DOI 10.1016/j.taap.2005.10.005; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Tsai YC, 2015, UROL SCI, V26, P153, DOI 10.1016/j.urols.2014.11.003; Tuffy KM., 2012, ISRN CELL BIOL, V4, P1, DOI [10.5402/2012/142313, DOI 10.5402/2012/142313]; Ueha S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00071; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Wang JP, 2017, AM J PHYSIOL-RENAL, V313, pF961, DOI 10.1152/ajprenal.00686.2016; Wang Q, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010117; Wang XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10124-4; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Weckmann K, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.119; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Wei PH, 2018, NICOTINE TOB RES, V20, P515, DOI 10.1093/ntr/ntx157; Wei YB, 2013, HONG KONG MED J, V19, P341, DOI 10.12809/hkmj134013; White AO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11725; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xi XJ, 2020, J CELL MOL MED, V24, P7609, DOI 10.1111/jcmm.15397; Xia CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-30; Xu Q, 2017, FREE RADICAL BIO MED, V109, P84, DOI 10.1016/j.freeradbiomed.2017.03.004; Yang HH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84734-4; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshimura N, 1997, J PHYSIOL-LONDON, V503, P269, DOI 10.1111/j.1469-7793.1997.269bh.x; Yu L, 2017, RENAL FAILURE, V39, P440, DOI 10.1080/0886022X.2017.1305968; Yu WQ, 2013, FASEB J, V27, P1895, DOI 10.1096/fj.12-219006; Yu WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048897; Yu ZY, 2019, J AM SOC NEPHROL, V30, P2159, DOI 10.1681/ASN.2019040335; Yuan T, 2019, REDOX BIOL, V20, P247, DOI 10.1016/j.redox.2018.09.025; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Zeng JF, 2017, J INT MED RES, V45, P792, DOI 10.1177/0300060517693956; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200; Zhou XH, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1865; Zvara Peter, 2007, BMC Physiology, V7, P9, DOI 10.1186/1472-6793-7-9	249	3	3	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21703	10.1096/fj.202100437	http://dx.doi.org/10.1096/fj.202100437			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105799	hybrid			2022-12-28	WOS:000667814100009
J	Anton-Plagaro, C; Sanchez, N; Valle, R; Mulet, JM; Duncan, MC; Roncero, C				Anton-Plagaro, Carlos; Sanchez, Noelia; Valle, Rosario; Mulet, Jose Miguel; Duncan, Mara C.; Roncero, Cesar			Exomer complex regulates protein traffic at the TGN through differential interactions with cargos and clathrin adaptor complexes	FASEB JOURNAL			English	Article						clathrin adaptor; endosomes; exomer; intracelullar traffic; TGN	TRANS-GOLGI NETWORK; AMINO-ACID PERMEASES; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; TRYPTOPHAN PERMEASE; TERMINAL REGIONS; CHITIN SYNTHESIS; YEAST; UBIQUITIN; DISTINCT	Protein sorting at the trans-Golgi network (TGN) usually requires the assistance of cargo adaptors. However, it remains to be examined how the same complex can mediate both the export and retention of different proteins or how sorting complexes interact among themselves. In Saccharomyces cerevisiae, the exomer complex is involved in the polarized transport of some proteins from the TGN to the plasma membrane (PM). Intriguingly, exomer and its cargos also show a sort of functional relationship with TGN clathrin adaptors that is still unsolved. Here, using a wide range of techniques, including time-lapse and BIFC microscopy, we describe new molecular implications of the exomer complex in protein sorting and address its different layers of functional interaction with clathrin adaptor complexes. Exomer mutants show impaired amino acid uptake because it facilitates not only the polarized delivery of amino acid permeases to the PM but also participates in their endosomal traffic. We propose a model for exomer where it modulates the recruitment of TGN clathrin adaptors directly or indirectly through the Arf1 function. Moreover, we describe an in vivo competitive relationship between the exomer and AP-1 complexes for the model cargo Chs3. These results highlight a broad role for exomer in regulating protein sorting at the TGN that is complementary to its role as cargo adaptor and present a model to understand the complexity of TGN protein sorting.	[Anton-Plagaro, Carlos; Sanchez, Noelia; Valle, Rosario; Roncero, Cesar] Univ Salamanca, CSIC, Inst Biol Func & Genom IBFG, Salamanca, Spain; [Anton-Plagaro, Carlos; Sanchez, Noelia; Valle, Rosario; Roncero, Cesar] Univ Salamanca, CSIC, Dept Microbiol & Genet, Salamanca, Spain; [Mulet, Jose Miguel] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Duncan, Mara C.] Univ Michigan, Cell & Dev Biol Dept, Ann Arbor, MI 48109 USA; [Anton-Plagaro, Carlos] Univ Bristol, Sch Biochem, Bristol, Avon, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Michigan System; University of Michigan; University of Bristol	Anton-Plagaro, C (corresponding author), Univ Bristol, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.; Roncero, C (corresponding author), CZacarias Gonzalez, IBFG, Salamanca 37007, Spain.; Anton-Plagaro, C (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	carlos.antonplagaro@bristol.ac.uk; crm@usal.es	Roncero, Cesar/B-5200-2017; Mulet, Jose Miguel/B-9063-2016	Roncero, Cesar/0000-0001-5964-3252; Mulet, Jose Miguel/0000-0002-9087-3838; Duncan, Mara/0000-0002-2383-0109	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat) [CICYT/FEDER BFU2017-84508-P]; Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile--Leon) [SA116G19]; Ministerio de Economia,Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat) [RTC-2017-6468-2-AR, BIO2016-77776-P]; Foundation for the National Institutes of Health (FNIH) [R01 GM092741]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat); Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile--Leon); Ministerio de Economia,Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat); Foundation for the National Institutes of Health (FNIH)	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat), Grant/Award Number: CICYT/FEDER BFU2017--84508--P; Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile--Leon), Grant/Award Number: SA116G19; Ministerio de Economia,Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat), Grant/Award Number: RTC--2017--6468--2--AR; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat), Grant/Award Number: BIO2016--77776--P; Foundation for the National Institutes of Health (FNIH), Grant/Award Number: R01 GM092741	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Anton C, 2018, GENETICS, V208, P1483, DOI 10.1534/genetics.118.300767; Anton C, 2017, MOL BIOL CELL, V28, P3672, DOI 10.1091/mbc.E17-09-0549; Arcones I, 2016, MOL BIOL CELL, V27, P4021, DOI 10.1091/mbc.E16-04-0239; Arcones I, 2016, METHODS MOL BIOL, V1369, P59, DOI 10.1007/978-1-4939-3145-3_5; Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324; Barlow L. D., 2014, CELL LOGIST, V4, DOI [DOI 10.4161/CL.28114, 10.4161/cl.28114]; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Buelto D, 2020, BIOL CELL, V112, P349, DOI 10.1111/boc.202000058; Caceres PS, 2019, P NATL ACAD SCI USA, V116, P11796, DOI 10.1073/pnas.1821076116; Casler JC, 2020, ELIFE, V9, DOI 10.7554/eLife.56844; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Day KJ, 2018, DEV CELL, V44, P56, DOI 10.1016/j.devcel.2017.12.014; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; FALCO SC, 1985, GENETICS, V109, P21; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gonzalez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120250; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Ha SA, 2003, MOL BIOL CELL, V14, P1319, DOI 10.1091/mbc.E02-10-0686; Hachiro T, 2013, J BIOL CHEM, V288, P3594, DOI 10.1074/jbc.M112.416263; Hess DC, 2006, PLOS BIOL, V4, P2012, DOI 10.1371/journal.pbio.0040351; Hirst J, 2012, CURR BIOL, V22, P1711, DOI 10.1016/j.cub.2012.07.012; Hoya M, 2017, GENETICS, V205, P673, DOI 10.1534/genetics.116.193458; Hung CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30305-z; Huranova M, 2016, EMBO REP, V17, P202, DOI 10.15252/embr.201540795; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; KANAZAWA S, 1988, MOL CELL BIOL, V8, P664, DOI 10.1128/MCB.8.2.664; LARIMER FW, 1978, MUTAT RES, V57, P155, DOI 10.1016/0027-5107(78)90262-2; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacDonald C, 2017, J CELL BIOL, V216, P3275, DOI 10.1083/jcb.201702177; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Martzoukou O, 2018, GENETICS, V209, P1121, DOI 10.1534/genetics.118.301240; Menant A, 2006, EMBO J, V25, P4436, DOI 10.1038/sj.emboj.7601330; Paczkowski JE, 2014, DEV CELL, V30, P610, DOI 10.1016/j.devcel.2014.07.014; Paczkowski JE, 2012, EMBO J, V31, P4191, DOI 10.1038/emboj.2012.268; Ramirez-Macias I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29416-4; Richardson BC, 2012, DEV CELL, V22, P799, DOI 10.1016/j.devcel.2012.02.006; Ritz AM, 2014, CELL REP, V7, P249, DOI 10.1016/j.celrep.2014.02.026; Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335; Rockenbauch U, 2012, MOL BIOL CELL, V23, P4402, DOI 10.1091/mbc.E11-12-1015; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Rose MD., 1990, METHODS YEAST GENETI; Sacristan C, 2013, MOL MICROBIOL, V90, P252, DOI 10.1111/mmi.12360; Santos B, 1997, J CELL BIOL, V136, P95, DOI 10.1083/jcb.136.1.95; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Starr TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046386; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Stuckey S, 2011, METHODS MOL BIOL, V745, P173, DOI 10.1007/978-1-61779-129-1_11; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tojima T, 2019, J CELL SCI, V132, DOI 10.1242/jcs.231159; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007; Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Vicent I, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov008; Wada M, 2008, BIOSCI BIOTECH BIOCH, V72, P582, DOI 10.1271/bbb.70534; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Weiskoff AM, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00047; Whitfield ST, 2016, MOL BIOL CELL, V27, P588, DOI 10.1091/mbc.E15-09-0621; Yeung BG, 2001, TRAFFIC, V2, P565, DOI 10.1034/j.1600-0854.2001.20806.x; Zanolari B, 2011, J CELL SCI, V124, P1055, DOI 10.1242/jcs.072371; Zhang WP, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00040-17; Ziman M, 1998, MOL BIOL CELL, V9, P1565, DOI 10.1091/mbc.9.6.1565; Zysnarski CJ, 2019, J BIOL CHEM, V294, P1410, DOI 10.1074/jbc.RA118.005253	80	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21615	10.1096/fj.202002610R	http://dx.doi.org/10.1096/fj.202002610R			26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33978245	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000655695900020
J	Mattila, SO; Tuhkanen, HE; Lackman, JJ; Konzack, A; Morato, X; Argerich, J; Saftig, P; Ciruela, F; Petaja-Repo, UE				Mattila, S. Orvokki; Tuhkanen, Hanna E.; Lackman, Jarkko J.; Konzack, Anja; Morato, Xavier; Argerich, Josep; Saftig, Paul; Ciruela, Francisco; Petaja-Repo, Ulla E.			GPR37 is processed in the N-terminal ectodomain by ADAM10 and furin	FASEB JOURNAL			English	Article						ADAM; GPR37; G protein-coupled receptor (GPCR); furin; shedding	PROTEIN-COUPLED RECEPTOR; CELL-SURFACE EXPRESSION; SUBCELLULAR-LOCALIZATION; PROPROTEIN CONVERTASES; CLEAVAGE; SUBSTRATE; DISINTEGRIN; METALLOPROTEASE; PROTEOLYSIS; MECHANISMS	GPR37 is an orphan G protein-coupled receptor (GPCR) implicated in several neurological diseases and important physiological pathways in the brain. We previously reported that its long N-terminal ectodomain undergoes constitutive metalloprotease-mediated cleavage and shedding, which have been rarely described for class A GPCRs. Here, we demonstrate that the protease that cleaves GPR37 at Glu167 down arrow Gln168 is a disintegrin and metalloprotease 10 (ADAM10). This was achieved by employing selective inhibition, RNAi-mediated downregulation, and genetic depletion of ADAM10 in cultured cells as well as in vitro cleavage of the purified receptor with recombinant ADAM10. In addition, the cleavage was restored in ADAM10 knockout cells by overexpression of the wild type but not the inactive mutant ADAM10. Finally, postnatal conditional depletion of ADAM10 in mouse neuronal cells was found to reduce cleavage of the endogenous receptor in the brain cortex and hippocampus, confirming the physiological relevance of ADAM10 as a GPR37 sheddase. Additionally, we discovered that the receptor is subject to another cleavage step in cultured cells. Using site-directed mutagenesis, the site (Arg54 down arrow Asp55) was localized to a highly conserved region at the distal end of the ectodomain that contains a recognition site for the proprotein convertase furin. The cleavage by furin was confirmed by using furin-deficient human colon carcinoma LoVo cells and proprotein convertase inhibitors. GPR37 is thus the first multispanning membrane protein that has been validated as an ADAM10 substrate and the first GPCR that is processed by both furin and ADAM10. The unconventional N-terminal processing may represent an important regulatory element for GPR37.	[Mattila, S. Orvokki; Tuhkanen, Hanna E.; Lackman, Jarkko J.; Konzack, Anja; Petaja-Repo, Ulla E.] Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, FI-90014 Oulu, Finland; [Morato, Xavier; Argerich, Josep; Ciruela, Francisco] Univ Barcelona, Fac Med & Ciencies Salut, Dept Patol & Terapeut Expt, Unitat Farmacol,IDIBELL, Barcelona, Spain; [Saftig, Paul] Univ Kiel, Inst Biochem, Kiel, Germany; [Ciruela, Francisco] Univ Barcelona, Inst Neurociencies, Barcelona, Spain; [Morato, Xavier] Int Univ Catalunya UIC, Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin, Fundacio ACE, Barcelona, Spain	University of Oulu; University of Barcelona; University of Kiel; University of Barcelona; Universitat Internacional de Catalunya (UIC)	Petaja-Repo, UE (corresponding author), Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, FI-90014 Oulu, Finland.	ulla.petaja-repo@oulu.fi	Petäjä-Repo, Ulla/AAV-6115-2021; Morató, Xavier/ABF-8667-2021; Saftig, Paul/A-7966-2010	Morató, Xavier/0000-0002-3012-2864; Konzack, Anja/0000-0001-9758-6164; Lackman, Jarkko/0000-0002-0422-5157	Orion Research Foundation; Finnish Concordia Fund; Magnus Ehrnrooth Foundation; Oskar Oflunds Stiftelse; FEBS; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion [SAF2017-87349-R]; Catalan government [2017 SGR 1604]; Academy of Finland [295140]; Deutscher Forschungsgemeinschaft [SFB877-A3]	Orion Research Foundation; Finnish Concordia Fund; Magnus Ehrnrooth Foundation; Oskar Oflunds Stiftelse; FEBS; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion(Spanish Government); Catalan government; Academy of Finland(Academy of Finland); Deutscher Forschungsgemeinschaft	Orion Research Foundation; Finnish Concordia Fund; Magnus Ehrnrooth Foundation; Oskar Oflunds Stiftelse; FEBS; Deutscher Forschungsgemeinschaft, Grant/Award Number: SFB877-A3; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion, Grant/Award Number: SAF2017-87349-R; Catalan government, Grant/Award Number: 2017 SGR 1604; Academy of Finland, Grant/Award Number: #295140	Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Coleman JLJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76384-9; Coleman JU, 2017, CELL SIGNAL, V33, P1, DOI 10.1016/j.cellsig.2017.02.004; Cork SM, 2012, ONCOGENE, V31, P5144, DOI 10.1038/onc.2012.1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Bernard S, 1999, J BIOL CHEM, V274, P101, DOI 10.1074/jbc.274.1.101; El Buri Ashref, 2018, Oncotarget, V9, P29453, DOI 10.18632/oncotarget.25658; Fujita-Jimbo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051155; Fukuzawa T, 2006, J BIOCHEM, V140, P445, DOI 10.1093/jb/mvj170; Gandia J, 2013, J NEUROCHEM, V125, P362, DOI 10.1111/jnc.12196; Goth CK, 2017, J BIOL CHEM, V292, P4714, DOI 10.1074/jbc.M116.730614; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Grantcharova E, 2006, ARTERIOSCL THROM VAS, V26, P1288, DOI 10.1161/01.ATV.0000220377.51354.30; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hartmann M, 2015, J BIOL CHEM, V290, P17041, DOI 10.1074/jbc.M114.610204; Hertz E, 2019, NEUROPHARMACOLOGY, V152, P51, DOI 10.1016/j.neuropharm.2018.11.009; Heuberger DM, 2019, THROMB J, V17, DOI 10.1186/s12959-019-0194-8; Hsia HE, 2019, CELL MOL LIFE SCI, V76, P3055, DOI 10.1007/s00018-019-03173-7; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kim W, 2015, MOL CELL BIOL, V35, P3684, DOI 10.1128/MCB.00764-15; Klenk C, 2010, J BIOL CHEM, V285, P8665, DOI 10.1074/jbc.M109.058685; KOJRO E, 1995, J BIOL CHEM, V270, P6476, DOI 10.1074/jbc.270.12.6476; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Lopes JP, 2015, J NEUROCHEM, V134, P135, DOI 10.1111/jnc.13109; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Mattila SO, 2016, J CELL SCI, V129, P1366, DOI 10.1242/jcs.176115; Meyer RC, 2014, BRAIN RES, V1585, P1, DOI 10.1016/j.brainres.2014.08.022; Morato X, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00232-7; Morato X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10147-x; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Noben JP, 2006, J PROTEOME RES, V5, P1647, DOI 10.1021/pr0504788; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Prox J, 2013, J NEUROSCI, V33, P12915, DOI 10.1523/JNEUROSCI.5910-12.2013; Rapoport B, 2016, ENDOCR REV, V37, P114, DOI [10.1210/er.2015-1098.2016.1, 10.1210/er.2015-1098]; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Sachan V, 2019, CELL DEATH DIFFER, V26, P1942, DOI 10.1038/s41418-018-0264-7; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Sebastiano M, 2017, BLOOD, V129, P883, DOI 10.1182/blood-2016-06-724245; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Sjostedt E, 2020, SCIENCE, V367, P1090, DOI 10.1126/science.aay5947; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tafesse FG, 2014, J BIOL CHEM, V289, P24005, DOI 10.1074/jbc.M114.589275; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tomita Hiroaki, 2013, Frontiers in Genetics, V4, P297, DOI 10.3389/fgene.2013.00297; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; van den Berg CW, 2012, IMMUNOBIOLOGY, V217, P935, DOI 10.1016/j.imbio.2012.01.005; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884	64	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21654	10.1096/fj.202002385RR	http://dx.doi.org/10.1096/fj.202002385RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042202	Green Published			2022-12-28	WOS:000655695900033
J	Park, WY; Park, J; Ahn, KS; Kwak, HJ; Um, JY				Park, Woo Yong; Park, Jinbong; Ahn, Kwang Seok; Kwak, Hyun Jeong; Um, Jae-Young			Ellagic acid induces beige remodeling of white adipose tissue by controlling mitochondrial dynamics and SIRT3	FASEB JOURNAL			English	Article						beige remodeling; ellagic acid; mitochondrial fission; sirtuin-3; thermogenesis	STROMAL-VASCULAR FRACTION; LIPID-METABOLISM; BROWN; THERMOGENESIS; ADIPOCYTES; LIPOLYSIS; INSIGHTS; FISSION; ORIGIN; CELL	To determine whether ellagic acid (EA) induces the "beige remodeling" of white adipose tissue (WAT), we treated cold-exposed mice and mouse stromal vascular fraction (SVF) cells with EA, a phytochemical abundant in fruits and vegetables, in particular berries. We then investigated the mechanism of EA in beige remodeling with a particular focus on DRP1-mediated mitochondrial fission and SIRT3. EA induced the trans-differentiation of white adipocytes to beige adipocytes by promoting the expression of UCP1 and other brown and beige adipocytes/fat factors (PRDM16, UCP1, PGC1 alpha, CD137, and TBX1) and mitochondrial dynamics-related factors (SIRT3, NRF1, CPT1 beta, DRP1, and FIS1) in 3T3-L1/SVF cells, and these were confirmed in the inguinal WAT of a cold-exposed mouse model. The browning effect of EA was abolished by a potent DRP1 inhibitor Mdivi-1 or SIRT3 knockdown, suggesting that EA induces beige remodeling of WAT by regulating the mitochondrial dynamics and SIRT3.	[Park, Woo Yong; Um, Jae-Young] Kyung Hee Univ, Grad Sch, Dept Sci Korean Med, Seoul, South Korea; [Park, Woo Yong; Park, Jinbong; Ahn, Kwang Seok; Um, Jae-Young] Kyung Hee Univ, Coll Korean Med, Basic Res Lab Comorbid Res, Seoul, South Korea; [Park, Woo Yong; Park, Jinbong; Ahn, Kwang Seok; Um, Jae-Young] Kyung Hee Univ, Coll Korean Med, Comorbid Res Inst, Seoul, South Korea; [Park, Jinbong; Um, Jae-Young] Kyung Hee Univ, Dept Pharmacol, Coll Korean Med, 26 Kyungheedae Ro, Seoul 02447, South Korea; [Kwak, Hyun Jeong] Kyonggi Univ, Dept Life Sci, Coll Nat Sci, Suwon, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyonggi University	Um, JY (corresponding author), Kyung Hee Univ, Dept Pharmacol, Coll Korean Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.	jyum@khu.ac.kr		Park, Woo Yong/0000-0003-4188-3826	National Research Foundation of Korea (NRF) [2015R1A4A1042399, 2017M3A9E4065333, 2018R1A2A3075684, 2020R1C1C1009721]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2015R1A4A1042399, 2017M3A9E4065333, 2018R1A2A3075684 and 2020R1C1C1009721	Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Azhar Y, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0150-6; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Blondin DP, 2014, J CLIN ENDOCR METAB, V99, pE438, DOI 10.1210/jc.2013-3901; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Bora P, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0598-y; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14; Cho SY, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105312; Chu DT, 2017, HORM METAB RES, V49, P276, DOI 10.1055/s-0043-100384; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Chu DT, 2017, BIOCHIMIE, V138, P102, DOI 10.1016/j.biochi.2017.04.017; Chu DT, 2017, J PHYSIOL BIOCHEM, V73, P1, DOI 10.1007/s13105-016-0536-y; Eichmann TO, 2012, J BIOL CHEM, V287, P41446, DOI 10.1074/jbc.M112.400416; Frazier T, 2018, ADIPOCYTE, V7, P183, DOI 10.1080/21623945.2018.1460009; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Hepler C, 2017, ELIFE, V6, DOI [10.7554/elife.27669, 10.7554/eLife.27669]; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Inagaki T, 2016, NAT REV MOL CELL BIO, V17, P480, DOI 10.1038/nrm.2016.62; Kang J, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104852; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; Lee JH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194924; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Lombard David B, 2011, Handb Exp Pharmacol, V206, P163, DOI 10.1007/978-3-642-21631-2_8; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Park H, 2019, J CLIN INVEST, V129, P694, DOI 10.1172/JCI120606; Park WY, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092164; Paulo E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121552; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pisani DF, 2018, MOL METAB, V7, P35, DOI 10.1016/j.molmet.2017.11.007; Rui LY, 2017, COMPR PHYSIOL, V7, P1281, DOI 10.1002/cphy.c170001; Schreiber R, 2017, CELL METAB, V26, P753, DOI 10.1016/j.cmet.2017.09.004; Sebaa R, 2019, MOL METAB, V25, P35, DOI 10.1016/j.molmet.2019.04.008; Sharma M, 2010, J AGR FOOD CHEM, V58, P3965, DOI 10.1021/jf902857v; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Townsend KL, 2012, ADIPOCYTE, V1, P13, DOI 10.4161/adip.18951; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0; Wang LF, 2019, ENDOCR J, V66, P923, DOI 10.1507/endocrj.EJ18-0467; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	56	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21548	10.1096/fj.202002491R	http://dx.doi.org/10.1096/fj.202002491R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33956354				2022-12-28	WOS:000655695900045
J	Song, CH; Shi, JY; Xu, JR; Zhao, LX; Zhang, YF; Huang, WY; Qiu, Y; Zhang, R; Chen, HZ; Wang, H				Song, Chenghuan; Shi, Jiyun; Xu, Jianrong; Zhao, Lanxue; Zhang, Yongfang; Huang, Wanying; Qiu, Yu; Zhang, Rui; Chen, Hongzhuan; Wang, Hao			Post-transcriptional regulation of alpha 7 nAChR expression by miR-98-5p modulates cognition and neuroinflammation in an animal model of Alzheimer's disease	FASEB JOURNAL			English	Article						cognition; miR-98-5p; neuroinflammation; post-transcriptional regulation; alpha 7 nAChR	NICOTINIC ACETYLCHOLINE-RECEPTORS; NF-KAPPA-B; TARGET; INFLAMMATION; ACTIVATION; MECHANISMS; PROTEINS; RNAS	Alzheimer's disease (AD) is a complicated neurodegenerative disease and therefore addressing multiple targets simultaneously has been believed as a promising therapeutic strategy against AD. alpha 7 nicotinic acetylcholine receptor (nAChR), which plays an important role in improving cognitive function and alleviating neuroinflammation in central nervous system (CNS), has been regarded as a potential target in the treatment of AD. However, the regulation of alpha 7 nAChR at post-transcriptional level in mammalian brain remains largely speculated. Herein, we uncovered a novel post-transcriptional regulatory mechanism of alpha 7 nAChR expression in AD and further demonstrated that miR-98-5p suppressed alpha 7 nAChR expression through directly binding to the 3 ' UTR of mRNA. Knockdown of miR-98-5p activated Ca2+ signaling pathway and consequently reversed cognitive deficits and A beta burden in APP/PS1 mice. Furthermore, miR-98-5p downregulation increased alpha 7 nAChR expression, and ameliorated neuroinflammation via inhibiting NF-kappa B pathway and upregulating Nrf2 target genes. Our findings illustrate a prominent regulatory role of miR-98-5p in targeting inflammation and cognition, and provide an insight into the potential of miR-98-5p/alpha 7 nAChR axis as a novel therapeutic strategy for AD.	[Song, Chenghuan; Shi, Jiyun; Zhao, Lanxue; Zhang, Yongfang; Huang, Wanying; Qiu, Yu; Zhang, Rui; Wang, Hao] Shanghai Jiao Tong Univ, Dept Pharmacol & Chem Biol, Sch Med, Shanghai 200025, Peoples R China; [Xu, Jianrong] Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Shanghai, Peoples R China; [Chen, Hongzhuan] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Sci, Shuguang Hosp, Shanghai 200025, Peoples R China; [Chen, Hongzhuan] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, Shuguang Hosp, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Wang, H (corresponding author), Shanghai Jiao Tong Univ, Dept Pharmacol & Chem Biol, Sch Med, Shanghai 200025, Peoples R China.; Chen, HZ (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Sci, Shuguang Hosp, Shanghai 200025, Peoples R China.	hongzhuan_chen@hotmail.com; angela_wanghao@sjtu.edu.cn			National Natural Science Foundation of China [81973297, 82073836, 81872841, 82003719]; Key project of Shanghai Science and Technology Commission [19JC1413100]; Research Foundation of Translational Medicine of Shanghai Jiao Tong University [ZH2018ZDA23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key project of Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Research Foundation of Translational Medicine of Shanghai Jiao Tong University	National Natural Science Foundation of China, Grant/Award Number: 81973297, 82073836, 81872841 and 82003719; Key project of Shanghai Science and Technology Commission, Grant/Award Number: 19JC1413100; Research Foundation of Translational Medicine of Shanghai Jiao Tong University, Grant/Award Number: ZH2018ZDA23	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Chen L, 2010, J NEUROSCI RES, V88, P1784, DOI 10.1002/jnr.22345; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016/j.neubiorev.2007.10.007; Cuello AC, 2017, TRENDS PHARMACOL SCI, V38, P956, DOI 10.1016/j.tips.2017.07.005; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Echeverria V, 2016, PROG NEUROBIOL, V144, P142, DOI 10.1016/j.pneurobio.2016.01.002; Egea J, 2015, BIOCHEM PHARMACOL, V97, P463, DOI 10.1016/j.bcp.2015.07.032; Giocomo LM, 2005, EUR J NEUROSCI, V22, P1349, DOI 10.1111/j.1460-9568.2005.04316.x; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hoskin JL, 2019, NICOTINE TOB RES, V21, P370, DOI 10.1093/ntr/nty116; Hu YK, 2013, NEUROSCI BULL, V29, P745, DOI 10.1007/s12264-013-1348-5; Hwang CJ, 2019, CNS NEUROL DISORD-DR, V18, P3, DOI 10.2174/1871527316666170807130011; Idda ML, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1463; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Kabbani N, 2018, TRENDS PHARMACOL SCI, V39, P354, DOI 10.1016/j.tips.2018.01.002; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Li QS, 2016, J MOL NEUROSCI, V60, P413, DOI 10.1007/s12031-016-0815-7; Ma KG, 2019, NEUROPEPTIDES, V73, P96, DOI 10.1016/j.npep.2018.12.003; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Patel H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0967-6; Pchitskaya E, 2018, CELL CALCIUM, V70, P87, DOI 10.1016/j.ceca.2017.06.008; Prickaerts J, 2012, NEUROPHARMACOLOGY, V62, P1099, DOI 10.1016/j.neuropharm.2011.10.024; Rauthan M, 2017, CELL REP, V21, P1434, DOI 10.1016/j.celrep.2017.10.043; Ren JM, 2020, MOL MED REP, V22, P2063, DOI 10.3892/mmr.2020.11253; Ruthirakuhan M, 2018, ALZHEIMERS DEMENT, V14, P1344, DOI 10.1016/j.jalz.2018.04.013; Sadigh-Eteghad S, 2015, EUR J PHARMACOL, V755, P34, DOI 10.1016/j.ejphar.2015.02.047; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Tan L, 2014, J ALZHEIMERS DIS, V40, P1017, DOI 10.3233/JAD-132144; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; Tolu S, 2013, MOL PSYCHIATR, V18, P382, DOI 10.1038/mp.2012.83; Velazquez R, 2019, AGING CELL, V18, DOI 10.1111/acel.13037; Wang J, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6353814; Wang XL, 2020, AGING-US, V12, P543, DOI 10.18632/aging.102640; Wang ZW, 2020, MOL MED REP, V22, P1053, DOI 10.3892/mmr.2020.11162; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	42	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21658	10.1096/fj.202100257R	http://dx.doi.org/10.1096/fj.202100257R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34010470				2022-12-28	WOS:000655695900025
J	Yang, GY; Ding, YY; Shang, XH; Zhao, T; Lu, S; Tian, JH; Weng, J; Zeng, XM				Yang, Guangying; Ding, Yuanyuan; Shang, Xiaohui; Zhao, Tong; Lu, Shan; Tian, Jinghan; Weng, Jun; Zeng, Xiaomei			Atp23p and Atp10p coordinate to regulate the assembly of yeast mitochondrial ATP synthase	FASEB JOURNAL			English	Article						assembly; Atp10p; Atp23p; coordinate; mitochondrial ATP synthase	SUBUNIT-6; F-0; IDENTIFICATION; BIOGENESIS; F-1-ATPASE	Two chaperones, Atp23p and Atp10p, were previously shown to regulate the assembly of yeast mitochondrial ATP synthase, and extra expression of ATP23 was found to partially rescue an atp10 deletion mutant, by an unknown mechanism. Here, we identified that the residues 112-115 (LRDK) of Atp23p were required for its function in assisting assembly of the synthase, and demonstrated both functions of Atp23p, processing subunit 6 precursor and assisting assembly of the synthase, were required for the partial rescue of atp10 deletion mutant. By chasing labeling with isotope S-35-methionine, we found the stability of subunit 6 of the synthase increased in atp10 null strain upon overexpression of ATP23. Further co-immunoprecipitation (Co-IP) and blue native PAGE experiments showed that Atp23p and Atp10p were physically associated with each other in wild type. Moreover, we revealed the expression level of Atp23p increased in atp10 null mutant compared with the wild type. Furthermore, we found that, after 72 hours growth, atp10 null mutant showed leaky growth on respiratory substrates, presence of low level of subunit 6 and partial recovery of oligomycin sensitivity of mitochondrial ATPase activity. Further characterization revealed the expression of Atp23p increased after 24 hours growth in the mutant. These results indicated, in atp10 null mutant, ATP10 deficiency could be partially complemented with increased expression of Atp23p by stabilizing some subunit 6 of the synthase. Taken together, this study revealed the two chaperones Atp23p and Atp10p coordinated to regulate the assembly of mitochondrial ATP synthase, which advanced our understanding of mechanism of assembly of yeast mitochondrial ATP synthase.	[Yang, Guangying; Ding, Yuanyuan; Zhao, Tong; Lu, Shan; Tian, Jinghan; Weng, Jun; Zeng, Xiaomei] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Chinese Minist Educ, Wuhan, Peoples R China; [Shang, Xiaohui] Hebei Univ Engn, Med Coll, Handan, Peoples R China	Huazhong University of Science & Technology; Hebei University of Engineering	Zeng, XM (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	xmzeng@hust.edu.cn	ding, yy/HHS-9589-2022		National Key Research and Development Program of China [2018YFA0902400]; Most--Key Program for International S&T Cooperation Projects of China [2017YFE0129100]; National Natural Science Foundation of China [31400665]	National Key Research and Development Program of China; Most--Key Program for International S&T Cooperation Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China (2018YFA0902400), Most--Key Program for International S&T Cooperation Projects of China (2017YFE0129100), and the National Natural Science Foundation of China (31400665) to XZ	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Ackerman SH, 2002, BBA-BIOENERGETICS, V1555, P101, DOI 10.1016/S0005-2728(02)00262-1; ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Helfenbein KG, 2003, J BIOL CHEM, V278, P19751, DOI 10.1074/jbc.M301679200; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; King EJ, 1932, BIOCHEM J, V26, P292, DOI 10.1042/bj0260292; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Naumenko N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01437-z; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Paul MF, 2000, J BIOL CHEM, V275, P29238, DOI 10.1074/jbc.M004546200; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rak M, 2016, MOL BIOL CELL, V27, P919, DOI 10.1091/mbc.E15-09-0642; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; Ruhle T, 2015, BBA-BIOENERGETICS, V1847, P849, DOI 10.1016/j.bbabio.2015.02.005; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; TZAGOLOFF A, 1969, J BIOL CHEM, V244, P5027; Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	31	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21538	10.1096/fj.202002475R	http://dx.doi.org/10.1096/fj.202002475R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33956347	hybrid			2022-12-28	WOS:000655695900021
J	Bhuiyan, S; Shen, M; Chelvaretnam, S; Tan, AY; Ho, G; Hossain, MA; Widdop, RE; Samuel, CS				Bhuiyan, Sadman; Shen, Matthew; Chelvaretnam, Sharenya; Tan, Andre Y.; Ho, Gideon; Hossain, Mohammed Akhter; Widdop, Robert E.; Samuel, Chrishan S.			Assessment of renal fibrosis and anti-fibrotic agents using a novel diagnostic and stain-free second-harmonic generation platform	FASEB JOURNAL			English	Article						ACE inhibition; B7-33; diagnostic platform; fibrosis; interstitial collagen; relaxin; second-harmonic generation	INTERSTITIAL FIBROSIS; EXTRACELLULAR-MATRIX; IN-VIVO; TUBULOINTERSTITIAL FIBROSIS; LIVER FIBROSIS; COLLAGEN; KIDNEY; MICROSCOPY; MODEL; PERINDOPRIL	Current histological measurement techniques for interstitial collagen, the basis of interstitial fibrosis, are semi-quantitative at best and only provide a ratio of collagen levels within tissues. The Genesis200 imaging system and supplemental image analysis software, FibroIndex from HistoIndex, is a novel, automated platform that uses second-harmonic generation (SHG) for imaging and characterization of interstitial collagen deposition and additional characteristics, in the absence of any staining. However, its ability to quantify renal fibrosis requires investigation. This study compared SHG imaging of renal fibrosis in mice with unilateral ureteric obstruction (UUO), to that of Masson's trichrome staining (MTS) and immunohistochemistry (IHC) of collagen I. Additionally, the platform generated data on collagen morphology and distribution patterns. While all three methods determined that UUO-injured mice underwent significantly increased renal fibrosis after 7 days, the HistoIndex platform additionally determined that UUO-injured mice had a significantly increased collagen-to-tissue cross reticulation ratio (all P < .001 vs sham group). Furthermore, in UUO-injured mice treated with the relaxin family peptide receptor-1 agonists, relaxin (0.5 mg/kg/day) or B7-33 (0.25 mg/kg/day), or angiotensin converting enzyme-inhibitor, perindopril (1 mg/kg/day) over the 7-day period, only the HistoIndex platform determined that the drug-induced prevention of renal fibrosis correlated with significantly reduced collagen fiber thickness and collagen-to-tissue cross reticulation ratio, but increased collagen fiber counts. Relaxin or B7-33 treatment also increased renal matrix metalloproteinase-2 and reduced tissue inhibitor of metalloproteinase-1 levels (all P <.01 vs UUO alone). This study demonstrated the diagnostic value of the HistoIndex platform over currently used staining techniques.	[Bhuiyan, Sadman; Shen, Matthew; Chelvaretnam, Sharenya; Widdop, Robert E.; Samuel, Chrishan S.] Monash Univ, Monash Biomed Discovery Inst, Cardiovasc Dis Program, Melbourne, Vic, Australia; [Bhuiyan, Sadman; Shen, Matthew; Chelvaretnam, Sharenya; Widdop, Robert E.; Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Melbourne, Vic 3800, Australia; [Tan, Andre Y.; Ho, Gideon] HistoIndex Pte Ltd, LaunchPad, Singapore, Singapore; [Hossain, Mohammed Akhter] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia	Monash University; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Widdop, RE; Samuel, CS (corresponding author), Monash Univ, Dept Pharmacol, Melbourne, Vic 3800, Australia.	robert.widdop@monash.edu; chrishan.samuel@monash.edu			Department of Health | National Health and Medical Research Council (NHMRC) [GNT1041766, GNT1122170]	Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: GNT1041766 and GNT1122170	Alexakis C, 2006, NEPHRON EXP NEPHROL, V102, pE71, DOI 10.1159/000089684; Backer GJ, 1997, J INTERN MED, V242, P93, DOI 10.1046/j.1365-2796.1997.00207.x; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Blacker TS, 2016, FREE RADICAL BIO MED, V100, P53, DOI 10.1016/j.freeradbiomed.2016.08.010; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Chang PE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199166; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chow BSM, 2019, J AM SOC NEPHROL, V30, P2191, DOI 10.1681/ASN.2019060597; Collino M, 2013, J CELL MOL MED, V17, P1494, DOI 10.1111/jcmm.12120; Diamond JR, 1998, SEMIN NEPHROL, V18, P594; Farris AB, 2014, KIDNEY INT SUPPL, V4, P9, DOI 10.1038/kisup.2014.3; FINE S, 1971, APPL OPTICS, V10, P2350, DOI 10.1364/AO.10.002350; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Garber SL, 2001, KIDNEY INT, V59, P876, DOI 10.1046/j.1523-1755.2001.059003876.x; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Hara S, 2016, HUM PATHOL, V55, P164, DOI 10.1016/j.humpath.2016.05.010; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Hossain MA, 2016, CHEM SCI, V7, P3805, DOI 10.1039/c5sc04754d; Huuskes BM, 2015, FASEB J, V29, P540, DOI 10.1096/fj.14-254789; Kelly D J, 2006, Kidney Int, V69, P1954, DOI 10.1038/sj.ki.5000376; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Liu F, 2009, KIDNEY INT, V75, P156, DOI 10.1038/ki.2008.509; Martinez-Klimova E, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040141; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Nagai M, 2004, CARDIOVASC DRUG THER, V18, P353, DOI 10.1007/s10557-005-5059-7; Oostendorp C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18780; Paull JRA, 2001, J HYPERTENS, V19, P1393, DOI 10.1097/00004872-200108000-00007; Samuel Chrishan S., 2009, V466, P223, DOI 10.1007/978-1-59745-352-3_16; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2005, J INVEST DERMATOL, V125, P692, DOI 10.1111/j.0022-202X.2005.23880.x; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Tatsukawa H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25674-4; Tran RJ, 2017, ANNU REV ANAL CHEM, V10, P387, DOI 10.1146/annurev-anchem-071015-041453; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; UNGER T, 1986, J CARDIOVASC PHARM, V8, P276, DOI 10.1097/00005344-198603000-00009; Wang BG, 2008, LASER SURG MED, V40, P247, DOI 10.1002/lsm.20628; Wang TH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12962; Wetzl V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00195; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Xu SY, 2016, J BIOPHOTONICS, V9, P351, DOI 10.1002/jbio.201500001; Yoshida T, 2012, NEPHROL DIAL TRANSPL, V27, P2190, DOI 10.1093/ndt/gfr618; Zhou D, 2016, NAT REV NEPHROL, V12, P68, DOI 10.1038/nrneph.2015.215; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	49	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21595	10.1096/fj.202002053RRR	http://dx.doi.org/10.1096/fj.202002053RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908676				2022-12-28	WOS:000645260100022
J	Shi, MX; Sekulovski, N; Whorton, AE; MacLean, JA; Greaves, E; Hayashi, K				Shi, Mingxin; Sekulovski, Nikola; Whorton, Allison E.; MacLean, James A., II; Greaves, Erin; Hayashi, Kanako			Efficacy of niclosamide on the intra-abdominal inflammatory environment in endometriosis	FASEB JOURNAL			English	Article						endometriosis; inflammation; macrophages; mice; niclosamide	PERITONEAL-FLUID CONCENTRATIONS; GROWTH-FACTOR-BETA; MOUSE MODEL; SIGNAL TRANSDUCER; MACROPHAGES; EXPRESSION; RECEPTOR; ACTIVATOR; WOMEN; STAT3	Endometriosis, a common gynecological disease, causes chronic pelvic pain and infertility in women of reproductive age. Due to the limited efficacy of current therapies, a critical need exists to develop new treatments for endometriosis. Inflammatory dysfunction, instigated by abnormal macrophage (MF) function, contributes to disease development and progression. However, the fundamental role of the heterogeneous population of peritoneal MF and their potential druggable functions is uncertain. Here we report that GATA6-expressing large peritoneal MF (LPM) were increased in the peritoneal cavity following lesion induction. This was associated with increased cytokine and chemokine secretion in the peritoneal fluid (PF), as well as MF infiltration, vascularization and innervation in endometriosis-like lesions (ELL). Niclosamide, an FDA-approved anti-helminthic drug, was effective in reducing LPM number, but not small peritoneal MF (SPM), in the PF. Niclosamide also inhibits aberrant inflammation in the PF, ELL, pelvic organs (uterus and vagina) and dorsal root ganglion (DRG), as well as MF infiltration, vascularization and innervation in the ELL. PF from ELL mice stimulated DRG outgrowth in vitro, whereas the PF from niclosamide-treated ELL mice lacked the strong stimulatory nerve growth response. These results suggest LPM induce aberrant inflammation in endometriosis promoting lesion progression and establishment of the inflammatory environment that sensitizes peripheral nociceptors in the lesions and other pelvic organs, leading to increased hyperalgesia. Our findings provide the rationale for targeting LPM and their functions with niclosamide and its efficacy in endometriosis as a new non-hormonal therapy to reduce aberrant inflammation which may ultimately diminish associated pain.	[Shi, Mingxin; Sekulovski, Nikola; Whorton, Allison E.; MacLean, James A., II; Hayashi, Kanako] Southern Illinois Univ, Dept Physiol, Sch Med, Carbondale, IL USA; [Shi, Mingxin; MacLean, James A., II; Hayashi, Kanako] Washington State Univ, Ctr Reprod Biol, 1815 Ferdinands Lane, Pullman, WA 99164 USA; [Greaves, Erin] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry, W Midlands, England	Southern Illinois University System; Southern Illinois University; Washington State University; University of Warwick	Hayashi, K (corresponding author), Washington State Univ, Ctr Reprod Biol, 1815 Ferdinands Lane, Pullman, WA 99164 USA.	k.hayashi@wsu.edu		Hayashi, Kanako/0000-0002-5028-799X; MacLean, James/0000-0003-3061-150X; Whorton, Allison/0000-0003-2983-401X	NIH [R21HD092739]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R21HD092739 (to KH)	Adamson GD, 2011, CURR OPIN OBSTET GYN, V23, P213, DOI 10.1097/GCO.0b013e328348a3ba; Al Kadri H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005997.pub2; Alotaibi FT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219064; [Anonymous], 2008, FERTIL STERIL, V90, pS260, DOI 10.1016/j.fertnstert.2008.08.057; Arnold J, 2012, BRAIN BEHAV IMMUN, V26, P132, DOI 10.1016/j.bbi.2011.08.004; As-Sanie S, 2019, AM J OBSTET GYNECOL, V221, P86, DOI 10.1016/j.ajog.2019.02.033; Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Beliard A, 2003, FERTIL STERIL, V79, P724, DOI 10.1016/S0015-0282(02)04819-7; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bulun SE, 2019, ENDOCR REV, V40, P1048, DOI 10.1210/er.2018-00242; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Capobianco A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00009; Capobianco A, 2011, AM J PATHOL, V179, P2651, DOI 10.1016/j.ajpath.2011.07.029; Chen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30404; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Crist AM, 2019, CIRCULATION, V139, P2049, DOI 10.1161/CIRCULATIONAHA.118.036952; DECHERNEY AH, 1992, CLIN THER, V14, P766; Demir AY, 2004, HUM REPROD, V19, P21, DOI 10.1093/humrep/deh042; Ding SJ, 2018, REPROD SCI, V25, P1045, DOI 10.1177/1933719117732161; Dou QC, 1997, MOL HUM REPROD, V3, P383, DOI 10.1093/molehr/3.5.383; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Evers J L, 1991, Br J Clin Pract Suppl, V72, P45; Forster R, 2019, FASEB J, V33, P11210, DOI 10.1096/fj.201900797R; Fortunel NO, 2000, BLOOD, V96, P2022; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gazvani MR, 1998, HUM REPROD, V13, P1957, DOI 10.1093/humrep/13.7.1957; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gonzalez-Ramos R, 2012, FERTIL STERIL, V98, P520, DOI 10.1016/j.fertnstert.2012.06.021; Gonzalez-Ramos R, 2012, FERTIL STERIL, V97, P645, DOI 10.1016/j.fertnstert.2011.12.006; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Greaves E, 2015, AM J PATHOL, V185, P2286, DOI 10.1016/j.ajpath.2015.04.012; Greaves E, 2014, ENDOCRINOLOGY, V155, P4015, DOI 10.1210/en.2014-1086; Greaves E, 2014, AM J PATHOL, V184, P1930, DOI 10.1016/j.ajpath.2014.03.011; Guo MM, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1470-y; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; HILL JA, 1988, FERTIL STERIL, V50, P216; Hogg C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013776118; Hogg C, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00007; Hull ML, 2012, AM J PATHOL, V180, P880, DOI 10.1016/j.ajpath.2011.11.013; Itoh F, 2013, FERTIL STERIL, V99, P1705, DOI 10.1016/j.fertnstert.2013.01.133; Iwabe T, 1998, FERTIL STERIL, V69, P924, DOI 10.1016/S0015-0282(98)00049-1; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Johnson MC, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-45; Jorgensen H, 2017, FERTIL STERIL, V107, P1191, DOI 10.1016/j.fertnstert.2017.03.013; Kalu E, 2007, J OBSTET GYNAECOL RE, V33, P490, DOI 10.1111/j.1447-0756.2007.00569.x; Kim BG, 2015, HUM REPROD, V30, P1069, DOI 10.1093/humrep/dev050; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kobayashi H, 2014, ARCH GYNECOL OBSTET, V289, P13, DOI 10.1007/s00404-013-3049-8; Kras JV, 2013, J NEUROSCI RES, V91, P1312, DOI 10.1002/jnr.23254; Kubala MH, 2018, CELL REP, V25, P2177, DOI 10.1016/j.celrep.2018.10.082; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Laske C, 2007, J PSYCHIATR RES, V41, P600, DOI 10.1016/j.jpsychires.2006.02.007; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Leconte M, 2014, J REPROD IMMUNOL, V103, P45, DOI 10.1016/j.jri.2013.12.121; Liu YG, 2009, MOL HUM REPROD, V15, P665, DOI 10.1093/molehr/gap043; Liu YN, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00095; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Oh HK, 2013, MOL HUM REPROD, V19, P160, DOI 10.1093/molehr/gas055; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Okamoto M, 2015, HUM REPROD, V30, P632, DOI 10.1093/humrep/deu332; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; Ouyang Z, 2018, Zhonghua Yi Xue Za Zhi, V98, P1854, DOI 10.3760/cma.j.issn.0376-2491.2018.23.010; Patel BG, 2018, BEST PRACT RES CL OB, V50, P50, DOI 10.1016/j.bpobgyn.2018.01.006; Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516; Prather GR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140236; Rana N, 1996, FERTIL STERIL, V65, P925, DOI 10.1016/S0015-0282(16)58262-4; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Sasmono RT, 2012, METHODS MOL BIOL, V844, P157, DOI 10.1007/978-1-61779-527-5_11; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekulovski N, 2020, BIOL REPROD, V102, P1011, DOI 10.1093/biolre/ioaa010; Sekulovski N, 2019, BIOL REPROD, V100, P398, DOI 10.1093/biolre/ioy222; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shafrir AL, 2018, BEST PRACT RES CL OB, V51, P1, DOI 10.1016/j.bpobgyn.2018.06.001; Simao AP, 2014, RHEUMATOL INT, V34, P1153, DOI 10.1007/s00296-013-2943-5; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Symons LK, 2018, TRENDS MOL MED, V24, P748, DOI 10.1016/j.molmed.2018.07.004; Tran LVP, 2009, HUM REPROD, V24, P835, DOI 10.1093/humrep/den483; Vallve-Juanico J, 2019, HUM REPROD UPDATE, V25, P565, DOI 10.1093/humupd/dmz018; WALLER KG, 1993, FERTIL STERIL, V59, P511; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125559; WHO, 2002, WHO SPEC EV PUBL HLT; Wu CS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091467; Wu JJ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0828-3; Young VJ, 2017, HUM REPROD UPDATE, V23, P548, DOI 10.1093/humupd/dmx016; Young VJ, 2014, J CLIN ENDOCR METAB, V99, P3450, DOI 10.1210/jc.2014-1026; Yuan M, 2017, HUM REPROD, V32, P94, DOI 10.1093/humrep/dew274; Zhang XM, 2005, BJOG-INT J OBSTET GY, V112, P1153, DOI 10.1111/j.1471-0528.2005.00639.x; Zhao YC, 2016, ENDOCRINOLOGY, V157, P900, DOI 10.1210/en.2015-1324; Zhao YC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010626; Zhao YC, 2014, MOL ENDOCRINOL, V28, P1934, DOI 10.1210/me.2014-1080; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	98	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21584	10.1096/fj.202002541RRR	http://dx.doi.org/10.1096/fj.202002541RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33860549				2022-12-28	WOS:000645260100039
J	Zou, D; Song, JC; Deng, MM; Ma, YJ; Yang, CJ; Liu, JQ; Wang, S; Wen, ZP; Tang, Y; Qu, XJ; Zhang, Y				Zou, Dan; Song, Jincheng; Deng, Mingming; Ma, Yanju; Yang, Chunjiao; Liu, Jiaqing; Wang, Song; Wen, Zhenpeng; Tang, Yu; Qu, Xiujuan; Zhang, Ye			Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway	FASEB JOURNAL			English	Article						bufalin; gastric cancer; MAPK; NOS3; peritoneal dissemination	CELL; EXPRESSION; PI3K/AKT	Peritoneal dissemination threatens the survival of patients with gastric cancer (GC). Bufalin is an extract of traditional Chinese medicine, which has been proved to have anticancer effect. The target of bufalin in suppressing gastric cancer peritoneal dissemination (GCPD) and the underlying mechanism are still unclear. In this research, GC cell line MGC-803 and high-potential peritoneal dissemination cell line MKN-45P were treated with bufalin or L-NAME. Malignant biological behavior and protein level of GC cell lines were detected with MTT, wound healing, transwell, adhesion, and western blotting. Bioinformatics analysis and patient tissues were used to verify the role of endothelial nitric oxide synthase (NOS3) in GC. Mice model was used to assess the effect of bufalin and role of NOS3 in vivo. We found that bufalin inhibited the proliferation, invasion, and migration in GC cell lines. NOS3, which was an independent prognostic factor of GC patients, was predicted to be a potential target of bufalin. Further experiments proved that bufalin reduced the phosphorylation of NOS3, thereby inhibiting the mitogen--activated protein kinase (MAPK) signaling pathway, and ultimately suppressed GCPD by inhibiting EMT process. In conclusion, NOS3 was a potential therapeutic target and prognostic biomarker of GC. Bufalin could suppress GCPD through NOS3--MAPK signaling pathway, which provided more evidence support for intraperitoneal perfusion of bufalin to treat GCPD.	[Zou, Dan; Song, Jincheng; Yang, Chunjiao; Liu, Jiaqing; Wang, Song; Wen, Zhenpeng; Zhang, Ye] China Med Univ, Hosp 1, Lab Canc Inst 1, 155 North Nanjing St, Shenyang 110001, Peoples R China; [Song, Jincheng] Dalian Med Univ, Affiliated Hosp 2, Dept Oncol, Dalian, Peoples R China; [Deng, Mingming] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China; [Ma, Yanju; Tang, Yu] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Med Oncol, Shenyang, Peoples R China; [Qu, Xiujuan] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China	China Medical University; Dalian Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Medical University; China Medical University	Zhang, Y (corresponding author), China Med Univ, Hosp 1, Lab Canc Inst 1, 155 North Nanjing St, Shenyang 110001, Peoples R China.	zhangyecmu@163.com	Deng, Mingming/GQH-4321-2022		National Natural Science Foundation of China (NSFC) [82073244, 81270036, 30901736]; Plan to Focus on Research and Development from Science and Technology project of Liaoning Province [2017225029]; Shenyang Youth Science and Technology Innovation Talent Project [RC200267]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Plan to Focus on Research and Development from Science and Technology project of Liaoning Province; Shenyang Youth Science and Technology Innovation Talent Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82073244, 81270036 and 30901736; the Plan to Focus on Research and Development from Science and Technology project of Liaoning Province, Grant/Award Number: 2017225029; Shenyang Youth Science and Technology Innovation Talent Project, Grant/Award Number: RC200267	Chen YY, 2020, CANCERS, V12, DOI 10.3390/cancers12082236; Cheng CS, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0806-1; Coccolini F, 2013, WORLD J GASTROENTERO, V19, P6979, DOI 10.3748/wjg.v19.i41.6979; Gao Y, 2019, DEV CELL, V49, P375, DOI 10.1016/j.devcel.2019.04.012; Huang AC, 2016, J ETHNOPHARMACOL, V194, P1043, DOI 10.1016/j.jep.2016.11.004; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanda M, 2016, WORLD J GASTROENTERO, V22, P6829, DOI 10.3748/wjg.v22.i30.6829; Kawamura T, 2001, INT J ONCOL, V18, P809; Koga Atsuhiko, 2011, Kurume Medical Journal, V58, P73; Kono K, 2017, GASTRIC CANCER, V20, pS122, DOI 10.1007/s10120-016-0660-y; Lan YL, 2019, ONCOL LETT, V17, P3635, DOI 10.3892/ol.2019.10062; Li D, 2009, ANTI-CANCER DRUG, V20, P59, DOI 10.1097/CAD.0b013e3283160fd6; Liu YX, 2019, MOL IMMUNOL, V107, P10, DOI 10.1016/j.molimm.2019.01.005; Maniyar R, 2018, J CANCER, V9, P3874, DOI 10.7150/jca.25581; Mazrouei S, 2019, BBA-MOL CELL RES, V1866, P1398, DOI 10.1016/j.bbamcr.2019.05.004; Mikula-Pietrasik J, 2018, CELL MOL LIFE SCI, V75, P509, DOI 10.1007/s00018-017-2663-1; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Penarando J, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0472-5; Pritchard KA, 2002, FREE RADICAL BIO MED, V33, P52, DOI 10.1016/S0891-5849(02)00851-1; Qi HY, 2019, CELL BIOL INT, V43, P33, DOI 10.1002/cbin.11076; Qian LQ, 2020, J CANCER, V11, P3114, DOI 10.7150/jca.38393; Qu M, 2017, EUR REV MED PHARMACO, V21, P3384; Sheng X, 2016, INT J ONCOL, V49, P1513, DOI 10.3892/ijo.2016.3667; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074464; Su EY, 2019, AM J CHINESE MED, V47, P237, DOI [10.1142/S0192415X19500125, 10.1142/s0192415x19500125]; Taguchi K, 2012, PFLUG ARCH EUR J PHY, V464, P205, DOI 10.1007/s00424-012-1131-x; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Trane AE, 2014, J BIOL CHEM, V289, P13273, DOI 10.1074/jbc.M113.528695; Wang X, 2017, NUCLEIC ACIDS RES, V45, pW356, DOI 10.1093/nar/gkx374; Wang XX, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01703-x; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Ying L, 2007, CANCER RES, V67, P1407, DOI 10.1158/0008-5472.CAN-06-2149; Zhang JJ, 2019, ACTA PHARMACOL SIN, V40, P1228, DOI 10.1038/s41401-019-0234-8; Zhang L, 2016, AM J PHYSIOL-HEART C, V310, pH1735, DOI 10.1152/ajpheart.00109.2016; Zhang Y, 2018, MOL CANCER THER, V17, P2341, DOI 10.1158/1535-7163.MCT-17-1296	36	3	3	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21601	10.1096/fj.202002780R	http://dx.doi.org/10.1096/fj.202002780R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913201				2022-12-28	WOS:000645260100056
J	Vasam, G; Nadeau, R; Cadete, VJJ; Lavallee-Adam, M; Menzies, KJ; Burelle, Y				Vasam, Goutham; Nadeau, Rachel; Cadete, Virgilio J. J.; Lavallee-Adam, Mathieu; Menzies, Keir J.; Burelle, Yan			Proteomics characterization of mitochondrial-derived vesicles under oxidative stress	FASEB JOURNAL			English	Article						hyper&#8208; reactive cysteine residues; mitochondrial stress; mitochondrial&#8208; derived vesicle proteome; mitochondrial quality control; mitochondrial iron transport	MEMBRANE-VESICLES; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-PRODUCTION; HUMAN THIOREDOXIN-1; INACTIVATION; PEROXIREDOXIN; TRANSPORT; OXYGEN; SITES; RATES	Mitochondria share attributes of vesicular transport with their bacterial ancestors given their ability to form mitochondrial-derived vesicles (MDVs). MDVs are involved in mitochondrial quality control and their formation is enhanced with stress and may, therefore, play a potential role in mitochondrial-cellular communication. However, MDV proteomic cargo has remained mostly undefined. In this study, we strategically used an in vitro MDV budding/reconstitution assay on cardiac mitochondria, followed by graded oxidative stress, to identify and characterize the MDV proteome. Our results confirmed previously identified cardiac MDV markers, while also revealing a complete map of the MDV proteome, paving the way to a better understanding of the role of MDVs. The oxidative stress vulnerability of proteins directed the cargo loading of MDVs, which was enhanced by antimycin A (Ant-A). Among OXPHOS complexes, complexes III and V were found to be Ant-A-sensitive. Proteins from metabolic pathways such as the TCA cycle and fatty acid metabolism, along with Fe-S cluster, antioxidant response proteins, and autophagy were also found to be Ant-A sensitive. Intriguingly, proteins containing hyper-reactive cysteine residues, metabolic redox switches, including professional redox enzymes and those that mediate iron metabolism, were found to be components of MDV cargo with Ant-A sensitivity. Last, we revealed a possible contribution of MDVs to the formation of extracellular vesicles, which may indicate mitochondrial stress. In conclusion, our study provides an MDV proteomics signature that delineates MDV cargo selectivity and hints at the potential for MDVs and their novel protein cargo to serve as vital biomarkers during mitochondrial stress and related pathologies.	[Vasam, Goutham; Burelle, Yan] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Fac Hlth Sci, Ottawa, ON, Canada; [Nadeau, Rachel; Lavallee-Adam, Mathieu; Menzies, Keir J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Nadeau, Rachel; Lavallee-Adam, Mathieu] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Cadete, Virgilio J. J.; Burelle, Yan] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON, Canada; [Cadete, Virgilio J. J.] Ottawa Hosp Res Inst, Sinclair Ctr Regenerat Med, Ottawa, ON, Canada; [Menzies, Keir J.] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Burelle, Y (corresponding author), Univ Ottawa, Univ Res Chair Integrat Mitochondrial Biol, Interdisciplinary Sch Hlth Sci, Fac Hlth Sci, RGN Bldg,451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	yburell2@uottawa.ca		Vasam, Goutham/0000-0003-1733-3189; Menzies, Keir J/0000-0002-1873-8500; Lavallee-Adam, Mathieu/0000-0003-2124-3872	Canadian Institutes of Health Research [MOP 136999, MOP 159455]; Natural Sciences and Engineering Research Council of Canada [RGPIN 2016-09932, RGPIN 2018-06838, DGECR 2018-00012]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Canadian Institutes of Health Research, Grant/Award Number: MOP 136999 and MOP 159455; Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: RGPIN 2016-09932, RGPIN 2018-06838 and DGECR 2018-00012	Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6; Boyd ES, 2014, BIOCHEMISTRY-US, V53, P5834, DOI 10.1021/bi500488r; Cadete VJJ, 2019, BBA-MOL BASIS DIS, V1865, P782, DOI 10.1016/j.bbadis.2018.11.018; Cadete VJJ, 2016, J PHYSIOL-LONDON, V594, P5343, DOI 10.1113/JP272703; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Cheow ESH, 2016, MOL CELL PROTEOMICS, V15, P2628, DOI 10.1074/mcp.M115.055731; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Colletti M, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600430; Cosme J, 2017, J PROTEOME RES, V16, P2836, DOI 10.1021/acs.jproteome.7b00144; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Du YT, 2013, J BIOL CHEM, V288, P32241, DOI 10.1074/jbc.M113.495150; Gangoda L, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600370; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; Ibrahim WH, 2013, FREE RADICAL BIO MED, V65, P143, DOI 10.1016/j.freeradbiomed.2013.06.026; Jang SC, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1635420; Jeannin P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23505-0; Jiang RL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017478; Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051; Kuang MY, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9225-5; Kucera Mike, 2016, F1000Res, V5, P1717; Li ZS, 1998, J BACTERIOL, V180, P5478, DOI 10.1128/JB.180.20.5478-5483.1998; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Merico D, 2011, METHODS MOL BIOL, V781, P257, DOI 10.1007/978-1-61779-276-2_12; Nanadikar MS, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101152; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Riemer J, 2015, BIOL CHEM, V396, P465, DOI 10.1515/hsz-2014-0293; Smith AC, 2016, NUCLEIC ACIDS RES, V44, pD1258, DOI 10.1093/nar/gkv1001; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	57	13	13	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21278	10.1096/fj.202002151R	http://dx.doi.org/10.1096/fj.202002151R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769614	Green Published			2022-12-28	WOS:000635216100051
J	Wu, YL; Chanclon, B; Micallef, P; Stener-Victorin, E; Asterholm, IW; Benrick, A				Wu, Yanling; Chanclon, Belen; Micallef, Peter; Stener-Victorin, Elisabet; Wernstedt Asterholm, Ingrid; Benrick, Anna			Maternal adiponectin prevents visceral adiposity and adipocyte hypertrophy in prenatal androgenized female mice	FASEB JOURNAL			English	Article						adiponectin; adiposity; imprinting; PCOS; PNA		Hyperandrogenism is the main characteristic of polycystic ovary syndrome, which affects placental function and fetal growth, and leads to reproductive and metabolic dysfunction in female offspring. Adiponectin acts on the placenta and may exert endocrine effects on the developing fetus. This study aims to investigate if maternal and/or fetal adiponectin can prevent metabolic and reproductive dysfunction in prenatal androgenized (PNA) female offspring. Adiponectin transgenic (APNtg) and wild-type dams received dihydrotestosterone/vehicle injections between gestational days 16.5-18.5 to induce PNA offspring, which were followed for 4 months. Offspring from APNtg dams were smaller than offspring from wild-type dams, independent of genotype. Insulin sensitivity was higher in wild-type mice from APNtg dams compared to wild-types from wild-type dams, and insulin sensitivity correlated with fat mass and adipocyte size. PNA increased visceral fat% and adipocyte size in wild-type offspring from wild-type dams, while wild-type and APNtg offspring from APNtg dams were protected against this effect. APNtg mice had smaller adipocytes than wild-types and this morphology was associated with an increased expression of genes regulating adipogenesis (Ppard, Pparg, Cebpa, and Cebpb) and metabolism (Chrebp and Lpl). Anogenital distance was increased in all PNA-exposed wild-type offspring, but there was no increase in PNA APNtg offspring, suggesting that adiponectin overexpression protects against this effect. In conclusion, elevated adiponectin levels in utero improve insulin sensitivity, reduce body weight and fat mass gain in the adult offspring and protect against PNA-induced visceral adiposity. In conclusion, these data suggest that PNA offspring benefit from prenatal adiponectin supplementation.	[Wu, Yanling; Chanclon, Belen; Micallef, Peter; Wernstedt Asterholm, Ingrid; Benrick, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Benrick, Anna] Univ Skovde, Sch Hlth Sci, Skovde, Sweden	University of Gothenburg; Karolinska Institutet; University of Skovde	Benrick, A (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Box 423, S-40530 Gothenburg, Sweden.	anna.benrick@gu.se	; Stener-Victorin, Elisabet/W-6322-2018	Chanclon Garcia, Belen/0000-0001-7170-9699; Wernstedt Asterholm, Ingrid/0000-0002-0755-5784; Stener-Victorin, Elisabet/0000-0002-3424-1502	Novo Nordisk Fonden (NNF) [NNF19OC0056601]; Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond) [DIA2019-419]; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation) [2017-02069]; Adlerbertska Stiftelserna (Adlerbertska Foundations) [GU2019/86]; Stiftelsen Handlanden Hjalmar Svenssons (Hjalmar Svensson Foundation) [HJSV2019056]; Kungl. Vetenskaps-och Vitterhets-Samhallet i Goteborg (KVVS) [2018-217]; Vetenskapsradet (VR) [2017-00792, 2018-02435, 2013-7107, 2020-02435]	Novo Nordisk Fonden (NNF); Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Adlerbertska Stiftelserna (Adlerbertska Foundations); Stiftelsen Handlanden Hjalmar Svenssons (Hjalmar Svensson Foundation); Kungl. Vetenskaps-och Vitterhets-Samhallet i Goteborg (KVVS); Vetenskapsradet (VR)(Swedish Research Council)	Novo Nordisk Fonden (NNF), Grant/Award Number: NNF19OC0056601; Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond), Grant/Award Number: DIA2019-419; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation), Grant/Award Number: 2017-02069; Adlerbertska Stiftelserna (Adlerbertska Foundations), Grant/Award Number: GU2019/86; Stiftelsen Handlanden Hjalmar Svenssons (Hjalmar Svensson Foundation), Grant/Award Number: HJSV2019056; Kungl. Vetenskaps-och Vitterhets-Samhallet i Goteborg (KVVS), Grant/Award Number: 2018-217; Vetenskapsradet (VR), Grant/Award Number: 2017-00792, 2018-02435, 2013-7107 and 2020-02435	Abbott DH, 2019, EXPERT REV ENDOCRINO, V14, P131, DOI 10.1080/17446651.2019.1576522; Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Astapova O, 2012, VITAM HORM, V90, P143, DOI 10.1016/B978-0-12-398313-8.00006-3; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Aye ILMH, 2013, PLACENTA, V34, pS40, DOI 10.1016/j.placenta.2012.11.024; Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Barbe A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071526; Benrick A, 2017, P NATL ACAD SCI USA, V114, pE7187, DOI 10.1073/pnas.1708854114; Caldwell ASL, 2015, ENDOCRINOLOGY, V156, P1441, DOI 10.1210/en.2014-1887; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Chabrolle C, 2009, FERTIL STERIL, V92, P1988, DOI 10.1016/j.fertnstert.2008.09.008; Dobrzyn K, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/7965071; Dulka EA, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqz038; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Jin ZX, 2015, ENDOCRINOLOGY, V156, P1504, DOI 10.1210/en.2014-1738; Kauffman AS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131631; Lagaly DV, 2008, MOL CELL ENDOCRINOL, V284, P38, DOI 10.1016/j.mce.2008.01.007; Lizneva D, 2016, FERTIL STERIL, V106, P6, DOI 10.1016/j.fertnstert.2016.05.003; Luquet S, 2005, BBA-MOL BASIS DIS, V1740, P313, DOI 10.1016/j.bbadis.2004.11.011; Maleszka A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/957076; Maliqueo M, 2015, HUM REPROD, V30, P692, DOI 10.1093/humrep/deu351; Maliqueo M, 2013, EUR J OBSTET GYN R B, V166, P151, DOI 10.1016/j.ejogrb.2012.10.015; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; Manno FAM, 2008, PHYSIOL BEHAV, V93, P364, DOI 10.1016/j.physbeh.2007.09.011; Manti M, 2018, FASEB J, V32, P4158, DOI 10.1096/fj.201701263RR; Mills G, 2020, HUM REPROD, V35, P1666, DOI 10.1093/humrep/deaa099; Moore AM, 2015, P NATL ACAD SCI USA, V112, P596, DOI 10.1073/pnas.1415038112; Moore AM, 2013, ENDOCRINOLOGY, V154, P796, DOI 10.1210/en.2012-1954; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Palin MF, 2012, VITAM HORM, V90, P239, DOI 10.1016/B978-0-12-398313-8.00010-5; Qiao LP, 2017, DIABETES, V66, P1126, DOI 10.2337/db16-1096; Qiao LP, 2016, DIABETOLOGIA, V59, P2417, DOI 10.1007/s00125-016-4061-x; Richards JS, 2012, FERTIL STERIL, V98, P471, DOI 10.1016/j.fertnstert.2012.04.050; Risal S, 2019, NAT MED, V25, P1894, DOI 10.1038/s41591-019-0666-1; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Sir-Petermann T, 2002, HUM REPROD, V17, P2573, DOI 10.1093/humrep/17.10.2573; Sir-Petermann T, 2007, HUM REPROD, V22, P1830, DOI 10.1093/humrep/dem090; Stener-Victorin E, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa010; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Takemura Y, 2006, ENDOCRINOLOGY, V147, P3203, DOI 10.1210/en.2005-1510; Wen JP, 2008, BIOCHEM BIOPH RES CO, V371, P756, DOI 10.1016/j.bbrc.2008.04.146; Witham EA, 2012, ENDOCRINOLOGY, V153, P4522, DOI 10.1210/en.2012-1283; Yang WK, 2018, MOL MED REP, V17, P428, DOI 10.3892/mmr.2017.7881	44	4	4	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21299	10.1096/fj.202002212R	http://dx.doi.org/10.1096/fj.202002212R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715227	Green Published			2022-12-28	WOS:000635216100077
J	Ducrot, C; Bourque, MJ; Delmas, CVL; Racine, AS; Bello, DG; Delignat-Lavaud, B; Lycas, MD; Fallon, A; Michaud-Tardif, C; Nanni, SB; Herborg, F; Gether, U; Nanci, A; Takahashi, H; Parent, M; Trudeau, LE				Ducrot, Charles; Bourque, Marie-Josee; Delmas, Constantin V. L.; Racine, Anne-Sophie; Guadarrama Bello, Dainelys; Delignat-Lavaud, Benoit; Domenic Lycas, Matthew; Fallon, Aurelie; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Herborg, Freja; Gether, Ulrik; Nanci, Antonio; Takahashi, Hideto; Parent, Martin; Trudeau, Louis-Eric			Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals	FASEB JOURNAL			English	Article						active zone; axon terminals; dopamine; exocytosis; synapse; volume transmission	PRESYNAPTIC ACTIVE ZONES; GLUTAMATE CORELEASE; ULTRASTRUCTURAL-LOCALIZATION; TYROSINE-HYDROXYLASE; NEUROLIGIN 1; RELEASE; SYNAPSES; INNERVATION; TRANSMISSION; EXPRESSION	Chemical neurotransmission typically occurs through synapses. Previous ultrastructural examinations of monoamine neuron axon terminals often failed to identify a pre- and postsynaptic coupling, leading to the concept of "volume" transmission. Whether this results from intrinsic properties of these neurons remains undefined. We find that dopaminergic neurons in vitro establish a distinctive axonal arbor compared to glutamatergic or GABAergic neurons in both size and propensity of terminals to avoid direct contact with target neurons. While most dopaminergic varicosities are active and contain exocytosis proteins like synaptotagmin 1, only similar to 20% of these are synaptic. The active zone protein bassoon was found to be enriched in dopaminergic terminals that are in proximity to a target cell. Finally, we found that the proteins neurexin-1 alpha(SS4-) and neuroligin-1(A+B) play a critical role in the formation of synapses by dopamine (DA) neurons. Our findings suggest that DA neurons are endowed with a distinctive developmental connectivity program.	[Ducrot, Charles; Bourque, Marie-Josee; Racine, Anne-Sophie; Delignat-Lavaud, Benoit; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Physiol & Pharmacol, Montreal, PQ H3C 3J7, Canada; [Ducrot, Charles; Bourque, Marie-Josee; Racine, Anne-Sophie; Delignat-Lavaud, Benoit; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada; [Ducrot, Charles; Bourque, Marie-Josee; Racine, Anne-Sophie; Delignat-Lavaud, Benoit; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Trudeau, Louis-Eric] CNS Res Grp GRSNC, Montreal, PQ, Canada; [Delmas, Constantin V. L.; Parent, Martin] Univ Laval, CERVO Brain Res Ctr, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Guadarrama Bello, Dainelys; Nanci, Antonio] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Copenhagen, Denmark; [Domenic Lycas, Matthew; Herborg, Freja; Gether, Ulrik] Univ Montreal, Fac Med Dent, Dept Stomatol, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] Inst Rech Clin Montreal, Synapse Dev, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] Inst Rech Clin Montreal, Plast Res Unit, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Laval University; University of Copenhagen; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Physiol & Pharmacol, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca		Delignat-Lavaud, Benoit/0000-0003-4680-9115; Ducrot, Charles/0000-0002-5451-1610; Gether, Ulrik/0000-0002-0020-3807; Nanci, Antonio/0000-0003-0616-843X	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP106556, MOP153068, PJT159588]; Lundbeckfonden (Lundbeck Foundation) [2018-792, 2017-4331, 2016-3154]; Krembil Foundation; Fondation Brain Canada (Brain Canada); Parkinson Canada; Henry and Berenice Kaufmann Foundation	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lundbeckfonden (Lundbeck Foundation); Krembil Foundation; Fondation Brain Canada (Brain Canada); Parkinson Canada; Henry and Berenice Kaufmann Foundation	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP106556, MOP153068 and PJT159588; Lundbeckfonden (Lundbeck Foundation), Grant/Award Number: 2018-792, 2017-4331, 2016-3154, 2017-4331 and 2016-3154; Krembil Foundation; Fondation Brain Canada (Brain Canada); Henry and Berenice Kaufmann Foundation; Parkinson Canada	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Bello DG, 2017, ACTA BIOMATER, V60, P339, DOI 10.1016/j.actbio.2017.07.022; Berube-Carriere N, 2012, EUR J NEUROSCI, V35, P527, DOI 10.1111/j.1460-9568.2012.07992.x; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; COUTEAUX R, 1963, PROC R SOC SER B-BIO, V158, P457, DOI 10.1098/rspb.1963.0058; Craig AM, 1996, J NEUROSCI, V16, P3166; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Daniel JA, 2009, J NEUROSCI, V29, P14670, DOI 10.1523/JNEUROSCI.1349-09.2009; Descarries L, 2000, PROG BRAIN RES, V125, P27; Descarries L, 1996, J COMP NEUROL, V375, P167; DESCARRIES L, 1975, BRAIN RES, V100, P563, DOI 10.1016/0006-8993(75)90158-4; Descarries L, 2008, BRAIN RES REV, V58, P290, DOI 10.1016/j.brainresrev.2007.10.005; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Eid L, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00111; El Beheiry M, 2013, NAT METHODS, V10, P689, DOI 10.1038/nmeth.2566; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Espinosa Felipe, 2015, Front Synaptic Neurosci, V7, P11, DOI 10.3389/fnsyn.2015.00011; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Fortin GM, 2019, FASEB J, V33, P400, DOI 10.1096/fj.201800713RR; Fortin GM, 2012, J NEUROSCI, V32, P17477, DOI 10.1523/JNEUROSCI.1939-12.2012; Giguere N, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008352; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GRAY EG, 1959, J ANAT, V93, P420; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Li YM, 2018, NAT METHODS, V15, P367, DOI 10.1038/nmeth.4661; Liu CL, 2018, CELL, V172, P706, DOI 10.1016/j.cell.2018.01.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Perez-Lopez JL, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00070; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Naito Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42548; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Parent M, 2006, J NEURAL TRANSM-SUPP, P85; Pereira DB, 2016, NAT NEUROSCI, V19, P578, DOI 10.1038/nn.4252; Pfeffer M., 2020, SYNAPTIC SUPRA SYNAP, DOI [10.1101/2020.02.18.952978, DOI 10.1101/2020.02.18.952978]; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Robinson BG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04728-z; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SESACK SR, 1994, J NEUROSCI, V14, P88; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Silm K, 2019, NEURON, V102, P786, DOI 10.1016/j.neuron.2019.03.031; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tritsch NX, 2016, NAT REV NEUROSCI, V17, P139, DOI 10.1038/nrn.2015.21; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Trudeau LE, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00113; Trudeau LE, 2014, PROG BRAIN RES, V211, P141, DOI 10.1016/B978-0-444-63425-2.00006-4; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; UMBRIACO D, 1994, J COMP NEUROL, V348, P351, DOI 10.1002/cne.903480304; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wang SSH, 2016, NEURON, V91, P777, DOI 10.1016/j.neuron.2016.07.005; Wang YN, 2014, OPT EXPRESS, V22, P15982, DOI 10.1364/OE.22.015982; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945	82	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21791	10.1096/fj.202100201RR	http://dx.doi.org/10.1096/fj.202100201RR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320240	Green Submitted			2022-12-28	WOS:000678975300024
J	Mele, M; De Luca, P; Santos, AR; Vieira, M; Salazar, IL; Pinheiro, PS; Duarte, CB				Mele, Miranda; De Luca, Pasqualino; Santos, Ana Rita; Vieira, Marta; Salazar, Ivan L.; Pinheiro, Paulo S.; Duarte, Carlos B.			GRASP1 ubiquitination regulates AMPA receptor surface expression and synaptic activity in cultured hippocampal neurons	FASEB JOURNAL			English	Article						AMPA receptors; GRASP1; receptor trafficking; synaptic expression; ubiquitination	ACTIVITY-DEPENDENT UBIQUITINATION; PROTEASOME; TRAFFICKING; DEGRADATION; PLASTICITY; DYNAMICS; GLUA1	The synaptic expression of glutamate receptors of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) type is dynamically controlled by interaction with binding partners and auxiliary proteins. These proteins can be regulated by posttranslational modifications, including ubiquitination. In this work, we investigated the regulation of glutamate receptor interacting protein-associated protein 1 (GRASP1) by ubiquitin-dependent mechanisms and its impact on surface expression and activity of synaptic AMPA receptors. Cotransfection of GFP-ubiquitin decreased myc-GRASP1 protein levels in HEK293T cells, and this effect was inhibited upon transfection of an ubiquitin mutant that cannot be ubiquitinated on Lys48. In addition, transfection of cultured hippocampal neurons with GFP-ubiquitin reduced the dendritic levels of endogenous GRASP1 and decreased the surface expression of GluA1 AMPA receptor subunits, an effect that was partly reversed by cotransfection with GRASP1. Similarly, transfection of hippocampal neurons with GFP-ubiquitin decreased the amplitude of miniature excitatory postsynaptic currents (mEPSCs) mediated by Ca2+-impermeable AMPA receptors, and this effect was abrogated by cotransfection of GRASP1. Together, the results show a role for ubiquitination in the regulation of the postsynaptic protein GRASP1, which has an impact on the surface distribution of AMPA receptors and on their activity at the synapse.	[Mele, Miranda; De Luca, Pasqualino; Santos, Ana Rita; Vieira, Marta; Salazar, Ivan L.; Pinheiro, Paulo S.; Duarte, Carlos B.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Mele, Miranda; De Luca, Pasqualino; Salazar, Ivan L.; Pinheiro, Paulo S.] Univ Coimbra, Inst Interdisciplinary Res, Coimbra, Portugal; [Duarte, Carlos B.] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Santos, Ana Rita] Bioincubator Leuven, VIB Discovery Sci, Bethesda, MD USA; [Vieira, Marta] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Duarte, CB (corresponding author), Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, Rua Larga, P-3004504 Coimbra, Portugal.	cbduarte@ci.uc.pt	santos, ana/GWV-5678-2022; Santos, Ana Cláudia/HHN-2939-2022; Mele, Miranda/L-7788-2014; Pinheiro, Paulo/O-8765-2017; Duarte, Carlos B./K-6358-2013	Mele, Miranda/0000-0002-8627-4883; Salazar, Ivan/0000-0001-9667-6766; Pinheiro, Paulo/0000-0002-9024-1021; Duarte, Carlos B./0000-0002-1474-0208	Portuguese Science and Technology Foundation (FCT) [POCI-01-0145-FEDER-028656, UIDB/04539/2020, UIDP/04539/2020, SFRH/BPD/115546/2016, PD/BD/135498/2018, IF/01302/2012]; European Regional Development Fund (ERDF), Centro 2020 Regional Operational Program, Operational Programme for Competitiveness and Internationalization-COMPETE 2020 [POCI-01-0145-FEDER-028656, CENTRO-01-0145-FEDER-000008:BrainHealth 2020]; European Social Fund (ESF) [IF/01302/2012, BPD/115546/2016, BD/135498/2018]	Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF), Centro 2020 Regional Operational Program, Operational Programme for Competitiveness and Internationalization-COMPETE 2020; European Social Fund (ESF)(European Social Fund (ESF))	Portuguese Science and Technology Foundation (FCT), Grant/Award Number: POCI-01-0145-FEDER-028656, UIDB/04539/2020, UIDP/04539/2020, SFRH/BPD/115546/2016, PD/BD/135498/2018 and IF/01302/2012; European Regional Development Fund (ERDF), Centro 2020 Regional Operational Program, Operational Programme for Competitiveness and Internationalization-COMPETE 2020: CENTRO-01-0145-FEDER-000008:BrainHealth 2020, POCI-01-0145-FEDER-028656; European Social Fund (ESF), Grant/Award Number: IF/01302/2012, BPD/115546/2016 and BD/135498/2018	Afonso P, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3577; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Buonarati OR, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aar6889; Cheng WW, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0218-19.2020; Chiu SL, 2017, NEURON, V93, P1405, DOI 10.1016/j.neuron.2017.02.031; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Dong CG, 2008, LEARN MEMORY, V15, P335, DOI 10.1101/lm.984508; Dong CH, 2014, J NEUROSCI, V34, P3171, DOI 10.1523/JNEUROSCI.3291-13.2014; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Hiester BG, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00391; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jacobi E, 2021, J PHYSIOL-LONDON, V599, P471, DOI 10.1113/JP276698; Jewett KA, 2015, J NEUROCHEM, V135, P226, DOI 10.1111/jnc.13271; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kamalova A, 2021, J PHYSIOL-LONDON, V599, P453, DOI 10.1113/JP278701; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lu WH, 2017, CELL REP, V21, P1783, DOI 10.1016/j.celrep.2017.10.073; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Park M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00361; Salazar IL, 2016, NEUROCHEM RES, V41, P156, DOI 10.1007/s11064-015-1752-5; Santos XR, 2015, J NEUROSCI, V35, P3319, DOI 10.1523/JNEUROSCI.4521-14.2015; Scudder SL, 2014, J NEUROSCI, V34, P16637, DOI 10.1523/JNEUROSCI.2452-14.2014; Tsai NP, 2014, BBA-MOL CELL RES, V1843, P2838, DOI 10.1016/j.bbamcr.2014.08.006; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Vaden JH, 2019, J NEUROCHEM, V148, P386, DOI 10.1111/jnc.14630; van der Sluijs P, 2011, SEMIN CELL DEV BIOL, V22, P499, DOI 10.1016/j.semcdb.2011.06.008; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Widagdo J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00347; Widagdo J, 2015, CELL REP, V10, P783, DOI 10.1016/j.celrep.2015.01.015; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8	38	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21763	10.1096/fj.201903061RR	http://dx.doi.org/10.1096/fj.201903061RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245609				2022-12-28	WOS:000678975300044
J	Chan, KHK; Hsu, YH; Yang, X; Goto, A; Chen, BH				Chan, Kei Hang Katie; Hsu, Yi-Hsiang; Yang, Xia; Goto, Atsushi; Chen, Brian H.			The 2020 FASEB virtual Catalyst Conference on Integrative Approach for Complex Diseases Prevention and Management and Beyond, December 16, 2020	FASEB JOURNAL			English	Editorial Material									[Chan, Kei Hang Katie] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Chan, Kei Hang Katie] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China; [Chan, Kei Hang Katie] Brown Univ, Ctr Global Cardiometabol Hlth, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Chan, Kei Hang Katie] Brown Univ, Warren Alpert Sch Med, Dept Med, Providence, RI 02912 USA; [Chan, Kei Hang Katie] Brown Univ, Warren Alpert Sch Med, Dept Surg, Providence, RI 02912 USA; [Hsu, Yi-Hsiang] Inst Aging Res, Hebrew SeniorLife, Boston, MA USA; [Hsu, Yi-Hsiang] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Yang, Xia] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Goto, Atsushi] Yokohama City Univ, Grad Sch Data Sci, Dept Hlth Data Sci, Yokohama, Japan; [Goto, Atsushi] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan; [Chen, Brian H.] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longevher, La Jolla, CA 92093 USA; [Chen, Brian H.] FOXO Technol Inc, Minneapolis, MN USA	City University of Hong Kong; City University of Hong Kong; Brown University; Brown University; Brown University; Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Los Angeles; Yokohama City University; National Cancer Center - Japan; University of California System; University of California San Diego	Chan, KHK (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, TYB-1A-315,3-F,Yuen Bldg,31 To Yuen St,Kowloon, Hong Kong, Peoples R China.	kkhchan@cityu.edu.hk	Goto, Atsushi/AAE-4863-2022	Goto, Atsushi/0000-0003-0669-654X; Chan, Kei Hang Katie/0000-0001-9070-5394	City University of Hong Kong (Hong Kong SAR, China) New Research Initiatives/Infrastructure Support from Central (APRC); Hong Kong Innovation and Technology Fund (ITF) (Hong Kong SAR, China)	City University of Hong Kong (Hong Kong SAR, China) New Research Initiatives/Infrastructure Support from Central (APRC)(City University of Hong Kong); Hong Kong Innovation and Technology Fund (ITF) (Hong Kong SAR, China)	Special thanks to all the speakers, the FASEB team (Dr. Hannah V. Carey, Ms. Andrea Bauerfeind, Ms. Ying Zhu, and their team members), and to all attendees for their genuine support throughout the organization and duration of the CC. K.K.C. is supported by grants from City University of Hong Kong (Hong Kong SAR, China) New Research Initiatives/Infrastructure Support from Central (APRC) and Hong Kong Innovation and Technology Fund (ITF) (Hong Kong SAR, China). B.H.C. is an employee of FOXO Technologies, Inc. (Minneapolis, MN, USA).		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21500	10.1096/fj.202100317	http://dx.doi.org/10.1096/fj.202100317			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165815				2022-12-28	WOS:000667814100003
J	Hatano, S; Matsuda, S; Okanobu, A; Furutama, D; Memida, T; Kajiya, M; Ouhara, K; Fujita, T; Mizuno, N; Kurihara, H				Hatano, Saki; Matsuda, Shinji; Okanobu, Ai; Furutama, Daisuke; Memida, Takumi; Kajiya, Mikihito; Ouhara, Kazuhisa; Fujita, Tsuyoshi; Mizuno, Noriyoshi; Kurihara, Hidemi			The role of nuclear receptor 4A1 (NR4A1) in drug-induced gingival overgrowth	FASEB JOURNAL			English	Article						cytosolic calcium; DIGO; NFATc3	NF-KAPPA-B; CYCLOSPORINE-A; CREVICULAR FLUID; TGF-BETA; NUR77; TACROLIMUS; EXPRESSION; ENLARGEMENT; CONVERSION; DISEASE	Drug-induced gingival overgrowth (DIGO) is a side effect of cyclosporine A (CsA), nifedipine (NIF), and phenytoin (PHT). Nuclear receptor 4A1 (NR4A1) plays a role in fibrosis in multiple organs. However, the relationship between NR4A1 and DIGO remains unclear. We herein investigated the involvement of NR4A1 in DIGO. In the DIGO mouse model, CsA inhibited the up-regulation of Nr4a1 expression induced by periodontal disease (PD) in gingival tissue, but not that of Col1a1 and Pai1. We detected gingival overgrowth (GO) in Nr4a1 knock out (KO) mice with PD. A NR4A1 agonist inhibited the development of GO in DIGO model mice. TGF-beta increased Col1a1 and Pai1 expression levels in KO mouse gingival fibroblasts (mGF) than in wild-type mice, while the overexpression of NR4A1 in KO mGF suppressed the levels. NR4A1 expression levels in gingival tissue were significantly lower in DIGO patients than in PD patients. We also investigated the relationship between nuclear factor of activated T cells (NFAT) and NR4A1. NFATc3 siRNA suppressed the TGF-beta-induced up-regulation of NR4A1 mRNA expression in human gingival fibroblasts (hGF). CsA suppressed the TGF-beta-induced translocation of NFATc3 into the nuclei of hGF. Furthermore, NIF and PHT also decreased NR4A1 mRNA expression levels and suppressed the translocation of NFATc3 in hGF. We confirmed that CsA, NIF, and PHT reduced cytosolic calcium levels increased by TGF-beta, while CaCl2 enhanced the TGF-beta-up-regulated NR4A1 expression. We propose that the suppression of the calcium-NFATc3-NR4A1 cascade by these three drugs plays a role in the development of DIGO.	[Hatano, Saki; Matsuda, Shinji; Okanobu, Ai; Furutama, Daisuke; Memida, Takumi; Kajiya, Mikihito; Ouhara, Kazuhisa; Fujita, Tsuyoshi; Mizuno, Noriyoshi; Kurihara, Hidemi] Hiroshima Univ, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Hatano, Saki; Matsuda, Shinji; Okanobu, Ai; Furutama, Daisuke; Memida, Takumi; Kajiya, Mikihito; Ouhara, Kazuhisa; Fujita, Tsuyoshi; Mizuno, Noriyoshi; Kurihara, Hidemi] Hiroshima Univ, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University	Matsuda, S (corresponding author), Hiroshima Univ, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	matsudas@hiroshima-u.ac.jp	Matsuda, Shinji/AAB-7387-2019; Kajiya, Mikihito/A-4288-2018	Matsuda, Shinji/0000-0002-4281-3216; Kajiya, Mikihito/0000-0001-6652-0007; Ouhara, Kazuhisa/0000-0001-6796-884X	JSPS [16K11830, 18K17070, 19K10130]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	JSPS, Grant/Award Number: 16K11830, 18K17070 and 19K10130	Al-Hamilly NS, 2016, ARCH ORAL BIOL, V66, P38, DOI 10.1016/j.archoralbio.2016.02.006; Alshargabi R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66660-z; Assaggaf MA, 2015, AM J PATHOL, V185, P1588, DOI 10.1016/j.ajpath.2015.02.004; Bader G, 1998, J PERIODONTOL, V69, P729, DOI 10.1902/jop.1998.69.6.729; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Chang JH, 2015, J DENT RES, V94, P1439, DOI 10.1177/0022034515594117; Diatchenko L, 2005, J LEUKOCYTE BIOL, V78, P1366, DOI 10.1189/jlb.0405211; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gaur Sumit, 2018, J Clin Exp Dent, V10, pe610, DOI 10.4317/jced.54715; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gong Y, 2014, J PERIODONTAL RES, V49, P448, DOI 10.1111/jre.12123; Hedrick E, 2018, MOL CANCER RES, V16, P1991, DOI 10.1158/1541-7786.MCR-18-0366; Hedrick E, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00306-17; Hernandez G, 2003, J PERIODONTOL, V74, P1816, DOI 10.1902/jop.2003.74.12.1816; Hiwatashi N, 2017, LARYNGOSCOPE, V127, pE317, DOI 10.1002/lary.26678; Khalaf H, 2014, CYTOKINE, V67, P29, DOI 10.1016/j.cyto.2014.02.007; Khocht A, 1997, J PERIODONTOL, V68, P1140, DOI 10.1902/jop.1997.68.11.1140; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Li N, 2013, BIOL CELL, V105, P261, DOI 10.1111/boc.201200064; Li XX, 2015, ELIFE, V4, DOI 10.7554/eLife.07217; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU J, 1993, TRENDS PHARMACOL SCI, V14, P182, DOI 10.1016/0165-6147(93)90206-Y; Livada R, 2014, J HUM HYPERTENS, V28, P10, DOI 10.1038/jhh.2013.47; Matsuda S, 2019, CLIN ORAL INVEST, V23, P4099, DOI 10.1007/s00784-019-02846-8; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Miranda J, 2001, J PERIODONTOL, V72, P605, DOI 10.1902/jop.2001.72.5.605; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Okanobu A, 2017, J IMMUNOL METHODS, V445, P31, DOI 10.1016/j.jim.2017.03.003; Paixao CG, 2011, J PERIODONTOL, V82, P251, DOI 10.1902/jop.2010.100368; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Park YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00195; PERNU HE, 1993, J PERIODONTOL, V64, P1098, DOI 10.1902/jop.1993.64.11.1098; Rodriguez-Calvo R, 2017, EXPERT OPIN THER TAR, V21, P291, DOI 10.1080/14728222.2017.1279146; Sadeghi L, 2018, DARU, V26, P191, DOI 10.1007/s40199-018-0224-2; Samaniego M, 2006, NAT CLIN PRACT NEPHR, V2, P688, DOI 10.1038/ncpneph0343; Sattari M, 2011, IRAN J IMMUNOL, V8, P20, DOI IJIv8i1A3; Sekiguchi RT, 2007, J CLIN PERIODONTOL, V34, P545, DOI 10.1111/j.1600-051X.2007.01074.x; Seymour RA, 2000, J CLIN PERIODONTOL, V27, P217, DOI 10.1034/j.1600-051x.2000.027004217.x; Sheng JQ, 2018, CELL PHYSIOL BIOCHEM, V48, P1675, DOI 10.1159/000492292; Smolyaninova LV, 2017, CELL CALCIUM, V68, P5, DOI 10.1016/j.ceca.2017.10.002; Takeda K, 2011, TISSUE ENG PT A, V17, P955, DOI [10.1089/ten.tea.2010.0070, 10.1089/ten.TEA.2010.0070]; Trackman PC, 2015, J DENT RES, V94, P540, DOI 10.1177/0022034515571265; Trackman PC, 2004, CRIT REV ORAL BIOL M, V15, P165, DOI 10.1177/154411130401500305; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Wu H, 2016, J PATHOL, V238, P457, DOI 10.1002/path.4670; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Xiong Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00158; Yan GJ, 2015, MOL CELL BIOL, V35, P3312, DOI 10.1128/MCB.00229-15; Zeng XL, 2018, CELL PHYSIOL BIOCHEM, V46, P1078, DOI 10.1159/000488838; Zhou FF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4388; Zhou H, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0094-1	51	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21693	10.1096/fj.202100032R	http://dx.doi.org/10.1096/fj.202100032R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34109683				2022-12-28	WOS:000667814100071
J	Chen, L; Liu, XJ; Zhou, H; Li, GY; Huang, FY; Zhang, JL; Xia, TL; Lei, WH; Zhao, JH; Li, CM; Chen, M				Chen, Li; Liu, Xiaojing; Zhou, Hao; Li, Guoyong; Huang, Fangyang; Zhang, Jialiang; Xia, Tianli; Lei, Wenhua; Zhao, Jiahao; Li, Changming; Chen, Mao			Activating transcription factor 4 regulates angiogenesis under lipid overload via methionine adenosyltransferase 2A-mediated endothelial epigenetic alteration	FASEB JOURNAL			English	Article						activating transcription factor 4; angiogenesis; epigenetics; lipid overload; methionine adenosyltransferase 2a	ACID; METABOLISM; EXPRESSION; PROMOTER; HISTONE; HEALTH; CARBON; CELLS; GENE; ATF4	Lipid overload is intimately connected with the change of endothelial epigenetic status which impacts cellular signaling activities and endothelial function. Activating transcription factor 4 (ATF4) is involved in the regulation of lipid metabolism and meanwhile an epigenetic modifier. However, the role of ATF4 in the angiogenesis under lipid overload is not well understood. Here, to induce lipid overload status, we employed high-fat diet (HFD)-induced obese mouse model in vivo and palmitic acid (PA) to stimulate endothelial cells in vitro. Compared with mice fed with normal chow diet (NCD), HFD-induced obese mice showed angiogenic defects evidenced by decline in (1) blood flow recovery after hind limb ischemia, (2) wound healing speed after skin injury, (3) capillary density in injured tissues and matrigel plugs, and (4) endothelial sprouts of aortic ring. ATF4 deficiency aggravated above angiogenic defects in mice while ATF4 overexpression improved the blunted angiogenic response. Mechanistically, lipid overload lowered the H3K4 methylation levels at the regulatory regions of NOS3 and ERK1 genes, leading to reduced angiogenic signaling activity. Methionine adenosyltransferase 2A (MAT2A) is identified as a target of ATF4 and formed complex with ATF4 to direct lysine methyltransferase 2A (MLL1) to the regulatory regions of both genes for the maintenance of the H3K4 methylation level and angiogenic signaling activity. Here, we uncovered a novel metabolic-epigenetic coupling orchestrated by the ATF4-MAT2A axis for angiogenesis. The ATF4-MAT2A axis links lipid overload milieu to altered epigenetic status of relevant angiogenic signaling in endothelial cells, suggesting a potential therapeutic target for angiogenesis impaired by lipid overload.	[Chen, Li; Liu, Xiaojing; Zhou, Hao; Lei, Wenhua; Zhao, Jiahao] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Lab Cardiovasc Dis, Chengdu, Peoples R China; [Li, Guoyong; Huang, Fangyang; Zhang, Jialiang; Xia, Tianli; Lei, Wenhua; Li, Changming; Chen, Mao] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China	Sichuan University; Sichuan University	Chen, M (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China.	2496275364@qq.com			National Natural Science Foundation of China (NSFC) [81800433, 81900258]; Post-Doctor Research Project, West China Hospital, Sichuan University [18HXBH008]; Chinese Postdoctoral Science Foundation [2018M643502]; Supporting Project of Sichuan Provincial and Technology [2020YFS0246, 2017SZ0054, 2020YJ0226]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Post-Doctor Research Project, West China Hospital, Sichuan University; Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Supporting Project of Sichuan Provincial and Technology	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81800433; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81900258; Post--Doctor Research Project, West China Hospital, Sichuan University, Grant/Award Number: 18HXBH008; Chinese Postdoctoral Science Foundation, Grant/Award Number: 2018M643502; Supporting Project of Sichuan Provincial and Technology, Grant/Award Number: 2017SZ0054; Supporting Project of Sichuan Provincial and Technology, Grant/Award Number: 2020YJ0226; Supporting Project of Sichuan Provincial and Technology, Grant/Award Number: 2020YFS0246	Balasubramanian MN, 2013, BIOCHEM J, V449, P219, DOI 10.1042/BJ20120958; Blaak EE, 2003, P NUTR SOC, V62, P753, DOI 10.1079/PNS2003290; Celardo I, 2017, CELL DEATH DIFFER, V24, P638, DOI 10.1038/cdd.2016.158; Cheng R, 2015, REV ENDOCR METAB DIS, V16, P67, DOI 10.1007/s11154-015-9310-7; Chunxia Wang ZH., 2010, CELL RES, V20, P10; Costantino S, 2019, EUR HEART J, V40, P383, DOI 10.1093/eurheartj/ehx615; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Feingold KR, 2000, ENDOTEXT INTERNET; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Graupera M, 2018, TRENDS ENDOCRIN MET, V29, P781, DOI 10.1016/j.tem.2018.09.003; Hall E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-103; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kumar A, 2013, ARTERIOSCL THROM VAS, V33, P1936, DOI 10.1161/ATVBAHA.113.301765; Kuo A, 2017, CIRC RES, V120, P1289, DOI 10.1161/CIRCRESAHA.116.310498; Longchamp A, 2018, CELL, V173, P117, DOI 10.1016/j.cell.2018.03.001; Masi S, 2021, ANTIOXID REDOX SIGN, V34, P1165, DOI 10.1089/ars.2020.8040; Mehra VC, 2014, AM J PATHOL, V184, P1562, DOI 10.1016/j.ajpath.2014.01.009; Mitra S, 2011, AM J PHYSIOL-HEART C, V301, pH506, DOI 10.1152/ajpheart.00252.2011; Monastero R, 2017, EUR J NUTR, V56, P715, DOI 10.1007/s00394-015-1115-7; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Rohlenova K, 2018, TRENDS CELL BIOL, V28, P224, DOI 10.1016/j.tcb.2017.10.010; Sawada N, 2017, PHYSIOLOGY, V32, P290, DOI 10.1152/physiol.00039.2016; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; Wong BW, 2017, NATURE, V542, P49, DOI 10.1038/nature21028; Wortel IMN, 2017, TRENDS ENDOCRIN MET, V28, P794, DOI 10.1016/j.tem.2017.07.003; Yla-Herttuala S., 2017, EUR HEART J; Yuan LS, 2017, J BIOL CHEM, V292, P15002, DOI 10.1074/jbc.M117.804005; Zhao EH, 2016, CELL REP, V14, P506, DOI 10.1016/j.celrep.2015.12.053; Zhu K, 2013, J BONE MINER RES, V28, P1870, DOI 10.1002/jbmr.1958	33	1	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21612	10.1096/fj.202100233R	http://dx.doi.org/10.1096/fj.202100233R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33948996	hybrid			2022-12-28	WOS:000655695900030
J	Ramakrishnan, S; Baptista, RP; Asady, B; Huang, GZ; Docampo, R				Ramakrishnan, Srinivasan; Baptista, Rodrigo P.; Asady, Beejan; Huang, Guozhong; Docampo, Roberto			TbVps41 regulates trafficking of endocytic but not biosynthetic cargo to lysosomes of bloodstream forms of Trypanosoma brucei	FASEB JOURNAL			English	Article						acidocalcisome; endocytosis; HOPS; lysosome; Trypanosoma brucei; Vps41	TETHERING COMPLEXES; HOPS COMPLEX; CAENORHABDITIS-ELEGANS; AP-3 COMPLEX; LIFE-CYCLE; PROTEIN; MEMBRANE; VPS41; ACIDOCALCISOMES; SUBUNIT	The bloodstream stage of Trypanosoma brucei, the causative agent of African trypanosomiasis, is characterized by its high rate of endocytosis, which is involved in remodeling of its surface coat. Here we present evidence that RNAi-mediated expression down-regulation of vacuolar protein sorting 41 (Vps41), a component of the homotypic fusion and vacuole protein sorting (HOPS) complex, leads to a strong inhibition of endocytosis, vesicle accumulation, enlargement of the flagellar pocket ("big eye" phenotype), and dramatic effect on cell growth. Unexpectedly, other functions described for Vps41 in mammalian cells and yeasts, such as delivery of proteins to lysosomes, and lysosome-related organelles (acidocalcisomes) were unaffected, indicating that in trypanosomes post-Golgi trafficking is distinct from that of mammalian cells and yeasts. The essentiality of TbVps41 suggests that it is a potential drug target.	[Ramakrishnan, Srinivasan; Baptista, Rodrigo P.; Asady, Beejan; Huang, Guozhong; Docampo, Roberto] Ctr Trop & Emerging Global Dis, Athens, GA USA; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Ramakrishnan, Srinivasan] Columbus State Univ, Dept Biol, Columbus, GA USA	University System of Georgia; University of Georgia; University System of Georgia; Columbus State University	Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Paul D Coverdell Ctr, 500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@uga.edu		de Paula Baptista, Rodrigo/0000-0002-1806-8260; Docampo, Roberto/0000-0003-4229-8784	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [AI077538]	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI077538	Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; Alexander DL, 2002, J CELL SCI, V115, P3253; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Amaya C, 2016, TRAFFIC, V17, P1181, DOI 10.1111/tra.12431; Angers CG, 2009, MOL BIOL CELL, V20, P4563, DOI 10.1091/mbc.E09-04-0272; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Demmel L, 2016, J CELL SCI, V129, P2285, DOI 10.1242/jcs.191569; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hao LH, 2016, P NATL ACAD SCI USA, V113, P6307, DOI 10.1073/pnas.1602757113; Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Huang GZ, 2018, MBIO, V9, DOI [10.1128/mBio.01700-18, 10.1128/mbio.01700-18]; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Huang GZ, 2011, J BIOL CHEM, V286, P36619, DOI 10.1074/jbc.M111.284661; Ibarrola-Villava M, 2015, INT J CANCER, V136, P2109, DOI 10.1002/ijc.29257; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khatter D, 2015, J CELL SCI, V128, P1746, DOI 10.1242/jcs.162651; Klinger CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076278; Lachmann J., 2014, CELL LOGIST, V4, DOI DOI 10.4161/21592780.2014.970840; Lander N, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00068; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Lin XS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07282; Lu S, 2007, PARASITOLOGY, V134, P1639, DOI 10.1017/S0031182007003046; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Morlon-Guyot J, 2015, CELL MICROBIOL, V17, P1157, DOI 10.1111/cmi.12426; MUNSON BR, 1989, J BACTERIOL, V171, P3803, DOI 10.1128/jb.171.7.3803-3809.1989; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Ramakrishnan S, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020033; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Silverman JS, 2013, TRAFFIC, V14, P1078, DOI 10.1111/tra.12094; Silverman JS, 2011, MOL MICROBIOL, V82, P664, DOI 10.1111/j.1365-2958.2011.07842.x; Sindhwani A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006700; Solinger JA, 2013, FEBS J, V280, P2743, DOI 10.1111/febs.12151; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; WEBSTER P, 1989, EUR J CELL BIOL, V49, P303; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	56	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21641	10.1096/fj.202100487R	http://dx.doi.org/10.1096/fj.202100487R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34041791	Green Accepted			2022-12-28	WOS:000655695900055
J	Vechetti, IJ; Peck, BD; Wen, Y; Walton, RG; Valentino, TR; Alimov, AP; Dungan, CM; Van Pelt, DW; von Walden, F; Alkner, B; Peterson, CA; McCarthy, JJ				Vechetti, Ivan J., Jr.; Peck, Bailey D.; Wen, Yuan; Walton, R. Grace; Valentino, Taylor R.; Alimov, Alexander P.; Dungan, Cory M.; Van Pelt, Douglas W.; von Walden, Ferdinand; Alkner, Bjorn; Peterson, Charlotte A.; McCarthy, John J.			Mechanical overload-induced muscle-derived extracellular vesicles promote adipose tissue lipolysis	FASEB JOURNAL			English	Article						adipose tissue; extracellular vesicles; lipolysis; microRNAs; skeletal muscle	ACUTE RESISTANCE EXERCISE; CYCLE ERGOMETER TEST; SKELETAL-MUSCLE; ENERGY-EXPENDITURE; BETA(3)-ADRENERGIC RECEPTOR; OXYGEN-CONSUMPTION; SATELLITE CELLS; INSULIN ACTION; BETA-AGONIST; CL 316,243	How regular physical activity is able to improve health remains poorly understood. The release of factors from skeletal muscle following exercise has been proposed as a possible mechanism mediating such systemic benefits. We describe a mechanism wherein skeletal muscle, in response to a hypertrophic stimulus induced by mechanical overload (MOV), released extracellular vesicles (EVs) containing muscle-specific miR-1 that were preferentially taken up by epidydimal white adipose tissue (eWAT). In eWAT, miR-1 promoted adrenergic signaling and lipolysis by targeting Tfap2 alpha, a known repressor of Adr beta 3 expression. Inhibiting EV release prevented the MOV-induced increase in eWAT miR-1 abundance and expression of lipolytic genes. Resistance exercise decreased skeletal muscle miR-1 expression with a concomitant increase in plasma EV miR-1 abundance, suggesting a similar mechanism may be operative in humans. Altogether, these findings demonstrate that skeletal muscle promotes metabolic adaptations in adipose tissue in response to MOV via EV-mediated delivery of miR-1.	[Vechetti, Ivan J., Jr.; Wen, Yuan] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA; [Vechetti, Ivan J., Jr.; Peck, Bailey D.; Walton, R. Grace; Valentino, Taylor R.; Alimov, Alexander P.; Dungan, Cory M.; Van Pelt, Douglas W.; Peterson, Charlotte A.; McCarthy, John J.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA; [Peck, Bailey D.; Wen, Yuan; Walton, R. Grace; Dungan, Cory M.; Van Pelt, Douglas W.; Peterson, Charlotte A.] Univ Kentucky, Dept Phys Therapy, Lexington, KY USA; [Valentino, Taylor R.; Alimov, Alexander P.; McCarthy, John J.] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [von Walden, Ferdinand; Alkner, Bjorn] Karolinska Inst, Div Neuropediat, Dept Womens & Childrens Hlth, Solna, Sweden; [Alkner, Bjorn] Reg Hosp Eksjo, Dept Orthopaed Eksjo, Jonkoping, Region Jonkopin, Sweden; [Alkner, Bjorn] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden	University of Nebraska System; University of Nebraska Lincoln; University of Kentucky; University of Kentucky; University of Kentucky; Karolinska Institutet; Linkoping University	McCarthy, JJ (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA.	jjmcca2@uky.edu	Alkner, Björn/AHC-5835-2022; Vechetti, Ivan/C-5406-2012	Vechetti, Ivan/0000-0003-1024-1011	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK119619]; Futurum-the Academy for Health and Care, Region Jonkoping County; Swedish Research Council for Sports Science	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Futurum-the Academy for Health and Care, Region Jonkoping County; Swedish Research Council for Sports Science	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grant no. R01DK119619) to CAP and JJM and Futurum-the Academy for Health and Care, Region Jonkoping County to BA and the Swedish Research Council for Sports Science to FVW. The authors also thank Dr Beibei Zhu for his input and guidance on the 3T3-L1 cell culture.	Alberga AS, 2015, INT J OBESITY, V39, P1494, DOI 10.1038/ijo.2015.133; Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bjorkman F, 2016, EUR J APPL PHYSIOL, V116, P1627, DOI 10.1007/s00421-016-3412-0; BLOOM JD, 1992, J MED CHEM, V35, P3081, DOI 10.1021/jm00094a025; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Broughton JP, 2016, MOL CELL, V64, P320, DOI 10.1016/j.molcel.2016.09.004; Chatzinikolaou A, 2008, DIABETES CARE, V31, P1397, DOI 10.2337/dc08-0072; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; Rodrigues MFC, 2017, APPL PHYSIOL NUTR ME, V42, P605, DOI 10.1139/apnm-2016-0443; De Gasperi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13105-9; Deusinger SS, 2012, PEDIATR BLOOD CANCER, V58, P135, DOI 10.1002/pbc.23368; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; DULLOO AG, 1985, METABOLISM, V34, P1061, DOI 10.1016/0026-0495(85)90080-0; Eikenberg JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148009; Ekblom-Bak E, 2014, SCAND J MED SCI SPOR, V24, P319, DOI 10.1111/sms.12014; Estrada A.L., 2020, SKELETAL MUSCLE TISS, DOI [10.1101/2020.09.27.313932, DOI 10.1101/2020.09.27.313932]; Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892; Finlin BS, 2017, DIABETES, V66, P1237, DOI 10.2337/db16-1057; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010; Ghosal S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22334; GOLDBERG LR, 1968, AM PSYCHOL, V23, P483, DOI 10.1037/h0026206; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; HANZLIKOVA V, 1975, CELL TISSUE RES, V160, P411; Heden T, 2011, EUR J APPL PHYSIOL, V111, P477, DOI 10.1007/s00421-010-1666-5; Hoeks J, 2003, AM J PHYSIOL-ENDOC M, V285, pE775, DOI 10.1152/ajpendo.00175.2003; Holt EH, 2001, BIOCHEM BIOPH RES CO, V288, P752, DOI 10.1006/bbrc.2001.5846; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; James AP, 2016, EUR J APPL PHYSIOL, V116, P2113, DOI 10.1007/s00421-016-3465-0; Jamurtas AZ, 2004, EUR J APPL PHYSIOL, V92, P393, DOI 10.1007/s00421-004-1156-8; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim MJ, 2016, KOREAN J PARASITOL, V54, P147, DOI 10.3347/kjp.2016.54.2.147; Kirby TJ, 2016, METHODS MOL BIOL, V1460, P43, DOI 10.1007/978-1-4939-3810-0_4; Knudsen JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189301; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Latroche C, 2018, METHODS, V134, P50, DOI 10.1016/j.ymeth.2017.12.013; Laurens C, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131870; Le Bihan MC, 2012, J PROTEOMICS, V77, P344, DOI 10.1016/j.jprot.2012.09.008; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leonska-Duniec A, 2018, J SPORT SCI MED, V17, P134; Lin YY, 2014, MOL CELL BIOL, V34, P2339, DOI 10.1128/MCB.00042-14; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Lorente-Cebrian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086800; Louis SNS, 2000, CARDIOVASC DRUG THER, V14, P565, DOI 10.1023/A:1007838125152; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Marie LS, 2003, ENDOCRINOLOGY, V144, P4427, DOI 10.1210/en.2003-0561; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; MELBY C, 1993, J APPL PHYSIOL, V75, P1847, DOI 10.1152/jappl.1993.75.4.1847; Meyers DS, 1997, J CLIN ENDOCR METAB, V82, P395, DOI 10.1210/jc.82.2.395; Murach KA, 2020, FUNCTION, V1, DOI 10.1093/function/zqaa009; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; Nayor M, 2015, CURR OPIN CARDIOL, V30, P543, DOI 10.1097/HCO.0000000000000206; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Ormsbee MJ, 2007, J APPL PHYSIOL, V102, P1767, DOI 10.1152/japplphysiol.00704.2006; Osterberg KL, 2000, INT J SPORT NUTR, V10, P71, DOI 10.1123/ijsnem.10.1.71; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reisi Jalil, 2016, Asian J Sports Med, V7, pe35205, DOI 10.5812/asjsm.35205; REVELLI JP, 1993, J MOL ENDOCRINOL, V10, P193, DOI 10.1677/jme.0.0100193; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SAINZ RD, 1988, BRIT J NUTR, V60, P85, DOI 10.1079/BJN19880079; SCHIAFFINO S, 1976, VIRCHOWS ARCH B, V21, P113; Seok H, 2016, MOL CELLS, V39, P375, DOI 10.14348/molcells.2016.0013; Sigal RJ, 2014, JAMA PEDIATR, V168, P1006, DOI 10.1001/jamapediatrics.2014.1392; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Pelt DW, 2020, AM J PHYSIOL-CELL PH, V319, pC419, DOI 10.1152/ajpcell.00223.2020; Vestri HS, 2007, NEUROPSYCHOPHARMACOL, V32, P765, DOI 10.1038/sj.npp.1301142; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Walton RG, 2016, AM J PHYSIOL-ENDOC M, V311, pE69, DOI 10.1152/ajpendo.00330.2015; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001; WILLIAMS PEV, 1987, BRIT J NUTR, V57, P417, DOI 10.1079/BJN19870049; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	80	16	16	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21644	10.1096/fj.202100242R	http://dx.doi.org/10.1096/fj.202100242R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34033143	Green Submitted, Green Accepted			2022-12-28	WOS:000655695900010
J	Zhu, S; Chen, X; Wang, JN; Xu, JJ; Wang, AO; Li, JJ; Wu, S; Wu, YY; Li, XF; Huang, C; Li, J				Zhu, Sai; Chen, Xin; Wang, Jia-Nan; Xu, Jin-Jin; Wang, Ao; Li, Juan-Juan; Wu, Sha; Wu, Yuan-Yuan; Li, Xiao-Feng; Huang, Cheng; Li, Jun			Circular RNA circUbe2k promotes hepatic fibrosis via sponging miR-149-5p/TGF-beta 2 axis	FASEB JOURNAL			English	Article						circUbe2k; circular RNA; hepatic fibrosis; miR&#8208; 149&#8208; 5p; TGF&#8208; &#946; 2	STELLATE CELL ACTIVATION; PROGRESSION; CANCER	Abundant regulatory genes and complex circuits involving non-coding RNAs (ncRNAs) monitor the formation and development of hepatic fibrosis (HF). Circular RNAs (circRNAs) are a class of RNAs generated from protein coding genes by back-splicing, playing crucial roles in various pathological processes, including HF. However, little is known about mechanisms of action of circRNAs, let alone in HF. In this study, we found circUbe2k enhanced in CCl4-induced HF mice and LX-2 cells stimulated with TGF-beta 1, regulating the development of HF. Restraining the expression of circUbe2k inhibited alpha-SMA and Col1 alpha 1 expression in CCl4-induced HF mice and in LX-2 cells stimulated with TGF-beta 1. Furthermore, inhibiting circUbe2k expression reduced hepatic stellate cells (HSCs) activation and proliferation in vivo and in vitro. Mechanistically, we demonstrated a direct interaction between circUbe2k and miR-149-5p, which results in the modulation of TGF-beta 2 expressions. Together, circUbe2k may act as a "catalyst" of HSCs activation and HF through the circUbe2k/miR-149-5p/TGF-beta 2 axis. Our results provide unprecedented evidence for a significant role for circUbe2k to serve as a potential biomarker for HF therapy.	[Zhu, Sai; Chen, Xin; Wang, Jia-Nan; Xu, Jin-Jin; Wang, Ao; Li, Juan-Juan; Wu, Sha; Wu, Yuan-Yuan; Li, Xiao-Feng; Huang, Cheng; Li, Jun] Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China; [Zhu, Sai; Chen, Xin; Wang, Jia-Nan; Xu, Jin-Jin; Wang, Ao; Li, Juan-Juan; Wu, Sha; Wu, Yuan-Yuan; Li, Xiao-Feng; Huang, Cheng; Li, Jun] Anhui Inst Innovat Drugs, Hefei, Peoples R China; [Zhu, Sai; Chen, Xin; Wang, Jia-Nan; Xu, Jin-Jin; Wang, Ao; Li, Juan-Juan; Wu, Sha; Wu, Yuan-Yuan; Huang, Cheng; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Huang, C; Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China.	huangcheng@ahmu.edu.cn; lj@ahum.edu.cn	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		National Science Foundation of China [81770609, 81970534, U19A2001]; Anhui Medical University of Science and Technology [1704a0802161]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Medical University of Science and Technology	National Science Foundation of China, Grant/Award Number: 81770609, 81970534 and U19A2001; Anhui Medical University of Science and Technology, Grant/Award Number: 1704a0802161	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cedric BC, 2020, EUR REV MED PHARMACO, V24, P9924, DOI 10.26355/eurrev_202010_23203; Chen H, 2019, JNCI-J NATL CANCER I, V111, P435, DOI 10.1093/jnci/djy116; Chen X, 2020, THERANOSTICS, V10, P4851, DOI 10.7150/thno.42423; Chen X, 2019, INT IMMUNOPHARMACOL, V76, DOI 10.1016/j.intimp.2019.105838; Chen Y, 2020, J CELL MOL MED, V24, P7405, DOI 10.1111/jcmm.15356; Chen YH, 2017, GENE, V629, P35, DOI 10.1016/j.gene.2017.07.078; Cherubini A, 2019, NUCLEIC ACIDS RES, V47, P5325, DOI 10.1093/nar/gkz199; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gong YF, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117909; He Y, 2017, HEPATOLOGY, V66, P220, DOI 10.1002/hep.29153; Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jin H, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00714; Lan HY, 1996, J IMMUNOL METHODS, V190, P1, DOI 10.1016/0022-1759(95)00233-2; Li H, 2021, DIGEST DIS SCI, V66, P2261, DOI 10.1007/s10620-020-06516-8; Li XH, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2607-9; Luo Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01203-8; Meng SJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0663-2; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Pandey PR, 2020, NUCLEIC ACIDS RES, V48, P3789, DOI 10.1093/nar/gkaa035; Parola M, 2019, MOL ASPECTS MED, V65, P37, DOI 10.1016/j.mam.2018.09.002; Pinheiro D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111339; Shi YJ, 2020, CANCER SCI, V111, P2824, DOI 10.1111/cas.14511; Tan SW, 2019, FASEB J, V33, P2000, DOI 10.1096/fj.201800828RR; Xu GS, 2020, CANCER MANAG RES, V12, P2789, DOI 10.2147/CMAR.S246272; Yan JY, 2020, TOXICOL LETT, V320, P1, DOI 10.1016/j.toxlet.2019.11.017; Yang JJ, 2017, INFLAMM RES, V66, P341, DOI 10.1007/s00011-016-1020-4; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; Yu HX, 2019, MOL IMMUNOL, V107, P29, DOI 10.1016/j.molimm.2019.01.004; Yu R, 2020, J CELL MOL MED, V24, P10177, DOI 10.1111/jcmm.15629; Zhang ZK, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4689-7; Zhou LN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2228-z; Zhu S, 2021, CURR PHARM DESIGN, V27, P3000, DOI 10.2174/1381612826666201023143542; Zou GL, 2019, WORLD J GASTROENTERO, V25, P4222, DOI 10.3748/wjg.v25.i30.4222	38	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21622	10.1096/fj.202002738R	http://dx.doi.org/10.1096/fj.202002738R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33982351				2022-12-28	WOS:000655695900049
J	Aboushousha, R; Elko, E; Chia, SB; Manuel, AM; van de Wetering, C; van der Velden, J; MacPherson, M; Erickson, C; Reisz, JA; D'Alessandro, A; Wouters, EFM; Reynaert, NL; Lam, YW; Anathy, V; van der Vliet, A; Seward, DJ; Janssen-Heininger, YMW				Aboushousha, Reem; Elko, Evan; Chia, Shi B.; Manuel, Allison M.; van de Wetering, Cheryl; van der Velden, Jos; MacPherson, Maximilian; Erickson, Cuixia; Reisz, Julie A.; D'Alessandro, Angelo; Wouters, Emiel F. M.; Reynaert, Niki L.; Lam, Ying-Wai; Anathy, Vikas; van der Vliet, Albert; Seward, David J.; Janssen-Heininger, Yvonne M. W.			Glutathionylation chemistry promotes interleukin-1 beta-mediated glycolytic reprogramming and pro-inflammatory signaling in lung epithelial cells	FASEB JOURNAL			English	Article						asthma; glutathionylation; glycolysis; inflammation	SKELETAL-MUSCLE; PHENOTYPIC FLEXIBILITY; SEASONAL-VARIATION; OXIDATIVE STRESS; BODY-TEMPERATURE; THERMOGENESIS; MITOCHONDRIA; BIRDS; LIVER; MECHANISMS	Glycolysis is a well-known process by which metabolically active cells, such as tumor or immune cells meet their high metabolic demands. Previously, our laboratory has demonstrated that in airway epithelial cells, the pleiotropic cytokine, interleukin-1 beta (IL1B) induces glycolysis and that this contributes to allergic airway inflammation and remodeling. Activation of glycolysis is known to increase NADPH reducing equivalents generated from the pentose phosphate pathway, linking metabolic reprogramming with redox homeostasis. In addition, numerous glycolytic enzymes are known to be redox regulated. However, whether and how redox chemistry regulates metabolic reprogramming more generally remains unclear. In this study, we employed a multi-omics approach in primary mouse airway basal cells to evaluate the role of protein redox biochemistry, specifically protein glutathionylation, in mediating metabolic reprogramming. Our findings demonstrate that IL1B induces glutathionylation of multiple proteins involved in metabolic regulation, notably in the glycolysis pathway. Cells lacking Glutaredoxin-1 (Glrx), the enzyme responsible for reversing glutathionylation, show modulation of multiple metabolic pathways including an enhanced IL1B-induced glycolytic response. This was accompanied by increased secretion of thymic stromal lymphopoietin (TSLP), a cytokine important in asthma pathogenesis. Targeted inhibition of glycolysis prevented TSLP release, confirming the functional relevance of enhanced glycolysis in cells stimulated with IL1B. Collectively, data herein point to an intriguing link between glutathionylation chemistry and glycolytic reprogramming in epithelial cells and suggest that glutathionylation chemistry may represent a therapeutic target in pulmonary pathologies with perturbations in the glycolysis pathway.	[Aboushousha, Reem; Elko, Evan; Chia, Shi B.; Manuel, Allison M.; van de Wetering, Cheryl; van der Velden, Jos; MacPherson, Maximilian; Erickson, Cuixia; Anathy, Vikas; van der Vliet, Albert; Seward, David J.; Janssen-Heininger, Yvonne M. W.] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT USA; [Lam, Ying-Wai] Univ Vermont, Coll Med, Dept Biol, Burlington, VT USA; [Reisz, Julie A.; D'Alessandro, Angelo] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO USA; [Wouters, Emiel F. M.; Reynaert, Niki L.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab Toxicol & Me, Dept Resp Med, Med Ctr, Maastricht, Netherlands; [Wouters, Emiel F. M.] Ludwig Boltzmann Inst Lung Res, Vienna, Austria	University of Vermont; University of Vermont; University of Colorado System; University of Colorado Anschutz Medical Campus; Maastricht University	Seward, DJ (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Hlth Sci Res Facil, Room 206, Burlington, VT 05405 USA.; Janssen-Heininger, YMW (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Hlth Sci Res Facil, Room 216A, Burlington, VT 05405 USA.	david.seward@uvmhealth.org; Yvonne.janssen@uvm.edu	Wouters, Emiel/ABD-6200-2021; D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; van der Velden, Jos/0000-0002-2451-3180; Aboushousha, Reem/0000-0003-2284-2180	National Institutes of Health [R35HL135828, R01HL137268, R01HL085646, R01HL138708, R21AG055325, T32HL076122, R01HL122383]; National Institute of General Medical Sciences (NIGMS) [P20GM103449]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health, Grant/Award Number: R35HL135828, R01HL137268, R01HL085646, R01HL138708, R21AG055325, T32HL076122 and R01HL122383; National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20GM103449	Andersson MN, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00093; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Blix A.S., 1989, P117; Blix AS, 2016, J EXP BIOL, V219, P1093, DOI 10.1242/jeb.120477; Blondin DP, 2017, J PHYSIOL-LONDON, V595, P2099, DOI 10.1113/JP273395; Bourguignon A, 2017, J EXP BIOL, V220, P2445, DOI 10.1242/jeb.159087; Brodin A, 2017, OECOLOGIA, V185, P43, DOI 10.1007/s00442-017-3923-3; Casagrande S, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.222513; Davis LM, 2008, EPILEPSIA, V49, P117, DOI 10.1111/j.1528-1167.2008.01854.x; Dawson NJ, 2020, EXP GERONTOL, V133, DOI 10.1016/j.exger.2020.110883; Dawson NJ, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13030; Dawson NJ, 2016, J EXP BIOL, V219, P3719, DOI 10.1242/jeb.142711; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; HAFTORN S, 1992, ORNIS SCAND, V23, P435, DOI 10.2307/3676674; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Laursen WJ, 2015, P NATL ACAD SCI USA, V112, P1607, DOI 10.1073/pnas.1421419112; Lenth RV., 2019, **DATA OBJECT**; Liknes ET, 2011, J THERM BIOL, V36, P430, DOI 10.1016/j.jtherbio.2011.07.011; Mahalingam S, 2020, J PHYSIOL-LONDON, V598, P5411, DOI 10.1113/JP280298; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Monternier PA, 2017, COMP BIOCHEM PHYS A, V212, P1, DOI 10.1016/j.cbpa.2017.06.018; Monternier PA, 2014, J EXP BIOL, V217, P2691, DOI 10.1242/jeb.104505; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; NICHOLLS DG, 2013, BIOENERGETICS; Perrins C.M., 1979, BRIT TITS; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rey B, 2017, COMP BIOCHEM PHYS A, V211, P56, DOI 10.1016/j.cbpa.2017.06.009; Roussel D, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.233684; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Salin K, 2018, FUNCT ECOL, V32, P2149, DOI 10.1111/1365-2435.13125; Salin K, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1028; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SCHOLANDER PF, 1950, BIOL BULL, V99, P225, DOI 10.2307/1538740; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; Sjovall F, 2013, CRIT CARE, V17, DOI 10.1186/cc12831; Sjovall F, 2013, MITOCHONDRION, V13, P7, DOI 10.1016/j.mito.2012.11.001; Stager M, 2015, J EXP BIOL, V218, P767, DOI 10.1242/jeb.113472; Stier A, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0536; Stier A, 2017, METHODS ECOL EVOL, V8, P1172, DOI 10.1111/2041-210X.12724; Stier A, 2014, J EXP BIOL, V217, P624, DOI 10.1242/jeb.092700; Stier A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-33; STOKKAN KA, 1986, AM J PHYSIOL, V251, pR264, DOI 10.1152/ajpregu.1986.251.2.R264; Swanson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101577; Swanson DL, 2015, J ORNITHOL, V156, pS377, DOI 10.1007/s10336-015-1192-7; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Talbot DA, 2004, J PHYSIOL-LONDON, V558, P123, DOI 10.1113/jphysiol.2004.063768; Toyomizu M, 2002, FEBS LETT, V529, P313, DOI 10.1016/S0014-5793(02)03395-1; Trzcionka M, 2008, J EXP BIOL, V211, P1911, DOI 10.1242/jeb.016519; Wang Y, 2019, ZOOL STUD, V58, DOI 10.6620/ZS.2019.58-06; Wijers SLJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001777; Zhang L, 2011, ANIM BIOL, V61, P385, DOI 10.1163/157075511X596873; Zheng WH, 2014, PHYSIOL BIOCHEM ZOOL, V87, P704, DOI 10.1086/676832; Zheng Wei-Hong, 2010, Zoological Research, V31, P319, DOI 10.3724/SP.J.1141.2010.03319	55	3	3	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21525	10.1096/fj.202002687RR	http://dx.doi.org/10.1096/fj.202002687RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817836	Green Accepted			2022-12-28	WOS:000645260100105
J	Chang, KT; Wang, LH; Lin, YM; Cheng, CF; Wang, GS				Chang, Kuei-Ting; Wang, Lee-Hsin; Lin, Yu-Mei; Cheng, Ching-Feng; Wang, Guey-Shin			CELF1 promotes vascular endothelial growth factor degradation resulting in impaired microvasculature in heart failure	FASEB JOURNAL			English	Article						cardiomyopathy; CELF1; mRNA degradation; VEGF	CUGBP1; HYPERTROPHY; STABILITY	Vascular rarefaction due to impaired angiogenesis is associated with contractile dysfunction and the transition from compensation to decompensation and heart failure. The regulatory mechanism controlling vascular rarefaction during the transition remains elusive. Increased expression of a nuclear RNA-binding protein CUGBP Elav-like family member 1 (CELF1) in the adult heart is associated with the transition from compensated hypertrophy to decompensated heart failure. Elevated CELF1 level resulted in degradation of the major cardiac gap junction protein, connexin 43, in dilated cardiomyopathy (DCM), the most common cause of heart failure. In the present study, we investigated the role of increased CELF1 expression in causing vascular rarefaction in DCM. CELF1 overexpression (CELF1-OE) in cardiomyocytes resulted in reduced capillary density. CELF1-OE mice administered hypoxyprobe showed immunoreactivity and increased mRNA levels of HIF1 alpha, Glut-1, and Pdk-1, which suggested the association of a reduced capillary density-induced hypoxic condition with CELF1 overexpression. Vegfa mRNA level was downregulated in mouse hearts exhibiting DCM, including CELF1-OE and infarcted hearts. Vegfa mRNA level was also downregulated to a similar extent in cardiomyocytes isolated from infarcted hearts by Langendorff preparation, which suggested cardiomyocyte-derived Vegfa expression mediated by CELF1. Cardiomyocyte-specific depletion of CELF1 preserved the capillary density and Vegfa mRNA level in infarcted mouse hearts. Also, CELF1 bound to Vegfa mRNA and regulated Vegfa mRNA stability via the 3' untranslated region. These results suggest that elevated CELF1 level has dual effects on impairing the functions of cardiomyocytes and microvasculature in DCM.	[Chang, Kuei-Ting; Lin, Yu-Mei; Cheng, Ching-Feng; Wang, Guey-Shin] Acad Sinica, Inst Biomed Sci, 128,Sect 2 Acad Rd, Taipei 11529, Taiwan; [Wang, Lee-Hsin; Wang, Guey-Shin] Natl Yang Ming Univ, Taiwan Int Grad Program Interdisciplinary Neurosc, Taipei, Taiwan; [Wang, Lee-Hsin; Wang, Guey-Shin] Acad Sinica, Taipei, Taiwan; [Cheng, Ching-Feng] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Cheng, Ching-Feng] Tzu Chi Univ, Dept Pediat, Hualien, Taiwan; [Wang, Guey-Shin] Natl Yang Ming Univ, Mol Med Program, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University	Wang, GS (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sect 2 Acad Rd, Taipei 11529, Taiwan.	gswang@ibms.sinica.edu.tw	Wang, Guey-Shin/Q-3968-2018; CHENG, Ching-Feng/AAB-8861-2019; Cheng, Ching-Feng/AAB-8523-2019	Wang, Guey-Shin/0000-0003-4485-1811; CHENG, Ching-Feng/0000-0003-0104-0146; Wang, Lee-Hsin/0000-0002-3824-8840	National Health Research Institute, Taiwan [NHRI-EX105-10342SI]; Institute of Biomedical Science, Academia Sinica, Taiwan [IBMS400503]	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Institute of Biomedical Science, Academia Sinica, Taiwan	This work was supported by the National Health Research Institute, Taiwan [NHRI-EX105--10342SI to GSW] and Institute of Biomedical Science, Academia Sinica, Taiwan [IBMS400503 to GSW].	Abraham D, 2000, CIRC RES, V87, P644, DOI 10.1161/01.RES.87.8.644; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Chang KT, 2017, CIRC RES, V121, P1140, DOI 10.1161/CIRCRESAHA.117.311281; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Giamouzis G, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003259; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Merz CNB, 2017, CIRCULATION, V135, P1075, DOI 10.1161/CIRCULATIONAHA.116.024534; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Nako H, 2012, HYPERTENS RES, V35, P194, DOI 10.1038/hr.2011.175; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359; Patel KV, 2018, EUR J HEART FAIL, V20, P1557, DOI 10.1002/ejhf.1253; Poltorak Z, 2000, HERZ, V25, P126, DOI 10.1007/PL00001950; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Wang GS, 2009, J CLIN INVEST, V119, P3797, DOI 10.1172/JCI37976	24	5	5	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21512	10.1096/fj.202002553R	http://dx.doi.org/10.1096/fj.202002553R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811692				2022-12-28	WOS:000645260100011
J	Ackun-Farmmer, MA; Soto, CA; Lesch, ML; Byun, D; Yang, LL; Calvi, LM; Benoit, DSW; Frisch, BJ				Ackun-Farmmer, Marian A.; Soto, Celia A.; Lesch, Maggie L.; Byun, Daniel; Yang, Lila; Calvi, Laura M.; Benoit, Danielle S. W.; Frisch, Benjamin J.			Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling	FASEB JOURNAL			English	Article						nanoparticles; acute myeloid leukemia; peptide; drug delivery; small molecule drug; MIP1&#8208; alpha	ACUTE MYELOID-LEUKEMIA; MESENCHYMAL STROMAL CELLS; IN-VIVO; MARROW NICHE; STEM-CELLS; FUNCTIONAL INHIBITION; DRUG-DELIVERY; MURINE MODEL; MOUSE MODEL; DISEASE	Leukemias are challenging diseases to treat due, in part, to interactions between leukemia cells and the bone marrow microenvironment (BMME) that contribute significantly to disease progression. Studies have shown that leukemic cells secrete C-chemokine (C-C motif) ligand 3 (CCL3), to disrupt the BMME resulting in loss of hematopoiesis and support of leukemic cell survival and proliferation. In this study, a murine model of blast crisis chronic myelogenous leukemia (bcCML) that expresses the translocation products BCR/ABL and Nup98/HoxA9 was used to determine the role of CCL3 in BMME regulation. Leukemic cells derived from CCL3(-/-) mice were shown to minimally engraft in a normal BMME, thereby demonstrating that CCL3 signaling was necessary to recapitulate bcCML disease. Further analysis showed disruption in hematopoiesis within the BMME in the bcCML model. To rescue the altered BMME, therapeutic inhibition of CCL3 signaling was investigated using bone-targeted nanoparticles (NP) to deliver Maraviroc, an inhibitor of C-C chemokine receptor type 5 (CCR5), a CCL3 receptor. NP-mediated Maraviroc delivery partially restored the BMME, significantly reduced leukemic burden, and improved survival. Overall, our results demonstrate that inhibiting CCL3 via CCR5 antagonism is a potential therapeutic approach to restore normal hematopoiesis as well as reduce leukemic burden within the BMME.	[Ackun-Farmmer, Marian A.; Benoit, Danielle S. W.; Frisch, Benjamin J.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Ackun-Farmmer, Marian A.; Byun, Daniel; Calvi, Laura M.; Benoit, Danielle S. W.; Frisch, Benjamin J.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA; [Ackun-Farmmer, Marian A.; Byun, Daniel; Calvi, Laura M.; Benoit, Danielle S. W.; Frisch, Benjamin J.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Soto, Celia A.; Lesch, Maggie L.; Frisch, Benjamin J.] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY USA; [Yang, Lila] New York Inst Technol, Coll Osteopath Med, New York, NY USA; [Calvi, Laura M.] Univ Rochester, Med Ctr, Dept Med, Div Endocrine, Rochester, NY 14642 USA; [Calvi, Laura M.; Frisch, Benjamin J.] Univ Rochester, Sch Med & Dent, Wilmot Canc Inst, Rochester, NY USA; [Benoit, Danielle S. W.] Univ Rochester, Mat Sci Program, Rochester, NY USA; [Benoit, Danielle S. W.] Univ Rochester, Dept Chem Engn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; New York Institute Technology; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Benoit, DSW; Frisch, BJ (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, 601 Elmwood Ave,Box 704, Rochester, NY 14642 USA.	benoit@bme.rochester.edu; benjamin_frisch2@urmc.rochester.edu		Ackun-Farmmer, Marian/0000-0003-3081-5115; Lesch, Maggie/0000-0002-7080-2020; Benoit, Danielle/0000-0001-7137-8164; Soto, Celia/0000-0003-1787-3249	HHS | NIH | National Cancer Institute (NCI) [CA180615, CA166280]; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR069655, AR064200, AR056696]; National Science Foundation (NSF) [CBET1450987]; University of Rochester (UR) [UL1 TR002001]	HHS | NIH | National Cancer Institute (NCI); HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); University of Rochester (UR)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: CA180615; HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: CA166280; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR069655; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR064200; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR056696; National Science Foundation (NSF), Grant/Award Number: CBET1450987; University of Rochester (UR), Grant/Award Number: UL1 TR002001	[Anonymous], 2017, CANC STAT FACTS AC M; Argyle D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02629; Baba T, 2013, J EXP MED, V210, P2661, DOI 10.1084/jem.20130112; Balderman SR, 2016, BLOOD, V127, P616, DOI 10.1182/blood-2015-06-653113; Baranello MP, 2014, BIOMACROMOLECULES, V15, P2629, DOI 10.1021/bm500468d; Baranello MP., 2015, CELLS-BASEL, V8, p455; Behrmann L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00444; Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Blau O, 2011, BLOOD, V118, P5583, DOI 10.1182/blood-2011-03-343467; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen YL, 2019, LEUKEMIA, V33, P2365, DOI 10.1038/s41375-019-0458-0; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Dairaghi DJ, 2012, BLOOD, V120, P1449, DOI 10.1182/blood-2011-10-384784; Dalela M, 2015, ACS APPL MATER INTER, V7, P26530, DOI 10.1021/acsami.5b07764; Deshantri AK, 2018, J CONTROL RELEASE, V287, P194, DOI 10.1016/j.jconrel.2018.08.034; Dong L, 2016, NATURE, V539, P304, DOI 10.1038/nature20131; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Feldman EJ, 2011, J CLIN ONCOL, V29, P979, DOI 10.1200/JCO.2010.30.5961; Frisch BJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124213; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Geyh S, 2016, LEUKEMIA, V30, P683, DOI 10.1038/leu.2015.325; Hoffmann VS, 2015, LEUKEMIA, V29, P1336, DOI 10.1038/leu.2015.73; Jain P, 2017, CANCER-AM CANCER SOC, V123, P4391, DOI 10.1002/cncr.30864; Kim S, 2017, LEUKEMIA, V31, P1582, DOI 10.1038/leu.2016.354; Krevvata M, 2014, BLOOD, V124, P2834, DOI 10.1182/blood-2013-07-517219; Kumar B, 2018, LEUKEMIA, V32, P575, DOI 10.1038/leu.2017.259; Liang M, 2000, J BIOL CHEM, V275, P19000, DOI 10.1074/jbc.M001222200; Lim WS, 2010, LEUKEMIA RES, V34, P1214, DOI 10.1016/j.leukres.2010.01.015; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Menu E, 2006, CLIN EXP METASTAS, V23, P291, DOI 10.1007/s10585-006-9038-6; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Newman MR, 2018, BIOMACROMOLECULES, V19, P71, DOI 10.1021/acs.biomac.7b01193; Oyajobi BO, 2001, BONE, V28, pS81; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Roboz GJ, 2012, CURR OPIN ONCOL, V24, P711, DOI 10.1097/CCO.0b013e328358f62d; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Sheu TJ, 2002, J BONE MINER RES, V17, P915, DOI 10.1359/jbmr.2002.17.5.915; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Staversky RJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32978-y; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Wang Y, 2016, LEUKEMIA, V30, P1897, DOI 10.1038/leu.2016.81; Wang YC, 2017, ACS NANO, V11, P9445, DOI 10.1021/acsnano.7b05103; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Yazdani Z, 2020, LIFE SCI, V240, DOI 10.1016/j.lfs.2019.117071; Ye HB, 2018, CANCER CELL, V34, P659, DOI 10.1016/j.ccell.2018.08.016; Zi J, 2017, AM J CANCER RES, V7, P869; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	50	5	5	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21402	10.1096/fj.202000938RR	http://dx.doi.org/10.1096/fj.202000938RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724567	Green Accepted			2022-12-28	WOS:000635216100040
J	O'Brien, BJ; Singer, HA; Adam, AP; Ginnan, RG				O'Brien, Brendan J.; Singer, Harold A.; Adam, Alejandro P.; Ginnan, Roman G.			CaMKII delta is upregulated by pro-inflammatory cytokine IL-6 in a JAK/STAT3-dependent manner to promote angiogenesis	FASEB JOURNAL			English	Article						angiogenesis; CaMKII; cell motility; endothelial biology; STAT3 signaling		Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a ubiquitous serine threonine kinase with established roles in physiological and pathophysiological vascular remodeling. Based on our previous study demonstrating that CaMKII delta promotes thrombin-induced endothelial permeability and recent reports that CaMKII may contribute to inflammatory remodeling in the heart, we investigated CaMKII delta-dependent regulation of endothelial function downstream of an interleukin-6 (IL-6)/JAK/STAT3 signaling axis. Upon treatment with IL-6 and its soluble receptor (sIL-6r), CaMKII delta expression is significantly induced in HUVEC. Using pharmacological inhibitors of JAK and siRNA targeting STAT3, we demonstrated that activation of STAT3 is sufficient to induce CaMKII delta expression. Under these conditions, rather than promoting IL-6-induced permeability, we found that CaMKII delta promotes endothelial cell migration as measured by live cell imaging of scratch wound closure and single-cell motility analysis. In a similar manner, endothelial cell proliferation was attenuated upon knockdown of CaMKII delta as determined by growth curves, cell cycle analysis, and capacitance of cell-covered electrodes as measured by ECIS. Using inducible endothelial-specific STAT3 knockout mice, we demonstrate that STAT3 signaling promotes developmental angiogenesis in the neonatal mouse retina assessed at postnatal day 6. CaMKII delta expression in retinal endothelium was attenuated in these animals as measured by qPCR. STAT3's effects on angiogenesis were phenocopied by the endothelial-specific knockout of CaMKII delta, with significantly reduced vascular outgrowth and number of junctions in the developing P6 retina. For the first time, we demonstrate that transcriptional regulation of CaMKII delta by STAT3 promotes endothelial motility, proliferation, and in vivo angiogenesis.	[O'Brien, Brendan J.; Singer, Harold A.; Adam, Alejandro P.; Ginnan, Roman G.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA	Albany Medical College	Ginnan, RG (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA.	ginnanr@amc.edu	Adam, Alejandro/M-6541-2013	Adam, Alejandro/0000-0001-6285-7235; O'Brien, Brendan/0000-0001-9425-7832	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI) [HL049426]	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI)	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL049426	Aggarwal S, 2011, EXP CLIN CARDIOL, V16, P11; Alsaffar H, 2018, AM J PHYSIOL-CELL PH, V314, pC589, DOI 10.1152/ajpcell.00235.2017; Ashraf S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122442; Babon JJ, 2014, SEMIN IMMUNOL, V26, P13, DOI 10.1016/j.smim.2013.12.004; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cheneby J, 2020, NUCLEIC ACIDS RES, V48, pD180, DOI 10.1093/nar/gkz945; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Fantin Alessandro, 2015, Methods Mol Biol, V1332, P177, DOI 10.1007/978-1-4939-2917-7_13; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Gao P, 2017, ONCOTARGET, V8, P69139, DOI 10.18632/oncotarget.19932; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Ginnan R, 2012, BIOCHEM J, V444, P105, DOI 10.1042/BJ20120152; Gopinathan G, 2015, CANCER RES, V75, P3098, DOI 10.1158/0008-5472.CAN-15-1227; Hamik A, 2006, ARTERIOSCL THROM VAS, V26, P1936, DOI 10.1161/01.ATV.0000232542.42968.e3; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Kayakabe K, 2012, RHEUMATOLOGY, V51, P1571, DOI 10.1093/rheumatology/kes093; Kokje VBC, 2016, ATHEROSCLEROSIS, V251, P139, DOI 10.1016/j.atherosclerosis.2016.06.021; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Rojas M, 2010, INVEST OPHTH VIS SCI, V51, P1709, DOI 10.1167/iovs.09-3375; Saddouk F Z, 2017, Adv Pharmacol, V78, P171, DOI 10.1016/bs.apha.2016.08.003; Saddouk FZ, 2016, FASEB J, V30, P1051, DOI 10.1096/fj.15-279158; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Saneyoshi T, 2019, NEURON, V102, P1199, DOI 10.1016/j.neuron.2019.04.012; Singer HA, 2012, J PHYSIOL-LONDON, V590, P1349, DOI 10.1113/jphysiol.2011.222232; Stahl A, 2012, BLOOD, V120, P2925, DOI 10.1182/blood-2012-04-422527; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Toussaint F, 2015, CELL CALCIUM, V58, P275, DOI 10.1016/j.ceca.2015.06.005; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Walker S, 2016, BLOOD, V127, P948, DOI 10.1182/blood-2015-06-654277; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xiao J, 2020, INT J CARDIOL, V312, P100, DOI 10.1016/j.ijcard.2020.03.072	43	4	4	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21437	10.1096/fj.202002755R	http://dx.doi.org/10.1096/fj.202002755R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749880	Green Accepted			2022-12-28	WOS:000635216100073
J	Ichiyama, Y; Obata, S; Saishin, Y; Sawada, O; Kakinoki, M; Sawada, T; Kubota, Y; Ohji, M				Ichiyama, Yusuke; Obata, Shumpei; Saishin, Yoshitsugu; Sawada, Osamu; Kakinoki, Masashi; Sawada, Tomoko; Kubota, Yoshiaki; Ohji, Masahito			The systemic antiangiogenic effect of intravitreal aflibercept injection in a mouse model of retinopathy of prematurity	FASEB JOURNAL			English	Article						anti&#8208; vascular endothelial growth factor; fellow eye; hematogenous effect; retinopathy of prematurity; systemic effect	ENDOTHELIAL GROWTH-FACTOR; VEGF; BEVACIZUMAB; ANGIOGENESIS; INHIBITION; LETHALITY; LASER	Retinopathy of prematurity (ROP) is a leading cause of childhood blindness and intravitreal anti-vascular endothelial growth factor (VEGF) injection is becoming a first-line choice for treatment of ROP. However, there is a major concern that intravitreally injected anti-VEGF agents could escape from the eye into the systemic circulation and impair systemic development. Moreover, escaped anti-VEGF agents could have an effect on the retina of the fellow eye. In this study, we investigated the hematogenous effect of a single intravitreal anti-VEGF injection in a mouse model of ROP. Here, we showed that single intravitreal aflibercept injection to one eye can affect body weight gain, the fellow eye, and renal vessels, although no apparent effect was observed in brain vessels. Furthermore, this hematogenous effect was dose-dependent. Our results provide very important insights into the clinical use of anti-VEGF agents for ROP treatment.	[Ichiyama, Yusuke; Obata, Shumpei; Saishin, Yoshitsugu; Sawada, Osamu; Kakinoki, Masashi; Sawada, Tomoko; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Seta Tsukinowacho, Otsu, Shiga 5202192, Japan; [Kubota, Yoshiaki] Keio Univ, Dept Anat, Sch Med, Tokyo, Japan	Shiga University of Medical Science; Keio University	Ichiyama, Y (corresponding author), Shiga Univ Med Sci, Dept Ophthalmol, Seta Tsukinowacho, Otsu, Shiga 5202192, Japan.	ichiyama@belle.shiga-med.ac.jp	Ichiyama, Yusuke/AAN-5983-2021		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19K18877, 2019-R-117, E00000559]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 19K18877; Novartis | Alcon, Grant/Award Number: 2019-R-117 and E00000559	Arima M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230678; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fan YY, 2019, OPHTHALMOLOGY, V126, P1567, DOI 10.1016/j.ophtha.2019.03.048; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fish JE, 2017, DEVELOPMENT, V144, P2428, DOI 10.1242/dev.146050; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hong YR, 2015, RETINA-J RET VIT DIS, V35, P1772, DOI 10.1097/IAE.0000000000000535; Huang CY, 2018, GRAEF ARCH CLIN EXP, V256, P479, DOI 10.1007/s00417-017-3878-4; Hwang CK, 2015, OPHTHALMOLOGY, V122, P1008, DOI 10.1016/j.ophtha.2014.12.017; Iacobelli S, 2007, AM J PERINAT, V24, P587, DOI 10.1055/s-2007-992173; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Kennedy KA, 2018, J AAPOS, V22, P61, DOI 10.1016/j.jaapos.2017.10.006; Kitamoto Y, 1997, J CLIN INVEST, V99, P2351, DOI 10.1172/JCI119416; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lien RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148019; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; Natarajan G, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-3537; Ogura S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90905; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Okuno Y, 2012, NAT MED, V18, P1208, DOI 10.1038/nm.2846; Roohipoor R, 2018, OPHTHALMOL RETINA, V2, P942, DOI 10.1016/j.oret.2018.01.017; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2019, LANCET, V394, P1551, DOI 10.1016/S0140-6736(19)31344-3; Tan JJ, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/4353129; Tang F, 2019, ANGIOGENESIS, V22, P369, DOI 10.1007/s10456-019-09662-4; Tokunaga CC, 2014, INVEST OPHTH VIS SCI, V55, P1884, DOI 10.1167/iovs.13-13397; Tschulakow A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113701; Valencia AM, 2017, EXP LUNG RES, V43, P120, DOI 10.1080/01902148.2017.1306897; Wallace DK, 2018, OPHTHALMOLOGY, V125, P1961, DOI 10.1016/j.ophtha.2018.05.001; Wallace DK, 2017, JAMA OPHTHALMOL, V135, P654, DOI 10.1001/jamaophthalmol.2017.1055; Wood EH, 2018, OSLI RETINA, V49, pE102, DOI 10.3928/23258160-20180907-16; Zhou Y, 2016, GRAEF ARCH CLIN EXP, V254, P31, DOI 10.1007/s00417-015-2996-0	39	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21390	10.1096/fj.202002414R	http://dx.doi.org/10.1096/fj.202002414R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566381	Bronze			2022-12-28	WOS:000629576700039
J	Kemas, AM; Youhanna, S; Shafagh, RZ; Lauschke, VM				Kemas, Aurino M.; Youhanna, Sonia; Shafagh, Reza Zandi; Lauschke, Volker M.			Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume	FASEB JOURNAL			English	Article						glucose disposition; insulin resistance; off&#8208; stoichiometric thiol&#8208; ene; organotypic cell culture; thiol&#8208; Michael addition reaction; type 2 diabetes	HORSERADISH-PEROXIDASE; HEPATOCYTE SPHEROIDS; ANIMAL-MODELS; CELL-CULTURE; METABOLISM; SYSTEMS	The liver plays a central role in glucose homeostasis and hepatic insulin resistance constitutes a key feature of type 2 diabetes. However, platforms that accurately mimic human hepatic glucose disposition and allow for rapid and scalable quantification of glucose consumption dynamics are lacking. Here, we developed and optimized a colorimetric glucose assay based on the glucose oxidase-peroxidase system and demonstrate that the system can monitor glucose consumption in 3D primary human liver cell cultures over multiple days. The system was highly sensitive (limit of detection of 3.5 mu M) and exceptionally accurate (R-2 = 0.999) while requiring only nanoliter input volumes (250 nL), enabling longitudinal profiling of individual liver microtissues. By utilizing a novel polymer, off-stoichiometric thiol-ene (OSTE), and click-chemistry based on thiol-Michael additions, we furthermore show that the assay can be covalently bound to custom-build chips, facilitating the integration of the sensor into microfluidic devices. Using this system, we find that glucose uptake of our 3D human liver cultures closely resembles human hepatic glucose uptake in vivo as measured by euglycemic-hyperinsulinemic clamp. By comparing isogenic insulin-resistant and insulin-sensitive liver cultures we furthermore show that insulin and extracellular glucose levels account for 55% and 45% of hepatic glucose consumption, respectively. In conclusion, the presented data show that the integration of accurate and scalable nanoliter glucose sensors with physiologically relevant organotypic human liver models enables longitudinal profiling of hepatic glucose consumption dynamics that will facilitate studies into the biology and pathobiology of glycemic control, as well as antidiabetic drug screening.	[Kemas, Aurino M.; Youhanna, Sonia; Shafagh, Reza Zandi; Lauschke, Volker M.] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Shafagh, Reza Zandi] KTH Royal Inst Tech, Dept Micro & Nanosyst, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Lauschke, VM (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.	volker.lauschke@ki.se	Shafagh, Reza Zandi/AAH-4641-2020; Lauschke, Volker/O-3014-2017	Shafagh, Reza Zandi/0000-0003-4322-6192; Kemas, Aurino M./0000-0001-9031-4748; Lauschke, Volker/0000-0002-1140-6204	Vetenskapsradet (VR) [2019-01837]; Innovative Medicines Initiative (IMI) [875510]	Vetenskapsradet (VR)(Swedish Research Council); Innovative Medicines Initiative (IMI)	Vetenskapsradet (VR), Grant/Award Number: 2016-01153; Vetenskapsradet (VR), Grant/Award Number: 201601154; Vetenskapsradet (VR), Grant/Award Number: 2019-01837; Innovative Medicines Initiative (IMI), Grant/Award Number: 875510	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; [Anonymous], 2015, Nat Rev Dis Primers, V1, P15039, DOI 10.1038/nrdp.2015.39; Bell CC, 2017, DRUG METAB DISPOS, V45, P419, DOI 10.1124/dmd.116.074369; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Chadt A, 2020, PFLUG ARCH EUR J PHY, V472, P1273, DOI 10.1007/s00424-020-02417-x; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Curcio E, 2007, BIOMATERIALS, V28, P5487, DOI 10.1016/j.biomaterials.2007.08.033; Davidson MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28178; Davidson MD, 2015, TISSUE ENG PART C-ME, V21, P716, DOI [10.1089/ten.tec.2014.0512, 10.1089/ten.TEC.2014.0512]; Ekhlaspour Laya, 2017, J Diabetes Sci Technol, V11, P558, DOI 10.1177/1932296816672237; Ewart L, 2018, ANNU REV PHARMACOL, V58, P65, DOI 10.1146/annurev-pharmtox-010617-052722; Fornera S, 2010, ANAL BIOCHEM, V407, P293, DOI 10.1016/j.ab.2010.07.034; Gonzales WV, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19040800; Heller A, 2008, CHEM REV, V108, P2482, DOI 10.1021/cr068069y; Honka MJ, 2018, EUR J ENDOCRINOL, V178, P523, DOI 10.1530/EJE-17-0882; Hurrell T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040964; Iozzo P, 2003, J NUCL MED, V44, P682; JAKOBSEN LK, 1960, SCAND J CLIN LAB INV, V12, P76, DOI 10.3109/00365516009046170; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Kemas AM, 2021, FASEB J, V35, DOI 10.1096/fj.202001989RR; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kozyra M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32722-6; Lauschke VM, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800347; Lauschke VM, 2016, HEPATOLOGY, V64, P1743, DOI 10.1002/hep.28780; Lauschke VM, 2016, PHARMACOGENOMICS, V17, P917, DOI 10.2217/pgs-2016-0023; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Li HX, 2019, NAT MED, V25, P850, DOI 10.1038/s41591-019-0404-8; Lin C, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1829148; Lu YH, 2012, BIOTECHNOL BIOENG, V109, P595, DOI 10.1002/bit.23349; Messner Simon, 2018, Appl In Vitro Toxicol, V4, P1, DOI 10.1089/aivt.2017.0022; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Mulukutla BC, 2010, TRENDS BIOTECHNOL, V28, P476, DOI 10.1016/j.tibtech.2010.06.005; Nagarajan SR, 2019, AM J PHYSIOL-ENDOC M, V316, pE578, DOI 10.1152/ajpendo.00365.2018; Nair DP, 2014, CHEM MATER, V26, P724, DOI 10.1021/cm402180t; Navale Archana M, 2016, Biophys Rev, V8, P5, DOI 10.1007/s12551-015-0186-2; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; PORSTMANN B, 1981, J CLIN CHEM CLIN BIO, V19, P435; Rebel Annette, 2012, J Diabetes Sci Technol, V6, P396; Sandstrom N, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/7/075002; Sandstrom N, 2017, J MICROMECH MICROENG, V27, DOI 10.1088/1361-6439/aa91fd; Santoleri D, 2019, CELL MOL GASTROENTER, V7, P447, DOI 10.1016/j.jcmgh.2018.10.016; Shafagh RZ, 2019, MICROSYST NANOENG, V5, DOI 10.1038/s41378-019-0065-2; Shafagh RZ, 2018, ACS NANO, V12, P9940, DOI 10.1021/acsnano.8b03709; Shen JX, 2020, CHEM RES TOXICOL, V33, P38, DOI 10.1021/acs.chemrestox.9b00245; Steiner MS, 2011, CHEM SOC REV, V40, P4805, DOI 10.1039/c1cs15063d; Tam CS, 2012, DIABETES CARE, V35, P1605, DOI 10.2337/dc11-2339; Underhill GH, 2018, CELL MOL GASTROENTER, V5, P426, DOI 10.1016/j.jcmgh.2017.11.012; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vojinovic V, 2004, J MOL CATAL B-ENZYM, V28, P129, DOI 10.1016/j.molcatb.2004.02.003; Vorrink SU, 2017, FASEB J, V31, P2696, DOI 10.1096/fj.201601375R; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wei JJ, 2020, J TISSUE ENG REGEN M, V14, P774, DOI 10.1002/term.3042; Wilson ZE, 2003, BRIT J CLIN PHARMACO, V56, P433, DOI 10.1046/j.1365-2125.2003.01881.x; Yamamoto Norio, 2015, Curr Protoc Pharmacol, V71, DOI 10.1002/0471141755.ph1214s71; Zhang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13982; Zhou YT, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01093	59	16	16	5	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21305	10.1096/fj.202001989RR	http://dx.doi.org/10.1096/fj.202001989RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566368	hybrid			2022-12-28	WOS:000629576700052
J	Lee, SJ; Kim, SJ; Jo, DH; Park, KS; Kim, JH				Lee, Seok Jae; Kim, Soo-Jin; Jo, Dong Hyun; Park, Kyu-Sang; Kim, Jeong Hun			Blockade of mTORC1-NOX signaling pathway inhibits TGF-beta 1-mediated senescence-like structural alterations of the retinal pigment epithelium	FASEB JOURNAL			English	Article						epithelial&#8208; mesenchymal transition; retinal pigment epithelium; senescence; TGF&#8208; &#946; 1; mTORC1&#8208; NOX signaling		The retinal pigment epithelium (RPE) undergoes characteristic structural changes and epithelial-mesenchymal transition (EMT) during normal aging, which are exacerbated in age-related macular degeneration (AMD). Although the pathogenic mechanisms of aging and AMD remain unclear, transforming growth factor-beta 1 (TGF-beta 1) is known to induce oxidative stress, morphometric changes, and EMT as a senescence-promoting factor. In this study, we examined whether intravitreal injection of TGF-beta 1 into the mouse eye elicits senescence-like morphological alterations in the RPE and if this can be prevented by suppressing mammalian target of rapamycin complex 1 (mTORC1) or NADPH oxidase (NOX) signaling. We verified that intravitreal TGF-beta 1-induced stress fiber formation and EMT in RPE cells, along with age-associated morphometric changes, including increased variation in cell size and reduced cell density. In RPE cells, exogenous TGF-beta 1 increased endogenous expression of TGF-beta 1 and upregulated Smad3-ERK1/2-mTORC1 signaling, increasing reactive oxygen species (ROS) production and EMT. We demonstrated that inhibition of the mTORC1-NOX4 pathway by pretreatment with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an activator of AMP-dependent protein kinase, or GKT137831, a NOX1/4 inhibitor, decreased ROS generation, prevented stress fiber formation, attenuated EMT, and improved the regularity of the RPE structure in vitro and in vivo. These results suggest that intravitreal TGF-beta 1 injection could be used as a screening model to investigate the aging-related structural and functional changes to the RPE. Furthermore, the regulation of TGF-beta-mTORC1-NOX signaling could be a potential therapeutic target for reducing pathogenic alterations in aged RPE and AMD.	[Lee, Seok Jae; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 03080, South Korea; [Lee, Seok Jae; Kim, Jeong Hun] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Kim, Soo-Jin; Park, Kyu-Sang] Yonsei Univ, Dept Physiol, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea; [Jo, Dong Hyun] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Med, Seoul, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Kim, Jeong Hun] Korea Res Inst Biosci & Biotechnol, Adv Biomed Res Ctr, Daejeon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 03080, South Korea.; Park, KS (corresponding author), Yonsei Univ, Dept Physiol, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea.	qsang@yonsei.ac.kr; steph25@snu.ac.kr		Kim, Jeong Hun/0000-0003-2957-1766; Lee, Seok Jae/0000-0003-1523-0012	Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2018M3D1A1058826]; National Research Foundation of Korea (NRF) [2015M3A7B6027946]; Development of Platform Technology for Innovative Medical Measurements - Korea Research Institute of Standards and Science [KRISS-2020-GP2020-0004]; Medical Research Center Program - Ministry of Science and ICT [2017R1A5A2015369]	Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT(National Research Foundation of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Development of Platform Technology for Innovative Medical Measurements - Korea Research Institute of Standards and Science; Medical Research Center Program - Ministry of Science and ICT	This research was supported by the Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2018M3D1A1058826 to JHK), the National Research Foundation of Korea (NRF) Grants (2015M3A7B6027946 to JHK), the Development of Platform Technology for Innovative Medical Measurements funded by Korea Research Institute of Standards and Science (KRISS-2020-GP2020-0004 to JHK), and the Medical Research Center Program funded by the Ministry of Science and ICT (2017R1A5A2015369 to K.-S.P).	Antikainen H, 2017, AGING CELL, V16, P1219, DOI 10.1111/acel.12689; Bai YJ, 2014, MOL VIS, V20, P1258; Bhatia SK, 2016, MOL VIS, V22, P898; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; Chen KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106554; Chen M, 2016, AGING CELL, V15, P436, DOI 10.1111/acel.12447; Choi K, 2012, MOL VIS, V18, P1010; Cichon MA, 2014, ONCOTARGET, V5, P2827, DOI 10.18632/oncotarget.1940; Das R, 2019, KIDNEY INT, V96, P927, DOI 10.1016/j.kint.2019.05.006; Das R, 2015, J BIOL CHEM, V290, P30830, DOI 10.1074/jbc.M115.703116; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Ghosh S, 2018, INVEST OPHTH VIS SCI, V59, P104, DOI 10.1167/iovs.18-24132; Golestaneh N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.453; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hindupur SK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019141; Hirsch L, 2015, CYTOKINE, V71, P394, DOI 10.1016/j.cyto.2014.11.014; Huang JC, 2019, THERANOSTICS, V9, P1170, DOI 10.7150/thno.26281; Hyttinen JMT, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225800; Jarman ER, 2014, AM J RESP CELL MOL, V50, P158, DOI 10.1165/rcmb.2013-0174OC; Kim SJ, 2020, BIOCHEM BIOPH RES CO, V529, P747, DOI 10.1016/j.bbrc.2020.06.034; Kimura K, 2015, J MOL MED, V93, P749, DOI 10.1007/s00109-015-1289-8; Lee SJ., 2021, FASEB J, V35; Li NS, 2016, TUMOR BIOL, V37, P8249, DOI 10.1007/s13277-015-4639-9; Matoba R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181481; Muller C, 2018, STEM CELL REP, V10, P1075, DOI 10.1016/j.stemcr.2018.01.017; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; Papageorgis Panagiotis, 2017, Critical Reviews in Oncogenesis, V22, P313, DOI 10.1615/CritRevOncog.2017025134; Radeke MJ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0183-x; Roehlecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071570; Santos F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040891; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Shu DY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124271; Stone JD, 2015, AM J PHYSIOL-HEART C, V309, pH251, DOI 10.1152/ajpheart.00846.2014; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tarau IS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143578; Teixeira G, 2017, BRIT J PHARMACOL, V174, P1647, DOI 10.1111/bph.13532; Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002; Tosi GM, 2017, INVEST OPHTH VIS SCI, V58, P162, DOI 10.1167/iovs.16-20922; Wilkinson-Berka JL, 2014, ANTIOXID REDOX SIGN, V20, P2726, DOI 10.1089/ars.2013.5357; Wu D, 2019, FASEB J, V33, P2498, DOI 10.1096/fj.201801227R; Yang J, 2018, INT J MOL MED, V42, P123, DOI 10.3892/ijmm.2018.3612; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Zhou M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00501	47	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21403	10.1096/fj.202001939RR	http://dx.doi.org/10.1096/fj.202001939RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559185				2022-12-28	WOS:000629576700028
J	Nissinen, TA; Hentila, J; Fachada, V; Lautaoja, JH; Pasternack, A; Ritvos, O; Kivela, R; Hulmi, JJ				Nissinen, Tuuli A.; Hentila, Jaakko; Fachada, Vasco; Lautaoja, Juulia H.; Pasternack, Arja; Ritvos, Olli; Kivela, Riikka; Hulmi, Juha J.			Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fasting	FASEB JOURNAL			English	Article						activins; myostatin; mechanistic target of rapamycin protein; physical activity; fasting		Blocking of myostatin and activins effectively counteracts muscle atrophy. However, the potential interaction with physical inactivity and fasting in the regulation of muscle protein synthesis is poorly understood. We used blockade of myostatin and activins by recombinant adeno-associated virus (rAAV)-mediated follistatin (FS288) overexpression in mouse tibialis anterior muscle. To investigate the effects on muscle protein synthesis, muscles were collected 7 days after rAAV-injection in the nighttime or in the daytime representing high and low levels of activity and feeding, respectively, or after overnight fasting, refeeding, or ad libitum feeding. Muscle protein synthesis was increased by FS288 independent of the time of the day or the feeding status. However, the activation of mTORC1 signaling by FS288 was attenuated in the daytime and by overnight fasting. FS288 also increased the amount of mTOR colocalized with lysosomes, but did not alter their localization toward the sarcolemma. This study shows that FS288 gene delivery increases muscle protein synthesis largely independent of diurnal fluctuations in physical activity and food intake or feeding status, overriding the physiological signals. This is important for eg cachectic and sarcopenic patients with reduced physical activity and appetite. The FS288-induced increase in mTORC1 signaling and protein synthesis may be in part driven by increased amount of mTOR colocalized with lysosomes, but not by their localization toward sarcolemma.	[Nissinen, Tuuli A.; Hentila, Jaakko; Fachada, Vasco; Lautaoja, Juulia H.; Hulmi, Juha J.] Univ Jyvaskyla, Fac Sport & Hlth Sci, NeuroMuscular Res Ctr, Rautpohjankatu 8, Jyvaskyla 40014, Finland; [Pasternack, Arja; Ritvos, Olli] Univ Helsinki, Fac Med, Dept Physiol, Helsinki, Finland; [Kivela, Riikka] Univ Helsinki, Fac Med, Res Programs Unit, Stem Cells & Metab Res Program, Helsinki, Finland; [Kivela, Riikka] Wihuri Res Inst, Helsinki, Finland	University of Jyvaskyla; University of Helsinki; University of Helsinki; Wihuri Research Institute	Hulmi, JJ (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, NeuroMuscular Res Ctr, Rautpohjankatu 8, Jyvaskyla 40014, Finland.	juha.hulmi@jyu.fi	Ritvos, Olli/GWC-2442-2022; Hentilä, Jaakko/GQI-1596-2022; Kivela, Riikka/I-2859-2016	Ritvos, Olli/0000-0001-7017-6931; Lautaoja, Juulia/0000-0003-2037-829X; Fachada, Vasco/0000-0002-6575-1943; Kivela, Riikka/0000-0002-2686-8890; Hentila, Jaakko/0000-0001-8211-8827; Hulmi, Juha/0000-0003-3813-2124; Pasternack, Arja/0000-0002-6088-4245	Academy of Finland [275922, 297245]; Ellen and Artturi Nyyssonen Foundation	Academy of Finland(Academy of Finland); Ellen and Artturi Nyyssonen Foundation	Academy of Finland, Grant/Award Number: 275922 and 297245; Ellen and Artturi Nyyssonen Foundation	Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; Ahren B, 2000, ACTA PHYSIOL SCAND, V169, P325, DOI 10.1046/j.1365-201x.2000.00746.x; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Brook MS, 2016, ACTA PHYSIOL, V216, P15, DOI 10.1111/apha.12532; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Collins-Hooper H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120524; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Davey JR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85477; Drummond MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1113, DOI 10.1152/ajpendo.00603.2011; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Han XQ, 2019, J CACHEXIA SARCOPENI, V10, P1241, DOI 10.1002/jcsm.12474; Hashimoto O, 2000, CELL SIGNAL, V12, P565, DOI 10.1016/S0898-6568(00)00099-1; Hentila J, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13069; Hodson N, 2019, EXERC SPORT SCI REV, V47, P46, DOI 10.1249/JES.0000000000000173; Hodson N, 2017, AM J PHYSIOL-CELL PH, V313, pC604, DOI 10.1152/ajpcell.00176.2017; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE171, DOI 10.1152/ajpendo.00065.2013; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Hulmi JJ, 2009, J APPL PHYSIOL, V106, P1720, DOI 10.1152/japplphysiol.00087.2009; Jacobs BL, 2014, J MUSCLE RES CELL M, V35, P11, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Kmiec Z, 2005, GERONTOLOGY, V51, P357, DOI 10.1159/000088698; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lessard SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05439-3; MacDonald EM, 2014, DIS MODEL MECH, V7, P471, DOI 10.1242/dmm.014126; Murphy KT, 2011, J APPL PHYSIOL, V110, P1065, DOI 10.1152/japplphysiol.01183.2010; Nissinen TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32695; Nissinen TA., 2021, FASEB J, V35; Nissinen TA, 2018, J CACHEXIA SARCOPENI, V9, P514, DOI 10.1002/jcsm.12310; OGATA ES, 1978, J NUTR, V108, P759, DOI 10.1093/jn/108.5.759; Oikawa SY, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00075; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; REEDS PJ, 1986, BIOSCIENCE REP, V6, P209, DOI 10.1007/BF01115008; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sedliak M, 2018, CHRONOBIOL INT, V35, P450, DOI 10.1080/07420528.2017.1411360; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sepulveda PV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17535; Shavlakadze T, 2013, AM J PHYSIOL-CELL PH, V305, pC26, DOI 10.1152/ajpcell.00027.2013; Shavlakadze T, 2013, J NUTR, V143, P403, DOI 10.3945/jn.112.171967; Silvennoinen M, 2014, J NEUROSCI METH, V235, P51, DOI 10.1016/j.jneumeth.2014.06.027; Song Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05483-x; Toledo M, 2016, INT J CANCER, V138, P2021, DOI 10.1002/ijc.29930; Welle S, 2011, AM J PHYSIOL-ENDOC M, V300, pE993, DOI 10.1152/ajpendo.00509.2010; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	58	4	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21387	10.1096/fj.202002008R	http://dx.doi.org/10.1096/fj.202002008R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559263	hybrid, Green Published			2022-12-28	WOS:000629576700008
J	De Angelis, M; Casciaro, B; Genovese, A; Brancaccio, D; Marcocci, ME; Novellino, E; Carotenuto, A; Palamara, AT; Mangoni, ML; Nencioni, L				De Angelis, M.; Casciaro, B.; Genovese, A.; Brancaccio, D.; Marcocci, M. E.; Novellino, E.; Carotenuto, A.; Palamara, A. T.; Mangoni, M. L.; Nencioni, L.			Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action	FASEB JOURNAL			English	Article						antimicrobial peptides; antiviral agents; influenza; parainfluenza; viral infection	POLY(LACTIDE-CO-GLYCOLIDE) NANOPARTICLES; STRATEGIES; INFECTION; IDENTIFICATION; EFFICACY; PROTEIN; TARGET; CELLS	Treatment of respiratory viral infections remains a global health concern, mainly due to the inefficacy of available drugs. Therefore, the discovery of novel antiviral compounds is needed; in this context, antimicrobial peptides (AMPs) like temporins hold great promise. Here, we discovered that the harmless temporin G (TG) significantly inhibited the early life-cycle phases of influenza virus. The in vitro hemagglutinating test revealed the existence of TG interaction with the viral hemagglutinin (HA) protein. Furthermore, the hemolysis inhibition assay and the molecular docking studies confirmed a TG/HA complex formation at the level of the conserved hydrophobic stem groove of HA. Remarkably, these findings highlight the ability of TG to block the conformational rearrangements of HA2 subunit, which are essential for the viral envelope fusion with intracellular endocytic vesicles, thereby neutralizing the virus entry into the host cell. In comparison, in the case of parainfluenza virus, which penetrates host cells upon a membrane-fusion process, addition of TG to infected cells provoked ~1.2 log reduction of viral titer released in the supernatant. Nevertheless, at the same condition, an immunofluorescent assay showed that the expression of viral hemagglutinin/neuraminidase protein was not significantly reduced. This suggested a peptide-mediated block of some late steps of viral replication and therefore the impairment of the extracellular release of viral particles. Overall, our results are the first demonstration of the ability of an AMP to interfere with the replication of respiratory viruses with a different mechanism of cell entry and will open a new avenue for the development of novel therapeutic approaches against a large variety of respiratory viruses, including the recent SARS-CoV2.	[De Angelis, M.; Genovese, A.; Marcocci, M. E.; Palamara, A. T.; Nencioni, L.] Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Casciaro, B.] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Brancaccio, D.; Novellino, E.; Carotenuto, A.] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Mangoni, M. L.] Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Biochem Sci, Piazzale Aldo Moro 5, Rome, Italy	Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; Sapienza University Rome	Nencioni, L (corresponding author), Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.; Mangoni, ML (corresponding author), Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Biochem Sci, Piazzale Aldo Moro 5, Rome, Italy.	marialuisa.mangoni@uniroma1.it	Nencioni, Lucia/K-5988-2016; Casciaro, Bruno/X-9564-2019; brancaccio, diego/AEP-3471-2022	Nencioni, Lucia/0000-0003-4427-4823; Casciaro, Bruno/0000-0003-1295-1084; brancaccio, diego/0000-0002-2256-5534; Marcocci, Maria Elena/0000-0003-4751-4263; Mangoni, Maria Luisa/0000-0002-5991-5868				Ahmed CM, 2009, J VIROL, V83, P1402, DOI 10.1128/JVI.01138-08; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Berkhout B, 2011, ANTIVIR RES, V92, P7, DOI 10.1016/j.antiviral.2011.04.002; Bizzarri BM, 2019, CATALYSTS, V9, DOI 10.3390/catal9120983; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Branche AR, 2016, SEMIN RESP CRIT CARE, V37, P538, DOI 10.1055/s-0036-1584798; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; Casciaro B., 2020, ANTIBIOTICS BASEL, V9; Casciaro B, 2020, CURR PROTEIN PEPT SC, V21, P429, DOI 10.2174/1389203720666191203101947; Casciaro B, 2020, CURR MED CHEM, V27, P1405, DOI 10.2174/0929867326666190722095408; Casciaro B, 2019, BIOMACROMOLECULES, V20, P1876, DOI 10.1021/acs.biomac.8b01829; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Checconi P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114084; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Davidson S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01946; Di Grazia A, 2014, ANTIMICROB AGENTS CH, V58, P2520, DOI 10.1128/AAC.02801-13; Di Sotto A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5919237; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Episcopio D, 2019, FASEB J, V33, P9516, DOI 10.1096/fj.201900428RR; Grieco P, 2013, BBA-BIOMEMBRANES, V1828, P652, DOI 10.1016/j.bbamem.2012.08.027; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; Hierholzer J.C., 1996, VIROLOGY METHODS MAN, P35, DOI 10.1038/s41541-021-00291-x; Holthausen DJ, 2017, IMMUNITY, V46, P587, DOI 10.1016/j.immuni.2017.03.018; Kadam RU, 2017, SCIENCE, V358, P496, DOI 10.1126/science.aan0516; Krol E, 2014, ACTA BIOCHIM POL, V61, P495; Lakshmaiah Narayana J., 2020, P NATL ACAD SCI USA; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2016, CURR TOP MED CHEM, V16, P54, DOI 10.2174/1568026615666150703121403; Mangoni ML, 2011, J MED CHEM, V54, P1298, DOI 10.1021/jm1012853; Mangoni ML, 2005, J BIOL CHEM, V280, P984, DOI 10.1074/jbc.M410795200; Marcocci ME, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02367-17, 10.1128/aac.02367-17]; Matarrese P, 2011, J CELL PHYSIOL, V226, P3368, DOI 10.1002/jcp.22696; Mifsud EJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104545; Mookherjee N, 2020, NAT REV DRUG DISCOV, V19, P311, DOI 10.1038/s41573-019-0058-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nicol MQ, 2012, J GEN VIROL, V93, P980, DOI 10.1099/vir.0.038679-0; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Saladino R, 2003, MED RES REV, V23, P427, DOI 10.1002/med.10036; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Schroeder C, 2005, EUR BIOPHYS J BIOPHY, V34, P52, DOI 10.1007/s00249-004-0424-1; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Sierra JM, 2017, EXPERT OPIN BIOL TH, V17, P663, DOI 10.1080/14712598.2017.1315402; Skalickova S, 2015, VIRUSES-BASEL, V7, P5428, DOI 10.3390/v7102883; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; van de Wakker SI, 2017, EUR J PHARMACOL, V809, P178, DOI 10.1016/j.ejphar.2017.05.038; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wan YL, 2010, J VIROL METHODS, V169, P359, DOI 10.1016/j.jviromet.2010.08.005; World Health Organization, INFL SEAS; Yu YS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100999; Zhang Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050405; Zhou P, 2018, NUCLEIC ACIDS RES, V46, pW443, DOI 10.1093/nar/gky357	57	14	14	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21358	10.1096/fj.202001885RR	http://dx.doi.org/10.1096/fj.202001885RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33538061	hybrid			2022-12-28	WOS:000647789600099
J	Yang, QL; Mumusoglu, S; Qin, YY; Sun, YP; Hsueh, AJ				Yang, Qingling; Mumusoglu, Sezcan; Qin, Yingying; Sun, Yingpu; Hsueh, Aaron J.			A kaleidoscopic view of ovarian genes associated with premature ovarian insufficiency and senescence	FASEB JOURNAL			English	Review						mitochondrial functions; ovarian senescence; premature ovarian insufficiency	STIMULATING-HORMONE RECEPTOR; GROWTH-DIFFERENTIATION FACTOR-9; HELIX TRANSCRIPTION FACTOR; INCREASED OVULATION RATE; GENOME-WIDE ASSOCIATION; FRAGILE-X PREMUTATION; SYNAPTONEMAL COMPLEX; MICE LACKING; FOLLICLE DEVELOPMENT; ANDROGEN RECEPTOR	Ovarian infertility and subfertility presenting with premature ovarian insufficiency (POI) and diminished ovarian reserve are major issues facing the developed world due to the trend of delaying childbirth. Ovarian senescence and POI represent a continuum of physiological/pathophysiological changes in ovarian follicle functions. Based on advances in whole exome sequencing, evaluation of gene copy variants, together with family-based and genome-wide association studies, we discussed genes responsible for POI and ovarian senescence. We used a gene-centric approach to sort out literature deposited in the Ovarian Kaleidoscope database () by sub-categorizing candidate genes as ligand-receptor signaling, meiosis and DNA repair, transcriptional factors, RNA metabolism, enzymes, and others. We discussed individual gene mutations found in POI patients and verification of gene functions in gene-deleted model organisms. Decreased expression of some of the POI genes could be responsible for ovarian senescence, especially those essential for DNA repair, meiosis and mitochondrial functions. We propose to set up a candidate gene panel for targeted sequencing in POI patients together with studies on mitochondria-associated genes in middle-aged subfertile patients.	[Yang, Qingling; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Reprod & Genet, Ctr Reprod Med, Zhengzhou, Peoples R China; [Yang, Qingling; Mumusoglu, Sezcan; Hsueh, Aaron J.] Stanford Univ, Dept Obstet & Gynecol, Sch Med, Stanford, CA 94305 USA; [Mumusoglu, Sezcan] Hacettepe Univ, Dept Obstet & Gynecol, Sch Med, Ankara, Turkey; [Qin, Yingying] Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, Jinan, Peoples R China	Zhengzhou University; Stanford University; Hacettepe University; Shandong University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Ctr Reprod Med, 40 Daxue Rd, Zhengzhou 450052, Henan, Peoples R China.; Hsueh, AJ (corresponding author), Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	syp2008@vip.sina.com; Aaron.Hsueh@Stanford.edu			National Natural Science Foundation of China (NSFC) [31970800]; National Key Research & Developmental Program of China [2019YFA0110900, 2017YFC1001100]; Key International (Regional) Cooperative Research	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research & Developmental Program of China; Key International (Regional) Cooperative Research	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31970800; National Key Research & Developmental Program of China, Grant/Award Number: 2019YFA0110900 and 2017YFC1001100; Key International (Regional) Cooperative Research	Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; Aboura A, 2009, J CLIN ENDOCR METAB, V94, P4540, DOI 10.1210/jc.2009-0186; Achrekar SK, 2010, J ASSIST REPROD GEN, V27, P317, DOI 10.1007/s10815-010-9404-9; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Al-Agha AE, 2018, J CLIN ENDOCR METAB, V103, P555, DOI 10.1210/jc.2017-01966; AlAsiri S, 2015, J CLIN INVEST, V125, P258, DOI 10.1172/JCI78473; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Bekheirnia MR, 2012, GENE, V499, P209, DOI 10.1016/j.gene.2012.02.034; Bertoldo MJ, 2020, CELL REP, V30, P1670, DOI 10.1016/j.celrep.2020.01.058; Bestetti I, 2019, HUM REPROD, V34, P574, DOI 10.1093/humrep/dey389; Beysen D, 2008, HUM MOL GENET, V17, P2030, DOI 10.1093/hmg/ddn100; Bianchi E, 2010, HUM MOL GENET, V19, P4886, DOI 10.1093/hmg/ddq422; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Bonomi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042423; Bouali N, 2017, FERTIL STERIL, V108, P694, DOI 10.1016/j.fertnstert.2017.07.015; Bouilly J, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0345-0; Bouilly J, 2016, J CLIN ENDOCR METAB, V101, P4541, DOI 10.1210/jc.2016-2152; Bouilly J, 2015, J CLIN ENDOCR METAB, V100, P994, DOI 10.1210/jc.2014-2761; Bouilly J, 2011, HUM MUTAT, V32, P1108, DOI 10.1002/humu.21543; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Bromberger JT, 1997, AM J EPIDEMIOL, V145, P124; Butts S, 2009, J CLIN ENDOCR METAB, V94, P4835, DOI 10.1210/jc.2008-2269; Caburet S, 2014, NEW ENGL J MED, V370, P943, DOI 10.1056/NEJMoa1309635; Cahoon CK, 2016, NAT STRUCT MOL BIOL, V23, P369, DOI 10.1038/nsmb.3208; Camats N, 2012, J CLIN ENDOCR METAB, V97, pE1294, DOI 10.1210/jc.2011-3169; Candelaria NR, 2019, ENDOCRINOLOGY, V160, P1377, DOI 10.1210/en.2018-00731; Carlosama C, 2017, HUM MOL GENET, V26, P3161, DOI 10.1093/hmg/ddx199; Carter NJ, 2019, GEN COMP ENDOCR, V277, P130, DOI 10.1016/j.ygcen.2019.04.003; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Patino LC, 2017, HUM REPROD, V32, P1512, DOI 10.1093/humrep/dex089; Cekic S, 2017, J CLIN IMMUNOL, V37, P524, DOI 10.1007/s10875-017-0412-8; Cerdo T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030635; Chatterjee S, 2009, HUM REPROD, V24, P3230, DOI 10.1093/humrep/dep296; Chen BL, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0413-0; Cheng Y, 2015, FASEB J, V29, P2423, DOI 10.1096/fj.14-267856; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; Chisholm CA, 2001, AM J MED GENET, V102, P136, DOI 10.1002/ajmg.1437; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Choi Y, 2008, BIOL REPROD, V79, P1176, DOI 10.1095/biolreprod.108.071217; Chrzanowska KH, 2010, J CLIN ENDOCR METAB, V95, P3133, DOI 10.1210/jc.2009-2628; Coppieters F, 2016, AM J HUM GENET, V99, P470, DOI 10.1016/j.ajhg.2016.06.017; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; de Vries L, 2014, J CLIN ENDOCR METAB, V99, pE2129, DOI 10.1210/jc.2014-1268; Demirhan O, 2005, J MED GENET, V42, P314, DOI 10.1136/jmg.2004.023564; Desai S, 2017, J CLIN ENDOCR METAB, V102, P576, DOI 10.1210/jc.2016-2565; Desai SS, 2013, REPRODUCTION, V146, pR235, DOI 10.1530/REP-13-0351; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dioguardi CC, 2016, MOL HUM REPROD, V22, P384, DOI 10.1093/molehr/gaw023; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dixit H, 2005, MENOPAUSE, V12, P749, DOI 10.1097/01.gme.0000184424.96437.7a; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dorsman JC, 2007, CELL ONCOL, V29, P211; Dranow DB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006323; Dubois EL, 2019, NUCLEIC ACIDS RES, V47, P7532, DOI 10.1093/nar/gkz514; Duncan FE, 2012, AGING CELL, V11, P1121, DOI 10.1111/j.1474-9726.2012.00866.x; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Faridi R, 2017, CLIN GENET, V91, P328, DOI 10.1111/cge.12867; Fauchereau F, 2016, CLIN GENET, V89, P603, DOI 10.1111/cge.12736; Fouquet B, 2017, ELIFE, V6, DOI 10.7554/eLife.30490; Fradet-Turcotte A, 2016, ENDOCR-RELAT CANCER, V23, pT1, DOI 10.1530/ERC-16-0297; Fraune J, 2014, J GENET GENOMICS, V41, P107, DOI 10.1016/j.jgg.2014.01.009; Fraune J, 2013, GENETICS, V195, P781, DOI 10.1534/genetics.113.156679; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Fu LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164671; Fukuda T, 2014, EMBO J, V33, P1243, DOI 10.1002/embj.201387329; Gallardo TD, 2008, HUM REPROD, V23, P216, DOI 10.1093/humrep/dem255; Gallardo TD, 2007, GENETICS, V177, P179, DOI 10.1534/genetics.107.074823; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gao F, 2014, HUM MOL GENET, V23, P333, DOI 10.1093/hmg/ddt423; Ghosh S, 2010, HUM GENET, V127, P403, DOI 10.1007/s00439-009-0785-8; Gispert S, 2013, HUM MOL GENET, V22, P4871, DOI 10.1093/hmg/ddt338; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gomathinayagam Rohini, 2014, Genes Cancer, V5, P84; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Guo T, 2017, HUM MOL GENET, V26, P1452, DOI 10.1093/hmg/ddx044; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; Haller-Kikkatalo K, 2015, HUM REPROD, V30, P1229, DOI 10.1093/humrep/dev021; Hammond ER, 2016, MOL HUM REPROD, V22, P261, DOI 10.1093/molehr/gaw003; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Harrison SM, 2013, AM J MED GENET A, V161, P2487, DOI 10.1002/ajmg.a.36084; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heddar A, 2020, J CLIN ENDOCR METAB, V105, P1973, DOI 10.1210/clinem/dgaa155; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Holt JE, 2009, MOL HUM REPROD, V15, P139, DOI 10.1093/molehr/gap007; Hsueh AJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099127; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Hu YC, 2004, P NATL ACAD SCI USA, V101, P11209, DOI 10.1073/pnas.0404372101; Hyon C, 2016, J CLIN ENDOCR METAB, V101, P2099, DOI 10.1210/jc.2016-1291; Inagaki A, 2016, CHROMOSOMA, V125, P151, DOI 10.1007/s00412-015-0535-8; Ismat A, 2013, DEVELOPMENT, V140, P1981, DOI 10.1242/dev.087908; Jaillard S, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0272-5; Fonseca DJ, 2015, FERTIL STERIL, V104, P154, DOI 10.1016/j.fertnstert.2015.04.016; Jiao X, 2018, TRENDS ENDOCRIN MET, V29, P795, DOI 10.1016/j.tem.2018.07.002; Jiao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074759; Jiao ZX, 2014, J ASSIST REPROD GEN, V31, P731, DOI 10.1007/s10815-014-0210-7; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; Jolly A, 2019, J CLIN ENDOCR METAB, V104, P3049, DOI 10.1210/jc.2019-00248; Karimov CB, 2011, HUM REPROD, V26, P2077, DOI 10.1093/humrep/der168; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Kelly KO, 2000, GENETICS, V156, P617; Kneitz B, 2000, GENE DEV, V14, P1085; Kossack ME., 2018, WNT4A PROMOTES FEMAL WNT4A PROMOTES FEMAL; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Laven JSE, 2016, MATURITAS, V92, P15, DOI 10.1016/j.maturitas.2016.07.006; Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019; Lee S, 2009, ENDOCRINOLOGY, V150, P3855, DOI 10.1210/en.2008-1774; Leo CP, 2000, ENDOCRINOLOGY, V141, P3052, DOI 10.1210/en.141.9.3052; Li JZ, 2020, MOL CELL ENDOCRINOL, V507, DOI 10.1016/j.mce.2020.110778; Li L, 2017, HUM REPROD, V32, P248, DOI 10.1093/humrep/dew271; Li L, 2012, MATURITAS, V73, P354, DOI 10.1016/j.maturitas.2012.09.008; Lim J, 2011, BIOL REPROD, V84, P775, DOI 10.1095/biolreprod.110.088583; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Liu HL, 2019, MOL CELL ENDOCRINOL, V492, DOI 10.1016/j.mce.2019.05.005; Liu L, 2004, P NATL ACAD SCI USA, V101, P6496, DOI 10.1073/pnas.0400755101; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Lorenz A, 2012, SCIENCE, V336, P1585, DOI 10.1126/science.1220111; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Lu B, 2008, BIOL REPROD, V78, P601, DOI 10.1095/biolreprod.107.065987; Lu CL, 2012, HUM MOL GENET, V21, P5039, DOI 10.1093/hmg/dds348; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; LUOTO R, 1994, AM J EPIDEMIOL, V139, P64, DOI 10.1093/oxfordjournals.aje.a116936; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Ma YP, 2017, ENDOCRINOLOGY, V158, P98, DOI 10.1210/en.2016-1608; Maclaren N, 2001, J SOC GYNECOL INVEST, V8, pS52, DOI 10.1016/S1071-5576(00)00109-X; Mandon-Pepin B, 2008, EUR J ENDOCRINOL, V158, P107, DOI 10.1530/EJE-07-0400; Mansouri MR, 2008, HUM MOL GENET, V17, P3776, DOI 10.1093/hmg/ddn274; Marangos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9706; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Marozzi A, 2000, HUM REPROD, V15, P197, DOI 10.1093/humrep/15.1.197; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; McCallum ML, 2016, ENDOCRINOLOGY, V157, P3309, DOI 10.1210/en.2016-1081; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McGuire MM, 2011, FERTIL STERIL, V95, P1595, DOI 10.1016/j.fertnstert.2010.12.052; Meduri G, 2003, J CLIN ENDOCR METAB, V88, P3491, DOI 10.1210/jc.2003-030217; Miao YL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1720-0; Moriwaki M, 2017, J ENDOCR SOC, V1, P162, DOI 10.1210/js.2016-1014; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Myers M, 2011, BIOL REPROD, V85, P1175, DOI 10.1095/biolreprod.111.091728; Nabti I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15346; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Newman W.G., 2018, GENEREVIEWS; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Oldak M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1129-4; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Panda B, 2011, GYNECOL ENDOCRINOL, V27, P572, DOI 10.3109/09513590.2010.507282; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Passe CMM, 2008, BIOL REPROD, V79, P598, DOI 10.1095/biolreprod.108.068304; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Perheentupa A, 2009, MOL CELL ENDOCRINOL, V299, P2, DOI 10.1016/j.mce.2008.11.004; Perry JRB, 2014, HUM MOL GENET, V23, P2490, DOI 10.1093/hmg/ddt620; Perry JRB, 2013, HUM MOL GENET, V22, P1465, DOI 10.1093/hmg/dds551; Peters AE, 2020, ANTIOXID REDOX SIGN, V32, P550, DOI 10.1089/ars.2019.7986; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Philibert P, 2008, J CLIN ENDOCR METAB, V93, P895, DOI 10.1210/jc.2007-2023; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Pyun JA, 2013, HUM REPROD, V28, P3146, DOI 10.1093/humrep/det365; Pyun JA, 2014, MENOPAUSE, V21, P530, DOI 10.1097/GME.0b013e3182a4323e; Qian Y, 2016, CURR MOL MED, V16, P243, DOI 10.2174/1566524016666160225151647; Qin MM, 2018, ENDOCRINOLOGY, V159, P3699, DOI 10.1210/en.2018-00648; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Qin YY, 2015, HUM REPROD UPDATE, V21, P787, DOI 10.1093/humupd/dmv036; Qin YY, 2014, FERTIL STERIL, V101, P1104, DOI 10.1016/j.fertnstert.2014.01.001; Qin YY, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-5; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Rattani A, 2013, ELIFE, V2, DOI 10.7554/eLife.01133; Renault L, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz226; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Sala C, 1997, GENOMICS, V40, P123, DOI 10.1006/geno.1996.4542; Santos MG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/787465; Santos M, 2019, J ASSIST REPROD GEN, V36, P2163, DOI 10.1007/s10815-019-01548-0; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schramm S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002088; Schuh-Huerta SM, 2012, HUM GENET, V131, P1709, DOI 10.1007/s00439-012-1184-0; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Shive HR, 2010, P NATL ACAD SCI USA, V107, P19350, DOI 10.1073/pnas.1011630107; Simpson CM, 2014, J CLIN ENDOCR METAB, V99, pE615, DOI 10.1210/jc.2013-3949; Smirin-Yosef P, 2017, J CLIN ENDOCR METAB, V102, P681, DOI 10.1210/jc.2016-2714; Smith KR, 2013, CURR OPIN OBSTET GYN, V25, P207, DOI 10.1097/GCO.0b013e32835f1731; Sohani ZN, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0211-2; Stabej PL, 2016, EUR J HUM GENET, V24, P135, DOI 10.1038/ejhg.2015.107; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Sun X, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002543; Suntharalingham JP, 2015, BEST PRACT RES CL EN, V29, P607, DOI 10.1016/j.beem.2015.07.004; Takabayashi S, 2009, EXP BIOL MED, V234, P994, DOI 10.3181/0808-RM-244; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Ting AY, 2017, BIOL REPROD, V96, DOI 10.1093/biolre/iox034; Tiotiu D, 2010, HUM REPROD, V25, P1581, DOI 10.1093/humrep/deq073; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; Tosh D, 2015, MENOPAUSE, V22, P520, DOI [10.1097/gme.0000000000000340, 10.1097/GME.0000000000000340]; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tsuiko O, 2016, HUM REPROD, V31, P1913, DOI 10.1093/humrep/dew142; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Venkatesh S, 2010, ARCH GYNECOL OBSTET, V282, P313, DOI 10.1007/s00404-010-1444-y; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Wan L, 2013, P NATL ACAD SCI USA, V110, P10646, DOI 10.1073/pnas.1220921110; Wang BB, 2017, HUM REPROD, V32, P2138, DOI 10.1093/humrep/dex263; Wang BB, 2010, REPROD BIOMED ONLINE, V20, P499, DOI 10.1016/j.rbmo.2010.01.008; Wang HD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13983; Wang LL, 2001, AM J MED GENET, V102, P11, DOI 10.1002/1096-8628(20010722)102:1<11::AID-AJMG1413>3.0.CO;2-A; Wang S, 2020, CELL, V180, P585, DOI 10.1016/j.cell.2020.01.009; Watkins WJ, 2006, FERTIL STERIL, V86, P1518, DOI 10.1016/j.fertnstert.2006.03.054; Webber L, 2016, HUM REPROD, V31, P926, DOI 10.1093/humrep/dew027; Weinberg-Shukron A, 2018, NEW ENGL J MED, V379, P1042, DOI 10.1056/NEJMoa1800024; Welt C., 2010, OVARIAN FAILURE DUE, V18; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Wood-Trageser MA, 2014, AM J HUM GENET, V95, P754, DOI 10.1016/j.ajhg.2014.11.002; Wu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.368; Wu XJ, 2019, GEN COMP ENDOCR, V282, DOI 10.1016/j.ygcen.2019.113218; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Xu XF, 2017, HUM REPROD, V32, P201, DOI 10.1093/humrep/dew283; Yamada-Fukunaga T, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-108; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yang F, 2015, EMBO MOL MED, V7, P1198, DOI 10.15252/emmm.201404967; Yang QL, 2020, FREE RADICAL BIO MED, V156, P1, DOI 10.1016/j.freeradbiomed.2020.05.003; Yang X, 2019, HUM GENET, V138, P1227, DOI 10.1007/s00439-019-02059-9; Yang YJ, 2020, HUM MUTAT, V41, P1033, DOI 10.1002/humu.23997; Yatsenko AN, 2015, NEW ENGL J MED, V372, P2097, DOI 10.1056/NEJMoa1406192; Yilmaz NK, 2016, J TURK-GER GYNECOL A, V17, P77, DOI 10.5152/jtgga.2016.16035; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zangen D, 2011, AM J HUM GENET, V89, P572, DOI 10.1016/j.ajhg.2011.09.006; Zhao H, 2008, AM J HUM GENET, V82, P1342, DOI 10.1016/j.ajhg.2008.04.018; Zhao SD, 2015, FERTIL STERIL, V103, P548, DOI 10.1016/j.fertnstert.2014.11.011; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019	246	5	5	8	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21753	10.1096/fj.202100756R	http://dx.doi.org/10.1096/fj.202100756R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34233068				2022-12-28	WOS:000678975300005
J	Pang, NN; Alimu, XRGL; Chen, R; Muhashi, M; Ma, JJ; Chen, G; Zhao, F; Wang, L; Qu, JH; Ding, JB				Pang, Nannan; Alimu, Xierenguli; Chen, Rong; Muhashi, Maliya; Ma, Jiajia; Chen, Gang; Zhao, Fang; Wang, Lei; Qu, Jianhua; Ding, Jianbing			Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia	FASEB JOURNAL			English	Article						chronic lymphocytic leukemia (CLL); CD4(+) T cell subset; Tim-3; Galectin-9 signal pathway	REGULATORY T-CELLS; TIM-3; EXPRESSION; PLASTICITY; RESISTANCE; THERAPY; BALANCE	Tim-3 is a negative immunoregulator in anti-tumor response, but its mechanism in chronic lymphocytic leukemia (CLL) is not yet clear. The aim of this study was to understand the role of Galectin-9/Tim-3 signaling pathway in the regulation of CD4(+) T cell subsets in CLL patients. Flow cytometry results showed that the number of Treg cells obviously increased, and there was a significant Treg/Th17 imbalance in CLL patients. In addition, Tim-3 overexpressed on the surface of Th1 and Treg cells in CLL patients. The levels of Galectin-9 and IL-10 were significantly elevated in patients of CLL, especially in stages of Binet B, and C. However, IFN-gamma decreased. Moreover, Galectin-9 in CLL patients was positively correlated with the number of Tim-3(+) Treg cells and the level of IL-10. Interestingly, when the Tim-3/Galectin-9 pathway was blocked in vitro, the level of IL-10 in the culture supernatant of CD4(+) T was significantly reduced, while the levels of IFN-gamma and TNF-alpha were increased. After co-culture with activated Th1 cells, the apoptosis of CLL cells was significantly increased, and this effect was reversed after treatment with Tim-3(+) Tregs. In summary, Galectin-9/Tim-3 are elevated in CLL and associated with disease progression. By the negative regulation of CD4(+) T cells, activated Galectin-9/Tim-3 suppresses Th1 effector function and also promotes Treg to be involved in immune escape of CLL. This pathway might become the potential target of immunotherapy in CLL patients.	[Pang, Nannan; Alimu, Xierenguli; Chen, Rong; Muhashi, Maliya; Ma, Jiajia; Chen, Gang; Zhao, Fang; Wang, Lei; Qu, Jianhua] Xinjiang Med Univ, Affiliated Hosp 1, Hematol Inst Xinjiang Uygur Autonomous Reg, Ctr Hematol, 1 Liyu Shan Rd, Urumqi 830054, Xinjiang, Peoples R China; [Pang, Nannan] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Pathogenesis Prevent & Treatment Hi, Urumqi, Peoples R China; [Ding, Jianbing] Xinjiang Med Univ, Basic Med Coll, 393 Xinyi Rd, Urumqi 830054, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Qu, JH (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Hematol Inst Xinjiang Uygur Autonomous Reg, Ctr Hematol, 1 Liyu Shan Rd, Urumqi 830054, Xinjiang, Peoples R China.; Ding, JB (corresponding author), Xinjiang Med Univ, Basic Med Coll, 393 Xinyi Rd, Urumqi 830054, Xinjiang, Peoples R China.	jhuaqu@163.com; 1601379937@qq.com		Ding, Jianbing/0000-0001-5506-7665	National Natural Science Foundation of China [81860033, 81960039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81860033 and 81960039	Allahmoradi E, 2017, IRAN J IMMUNOL, V14, P257, DOI IJIv14i4A1; Asadzadeh Z, 2017, CELL IMMUNOL, V322, P15, DOI 10.1016/j.cellimm.2017.10.015; Audino AN, 2019, RESIST TARGET ANTI-C, V21, P155, DOI 10.1007/978-3-030-24424-8_7; Aue G, 2018, J IMMUNOL, V201, P1967, DOI 10.4049/jimmunol.1800570; Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; De Matteis S, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1545-0; Duffield AS, 2017, BLOOD ADV, V1, P1324, DOI 10.1182/bloodadvances.2017007260; Gao JW, 2018, BIOCHEM BIOPH RES CO, V498, P409, DOI 10.1016/j.bbrc.2018.02.114; Giannoni P, 2017, CURR MOL MED, V17, P24, DOI 10.2174/1566524017666170220095838; Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020; Granier C, 2017, CANCER RES, V77, P1075, DOI 10.1158/0008-5472.CAN-16-0274; Ha D, 2019, P NATL ACAD SCI USA, V116, P609, DOI 10.1073/pnas.1812186116; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Hematology Committee of Chinese Medical Association, 2018, Zhonghua Xue Ye Xue Za Zhi, V39, P353, DOI 10.3760/cma.j.issn.0253-2727.2018.05.001; Idler I, 2010, BRIT J HAEMATOL, V148, P948, DOI 10.1111/j.1365-2141.2009.08014.x; Karmali R, 2013, J LEUKOCYTE BIOL, V93, P161, DOI 10.1189/jlb.0612301; Knochelmann HM, 2018, CELL MOL IMMUNOL, V15, P458, DOI 10.1038/s41423-018-0004-4; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Lad DP, 2015, LEUKEMIA LYMPHOMA, V56, P2424, DOI 10.3109/10428194.2014.986479; Liu FF, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0667-4; Liu Y, 2015, AM J TRANSPLANT, V15, P954, DOI 10.1111/ajt.13067; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mulvey JJ, 2016, AM J DERMATOPATH, V38, P492, DOI 10.1097/DAD.0000000000000441; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Pang NN, 2016, INT IMMUNOPHARMACOL, V40, P57, DOI 10.1016/j.intimp.2016.07.008; Qorraj M, 2017, LEUKEMIA, V31, P470, DOI 10.1038/leu.2016.214; Sheng CC, 2019, NEOPLASMA, V66, P167, DOI 10.4149/neo_2018_180610N385; Shi HB, 2020, ADV EXP MED BIOL, V1248, P83, DOI 10.1007/978-981-15-3266-5_5; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; Taghiloo Saeid, 2017, Asian Pac J Cancer Prev, V18, P2269; Ueno A, 2018, J AUTOIMMUN, V87, P38, DOI 10.1016/j.jaut.2017.12.004; Wang JY, 2019, SCAND J IMMUNOL, V89, DOI 10.1111/sji.12755; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Yousefi M, 2015, FUTURE ONCOL, V11, P1567, DOI 10.2217/fon.14.298; Yu JT, 2019, ONCOL LETT, V17, P1461, DOI 10.3892/ol.2018.9743; Zhao MG, 2018, CLIN EXP PHARMACOL P, V45, P1206, DOI 10.1111/1440-1681.13007	38	6	7	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21556	10.1096/fj.202100013R	http://dx.doi.org/10.1096/fj.202100013R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34137463	hybrid			2022-12-28	WOS:000667814100028
J	Yoshihisa, Y; Rehman, MU; Andoh, T; Tabuchi, Y; Makino, T; Shimizu, T				Yoshihisa, Yoko; Rehman, Mati Ur; Andoh, Tsugunobu; Tabuchi, Yoshiaki; Makino, Teruhiko; Shimizu, Tadamichi			Overexpression of D-dopachrome tautomerase increases ultraviolet B irradiation-induced skin tumorigenesis in mice	FASEB JOURNAL			English	Article						apoptosis; cancer; carcinogenesis; D-dopachrome tautomerase; macrophage migration inhibitory factor; p53; skin; ultraviolet	MIGRATION INHIBITORY FACTOR; FACTOR MIF; EXPRESSION; HOMOLOG; CELLS; GENE; CYTOKINE; DAMAGE; LIGHT; IL-6	Ultraviolet irradiation (UV) exposure is the leading factor underlying the development of skin malignancies. D-dopachrome tautomerase (D-DT), a functional homolog of macrophage migration inhibitory factor (MIF), has functional similarities to MIF. However, its role, unlike the role of MIF in photocarcinogenesis, is unknown. We therefore explored the role of D-DT in photocarcinogenesis by developing D-DT transgenic (D-DT Tg) mice and provided a research model for future studies targeting D-DT. Chronic UVB exposure accelerated tumor development in D-DT Tg mice compared with wild-type (WT) mice, with a higher incidence of tumors observed in D-DT Tg mice than in WT mice. In D-DT Tg irradiated mouse keratinocytes, the p53, PUMA, and Bax expression was lower than that in WT mice. These results indicate that D-DT Tg overexpression confers prevention against UVB-induced apoptosis in keratinocytes. Taken together, these findings support D-DT as a functionally important cytokine in photocarcinogenesis and potential therapeutic target for the prevention of photocarcinogenesis.	[Yoshihisa, Yoko; Makino, Teruhiko; Shimizu, Tadamichi] Univ Toyama, Acad Assembly, Fac Med, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan; [Rehman, Mati Ur] Univ Toyama, Acad Assembly, Fac Med, Dept Radiol, Toyama, Japan; [Andoh, Tsugunobu] Kinjo Gakuin Univ, Coll Pharm, Dept Pharmacol & Pathophysiol, Nagoya, Aichi, Japan; [Tabuchi, Yoshiaki] Univ Toyama, Acad Assembly, Fac Med, Life Sci Res Ctr,Div Mol Genet Res, Toyama, Japan	University of Toyama; University of Toyama; University of Toyama	Shimizu, T (corresponding author), Univ Toyama, Acad Assembly, Fac Med, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan.	shimizut@med.u-toyama.ac.jp		Shimizu, Tadamichi/0000-0002-3231-0279; Makino, Teruhiko/0000-0002-0536-1679; Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [20K08686]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science, Grant/Award Number: 20K08686	Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; ANSEL JC, 1988, J IMMUNOL, V140, P2274; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Cadet J, 2018, PHOTOCH PHOTOBIO SCI, V17, P1816, DOI 10.1039/c7pp00395a; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cavalli E, 2020, MOLECULES, V25, DOI 10.3390/molecules25051194; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Faurschou A, 2010, DAN MED BULL, V57; Gunther S, 2019, DRUG DISCOV TODAY, V24, P428, DOI 10.1016/j.drudis.2018.11.003; Guo DW, 2016, INT J CANCER, V139, P2056, DOI 10.1002/ijc.30278; Harris J, 2019, TRENDS IMMUNOL, V40, P447, DOI 10.1016/j.it.2019.03.002; Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007; Honda A, 2009, CARCINOGENESIS, V30, P1597, DOI 10.1093/carcin/bgp160; Ishimoto K, 2012, CYTOKINE, V60, P772, DOI 10.1016/j.cyto.2012.07.037; Kang I, 2019, NAT REV RHEUMATOL, V15, P427, DOI 10.1038/s41584-019-0238-2; Kim BS, 2016, BURNS, V42, P1265, DOI 10.1016/j.burns.2016.02.005; KIRNBAUER R, 1991, J INVEST DERMATOL, V96, P484, DOI 10.1111/1523-1747.ep12470181; Kobold S, 2014, ONCOTARGET, V5, P103, DOI 10.18632/oncotarget.1560; KUPPER TS, 1987, J CLIN INVEST, V80, P430, DOI 10.1172/JCI113090; Lan CCE, 2019, EXP DERMATOL, V28, P23, DOI 10.1111/exd.13818; Lang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04581-2; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Pohl J, 2017, J CRIT CARE, V40, P52, DOI 10.1016/j.jcrc.2017.03.012; PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rajasekaran D, 2014, FASEB J, V28, P4961, DOI 10.1096/fj.14-256636; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimizu T, 1999, J INVEST DERMATOL, V112, P210, DOI 10.1046/j.1523-1747.1999.00486.x; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Shimizu T, 1999, J ALLERGY CLIN IMMUN, V104, P659, DOI 10.1016/S0091-6749(99)70339-8; Shimizu T, 1997, BIOCHEM BIOPH RES CO, V240, P173, DOI 10.1006/bbrc.1997.7633; Shimizu T, 1996, FEBS LETT, V381, P199, DOI 10.1016/0014-5793(96)00120-2; Sonesson B, 2003, EXP DERMATOL, V12, P278, DOI 10.1034/j.1600-0625.2003.120307.x; Stenback F, 1998, EUR J CANCER, V34, P1415, DOI 10.1016/S0959-8049(98)00062-8; Stoppe C, 2015, ANTIOXID REDOX SIGN, V23, P865, DOI 10.1089/ars.2014.6243; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101	43	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21671	10.1096/fj.202002631RRR	http://dx.doi.org/10.1096/fj.202002631RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105803				2022-12-28	WOS:000667814100026
J	Chu, XY; Li, J; Qiao, CP; Wang, J; Wang, YQ; Jiang, XC; You, HB; Xiao, X; Wang, B				Chu, Xiangyu; Li, Juan; Qiao, Chunping; Wang, Jing; Wang, Yiqing; Jiang, Xian-Cheng; You, Hongbo; Xiao, Xiao; Wang, Bing			Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; functional outcomes; gene therapy; human mini&#8208; dystrophin gene (&#8710; hDys3849); transgenic mdx mice	DUCHENNE MUSCULAR-DYSTROPHY; GENE-THERAPY; LIFE-SPAN; MINIDYSTROPHIN; MOUSE; EXPRESSION; VECTOR; NNOS; UTROPHIN; SKELETAL	Duchenne muscular dystrophy (DMD) is a lethal genetic muscle disorder caused by recessive mutations in dystrophin gene, affecting 1/3000 males. Gene therapy has been proven to ameliorate dystrophic pathology. To investigate therapeutic benefits from long-term effect of human mini-dystrophin and functional outcomes, transgenic mdx mice (Tg-mdx) containing a single copy of human mini-dystrophin ( increment hDys3849) gene, five rods (Rods1-2, Rods22-24), and two hinges (H1 and H4) driven by a truncated creatine-kinase promoter (dMCK) in a recombinant adeno-associated viral vector (rAAV) backbone, were generated and used to determine gene expression and improvement of muscle function. Human mini-dystrophin gene expression was found in a majority of the skeletal muscles, but no expression in cardiac muscle. Dystrophin-associated glycoproteins (DAGs) such as sarcoglycans and nNOS were restored at the sarcolemma and coincided with human mini-dystrophin gene expression at the ages of 6, 10, and 20 months; Morphology of dystrophic muscle expressing the human mini-dystrophin gene was improved and central nuclei were reduced. Myofiber membrane integrity was improved by Evans blue dye test. Improvement in treadmill running and grip force was observed in transgenic mice at 6 months. Tetanic force and specific force of tibialis anterior (TA) muscle were significantly increased at the ages of 6, 10, and 20 months. Pseudohypertrophy was not found in TA muscle at 10 and 20 months when compared with wild-type C57 (WT) group. This study demonstrated that the long-term effects of human mini-dystrophin effectively ameliorated pathology and improved the functions of the dystrophic muscles in the transgenic DMD mouse model.	[Chu, Xiangyu; Wang, Jing; Wang, Yiqing; Wang, Bing] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15219 USA; [Li, Juan; Qiao, Chunping; Xiao, Xiao] Univ N Carolina, Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27515 USA; [Jiang, Xian-Cheng] SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Brooklyn, NY USA; [Chu, Xiangyu; You, Hongbo] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Orthoped, Wuhan, Peoples R China; [Wang, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurol, Wuhan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, B (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15219 USA.; Xiao, X (corresponding author), Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA.	xxiao@email.unc.edu; bingwang@pitt.edu	xiao, xiang/GWU-6035-2022; Wu, Jing/GZK-5063-2022; wang, jing/GVT-8700-2022; Xiao, Xiao/GQP-7793-2022; Wang, Jin/GYA-2019-2022		Pittsburgh Foundation (TPF) [AD2014-73915-12, AD2017-91232]	Pittsburgh Foundation (TPF)	Pittsburgh Foundation (TPF), Grant/Award Number: AD2014-73915-12 and AD2017-91232	Adams ME, 2008, J CELL SCI, V121, P48, DOI 10.1242/jcs.020701; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Amalfitano A, 1996, MUSCLE NERVE, V19, P1549, DOI 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A; Arora H, 2019, NEUROL INDIA, V67, P717, DOI 10.4103/0028-3886.263203; Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237; Cavazza M, 2016, EUR J HEALTH ECON, V17, P19, DOI 10.1007/s10198-016-0782-5; Choi YA, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2661-6; CROS D, 1989, J NEUROL, V236, P43, DOI 10.1007/BF00314217; Davies KE, 2019, MOL THER, V27, P486, DOI 10.1016/j.ymthe.2019.01.019; Delerue F, 2017, JOVE-J VIS EXP, DOI 10.3791/55765; Demayo Janet L, 2012, Curr Protoc Mouse Biol, V2, P245; Duan DS, 2018, HUM GENE THER, V29, P733, DOI 10.1089/hum.2018.012; Duan DS, 2018, MOL THER, V26, P2337, DOI 10.1016/j.ymthe.2018.07.011; Gaedigk R, 2006, NEUROMUSCULAR DISORD, V16, P192, DOI 10.1016/j.nmd.2005.12.007; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Hakim CH, 2017, MOL THER-METH CLIN D, V6, P216, DOI 10.1016/j.omtm.2017.06.006; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Isaac C, 2013, J ORTHOP RES, V31, P343, DOI 10.1002/jor.22236; Judge LM, 2011, HUM MOL GENET, V20, P4978, DOI 10.1093/hmg/ddr433; Kodippili K, 2018, J PHYSIOL-LONDON, V596, P5199, DOI 10.1113/JP275672; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; Li HS, 2020, J BONE MINER RES, V35, P738, DOI 10.1002/jbmr.3932; Li S, 2006, HUM MOL GENET, V15, P1610, DOI 10.1093/hmg/ddl082; Liu CY, 2013, METHODS MOL BIOL, V1027, P217, DOI 10.1007/978-1-60327-369-5_10; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; McDonald AA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12391; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; Ramos JN, 2019, MOL THER, V27, P623, DOI 10.1016/j.ymthe.2019.01.002; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shimizu-Motohashi Y, 2019, J PERS MED, V9, DOI 10.3390/jpm9010001; Van Ruiten HJA, 2016, EUR J PAEDIATR NEURO, V20, P904, DOI 10.1016/j.ejpn.2016.07.020; Verhaart IEC, 2019, NAT REV NEUROL, V15, P373, DOI 10.1038/s41582-019-0203-3; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; Wang B, 2008, GENE THER, V15, P1099, DOI 10.1038/gt.2008.70; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Wang B, 2009, J ORTHOP RES, V27, P421, DOI 10.1002/jor.20781; Watchko J, 2002, HUM GENE THER, V13, P1451, DOI 10.1089/10430340260185085; Wittlieb-Weber CA, 2020, PEDIATR CARDIOL, V41, P764, DOI 10.1007/s00246-020-02309-y; Yang Q, 2012, GENE THER, V19, P1196, DOI 10.1038/gt.2011.207; Yiu EM, 2015, J PAEDIATR CHILD H, V51, P759, DOI 10.1111/jpc.12868; Yu CY, 2009, GENE THER, V16, P953, DOI 10.1038/gt.2009.59; Zhang YD, 2013, HUM MOL GENET, V22, P3720, DOI 10.1093/hmg/ddt224; Zhao JL, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0101-6	48	0	0	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21628	10.1096/fj.202100057RR	http://dx.doi.org/10.1096/fj.202100057RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33982338				2022-12-28	WOS:000655695900041
J	Jenkins, BR; Blaseg, NA; Grifka-Walk, HM; Deuling, B; Swain, SD; Campbell, EL; Walk, ST; Kominsky, DJ				Jenkins, Brittany R.; Blaseg, Nathan A.; Grifka-Walk, Heather M.; Deuling, Benjamin; Swain, Steve D.; Campbell, Eric L.; Walk, Seth T.; Kominsky, Douglas J.			Loss of interleukin-10 receptor disrupts intestinal epithelial cell proliferation and skews differentiation towards the goblet cell fate	FASEB JOURNAL			English	Article						absorptive cells; differentiation; goblet cells; interleukin&#8208; 10 receptor; intestines	INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; IL-10 RECEPTOR; MOUSE MODEL; CANCER; PROGENITORS; HOMEOSTASIS; POLYPS; MUCOSA; TARGET	Intestinal epithelial cells (IEC) are crucial for maintaining proper digestion and overall homeostasis of the gut mucosa. IEC proliferation and differentiation are tightly regulated by well described pathways, however, relatively little is known about how cytokines shape these processes. Given that the anti-inflammatory cytokine interleukin (IL)-10 promotes intestinal barrier function, and insufficient IL-10 signaling increases susceptibility to intestinal diseases like inflammatory bowel disease, we hypothesized that IL-10 signaling modulates processes underlying IEC proliferation and differentiation. This was tested using in vivo and in vitro IEC-specific IL-10 receptor 1 (IL-10R1) depletion under homeostatic conditions. Our findings revealed that loss of IL-10R1 drove lineage commitment toward a dominant goblet cell phenotype while decreasing absorptive cell-related features. Diminished IL-10 signaling also significantly elevated IEC proliferation with relatively minor changes to apoptosis. Characterization of signaling pathways upstream of proliferation demonstrated a significant reduction in the Wnt inhibitor, DKK1, increased nuclear localization of beta-catenin, and increased transcripts of the proliferation marker, OLFM4, with IL-10R1 depletion. Phosphorylated STAT3 was nearly completely absent in IL-10R1 knockdown cells and may provide a mechanistic link between our observations and the regulation of these cellular processes. Our results demonstrate a novel role for IL-10 signaling in intestinal mucosal homeostasis by regulating proper balance of proliferation and IEC lineage fate.	[Jenkins, Brittany R.; Grifka-Walk, Heather M.; Deuling, Benjamin; Swain, Steve D.; Walk, Seth T.; Kominsky, Douglas J.] Montana State Univ, Dept Microbiol & Immunol, 109 Lewis Hall, Bozeman, MT 59717 USA; [Blaseg, Nathan A.] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Campbell, Eric L.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland	Montana State University System; Montana State University Bozeman; University of South Dakota; Queens University Belfast	Kominsky, DJ (corresponding author), Montana State Univ, Dept Microbiol & Immunol, 109 Lewis Hall, Bozeman, MT 59717 USA.	douglas.kominsky@montana.edu	Campbell, Eric/N-5357-2015	Campbell, Eric/0000-0003-0744-6577	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK09945]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [U54GM115371]; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project [1015883]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); United States Department of Agriculture National Institute of Food and Agriculture Hatch Project	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK09945; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: U54GM115371; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project, Grant/Award Number: 1015883	Akedo I, 2001, CANCER EPIDEM BIOMAR, V10, P925; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bianco AM, 2015, WORLD J GASTROENTERO, V21, P12296, DOI 10.3748/wjg.v21.i43.12296; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bourreille A, 1999, EUR J CLIN INVEST, V29, P48; Bousoik E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00287; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Contreras-Ruiz L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/636812; Dahan S, 2008, GASTROENTEROLOGY, V134, P192, DOI 10.1053/j.gastro.2007.10.022; Dame MK, 2014, LAB INVEST, V94, P222, DOI 10.1038/labinvest.2013.145; DELEON MP, 1988, CANCER RES, V48, P4121; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gassler N, 2006, GUT, V55, P1084, DOI 10.1136/gut.2005.073262; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hasnain SZ, 2013, GASTROENTEROLOGY, V144, P357, DOI 10.1053/j.gastro.2012.10.043; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kim TH, 2016, CELL REP, V16, P2053, DOI 10.1016/j.celrep.2016.07.056; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Kominsky DJ, 2014, J IMMUNOL, V192, P1267, DOI 10.4049/jimmunol.1301757; Kopp ZA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00017; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lanis JM, 2017, MUCOSAL IMMUNOL, V10, P1133, DOI 10.1038/mi.2016.133; LEV R, 1982, GASTROENTEROLOGY, V82, P1427; Liljegren A, 2003, GUT, V52, P1140, DOI 10.1136/gut.52.8.1140; Liu XD, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0206-6; Liu ZS, 2020, DNA CELL BIOL, V39, P599, DOI 10.1089/dna.2019.5215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzon E, 2002, MOL MED, V8, P353, DOI 10.1007/BF03402016; Moor AE, 2018, CELL, V175, P1156, DOI 10.1016/j.cell.2018.08.063; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morhardt TL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38125-x; MORI M, 1993, GASTROENTEROLOGY, V105, P820, DOI 10.1016/0016-5085(93)90900-W; Navabi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068761; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Oft M, 2014, CANCER IMMUNOL RES, V2, P194, DOI 10.1158/2326-6066.CIR-13-0214; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Parang B, 2016, METHODS MOL BIOL, V1422, P297, DOI 10.1007/978-1-4939-3603-8_26; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Quiros M, 2017, J CLIN INVEST, V127, P3516, DOI 10.1172/JCI90229; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567	58	1	1	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21551	10.1096/fj.202002369R	http://dx.doi.org/10.1096/fj.202002369R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042222				2022-12-28	WOS:000655695900037
J	Siren, EMJ; Luo, HMD; Bajaj, S; MacKenzie, J; Daneshi, M; Martinez, DM; Conway, EM; Cheung, KC; Kizhakkedathu, JN				Siren, Erika M. J.; Luo, Haiming D.; Bajaj, Sargun; MacKenzie, Jordan; Daneshi, Masoud; Martinez, D. Mark; Conway, Edward M.; Cheung, Karen C.; Kizhakkedathu, Jayachandran N.			An improved in vitro model for studying the structural and functional properties of the endothelial glycocalyx in arteries, capillaries and veins	FASEB JOURNAL			English	Article						blood; endothelial biology; mechanosensing; microfluidic; shear stress	ATHEROSCLEROSIS-RESISTANT REGIONS; NECROSIS-FACTOR-ALPHA; SHEAR-STRESS; TRANSENDOTHELIAL MIGRATION; 2-PHOTON MICROSCOPY; SURFACE GLYCOCALYX; TNF-ALPHA; CELL; FLOW; ICAM-1	The endothelial glycocalyx is a dynamic structure integral to blood vessel hemodynamics and capable of tightly regulating a range of biological processes (ie, innate immunity, inflammation, and coagulation) through dynamic changes in its composition of the brush structure. Evaluating the specific roles of the endothelial glycocalyx under a range of pathophysiologic conditions has been a challenge in vitro as it is difficult to generate functional glycocalyces using commonly employed 2D cell culture models. We present a new multi-height microfluidic platform that promotes the growth of functional glycocalyces by eliciting unique shear stress forces over a continuous human umbilical vein endothelial cell monolayer at magnitudes that recapitulate the physical environment in arterial, capillary and venous regions of the vasculature. Following 72 hours of shear stress, unique glycocalyx structures formed within each region that were distinct from that observed in short (3 days) and long-term (21 days) static cell culture. The model demonstrated glycocalyx-specific properties that match the characteristics of the endothelium in arteries, capillaries and veins, with respect to surface protein expression, platelet adhesion, lymphocyte binding and nanoparticle uptake. With artery-to-capillary-to-vein transition on a continuous endothelial monolayer, this in vitro platform is an improved system over static cell culture for more effectively studying the role of the glycocalyx in endothelial biology and disease.	[Siren, Erika M. J.; Luo, Haiming D.; Bajaj, Sargun; Conway, Edward M.; Cheung, Karen C.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Life Sci Inst, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Siren, Erika M. J.; Luo, Haiming D.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [MacKenzie, Jordan; Martinez, D. Mark] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC, Canada; [MacKenzie, Jordan; Daneshi, Masoud; Martinez, D. Mark] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Conway, Edward M.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Cheung, Karen C.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC, Canada; [Cheung, Karen C.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Kizhakkedathu, JN (corresponding author), Univ British Columbia, Life Sci Inst, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada.	jay@pathology.ubc.ca		Luo, Haiming/0000-0001-5929-315X	Natural Sciences and Engineering Council of Canada (NSERC); Centre for Blood Research graduate award; NSERC scholarship; NSERC CREATE Nanomat; Michael Smith Foundation for Health Research Career Scholar Award	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre for Blood Research graduate award; NSERC scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CREATE Nanomat; Michael Smith Foundation for Health Research Career Scholar Award	We gratefully acknowledge Dr Ivan R. Nabi for access to the UBC imaging facility and David Feixo Irazabal from Electrical and Engineering Services at UBC for use of their 3D printers. JNK and EMC acknowledge funding from the Canadian Institutes of Health Research and Natural Sciences and Engineering Council of Canada (NSERC). EMC holds a Tier 1 Canada Research Chair in Endothelial Cell Biology. EMJS acknowledges the support from Centre for Blood Research graduate award. HDL acknowledges the support from NSERC scholarship and NSERC CREATE Nanomat. JNK is a recipient of a Michael Smith Foundation for Health Research Career Scholar Award. The infrastructure facility is supported by Canada Foundation for Innovation (CFI) and the British Columbia Knowledge Development Fund (BCKDF).	Abaci HE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04951; Anselmo AC, 2016, BIOENG TRANSL MED, V1, P10, DOI 10.1002/btm2.10003; Bai K, 2012, J R SOC INTERFACE, V9, P2290, DOI 10.1098/rsif.2011.0901; Baker GR, 1997, AM J HEMATOL, V56, P17; Barker AL, 2004, PHYS CHEM CHEM PHYS, V6, P1006, DOI 10.1039/b312189e; Becker BF, 2010, CARDIOVASC RES, V87, P300, DOI 10.1093/cvr/cvq137; Bhowmick T, 2012, J CONTROL RELEASE, V157, P485, DOI 10.1016/j.jconrel.2011.09.067; Brown D C, 2001, BMC Immunol, V2, P9, DOI 10.1186/1471-2172-2-9; Calderon Andres J, 2011, Int J Transp Phenom, V12, P63; Calderon AJ, 2009, BIORHEOLOGY, V46, P323, DOI 10.3233/BIR-2009-0544; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Feng SB, 2016, BIOMATERIALS, V105, P167, DOI 10.1016/j.biomaterials.2016.08.003; Fu BMM, 2013, WIRES SYST BIOL MED, V5, P381, DOI 10.1002/wsbm.1211; Galbusera M, 1997, BLOOD, V90, P1558, DOI 10.1182/blood.V90.4.1558.1558_1558_1564; Ghavampour S, 2018, FASEB J, V32, P5612, DOI 10.1096/fj.201800331R; Girerd X, 1996, HYPERTENSION, V27, P799, DOI 10.1161/01.HYP.27.3.799; Gouverneur M, 2006, AM J PHYSIOL-HEART C, V290, pH458, DOI 10.1152/ajpheart.00592.2005; Han JY, 2012, ACS NANO, V6, P8824, DOI 10.1021/nn302687n; Hempel C, 2019, FASEB J, V33, P2058, DOI 10.1096/fj.201800657R; Hsiai TK, 2003, FASEB J, V17, P1648, DOI 10.1096/fj.02-1064com; Huxley VH, 2000, AM J PHYSIOL-HEART C, V278, pH1177, DOI 10.1152/ajpheart.2000.278.4.H1177; Jain A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007104; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Koutsiaris AG, 2007, BIORHEOLOGY, V44, P375; Kumagai R, 2009, FREE RADICAL BIO MED, V47, P600, DOI 10.1016/j.freeradbiomed.2009.05.034; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee VK, 2014, BIOMATERIALS, V35, P8092, DOI 10.1016/j.biomaterials.2014.05.083; Li WQ, 2018, BIOMECH MODEL MECHAN, V17, P147, DOI 10.1007/s10237-017-0950-2; Lipowsky HH, 2017, MICROVASC RES, V112, P72, DOI 10.1016/j.mvr.2017.03.007; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; Maroski J, 2011, EXP PHYSIOL, V96, P977, DOI 10.1113/expphysiol.2010.056051; Megens RTA, 2007, J VASC RES, V44, P87, DOI 10.1159/000098259; Mehta BP, 2012, NEUROLOGY, V79, pS63, DOI 10.1212/WNL.0b013e3182695859; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Model Lynn S., 2014, Yale Journal of Biology and Medicine, V87, P359; Mockl L, 2017, NANOMEDICINE-UK, V12, P207, DOI 10.2217/nnm-2016-0332; Morikawa H, 2000, HEPATOLOGY, V31, P83, DOI 10.1002/hep.510310115; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Muller WA, 2008, METHOD ENZYMOL, V443, P155, DOI 10.1016/S0076-6879(08)02009-0; Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Noble MIM, 2008, QJM-INT J MED, V101, P513, DOI 10.1093/qjmed/hcn024; Pollinger K, 2013, P NATL ACAD SCI USA, V110, P6115, DOI 10.1073/pnas.1220281110; Poston RS, 1997, ANN THORAC SURG, V64, P1004, DOI 10.1016/S0003-4975(97)00816-3; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Ramkhelawon B, 2013, FASEB J, V27, P3008, DOI 10.1096/fj.12-222299; Ramnath R, 2014, FASEB J, V28, P4686, DOI 10.1096/fj.14-252221; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rotenberg MY, 2012, LAB CHIP, V12, P2696, DOI [10.1039/c2lc40144d, 10.1039/c21c40144d]; Rouleau L, 2010, ANN BIOMED ENG, V38, P1451, DOI 10.1007/s10439-010-9934-4; Ruggeri ZM, 2007, THROMB RES, V120, pS5, DOI 10.1016/j.thromres.2007.03.011; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schaff UY, 2007, LAB CHIP, V7, P448, DOI 10.1039/b617915k; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shemesh J, 2015, LAB CHIP, V15, P4114, DOI 10.1039/c5lc00633c; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Siren EMJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25870-2; Sperandio M, 2006, METHOD ENZYMOL, V416, P346, DOI 10.1016/S0076-6879(06)16023-1; Stevens AP, 2007, AM J PHYSIOL-LUNG C, V293, pL328, DOI 10.1152/ajplung.00390.2006; Torosean S, 2013, NANOMED-NANOTECHNOL, V9, P151, DOI 10.1016/j.nano.2012.07.002; Tsvirkun D, 2017, SCI REP-UK, V7, DOI 10.1038/srep45036; van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003; van Zandvoort M, 2004, J VASC RES, V41, P54, DOI 10.1159/000076246; Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573; Wu LB, 2017, J AM CHEM SOC, V139, P14684, DOI 10.1021/jacs.7b07768; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005; Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249; Zhang BY, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4818837; Zhou YB, 2014, JOVE-J VIS EXP, DOI 10.3791/51410	78	4	4	3	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21643	10.1096/fj.201802376RRRR	http://dx.doi.org/10.1096/fj.201802376RRRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33977574				2022-12-28	WOS:000655695900011
J	Kolosenko, I; Goroshchuk, O; Vidarsdottir, L; Bjorklund, AC; Dowdy, SF; Palm-Apergi, C				Kolosenko, Iryna; Goroshchuk, Oksana; Vidarsdottir, Linda; Bjorklund, Ann-Charlotte; Dowdy, Steven F.; Palm-Apergi, Caroline			RNAi prodrugs decrease elevated mRNA levels of Polo-like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patients	FASEB JOURNAL			English	Article						cytarabine; pediatric acute myeloid leukemia; Polo-like kinase; Prodrugs; RNA interference	TARGETING PLK1; VOLASERTIB; DELIVERY; NANOPARTICLES; CYTARABINE; INHIBITOR; TRIAL; SIRNA	Polo-like kinase 1 (Plk1) is an important regulator of the cell cycle and it is frequently overexpressed in cancer cells. Several small molecule inhibitors have been developed to target Plk1 and some of them have reached clinical trials in adults with acute myeloid leukemia (AML). Pediatric AML patients have a poor prognosis and survivors suffer from long-term side effects. As adult AML cells have an elevated expression of Plk1, AML is a disease candidate for Plk1 inhibition. However, the relative success of clinical trials have been hampered by adverse reactions. Herein, PLK1-targeting RNA interference (RNAi) prodrugs that enter cells without a trans-fection reagent are used to target PLK1 selectively in primary cells from pediatric AML patients. We show that PLK1 and PLK4 mRNA expression are significantly higher in pediatric AML patients when compared to healthy donors and that PLK1 is downregulated by on average 50% using RNAi prodrugs without a significant effect on other PLK family members. In addition, the RNAi prodrug-induced decrease in PLK1 can be used to potentiate the effect of cytarabine. In summary, PLK1-targeting RNAi prodrugs can decrease the elevated levels of PLK1 in primary cells from pediatric AML patients and sensitize pediatric AML cells to chemotherapeutics.	[Kolosenko, Iryna; Goroshchuk, Oksana; Vidarsdottir, Linda; Bjorklund, Ann-Charlotte; Palm-Apergi, Caroline] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med Biomol & Cellular Med, 5th Floor,Halsovagen 7, S-14157 Stockholm, Sweden; [Dowdy, Steven F.] UCSD Sch Med, Dept Cellular & Mol Med, La Jolla, CA USA	Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Diego	Palm-Apergi, C (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med Biomol & Cellular Med, 5th Floor,Halsovagen 7, S-14157 Stockholm, Sweden.	caroline.palm.apergi@ki.se		Vidarsdottir, Linda/0000-0003-3082-1320; Goroshchuk, Oksana/0000-0002-1585-1962; Palm Apergi, Caroline/0000-0003-2236-2099	Swedish Childhood Cancer Foundation; Gunvor and Josef Aner Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Karolinska Institutets Forskningsstiftelser; Stiftelsen Clas Groschinskys Minnesfond	Swedish Childhood Cancer Foundation(European Commission); Gunvor and Josef Aner Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Karolinska Institutets Forskningsstiftelser; Stiftelsen Clas Groschinskys Minnesfond	Swedish Childhood Cancer Foundation; Gunvor and Josef Aner Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Karolinska Institutets Forskningsstiftelser; Stiftelsen Clas Groschinskys Minnesfond	Alexander S, 2015, LANCET ONCOL, V16, pE604, DOI 10.1016/S1470-2045(15)00197-7; [Anonymous], 2018, TECHNIQUES; Blum WG, 2020, CANCER-AM CANCER SOC, V126, P4668, DOI 10.1002/cncr.32904; Brandwein JM, 2015, THER ADV HEMATOL, V6, P80, DOI 10.1177/2040620715571077; Chevallier P, 2011, LEUKEMIA, V25, P939, DOI 10.1038/leu.2011.25; De Braud FG, 2013, J CLIN ONCOL, V31; Debacker AJ, 2020, MOL THER, V28, P1759, DOI 10.1016/j.ymthe.2020.06.015; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Driscoll DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111060; Megias-Vericat JE, 2018, ANN HEMATOL, V97, P1115, DOI 10.1007/s00277-018-3304-y; Ellis PM., 2013, J THORAC ONCOL, V8, pS2; Goroshchuk O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59653-5; Goroshchuk O, 2019, ONCOGENE, V38, P1, DOI 10.1038/s41388-018-0443-5; Guo JF, 2017, MOL PHARMACEUT, V14, P940, DOI 10.1021/acs.molpharmaceut.6b01150; Hao ZL, 2015, ONCOTARGETS THER, V8, P1761, DOI 10.2147/OTT.S60762; Hou HA, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00674-7; Ikezoe T, 2009, LEUKEMIA, V23, P1564, DOI 10.1038/leu.2009.94; Jarfelt M, 2016, BRIT J HAEMATOL, V175, P577, DOI 10.1111/bjh.14374; Kassim Adetola A, 2017, Hematol Oncol Stem Cell Ther, V10, P245, DOI 10.1016/j.hemonc.2017.05.021; Kolosenko I, 2017, J CONTROL RELEASE, V261, P199, DOI 10.1016/j.jconrel.2017.07.002; Kristen AV, 2019, NEURODEGENER DIS MAN, V9, P5, DOI 10.2217/nmt-2018-0033; Landry B, 2016, J CONTROL RELEASE, V224, P8, DOI 10.1016/j.jconrel.2015.12.052; Lee KS, 2015, TRENDS PHARMACOL SCI, V36, P858, DOI 10.1016/j.tips.2015.08.013; Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003; McCarroll JA, 2015, ONCOTARGET, V6, P12020, DOI 10.18632/oncotarget.2664; Meade BR, 2014, NAT BIOTECHNOL, V32, P1256, DOI 10.1038/nbt.3078; Medinger Michael, 2016, Leuk Res Rep, V6, P39; Molgaard-Hansen L, 2011, PEDIATR BLOOD CANCER, V57, P1222, DOI 10.1002/pbc.22931; Molgaard-Hansen L, 2010, BRIT J HAEMATOL, V151, P447, DOI 10.1111/j.1365-2141.2010.08389.x; Ottmann OG, 2019, BRIT J HAEMATOL, V184, P1017, DOI 10.1111/bjh.15204; Peeters M, 2013, J CLIN ONCOL, V31; Pujade-Lauraine E, 2013, J CLIN ONCOL, V31; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Renner AG, 2009, BLOOD, V114, P659, DOI 10.1182/blood-2008-12-195867; Richardson DR, 2019, SEMIN ONCOL NURS, V35, DOI 10.1016/j.soncn.2019.150957; Rudolph D, 2015, J PHARMACOL EXP THER, V352, P579, DOI 10.1124/jpet.114.221150; Setten RL, 2019, NAT REV DRUG DISCOV, V18, P421, DOI 10.1038/s41573-019-0017-4; Solans BP, 2018, CLIN PHARMACOKINET, V57, P379, DOI 10.1007/s40262-017-0566-9; Talati C, 2016, CRIT REV ONCOL HEMAT, V98, P200, DOI 10.1016/j.critrevonc.2015.10.013; Tsvetkov L, 2005, J BIOL CHEM, V280, P11943, DOI 10.1074/jbc.M413514200; Turcotte LM, 2019, BLOOD, V134, DOI 10.1182/blood-2019-123477; van Ens D, 2020, BONE MARROW TRANSPL, V55, P2308, DOI 10.1038/s41409-020-0966-6; Wang NN, 2015, INT J MOL SCI, V16, P1266, DOI 10.3390/ijms16011266; Wang YQ, 2020, CANCER GENE THER, V27, P45, DOI 10.1038/s41417-019-0095-9; Wilhelmsson M, 2019, BONE MARROW TRANSPL, V54, P726, DOI 10.1038/s41409-018-0337-8; Yang ZG, 2014, NANOSCALE, V6, P9742, DOI 10.1039/c4nr01510j; Yim HS, 2009, MOL CELL BIOL, V29, P2609, DOI 10.1128/MCB.01277-08; Zeidan AM, 2020, CLIN CANCER RES, V26, P6132, DOI 10.1158/1078-0432.CCR-20-2586	48	1	1	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21476	10.1096/fj.202002454RR	http://dx.doi.org/10.1096/fj.202002454RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788972	hybrid			2022-12-28	WOS:000645260100019
J	Sun, DX; Hou, YL; Xie, Y; Yang, SH; Han, B; Shi, LJ; Bai, X; Liang, RB; Dong, T; Zhang, SL; Zhang, Q				Sun, Dongxiao; Hou, Yali; Xie, Yan; Yang, Shaohua; Han, Bo; Shi, Lijun; Bai, Xue; Liang, Ruobing; Dong, Tian; Zhang, Shengli; Zhang, Qin			EEF1D facilitates milk lipid synthesis by regulation of PI3K-Akt signaling in mammals	FASEB JOURNAL			English	Article						CRISPR/Cas9 knockout mice; lipid droplet formation; mammary gland development; milk composition; milk lipid synthesis	GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; GENETIC ARCHITECTURE; MISSENSE MUTATION; YIELD; IDENTIFICATION; NUCLEOTIDE; PREDICTION; EF-1-DELTA; DELTA-EF1	Mammal's milk is an abundantly foremost source of proteins, lipids, and micronutrients for human nutrition and health. Understanding the molecular mechanisms underlying synthesis of milk components provides practical benefits to improve the milk quality via systematic breeding program in mammals. Through RNAi with EEF1D in primary bovine mammary epithelial cells, we phenotypically observed aberrant formation of cytoplasmic lipid droplets and significantly decreased milk triglyceride level by 37.7%, and exploited the mechanisms by which EEF1D regulated milk lipid synthesis via insulin (PI3K-Akt), AMPK, and PPAR pathways. In the EEF1D CRISPR/Cas9 knockout mice, incompletely developed mammary glands at 9th day postpartum with small or unformed lumens, and significantly decreased triglyceride concentration in milk by 23.4% were observed, as well as the same gene expression alterations in the three pathways. For dairy cattle, we identified a critical regulatory mutation modifying EEF1D transcription activity, which interpreted 7% of the genetic variances of milk lipid yield and percentage. Our findings highlight the significance of EEF1D in mammary gland development and milk lipid synthesis in mammals.	[Sun, Dongxiao; Xie, Yan; Yang, Shaohua; Han, Bo; Shi, Lijun; Liang, Ruobing; Dong, Tian; Zhang, Shengli; Zhang, Qin] China Agr Univ, Dept Anim Genet & Breeding, Coll Anim Sci & Technol,Key Lab Anim Genet Breedi, Minist Agr & Rural Affairs,Natl Engn Lab Anim Bre, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Hou, Yali; Bai, Xue] China Natl Ctr Bioinformat, Beijing, Peoples R China; [Hou, Yali; Bai, Xue] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China; [Xie, Yan] Chengde Med Univ, Inst Sericulture, Appl Technol Res & Dev Ctr Sericulture & Special, Chengde, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chengde Medical University	Sun, DX (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Coll Anim Sci & Technol,Key Lab Anim Genet Breedi, Minist Agr & Rural Affairs,Natl Engn Lab Anim Bre, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	sundx@cau.edu.cn			National Natural Science Foundation of China (NSFC) [31872330, 31072016]; National Key R&D Program of China [2018YFC0910402]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13040300]; Youth Innovation Promotion Association of the Chinese Academy of Sciences (Youth Innovation Promotion Association CAS) [2015081]; High Technology R&D Program of China [2013AA102504]; Program for Changjiang Scholar and Innovation Research Team in University [IRT_15R62]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of the Chinese Academy of Sciences (Youth Innovation Promotion Association CAS); High Technology R&D Program of China; Program for Changjiang Scholar and Innovation Research Team in University	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31872330,31072016; National Key R&D Program of China, Grant/Award Number: 2018YFC0910402; Strategic Priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDB13040300; Youth Innovation Promotion Association of the Chinese Academy of Sciences (Youth Innovation Promotion Association CAS), Grant/Award Number: 2015081; High Technology R&D Program of China, Grant/Award Number: 2013AA102504; Program for Changjiang Scholar and Innovation Research Team in University, Grant/Award Number: IRT_15R62	AMONS R, 1994, BBA-GENE STRUCT EXPR, V1218, P346, DOI 10.1016/0167-4781(94)90187-2; Barton NH, 2017, HEREDITY, V118, P96, DOI 10.1038/hdy.2016.109; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; Blott S, 2003, GENETICS, V163, P253; Cheng DD, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0715-5; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emig D, 2011, J PROTEOME RES, V10, P1893, DOI 10.1021/pr101132h; Falconer DS, 1996, INTRO QUANTITATIVE G; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Georges M, 2014, NAT GENET, V46, P807, DOI 10.1038/ng.3048; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guerrucci MA, 1999, GENE, V233, P83, DOI 10.1016/S0378-1119(99)00153-5; Higashi Y, 1997, J EXP MED, V185, P1467, DOI 10.1084/jem.185.8.1467; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jedrzejczak M, 2014, IN VITRO CELL DEV-AN, V50, P389, DOI 10.1007/s11626-013-9711-4; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Lee C, 2014, BIOINFORMATICS, V30, P1923, DOI 10.1093/bioinformatics/btu115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McLachlan F, 2019, HUM MUTAT, V40, P131, DOI 10.1002/humu.23677; Misztal I., 1999, P INT WORKSH COMP CA, V20; Morgante F, 2018, HEREDITY, V120, P500, DOI 10.1038/s41437-017-0043-0; Reshef YA, 2018, NAT GENET, V50, P1483, DOI 10.1038/s41588-018-0196-7; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sekido R, 1997, GENES CELLS, V2, P771, DOI 10.1046/j.1365-2443.1997.1570355.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Swami M, 2010, NAT REV GENET, V11, P748, DOI 10.1038/nrg2888; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Yang SH, 2015, INT J MOL SCI, V16, P26530, DOI 10.3390/ijms161125976; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023	38	2	2	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21455	10.1096/fj.202000682RR	http://dx.doi.org/10.1096/fj.202000682RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913197				2022-12-28	WOS:000645260100049
J	Zhang, JX; Lyu, T; Cao, YM; Feng, H				Zhang, Jiaxue; Lyu, Tong; Cao, Yaming; Feng, Hui			Role of TCF-1 in differentiation, exhaustion, and memory of CD8(+) T cells: A review	FASEB JOURNAL			English	Review						cancer; CD8(+) T cells; exhaustion; immune memory; TCF-1; viral Infection	ALLERGIC RHINITIS MODEL; AIRWAY INFLAMMATION; MURINE MODEL; SUBSTANCE-P; CHANNEL TRPA1; GUINEA-PIG; ASTHMA; CHALLENGE; EXPRESSION; RESPONSIVENESS	T cell factor-1 (TCF-1) (encoded by the TCF7 gene) is a transcription factor that plays important role during the T cell development and differentiation for T cell to exercise its functions including producing memory T cells. Not only TCF-1 can modulate the T cell development but also exerts various effects on the differentiation and function of mature CD8(+) T cells. In addition, it drives the production and maintenance of the immune response of CD8(+) T cells after PD-1 checkpoint blockade therapy. TCF-1 can serve as a potential target of immunotherapy and may provide promising novel treatment strategies for patients with cancer and infections. Moreover, TCF-1 is a potential biomarker of CD8(+) T cell functionality to predict the efficacy of immunotherapy in fighting against cancer and infections. Herein, we summarize the role of TCF-1 in T cell development and its applications in the treatment of cancer and infectious diseases.	[Zhang, Jiaxue] China Med Univ, Clin Med Fac 1, Shenyang, Liaoning, Peoples R China; [Lyu, Tong; Cao, Yaming; Feng, Hui] China Med Univ, Coll Basic Med Sci, Dept Immunol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China	China Medical University; China Medical University	Feng, H (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Immunol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	hfeng@cmu.edu.cn						Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bonay M, 2006, ALLERGY, V61, P111, DOI 10.1111/j.1398-9995.2006.00967.x; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Brozek JL, 2017, J ALLERGY CLIN IMMUN, V140, P950, DOI 10.1016/j.jaci.2017.03.050; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Buch TRH, 2013, CHEM-BIOL INTERACT, V206, P462, DOI 10.1016/j.cbi.2013.08.012; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; CORREN J, 1992, J ALLERGY CLIN IMMUN, V89, P611, DOI 10.1016/0091-6749(92)90329-Z; Deng HY, 2019, ALLERGY, V74, P731, DOI 10.1111/all.13647; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Fang ZF, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.OA3541; Hens G, 2011, AM J RESP CELL MOL, V44, P517, DOI 10.1165/rcmb.2009-0425OC; Hirano A, 2006, AM J RESP CELL MOL, V35, P366, DOI 10.1165/rcmb.2005-0452OC; Ikeda RK, 2003, J IMMUNOL, V171, P4860, DOI 10.4049/jimmunol.171.9.4860; Inui K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13098; Kaelberer MM, 2016, JOVE-J VIS EXP, DOI 10.3791/53917; KleinJan A, 2010, CLIN EXP ALLERGY, V40, P494, DOI 10.1111/j.1365-2222.2009.03417.x; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; Liu ZY, 2015, AM J PHYSIOL-GASTR L, V308, pG482, DOI 10.1152/ajpgi.00374.2014; McCusker C, 2002, J ALLERGY CLIN IMMUN, V110, P891, DOI 10.1067/mai.2002.130048; MOSIMANN BL, 1993, J ALLERGY CLIN IMMUN, V92, P95, DOI 10.1016/0091-6749(93)90043-F; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Mukhopadhyay I, 2011, J RECEPT SIG TRANSD, V31, P350, DOI 10.3109/10799893.2011.602413; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; OKAMOTO Y, 1993, J IMMUNOL, V151, P4391; Passalacqua G, 2001, CURR OPIN ALLERGY CL, V1, P7; Reznikov LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166089; Samitas K, 2018, ALLERGY, V73, P993, DOI 10.1111/all.13373; Saranz RJ, 2017, CLIN EXP ALLERGY, V47, P988, DOI 10.1111/cea.12938; SETTIPANE RJ, 1994, ALLERGY PROC, V15, P21, DOI 10.2500/108854194778816634; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Taylor-Clark TE, 2009, AM J RESP CELL MOL, V40, P756, DOI 10.1165/rcmb.2008-0292OC; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Togias A, 1999, ALLERGY, V54, P94, DOI 10.1111/j.1398-9995.1999.tb04410.x; Tourangeau LM, 2011, J ALLERGY CLIN IMMUN, V127, pAB52, DOI 10.1016/j.jaci.2010.12.218; Tsunematsu M, 2007, LIFE SCI, V80, P1388, DOI 10.1016/j.lfs.2006.12.038; Underwood S, 1995, EUR RESPIR J, V8, P2104, DOI 10.1183/109031936.95.08122104; Van Gerven L, 2012, RHINOLOGY, V50, P227, DOI [10.4193/Rhino11.152, 10.4193/Rhino.11.152]; Wang W, 2016, ALLERGY, V71, P378, DOI 10.1111/all.12808; Wang Y, 2005, CLIN EXP ALLERGY, V35, P1104, DOI 10.1111/j.1365-2222.2005.02301.x; Xie JX, 2015, ALLERGY ASTHMA IMMUN, V7, P76, DOI 10.4168/aair.2015.7.1.76; Yarova PL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0282; Yorgancioglu A, 2008, TUBERK TORAK, V56, P224; Zhang QL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-61	50	7	7	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21549	10.1096/fj.202002566R	http://dx.doi.org/10.1096/fj.202002566R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913198				2022-12-28	WOS:000645260100083
J	Han, JH; Kim, W				Han, Ji Hye; Kim, Wook			Peripheral CB1R as a modulator of metabolic inflammation	FASEB JOURNAL			English	Review						cannabinoid 1 receptor; endocannabinoid; inflammation; macrophage; metabolic disorder	CANNABINOID RECEPTOR ANTAGONIST; IMPROVES INSULIN SENSITIVITY; ENDOCANNABINOID SYSTEM; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; GUT MICROBIOTA; NLRP3 INFLAMMASOME; BODY-WEIGHT; FOOD-INTAKE; OBESITY	Obesity is associated with chronic inflammation in insulin-sensitive tissues, including liver and adipose tissue, and causes hormonal/metabolic complications, such as insulin resistance. There is growing evidence that peripheral cannabinoid-type 1 receptor (CB1R) is a crucial participant in obesity-induced pro-inflammatory responses in insulin-target tissues, and its selective targeting could be a novel therapeutic strategy to break the link between insulin resistance and metabolic inflammation. In this review, we introduce the role of peripheral CB1R in metabolic inflammation and as a mediator of hormonal/metabolic complications that underlie metabolic syndrome, including fatty liver, insulin resistance, and dyslipidemia. We also discuss the therapeutic potential of second- and third-generation peripherally restricted CB1R antagonists for treating obesity-induced metabolic inflammation without eliciting central CB1R-mediated neurobehavioral effects, predictive of neuropsychiatric side effects, in humans.	[Han, Ji Hye; Kim, Wook] Ajou Univ, Dept Mol Sci & Technol, 206,World cup Ro, Suwon 16499, South Korea	Ajou University	Kim, W (corresponding author), Ajou Univ, Dept Mol Sci & Technol, 206,World cup Ro, Suwon 16499, South Korea.	wookkim21@ajou.ac.kr		Kim, Wook/0000-0002-7701-4684	National Research Foundation of Korea (NRF) [2019R1A6A1A11051471, 2019R1A2B5B03100464, 2019R1I1A1A01061122]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2019R1A6A1A11051471, 2019R1A2B5B03100464 and 2019R1I1A1A01061122	Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6; Alonso M, 2012, BRIT J PHARMACOL, V165, P2274, DOI 10.1111/j.1476-5381.2011.01698.x; Argenziano M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235875; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barutta F, 2018, BRIT J PHARMACOL, V175, P4371, DOI 10.1111/bph.14495; Barutta F, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-0975-7; Barutta F, 2017, NEPHROL DIAL TRANSPL, V32, P1655, DOI 10.1093/ndt/gfx010; Barutta F, 2010, DIABETES, V59, P1046, DOI 10.2337/db09-1336; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bronova I, 2015, AM J RESP CELL MOL, V53, P555, DOI 10.1165/rcmb.2014-0331OC; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211; Chang E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206152; Chen RZ, 2008, EUR J PHARMACOL, V584, P338, DOI 10.1016/j.ejphar.2008.02.029; Chorvat RJ, 2012, BIOORG MED CHEM LETT, V22, P6173, DOI 10.1016/j.bmcl.2012.08.004; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Cinar R, 2020, PHARMACOL THERAPEUT, V208, DOI 10.1016/j.pharmthera.2020.107477; Cinar R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92281; Cinar R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87336; Cinar R, 2014, HEPATOLOGY, V59, P143, DOI 10.1002/hep.26606; Cluny NL, 2010, BRIT J PHARMACOL, V161, P629, DOI 10.1111/j.1476-5381.2010.00908.x; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; de Azua IR, 2017, J CLIN INVEST, V127, P4148, DOI 10.1172/JCI83626; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Dhopeshwarkar A, 2017, J PHARMACOL EXP THER, V360, P300, DOI 10.1124/jpet.116.236539; Dong ZQ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00167; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Francois H, 2018, CURR MED CHEM, V25, P793, DOI 10.2174/0929867324666170911170020; Gonzalez-Mariscal I, 2019, FASEB J, V33, P5850, DOI 10.1096/fj.201801145R; Gonzalez-Mariscal I, 2018, DIABETOLOGIA, V61, P1470, DOI 10.1007/s00125-018-4576-4; Gonzalez-Mariscal I, 2016, MOL CELL ENDOCRINOL, V423, P1, DOI 10.1016/j.mce.2015.12.015; Gordon CM, 2005, AIDS EDUC PREV, V17, P6, DOI 10.1521/aeap.17.2.6.58697; Grunewald ZI, 2019, PHYSIOL BEHAV, V199, P282, DOI 10.1016/j.physbeh.2018.11.035; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han JH, 2018, DIABETES OBES METAB, V20, P2179, DOI 10.1111/dom.13350; Han JH, 2019, FASEB J, V33, P4314, DOI [10.1096/fj.201801152rr, 10.1096/fj.201801152RR]; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iyer MR, 2017, J MED CHEM, V60, P1126, DOI 10.1021/acs.jmedchem.6b01504; Jagerovic N, 2004, J MED CHEM, V47, P2939, DOI 10.1021/jm031099y; Jourdan T, 2018, DIABETES OBES METAB, V20, P698, DOI 10.1111/dom.13150; Jourdan T, 2017, MOL METAB, V6, P1517, DOI 10.1016/j.molmet.2017.08.011; Jourdan T, 2017, DIABETES, V66, P994, DOI 10.2337/db16-1199; Jourdan T, 2014, P NATL ACAD SCI USA, V111, pE5420, DOI 10.1073/pnas.1419901111; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Jourdan T, 2012, HEPATOLOGY, V55, P790, DOI 10.1002/hep.24733; Kabir M, 2015, AM J PHYSIOL-ENDOC M, V309, pE747, DOI 10.1152/ajpendo.00196.2015; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Liu J, 2019, HEPATOLOGY, V69, P1535, DOI 10.1002/hep.30364; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Liu YJ, 2003, CURR MOL MED, V3, P325, DOI 10.2174/1566524033479735; LoVerme J, 2009, BIOORG MED CHEM LETT, V19, P639, DOI 10.1016/j.bmcl.2008.12.059; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mai P, 2015, J IMMUNOL, V195, P3390, DOI 10.4049/jimmunol.1403205; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Mehrpouya-Bahrami P, 2019, J BIOL CHEM, V294, P7669, DOI 10.1074/jbc.RA118.005094; Mehrpouya-Bahrami P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15154-6; Mendizabal-Zubiaga J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00476; Miranda K, 2019, FRONT IMMUNOL, V10, P1, DOI 10.3389/fimmu.2019.01049; Miranville A, 2010, OBESITY, V18, P2247, DOI 10.1038/oby.2010.81; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nagappan A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092109; Naughton SS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/361895; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pavon FJ, 2008, J NEUROENDOCRINOL, V20, P116, DOI 10.1111/j.1365-2826.2008.01693.x; Pavon FJ, 2006, NEUROPHARMACOLOGY, V51, P358, DOI 10.1016/j.neuropharm.2006.03.029; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Romero-Zerbo SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03292-w; Rossi F, 2016, J CLIN ENDOCR METAB, V101, P3469, DOI 10.1210/jc.2015-4381; Rossi F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092690; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shin H, 2018, J CELL MOL MED, V22, P2337, DOI 10.1111/jcmm.13523; Shin S, 2015, IMMUNITY, V43, P409, DOI 10.1016/j.immuni.2015.08.027; Simon V, 2017, EUR J ENDOCRINOL, V176, pR309, DOI 10.1530/EJE-16-1044; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Tam Joseph, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P267, DOI 10.1515/jbcpp-2015-0055; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tan SW, 2020, BRIT J PHARMACOL, V177, P2830, DOI 10.1111/bph.15010; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Tian L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01214; Udi S, 2020, BRIT J PHARMACOL, V177, P110, DOI 10.1111/bph.14849; Udi S, 2017, J AM SOC NEPHROL, V28, P3518, DOI 10.1681/ASN.2016101085; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Verty ANA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140592; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	96	4	4	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21232	10.1096/fj.202001960R	http://dx.doi.org/10.1096/fj.202001960R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715173				2022-12-28	WOS:000635216100009
J	Li, HY; Zhuang, P; Zhang, Y; Shou, QY; Lu, YH; Wang, GF; Qiu, JN; Wang, J; He, LL; Chen, JN; Jiao, JJ				Li, Haoyu; Zhuang, Pan; Zhang, Yu; Shou, Qiyang; Lu, Yanhua; Wang, Guangfa; Qiu, Jieni; Wang, Jun; He, Lilin; Chen, Jingnan; Jiao, Jingjing			Mixed conjugated linoleic acid sex-dependently reverses high-fat diet-induced insulin resistance via the gut-adipose axis	FASEB JOURNAL			English	Article						conjugated linoleic acid; gut&#8208; adipose axis; insulin resistance; obesity; sexual dimorphism	BODY-FAT; MICROBIOTA; TISSUE; OBESE; INFLAMMATION; BROWN; SUPPLEMENTATION; WHITE; OVERWEIGHT; EXPRESSION	Conjugated linoleic acid (CLA) may prevent the development of obesity and metabolic disorders. However, the effects of CLA on inflammation and glucose metabolism are controversial. The underlying mechanisms governing the gut microbiota and sexual dimorphisms have also not been elucidated. The present study assessed the effect of CLA on glucose and lipid metabolism in established obesity and examined the mechanism of action based on gut microbiota. Four-week-old C57BL/6J mice were fed a high-fat diet (HFD) for 10 weeks to induce obesity. The diet-induced obese (DIO) mice were fed an HFD supplemented with mixed CLA (50% cis-9, trans-11 isomer and 50% trans-10, cis-12 isomers, 0.2% wt/wt) for 15 weeks. CLA supplementation remarkably reversed body weight in both sexes. CLA favored anti-inflammatory microbiota in male mice, mediating increased short-chain fatty acids and decreased lipopolysaccharide (LPS) production, which alleviated global inflammation and improved insulin sensitivity via inhibition of the TLR4-NF-kappa B pathway in adipose tissue. CLA promoted the growth of hydrogen sulfide-producing Desulfovibrio and the release of LPS in female mice, which aggravated adipose inflammation and insulin resistance. Although CLA impaired glucose metabolism in females, brown adipose tissue was significantly activated with browning of white adipose tissue in both sexes, which led to enhanced energy expenditure. Fecal transplantation from CLA-treated mice to DIO mice mimicked the sex-dependent phenotype. In conclusion, CLA decreased body weight and increased energy expenditure but sex-dependently modulated insulin resistance via the gut-adipose axis.	[Li, Haoyu; Zhuang, Pan; Zhang, Yu; Wang, Jun; He, Lilin; Chen, Jingnan] Zhejiang Key Lab Agrofood Proc, Natl Engn Lab Intelligent Food Technol & Equipmen, Hangzhou, Peoples R China; [Li, Haoyu; Zhuang, Pan; Zhang, Yu; Wang, Jun; He, Lilin; Chen, Jingnan] Zhejiang Univ, Fuli Inst Food Sci, Coll Biosyst Engn & Food Sci, Hangzhou, Peoples R China; [Shou, Qiyang] Zhejiang Chinese Med Univ, Inst Comparat Med, Expt Anim Res Ctr, Hangzhou, Peoples R China; [Lu, Yanhua] Hangzhou Normal Univ, Inst Aging Res, Sch Med, Hangzhou, Peoples R China; [Wang, Guangfa] Zhejiang Univ, Dept PET Ctr, Affiliated First Hosp, Sch Med, Hangzhou, Peoples R China; [Qiu, Jieni; Jiao, Jingjing] Zhejiang Univ, Dept Nutr, Sch Publ Hlth, Affiliated Second Hosp,Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang Chinese Medical University; Hangzhou Normal University; Zhejiang University; Zhejiang University	Jiao, JJ (corresponding author), Zhejiang Univ, Dept Nutr, Sch Publ Hlth, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	jingjingjiao@zju.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LR18C200001]; National Natural Science Foundation of China (NSFC) [81773419]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LR18C200001; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81773419	Bettini S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00548; Bezan PN, 2018, EXP CLIN ENDOCR DIAB, V126, P379, DOI 10.1055/s-0043-118348; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carvalho BM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/986734; Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409; Chen SC, 2012, NUTRITION, V28, P559, DOI 10.1016/j.nut.2011.09.008; den Hartigh LJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020370; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Fu SP, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0230-3; Garibay-Nieto N, 2017, J CLIN ENDOCR METAB, V102, P132, DOI 10.1210/jc.2016-2701; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Halade GV, 2010, J NUTR BIOCHEM, V21, P332, DOI 10.1016/j.jnutbio.2009.01.006; Hanatani S, 2016, J CLIN BIOCHEM NUTR, V59, P207, DOI 10.3164/jcbn.16-23; Hernandez JB, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8216, 10.1038/ncomms8489]; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jang H, 2020, CLIN NUTR, V39, P765, DOI 10.1016/j.clnu.2019.03.032; Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450; Jin CY, 2016, CHEMOSPHERE, V160, P349, DOI 10.1016/j.chemosphere.2016.06.105; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kim BS, 2014, J ETHNOPHARMACOL, V152, P532, DOI 10.1016/j.jep.2014.01.038; Kim JH, 2016, ANNU REV FOOD SCI T, V7, P221, DOI 10.1146/annurev-food-041715-033028; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015; Lam YY, 2015, OBESITY, V23, P1429, DOI 10.1002/oby.21122; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mirbolooki MR, 2014, NUCL MED BIOL, V41, P10, DOI 10.1016/j.nucmedbio.2013.08.009; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; O'Reilly ME, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900599; Onakpoya Igho J, 2012, Eur J Nutr, V51, P127, DOI 10.1007/s00394-011-0253-9; Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Ribeiro AS, 2016, INT J SPORT NUTR EXE, V26, P135, DOI 10.1123/ijsnem.2015-0236; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rodriguez-Alcala LM, 2007, J DAIRY SCI, V90, P2083, DOI 10.3168/jds.2006-693; Roura-Guiberna A, 2019, CELL SIGNAL, V53, P281, DOI 10.1016/j.cellsig.2018.10.013; Saad MJA, 2016, PHYSIOLOGY, V31, P283, DOI 10.1152/physiol.00041.2015; Sahuri-Arisoylu M, 2016, INT J OBESITY, V40, P955, DOI 10.1038/ijo.2016.23; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Sharifnia T, 2015, AM J PHYSIOL-GASTR L, V309, pG270, DOI 10.1152/ajpgi.00304.2014; Shen W, 2015, J NUTR BIOCHEM, V26, P616, DOI 10.1016/j.jnutbio.2014.12.016; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wang XK, 2012, JOVE-J VIS EXP, DOI 10.3791/4060; Wei ZS, 2015, FEBS LETT, V589, P165, DOI 10.1016/j.febslet.2014.11.042; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu PF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12399; Yamasaki M, 1999, BIOSCI BIOTECH BIOCH, V63, P1104, DOI 10.1271/bbb.63.1104; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhou XR, 2008, GROWTH HORM IGF RES, V18, P361, DOI 10.1016/j.ghir.2008.01.001; Zhuang P, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900946; Zhuang P, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800448; Zhuang P, 2017, BBA-MOL BASIS DIS, V1863, P2715, DOI 10.1016/j.bbadis.2017.07.003	65	3	3	6	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21466	10.1096/fj.202002161RR	http://dx.doi.org/10.1096/fj.202002161RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734496				2022-12-28	WOS:000635216100092
J	Sekulovski, N; Whorton, AE; Shi, MX; Hayashi, K; MacLean, JA				Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II			Insulin signaling is an essential regulator of endometrial proliferation and implantation in mice	FASEB JOURNAL			English	Article						endometrial proliferation; implantations; insulin signaling; knockout mice; uterus		Insulin signaling is critical for the development of preovulatory follicles and progression through the antral stage. Using a conditional knockout model that escapes this blockage, we recently described the role of insulin signaling in granulosa cells during the periovulatory window in mice lacking Insr and Igf1r driven by Pgr-Cre. These mice were infertile, exhibiting defects in ovulation, luteinization, steroidogenesis, and early embryo development. Herein, we demonstrate that while these mice exhibit normal uterine receptivity, uterine cell proliferation and decidualization are compromised resulting in complete absence of embryo implantation in uteri lacking both receptors. While the histological organization of double knockout mice appeared normal, the thickness of their endometrium was significantly reduced. This was supported by the reduced proliferation of both epithelial and stromal cells during the preimplantation stages of pregnancy. Expression and localization of the main drivers of uterine proliferation, ESR1 and PGR, was normal in knockouts, suggesting that insulin signaling acts downstream of these two receptors. While AKT/PI3K signaling was unaffected by insulin receptor ablation, activation of p44/42 MAPK was significantly reduced in both single and double knockout uteri at 3.5 dpc. Overall, we conclude that both INSR and IGF1R are necessary for optimal endometrial proliferation and implantation.	[Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II] Southern Illinois Sch Med, Dept Physiol, Carbondale, IL USA; [Hayashi, Kanako; MacLean, James A., II] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [MacLean, James A., II] Washington State Univ, Coll Vet Med, Sch Mol Biosci, POB 647520, Pullman, WA 99164 USA	Washington State University; Washington State University	MacLean, JA (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, POB 647520, Pullman, WA 99164 USA.	james.maclean@wsu.edu		MacLean, James/0000-0003-3061-150X; Whorton, Allison/0000-0003-2983-401X; Hayashi, Kanako/0000-0002-5028-799X	Research Seed Grant from the Southern Illinois University School of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD093802]	Research Seed Grant from the Southern Illinois University School of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	These studies were supported by a Research Seed Grant from the Southern Illinois University School of Medicine and by Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant HD093802.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Ardon O, 2014, MOLEC GENET METAB RE, V1, P71, DOI 10.1016/j.ymgmr.2013.12.006; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Brown RM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103267; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Dai CW, 2016, AM J TRANSL RES, V8, P3329; DeSouza MM, 1999, J REPROD IMMUNOL, V45, P127, DOI 10.1016/S0165-0378(99)00046-7; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; Escobar-Morreale HF, 2016, DIABETES CARE, V39, P639, DOI 10.2337/dc15-2577; Fukui Y, 2019, REPROD MED BIOL, V18, P234, DOI 10.1002/rmb2.12280; GIUDICE LC, 1994, J CLIN ENDOCR METAB, V79, P1284, DOI 10.1210/jc.79.5.1284; Gomez-Hernandez A, 2013, ENDOCRINOLOGY, V154, P2352, DOI 10.1210/en.2012-2161; Hewitt SC, 2019, J BIOL CHEM, V294, P9746, DOI 10.1074/jbc.RA119.008759; Hewitt SC, 2017, ENDOCRINOLOGY, V158, P2427, DOI 10.1210/en.2017-00349; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Huang Y, 2018, DIABETES RES CLIN PR, V140, P351, DOI 10.1016/j.diabres.2018.05.033; Johansson GS, 2006, AM J PHYSIOL-ENDOC M, V291, pE1124, DOI 10.1152/ajpendo.00565.2005; Kalantari H, 2018, REPROD BIOMED ONLINE, V36, P210, DOI 10.1016/j.rbmo.2017.10.115; KAPUR S, 1992, BIOL REPROD, V46, P208, DOI 10.1095/biolreprod46.2.208; Kirkwood A, 2018, PEDIATR ANESTH, V28, P23, DOI 10.1111/pan.13273; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Li ML, 2016, J BIOL REG HOMEOS AG, V30, P1059; Lindberg ME, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109462; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKWOOD CJ, 1993, J CLIN ENDOCR METAB, V76, P231, DOI 10.1210/jc.76.1.231; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Majchrzak-Baczmanska D, 2016, GINEKOL POL, V87, P598, DOI 10.5603/GP.2016.0052; Matsumoto H, 2008, MOL HUM REPROD, V14, P485, DOI 10.1093/molehr/gan038; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Neff AM, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqz021; Pitetti JL, 2009, SEX DEV, V3, P264, DOI 10.1159/000252813; Porksen N, 2002, DIABETOLOGIA, V45, P3, DOI 10.1007/s125-002-8240-x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Richards RG, 1998, J BIOL CHEM, V273, P11962, DOI 10.1074/jbc.273.19.11962; RUTANEN EM, 1991, J CLIN ENDOCR METAB, V72, P27, DOI 10.1210/jcem-72-1-27; Satin LS, 2015, MOL ASPECTS MED, V42, P61, DOI 10.1016/j.mam.2015.01.003; Sato T, 2002, ENDOCRINOLOGY, V143, P2673, DOI 10.1210/en.143.7.2673; Schaefer-Graf U, 2018, DIABETOLOGIA, V61, P1012, DOI 10.1007/s00125-018-4545-y; Sekulovski N, 2020, FASEB J, V34, P2376, DOI 10.1096/fj.201901791R; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thong EP, 2020, LANCET DIABETES ENDO, V8, P134, DOI 10.1016/S2213-8587(19)30345-6; US Department of Health and Human Services Centers for Disease Control and Prevention, 2020, NAT DIAB STAT REP; Welborn JP, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.124834; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Whitworth KW, 2011, DIABETOLOGIA, V54, P516, DOI 10.1007/s00125-010-2003-6; Winuthayanon W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07728-1; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	61	5	5	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21440	10.1096/fj.202002448R	http://dx.doi.org/10.1096/fj.202002448R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749878	Green Accepted			2022-12-28	WOS:000635216100069
J	Harasymowicz, NS; Rashidi, N; Savadipour, A; Wu, CL; Tang, RH; Bramley, J; Buchser, W; Guilak, F				Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Bramley, John; Buchser, William; Guilak, Farshid			Single-cell RNA sequencing reveals the induction of novel myeloid and myeloid-associated cell populations in visceral fat with long-term obesity	FASEB JOURNAL			English	Article						adipokine; canonical correlation analysis; collagen; fibrotic; metabolic syndrome; scRNA&#8208; seq	HYALURONAN RECEPTOR LYVE-1; ADIPOSE-TISSUE MACROPHAGES; DIET-INDUCED OBESITY; BONE-MARROW; PROGENITOR CELLS; DENDRITIC CELLS; IN-VIVO; FIBROCYTES; EXPRESSION; MICE	Macrophages and other immune cells are important contributors to obesity-associated inflammation; however, the cellular identities of these specific populations remain unknown. In this study, we identified individual populations of myeloid cells found in mouse epididymal/visceral adipose tissue by single-cell RNA sequencing, immunofluorescence, and flow cytometry. Multiple canonical correlation analysis identified 11 unique myeloid and myeloid-associate cell populations. In obese mice, we detected an increased percentage of monocyte-derived pro-inflammatory cells expressing Cd9 and Trem2, as well as significantly decreased percentages of multiple cell populations, including tissue-resident cells expressing Lyve1, Mafb, and Mrc1. We have identified and validated a novel myeloid/macrophage population defined by Ly6a expression, exhibiting both myeloid and mesenchymal characteristics, which increased with obesity and showed high pro-fibrotic characteristics in vitro. Our mouse adipose tissue myeloid cell atlas provides an important resource to investigate obesity-associated inflammation and fibrosis.	[Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Guilak, Farshid] Shriners Hosp Children, St Louis, MO USA; [Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO 63110 USA; [Rashidi, Neda; Savadipour, Alireza; Guilak, Farshid] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA; [Bramley, John; Buchser, William] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Guilak, F (corresponding author), Ctr Regenerat Med, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA.	guilak@wustl.edu		Buchser, William/0000-0002-6675-6359	HHS \ National Institutes of Health (NIH) [AG15768, AG46927]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: AG15768; HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: AG46927	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caslin HL, 2020, IMMUNOL REV, V295, P101, DOI 10.1111/imr.12853; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Cousin B, 2003, BIOCHEM BIOPH RES CO, V301, P1016, DOI 10.1016/S0006-291X(03)00061-5; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-019-0363-8, 10.1038/s41590-018-0272-2]; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Eto H, 2013, STEM CELLS DEV, V22, P985, DOI 10.1089/scd.2012.0442; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Griffin TM, 2008, BIORHEOLOGY, V45, P387, DOI 10.3233/BIR-2008-0485; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Han J, 2010, BLOOD, V115, P957, DOI 10.1182/blood-2009-05-219923; Harasymowicz NS, 2020, ARTHRITIS RHEUMATOL, V72, P632, DOI 10.1002/art.41147; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Huang ZF, 2008, SCANNING, V30, P452, DOI 10.1002/sca.20130; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; LaRue AC, 2006, EXP HEMATOL, V34, P208, DOI 10.1016/j.exphem.2005.10.009; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.06.008, 10.1016/j.immuni.2018.12.009]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; McDonald LT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180724; Minchenko D., 2013, CELLBIO, V02, P45, DOI [10.4236/cellbio.2013.22006, DOI 10.4236/CELLBIO.2013.22006]; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mraz M, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/5481725; Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Poczobutt JM, 2016, J IMMUNOL, V196, P2847, DOI 10.4049/jimmunol.1502364; Psaltis PJ, 2012, CIRCULATION, V125, P592, DOI 10.1161/CIRCULATIONAHA.111.059360; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Sharma M., 2019, IMMUNOMETABOLISM, V1; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sidles SJ, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1648614; Silva HM, 2019, J EXP MED, V216, P786, DOI 10.1084/jem.20181049; Singer G, 2007, MICROCIRCULATION, V14, P375, DOI 10.1080/10739680701283158; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Stock AT, 2019, J IMMUNOL, V202, P3282, DOI 10.4049/jimmunol.1900071; Tang-Huau TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04985-0; Tokunaga M, 2014, MATRIX BIOL, V36, P28, DOI 10.1016/j.matbio.2014.03.005; Toledo-Flores D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43765-8; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vijay J, 2020, NAT METAB, V2, P97, DOI 10.1038/s42255-019-0152-6; Weinstock Ada, 2019, Immunometabolism, V1, DOI 10.20900/immunometab20190008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CL, 2013, INT J OBESITY, V37, P1079, DOI 10.1038/ijo.2012.171; Xia Y, 2019, AUTOPHAGY, V15, P960, DOI 10.1080/15548627.2019.1569916; Xu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04726-3	66	11	11	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21417	10.1096/fj.202001970R	http://dx.doi.org/10.1096/fj.202001970R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566380	Bronze, Green Accepted			2022-12-28	WOS:000629576700017
J	Pintado-Berninches, L; Montes-Worboys, A; Manguan-Garcia, C; Arias-Salgado, EG; Serrano, A; Fernandez-Varas, B; Guerrero-Lopez, R; Iarriccio, L; Planas, L; Guenechea, G; Egusquiaguirre, SP; Hernandez, RM; Igartua, M; Pedraz, JL; Cortijo, J; Sastre, L; Molina-Molina, M; Perona, R				Pintado-Berninches, Laura; Montes-Worboys, Ana; Manguan-Garcia, Cristina; Arias-Salgado, Elena G.; Serrano, Adela; Fernandez-Varas, Beatriz; Guerrero-Lopez, Rosa; Iarriccio, Laura; Planas, Lurdes; Guenechea, Guillermo; Egusquiaguirre, Susana P.; Hernandez, Rosa M.; Igartua, Manoli; Luis Pedraz, Jose; Cortijo, Julio; Sastre, Leandro; Molina-Molina, Maria; Perona, Rosario			GSE4-loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage	FASEB JOURNAL			English	Article						alveolar cells; GSE4; pulmonary fibrosis; telomerase	EPITHELIAL-MESENCHYMAL-TRANSITION; IDIOPATHIC PULMONARY-FIBROSIS; DYSKERATOSIS-CONGENITA; TELOMERASE ACTIVITY; CELLS; PEPTIDE; PIRFENIDONE; MECHANISMS; SENESCENCE; NINTEDANIB	Idiopathic pulmonary fibrosis is a lethal lung fibrotic disease, associated with aging with a mean survival of 2-5 years and no curative treatment. The GSE4 peptide is able to rescue cells from senescence, DNA and oxidative damage, inflammation, and induces telomerase activity. Here, we investigated the protective effect of GSE4 expression in vitro in rat alveolar epithelial cells (AECs), and in vivo in a bleomycin model of lung fibrosis. Bleomycin-injured rat AECs, expressing GSE4 or treated with GSE4-PLGA/PEI nanoparticles showed an increase of telomerase activity, decreased DNA damage, and decreased expression of IL6 and cleaved-caspase 3. In addition, these cells showed an inhibition in expression of fibrotic markers induced by TGF-beta such as collagen-I and III among others. Furthermore, treatment with GSE4-PLGA/PEI nanoparticles in a rat model of bleomycin-induced fibrosis, increased telomerase activity and decreased DNA damage in proSP-C cells. Both in preventive and therapeutic protocols GSE4-PLGA/PEI nanoparticles prevented and attenuated lung damage monitored by SPECT-CT and inhibited collagen deposition. Lungs of rats treated with bleomycin and GSE4-PLGA/PEI nanoparticles showed reduced expression of alpha-SMA and pro-inflammatory cytokines, increased number of pro-SPC-multicellular structures and increased DNA synthesis in proSP-C cells, indicating therapeutic efficacy of GSE4-nanoparticles in experimental lung fibrosis and a possible curative treatment for lung fibrotic patients.	[Pintado-Berninches, Laura; Manguan-Garcia, Cristina; Arias-Salgado, Elena G.; Fernandez-Varas, Beatriz; Guerrero-Lopez, Rosa; Iarriccio, Laura; Sastre, Leandro; Perona, Rosario] CSIC UAM, IDIPaz, Inst Invest Biomed, Madrid, Spain; [Pintado-Berninches, Laura; Manguan-Garcia, Cristina; Guerrero-Lopez, Rosa; Guenechea, Guillermo; Sastre, Leandro; Perona, Rosario] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Montes-Worboys, Ana; Planas, Lurdes; Molina-Molina, Maria] Univ Barcelona, Univ Hosp Bellvitge, Pneumol Dept, ILD,IDIBELL, Barcelona, Spain; [Serrano, Adela; Cortijo, Julio] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain; [Serrano, Adela; Cortijo, Julio; Molina-Molina, Maria] Hlth Inst Carlos III, CIBER Resp Dis CIBERES, Madrid, Spain; [Guenechea, Guillermo] Fdn Jimenez Diaz IIS FJD UAM, Ctr Invest Energet Medioambientales & Tecnol CIEM, Div Hematopoiet Innovat Therapies, Inst Invest Sanitaria, Madrid, Spain; [Egusquiaguirre, Susana P.; Hernandez, Rosa M.; Igartua, Manoli; Luis Pedraz, Jose] Univ Basque Country, Sch Pharm, Lab Pharmaceut, NanoBioCel Grp,UPV EHU,CIBER BBN, Vitoria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Basque Country	Perona, R (corresponding author), CSIC UAM, Inst Invest Biomed, C Arturo Duperier 4, Madrid 28029, Spain.	rperona@iib.uam.es	Hernandez, Rosa Maria/S-6332-2017; Varas, Beatriz Fernández/ABI-6381-2020; Hernández, Rosa/GRF-5998-2022; Pedraz, Jose Luis/AAR-1338-2021; Guenechea, Guillermo/L-6119-2014	Hernandez, Rosa Maria/0000-0002-3947-409X; Varas, Beatriz Fernández/0000-0002-3361-1065; Guenechea, Guillermo/0000-0001-7679-0895; Garcia Arias-Salgado, Elena/0000-0002-3612-5791; MOLINA MOLINA, MARIA/0000-0002-1852-1723; Sastre, Leandro/0000-0003-3613-5938; Planas-Cerezales, Lurdes/0000-0001-7636-444X	CIBER [576/805_ER16PE06P2016]; MINECO, INNPACTO [IPT-2012-0674-090000]; Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III (FEDER funds) [PI18/00367, P17-01401]; CICYT [SAF2014-55322-P]; MINECO/FEDER funds [SAF2015-68073-R]	CIBER; MINECO, INNPACTO; Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III (FEDER funds); CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); MINECO/FEDER funds(Spanish Government)	CIBER, Grant/Award Number: 576/805_ER16PE06P2016; MINECO, INNPACTO, Grant/Award Number: IPT-2012-0674-090000; Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III (FEDER funds), Grant/Award Number: PI18/00367 and P17-01401; CICYT, Grant/Award Number: SAF2014-55322-P; MINECO/FEDER funds, Grant/Award Number: SAF2015-68073-R	Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Almudever P, 2013, THORAX, V68, P938, DOI 10.1136/thoraxjnl-2013-203408; ANTONIADES HN, 1990, J CLIN INVEST, V86, P1055, DOI 10.1172/JCI114808; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P52, DOI 10.1016/j.mrfmmm.2011.10.013; Benyelles M, 2020, HUM MOL GENET, V29, P907, DOI 10.1093/hmg/ddaa011; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Cardenes N, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0970-6; Chen RP, 2015, J BIOL CHEM, V290, P30813, DOI 10.1074/jbc.M115.681619; Chowdhury S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070528; Cortijo J, 2009, BRIT J PHARMACOL, V156, P534, DOI 10.1111/j.1476-5381.2008.00041.x; Ding DW, 2018, MAT SCI ENG C-MATER, V92, P1041, DOI 10.1016/j.msec.2017.12.036; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Egusquiaguirre SP, 2015, EUR J PHARM BIOPHARM, V91, P91, DOI 10.1016/j.ejpb.2015.01.028; Egusquiaguirre SP, 2014, J CHROMATOGR B, V972, P95, DOI 10.1016/j.jchromb.2014.09.041; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goldmann T, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0841-9; Hoffman TW, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00809-2019; Hoffman TW, 2018, CURR OPIN PULM MED, V24, P269, DOI 10.1097/MCP.0000000000000475; Iarriccio L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142980; Inomata M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-16; Kannengiesser C, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.02465-2019; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Konigshoff M, 2011, RESPIRATION, V81, P353, DOI 10.1159/000326299; Li LF, 2017, J CELL MOL MED, V21, P2937, DOI 10.1111/jcmm.13206; Liu YY, 2018, ACTA PHARMACOL SIN, V39, P1735, DOI 10.1038/s41401-018-0007-9; Liu Y, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0405-7; Machado-Pinilla R, 2008, BLOOD, V111, P2606, DOI 10.1182/blood-2007-04-083261; Machado-Pinilla R, 2012, CLIN TRANSL ONCOL, V14, P755, DOI 10.1007/s12094-012-0865-4; Manguan-Garcia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101424; Povedano JM, 2018, ELIFE, V7, DOI 10.7554/eLife.31299; Milara J, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0728-9; Milara J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133453; Mora AL, 2017, NAT REV DRUG DISCOV, V16, DOI [10.1038/nrd.2017.225, 10.1038/nrd.2017.170]; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Naikawadi RP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86704; Ng B, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1237; Perona R, 2016, TELOMERE - A COMPLEX END OF A CHROMOSOME, P77, DOI 10.5772/65353; Pintado-Berninches L, 2019, CELL DEATH DIFFER, V26, P1998, DOI 10.1038/s41418-018-0272-7; Planas-Cerezales L, 2019, RESPIROLOGY, V24, P146, DOI 10.1111/resp.13423; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sasser TA, 2012, JOVE-J VIS EXP, DOI 10.3791/3680; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Stanley SE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7837; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Tang S, 2019, TUBERC RESPIR DIS, V82, P133, DOI 10.4046/trd.2017.0124; Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319; Trivedi R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/50/505101; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK	56	6	6	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21422	10.1096/fj.202001160RR	http://dx.doi.org/10.1096/fj.202001160RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33638895	Green Published			2022-12-28	WOS:000629576700011
J	Kim, HG; Huot, JR; Pin, F; Guo, B; Bonetto, A; Nader, GA				Kim, Hyo-Gun; Huot, Joshua R.; Pin, Fabrizio; Guo, Bin; Bonetto, Andrea; Nader, Gustavo A.			Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia	FASEB JOURNAL			English	Article						anabolic deficit; cancer cachexia; muscle wasting; rDNA transcription; ribosome biogenesis; RNA Polymerase 1	RNA GENES; MEASURED INVIVO; BEARING; TUMOR; DEGRADATION; TURNOVER; SURVIVAL; LIVER; PREVALENCE; METABOLISM	Muscle wasting in cancer is associated with deficits in protein synthesis, yet, the mechanisms underlying this anabolic impairment remain poorly understood. The capacity for protein synthesis is mainly determined by the abundance of muscle ribosomes, which is in turn regulated by transcription of the ribosomal (r)RNA genes (rDNA). In this study, we investigated whether muscle loss in a preclinical model of ovarian cancer is associated with a reduction in ribosomal capacity and was a consequence of impaired rDNA transcription. Tumor bearing resulted in a significant loss in gastrocnemius muscle weight and protein synthesis capacity, and was consistent with a significant reduction in rDNA transcription and ribosomal capacity. Despite the induction of the ribophagy receptor NUFIP1 mRNA and the loss of NUFIP1 protein, in vitro studies revealed that while inhibition of autophagy rescued NUFIP1, it did not prevent the loss of rRNA. Electrophoretic analysis of rRNA fragmentation from both in vivo and in vitro models showed no evidence of endonucleolytic cleavage, suggesting that rRNA degradation may not play a major role in modulating muscle ribosome abundance. Our results indicate that in this model of ovarian cancer-induced cachexia, the ability of skeletal muscle to synthesize protein is compromised by a reduction in rDNA transcription and consequently a lower ribosomal capacity. Thus, impaired ribosomal production appears to play a key role in the anabolic deficits associated with muscle wasting in cancer cachexia.	[Kim, Hyo-Gun; Guo, Bin; Nader, Gustavo A.] Penn State Univ, Dept Kinesiol, 101 Noll Lab, University Pk, PA 16802 USA; [Huot, Joshua R.; Bonetto, Andrea] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Pin, Fabrizio; Bonetto, Andrea] Indiana Univ Sch Med, Dept Anat & Cell Biol & Physiol, Indianapolis, IN 46202 USA; [Bonetto, Andrea] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Nader, Gustavo A.] Penn State Univ, Penn State Canc Inst, University Pk, PA 16802 USA; [Nader, Gustavo A.] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; Indiana University System; Indiana University Bloomington	Nader, GA (corresponding author), Penn State Univ, Dept Kinesiol, 101 Noll Lab, University Pk, PA 16802 USA.	gan11@psu.edu						Aust S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140403; Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bronger H, 2017, INT J GYNECOL CANCER, V27, P223, DOI 10.1097/IGC.0000000000000867; Burckart K, 2010, CURR OPIN CLIN NUTR, V13, P410, DOI 10.1097/MCO.0b013e328339fdd2; Choi RH, 2019, FASEB J, V33, P5654, DOI 10.1096/fj.201802145RR; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Cui CH, 2004, BIOTECHNIQUES, V36, P134, DOI 10.2144/04361RR04; Durham WJ, 2009, CURR OPIN CLIN NUTR, V12, P72, DOI 10.1097/MCO.0b013e32831cef61; Dworzak F, 1998, CANCER, V82, P42, DOI 10.1002/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M; EMERY PW, 1984, CANCER RES, V44, P2779; EMERY PW, 1984, BRIT MED J, V289, P584, DOI 10.1136/bmj.289.6445.584; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; GOODLAD GAJ, 1988, BIOCHIM BIOPHYS ACTA, V950, P296, DOI 10.1016/0167-4781(88)90125-X; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Hannan Katherine M., 1998, Frontiers in Bioscience, V3, pD376; HIRSCH CA, 1966, J BIOL CHEM, V241, P5936; Huang CY, 2020, J CACHEXIA SARCOPENI, V11, P534, DOI 10.1002/jcsm.12524; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; King KL, 2000, CELL DEATH DIFFER, V7, P994, DOI 10.1038/sj.cdd.4400731; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Li M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0502; LOPES MN, 1989, BIOCHEM J, V264, P713, DOI 10.1042/bj2640713; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Mathis AD, 2017, MOL CELL PROTEOMICS, V16, P243, DOI 10.1074/mcp.M116.063255; MILLWARD DJ, 1973, NATURE, V241, P204, DOI 10.1038/241204a0; MILLWARD DJ, 1976, BIOCHEM J, V156, P185, DOI 10.1042/bj1560185; MILLWARD DJ, 1975, BIOCHEM J, V150, P235, DOI 10.1042/bj1500235; Millward DJ., 1980, CIBA FDN S, P307; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Mueller O., 2004, AGIL APPL NOTE, V2011, P1, DOI DOI 10.1186/1471-2199-7-3; NIKOLOV EN, 1983, BIOSCIENCE REP, V3, P781, DOI 10.1007/BF01120990; Paule MR, 1998, TRANSCRIPTION RIBOSO; Pin F, 2018, J CACHEXIA SARCOPENI, V9, P685, DOI 10.1002/jcsm.12311; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2011, CURR OPIN CLIN NUTR, V14, P250, DOI 10.1097/MCO.0b013e3283455d45; Ramachandran KV, 2018, MOL CELL, V71, P169, DOI 10.1016/j.molcel.2018.06.013; Reeder RH, 1999, PROG NUCLEIC ACID RE, V62, P293; Rosa-Caldwell ME, 2020, J APPL PHYSIOL, V128, P25, DOI 10.1152/japplphysiol.00622.2019; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Rutten IJG, 2016, J CACHEXIA SARCOPENI, V7, P458, DOI 10.1002/jcsm.12107; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; SVANINGER G, 1983, J NATL CANCER I, V71, P341; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; TESSITORE L, 1993, ARCH BIOCHEM BIOPHYS, V306, P52, DOI 10.1006/abbi.1993.1479; Thoresen L, 2013, CLIN NUTR, V32, P65, DOI 10.1016/j.clnu.2012.05.009; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tseng H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001843; von Walden F, 2016, AM J PHYSIOL-CELL PH, V311, pC663, DOI 10.1152/ajpcell.00144.2016; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; WOOL IG, 1967, P NATL ACAD SCI USA, V58, P2401, DOI 10.1073/pnas.58.6.2401; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Yan SF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010210	63	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21335	10.1096/fj.202002257R	http://dx.doi.org/10.1096/fj.202002257R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33527503	Green Accepted			2022-12-28	WOS:000647789600014
J	Adam, G; Shiomi, T; Monica, G; Jarrod, S; Vincent, A; Becky, M; Tina, Z; Jeanine, D				Adam, Gerber; Shiomi, Takayuki; Monica, Goldklang; Jarrod, Sonett; Vincent, Anguiano; Becky, Mercer; Tina, Zelonina; Jeanine, D'Armiento			Suppression of cigarette smoke induced MMP1 expression by selective serotonin re-uptake inhibitors	FASEB JOURNAL			English	Article							MATRIX METALLOPROTEINASE-1; PULMONARY; EMPHYSEMA; INFLAMMATION; APOPTOSIS; STATINS; CELLS; COPD	Globally, COPD remains a major cause of disability and death. In the United States alone, it is estimated that approximately 14 million people suffer from the disease. Given the high disease burden and requirement for chronic, long-term medical care associated with COPD, it is essential that new disease modifying agents are developed to complement the symptomatic therapeutics currently available. In the present report, we have identified a potentially novel therapeutic agent through the use of a high throughput screen based on the knowledge that cigarette smoke induces the proteolytic enzyme MMP1 leading to destruction of the lung in COPD. A construct utilizing the cigarette responsive promoter element of MMP-1 was conjugated to a luciferase reporter and utilized in an in vitro assay to screen the NIH Molecular Libraries Small Molecule Repository to identify putative targets that suppressed luciferase expression in response to cigarette smoke extract (CSE). Selective serotonin reuptake inhibitors potently inhibited luciferase expression and were further validated. SSRI treatment suppressed MMP-1 production in small airway epithelial cells exposed to (CSE) in vitro as well as in smoke exposed rabbits. In addition, SSRI treatment inhibited inflammatory cytokine production while rescuing cigarette smoke induced downregulation in vivo of the anti-inflammatory lipid transporter ABCA1, previously shown by our laboratory to be lung protective. Importantly, SSRI treatment prevented lung destruction in smoke exposed rabbits as measured by morphometry. These studies support further investigation into SSRIs as a novel therapeutic for COPD may be warranted.	[Adam, Gerber; Monica, Goldklang; Jarrod, Sonett; Tina, Zelonina; Jeanine, D'Armiento] Columbia Univ, Coll Phys & Surg, Dept Med Anesthesiol Physiol & Cell Biol, Irving Med Ctr, New York, NY 10027 USA; [Shiomi, Takayuki] Int Univ Hlth & Welf, Ctr Basic Med Sci, Grad Sch, Chiba, Japan; [Vincent, Anguiano] Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Becky, Mercer] Palm Beach State Coll, Off Acad Affairs, Lake Worth, FL USA	Columbia University; NewYork-Presbyterian Hospital; International University of Health & Welfare; Icahn School of Medicine at Mount Sinai	Jeanine, D (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med Anesthesiol Physiol & Cell Biol, Irving Med Ctr, New York, NY 10027 USA.	jmd12@cumc.columbia.edu	Shiomi, Takayuki/A-2228-2014	Shiomi, Takayuki/0000-0002-4250-1204	NHLBI [R01 HL086936]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI, Grant/Award Number: R01 HL086936	Caiaffo V, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.231; Centers for Disease C, 2003, MMWR MORB MORTAL WKL, V52, P303; Chai AB, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0526-9; Chen HP, 2019, INT J CHRONIC OBSTR, V14, P1009, DOI 10.2147/COPD.S196210; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Durairaj H, 2015, INT IMMUNOPHARMACOL, V25, P485, DOI 10.1016/j.intimp.2015.02.029; Fessler MB, 2018, PHARMACOL THERAPEUT, V181, P1, DOI 10.1016/j.pharmthera.2017.07.010; Gao W, 2015, RESPIROLOGY, V20, P722, DOI 10.1111/resp.12542; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Goldklang MP, 2016, AM J RESP CELL MOL, V55, P848, DOI 10.1165/rcmb.2015-0407OC; Gu HF, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00165; Habib M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120559; Hamsanathan S, 2019, AM J RESP CELL MOL, V61, P21, DOI 10.1165/rcmb.2018-0410TR; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Janda S, 2009, CHEST, V136, P734, DOI 10.1378/chest.09-0194; Kiecolt-Glaser JK, 2015, AM J PSYCHIAT, V172, P1075, DOI 10.1176/appi.ajp.2015.15020152; Knadler MP, 2011, CLIN PHARMACOKINET, V50, P281, DOI 10.2165/11539240-000000000-00000; Kohler CA, 2018, MOL NEUROBIOL, V55, P4195, DOI 10.1007/s12035-017-0632-1; Lareau Suzanne C, 2010, Int J Chron Obstruct Pulmon Dis, V5, P401, DOI 10.2147/COPD.S14715; LAURENT P, 1983, CHEST, V83, pS63, DOI 10.1378/chest.83.5.63S; Liu FY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1388-x; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Michaeloudes C, 2020, J INNATE IMMUN, V12, P31, DOI 10.1159/000504344; Rawdin BJ, 2013, BRAIN BEHAV IMMUN, V31, P143, DOI 10.1016/j.bbi.2012.11.011; Sanja M, 2018, SCAND J CLIN LAB INV, V78, P533, DOI 10.1080/00365513.2018.1514464; Seagrave J, 2004, EXP LUNG RES, V30, P1, DOI 10.1080/01902140490252858; Sekine T, 2019, J APPL TOXICOL, V39, P717, DOI 10.1002/jat.3761; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615; Sonett J, 2018, FASEB J, V32, P6724, DOI 10.1096/fj.201701381; Vozoris NT, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00475-2018; Waiskopf N, 2014, J MOL NEUROSCI, V53, P306, DOI 10.1007/s12031-013-0174-6; Wallace AM, 2014, LUNG, V192, P467, DOI 10.1007/s00408-014-9585-6; Wallace AM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-79; Wang LN, 2019, BRAIN BEHAV IMMUN, V79, P24, DOI 10.1016/j.bbi.2019.02.021; Yeo J, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0603-y; Zhang W, 2017, CHEST, V152, P1159, DOI 10.1016/j.chest.2017.08.015	39	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21519	10.1096/fj.202001966RR	http://dx.doi.org/10.1096/fj.202001966RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34137477	Green Published, hybrid			2022-12-28	WOS:000667814100042
J	Dos Santos, GRRM; Leite, ACR; Lander, N; Chiurillo, MA; Vercesi, AE; Docampo, R				Dos Santos, Guilherme Rodrigo R. M.; Rezende Leite, Ana Catarina; Lander, Noelia; Chiurillo, Miguel Angel; Vercesi, Anibal Eugenio; Docampo, Roberto			Trypanosoma cruzi Letm1 is involved in mitochondrial Ca2+ transport, and is essential for replication, differentiation, and host cell invasion	FASEB JOURNAL			English	Article						calcium signaling; cell bioenergetics; Letm1; mitochondria; Trypanosoma cruzi	ESSENTIAL COMPONENT; CA-2+ TRANSPORT; CANDIDATE GENE; PROTEIN; MEMBRANE; TOPOLOGY; BIOENERGETICS; METABOLISM; PREDICTION; AUTOPHAGY	Leucine zipper-EF-hand containing transmembrane protein 1 (Letm1) is a mitochondrial inner membrane protein involved in Ca2+ and K+ homeostasis in mammalian cells. Here, we demonstrate that the Letm1 orthologue of Trypanosoma cruzi, the etiologic agent of Chagas disease, is important for mitochondrial Ca2+ uptake and release. The results show that both mitochondrial Ca2+ influx and efflux are reduced in TcLetm1 knockdown (TcLetm1-KD) cells and increased in TcLetm1 overexpressing cells, without alterations in the mitochondrial membrane potential. Remarkably, TcLetm1 knockdown or overexpression increases or does not affect mitochondrial Ca2+ levels in epimastigotes, respectively. TcLetm1-KD epimastigotes have reduced growth, and both overexpression and knockdown of TcLetm1 cause a defect in metacyclogenesis. TcLetm1-KD also affected mitochondrial bioenergetics. Invasion of host cells by TcLetm1-KD trypomastigotes and their intracellular replication is greatly impaired. Taken together, our findings indicate that TcLetm1 is important for Ca2+ homeostasis and cell viability in T cruzi.	[Dos Santos, Guilherme Rodrigo R. M.; Vercesi, Anibal Eugenio; Docampo, Roberto] Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Rua Cinco de Junho 350,Cidade Univ, BR-13083877 Campinas, SP, Brazil; [Rezende Leite, Ana Catarina] Univ Fed Alagoas, Inst Quim & Biotecnol, Lab Bioenerget, Maceio, Alagoas, Brazil; [Lander, Noelia; Chiurillo, Miguel Angel; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Docampo, Roberto] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA; [Lander, Noelia; Chiurillo, Miguel Angel] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Universidade Estadual de Campinas; Universidade Federal de Alagoas; University System of Georgia; University of Georgia; University System of Ohio; University of Cincinnati; University System of Georgia; University of Georgia	Vercesi, AE (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Rua Cinco de Junho 350,Cidade Univ, BR-13083877 Campinas, SP, Brazil.; Docampo, R (corresponding author), Univ Georgia, Paul D Coverdell Ctr, Dept Cellular Biol, 500 DW Brooks Dr, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Paul D Coverdell Ctr, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	anibal@unicamp.br; rdocampo@uga.edu	Leite, Ana C. R./K-8340-2014; dos Santos, Guilherme Rodrigo Reis M/D-8868-2018	Leite, Ana C. R./0000-0002-3426-3357; dos Santos, Guilherme Rodrigo Reis M/0000-0001-8680-869X; Vercesi, Anibal Eugenio/0000-0001-6671-7125; Docampo, Roberto/0000-0003-4229-8784; Lander, Noelia/0000-0003-2178-381X	Sao Paulo Research Foundation (FAPESP) [2013/50624--0, 2018/04559--6]; CNPq [405909/2015--2]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K99AI137322, AI108222]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sao Paulo Research Foundation (FAPESP), Grant/Award Number: 2013/50624--0 and 2018/04559--6; CNPq, Grant/Award Number: 405909/2015--2; National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Grant/Award Number: K99AI137322 and AI108222	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; [Anonymous], 2001, BIOENERGETICS; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Austin S, 2019, TRENDS BIOCHEM SCI, V44, P648, DOI 10.1016/j.tibs.2019.04.002; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Brennand Ana, 2012, Cells, V1, P346, DOI 10.3390/cells1030346; CARAFOLI E, 1970, BIOCHIM BIOPHYS ACTA, V205, P18, DOI 10.1016/0005-2728(70)90057-5; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chang L, 2019, ACTA BIOCH BIOPH SIN, V51, P78, DOI 10.1093/abbs/gmy138; Chiurillo MA, 2017, MBIO, V8, DOI [10.1128/mBio.00574-17, 10.1128/mbio.00574-17]; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; DOCAMPO R, 1989, ARCH BIOCHEM BIOPHYS, V272, P122, DOI 10.1016/0003-9861(89)90202-6; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Doonan PJ, 2014, FASEB J, V28, P4936, DOI 10.1096/fj.14-256453; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Gao P, 2020, DIABETES, V69, P165, DOI 10.2337/db19-0526; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Hashimi H, 2013, J BIOL CHEM, V288, P26914, DOI 10.1074/jbc.M113.495119; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Jiang DW, 2013, P NATL ACAD SCI USA, V110, pE2249, DOI 10.1073/pnas.1308558110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lander N, 2019, METHODS MOL BIOL, V1955, P61, DOI 10.1007/978-1-4939-9148-8_5; Lander N, 2018, J BIOL CHEM, V293, P17402, DOI [10.1074/jbc.RA118.004498, 10.1074/jbc.ra118.004498]; Lander N, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2299; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Li FJ, 2017, AUTOPHAGY, V13, P715, DOI 10.1080/15548627.2017.1280218; Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nakamura S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0832-5; Negreiros RS, 2021, MBIO, V12, DOI 10.1128/mBio.00540-21; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Palty R, 2012, J BIOL CHEM, V287, P31650, DOI 10.1074/jbc.R112.355867; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santulli G, 2015, P NATL ACAD SCI USA, V112, P11389, DOI 10.1073/pnas.1513047112; Smaili SS, 2013, CURR MOL MED, V13, P252; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Tang GF, 2018, MOL PLANT PATHOL, V19, P1595, DOI 10.1111/mpp.12633; Tsai MF, 2014, J GEN PHYSIOL, V143, P67, DOI 10.1085/jgp.201311096; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; VERCESI AE, 1992, BIOCHEM J, V284, P463, DOI 10.1042/bj2840463; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	62	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21685	10.1096/fj.202100120RR	http://dx.doi.org/10.1096/fj.202100120RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085343				2022-12-28	WOS:000667814100056
J	Liu, LR; Liu, F; Guan, YJ; Zou, JA; Zhang, CY; Xiong, CX; Zhao, TC; Bayliss, G; Li, XG; Zhuang, SG				Liu, Lirong; Liu, Feng; Guan, Yingjie; Zou, Jianan; Zhang, Chunyun; Xiong, Chongxiang; Zhao, Ting C.; Bayliss, George; Li, Xiaogang; Zhuang, Shougang			Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis	FASEB JOURNAL			English	Article						proliferation; renal interstitial fibroblasts; Smad3; SMYD2; TGF-beta 1; unilateral ureteral obstruction	TO-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; INTERSTITIAL FIBROSIS; EMERGING ROLES; METHYLATION; INHIBITION; CANCER; PROGRESSION; GENE; MECHANISMS	SET and MYND domain protein 2 (SMYD2) is a lysine methyltransferase that mediates histone H3 lysine 36 trimethylation (H3K36me3) and acts as a regulator of tumorgenesis and cystic growth. However, its role in renal fibrosis remains unknown. In this study, we found that SMYD2 was highly expressed in the murine kidney of renal fibrosis induced by unilateral ureteral obstruction, and primarily located in interstitial fibroblasts and renal tubular epithelial cells. Pharmacological inhibition of SMYD2 with AZ505, a highly selective inhibitor of SMYD2, protected against renal fibrosis and inhibited activation/proliferation of renal interstitial fibroblasts and conversion of epithelial cells to a profibrotic phenotype in this model. In cultured renal interstitial fibroblasts, treatment with AZ505 or silencing of SMYD2 by specific siRNA also inhibited serum- or TGF-beta 1-induced activation and proliferation of renal interstitial fibroblasts. Mechanistic studies showed that SMYD2 inhibition reduced phosphorylation of several profibrotic signaling molecules, including Smad3, extracellular signal-regulated kinase 1/2, AKT, signal transducer and activator of transcription-3 and nuclear factor-kappa B in both injured kidney and cultured renal fibroblasts. AZ505 was also effective in suppressing renal expression of Snail and Twist, two transcriptional factors that mediate renal partial epithelial-mesenchymal transition and fibrosis. Conversely, AZ505 treatment prevented downregulation of Smad7, a renoprotective factor in vivo and in vitro. These results indicate that SMYD2 plays a critical role in mediating conversion of epithelial cells to a profibrotic phenotype, renal fibroblast activation and renal fibrogenesis, and suggest that SMYD2 may be a potential target for the treatment of chronic fibrosis in kidney disease.	[Liu, Lirong; Guan, Yingjie; Zou, Jianan; Zhang, Chunyun; Xiong, Chongxiang; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Liu, Lirong; Guan, Yingjie; Zou, Jianan; Zhang, Chunyun; Xiong, Chongxiang; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Liu, Lirong] Guizhou Med Univ, Affiliated Hosp, Ctr Clin Labs, Guiyang, Peoples R China; [Liu, Lirong] Guizhou Med Univ, Sch Clin Lab Sci, Guiyang, Peoples R China; [Liu, Feng; Zhuang, Shougang] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China; [Zhao, Ting C.] Rhode Isl Hosp, Dept Surg, Providence, RI USA; [Li, Xiaogang] Mayo Clin, Dept Med, Rochester, MN USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Guizhou Medical University; Guizhou Medical University; Tongji University; Lifespan Health Rhode Island; Rhode Island Hospital; Mayo Clinic	Zhuang, SG (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China.	szhuang@lifespan.org			National Natural Science Foundation of China [81670623, 81830021]; National key R&D Program of China [2018YFA0108802]; US National Institutes of Health [2R01DK08506505A1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key R&D Program of China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Natural Science Foundation of China grants (81670623 and 81830021 to SZ), National key R&D Program of China (2018YFA0108802 to SZ), and US National Institutes of Health (2R01DK08506505A1 to SZ).	Andrikopoulos P, 2019, J AM SOC NEPHROL, V30, P33, DOI 10.1681/ASN.2018020209; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Chung ACK, 2013, MOL THER, V21, P388, DOI 10.1038/mt.2012.251; El-Deiry WS, 2016, CANCER RES, V76, P5189, DOI 10.1158/0008-5472.CAN-16-2055; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Lan AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105451; Li B, 2018, FUTURE ONCOL, V14, P1825, DOI 10.2217/fon-2017-0682; Li LDXY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0347-x; Li LX, 2017, J CLIN INVEST, V127, P2751, DOI 10.1172/JCI90921; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Nakakido M, 2015, NEOPLASIA, V17, P367, DOI 10.1016/j.neo.2015.03.002; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Pace J, 2019, AM J PHYSIOL-RENAL, V316, pF1151, DOI 10.1152/ajprenal.00034.2019; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Parmar N, 2020, J IMMUNOL, V204, P2762, DOI 10.4049/jimmunol.1900251; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; Santos F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040891; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Stenvinkel P, 2018, NAT REV NEPHROL, V14, P265, DOI 10.1038/nrneph.2017.169; Tamada S, 2006, J PHARMACOL SCI, V100, P17, DOI 10.1254/jphs.FMJ05003X4; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Sakamoto LHT, 2014, LEUKEMIA RES, V38, P496, DOI 10.1016/j.leukres.2014.01.013; Tracy CM, 2018, CURR OPIN PHYSIOL, V1, P140, DOI 10.1016/j.cophys.2017.10.001; Wang Y, 2019, ONCOGENE, V38, P4948, DOI 10.1038/s41388-019-0766-x; Wanner N, 2017, CELL TISSUE RES, V369, P75, DOI 10.1007/s00441-017-2588-x; Yan LB, 2019, THERANOSTICS, V9, P8377, DOI 10.7150/thno.37628; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yi X, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0711-4; Zhang HS, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0056-4; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52	43	7	8	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21715	10.1096/fj.202000554RRR	http://dx.doi.org/10.1096/fj.202000554RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143514	Green Accepted			2022-12-28	WOS:000667814100045
J	Brier, S; Rasetti-Escargueil, C; Wijkhuisen, A; Simon, S; Marechal, M; Lemichez, E; Popoff, MR				Brier, Sebastien; Rasetti-Escargueil, Christine; Wijkhuisen, Anne; Simon, Stephanie; Marechal, Maud; Lemichez, Emmanuel; Popoff, Michel R.			Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A	FASEB JOURNAL			English	Article						botulinum neurotoxin; botulism; epitope mapping; GT1b; mass spectrometry; Hydrogen-Deuterium eXchange; monoclonal antibody; synaptic vesicle protein 2	CD8(+) T-CELLS; TRANSCRIPTION FACTOR; CUTTING EDGE; REVEALS TOX; FACTOR-I; MEMORY; TCF-1; EXPRESSION; CHECKPOINT; DIFFERENTIATION	Compared to conventional antisera strategies, monoclonal antibodies (mAbs) represent an alternative and safer way to treat botulism, a fatal flaccid paralysis due to botulinum neurotoxins (BoNTs). In addition, mAbs offer the advantage to be produced in a reproducible manner. We previously identified a unique and potent mouse mAb (TA12) targeting BoNT/A1 with high affinity and neutralizing activity. In this study, we characterized the molecular basis of TA12 neutralization by combining Hydrogen/Deuterium eXchange Mass Spectrometry (HDX-MS) with site-directed mutagenesis and functional studies. We found that TA12 recognizes a conformational epitope located at the interface between the H-CN and H-CC subdomains of the BoNT/A1 receptor-binding domain (H-C). The TA12-binding interface shares common structural features with the ciA-C2 VHH epitope and lies on the face opposite recognized by ciA-C2-and the CR1/CR2-neutralizing mAbs. The single substitution of N1006 was sufficient to affect TA12 binding to H-C confirming the position of the epitope. We further uncovered that the TA12 epitope overlaps with the BoNT/A1-binding site for both the neuronal cell surface receptor synaptic vesicle glycoprotein 2 isoform C (SV2C) and the GT1b ganglioside. Hence, TA12 potently blocks the entry of BoNT/A1 into neurons by interfering simultaneously with the binding of SV2C and to a lower extent GT1b. Our study reveals the unique neutralization mechanism of TA12 and emphasizes on the potential of using single mAbs for the treatment of botulism type A.	[Brier, Sebastien] Inst Pasteur, CNRS, UMR3528, Biol NMR Technol Platform, Paris, France; [Rasetti-Escargueil, Christine; Marechal, Maud; Lemichez, Emmanuel; Popoff, Michel R.] Inst Pasteur, UMR CNRS 2001, Unite Toxines Bacteriennes, Paris, France; [Wijkhuisen, Anne; Simon, Stephanie] Univ Paris Saclay, CEA, INRAE, Dept Medicaments & Technol Sante, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Popoff, MR (corresponding author), Inst Pasteur, Toxines Bacteriennes, UMR CNRS 2001, F-75015 Paris, France.	popoff2m@gmail.com	Simon, Stephanie/E-4289-2012; lemichez, emmanuel/G-3559-2013; Popoff, Michel/O-7719-2016	Simon, Stephanie/0000-0002-6071-8255; lemichez, emmanuel/0000-0001-9080-7761; Popoff, Michel/0000-0001-9305-8989; Brier, Sebastien/0000-0003-1758-8237	CACSICE Equipex [ANR-11-EQPX-0008]; French joint ministerial program against CBRNE	CACSICE Equipex; French joint ministerial program against CBRNE	CACSICE Equipex, Grant/Award Number: ANR--11--EQPX--0008; French joint ministerial program against CBRNE	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Batra SA, 2020, CANCER IMMUNOL RES, V8, P309, DOI 10.1158/2326-6066.CIR-19-0293; Beavis PA, 2017, J CLIN INVEST, V127, P929, DOI 10.1172/JCI89455; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Cai HM, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12091051; Chang YM, 2020, J VIROL, V94, DOI 10.1128/JVI.00935-20; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Chu T, 2020, IMMUNITY, V52, P724, DOI 10.1016/j.immuni.2020.04.019; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Delpoux A, 2018, J EXP MED, V215, P575, DOI 10.1084/jem.20170697; Delpoux A, 2017, P NATL ACAD SCI USA, V114, pE8865, DOI 10.1073/pnas.1618916114; Donnarumma T, 2016, CELL REP, V17, P1571, DOI 10.1016/j.celrep.2016.10.013; Emmanuel AO, 2018, NAT IMMUNOL, V19, P1366, DOI 10.1038/s41590-018-0254-4; Ferreira DP, 2020, IMMUNITY, V53, P985, DOI 10.1016/j.immuni.2020.09.005; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Garcia-Perez L, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw7313; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Gentzler R, 2016, IMMUNOTHERAPY-UK, V8, P583, DOI 10.2217/imt-2015-0029; Giuffrida L, 2020, MOL THER, V28, P2379, DOI 10.1016/j.ymthe.2020.07.018; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guan Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00586; Harly C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00470; Harly C, 2019, NAT IMMUNOL, V20, P1150, DOI 10.1038/s41590-019-0445-7; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kim K, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00722-9; Kratchmarov R, 2018, BLOOD ADV, V2, P1685, DOI 10.1182/bloodadvances.2018016279; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Liu ZY, 2019, J IMMUNOL, V203, P323, DOI 10.4049/jimmunol.1900014; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Maier E, 2011, J BIOL CHEM, V286, P919, DOI 10.1074/jbc.M110.144949; Marcel N, 2020, CURR OPIN IMMUNOL, V63, P51, DOI 10.1016/j.coi.2020.02.001; Martinez M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00128; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Miron M, 2018, J IMMUNOL, V201, P2132, DOI 10.4049/jimmunol.1800716; Newick K, 2017, ANNU REV MED, V68, P139, DOI 10.1146/annurev-med-062315-120245; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Ouyang KF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5814; Paley MA, 2013, J LEUKOCYTE BIOL, V93, P307, DOI 10.1189/jlb.0812400; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pilipow K, 2020, METHOD ENZYMOL, V631, P137, DOI 10.1016/bs.mie.2019.08.016; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rutishauser RL, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.136648; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Saeidi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02569; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sekine T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba7918; Shan Q, 2021, CELL MOL IMMUNOL, V18, P1262, DOI 10.1038/s41423-020-0436-5; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simsek M, 2019, EURASIAN J MED, V51, P90, DOI 10.5152/eurasianjmed.2018.18194; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2018, CELL REP, V22, P3454, DOI 10.1016/j.celrep.2018.03.020; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang F, 2021, CELL MOL IMMUNOL, V18, P644, DOI 10.1038/s41423-020-00527-1; Wang YF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00169; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Welten SPM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16219-3; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yang J, 2020, J CELL PHYSIOL, V235, P3894, DOI 10.1002/jcp.29283; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yu Q, 2010, IMMUNOL RES, V47, P45, DOI 10.1007/s12026-009-8137-2; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhang J, 2018, J IMMUNOL, V200, P3397, DOI 10.4049/jimmunol.1800193; Zhang LP, 2019, EBIOMEDICINE, V44, P275, DOI 10.1016/j.ebiom.2019.03.076; Zhang XP, 2013, J CLIN ENDOCR METAB, V98, pE1305, DOI 10.1210/jc.2012-3602; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhao MZ, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008555; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	111	3	3	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21540	10.1096/fj.202002492R	http://dx.doi.org/10.1096/fj.202002492R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817838	Green Submitted			2022-12-28	WOS:000645260100084
J	Kaneva, MK; Muley, MM; Krustev, E; Reid, AR; Souza, PR; Dell'Accio, F; McDougall, JJ; Perretti, M				Kaneva, Magdalena K.; Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; Souza, Patricia R.; Dell'Accio, Francesco; McDougall, Jason J.; Perretti, Mauro			Alpha-1-antitrypsin reduces inflammation and exerts chondroprotection in arthritis	FASEB JOURNAL			English	Article						alpha-1-antitrypsin; arthritis; cartilage; chondrocyte; SERPINA1; tissue protection	WNT SIGNALING PATHWAY; NEUTROPHIL ELASTASE; ARTICULAR-CARTILAGE; PROTEINASE-INHIBITORS; GENE-EXPRESSION; ACTIVATION; PAIN; OSTEOARTHRITIS; COMPLEXES; LEUKOCYTE	While new treatments have been developed to control joint disease in rheumatoid arthritis, they are partially effective and do not promote structural repair of cartilage. Following an initial identification of alpha-1-Antitrypsin (AAT) during the resolution phase of acute inflammation, we report here the properties of this protein in the context of cartilage protection, joint inflammation, and associated pain behavior. Intra-articular and systemic administration of AAT reversed joint inflammation, nociception, and cartilage degradation in the KBxN serum and neutrophil elastase models of arthritis. Ex vivo analyses of arthritic joints revealed that AAT promoted transcription of col2a1, acan, and sox9 and downregulated mmp13 and adamts5 gene expression. In vitro studies using human chondrocytes revealed that SERPINA1 transfection and rAAT protein promoted chondrogenic differentiation through activation of PKA-dependent CREB signaling and inhibition of Wnt/beta-catenin pathways. Thus, AAT is endowed with anti-inflammatory, analgesic, and chondroprotective properties that are partially inter-related. We propose that AAT could be developed for new therapeutic strategies to reduce arthritic pain and repair damaged cartilage.	[Kaneva, Magdalena K.; Souza, Patricia R.; Dell'Accio, Francesco; Perretti, Mauro] Queen Mary Univ London, London Sch Med, William Harvey Res Inst, London, England; [Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; McDougall, Jason J.] Dalhousie Univ, Dept Pharmacol & Anaesthesia, Halifax, NS, Canada; [Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; McDougall, Jason J.] Dalhousie Univ, Dept Pain Management, Halifax, NS, Canada; [Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; McDougall, Jason J.] Dalhousie Univ, Dept Perioperat Med, Halifax, NS, Canada; [Dell'Accio, Francesco; Perretti, Mauro] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Muley, Milind M.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning PGCRL, Neurosci & Mental Hlth, Toronto, ON, Canada	University of London; Queen Mary University London; Dalhousie University; Dalhousie University; Dalhousie University; University of London; Queen Mary University London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kaneva, MK (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	kaneva.magdalena@gmail.com	Souza, Patricia/GLQ-8979-2022	Souza, Patricia/0000-0003-3826-6261; Kaneva, Magdalena K/0000-0003-3822-749X; Muley, Milind/0000-0002-8138-9964; Perretti, Mauro/0000-0003-2068-3331	William Harvey Research Foundation; Canadian Institute for Health Research; MRC [MR/R000956/1]; CIHR team grant [PJT-153303]	William Harvey Research Foundation; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CIHR team grant(Canadian Institutes of Health Research (CIHR))	This work was largely supported by the William Harvey Research Foundation through an unrestricted grant (MKK and MP), with additional support by operating grants from the Canadian Institute for Health Research and a CIHR team grant (PJT--153303; REACH; JJMcD) and the MRC (MR/R000956/1, FDA).	Aldonyte R, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-11; Andruski B, 2008, AM J PHYSIOL-REG I, V295, pR814, DOI 10.1152/ajpregu.90524.2008; Bergin DA, 2012, ARCH IMMUNOL THER EX, V60, P81, DOI 10.1007/s00005-012-0162-5; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Carroll TP, 2010, J IMMUNOL, V184, P4538, DOI 10.4049/jimmunol.0802864; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cichy J, 1997, J BIOL CHEM, V272, P8250, DOI 10.1074/jbc.272.13.8250; Potilinski MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228895; Deshmukh V, 2019, OSTEOARTHR CARTILAGE, V27, P1347, DOI 10.1016/j.joca.2019.05.006; Deshmukh V, 2018, OSTEOARTHR CARTILAGE, V26, P18, DOI 10.1016/j.joca.2017.08.015; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; DUBOIS RM, 1991, BLOOD, V77, P2724; Eldridge SE, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax9086; Gao WX, 2014, J HEART LUNG TRANSPL, V33, P309, DOI 10.1016/j.healun.2013.10.031; Gold M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0165-8; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Greco KV, 2014, BIOCHEM PHARMACOL, V91, P348, DOI 10.1016/j.bcp.2014.07.034; Grimstein C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-21; Grimstein C, 2010, J GENE MED, V12, P35, DOI 10.1002/jgm.1409; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; JAMES HL, 1978, J CLIN INVEST, V62, P1344, DOI 10.1172/JCI109255; Janciauskiene S, 2004, BIOCHEM BIOPH RES CO, V321, P592, DOI 10.1016/j.bbrc.2004.06.123; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Janciauskiene SM, 2007, NEW TRICKS J BIOL CH, V282, P8573; Joosten LAB, 2016, ANN RHEUM DIS, V75, P1219, DOI 10.1136/annrheumdis-2014-206966; Juhasz T, 2014, CELL SIGNAL, V26, P468, DOI 10.1016/j.cellsig.2013.12.001; KAKIMOTO K, 1995, CELL IMMUNOL, V165, P26, DOI 10.1006/cimm.1995.1183; Kaneva MK, 2017, J IMMUNOL, V198, P2876, DOI 10.4049/jimmunol.1601111; Kaneva MK, 2012, BRIT J PHARMACOL, V167, P67, DOI 10.1111/j.1476-5381.2012.01968.x; Kim KH, 2009, ANIM CELLS SYST, V13, P289, DOI 10.1080/19768354.2009.9647221; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Krustev E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0437-9; Landman EBM., 2013, ARTHRITIS RES THER, V15, P1; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Malerba M, 2006, THORAX, V61, P129, DOI 10.1136/thx.2005.043471; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McBride JD, 2014, J INVEST DERMATOL, V134, P1725, DOI 10.1038/jid.2014.40; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Miao CG, 2013, CELL SIGNAL, V25, P2069, DOI 10.1016/j.cellsig.2013.04.002; Momohara S, 1997, CLIN RHEUMATOL, V16, P133, DOI 10.1007/BF02247841; Monteagudo S, 2017, NAT REV RHEUMATOL, V13, P670, DOI 10.1038/nrrheum.2017.171; Moore AR, 1999, ANN RHEUM DIS, V58, P109, DOI 10.1136/ard.58.2.109; Muley MM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0944-0; Muley MM, 2016, BRIT J PHARMACOL, V173, P766, DOI 10.1111/bph.13237; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Philpott HT, 2017, PAIN, V158, P2442, DOI 10.1097/j.pain.0000000000001052; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Rabelo FD, 2010, AUTOIMMUN REV, V9, P207, DOI 10.1016/j.autrev.2009.08.003; Salgado E, 2014, MED CLIN-BARCELONA, V143, P461, DOI 10.1016/j.medcli.2013.11.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahaf G, 2011, MOL MED, V17, P1000, DOI 10.2119/molmed.2011.00145; TRAVIS J, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P313; TURINO GM, 1969, SCIENCE, V165, P709, DOI 10.1126/science.165.3894.709; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; WATANABE H, 1990, J BIOCHEM-TOKYO, V108, P753, DOI 10.1093/oxfordjournals.jbchem.a123277; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Yazici Y, 2017, OSTEOARTHR CARTILAGE, V25, P1598, DOI 10.1016/j.joca.2017.07.006; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107	69	9	9	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21472	10.1096/fj.202001801R	http://dx.doi.org/10.1096/fj.202001801R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788977				2022-12-28	WOS:000645260100014
J	Sopariwala, DH; Likhite, N; Pei, GS; Haroon, F; Lin, LS; Yadav, V; Zhao, ZM; Narkar, VA				Sopariwala, Danesh H.; Likhite, Neah; Pei, Gungsheng; Haroon, Fnu; Lin, Lisa; Yadav, Vikas; Zhao, Zhongming; Narkar, Vihang A.			Estrogen-related receptor a is involved in angiogenesis and skeletal muscle revascularization in hindlimb ischemia	FASEB JOURNAL			English	Article						angiogenesis; gene expression; ischemia; nuclear receptors; skeletal muscle	ENDOTHELIAL GROWTH-FACTOR; PROLIFERATOR-ACTIVATED RECEPTOR; ERR-ALPHA; PROMOTES ANGIOGENESIS; LIPID-ACCUMULATION; KEY REGULATOR; FIBER-TYPE; EXPRESSION; EXERCISE; METABOLISM	Skeletal muscle ischemia is a major consequence of peripheral arterial disease (PAD) or critical limb ischemia (CLI). Although therapeutic options for resolving muscle ischemia in PAD/CLI are limited, the issue is compounded by poor understanding of the mechanisms driving muscle vascularization. We found that nuclear receptor estrogen-related receptor alpha (ERR alpha) expression is induced in murine skeletal muscle by hindlimb ischemia (HLI), and in cultured myotubes by hypoxia, suggesting a potential role for ERR alpha in ischemic response. To test this, we generated skeletal muscle-specific ERR alpha transgenic (TG) mice. In these mice, ERR alpha drives myofiber type switch from glycolytic type IIB to oxidative type IIA/IIX myofibers, which are typically associated with more vascular supply in muscle. Indeed, RNA sequencing and functional enrichment analysis of TG muscle revealed that "paracrine angiogenesis" is the top-ranked transcriptional program activated by ERR alpha in the skeletal muscle. Immunohistochemistry and angiography showed that ERR alpha overexpression increases baseline capillarity, arterioles and non-leaky blood vessel formation in the skeletal muscles. Moreover, ERR alpha overexpression facilitates ischemic neo-angiogenesis and perfusion recovery in hindlimb musculature of mice subjected to HLI. Therefore, ERR alpha is a hypoxia inducible nuclear receptor that is involved in skeletal muscle angiogenesis and could be potentially targeted for treating PAD/CLI.	[Sopariwala, Danesh H.; Likhite, Neah; Haroon, Fnu; Lin, Lisa; Yadav, Vikas; Narkar, Vihang A.] UTHlth, McGovern Med Sch, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Pei, Gungsheng; Zhao, Zhongming] UTHlth, Sch Biomed Informat, Ctr Precis Med, Houston, TX 77030 USA; [Lin, Lisa] Rice Univ, Biochem & Cell Biol, Houston, TX USA; [Zhao, Zhongming] UTHlth, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Narkar, Vihang A.] UTHlth, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Yadav, Vikas] Jawaharlal Nehru Univ, Life Sci, New Delhi, India	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Rice University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Jawaharlal Nehru University, New Delhi	Narkar, VA (corresponding author), UTHlth, McGovern Med Sch, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	vihang.a.narkar@uth.tmc.edu		Pei, Guangsheng/0000-0003-1804-7598; yadav, vikas/0000-0001-5445-3775	NIH [1R01HL129191, R01LM012806]; Bayer Pharmaceuticals [0014079]; American Heart Association [20TPA35410038, 19POST34380771]; Hamman Foundation Endowment in Cardiovascular Research; Ramalingaswami Department of Biotechnology, Government of India Fellowship [BT/RLF/Re-entry/29/2014]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP180734]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer Pharmaceuticals(Bayer AG); American Heart Association(American Heart Association); Hamman Foundation Endowment in Cardiovascular Research; Ramalingaswami Department of Biotechnology, Government of India Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT)	This research was supported by funding to V.A.N from NIH (#1R01HL129191), Bayer Pharmaceuticals (#0014079), American Heart Association (20TPA35410038) and Hamman Foundation Endowment in Cardiovascular Research. D.H.S. was supported by a post--doctoral fellowship from American Heart Association (#19POST34380771). V.Y. was supported by Ramalingaswami Department of Biotechnology, Government of India Fellowship (#BT/RLF/Re--entry/29/2014). Z.Z. is supported by NIH grant #R01LM012806. RNA sequencing and data analysis work was performed through the UTHealth Cancer Genomics Core funded by Cancer Prevention and Research Institute of Texas (CPRIT) core grant (#RP180734). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amoasii L, 2019, P NATL ACAD SCI USA, V116, P11299, DOI 10.1073/pnas.1902490116; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Ashoff A, 2012, J VASC RES, V49, P260, DOI 10.1159/000335214; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bonaca MP, 2015, CIRC RES, V116, P1579, DOI 10.1161/CIRCRESAHA.114.303505; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cooke JP, 2015, CIRC RES, V116, P1561, DOI 10.1161/CIRCRESAHA.115.303565; Cozzone D, 2006, DIABETOLOGIA, V49, P990, DOI 10.1007/s00125-006-0140-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Geretti E, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4490; Hamburg NM, 2017, CIRC J, V81, P281, DOI 10.1253/circj.CJ-16-1286; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hiatt WR, 2015, CIRC RES, V116, P1527, DOI 10.1161/CIRCRESAHA.116.303566; Horard B, 2004, J MOL ENDOCRINOL, V33, P493, DOI 10.1677/jme.1.01538; Huppunen J, 2004, BIOCHEM BIOPH RES CO, V314, P964, DOI 10.1016/j.bbrc.2003.12.194; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Jude EB, 2010, DIABETIC MED, V27, P4, DOI 10.1111/j.1464-5491.2009.02866.x; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Khazaei M, 2012, J DIABETES COMPLICAT, V26, P137, DOI 10.1016/j.jdiacomp.2012.02.005; Kim SY, 2018, AUTOPHAGY, V14, P152, DOI 10.1080/15548627.2017.1339001; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kupr B, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029835; LaBarge S, 2014, FASEB J, V28, P1082, DOI 10.1096/fj.13-229211; Li P, 2010, AM J PHYSIOL-ENDOC M, V299, pE560, DOI 10.1152/ajpendo.00284.2010; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Likhite N, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00411-18; Matsakas A, 2013, FASEB J, V27, P4004, DOI 10.1096/fj.13-228296; Matsakas A, 2012, CIRC RES, V110, P1087, DOI 10.1161/CIRCRESAHA.112.266478; Matsakas A, 2010, CURR SPORT MED REP, V9, P227, DOI 10.1249/JSR.0b013e3181e93938; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Murray J, 2011, AM J PHYSIOL-CELL PH, V301, pC630, DOI 10.1152/ajpcell.00033.2011; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Nagahama R, 2012, ARTERIOSCL THROM VAS, V32, P2427, DOI 10.1161/ATVBAHA.112.253823; Nagai H, 1987, Josanpu Zasshi, V41, P602; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Perez-Schindler J, 2012, MOL CELL BIOL, V32, P4913, DOI 10.1128/MCB.00877-12; Perry MC, 2014, MOL ENDOCRINOL, V28, P2060, DOI 10.1210/me.2014-1281; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salehi E, 2012, GEN PHYSIOL BIOPHYS, V31, P255, DOI 10.4149/gpb_2012_033; Sass FA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030835; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tontonoz P, 2015, MOL CELL BIOL, V35, P1125, DOI 10.1128/MCB.00715-14; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yadav V, 2014, CELL REP, V8, P783, DOI 10.1016/j.celrep.2014.06.040; Yang QB, 2018, ANGIOGENESIS, V21, P313, DOI 10.1007/s10456-018-9597-6; Yoshida S, 2013, CIRCULATION, V128, P60, DOI 10.1161/CIRCULATIONAHA.113.001533; Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003	75	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21480	10.1096/fj.202001794RR	http://dx.doi.org/10.1096/fj.202001794RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788962				2022-12-28	WOS:000645260100007
J	Spiroski, AM; Niu, YG; Nicholas, LM; Austin-Williams, S; Camm, EJ; Sutherland, MR; Ashmore, TJ; Skeffington, KL; Logan, A; Ozanne, SE; Murphy, MP; Giussani, DA				Spiroski, Ana-Mishel; Niu, Youguo; Nicholas, Lisa M.; Austin-Williams, Shani; Camm, Emily J.; Sutherland, Megan R.; Ashmore, Thomas J.; Skeffington, Katie. L.; Logan, Angela; Ozanne, Susan E.; Murphy, Michael P.; Giussani, Dino A.			Mitochondria antioxidant protection against cardiovascular dysfunction programmed by early-onset gestational hypoxia	FASEB JOURNAL			English	Article						cardiovascular; fetus; hypoxia; IUGR; mitochondria; oxidative stress; programming	INTRAUTERINE GROWTH RESTRICTION; PRENATAL HYPOXIA; OXIDATIVE STRESS; MATERNAL HYPOXIA; ACUTE HYPOXEMIA; NITRIC-OXIDE; BLOOD-FLOW; FETAL; RAT; DEFENSE	Mitochondria-derived oxidative stress during fetal development increases cardiovascular risk in adult offspring of pregnancies complicated by chronic fetal hypoxia. We investigated the efficacy of the mitochondria-targeted antioxidant MitoQ in preventing cardiovascular dysfunction in adult rat offspring exposed to gestational hypoxia, integrating functional experiments in vivo, with those at the isolated organ and molecular levels. Rats were randomized to normoxic or hypoxic (13%-14% O2) pregnancy +/- MitoQ (500 mu M day(-1)) in the maternal drinking water. At 4 months of age, one cohort of male offspring was chronically instrumented with vascular catheters and flow probes to test in vivo cardiovascular function. In a second cohort, the heart was isolated and mounted onto a Langendorff preparation. To establish mechanisms linking gestational hypoxia with cardiovascular dysfunction and protection by MitoQ, we quantified the expression of antioxidant system, beta-adrenergic signaling, and calcium handling genes in the fetus and adult, in frozen tissues from a third cohort. Maternal MitoQ in hypoxic pregnancy protected offspring against increased alpha(1)-adrenergic reactivity of the cardiovascular system, enhanced reactive hyperemia in peripheral vascular beds, and sympathetic dominance, hypercontractility and diastolic dysfunction in the heart. Inhibition of Nfe2l2-mediated oxidative stress in the fetal heart and preservation of calcium regulatory responses in the hearts of fetal and adult offspring link molecular mechanisms to the protective actions of MitoQ treatment of hypoxic pregnancy. Therefore, these data show the efficacy of MitoQ in buffering mitochondrial stress through NADPH-induced oxidative damage and the prevention of programmed cardiovascular disease in adult offspring of hypoxic pregnancy.	[Spiroski, Ana-Mishel; Niu, Youguo; Austin-Williams, Shani; Camm, Emily J.; Sutherland, Megan R.; Ashmore, Thomas J.; Skeffington, Katie. L.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Spiroski, Ana-Mishel; Niu, Youguo; Ozanne, Susan E.; Giussani, Dino A.] Cambridge Cardiovasc Strateg Res Initiat, Cambridge, England; [Nicholas, Lisa M.; Ozanne, Susan E.] Univ Cambridge, Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Cambridge, England; [Logan, Angela; Murphy, Michael P.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England; [Ozanne, Susan E.; Giussani, Dino A.] Strateg Res Initiat Reprod, Cambridge, England; [Murphy, Michael P.] Univ Cambridge, Dept Med, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	dag26@cam.ac.uk		Spiroski, Ana-Mishel/0000-0002-8584-8048; Austin-Williams, Shani/0000-0002-8255-583X	British Heart Foundation [PG/14/5/30547, RG/17/12/33167]; Medical Research Council UK [MC_U105663142, MC_UU_00014/4]; Wellcome Trust [110159/A/15/Z]	British Heart Foundation(British Heart Foundation); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to the staff of the University of Cambridge Combined Animal Facility. This work was supported by the British Heart Foundation (Giussani lab: PG/14/5/30547). Work in the Murphy lab is supported by the Medical Research Council UK (MC_U105663142) and by a Wellcome Trust Investigator award (110159/A/15/Z). MPM consults for MitoQ Inc Work in the Ozanne lab is supported by the Medical Research Council UK (MC_UU_00014/4) and the British Heart Foundation (RG/17/12/33167).	Aljunaidy MM, 2018, PHARMACOL RES, V134, P332, DOI 10.1016/j.phrs.2018.05.006; Allison BJ, 2016, J PHYSIOL-LONDON, V594, P1247, DOI 10.1113/JP271091; Bansal A, 2020, J DEV ORIG HLTH DIS, P1; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Beeson JH, 2018, MOL METAB, V16, P35, DOI 10.1016/j.molmet.2018.06.009; Bertagnolli M, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0637-6; Botting KJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb1929; Brain KL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006552; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Coney AM, 2010, J PHYSIOL-LONDON, V588, P5115, DOI 10.1113/jphysiol.2010.198275; Danielson L, 2005, J PHYSIOL-LONDON, V563, P611, DOI 10.1113/jphysiol.2004.080523; Darby JRT, 2021, J PHYSIOL-LONDON, V599, P1307, DOI 10.1113/JP280693; Darby JRT, 2020, THERIOGENOLOGY, V150, P84, DOI 10.1016/j.theriogenology.2020.01.080; Donovan EL, 2017, REPROD SCI, V24, P865, DOI 10.1177/1933719116670516; Dunbar SB, 2018, CIRCULATION, V137, pE558, DOI 10.1161/CIR.0000000000000570; Fortner KA, 2020, LUPUS SCI MED, V7; Fowden AL, 2021, CURR VASC PHARMACOL, V19, P113, DOI 10.2174/1570161118666200513115316; FUJII J, 1991, J BIOL CHEM, V266, P11669; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Ganguly E, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104836; Ganguly E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00562; Gardner DS, 2002, J PHYSIOL-LONDON, V540, P351, DOI 10.1113/jphysiol.2001.013434; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 1999, J PHYSIOL-LONDON, V515, P233, DOI 10.1111/j.1469-7793.1999.233ad.x; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gonzalez-Candia A, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101128; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; HECHER K, 1995, AM J OBSTET GYNECOL, V173, P10, DOI 10.1016/0002-9378(95)90161-2; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Heimlich JB, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12052; Herrera EA, 2017, J PHYSIOL-LONDON, V595, P1077, DOI 10.1113/JP273396; Hovnanian A., 2007, V45, P337; Kane AD, 2014, J PHYSIOL-LONDON, V592, P475, DOI 10.1113/jphysiol.2013.264275; Kane AD, 2013, CIRC J, V77, P2604, DOI 10.1253/circj.CJ-13-0311; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kumar P, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14327; Leo F, 2020, BIOCHEM PHARMACOL, V176, DOI 10.1016/j.bcp.2020.113893; Lindgren I, 2013, AM J PHYSIOL-REG I, V305, pR1093, DOI 10.1152/ajpregu.00320.2013; Mortensen SP, 2012, J PHYSIOL-LONDON, V590, P4391, DOI 10.1113/jphysiol.2012.235952; Niu YG, 2018, HYPERTENSION, V72, P971, DOI 10.1161/HYPERTENSIONAHA.118.11363; Niu YG, 2013, J PHYSIOL-LONDON, V591, P5083, DOI 10.1113/jphysiol.2013.258210; Nuzzo AM, 2018, AM J PATHOL, V188, P2704, DOI 10.1016/j.ajpath.2018.07.027; OTSU K, 1990, J BIOL CHEM, V265, P13472; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06300-1; Pinho BR, 2020, FREE RADICAL BIO MED, V146, P372, DOI 10.1016/j.freeradbiomed.2019.11.021; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Rook W, 2014, HYPERTENSION, V64, P1321, DOI 10.1161/HYPERTENSIONAHA.114.04374; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Ruijtenbeek K, 2003, PFLUG ARCH EUR J PHY, V447, P158, DOI 10.1007/s00424-003-1170-4; Ruijtenbeek K, 2000, CIRCULATION, V102, P2892; Ryoo IG, 2018, TOXICOL APPL PHARM, V359, P24, DOI 10.1016/j.taap.2018.09.014; Shah A, 2016, J PHYSIOL-LONDON, V594, P1465, DOI 10.1113/JP271133; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Skeffington KL, 2020, HYPERTENSION, V76, P533, DOI 10.1161/HYPERTENSIONAHA.120.15045; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Soria R, 2013, PEDIATR RES, V74, P633, DOI 10.1038/pr.2013.150; Spiroski AM, 2018, J PHYSIOL-LONDON, V596, P5925, DOI 10.1113/JP274999; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Thakor AS, 2010, J PHYSIOL-LONDON, V588, P4235, DOI 10.1113/jphysiol.2010.196402; Thakor AS, 2015, J PINEAL RES, V59, P80, DOI 10.1111/jpi.12242; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Thompson LP, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/582748; Tymko MM, 2020, CIRC RES, V127, pE1, DOI 10.1161/CIRCRESAHA.119.316053; Van Buren T, 1998, CARDIOVASC RES, V38, P763, DOI 10.1016/S0008-6363(98)00038-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh MP, 2006, J PHYSIOL-LONDON, V575, P263, DOI 10.1113/jphysiol.2006.108753; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004	76	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21446	10.1096/fj.202002705R	http://dx.doi.org/10.1096/fj.202002705R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788974	Green Published, Green Accepted			2022-12-28	WOS:000645260100062
J	Feng, HP; Cheng, HY; Hsiao, TF; Lin, TW; Hsu, JW; Huang, LH; Yu, CJ				Feng, Hsiang-Pu; Cheng, Hsiao-Yun; Hsiao, Ting-Feng; Lin, Tai-Wei; Hsu, Jia-Wei; Huang, Lien-Hung; Yu, Chia-Jung			ArfGAP1 acts as a GTPase-activating protein for human ADP-ribosylation factor-like 1 protein	FASEB JOURNAL			English	Article						ADP&#8208; ribosylation factor; Arf&#8208; like protein Arl1; Golgi; GTPase&#8208; activating protein; vesicle trafficking		ADP-ribosylation factors (Arfs) and Arf-like (Arl) GTPases are key regulators of intracellular vesicle trafficking and Golgi structure. Both Arf and Arl proteins cycle between active GTP-bound and inactive GDP-bound forms, where guanine nucleotide exchange factors (GEFs) regulate the exchange of GDP for GTP, whereas GTPase-activating proteins (GAPs) promote the hydrolysis of bound GTP. Human Arl1 is located at the trans-Golgi network (TGN) and regulates the function and structure of the Golgi complex. However, neither GEFs nor GAPs for human Arl1 have been identified. Here, we report that ArfGAP1, an Arf1 GAP, can promote GTP hydrolysis of Arl1. We show that ArfGAP1 directly interacts with GTP-bound Arl1 and exhibits GAP activity toward Arl1 in vitro. Exogenous expression of ArfGAP1, but not ArfGAP2 and ArfGAP3, causes dissociation of endogenous Arl1 from the TGN. In addition, GAP activity-deficient ArfGAP1 fails to regulate the Golgi localization of Arl1. Using an activity pull-down assay, we demonstrated that ArfGAP1 regulates the levels of Arl1-GTP in cells expressing ArfGAP1-myc or with ArfGAP1 knockdown. Finally, we observed that, similar to expression of putative active Arl1 (Arl1QL), ArfGAP1 knockdown impairs endosome-to-TGN retrograde transport of the Shiga toxin B-subunit. Thus, our findings support the idea that ArfGAP1 acts as an Arl1 GAP to regulate the function of Arl1 in vesicle trafficking at the TGN.	[Feng, Hsiang-Pu; Hsiao, Ting-Feng; Lin, Tai-Wei; Huang, Lien-Hung; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Cheng, Hsiao-Yun; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Dept Cell & Mol Biol, 259 Wen Hwa 1st Rd, Taoyuan, Taiwan; [Hsu, Jia-Wei] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei, Taiwan; [Hsu, Jia-Wei] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei, Taiwan; [Huang, Lien-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Yu, Chia-Jung] Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan; [Yu, Chia-Jung] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Yu, CJ (corresponding author), Chang Gung Univ, Coll Med, Dept Cell & Mol Biol, 259 Wen Hwa 1st Rd, Taoyuan, Taiwan.	yucj1124@mail.cgu.edu.tw		Hsiao, Ting-Feng/0000-0003-4074-9019; Huang, Lien-Hung/0000-0001-8641-9897; Yu, Chia-Jung/0000-0001-6301-7190	Ministry of Science and Technology, Taiwan [105-2320-B-182-035-MY3, 108-2320-B-182-007-MY3, MOST-109-2636-B-002-015]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CORPD1J0092, CMRPD1H0081-3, BMRP894]; Molecular Medicine Research Center, Chang Gung University, from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital); Molecular Medicine Research Center, Chang Gung University, from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan	This work was financially supported by grants from the Ministry of Science and Technology, Taiwan (105-2320-B-182-035-MY3 and 108-2320-B-182-007-MY3 to C.-J. Y., MOST-109-2636-B-002-015 to J.-W. H.); the Chang Gung Memorial Hospital, Taoyuan, Taiwan (CORPD1J0092, CMRPD1H0081-3, and BMRP894 to C.-J. Y.); and the Molecular Medicine Research Center, Chang Gung University, from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan.	Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Souza RS, 2014, CURR BIOL, V24, P1187, DOI 10.1016/j.cub.2014.04.003; Dembla M, 2014, J NEUROSCI, V34, P5245, DOI 10.1523/JNEUROSCI.3837-13.2014; Dodonova SO, 2017, ELIFE, V6, DOI 10.7554/eLife.26691; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Eiseler T, 2016, J BIOL CHEM, V291, P462, DOI 10.1074/jbc.M115.673582; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Goud Bruno, 2018, Small GTPases, V9, P66, DOI 10.1080/21541248.2017.1384087; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Huang LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118743; Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786; Huber I, 2001, METHOD ENZYMOL, V329, P307; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lowe SL, 1996, J CELL SCI, V109, P209; Lu L, 2005, METHOD ENZYMOL, V404, P432, DOI 10.1016/S0076-6879(05)04038-3; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2001, J CELL SCI, V114, P4543; Luo RB, 2008, J BIOL CHEM, V283, P21965, DOI 10.1074/jbc.M802268200; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Pevzner I, 2012, TRAFFIC, V13, P849, DOI 10.1111/j.1600-0854.2012.01349.x; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Saitoh A, 2009, J BIOL CHEM, V284, P13948, DOI 10.1074/jbc.M900749200; Shiba Y, 2013, CURR BIOL, V23, P1945, DOI 10.1016/j.cub.2013.07.087; Shiba Yoko, 2011, Cell Logist, V1, P139, DOI 10.4161/cl.1.4.18896; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Siu KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018458; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Sztul E, 2019, MOL BIOL CELL, V30, P1249, DOI 10.1091/mbc.E18-12-0820; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Yu CJ, 2017, J CELL SCI, V130, P1691, DOI 10.1242/jcs.201319; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015	56	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21337	10.1096/fj.202000818RR	http://dx.doi.org/10.1096/fj.202000818RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715220				2022-12-28	WOS:000635216100099
J	Mirra, P; Desiderio, A; Spinelli, R; Nigro, C; Longo, M; Parrillo, L; D'Esposito, V; Carissimo, A; Hedjazifar, S; Smith, U; Formisano, P; Miele, C; Raciti, GA; Beguinot, F				Mirra, Paola; Desiderio, Antonella; Spinelli, Rosa; Nigro, Cecilia; Longo, Michele; Parrillo, Luca; D'Esposito, Vittoria; Carissimo, Annamaria; Hedjazifar, Shahram; Smith, Ulf; Formisano, Pietro; Miele, Claudia; Raciti, Gregory A.; Beguinot, Francesco			Adipocyte precursor cells from first degree relatives of type 2 diabetic patients feature changes in hsa-mir-23a-5p, -193a-5p, and -193b-5p and insulin-like growth factor 2 expression	FASEB JOURNAL			English	Article						adipocyte precursor cells; first degree relatives of type 2 diabetic patients; marks; miRNAs; type 2 diabetes	WHITE ADIPOSE-TISSUE; FAMILY-HISTORY; 1ST-DEGREE RELATIVES; IMPAIRED ADIPOGENESIS; NONOBESE INDIVIDUALS; HYPERTROPHIC OBESITY; FAT DISTRIBUTION; WNT; RESISTANCE; DIFFERENTIATION	First-degree relatives (FDRs) of type 2 diabetics (T2D) feature dysfunction of subcutaneous adipose tissue (SAT) long before T2D onset. miRNAs have a role in adipocyte precursor cells (APC) differentiation and in adipocyte identity. Thus, impaired miRNA expression may contribute to SAT dysfunction in FDRs. In the present work, we have explored changes in miRNA expression associated with T2D family history which may affect gene expression in SAT APCs from FDRs. Small RNA-seq was performed in APCs from healthy FDRs and matched controls and omics data were validated by qPCR. Integrative analyses of APC miRNome and transcriptome from FDRs revealed down-regulated hsa-miR-23a-5p, -193a-5p and -193b-5p accompanied by up-regulated Insulin-like Growth Factor 2 (IGF2) gene which proved to be their direct target. The expression changes in these marks were associated with SAT adipocyte hypertrophy in FDRs. APCs from FDRs further demonstrated reduced capability to differentiate into adipocytes. Treatment with IGF2 protein decreased APC adipogenesis, while over-expression of hsa-miR-23a-5p, -193a-5p and -193b-5p enhanced adipogenesis by IGF2 targeting. Indeed, IGF2 increased the Wnt Family Member 10B gene expression in APCs. Down-regulation of the three miRNAs and IGF2 up-regulation was also observed in Peripheral Blood Leukocytes (PBLs) from FDRs. In conclusion, APCs from FDRs feature a specific miRNA/gene profile, which associates with SAT adipocyte hypertrophy and appears to contribute to impaired adipogenesis. PBL detection of this profile may help in identifying adipocyte hypertrophy in individuals at high risk of T2D.	[Mirra, Paola; Desiderio, Antonella; Spinelli, Rosa; Nigro, Cecilia; Longo, Michele; Parrillo, Luca; D'Esposito, Vittoria; Formisano, Pietro; Miele, Claudia; Raciti, Gregory A.; Beguinot, Francesco] CNR, Inst Expt Endocrinol & Oncol, URT Genom Diabet, Via Pansini 5, I-80131 Naples, Italy; [Mirra, Paola; Desiderio, Antonella; Spinelli, Rosa; Nigro, Cecilia; Longo, Michele; Parrillo, Luca; D'Esposito, Vittoria; Formisano, Pietro; Miele, Claudia; Raciti, Gregory A.; Beguinot, Francesco] Federico II Univ Naples, Dept Translat Med, Naples, Italy; [Carissimo, Annamaria] Telethon Inst Genet & Med, Pozzuoli, Italy; [Hedjazifar, Shahram; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Gothenburg	Miele, C; Beguinot, F (corresponding author), CNR, Inst Expt Endocrinol & Oncol, URT Genom Diabet, Via Pansini 5, I-80131 Naples, Italy.	c.miele@ieos.cnr.it; beguino@unina.it	Parrillo, Luca/AIA-1186-2022	Parrillo, Luca/0000-0001-9801-9778; D'Esposito, Vittoria/0000-0002-3675-8062	Ministero dell'Istruzione, Universita e della Ricerca Scientifica [PRIN 2017, ARS01_01270]; Regione Campania; European Foundation for the Study of Diabetes (EFSD); Boehringer Ingelheim; Swedish Research Council; Torsten Soderberg Foundation; Novo Nordisk Foundation	Ministero dell'Istruzione, Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Regione Campania(Regione Campania); European Foundation for the Study of Diabetes (EFSD); Boehringer Ingelheim(Boehringer Ingelheim); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Ministero dell'Istruzione, Universita e della Ricerca Scientifica, Grant/Award Number: PRIN 2017 and ARS01_01270; Regione Campania; European Foundation for the Study of Diabetes (EFSD); Boehringer Ingelheim; Swedish Research Council; Torsten Soderberg Foundation; Novo Nordisk Foundation	Acosta JR, 2016, DIABETOLOGIA, V59, P560, DOI 10.1007/s00125-015-3810-6; Alfares MN, 2018, AM J PHYSIOL-ENDOC M, V315, pE1098, DOI 10.1152/ajpendo.00409.2017; Anthanont P, 2017, INT J OBESITY, V41, P1621, DOI 10.1038/ijo.2017.171; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bianchi M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040840; Blake GET, 2016, CURR OPIN CHEM BIOL, V33, P101, DOI 10.1016/j.cbpa.2016.06.008; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brandao BB, 2017, REDOX BIOL, V12, P82, DOI 10.1016/j.redox.2017.01.020; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cederberg H, 2015, J INTERN MED, V277, P540, DOI 10.1111/joim.12289; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Corral-Fernandez NE, 2013, EXP CLIN ENDOCR DIAB, V121, P347, DOI 10.1055/s-0033-1341516; Corrales P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072124; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; DUPUIS J, 2010, NAT GENET, V42; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Forouhi Nita G, 2014, Curr Nutr Rep, V3, P355; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Hammarstedt A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34113-3; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Hashimoto N, 2017, J HUM GENET, V62, P141, DOI 10.1038/jhg.2016.150; He YQ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030456; Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; Johanson EH, 2003, J CLIN ENDOCR METAB, V88, P4232, DOI 10.1210/jc.2002-021961; Kanherkar RR, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00049; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kleiman A, 2013, EXP MOL PATHOL, V94, P126, DOI 10.1016/j.yexmp.2012.09.023; Knowles NG, 2002, DIABETES CARE, V25, P292, DOI 10.2337/diacare.25.2.292; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee PL, 2016, MOL METAB, V5, P422, DOI 10.1016/j.molmet.2016.04.001; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Longo M, 2018, DIABETOLOGIA, V61, P369, DOI 10.1007/s00125-017-4471-4; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Mirra P, 2017, BBA-MOL BASIS DIS, V1863, P440, DOI 10.1016/j.bbadis.2016.11.018; Mitchell BD, 2004, OBES RES, V12, P831, DOI 10.1038/oby.2004.100; Mohlke KL, 2015, HUM MOL GENET, V24, pR85, DOI 10.1093/hmg/ddv264; Nyholm B, 2004, EUR J ENDOCRINOL, V150, P207, DOI 10.1530/eje.0.1500207; Panzeri I, 2018, MOL METAB, V14, P26, DOI 10.1016/j.molmet.2018.05.010; Parrillo L, 2020, EPIGENOMICS-UK, V12, P873, DOI 10.2217/epi-2019-0267; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Raciti GA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43526; Raciti GA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193704; Rassoulzadegan M, 2015, SEMIN CELL DEV BIOL, V44, P47, DOI 10.1016/j.semcdb.2015.08.007; Ren G, 2018, MOL MED REP, V17, P4554, DOI 10.3892/mmr.2018.8452; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Stancakova A, 2016, ENDOCR DEV, V31, P203, DOI 10.1159/000439418; Vassy Jason L, 2011, Diabetes Res Clin Pract, V93, pe76, DOI 10.1016/j.diabres.2011.04.013; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Xu L, 2015, BIOMOLECULES, V5, P1563, DOI 10.3390/biom5031563; Yang J, 2012, OBESITY, V20, P932, DOI 10.1038/oby.2011.371; Yang J, 2020, MOL MED REP, V21, P2395, DOI 10.3892/mmr.2020.11069; Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152; Yi F, 2017, BIOCHEM BIOPH RES CO, V491, P876, DOI 10.1016/j.bbrc.2017.07.108; Zhang K, 2019, EXP THER MED, V17, P1663, DOI 10.3892/etm.2018.7132; Zhou J, 2016, J CANCER, V7, P1740, DOI 10.7150/jca.15620	74	4	4	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21357	10.1096/fj.202002156RRR	http://dx.doi.org/10.1096/fj.202002156RRR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710685				2022-12-28	WOS:000635216100005
J	Wei, XM; Li, C; Zhang, Y; Li, K; Li, JQ; Ai, KT; Li, KM; Zhang, JS; Yang, JL				Wei, Xiumei; Li, Cheng; Zhang, Yu; Li, Kang; Li, Jiaqi; Ai, Kete; Li, Kunming; Zhang, Jiansong; Yang, Jialong			Fish NF-kappa B couples TCR and IL-17 signals to regulate ancestral T-cell immune response against bacterial infection	FASEB JOURNAL			English	Article						adaptive immunity; evolution; IL&#8208; 17; NF&#8208; &#954; B; T cells; teleost	PEPTIDOGLYCAN RECOGNITION PROTEINS; EVOLUTION ANALYSIS; FAMILY CYTOKINES; HOST-DEFENSE; TH17 CELLS; RECEPTOR; GENES; ROLES; ACTIVATION; DIVERSITY	As fish constitute the first evolutionary group with primordial T cells, they are of importance for understanding the origin and evolution of adaptive immunity. Yet, the knowledge about how ancestral T cells function remains limited. Therefore, the teleost model Nile tilapia (Oreochromis niloticus) was used in this study to investigate the regulatory mechanisms of T-cell immunity in fish. We identified an evolutionarily conserved canonical NF-kappa B signaling pathway in Nile tilapia, which participates in primary adaptive immune response during Streptococcus agalactiae infection. Blockade of NF-kappa B activity severely impairs T-cell activation and expansion, rendering the animals more vulnerable to pathogen attack. Meanwhile, NF-kappa B signaling is indispensable for fish T cells to produce IL-17A during the antibacterial immune response. Moreover, IL-17A binds its receptor IL-17RA, initiates the ACT1-TRAF6-TAK1 axis, and triggers NF-kappa B-dependent T-cell activation, thus forming a positive feedback loop of T-cell immunity in Nile tilapia. Furthermore, IL-17A seems to promote innate immunity by regulating pro-inflammatory cytokines via TRAF6-NF-kappa B axis, indicating the presence of an NF-kappa B-dependent IL-17A signaling pathway for coordinating adaptive and innate immunity in fish. Our results suggest that fish NF-kappa B couples TCR and IL-17 signals to modulate ancestral T-cell immunity against bacterial infection, and the regulation of T-cell immunity by NF-kappa B and IL-17 is a strategy that existed prior to the divergence of the tetrapod lineage from teleost fish. This study, therefore, provides a new perspective on the evolution of adaptive immunity.	[Wei, Xiumei; Li, Cheng; Zhang, Yu; Li, Kang; Li, Jiaqi; Ai, Kete; Li, Kunming; Zhang, Jiansong; Yang, Jialong] East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China; [Yang, Jialong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	East China Normal University; Qingdao National Laboratory for Marine Science & Technology	Yang, JL (corresponding author), East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China.	jlyang@bio.ecnu.edu.cn	kang, li/HCH-5087-2022		National Natural Science Foundation of China (NSFC) [32022086, 31972822, 31872591]; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation) [20ZR1417500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 32022086, 31972822 and 31872591; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation), Grant/Award Number: 20ZR1417500	Algood HMS, 2009, J IMMUNOL, V183, P5837, DOI 10.4049/jimmunol.0901206; Aronica MA, 1999, J IMMUNOL, V163, P5116; Bottcher J, 2015, SEMIN IMMUNOL, V27, P4, DOI 10.1016/j.smim.2015.03.001; Brenke JK, 2018, J BIOL CHEM, V293, P13191, DOI 10.1074/jbc.RA118.002649; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Ding Y, 2016, FISH SHELLFISH IMMUN, V58, P332, DOI 10.1016/j.fsi.2016.09.017; Dong CJ, 2019, GENE, V686, P68, DOI 10.1016/j.gene.2018.10.038; Ferreira V, 1999, J IMMUNOL, V162, P6442; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gonzalez-Fernandez C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072439; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hui SP, 2017, DEV CELL, V43, P659, DOI 10.1016/j.devcel.2017.11.010; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Kim JS, 2013, CELL MOL LIFE SCI, V70, P2271, DOI 10.1007/s00018-012-1163-6; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li C, 2020, DEV COMP IMMUNOL, V103, DOI 10.1016/j.dci.2019.103526; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li YN, 2020, FISH SHELLFISH IMMUN, V97, P474, DOI 10.1016/j.fsi.2019.11.036; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Loo TT, 2018, J LEUKOCYTE BIOL, V104, P1069, DOI 10.1002/JLB.1RI0418-152RR; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Mousallem T, 2014, BLOOD, V124, P2046, DOI 10.1182/blood-2014-04-571265; Nakanishi Teruyuki, 2015, Biology-Basel, V4, P640, DOI 10.3390/biology4040640; Ouaaz F, 1999, J EXP MED, V189, P999, DOI 10.1084/jem.189.6.999; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Royet J, 2004, CELL MOL LIFE SCI, V61, P537, DOI 10.1007/s00018-003-3243-0; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sumiyoshi M, 2021, J IMMUNOL, V206, P366, DOI 10.4049/jimmunol.2000971; Sun JJ, 2019, J IMMUNOL, V203, P1845, DOI 10.4049/jimmunol.1900238; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Takeuchi Y, 2020, IMMUNOL REV, V294, P164, DOI 10.1111/imr.12841; Takizawa F, 2016, J IMMUNOL, V196, P4522, DOI 10.4049/jimmunol.1600222; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Thaventhiran JED, 2013, CURR OPIN IMMUNOL, V25, P321, DOI 10.1016/j.coi.2013.05.010; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00675; Wang L., 2020, FISH SHELLFISH IMMUN, V97, p554; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei XM, 2020, J BIOL CHEM, V295, P3000, DOI 10.1074/jbc.RA119.012231; Wei XM, 2020, J IMMUNOL, V204, P569, DOI 10.4049/jimmunol.1901065; Wei XM, 2019, J IMMUNOL, V203, P1172, DOI 10.4049/jimmunol.1900008; Wu Z., 2019, FISH SHELLFISH IMMUN, V93, p1084; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Xu TJ, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00256-18, 10.1128/iai.00256-18]; Yang Q, 2016, FISH SHELLFISH IMMUN, V49, P243, DOI 10.1016/j.fsi.2015.12.031	62	6	6	5	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21457	10.1096/fj.202002393RR	http://dx.doi.org/10.1096/fj.202002393RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33689192				2022-12-28	WOS:000635216100100
J	Zhang, Z; Wen, HQ; Peng, BJ; Weng, J; Zeng, FH				Zhang, Zhi; Wen, Huiqing; Peng, Bangjian; Weng, Jun; Zeng, Fanhong			CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis	FASEB JOURNAL			English	Article						CFLAR; cyclin&#8208; dependent kinase inhibitor 2A; fatty liver disease; lipogenesis; PIAS1; PRMT1; SUMOylation		Previous literature has indicated that cyclin-dependent kinase inhibitor 2 A (CDKN2A) is upregulated, while the Protein Inhibitor of Activated STAT1 (PIAS1) is downregulated in the liver tissues of obese mice. The current study aimed to investigate the relationship between CDKN2A and PIAS1 in the lipogenesis of fatty liver disease. In the C57BL/6J db/db mouse model and hepatocyte model of fatty liver, the expression pattern of CDKN2A, PIAS1, Protein arginine methyltransferase 1 (PRMT1) and CASP8 and FADD-like apoptosis regulator (CFLAR) was characterized by RNA quantitative and Western blot analysis. The lipogenesis-related genes (Srebp1c and Fas) in the liver tissues and cells were employed in the assessment of lipogenesis in response to gain- or loss-of-function of CDKN2A, PIAS1, PRMT1, and CFLAR, while triglyceride and fat content were evaluated in relation to fat accumulation. Western blot analysis was conducted to determine c-Jun amino-terminal kinase (JNK) phosphorylation, while the ubiquitination of CFLAR and SUMOylation of PIAS1 was examined by immunoprecipitation. PIAS1 and CFLAR were downregulated, while CDKN2A, PRMT1, and phosphorylation of JNK was elevated in the tissues and cells of the fatty liver models. Our results suggested that CDKN2A enhanced the SUMOylation of PIAS1 to reduce the expression of PIAS1. PRMT1 downregulated CFLAR by triggering its ubiquitination, while CFLAR repressed phosphorylation of JNK. The in vitro and in vivo results indicated that CDKN2A silencing prevented lipogenesis and fat accumulation by impairing the PRMT1-dependent ubiquitination of CFLAR and blocking the phosphorylation of JNK. Taken together, the central observations of our study demonstrate that targeting CDKN2A contributes to the suppression of lipogenesis and fat accumulation in fatty liver disease. The findings of our study highlight the potential of CDKN2A as a promising target against fatty liver.	[Zhang, Zhi; Wen, Huiqing; Peng, Bangjian] Southern Med Univ, Affiliated Hosp 5, Dept Hepatobiliary Surg, 566,Dongcheng Ave, Guangzhou 510900, Guangdong, Peoples R China; [Weng, Jun; Zeng, Fanhong] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhang, Z (corresponding author), Southern Med Univ, Affiliated Hosp 5, Dept Hepatobiliary Surg, 566,Dongcheng Ave, Guangzhou 510900, Guangdong, Peoples R China.	mshijizhang@163.com						Alagu J, 2018, J IMMUNOL, V201, P451, DOI 10.4049/jimmunol.1800327; Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Baidal JAW, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8390; Bantubungi K, 2014, DIABETES, V63, P3199, DOI 10.2337/db13-1921; Christen V, 2007, J VIROL, V81, P159, DOI 10.1128/JVI.01292-06; Gao B, 2016, GASTROENTEROLOGY, V150, P1704, DOI 10.1053/j.gastro.2016.01.025; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Li MY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1064-8; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21810; Liu Y, 2015, DIABETES, V64, P4061, DOI 10.2337/db15-0278; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Liu YY, 2019, ACTA PHARM SIN B, V9, P745, DOI 10.1016/j.apsb.2019.02.006; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Marchesini G, 2016, HEPATOLOGY, V63, P2032, DOI 10.1002/hep.28392; Mitterberger MC, 2014, J GERONTOL A-BIOL, V69, P13, DOI 10.1093/gerona/glt043; Musso G, 2016, DIABETES CARE, V39, P1830, DOI 10.2337/dc15-1182; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Pacana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136822; Pal A, 2016, DIABETES, V65, P527, DOI 10.2337/db15-0602; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Qiao XN, 2019, ENDOCRINOLOGY, V160, P2773, DOI 10.1210/en.2019-00504; Rabhi N, 2018, MOL METAB, V8, P65, DOI 10.1016/j.molmet.2017.11.012; Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8; Toropainen S, 2015, NUCLEIC ACIDS RES, V43, P848, DOI 10.1093/nar/gku1375; Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056; Zeng L, 2014, INT J CLIN EXP MED, V7, P1624; Zhang XY, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0595-5; Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011; Zhang YL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.403139; Zhuge BZ, 2017, BIOCHEM BIOPH RES CO, V494, P687, DOI 10.1016/j.bbrc.2017.10.149	31	1	1	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21230	10.1096/fj.202000683R	http://dx.doi.org/10.1096/fj.202000683R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769609				2022-12-28	WOS:000635216100007
J	Lan, XY; Liang, Y; Erkut, EJN; Kunze, M; Mulet-Sierra, A; Gong, TX; Osswald, M; Ansari, K; Seikaly, H; Boluk, Y; Adesida, AB				Lan, Xiaoyi; Liang, Yan; Erkut, Esra J. N.; Kunze, Melanie; Mulet-Sierra, Aillette; Gong, Tianxing; Osswald, Martin; Ansari, Khalid; Seikaly, Hadi; Boluk, Yaman; Adesida, Adetola B.			Bioprinting of human nasoseptal chondrocytes-laden collagen hydrogel for cartilage tissue engineering	FASEB JOURNAL			English	Article						bioprinting; chondrocytes; collagen; hydrogel; nasal cartilage; tissue engineering	MESENCHYMAL STEM-CELLS; BIOMATERIALS; SOX9; REPAIR; INDUCTION; HYPERTROPHY; EXPRESSION; SCAFFOLDS; DEFECTS; BIOINK	Skin cancer patients often have tumorigenic lesions on their noses. Surgical resection of the lesions often results in nasal cartilage removal. Cartilage grafts taken from other anatomical sites are used for the surgical reconstruction of the nasal cartilage, but donor-site morbidity is a common problem. Autologous tissue-engineered nasal cartilage grafts can mitigate the problem, but commercially available scaffolds define the shape and sizes of the engineered grafts during tissue fabrication. Moreover, the engineered grafts suffer from the inhomogeneous distribution of the functional matrix of cartilage. Advances in 3D bioprinting technology offer the opportunity to engineer cartilages with customizable dimensions and anatomically shaped configurations without the inhomogeneous distribution of cartilage matrix. Here, we report the fidelity of Freeform Reversible Embedding of Suspended Hydrogel (FRESH) bioprinting as a strategy to generate customizable and homogenously distributed functional cartilage matrix engineered nasal cartilage. Using FRESH and in vitro chondrogenesis, we have fabricated tissue-engineered nasal cartilage from combining bovine type I collagen hydrogel and human nasoseptal chondrocytes. The engineered nasal cartilage constructs displayed molecular, biochemical and histological characteristics akin to native human nasal cartilage.	[Lan, Xiaoyi; Boluk, Yaman] Univ Alberta, Fac Engn, Dept Civil & Environm Engn, Edmonton, AB, Canada; [Liang, Yan; Erkut, Esra J. N.; Kunze, Melanie; Mulet-Sierra, Aillette; Gong, Tianxing; Adesida, Adetola B.] Univ Alberta, Dept Surg, Div Orthoped Surg, Edmonton, AB, Canada; [Liang, Yan; Erkut, Esra J. N.; Kunze, Melanie; Mulet-Sierra, Aillette; Gong, Tianxing; Adesida, Adetola B.] Univ Alberta, Dept Surg, Div Surg Res, Edmonton, AB, Canada; [Osswald, Martin] Misericordia Community Hosp, Inst Reconstruct Sci Med iRSM, Edmonton, AB, Canada; [Osswald, Martin; Ansari, Khalid; Seikaly, Hadi; Adesida, Adetola B.] Univ Alberta, Dept Surg, Div Otolaryngol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Boluk, Y (corresponding author), Univ Alberta, Dept Civil & Environm Engn, 7-273 Donadeo Innovat Ctr Engn, Edmonton, AB T6G 2H9, Canada.; Adesida, AB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, 3-002E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada.	yaman.boluk@ualberta.ca; adesida@ualberta.ca	/AAE-4337-2022; Lan, Xiaoyi (Michelle)/GNW-4073-2022	Lan, Xiaoyi (Michelle)/0000-0002-0465-1869; Liang, Yan/0000-0002-1847-1703; Erkut, Esra/0000-0003-2027-8344	Canadian Institutes for Health Research [CIHR PS 159661]; Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program [ACF-MIBRP 27128]; Edmonton Civic Employees Charitable Assistance Fund [RES0041788]; Canadian Foundation for Innovation [CFI 33786]; University Hospital Foundation [RES0028185]; Natural Sciences and Engineering Research Council of Canada-Discovery Grant Program [NSERC RGPIN 06431]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program; Edmonton Civic Employees Charitable Assistance Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); University Hospital Foundation; Natural Sciences and Engineering Research Council of Canada-Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institutes for Health Research, Grant/Award Number: CIHR PS 159661; Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program, Grant/Award Number: ACF-MIBRP 27128; Edmonton Civic Employees Charitable Assistance Fund, Grant/Award Number: RES0041788; Canadian Foundation for Innovation, Grant/Award Number: CFI 33786; University Hospital Foundation, Grant/Award Number: RES0028185; Natural Sciences and Engineering Research Council of Canada-Discovery Grant Program, Grant/Award Number: NSERC RGPIN 06431	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Andrews SHJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06666-2; Ansari M, 2019, BIO-DES MANUF, V2, P41, DOI 10.1007/s42242-018-0031-0; Austin GK, 2016, CURR OPIN OTOLARYNGO, V24, P453, DOI 10.1097/MOO.0000000000000295; Avila Hector Martinez, 2016, Bioprinting, V1-2, P22, DOI 10.1016/j.bprint.2016.08.003; Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; BURGET GC, 1985, PLAST RECONSTR SURG, V76, P239, DOI 10.1097/00006534-198508000-00010; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686; Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779; Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]; Demirtas TT, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa7b1d; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Fulco I, 2014, LANCET, V384, P337, DOI 10.1016/S0140-6736(14)60544-4; Gao T, 2018, BIOFABRICATION, V10, DOI 10.1088/1758-5090/aacdc7; Gatenholm P, 2018, REF SER BIOMED ENG, P331, DOI 10.1007/978-3-319-45444-3_14; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Grogan SP, 2006, TISSUE ENG, V12, P2141, DOI 10.1089/ten.2006.12.2141; Gudmann NS, 2016, BIOCHEMISTRY OF COLLAGENS, LAMININS AND ELASTIN: STRUCTURE, FUNCTION AND BIOMARKERS, P13, DOI 10.1016/B978-0-12-809847-9.00002-7; Gupta N, 2019, ANN OTO RHINOL LARYN, V128, P640, DOI 10.1177/0003489419836667; Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k; Hinton TJ, 2016, ACS BIOMATER SCI ENG, V2, P1781, DOI 10.1021/acsbiomaterials.6b00170; Hinton TJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500758; Holden PK, 2008, LARYNGOSCOPE, V118, P1153, DOI 10.1097/MLG.0b013e31816ed5ad; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Irawan V, 2018, TISSUE ENG REGEN MED, V15, P673, DOI 10.1007/s13770-018-0135-9; Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285; Kajave NS, 2020, MAT SCI ENG C-MATER, V107, DOI 10.1016/j.msec.2019.110290; Kim YB, 2016, ACS APPL MATER INTER, V8, P32230, DOI 10.1021/acsami.6b11669; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Kundu J, 2015, J TISSUE ENG REGEN M, V9, P1286, DOI 10.1002/term.1682; Lee A, 2019, SCIENCE, V365, P482, DOI 10.1126/science.aav9051; Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096; Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011; Markstedt K, 2015, BIOMACROMOLECULES, V16, P1489, DOI 10.1021/acs.biomac.5b00188; Menick FJ, 2010, PLAST RECONSTR SURG, V125, p138E, DOI 10.1097/PRS.0b013e3181d0ae2b; Middleman S., 1977, FUNDAMENTALS POLYM P; Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17; Muller M, 2017, ANN BIOMED ENG, V45, P210, DOI 10.1007/s10439-016-1704-5; Mumme M, 2016, LANCET, V388, P1985, DOI 10.1016/S0140-6736(16)31658-0; Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326; Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110; Ng WL, 2016, INT J BIOPRINTING, V2, P53, DOI 10.18063/IJB.2016.01.009; Nguyen D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00690-y; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Park JY, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035004; Park SH, 2019, NPG ASIA MATER, V11, DOI 10.1038/s41427-019-0130-1; Paxton N, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa8dd8; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pescosolido L, 2011, BIOMACROMOLECULES, V12, P1831, DOI 10.1021/bm200178w; Radhakrishnan S, 2020, LECT N EARTH SYST SC, P3, DOI 10.1007/978-3-030-21614-6_1; Raimer David W, 2011, Dermatol Online J, V17, P1; Rhee S, 2016, ACS BIOMATER SCI ENG, V2, P1800, DOI 10.1021/acsbiomaterials.6b00288; Romo T 3rd, 1998, Facial Plast Surg, V14, P151, DOI 10.1055/s-2008-1064339; Sayed KE., 2010, TISSUE ENG PART B RE, V16, p603; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz S, 2020, MAT SCI ENG C-MATER, V116, DOI 10.1016/j.msec.2020.111189; Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011; Toriumi DM, 2000, ARCH OTOLARYNGOL, V126, P562, DOI 10.1001/archotol.126.4.562; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Vinatier C, 2016, ANN PHYS REHABIL MED, V59, P139, DOI 10.1016/j.rehab.2016.03.002; Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004; WALLACE DG, 1983, BIOPOLYMERS, V22, P1793, DOI 10.1002/bip.360220713; Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]; YOO TJ, 1986, ANN NY ACAD SCI, V475, P341, DOI 10.1111/j.1749-6632.1986.tb20886.x	71	6	6	6	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21191	10.1096/fj.202002081R	http://dx.doi.org/10.1096/fj.202002081R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33595884				2022-12-28	WOS:000629576700038
J	Dasgupta, A; Chen, KH; Lima, PDA; Mewburn, J; Wu, DC; Al-Qazazi, R; Jones, O; Tian, L; Potus, F; Bonnet, S; Archer, SL				Dasgupta, Asish; Chen, Kuang-Hueih; Lima, Patricia D. A.; Mewburn, Jeffrey; Wu, Danchen; Al-Qazazi, Ruaa; Jones, Oliver; Tian, Lian; Potus, Francois; Bonnet, Sebastien; Archer, Stephen L.			PINK1-induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension	FASEB JOURNAL			English	Article						adenoviral gene therapy; mitochondrial dynamics; non-small cell lung cancer (NSCLC); phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1); protein kinase A (PKA)	SMOOTH-MUSCLE-CELLS; MITOCHONDRIAL FISSION; DOWN-REGULATION; INHIBITION; DIVISION; DRP1; APOPTOSIS; DYNAMICS; MFN2	Impaired mitochondrial fusion, due in part to decreased mitofusin 2 (Mfn2) expression, contributes to unrestricted cell proliferation and apoptosis-resistance in hyperproliferative diseases like pulmonary arterial hypertension (PAH) and non-small cell lung cancer (NSCLC). We hypothesized that Mfn2 levels are reduced due to increased proteasomal degradation of Mfn2 triggered by its phosphorylation at serine 442 (S442) and investigated the potential kinase mediators. Mfn2 expression was decreased and Mfn2 S442 phosphorylation was increased in pulmonary artery smooth muscle cells from PAH patients and in NSCLC cells. Mfn2 phosphorylation was mediated by PINK1 and protein kinase A (PKA), although only PINK1 expression was increased in these diseases. We designed a S442 phosphorylation deficient Mfn2 construct (PD-Mfn2) and a S442 constitutively phosphorylated Mfn2 construct (CP-Mfn2). The effects of these modified Mfn2 constructs on Mfn2 expression and biological function were compared with those of the wildtype Mfn2 construct (WT-Mfn2). WT-Mfn2 increased Mfn2 expression and mitochondrial fusion in both PAH and NSCLC cells resulting in increased apoptosis and decreased cell proliferation. Compared to WT-Mfn2, PD-Mfn2 caused greater Mfn2 expression, suppression of proliferation, apoptosis induction, and cell cycle arrest. Conversely, CP-Mfn2 caused only a small increase in Mfn2 expression and did not restore mitochondrial fusion, inhibit cell proliferation, or induce apoptosis. Silencing PINK1 or PKA, or proteasome blockade using MG132, increased Mfn2 expression, enhanced mitochondrial fusion and induced apoptosis. In a xenotransplantation NSCLC model, PD-Mfn2 gene therapy caused greater tumor regression than did therapy with WT-Mfn2. Mfn2 deficiency in PAH and NSCLC reflects proteasomal degradation triggered by Mfn2-S442 phosphorylation by PINK1 and/or PKA. Inhibiting Mfn2 phosphorylation has potential therapeutic benefit in PAH and lung cancer.	[Dasgupta, Asish; Chen, Kuang-Hueih; Mewburn, Jeffrey; Wu, Danchen; Al-Qazazi, Ruaa; Tian, Lian; Potus, Francois; Archer, Stephen L.] Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada; [Lima, Patricia D. A.; Jones, Oliver; Archer, Stephen L.] Queens Univ, Translat Inst Med TIME, Dept Med, Queens Cardiopulm Unit QCPU, Kingston, ON, Canada; [Tian, Lian] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Potus, Francois; Bonnet, Sebastien] Laval Univ, Inst Univ Cardiol & Pneumol, Quebec Res Ctr, Pulm Hypertens Res Grp, Quebec City, PQ, Canada	Queens University - Canada; Queens University - Canada; University of Strathclyde; Laval University	Archer, SL (corresponding author), Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada.	stephen.archer@queensu.ca	Wu, Danchen/W-4727-2019	Wu, Danchen/0000-0003-3901-5907; Tian, Lian/0000-0002-9699-8009; Al-Qazazi, Ruaa/0000-0003-0983-9745	CIHR Foundation Grant; Tier 1 Canada Research Chair in Mitochondrial Dynamics; William J Henderson Foundation; Canadian Vascular Network Scholar Award;  [NIH-RO1-HL071115];  [1RC1HL099462]	CIHR Foundation Grant(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair in Mitochondrial Dynamics; William J Henderson Foundation; Canadian Vascular Network Scholar Award; ; 	CIHR Foundation Grant, NIH--RO1-HL071115, 1RC1HL099462, a Tier 1 Canada Research Chair in Mitochondrial Dynamics and the William J Henderson Foundation (SLA), Canadian Vascular Network Scholar Award (AD and DW)	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Cai PC, 2017, AM J PHYSIOL-LUNG C, V312, P1638, DOI 10.1152/ajplung.00260.2016; Caretta Antonio, 2011, Cancers (Basel), V3, P913, DOI 10.3390/cancers3010913; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cheng X, 2013, NEOPLASMA, V60, P620, DOI 10.4149/neo_2013_080; Dasgupta A, 2020, FASEB J, V34, P5106, DOI 10.1096/fj.201903117R; Dasgupta A, 2015, J IMMUNOL, V195, P5780, DOI 10.4049/jimmunol.1501023; Day RM, 2006, BIOCHEM PHARMACOL, V71, P386, DOI 10.1016/j.bcp.2005.10.035; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; He YH, 2020, AM J RESP CRIT CARE, V201, P1263, DOI 10.1164/rccm.201911-2137OC; Huang CY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1019-6; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Mashima T, 1998, CYTOTECHNOLOGY, V27, P293, DOI 10.1023/A:1008058031511; Potus F, 2015, CIRCULATION, V132, P932, DOI 10.1161/CIRCULATIONAHA.115.016382; Prieto J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11124; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Ryan J, 2015, J MOL MED, V93, P229, DOI 10.1007/s00109-015-1263-5; Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC; Sapio L, 2014, EXCLI J, V13, P843; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tian L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00828; Wang WL, 2012, MED ONCOL, V29, P70, DOI 10.1007/s12032-010-9779-6; Wu DC, 2020, FASEB J, V34, P1447, DOI 10.1096/fj.201901467R; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Xu SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13189; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940; Zhang GE, 2013, INT J MOL SCI, V14, P13005, DOI 10.3390/ijms140713005	35	7	8	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21771	10.1096/fj.202100361R	http://dx.doi.org/10.1096/fj.202100361R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34275172	Green Accepted			2022-12-28	WOS:000678975300052
J	Pirmardan, ER; Barakat, A; Zhang, YN; Naseri, M; Hafezi-Moghadam, A				Ranaei Pirmardan, Ehsan; Barakat, Aliaa; Zhang, Yuanlin; Naseri, Marzieh; Hafezi-Moghadam, Ali			Diabetic cataract in the Nile grass rat: A longitudinal phenotypic study of pathology formation	FASEB JOURNAL			English	Article						animal model; anterior; posterior subcapsular cataract (ASC; PSC); lens epithelial cells (LEC); metabolic syndrome (MetS); type 2 diabetes (T2D)	ANTERIOR SUBCAPSULAR CATARACT; METABOLIC SYNDROME; ALDOSE REDUCTASE; N-CADHERIN; MODEL; MOUSE; COMPLICATIONS; RETINOPATHY; MECHANISMS; OPACITIES	Diabetes is a major risk factor for cataract, the leading cause of blindness worldwide. There is an unmet need for a realistic model of diabetic cataract for mechanistic and longitudinal studies, as existing models do not reflect key aspects of the complex human disease. Here, we introduce and characterize diabetic cataract in the Nile grass rat (NGR, Arvicanthis niloticus), an established model of metabolic syndrome and type 2 diabetes (T2D). We conducted a longitudinal study of cataract in over 88 NGRs in their non-diabetic, pre-diabetic, and diabetic stages of metabolism. Oral glucose tolerance test (OGTT) results distinguished the metabolic stages. Diverse cataract types were observed in the course of diabetes, including cortical, posterior subcapsular (PSC), and anterior subcapsular (ASC), all of which succeeded a characteristic dotted ring stage in all animals. The onset ages of diabetes and cataract were 44 +/- 3 vs 29 +/- 1 (P < .001) and 66 +/- 5 vs 58 +/- 6 (not significant) weeks in females and males, respectively. Histological analysis revealed fiber disorganization, vacuolar structures, and cellular proliferation and migration in cataractous lenses. The lens epithelial cells (LECs) in non-diabetic young NGRs expressed the stress marker GRP78, as did LECs and migrated cells in the lenses of diabetic animals. Elucidating mechanisms underlying LEC proliferation and migration will be clinically valuable in prevention and treatment of posterior capsule opacification, a dreaded complication of cataract surgery. Marked changes in N-cadherin expression emphasized a role for LEC integrity in cataractogenesis. Apoptotic cells were dispersed in the equatorial areas in early cataractogenesis. Our study reveals diverse cataract types that spontaneously develop in the diabetic NGR, and which uniquely mirror the cataract and its chronic course of development in individuals with diabetes. We provide mechanistic insights into early stages of diabetic cataract. These unique characteristics make NGR highly suited for mechanistic studies, especially in the context of metabolism, diabetes, and aging.	[Ranaei Pirmardan, Ehsan; Barakat, Aliaa; Zhang, Yuanlin; Hafezi-Moghadam, Ali] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Mol Biomarkers Nanoimaging Lab, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA; [Naseri, Marzieh] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran; [Naseri, Marzieh] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran, Iran	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Iran University of Medical Sciences; Iran University of Medical Sciences	Hafezi-Moghadam, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Mol Biomarkers Nanoimaging Lab, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA.	ahm@bwh.harvard.edu		Ranaei Pirmardan, Ehsan/0000-0002-6848-5839	NIH Impact Award [DK108238-01]; JDRF Innovation award; Malaysian Palm Oil Board (MPOB)	NIH Impact Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF Innovation award; Malaysian Palm Oil Board (MPOB)	NIH Impact Award, Grant/Award Number: DK108238-01; JDRF Innovation award; Malaysian Palm Oil Board (MPOB)	Ai YJ, 2000, HUM MOL GENET, V9, P1821, DOI 10.1093/hmg/9.12.1821; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Casas C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00177; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Chitra PS, 2020, EXP EYE RES, V200, DOI 10.1016/j.exer.2020.108230; Donma O, 2002, CURR EYE RES, V25, P9, DOI 10.1076/ceyr.25.1.9.9960; Drinkwater JJ, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3073; Firtina Z, 2011, GENE EXPR PATTERNS, V11, P135, DOI 10.1016/j.gep.2010.10.005; Foreman J, 2018, JAMA OPHTHALMOL, V136, P567, DOI 10.1001/jamaophthalmol.2018.0597; FRASER FC, 1962, GENET RES, V3, P383, DOI 10.1017/S0016672300003220; FUKUSHI S, 1980, INVEST OPHTH VIS SCI, V19, P313; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Graw J, 2019, HUM GENET, V138, P1007, DOI 10.1007/s00439-019-01995-w; Grzybowski A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050716; Hiller R, 2003, OPHTHALMOLOGY, V110, P578, DOI 10.1016/S0161-6420(02)01762-1; KADOR PF, 1980, EXP EYE RES, V30, P59, DOI 10.1016/0014-4835(80)90124-4; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Khan A, 2017, DIABETIC MED, V34, P478, DOI 10.1111/dme.13296; Kikuchi K, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/3058547; Kiziltoprak H, 2019, WORLD J DIABETES, V10, P140, DOI 10.4239/wjd.v10.i3.140; Lang RA, 1997, CELL DEATH DIFFER, V4, P12, DOI 10.1038/sj.cdd.4400211; Leonard M, 2011, DEV BIOL, V349, P363, DOI 10.1016/j.ydbio.2010.10.009; Lin J, 2018, POPUL HEALTH METR, V16, DOI 10.1186/s12963-018-0166-4; Little JA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66642-1; Logan CM, 2017, DEV BIOL, V428, P118, DOI 10.1016/j.ydbio.2017.05.022; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; Long EP, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.6.2; Mrozik KM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4845-0; Na KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096461; Noda K, 2014, FASEB J, V28, P2038, DOI 10.1096/fj.12-215715; Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678; Obrosova IG, 2010, DIABETES-METAB RES, V26, P172, DOI 10.1002/dmrr.1075; Oishi N, 2006, INVEST OPHTH VIS SCI, V47, P2061, DOI 10.1167/iovs.05-1042; Paz-Filho G, 2010, ARQ BRAS ENDOCRINOL, V54, P690, DOI 10.1590/S0004-27302010000800005; Peterson SR, 2018, SEMIN OPHTHALMOL, V33, P75, DOI 10.1080/08820538.2017.1353817; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Raman R, 2010, INVEST OPHTH VIS SCI, V51, P6253, DOI 10.1167/iovs.10-5414; Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Shirai K, 2006, MOL VIS, V12, P681; Srinivasan S, 2017, INVEST OPHTH VIS SCI, V58, P5913, DOI 10.1167/iovs.17-22264; Srinivasan Y, 1998, J CLIN INVEST, V101, P625, DOI 10.1172/JCI1360; Su S, 2014, INVEST OPHTH VIS SCI, V55, P7848, DOI 10.1167/iovs.14-15175; Subramaniam A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020235; Sun N, 2015, MOL VIS, V21, P428; Tangvarasittichai O, 2018, CURR PHARM DESIGN, V24, P4726, DOI 10.2174/1381612825666190115121531; Wernecke L, 2018, INVEST OPHTH VIS SCI, V59, P5785, DOI 10.1167/iovs.18-23789; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Wu KK., 2008, CURR PROTOC PHARM; Xiao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08362; Zhang J, 2017, EXP EYE RES, V161, P36, DOI 10.1016/j.exer.2017.05.014	51	2	2	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21593	10.1096/fj.202100353R	http://dx.doi.org/10.1096/fj.202100353R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33991133				2022-12-28	WOS:000655695900040
J	Stadler, B; Nowell, CJ; Whittaker, MR; Arnhold, S; Pilatz, A; Wagenlehner, FM; Exintaris, B; Middendorff, R				Stadler, Beatrix; Nowell, Cameron J.; Whittaker, Michael R.; Arnhold, Stefan; Pilatz, Adrian; Wagenlehner, Florian M.; Exintaris, Betty; Middendorff, Ralf			Physiological and pharmacological impact of oxytocin on epididymal propulsion during the ejaculatory process in rodents and men	FASEB JOURNAL			English	Article						contraction; epididymis; human; noradrenaline; oxytocin; sperm transport	DUCTUS DEFERENS; IN-VITRO; SPONTANEOUS CONTRACTILITY; ADRENERGIC-INNERVATION; GENITAL ORGANS; SPERM OUTPUT; DOUBLE-BLIND; LONG-TERM; VASOPRESSIN; RECEPTORS	During the emission phase of ejaculation, the sperm is driven from the cauda epididymidis, where it is stored, through the vas deferens by strong contractions. These contractions are thought of as being mainly induced by the sympathetic nervous system and the neurotransmitter noradrenaline. In the present study, we investigated the effect of oxytocin (suggested to exert effects during ejaculation as well) on defined segments of the rat and human epididymis using live imaging. Our results indicate that it is the very last part of the epididymis, segment 19 (S19) in rat and likewise segment 9 in human, which responds in a uniquely strong and rapid manner to oxytocin (similar to noradrenaline). Because of the complex nature of this contractile response, we developed an imaging analysis method, which allowed us to quantify multidirectional contractions and to display them using heat maps. The reaction of S19 to oxytocin was concentration-dependent and could be inhibited by pretreatment with oxytocin antagonists (atosiban and cligosiban), but not with an arginine vasopressin 1(A) antagonist (SR49059). In both rat and human tissue, pretreatment with the alpha-1 adrenoreceptor antagonist tamsulosin inhibited the response to noradrenaline, whereas the effect of oxytocin was unimpaired. Our data (from men and rodents) strongly suggest that the hormone oxytocin is involved in the ejaculatory process. Thus, oxytocin-based medications might be a promising non-adrenergic treatment option for ejaculatory disorders. Additionally, we propose that S19 could be an advantageous model (detecting very low concentrations of oxytocin) to test the bioactivity of new oxytocin agonists and oxytocin antagonists.	[Stadler, Beatrix; Middendorff, Ralf] Justus Liebig Univ, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany; [Stadler, Beatrix; Nowell, Cameron J.; Exintaris, Betty] Monash Inst Pharmaceut Sci, Drug Discovery Biol, Melbourne, Vic, Australia; [Whittaker, Michael R.] Monash Inst Pharmaceut Sci, Drug Discovery Disposit & Dynam, Melbourne, Vic, Australia; [Arnhold, Stefan] Justus Liebig Univ, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Pilatz, Adrian; Wagenlehner, Florian M.] Justus Liebig Univ, Dept Urol Pediat Urol & Androl, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Stadler, B (corresponding author), Justus Liebig Univ, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany.	bea.stadler@web.de	Exintaris, Betty/ABB-8055-2021; whittaker, michael/C-2449-2008	whittaker, michael/0000-0001-5706-3932	Deutsche Forschungsgemeinschaft (DFG) [GRK 1871]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: GRK 1871	Althof S, 2019, J SEX MED, V16, P1188, DOI 10.1016/j.jsxm.2019.05.015; Alwaal A, 2015, FERTIL STERIL, V104, P1051, DOI 10.1016/j.fertnstert.2015.08.033; ARLETTI R, 1985, HORM BEHAV, V19, P14, DOI 10.1016/0018-506X(85)90002-9; BAUMGARTEN HG, 1968, Z ZELLFORSCH MIK ANA, V90, P81, DOI 10.1007/BF00496704; BAUMGARTEN HG, 1971, Z ZELLFORSCH MIK ANA, V120, P37, DOI 10.1007/BF00331243; BURNS PJ, 1981, THERIOGENOLOGY, V16, P531, DOI 10.1016/0093-691X(81)90038-8; Byrne MM, 2003, HUM REPROD, V18, P2098, DOI 10.1093/humrep/deg416; Carbone DJ, 2003, INT J IMPOT RES, V15, P299, DOI 10.1038/sj.ijir.3901017; CARMICHAEL MS, 1987, J CLIN ENDOCR METAB, V64, P27, DOI 10.1210/jcem-64-1-27; CARMICHAEL MS, 1994, ARCH SEX BEHAV, V23, P59, DOI 10.1007/BF01541618; Corona G, 2012, NAT REV UROL, V9, P508, DOI 10.1038/nrurol.2012.147; DEBACKERE M, 1961, J ENDOCRINOL, V22, P321, DOI 10.1677/joe.0.0220321; Denecke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145051; Domeniconi RF, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138768; Einspanier A, 1997, BIOL REPROD, V56, P416, DOI 10.1095/biolreprod56.2.416; Elfgen V, 2018, REPRODUCTION, V156, pR125, DOI 10.1530/REP-17-0754; Filippi S, 2002, MOL CELL ENDOCRINOL, V193, P89, DOI 10.1016/S0303-7207(02)00101-6; FJELLSTROM D, 1968, J REPROD FERTIL, V17, P207, DOI 10.1530/jrf.0.0170207; Frayne J, 1998, MOL HUM REPROD, V4, P527, DOI 10.1093/molehr/4.6.527; Giuliano F, 2005, EUR UROL, V48, P408, DOI 10.1016/j.eururo.2005.05.017; Goverde HJM, 1998, ARCH ANDROLOGY, V41, P17, DOI 10.3109/01485019808988540; Gupta J, 2008, BRIT J PHARMACOL, V155, P118, DOI 10.1038/bjp.2008.226; HIB J, 1974, J REPROD FERTIL, V36, P191, DOI 10.1530/jrf.0.0360191; HIB J, 1977, INT J FERTIL, V22, P63; HIB J, 1974, BIOL REPROD, V11, P436, DOI 10.1095/biolreprod11.4.436; Holstein AF., 1969, MORPHOLOGISCHE STUDI; JAAKKOLA UM, 1981, J REPROD FERTIL, V63, P47, DOI 10.1530/jrf.0.0630047; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; KIHLSTROM JE, 1963, ACTA PHYSIOL SCAND, V59, P370, DOI 10.1111/j.1748-1716.1963.tb02753.x; KNIGHT TW, 1974, J REPROD FERTIL, V40, P19, DOI 10.1530/jrf.0.0400019; KNIGHT TW, 1970, J REPROD FERTIL, V21, P523, DOI 10.1530/jrf.0.0210523; Kraft T., 2018, PHYSIOLOGIE, V8th; Kruger THC, 2003, J ENDOCRINOL, V177, P57, DOI 10.1677/joe.0.1770057; McMahon C, 2019, J SEX MED, V16, P1178, DOI 10.1016/j.jsxm.2019.05.016; MELIN P, 1970, J REPROD FERTIL, V22, P283; Mewe M, 2007, REPRODUCTION, V134, P493, DOI 10.1530/REP-07-0220; Mietens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092603; MURPHY MR, 1987, J CLIN ENDOCR METAB, V65, P738, DOI 10.1210/jcem-65-4-738; MURPHY MR, 1990, J CLIN ENDOCR METAB, V71, P1056, DOI 10.1210/jcem-71-4-1056; Narayan P, 2001, UROLOGY, V57, P466, DOI 10.1016/S0090-4295(00)01042-6; OGAWA S, 1980, CLIN ENDOCRINOL, V13, P95, DOI 10.1111/j.1365-2265.1980.tb01027.x; Parry LJ, 1998, BIOL REPROD, V59, P1101, DOI 10.1095/biolreprod59.5.1101; PEETERS G, 1983, J ENDOCRINOL, V99, P161, DOI 10.1677/joe.0.0990161; POWERS RE, 1982, UROLOGY, V19, P523, DOI 10.1016/0090-4295(82)90610-0; Preston S, 2016, MOL CELL PROBE, V30, P13, DOI 10.1016/j.mcp.2015.08.005; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Rowland D, 2010, J SEX MED, V7, P1668, DOI 10.1111/j.1743-6109.2010.01782.x; Sanbe A, 2007, BRIT J PHARMACOL, V152, P332, DOI 10.1038/sj.bjp.0707366; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; Studdard PW, 2002, INT J ANDROL, V25, P65, DOI 10.1046/j.1365-2605.2002.00323.x; Sullivan R, 2019, ANDROLOGY-US, V7, P748, DOI 10.1111/andr.12633; Vignozzi L, 2008, J SEX MED, V5, P2010, DOI 10.1111/j.1743-6109.2008.00914.x; Walch K, 2001, J ASSIST REPROD GEN, V18, P655, DOI 10.1023/A:1013115301159; Wayman C, 2018, J SEX MED, V15, P1698, DOI 10.1016/j.jsxm.2018.10.008; Whittington K, 2001, REPRODUCTION, V122, P317, DOI 10.1530/reprod/122.2.317	56	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21639	10.1096/fj.202100435R	http://dx.doi.org/10.1096/fj.202100435R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34041782				2022-12-28	WOS:000655695900059
J	Flormann, DAD; Schu, M; Terriac, E; Thalla, D; Kainka, L; Koch, M; Gad, AKB; Lautenschlaeger, F				Flormann, Daniel A. D.; Schu, Moritz; Terriac, Emmanuel; Thalla, Divyendu; Kainka, Lucina; Koch, Marcus; Gad, Annica K. B.; Lautenschlaeger, Franziska			A novel universal algorithm for filament network tracing and cytoskeleton analysis	FASEB JOURNAL			English	Article						actin; cytoskeleton; image analysis; intermediate filaments; microtubules	ACTIN CYTOSKELETON; ARCHITECTURE	The rapid development of advanced microscopy techniques over recent decades has significantly increased the quality of imaging and our understanding of subcellular structures, such as the organization of the filaments of the cytoskeleton using fluorescence and electron microscopy. However, these recent improvements in imaging techniques have not been matched by similar development of techniques for computational analysis of the images of filament networks that can now be obtained. Hence, for a wide range of applications, reliable computational analysis of such two-dimensional methods remains challenging. Here, we present a new algorithm for tracing of filament networks. This software can extract many important parameters from grayscale images of filament networks, including the mesh hole size, and filament length and connectivity (also known as Coordination Number). In addition, the method allows sub-networks to be distinguished in two-dimensional images using intensity thresholding. We show that the algorithm can be used to analyze images of cytoskeleton networks obtained using different advanced microscopy methods. We have thus developed a new improved method for computational analysis of two-dimensional images of filamentous networks that has wide applications for existing imaging techniques. The algorithm is available as open-source software.	[Flormann, Daniel A. D.; Schu, Moritz; Thalla, Divyendu; Kainka, Lucina; Lautenschlaeger, Franziska] Saarland Univ, Dept Phys, Campus D2-2, D-66123 Saarbrucken, Germany; [Flormann, Daniel A. D.; Terriac, Emmanuel; Thalla, Divyendu; Kainka, Lucina; Koch, Marcus; Lautenschlaeger, Franziska] INM Leibniz Inst New Mat, Saarbrucken, Germany; [Gad, Annica K. B.] Weston Pk Canc Ctr, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Gad, Annica K. B.] Univ Madeira, Ctr Quim Madeira, Funchal, Portugal	Saarland University; Leibniz Institut fur Neue Materialien (INM); Universidade da Madeira	Flormann, DAD (corresponding author), Saarland Univ, Dept Phys, Campus D2-2, D-66123 Saarbrucken, Germany.	Daniel.Florrnann@web.de	Gad, Annica/X-8294-2018	Gad, Annica/0000-0002-1098-9129; Terriac, Emmanuel/0000-0002-8769-242X	Leibniz Institute for New Materials (INM); Saarland University; DFG [CRC 1027]; Fundacao para a Ciencia e a Tecnologia (FCT); Portuguese Government [PEst-OE/QUI/UI0674/2013]; Agencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao (ARDITI); Centro de Quimica da Madeira [M1420-01-0145-FEDER-000005]	Leibniz Institute for New Materials (INM); Saarland University; DFG(German Research Foundation (DFG)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Government(Portuguese Foundation for Science and Technology); Agencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao (ARDITI); Centro de Quimica da Madeira	Leibniz Institute for New Materials (INM); Saarland University; DFG, Grant/Award Number: CRC 1027; Fundacao para a Ciencia e a Tecnologia (FCT); Portuguese Government, Grant/Award Number: PEst-OE/QUI/UI0674/2013; Agencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao (ARDITI); Centro de Quimica da Madeira, Grant/Award Number: M1420-01-0145-FEDER-000005	Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chikina AS, 2019, J CELL BIOL, V218, P445, DOI 10.1083/jcb.201806075; Chugh P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.186254; Chugh P, 2017, NAT CELL BIOL, V19, P689, DOI 10.1038/ncb3525; Cordes A, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.068101; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hecht FM, 2015, SOFT MATTER, V11, P4584, DOI 10.1039/c4sm02718c; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Nasrollahi S, 2017, ACS BIOMATER SCI ENG, V3, P2980, DOI 10.1021/acsbiomaterials.6b00554; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Su R, 2012, PATTERN RECOGN, V45, P3695, DOI 10.1016/j.patcog.2012.04.013; Svitkina TM, 2020, TRENDS CELL BIOL, V30, P556, DOI 10.1016/j.tcb.2020.03.005; Svitkina TM, 2017, INT J BIOCHEM CELL B, V86, P37, DOI 10.1016/j.biocel.2017.03.009; Xia SM, 2019, CELL REP, V28, P1251, DOI 10.1016/j.celrep.2019.06.089; Xu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09081; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	21	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21582	10.1096/fj.202100048R	http://dx.doi.org/10.1096/fj.202100048R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835502	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000645260100033
J	Khajavi, M; Zhou, Y; Schiffer, AJ; Bazinet, L; Birsner, AE; Zon, L; D'Amato, RJ				Khajavi, Mehrdad; Zhou, Yi; Schiffer, Alex J.; Bazinet, Lauren; Birsner, Amy E.; Zon, Leonard; D'Amato, Robert J.			Identification of Basp1 as a novel angiogenesis-regulating gene by multi-model system studies	FASEB JOURNAL			English	Article						angiogenesis; basic fibroblast growth factor (bFGF); brain abundant membrane attached signal protein 1 (BASP1); corneal micropocket neovascularization (CoNV); efficient mixed model association (EMMA); genome-wide association (GWAS); Wilm's tumor (WT1); Wnt/beta-catenin pathway	CIRCADIAN CLOCK; RENAL FIBROSIS; BLOOD-PRESSURE; INTERSTITIAL FIBROSIS; MICE; HYPERTENSION; RHYTHMS; BMAL1; INHIBITION; MECHANISMS	We have previously used the genetic diversity available in common inbred mouse strains to identify quantitative trait loci (QTLs) responsible for the differences in angiogenic response using the corneal micropocket neovascularization (CoNV) assay. Employing a mouse genome-wide association study (GWAS) approach, the region on chromosome 15 containing Basp1 was identified as being significantly associated with angiogenesis in inbred strains. Here, we developed a unique strategy to determine and verify the role of BASP1 in angiogenic pathways. Basp1 expression in cornea had a strong correlation with a haplotype shared by mouse strains with varied angiogenic phenotypes. In addition, inhibition of BASP1 demonstrated a dosage-dependent effect in both primary mouse brain endothelial and human microvascular endothelial cell (HMVEC) migration. To investigate its role in vivo, we knocked out basp1 in transgenic kdrl:zsGreen zebrafish embryos using a widely adopted CRISPR-Cas9 system. These embryos had severely disrupted vessel formation compared to control siblings. We further show that basp1 promotes angiogenesis by upregulating beta-catenin gene and the Dll4/Notch1 signaling pathway. These results, to the best of our knowledge, provide the first in vivo evidence to indicate the role of Basp1 as an angiogenesis-regulating gene and opens the potential therapeutic avenues for a wide variety of systemic angiogenesis-dependent diseases.	[Khajavi, Mehrdad; Schiffer, Alex J.; Bazinet, Lauren; Birsner, Amy E.; D'Amato, Robert J.] Harvard Med Sch, Dept Surg, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Zhou, Yi; Zon, Leonard] Harvard Med Sch, Boston Childrens Hosp, Harvard Stem Cell Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Zon, Leonard] Howard Hughes Med Inst, Boston, MA 02115 USA; [D'Amato, Robert J.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	D'Amato, RJ (corresponding author), Harvard Med Sch, Dept Surg, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.	robert.damato@childrens.harvard.edu			NIH National Eye Institute [R01EY012726--12]; HHMI [5R24OD017870--03]	NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); HHMI(Howard Hughes Medical Institute)	This work was supported, in part, by the NIH National Eye Institute under Award Number R01EY012726--12 (to RJD); LZ is supported by HHMI and "A Community Zebrafish Resource for Modeling GWAS Biology" (5R24OD017870--03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P1258, DOI 10.2215/CJN.10581110; Ansermet C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52682-9; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang L, 2018, CIRCULATION, V138, P67, DOI 10.1161/CIRCULATIONAHA.117.029972; Chen WD, 2015, AM J PATHOL, V185, P3152, DOI 10.1016/j.ajpath.2015.08.003; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ST., 2018, JCI INSIGHT, V3; Crislip GR, 2020, AM J PHYSIOL-RENAL, V318, pF1463, DOI 10.1152/ajprenal.00014.2020; Crislip GR, 2018, CURR OPIN PHYSIOL, V5, P38, DOI 10.1016/j.cophys.2018.06.002; Crosby P, 2019, CELL, V177, P896, DOI 10.1016/j.cell.2019.02.017; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dan H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107661; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Hara M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07767-8; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Honma S, 2016, EUR J PHARMACOL, V780, P136, DOI 10.1016/j.ejphar.2016.03.041; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Jiang SL, 2021, PHYTOMEDICINE, V80, DOI 10.1016/j.phymed.2020.153393; Johnston JG, 2020, HYPERTENSION, V75, P1624, DOI 10.1161/HYPERTENSIONAHA.119.13908; Johnston JG, 2018, FREE RADICAL BIO MED, V119, P93, DOI 10.1016/j.freeradbiomed.2018.01.018; Kim H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020305; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kramann R, 2016, NEPHROL DIAL TRANSPL, V31, P1989, DOI 10.1093/ndt/gfw102; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Motohashi H, 2020, KIDNEY INT, V97, P728, DOI 10.1016/j.kint.2019.09.032; Nikolaeva S, 2016, J AM SOC NEPHROL, V27, P2997, DOI 10.1681/ASN.2015091055; Nikolaeva S, 2012, J AM SOC NEPHROL, V23, P1019, DOI 10.1681/ASN.2011080842; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; Solocinski K, 2017, ACTA PHYSIOL, V220, P72, DOI 10.1111/apha.12804; Solocinski K, 2015, J BIOL RHYTHM, V30, P470, DOI 10.1177/0748730415610879; Tokonami N, 2014, J AM SOC NEPHROL, V25, P1430, DOI 10.1681/ASN.2013060641; Townsend RR, 2015, NAT REV NEPHROL, V11, P555, DOI 10.1038/nrneph.2015.114; Xie ZW, 2015, J CLIN INVEST, V125, P324, DOI 10.1172/JCI76881; Yang GR, 2020, ARTERIOSCL THROM VAS, V40, P1523, DOI 10.1161/ATVBAHA.120.314318; Yang GR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125133; Yang GR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3305; Yang GR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007225; Zha M, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2655-1; Zhang DG, 2020, AM J PHYSIOL-RENAL, V318, pF710, DOI 10.1152/ajprenal.00364.2019; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	49	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21404	10.1096/fj.202001936RRR	http://dx.doi.org/10.1096/fj.202001936RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33899275	Green Accepted			2022-12-28	WOS:000645260100104
J	Choi, HM; Lee, SH; Lee, MS; Park, D; Choi, SS				Choi, Hye-Mi; Lee, Sang-Hyeop; Lee, Min-Seok; Park, Donghyun; Choi, Sun Shim			Investigation of the putative role of antisense transcripts as regulators of sense transcripts by correlation analysis of sense-antisense pairs in colorectal cancers	FASEB JOURNAL			English	Article						differential gene correlation analysis (DGCA); sense&#8208; antisense gene pairs (SAGPs); significantly correlated pairs (SCPs)		Antisense transcription occurs widely more expected than when it was first identified in bacteria in the 1980s. However, the functional relevance of antisense transcripts in transcription remains controversial. Here, we investigated the putative role of antisense transcripts in regulating their corresponding sense transcripts by analyzing changes in correlative relationships between sense-antisense pairs under tumor and normal conditions. A total of 3469 sense-antisense gene pairs (SAGPs) downloaded from BioMart mapped to a list of sense and antisense genes in RNA-seq data derived from 80 paired colorectal cancer (CRC) samples were analyzed. As a result, cancer-related genes were significantly enriched in the significantly correlated SAGPs (SCPs). Differentially expressed genes estimated between normal and tumor conditions were also significantly more enriched in SCPs than in non-SCPs. Interestingly, using differential correlation analysis, we found that tumor samples had a significantly larger density of genes with higher correlation coefficients than normal samples, as verified by various cancer transcriptomes from The Cancer Genome Atlas (TCGA). Moreover, we found that the magnitude of the correlation between SAGPs could distinguish poor prognostic CRCs from good prognostic CRCs, showing that correlation coefficients between the SAGPs of CRCs with a poor prognosis were significantly stronger than CRCs with a good prognosis. Consistent with this finding, the Cox proportion hazards model showed that the survival rates were significantly different between patients with high and low expression of genes in the SCPs. All these results strongly support the idea that antisense transcripts are important regulators of their corresponding sense transcripts.	[Choi, Hye-Mi; Lee, Sang-Hyeop; Lee, Min-Seok; Choi, Sun Shim] Kangwon Natl Univ, Inst Biosci & Biotechnol, Coll Biomed Sci, Div Biomed Convergence, Chunchon 24341, South Korea; [Park, Donghyun] GENINUS Inc, Seoul, South Korea	Kangwon National University	Choi, SS (corresponding author), Kangwon Natl Univ, Inst Biosci & Biotechnol, Coll Biomed Sci, Div Biomed Convergence, Chunchon 24341, South Korea.	schoi@kangwon.ac.kr		Choi, Hye-Mi/0000-0002-6425-3563; Choi, Sun Shim/0000-0001-6289-4220	National Research Foundation of Korea (NRF) [2019R1A2C1002350, 2018M3C9A6017315, 2017M3A9G7073033]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2019R1A2C1002350, 2018M3C9A6017315 and 2017M3A9G7073033	Anders S., 2012, HEIDELB GER EUR MOL, V10, pf1000r; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Avazpour N, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00170; Balbin OA, 2015, GENOME RES, V25, P1068, DOI 10.1101/gr.180596.114; Barman P, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010011; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Boque-Sastre R, 2015, P NATL ACAD SCI USA, V112, P5785, DOI 10.1073/pnas.1421197112; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Chiu HS, 2018, CELL REP, V23, P297, DOI 10.1016/j.celrep.2018.03.064; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dianatpour A, 2017, INT J MOL CELL MED, V6, P1, DOI 10.22088/acadpub.BUMS.6.1.1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Grigoriadis A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-324; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Jadaliha M, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007802; Kassambara A., PACKAGE SURVMINER 20; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Li C, 2018, ONCOTARGETS THER, V11, P3969, DOI 10.2147/OTT.S163883; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu YH, 2012, AM J CANCER RES, V2, P658; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu XB, 2004, J VIROL, V78, P7079, DOI 10.1128/JVI.78.13.7079-7088.2004; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; McKenzie AT, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0349-1; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Piatek MJ, 2016, GENOMICS, V108, P56, DOI 10.1016/j.ygeno.2016.05.004; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Su WY, 2012, CELL RES, V22, P1374, DOI 10.1038/cr.2012.57; Therneau T.M., 2014, SURVIVAL ANAL PUBLIS, V2, P3, DOI DOI 10.1038/S41525-021-00179-8; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Zhao SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1876-7; Zhuo YF, 2017, CLIN CHEM LAB MED, V55, P38, DOI 10.1515/cclm-2016-0056	64	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21482	10.1096/fj.202002297RRR	http://dx.doi.org/10.1096/fj.202002297RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710708				2022-12-28	WOS:000635216100024
J	Pouzol, L; Baumlin, N; Sassi, A; Tunis, M; Marrie, J; Vezzali, E; Farine, H; Mentzel, U; Martinic, MM				Pouzol, Laetitia; Baumlin, Nadege; Sassi, Anna; Tunis, Melanie; Marrie, Julia; Vezzali, Enrico; Farine, Herve; Mentzel, Ulrich; Martinic, Marianne M.			ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases	FASEB JOURNAL			English	Article						CXCR7; experimental autoimmune encephalomyelitis; immunomodulation; myelin repair; demyelinating diseases	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR; REMYELINATION FAILURE; PROGENITOR CELLS; AXONAL INJURY; VIRAL MODEL; CXCL12; PROMOTES; EXPRESSION; MIGRATION	Current strategies for the treatment of demyelinating diseases such as multiple sclerosis (MS) are based on anti-inflammatory or immunomodulatory drugs. Those drugs have the potential to reduce the frequency of new lesions but do not directly promote remyelination in the damaged central nervous system (CNS). Targeting CXCR7 (ACKR3) has been postulated as a potential therapeutic approach in demyelinating diseases, leading to both immunomodulation by reducing leukocyte infiltrates and promyelination by enhancing myelin repair. ACT-1004-1239 is a potent, selective, insurmountable, and orally available first-in-class CXCR7 receptor antagonist. The effect of ACT-1004-1239 was evaluated in the myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) and the cuprizone-induced demyelination mouse models. In addition, ACT-1004-1239 was assessed in a rat oligodendrocyte precursor cell (OPC) differentiation assay in vitro. In the MOG-induced EAE model, ACT-1004-1239 treatment (10-100 mg/kg, twice daily, orally) showed a significant dose-dependent reduction in disease clinical scores, resulting in increased survival. At the highest dose tested (100 mg/kg, twice daily), ACT-1004-1239 delayed disease onset and significantly reduced immune cell infiltrates into the CNS and plasma neurofilament light chain concentration. Treatment with ACT-1004-1239 dose-dependently increased plasma CXCL12 concentration, which correlated with a reduction of the cumulative disease score. Furthermore, in the cuprizone model, ACT-1004-1239 treatment significantly increased the number of mature myelinating oligodendrocytes and enhanced myelination in vivo. In vitro, ACT-1004-1239 promoted the maturation of OPCs into myelinating oligodendrocytes. These results provide evidence that ACT-1004-1239 both reduces neuroinflammation and enhances myelin repair substantiating the rationale to explore its therapeutic potential in a clinical setting.	[Pouzol, Laetitia; Baumlin, Nadege; Sassi, Anna; Tunis, Melanie; Marrie, Julia; Vezzali, Enrico; Farine, Herve; Mentzel, Ulrich; Martinic, Marianne M.] Idorsia Pharmaceut Ltd, Allschwil, Switzerland	Idorsia Pharmaceuticals Ltd	Pouzol, L (corresponding author), Idorsia Pharmaceut Ltd, Hegenheimermattweg 91, CH-4123 Basel, Switzerland.	laetitia.pouzol@idorsia.com		Martinic, Marianne/0000-0003-4407-3423; Pouzol, Laetitia/0000-0001-8727-1142; Vezzali, Enrico/0000-0002-5550-9387				Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Banisadr G, 2016, J NEUROIMMUNE PHARM, V11, P26, DOI 10.1007/s11481-015-9616-y; Bao JH, 2016, BIOCHEM BIOPH RES CO, V469, P1, DOI 10.1016/j.bbrc.2015.11.059; Berahovich RD, 2014, IMMUNOLOGY, V141, P111, DOI 10.1111/imm.12176; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carbajal KS, 2011, GLIA, V59, P1813, DOI 10.1002/glia.21225; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Cheng WJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/659206; Chu TC, 2017, NEUROSCIENTIST, V23, P627, DOI 10.1177/1073858416685690; Cruz-Orengo L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-170; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Doan V, 2013, J NEUROSCI RES, V91, P363, DOI 10.1002/jnr.23174; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Gottle P, 2010, ANN NEUROL, V68, P915, DOI 10.1002/ana.22214; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hauser J, 2020, NUTR NEUROSCI, V23, P931, DOI 10.1080/1028415X.2019.1580918; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Huynh C, 2021, CLIN PHARMACOL THER, V109, P1648, DOI 10.1002/cpt.2154; Jakimovski D, 2020, MULT SCLER J, V26, P1670, DOI 10.1177/1352458519881428; Kadi L, 2006, J NEUROIMMUNOL, V174, P133, DOI 10.1016/j.jneuroim.2006.01.011; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P598, DOI 10.2174/187152712801661257; Kremer D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146503; Kuhle J, 2019, NEUROLOGY, V92, pE1007, DOI 10.1212/WNL.0000000000007032; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lewellis SW, 2012, SEMIN CELL DEV BIOL, V23, P333, DOI 10.1016/j.semcdb.2012.03.009; Li YN, 2015, STEM CELL TRANSL MED, V4, P1122, DOI 10.5966/sctm.2015-0074; Lounsbury N, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13020033; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Magalon K, 2012, ANN NEUROL, V71, P213, DOI 10.1002/ana.22593; Martin R, 2016, EUR J IMMUNOL, V46, P2078, DOI 10.1002/eji.201646485; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Menhaji-Klotz E., 2020, ACS MED CHEM LETT; Meyrath M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16664-0; Moll NM, 2009, ARCH NEUROL-CHICAGO, V66, P44, DOI 10.1001/archneurol.2008.512; Motavaf M, 2017, CELL MOL NEUROBIOL, V37, P1335, DOI 10.1007/s10571-017-0472-6; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Oh J, 2014, THER ADV NEUROL DISO, V7, P239, DOI 10.1177/1756285614546855; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Pouzol L, 2021, FASEB J, V35; Puchert M, 2017, MOL CELL NEUROSCI, V85, P105, DOI 10.1016/j.mcn.2017.09.001; Quinn KE, 2018, CYTOKINE, V109, P17, DOI 10.1016/j.cyto.2018.02.024; Richard-Bildstein S, 2020, J MED CHEM, V63, P15864, DOI 10.1021/acs.jmedchem.0c01588; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Sadeghian-Rizi T, 2018, CNS NEUROL DISORD-DR, V17, P496, DOI 10.2174/1871527317666180713111100; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stritt M, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007313; Wang C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00641; Williams JL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00154; Williams JL, 2014, J EXP MED, V211, P791, DOI 10.1084/jem.20131224; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zilkha-Falb R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0468-4	67	9	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21431	10.1096/fj.202002465R	http://dx.doi.org/10.1096/fj.202002465R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33595155				2022-12-28	WOS:000629576700049
J	Garcia-Ayllon, MS; Moreno-Perez, O; Garcia-Arriaza, J; Ramos-Rincon, JM; Cortes-Gomez, MA; Brinkmalm, G; Andres, M; Leon-Ramirez, JM; Boix, V; Gil, J; Zetterberg, H; Esteban, M; Merino, E; Saez-Valero, J				Garcia-Ayllon, Maria-Salud; Moreno-Perez, Oscar; Garcia-Arriaza, Juan; Ramos-Rincon, Jose-Manuel; Cortes-Gomez, Maria-Angeles; Brinkmalm, Gunnar; Andres, Mariano; Leon-Ramirez, Jose-Manuel; Boix, Vicente; Gil, Joan; Zetterberg, Henrik; Esteban, Mariano; Merino, Esperanza; Saez-Valero, Javier			Plasma ACE2 species are differentially altered in COVID-19 patients	FASEB JOURNAL			English	Article						ACE2; biomarker; COVID-19; plasma; SARS-CoV-2	ANGIOTENSIN-CONVERTING ENZYME; SARS-CORONAVIRUS; FUNCTIONAL RECEPTOR; MESSENGER-RNA; SPIKE PROTEIN; EXPRESSION; COV; SARS-COV-2; TMPRSS2; CLONING	Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and the C-terminal domain, using a recombinant human ACE2 protein as control. In addition, changes in the cleaved and full-length ACE2 species were also examined in serum samples derived from humanized K18-hACE2 mice challenged with a lethal dose of SARS-CoV-2. ACE2 immunoreactivity was present in human plasma as several molecular mass species that probably comprise truncated (70 and 75 kDa) and full-length forms (95, 100, 130, and 170 kDa). COVID-19 patients in the acute phase of infection (n = 46) had significantly decreased levels of ACE2 full-length species, while a truncated 70-kDa form was marginally higher compared with non-disease controls (n = 26). Levels of ACE2 full-length species were in the normal range in patients after a recovery period with an interval of 58-70 days (n = 29), while the 70-kDa species decreased. Levels of the truncated ACE2 species served to discriminate between individuals infected by SARS-CoV-2 and those infected with influenza A virus (n = 17). In conclusion, specific plasma ACE2 species are altered in patients with COVID-19 and these changes normalize during the recovery phase. Alterations in ACE2 species following SARS-CoV-2 infection warrant further investigation regarding their potential usefulness as biomarkers for the disease process and to asses efficacy during vaccination.	[Garcia-Ayllon, Maria-Salud; Cortes-Gomez, Maria-Angeles; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain; [Garcia-Ayllon, Maria-Salud; Cortes-Gomez, Maria-Angeles; Saez-Valero, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Garcia-Ayllon, Maria-Salud; Cortes-Gomez, Maria-Angeles] Univ Elche, Gen Hosp, Unidad Invest, FISABIO, Elche, Spain; [Moreno-Perez, Oscar; Ramos-Rincon, Jose-Manuel; Andres, Mariano; Leon-Ramirez, Jose-Manuel; Boix, Vicente; Gil, Joan; Merino, Esperanza; Saez-Valero, Javier] Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain; [Moreno-Perez, Oscar] Hosp Gen Univ Alicante, Endocrinol & Nutr Dept, Alicante, Spain; [Moreno-Perez, Oscar; Ramos-Rincon, Jose-Manuel; Andres, Mariano; Boix, Vicente] Univ Miguel Hernandez, Clin Med Dept, Elche, Spain; [Garcia-Arriaza, Juan; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol CNB, Dept Mol & Cellular Biol, Madrid, Spain; [Ramos-Rincon, Jose-Manuel] Alicante Gen Univ Hosp, Dept Internal Med, Alicante, Spain; [Brinkmalm, Gunnar; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Brinkmalm, Gunnar; Andres, Mariano; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Andres, Mariano] Alicante Gen Univ Hosp Alicante, Dept Rheumatol, Alicante, Spain; [Leon-Ramirez, Jose-Manuel; Gil, Joan] Alicante Gen Univ Hosp, Dept Pneumol, Alicante, Spain; [Boix, Vicente; Merino, Esperanza] Alicante Gen Univ Hosp, Infect Dis Unit, Alicante, Spain; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); CIBERNED; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); General University Hospital of Alicante; Sahlgrenska University Hospital; University of Gothenburg; General University Hospital of Alicante; General University Hospital of Alicante; University of London; University College London; University of London; University College London	Merino, E; Saez-Valero, J (corresponding author), Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain.	merino_luc@gva.es; j.saez@umh.es	Cortes Gomez, Mariangeles/AFY-2230-2022; Boix, Vicente/AAH-1607-2020; Andrés, Mariano/G-7708-2017; Merino de Lucas, Esperanza/AFQ-1126-2022	Boix, Vicente/0000-0002-7015-3948; Andrés, Mariano/0000-0002-0219-9055; Merino de Lucas, Esperanza/0000-0003-3854-4874; Garcia-Ayllon, Maria-Salud/0000-0001-5140-9752	Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL) [190258, 2020-0308]; Instituto de Salud Carlos III (ISCIII) [PI19-01359]; Fondo Europeo de Desarrollo Regional (FEDER, "Investing in your future"); CIBERNED, ISCIII; Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in RD [SEV-2017-0723]; Spanish Health Ministry, ISCIII; BEFPI fellowship from the Generalitat Valenciana; Swedish Research Council [2018-02532]; European Research Council [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Fondo COVID-19 grant [COV20/00151]; Fondo Supera COVID-19 (Crue Universidades-Banco Santander)	Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER, "Investing in your future"); CIBERNED, ISCIII(Instituto de Salud Carlos III); Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in RD; Spanish Health Ministry, ISCIII; BEFPI fellowship from the Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish State Support for Clinical Research; Fondo COVID-19 grant; Fondo Supera COVID-19 (Crue Universidades-Banco Santander)	We want to particularly acknowledge the patients and the BioBank ISABIAL integrated in the Spanish National Biobanks Network and in the Valencian Biobanking Network for their collaboration. We also thank Dr Ruben Frances (Dpto. Medicina Clinica, UMH; IIS ISABIAL, Hospital General Universitario de Alicante) and Dr Ana Gutierrez (IIS ISABIAL, Hospital General Universitario de Alicante) for kindly providing human colon tissue. This study was funded in part by the Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL; grants 190258 and 2020-0308) and by the Instituto de Salud Carlos III (ISCIII, grants PI19-01359), co-financed by the Fondo Europeo de Desarrollo Regional (FEDER, "Investing in your future") and through CIBERNED, ISCIII. We also acknowledge financial support from the Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in R&D (SEV-2017-0723). Work at CNB and CISA is funded by the Spanish Health Ministry, ISCIII, Fondo COVID-19 grant COV20/00151, and Fondo Supera COVID-19 (Crue Universidades--Banco Santander) (to JGA). MACG is supported by BEFPI fellowship from the Generalitat Valenciana. HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712), and Swedish State Support for Clinical Research (#ALFGBG-720931).	Amraei R, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071652; Anguiano L, 2017, CURR MED CHEM, V24, P3231, DOI 10.2174/0929867324666170414162841; Blume C, 2021, NAT GENET, V53, P205, DOI 10.1038/s41588-020-00759-x; Cai H, 2020, LANCET RESP MED, V8, pE20, DOI 10.1016/S2213-2600(20)30117-X; Chodavarapu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062833; Chow YH, 1997, P NATL ACAD SCI USA, V94, P14695, DOI 10.1073/pnas.94.26.14695; Clarke NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034747; Dou D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01581; Feng QS, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.568954; Fernandez-Atucha A, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0128-8; Garcia-Arriaza J, 2021, J VIROL, V95, DOI 10.1128/JVI.02260-20; Garvin MR, 2020, ELIFE, V9, DOI 10.7554/eLife.59177; Gingrich JC, 2000, BIOTECHNIQUES, V29, P636, DOI 10.2144/00293pf02; Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09; Gu HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19840; Gutta S, 2018, AM J PHYSIOL-RENAL, V315, pF263, DOI 10.1152/ajprenal.00565.2017; Haga S, 2010, ANTIVIR RES, V85, P551, DOI 10.1016/j.antiviral.2009.12.001; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; Hikmet F, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209610; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Jia HP, 2016, SHOCK, V46, P239, DOI 10.1097/SHK.0000000000000633; Kintscher U, 2020, HYPERTENSION, V76, pE34, DOI 10.1161/HYPERTENSIONAHA.120.15841; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; Kornilov SA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03141-9; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuba K, 2010, PHARMACOL THERAPEUT, V128, P119, DOI 10.1016/j.pharmthera.2010.06.003; Kutz A, 2021, EUR J ENDOCRINOL, V184, P543, DOI 10.1530/EJE-20-1445; La Vignera S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082948; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lew RA, 2008, EXP PHYSIOL, V93, P685, DOI 10.1113/expphysiol.2007.040352; Lew RA, 2006, INT J PEPT RES THER, V12, P283, DOI 10.1007/s10989-006-9031-6; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu J., 2010, BIOL SEX DIFFER, V1, P6, DOI DOI 10.1186/2042-6410-1-6; Liu X, 2014, VIRUS RES, V185, P64, DOI 10.1016/j.virusres.2014.03.010; Lopez-Font I, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00125; Luo J, 2021, GENE, V768, DOI 10.1016/j.gene.2020.145325; Maggi F, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00713-2020; Mathews ST, 2009, METHODS MOL BIOL, V536, P499, DOI 10.1007/978-1-59745-542-8_51; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Nagy B, 2021, INT J INFECT DIS, V103, P412, DOI 10.1016/j.ijid.2020.11.184; Narula S, 2020, LANCET, V396, P968, DOI 10.1016/S0140-6736(20)31964-4; Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x; Patel SK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03730-2020; Pedrosa MA, 2021, CLIN SCI, V135, P465, DOI 10.1042/CS20201511; Reindl-Schwaighofer R, 2021, AM J RESP CRIT CARE, V203, P1191, DOI 10.1164/rccm.202101-0142LE; Rieder M, 2021, AM J HYPERTENS, V34, P278, DOI 10.1093/ajh/hpaa169; Robson B, 2020, COMPUT BIOL MED, V122, DOI 10.1016/j.compbiomed.2020.103849; Rojas M, 2021, AM J HYPERTENS, V34, P296, DOI 10.1093/ajh/hpaa178; Sama IE, 2020, EUR HEART J, V41, P1810, DOI 10.1093/eurheartj/ehaa373; Shajahan A, 2021, GLYCOBIOLOGY, V31, P410, DOI 10.1093/glycob/cwaa101; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; South AM, 2020, NAT REV NEPHROL, V16, P305, DOI 10.1038/s41581-020-0279-4; Stienen S, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00322-7; Sullivan SJ, 2010, MAYO CLIN PROC, V85, P64, DOI 10.4065/mcp.2009.0588; Sward P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02942-2; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; van Lier D, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00848-2020; Wallentin L, 2020, EUR HEART J, V41, P4037, DOI [10.1093/eurheartj/ehaa761, 10.1093/eurheartj/ehaa697]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang S, 2008, VIRUS RES, V136, P8, DOI 10.1016/j.virusres.2008.03.004; Wang YL, 2020, INT J MED SCI, V17, P1522, DOI 10.7150/ijms.46695; Wenzel UO, 2021, AM J HYPERTENS, V34, P274, DOI 10.1093/ajh/hpaa175; Xiao FX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085958; Xiao FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037649; Xie XD, 2006, LIFE SCI, V78, P2166, DOI 10.1016/j.lfs.2005.09.038; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07027; Zhang Q., 2020, GASTROENTEROLOGY; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594	75	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21745	10.1096/fj.202100051R	http://dx.doi.org/10.1096/fj.202100051R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34191346	Green Published			2022-12-28	WOS:000678975300022
J	Gifford, CC; Lian, F; Tang, JQ; Costello, A; Goldschmeding, R; Samarakoon, R; Higgins, PJ				Gifford, Cody C.; Lian, Fei; Tang, Jiaqi; Costello, Angelica; Goldschmeding, Roel; Samarakoon, Rohan; Higgins, Paul J.			PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-beta 1-receptor signaling	FASEB JOURNAL			English	Article						cell cycle arrest; chronic kidney disease; epithelial dysfunction; klotho; obstructive nephropathy; p53; PAI-1; renal fibrosis; TGF-beta 1	PLASMINOGEN-ACTIVATOR INHIBITOR-1; CELL-CYCLE ARREST; TGF-BETA; TARGET GENES; FIBROSIS; DISEASE; SENESCENCE; EXPRESSION; MECHANISMS	Renal fibrosis leads to chronic kidney disease, which affects over 15% of the U.S. population. PAI-1 is highly upregulated in the tubulointerstitial compartment in several common nephropathies and PAI-1 global ablation affords protection from fibrogenesis in mice. The precise contribution of renal tubular PAI-1 induction to disease progression, however, is unknown and surprisingly, appears to be independent of uPA inhibition. Human renal epithelial (HK-2) cells engineered to stably overexpress PAI-1 underwent dedifferentiation (E-cadherin loss, gain of vimentin), G2/M growth arrest (increased p-Histone3, p21), and robust induction of fibronectin, collagen-1, and CCN2. These cells are also susceptible to apoptosis (elevated cleaved caspase-3, annexin-V positivity) compared to vector controls, demonstrating a previously unknown role for PAI-1 in tubular dysfunction. Persistent PAI-1 expression results in a loss of klotho expression, p53 upregulation, and increases in TGF-beta RI/II levels and SMAD3 phosphorylation. Ectopic restoration of klotho in PAI-1-transductants attenuated fibrogenesis and reversed the proliferative defects, implicating PAI-1 in klotho loss in renal disease. Genetic suppression of p53 reversed the PA1-1-driven maladaptive repair, moreover, confirming a pathogenic role for p53 upregulation in this context and uncovering a novel role for PAI-1 in promoting renal p53 signaling. TGF-beta RI inhibition also attenuated PAI-1-initiated epithelial dysfunction, independent of TGF-beta 1 ligand synthesis. Thus, PAI-1 promotes tubular dysfunction via klotho reduction, p53 upregulation, and activation of the TGF-beta RI-SMAD3 axis. Since klotho is an upstream regulator of both PAI-1-mediated p53 induction and SMAD3 signaling, targeting tubular PAI-1 expression may provide a novel, multi-level approach to the therapy of CKD.	[Gifford, Cody C.; Tang, Jiaqi; Costello, Angelica; Samarakoon, Rohan; Higgins, Paul J.] Albany Med Coll, Dept Regenerat & Canc Cell Biol, MC 165,47 New Scotland Ave, Albany, NY 12208 USA; [Lian, Fei; Higgins, Paul J.] Albany Med Coll, Div Urol, Albany, NY 12208 USA; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Albany Medical College; Albany Medical College; Utrecht University; Utrecht University Medical Center	Samarakoon, R; Higgins, PJ (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, MC 165,47 New Scotland Ave, Albany, NY 12208 USA.	samarar@amc.edu; higginp@amc.edu		Tang, Jiaqi/0000-0002-3544-3456	NIH [GM057242]; Capital District Medical Research Institute; Friedman Family Research Fund; Charlotte Graver Foundation; John Faunce & Alicia Tracy Roach Fund; Edith Dickstein & Sylvan Kessler Estate Foundation; Butler Family Mesothelioma Research Fund; Mueller Family Cancer Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Capital District Medical Research Institute; Friedman Family Research Fund; Charlotte Graver Foundation; John Faunce & Alicia Tracy Roach Fund; Edith Dickstein & Sylvan Kessler Estate Foundation; Butler Family Mesothelioma Research Fund; Mueller Family Cancer Foundation	This study was supported by NIH Grant GM057242 to PJH, a Capital District Medical Research Institute Grant to RS, the Friedman Family Research Fund, the Charlotte Graver Foundation, the John Faunce & Alicia Tracy Roach Fund, the Edith Dickstein & Sylvan Kessler Estate Foundation, the Butler Family Mesothelioma Research Fund, and TMueller Family Cancer Foundation	Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; de Oliveira RM, 2006, FEBS LETT, V580, P5753, DOI 10.1016/j.febslet.2006.09.036; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Eren M, 2014, SEMIN THROMB HEMOST, V40, P645, DOI 10.1055/s-0034-1387883; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Guan X, 2014, J PATHOL, V234, P560, DOI 10.1002/path.4420; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Krag S, 2005, KIDNEY INT, V68, P2651, DOI 10.1111/j.1523-1755.2005.00737.x; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209; Liu Y, 2019, MOL THER, V27, P1051, DOI 10.1016/j.ymthe.2019.02.009; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Ma J, 2006, KIDNEY INT, V69, P1064, DOI 10.1038/sj.ki.5000201; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Patel S, 2019, FASEB J, V33, P9797, DOI 10.1096/fj.201802489RR; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Samarakoon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022896; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Yamaguchi I, 2007, AM J PHYSIOL-RENAL, V293, pF12, DOI 10.1152/ajprenal.00380.2006; Yan YL, 2016, KIDNEY INT, V89, P68, DOI 10.1038/ki.2015.293; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Yao L, 2019, NEPHROL DIAL TRANSPL, V34, P2042, DOI 10.1093/ndt/gfz050; Yin SS, 2017, BBA-MOL CELL RES, V1864, P1207, DOI 10.1016/j.bbamcr.2017.03.002; Ying Y, 2014, J AM SOC NEPHROL, V25, P2707, DOI 10.1681/ASN.2013121270; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	50	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21725	10.1096/fj.202002652RR	http://dx.doi.org/10.1096/fj.202002652RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110636	Green Accepted			2022-12-28	WOS:000667814100057
J	Li, Y; Jiang, YD; Zhang, L; Qian, W; Hou, XH; Lin, R				Li, Ying; Jiang, Yudong; Zhang, Lei; Qian, Wei; Hou, Xiaohua; Lin, Rong			Exogenous l-fucose protects the intestinal mucosal barrier depending on upregulation of FUT2-mediated fucosylation of intestinal epithelial cells	FASEB JOURNAL			English	Article						fucosylation; FUT2; inflammatory bowel disease; intestinal barrier; l-fucose	EXCLUSIVE ENTERAL NUTRITION; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; TRANSFERASE 2; ASSOCIATION	FUT2, a protein that uses l-fucose to mediate fucosylation of intestinal epithelial cells, is one of the detected gene variants in IBD patients. We aimed to investigate whether exogenous l-fucose could be an enteral nutritional supplement to protect intestinal barrier function. The effect of l-fucose on the restoration of epithelial barrier function in both the DSS-induced colitis mouse model and LPS-stimulated Caco-2 cells was investigated, and the impact on fucosylation of epithelial cells was examined. The severity of DSS-induced colitis was significantly reduced by l-fucose. Restoration of epithelial barrier function by l-fucose was detected. Direct l-fucose-mediated protection of tight junctions was observed in Caco-2 cells. Moreover, exogenous l-fucose promoted the exogenous metabolic pathway of l-fucose, and fucosylation of epithelial cells both in vivo and in vitro. Moreover, knockout of the FUT2 gene restrained fucosylation and the protective effect of l-fucose on barrier function. The severity of colitis was not improved by l-fucose in Fut2 knockout mice. Therefore we conclude that exogenous l-fucose protects intestinal barrier function and relieves intestinal inflammation via upregulation of FUT2-mediated fucosylation of intestinal epithelial cells.	[Li, Ying; Jiang, Yudong; Zhang, Lei; Qian, Wei; Hou, Xiaohua; Lin, Rong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Hou, XH; Lin, R (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China.	houxh@hust.edu.cn; selinalin35@hotmail.com		Jiang, Yudong/0000-0001-5783-539X; lin, rong/0000-0001-9463-8942	National Natural Science Foundation of China (NSFC) [81330014]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81330014	Aheman A, 2012, WORLD J GASTROENTERO, V18, P4758, DOI 10.3748/wjg.v18.i34.4758; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Citkowska A, 2019, MAR DRUGS, V17, DOI 10.3390/md17080458; Cott C, 2016, BBA-MOL CELL RES, V1863, P1106, DOI 10.1016/j.bbamcr.2016.02.004; de Bie C, 2013, J CROHNS COLITIS, V7, P263, DOI 10.1016/j.crohns.2012.07.001; Dias CC, 2019, DIGEST LIVER DIS, V51, P952, DOI 10.1016/j.dld.2019.01.016; Gerasimidis K, 2013, INFLAMM BOWEL DIS, V19, P2411, DOI 10.1097/MIB.0b013e31829ed855; Goto Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15918; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Guo Z, 2013, NUTR CLIN PRACT, V28, P499, DOI 10.1177/0884533613487218; Huoponen S., 2015, PLOS ONE, V10; Jones Jennifer L, 2019, J Can Assoc Gastroenterol, V2, pS42, DOI 10.1093/jcag/gwy048; Maroni L, 2015, CLIN REV ALLERG IMMU, V48, P182, DOI 10.1007/s12016-014-8423-1; NAKAJIMA H, 1995, J GASTROENTEROL, V30, P115; Parmar AS, 2012, TISSUE ANTIGENS, V80, P488, DOI 10.1111/tan.12016; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pillai N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185500; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Rausch P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00991; Rolandsdotter H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020414; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Terahara K, 2011, BIOCHEM BIOPH RES CO, V404, P822, DOI 10.1016/j.bbrc.2010.12.067; Vivinus-Nebot M, 2014, GUT, V63, P744, DOI 10.1136/gutjnl-2012-304066; Wang YW, 2017, GASTROENTEROLOGY, V152, P193, DOI 10.1053/j.gastro.2016.09.004; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu H, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/4148651	28	4	4	7	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21699	10.1096/fj.202002446RRRR	http://dx.doi.org/10.1096/fj.202002446RRRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34151459				2022-12-28	WOS:000667814100073
J	Yu, F; Yu, N; Peng, J; Zhao, Y; Zhang, L; Wang, XH; Xu, XN; Zhou, J; Wang, F				Yu, Fang; Yu, Nan; Peng, Jie; Zhao, Yan; Zhang, Lei; Wang, Xiaohui; Xu, Xiaona; Zhou, Jian; Wang, Feng			Emodin inhibits lipid accumulation and inflammation in adipose tissue of high-fat diet-fed mice by inducing M2 polarization of adipose tissue macrophages	FASEB JOURNAL			English	Article						adipose tissue macrophages; emodin; M2 macrophage; obesity; TREM2	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; AIRWAY INFLAMMATION; CANCER-CELLS; IN-VITRO; OBESITY; PROTECTS; LIVER; AMPK; ATTENUATION; DISEASE	Adipose tissue macrophages (ATMs) represent the most abundant leukocytes in adipose tissue (AT). An increase in number and a phenotypical switch of ATMs during the development of obesity contribute to chronic inflammation and metabolic disorders, which have been regarded as potential therapeutic targets to restore AT homeostasis. Emodin has been shown to exert strong anti-inflammatory property via acting on macrophages in a range of disease models. However, whether emodin exerts a beneficial effect on obesity via modulating ATMs has not been reported. In high-fat diet (HFD)-induced obese mice, emodin significantly inhibited the increase of body weight and lipid accumulation in ATs. Emodin apparently reduced glucose and insulin levels and ameliorated serum lipid profiles in HFD-fed mice. Moreover, the local and systemic inflammation was dramatically alleviated by emodin. We next discovered that M2 macrophage percentage was greatly increased by emodin although total ATMs was not altered, which resulted in a net increase of M2 macrophages in AT. In vitro studies confirmed that emodin promoted the polarization of macrophages towards M2. Gene ontology (GO) analysis showed that myeloid leukocyte differentiation and activation were among the most significant biological processes in emodin-treated ATMs. We further identified that TREM2 was the most dramatically upregulated molecule by emodin and emodin-induced M2 macrophage polarization was dependent on TREM2. Furthermore, silencing TREM2 apparently abrogated the effect of emodin on AT inflammation and adipogenesis. We, for the first time, disclosed that emodin inhibited obesity by promoting M2 macrophage polarization via TREM2, suggesting that emodin may be explored as a clinical and translational candidate in preventing obesity and its related metabolic diseases.	[Yu, Fang; Zhang, Lei; Wang, Xiaohui; Xu, Xiaona; Zhou, Jian; Wang, Feng] Air Force Med Univ, Dept Nutr & Food Hyg, 169 Changle West Rd, Xian 710032, Peoples R China; [Yu, Fang; Zhang, Lei; Wang, Xiaohui; Xu, Xiaona; Zhou, Jian; Wang, Feng] Air Force Med Univ, Dept Hlth Educ & Hlth Management, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian, Peoples R China; [Yu, Nan] Changzhi Med Coll, Dept Ophthalmol, Heping Hosp, Changzhi, Peoples R China; [Peng, Jie] Air Force Med Univ, Dept Toxicol, Xian, Peoples R China; [Zhao, Yan] Air Force Med Univ, Dept Pharmacogen, State Key Lab Canc Biol, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Changzhi Medical College; Air Force Military Medical University; Air Force Military Medical University	Yu, F; Wang, F (corresponding author), Air Force Med Univ, Dept Nutr & Food Hyg, 169 Changle West Rd, Xian 710032, Peoples R China.	yufang@fmmu.edu.cn; wfeng@fmmu.edu.cn			Shaanxi Science and Technology Innovation Team [2018TD-001]; Key Research and Development Plan of Shaanxi Province [2018SF-342]; Logistics Research Project of China [AWS17J014, BWS18J011]; Medical Science and Technology Youth Training Project of Ministry of Health [14QNP093]	Shaanxi Science and Technology Innovation Team; Key Research and Development Plan of Shaanxi Province; Logistics Research Project of China; Medical Science and Technology Youth Training Project of Ministry of Health	Shaanxi Science and Technology Innovation Team, Grant/Award Number: 2018TD-001; Key Research and Development Plan of Shaanxi Province, Grant/Award Number: 2018SF-342; Logistics Research Project of China, Grant/Award Number: AWS17J014 and BWS18J011; Medical Science and Technology Youth Training Project of Ministry of Health, Grant/Award Number: 14QNP093	Bluher M, 2016, CLIN SCI, V130, P1603, DOI 10.1042/CS20160005; Caslin HL, 2020, IMMUNOL REV, V295, P101, DOI 10.1111/imr.12853; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen ZF, 2012, J CELL BIOCHEM, V113, P3547, DOI 10.1002/jcb.24232; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Fang L, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105763; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Genua M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0293-z; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Han JW, 2015, INT J MOL SCI, V16, P8102, DOI 10.3390/ijms16048102; Herrada AA, 2021, OBES REV, V22, DOI 10.1111/obr.13200; Hua S, 2019, MED SCI MONITOR, V25, P5621, DOI 10.12659/MSM.915080; Iwanowycz S, 2016, MOL CANCER THER, V15, P1931, DOI 10.1158/1535-7163.MCT-15-0987; Iwanowycz S, 2016, J BIOL CHEM, V291, P11491, DOI 10.1074/jbc.M115.702092; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jia XM, 2014, BREAST CANCER RES TR, V148, P291, DOI 10.1007/s10549-014-3164-7; Jia XM, 2014, EXP BIOL MED, V239, P1025, DOI 10.1177/1535370214530247; Kober DL, 2017, J MOL BIOL, V429, P1607, DOI 10.1016/j.jmb.2017.04.004; Lee EH, 2020, PHARM BIOL, V58, P333, DOI 10.1080/13880209.2020.1750658; Li JM, 2016, EUR J PHARMACOL, V770, P99, DOI 10.1016/j.ejphar.2015.11.045; Liu C, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2050-9; Liu DL, 2012, INT J ONCOL, V40, P1049, DOI 10.3892/ijo.2011.1285; Lu Y, 2011, BIOCHEM PHARMACOL, V82, P1700, DOI 10.1016/j.bcp.2011.08.022; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Shang Xiao-yu, 2002, Yaoxue Xuebao, V37, P798; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Song YD, 2018, ACTA PHARMACOL SIN, V39, P1317, DOI 10.1038/aps.2017.147; Subramanian S, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1187-7; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tong HF, 2011, ANAT REC, V294, P445, DOI 10.1002/ar.21352; Tzeng TF, 2012, PLANTA MED, V78, P943, DOI 10.1055/s-0031-1298626; Vieira-Potter VJ, 2014, CELL MICROBIOL, V16, P1484, DOI 10.1111/cmi.12336; Wang YJ, 2012, ACTA PHARMACOL SIN, V33, P1195, DOI 10.1038/aps.2012.87; Xue JF, 2010, FITOTERAPIA, V81, P173, DOI 10.1016/j.fitote.2009.08.020; Xue JH, 2015, CELL PHYSIOL BIOCHEM, V35, P1557, DOI 10.1159/000373971; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Yu LY, 2020, DRUG DES DEV THER, V14, P1493, DOI 10.2147/DDDT.S243893; Zhang XB, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9340610; Zhang Yin-Huan, 2019, Zhongguo Zhong Yao Za Zhi, V44, P2820, DOI 10.19540/j.cnki.cjcmm.20190321.401; Zhao JY, 2019, J ASIAN NAT PROD RES, V21, P186, DOI 10.1080/10286020.2017.1408594; Zhou Y, 2015, CELL METAB, V22, P1045, DOI 10.1016/j.cmet.2015.09.013; Zhu SY, 2014, PHARM BIOL, V52, P51, DOI 10.3109/13880209.2013.810648	45	6	6	2	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21730	10.1096/fj.202100157RR	http://dx.doi.org/10.1096/fj.202100157RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110631				2022-12-28	WOS:000667814100077
J	Impheng, H; Lemmers, C; Bouasse, M; Legros, C; Pakaprot, N; Guerineau, NC; Lory, P; Monteil, A				Impheng, Hathaichanok; Lemmers, Celine; Bouasse, Malik; Legros, Christian; Pakaprot, Narawut; Guerineau, Nathalie C.; Lory, Philippe; Monteil, Arnaud			The sodium leak channel NALCN regulates cell excitability of pituitary endocrine cells	FASEB JOURNAL			English	Article						background conductance; extracellular Ca2+; ion channels; resting membrane potential	NONSELECTIVE CATION CHANNELS; MEMBRANE-POTENTIAL CHANGES; ELECTRICAL-ACTIVITY; NEURONAL EXCITABILITY; GROWTH-HORMONE; CLONAL STRAINS; TUMOR CELLS; CALCIUM; PROLACTIN; LINE	Anterior pituitary endocrine cells that release hormones such as growth hormone and prolactin are excitable and fire action potentials. In these cells, several studies previously showed that extracellular sodium (Na+) removal resulted in a negative shift of the resting membrane potential (RMP) and a subsequent inhibition of the spontaneous firing of action potentials, suggesting the contribution of a Na+ background conductance. Here, we show that the Na+ leak channel NALCN conducts a Ca2+-Gd3+-sensitive and TTX-resistant Na+ background conductance in the GH(3) cell line, a cell model of pituitary endocrine cells. NALCN knockdown hyperpolarized the RMP, altered GH(3) cell electrical properties and inhibited prolactin secretion. Conversely, the overexpression of NALCN depolarized the RMP, also reshaping the electrical properties of GH(3) cells. Overall, our results indicate that NALCN is functional in GH(3) cells and involved in endocrine cell excitability as well as in hormone secretion. Indeed, the GH(3) cell line suitably models native pituitary cells that display a similar Na+ background conductance and appears as a proper cellular model to study the role of NALCN in cellular excitability.	[Impheng, Hathaichanok; Lemmers, Celine; Bouasse, Malik; Guerineau, Nathalie C.; Lory, Philippe; Monteil, Arnaud] Univ Montpellier, CNRS, IGF, INSERM, Montpellier, France; [Impheng, Hathaichanok; Bouasse, Malik; Guerineau, Nathalie C.; Lory, Philippe; Monteil, Arnaud] LabEx Ion Channel Sci & Therapeut, Montpellier, France; [Lemmers, Celine; Monteil, Arnaud] Univ Montpellier, INSERM, CNRS, BCM,PVM, Montpellier, France; [Legros, Christian] Univ Angers, MITOVASC Inst, UMR CNRS 6015, UMR INSERM U1083, Angers, France; [Pakaprot, Narawut] Mahidol Univ, Fac Med, Dept Physiol, Siriraj Hosp, Bangkok, Thailand; [Impheng, Hathaichanok] Naresuan Univ, Fac Med Sci, Dept Physiol, Phitsanulok, Thailand	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite d'Angers; Mahidol University; Naresuan University	Monteil, A (corresponding author), Univ Montpellier, CNRS, IGF, INSERM, Montpellier, France.	arnaud.monteil@igf.cnrs.fr		LEGROS, Christian/0000-0002-3346-7059; Monteil, Arnaud/0000-0003-1632-7318; Impheng, Hathaichanok/0000-0001-8350-1692; LORY, philippe/0000-0002-1638-7604; Guerineau, Nathalie/0000-0003-2517-4210	Fondation pour la Recherche Medicale (FRM) [DEQ20170336728]; Laboratory of Excellence 'Ion Channel Science and Therapeutics'; Association Francaise contre les Myopathies (AFM) [20151]; Fondation Maladies Rares; Naresuan University (NU); French Ministry for Foreign Affairs	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Laboratory of Excellence 'Ion Channel Science and Therapeutics'; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Maladies Rares; Naresuan University (NU); French Ministry for Foreign Affairs	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: DEQ20170336728; Laboratory of Excellence 'Ion Channel Science and Therapeutics'; Association Francaise contre les Myopathies (AFM), Grant/Award Number: 20151; Fondation Maladies Rares; Naresuan University (NU); French Ministry for Foreign Affairs	Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; BIALES B, 1977, NATURE, V267, P172, DOI 10.1038/267172a0; Bouasse M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48071-x; CHILDS GV, 1987, ENDOCRINOLOGY, V120, P2059, DOI 10.1210/endo-120-5-2059; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Chua HC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz3154; Cochet-Bissuel M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00132; COLLU R, 1984, ENDOCRINOLOGY, V114, P1302, DOI 10.1210/endo-114-4-1302; Fletcher PA, 2018, MOL CELL ENDOCRINOL, V463, P23, DOI 10.1016/j.mce.2017.06.022; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Ford NC, 2018, PAIN, V159, P1719, DOI 10.1097/j.pain.0000000000001258; Fujisawa S, 2006, CEREB CORTEX, V16, P639, DOI 10.1093/cercor/bhj010; Funato H, 2016, NATURE, V539, P378, DOI 10.1038/nature20142; Gao SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7323; Kayano T, 2019, CELL CALCIUM, V79, P11, DOI 10.1016/j.ceca.2019.02.001; KIDOKORO Y, 1975, NATURE, V258, P741, DOI 10.1038/258741a0; Kschonsak M, 2020, NATURE, V587, P313, DOI 10.1038/s41586-020-2570-8; Kucka M, 2012, PHYSIOL RES, V61, P267, DOI 10.33549/physiolres.932301; Kucka M, 2010, MOL PHARMACOL, V77, P270, DOI 10.1124/mol.109.059386; Kwiecien R, 1998, J PHYSIOL-LONDON, V508, P883, DOI 10.1111/j.1469-7793.1998.883bp.x; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lee SY, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0325-0; Liang Z, 2011, J PHYSIOL-LONDON, V589, P5965, DOI 10.1113/jphysiol.2011.219378; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Lu TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018745; Lutas A, 2016, ELIFE, V5, DOI 10.7554/eLife.15271; OSTLUND RE, 1978, ENDOCRINOLOGY, V103, P1245, DOI 10.1210/endo-103-4-1245; OZAWA S, 1979, P NATL ACAD SCI USA, V76, P6017, DOI 10.1073/pnas.76.11.6017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philippart F, 2018, ELIFE, V7, DOI 10.7554/eLife.40984; Reinl EL, 2015, MOL HUM REPROD, V21, P816, DOI 10.1093/molehr/gav038; Sankaranarayanan S, 1996, AM J PHYSIOL-CELL PH, V271, pC1927, DOI 10.1152/ajpcell.1996.271.6.C1927; Shi YT, 2016, J NEUROSCI, V36, P8174, DOI 10.1523/JNEUROSCI.1096-16.2016; SIMASKO SM, 1994, AM J PHYSIOL, V266, pC709, DOI 10.1152/ajpcell.1994.266.3.C709; Snutch TP, 2007, NEURON, V54, P505, DOI 10.1016/j.neuron.2007.05.005; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; TARASKEVICH PS, 1980, NEUROSCIENCE, V5, P421, DOI 10.1016/0306-4522(80)90117-7; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; Tomic M, 2011, AM J PHYSIOL-ENDOC M, V301, pE370, DOI 10.1152/ajpendo.00130.2011; Tsaneva-Atanasova K, 2007, J NEUROPHYSIOL, V98, P131, DOI 10.1152/jn.00872.2006; TSE A, 1993, ENDOCRINOLOGY, V132, P1475, DOI 10.1210/en.132.4.1475; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Goor F, 2001, MOL ENDOCRINOL, V15, P1222, DOI 10.1210/me.15.7.1222; Xie L, 2013, NEURON, V77, P1069, DOI 10.1016/j.neuron.2013.01.018; Yang SK, 2008, ENDOCRINOLOGY, V149, P4726, DOI 10.1210/en.2008-0405; Yeh SY, 2017, NEURON, V94, P294, DOI 10.1016/j.neuron.2017.03.024; Zemkova H, 2016, ENDOCRINOLOGY, V157, P1576, DOI 10.1210/en.2015-1899	50	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21400	10.1096/fj.202000841RR	http://dx.doi.org/10.1096/fj.202000841RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33793981	hybrid, Green Published			2022-12-28	WOS:000645260100004
J	Ives, A; Le Roy, D; Theroude, C; Bernhagen, J; Roger, T; Calandra, T				Ives, Annette; Le Roy, Didier; Theroude, Charlotte; Bernhagen, Juergen; Roger, Thierry; Calandra, Thierry			Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway	FASEB JOURNAL			English	Article						chemokine; cytokine; dendritic cell; innate immunity; MIF; motility	ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; STEM-CELLS; FAT-CELL; OBESITY; WHITE; BROWN; ADIPOGENESIS; EXPANSION; GIP	Constitutively expressed by innate immune cells, the cytokine macrophage migration inhibitory factor (MIF) initiates host immune responses and drives pathogenic responses in infectious, inflammatory, and autoimmune diseases. Dendritic cells (DCs) express high levels of MIF, but the role of MIF in DC function remains poorly characterized. As migration is critical for DC immune surveillance, we investigated whether MIF promoted the migration of DCs. In classical transwell experiments, MIF-/- bone marrow-derived DCs (BMDCs) or MIF+/+ BMDCs treated with ISO-1, an inhibitor of MIF, showed markedly reduced spontaneous migration and chemotaxis. CD74(-/-) BMDCs that are deficient in the ligand-binding component of the cognate MIF receptor exhibited a migration defect similar to that of MIF-/- BMDCs. Adoptive transfer experiments of LPS-matured MIF+/+ and MIF-/- and of CD74(+/+) and CD74(-/-) BMDCs injected into the hind footpads of homologous or heterologous mice showed that the autocrine and paracrine MIF activity acting via CD74 contributed to the recruitment of DCs to the draining lymph nodes. Mechanistically, MIF activated the Src/PI3K signaling pathway and myosin II complexes, which were required for the migration of BMDCs. Altogether, these data show that the cytokine MIF exerts chemokine-like activity for DC motility and trafficking.	[Ives, Annette; Le Roy, Didier; Theroude, Charlotte; Roger, Thierry; Calandra, Thierry] Lausanne Univ Hosp, Dept Med, Infect Dis Serv, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland; [Ives, Annette; Le Roy, Didier; Theroude, Charlotte; Roger, Thierry; Calandra, Thierry] Univ Lausanne, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland; [Bernhagen, Juergen] Ludwig Maximilians Univ LMU, Klinikum Univ Munchen KUM, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Munich; University of Munich	Calandra, T (corresponding author), Lausanne Univ Hosp, Dept Med, Infect Dis Serv, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland.; Calandra, T (corresponding author), Univ Lausanne, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	Thierry.Calandra@chuv.ch	Roger, Thierry/G-2007-2012; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Ives, Annette/0000-0002-7407-960X; Calandra, Thierry/0000-0003-3051-1285; Theroude, Charlotte/0000-0002-9864-1644	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF) [310030_138488, CRSII3_147662S, 316030_145014, 310030_173123]; Wilhelm Sander-Stiftung (Wilhelm Sander Foundation) [2017.009.1]; Deutsche Forschungsgemeinschaft (DFG) [SFB1123/A3]; Societe Academique Vaudoise, Lausanne, Switzerland; EC \ Horizon 2020 Framework Programme (H2020) [676129]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF); Wilhelm Sander-Stiftung (Wilhelm Sander Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Societe Academique Vaudoise, Lausanne, Switzerland; EC \ Horizon 2020 Framework Programme (H2020)	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 310030_138488, CRSII3_147662S, 316030_145014 and 310030_173123; Wilhelm Sander-Stiftung (Wilhelm Sander Foundation), Grant/Award Number: 2017.009.1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1123/A3; EC | Horizon 2020 Framework Programme (H2020), Grant/Award Number: 676129; Societe Academique Vaudoise, Lausanne, Switzerland	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; Beaudry JL, 2019, MOL METAB, V28, P14, DOI 10.1016/j.molmet.2019.08.006; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Coskun T, 2018, MOL METAB, V18, P3, DOI 10.1016/j.molmet.2018.09.009; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Frias JP, 2018, LANCET, V392, P2180, DOI 10.1016/S0140-6736(18)32260-8; Goedecke JH, 2011, J CLIN ENDOCR METAB, V96, pE2029, DOI 10.1210/jc.2011-1576; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Ha J, 2015, MOL ASPECTS MED, V46, P46, DOI 10.1016/j.mam.2015.08.002; He XY, 2018, INT J OBESITY, V42, P1051, DOI 10.1038/s41366-018-0024-2; Inoue N, 2008, J BIOL CHEM, V283, P21220, DOI 10.1074/jbc.M801824200; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Kim SM, 2014, CELL METAB, V20, P1049, DOI 10.1016/j.cmet.2014.10.010; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Liang WW, 2015, ONCOTARGET, V6, P31780, DOI 10.18632/oncotarget.5566; Lopez-Mejia IC, 2018, CELL MOL LIFE SCI, V75, P975, DOI 10.1007/s00018-017-2668-9; Louwen F, 2018, OBES REV, V19, P888, DOI 10.1111/obr.12679; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; McIntosh CHS, 2012, J DIABETES INVEST, V3, P96, DOI 10.1111/j.2040-1124.2012.00196.x; Moisan A, 2015, NAT CELL BIOL, V17, P57, DOI 10.1038/ncb3075; Montanari T, 2017, OBES REV, V18, P495, DOI 10.1111/obr.12520; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Ng SYA, 2014, EXPERT OPIN BIOL TH, V14, P1215, DOI 10.1517/14712598.2014.925870; Panina YA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01656; Perez LM, 2016, OBESITY, V24, P661, DOI 10.1002/oby.21405; Preston KJ, 2019, FASEB J, V33, P11993, DOI 10.1096/fj.201802637RR; Quang MDX, 2013, CYTOM PART A, V83, P933, DOI 10.1002/cyto.a.22333; Rose F, 2019, EXPERT OPIN DRUG DIS, V14, P1151, DOI 10.1080/17460441.2019.1646243; Rui LY, 2017, COMPR PHYSIOL, V7, P1281, DOI 10.1002/cphy.c170001; Sarantopoulos CN, 2018, STEM CELL REV REP, V14, P27, DOI 10.1007/s12015-017-9774-9; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schrover IM, 2018, EUR J PREV CARDIOL, V25, P1548, DOI 10.1177/2047487318790722; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Silva KR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0029-x; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srivastava G, 2018, NAT REV ENDOCRINOL, V14, P12, DOI 10.1038/nrendo.2017.122; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Verma MK, 2018, EXPERT OPIN THER TAR, V22, P615, DOI 10.1080/14728222.2018.1487952; Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weaver RE, 2008, INT J OBESITY, V32, P1705, DOI 10.1038/ijo.2008.148; Wilkins HM, 2016, J NEUROCHEM, V137, P76, DOI 10.1111/jnc.13545; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhang Y, 2018, J CLIN INVEST, V128, P4898, DOI 10.1172/JCI98353; Zhang Z, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110970	53	9	9	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21418	10.1096/fj.202001605R	http://dx.doi.org/10.1096/fj.202001605R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774873	Green Published, hybrid			2022-12-28	WOS:000645260100090
J	Zhang, YY; Xu, C; Tang, ZS; Guo, DW; Yao, RJ; Zhao, HN; Chen, ZX; Ni, X				Zhang, Youyi; Xu, Chen; Tang, Zhengshan; Guo, Dewei; Yao, Ruojin; Zhao, Huina; Chen, Zixi; Ni, Xin			Furin is involved in uterine activation for labor	FASEB JOURNAL			English	Article						FN14; furin; parturition; pregnancy; TWEAK	PROTEIN PHOSPHATASE 2A; A-BETA-SUBUNIT; MEIOTIC RECOMBINATION; PPP2R1B GENE; E3 LIGASE; MUTATIONS; HETEROZYGOSITY; PROGRESSION; EXPRESSION; DISTINCT	The uterus undergoes distinct molecular and functional changes during pregnancy and parturition. These processes are associated with the dramatic changes in various proteins. Given that the maturation and activation of many proteins require proteolytic processing by proprotein convertases (PCs), we sought to explore the role of PCs in uterine activation for labor. First, we found that furin was the most dramatically increased PC member in myometrial tissues from the pregnant women after onset of labor at term. Using the model of cultured human myometrial smooth muscle cells (HMSMCs), we showed that furin inhibitor CMK, D6R treatment and furin siRNA transfection suppressed contractility. Inhibition of furin activity or interfering furin expression decreased connexin 43 (CX43), prostaglandin (PG) endoperoxide synthase-2 (COX-2) and PGF2a receptor (FP) expression and NF-kappa B activation. In mouse model, administration of furin inhibitors prolonged gestational length. However, D6R treatment did not affect RU38486-and lipopolysaccharides (LPS)-induced preterm birth. Furthermore, D6R and furin siRNA treatment reduced the release of soluble form of tumor necrosis factor (TNF)-related weak inducer of apoptosis (TWEAK), while furin overexpression led to an increase in soluble TWEAK release in cultured HMSMCs. D6R treatment decreased TWEAK level in blood of pregnant mice. TWEAK treatment promoted contractility and NF-kappa B activation, while TWEAK receptor fibroblast growth factor-inducible 14 (FN14) antagonist treatment inhibited contractility and NF--.B activation in HMSMCs. In pregnant mice, administration of FN14 antagonist prolonged gestational length. Our data suggest that furin can act as a stimulator for uterine activation for labor at term. TWEAK is one of the potential substrates which mediate furin regulation of parturition initiation.	[Zhang, Youyi; Tang, Zhengshan; Guo, Dewei; Yao, Ruojin; Ni, Xin] Cent South Univ, Dept Gynecol & Obstet, Res Ctr Mol Metabol, Xiangya Hosp, Changsha 410008, Peoples R China; [Zhang, Youyi; Chen, Zixi; Ni, Xin] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Zhang, Youyi] Gen Hosp Western Theater Command PLA, Dept Gynecol & Obstet, Chengdu, Peoples R China; [Xu, Chen] Fundan Univ, Dept Physiol & Pathophysiol, Shanghai Med Sch, Shanghai, Peoples R China; [Zhao, Huina] Changhai Hosp, Dept Gynecol & Obstet, Shanghai, Peoples R China; [Zhao, Huina] Shanghai Seventh Peoples Hosp, Dept Gynecol & Obstet, Shanghai, Peoples R China; [Ni, Xin] Cent South Univ, Natl Clin Res Ctr Geriatr Disorders, Xiangya Hosp, Changsha, Peoples R China	Central South University; Naval Medical University; Fudan University; Naval Medical University; Central South University	Ni, X (corresponding author), Cent South Univ, Dept Gynecol & Obstet, Res Ctr Mol Metabol, Xiangya Hosp, Changsha 410008, Peoples R China.	xinni2018@csu.edu.cn		Xu, Chen/0000-0001-5146-5260	Natural Science Foundation of China [81620108013, 31972892]; Sate Key Research and Development Program of China [2017YFC1001404, 2018YFC1002802]; Science and Technology Commission of Shanghai Municipals [1814090300]; Hunan Provincial Science and Technology Department [2018RS3030]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sate Key Research and Development Program of China; Science and Technology Commission of Shanghai Municipals; Hunan Provincial Science and Technology Department	The authors wish to thank all the patients participated in this study, and Mr Jiefeng Luo and Ms Yalin Shan for their assistance in animal studies. This work was supported by Natural Science Foundation of China (No.81620108013&No.31972892), Sate Key Research and Development Program of China (2017YF C1001404&2018YFC1002802), Science and Technology Commission of Shanghai Municipals (1814090300) and Hunan Provincial Science and Technology Department (2018RS3030).	Ali EZ, 2018, MOL GENET METAB REP, V17, P22, DOI 10.1016/j.ymgmr.2018.08.006; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Arafat M, 2017, J MED GENET, V54, P633, DOI 10.1136/jmedgenet-2017-104514; Astashchanka A, 2019, BREAST CANCER RES TR, V173, P289, DOI 10.1007/s10549-018-4989-2; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; CARTER SL, 1994, CANCER RES, V54, P6270; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Choi Y, 2010, HUM MUTAT, V31, P788, DOI 10.1002/humu.21264; Cocuzza M, 2013, CLINICS, V68, P15, DOI 10.6061/clinics/2013(Sup01)03; Colombo R, 2017, GYNECOL OBSTET INVES, V82, P283, DOI 10.1159/000468934; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Davis M, 1996, CANCER RES, V56, P741; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; Esplin ED, 2006, GENE CHROMOSOME CANC, V45, P182, DOI 10.1002/gcc.20284; Faieta M, 2016, CHROMOSOMA, V125, P189, DOI 10.1007/s00412-015-0544-7; Ferlin A, 2012, ASIAN J ANDROL, V14, P807, DOI 10.1038/aja.2012.84; Gabra H, 1996, CANCER RES, V56, P950; Gao JM, 2018, TRENDS GENET, V34, P232, DOI 10.1016/j.tig.2017.12.001; Gopinathan L, 2017, CELL REP, V20, P697, DOI 10.1016/j.celrep.2017.06.033; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Hwang JH, 2013, J BIOL CHEM, V288, P32064, DOI 10.1074/jbc.M113.497644; Jiang Z, 2008, INT J BIOL SCI, V4, P96; Kanthimathi S, 2016, ANN HUM GENET, V80, P241, DOI 10.1111/ahg.12155; Karasu ME, 2019, CHROMOSOMA, V128, P473, DOI 10.1007/s00412-019-00725-5; Kim JH, 2010, J HUM GENET, V55, P358, DOI 10.1038/jhg.2010.34; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee NPY, 2008, ADV EXP MED BIOL, V636, P172, DOI 10.1007/978-0-387-09597-4_10; Lei WL, 2020, CELL DEATH DIFFER, V27, P1952, DOI 10.1038/s41418-019-0472-9; Liao MJ, 2019, EBIOMEDICINE, V41, P200, DOI 10.1016/j.ebiom.2019.01.035; Luddi A, 2016, SYST BIOL REPROD MED, V62, P372, DOI 10.1080/19396368.2016.1238116; Maor-Sagie E, 2015, J ASSIST REPROD GEN, V32, P887, DOI 10.1007/s10815-015-0445-y; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Muller JS, 2006, BRAIN, V129, P2784, DOI 10.1093/brain/awl188; Nakazawa N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217331; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Price NE, 2000, BIOCHEMISTRY-US, V39, P11312, DOI 10.1021/bi0008478; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Sinha N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047623; Sun MM, 2017, CANCER SCI, V108, P267, DOI 10.1111/cas.13128; Tamaki M, 2004, ONCOL REP, V11, P655; Totonchi M, 2012, J ASSIST REPROD GEN, V29, P847, DOI 10.1007/s10815-012-9798-7; Tran TN, 2018, HUM MOL GENET, V27, P3911, DOI 10.1093/hmg/ddy286; Wamelink MMC, 2015, J INHERIT METAB DIS, V38, P889, DOI 10.1007/s10545-014-9809-1; Wang LY, 2017, NUCLEUS-PHILA, V8, P461, DOI 10.1080/19491034.2017.1330237; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, P9681, DOI 10.1093/nar/gkw652; Yatsenko AN, 2015, NEW ENGL J MED, V372, P2097, DOI 10.1056/NEJMoa1406192; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yoneda R, 2013, BIOCHEM BIOPH RES CO, V441, P120, DOI 10.1016/j.bbrc.2013.10.028; Zhang QT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11346-y; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	59	0	0	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21565	10.1096/fj.202002128RR	http://dx.doi.org/10.1096/fj.202002128RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864414				2022-12-28	WOS:000645260100068
J	Zhao, X; Lu, JC; Chen, XB; Gao, ZX; Zhang, C; Chen, CX; Qiao, DF; Wang, HJ				Zhao, Xu; Lu, Jiancong; Chen, Xuebing; Gao, Zhengxiang; Zhang, Cui; Chen, Chuanxiang; Qiao, Dongfang; Wang, Huijun			Methamphetamine exposure induces neuronal programmed necrosis by activating the receptor-interacting protein kinase 3-related signalling pathway	FASEB JOURNAL			English	Article						dynamin-related protein 1; methamphetamine; mixed lineage kinase domain-like protein; programmed necrosis; the receptor-interacting protein kinase 3	ACTIN-ASSOCIATED PROTEIN; F-ACTIN; FILAMIN; PODOCYTES; IDENTIFICATION; EXPRESSION; KIDNEY	Methamphetamine (METH) is a synthetic drug with severe neurotoxicity, however, the regulation of METH-induced neuronal programmed necrosis remains poorly understood. The aim of this study was to identify the molecular mechanisms of METH-induced neuronal programmed necrosis. We found that neuronal programmed necrosis occurred in the striatum of brain samples from human and mice that were exposed to METH. The receptor-interacting protein kinase 3 (RIP3) was highly expressed in the neurons of human and mice exposed to METH, and RIP3-silenced or RIP1-inhibited protected neurons developed neuronal programmed necrosis in vitro and in vivo following METH exposure. Moreover, the RIP1-RIP3 complex causes cell programmed necrosis by regulating mixed lineage kinase domain-like protein (MLKL)-mediated cell membrane rupture and dynamin-related protein 1 (Drp1)-mediated mitochondrial fission. Together, these data indicate that RIP3 plays an indispensable role in the mechanism of METH-induced neuronal programmed necrosis, which may represent a potential therapeutic target for METH-induced neurotoxicity.	[Zhao, Xu; Lu, Jiancong; Chen, Xuebing; Gao, Zhengxiang; Zhang, Cui; Chen, Chuanxiang; Qiao, Dongfang; Wang, Huijun] Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China	Southern Medical University - China	Qiao, DF; Wang, HJ (corresponding author), Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China.	qiaodf@163.com; hjwang@smu.edu.cn	Zhao, Xiaoshan/GPF-7929-2022; wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022		National Natural Science Foundation of China [81871528]; Guangzhou Science and Technology Project [201803010005]; Natural Science Foundation of Guangdong Province [2019A1515011987]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 81871528 to H. Wang), Guangzhou Science and Technology Project (Grant No. 201803010005 to H. Wang), and Natural Science Foundation of Guangdong Province (Grant No.2019A1515011987 to D. Qiao)	Albrecht T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44492; Artelt N, 2018, J AM SOC NEPHROL, V29, P1662, DOI 10.1681/ASN.2017091039; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Campa Carlo C, 2015, Small GTPases, V6, P71, DOI 10.4161/21541248.2014.989789; Chakarova C, 2000, HUM GENET, V107, P597, DOI 10.1007/s004390000414; Chen H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01642; Cockwell P, 2020, LANCET, V395, P662, DOI 10.1016/S0140-6736(19)32977-0; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; D'Addario M, 2001, J BIOL CHEM, V276, P31969, DOI 10.1074/jbc.M102715200; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Endlich K, 2017, PFLUG ARCH EUR J PHY, V469, P937, DOI 10.1007/s00424-017-2025-8; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; He FF, 2013, CURR GENOMICS, V14, P477, DOI 10.2174/13892029113146660014; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; HOLSTEINRATHLOU NH, 1991, AM J PHYSIOL, V260, pF53, DOI 10.1152/ajprenal.1991.260.1.F53; Hu JJ, 2017, HUM MOL GENET, V26, P1294, DOI 10.1093/hmg/ddx047; Hugo C, 1998, KIDNEY INT, V54, P1934, DOI 10.1046/j.1523-1755.1998.00195.x; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kliewe F., 2019, FASEB J, V33, P14450, DOI DOI 10.1096/fj.201900978RR; Kliewe F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10116-4; KRETZLER M, 1994, VIRCHOWS ARCH, V425, P181; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; Kumar A, 2019, J CELL BIOL, V218, P2481, DOI 10.1083/jcb.201901086; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Lindenmeyer MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011545; Liu JM, 2015, NAT STRUCT MOL BIOL, V22, P383, DOI 10.1038/nsmb.2999; MacPherson M, 2010, AM J PHYSIOL-CELL PH, V298, pC206, DOI 10.1152/ajpcell.00505.2009; Martini S, 2014, J AM SOC NEPHROL, V25, P2559, DOI 10.1681/ASN.2013080906; Mathieson PW, 2012, CLIN KIDNEY J, V5, P498, DOI 10.1093/ckj/sfs153; Mezawa M, 2016, FASEB J, V30, P3613, DOI 10.1096/fj.201600354RR; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto VI, 2014, FASEB J, V28, P453, DOI 10.1096/fj.13-233759; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Pozzi A, 2013, J AM SOC NEPHROL, V24, P1034, DOI 10.1681/ASN.2013010012; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rognoni L, 2012, P NATL ACAD SCI USA, V109, P19679, DOI 10.1073/pnas.1211274109; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schordan S, 2013, AM J PHYSIOL-RENAL, V304, pF1458, DOI 10.1152/ajprenal.00615.2012; Seppala J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136969; Shao QQ, 2016, PATHOL ONCOL RES, V22, P245, DOI 10.1007/s12253-015-9980-1; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; SIMONS JL, 1993, J AM SOC NEPHROL, V3, P1775; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dokkum RPE, 1999, AM J PHYSIOL-REG I, V276, pR855, DOI 10.1152/ajpregu.1999.276.3.R855; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; WANG K, 1977, P NATL ACAD SCI USA, V74, P2021, DOI 10.1073/pnas.74.5.2021; Wang L, 2019, BIOCHEMISTRY-US, V58, P4726, DOI 10.1021/acs.biochem.9b00100; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433	75	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21561	10.1096/fj.202100188R	http://dx.doi.org/10.1096/fj.202100188R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864423				2022-12-28	WOS:000645260100066
J	Ji, KY; Kim, SM; Yee, SM; Kim, MJ; Ban, YJ; Kim, EM; Lee, EH; Choi, H; Yun, H; Lee, CW; Yun, CH; Lee, CJ; Lee, HB; Kang, HS				Ji, Kon-Young; Kim, Su-Man; Yee, Su-Min; Kim, Min-Jae; Ban, Yu-Jin; Kim, Eun-Mi; Lee, Eun-Hee; Choi, Ha-Rim; Yun, Hyosuk; Lee, Chul Won; Yun, Chul-Ho; Lee, C. Justin; Lee, Hyang Burm; Kang, Hyung-Sik			Cyclophilin A is an endogenous ligand for the triggering receptor expressed on myeloid cells-2 (TREM2)	FASEB JOURNAL			English	Article						anti&#8208; inflammation; CD147; cyclophilin A; TREM2; TREM2 ligand		Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface receptor expressed on macrophages, microglial cells, and pre-osteoclasts, and that participates in diverse cellular function, including inflammation, bone homeostasis, neurological development, and coagulation. In spite of the indispensable role of the TREM2 protein in the maintenance of immune homeostasis and osteoclast differentiation, the exact ligand for TREM2 has not yet been identified. Here, we report a putative TREM2 ligand which is secreted from MC38 cells and identified as a cyclophilin A (CypA). A specific interaction between CypA and TREM2 was shown at both protein and cellular levels. Exogenous CypA specifically interacted and co-localized with TREM2 in RAW264.7 cells, and the physical interactions were shown to regulate TREM2 signaling transduction. The Pro(144) residue in the extracellular domain of TREM2 was found to be the specific binding site of CypA. When considered together, this provides evidence that CypA interacts specifically with TREM2 as a potent ligand.	[Ji, Kon-Young; Kim, Su-Man; Yee, Su-Min; Kim, Min-Jae; Ban, Yu-Jin; Yun, Chul-Ho; Kang, Hyung-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea; [Kim, Eun-Mi] Korea Inst Toxicol, R&D Ctr Adv Pharmaceut & Evaluat, Daejeon, South Korea; [Lee, Eun-Hee] Deagu Gyeongbuk Med Innovat Fdn, Adv Interdisciplinary Team, Prod R&D Div, Daegu, South Korea; [Choi, Ha-Rim] Nambu Univ, Dept Nursing, Gwangju, South Korea; [Yun, Hyosuk; Lee, Chul Won] Chonnam Natl Univ, Dept Chem, Gwangju, South Korea; [Lee, C. Justin] Inst for Basic Sci Korea, Ctr Cognit & Social, Daejeon, South Korea; [Lee, Hyang Burm] Chonnam Natl Univ, Div Food Technol Biotechnol & Agrochem, Gwangju, South Korea	Chonnam National University; Korea Institute of Toxicology; Nambu University; Chonnam National University; Institute for Basic Science - Korea (IBS); Chonnam National University	Kang, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea.	kanghs@jnu.ac.kr	Ji, Kon-Young/GZB-2640-2022	Lee, C Justin/0000-0002-3555-0980; Kim, Su-Man/0000-0002-0588-8294	National Research Foundation of Korea (NRF) [NRF--2018R1A4A1023882]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2B6005139; National Research Foundation of Korea (NRF), Grant/Award Number: NRF--2018R1A4A1023882	Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Bhagwat B, 2018, J IMMUNOL METHODS, V456, P7, DOI 10.1016/j.jim.2018.02.003; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Garcia JEL, 2000, MEDIAT INFLAMM, V9, P169, DOI 10.1080/09629350020008682; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Huang YWA, 2019, J NEUROSCI, V39, P7408, DOI 10.1523/JNEUROSCI.2994-18.2019; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kobayashi M, 2016, J NEUROSCI, V36, P11138, DOI 10.1523/JNEUROSCI.1238-16.2016; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Park M, 2015, DIABETES, V64, P117, DOI 10.2337/db13-1869; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Schlegel J, 2009, J MOL BIOL, V391, P518, DOI 10.1016/j.jmb.2009.05.080; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Song F, 2011, J BIOL CHEM, V286, P8197, DOI 10.1074/jbc.C110.181347; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xing JJ, 2015, RES REP BIOCHEM, V5, P89, DOI 10.2147/RRBC.S58057; XU Q, 1992, J BIOL CHEM, V267, P11968; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2005, J BIOL CHEM, V280, P17013, DOI 10.1074/jbc.M412851200; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	36	5	5	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21479	10.1096/fj.202002325RR	http://dx.doi.org/10.1096/fj.202002325RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710680				2022-12-28	WOS:000635216100030
J	Jie, QL; Sun, F; Li, Q; Zhu, J; Wei, YJ; Yang, HM; Long, P; Wang, Z; Yang, XH; Li, D; Huang, LP; Ma, YL				Jie, Qiuling; Sun, Fei; Li, Qi; Zhu, Juan; Wei, Yunjian; Yang, Huamei; Long, Ping; Wang, Zhen; Yang, Xiaohui; Li, Dan; Huang, Liping; Ma, Yanlin			Downregulated ribosomal protein L39 inhibits trophoblast cell migration and invasion by targeting E-cadherin in the placenta of patients with preeclampsia	FASEB JOURNAL			English	Article						E&#8208; cadherin; early&#8208; onset preeclampsia; invasion; migration; proliferation; ribosomal protein L39		Early-onset preeclampsia (PE) is a pregnancy complication that can lead to severe adverse maternal and fetal outcomes. However, the mechanisms underlying the development of early-onset PE are not fully understood. Ribosomal protein L39 (RPL39) is a member of the S39E family of ribosomal proteins that plays an important role in stem cell self-renewal, cancer metastasis, and chemoresistance. In this study, we aimed to explore the potential function of RPL39 in placental trophoblast cells. We analyzed the expression of RPL39 in early-onset PE and normal placental tissues using real-time PCR, western blot analysis, and immunohistochemistry. The results showed that RPL39 was markedly downregulated in early-onset PE placental tissues. RPL39 knockdown inhibited trophoblast cell proliferation, migration, and invasion, as well as placental explant outgrowth. Flow cytometry analysis suggested that knockdown of RPL39 resulted in cell cycle arrest at the G0/G1 phase, but had no significant effect on cell apoptosis. We also found that RPL39 knockdown could alter cell morphology. We then measured the expression of the epithelial cell marker E-cadherin following knockdown of RPL39 in Bewo and HTR8/SVneo cells. RPL39 knockdown increased the expression of E-cadherin. Furthermore, E-cadherin expression was upregulated in placental explant outgrowth tissues transfected with RPL39 small interfering RNA. In conclusion, RPL39 plays an essential role in proliferation, invasion, and migration of trophoblast cells by targeting E-cadherin. Our findings provide novel insight into the mechanisms underlying the occurrence of early-onset PE.	[Jie, Qiuling; Sun, Fei; Zhu, Juan; Huang, Liping] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 Guangzhou North Ave, Guangzhou 510515, Peoples R China; [Jie, Qiuling; Sun, Fei; Li, Qi; Zhu, Juan; Wei, Yunjian; Yang, Huamei; Long, Ping; Wang, Zhen; Yang, Xiaohui; Li, Dan; Ma, Yanlin] Hainan Med Univ, Dept Hainan Prov Key Lab Human Reprod Med & Genet, Key Lab Trop Translat Med, Minist Educ,Reprod Med,Affiliated Hosp 1, 31 Longhua Rd, Haikou 570102, Hainan, Peoples R China	Southern Medical University - China; Hainan Medical University	Huang, LP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 Guangzhou North Ave, Guangzhou 510515, Peoples R China.; Ma, YL (corresponding author), Hainan Med Univ, Dept Hainan Prov Key Lab Human Reprod Med & Genet, Key Lab Trop Translat Med, Minist Educ,Reprod Med,Affiliated Hosp 1, 31 Longhua Rd, Haikou 570102, Hainan, Peoples R China.	lphuang@126.com; mayl1990@foxmail.com	龙, 平/HIK-1699-2022; Ma, Yanlin/CAH-2185-2022	Ma, Yanlin/0000-0001-9668-0204; Jie, Qiuling/0000-0002-1338-0888	Finance science and technology project of hainan province [ZDKJ2017007]; National Natural Science Foundation of China [81960283, 82072880, 82003144, 81660433]; Natural Science Foundation of Hainan Province [2019CXTD408]; Natural Science Foundation of Guangdong Province [2019A1515010019, 2017A030313584]; Presidential Foundation of Nanfang Hospital, Southern Medical University [2018Z014, 2017C001]	Finance science and technology project of hainan province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Presidential Foundation of Nanfang Hospital, Southern Medical University	Finance science and technology project of hainan province, Grant/Award Number: ZDKJ2017007; National Natural Science Foundation of China, Grant/Award Number: 81960283, 82072880, 82003144 and 81660433; Natural Science Foundation of Hainan Province, Grant/Award Number: 2019CXTD408; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2019A1515010019 and 2017A030313584; Presidential Foundation of Nanfang Hospital, Southern Medical University, Grant/Award Number: 2018Z014 and 2017C001	Aiello NM, 2018, DEV CELL, V45, P681, DOI 10.1016/j.devcel.2018.05.027; [Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; Beckers KF, 2020, AM J PHYSIOL-HEART C, V318, pH1, DOI 10.1152/ajpheart.00469.2019; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Chen XH, 2018, HYPERTENSION, V71, P481, DOI 10.1161/HYPERTENSIONAHA.117.10250; Cheng D, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/4976845; Cui JH, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01720-9; Dave B, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw292; Dave B, 2014, P NATL ACAD SCI USA, V111, P8838, DOI 10.1073/pnas.1320769111; de las Heras-Rubio A, 2014, CANCER METAST REV, V33, P115, DOI 10.1007/s10555-013-9460-6; Fedorova L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-15; Graifer D, 2015, BIOCHIMIE, V109, P1, DOI 10.1016/j.biochi.2014.11.016; He CJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46699-3; Ji PG, 2019, J CELL BIOCHEM, V120, P3259, DOI 10.1002/jcb.27592; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Kumar S, 2018, REPRODUCTION, V156, pR155, DOI 10.1530/REP-18-0278; Le YP, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.10.11; Li CD, 2014, BIOTECHNOL J, V9, P652, DOI 10.1002/biot.201300321; Li F, 2018, HYPERTENSION, V71, P894, DOI 10.1161/HYPERTENSIONAHA.117.10849; Liu HS, 2014, ASIAN PAC J CANCER P, V15, P3093, DOI 10.7314/APJCP.2014.15.7.3093; Liu J, 2020, J CELL PHYSIOL, V235, P7410, DOI 10.1002/jcp.29643; Liu ZB, 2019, BREAST CANCER RES TR, V178, P251, DOI 10.1007/s10549-019-05374-x; Loh CY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101118; Mendonsa AM, 2018, ONCOGENE, V37, P4769, DOI 10.1038/s41388-018-0304-2; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Owusu-Akyaw A, 2019, HUM REPROD UPDATE, V25, P114, DOI 10.1093/humupd/dmy035; Peng W, 2019, FASEB J, V33, P6327, DOI 10.1096/fj.201802058RR; Phipps EA, 2019, NAT REV NEPHROL, V15, P275, DOI 10.1038/s41581-019-0119-6; Prakash V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10100-8; Raguema N, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00098; Sani HM, 2019, BIOMED PHARMACOTHER, V109, P408, DOI 10.1016/j.biopha.2018.10.082; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Wang SL, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.166; Wang XN, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1025; Wen YW, 2019, UROL ONCOL-SEMIN ORI, V37, DOI 10.1016/j.urolonc.2019.01.011; Ye YZ, 2019, FASEB J, V33, P2732, DOI 10.1096/fj.201800934RRR; Yue XJ, 2018, PLACENTA, V62, P43, DOI 10.1016/j.placenta.2017.12.009; Zhou L, 2019, AM J PHYSIOL-ENDOC M, V316, pE773, DOI 10.1152/ajpendo.00383.2018; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	40	1	1	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21322	10.1096/fj.202002061R	http://dx.doi.org/10.1096/fj.202002061R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710681				2022-12-28	WOS:000635216100062
J	Kim, BS; Jang, T; Yoo, SE; Lee, JM; Kim, E				Kim, Bok-Seok; Jang, Taeik; Yoo, Sung-Eun; Lee, Jae Moon; Kim, Eunhee			Fas-associated factor 1 induces the accumulation of alpha-synuclein through autophagic suppression in dopaminergic neurons	FASEB JOURNAL			English	Article						macroautophagy; Parkinson&apos; s disease; striatum; substantia nigra		Impairment of protein clearance mechanisms leads to alpha-synuclein accumulation in dopaminergic neurons, contributing to the pathogenesis of Parkinson's disease (PD). Based on the finding that Fas-associated factor 1 (FAF1), a positive modulator of PD, colocalizes with alpha-synuclein in PD patient brains, we investigated the existence of pathological interplay between FAF1 and alpha-synuclein. Monomeric and high-molecular-weight forms of alpha-synuclein were increased in FAF1-overexpressing SH-SY5Y cells. In particular, alpha-synuclein turnover was accelerated by genetic depletion of FAF1 in SH-SY5Y cells. Therefore, we questioned whether FAF1 is involved in the alpha-synuclein clearance process. Autophagy inhibitors, but not proteasome inhibitors, restored concurrent attenuation of alpha-synuclein expression by FAF1 depletion in SH-SY5Y cells. Moreover, we found alterations in autophagy markers in SH-SY5Y cells caused by FAF1 overexpression, indicating that FAF1 disturbed alpha-synuclein clearance through the autophagy-lysosome pathway. Indeed, FAF1 activated the mammalian target of rapamycin (mTOR) pathway, subsequently suppressing autophagosome formation. Consistently, alpha-synuclein-mediated mitochondrial dysfunction was observed in FAF1-overexpressing SH-SY5Y cells. Furthermore, FAF1 overexpression using stereotaxic injection of adeno-associated virus led to alpha-synuclein accumulation and autophagy dysregulation in the PD model mice. Taken together, our results reveal a novel role for FAF1: that of a negative regulator of autophagic alpha-synuclein clearance.	[Kim, Bok-Seok; Jang, Taeik; Kim, Eunhee] Chungnam Natl Univ, Dept Biol Sci, 99 Daehak Ro, Daejeon 34134, South Korea; [Yoo, Sung-Eun; Lee, Jae Moon] Kainos Med Inc, Seongnam, South Korea	Chungnam National University	Kim, E (corresponding author), Chungnam Natl Univ, Dept Biol Sci, 99 Daehak Ro, Daejeon 34134, South Korea.	eunhee@cnu.ac.kr			Korea Health Industry Development Institute (KHIDI) [HI16C0947]	Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI))	Korea Health Industry Development Institute (KHIDI), Grant/Award Number: HI16C0947, HI16C0947 and HI16C0947	Ahn TB, 2008, NEUROLOGY, V70, P43, DOI 10.1212/01.wnl.0000271080.53272.c7; Alvarez-Erviti L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.73; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Antonia RJ, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan5850; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2008, NEUROBIOL DIS, V31, P309, DOI 10.1016/j.nbd.2008.05.006; Bian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060184; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Cartier AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034713; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; El-Masry OS, 2015, ONCOL REP, V34, P1675, DOI 10.3892/or.2015.4198; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Giacoppo S, 2017, NEUROREPORT, V28, P996, DOI 10.1097/WNR.0000000000000871; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hamano T, 2009, INT J CLIN EXP PATHO, V2, P561; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Jang MS, 2008, J BIOL CHEM, V283, P32344, DOI 10.1074/jbc.M804199200; Kam TI, 2018, SCIENCE, V362, P557, DOI 10.1126/science.aat8407; Kim C, 2015, CELL REP, V13, P771, DOI 10.1016/j.celrep.2015.09.044; Kim Han-Joon, 2013, Exp Neurobiol, V22, P77, DOI 10.5607/en.2013.22.2.77; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; Kim JH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006398; Kim WS, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0073-2; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lim GGY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073235; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Lopez-Perez O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38500-2; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Olsen BB, 2003, FEBS LETT, V546, P218, DOI 10.1016/S0014-5793(03)00575-1; Pankratz N, 2009, MOVEMENT DISORD, V24, P1125, DOI 10.1002/mds.22524; Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Sala G, 2014, BRAIN RES, V1546, P46, DOI 10.1016/j.brainres.2013.12.017; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Sul JW, 2013, HUM MOL GENET, V22, P1558, DOI 10.1093/hmg/ddt006; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trojanowski JQ, 1999, BRAIN PATHOL, V9, P733; Visanji NP, 2016, TRENDS NEUROSCI, V39, P750, DOI 10.1016/j.tins.2016.09.003; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Xie F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15021; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Yu CS, 2016, CELL DEATH DIFFER, V23, P1873, DOI 10.1038/cdd.2016.99; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	66	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21363	10.1096/fj.202001371RR	http://dx.doi.org/10.1096/fj.202001371RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749937				2022-12-28	WOS:000635216100027
J	Oduwole, OO; Poliandri, A; Okolo, A; Rawson, P; Doroszko, M; Chrusciel, M; Rahman, NA; de Almeida, GS; Bevan, CL; Koechling, W; Huhtaniemi, IT				Oduwole, Olayiwola O.; Poliandri, Ariel; Okolo, Anthony; Rawson, Phil; Doroszko, Milena; Chrusciel, Marcin; Rahman, Nafis A.; Serrano de Almeida, Gilberto; Bevan, Charlotte L.; Koechling, Wolfgang; Huhtaniemi, Ilpo T.			Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenografts	FASEB JOURNAL			English	Article						follicle&#8208; stimulating hormone; follicle&#8208; stimulating hormone receptor; gonadectomy; gonadotropin&#8208; releasing hormone antagonist; prostate cancer		Chemical castration in prostate cancer can be achieved with gonadotropin-releasing hormone (GnRH) agonists or antagonists. Their effects differ by the initial flare of gonadotropin and testosterone secretion with agonists and the immediate pituitary-testicular suppression by antagonists. While both suppress luteinizing hormone (LH) and follicle-stimulating hormone (FSH) initially, a rebound in FSH levels occurs during agonist treatment. This rebound is potentially harmful, taken the expression of FSH receptors (R) in prostate cancer tissue. We herein assessed the role of FSH in promoting the growth of androgen-independent (PC-3, DU145) and androgen-dependent (VCaP) human prostate cancer cell line xenografts in nude mice. Gonadotropins were suppressed with the GnRH antagonist degarelix, and effects of add-back human recombinant FSH were assessed on tumor growth. All tumors expressed GnRHR and FSHR, and degarelix treatment suppressed their growth. FSH supplementation reversed the degarelix-evoked suppression of PC-3 tumors, both in preventive (degarelix and FSH treatment started upon cell inoculation) and therapeutic (treatments initiated 3 weeks after cell inoculation) setting. A less marked, though significant FSH effect occurred in DU145, but not in VCaP xenografts. FSHR expression in the xenografts supports direct FSH stimulation of tumor growth. Testosterone supplementation, to maintain the VCaP xenografts, apparently masked the FSH effect on their growth. Treatment with the LH analogue hCG did not affect PC-3 tumor growth despite their expression of luteinizing hormone/choriongonadotropin receptor. In conclusion, FSH, but not LH, may directly stimulate the growth of androgen-independent prostate cancer, suggesting that persistent FSH suppression upon GnRH antagonist treatment offers a therapeutic advantage over agonist.	[Oduwole, Olayiwola O.; Okolo, Anthony; Huhtaniemi, Ilpo T.] Imperial Coll London, Dept Digest Metab & Reprod, Inst Reprod & Dev Biol, London, England; [Poliandri, Ariel] St Georges Univ London, Dept Mol & Clin Sci, London, England; [Rawson, Phil] Imperial Coll London, Cent Biomed Serv, London, England; [Doroszko, Milena; Chrusciel, Marcin; Rahman, Nafis A.; Huhtaniemi, Ilpo T.] Univ Turku, Inst Biomed, Turku, Finland; [Rahman, Nafis A.] Med Univ Bialystok, Dept Reprod & Gynecol Endocrinol, Bialystok, Poland; [Serrano de Almeida, Gilberto; Bevan, Charlotte L.] Imperial Coll London, Imperial Ctr Translat & Expt Med, London, England; [Koechling, Wolfgang] Ferring Pharmaceut AS, Nonclin Dev, Copenhagen, Denmark	Imperial College London; St Georges University London; Imperial College London; University of Turku; Medical University of Bialystok; Imperial College London; Ferring Pharmaceuticals	Huhtaniemi, IT (corresponding author), Imperial Coll London, Dept Digest Metab & Reprod, Inst Reprod & Dev Biol, London, England.	ilpo.huhtaniemi@imperial.ac.uk	Bevan, Charlotte L/K-2276-2012	Bevan, Charlotte L/0000-0002-7533-0552; Oduwole, Olayiwola/0000-0003-3840-7335	Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Investigator Initiated Funding from Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; Crawford ED, 2018, SCAND J UROL, V52, P349, DOI 10.1080/21681805.2018.1522372; Crawford ED, 2014, UROLOGY, V83, P1122, DOI 10.1016/j.urology.2014.01.013; Cucchiara V, 2019, MOL CANCER THER, V18, P1811, DOI 10.1158/1535-7163.MCT-18-1337; Dirnhofer S, 1998, PROSTATE, V35, P212; Dizeyi N, 2019, UROL ONCOL-SEMIN ORI, V37, DOI 10.1016/j.urolonc.2018.12.011; GARDE SV, 1993, CANCER LETT, V75, P1, DOI 10.1016/0304-3835(93)90200-S; GARDE SV, 1991, PROSTATE, V18, P271, DOI 10.1002/pros.2990180402; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Hoare D, 2015, CUAJ-CAN UROL ASSOC, V9, P122, DOI 10.5489/cuaj.2545; HUHTANIEMI I, 1987, J ANDROL, V8, P355; Hupe MC, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00543; HURKADLI KS, 1990, BRIT J CANCER, V61, P225, DOI 10.1038/bjc.1990.42; KEER HN, 1991, PROSTATE, V18, P201, DOI 10.1002/pros.2990180303; Kim K, 2018, CLIN CANCER RES, V24, P2408, DOI 10.1158/1078-0432.CCR-17-3474; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Limonta P, 2012, ENDOCR REV, V33, P784, DOI 10.1210/er.2012-1014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariani S, 2006, J UROLOGY, V175, P2072, DOI 10.1016/S0022-5347(06)00273-4; Oduwole OO, 2018, J CLIN INVEST, V128, P1787, DOI 10.1172/JCI96794; Owen LJ, 2012, ANN CLIN BIOCHEM, V49, P600, DOI 10.1258/acb.2012.012037; Poliandri AHB, 2011, J BIOL RHYTHM, V26, P187, DOI 10.1177/0748730411401579; Porter AT, 2001, UROL ONCOL, V6, P131, DOI 10.1016/S1078-1439(00)00124-1; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Salciccia S, 2016, UROLOGIA J, V83, P173, DOI 10.5301/uro.5000194; Scailteux LM, 2017, EUR J CANCER, V77, P99, DOI 10.1016/j.ejca.2017.03.002; SHAH MG, 1991, PROSTATE, V18, P1, DOI 10.1002/pros.2990180102; Tao YX, 1997, BIOL REPROD, V56, P67, DOI 10.1095/biolreprod56.1.67; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Vaz CV, 2012, INT J BIOCHEM CELL B, V44, P2077, DOI 10.1016/j.biocel.2012.08.013; Vis AN, 2015, UROL ONCOL-SEMIN ORI, V33, P7, DOI 10.1016/j.urolonc.2014.04.016; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Weiss J, 1999, LAB ANIM, V33, P192, DOI 10.1258/002367799780578417; Xiong SG, 2015, PROSTATE, V75, P141, DOI 10.1002/pros.22899	36	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21464	10.1096/fj.202002168RR	http://dx.doi.org/10.1096/fj.202002168RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724574				2022-12-28	WOS:000635216100089
J	Saika, A; Nagatake, T; Hirata, SI; Sawane, K; Adachi, J; Abe, Y; Isoyama, J; Morimoto, S; Node, E; Tiwari, P; Hosomi, K; Matsunaga, A; Honda, T; Tomonaga, T; Arita, M; Kabashima, K; Kunisawa, J				Saika, Azusa; Nagatake, Takahiro; Hirata, So-ichiro; Sawane, Kento; Adachi, Jun; Abe, Yuichi; Isoyama, Junko; Morimoto, Sakiko; Node, Eri; Tiwari, Prabha; Hosomi, Koji; Matsunaga, Ayu; Honda, Tetsuya; Tomonaga, Takeshi; Arita, Makoto; Kabashima, Kenji; Kunisawa, Jun			omega 3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor alpha	FASEB JOURNAL			English	Article						12&#8208; hydroxyeicosapentaenoic acid; allergic contact dermatitis; keratinocytes; lipid metabolite; retinoid X receptor	POLYUNSATURATED FATTY-ACIDS; T-CELLS; 17,18-EPOXYEICOSATETRAENOIC ACID; ANTIINFLAMMATORY ACTIONS; NEUTROPHIL INFILTRATION; SKIN INFLAMMATION; LIPID-METABOLISM; IMMUNE EVENTS; RESOLVIN E2; RECRUITMENT	omega 3 fatty acids show potent bioactivities via conversion into lipid mediators; therefore, metabolism of dietary lipids is a critical determinant in the properties of omega 3 fatty acids in the control of allergic inflammatory diseases. However, metabolic progression of omega 3 fatty acids in the skin and their roles in the regulation of skin inflammation remains to be clarified. In this study, we found that 12-hydroxyeicosapentaenoic acid (12-HEPE), which is a 12-lipoxygenase metabolite of eicosapentaenoic acid, was the prominent metabolite accumulated in the skin of mice fed omega 3 fatty acid-rich linseed oil. Consistently, the gene expression levels of Alox12 and Alox12b, which encode proteins involved in the generation of 12-HEPE, were much higher in the skin than in the other tissues (eg, gut). We also found that the topical application of 12-HEPE inhibited the inflammation associated with contact hypersensitivity by inhibiting neutrophil infiltration into the skin. In human keratinocytes in vitro, 12-HEPE inhibited the expression of two genes encoding neutrophil chemoattractants, CXCL1 and CXCL2, via retinoid X receptor alpha. Together, the present results demonstrate that the metabolic progression of dietary omega 3 fatty acids differs in different organs, and identify 12-HEPE as the dominant omega 3 fatty acid metabolite in the skin.	[Saika, Azusa; Nagatake, Takahiro; Hirata, So-ichiro; Sawane, Kento; Morimoto, Sakiko; Node, Eri; Tiwari, Prabha; Hosomi, Koji; Matsunaga, Ayu; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Vaccine & Adjuvant Res, Lab Vaccine Mat, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan; [Saika, Azusa; Nagatake, Takahiro; Hirata, So-ichiro; Sawane, Kento; Morimoto, Sakiko; Node, Eri; Tiwari, Prabha; Hosomi, Koji; Matsunaga, Ayu; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Gut Environm Syst, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan; [Saika, Azusa; Sawane, Kento; Kunisawa, Jun] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Sawane, Kento] Nippon Flour Mills Co Ltd, Innovat Ctr, Atsugi, Kanagawa, Japan; [Adachi, Jun; Abe, Yuichi; Isoyama, Junko; Tomonaga, Takeshi] NIBIOHN, Lab Proteome Res, Osaka, Japan; [Adachi, Jun; Abe, Yuichi; Isoyama, Junko; Tomonaga, Takeshi] NIBIOHN, Lab Prote Drug Discovery, Osaka, Japan; [Abe, Yuichi] Aichi Canc Ctr, Res Inst, Div Mol Diag, Nagoya, Aichi, Japan; [Matsunaga, Ayu] Azabu Univ, Sch Life & Environm Sci, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Honda, Tetsuya; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Honda, Tetsuya] Hamamatsu Univ, Sch Med, Dept Dermatol, Shizuoka, Japan; [Arita, Makoto] Keio Univ, Fac Pharm, Div Physiol Chem & Metab, Tokyo, Japan; [Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa, Japan; [Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan; [Kunisawa, Jun] Kobe Univ, Grad Sch Med, Dept Microbiol & Immunol, Kobe, Hyogo, Japan; [Kunisawa, Jun] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kunisawa, Jun] Osaka Univ, Grad Sch Dent, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Aichi Cancer Center; Azabu University; Kyoto University; Hamamatsu University School of Medicine; Keio University; RIKEN; Yokohama City University; Kobe University; University of Tokyo; Osaka University	Kunisawa, J (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Vaccine & Adjuvant Res, Lab Vaccine Mat, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.; Kunisawa, J (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Gut Environm Syst, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	kunisawa@nibiohn.go.jp	Nagatake, Takahiro/AAL-1995-2020; Tiwari, Prabha/GQR-2661-2022; Tiwari, Prabha/GPF-6552-2022; Adachi, Jun/H-2813-2014	Tiwari, Prabha/0000-0002-7143-7504; Adachi, Jun/0000-0003-1220-3246; Hirata, So-ichiro/0000-0002-9503-4646	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science KAKENHI [JP19K07617, 19K08790, 15H05897, 18H02674, 18H02150, 15H05790, 20H00534]; Japan Agency for Medical Research and Development (AMED) [JP20ek0410062s0202, JP19gm1210006, JP20ek0410062h0002, JP20ak0101068h0004, JP20gm1010006h004]; Ministry of Health and Welfare of Japan; Public/Private R&D Investment Strategic Expansion Program: PRISM; Cross-ministerial Strategic Innovation Promotion Program: SIP; Grant for Joint Research Project of the Institute of Medical Science; University of Tokyo; Ono Medical Research Foundation; Canon Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Public/Private R&D Investment Strategic Expansion Program: PRISM; Cross-ministerial Strategic Innovation Promotion Program: SIP; Grant for Joint Research Project of the Institute of Medical Science; University of Tokyo; Ono Medical Research Foundation; Canon Foundation(Canon Foundation)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: JP19K07617, 19K08790, 15H05897, 18H02674, 18H02150, 15H05790 and 20H00534; Japan Agency for Medical Research and Development (AMED, Grant/ Award Number: JP20ek0410062s0202, JP19gm1210006, JP20ek0410062h0002, JP20ak0101068h0004 and JP20gm1010006h004; Ministry of Health and Welfare of Japan; Public/Private R&D Investment Strategic Expansion Program: PRISM; Cross-ministerial Strategic Innovation Promotion Program: SIP; Grant for Joint Research Project of the Institute of Medical Science; University of Tokyo; Ono Medical Research Foundation; Canon Foundation	Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Alinaghi F, 2019, CONTACT DERMATITIS, V80, P77, DOI 10.1111/cod.13119; Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017; Bedi S, 2017, J LIPID RES, V58, P393, DOI 10.1194/jlr.M072447; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Calder PC, 2018, P NUTR SOC, V77, P52, DOI [10.1017/S0029665117003950, 10.1017/s0029665117003950]; Calder PC, 2008, P NUTR SOC, V67, P409, DOI 10.1017/S0029665108008690; Cattani F, 2006, EUR CYTOKINE NETW, V17, P42; Chertov O, 2000, IMMUNOL REV, V177, P68, DOI 10.1034/j.1600-065X.2000.17702.x; Christensen AD, 2014, IMMUN INFLAMM DIS, V2, P21, DOI 10.1002/iid3.16; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; ClinicalTrials.gov Website, EFFICACY SAFETY RX 1; ClinicalTrials.gov Website, STUDY RX 10045 TREAT; Coll T, 2010, PPAR RES, V2010, DOI 10.1155/2010/368467; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Dilulio NA, 1999, EUR J IMMUNOL, V29, P3485, DOI 10.1002/(SICI)1521-4141(199911)29:11<3485::AID-IMMU3485>3.0.CO;2-B; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Ecker J, 2009, BIOCHEM BIOPH RES CO, V388, P660, DOI 10.1016/j.bbrc.2009.08.048; Engeman T, 2004, J LEUKOCYTE BIOL, V76, P941, DOI 10.1189/jlb.0304193; Gericke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062643; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Hirakata T, 2019, FASEB J, V33, P3392, DOI 10.1096/fj.201801805R; Hirata S, 2020, ALLERGY, V75, P1939, DOI 10.1111/all.14217; Honda T, 2016, P JPN ACAD B-PHYS, V92, P20, DOI 10.2183/pjab.92.20; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Huang PX, 2014, CHEM REV, V114, P233, DOI 10.1021/cr400161b; Isobe Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26325-4; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jiang M, 2019, FASEB J, V33, P13241; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kish DD, 2012, J IMMUNOL, V189, P2191, DOI 10.4049/jimmunol.1102729; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Latif MA, 2015, ASIAN PAC J ALLERGY, V33, P33, DOI 10.12932/AP0499.33.1.2015; Lee HY, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/916497; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2001, DEVELOPMENT, V128, P675; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lin ZC, 2018, FASEB J, V32, P6783, DOI 10.1096/fj.201800354; Lo HM, 2014, ACTA PHARMACOL SIN, V35, P339, DOI 10.1038/aps.2013.182; Bargut TCL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075059; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marzano AV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01059; Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006; MCARDLE JJ, 1992, EXP AGING RES, V18, P87, DOI 10.1080/03610739208253915; Moniaga CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15319; Nagakura T, 2000, EUR RESPIR J, V16, P861, DOI 10.1183/09031936.00.16586100; Nagatake T, 2018, J ALLERGY CLIN IMMUN, V142, P470, DOI 10.1016/j.jaci.2017.09.053; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Onuki M, 2019, INT IMMUNOL, V31, P251, DOI 10.1093/intimm/dxy089; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Rauschenberger T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01917; Saika A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00036; Sanz MJ, 2012, J IMMUNOL, V189, P411, DOI 10.4049/jimmunol.1102942; Sawada Y, 2015, J EXP MED, V212, P1921, DOI 10.1084/jem.20150381; Sawane K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122868; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Tiwari P, 2019, ALLERGY, V74, P1522, DOI 10.1111/all.13762; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Walsh CM, 2019, ELIFE, V8, DOI [10.7554/elife.48448, 10.7554/eLife.48448]; Wang W, 2019, J NAT MED-TOKYO, V73, P419, DOI 10.1007/s11418-018-01277-1; Wang WH, 2014, AM J PHYSIOL-RENAL, V307, pF453, DOI 10.1152/ajprenal.00123.2014; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042	80	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21354	10.1096/fj.202001687R	http://dx.doi.org/10.1096/fj.202001687R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749892	hybrid			2022-12-28	WOS:000635216100003
J	Wang, LZ; Yu, C; Pei, WJ; Geng, MY; Zhang, Y; Li, ZH; Liang, FT; Tan, FB; Du, H; Gao, JL				Wang, Lizhuo; Yu, Cui; Pei, Wenjun; Geng, Mengya; Zhang, Yao; Li, Zihui; Liang, Feiteng; Tan, Fengbiao; Du, Hui; Gao, Jialin			The lysosomal membrane protein Sidt2 is a vital regulator of mitochondrial quality control in skeletal muscle	FASEB JOURNAL			English	Article						autophagy; mitochondria; myopathy; quality control; Sidt2	AUTOPHAGY; METABOLISM; FUSION; HEALTH; MITOPHAGY; FISSION	The role of Sidt2 in the process of glucose and lipid metabolism has been recently reported. However, whether Sidt2 is involved in the metabolic regulation in skeletal muscle remains unknown. In this study, for the first time, using skeletal muscle-selective Sidt2 knockout mice, we found that Sidt2 was vital for the quality control of mitochondria in mouse skeletal muscle. These mice showed significantly reduced muscle tolerance and structurally abnormal mitochondria. Deletion of the Sidt2 gene resulted in decreased expression of mitochondrial fusion protein 2 (Mfn2) and Dynamin-related protein 1 (Drp1), as well as peroxisome proliferator-activated receptor gamma coactivator-1 (PGC1-alpha). In addition, the clearance of damaged mitochondria in skeletal muscle was inhibited upon Sidt2 deletion, which was caused by blockade of autophagy flow. Mechanistically, the fusion of autophagosomes and lysosomes was compromised in Sidt2 knockout skeletal muscle cells. In summary, the deletion of the Sidt2 gene not only interfered with the quality control of mitochondria, but also inhibited the clearance of mitochondria and caused the accumulation of a large number of damaged mitochondria, ultimately leading to the abnormal structure and function of skeletal muscle.	[Wang, Lizhuo; Geng, Mengya; Du, Hui; Gao, Jialin] Wannan Med Coll, Affiliated Hosp 1, Inst Endocrine & Metab Dis, Wannan Med Coll,Yijishan Hosp, Wuhu, Peoples R China; [Wang, Lizhuo; Yu, Cui; Geng, Mengya; Du, Hui; Gao, Jialin] Wannan Med Coll, Affiliated Hosp 1, Dept Endocrinol & Genet Metab, Wannan Med Coll,Yijishan Hosp, Wuhu 241002, Peoples R China; [Wang, Lizhuo; Zhang, Yao] Wannan Med Coll, Dept Biochem & Mol Biol, Wuhu, Peoples R China; [Pei, Wenjun; Zhang, Yao; Tan, Fengbiao; Gao, Jialin] Wannan Med Coll, Anhui Prov Key Lab Biol Macromol Res, Wannan Med Coll, Wuhu, Peoples R China; [Li, Zihui; Liang, Feiteng] Wannan Med Coll, Sch Clin Med, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College	Gao, JL (corresponding author), Wannan Med Coll, Affiliated Hosp 1, Dept Endocrinol & Genet Metab, Wannan Med Coll,Yijishan Hosp, Wuhu 241002, Peoples R China.	jialing.gao@yahoo.com	GAO, JIALIN/GWN-1905-2022	Pei, Wenjun/0000-0002-3106-3309	National Natural Science Foundation of China (NSFC) [81471002, 81800766]; Funding of "Climbing Peak" Training Program for Innovative Technology team of Yijishan Hospital [PF2019013]; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital [GF2019J07]; Key Program Research Fund of Wannan Medical College [WK2020Z02]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Funding of "Climbing Peak" Training Program for Innovative Technology team of Yijishan Hospital; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital; Key Program Research Fund of Wannan Medical College	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81471002 and 81800766; Funding of "Climbing Peak" Training Program for Innovative Technology team of Yijishan Hospital, Grant/Award Number: PF2019013; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Grant/Award Number: GF2019J07; The Key Program Research Fund of Wannan Medical College, Grant/Award Number: WK2020Z02	Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4; Argiles JM, 2016, J AM MED DIR ASSOC, V17, P789, DOI 10.1016/j.jamda.2016.04.019; Bajaj L, 2019, J NEUROCHEM, V148, P573, DOI 10.1111/jnc.14564; Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cheng ZY, 2019, TRENDS ENDOCRIN MET, V30, P658, DOI 10.1016/j.tem.2019.07.009; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dombi E, 2018, CURR MED CHEM, V25, P5597, DOI 10.2174/0929867324666170616101741; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Gao JL, 2015, INT J CLIN EXP PATHO, V8, P15622; Gao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066139; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kim Y, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3165396; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770; Li JX, 2002, NATURE, V418, P793, DOI 10.1038/nature00936; Liang QR, 2016, J MOL CELL CARDIOL, V95, P57, DOI 10.1016/j.yjmcc.2015.12.025; Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003; Liu H, 2018, METABOLISM, V85, P259, DOI 10.1016/j.metabol.2018.05.004; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Man SM, 2016, AUTOPHAGY, V12, P2504, DOI 10.1080/15548627.2016.1239679; Pagliuso A, 2018, CELL MOL LIFE SCI, V75, P355, DOI 10.1007/s00018-017-2603-0; Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Sandoval H, 2018, MITOCHONDRION, V41, P58, DOI 10.1016/j.mito.2017.11.005; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Siddiqui A, 2015, J NEUROSCI, V35, P12833, DOI 10.1523/JNEUROSCI.0109-15.2015; Simsek-Duran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064955; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; Yamashita S, 2017, AUTOPHAGY, V13, P980, DOI 10.1080/15548627.2017.1291113; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164	39	2	2	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21223	10.1096/fj.202000424R	http://dx.doi.org/10.1096/fj.202000424R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715196				2022-12-28	WOS:000635216100088
J	Zhang, N; Ye, FM; Zhou, Y; Zhu, W; Xie, CP; Zheng, HQ; Chen, H; Chen, JH; Xie, XJ				Zhang, Na; Ye, Feiming; Zhou, Yu; Zhu, Wei; Xie, Cuiping; Zheng, Haiqiong; Chen, Han; Chen, Jinghai; Xie, Xiaojie			Cardiac ankyrin repeat protein contributes to dilated cardiomyopathy and heart failure	FASEB JOURNAL			English	Article						calcium homeostasis; cardiac ankyrin repeat protein; dilated cardiomyopathy; heart failure		Cardiac ankyrin repeat protein (CARP) is a cardiac-specific stress-response protein which exerts diverse effects to modulate cardiac remodeling in response to pathological stimuli. We examined the role of CARP in postnatal cardiac development and function under basal conditions in mice. Transgenic mice that selectively overexpressed CARP in heart (CARP Tg) exhibited dilated cardiac chambers, impaired heart function, and cardiac fibrosis as assessed by echocardiography and histological staining. Furthermore, the mice had a shorter lifespan and reduced survival rate in response to ischemic acute myocardial infarction. Immunofluorescence demonstrated the overexpressed CARP protein was predominantly accumulated in the nuclei of cardiomyocytes. Microarray analysis revealed that the nuclear localization of CARP was associated with the suppression of calcium-handling proteins. In vitro experiments revealed that CARP overexpression resulted in decreased cell contraction and calcium transient. In post-mortem cardiac specimens from patients with dilated cardiomyopathy and end-stage heart failure, CARP was significantly increased. Taken together, our data identified CARP as a crucial contributor in dilated cardiomyopathy and heart failure which was associated with its regulation of calcium-handling proteins.	[Zhang, Na; Ye, Feiming; Zhou, Yu; Zhu, Wei; Xie, Cuiping; Zheng, Haiqiong; Chen, Han; Chen, Jinghai; Xie, Xiaojie] Zhejiang Univ, Affiliated Hosp 2, Cardiovasc Key Lab Zhejiang Prov, Dept Cardiol,Sch Med, Hangzhou, Peoples R China; [Zhang, Na] Hangzhou Normal Univ, Sch Med, Hangzhou, Peoples R China; [Chen, Jinghai] Zhejiang Univ, Inst Translat Med, Hangzhou, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang University	Xie, XJ (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Cardiovasc Key Lab Zhejiang Prov, Dept Cardiol,Sch Med, Hangzhou, Peoples R China.	xiexj@zju.edu.cn		Xie, Xiaojie/0000-0001-8421-2737	National Natural Science Foundation of China [31171392, 81571932, 81700380, 82000403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31171392, 81571932, 81700380, and 82000403)	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Almodovar-Garcia K, 2014, MOL CELL BIOL, V34, P1500, DOI 10.1128/MCB.01357-13; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; Bogomolovas J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/273936; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Buyandelger B, 2011, PFLUG ARCH EUR J PHY, V462, P135, DOI 10.1007/s00424-011-0961-2; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104040; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Gercek M, 2017, AM J PATHOL, V187, P752, DOI 10.1016/j.ajpath.2016.12.018; Ghosh AK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063825, 10.1371/journal.pone.0069949]; Herrer I, 2014, LAB INVEST, V94, P645, DOI 10.1038/labinvest.2014.54; Hutchinson KR, 2015, J MOL CELL CARDIOL, V79, P104, DOI 10.1016/j.yjmcc.2014.10.020; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Jia YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160755; Kar P, 2016, MOL CELL, V64, P746, DOI 10.1016/j.molcel.2016.11.011; Lange S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12120; Ling SSM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071362; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Sarikhani M, 2018, J BIOL CHEM, V293, P5281, DOI 10.1074/jbc.RA117.000915; Shen L, 2015, CLIN SCI, V128, P665, DOI 10.1042/CS20140586; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Wu QQ, 2017, CLIN SCI, V131, P2319, DOI 10.1042/CS20171167; Yang J, 2018, J BIOL CHEM, V293, P794, DOI 10.1074/jbc.M117.812289; Yano M, 2006, NAT CLIN PRACT CARD, V3, P43, DOI 10.1038/ncpcardio0419; Zhang N, 2016, BBA-MOL CELL RES, V1863, P3040, DOI 10.1016/j.bbamcr.2016.09.024; Zhang N, 2016, J ZHEJIANG UNIV-SC B, V17, P333, DOI 10.1631/jzus.B1500247; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108; Zima AV, 2016, REV PHYSIOL BIOCH P, V171, P39, DOI 10.1007/112_2016_2; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X	43	1	1	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21488	10.1096/fj.201902802RR	http://dx.doi.org/10.1096/fj.201902802RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734499				2022-12-28	WOS:000635216100023
J	Kang, J; Kim, YW; Park, S; Kang, Y; Kim, A				Kang, Jin; Kim, Yea Woon; Park, Seongwon; Kang, Yujin; Kim, AeRi			Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the beta-globin locus	FASEB JOURNAL			English	Article						chromatin interaction; CTCF; enhancer; TAD; beta-glohin	CONTROL REGION; INSULATED NEIGHBORHOODS; ACTIVATOR GATA-1; CHROMATIN; GENE; TRANSCRIPTION; DOMAINS; GENOME; DISSECTION; MEDIATOR	Insulators are cis-regulatory elements that block enhancer activity and prevent heterochromatin spreading. The binding of CCCTC-binding factor (CTCF) protein is essential for insulators to play the roles in a chromatin context. The beta-globin locus, consisting of multiple genes and enhancers, is flanked by two insulators 3'HS1 and HS5. However, it has been reported that the absence of these insulators did not affect the p-globin transcription. To explain the unexpected finding, we have deleted a CTCF motif at 3'HS1 or HS5 in the human beta-globin locus and analyzed chromatin interactions around the locus. It was found that a topologically associating domain (TAD) containing the beta-globin locus is maintained by neighboring CTCF sites in the CTCF motif-deleted loci. The additional deletions of neighboring CTCF motifs disrupted the beta-glohin TAD, resulting in decrease of the beta-glohin transcription. Chromatin interactions of the beta-globin enhancers with gene promoter were weakened in the multiple CTCF motifs-deleted loci, even though the enhancers have still active chromatin features such as histone H3K27ac and histone H3 depletion. Genome-wide analysis using public CTCF ChIA-PET and ChIP-seq data showed that chromatin domains possessing multiple CTCF binding sites tend to contain super-enhancers like the beta-globin enhancers. Taken together, our results show that multiple CTCF sites surrounding the beta-globin locus cooperate with each other to maintain a TAD. The beta-globin TAD appears to provide a compact spatial environment that enables enhancers to interact with promoter.	[Kang, Jin; Kim, Yea Woon; Park, Seongwon; Kang, Yujin; Kim, AeRi] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Busan, South Korea	Pusan National University	Kim, A (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Busan, South Korea.	kimaeri@pusan.ac.kr			National Research Foundation of Korea [NRF-2020R1I1A3054808, NRF-2020R1I1A1A01053130]	National Research Foundation of Korea(National Research Foundation of Korea)	National Research Foundation of Korea, Grant/Award Number: NRF-2020R1I1A3054808 and NRF-2020R1I1A1A01053130	Andrews S., 2010, FASTQC QUALITY CONTR; Bender MA, 2006, BLOOD, V108, P1395, DOI 10.1182/blood-2006-04-014431; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chan PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002134; Chetverina D, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600233; Chien R, 2011, J BIOL CHEM, V286, P17870, DOI 10.1074/jbc.M110.207365; Cho Y, 2008, NUCLEIC ACIDS RES, V36, P4521, DOI 10.1093/nar/gkn368; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Despang A, 2019, NAT GENET, V51, P1263, DOI 10.1038/s41588-019-0466-z; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hanssen LLP, 2017, NAT CELL BIOL, V19, P952, DOI 10.1038/ncb3573; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Hyle J, 2019, NUCLEIC ACIDS RES, V47, P6699, DOI 10.1093/nar/gkz462; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kim YW, 2020, FASEB J, V34, P14736, DOI 10.1096/fj.202001526R; Kim YW, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170976; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Krivega I, 2017, NUCLEIC ACIDS RES, V45, P8255, DOI 10.1093/nar/gkx433; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee HK, 2017, NUCLEIC ACIDS RES, V45, P4606, DOI 10.1093/nar/gkx185; Lee J, 2017, CELL REP, V19, P2490, DOI 10.1016/j.celrep.2017.05.072; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LI QL, 1994, BLOOD, V84, P1399; Li Y, 2020, NUCLEIC ACIDS RES, V48, P3119, DOI 10.1093/nar/gkaa098; Luo HC, 2018, BLOOD, V132, P837, DOI 10.1182/blood-2017-11-814319; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02525-w; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reik A, 1998, MOL CELL BIOL, V18, P5992, DOI 10.1128/MCB.18.10.5992; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Wai AWK, 2003, EMBO J, V22, P4489, DOI 10.1093/emboj/cdg437; Weth O, 2014, NUCLEIC ACIDS RES, V42, P11941, DOI 10.1093/nar/gku937; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Willi M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16069; Xiang G., 2020, S3V2 IDEAS PACKAGE N; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358; Yun WJ, 2014, NUCLEIC ACIDS RES, V42, P4283, DOI 10.1093/nar/gku072	56	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21768	10.1096/fj.202100105RR	http://dx.doi.org/10.1096/fj.202100105RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245617				2022-12-28	WOS:000678975300050
J	Kunimi, H; Lee, D; Ibuki, M; Katada, Y; Negishi, K; Tsubota, K; Kurihara, T				Kunimi, Hiromitsu; Lee, Deokho; Ibuki, Mari; Katada, Yusaku; Negishi, Kazuno; Tsubota, Kazuo; Kurihara, Toshihide			Inhibition of the HIF-1 alpha/BNIP3 pathway has a retinal neuroprotective effect	FASEB JOURNAL			English	Article						BNIP3; HIF; inner retinal degeneration; neuroprotection; retinal ischemia	GANGLION-CELL DEATH; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INTRAOCULAR-PRESSURE; AUTOPHAGY; BNIP3; APOPTOSIS; ISCHEMIA; SURVIVAL; PROTEIN; CONTRIBUTES	Retinal ischemia is a leading cause of irreversible blindness worldwide. Inner retinal dysfunction including loss of retinal ganglion cells is encountered in a number of retinal ischemic disorders. We previously reported administration of two different hypoxia-inducible factor (HIF) inhibitors exerted neuroprotective effects in a murine model of retinal ischemia/reperfusion (I/R) which mimics these disorders, as inner retinal degeneration could be involved in pathological HIF induction. However, this notion needs further investigation. Therefore, in this study, we attempted to use retina-specific Hif-1 alpha conditional knockout (cKO) mice to uncover this notion more clearly under the same condition. Hif-1 alpha cKO mice showed inner retinal neurodegeneration to a lesser extent than control mice. Hif-1 alpha depletion in a murine 661W retinal cell line reduced cell death under pseudohypoxic and hypoxic conditions. Among hypoxia-related genes, the expression of BCL2 19 kDa protein-interacting protein 3 (Bnip3) was substantially upregulated in the inner retinal layer after retinal I/R. In this regard, we further examined Bnip3 depletion in retinal neurons in vitro and in vivo and found the similar neuroprotective effects. Our results support the notion that the HIF-1 alpha/BNIP3 pathway may have a critical role in inner retinal neurodegeneration, which can be linked with the development of new promising therapeutics for inner retinal ischemic disorders.	[Kunimi, Hiromitsu; Lee, Deokho; Ibuki, Mari; Katada, Yusaku; Kurihara, Toshihide] Keio Univ, Sch Med, Lab Photobiol, Shinanomachi, Japan; [Kunimi, Hiromitsu; Lee, Deokho; Ibuki, Mari; Katada, Yusaku; Negishi, Kazuno; Tsubota, Kazuo; Kurihara, Toshihide] Keio Univ, Sch Med, Dept Ophthalmol, Shinanomachi, Japan; [Tsubota, Kazuo] Tsubota Lab Inc, Tokyo, Japan	Keio University; Keio University	Tsubota, K (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Dept Chair,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.; Kurihara, T (corresponding author), Keio Univ, Sch Med, Lab Photobiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tsubota@z3.keio.jp; kurihara@z8.keio.jp		Lee, Deokho/0000-0002-5992-9039; Kurihara, Toshihide/0000-0002-5457-2720	KAKENHI [15K10881, 18K09424, 20K22692]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants--in--Aid for Scientific Research (KAKENHI), Grant/Award Number: 15K10881, 18K09424 and 20K22692	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Agarwal N, 2013, INVEST OPHTH VIS SCI, V54, P7884, DOI 10.1167/iovs.13-13292; Barteczek P, 2017, J CEREBR BLOOD F MET, V37, P291, DOI 10.1177/0271678X15624933; Boatright JH, 2013, MOL VIS, V19, P1848; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Feng CC, 2016, GROWTH FACTORS, V34, P73, DOI 10.1080/08977194.2016.1191480; Gorbunova AS, 2020, CANCERS, V12, DOI 10.3390/cancers12113390; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Hartsock MJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54065; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Katada Y, 2019, PEERJ, V7, DOI 10.7717/peerj.6317; Kim BJ, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-21; Kunimi H, 2019, PEERJ, V7, DOI 10.7717/peerj.7849; Kunimi H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133171; Kurihara T, 2018, KEIJO J MED, V67, P1, DOI 10.2302/kjm.2017-0002-IR; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Lee D, 2021, PEERJ, V9, DOI 10.7717/peerj.11665; Lee D, 2022, KEIJO J MED, V71, P1, DOI [10.2302/kjm.2021-0004-IR, 10.2302/kjm.2021-0004-IR)]; Lee D, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14030223; Lee D, 2020, JOVE-J VIS EXP, DOI 10.3791/61865; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Lin KH, 2015, CELL PHYSIOL BIOCHEM, V36, P334, DOI 10.1159/000374076; Liu SP, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-0432-x; Liu W, 2019, INVEST OPHTH VIS SCI, V60, P965, DOI 10.1167/iovs.18-26216; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Mendonca HR, 2018, BRAIN RES, V1700, P126, DOI 10.1016/j.brainres.2018.07.018; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; Samardzija M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52508-8; Sayyad Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17241-0; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Shao YX, 2019, INT J ONCOL, V54, P348, DOI 10.3892/ijo.2018.4603; Shelby SJ, 2015, EXP EYE RES, V137, P84, DOI 10.1016/j.exer.2015.06.016; Singh C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129398; Smedowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05910; Sowter HM, 2001, CANCER RES, V61, P6669; Sun L, 2014, FUTURE ONCOL, V10, P1387, DOI [10.2217/FON.14.70, 10.2217/fon.14.70]; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Uehara F, 2001, INVEST OPHTH VIS SCI, V42, P2164; Vidal-Sanz M, 2001, SURV OPHTHALMOL, V45, pS261, DOI 10.1016/S0039-6257(01)00205-3; Walls KC, 2009, J NEUROPATH EXP NEUR, V68, P1326, DOI 10.1097/NEN.0b013e3181c3b9be; Wang Y, 2015, BRAIN RES BULL, V117, P1, DOI 10.1016/j.brainresbull.2015.06.001; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Xue J, 2017, FEBS J, V284, P97, DOI 10.1111/febs.13955; Yang L, 2019, PEERJ, V7, DOI 10.7717/peerj.7165; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhao XR, 2018, MED SCI MONITOR, V24, P8722, DOI 10.12659/MSM.913384	65	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21829	10.1096/fj.202100572R	http://dx.doi.org/10.1096/fj.202100572R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314069				2022-12-28	WOS:000678975300014
J	Alves, CRR; Eichelberger, EJ; das Neves, W; Ribeiro, MAC; Bechara, LRG; Voltarelli, VA; de Almeida, NR; Hagen, L; Sharma, A; Ferreira, JCB; Swoboda, KJ; Slupphaug, G; Brum, PC				Alves, Christiano R. R.; Eichelberger, Eric J.; das Neves, Willian; Ribeiro, Marcio A. C.; Bechara, Luiz R. G.; Voltarelli, Vanessa A.; de Almeida, Ney R.; Hagen, Lars; Sharma, Animesh; Ferreira, Julio C. B.; Swoboda, Kathryn J.; Slupphaug, Geir; Brum, Patricia C.			Cancer-induced muscle atrophy is determined by intrinsic muscle oxidative capacity	FASEB JOURNAL			English	Article						aerobic metabolism; atrophy; cancer cachexia; fiber type; muscle wasting	SKELETAL-MUSCLE; HEART-FAILURE; REDOX REGULATION; MECHANISMS; CACHEXIA; PROTEOME; GLUTATHIONYLATION; INHIBITION; PATHWAY; DAMAGE	We tested the hypothesis that cancer cachexia progression would induce oxidative post-translational modifications (Ox-PTMs) associated with skeletal muscle wasting, with different responses in muscles with the prevalence of glycolytic and oxidative fibers. We used cysteine-specific isotopic coded affinity tags (OxICAT) and gel-free mass spectrometry analysis to investigate the cysteine Ox-PTMs profile in the proteome of both plantaris (glycolytic) and soleus (oxidative) muscles in tumor-bearing and control rats. Histological analysis revealed muscle atrophy in type II fibers in plantaris muscle, with no changes in plantaris type I fibers and no differences in both soleus type I and II fibers in tumor-bearing rats when compared to healthy controls. Tumor progression altered the Ox-PTMs profile in both plantaris and soleus. However, pathway analysis including the differentially oxidized proteins revealed tricarboxylic acid cycle and oxidative phosphorylation as main affected pathways in plantaris muscle from tumor-bearing rats, while the same analysis did not show main metabolic pathways affected in the soleus muscle. In addition, cancer progression affected several metabolic parameters such as ATP levels and markers of oxidative stress associated with muscle atrophy in plantaris muscle, but not in soleus. However, isolated soleus from tumor-bearing rats had a reduced force production capacity when compared to controls. These novel findings demonstrate that tumor-bearing rats have severe muscle atrophy exclusively in glycolytic fibers. Cancer progression is associated with cysteine Ox-PTMs in the skeletal muscle, but these modifications affect different pathways in a glycolytic muscle compared to an oxidative muscle, indicating that intrinsic muscle oxidative capacity determines the response to cancer cachectic effects.	[Alves, Christiano R. R.; das Neves, Willian; Voltarelli, Vanessa A.; de Almeida, Ney R.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Alves, Christiano R. R.; Eichelberger, Eric J.; Swoboda, Kathryn J.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Ribeiro, Marcio A. C.; Bechara, Luiz R. G.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Hagen, Lars; Sharma, Animesh; Slupphaug, Geir] NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Hagen, Lars; Sharma, Animesh; Slupphaug, Geir] NTNU, PROMEC Prote & Mod Expt Core, Trondheim, Norway; [Hagen, Lars; Sharma, Animesh; Slupphaug, Geir] Cent Norway Reg Hlth Author, Trondheim, Norway	Universidade de Sao Paulo; Harvard University; Massachusetts General Hospital; Universidade de Sao Paulo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Alves, CRR; Brum, PC (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	calves2@mgh.harvard.edu; pcbrum@usp.br	Brum, Patricia C/E-6605-2011; Ferreira, Julio Cesar Batista/AEU-0494-2022; Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/I-3177-2012; Bechara, Luiz R G/K-4095-2012; Voltarelli, Vanessa Azevedo/J-3419-2015; Alves, Christiano RR/C-5912-2013	Brum, Patricia C/0000-0002-4750-6506; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Voltarelli, Vanessa Azevedo/0000-0003-0087-646X; Alves, Christiano RR/0000-0002-2646-9689; das Neves Silva, Willian/0000-0002-8796-0025; Ribeiro, Marcio/0000-0002-8431-4968; Bechara, Luiz/0000-0002-1642-1008	FAPESP [2015/22814-5, 2016/01478-0, 2014/03016-8, 2012/25240-1, 2012/02528-0, Sprint 16/50336-3, 2016/20187-6]; Conselho Nacional de Pesquisa e Desenvolvimento [CNPq 306261/2016-2]; NICHD [R01HD054599]; Biogen; Cure SMA	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biogen(Biogen); Cure SMA	FAPESP, Grant/Award Number: 2015/22814-5, 2016/01478-0, 2014/03016-8, 2012/25240-1, 2012/02528-0, Sprint 16/50336-3 and 2016/20187-6; Conselho Nacional de Pesquisa e Desenvolvimento, Grant/Award Number: CNPq 306261/2016-2; NICHD, Grant/Award Number: R01HD054599; Biogen; Cure SMA;	Abrigo J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2063179; Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Alves CRR, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101012; Alves CRR, 2018, LIFE SCI, V206, P29, DOI 10.1016/j.lfs.2018.05.030; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Bacurau AVN, 2016, INT J CARDIOL, V214, P137, DOI 10.1016/j.ijcard.2016.03.071; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Bechara LRG, 2014, INT J CARDIOL, V175, P499, DOI 10.1016/j.ijcard.2014.06.046; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Blackwell TA, 2018, PHYSIOL GENOMICS, V50, P1071, DOI 10.1152/physiolgenomics.00061.2018; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Byrne DP, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax2713; Chiappetta G, 2010, METHOD ENZYMOL, V473, P199, DOI 10.1016/S0076-6879(10)73010-X; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Correia JC, 2020, SCIENCE, V368, P470, DOI 10.1126/science.abb4116; Cunha TF, 2017, J APPL PHYSIOL, V122, P817, DOI 10.1152/japplphysiol.00182.2016; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; das Neves W, 2016, LIFE SCI, V163, P11, DOI 10.1016/j.lfs.2016.08.025; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fu CX, 2008, J PROTEOME RES, V7, P3789, DOI 10.1021/pr800233r; Fukawa T, 2016, NAT MED, V22, P666, DOI 10.1038/nm.4093; Gutierrez VP, 2008, EUR J PHARMACOL, V594, P84, DOI 10.1016/j.ejphar.2008.07.053; HARRINGTON GM, 1983, BEHAV GENET, V13, P91, DOI 10.1007/BF01071746; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; HSIEH ST, 1994, J NEUROSCI, V14, P6392; Hyltander A, 2000, EUR J CANCER, V36, P330, DOI 10.1016/S0959-8049(99)00273-7; Jannig PR, 2017, LIFE SCI, V191, P46, DOI 10.1016/j.lfs.2017.10.012; Kimura M, 2015, SUPPORT CARE CANCER, V23, P1699, DOI 10.1007/s00520-014-2534-3; Kriegenburg F, 2011, ANTIOXID REDOX SIGN, V15, P2265, DOI 10.1089/ars.2010.3590; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mallis RJ, 2000, FEBS LETT, V482, P237, DOI 10.1016/S0014-5793(00)02022-6; Margaritelis NV, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101499; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; Milzani A, 1997, FASEB J, V11, P261, DOI 10.1096/fasebj.11.4.9068615; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piccirillo R, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00287; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Quiros Pedro M, 2017, Curr Protoc Mouse Biol, V7, P47, DOI 10.1002/cpmo.21; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Souza RWA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35728-2; Springer J, 2012, INT J CANCER, V131, P2187, DOI 10.1002/ijc.27494; Stanford KI, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029801; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Xiao HP, 2020, CELL, V180, P968, DOI 10.1016/j.cell.2020.02.012; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540	54	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21714	10.1096/fj.202100263R	http://dx.doi.org/10.1096/fj.202100263R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118107				2022-12-28	WOS:000667814100033
J	Kowarschik, S; Schollkopf, J; Muller, T; Tian, SH; Knerr, J; Bakker, H; Rein, S; Dong, M; Weber, S; Grosse, R; Schmidt, G				Kowarschik, Stefanie; Schoellkopf, Julian; Mueller, Thomas; Tian, Songhai; Knerr, Julian; Bakker, Hans; Rein, Stephan; Dong, Min; Weber, Stefan; Grosse, Robert; Schmidt, Gudula			Yersinia pseudotuberculosis cytotoxic necrotizing factor interacts with glycosaminoglycans	FASEB JOURNAL			English	Article						cytotoxic necrotizing factor; glycosamioglycan; receptor; toxin; Yersinia	RHO; PEPTIDE	The Cytotoxic Necrotizing Factor Y (CNFY) is produced by the gram-negative, enteric pathogen Yersinia pseudotuberculosis. The bacterial toxin belongs to a family of deamidases, which constitutively activate Rho GTPases, thereby balancing inflammatory processes. We identified heparan sulfate proteoglycans as essential host cell factors for intoxication with CNFY. Using flow cytometry, microscopy, knockout cell lines, pulsed electron-electron double resonance, and bio-layer interferometry, we studied the role of glucosaminoglycans in the intoxication process of CNFY. Especially the C-terminal part of CNFY, which encompasses the catalytic activity, binds with high affinity to heparan sulfates. CNFY binding with the N-terminal domain to a hypothetical protein receptor may support the interaction between the C-terminal domain and heparan sulfates, which seems sterically hindered in the full toxin. A second conformational change occurs by acidification of the endosome, probably allowing insertion of the hydrophobic regions of the toxin into the endosomal membrane. Our findings suggest that heparan sulfates play a major role for intoxication within the endosome, rather than being relevant for an interaction at the cell surface.	[Kowarschik, Stefanie; Schoellkopf, Julian; Mueller, Thomas; Knerr, Julian; Grosse, Robert; Schmidt, Gudula] Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany; [Tian, Songhai; Dong, Min] Boston Childrens Hosp, Dept Urol, Boston, MA USA; [Tian, Songhai; Dong, Min] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Bakker, Hans] Hannover Med Sch, Inst Clin Biochem, Hannover, Germany; [Rein, Stephan; Weber, Stefan] Univ Freiburg, Inst Phys Chem, Freiburg, Germany	University of Freiburg; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hannover Medical School; University of Freiburg	Schmidt, G (corresponding author), Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany.	Gudula.Schmidt@pharmakol.uni-freiburg.de	Bakker, Hans/A-1787-2017	Bakker, Hans/0000-0002-1364-9154; Knerr, Julian/0000-0002-2614-6185	Deutsche Forschungsgemeinschaft (DFG) [SFB850]; SIBW	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); SIBW	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB850 (C2) and SIBW	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Blumenthal B, 2007, INFECT IMMUN, V75, P3344, DOI 10.1128/IAI.01937-06; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Cagno V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070596; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Collins LE, 2019, J LEUKOCYTE BIOL, V105, P81, DOI 10.1002/JLB.3RU0618-246R; Elgundi Z, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01482; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Garcia J, 2019, ANN BIOMED ENG, V47, P1078, DOI 10.1007/s10439-019-02202-7; GREVE H, 1988, J BIOL CHEM, V263, P12886; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Hoffmann C, 2005, REV PHYSIOL BIOCH P, V152, P49, DOI 10.1007/s10254-004-0026-4; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2016, EMAGRES, V5, P1459, DOI 10.1002/9780470034590.emrstm1518; Jewell SA, 2015, SOFT MATTER, V11, P7748, DOI 10.1039/c5sm00876j; Kim JS, 2016, J CONTROL RELEASE, V235, P165, DOI 10.1016/j.jconrel.2016.05.066; Knust Z, 2009, INFECT IMMUN, V77, P1835, DOI 10.1128/IAI.01145-08; Mani K, 2004, GLYCOBIOLOGY, V14, P599, DOI 10.1093/glycob/cwh067; Monnappa AK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32530-y; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Piteau M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003884; Rein S, 2018, J MAGN RESON, V295, P17, DOI 10.1016/j.jmr.2018.07.015; Reppin F, 2018, TOXINS, V10, DOI 10.3390/toxins10010003; Ronnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schweer J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003746; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Tao L, 2019, NAT MICROBIOL, V4, P1760, DOI 10.1038/s41564-019-0464-z; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; Wuyts W, 1998, AM J HUM GENET, V62, P346, DOI 10.1086/301726; Xie M, 2019, CELL SIGNAL, V54, P115, DOI 10.1016/j.cellsig.2018.11.022	34	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21647	10.1096/fj.202001630R	http://dx.doi.org/10.1096/fj.202001630R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165206	hybrid			2022-12-28	WOS:000667814100059
J	Drabik, K; Piecyk, K; Wolny, A; Szulc-Dabrowska, L; Debska-Vielhaber, G; Vielhaber, S; Duszynski, J; Malinska, D; Szczepanowska, J				Drabik, Karolina; Piecyk, Karolina; Wolny, Artur; Szulc-Dabrowska, Lidia; Debska-Vielhaber, Grazyna; Vielhaber, Stefan; Duszynski, Jerzy; Malinska, Dominika; Szczepanowska, Joanna			Adaptation of mitochondrial network dynamics and velocity of mitochondrial movement to chronic stress present in fibroblasts derived from patients with sporadic form of Alzheimer's disease	FASEB JOURNAL			English	Article						Alzheimer&#8217; s disease; fibroblasts; mitochondrial dynamics	AMYLOID-BETA; MOUSE MODEL; ABNORMAL INTERACTION; DYSFUNCTION; CELL; TRANSPORT; FISSION; FUSION; MORPHOLOGY; PROTEINS	Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. Only 10% of all cases are familial form, the remaining 90% are sporadic form with unknown genetic background. The etiology of sporadic AD is still not fully understood. Pathogenesis and pathobiology of this disease are limited due to the limited number of experimental models. We used primary culture of fibroblasts derived from patients diagnosed with sporadic form of AD for investigation of dynamic properties of mitochondria, including fission-fusion process and localization of mitochondria within the cell. We observed differences in mitochondrial network organization with decreased mitochondrial transport velocity, and a drop in the frequency of fusion-fission events. These studies show how mitochondrial dynamics adapt to the conditions of long-term mitochondrial stress that prevails in cells of sporadic form of AD.	[Drabik, Karolina; Piecyk, Karolina; Wolny, Artur; Duszynski, Jerzy; Malinska, Dominika; Szczepanowska, Joanna] Nencki Inst Expt Biol, Pasteur St 3, PL-02093 Warsaw, Poland; [Piecyk, Karolina] Univ Warsaw, Fac Chem, Warsaw, Poland; [Szulc-Dabrowska, Lidia] Warsaw Univ Life Sci, Inst Vet Med, Dept Preclin Sci, Warsaw, Poland; [Debska-Vielhaber, Grazyna; Vielhaber, Stefan] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw; Warsaw University of Life Sciences; Otto von Guericke University	Malinska, D; Szczepanowska, J (corresponding author), Nencki Inst Expt Biol, Pasteur St 3, PL-02093 Warsaw, Poland.	d.malinska@nencki.edu.pl; j.szczepanowska@nencki.edu.pl		Wolny, Artur/0000-0002-2180-6906; Malinska, Dominika/0000-0002-0526-7914; Szczepanowska, Joanna/0000-0002-0434-1262; Duszynski, Jerzy/0000-0003-2937-6725	NCN Harmonia grant [UMO-2013/08/M/NZ3/00707]; European Social Fund [POWR.03.02.00-00-I007/16-00 (POWER 2014-2020)]	NCN Harmonia grant; European Social Fund(European Social Fund (ESF))	This work was supported by the NCN Harmonia grant, UMO-2013/08/M/NZ3/00707 and implemented as a part of Operational Project Knowledge Education Development 2014-2020 co-financed by European Social Fund, Project No POWR.03.02.00-00-I007/16-00 (POWER 2014-2020).	Babbar Mansi, 2013, Mol Cell Pharmacol, V5, P109; Baek SH, 2017, J NEUROSCI, V37, P5099, DOI 10.1523/JNEUROSCI.2385-16.2017; Bartolome F, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0352-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Cai Q, 2017, J ALZHEIMERS DIS, V57, P1087, DOI 10.3233/JAD-160726; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Coskun PE, 2010, J ALZHEIMERS DIS, V20, pS293, DOI 10.3233/JAD-2010-100351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gottlieb RA, 2016, CELL CALCIUM, V60, P88, DOI 10.1016/j.ceca.2016.04.006; Grimm A, 2016, BIOGERONTOLOGY, V17, P281, DOI 10.1007/s10522-015-9618-4; Htike TT, 2019, MOL NEUROBIOL, V56, P2256, DOI 10.1007/s12035-018-1151-4; Kay L, 2018, MOL NEUROBIOL, V55, P7352, DOI 10.1007/s12035-018-0927-x; Khan A, 2017, EXPERT REV NEUROTHER, V17, P683, DOI 10.1080/14737175.2017.1326818; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lin MY, 2015, EXP CELL RES, V334, P35, DOI 10.1016/j.yexcr.2015.01.004; Lu MH, 2018, NEUROSCI BULL, V34, P1127, DOI 10.1007/s12264-018-0310-y; Macdonald R, 2018, BIOCHEM SOC T, V46, P891, DOI 10.1042/BST20170501; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Martin-Maestro P, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9302761; Melkov A, 2018, CELL MOL LIFE SCI, V75, P163, DOI 10.1007/s00018-017-2590-1; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mitra Kasturi, 2010, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0425s46; Modi S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12382-4; Nemani N, 2018, CELL REP, V23, P1005, DOI 10.1016/j.celrep.2018.03.098; Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001; Perez MJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00553; Rambold AS, 2011, AUTOPHAGY, V7, P1568, DOI 10.4161/auto.7.12.17992; Reddy PH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050488; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Ronnback A, 2016, J NEUROCHEM, V136, P497, DOI 10.1111/jnc.13410; Sebastian D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003; Spurlock B, 2020, EXP GERONTOL, V135, DOI 10.1016/j.exger.2020.110919; Tang BL, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030018; Thubron EB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47783-4; Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104; Trimmer PA, 2005, ANTIOXID REDOX SIGN, V7, P1101, DOI 10.1089/ars.2005.7.1101; Valente AJ, 2019, ADV EXP MED BIOL, V1158, P183, DOI 10.1007/978-981-13-8367-0_10; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Van Bulck M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030719; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang J, 2016, GENES DIS, V3, P220, DOI 10.1016/j.gendis.2016.05.001; Wang S, 2012, EUR J NEUROL, V19, P1015, DOI 10.1111/j.1468-1331.2012.03670.x; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Weidling I, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020039; Wojewoda M, 2010, BBA-BIOENERGETICS, V1797, P890, DOI 10.1016/j.bbabio.2010.01.035; Wu LY, 2012, CAN J NEUROL SCI, V39, P436, DOI 10.1017/S0317167100013949; Xie H, 2013, J NEUROSCI, V 33, P17042, DOI 10.1523/JNEUROSCI.1836-13.2013; Xu LL, 2017, NEUROREPORT, V28, P222, DOI 10.1097/WNR.0000000000000739; Yu Q, 2016, J ALZHEIMERS DIS, V54, P679, DOI 10.3233/JAD-160532; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027; Zhang L, 2018, NEUROBIOL DIS, V114, P1, DOI 10.1016/j.nbd.2018.02.003; Zhang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18725	61	1	1	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21586	10.1096/fj.202001978RR	http://dx.doi.org/10.1096/fj.202001978RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33960016				2022-12-28	WOS:000655695900014
J	Lior, C; Hodge, F; De-Souza, EA; Bourboulia, D; Calderwood, SK; David, D; Drummond, DA; Edkins, A; Morimoto, RI; Prahlad, V; Rechavi, O; Sistonen, L; Wilson, M; Wiseman, RL; Zanetti, M; Taylor, R; Scherz-Shouval, R; van Oosten-Hawle, P				Lior, Chen; Hodge, Francesca; De-Souza, Evandro A.; Bourboulia, Dimitra; Calderwood, Stuart K.; David, Della; Allan Drummond, D.; Edkins, Adrienne; Morimoto, Richard I.; Prahlad, Veena; Rechavi, Oded; Sistonen, Lea; Wilson, Mark; Wiseman, R. Luke; Zanetti, Maurizio; Taylor, Rebecca; Scherz-Shouval, Ruth; van Oosten-Hawle, Patricija			The 2021 FASEB Virtual Catalyst Conference on Extracellular and Organismal Proteostasis in Health and Disease, February 3-4, 2021	FASEB JOURNAL			English	Editorial Material							STRESS; INFLAMMATION; CHAPERONES		[Lior, Chen; Scherz-Shouval, Ruth] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Hodge, Francesca; van Oosten-Hawle, Patricija] Univ Leeds, Sch Mol & Cell Biol, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [De-Souza, Evandro A.; Taylor, Rebecca] Med Res Council Lab Mol Biol, Div Neurobiol, Cambridge, England; [Bourboulia, Dimitra] SUNY Upstate Med Univ, Dept Urol, Dept Biochem & Mol Biol, Upstate Canc Ctr, Syracuse, NY 13210 USA; [Calderwood, Stuart K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA; [David, Della] Univ Tubingen, German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Allan Drummond, D.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA; [Edkins, Adrienne] Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, Grahamstown, South Africa; [Morimoto, Richard I.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Prahlad, Veena] Univ Iowa, Dept Biol, Aging Mind & Brain Initiat, Iowa City, IA 52242 USA; [Rechavi, Oded] Tel Aviv Univ, Dept Neurobiol, Wise Fac Life Sci, Tel Aviv, Israel; [Rechavi, Oded] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Sistonen, Lea] Abo Akad Univ, Dept Cell Biol, Turku, Finland; [Sistonen, Lea] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Sistonen, Lea] Abo Akad Univ, Turku, Finland; [Wilson, Mark] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Wiseman, R. Luke] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA; [Zanetti, Maurizio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Weizmann Institute of Science; University of Leeds; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Chicago; Rhodes University; Northwestern University; University of Iowa; Tel Aviv University; Tel Aviv University; Abo Akademi University; University of Turku; Abo Akademi University; University of Wollongong; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scherz-Shouval, R (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel.; van Oosten-Hawle, P (corresponding author), Univ Leeds, Sch Mol & Cell Biol, Leeds LS2 9JT, W Yorkshire, England.; van Oosten-Hawle, P (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	ruth.shouval@weizmann.ac.il; p.vanoosten-hawle@leeds.ac.uk	de Souza, Evandro Araujo/G-3696-2014; Edkins, Adrienne L/C-8704-2012; van Oosten-Hawle, Patricija/GVS-1791-2022; Wilson, Mark R/B-3254-2018	de Souza, Evandro Araujo/0000-0002-9080-3864; Edkins, Adrienne L/0000-0002-3615-6651; Wilson, Mark R/0000-0002-9551-7445; Sistonen, Lea/0000-0003-1341-2867; Prahlad, Veena/0000-0002-0413-6074; Taylor, Rebecca/0000-0003-3429-3123	Medical Research Council [MC_UP_1201/7] Funding Source: Medline; NIA NIH HHS [RF1 AG057296, R37 AG026647, P01 AG049665, P01 AG054407] Funding Source: Medline; NIGMS NIH HHS [R01 GM139932] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker-Williams AJ, 2019, CELL REP, V28, P1894, DOI 10.1016/j.celrep.2019.07.045; Chakraborty A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020272; Das S, 2020, ELIFE, V9, DOI 10.7554/eLife.55246; Gallotta I, 2020, NATURE, V584, P410, DOI 10.1038/s41586-020-2461-z; Grunberg N, 2021, CANCER RES, V81, P1639, DOI 10.1158/0008-5472.CAN-20-2756; Levi-Galibov O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20054-x; Luoto J.C., 2020, IN VIVO MIMICKING 3D, DOI [10.1101/2020.12.22.423913, DOI 10.1101/2020.12.22.423913]; O'Brien D, 2018, CELL REP, V23, P3905, DOI 10.1016/j.celrep.2018.05.093; Ozbey NP, 2020, DEV CELL, V55, P754, DOI 10.1016/j.devcel.2020.10.024; Posner R, 2019, CELL, V177, P1814, DOI 10.1016/j.cell.2019.04.029; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Rodvold JJ, 2016, CANCER LETT, V380, P227, DOI 10.1016/j.canlet.2015.09.009; Romine Isabelle C, 2020, Biochem J, V477, P1721, DOI 10.1042/BCJ20190312; Sala AJ, 2020, GENE DEV, V34, P678, DOI 10.1101/gad.335422.119; Sanchez-Pozo J, 2018, ISCIENCE, V1, P87, DOI 10.1016/j.isci.2018.02.004; Vihervaara A, 2021, MOL CELL, V81, P1715, DOI 10.1016/j.molcel.2021.03.007; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904	17	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21631	10.1096/fj.202100566	http://dx.doi.org/10.1096/fj.202100566			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046940	Green Accepted			2022-12-28	WOS:000655695900063
J	Campbell, GE; Bender, HR; Parker, GA; Curry, TE; Duffy, DM				Campbell, Genevieve E.; Bender, Hannah R.; Parker, Grace A.; Curry, Thomas E., Jr.; Duffy, Diane M.			Neurotensin: A novel mediator of ovulation?	FASEB JOURNAL			English	Article						angiogenesis; fertility; ovary; primate; sortilin	GROWTH-FACTOR; LUTEINIZING-HORMONE; GRANULOSA-CELLS; PROGESTERONE SYNTHESIS; NEUROENDOCRINE TUMORS; KINASE-C; RECEPTOR; OVARIAN; EXPRESSION; PROSTAGLANDIN-E2	The midcycle luteinizing hormone (LH) surge initiates a cascade of events within the ovarian follicle which culminates in ovulation. Only mural granulosa cells and theca cells express large numbers of LH receptors, and LH-stimulated paracrine mediators communicate the ovulatory signal within the follicle. Recent reports identified the neuropeptide neurotensin (NTS) as a product of granulosa cells. Here, we demonstrate that granulosa cells were the primary site of NTS expression in macaque ovulatory follicles. Granulosa cell NTS mRNA and protein increased after human chorionic gonadotropin (hCG) administration, which substitutes for the LH surge. To identify ovulatory actions of NTS, a NTS-neutralizing antibody was injected into preovulatory macaque follicles. hCG administration immediately followed, and ovaries were removed 48 hours later to evaluate ovulatory events. Follicles injected with control IgG ovulated normally. In contrast, 75% of NTS antibody-injected follicles failed to ovulate, containing oocytes trapped within unruptured, hemorrhagic follicles. Serum progesterone was unchanged. Of the three NTS receptors, SORT1 was highly expressed in follicular granulosa, theca, and endothelial cells; NTSR1 and NTSR2 were expressed at lower levels. Excessive blood cells in NTS antibody-injected follicles indicated vascular anomalies, so the response of monkey ovarian endothelial cells to NTS was evaluated in vitro. NTS stimulated endothelial cell migration and capillary sprout formation, consistent with a role for NTS in vascular remodeling associated with ovulation. In summary, we identified NTS as a possible paracrine mediator of ovulation. Further investigation of the NTS synthesis/response pathway may lead to improved treatments for infertility and novel targets for contraception.	[Campbell, Genevieve E.; Bender, Hannah R.; Parker, Grace A.; Duffy, Diane M.] Eastern Virginia Med Sch, Dept Physiol Sci, POB 1980, Norfolk, VA 23501 USA; [Curry, Thomas E., Jr.] Univ Kentucky, Dept Obstet & Gynecol, Lexington, KY USA	Eastern Virginia Medical School; University of Kentucky	Duffy, DM (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, POB 1980, Norfolk, VA 23501 USA.	duffydm@evms.edu			HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P01 HD071875, R01 HD097675]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: P01 HD071875 and R01 HD097675	Akter H, 2015, TUMOR BIOL, V36, P6053, DOI 10.1007/s13277-015-3282-9; Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Bender HR, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00727; Bender HR, 2018, ENDOCRINOLOGY, V159, P710, DOI 10.1210/en.2017-00739; Beraud-Dufour S, 2009, INT J BIOCHEM CELL B, V41, P2398, DOI 10.1016/j.biocel.2009.04.002; Besserer-Offroy E, 2017, EUR J PHARMACOL, V805, P1, DOI 10.1016/j.ejphar.2017.03.046; BIDARD JN, 1993, BIOCHEM J, V291, P225, DOI 10.1042/bj2910225; Bishop CV, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134981; Boules Mona, 2013, Front Endocrinol (Lausanne), V4, P36, DOI 10.3389/fendo.2013.00036; Campbell GE., 2020, FERTIL STERIL SCI, V1, p27; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Cerny KL, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0077-1; Choi Y, 2017, J CLIN ENDOCR METAB, V102, P1971, DOI 10.1210/jc.2016-3153; Coppola T, 2008, INT J BIOCHEM CELL B, V40, P2296, DOI 10.1016/j.biocel.2008.03.015; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; DAVIES WA, 1993, ENDOCRINOLOGY, V132, P2491, DOI 10.1210/en.132.6.2491; Devader C, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00542; Di Florio A, 2013, BBA-MOL CELL RES, V1833, P573, DOI 10.1016/j.bbamcr.2012.11.021; Dissen GA, 1996, ENDOCRINOLOGY, V137, P198, DOI 10.1210/en.137.1.198; Driessen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083098; Duffy DM, 2019, ENDOCR REV, V40, P369, DOI 10.1210/er.2018-00075; Duffy DM, 2015, HUM REPROD UPDATE, V21, P652, DOI 10.1093/humupd/dmv026; Duffy DM, 2005, HUM REPROD, V20, P1485, DOI 10.1093/humrep/deh784; Duffy DM, 2005, J CLIN ENDOCR METAB, V90, P1021, DOI 10.1210/jc.2004-1229; Dupouy S, 2014, ONCOTARGET, V5, P8235, DOI 10.18632/oncotarget.1632; Elvin JA, 2000, P NATL ACAD SCI USA, V97, P10288, DOI 10.1073/pnas.180295197; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Ghaemimanesh Fatemeh, 2014, Avicenna Journal of Medical Biotechnology, V6, P169; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hibbert ML, 1996, P NATL ACAD SCI USA, V93, P1897, DOI 10.1073/pnas.93.5.1897; Hiradate Y, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.112789; Huber S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175842; Kalafatakis K, 2011, REGUL PEPTIDES, V170, P7, DOI 10.1016/j.regpep.2011.04.005; Kim JT, 2018, NEOPLASIA, V20, P175, DOI 10.1016/j.neo.2017.11.012; Kim SO, 2014, ENDOCRINOLOGY, V155, P1466, DOI 10.1210/en.2013-2096; Lemko HMD, 2010, AM J PHYSIOL-ENDOC M, V298, pE80, DOI 10.1152/ajpendo.00380.2009; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Luckmann M, 2016, MOL INFORM, V35, P19, DOI 10.1002/minf.201500080; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Mazella Jean, 2012, Front Endocrinol (Lausanne), V3, P143, DOI 10.3389/fendo.2012.00143; MCALLISTER JM, 1989, ENDOCRINOLOGY, V125, P1959, DOI 10.1210/endo-125-4-1959; McAllister JM., METHODS TOXICOL, V10, P329, DOI [10.1210/endo-125-4-1959, DOI 10.1210/ENDO-125-4-1959]; Mijatovic T, 2007, CELL ONCOL, V29, P315; Muller KM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-421; Niringiyumukiza JD, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0359-5; Nykjaer A, 2012, TRENDS NEUROSCI, V35, P261, DOI 10.1016/j.tins.2012.01.003; Pelaprat D, 2006, PEPTIDES, V27, P2476, DOI 10.1016/j.peptides.2006.04.027; PENG XR, 1991, ENDOCRINOLOGY, V129, P3200, DOI 10.1210/endo-129-6-3200; REINECKE M, 1987, NEUROSCI LETT, V73, P220, DOI 10.1016/0304-3940(87)90248-5; Richard F, 2001, MOL PHARMACOL, V60, P1392, DOI 10.1124/mol.60.6.1392; Robker RL, 2018, ENDOCRINOLOGY, V159, P3209, DOI 10.1210/en.2018-00485; Rothchild I, 1981, Recent Prog Horm Res, V37, P183; Sakumoto R, 2015, J REPROD DEVELOP, V61, P297, DOI 10.1262/jrd.2015-024; Seachord CL, 2005, BIOL REPROD, V72, P1305, DOI 10.1095/biolreprod.104.037523; Sicard F, 2006, J CLIN ENDOCR METAB, V91, P3131, DOI 10.1210/jc.2006-0105; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Stouffer RL, 2013, REPROD BIOL, V13, P259, DOI 10.1016/j.repbio.2013.08.002; Su ZJ, 2019, GENE, V687, P143, DOI 10.1016/j.gene.2018.10.062; Tena-Sempere M, 2017, NAT REV ENDOCRINOL, V13, P67, DOI 10.1038/nrendo.2016.216; Trau HA, 2016, HUM REPROD, V31, P436, DOI 10.1093/humrep/dev320; Trau HA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123711; Umezu K, 2016, J REPROD DEVELOP, V62, P409, DOI 10.1262/jrd.2016-055; Ushiro S, 1997, FEBS LETT, V418, P341, DOI 10.1016/S0014-5793(97)01403-8; WEICK RF, 1973, ENDOCRINOLOGY, V93, P1140; Wissing ML, 2014, HUM REPROD, V29, P997, DOI 10.1093/humrep/deu008; Xu FH, 2005, CONTRACEPTION, V71, P239, DOI 10.1016/j.contraception.2004.12.017; Younes M, 2014, ONCOTARGET, V5, P8252, DOI 10.18632/oncotarget.1633; Yung Y, 2014, MOL HUM REPROD, V20, P844, DOI 10.1093/molehr/gau041	69	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21481	10.1096/fj.202002547RR	http://dx.doi.org/10.1096/fj.202002547RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710668	Green Accepted			2022-12-28	WOS:000635216100016
J	Kong, CS; Ordonez, AA; Turner, S; Tremaine, T; Muter, J; Lucas, ES; Salisbury, E; Vassena, R; Tiscornia, G; Fouladi-Nashta, AA; Hartshorne, G; Brosens, JJ; Brighton, PJ				Kong, Chow-Seng; Ordonez, Alexandra Almansa; Turner, Sarah; Tremaine, Tina; Muter, Joanne; Lucas, Emma S.; Salisbury, Emma; Vassena, Rita; Tiscornia, Gustavo; Fouladi-Nashta, Ali A.; Hartshorne, Geraldine; Brosens, Jan J.; Brighton, Paul J.			Embryo biosensing by uterine natural killer cells determines endometrial fate decisions at implantation	FASEB JOURNAL			English	Article						decidualization; embryo implantation; endometrium; hyaluronan; senescence; uterine natural killer cells	RECURRENT PREGNANCY LOSS; HYALURONAN; EXPRESSION; CD44; DECIDUALIZATION; INVASION; PATHWAY; SULFATE; BINDING; SYSTEM	Decidualizing endometrial stromal cells (EnSC) critically determine the maternal response to an implanting conceptus, triggering either menstruation-like disposal of low-fitness embryos or creating an environment that promotes further development. However, the mechanism that couples maternal recognition of low-quality embryos to tissue breakdown remains poorly understood. Recently, we demonstrated that successful transition of the cycling endometrium to a pregnancy state requires selective elimination of pro-inflammatory senescent decidual cells by activated uterine natural killer (uNK) cells. Here we report that uNK cells express CD44, the canonical hyaluronan (HA) receptor, and demonstrate that high molecular weight HA (HMWHA) inhibits uNK cell-mediated killing of senescent decidual cells. In contrast, low molecular weight HA (LMWHA) did not attenuate uNK cell activity in co-culture experiments. Killing of senescent decidual cells by uNK cells was also inhibited upon exposure to medium conditioned by IVF embryos that failed to implant, but not successful embryos. Embryo-mediated inhibition of uNK cell activity was reversed by recombinant hyaluronidase 2 (HYAL2), which hydrolyses HMWHA. We further report a correlation between the levels of HYAL2 secretion by human blastocysts, morphological scores, and implantation potential. Taken together, the data suggest a pivotal role for uNK cells in embryo biosensing and endometrial fate decisions at implantation.	[Kong, Chow-Seng; Muter, Joanne; Lucas, Emma S.; Salisbury, Emma; Hartshorne, Geraldine; Brosens, Jan J.; Brighton, Paul J.] Univ Warwick, Warwick Med Sch, Ctr Early Life, Coventry CV2 2DX, W Midlands, England; [Ordonez, Alexandra Almansa; Vassena, Rita; Tiscornia, Gustavo] Eugin Clin, Barcelona, Spain; [Turner, Sarah; Hartshorne, Geraldine] Univ Hosp Coventry & Warwickshire NHS Trust, Ctr Reprod Med, Coventry, W Midlands, England; [Tremaine, Tina; Fouladi-Nashta, Ali A.] Univ London, Royal Vet Coll, Comparat Biomed Sci, Hatfield, Herts, England; [Muter, Joanne; Brosens, Jan J.] Univ Hosp Coventry & Warwickshire NHS Trust, Tommys Natl Ctr Miscarriage Res, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of London; University of London Royal Veterinary College; University of Warwick	Brosens, JJ (corresponding author), Univ Warwick, Warwick Med Sch, Ctr Early Life, Coventry CV2 2DX, W Midlands, England.	J.J.Brosens@warwick.ac.uk			Wellcome Trust (Wellcome) [212233/Z/18/Z]; Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia [GENCAT 2018 DI 103]; WPH Charitable Trust (W P H Charitable Trust); University Hospital Coventry and Warwickshire (UHCW) NHS Trust; Torres Quevedo Program of the Spanish Ministry of Science and Innovation; Clinica Eugin Intramural Fund; Tommy's	Wellcome Trust (Wellcome); Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia; WPH Charitable Trust (W P H Charitable Trust); University Hospital Coventry and Warwickshire (UHCW) NHS Trust; Torres Quevedo Program of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Clinica Eugin Intramural Fund; Tommy's	Tommy's; Wellcome Trust (Wellcome), Grant/Award Number: 212233/Z/18/Z; Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia, Grant/Award Number: GENCAT 2018 DI 103; WPH Charitable Trust (W P H Charitable Trust); University Hospital Coventry and Warwickshire (UHCW) NHS Trust; Torres Quevedo Program of the Spanish Ministry of Science and Innovation; Clinica Eugin Intramural Funding	Al-Sabbagh M, 2011, ENDOCRINOLOGY, V152, P730, DOI 10.1210/en.2010-0899; Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Baggenstoss BA, 2017, GLYCOBIOLOGY, V27, P154, DOI 10.1093/glycob/cww089; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Berkhout RP, 2018, J ASSIST REPROD GEN, V35, P659, DOI 10.1007/s10815-017-1107-z; Berkhout RP, 2020, HUM REPROD, V35, P1797, DOI 10.1093/humrep/deaa149; Biase FH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000046; Brighton, 2016, BIO PROTOCOL, V6; Brighton PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.31274; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; BROWN JJG, 1992, DIFFERENTIATION, V52, P61, DOI 10.1111/j.1432-0436.1992.tb00500.x; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Critchley HOD, 2020, PHYSIOL REV, V100, P1149, DOI 10.1152/physrev.00031.2019; Erkenbrack EM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005594; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Ewington LJ, 2019, J OBSTET GYNAECOL RE, V45, P258, DOI 10.1111/jog.13837; Feng RZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08689; Foo L, 2020, PAEDIATR PERINAT EP, V34, P495, DOI 10.1111/ppe.12613; Fouladi-Nashta AA, 2017, REPRODUCTION, V153, pR43, DOI [10.1530/REP-16-0240, 10.1530/rep-16-0240]; Fukui A, 2017, J OBSTET GYNAECOL RE, V43, P1678, DOI 10.1111/jog.13448; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig D, 2019, CURR BIOL, V29, pR455, DOI 10.1016/j.cub.2019.04.040; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Kane N, 2009, ENDOCRINOLOGY, V150, P2882, DOI 10.1210/en.2008-1309; Katano K, 2013, FERTIL STERIL, V100, P1629, DOI 10.1016/j.fertnstert.2013.07.1996; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; Lucas ES, 2016, STEM CELLS, V34, P346, DOI 10.1002/stem.2222; Macklon Nick S, 2014, Biol Reprod, V91, P98, DOI 10.1095/biolreprod.114.122846; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Marei WFA, 2016, THERIOGENOLOGY, V86, P940, DOI 10.1016/j.theriogenology.2016.03.017; Marei WFA, 2013, MOL HUM REPROD, V19, P590, DOI 10.1093/molehr/gat032; Martin-DeLeon PA, 2006, MOL CELL ENDOCRINOL, V250, P114, DOI 10.1016/j.mce.2005.12.033; McCoy RC, 2017, TRENDS GENET, V33, P448, DOI 10.1016/j.tig.2017.04.001; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Muter J, 2018, ENDOCRINOLOGY, V159, P994, DOI 10.1210/en.2017-03064; Ochiai A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1511-7; Ohno-Nakahara M, 2004, J BIOCHEM, V135, P567, DOI 10.1093/jb/mvh069; RIPELLINO JA, 1985, J HISTOCHEM CYTOCHEM, V33, P1060, DOI 10.1177/33.10.4045184; Rowley JE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031036; Ruane PT, 2020, HUM REPROD OPEN, V2020, DOI 10.1093/hropen/hoz033; Sague SL, 2004, J INTERF CYTOK RES, V24, P301, DOI 10.1089/107999004323065093; Salamonsen LA, 2001, CELL TISSUE RES, V306, P335, DOI 10.1007/s004410100452; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Starostik MR, 2020, GENOME RES, V30, P814, DOI 10.1101/gr.262774.120; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takahashi H, 2014, PLACENTA, V35, P163, DOI 10.1016/j.placenta.2013.12.009; Tavianatou AG, 2019, FEBS J, V286, P2883, DOI 10.1111/febs.14777; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Weimar CHE, 2013, HUM REPROD UPDATE, V19, P542, DOI 10.1093/humupd/dmt025; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yasuo T, 2008, J REPROD IMMUNOL, V78, P1, DOI 10.1016/j.jri.2007.09.002; Zhu R, 2013, PLACENTA, V34, P784, DOI 10.1016/j.placenta.2013.05.009; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	64	18	19	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21336	10.1096/fj.202002217R	http://dx.doi.org/10.1096/fj.202002217R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749894	Green Published, hybrid			2022-12-28	WOS:000635216100101
J	Mamaeva, D; Jazouli, Z; DiFrancesco, ML; Erkilic, N; Dubois, G; Hilaire, C; Meunier, I; Boukhaddaoui, H; Kalatzis, V				Mamaeva, Daria; Jazouli, Zhour; DiFrancesco, Mattia L.; Erkilic, Nejla; Dubois, Gregor; Hilaire, Cecile; Meunier, Isabelle; Boukhaddaoui, Hassan; Kalatzis, Vasiliki			Novel roles for voltage-gated T-type Ca2+ and ClC-2 channels in phagocytosis and angiogenic factor balance identified in human iPSC-derived RPE	FASEB JOURNAL			English	Article						Ca2+ and K+ channels; ClC&#8208; 2 chloride channel; iPSC&#8208; derived RPE; phagocytosis; secretion	RETINAL-PIGMENT EPITHELIUM; GROWTH-FACTOR SECRETION; PLURIPOTENT STEM-CELLS; CHLORIDE CHANNEL; ION CHANNELS; POTASSIUM CHANNELS; TRANSPORT MECHANISMS; LARGE-CONDUCTANCE; CALCIUM-CHANNELS; MESSENGER-RNA	Human-induced pluripotent stem cell (hiPSC)-derived retinal pigment epithelium (RPE) is a powerful tool for pathophysiological studies and preclinical therapeutic screening, as well as a source for clinical cell transplantation. Thus, it must be validated for maturity and functionality to ensure correct data readouts and clinical safety. Previous studies have validated hiPSC-derived RPE as morphologically characteristic of the tissue in the human eye. However, information concerning the expression and functionality of ion channels is still limited. We screened hiPSC-derived RPE for the polarized expression of a panel of L-type (Ca(V)1.1, Ca(V)1.3) and T-type (Ca(V)3.1, Ca(V)3.3) Ca2+ channels, K+ channels (Maxi-K, Kir4.1, Kir7.1), and the Cl- channel ClC-2 known to be expressed in native RPE. We also tested the roles of these channels in key RPE functions using specific inhibitors. In addition to confirming the native expression profiles and function of certain channels, such as L-type Ca2+ channels, we show for the first time that T-type Ca2+ channels play a role in both phagocytosis and vascular endothelial growth factor (VEGF) secretion. Moreover, we demonstrate that Maxi-K and Kir7.1 channels are involved in the polarized secretion of VEGF and pigment epithelium-derived factor (PEDF). Furthermore, we show a novel localization for ClC-2 channel on the apical side of hiPSC-derived RPE, with an overexpression at the level of fluid-filled domes, and demonstrate that it plays an important role in phagocytosis, as well as VEGF and PEDF secretion. Taken together, hiPSC-derived RPE is a powerful model for advancing fundamental knowledge of RPE functions.	[Mamaeva, Daria; Jazouli, Zhour; DiFrancesco, Mattia L.; Erkilic, Nejla; Dubois, Gregor; Hilaire, Cecile; Meunier, Isabelle; Boukhaddaoui, Hassan; Kalatzis, Vasiliki] Montpellier Univ, Inst Neurosci Montpellier, INSERM, Montpellier, France; [Erkilic, Nejla; Meunier, Isabelle] Montpellier Univ, CHU Montpellier, Natl Reference Ctr Inherited Sensory Dis, Montpellier, France; [DiFrancesco, Mattia L.] Italian Inst Technol, Ctr Synapt Neurosci & Technol, Genoa, Italy; [DiFrancesco, Mattia L.] IRCCS Osped Policlin San Martino, Genoa, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Istituto Italiano di Tecnologia - IIT	Mamaeva, D; Kalatzis, V (corresponding author), INSERM, Inst Neurosci Montpellier INM, U1298, 80 Ave Augustin Fliche, F-34091 Montpellier, France.	daria.mamaeva@inserm.fr; vasiliki.kalatzis@inserm.fr	DiFrancesco, Mattia Lorenzo/AAC-1029-2022; Kalatzis, Vasiliki/F-6170-2019	DiFrancesco, Mattia Lorenzo/0000-0002-7511-4438; Kalatzis, Vasiliki/0000-0002-9626-8807; BOUKHADDAOUI, HASSAN/0000-0003-1808-7901	Fondation de France [2015 00061320]	Fondation de France(Fondation de France)	Fondation de France, Grant/Award Number: 2015 00061320	Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Bailey CS, 2019, J GEN PHYSIOL, V151, P1173, DOI 10.1085/jgp.201912457; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bi MM, 2014, INT J MOL SCI, V15, P218, DOI 10.3390/ijms15010218; BIALEK S, 1994, J PHYSIOL-LONDON, V475, P401, DOI 10.1113/jphysiol.1994.sp020081; Bilmen JG, 2002, ARCH BIOCHEM BIOPHYS, V406, P55, DOI 10.1016/S0003-9861(02)00240-0; Blaug S, 2003, DOC OPHTHALMOL, V106, P43, DOI 10.1023/A:1022514031645; Borooah S, 2013, PROG RETIN EYE RES, V37, P163, DOI 10.1016/j.preteyeres.2013.09.002; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Brandl C, 2014, NEUROMOL MED, V16, P551, DOI 10.1007/s12017-014-8308-8; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Calderone V, 2002, CURR MED CHEM, V9, P1385, DOI 10.2174/0929867023369871; Catalan M, 2002, AM J PHYSIOL-GASTR L, V283, pG1004, DOI 10.1152/ajpgi.00158.2002; Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11; Collison DJ, 2005, EXP EYE RES, V80, P465, DOI 10.1016/j.exer.2004.09.009; Cordes M, 2020, FASEB J, V34, P4055, DOI 10.1096/fj.201901202RR; Depienne C, 2013, LANCET NEUROL, V12, P659, DOI 10.1016/S1474-4422(13)70053-X; Doss MX, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050403; Duan D, 2000, CIRC RES, V86, pE63, DOI 10.1161/01.RES.86.4.e63; Ebert AD, 2012, J CARDIOVASC PHARM, V60, P408, DOI 10.1097/FJC.0b013e318247f642; EDELMAN JL, 1994, AM J PHYSIOL, V266, pC957, DOI 10.1152/ajpcell.1994.266.4.C957; Edwards MM, 2010, INVEST OPHTH VIS SCI, V51, P3264, DOI 10.1167/iovs.09-4887; Erkilic N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091068; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; Geng YY, 2013, J GEN PHYSIOL, V141, P493, DOI 10.1085/jgp.201210955; Giblin JP, 2016, ADV PROTEIN CHEM STR, V104, P157, DOI 10.1016/bs.apcsb.2015.11.006; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Gyomorey K, 2000, AM J PHYSIOL-CELL PH, V279, pC1787, DOI 10.1152/ajpcell.2000.279.6.C1787; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell HC, 2003, J PHYSIOL-LONDON, V549, P453, DOI 10.1113/jphysiol.2003.040428; He XM, 2015, CLIN SCI, V128, P805, DOI 10.1042/CS20130463; Heckmann BL, 2019, J CELL SCI, V132, DOI 10.1242/jcs.231472; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Niemeyer MI, 2009, J PHYSIOL-LONDON, V587, P1387, DOI 10.1113/jphysiol.2008.167353; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Jentsch TJ, 2015, J PHYSIOL-LONDON, V593, P4091, DOI 10.1113/JP270043; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Johnson AA, 2017, PROG RETIN EYE RES, V58, P45, DOI 10.1016/j.preteyeres.2017.01.006; Joksimovic SM, 2017, J PHYSIOL-LONDON, V595, P6327, DOI 10.1113/JP274565; Kanzaki Y, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.5.38; Karl MO, 2008, CELL SIGNAL, V20, P1159, DOI 10.1016/j.cellsig.2008.02.005; Keckeis S, 2017, EXP EYE RES, V154, P139, DOI 10.1016/j.exer.2016.12.003; Kharade SV, 2017, MOL PHARMACOL, V92, P338, DOI 10.1124/mol.117.108472; Klettner AK, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P85, DOI 10.1007/978-3-030-28384-1_5; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Korkka I., 2017, EMBEC NBC, V65, p454; Korkka I, 2019, STEM CELL TRANSL MED, V8, P179, DOI 10.1002/sctm.18-0026; Krohne TU, 2012, STEM CELL TRANSL MED, V1, P96, DOI 10.5966/sctm.2011-0057; Kumar M, 2014, CHANNELS, V8, P488, DOI 10.4161/19336950.2014.959809; Kusaka S, 1999, J PHYSIOL-LONDON, V520, P373, DOI 10.1111/j.1469-7793.1999.00373.x; Kusaka S, 2001, J PHYSIOL-LONDON, V531, P27, DOI 10.1111/j.1469-7793.2001.0027j.x; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Lipecka J, 2002, AM J PHYSIOL-CELL PH, V282, pC805, DOI 10.1152/ajpcell.00291.2001; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mehta A, 2005, PEDIATR PULM, V39, P292, DOI 10.1002/ppul.20147; Mergler S, 2002, EXP EYE RES, V74, P29, DOI 10.1006/exer.2001.1128; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Muller C, 2014, CELL SIGNAL, V26, P968, DOI 10.1016/j.cellsig.2013.12.021; Muller C, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P47, DOI 10.1007/978-3-030-28384-1_3; Mullin NK., 2020, PROG RETIN EYE RES, V29; Nachtigal AL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051597; Nguyen HV, 2015, J CLIN MED, V4, P567, DOI 10.3390/jcm4040567; Peterson WM, 1997, J NEUROSCI, V17, P2324; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Reichhart N, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P65, DOI 10.1007/978-3-030-28384-1_4; Reichhart N, 2015, CELL SIGNAL, V27, P2231, DOI 10.1016/j.cellsig.2015.07.023; Reichhart N, 2010, EXP EYE RES, V91, P630, DOI 10.1016/j.exer.2010.08.001; Rosenthal R, 2007, MOL VIS, V13, P443; Rossier MF, 1996, ENDOCRINOLOGY, V137, P4817, DOI 10.1210/en.137.11.4817; Ryan JS, 1999, J PHYSIOL-LONDON, V520, P745, DOI 10.1111/j.1469-7793.1999.00745.x; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sanjurjo-Soriano C, 2020, MOL THER-METH CLIN D, V17, P156, DOI 10.1016/j.omtm.2019.11.016; Sanjurjo-Soriano C, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5056279; Schnichels S, 2021, PROG RETIN EYE RES, V81, DOI 10.1016/j.preteyeres.2020.100880; Shahi PK, 2019, AM J HUM GENET, V104, P310, DOI 10.1016/j.ajhg.2018.12.019; Sheu SJ, 2009, KAOHSIUNG J MED SCI, V25, P381, DOI 10.1016/S1607-551X(09)70531-5; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Simonin Y, 2019, EBIOMEDICINE, V39, P315, DOI 10.1016/j.ebiom.2018.12.010; Singh R, 2015, MOL THER, V23, P1700, DOI 10.1038/mt.2015.141; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strauss O, 2016, ADV EXP MED BIOL, V854, P739, DOI 10.1007/978-3-319-17121-0_98; Sullivan DM, 1997, J NEUROSCI RES, V49, P43, DOI 10.1002/(SICI)1097-4547(19970701)49:1<43::AID-JNR5>3.0.CO;2-D; Tanimoto N, 2012, J NEUROSCI, V32, P4861, DOI 10.1523/JNEUROSCI.4654-11.2012; Tao QP, 1996, CURR EYE RES, V15, P237, DOI 10.3109/02713689609007617; Thompson CH, 2009, J BIOL CHEM, V284, P26051, DOI 10.1074/jbc.M109.031724; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Torriano S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26481-7; Torriano S, 2017, HUM MOL GENET, V26, P3573, DOI 10.1093/hmg/ddx244; Tovell VE, 2008, INVEST OPHTH VIS SCI, V49, P350, DOI 10.1167/iovs.07-1040; Wang HW, 2017, MOL MED REP, V16, P11, DOI 10.3892/mmr.2017.6600; Weng TX, 2002, AM J PHYSIOL-CELL PH, V283, pC839, DOI 10.1152/ajpcell.00445.2001; Wills NK, 2000, INVEST OPHTH VIS SCI, V41, P4247; Wimmers S, 2008, GRAEF ARCH CLIN EXP, V246, P685, DOI 10.1007/s00417-008-0778-7; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wimmers S, 2008, MOL VIS, V14, P2340; Wolfensberger T., 1998, RETINAL PIGMENT EPIT, P103; Wollmann G, 2006, VISION RES, V46, P688, DOI 10.1016/j.visres.2005.08.030; Ye K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70979-y; Zhao SL, 2001, MOL VIS, V7, P277; Zhu DH, 2011, INVEST OPHTH VIS SCI, V52, P1573, DOI 10.1167/iovs.10-6413	110	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21406	10.1096/fj.202002754R	http://dx.doi.org/10.1096/fj.202002754R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724552				2022-12-28	WOS:000635216100038
J	Miyashita, Y; Tsukamoto, O; Matsuoka, K; Kamikubo, K; Kuramoto, Y; Fu, HY; Tsubota, T; Hasuike, H; Takayama, T; Ito, H; Hitsumoto, T; Okamoto, C; Kioka, H; Oya, R; Shinomiya, H; Hakui, H; Shintani, Y; Kato, H; Kitakaze, M; Sakata, Y; Asano, Y; Takashima, S				Miyashita, Yohei; Tsukamoto, Osamu; Matsuoka, Ken; Kamikubo, Kenta; Kuramoto, Yuki; Ying Fu, Hai; Tsubota, Tomoya; Hasuike, Hirona; Takayama, Toshio; Ito, Hiroaki; Hitsumoto, Tatsuro; Okamoto, Chisato; Kioka, Hidetaka; Oya, Ryohei; Shinomiya, Haruki; Hakui, Hideyuki; Shintani, Yasunori; Kato, Hisakazu; Kitakaze, Masafumi; Sakata, Yasushi; Asano, Yoshihiro; Takashima, Seiji			The CR9 element is a novel mechanical load-responsive enhancer that regulates natriuretic peptide genes expression	FASEB JOURNAL			English	Article						cardiomyocyte; CR9; enhancer; mechanical loads; natriuretic peptides		Enhancers regulate gene expressions in a tissue- and pathology-specific manner by altering its activities. Plasma levels of atrial and brain natriuretic peptides, encoded by the Nppa and Nppb, respectively, and synthesized predominantly in cardiomyocytes, vary depending on the severity of heart failure. We previously identified the noncoding conserved region 9 (CR9) element as a putative Nppb enhancer at 22-kb upstream from the Nppb gene. However, its regulatory mechanism remains unknown. Here, we therefore investigated the mechanism of CR9 activation in cardiomyocytes using different kinds of drugs that induce either cardiac hypertrophy or cardiac failure accompanied by natriuretic peptides upregulation. Chronic treatment of mice with either catecholamines or doxorubicin increased CR9 activity during the progression of cardiac hypertrophy to failure, which is accompanied by proportional increases in Nppb expression. Conversely, for cultured cardiomyocytes, doxorubicin decreased CR9 activity and Nppb expression, while catecholamines increased both. However, exposing cultured cardiomyocytes to mechanical loads, such as mechanical stretch or hydrostatic pressure, upregulate CR9 activity and Nppb expression even in the presence of doxorubicin. Furthermore, the enhancement of CR9 activity and Nppa and Nppb expressions by either catecholamines or mechanical loads can be blunted by suppressing mechanosensing and mechanotransduction pathways, such as muscle LIM protein (MLP) or myosin tension. Finally, the CR9 element showed a more robust and cell-specific response to mechanical loads than the -520-bp BNP promoter. We concluded that the CR9 element is a novel enhancer that responds to mechanical loads by upregulating natriuretic peptides expression in cardiomyocytes.	[Miyashita, Yohei; Tsukamoto, Osamu; Matsuoka, Ken; Kamikubo, Kenta; Tsubota, Tomoya; Hasuike, Hirona; Hitsumoto, Tatsuro; Okamoto, Chisato; Oya, Ryohei; Kato, Hisakazu; Takashima, Seiji] Osaka Univ, Grad Sch Med Frontier Biosci, Dept Med Biochem, Suita, Osaka, Japan; [Miyashita, Yohei] Osaka Univ, Grad Sch Med, Dept Legal Med, Suita, Osaka, Japan; [Miyashita, Yohei; Kuramoto, Yuki; Kioka, Hidetaka; Shinomiya, Haruki; Hakui, Hideyuki; Sakata, Yasushi; Asano, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Ying Fu, Hai] Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Fac Med, Takamatsu, Kagawa, Japan; [Takayama, Toshio] Tokyo Inst Technol, Sch Engn, Dept Mech Engn, Tokyo, Japan; [Ito, Hiroaki] Chiba Univ, Grad Sch Sci, Dept Phys, Chiba, Japan; [Shintani, Yasunori] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Suita, Osaka, Japan; [Kitakaze, Masafumi] Hanwa Daini Senboku Hosp, Osaka, Japan	Osaka University; Osaka University; Osaka University; Kagawa University; Tokyo Institute of Technology; Chiba University; National Cerebral & Cardiovascular Center - Japan	Tsukamoto, O (corresponding author), Osaka Univ, Dept Med Biochem, Suita, Osaka, Japan.; Asano, Y (corresponding author), Osaka Univ, Grad Sch Med Frontier Biosci, Dept Cardiovasc Med, Suita, Osaka, Japan.	tsuka@medbio.med.osaka-u.ac.jp; asano@cardiology.med.osaka-u.ac.jp	Oya, Ryohei/I-4142-2019; Okamoto, Chisato/HGA-8881-2022	Oya, Ryohei/0000-0001-8991-0315; Okamoto, Chisato/0000-0002-0671-793X; Ito, Hiroaki/0000-0003-3769-7115; Kato, Hisakazu/0000-0003-4619-3680; Takayama, Toshio/0000-0002-0411-4764; Shintani, Yasunori/0000-0001-9579-0727; Tsukamoto, Osamu/0000-0002-9504-8001; Miyashita, Yohei/0000-0002-1739-4734; Sakata, Yasushi/0000-0002-5618-4721	MEXT | Japan Society for the Promotion of Science (JSPS) [JP17K09578, JP18H04050, JP18H06212, JP20K17151]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP17K09578; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H04050; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H06212; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP20K17151	Abugessaisa I, 2017, METHODS MOL BIOL, V1611, P199, DOI 10.1007/978-1-4939-7015-5_15; Adamcova M, 2015, INT J CARDIOL, V201, P358, DOI 10.1016/j.ijcard.2015.07.103; Bruggink AH, 2006, J HEART LUNG TRANSPL, V25, P174, DOI 10.1016/j.healun.2005.09.007; Chen SC, 1999, HYPERTENSION, V34, P1223, DOI 10.1161/01.HYP.34.6.1223; Chopra A, 2018, DEV CELL, V44, P87, DOI 10.1016/j.devcel.2017.12.012; Desai VG, 2013, TOXICOL APPL PHARM, V266, P109, DOI 10.1016/j.taap.2012.10.025; Fish-Trotter H, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.119.006570; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Goetze JP, 2020, NAT REV CARDIOL, V17, P698, DOI 10.1038/s41569-020-0381-0; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Grossman W, 2013, J CLIN INVEST, V123, P3701, DOI 10.1172/JCI69830; Hayakawa T, 2014, J MOL CELL CARDIOL, V77, P178, DOI 10.1016/j.yjmcc.2014.09.010; Ibrahim NE, 2018, CIRC RES, V123, P614, DOI 10.1161/CIRCRESAHA.118.312706; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Ichiki T, 2013, ADV CLIN CHEM, V61, P1, DOI 10.1016/B978-0-12-407680-8.00001-4; Kawas RF, 2017, J BIOL CHEM, V292, P16571, DOI 10.1074/jbc.M117.776815; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kuhn M, 2009, J CLIN INVEST, V119, P2019, DOI 10.1172/JCI37430; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Ma KK, 2004, J MOL CELL CARDIOL, V36, P505, DOI 10.1016/j.yjmcc.2004.01.001; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Matsuoka K, 2014, FASEB J, V28, P1870, DOI 10.1096/fj.13-245522; Milano G, 2014, J AM SOC ECHOCARDIOG, V27, P568, DOI 10.1016/j.echo.2014.01.014; Ovchinnikova E, 2018, STEM CELL REP, V10, P794, DOI 10.1016/j.stemcr.2018.01.016; Pandey P, 2018, DEV CELL, V44, P326, DOI 10.1016/j.devcel.2017.12.024; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Pitoulis FG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00092; Raj Shashi, 2014, Curr Treat Options Cardiovasc Med, V16, P315, DOI 10.1007/s11936-014-0315-4; Romano S, 2011, BRIT J CANCER, V105, P1663, DOI 10.1038/bjc.2011.439; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Rysa J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23042-w; Saucerman JJ, 2019, NAT REV CARDIOL, V16, P361, DOI 10.1038/s41569-019-0155-8; Sergeeva IA, 2016, DEVELOPMENT, V143, P2135, DOI 10.1242/dev.132019; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Stavenschi E, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1025-8; Ward M, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.01.017; Yokoyama U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00237-1; Yu NYL, 2015, NUCLEIC ACIDS RES, V43, P6787, DOI 10.1093/nar/gkv608; ZAHRINGER J, 1980, BIOCHIM BIOPHYS ACTA, V608, P315, DOI 10.1016/0005-2787(80)90177-X	43	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21495	10.1096/fj.202002111RR	http://dx.doi.org/10.1096/fj.202002111RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33689182	Green Submitted, hybrid			2022-12-28	WOS:000635216100036
J	Recchiuti, A; Patruno, S; Mattoscio, D; Isopi, E; Pomilio, A; Lamolinara, A; Iezzi, M; Pecce, R; Romano, M				Recchiuti, Antonio; Patruno, Sara; Mattoscio, Domenico; Isopi, Elisa; Pomilio, Antonella; Lamolinara, Alessia; Iezzi, Manuela; Pecce, Romina; Romano, Mario			Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages	FASEB JOURNAL			English	Article						omega-3 fatty acids; COVID-19; resolution; respiratory viruses; specialized proresolving lipid mediators	PSEUDOMONAS-AERUGINOSA; INFLUENZA-VIRUS; RESOLUTION; MEDIATORS; REGULATOR; EXPRESSION; MICRORNAS; MECHANISMS; DISEASE	An excessive, non-resolving inflammatory response underlies severe COVID-19 that may have fatal outcomes. Therefore, the investigation of endogenous pathways leading to resolution of inflammation is of interest to uncover strategies for mitigating inflammation in people with SARS-CoV-2 infection. This becomes particularly urgent in individuals with preexisting pathologies characterized by chronic respiratory inflammation and prone to bacterial infection, such as cystic fibrosis (CF). Here, we analyzed the immune responses to SARS-CoV-2 virion spike 1 glycoprotein (S1) of macrophages (M phi) from volunteers with and without CF and tested the efficacy of resolvins (Rv) D1 and D2 in regulating the inflammatory and antimicrobial functions of M phi exposed to S1. S1 significantly increased chemokine release, including interleukin (IL)-8, in CF and non-CF M phi, while it enhanced IL-6 and tumor necrosis factor (TNF)-alpha in non-CF M phi, but not in CF cells. S1 also triggered the biosynthesis of RvD1 and modulated microRNAs miR-16, miR-29a, and miR-103, known to control the inflammatory responses. RvD1 and RvD2 treatment abated S1-induced inflammatory responses in CF and non-CF M phi, significantly reducing the release of select chemokines and cytokines including IL-8 and TNF-alpha. RvD1 and RvD2 both restored the expression of miR-16 and miR-29a, while selectively increasing miR-223 and miR-125a, which are involved in NF-kappa B activation and M phi inflammatory polarization. During Pseudomonas aeruginosa infection, S1 stimulated the M phi phagocytic activity that was further enhanced by RvD1 and RvD2. These results provide a map of molecular responses to SARS-CoV-2 in M phi, key determinants of COVID-19-related inflammation, unveiling some peculiarity in the response of cells from individuals with CF. They also demonstrate beneficial, regulatory actions of RvD1 and RvD2 on SARS-CoV-2-induced inflammation.	[Recchiuti, Antonio; Patruno, Sara; Mattoscio, Domenico; Isopi, Elisa; Pomilio, Antonella; Pecce, Romina; Romano, Mario] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Polacchi,13, I-66100 Chieti, Italy; [Recchiuti, Antonio; Patruno, Sara; Mattoscio, Domenico; Isopi, Elisa; Pomilio, Antonella; Lamolinara, Alessia; Iezzi, Manuela; Pecce, Romina; Romano, Mario] Univ G dAnnunzio, Ctr Adv Studies & Technol, Chieti, Italy; [Lamolinara, Alessia; Iezzi, Manuela] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Recchiuti, A (corresponding author), Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Polacchi,13, I-66100 Chieti, Italy.	a.recchiuti@unich.it	Romano, Mario/I-7986-2012; Iezzi, Manuela/AAB-7939-2019; lamolinara, alessia/AAB-8833-2019; Mattoscio, Domenico/K-1411-2018; recchiuti, antonio/K-7670-2016; Patruno, Sara/P-7868-2018	Romano, Mario/0000-0001-8512-1458; Iezzi, Manuela/0000-0002-6296-6498; lamolinara, alessia/0000-0002-7421-4509; Mattoscio, Domenico/0000-0002-2149-2855; recchiuti, antonio/0000-0002-1409-5261; Patruno, Sara/0000-0002-8425-7844; ISOPI, ELISA/0000-0002-4520-6139	Cystic Fibrosis Foundation (CF Foundation) [RECCHI19I0, ROMANO19IO, RECCHI20G1]; Ministero della Salute (Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Cystic Fibrosis Foundation (CF Foundation); Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	Cystic Fibrosis Foundation (CF Foundation), Grant/Award Number: RECCHI19I0, ROMANO19IO and RECCHI20G1; Ministero della Salute (Ministry of Health, Italy), Grant/Award Number: L.548/93; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: Ex 60% (2019-2020)	Akkaya-Ulum YZ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80097-4; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Bruscia EM, 2016, J INNATE IMMUN, V8, P550, DOI 10.1159/000446825; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Centers for Disease Control Prevention, PEOPL WHO AR HIGH RI; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Codagnone M, 2018, MUCOSAL IMMUNOL, V11, P35, DOI 10.1038/mi.2017.36; Croasdell A, 2016, FASEB J, V30, P3181, DOI 10.1096/fj.201600375R; Curtale G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00799; Eickmeier O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171249; Fattorini L, 2020, ANN I SUPER SANITA, V56, P359, DOI 10.4415/ANN_20_03_14; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Gilroy DW, 2019, BRIT J PHARMACOL, V176, P1009, DOI 10.1111/bph.14587; Gromovsky AD, 2018, ARTERIOSCL THROM VAS, V38, P218, DOI 10.1161/ATVBAHA.117.309660; Heltshe SL, 2015, CLIN INFECT DIS, V60, P703, DOI 10.1093/cid/ciu944; Hisert KB, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01219; Hisert KB, 2017, AM J RESP CRIT CARE, V195, P1617, DOI [10.1164/rccm.201609-1954OC, 10.1164/rccm.201609-1954oc]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hsu YL, 2018, MOL THER, V26, P568, DOI 10.1016/j.ymthe.2017.11.016; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lescoat A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030894; Li CX, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23590; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Matte A, 2019, BLOOD, V133, P252, DOI 10.1182/blood-2018-07-865378; Mattoscio D., 2020, RESOLVIN D1 D2 REDUC, DOI DOI 10.1101/2020.08.28.255463; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McClenaghan E., 2020, J CYSTIC FIBROSIS; Montgomery ST, 2018, J CYST FIBROS, V17, P715, DOI 10.1016/j.jcf.2018.05.006; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Motwani MP, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94463; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Perretti M, 2017, MOL ASPECTS MED, V58, P57, DOI 10.1016/j.mam.2017.04.005; Ramon S, 2014, J IMMUNOL, V193, P6031, DOI 10.4049/jimmunol.1302795; Recchiuti A, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00252; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ringholz FC, 2014, EUR RESPIR J, V44, P394, DOI 10.1183/09031936.00106013; Roesch EA, 2018, PEDIATR PULM, V53, pS30, DOI 10.1002/ppul.24129; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Spite Matthew, 2014, Cell Metab, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stefani S, 2017, INT J MED MICROBIOL, V307, P353, DOI 10.1016/j.ijmm.2017.07.004; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Tseng CTK, 2005, J IMMUNOL, V174, P7977, DOI 10.4049/jimmunol.174.12.7977; Wang HM, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1031440; Wang ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep25602; Watanabe Y, 2004, MICROBIOL IMMUNOL, V48, P875, DOI 10.1111/j.1348-0421.2004.tb03619.x; World Health Organization, COR DIS COVID 19 OUT; Wu SH, 2013, BRIT J DERMATOL, V168, P172, DOI 10.1111/j.1365-2133.2012.11177.x	58	13	13	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21441	10.1096/fj.202001952R	http://dx.doi.org/10.1096/fj.202001952R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749902	Green Published, Green Submitted			2022-12-28	WOS:000635216100068
J	Choi, W; Lee, HW; Pak, B; Han, O; Kim, M; Jin, SW				Choi, Woosoung; Lee, Heon-Woo; Pak, Boryeong; Han, Orjin; Kim, Minjung; Jin, Suk-Won			Transcriptomic analysis identifies novel targets for individual bone morphogenetic protein type 1 receptors in endothelial cells	FASEB JOURNAL			English	Article						ALK2; BMP signaling; BMPR1; endothelial cell; transcriptomics	I RECEPTOR; OLIGOMERIZATION; BETA; ACTIVATION; DIVERSITY; COMPLEXES; MODE; ALK1	Bone Morphogenetic Protein (BMP) signaling regulates diverse biological processes. Upon ligand binding, BMP receptors (BMPRs) phosphorylate SMAD1/5 and other noncanonical downstream effectors to induce transcription of downstream targets. However, the precise role of individual BMP receptors in this process remains largely unknown due to the complexity of downstream signaling and the innate promiscuity of ligand-receptor interaction. To delineate unique downstream effectors of individual BMPR1s, we analyzed the transcriptome of human umbilical endothelial cells (HUVECs) expressing three distinct constitutively active BMPR1s of which expression was detected in endothelial cells (ECs). From our analyses, we identified a number of novel downstream targets of BMPR1s in ECs. More importantly, we found that each BMPR1 possesses a distinctive set of downstream effectors, suggesting that each BMPR1 is likely to retain unique function in ECs. Taken together, our analyses suggest that each BMPR1 regulates downstream targets non-redundantly in ECs to create context-dependent outcomes of the BMP signaling.	[Choi, Woosoung; Pak, Boryeong; Han, Orjin; Kim, Minjung; Jin, Suk-Won] Gwangju Inst Sci & Technol, Cell Logist Res Ctr, Gwangju, South Korea; [Choi, Woosoung; Pak, Boryeong; Han, Orjin; Kim, Minjung; Jin, Suk-Won] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea; [Lee, Heon-Woo; Jin, Suk-Won] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT USA; [Lee, Heon-Woo; Jin, Suk-Won] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Yale University; Yale University	Jin, SW (corresponding author), Gwangju Inst Sci & Technol, Cell Logist Res Ctr, Gwangju, South Korea.; Jin, SW (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea.	sukwonjin@gist.ac.kr	Lee, Heon-Woo/AAN-6241-2021; Lee, Heon-Woo/GZL-9270-2022; Choi, Woosoung/ABF-2933-2020	Lee, Heon-Woo/0000-0002-0620-6937; Choi, Woosoung/0000-0002-8017-3838	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL114820]; National Research Foundation of Korea (NRF) [NRF-2016R1A5A1007318, NRF-2017R1A2B2007211, NRF2019R1A2C2088125]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL114820; National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2016R1A5A1007318, NRF-2017R1A2B2007211 and NRF2019R1A2C2088125	Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Choi W., 2021, FASEB J, V35; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Dyer LA, 2014, TRENDS ENDOCRIN MET, V25, P472, DOI 10.1016/j.tem.2014.05.003; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Gomez-Puerto MC, 2019, J PATHOL, V247, P9, DOI 10.1002/path.5170; Guo XD, 2013, CELL RES, V23, P142, DOI 10.1038/cr.2012.180; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Kim JD, 2014, ARTERIOSCL THROM VAS, V34, P1838, DOI 10.1161/ATVBAHA.114.303219; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lee HW, 2017, ARTERIOSCL THROM VAS, V37, P657, DOI 10.1161/ATVBAHA.116.308422; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Lowery JW, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022327; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Ota T, 2002, J CELL PHYSIOL, V193, P299, DOI 10.1002/jcp.10170; Park WB, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e84; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Traeger L, 2018, FREE RADICAL BIO MED, V129, P127, DOI 10.1016/j.freeradbiomed.2018.09.021; Varley JE, 1998, DEV BIOL, V196, P107, DOI 10.1006/dbio.1998.8853; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wiley DM, 2011, SEMIN CELL DEV BIOL, V22, P1012, DOI 10.1016/j.semcdb.2011.10.005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	33	3	3	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21386	10.1096/fj.202002071R	http://dx.doi.org/10.1096/fj.202002071R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565137	Green Accepted			2022-12-28	WOS:000629576700007
J	Mia, S; Sonkar, R; Williams, L; Latimer, MN; Robillard, IF; Diwan, A; Frank, SJ; Des Rosiers, C; Young, ME				Mia, Sobuj; Sonkar, Ravi; Williams, Lamario; Latimer, Mary N.; Robillard, Isabelle Frayne; Diwan, Abhinav; Frank, Stuart J.; Des Rosiers, Christine; Young, Martin E.			Impact of obesity on day-night differences in cardiac metabolism	FASEB JOURNAL			English	Article						chronobiology; gene expression; heart; metabolism; obesity	CARDIOMYOCYTE CIRCADIAN CLOCK; FATTY-ACID OXIDATION; CARDIOVASCULAR-DISEASE; CONTRACTILE FUNCTION; MYOCARDIAL-METABOLISM; QUANTITATIVE-ANALYSIS; SCIENTIFIC STATEMENT; ATP PRODUCTION; HEART-FAILURE; DYSFUNCTION	An intrinsic property of the heart is an ability to rapidly and coordinately adjust flux through metabolic pathways in response to physiologic stimuli (termed metabolic flexibility). Cardiac metabolism also fluctuates across the 24-hours day, in association with diurnal sleep-wake and fasting-feeding cycles. Although loss of metabolic flexibility has been proposed to play a causal role in the pathogenesis of cardiac disease, it is currently unknown whether day-night variations in cardiac metabolism are altered during disease states. Here, we tested the hypothesis that diet-induced obesity disrupts cardiac "diurnal metabolic flexibility", which is normalized by time-of-day-restricted feeding. Chronic high fat feeding (20-wk)-induced obesity in mice, abolished diurnal rhythms in whole body metabolic flexibility, and increased markers of adverse cardiac remodeling (hypertrophy, fibrosis, and steatosis). RNAseq analysis revealed that 24-hours rhythms in the cardiac transcriptome were dramatically altered during obesity; only 22% of rhythmic transcripts in control hearts were unaffected by obesity. However, day-night differences in cardiac substrate oxidation were essentially identical in control and high fat fed mice. In contrast, day-night differences in both cardiac triglyceride synthesis and lipidome were abolished during obesity. Next, a subset of obese mice (induced by 18-wks ad libitum high fat feeding) were allowed access to the high fat diet only during the 12-hours dark (active) phase, for a 2-wk period. Dark phase restricted feeding partially restored whole body metabolic flexibility, as well as day-night differences in cardiac triglyceride synthesis and lipidome. Moreover, this intervention partially reversed adverse cardiac remodeling in obese mice. Collectively, these studies reveal diurnal metabolic inflexibility of the heart during obesity specifically for nonoxidative lipid metabolism (but not for substrate oxidation), and that restricting food intake to the active period partially reverses obesity-induced cardiac lipid metabolism abnormalities and adverse remodeling of the heart.	[Mia, Sobuj; Williams, Lamario; Latimer, Mary N.; Young, Martin E.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St S,ZRB 308, Birmingham, AL 35294 USA; [Sonkar, Ravi; Frank, Stuart J.] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Robillard, Isabelle Frayne; Des Rosiers, Christine] Univ Montreal, Dept Nutr, Montreal, PQ, Canada; [Robillard, Isabelle Frayne; Des Rosiers, Christine] Montreal Heart Inst, Montreal, PQ, Canada; [Diwan, Abhinav] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diwan, Abhinav] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Diwan, Abhinav] John Cochran VA Med Ctr, St Louis, MO USA; [Frank, Stuart J.] Birmingham VAMC Med Serv, Endocrinol Sect, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Universite de Montreal; Universite de Montreal; Washington University (WUSTL); Washington University (WUSTL)	Young, ME (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St S,ZRB 308, Birmingham, AL 35294 USA.	meyoung@uab.edu	Sonkar, Ravi/AHC-5455-2022	Williams, Lamario J/0000-0003-0704-0219; Latimer, Mary/0000-0002-6677-2877	National Heart, Lung, and Blood Institute [HL123574, HL142216]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute, Grant/Award Number: HL123574 and HL142216	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137; Bray MS, 2010, INT J OBESITY, V34, P1589, DOI 10.1038/ijo.2010.63; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Brewer RA, 2018, LIFE SCI, V197, P30, DOI 10.1016/j.lfs.2018.01.031; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Cahill LE, 2013, CIRCULATION, V128, P337, DOI 10.1161/CIRCULATIONAHA.113.001474; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; DEGASQUET P, 1977, J NUTR, V107, P199, DOI 10.1093/jn/107.2.199; DEGAUTE JP, 1991, HYPERTENSION, V18, P199, DOI 10.1161/01.HYP.18.2.199; Durgan DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2385, DOI 10.1152/ajpheart.01361.2006; Durgan DJ, 2011, J BIOL CHEM, V286, P44606, DOI 10.1074/jbc.M111.278903; Durgan DJ, 2011, CHRONOBIOL INT, V28, P187, DOI 10.3109/07420528.2010.550406; Ebong IA, 2014, OBES RES CLIN PRACT, V8, pE540, DOI 10.1016/j.orcp.2013.12.005; Forest A, 2018, J PROTEOME RES, V17, P3657, DOI 10.1021/acs.jproteome.8b00270; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Ingle KA, 2015, AM J PHYSIOL-HEART C, V309, pH1827, DOI 10.1152/ajpheart.00608.2015; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kung TA, 2007, J MOL CELL CARDIOL, V43, P744, DOI 10.1016/j.yjmcc.2007.08.018; Larsen TS, 2008, CARDIOVASC DRUG THER, V22, P91, DOI 10.1007/s10557-008-6083-1; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luptak I, 2018, J MOL CELL CARDIOL, V116, P106, DOI 10.1016/j.yjmcc.2018.01.017; Martino TA, 2015, J BIOL RHYTHM, V30, P183, DOI 10.1177/0748730415575246; McGinnis GR, 2017, J MOL CELL CARDIOL, V110, P80, DOI 10.1016/j.yjmcc.2017.07.005; Mia S., 2021, FASEB J, V35; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, DOI 10.1161/CIR.0000000000000219]; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Peliciari-Garcia RA, 2016, BBA-MOL CELL BIOL L, V1861, P1579, DOI 10.1016/j.bbalip.2015.12.012; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rong S, 2019, J AM COLL CARDIOL, V73, P2025, DOI 10.1016/j.jacc.2019.01.065; Ruiz M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123231; St-Onge MP, 2017, CIRCULATION, V135, pE96, DOI 10.1161/CIR.0000000000000476; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Taegtmeyer H, 2016, CIRC RES, V118, P1659, DOI 10.1161/RES.0000000000000097; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tsai JY, 2013, J MOL CELL CARDIOL, V55, P147, DOI 10.1016/j.yjmcc.2012.09.010; Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800; Wende Adam R, 2017, JACC Basic Transl Sci, V2, P297, DOI 10.1016/j.jacbts.2016.11.009; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Young ME, 2016, EXP PHYSIOL, V101, P1035, DOI 10.1113/EP085779; Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87	59	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21298	10.1096/fj.202001706RR	http://dx.doi.org/10.1096/fj.202001706RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33660366	hybrid, Green Published			2022-12-28	WOS:000629576700020
J	Portillo, JAC; Yu, JS; Hansen, S; Kern, TS; Subauste, MC; Subauste, CS				Portillo, Jose-Andres C.; Yu, Jin-Sang; Hansen, Samuel; Kern, Timothy S.; Subauste, M. Cecilia; Subauste, Carlos S.			A cell-penetrating CD40-TRAF2,3 blocking peptide diminishes inflammation and neuronal loss after ischemia/reperfusion	FASEB JOURNAL			English	Article						endothelial; muller cell; polymorphonuclear leukocyte; retina; toxoplasma	NITRIC-OXIDE SYNTHASE; TRAF BINDING-SITES; N-TERMINAL KINASE; ISCHEMIA-REPERFUSION; RETINAL ISCHEMIA; ANTIMICROBIAL ACTIVITY; LIGAND INTERACTION; IMMUNE-RESPONSE; BOWEL-DISEASE; MULLER CELLS	While the administration of anti-CD154 mAbs in mice validated the CD40-CD154 pathway as a target against inflammatory disorders, this approach caused thromboembolism in humans (unrelated to CD40 inhibition) and is expected to predispose to opportunistic infections. There is a need for alternative approaches to inhibit CD40 that avoid these complications. CD40 signals through TRAF2,3 and TRAF6-binding sites. Given that CD40-TRAF6 is the pathway that stimulates responses key for cell-mediated immunity against opportunistic pathogens, we examined the effects of pharmacologic inhibition of CD40-TRAF2,3 signaling. We used a model of ischemia/reperfusion (I/R)-induced retinopathy, a CD40-driven inflammatory disorder. Intravitreal administration of a cell-penetrating CD40-TRAF2,3 blocking peptide impaired ICAM-1 upregulation in retinal endothelial cells and CXCL1 upregulation in endothelial and Muller cells. The peptide reduced leukocyte infiltration, upregulation of NOS2/COX-2/TNF-alpha/IL-1 beta, and ameliorated neuronal loss, effects that mimic those observed after I/R in Cd40-/- mice. While a cell-penetrating CD40-TRAF6 blocking peptide also diminished I/R-induced inflammation, this peptide (but not the CD40-TRAF2,3 blocking peptide) impaired control of the opportunistic pathogen Toxoplasma gondii in the retina. Thus, inhibition of the CD40-TRAF2,3 pathway is a novel and potent approach to reduce CD40-induced inflammation, while likely diminishing the risk of opportunistic infections that would otherwise accompany CD40 inhibition.	[Portillo, Jose-Andres C.; Yu, Jin-Sang; Hansen, Samuel; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Subauste, M. Cecilia] Case Western Reserve Univ, Dept Med, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Subauste, M. Cecilia] Vet Adm Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, 10701 East Blvd, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University	Subauste, CS (corresponding author), Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44106 USA.	carlos.subauste@case.edu		Hansen, Samuel/0000-0002-7678-357X	NIH [EY019250, EY018341, P30 EY11373]; Crohn's and Colitis Foundation of America (Litwin Pioneers Program) [529250]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (Litwin Pioneers Program)	This work was supported by NIH grants EY019250 (C.S.S), EY018341 (C.S.S), P30 EY11373, and Crohn's and Colitis Foundation of America (Litwin Pioneers Program) grant 529250 (C.S.S.).	Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Andrade RM, 2005, J IMMUNOL, V175, P6014, DOI 10.4049/jimmunol.175.9.6014; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Butler NJ, 2013, CLIN EXP OPHTHALMOL, V41, P95, DOI 10.1111/j.1442-9071.2012.02838.x; Choi JS, 2006, NUTRITION, V22, P668, DOI 10.1016/j.nut.2005.08.011; de Ramon L, 2015, KIDNEY INT, V88, P538, DOI 10.1038/ki.2015.146; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gold JA, 2003, INFECT IMMUN, V71, P3521, DOI 10.1128/IAI.71.6.3521-3528.2003; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Hangai M, 1996, EXP EYE RES, V63, P501, DOI 10.1006/exer.1996.0140; Hermann DM, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418798607; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Jian ZH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02167; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kobayashi M, 2000, JPN J OPHTHALMOL, V44, P235, DOI 10.1016/S0021-5155(99)00220-8; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Lu LF, 2003, J BIOL CHEM, V278, P45414, DOI 10.1074/jbc.M309601200; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mackey MF, 2003, EUR J IMMUNOL, V33, P779, DOI 10.1002/eji.200323729; Miura M, 2001, AM J PATHOL, V159, P2137, DOI 10.1016/S0002-9440(10)63065-9; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Oura T, 2012, AM J TRANSPLANT, V12, P1740, DOI 10.1111/j.1600-6143.2012.04014.x; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; PINKUS GS, 1991, MODERN PATHOL, V4, P733; Portillo JAC, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00868-18; Portillo JAC, 2017, DIABETES, V66, P483, DOI 10.2337/db16-0051; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Portillo JAC, 2015, IMMUNOLOGY, V144, P21, DOI 10.1111/imm.12361; Portillo JAC, 2014, DIABETOLOGIA, V57, P2222, DOI 10.1007/s00125-014-3321-x; Portillo JAC, 2012, IMMUNOLOGY, V135, P140, DOI 10.1111/j.1365-2567.2011.03519.x; Portillo JAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014472; Portillo JAC, 2009, MOL VIS, V15, P1383; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Prive GG, 2006, CURR OPIN GENET DEV, V16, P71, DOI 10.1016/j.gde.2005.12.010; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Reichmann G, 2000, INFECT IMMUN, V68, P1312, DOI 10.1128/IAI.68.3.1312-1318.2000; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; Schorderet DF, 2005, CLIN EXP OPHTHALMOL, V33, P628, DOI 10.1111/j.1442-9071.2005.01108.x; Seijkens TTP, 2018, J AM COLL CARDIOL, V71, P527, DOI 10.1016/j.jacc.2017.11.055; Song ZF, 2012, ARTERIOSCL THROM VAS, V32, P50, DOI 10.1161/ATVBAHA.111.238329; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Subauste CS, 1999, J IMMUNOL, V162, P6690; Sutherland CL, 1999, J IMMUNOL, V162, P4720; Tejeda GS, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809950; Touchard E, 2010, INVEST OPHTH VIS SCI, V51, P4683, DOI 10.1167/iovs.09-4733; Trivedi PJ, 2018, J CROHNS COLITIS, V12, pS641, DOI 10.1093/ecco-jcc/jjx145; Tsujikawa A, 1999, INVEST OPHTH VIS SCI, V40, P1183; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; YAMAZAKI T, 1993, AM J PATHOL, V143, P410; Yasui T, 2002, INT IMMUNOL, V14, P319, DOI 10.1093/intimm/14.3.319; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zarzycka B, 2015, J CHEM INF MODEL, V55, P294, DOI 10.1021/ci500631e; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zundler S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00891	61	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21412	10.1096/fj.201903203RR	http://dx.doi.org/10.1096/fj.201903203RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33675257	Green Published, hybrid			2022-12-28	WOS:000629576700026
J	Abdulkareem, NM; Bhat, R; Qin, LF; Vasaikar, S; Gopinathan, A; Mitchell, T; Shea, MJ; Nanda, S; Thangavel, H; Zhang, B; De Angelis, C; Schiff, R; Trivedi, MV				Abdulkareem, Noor Mazin; Bhat, Raksha; Qin, Lanfang; Vasaikar, Suhas; Gopinathan, Ambily; Mitchell, Tamika; Shea, Martin J.; Nanda, Sarmistha; Thangavel, Hariprasad; Zhang, Bing; De Angelis, Carmine; Schiff, Rachel; Trivedi, Meghana, V			A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer	FASEB JOURNAL			English	Article						ADGRF1; breast cancer; chemoresistance; GPR110; HER2; quiescence; tumorigenesis	PROTEIN-COUPLED RECEPTORS; ADHESION GPCRS; EXPRESSION; CELLS; GPR56/ADGRG1; ENCYCLOPEDIA; METASTASIS; ACTIVATION; DIVERSE; TRENDS	While G protein-coupled receptors (GPCRs) are known to be excellent drug targets, the second largest family of adhesion-GPCRs is less explored for their role in health and disease. ADGRF1 (GPR110) is an adhesion-GPCR and has an important function in neurodevelopment and cancer. Despite serving as a poor predictor of survival, ADGRF1's coupling to G proteins and downstream pathways remain unknown in cancer. We evaluated the effects of ADGRF1 overexpression on tumorigenesis and signaling pathways using two human epidermal growth factor receptor-2-positive (HER2+) breast cancer (BC) cell-line models. We also interrogated publicly available clinical datasets to determine the expression of ADGRF1 in various BC subtypes and its impact on BC-specific survival (BCSS) and overall survival (OS) in patients. ADGRF1 overexpression in HER2+ BC cells increased secondary mammosphere formation, soft agar colony formation, and % of Aldefluor-positive tumorigenic population in vitro and promoted tumor growth in vivo. ADGRF1 co-immunoprecipitated with both G alpha s and G alpha q proteins and increased cAMP and IP1 when overexpressed. However, inhibition of only the G alpha s pathway by SQ22536 reversed the pro-tumorigenic effects of ADGRF1 overexpression. RNA-sequencing and RPPA analysis revealed inhibition of cell cycle pathways with ADGRF1 overexpression, suggesting cellular quiescence, as also evidenced by cell cycle arrest at the G0/1 phase and resistance to chemotherapy in HER2+ BC. ADGRF1 was significantly overexpressed in the HER2-enriched BC compared to luminal A and B subtypes and predicted worse BCSS and OS in these patients. Therefore, ADGRF1 represents a novel drug target in HER2+ BC, warranting discovery of novel ADGRF1 antagonists.	[Abdulkareem, Noor Mazin; Bhat, Raksha; Trivedi, Meghana, V] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA; [Bhat, Raksha; Gopinathan, Ambily; Thangavel, Hariprasad; Trivedi, Meghana, V] Univ Houston, Coll Pharm, Dept Pharm Practice & Translat Res, Houston, TX 77204 USA; [Qin, Lanfang; Vasaikar, Suhas; Mitchell, Tamika; Shea, Martin J.; Nanda, Sarmistha; Zhang, Bing; De Angelis, Carmine; Schiff, Rachel; Trivedi, Meghana, V] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Zhang, Bing] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [De Angelis, Carmine] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Schiff, Rachel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA; [Schiff, Rachel; Trivedi, Meghana, V] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; University of Naples Federico II; Baylor College of Medicine; Baylor College of Medicine	Trivedi, MV (corresponding author), Univ Houston, Dept Pharm Practice & Translat Res, Hlth 2,4849 Calhoun Rd, Houston, TX 77204 USA.	mtrivedi@central.uh.edu	Bhat, Raksha/GNW-3971-2022	Bhat, Raksha/0000-0002-0026-1118; DE ANGELIS, CARMINE/0000-0003-1158-4630; Trivedi, Meghana V/0000-0002-0585-5580	Department of Defense BCRP [W81XWH-14-1-0340, W81XWH-14-1-0341]; Breast Cancer Research Foundation [BCRF-18-145, 19-145]; NIH [CA125123, P50 CA058183, CA186784-01]	Department of Defense BCRP(United States Department of Defense); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in parts by Department of Defense BCRP grants W81XWH-14-1-0340 and W81XWH-14-1-0341; Breast Cancer Research Foundation (BCRF-18-145 and 19-145 grants); and NIH grants CA125123, P50 CA058183, and CA186784-01. None of the funding agencies had any role in the design, analysis, or reporting of the analyses. The authors thank Joe Gray and Thomas Westbrook labs for providing SKBR3 cells and lentiviral vector (pHAGE-ind-ubc-DEST) containing a c-terminal HA tag, respectively. We also thank Dr. Shixia Huang from the Antibody-based Proteomics Core/Shared Resource and Dr. Preethi Gunaratne, Dr. Kimberly Holloway, and Mr. Brandon Mistretta from the UH Seq-N-Edit Core for their excellent technical assistant in performing RPPA and RNA-Seq studies, respectively.	Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Ariazi EA, 2006, J STEROID BIOCHEM, V102, P128, DOI 10.1016/j.jsbmb.2006.09.003; Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; Aust G, 2016, HANDB EXP PHARMACOL, V234, P369, DOI 10.1007/978-3-319-41523-9_17; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beristain AG, 2015, ONCOGENE, V34, P1160, DOI 10.1038/onc.2014.41; Bhat RR, 2018, BREAST CANCER RES TR, V170, P279, DOI 10.1007/s10549-018-4751-9; Brown JA, 2017, CELL STEM CELL, V21, P650, DOI 10.1016/j.stem.2017.10.001; Caretta Antonio, 2011, Cancers (Basel), V3, P913, DOI 10.3390/cancers3010913; Chen W, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1740936; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; De Angelis ML, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00626; Demberg LM, 2017, J BIOL CHEM, V292, P4383, DOI 10.1074/jbc.M116.763656; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Gad AA, 2020, ACS PHARMACOL TRANSL, V3, P29, DOI 10.1021/acsptsci.9b00093; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hasan AN, 2015, BIOINFORMATION, V11, P229, DOI 10.6026/97320630011229; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Huang BX, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0831-6; Huang C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2936; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kishore A, 2016, HANDB EXP PHARMACOL, V234, P127, DOI 10.1007/978-3-319-41523-9_7; Knapp B, 2016, HANDB EXP PHARMACOL, V234, P147, DOI 10.1007/978-3-319-41523-9_8; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lee JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13123; Lee SH, 2020, STEM CELL REV REP, V16, P1185, DOI 10.1007/s12015-020-10031-8; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu ZQ, 2018, MED SCI MONITOR, V24, P5216, DOI 10.12659/MSM.909555; Lum AM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-40; Ma BT, 2017, AM J CANCER RES, V7, P433; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Moreno M, 2017, CELL REP, V21, P2183, DOI 10.1016/j.celrep.2017.10.083; Nair A, 2018, NAT MED, V24, P505, DOI 10.1038/nm.4507; Nardone A, 2019, BRIT J CANCER, V120, P331, DOI 10.1038/s41416-018-0354-9; Parish AJ, 2018, CANCER-AM CANCER SOC, V124, P4080, DOI 10.1002/cncr.31724; Park T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1621-2; Peeters MC, 2015, CELL SIGNAL, V27, P2579, DOI 10.1016/j.cellsig.2015.08.015; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Scholz N, 2019, ANN NY ACAD SCI, V1456, P80, DOI 10.1111/nyas.14192; Sethunath V, 2019, MOL CANCER RES, V17, P2318, DOI 10.1158/1541-7786.MCR-19-0756; Shi HP, 2017, BIOCHEM BIOPH RES CO, V491, P349, DOI 10.1016/j.bbrc.2017.07.097; Stoveken HM, 2018, MOL PHARMACOL, V93, P477, DOI 10.1124/mol.117.111476; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; Thangavel H, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111772; Valtcheva N, 2013, J BIOL CHEM, V288, P35736, DOI 10.1074/jbc.M113.512954; van Oirschot BA, 2001, J BIOL CHEM, V276, P33854, DOI 10.1074/jbc.M104395200; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Vizurraga A, 2020, J BIOL CHEM, V295, P14065, DOI 10.1074/jbc.REV120.007423; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Ward Y, 2018, CELL REP, V23, P808, DOI 10.1016/j.celrep.2018.03.092; Yona S, 2008, FASEB J, V22, P741, DOI 10.1096/fj.07-9435com; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhu XL, 2019, PATHOL RES PRACT, V215, P539, DOI 10.1016/j.prp.2018.12.004	61	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21719	10.1096/fj.202100070R	http://dx.doi.org/10.1096/fj.202100070R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110646	Green Accepted			2022-12-28	WOS:000667814100046
J	Romani-Perez, M; Lopez-Almela, I; Bullich-Vilarrubias, C; Rueda-Ruzafa, L; Del Pulgar, EMG; Benitez-Paez, A; Liebisch, G; Lamas, JA; Sanz, Y				Romani-Perez, Marina; Lopez-Almela, Inmaculada; Bullich-Vilarrubias, Clara; Rueda-Ruzafa, Lola; Gomez Del Pulgar, Eva M.; Benitez-Paez, Alfonso; Liebisch, Gerhard; Antonio Lamas, Jose; Sanz, Yolanda			Holdemanella biformis improves glucose tolerance and regulates GLP-1 signaling in obese mice	FASEB JOURNAL			English	Article						glucagon-like peptide 1; gut microbiota; Holdemanella biformis; obesity; type 2 diabetes; vagal afferent neurons	CHAIN FATTY-ACIDS; PEPTIDE-1 SECRETION; GUT-MICROBIOME; DIET; RECEPTORS; IMMUNE	Impaired glucose homeostasis in obesity is mitigated by enhancing the glucoregulatory actions of glucagon-like peptide 1 (GLP-1), and thus, strategies that improve GLP-1 sensitivity and secretion have therapeutic potential for the treatment of type 2 diabetes. This study shows that Holdemanella biformis, isolated from the feces of a metabolically healthy volunteer, ameliorates hyperglycemia, improves oral glucose tolerance and restores gluconeogenesis and insulin signaling in the liver of obese mice. These effects were associated with the ability of H. biformis to restore GLP-1 levels, enhancing GLP-1 neural signaling in the proximal and distal small intestine and GLP-1 sensitivity of vagal sensory neurons, and to modify the cecal abundance of unsaturated fatty acids and the bacterial species associated with metabolic health. Our findings overall suggest the potential use of H biformis in the management of type 2 diabetes in obesity to optimize the sensitivity and function of the GLP-1 system, through direct and indirect mechanisms.	[Romani-Perez, Marina; Lopez-Almela, Inmaculada; Bullich-Vilarrubias, Clara; Gomez Del Pulgar, Eva M.; Benitez-Paez, Alfonso; Sanz, Yolanda] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia 46980, Spain; [Rueda-Ruzafa, Lola; Antonio Lamas, Jose] Univ Vigo, Biomed Res Ctr CINBIO, Lab Neurosci, Vigo, Spain; [Liebisch, Gerhard] Univ Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universidade de Vigo; CINBIO; University of Regensburg	Romani-Perez, M (corresponding author), Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia 46980, Spain.	marina.romani@iata.csic.es	Benítez-Páez, Alfonso/AAY-7143-2020; Rueda, Lola/AGQ-6540-2022; Liebisch, Gerhard/G-6130-2010; Sanz, Yolanda/H-5498-2012; Romani Perez, Marina/K-4124-2017; Lamas, J Antonio/O-1434-2019	Benítez-Páez, Alfonso/0000-0001-5707-4340; Liebisch, Gerhard/0000-0003-4886-0811; Sanz, Yolanda/0000-0002-1615-1976; Lopez Almela, Inmaculada/0000-0001-9886-8622; , Lola/0000-0002-0151-8018; , IIS Galicia Sur/0000-0003-3812-7413; Gomez del Pulgar Villanueva, Eva Maria/0000-0002-4509-1044; Romani Perez, Marina/0000-0002-1009-0156; Lamas, J Antonio/0000-0002-4453-4595	European Union Horizon 2020 research and innovation program [797297]; Spanish Ministry of Science and Innovation [AGL2017-88801-P]; European Union 7th Framework Program [613979]	European Union Horizon 2020 research and innovation program; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union 7th Framework Program(European Commission)	European Union Horizon 2020 research and innovation program, Grant/Award Number: 797297; European Union 7th Framework Program, Grant/Award Number: 613979; Spanish Ministry of Science and Innovation, Grant/Award Number: AGL2017-88801-P	Bauer PV, 2018, CELL METAB, V27, P572, DOI 10.1016/j.cmet.2018.01.013; Boets E, 2017, J PHYSIOL-LONDON, V595, P541, DOI 10.1113/JP272613; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Brubaker PL, 2018, COMPR PHYSIOL, V8, P1185, DOI 10.1002/cphy.c170055; Cadaveira-Mosquera A, 2012, J MOL NEUROSCI, V48, P86, DOI 10.1007/s12031-012-9780-y; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cheng YH, 2015, J BIOL CHEM, V290, P14302, DOI 10.1074/jbc.M115.655662; Chimerel C, 2014, CELL REP, V9, P1202, DOI 10.1016/j.celrep.2014.10.032; Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020; Claus SP, 2017, CELL METAB, V26, P6, DOI 10.1016/j.cmet.2017.06.009; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Maesschalck C, 2014, INT J SYST EVOL MICR, V64, P3877, DOI 10.1099/ijs.0.064626-0; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Drucker DJ, 2018, CELL METAB, V27, P740, DOI 10.1016/j.cmet.2018.03.001; Duca FA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21235-y; Duca FA, 2013, J NUTR BIOCHEM, V24, P1663, DOI 10.1016/j.jnutbio.2013.05.005; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Grasset E, 2017, CELL METAB, V25, P1075, DOI 10.1016/j.cmet.2017.04.013; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Krieger JP, 2016, DIABETES, V65, P34, DOI 10.2337/db15-0973; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lewis JE, 2020, DIABETOLOGIA, V63, P1396, DOI 10.1007/s00125-020-05149-w; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liebisch G, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040121; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin CR, 2018, CELL MOL GASTROENTER, V6, P133, DOI 10.1016/j.jcmgh.2018.04.003; Modasia A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.575595; Natividad JM, 2018, CELL METAB, V28, P737, DOI 10.1016/j.cmet.2018.07.001; O'Toole PW, 2017, MICROB BIOTECHNOL, V10, P1066, DOI 10.1111/1751-7915.12752; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Pujo J, 2021, GUT, V70, P1088, DOI 10.1136/gutjnl-2020-321173; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rastelli M, 2019, ENDOCR REV, V40, P1271, DOI 10.1210/er.2018-00280; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rocca AS, 2001, ENDOCRINOLOGY, V142, P1148, DOI 10.1210/en.142.3.1148; Romani-Perez M, 2017, CURR OPIN CLIN NUTR, V20, P484, DOI 10.1097/MCO.0000000000000419; Sandoval D, 2015, MOL CELL ENDOCRINOL, V418, P27, DOI 10.1016/j.mce.2015.02.017; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tsai YL, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-018-0493-6; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wollam J, 2019, DIABETES, V68, P1415, DOI 10.2337/db18-1307; Yang ML, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.28; Zagato E, 2020, NAT MICROBIOL, V5, P511, DOI 10.1038/s41564-019-0649-5	60	7	7	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21734	10.1096/fj.202100126R	http://dx.doi.org/10.1096/fj.202100126R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143451	Green Published			2022-12-28	WOS:000667814100083
J	Howell, KL; Kaji, DA; Li, TMM; Montero, A; Yeoh, K; Nasser, P; Huang, AH				Howell, Kristen L.; Kaji, Deepak A.; Li, Thomas M.; Montero, Angela; Yeoh, Kenji; Nasser, Philip; Huang, Alice H.			Macrophage depletion impairs neonatal tendon regeneration	FASEB JOURNAL			English	Article						macrophages; mouse; regeneration; tendon healing	INCREASES MACROPHAGE; CELL-PROLIFERATION; WOUND SIZE; FETAL; ACCUMULATION; PHENOTYPE; MUSCLE; INJURY; REPAIR; SKIN	Tendons are dense connective tissues that transmit muscle forces to the skeleton. After adult injury, healing potential is generally poor and dominated by scar formation. Although the immune response is a key feature of healing, the specific immune cells and signals that drive tendon healing have not been fully defined. In particular, the immune regulators underlying tendon regeneration are almost completely unknown due to a paucity of tendon regeneration models. Using a mouse model of neonatal tendon regeneration, we screened for immune-related markers and identified upregulation of several genes associated with inflammation, macrophage chemotaxis, and TGF beta signaling after injury. Depletion of macrophages using AP20187 treatment of MaFIA mice resulted in impaired functional healing, reduced cell proliferation, reduced ScxGFP+ neo-tendon formation, and altered tendon gene expression. Collectively, these results show that inflammation is a key component of neonatal tendon regeneration and demonstrate a requirement for macrophages in effective functional healing.	[Howell, Kristen L.; Kaji, Deepak A.; Li, Thomas M.; Montero, Angela; Yeoh, Kenji; Nasser, Philip; Huang, Alice H.] Icahn Sch Med Mt Sinai, Dept Orthopaed, 1 Gustave Levy Pl,Box 1188, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Huang, AH (corresponding author), Icahn Sch Med Mt Sinai, Dept Orthopaed, 1 Gustave Levy Pl,Box 1188, New York, NY 10029 USA.	alice.huang@mssm.edu	Huang, Alice H/L-2256-2015	Huang, Alice H/0000-0002-5037-6829; Li, Thomas/0000-0003-3503-3593; Kaji, Deepak/0000-0002-0470-3219	NIH/NIAMS [R01AR069537, R56AR076984, F31AR073626]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIH/NIAMS, Grant/Award Number: R01AR069537, R56AR076984 and F31AR073626	Abraham AC, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav4319; Ackerman JE, 2019, ELIFE, V8, DOI 10.7554/eLife.45342; Ackerman JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181127; [Anonymous], 2011, US BON JOINT IN BURD, V4th; Arble JR, 2016, CONNECT TISSUE RES, V57, P496, DOI 10.1080/03008207.2016.1213247; Basha S, 2014, EXPERT REV CLIN IMMU, V10, P1171, DOI 10.1586/1744666X.2014.942288; Beason DP, 2012, J BIOMECH, V45, P1550, DOI 10.1016/j.jbiomech.2012.02.022; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Best KT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47461-5; Bevan L, 2020, CARDIOVASC RES, V116, P1357, DOI 10.1093/cvr/cvz221; Blomgran P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12657-0; Blomgran P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29824; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chamberlain CS, 2019, STEM CELLS, V37, P652, DOI 10.1002/stem.2988; Chisari E, 2020, BRIT MED BULL, V133, P49, DOI 10.1093/bmb/ldz040; Dakin SG, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1218-4; de la Durantaye M, 2014, J ORTHOP RES, V32, P279, DOI 10.1002/jor.22504; Debock I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00393; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Godbout C, 2010, J ORTHOP RES, V28, P1084, DOI 10.1002/jor.21092; Godwin JW, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0027-y; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Hays PL, 2008, J BONE JOINT SURG AM, V90A, P565, DOI 10.2106/JBJS.F.00531; Herdrich BJ, 2010, EUR J CARDIO-THORAC, V38, P691, DOI 10.1016/j.ejcts.2010.03.049; Herdrich BJ, 2010, WOUND REPAIR REGEN, V18, P543, DOI 10.1111/j.1524-475X.2010.00615.x; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jomaa G, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-3094-y; Kaji DA, 2020, ELIFE, V9, DOI 10.7554/eLife.51779; Kawamura S, 2005, J ORTHOP RES, V23, P1425, DOI 10.1016/j.orthres.2005.01.014; Kendal AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70786-5; Kurtaliaj I, 2019, JOVE-J VIS EXP, DOI 10.3791/60280; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; LONGAKER MT, 1994, ANN SURG, V219, P65, DOI 10.1097/00000658-199401000-00011; Magnusson SP, 2019, J PHYSIOL-LONDON, V597, P1283, DOI 10.1113/JP275450; Millar NL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27149; Morales RA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00253; Morris MW, 2014, WOUND REPAIR REGEN, V22, P406, DOI 10.1111/wrr.12180; Noah AC, 2020, J APPL PHYSIOL, V128, P473, DOI 10.1152/japplphysiol.00682.2019; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Schoenenberger AD, 2020, BIOMATERIALS, V249, DOI 10.1016/j.biomaterials.2020.120034; Sereysky JB, 2013, INT J EXP PATHOL, V94, P293, DOI 10.1111/iep.12031; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Simoes FC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14263-2; Sugg KB, 2014, J ORTHOP RES, V32, P944, DOI 10.1002/jor.22624; Sunwoo JY, 2020, J ORTHOP RES, V38, P1666, DOI 10.1002/jor.24667; VANROOIJEN N, 1984, CELL TISSUE RES, V238, P355, DOI 10.1007/BF00217308; Walraven M, 2016, WOUND REPAIR REGEN, V24, P533, DOI 10.1111/wrr.12421; Wu CL, 2017, ARTHRITIS RHEUMATOL, V69, P1772, DOI 10.1002/art.40161; Zhang K, 2016, MATRIX BIOL, V52-54, P315, DOI 10.1016/j.matbio.2016.01.015	53	6	6	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21618	10.1096/fj.202100049R	http://dx.doi.org/10.1096/fj.202100049R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33982337	Green Accepted, Green Submitted			2022-12-28	WOS:000655695900019
J	Song, WY; Xin, S; He, M; Pfeiffer, S; Cao, AP; Li, HB; Schick, JA; Jin, X				Song, Wangyang; Xin, Shan; He, Meng; Pfeiffer, Susanne; Cao, Aiping; Li, Hongbin; Schick, Joel A.; Jin, Xiang			Evolutionary and functional analyses demonstrate conserved ferroptosis protection by Arabidopsis GPXs in mammalian cells	FASEB JOURNAL			English	Article						reactive oxygen species; evolution; selenoprotein; thioredoxin; subcellular location	HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; GENOME-WIDE IDENTIFICATION; GENE FAMILY; THIOREDOXIN PEROXIDASE; ANTIOXIDANT ENZYMES; EXPRESSION ANALYSIS; SELENIUM; STRESS; DEATH; CLASSIFICATION	Species have evolved unique mechanisms to combat the effects of oxidative stress inside cells. A particularly devastating consequence of an unhindered oxidation of membrane lipids in the presence of iron results in cell death, known as ferroptosis. Hallmarks of ferroptosis, including peroxidation of polyunsaturated fatty acids, are conserved among animals and plants, however, early divergence of an ancestral mammalian GPX4 (mGPX4) has complicated our understanding of mechanistic similarities between species. To this end, we performed a comprehensive phylogenetic analysis and identified that orthologous Arabidopsis GPXs (AtGPXs) are more highly related to mGPX4 than mGPX4 is to other mammalian GPXs. This high degree of conservation suggested that experimental substitution may be possible. We, therefore, ectopically expressed AtGPX1-8 in ferroptosis-sensitive mouse fibroblasts. This substitution experiment revealed highest protection against ferroptosis induction by AtGPX5, as well as moderate protection by AtGPX2, -7, and -8. Further analysis of these cells revealed substantial abatement of lipid peroxidation in response to pharmacological challenge. The results suggest that the presence of ancestral GPX4 resulted in later functional divergence and specialization of GPXs in plants. The results also challenge a strict requirement for selenocysteine activity and suggest thioredoxin as a potent parallel antioxidant system in both plants and mammals.	[Song, Wangyang; He, Meng; Jin, Xiang] Hainan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Ecol Trop Isl,Key Lab Trop Anim & Plant E, Haikou 571158, Hainan, Peoples R China; [Song, Wangyang; Cao, Aiping; Li, Hongbin; Jin, Xiang] Shihezi Univ, Coll Life Sci, Key Lab Xinjiang Phytomedicine Resource & Utiliza, Minist Educ, Shihezi, Peoples R China; [Xin, Shan; Pfeiffer, Susanne; Schick, Joel A.] Helmholtz Zentrum Munich, Inst Mol Toxicol & Pharmacol, Genet & Cellular Engn Grp, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany	Hainan Normal University; Shihezi University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Jin, X (corresponding author), Hainan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Ecol Trop Isl,Key Lab Trop Anim & Plant E, Haikou 571158, Hainan, Peoples R China.; Schick, JA (corresponding author), Helmholtz Zentrum Munich, Inst Mol Toxicol & Pharmacol, Genet & Cellular Engn Grp, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	joel.schick@helmholtz-muenchen.de; jinx@hainnu.edu.cn	Schick, Joel/ABA-3728-2021	Schick, Joel/0000-0002-8623-4910; Li, Hongbin/0000-0001-5350-7540	National Natural Science Foundation of China (NSFC) [31860068]; International Scientific and Technological Cooperation Project by Shihezi University [GJHZ201708]; Science and Technology Project of Bingtuan [2018AB012]; Helmholtz Zentrum Muenchen GmbH (JAS)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); International Scientific and Technological Cooperation Project by Shihezi University; Science and Technology Project of Bingtuan; Helmholtz Zentrum Muenchen GmbH (JAS)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31860068; International Scientific and Technological Cooperation Project by Shihezi University, Grant/Award Number: GJHZ201708; Science and Technology Project of Bingtuan, Grant/Award Number: 2018AB012; Helmholtz Zentrum Muenchen GmbH (JAS)	Angeli JPF, 2017, TRENDS PHARMACOL SCI, V38, P489, DOI 10.1016/j.tips.2017.02.005; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Attacha S, 2017, PLANT CELL ENVIRON, V40, P1281, DOI 10.1111/pce.12919; Bela K, 2015, J PLANT PHYSIOL, V176, P192, DOI 10.1016/j.jplph.2014.12.014; Burk RF, 2015, ANNU REV NUTR, V35, P109, DOI 10.1146/annurev-nutr-071714-034250; Cardoso BR, 2017, MOL PSYCHIATR, V22, P328, DOI 10.1038/mp.2016.196; Chen MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep44743; Conlon M, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1302906; Dangol S, 2019, PLANT CELL, V31, P189, DOI 10.1105/tpc.18.00535; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Djanaguiraman M, 2005, PLANT SOIL, V272, P77, DOI 10.1007/s11104-004-4039-1; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Gao F, 2014, INT J MOL SCI, V15, P3319, DOI 10.3390/ijms15023319; Gardy JL, 2006, NAT REV MICROBIOL, V4, P741, DOI 10.1038/nrmicro1494; GLADYSHEV VN, 1994, P NATL ACAD SCI USA, V91, P232, DOI 10.1073/pnas.91.1.232; Hazebrouck S, 2000, J BIOL CHEM, V275, P28715, DOI 10.1074/jbc.M004985200; Herbette S, 2002, EUR J BIOCHEM, V269, P2414, DOI 10.1046/j.1432-1033.2002.02905.x; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Ingold I, 2015, J BIOL CHEM, V290, P14668, DOI 10.1074/jbc.M115.656363; Iqbal A, 2006, FEBS J, V273, P5589, DOI 10.1111/j.1742-4658.2006.05548.x; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Kieliszek M, 2015, APPL MICROBIOL BIOT, V99, P5373, DOI 10.1007/s00253-015-6650-x; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; Kraft VAN, 2020, ACS CENTRAL SCI, V6, P41, DOI 10.1021/acscentsci.9b01063; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Llabani E, 2019, NAT CHEM, V11, P521, DOI 10.1038/s41557-019-0261-6; Long JA, 2016, GONDWANA RES, V36, P209, DOI 10.1016/j.gr.2015.10.001; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; Distefano AM, 2017, J CELL BIOL, V216, P463, DOI 10.1083/jcb.201605110; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Passaia G, 2015, PLANT SCI, V234, P22, DOI 10.1016/j.plantsci.2015.01.017; Passaia G, 2014, J EXP BOT, V65, P1403, DOI 10.1093/jxb/ert486; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shen Q, 2020, NEW PHYTOL, V227, P1831, DOI 10.1111/nph.16636; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; White PJ, 2016, ANN BOT-LONDON, V117, P217, DOI 10.1093/aob/mcv180; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang LP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113329	54	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21550	10.1096/fj.202000856R	http://dx.doi.org/10.1096/fj.202000856R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33960023	hybrid			2022-12-28	WOS:000655695900036
J	Padgett, LR; Robertson, MA; Anderson-Baucum, EK; Connors, CT; Wu, WT; Mirmira, RG; Mastracci, TL				Padgett, Leah R.; Robertson, Morgan A.; Anderson-Baucum, Emily K.; Connors, Craig T.; Wu, Wenting; Mirmira, Raghavendra G.; Mastracci, Teresa L.			Deoxyhypusine synthase, an essential enzyme for hypusine biosynthesis, is required for proper exocrine pancreas development	FASEB JOURNAL			English	Article						acinar cells; DHPS; eIF5A; exocrine pancreas; hypusine biosynthesis; mRNA translation; translational regulation	DIABETES-MELLITUS; POSTTRANSLATIONAL SYNTHESIS; TRANSLATION ELONGATION; PROMOTES TRANSLATION; CONTAINING PROTEIN; AMINO-ACID; BETA-CELLS; EIF5A; DIFFERENTIATION; IDENTIFICATION	Pancreatic diseases including diabetes and exocrine insufficiency would benefit from therapies that reverse cellular loss and/or restore cellular mass. The identification of molecular pathways that influence cellular growth is therefore critical for future therapeutic generation. Deoxyhypusine synthase (DHPS) is an enzyme that post-translationally modifies and activates the mRNA translation factor eukaryotic initiation factor 5A (eIF5A). Previous work demonstrated that the inhibition of DHPS impairs zebrafish exocrine pancreas development; however, the link between DHPS, eIF5A, and regulation of pancreatic organogenesis remains unknown. Herein we identified that the conditional deletion of either Dhps or Eif5a in the murine pancreas results in the absence of acinar cells. Because DHPS catalyzes the activation of eIF5A, we evaluated and uncovered a defect in mRNA translation concomitant with defective production of proteins that influence cellular development. Our studies reveal a heretofore unappreciated role for DHPS and eIF5A in the synthesis of proteins required for cellular development and function.	[Padgett, Leah R.; Anderson-Baucum, Emily K.; Mastracci, Teresa L.] Indiana Biosci Res Inst, Indianapolis, IN USA; [Robertson, Morgan A.; Connors, Craig T.; Mastracci, Teresa L.] Indiana Univ Purdue Univ Indianapolis, Dept Biol, 723 W Michigan St,SL 306, Indianapolis, IN 46202 USA; [Wu, Wenting; Mirmira, Raghavendra G.; Mastracci, Teresa L.] Indiana Univ, Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN USA; [Wu, Wenting] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.; Mastracci, Teresa L.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Univ Chicago, Kovler Diabet Ctr, Chicago, IL 60637 USA; [Mirmira, Raghavendra G.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Chicago; University of Chicago	Mastracci, TL (corresponding author), Indiana Univ Purdue Univ Indianapolis, Dept Biol, 723 W Michigan St,SL 306, Indianapolis, IN 46202 USA.	tmastrac@iu.edu		Mastracci, Teresa L./0000-0003-1956-1951	Juvenile Diabetes Research Foundation International (JDRF) [5-CDA-2016-194-A-N]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01DK121987-01A1]	Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Juvenile Diabetes Research Foundation International (JDRF), Grant/Award Number: 5--CDA--2016--194--A--N; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: 1R01DK121987--01A1	Accili D, 2016, DIABETES OBES METAB, V18, P117, DOI 10.1111/dom.12723; Bergeron RJ, 1998, J MED CHEM, V41, P3901, DOI 10.1021/jm980390o; Campbell-Thompson M, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0653-y; Castro-Gutierrez R, 2018, CURR OPIN ENDOCRINOL, V25, P251, DOI 10.1097/MED.0000000000000418; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Cleveland MH, 2012, SEMIN CELL DEV BIOL, V23, P711, DOI 10.1016/j.semcdb.2012.06.008; Colvin SC, 2013, J BIOL CHEM, V288, P36226, DOI 10.1074/jbc.M113.473942; Das SLM, 2014, GUT, V63, P818, DOI 10.1136/gutjnl-2013-305062; Dominguez-Munoz JE, 2018, CURR OPIN GASTROEN, V34, P349, DOI 10.1097/MOG.0000000000000459; Ganapathi M, 2019, AM J HUM GENET, V104, P287, DOI 10.1016/j.ajhg.2018.12.017; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hart PA, 2016, LANCET GASTROENTEROL, V1, P226, DOI 10.1016/S2468-1253(16)30106-6; Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Levasseur EM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax0715; Li X, 2017, DIABETES CARE, V40, P577, DOI 10.2337/dc16-1774; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandal A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25795; Mastracci TL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230627; Mastracci TL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13269; Mastracci TL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003278; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Nair GG, 2019, NAT CELL BIOL, V21, P263, DOI 10.1038/s41556-018-0271-4; Nishiki Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-421; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Olesen HV, 2020, J CYST FIBROS, V19, P321, DOI 10.1016/j.jcf.2019.10.009; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Raman VS, 2011, J PEDIATR-US, V158, P612, DOI 10.1016/j.jpeds.2010.09.066; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sambathkumar R, 2018, PHYSIOLOGY, V33, P394, DOI 10.1152/physiol.00026.2018; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Sneddon JB, 2018, CELL STEM CELL, V22, P810, DOI 10.1016/j.stem.2018.05.016; Templin AT, 2011, CELL CYCLE, V10, P1043, DOI 10.4161/cc.10.7.15206; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; TORRELIO BM, 1987, BIOCHEM BIOPH RES CO, V145, P1335, DOI 10.1016/0006-291X(87)91584-1; Uc A, 2016, PANCREAS, V45, P1365, DOI 10.1097/MPA.0000000000000713; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0	46	7	7	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21473	10.1096/fj.201903177R	http://dx.doi.org/10.1096/fj.201903177R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811703	Green Published, hybrid			2022-12-28	WOS:000645260100016
J	Vann, CG; Morton, RW; Mobley, CB; Vechetti, IJ; Ferguson, BK; Haun, CT; Osburn, SC; Sexton, CL; Fox, CD; Romero, MA; Roberson, PA; Oikawa, SY; McGlory, C; Young, KC; McCarthy, JJ; Phillips, SM; Roberts, MD				Vann, Christopher G.; Morton, Robert W.; Mobley, Christopher B.; Vechetti, Ivan J.; Ferguson, Brian K.; Haun, Cody T.; Osburn, Shelby C.; Sexton, Casey L.; Fox, Carlton D.; Romero, Matthew A.; Roberson, Paul A.; Oikawa, Sara Y.; McGlory, Chris; Young, Kaelin C.; McCarthy, John J.; Phillips, Stuart M.; Roberts, Michael D.			An intron variant of the GLI family zinc finger 3 (GLI3) gene differentiates resistance training-induced muscle fiber hypertrophy in younger men	FASEB JOURNAL			English	Article						GLI3; hypertrophy; polymorphisms; skeletal muscle	MAXIMAL O-2 UPTAKE; SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; STRENGTH RESPONSE; POLYMORPHISMS; EXERCISE; GENOTYPE; ACTN3; PHENOTYPES	We examined the association between genotype and resistance training-induced changes (12 wk) in dual x--ray energy absorptiometry (DXA)-derived lean soft tissue mass (LSTM) as well as muscle fiber cross-sectional area (fCSA; vastus lateralis; n = 109; age = 22 +/- 2 y, BMI = 24.7 +/- 3.1 kg/m(2)). Over 315 000 genetic polymorphisms were interrogated from muscle using DNA microarrays. First, a targeted investigation was performed where single nucleotide polymorphisms (SNP) identified from a systematic literature review were related to changes in LSTM and fCSA. Next, genome-wide association (GWA) studies were performed to reveal associations between novel SNP targets with pre-to post-training change scores in mean fCSA and LSTM. Our targeted investigation revealed no genotype-by-time interactions for 12 common polymorphisms regarding the change in mean fCSA or change in LSTM. Our first GWA study indicated no SNP were associated with the change in LSTM. However, the second GWA study indicated two SNP exceeded the significance level with the change in mean fCSA (P = 6.9 x 10(-7) for rs4675569, 1.7 x 10(-6) for rs10263647). While the former target is not annotated (chr2:205936846 (GRCh38.p12)), the latter target (chr7:41971865 (GRCh38.p12)) is an intron variant of the GLI Family Zinc Finger 3 (GLI3) gene. Follow-up analyses indicated fCSA increases were greater in the T/C and C/C GLI3 genotypes than the T/T GLI3 genotype (P < .05). Data from the Auburn cohort also revealed participants with the T/C and C/C genotypes exhibited increases in satellite cell number with training (P < .05), whereas T/T participants did not. Additionally, those with the T/C and C/C genotypes achieved myonuclear addition in response to training (P < .05), whereas the T/T participants did not. In summary, this is the first GWA study to examine how polymorphisms associate with the change in hypertrophy measures following resistance training. Future studies are needed to determine if the GLI3 variant differentiates hypertrophic responses to resistance training given the potential link between this gene and satellite cell physiology.	[Vann, Christopher G.; Ferguson, Brian K.; Osburn, Shelby C.; Sexton, Casey L.; Fox, Carlton D.; Romero, Matthew A.; Roberson, Paul A.; Young, Kaelin C.; Roberts, Michael D.] Auburn Univ, Sch Kinesiol, 301 Wire Rd,Off 260, Auburn, AL 36849 USA; [Vann, Christopher G.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Morton, Robert W.; Oikawa, Sara Y.; McGlory, Chris; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Mobley, Christopher B.; McCarthy, John J.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Mobley, Christopher B.; McCarthy, John J.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA; [Vechetti, Ivan J.] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA; [Haun, Cody T.] Fitomics LLC, Birmingham, AL USA; [Young, Kaelin C.; Roberts, Michael D.] Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn, AL USA	Auburn University System; Auburn University; Duke University; McMaster University; University of Kentucky; University of Kentucky; University of Nebraska System; University of Nebraska Lincoln	Roberts, MD (corresponding author), Auburn Univ, Sch Kinesiol, 301 Wire Rd,Off 260, Auburn, AL 36849 USA.; Roberts, MD (corresponding author), Auburn Univ, Mol & Appl Sci Lab, 301 Wire Rd,Off 260, Auburn, AL 36849 USA.; Roberts, MD (corresponding author), Auburn Univ, Appl Physiol Lab, 301 Wire Rd,Off 260, Auburn, AL 36849 USA.	mdr0024@auburn.edu	Vechetti, Ivan/C-5406-2012; Morton, Robert/J-8906-2018; Phillips, Stuart/B-2343-2009	Vechetti, Ivan/0000-0003-1024-1011; Morton, Robert/0000-0003-0099-4167; Phillips, Stuart/0000-0002-1956-4098	Auburn University (AU); Natural Science and Engineering Research Council of Canada; Office of Extramural Research, National Institutes of Health (OER) [R01AG054840, F32DK126312]	Auburn University (AU); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Office of Extramural Research, National Institutes of Health (OER)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Auburn University (AU); Natural Science and Engineering Research Council of Canada; Office of Extramural Research, National Institutes of Health (OER), Grant/Award Number: R01AG054840 and F32DK126312	Antonio J, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0307-6; Ash GI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148112; Bea JW, 2010, BEHAV GENET, V40, P649, DOI 10.1007/s10519-010-9361-1; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Chaillou T, 2013, J APPL PHYSIOL, V115, P1065, DOI 10.1152/japplphysiol.00611.2013; Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Damas F, 2018, EUR J APPL PHYSIOL, V118, P2607, DOI 10.1007/s00421-018-3984-y; Delmonico MJ, 2007, J GERONTOL A-BIOL, V62, P206, DOI 10.1093/gerona/62.2.206; Devaney JM, 2009, J CELL BIOCHEM, V107, P1073, DOI 10.1002/jcb.22209; Erskine RM, 2014, SCAND J MED SCI SPOR, V24, P642, DOI 10.1111/sms.12055; Erskine RM, 2012, J APPL PHYSIOL, V112, P1329, DOI 10.1152/japplphysiol.01137.2011; Fu L, 2016, ELIFE, V5, DOI 10.7554/eLife.15690; Gacesa JZP, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-217; Gineviciene V, 2016, BIOL SPORT, V33, P199, DOI 10.5604/20831862.1201051; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Hand BD, 2007, J APPL PHYSIOL, V103, P1678, DOI 10.1152/japplphysiol.00420.2007; Harmon BT, 2010, J APPL PHYSIOL, V109, P1779, DOI 10.1152/japplphysiol.00633.2010; Haun CT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00247; Haun CT, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00084; He LX, 2019, MENOPAUSE, V26, P899, DOI 10.1097/GME.0000000000001364; Hoffman EP, 2013, MED SCI SPORT EXER, V45, P1060, DOI 10.1249/MSS.0b013e31828093c1; Hong AR, 2014, J SPORT SCI MED, V13, P680; Ivey FM, 2000, J GERONTOL A-BIOL, V55, pM641, DOI 10.1093/gerona/55.11.M641; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Keogh Justin W L, 2015, PeerJ, V3, pe980, DOI 10.7717/peerj.980; Kephart WC, 2016, AMINO ACIDS, V48, P779, DOI 10.1007/s00726-015-2125-8; Klimentidis YC, 2015, INT J OBESITY, V39, P1371, DOI 10.1038/ijo.2015.78; Kostek MA, 2009, MED SCI SPORT EXER, V41, P1063, DOI 10.1249/MSS.0b013e3181930337; Kostek MC, 2005, J APPL PHYSIOL, V98, P2147, DOI 10.1152/japplphysiol.00817.2004; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Lavin KM, 2019, PHYSIOLOGY, V34, P112, DOI 10.1152/physiol.00044.2018; Li X, 2014, J SPORT SCI, V32, P883, DOI 10.1080/02640414.2013.865252; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054685; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Mobley CB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090972; Mobley CB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195203; Morton RW, 2016, J APPL PHYSIOL, V121, P129, DOI 10.1152/japplphysiol.00154.2016; Murakami SI, 2009, INT J MOL MED, V23, P81, DOI 10.3892/ijmm_00000104; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; Orkunoglu-Suer FE, 2011, OBESITY, V19, P662, DOI 10.1038/oby.2010.180; Orkunoglu-Suer FE, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-117; Pereira A, 2013, AGE, V35, P1949, DOI 10.1007/s11357-012-9461-3; Pescatello LS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/643575; Pescatello LS, 2006, MED SCI SPORT EXER, V38, P1074, DOI 10.1249/01.mss.0000222835.28273.80; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rankinen T, 2010, OBESITY, V18, P322, DOI 10.1038/oby.2009.205; Renault MA, 2013, CIRC RES, V113, P1148, DOI 10.1161/CIRCRESAHA.113.301546; Riechman SE, 2004, J APPL PHYSIOL, V97, P2214, DOI 10.1152/japplphysiol.00491.2004; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roberts MD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00834; Schalk A, 2018, EUR J HUM GENET, V26, P527, DOI 10.1038/s41431-017-0009-y; Sprouse C, 2014, DIABETES, V63, P363, DOI 10.2337/db13-1150; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Thompson PD, 2004, MED SCI SPORT EXER, V36, P1132, DOI 10.1249/01.MSS.0000132274.26612.23; Van Deveire KN, 2012, J STRENGTH COND RES, V26, P1740, DOI 10.1519/JSC.0b013e31825c2bef; Walsh S, 2012, GENE, V510, P66, DOI 10.1016/j.gene.2012.08.020; Walsh S, 2009, J APPL PHYSIOL, V107, P1235, DOI 10.1152/japplphysiol.90835.2008; Yoo J, 2016, EUR J APPL PHYSIOL, V116, P947, DOI 10.1007/s00421-016-3353-7	62	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21587	10.1096/fj.202100113RR	http://dx.doi.org/10.1096/fj.202100113RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33891350	Green Published, hybrid			2022-12-28	WOS:000645260100038
J	Voigt, AL; Kondro, DA; Powell, D; Valli-Pulaski, H; Ungrin, M; Stukenborg, JB; Klein, C; Lewis, IA; Orwig, KE; Dobrinski, I				Voigt, Anna Laura; Kondro, Douglas Andrew; Powell, Diana; Valli-Pulaski, Hanna; Ungrin, Mark; Stukenborg, Jan-Bernd; Klein, Claudia; Lewis, Ian A.; Orwig, Kyle E.; Dobrinski, Ina			Unique metabolic phenotype and its transition during maturation of juvenile male germ cells	FASEB JOURNAL			English	Article						maturation; metabolism; prepubertal spermatogonia; reactive oxygen species	SPERMATOGONIAL STEM-CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-S; ENERGY-METABOLISM; SELF-RENEWAL; MITOCHONDRIAL BIOGENESIS; FERTILITY PRESERVATION; POSTNATAL-DEVELOPMENT; SEMINIFEROUS TUBULES; ANTIOXIDANT ENZYMES; RESTORES FERTILITY	Human male reproductive development has a prolonged prepubertal period characterized by juvenile quiescence of germ cells with immature spermatogonial stem cell (SSC) precursors (gonocytes) present in the testis for an extended period of time. The metabolism of gonocytes is not defined. We demonstrate with mitochondrial ultrastructure studies via TEM and IHC and metabolic flux studies with UHPLC-MS that a distinct metabolic transition occurs during the maturation to SSCs. The mitochondrial ultrastructure of prepubertal human spermatogonia is shared with prepubertal pig spermatogonia. The metabolism of early prepubertal porcine spermatogonia (gonocytes) is characterized by the reliance on OXPHOS fuelled by oxidative decarboxylation of pyruvate. Interestingly, at the same time, a high amount of the consumed pyruvate is also reduced and excreted as lactate. With maturation, prepubertal spermatogonia show a metabolic shift with decreased OXHPOS and upregulation of the anaerobic metabolism-associated uncoupling protein 2 (UCP2). This shift is accompanied with stem cell specific promyelocytic leukemia zinc finger protein (PLZF) protein expression and glial cell-derived neurotropic factor (GDNF) pathway activation. Our results demonstrate that gonocytes differently from mature spermatogonia exhibit unique metabolic demands that must be attained to enable their maintenance and growth in vitro.	[Voigt, Anna Laura; Kondro, Douglas Andrew; Powell, Diana; Ungrin, Mark; Klein, Claudia; Dobrinski, Ina] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada; [Valli-Pulaski, Hanna; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA USA; [Stukenborg, Jan-Bernd] Karolinska Inst, Dept Womens & Childrens Hlth, NORDFERTIL Res Lab Stockholm, Childhood Canc Res Unit, Solna, Sweden; [Stukenborg, Jan-Bernd] Karolinska Univ Hosp, Solna, Sweden; [Lewis, Ian A.] Univ Calgary, Fac Sci, Dept Biol Sci, Calgary, AB, Canada	University of Calgary; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Calgary	Dobrinski, I (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Dept Biochem & Mol Biol,Cumming Sch Med, 404 HMRB,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	Idobrins@ucalgary.ca		Dobrinski, Ina/0000-0002-0695-2606; Ungrin, Mark/0000-0002-7410-1491; Valli-Pulaski, Hanna/0000-0001-8092-0066; Voigt, Anna Laura/0000-0003-3970-6011; Stukenborg, Jan-bernd/0000-0002-2839-1870	HHS vertical bar National Institutes of Health (NIH) [OD016575, HD092084]; Barncancerfonden (Swedish Childhood Cancer Foundation) [TJ2020-0026, PR2019-0123]	HHS vertical bar National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barncancerfonden (Swedish Childhood Cancer Foundation)	HHS broken vertical bar National Institutes of Health (NIH), Grant/Award Number: OD016575 and HD092084; Barncancerfonden (Swedish Childhood Cancer Foundation), Grant/Award Number: TJ2020-0026,PR2019-0123	Al-Ani A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204269; Barton LJ, 2016, CURR OPIN CELL BIOL, V42, P128, DOI 10.1016/j.ceb.2016.07.007; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Boussouar F, 2014, ANDROLOGY-US, V2, P351, DOI 10.1111/j.2047-2927.2014.00184.x; Brinster RL, 1998, SEMIN CELL DEV BIOL, V9, P401, DOI 10.1006/scdb.1998.0205; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; Butcher L, 1998, BIOL REPROD, V58, P1054, DOI 10.1095/biolreprod58.4.1054; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Lopez KGDC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01373; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; David S, 2020, UROL CLIN N AM, V47, P227, DOI 10.1016/j.ucl.2020.01.001; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eguizabal C, 2016, STEM CELLS, V34, P2418, DOI 10.1002/stem.2422; Fillmore N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120257; Flores A, 2017, NAT CELL BIOL, V19, P1017, DOI 10.1038/ncb3575; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Foster DL, 2015, KNOBIL NEILLS PHYSL, V2, DOI [10.1016/B978-0-12-397175-3.00031-4, DOI 10.1016/B978-0-12-397175-3.00031-4]; Franca LR, 2000, BIOL REPROD, V63, P1629, DOI 10.1095/biolreprod63.6.1629; Galetzka D, 2007, MOL REPROD DEV, V74, P233, DOI 10.1002/mrd.20615; Godmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012727; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; Goossens E, 2020, HUM REPROD OPEN, V2020, DOI 10.1093/hropen/hoaa016; Green DM, 2017, HUM REPROD, V32, P1192, DOI 10.1093/humrep/dex082; Grumbach MM, 2002, HORM RES, V57, P2, DOI 10.1159/000058094; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Harvey A, 2019, STEM CELL REP, V13, P573, DOI 10.1016/j.stemcr.2019.09.003; Hayashi Y, 2017, P NATL ACAD SCI USA, V114, P8289, DOI 10.1073/pnas.1620915114; Helsel AR, 2017, STEM CELL REP, V8, P1430, DOI 10.1016/j.stemcr.2017.03.004; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hermann BP, 2012, CELL STEM CELL, V11, P715, DOI 10.1016/j.stem.2012.07.017; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Honaramooz A, 2002, BIOL REPROD, V66, P21, DOI 10.1095/biolreprod66.1.21; Honaramooz A, 2003, BIOL REPROD, V69, P1260, DOI 10.1095/biolreprod.103.018788; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Ito K, 2018, EXP HEMATOL, V64, P1, DOI 10.1016/j.exphem.2018.05.005; Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225; Johnson MT, 2003, J BIOL CHEM, V278, P31457, DOI 10.1074/jbc.R300002200; JUTTE NHPM, 1983, J REPROD FERTIL, V68, P219, DOI 10.1530/jrf.0.0680219; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2016, GENE DEV, V30, P2637, DOI 10.1101/gad.287045.116; Kanatsu-Shinohara M, 2011, BIOL REPROD, V84, P97, DOI 10.1095/biolreprod.110.086462; Kollin C, 2012, J CLIN ENDOCR METAB, V97, P4588, DOI 10.1210/jc.2012-2325; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KOSCO MS, 1989, J REPROD FERTIL, V87, P1, DOI 10.1530/jrf.0.0870001; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; LEGAC F, 1983, ARCH ANDROLOGY, V10, P149; Levine J, 2010, J CLIN ONCOL, V28, P4831, DOI 10.1200/JCO.2009.22.8312; Li XL, 2017, ONCOTARGET, V8, P46363, DOI 10.18632/oncotarget.18199; Lord T, 2020, DEV CELL, V52, P399, DOI 10.1016/j.devcel.2020.01.014; Lu V, 2019, EMBO J, V38, DOI 10.15252/embj.2018100615; Manku G, 2015, REPRODUCTION, V149, pR139, DOI 10.1530/REP-14-0431; Mauduit C, 1999, HUM REPROD UPDATE, V5, P535, DOI 10.1093/humupd/5.5.535; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mikedis MM, 2020, ELIFE, V9, DOI 10.7554/eLife.56523; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morimoto H, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900374; Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001; Motta P M, 2000, Hum Reprod, V15 Suppl 2, P129; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NAKAMURA M, 1982, J BIOL CHEM, V257, P3945; NAKAMURA M, 1984, AM J PHYSIOL, V247, pE234, DOI 10.1152/ajpendo.1984.247.2.E234; NOVI AM, 1968, Z ZELLFORSCH MIK ANA, V86, P313, DOI 10.1007/BF00332472; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Oliveira PF, 2015, MED RES REV, V35, P126, DOI 10.1002/med.21325; Oliveira PF, 2015, SERTOLI CELL METABOL, P41, DOI [10.1007/978-3-319-19791-3, DOI 10.1007/978-3-319-19791-3]; PANIAGUA R, 1984, J ANAT, V139, P535; PANIAGUA R, 1985, J ANAT, V143, P201; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Picut CA, 2018, BIRTH DEFECTS RES, V110, P190, DOI 10.1002/bdr2.1133; Pietila M, 2012, STEM CELLS DEV, V21, P575, DOI 10.1089/scd.2011.0023; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; Plant TM., 2015, KNOBIL NEILLS PHYSL, P1487, DOI DOI 10.1016/B978-0-12-397175-3.00032-6; Poganitsch-Korhonen M, 2017, LEUKEMIA, V31, P1460, DOI 10.1038/leu.2017.76; Pui HP, 2017, MECH DEVELOP, V144, P125, DOI 10.1016/j.mod.2017.03.002; Puszyk W, 2013, EMBO J, V32, P1941, DOI 10.1038/emboj.2013.118; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; Richardson TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006308; Ryall JG, 2015, CELL STEM CELL, V17, P651, DOI 10.1016/j.stem.2015.11.012; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sakib S, 2019, JOVE-J VIS EXP, DOI 10.3791/60387; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Simkins C. L., 1923, Acta Zoologica Stockholm, V4, P241; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Snyder EM, 2010, BIOL REPROD, V83, P783, DOI 10.1095/biolreprod.110.085811; Sohni A, 2019, CELL REP, V26, P1501, DOI 10.1016/j.celrep.2019.01.045; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Stukenborg JB, 2018, HUM REPROD, V33, P1677, DOI 10.1093/humrep/dey240; Sun YC, 2017, ONCOTARGET, V8, P57836, DOI 10.18632/oncotarget.18444; Tang L, 2018, MOL REPROD DEV, V85, P250, DOI 10.1002/mrd.22961; Tischler J, 2019, EMBO J, V38, DOI 10.15252/embj.201899518; TRAN D, 1981, BIOL REPROD, V24, P923, DOI 10.1095/biolreprod24.4.923; Trisciuoglio D, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8908751; Tsogtbaatar E, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00087; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wang XL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020399; Wang XL, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700478; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Zagore LL, 2018, CELL REP, V25, P1225, DOI 10.1016/j.celrep.2018.10.012; Zeng Y, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040257; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	128	9	10	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21513	10.1096/fj.202002799R	http://dx.doi.org/10.1096/fj.202002799R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811704	Green Accepted			2022-12-28	WOS:000645260100008
J	Castro-Sepulveda, M; Fernandez-Verdejo, R; Tunon-Suarez, M; Morales-Zuniga, J; Troncoso, M; Jannas-Vela, S; Zbinden-Foncea, H				Castro-Sepulveda, Mauricio; Fernandez-Verdejo, Rodrigo; Tunon-Suarez, Mauro; Morales-Zuniga, Jorge; Troncoso, Mayarling; Jannas-Vela, Sebastian; Zbinden-Foncea, Hermann			Low abundance of Mfn2 protein correlates with reduced mitochondria-SR juxtaposition and mitochondrial cristae density in human men skeletal muscle: Examining organelle measurements from TEM images	FASEB JOURNAL			English	Article						MICOS complex; mitochondria dynamics; organelle communication; repeatability; reproducibility; transmission electron microscopy		The role of mitofusin 2 (Mfn2) in the regulation of skeletal muscle (SM) mitochondria-sarcoplasmic (SR) juxtaposition, mitochondrial morphology, mitochondrial cristae density (MCD), and SM quality has not been studied in humans. In in vitro studies, whether Mfn2 increases or decreases mitochondria-SR juxtaposition remains controversial. Transmission electron microscopy (TEM) images are commonly used to measure the organelle juxtaposition, but the measurements are performed "by-hand," thus potentially leading to between-rater differences. The purposes of this study were to: (1) examine the repeatability and reproducibility of mitochondrial-SR juxtaposition measurement from TEM images of human SM between three raters with different experience and (2) compare the mitochondrial-SR juxtaposition, mitochondrial morphology, MCD (stereological-method), and SM quality (cross-sectional area [CSA] and the maximum voluntary contraction [MVC]) between subjects with high abundance (Mfn2-HA; n = 6) and low abundance (Mfn2-LA; n = 6) of Mfn2 protein. The mitochondria-SR juxtaposition had moderate repeatability and reproducibility, with the most experienced raters showing the best values. There were no differences between Mfn2-HA and Mfn2-LA groups in mitochondrial size, distance from mitochondria to SR, CSA, or MVC. Nevertheless, the Mfn2-LA group showed lower mitochondria-SR interaction, MCD, and VO2max. In conclusion, mitochondrial-SR juxtaposition measurement depends on the experience of the rater, and Mfn2 protein seems to play a role in the metabolic control of human men SM, by regulating the mitochondria-SR interaction.	[Castro-Sepulveda, Mauricio; Tunon-Suarez, Mauro; Jannas-Vela, Sebastian; Zbinden-Foncea, Hermann] Univ Finis Terrae, Fac Med, Escuela Kinesiol, Santiago, Chile; [Castro-Sepulveda, Mauricio] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Fernandez-Verdejo, Rodrigo] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Nutr & Dietet, Santiago, Chile; [Morales-Zuniga, Jorge] Clin Sports Med Deport, Lab Ciencias Deporte, Vina Del Mar, Chile; [Troncoso, Mayarling] Univ Chile, Fac Chem & Pharmaceut Sci, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Troncoso, Mayarling] Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Zbinden-Foncea, Hermann] Ctr Salud Deport, Clin Santa Maria, Santiago, Chile	Universidad Finis Terrae; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile	Castro-Sepulveda, M; Zbinden-Foncea, H (corresponding author), Univ Finis Terrae, Fac Med, Escuela Kinesiol, Santiago, Chile.; Castro-Sepulveda, M; Zbinden-Foncea, H (corresponding author), Av Pedro Valdivia 1509, Providencia, Chile.	mcastro@uft.cl; hzbinden@uft.cl		Fernandez-Verdejo, Rodrigo/0000-0002-5948-2281	Universidad Finis Terrae [CAI 2019]	Universidad Finis Terrae	This study was funded by Research Grant awarded to MCS by Universidad Finis Terrae (Grant no. CAI 2019)	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Arribat Y, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13179; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Castro-Sepulveda M, 2020, AM J PHYSIOL-ENDOC M, V318, pE848, DOI 10.1152/ajpendo.00025.2020; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Cieri D, 2018, CELL DEATH DIFFER, V25, P1131, DOI 10.1038/s41418-017-0033-z; Csordas G, 2018, TRENDS CELL BIOL, V28, P523, DOI 10.1016/j.tcb.2018.02.009; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; del Campo A, 2018, AGING-US, V10, P34, DOI 10.18632/aging.101358; Distefano G, 2017, J GERONTOL A-BIOL, V72, P535, DOI 10.1093/gerona/glw102; Echeverria F, 2021, BRIT J NUTR, V126, P825, DOI 10.1017/S000711452000481X; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Faustini G, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4246350; Fernandez-Verdejo R, 2020, OBESITY, V28, P1110, DOI 10.1002/oby.22783; Fernandez-Verdejo R, 2018, AM J PHYSIOL-ENDOC M, V315, pE715, DOI 10.1152/ajpendo.00126.2018; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Filadi R, 2017, P NATL ACAD SCI USA, V114, pE2266, DOI 10.1073/pnas.1616040114; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Galgani JE, 2021, OBES REV, V22, DOI 10.1111/obr.13131; Huang TY, 2019, METABOLISM, V98, P53, DOI 10.1016/j.metabol.2019.06.009; Hernandez-Alvarez MI, 2019, CELL, V177, P881, DOI 10.1016/j.cell.2019.04.010; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; Kalkhoran SB, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13437; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Mingrone G, 2005, DIABETOLOGIA, V48, P2108, DOI 10.1007/s00125-005-1918-9; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Nielsen J, 2017, J PHYSIOL-LONDON, V595, P2839, DOI 10.1113/JP273040; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE986, DOI 10.1152/ajpendo.00399.2006; Penailillo L, 2020, J STRENGTH COND RES, V34, P2895, DOI 10.1519/JSC.0000000000002732; Puri R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11636-5; Sebastian D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084; Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111; Sugiura A, 2017, NATURE, V542, P251, DOI 10.1038/nature21375; Tubbs E, 2018, DIABETES, V67, P636, DOI 10.2337/db17-0316; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Yang RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep07990	38	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21553	10.1096/fj.202002615RR	http://dx.doi.org/10.1096/fj.202002615RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749943				2022-12-28	WOS:000635216100050
J	Karki, P; Cha, BY; Zhang, CO; Li, Y; Ke, YB; Promnares, K; Kaibuchi, K; Yoshimura, A; Birukov, KG; Birukova, AA				Karki, Pratap; Cha, Boyoung; Zhang, Chen-Ou; Li, Yue; Ke, Yunbo; Promnares, Kamoltip; Kaibuchi, Kozo; Yoshimura, Akihiko; Birukov, Konstantin G.; Birukova, Anna A.			Microtubule-dependent mechanism of anti-inflammatory effect of SOCS1 in endothelial dysfunction and lung injury	FASEB JOURNAL			English	Article						cytoskeleton; endothelial permeability; inflammation; lung injury; microtubules; vascular endothelium		Suppressors of cytokine signaling (SOCS) provide negative regulation of inflammatory reaction. The role and precise cellular mechanisms of SOCS1 in control of endothelial dysfunction and barrier compromise associated with acute lung injury remain unexplored. Our results show that siRNA-mediated SOCS1 knockdown augmented lipopolysaccharide (LPS)-induced pulmonary endothelial cell (EC) permeability and enhanced inflammatory response. Consistent with in vitro data, EC-specific SOCS1 knockout mice developed more severe lung vascular leak and accumulation of inflammatory cells in bronchoalveolar lavage fluid. SOCS1 overexpression exhibited protective effects against LPS-induced endothelial permeability and inflammation, which were dependent on microtubule (MT) integrity. Biochemical and image analysis of unstimulated EC showed SOCS1 association with the MT, while challenge with LPS or MT depolymerizing agent colchicine impaired this association. SOCS1 directly interacted with N2 domains of MT-associated proteins CLIP-170 and CLASP2. Furthermore, N-terminal region of SOCS1 was indispensable for these interactions and SOCS1-Delta N mutant lacking N-terminal 59 amino acids failed to rescue LPS-induced endothelial dysfunction. Depletion of endogenous CLIP-170 or CLASP2 abolished SOCS1 interaction with Toll-like receptor-4 and Janus kinase-2 leading to impairment of SOCS1 inhibitory effects on LPS-induced inflammation. Altogether, these findings suggest that endothelial barrier protective and anti-inflammatory effects of SOCS1 are critically dependent on its targeting to the MT.	[Karki, Pratap; Zhang, Chen-Ou; Li, Yue; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Cha, Boyoung; Ke, Yunbo; Promnares, Kamoltip; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Nagoya, Aichi, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Tokyo, Japan	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nagoya University; Keio University	Birukova, AA (corresponding author), Univ Maryland, Sch Med, Dept Med, UMSOM Lung Biol Program, 20 Penn St,HSF-2,Room S143, Baltimore, MD 21201 USA.	abirukova@som.umaryland.edu	Birukov, Konstantin/FJB-5755-2022		HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI) [HL107920, HL130431, HL076259, HL087823]; HHS, NIH, National Institute of General Medical Sciences (NIGMS) [GM114171]; JSPS KAKENHI (S) [JP17H06175]; AMED-CREST JP [20GM1110009, JP18H05376]; Challenging Research (P) [JP18H05376]	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI); HHS, NIH, National Institute of General Medical Sciences (NIGMS); JSPS KAKENHI (S)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED-CREST JP; Challenging Research (P)	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL107920, HL130431, HL076259 and HL087823; HHS, NIH, National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM114171; JSPS KAKENHI (S), Grant/Award Number: JP17H06175; AMED-CREST JP, Grant/Award Number: 20GM1110009; Challenging Research (P), Grant/Award Number: JP18H05376	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Alieva IB, 2014, BIOCHEMISTRY-MOSCOW+, V79, P964, DOI 10.1134/S0006297914090119; Alieva IB, 2013, J CELL BIOCHEM, V114, P2258, DOI 10.1002/jcb.24575; Baig MS, 2015, J EXP MED, V212, P1725, DOI 10.1084/jem.20140654; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galam L, 2016, ONCOTARGET, V7, P29081, DOI 10.18632/oncotarget.8543; GOLDBLUM SE, 1989, INFECT IMMUN, V57, P1218, DOI 10.1128/IAI.57.4.1218-1226.1989; GRESSER I, 1981, J IMMUNOL, V127, P1569; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Higginbotham K, 2014, CELL SIGNAL, V26, P2306, DOI 10.1016/j.cellsig.2014.07.032; Horvath Curt M, 2004, Sci STKE, V2004, ptr9, DOI 10.1126/stke.2602004tr9; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Karki P, 2019, J BIOL CHEM, V294, P3369, DOI 10.1074/jbc.RA118.004030; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krebs DL, 2000, J CELL SCI, V113, P2813; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Linossi EM, 2012, IUBMB LIFE, V64, P316, DOI 10.1002/iub.1011; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakashima T, 2008, J ALLERGY CLIN IMMUN, V121, P1269, DOI 10.1016/j.jaci.2008.02.003; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Oda M, 2000, CLIN HEMORHEOL MICRO, V23, P199; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Tian XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105912; Tian XY, 2012, FASEB J, V26, P3862, DOI 10.1096/fj.12-207746; Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Wang W, 2016, AM J PHYSIOL-LUNG C, V311, pL494, DOI 10.1152/ajplung.00001.2016; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshida T, 2004, J EXP MED, V199, P1701, DOI 10.1084/jem.20031675; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhang LF, 2018, INFLAMMATION, V41, P1557, DOI 10.1007/s10753-018-0802-y	61	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21388	10.1096/fj.202001477RR	http://dx.doi.org/10.1096/fj.202001477RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724556				2022-12-28	WOS:000635216100044
J	Meng, LK; Yuan, W; Chi, HJ; Han, RJ; Zhang, YP; Pan, XB; Meng, J; Liu, Y; Song, JW; Zhong, JC; Liu, XY				Meng, Liukun; Yuan, Wen; Chi, Hongjie; Han, Ruijuan; Zhang, Yeping; Pan, Xiangbin; Meng, Jian; Liu, Ying; Song, Jiawei; Zhong, Jiuchang; Liu, Xiaoyan			Genetic deletion of CMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterial hypertension	FASEB JOURNAL			English	Article						capillary morphogenesis gene&#8208; 2; congenital heart disease; pulmonary vascular remodeling	CAPILLARY MORPHOGENESIS; PROGRESSION; ACTIVATION; APOPTOSIS; TRIGGERS	Pulmonary arterial hypertension (PAH) secondary to congenital heart disease (CHD-PAH) with systemic-to-pulmonary shunt (SPS) is characterized by proliferative vascular remodeling. Capillary morphogenesis gene-2 (CMG2) plays a key role in cell proliferation and apoptosis. This study aimed to determine the role of CMG2 in the pathogenesis of SPS-induced PAH. CMG2 levels were significantly downregulated in pulmonary arterioles from patients with Eisenmenger syndrome and rats with SPS-induced PAH. CMG2 was highly expressed in several cells including human pulmonary arterial smooth muscle cells (HPASMCs). CMG2(-/-) rats exhibited more severe PAH and pulmonary vascular remodeling than wild-type rats when exposed to SPS for 8 weeks. Overexpression of CMG2 significantly inhibited proliferation and promoted apoptosis of HPASMCs, while knockdown of CMG2 promoted cell proliferation and inhibited cell apoptosis. Next-generation sequencing and subsequent validation results suggested that PI3K-AKT was the most prominent signaling pathway regulated by differentially expressed genes (DEGs) in CMG2(-/-) rat lungs. Our work identified a novel role for CMG2 in SPS-induced PAH based on the findings that CMG2 deficiency exacerbates SPS-induced vascular remodeling in the development of PAH, indicating that CMG2 might act as a potential target for the treatment of CHD-PAH.	[Meng, Liukun; Pan, Xiangbin; Meng, Jian] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing, Peoples R China; [Yuan, Wen; Liu, Xiaoyan] Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing 100020, Peoples R China; [Yuan, Wen; Chi, Hongjie; Zhang, Yeping; Liu, Ying; Song, Jiawei; Zhong, Jiuchang; Liu, Xiaoyan] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Hypertens Res, Beijing 100020, Peoples R China; [Chi, Hongjie; Zhang, Yeping; Liu, Ying; Song, Jiawei; Zhong, Jiuchang; Liu, Xiaoyan] Capital Med Univ, Beijing Chao Yang Hosp, Heart Ctr, Beijing 100020, Peoples R China; [Han, Ruijuan] Baotou Cent Hosp, Dept Cardiol, Inner Mongolia, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Capital Medical University; Capital Medical University; Capital Medical University	Liu, XY (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing 100020, Peoples R China.; Zhong, JC; Liu, XY (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Hypertens Res, Beijing 100020, Peoples R China.; Zhong, JC (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Heart Ctr, Beijing 100020, Peoples R China.	jiuchangzhong@aliyun.com; lxy-213@163.com	Liu, XiaoYan/GQA-7216-2022	Zhong, Jiuchang/0000-0002-2315-3515	National Natural Science Foundation [81500038, 82070325, 81400034, 81770253, 81370362]; Beijing Hospitals Authority Youth Programme [QML20200305]; Beijing Natural Science Foundation [7172078, 7172182]; National Major Research Plan Training Program of China [91849111, 91339108]; Beijing Chaoyang Hospital [CYXX-2017-36]; Open Foundation from Beijing Key Laboratory of Hypertension Research [2019GXY-KFKT-02]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2019MS08062]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Hospitals Authority Youth Programme; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Major Research Plan Training Program of China; Beijing Chaoyang Hospital; Open Foundation from Beijing Key Laboratory of Hypertension Research; Natural Science Foundation of Inner Mongolia Autonomous Region of China	This work was supported by National Natural Science Foundation (81500038, 82070325, 81400034; 81770253; 81370362), Beijing Hospitals Authority Youth Programme (QML20200305), Beijing Natural Science Foundation (7172078 and 7172182), the National Major Research Plan Training Program of China (91849111; 91339108), Beijing Chaoyang Hospital Affiliated to Capital Medical University 1351 Talent Training Program (CYXX-2017-36), Open Foundation from Beijing Key Laboratory of Hypertension Research (2019GXY-KFKT-02), and research grants from Natural Science Foundation of Inner Mongolia Autonomous Region of China (2019MS08062).	Abrami L, 2010, P NATL ACAD SCI USA, V107, P1420, DOI 10.1073/pnas.0910782107; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Bell SE, 2001, J CELL SCI, V114, P2755; Burgi J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15861; Casas-Alba D, 2018, HUM MUTAT, V39, P1752, DOI 10.1002/humu.23638; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Cozma C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1183-5; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; El-Kamah GY, 2010, BRIT J DERMATOL, V163, P213, DOI 10.1111/j.1365-2133.2010.09769.x; Fang X, 2016, J CARDIOVASC PHARM, V67, P164, DOI 10.1097/FJC.0000000000000333; Friebe S, 2016, TOXINS, V8, DOI 10.3390/toxins8030069; Greither T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122648; Hanks S, 2003, AM J HUM GENET, V73, P791, DOI 10.1086/378418; Ji CD, 2018, ONCOGENE, V37, P3953, DOI 10.1038/s41388-018-0226-z; Lin SC, 2019, THERANOSTICS, V9, P620, DOI 10.7150/thno.30655; Liu X, 2015, ACTA PHYSIOL, V213, P505, DOI 10.1111/apha.12352; Liu XY, 2017, AM J HYPERTENS, V30, P182, DOI 10.1093/ajh/hpw125; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Meng LK, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13263; Meng LK, 2013, J THORAC CARDIOV SUR, V146, P1220, DOI 10.1016/j.jtcvs.2013.01.018; Pullamsetti SS, 2014, AM J RESP CRIT CARE, V189, P394, DOI 10.1164/rccm.201308-1543PP; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sun JJ, 2016, TOXINS, V8, DOI 10.3390/toxins8020034; Tan J, 2018, J PATHOL, V245, P160, DOI 10.1002/path.5062; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Ye L, 2014, J CANCER RES CLIN, V140, P957, DOI 10.1007/s00432-014-1650-2	28	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21421	10.1096/fj.202000299R	http://dx.doi.org/10.1096/fj.202000299R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749907				2022-12-28	WOS:000635216100045
J	Guo, FL; Shi, YJ; Yang, MF; Guo, YL; Shen, Z; Li, MX; Chen, YX; Liang, R; Yang, YL; Chen, HC; Peng, GQ				Guo, Fenglin; Shi, Yuejun; Yang, Mengfang; Guo, Yilin; Shen, Zhou; Li, Mengxia; Chen, Yixi; Liang, Rui; Yang, Yilin; Chen, Huanchun; Peng, Guiqing			The structural basis of African swine fever virus core shell protein p15 binding to DNA	FASEB JOURNAL			English	Article						African swine fever virus; crystal structure; core shell; DNA binding; p15	CRYO-EM STRUCTURE; GENE; POLYPROTEIN; VIRULENCE; L4R	African swine fever (ASF) is an acute, hemorrhagic, and highly contagious disease caused by African swine fever virus (ASFV). The mortality rate of acute infection up to 100% have posed an unprecedented challenge of the swine industry. Currently no commercial antiviral drug is available for the control and treatment of ASFV. The structural resolution of ASFV virions reveals the details of ASFV morphogenesis, providing a new perspective for the research and promotion of the development of ASFV vaccines. Although the architecture of ASFV have been solved via cryo-EM, the structural details of four of the five viral layers remain unclear (except the outer capsid). In this study, we resolved the crystal structure of the ASFV core shell protein p15. The secondary structural elements of a protomer include four alpha-helix structures and six antiparallel beta-strands. Further analysis revealed that ASFV p15 forms disulfide-linked trimers between the Cys9 from one protomer and Cys30 from other protomer. Additionally, the nucleic acid-binding property was characterized by electrophoretic mobility shift assay. Two critical amino acid Lys10 and Lys39 have been identified which is essential to the nucleic acid-binding affinity of ASFV p15. Together, these findings may provide new insight into antiviral drug development.	[Guo, Fenglin; Shi, Yuejun; Yang, Mengfang; Guo, Yilin; Shen, Zhou; Li, Mengxia; Chen, Yixi; Liang, Rui; Yang, Yilin; Chen, Huanchun; Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Guo, Fenglin; Shi, Yuejun; Yang, Mengfang; Guo, Yilin; Shen, Zhou; Li, Mengxia; Chen, Yixi; Liang, Rui; Yang, Yilin; Chen, Huanchun; Peng, Guiqing] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Peoples R China	Huazhong Agricultural University	Peng, GQ (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	penggq@mail.hzau.edu.cn	chen, huan/GXZ-8858-2022		National Key R&D program of China [2018YFC0840402]; National Natural Science Foundation of China (NSFC) [31722056, U20A2059]; Huazhong Agricultural University Scientific & technological Self-Innovation Foundation [2662017PY028]	National Key R&D program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University Scientific & technological Self-Innovation Foundation	National Key R&D program of China, Grant/Award Number: 2018YFC0840402; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31722056 and U20A2059; Huazhong Agricultural University Scientific & technological Self-Innovation Foundation, Grant/Award Number: 2662017PY028	Alejo A, 2018, J VIROL, V92, DOI 10.1128/JVI.01293-18; Alonso C, 2018, J GEN VIROL, V99, P613, DOI 10.1099/jgv.0.001049; Andres G, 2002, J VIROL, V76, P2654, DOI 10.1128/JVI.76.6.2654-2666.2002; Andres G, 2002, J VIROL, V76, P12473, DOI 10.1128/JVI.76.24.12473-12482.2002; Andres G, 1998, J VIROL, V72, P8988; Andres G, 2020, J BIOL CHEM, V295, P1, DOI 10.1074/jbc.AC119.011196; Bayliss CD, 1996, J GEN VIROL, V77, P2827, DOI 10.1099/0022-1317-77-11-2827; Bayliss CD, 1997, NUCLEIC ACIDS RES, V25, P3984, DOI 10.1093/nar/25.20.3984; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Chinchar V., 2005, SAN DIEGO, P145; Frouco G, 2017, J VIROL, V91, DOI 10.1128/JVI.02498-16; Fu D, 2020, PROTEIN CELL, V11, P606, DOI 10.1007/s13238-020-00731-9; Ge SQ, 2018, EMERG INFECT DIS, V24, P2131, DOI 10.3201/eid2411.181274; Guo FL, 2021, FASEB J, V35, DOI 10.1096/fj.202002145R; Hakim M, 2009, J MOL BIOL, V391, P758, DOI 10.1016/j.jmb.2009.06.070; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Khajeh JA, 2014, J MOL BIOL, V426, P2755, DOI 10.1016/j.jmb.2014.05.011; Lewis T, 2000, J VIROL, V74, P1275, DOI 10.1128/JVI.74.3.1275-1285.2000; Li GB, 2020, PROTEIN CELL, V11, P600, DOI 10.1007/s13238-020-00730-w; Li GB, 2020, J VIROL, V94, DOI 10.1128/JVI.02125-19; Liu RL, 2020, P NATL ACAD SCI USA, V117, P11000, DOI 10.1073/pnas.1922523117; Liu S, 2019, CELL HOST MICROBE, V26, P836, DOI 10.1016/j.chom.2019.11.004; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P159; MUNOZ M, 1993, ARCH VIROL, V130, P93, DOI 10.1007/BF01318999; O'Donnell V, 2017, J VIROL, V91, DOI 10.1128/JVI.01760-16; Revilla Y, 2018, ADV VIRUS RES, V100, P41, DOI 10.1016/bs.aivir.2017.10.002; Salas ML, 2013, VIRUS RES, V173, P29, DOI 10.1016/j.virusres.2012.09.016; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Simon-Mateo C, 1997, J VIROL, V71, P5799; Suarez C, 2010, J VIROL, V84, P176, DOI 10.1128/JVI.01858-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urbano AC, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040585; VINUELA E, 1985, CURR TOP MICROBIOL, V116, P151; Wang N, 2019, SCIENCE, V366, P640, DOI 10.1126/science.aaz1439; Yan XD, 2000, NAT STRUCT BIOL, V7, P101, DOI 10.1038/72360; Zeng Z, 2018, J VIROL, V92, DOI 10.1128/JVI.00692-18; Zhao DM, 2019, EMERG MICROBES INFEC, V8, P438, DOI 10.1080/22221751.2019.1590128	39	6	7	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21350	10.1096/fj.202002145R	http://dx.doi.org/10.1096/fj.202002145R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33629764				2022-12-28	WOS:000629576700043
J	Medapati, MR; Singh, N; Bhagirath, AY; Duan, KM; Triggs-Raine, B; Batista, EL; Chelikani, P				Medapati, Manoj Reddy; Singh, Nisha; Bhagirath, Anjali Yadav; Duan, Kangmin; Triggs-Raine, Barbara; Batista, Eraldo L.; Chelikani, Prashen			Bitter taste receptor T2R14 detects quorum sensing molecules from cariogenic Streptococcus mutans and mediates innate immune responses in gingival epithelial cells	FASEB JOURNAL			English	Article						competence stimulating peptide (CSP); gingival epithelial cell (GEC); host&#8208; pathogen interaction; innate immune responses; S; mutans	NF-KAPPA-B; PROTEIN-KINASE; ACTIVATION; EXPRESSION; PEPTIDE; FIBROBLASTS; INDUCTION; MECHANISM; GENOTYPE; CARIES	Host-pathogen interactions play an important role in defining the outcome of a disease. Recent studies have shown that the bacterial quorum sensing molecules (QSM) can interact with host cell membrane proteins, mainly G protein-coupled receptors (GPCRs), and induce innate immune responses. However, few studies have examined QSM-GPCR interactions and their influence on oral innate immune responses. In this study, we examined the role of bitter taste receptor T2R14 in sensing competence stimulating peptides (CSPs) secreted by cariogenic bacterium Streptococcus mutans and in mediating innate immune responses in gingival epithelial cells (GECs). Transcriptomic and western blot analyses identify T2R14 to be highly expressed in GECs. Our data show that only CSP-1 from S. mutans induces robust intracellular calcium mobilization compared to CSP-2 and CSP-3. By using CRISPR-Cas9, we demonstrate that CSP-1 induced calcium signaling and secretion of cytokines CXCL-8/IL-8, TNF-alpha, and IL-6 is mediated through T2R14 in GECs. Interestingly, the NF-kB signaling activated by CSP-1 in GECs was independent of T2R14. CSP-1-primed GECs attracted differentiated HL-60 immune cells (dHL-60) and this effect was abolished in T2R14 knock down GECs and also in cells primed with T2R14 antagonist 6-Methoxyflavone (6-MF). Our findings identify S. mutans CSP-1 as a peptide ligand for the T2R family. Our study establishes a novel host-pathogen interaction between cariogenic S. mutans CSP-1 and T2R14 in GECs leading to an innate immune response. Collectively, these findings suggest T2Rs as potential therapeutic targets to modulate innate immune responses upon oral bacterial infections.	[Medapati, Manoj Reddy; Singh, Nisha; Bhagirath, Anjali Yadav; Duan, Kangmin; Chelikani, Prashen] Univ Manitoba, Rady Fac Hlth Sci, Dr Gerald Niznick Coll Dent, Manitoba Chemosensory Biol Res Grp, Winnipeg, MB, Canada; [Medapati, Manoj Reddy; Singh, Nisha; Bhagirath, Anjali Yadav; Duan, Kangmin; Chelikani, Prashen] Univ Manitoba, Rady Fac Hlth Sci, Dr Gerald Niznick Coll Dent, Dept Oral Biol, Winnipeg, MB, Canada; [Bhagirath, Anjali Yadav; Duan, Kangmin; Triggs-Raine, Barbara; Chelikani, Prashen] Univ Manitoba, Childrens Hosp Res Inst Manitoba CHRIM, Winnipeg, MB, Canada; [Triggs-Raine, Barbara] Univ Manitoba, Rady Fac Hlth Sci, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Batista, Eraldo L.] Univ Manitoba, Rady Fac Hlth Sci, Dr Gerald Niznick Coll Dent, Dept Dent Diagnost & Clin Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Manitoba Chemosensory Biol Res Grp, D319, Winnipeg, MB R3E 0W4, Canada.; Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, 780 Bannatyne Ave, Winnipeg, MB R3E 0W4, Canada.	Prashen.Chelikani@umanitoba.ca	Bhagirath, Anjali Y./AAN-7643-2020; Medapati, Manoj Reddy/AAO-8337-2021; Batista, Eraldo/ABC-2646-2020; Medapati, Manoj Reddy/AFK-7969-2022	Bhagirath, Anjali Y./0000-0001-5175-0811; Medapati, Manoj Reddy/0000-0002-6342-5546; Triggs-Raine, Barbara/0000-0003-4719-6779; Batista Junior, Eraldo/0000-0003-0429-3560; Chelikani, Prashen/0000-0003-1129-7957; Duan, Kangmin/0000-0002-3016-786X	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [PJT-159731]; Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-04099, RGPIN-2020-05670]	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT-159731; Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: RGPIN-2014-04099 and RGPIN-2020-05670	Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P356, DOI 10.1002/alr.21675; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Alfonso-Prieto M, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00029; Allen JA, 2017, FASEB J, V31; Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Bikash CR, 2018, ACS INFECT DIS, V4, P1385, DOI 10.1021/acsinfecdis.8b00115; Boneschansker L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5787; Braschi B, 2019, NUCLEIC ACIDS RES, V47, pD786, DOI 10.1093/nar/gky930; Bufe B, 2015, J BIOL CHEM, V290, P7369, DOI 10.1074/jbc.M114.626747; Chandler JD, 2015, AM J RESP CELL MOL, V53, P193, DOI 10.1165/rcmb.2014-0208OC; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Feng P, 2015, BRAIN BEHAV IMMUN, V49, P32, DOI 10.1016/j.bbi.2015.04.001; Freund JR, 2018, J BIOL CHEM, V293, P9824, DOI 10.1074/jbc.RA117.001005; Gil S, 2015, MOL IMMUNOL, V68, P663, DOI 10.1016/j.molimm.2015.10.012; Gopallawa I, 2021, CELL MOL LIFE SCI, V78, P271, DOI 10.1007/s00018-020-03494-y; Gu Q, 2017, AM J PHYSIOL-LUNG C, V312, P1326, DOI 10.1152/ajplung.00468.2016; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; HILLMAN JD, 1987, J DENT RES, V66, P1092, DOI 10.1177/00220345870660060101; Horst OV, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-9; Hossain MS, 2012, J BACTERIOL, V194, P5886, DOI 10.1128/JB.01381-12; Jaggupilli A, 2018, ACS INFECT DIS, V4, P1146, DOI 10.1021/acsinfecdis.8b00094; Jaggupilli A, 2017, MOL CELL BIOCHEM, V426, P137, DOI 10.1007/s11010-016-2902-z; Kaur H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09334-3; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; Meyle J, 2017, J CLIN PERIODONTOL, V44, P1215, DOI 10.1111/jcpe.12781; Millius A, 2010, METHODS MOL BIOL, V591, P147, DOI 10.1007/978-1-60761-404-3_9; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Petersen FC, 2006, MOL MICROBIOL, V61, P1322, DOI 10.1111/j.1365-2958.2006.05312.x; Pundir P, 2019, CELL HOST MICROBE, V26, P114, DOI 10.1016/j.chom.2019.06.003; Qiao H, 2009, FREE RADICAL BIO MED, V46, P1221, DOI 10.1016/j.freeradbiomed.2009.02.004; Ra C, 2017, J DENT ORAL HEALTH, V3, P1; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rasoamanana R, 2012, P NUTR SOC, V71, P446, DOI 10.1017/S0029665112000110; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Satoh A, 2006, AM J PHYSIOL-GASTR L, V291, pG432, DOI 10.1152/ajpgi.00579.2005; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shahrestanifar M, 1999, J BIOL CHEM, V274, P3828, DOI 10.1074/jbc.274.6.3828; Shaik FA, 2019, AM J PHYSIOL-LUNG C, V316, pL45, DOI 10.1152/ajplung.00169.2018; Shaik FA, 2016, INT J BIOCHEM CELL B, V77, P197, DOI 10.1016/j.biocel.2016.03.011; Shandilya J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.343; Shultz S, 2008, J Biomol Tech, V19, P267; Singh N, 2020, MOL CELL BIOCHEM, V465, P199, DOI 10.1007/s11010-019-03679-5; Siripurapu P, 2017, J BIOL CHEM, V292, P17482, DOI 10.1074/jbc.M117.787838; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Syvitski RT, 2007, J BACTERIOL, V189, P1441, DOI 10.1128/JB.00832-06; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; Tanzer J M, 2001, J Dent Educ, V65, P1028; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiley SZ, 2018, FASEB J, V32, P1170, DOI 10.1096/fj.201700834R; Yadav VK, 2018, INT J MED MICROBIOL, V308, P858, DOI 10.1016/j.ijmm.2018.07.009; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003; Zheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12505-x; Zhu H, 2008, EYE CONTACT LENS, V34, P179, DOI 10.1097/ICL.0b013e318159afde; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	64	13	13	6	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21375	10.1096/fj.202000208R	http://dx.doi.org/10.1096/fj.202000208R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559200	Green Submitted			2022-12-28	WOS:000629576700021
J	Chiodi, V; Domenici, MR; Biagini, T; De Simone, R; Tartaglione, AM; Di Rosa, M; Lo Re, O; Mazza, T; Micale, V; Vinciguerra, M				Chiodi, Valentina; Domenici, Maria Rosaria; Biagini, Tommaso; De Simone, Roberta; Tartaglione, Anna Maria; Di Rosa, Michelino; Lo Re, Oriana; Mazza, Tommaso; Micale, Vincenzo; Vinciguerra, Manlio			Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice	FASEB JOURNAL			English	Article						epigenetics; hippocampus; 1; social behavior	LONG-TERM POTENTIATION; MOUSE MODEL; CONDITIONED FEAR; LTP; MECHANISMS; DEPRESSION; RATS; MODULATION; EXPRESSION; AMYGDALA	Gene expression and epigenetic processes in several brain regions regulate physiological processes such as cognitive functions and social behavior. MacroH2A1.1 is a ubiquitous variant of histone H2A that regulates cell stemness and differentiation in various organs. Whether macroH2A1.1 has a modulatory role in emotional behavior is unknown. Here, we employed macroH2A1.1 knock-out ((-/-)) mice to perform a comprehensive battery of behavioral tests, and an assessment of hippocampal synaptic plasticity (long-term potentiation) accompanied by whole hippocampus RNA sequencing. MacroH2A1.1(-/-) mice exhibit a stunningly enhancement both of sociability and of active stress-coping behavior, reflected by the increased social behavior in social activity tests and higher mobility time in the forced swim test, respectively. They also display an increased hippocampal synaptic plasticity, accompanied by significant neurotransmission transcriptional networks changes. These results suggest that systemic depletion of histone macroH2A1.1 supports an epigenetic control necessary for hippocampal function and social behavior.	[Chiodi, Valentina; Domenici, Maria Rosaria; De Simone, Roberta; Micale, Vincenzo] Ist Super Sanita, Natl Ctr Drug Res & Evaluat, Rome, Italy; [Biagini, Tommaso; Mazza, Tommaso] IRCCS Casa Sollievo Sofferenza, Bioinformat Unit, San Giovanni Rotondo, Italy; [Tartaglione, Anna Maria] Ist Super Sanita, Ctr Behav Sci & Mental Hlth, Rome, Italy; [Di Rosa, Michelino; Micale, Vincenzo] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Biol Tower, Catania, Italy; [Lo Re, Oriana; Vinciguerra, Manlio] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Vinciguerra, Manlio] Med Univ Varna, ERA Chair Translat Stem Cell Biol, Varna, Bulgaria; [Vinciguerra, Manlio] Univ Coll London UCL, Div Med, London, England	Istituto Superiore di Sanita (ISS); IRCCS Casa Sollievo Della Sofferenza; Istituto Superiore di Sanita (ISS); University of Catania; St Anne's University Hospital Brno (FNUSA-ICRC); Medical University Varna; University of London; University College London	Micale, V (corresponding author), Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Biol Tower, Catania, Italy.; Vinciguerra, M (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.	vincenzomicale@inwind.it; manlio.vinciguerra@fnusa.cz	Vinciguerra, Manlio/N-1309-2015; Mazza, Tommaso/I-4531-2019; Lo Re, Oriana/ACC-4425-2022; Tartaglione, Anna Maria/K-4844-2018; Biagini, Tommaso/K-3044-2016	Vinciguerra, Manlio/0000-0002-1768-3894; Mazza, Tommaso/0000-0003-0434-8533; Lo Re, Oriana/0000-0002-4798-6802; Tartaglione, Anna Maria/0000-0002-9761-8098; Biagini, Tommaso/0000-0002-4539-028X	European Regional Development Fund-Project MAGNET [CZ.02.1.01/0.0/0.0/15_003/0000492]; Ministry of Health of the Czech Republic [NV18-03-00058]; European Commission Horizon 2020 Framework Program [856871-TRANSTEM]; University of Catania	European Regional Development Fund-Project MAGNET; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); European Commission Horizon 2020 Framework Program; University of Catania	This research was funded by the European Regional Development Fund-Project MAGNET (No. CZ.02.1.01/0.0/0.0/15_003/0000492), by the Ministry of Health of the Czech Republic, grant nr. NV18-03-00058, and by the European Commission Horizon 2020 Framework Program (Project 856871-TRANSTEM), and by a Starting Grant 2020, University of Catania (to VM)	Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Alexander GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10300; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Barak B, 2016, NAT NEUROSCI, V19, P647, DOI 10.1038/nn.4276; Bereshchenko O, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0724-z; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borghesan M, 2016, CANCER RES, V76, P594, DOI 10.1158/0008-5472.CAN-15-1336; Buschbeck M, 2017, NAT REV MOL CELL BIO, V18, P299, DOI 10.1038/nrm.2016.166; Campbell SL, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0396-6; Chalkiadaki K, 2019, NEUROPHARMACOLOGY, V144, P193, DOI 10.1016/j.neuropharm.2018.10.026; Chilton JK, 2017, DEV NEUROBIOL, V77, P861, DOI 10.1002/dneu.22477; Commons KG, 2017, ACS CHEM NEUROSCI, V8, P955, DOI 10.1021/acschemneuro.7b00042; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; De Filippis B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00086; De Filippis D, 2014, EUR J PHARMACOL, V725, P64, DOI 10.1016/j.ejphar.2013.12.021; Diogenes MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1823, DOI 10.1038/npp.2011.64; Direnberger S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2035; Drago F, 2001, EUR NEUROPSYCHOPHARM, V11, P209, DOI 10.1016/S0924-977X(01)00084-0; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; Ferrante A, 2018, NEUROBIOL DIS, V110, P1, DOI 10.1016/j.nbd.2017.10.013; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Giallongo S, 2021, ANTIOXID REDOX SIGN, V34, P335, DOI 10.1089/ars.2019.7983; Glerup S, 2016, MOL PSYCHIATR, V21, P1740, DOI 10.1038/mp.2016.108; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Guttula Satya Vani, 2012, Int J Alzheimers Dis, V2012, P649456, DOI 10.1155/2012/649456; Hazane F, 2009, NEUROTOX RES, V15, P311, DOI 10.1007/s12640-009-9035-z; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hofelmann D, 2013, BRAIN RES, V1527, P47, DOI 10.1016/j.brainres.2013.06.011; Hu Y, 2011, P NATL ACAD SCI USA, V108, P17141, DOI 10.1073/pnas.1104409108; Kalman E, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.775; Laviola G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188907; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lo Re O, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120367; Lundbye CJ, 2018, J PHYSIOL-LONDON, V596, P5017, DOI 10.1113/JP276304; Macri S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13257; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Meira T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06501-w; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Micale V, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00207; Micale V, 2013, CELL TISSUE RES, V354, P309, DOI 10.1007/s00441-013-1692-9; Mizuno S, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.595607; Monday HR, 2018, ANNU REV NEUROSCI, V41, P299, DOI 10.1146/annurev-neuro-080317-062155; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nguyen PV, 2000, J NEUROPHYSIOL, V84, P2484, DOI 10.1152/jn.2000.84.5.2484; Okuyama T, 2016, SCIENCE, V353, P1536, DOI 10.1126/science.aaf7003; Oliva A, 2020, NATURE, V587, P264, DOI 10.1038/s41586-020-2758-y; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Pazienza V, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0098-9; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Rao RP, 2019, CELL REP, V27, P3460, DOI 10.1016/j.celrep.2019.05.081; Rozov AV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P257, DOI 10.1134/S0006297917030038; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Serrano Mercedes, 2018, Handb Clin Neurol, V155, P227, DOI 10.1016/B978-0-444-64189-2.00015-9; Smit-Rigter LA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00169; Stark T, 2019, NEUROPHARMACOLOGY, V146, P212, DOI 10.1016/j.neuropharm.2018.11.035; Terzian AL, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00049; Terzian ALB, 2014, EUR J NEUROSCI, V40, P2293, DOI 10.1111/ejn.12561; Tzakis N, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00233; Uttl L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00703; van der Kooij MA, 2012, NEUROSCI BIOBEHAV R, V36, P1763, DOI 10.1016/j.neubiorev.2011.10.006; Wegener S, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0398-17.2018; Yen YC, 2012, NEUROBIOL LEARN MEM, V98, P56, DOI 10.1016/j.nlm.2012.04.009; Zoratto F, 2018, BEHAV BRAIN RES, V347, P37, DOI 10.1016/j.bbr.2018.02.033; Zoratto F, 2018, NEUROPHARMACOLOGY, V143, P250, DOI 10.1016/j.neuropharm.2018.09.010; Zovkic IB, 2014, NATURE, V515, P582, DOI 10.1038/nature13707	67	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21793	10.1096/fj.202100569R	http://dx.doi.org/10.1096/fj.202100569R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320234				2022-12-28	WOS:000678975300025
J	Marasco, V; Boner, W; Griffiths, K; Heidinger, B; Monaghan, P				Marasco, Valeria; Boner, Winnie; Griffiths, Kate; Heidinger, Britt; Monaghan, Pat			Repeated exposure to challenging environmental conditions influences telomere dynamics across adult life as predicted by changes in mortality risk	FASEB JOURNAL			English	Article						aging; glucocorticoids; stress resilience; stress vulnerability; telomere dynamics; telomere length	CALORIC RESTRICTION; STRESS; LENGTH; MECHANISMS; CONSEQUENCES; ADAPTATION; CONNECTION; NUTRITION	The effects of stress exposure are likely to vary depending on life-stage and stressor. While it has been postulated that mild stress exposure may have beneficial effects, the duration of such effects and the underlying mechanisms are unclear. While the long-term effects of early-life stress are relatively well studied, we know much less about the effects of exposure in adulthood since the early- and adult-life environments are often similar. We previously reported that repeated experimental exposure to a relatively mild stressor in female zebra finches, first experienced in young adulthood, initially had no effect on mortality risk, reduced mortality in middle age, but the apparently beneficial effects disappeared in old age. We show here that this is underpinned by differences between the control and stress-exposed group in the pattern of telomere change, with stress-exposed birds showing reduced telomere loss in middle adulthood. We thereby provide novel experimental evidence that telomere dynamics play a key role linking stress resilience and aging.	[Marasco, Valeria] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Savoyenstr 1a, A-1160 Vienna, Austria; [Marasco, Valeria; Boner, Winnie; Griffiths, Kate; Heidinger, Britt; Monaghan, Pat] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Graham Kerr Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Heidinger, Britt] North Dakota State Univ, Dept Biol Sci, Fargo, ND USA	University of Veterinary Medicine Vienna; University of Glasgow; North Dakota State University Fargo	Marasco, V (corresponding author), Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Savoyenstr 1a, A-1160 Vienna, Austria.; Marasco, V; Monaghan, P (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Graham Kerr Bldg, Glasgow G12 8QQ, Lanark, Scotland.	valeria.marasco@vetmeduni.ac.uk; pat.monaghan@glasgow.ac.uk	Marasco, Valeria/AEY-9298-2022; Monaghan, Pat/E-6810-2015	Marasco, Valeria/0000-0002-2981-7909	ERC [268926]; BBSRC [BB/P009174/1]; FWF Der Wissenschaftsfonds Lise Meitner Fellowship [M2520-B29]; Marie Sklodowska-Curie Individual Fellowship [704582]	ERC(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FWF Der Wissenschaftsfonds Lise Meitner Fellowship; Marie Sklodowska-Curie Individual Fellowship	The work was supported by ERC Advanced Grant 268926 and BBSRC Grant BB/P009174/1 to PM. VM was additionally supported by a Marie Sklodowska--Curie Individual Fellowship (704582) and a FWF Der Wissenschaftsfonds Lise Meitner Fellowship (#M2520--B29)	[Anonymous], 2008, CONCISE ENCY STAT, P192, DOI [10.1007/978-0-387-32833-1_136, DOI 10.1007/978-0-387-32833-1_136]; Asghar M, 2015, SCIENCE, V347, P436, DOI 10.1126/science.1261121; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0436; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bateson M, 2016, BIOESSAYS, V38, P201, DOI 10.1002/bies.201500127; Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blackburn EH, 2012, NATURE, V490, P169, DOI 10.1038/490169a; Boonekamp JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3287; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Fathi Ezzatollah, 2019, Stem Cell Investig, V6, P7, DOI 10.21037/sci.2019.02.04; Haussmann MF, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0396; Hayward AD, 2013, P NATL ACAD SCI USA, V110, P13886, DOI 10.1073/pnas.1301817110; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herborn KA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3151; Karatsoreos IN, 2013, J CHILD PSYCHOL PSYC, V54, P337, DOI 10.1111/jcpp.12054; Kim W, 2018, DIFFERENTIATION, V99, P1, DOI 10.1016/j.diff.2017.11.005; Koehler K, 2017, EUR J CLIN NUTR, V71, P365, DOI 10.1038/ejcn.2016.203; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Marasco V, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2442; Marasco V, 2015, EXP GERONTOL, V69, P170, DOI 10.1016/j.exger.2015.06.011; Marshall HH, 2017, ECOL EVOL, V7, P1712, DOI 10.1002/ece3.2747; Mattson MP, 2014, DOSE-RESPONSE, V12, P600, DOI 10.2203/dose-response.14-028.Mattson; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Monaghan P, 2015, EARLY HUM DEV, V91, P643, DOI 10.1016/j.earlhumdev.2015.08.008; Monaghan P, 2014, J EXP BIOL, V217, P57, DOI 10.1242/jeb.090043; Nestler EJ, 2012, NATURE, V490, P171, DOI 10.1038/490171a; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1610; Puterman E, 2016, P NATL ACAD SCI USA, V113, pE6335, DOI 10.1073/pnas.1525602113; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Ridout KK, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800077; Rynders CA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102442; Sapolsky RM, 2015, NAT NEUROSCI, V18, P1344, DOI 10.1038/nn.4109; Shalev I, 2012, BIOESSAYS, V34, P943, DOI 10.1002/bies.201200084; Tarry-Adkins JL, 2016, DIS MODEL MECH, V9, P1221, DOI 10.1242/dmm.026591; Vaiserman A, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.630186; Raamsdonk JM, 2018, EXP GERONTOL, V107, P136, DOI 10.1016/j.exger.2017.08.005; Verhulst S, 2013, EUR J EPIDEMIOL, V28, P859, DOI 10.1007/s10654-013-9845-4; Wilbourn RV, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0447; Zuur Alain F., 2009, P1	47	1	1	6	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21743	10.1096/fj.202100556R	http://dx.doi.org/10.1096/fj.202100556R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34192361	Green Accepted, hybrid			2022-12-28	WOS:000678975300018
J	Armbrust, F; Bickenbach, K; Koudelka, T; Tholey, A; Pietrzik, C; Becker-Pauly, C				Armbrust, Fred; Bickenbach, Kira; Koudelka, Tomas; Tholey, Andreas; Pietrzik, Claus; Becker-Pauly, Christoph			Phosphorylation of meprin beta controls its cell surface abundance and subsequently diminishes ectodomain shedding	FASEB JOURNAL			English	Article						APP; IL6-R; meprin beta; metalloprotease; phosphorylation; PKC	AMYLOID PRECURSOR PROTEIN; METALLOPROTEASE MEPRIN; ALZHEIMERS-DISEASE; ALPHA; PKC; INTERNALIZATION; ACTIVATION; RELEASE; CASCADE; ADAM10	Meprin beta is a zinc-dependent metalloprotease exhibiting a unique cleavage specificity with strong preference for acidic amino acids at the cleavage site. Proteomic studies revealed a diverse substrate pool of meprin beta including the interleukin-6 receptor (IL-6R) and the amyloid precursor protein (APP). Dysregulation of meprin beta is often associated with pathological conditions such as chronic inflammation, fibrosis, or Alzheimer's disease (AD). The extracellular regulation of meprin beta including interactors, sheddases, and activators has been intensively investigated while intracellular regulation has been barely addressed in the literature. This study aimed to analyze C-terminal phosphorylation of meprin beta with regard to cell surface expression and proteolytic activity. By immunoprecipitation of endogenous meprin beta from the colon cancer cell line Colo320 and subsequent LC-MS analysis, we identified several phosphorylation sites in its C-terminal region. Here, T694 in the C-terminus of meprin beta was the most preferred residue after phorbol 12-myristate 13-acetate (PMA) stimulation. We further demonstrated the role of protein kinase C (PKC) isoforms for meprin beta phosphorylation and identified the involvement of PKC-alpha and PKC-beta. As a result of phosphorylation, the meprin beta activity at the cell surface is reduced and, consequently, the extent of substrate cleavage is diminished. Our data indicate that this decrease of the surface activity is caused by the internalization and degradation of meprin beta.	[Armbrust, Fred; Bickenbach, Kira; Becker-Pauly, Christoph] Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24118 Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Systemat Prote & Bioanalyt, Kiel, Germany; [Pietrzik, Claus] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany	University of Kiel; University of Kiel; Johannes Gutenberg University of Mainz	Becker-Pauly, C (corresponding author), Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Becker-Pauly, Christoph/B-7569-2011	Bickenbach, Kira/0000-0001-5079-0512; Armbrust, Fred/0000-0002-3331-5522	Deutsche Forschungsgemeinschaft (DFG) [125440785 SFB 877]; Alzheimer Forschungsinitiative e.V. (AFI) project [18007]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alzheimer Forschungsinitiative e.V. (AFI) project	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Project-number 125440785 SFB 877 (Proteolysis as a Regulatory Event in Pathophysiology, Projects A9 (to C.B.-P.), A15 (to C.B.-P. and C.U.P.), and Z2 (to T.K and A.T.), and by the Alzheimer Forschungsinitiative e.V. (AFI) project 18007 (to C.B.-P. and C.U.P.)	Amin ARMR, 2003, INT J ONCOL, V23, P1727; Arnold P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44053; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00159; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Berner DK, 2020, FASEB J, V34, P6675, DOI 10.1096/fj.201902183R; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bian JW, 2018, VASC PHARMACOL, V103, P1, DOI 10.1016/j.vph.2018.01.008; Biasin V, 2017, SCI REP-UK, V7, DOI 10.1038/srep39969; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Choi DS, 2006, P NATL ACAD SCI USA, V103, P8215, DOI 10.1073/pnas.0509725103; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Filippova N, 1999, J PHYSIOL-LONDON, V518, P385, DOI 10.1111/j.1469-7793.1999.0385p.x; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog C, 2014, J BIOL CHEM, V289, P13308, DOI 10.1074/jbc.M114.559088; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Ji LN, 2010, J ALZHEIMERS DIS, V19, P829, DOI 10.3233/JAD-2010-1281; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Peters F, 2019, FASEB J, V33, P7490, DOI 10.1096/fj.201802391R; Prox J, 2015, MATRIX BIOL, V44-46, P7, DOI 10.1016/j.matbio.2015.01.010; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sammel M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153677; Scharfenberg F, 2019, CELL MOL LIFE SCI, V76, P3193, DOI 10.1007/s00018-019-03179-1; Schlenzig D, 2018, J ALZHEIMERS DIS, V66, P359, DOI 10.3233/JAD-171183; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Talman V, 2016, BASIC CLIN PHARMACOL, V119, P149, DOI 10.1111/bcpt.12581; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Varedi SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014029; Webb BLJ, 2000, BRIT J PHARMACOL, V130, P1433, DOI 10.1038/sj.bjp.0703452; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087; Zemoura K, 2019, MOL NEUROBIOL, V56, P1293, DOI 10.1007/s12035-018-1142-5	45	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21677	10.1096/fj.202100271R	http://dx.doi.org/10.1096/fj.202100271R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34125978	hybrid			2022-12-28	WOS:000667814100029
J	Li, B; Zhang, L; Zhu, L; Cao, YQ; Dou, ZM; Yu, Q				Li, Bin; Zhang, Lei; Zhu, Lei; Cao, Yongqiang; Dou, Zhimin; Yu, Qin			HDAC5 promotes intestinal sepsis via the Ghrelin/E2F1/NF-kappa B axis	FASEB JOURNAL			English	Article						Ghrelin; HDAC5; intestinal dysfunction; intestinal sepsis; NF-kappa B	NF-KAPPA-B; GHRELIN; INFLAMMATION; APOPTOSIS; E2F1; DIAGNOSIS; PROTECTS; PATHWAY; BARRIER; INJURY	In the current study, we sought to determine the roles of histone deacetylase 5 (HDAC5) on the promotion of intestinal sepsis in a mouse model. Dual luciferase reporter gene assay was used to determine the binding relationship between HDAC5 and Ghrelin. Cecal ligation and puncture (CLP) was used as an animal model of intestinal sepsis. The roles of HDAC5 on intestinal sepsis were determined by HDAC5 knockdown, overexpression, and inhibitor (LMK-235) in vivo. Mice intestinal permeability and intestinal epithelial damage were evaluated, and HE staining was used to evaluate the intestinal mucosal injury index. Lipopolysaccharide (LPS)-treated intestinal-derived macrophages served as a cell model of sepsis, followed by the loss-of-function and gain-of-function assays. ELISA was used to determine the levels of inflammatory factors, and TUNEL staining was used to detect intestinal cell apoptosis. HDAC5 was upregulated in the intestine of sepsis patients. This increased HDAC5 expression was positively correlated with the expression of inflammatory factors TNF-alpha, IL-1 beta, IL-6, and HMGB1, as well as the intestinal dysfunction-related factors IFABP. In sepsis mice, the expression of inflammatory factors was reduced by HDAC5 knockdown. HDAC5 knockdown also improved survival, morphology of intestinal tissue, intestinal permeability, and epithelial damage. Ghrelin was bound and inhibited by HDAC5, but E2F1 expression was increased by Ghrelin overexpression, leading to inhibition of the NF-kappa B pathway. Ghrelin and E2F1 expression were increased by the treatment with HDAC5 inhibitor LMK-235, which inhibited the NF-kappa B pathway to improve intestinal dysfunction in the sepsis model. In conclusion, HDAC5 inhibits Ghrelin to reduce E2F1 and thus activate the NF-kappa B pathway, thereby promoting intestinal sepsis.	[Li, Bin; Zhang, Lei; Zhu, Lei; Cao, Yongqiang; Dou, Zhimin] Lanzhou Univ, Hosp 1, Dept Crit Med, Lanzhou, Peoples R China; [Yu, Qin] Lanzhou Univ, Hosp 1, Sch Clin Med 1, Dept Resp, 1 West Donggang Rd, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Yu, Q (corresponding author), Lanzhou Univ, Hosp 1, Sch Clin Med 1, Dept Resp, 1 West Donggang Rd, Lanzhou 730000, Gansu, Peoples R China.	yuqin@lzu.edu.cn						Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Cheyuo C, 2012, AM J PHYSIOL-ENDOC M, V302, pE265, DOI 10.1152/ajpendo.00508.2011; Chung H, 2016, J ENDOCRINOL, V230, P239, DOI 10.1530/JOE-16-0126; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Cummins EP, 2013, LAB INVEST, V93, P378, DOI 10.1038/labinvest.2013.9; Di Giorgio E, 2016, EPIGENOMICS-UK, V8, P251, DOI 10.2217/epi.15.106; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Hsing CH, 2012, AM J PHYSIOL-RENAL, V303, pF1443, DOI 10.1152/ajprenal.00143.2012; Jacob A, 2010, HEPATIC MED-EVID RES, V2, P33; Jain S, 2018, AM J MED SCI, V356, P277, DOI 10.1016/j.amjms.2018.06.012; Ji ZR, 2019, INFLAMMATION, V42, P731, DOI 10.1007/s10753-018-0931-3; Jiang C, 2020, J ETHNOPHARMACOL, V251, DOI 10.1016/j.jep.2019.112501; Jiang LY, 2010, WORLD J EMERG MED, V1, P138; Joe Y, 2020, CELL REP, V30, P1063, DOI 10.1016/j.celrep.2019.12.090; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kempker JA, 2016, CLIN CHEST MED, V37, P165, DOI 10.1016/j.ccm.2016.01.002; Kockara A, 2013, RENAL FAILURE, V35, P291, DOI 10.3109/0886022X.2012.744040; Lee HJ, 2009, BIOCHEM J, V420, P403, DOI 10.1042/BJ20081850; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lu HJ, 2018, LIFE SCI, V199, P167, DOI 10.1016/j.lfs.2018.02.016; Ma L, 2017, NEUROSCI LETT, V644, P55, DOI 10.1016/j.neulet.2017.02.038; Ma LX, 2015, MOL ENDOCRINOL, V29, P1571, DOI 10.1210/me.2015-1184; Miksa M, 2005, FRONT BIOSCI-LANDMRK, V10, P2217, DOI 10.2741/1691; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Ouyang Lin, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P464, DOI 10.11817/j.issn.1672-7347.2015.05.002; Palomer X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019724; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tian R, 2019, BBA-MOL BASIS DIS, V1865, P1701, DOI 10.1016/j.bbadis.2019.04.009; Verdonk F, 2017, CURR OPIN ANESTHESIO, V30, P200, DOI 10.1097/ACO.0000000000000446; von Knethen A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020346; Wu RQ, 2009, CRIT CARE MED, V37, P2421, DOI 10.1097/CCM.0b013e3181a557a2; Wu XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04231-5; Yang BC, 2017, J SURG RES, V211, P70, DOI 10.1016/j.jss.2016.11.061; Yang D, 2018, INT J MOL MED, V41, P43, DOI 10.3892/ijmm.2017.3212	35	6	6	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21368	10.1096/fj.202001584R	http://dx.doi.org/10.1096/fj.202001584R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34125448				2022-12-28	WOS:000667814100051
J	Liang, JL; Li, HH; Mei, JX; Cao, Z; Tang, Y; Huang, RF; Xia, H; Zhang, QH; Xiang, Q; Yang, Y; Huang, YD				Liang, Jinlian; Li, Hanhao; Mei, Jiaxin; Cao, Zhen; Tang, Yan; Huang, Rufei; Xia, Huan; Zhang, Qihao; Xiang, Qi; Yang, Yan; Huang, Yadong			Sertoli cell-derived exosome-mediated transfer of miR-145-5p inhibits Leydig cell steroidogenesis by targeting steroidogenic factor 1	FASEB JOURNAL			English	Article						exosome; Leydig cell; miR&#8208; 145&#8208; 5p; Sertoli cell; testosterone	EXTRACELLULAR VESICLES; DIFFERENTIATION; COMMUNICATION; AD4BP/SF-1; MICRORNAS; MODEL; SF-1; STAR	In the mammalian testis, two distinct populations of Sertoli cells (SCs), the immature SCs (ISCs) and adult SCs (ASCs), play significant roles in regulating the development and function of Leydig cells. However, the effect of different SC types on the function of Leydig cells is poorly understood. Here, our study showed that miR-145-5p expression was significantly different in SCs at different stages, with the highest expression observed in ISCs. Exosomes mediate the transfer of miR-145-5p from ISCs to Leydig cells. Overexpression of miR-145-5p in Leydig cells significantly downregulated steroidogenic gene expression and inhibited testosterone synthesis. Additionally, miR-145-5p functioned by directly targeted steroidogenic factor-1 (Sf-1) and downregulated the expression of SF-1, which further downregulated the expression of steroidogenic genes, induced accumulation of lipid droplets, and eventually suppressed testosterone production. These findings demonstrate that SC-derived miR-145-5p plays a significant role in regulating the functions of Leydig cells and may therefore serve as a diagnostic biomarker for male hypogonadism developmental abnormalities during puberty.	[Liang, Jinlian; Mei, Jiaxin; Cao, Zhen; Tang, Yan; Xia, Huan; Zhang, Qihao; Xiang, Qi; Yang, Yan; Huang, Yadong] Jinan Univ, Dept Cell Biol, Guangzhou 510632, Peoples R China; [Liang, Jinlian; Mei, Jiaxin; Cao, Zhen; Tang, Yan; Xia, Huan; Zhang, Qihao; Xiang, Qi; Yang, Yan; Huang, Yadong] Jinan Univ, Guangdong Prov Key Lab Bioengn Med, Guangzhou 510632, Peoples R China; [Li, Hanhao; Huang, Rufei; Huang, Yadong] Jinan Univ, Dept Pharmacol, Guangzhou, Peoples R China; [Zhang, Qihao; Xiang, Qi; Yang, Yan; Huang, Yadong] Jinan Univ, Dept Cell Biol, Natl Engn Res Ctr Genet Med, Guangzhou, Peoples R China; [Zhang, Qihao; Xiang, Qi; Yang, Yan; Huang, Yadong] Jinan Univ, Biopharmaceut Res & Dev Ctr, Guangzhou, Peoples R China	Jinan University; Jinan University; Jinan University; Jinan University; Jinan University	Yang, Y; Huang, YD (corresponding author), Jinan Univ, Dept Cell Biol, Guangzhou 510632, Peoples R China.; Yang, Y; Huang, YD (corresponding author), Jinan Univ, Guangdong Prov Key Lab Bioengn Med, Guangzhou 510632, Peoples R China.	yangyan107@163.com; tydhuang@jnu.edu.cn			National Natural Science Foundation of China [81871150, 31801235, 82071634]; Natural Science Foundation of Guangdong Province [2018A030313473]; Science and Technology Plan Project of Guangzhou [201508020001, 2016A020214013, 201803010044, 201704YG066, 2020A1515011203]; Guangzhou Science and Technology Program Key Project [201803010044]; Special Innovation Projects of Universities in Guangdong Province [2019KTSCXo11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Plan Project of Guangzhou; Guangzhou Science and Technology Program Key Project; Special Innovation Projects of Universities in Guangdong Province	This work was supported by National Natural Science Foundation of China (No. 81871150, 31801235, and 82071634); Natural Science Foundation of Guangdong Province (No. 2018A030313473); the Science and Technology Plan Project of Guangzhou (No. 201508020001, 2016A020214013, 201803010044, 201704YG066, 2020A1515011203); Guangzhou Science and Technology Program Key Project (No. 201803010044), and Special Innovation Projects of Universities in Guangdong Province (No. 2019KTSCXo11).	Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Baba T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0020-z; Barcelo M, 2018, HUM REPROD, V33, P1087, DOI 10.1093/humrep/dey072; CALKINS JH, 1988, ENDOCRINOLOGY, V123, P1605, DOI 10.1210/endo-123-3-1605; Chen HL, 2017, MOL CELL ENDOCRINOL, V445, P65, DOI 10.1016/j.mce.2016.10.010; Ferraz-de-Souza B, 2011, MOL CELL ENDOCRINOL, V336, P198, DOI 10.1016/j.mce.2010.11.006; Geng XJ, 2017, REPRODUCTION, V154, P229, DOI 10.1530/REP-17-0234; Grossman H, 2016, RESULTS PROBL CELL D, V58, P309, DOI 10.1007/978-3-319-31973-5_12; Hatano M, 2016, ENDOCRINE, V54, P484, DOI 10.1007/s12020-016-1043-1; Hutchison GR, 2008, BIOL REPROD, V78, P352, DOI 10.1095/biolreprod.107.064006; Inoue M, 2018, MOL CELL ENDOCRINOL, V468, P39, DOI 10.1016/j.mce.2017.12.013; Li CL, 2018, MOL REPROD DEV, V85, P768, DOI 10.1002/mrd.23058; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Manna PR, 2006, J MOL ENDOCRINOL, V37, P81, DOI 10.1677/jme.1.02065; Martin LJ, 2016, MOL REPROD DEV, V83, P470, DOI 10.1002/mrd.22648; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Nel-Themaat L, 2011, BIOL REPROD, V84, P342, DOI 10.1095/biolreprod.110.086900; Ni FD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1782-z; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Rebourcet D., 2019, CURR OPIN ENDOCR MET, V6, P42, DOI [10.1016/j.coemr.2019.04.003, DOI 10.1016/J.COEMR.2019.04.003]; Rebourcet D, 2017, ENDOCRINOLOGY, V158, P2955, DOI 10.1210/en.2017-00196; Rebourcet D, 2016, ENDOCRINOLOGY, V157, P2479, DOI 10.1210/en.2016-1156; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Reza AMT, 2019, BIOL REV, V94, P415, DOI 10.1111/brv.12459; Sakurai K, 2016, J APPL TOXICOL, V36, P1614, DOI 10.1002/jat.3326; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; SHARPE RM, 1981, NATURE, V290, P785, DOI 10.1038/290785a0; Sung S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123715; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Ye LP, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00430	33	2	2	4	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21660	10.1096/fj.202002589RRRR	http://dx.doi.org/10.1096/fj.202002589RRRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34010469	hybrid			2022-12-28	WOS:000655695900016
J	Pospiech, M; Owens, SE; Miller, DJ; Austin-Muttitt, K; Mullins, JGL; Cronin, JG; Allemann, RK; Sheldon, IM				Pospiech, Mateusz; Owens, Sian E.; Miller, David J.; Austin-Muttitt, Karl; Mullins, Jonathan G. L.; Cronin, James G.; Allemann, Rudolf K.; Sheldon, I. Martin			Bisphosphonate inhibitors of squalene synthase protect cells against cholesterol-dependent cytolysins	FASEB JOURNAL			English	Article						bisphosphonate; cholesterol; cholesterol-dependent cytolysins; cytoprotection; pore-forming toxins; squalene synthase	PORE-FORMING TOXINS; STREPTOLYSIN-O; DISEASE TOLERANCE; SCORING FUNCTION; PLASMA-MEMBRANE; ZARAGOZIC ACIDS; HIGHLY POTENT; MEVALONATE; MECHANISM; DOCKING	Certain species of pathogenic bacteria damage tissues by secreting cholesterol-dependent cytolysins, which form pores in the plasma membranes of animal cells. However, reducing cholesterol protects cells against these cytolysins. As the first committed step of cholesterol biosynthesis is catalyzed by squalene synthase, we explored whether inhibiting this enzyme protected cells against cholesterol-dependent cytolysins. We first synthesized 22 different nitrogen-containing bisphosphonate molecules that were designed to inhibit squalene synthase. Squalene synthase inhibition was quantified using a cell-free enzyme assay, and validated by computer modeling of bisphosphonate molecules binding to squalene synthase. The bisphosphonates were then screened for their ability to protect HeLa cells against the damage caused by the cholesterol-dependent cytolysin, pyolysin. The most effective bisphosphonate reduced pyolysin-induced leakage of lactate dehydrogenase into cell supernatants by >80%, and reduced pyolysin-induced cytolysis from >75% to <25%. In addition, this bisphosphonate reduced pyolysin-induced leakage of potassium from cells, limited changes in the cytoskeleton, prevented mitogen-activated protein kinases cell stress responses, and reduced cellular cholesterol. The bisphosphonate also protected cells against another cholesterol-dependent cytolysin, streptolysin O, and protected lung epithelial cells and primary dermal fibroblasts against cytolysis. Our findings imply that treatment with bisphosphonates that inhibit squalene synthase might help protect tissues against pathogenic bacteria that secrete cholesterol-dependent cytolysins.	[Pospiech, Mateusz; Owens, Sian E.; Austin-Muttitt, Karl; Mullins, Jonathan G. L.; Cronin, James G.; Sheldon, I. Martin] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Miller, David J.; Allemann, Rudolf K.] Cardiff Univ, Sch Chem, Cardiff, Wales; [Pospiech, Mateusz] Univ Paris, Fac Pharm, CiTCoM, UMR 8038 CNRS, Paris, France	Swansea University; Cardiff University; UDICE-French Research Universities; Universite Paris Cite	Pospiech, M; Sheldon, IM (corresponding author), Swansea Univ, Sch Med, Swansea, W Glam, Wales.	mateusz.pospiech@parisdescartes.fr; i.m.sheldon@swansea.ac.uk	Sheldon, I Martin/E-1567-2013	Sheldon, I Martin/0000-0001-7902-5558; Owens, Sian-Eleri/0000-0003-1806-5235; Pospiech, Mateusz/0000-0002-7425-8800; Cronin, James/0000-0002-0590-9462	Life Science Research Network Wales [NRNS3APR009]	Life Science Research Network Wales	Life Science Research Network Wales, Grant/Award Number: NRNS3APR009	Abdelmaksoud AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183765; Abrams ME, 2020, NAT MICROBIOL, V5, P929, DOI 10.1038/s41564-020-0701-5; AGNEW WS, 1978, J BIOL CHEM, V253, P4574; Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; AMIN D, 1992, J LIPID RES, V33, P1657; Amin D, 1997, J PHARMACOL EXP THER, V281, P746; Amos MR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115972; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; BAXTER A, 1992, J BIOL CHEM, V267, P11705; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Boucher E, 2015, BBA-MOL CELL RES, V1853, P2649, DOI 10.1016/j.bbamcr.2015.07.012; CIOSEK CP, 1993, J BIOL CHEM, V268, P24832; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Das A, 2013, P NATL ACAD SCI USA, V110, P10580, DOI 10.1073/pnas.1309273110; Fukuchi J, 2003, STEROIDS, V68, P685, DOI 10.1016/S0039-128X(03)00100-4; Geidl S, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0107-1; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Goldeman W, 2012, TETRAHEDRON LETT, V53, P5290, DOI 10.1016/j.tetlet.2012.07.085; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Griffin S, 2018, BIOL REPROD, V99, P749, DOI 10.1093/biolre/ioy099; Griffin S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17138-y; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Ichikawa M, 2011, BIOORGAN MED CHEM, V19, P5207, DOI 10.1016/j.bmc.2011.07.007; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Jost BH, 2005, ANTON LEEUW INT J G, V88, P87, DOI 10.1007/s10482-005-2316-5; KANDUTSCH AA, 1974, J BIOL CHEM, V249, P6057; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Keller RK, 2013, LIPIDS, V48, P219, DOI 10.1007/s11745-013-3762-x; Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kurzak B, 2015, POLYHEDRON, V85, P675, DOI 10.1016/j.poly.2014.09.031; Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9; MAGNIN DR, 1995, J MED CHEM, V38, P2596, DOI 10.1021/jm00014a012; Maxfield FR, 2012, METHOD CELL BIOL, V108, P367, DOI 10.1016/B978-0-12-386487-1.00017-1; McCarville JL, 2018, CURR OPIN IMMUNOL, V50, P88, DOI 10.1016/j.coi.2017.12.003; MCKENNA CE, 1979, J CHEM SOC CHEM COMM, P739, DOI 10.1039/c39790000739; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Miquel K, 1996, BIOCHEM BIOPH RES CO, V225, P869, DOI 10.1006/bbrc.1996.1265; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; PAGE B, 1993, INT J ONCOL, V3, P473; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pleckaityte M, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00452; Preta G, 2015, FASEB J, V29, P1516, DOI 10.1096/fj.14-265207; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Radisky ES, 2000, BIOCHEMISTRY-US, V39, P1748, DOI 10.1021/bi9915014; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rogers MJ, 2004, CALCIFIED TISSUE INT, V75, P451, DOI 10.1007/s00223-004-0024-1; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Sheldon IM, 2019, ANNU REV ANIM BIOSCI, V7, P361, DOI 10.1146/annurev-animal-020518-115227; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Statt S, 2015, AM J RESP CELL MOL, V53, P689, DOI 10.1165/rcmb.2014-0391OC; Suzuki F., N PYRIDYLAMINOMETHYL; TAIT RM, 1992, ANAL BIOCHEM, V203, P310, DOI 10.1016/0003-2697(92)90318-2; Tan JMJ, 2018, NAT MICROBIOL, V3, P1472, DOI 10.1038/s41564-018-0293-5; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; Thompson JF, 1998, ARCH BIOCHEM BIOPHYS, V350, P283, DOI 10.1006/abbi.1997.0502; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Vainio MJ, 2007, J CHEM INF MODEL, V47, P2462, DOI 10.1021/ci6005646; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang YQ, 2008, J PROTEOME RES, V7, P1606, DOI 10.1021/pr7006076; Wasko BM, 2011, J LIPID RES, V52, P1957, DOI 10.1194/jlr.M016089; Widler L, 2002, J MED CHEM, V45, P3721, DOI 10.1021/jm020819i; Yoshioka H, 2020, P NATL ACAD SCI USA, V117, P7150, DOI 10.1073/pnas.1915923117; ZHANG DL, 1993, ARCH BIOCHEM BIOPHYS, V304, P133, DOI 10.1006/abbi.1993.1331; Zhou QD, 2020, NAT IMMUNOL, V21, P746, DOI 10.1038/s41590-020-0695-4	80	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21640	10.1096/fj.202100164R	http://dx.doi.org/10.1096/fj.202100164R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33991130	Green Accepted, Green Published			2022-12-28	WOS:000655695900054
J	Greiten, JK; Kliewe, F; Schnarre, A; Artelt, N; Schroder, S; Rogge, H; Amann, K; Daniel, C; Lindenmeyer, MT; Cohen, CD; Endlich, K; Endlich, N				Greiten, Jonas K.; Kliewe, Felix; Schnarre, Annabel; Artelt, Nadine; Schroeder, Sindy; Rogge, Henrik; Amann, Kerstin; Daniel, Christoph; Lindenmeyer, Maja T.; Cohen, Clemens D.; Endlich, Karlhans; Endlich, Nicole			The role of filamins in mechanically stressed podocytes	FASEB JOURNAL			English	Article						diabetic nephropathy; Flna; mechanosensor; mechanotransducer; mechanical load	ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; MONOCYTE SUBSETS; PROGNOSTIC-SIGNIFICANCE; HEART-FAILURE; RECRUITMENT; FRACTALKINE; KINETICS; CELLS; IDENTIFICATION	Glomerular hypertension induces mechanical load to podocytes, often resulting in podocyte detachment and the development of glomerulosclerosis. Although it is well known that podocytes are mechanosensitive, the mechanosensors and mechanotransducers are still unknown. Since filamin A, an actin-binding protein, is already described to be a mechanosensor and mechanotransducer, we hypothesized that filamins could be important for the outside-in signaling as well as the actin cytoskeleton of podocytes under mechanical stress. In this study, we demonstrate that filamin A is the main isoform of the filamin family that is expressed in cultured podocytes. Together with filamin B, filamin A was significantly up-regulated during mechanical stretch (3 days, 0.5 Hz, and 5% extension). To study the role of filamin A in cultured podocytes under mechanical stress, filamin A was knocked down (Flna KD) by specific siRNA. Additionally, we established a filamin A knockout podocyte cell line (Flna KO) by CRISPR/Cas9. Knockdown and knockout of filamin A influenced the expression of synaptopodin, a podocyte-specific protein, focal adhesions as well as the morphology of the actin cytoskeleton. Moreover, the cell motility of Flna KO podocytes was significantly increased. Since the knockout of filamin A has had no effect on cell adhesion of podocytes during mechanical stress, we simultaneously knocked down the expression of filamin A and B. Thereby, we observed a significant loss of podocytes during mechanical stress indicating a compensatory mechanism. Analyzing hypertensive mice kidneys as well as biopsies of patients suffering from diabetic nephropathy, we found an up-regulation of filamin A in podocytes in contrast to the control. In summary, filamin A and B mediate matrix-actin cytoskeleton interactions which are essential for the adaptation of cultured podocyte to mechanical stress.	[Greiten, Jonas K.; Kliewe, Felix; Schnarre, Annabel; Artelt, Nadine; Schroeder, Sindy; Rogge, Henrik; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Amann, Kerstin; Daniel, Christoph] Friedrich Alexander Univ FAU Erlangen Nuremberg, Dept Nephropathol, Erlangen, Germany; [Lindenmeyer, Maja T.] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany; [Cohen, Clemens D.] Univ Munich, Nephrol Ctr, Med Clin & Policlin 4, Munich, Germany	Greifswald Medical School; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Endlich, N (corresponding author), Univ Med Greifswald, Inst Anat & Zellbiol, Friedrich Loeffler Str 23c, D-17489 Greifswald, Germany.	nicole.endlich@uni-greifswald.de		Endlich, Karlhans/0000-0001-6052-6061	Research Network Molecular Medicine of the University Medicine Greifswald [FOVB-2018-02, FOVB-2019-04]; Federal Ministry of Education and Research (BMBF) [01GM1518B]; Else Kroner-Fresenius Foundation; Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (Germany); Martini et al JASN [11, 2559-2572]	Research Network Molecular Medicine of the University Medicine Greifswald; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Else Kroner-Fresenius Foundation; Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (Germany); Martini et al JASN	The authors thank Mandy Weise and Claudia Weber for technical assistance. The eGFP--synaptopodin plasmid was kindly provided by Anja Konietzny and Marina Mikhaylova (DFG Emmy Noether Group "Neuronal Protein Transport", Center for Molecular Neurobiology, University Medical Center Hamburg--Eppendorf, Hamburg, Germany). This work was supported by the Research Network Molecular Medicine of the University Medicine Greifswald [FOVB-2018-02 and FOVB-2019-04] and by a grant of the Federal Ministry of Education and Research (BMBF, grant 01GM1518B, STOP-FSGS) to Nicole Endlich. C.D.C and M.T.L are supported by the Else Kroner-Fresenius Foundation. We thank all participating centers of the European Renal cDNA Bank-Kroner-Fresenius Biopsy Bank (ERCB-KFB) and their patients for their cooperation. Active members at the time of the study are listed in ref. (Martini et al JASN 2014, Vol 25, No 11, 2559-2572). Part of the work was also supported by an Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (Germany).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bianchini M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aar3054; Boag SE, 2015, J CLIN INVEST, V125, P3063, DOI 10.1172/JCI80055; Buscher K, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00080; Cahill TJ, 2017, WORLD J CARDIOL, V9, P407, DOI 10.4330/wjc.v9.i5.407; Chapman GA, 2000, EUR J PHARMACOL, V392, P189, DOI 10.1016/S0014-2999(00)00117-5; Chimen M, 2017, J IMMUNOL, V198, P2834, DOI 10.4049/jimmunol.1601281; Frangogiannis NG, 2015, CURR OPIN CARDIOL, V30, P240, DOI 10.1097/HCO.0000000000000158; Halkin A, 2005, AM J CARDIOL, V96, P325, DOI 10.1016/j.amjcard.2005.03.069; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jung K, 2013, CIRC RES, V112, P891, DOI 10.1161/CIRCRESAHA.111.300484; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lewis EF, 2003, J AM COLL CARDIOL, V42, P1446, DOI 10.1016/S0735-1097(03)01057-X; Liebetrau C, 2015, CIRC RES, V116, P867, DOI 10.1161/CIRCRESAHA.116.304653; Lonborg J, 2013, EUR HEART J-CARD IMG, V14, P387, DOI 10.1093/ehjci/jes271; Maekawa Y, 2002, J AM COLL CARDIOL, V39, P241, DOI 10.1016/S0735-1097(01)01721-1; Meghraoui-Kheddar A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01117; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Redgrave RE, 2017, STEM CELL REP, V8, P1287, DOI 10.1016/j.stemcr.2017.04.015; Ruparelia N, 2015, EUR HEART J, V36, P1923, DOI 10.1093/eurheartj/ehv195; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; STONE PH, 1988, J AM COLL CARDIOL, V11, P453, DOI 10.1016/0735-1097(88)91517-3; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Toor IS, 2019, CLIN EXP IMMUNOL, V198, P83, DOI 10.1111/cei.13330; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; van der Laan AM, 2012, AM HEART J, V163, P57, DOI 10.1016/j.ahj.2011.09.002; Weber C, 2016, THROMB HAEMOSTASIS, V116, P626, DOI 10.1160/TH16-02-0091; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Zhou X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003466; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	35	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21560	10.1096/fj.202001179RR	http://dx.doi.org/10.1096/fj.202001179RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33860543				2022-12-28	WOS:000645260100065
J	Hesse, J; Groterath, W; Owenier, C; Steinhausen, J; Ding, ZP; Steckel, B; Czekelius, C; Alter, C; Marzoq, A; Schrader, J				Hesse, Julia; Groterath, Wiebke; Owenier, Christoph; Steinhausen, Julia; Ding, Zhaoping; Steckel, Bodo; Czekelius, Constantin; Alter, Christina; Marzoq, Aseel; Schrader, Juergen			Normoxic induction of HIF-1 alpha by adenosine-A(2B)R signaling in epicardial stromal cells formed after myocardial infarction	FASEB JOURNAL			English	Article						A(2B) receptor; cardioprotection; HIF-1 alpha; hypoxia; myocardial infarction	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ECTO-5'-NUCLEOTIDASE CD73; RECEPTOR; PROMOTES; HIF-1; ATP; DEGRADATION; MECHANISMS; ADAPTATION; PATHWAYS	Myocardial infarction (MI) activates the epicardium to form epicardial stromal cells (EpiSC) that reside in the epicardial hypoxic microenvironment. Paracrine factors secreted by EpiSC were shown to modulate the injury response of the post-MI heart and improve cardiac function. We have previously reported that the expression of the angiogenic cytokines vascular endothelial growth factor A (VEGFA) and IL-6 is strongly upregulated in EpiSC by adenosine acting via the A(2B) receptor (A(2B)R). Since tissue hypoxia is well known to be a potent stimulus for the generation of extracellular adenosine, the present study explored the crosstalk of A(2B)R activation and hypoxia-hypoxia-inducible factor 1 alpha (HIF-1 alpha) signaling in cultured EpiSC, isolated from rat hearts 5 days after MI. We found substantial nuclear accumulation of HIF-1 alpha after A(2B)R activation even in the absence of hypoxia. This normoxic HIF-1 alpha induction was PKC-dependent and involved upregulation of HIF-1 alpha mRNA expression. While the influence of hypoxia on adenosine generation and A(2B)R signaling was only minor, hypoxia and A(2B)R activation cumulatively increased VEGFA expression. Normoxic A(2B)R activation triggered an HIF-1 alpha-associated cell-protective metabolic switch and reduced oxygen consumption. HIF-1 alpha targets and negative regulators PHD2 and PHD3 were only weakly induced by A(2B)R signaling, which may result in a sustained HIF-1 alpha activity. The A(2B)R-mediated normoxic HIF-1 alpha induction was also observed in cardiac fibroblasts from healthy mouse hearts, suggesting that this mechanism is also functional in other A(2B)R-expressing cell types. Altogether, we identified A(2B)R-mediated HIF-1 alpha induction as novel aspect in the HIF-1 alpha-adenosine crosstalk, which modulates EpiSC activity and can amplify HIF-1 alpha-mediated cardioprotection.	[Hesse, Julia; Groterath, Wiebke; Owenier, Christoph; Steinhausen, Julia; Ding, Zhaoping; Steckel, Bodo; Alter, Christina; Marzoq, Aseel; Schrader, Juergen] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Mol Cardiol, D-40225 Dusseldorf, Germany; [Hesse, Julia; Groterath, Wiebke; Owenier, Christoph; Steinhausen, Julia; Ding, Zhaoping; Steckel, Bodo; Alter, Christina; Marzoq, Aseel; Schrader, Juergen] Heinrich Heine Univ Dusseldorf, Univ Hosp DUsseldorf, D-40225 Dusseldorf, Germany; [Czekelius, Constantin] Heinrich Heine Univ Dusseldorf, Inst Organ Chem & Macromol Chem, Dusseldorf, Germany; [Marzoq, Aseel] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; German Heart Centre Munich; Technical University of Munich	Hesse, J; Schrader, J (corresponding author), Heinrich Heine Univ Dusseldorf, Med Fac, Dept Mol Cardiol, D-40225 Dusseldorf, Germany.; Hesse, J; Schrader, J (corresponding author), Heinrich Heine Univ Dusseldorf, Univ Hosp DUsseldorf, D-40225 Dusseldorf, Germany.	julia.hesse@uni-duesseldorf.de; schrader@uni-duesseldorf.de			HHU \ Medizinische Fakultat, Heinrich-Heine-Universitat Dusseldorf (HHU) [2018-12]; Deutsche Forschungsgemeinschaft (DFG) [236177352, 220652768]	HHU \ Medizinische Fakultat, Heinrich-Heine-Universitat Dusseldorf (HHU); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	HHU | Medizinische Fakultat, Heinrich-Heine--Universitat Dusseldorf (HHU), Grant/Award Number: 2018--12; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 236177352; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 220652768	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Alter C, 2019, AM J PHYSIOL-HEART C, V317, pH190, DOI 10.1152/ajpheart.00029.2019; Aurelio L, 2008, BIOORGAN MED CHEM, V16, P1319, DOI 10.1016/j.bmc.2007.10.065; Aurelio L, 2018, J MED CHEM, V61, P2087, DOI 10.1021/acs.jmedchem.8b00047; Bakhashab S, 2014, G3-GENES GENOM GENET, V4, P2159, DOI 10.1534/g3.114.013102; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Borg N, 2017, CIRCULATION, V136, P297, DOI 10.1161/CIRCULATIONAHA.116.023365; Boros D, 2016, PERFUSION-UK, V31, P103, DOI 10.1177/0267659115586579; Cao JL, 2018, NAT REV CARDIOL, V15, P631, DOI 10.1038/s41569-018-0046-4; Caprara V, 2014, LIFE SCI, V118, P185, DOI 10.1016/j.lfs.2014.02.030; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Ding ZP, 2016, STEM CELL TRANSL MED, V5, P639, DOI 10.5966/sctm.2015-0159; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fan QY, 2019, CIRCULATION, V140, P440, DOI 10.1161/CIRCULATIONAHA.118.039276; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Gessi S, 2010, ARTERIOSCL THROM VAS, V30, P90, DOI 10.1161/ATVBAHA.109.194902; Gile J., 2016, J NAT SCI, V2; Gorlach A, 2009, CURR PHARM DESIGN, V15, P3844, DOI 10.2174/138161209789649420; Gregg A, 2007, BIOORG MED CHEM LETT, V17, P5437, DOI 10.1016/j.bmcl.2007.07.035; Hesse J, 2017, FASEB J, V31, P3040, DOI 10.1096/fj.201601307R; Hilaire CS, 2009, J CELL PHYSIOL, V218, P35, DOI 10.1002/jcp.21579; Iommarini L, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00286; Kietzmann T, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00011; Kocabas F, 2012, J CARDIOVASC TRANSL, V5, P654, DOI 10.1007/s12265-012-9366-7; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Masters M, 2014, STEM CELL RES, V13, P683, DOI 10.1016/j.scr.2014.04.007; Owenier C, 2020, CARDIOVASC RES, V116, P1047, DOI 10.1093/cvr/cvz193; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Quijada P, 2020, CIRC RES, V126, P377, DOI 10.1161/CIRCRESAHA.119.315857; Ragni E, 2013, J CELL MOL MED, V17, P168, DOI 10.1111/j.1582-4934.2012.01660.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Sun Y, 2016, FRONT CHEM, V4, DOI [10.3339/fchem.2016.00037, 10.3389/fchem.2016.00037]; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; To WKL, 2015, PLACENTA, V36, P759, DOI 10.1016/j.placenta.2015.04.005; Valant C, 2014, P NATL ACAD SCI USA, V111, P4614, DOI 10.1073/pnas.1320962111; Vecchio EA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00243; Vecchio EA, 2016, BIOCHEM PHARMACOL, V117, P46, DOI 10.1016/j.bcp.2016.08.007; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	53	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21517	10.1096/fj.202002545R	http://dx.doi.org/10.1096/fj.202002545R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913581	hybrid			2022-12-28	WOS:000645260100012
J	Wang, HX; Zhang, Q; Zhang, JY; Luan, R; Liang, ZF; Tan, L; Xu, YA; Zhang, P; Zheng, L; Zhao, Y; Qiu, YR				Wang, Hong-Xia; Zhang, Qian; Zhang, Jiayu; Luan, Rong; Liang, Zhanfeng; Tan, Liang; Xu, Yanan; Zhang, Peng; Zheng, Lei; Zhao, Yong; Qiu, Yu-Rong			CD74 regulates cellularity and maturation of medullary thymic epithelial cells partially by activating the canonical NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						CD74 (invariant chain); maturation; medullary thymic epithelial cells (mTECs); NF-kappa b; thymic epithelial cells (TECs)	SELF-ANTIGEN EXPRESSION; LACKING INVARIANT CHAIN; MICE LACKING; SURFACE EXPRESSION; HEMATOPOIETIC PROGENITORS; TOLERANCE; ALPHA; REQUIREMENT; SELECTION; ABSENCE	Thymic epithelial cells (TECs) are indispensable for T cell development, T cell receptor (TCR) repertoire selection, and specific lineage differentiation. Medullary thymic epithelial cells (mTECs), which account for the majority of TECs in adults, are critical for thymocyte selection and self-tolerance. CD74 is a nonpolymorphic transmembrane glycoprotein of major histocompatibility complex class II (MHCII) that is expressed in TECs. However, the exact role of CD74 in regulating the development of mTEC is poorly defined. In this research, we found that loss of CD74 resulted in a significant diminution in the medulla, a selective reduction in the cell number of mature mTECs expressing CD80 molecules, which eventually led to impaired thymic CD4(+) T cell development. Moreover, RNA-sequence analysis showed that CD74 deficiency obviously downregulated the canonical nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) signaling pathway in mTECs. Our results suggest that CD74 positively controls mTEC cellularity and maturation partially by activating the canonical NF-kappa B signaling pathway.	[Wang, Hong-Xia; Zheng, Lei; Qiu, Yu-Rong] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Hong-Xia; Zhang, Qian; Zhang, Jiayu; Luan, Rong; Liang, Zhanfeng; Xu, Yanan; Zhang, Peng; Zhao, Yong] Chinese Acad Sci, Transplantat Biol Res Div, State Key Lab Membrane Biol, Inst Zool, Beichen West Rd 1-5, Beijing 100101, Peoples R China; [Tan, Liang] Cent South Univ, Dept Urol Organ Transplantat, Ctr Organ Transplantat, Xiangya Hosp 2, Changsha, Peoples R China	Southern Medical University - China; Chinese Academy of Sciences; Central South University	Qiu, YR (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China.; Zhao, Y (corresponding author), Chinese Acad Sci, Transplantat Biol Res Div, State Key Lab Membrane Biol, Inst Zool, Beichen West Rd 1-5, Beijing 100101, Peoples R China.	zhaoy@ioz.ac.cn			National Natural Science Foundation of China [81801390, 81871712, 31800754]; National Key Research and Development Program of China [2017YFA0105002, 2017YFA0104402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China, Grant/Award Number: 81801390, 81871712 and 31800754; National Key Research and Development Program of China, Grant/Award Number: 2017YFA0105002 and 2017YFA0104402	Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Alexandropoulos K, 2012, IMMUNOL RES, V54, P177, DOI 10.1007/s12026-012-8301-y; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Bichele R, 2016, MOL IMMUNOL, V72, P92, DOI 10.1016/j.molimm.2016.02.015; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Binsky I, 2007, P NATL ACAD SCI USA, V104, P13408, DOI 10.1073/pnas.0701553104; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Ceman S, 1995, Semin Immunol, V7, P373, DOI 10.1006/smim.1995.0042; Cowan JE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13465-y; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Datta MW, 2000, APPL IMMUNOHISTO M M, V8, P210, DOI 10.1097/00022744-200009000-00007; De R, 2018, J BIOL CHEM, V293, P19740, DOI 10.1074/jbc.RA118.003935; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; Gil-Yarom N, 2017, P NATL ACAD SCI USA, V114, P562, DOI 10.1073/pnas.1612195114; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; HENNE C, 1995, IMMUNOLOGY, V84, P177; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Irla M, 2013, J IMMUNOL, V190, P586, DOI 10.4049/jimmunol.1200119; Jenkinson SR, 2013, P NATL ACAD SCI USA, V110, P21107, DOI 10.1073/pnas.1314859111; Kenty G, 1998, J IMMUNOL, V160, P606; Klasen C, 2018, CELL SIGNAL, V46, P32, DOI 10.1016/j.cellsig.2018.02.010; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Levi D, 2013, CYTOKINE, V62, P433, DOI 10.1016/j.cyto.2013.03.026; Liang ZF, 2021, J CELL PHYSIOL, V236, P4725, DOI 10.1002/jcp.30192; Liang ZF, 2018, AUTOPHAGY, V14, P505, DOI 10.1080/15548627.2017.1376161; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marin V, 2017, J HEPATOL, V67, P1018, DOI 10.1016/j.jhep.2017.06.014; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Matza D, 2002, IMMUNITY, V17, P549, DOI 10.1016/S1074-7613(02)00455-7; Matza D, 2001, J BIOL CHEM, V276, P27203, DOI 10.1074/jbc.M104684200; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Riemann M, 2017, J AUTOIMMUN, V81, P56, DOI 10.1016/j.jaut.2017.03.007; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Shen H, 2019, P NATL ACAD SCI USA, V116, P19090, DOI 10.1073/pnas.1901056116; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Su HT, 2017, INFLAMM RES, V66, P209, DOI 10.1007/s00011-016-0995-1; Su M, 2018, IMMUNOL CELL BIOL, V96, P229, DOI 10.1111/imcb.1026; Sun LG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/816979; Sun LN, 2013, J IMMUNOL, V191, P3210, DOI 10.4049/jimmunol.1300363; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Venables T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11879-2; Villegas JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01663; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; Wang HX, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03099; Wang HX, 2016, J IMMUNOL, V197, P141, DOI 10.4049/jimmunol.1502698; Wang HX, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002370; Wei CN, 2018, PHYSIOL GENOMICS, V50, DOI 10.1152/physiolgenomics.00098.2017; Williams JA, 2014, J IMMUNOL, V192, P630, DOI 10.4049/jimmunol.1302550; Wong P, 1996, J IMMUNOL, V156, P2133; Wright RJ, 1998, IMMUNOLOGY, V95, P309, DOI 10.1046/j.1365-2567.1998.00595.x; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	64	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21535	10.1096/fj.202100139R	http://dx.doi.org/10.1096/fj.202100139R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817835				2022-12-28	WOS:000645260100086
J	Yan, SM; Wu, G				Yan, Shaomin; Wu, Guang			Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development	FASEB JOURNAL			English	Review						3CL(pro); COVID-19; MERS-CoV; nsp; SARS-CoV; SARS-CoV-2	STRANDED-RNA VIRUS; SARS-COV; 3C-LIKE PROTEASE; MAIN PROTEASE; DIMER INTERFACE; POLYMERASE GENE; M-PRO; SEQUENCE; IDENTIFICATION; PSEUDOKNOT	Coronavirus (CoV) 3-chymotrypsin (C)-like cysteine protease (3CL(pro)) is a target for anti-CoV drug development and drug repurposing because along with papain-like protease, it cleaves CoV-encoded polyproteins (pp1a and pp1ab) into nonstructural proteins (nsps) for viral replication. However, the cleavage sites of 3CL(pro) and their relevant nsps remain unclear, which is the subject of this perspective. Here, we address the subject from three standpoints. First, we explore the inconsistency in the cleavage sites and relevant nsps across CoVs, and investigate the function of nsp11. Second, we consider the nsp16 mRNA overlapping of the spike protein mRNA, and analyze the effect of this overlapping on mRNA vaccines. Finally, we study nsp12, whose existence depends on ribosomal frameshifting, and investigate whether 3CL(pro) requires a large number of inhibitors to achieve full inhibition. This perspective helps us to clarify viral replication and is useful for developing anti-CoV drugs with 3CL(pro) as a target in the current coronavirus disease 2019 (COVID-19) pandemic.	[Yan, Shaomin; Wu, Guang] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Guangxi Key Lab Biorefinery,Guangxi Biomass Engn, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China		Wu, G (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Guangxi Key Lab Biorefinery,Guangxi Biomass Engn, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China.	hongguanglishibahao@gxas.cn		Wu, Guang/0000-0003-0775-5759; Yan, Shaomin/0000-0001-7642-3972	Scientific Development Fund of Guangxi Academy of Sciences; Key Project of Guangxi Scientific Research and Technology Development Plan [AB17190534]	Scientific Development Fund of Guangxi Academy of Sciences; Key Project of Guangxi Scientific Research and Technology Development Plan	This study was supported by Scientific Development Fund of Guangxi Academy of Sciences and Key Project of Guangxi Scientific Research and Technology Development Plan (AB17190534).	Abuhammad A, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2644; Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Al-Obaidi MMJ, 2018, ACTA VIROL, V62, P16, DOI 10.4149/av_2018_102; Alberer M, 2017, LANCET, V390, P1511, DOI 10.1016/S0140-6736(17)31665-3; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; [Anonymous], REMD EUA FACT SHEET; Baranov PV, 2005, VIROLOGY, V332, P498, DOI 10.1016/j.virol.2004.11.038; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; BREDENBEEK PJ, 1990, NUCLEIC ACIDS RES, V18, P1825, DOI 10.1093/nar/18.7.1825; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Cannalire R, 2022, J MED CHEM, V65, P2716, DOI 10.1021/acs.jmedchem.0c01140; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chen S, 2008, J BIOCHEM, V143, P525, DOI 10.1093/jb/mvm246; Chen S, 2008, J BIOL CHEM, V283, P554, DOI 10.1074/jbc.M705240200; Chen S, 2010, PROTEIN CELL, V1, P59, DOI 10.1007/s13238-010-0011-4; Chen YQ, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04793; Chen Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002294; Cheng A, 2005, VIROLOGY, V335, P165, DOI 10.1016/j.virol.2005.02.017; Cho A, 2012, BIOORG MED CHEM LETT, V22, P2705, DOI 10.1016/j.bmcl.2012.02.105; Chuck CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013197; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Decroly E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002059; DENISON MR, 1991, J VIROL, V65, P3076, DOI 10.1128/JVI.65.6.3076-3082.1991; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Durojaiye AB, 2021, J BIOMOL STRUCT DYN, V39, P4547, DOI 10.1080/07391102.2020.1777904; Elshabrawy HA, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020335; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Gao F, 2003, FEBS LETT, V553, P451, DOI 10.1016/S0014-5793(03)01091-3; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4847, DOI 10.1093/nar/17.12.4847; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; HEROLD J, 1993, VIROLOGY, V195, P680, DOI 10.1006/viro.1993.1419; HEROLD J, 1993, NUCLEIC ACIDS RES, V21, P5838; Hilgenfeld R, 2013, ANTIVIR RES, V100, P286, DOI 10.1016/j.antiviral.2013.08.015; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hu TC, 2009, VIROLOGY, V388, P324, DOI 10.1016/j.virol.2009.03.034; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Hung M, 1998, J VIROL, V72, P4819, DOI 10.1128/JVI.72.6.4819-4824.1998; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Joshi S, 2020, FUTURE MED CHEM, V12, P1579, DOI 10.4155/fmc-2020-0147; Kankanamalage ACG, 2018, EUR J MED CHEM, V150, P334, DOI 10.1016/j.ejmech.2018.03.004; Kiemer L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-72; Kumar V, 2016, BIOORGAN MED CHEM, V24, P3035, DOI 10.1016/j.bmc.2016.05.013; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; Lin CW, 2004, FEBS LETT, V574, P131, DOI 10.1016/j.febslet.2004.08.017; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Miczi M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249523; Muramatsu T, 2016, P NATL ACAD SCI USA, V113, P12997, DOI 10.1073/pnas.1601327113; NAM SH, 1993, J VIROL, V67, P196, DOI 10.1128/JVI.67.1.196-203.1993; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Park SJ, 2011, J AM CHEM SOC, V133, P10094, DOI 10.1021/ja1098325; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Peselis A, 2014, WIRES RNA, V5, P803, DOI 10.1002/wrna.1247; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Plant EP, 2008, FRONT BIOSCI-LANDMRK, V13, P4873, DOI 10.2741/3046; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; SNIJDER EJ, 1990, J VIROL, V64, P331, DOI 10.1128/JVI.64.1.331-338.1990; SNIJDER EJ, 1993, J GEN VIROL, V74, P2305, DOI 10.1099/0022-1317-74-11-2305; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; SNIJDER EJ, 1990, VIROLOGY, V178, P355, DOI 10.1016/0042-6822(90)90332-L; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Stoddard SV, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12090942; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; Wang FH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22677; Wang H, 2020, ACS CATAL, V10, P5871, DOI 10.1021/acscatal.0c00110; Wu F, 2020, NATURE, V580, pE7; Xia B, 2011, PROTEIN CELL, V2, P282, DOI 10.1007/s13238-011-1034-1; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2006, CURR PHARM DESIGN, V12, P4573, DOI 10.2174/138161206779010369; Yang HT, 2005, PLOS BIOL, V3, P1742, DOI 10.1371/journal.pbio.0030324; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhang NN, 2020, CELL, V182, P1271, DOI 10.1016/j.cell.2020.07.024; Zhang SN, 2010, PROTEIN CELL, V1, P371, DOI 10.1007/s13238-010-0044-8; Zhang Y, 2021, J PROTEOME RES, V20, P49, DOI 10.1021/acs.jproteome.0c00526; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853; ZIEBUHR J, 1995, J VIROL, V69, P4331, DOI 10.1128/JVI.69.7.4331-4338.1995; Ziebuhr J, 2001, J BIOL CHEM, V276, P33220, DOI 10.1074/jbc.M104097200	96	9	9	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21573	10.1096/fj.202100280RR	http://dx.doi.org/10.1096/fj.202100280RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913206	Green Published			2022-12-28	WOS:000645260100051
J	Zhang, F; Li, Y; Gan, LP; Tong, XM; Qi, DD; Wang, QH; Ye, X				Zhang, Fang; Li, Yong; Gan, Lipeng; Tong, Xiaomei; Qi, Dandan; Wang, Qihui; Ye, Xin			HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA	FASEB JOURNAL			English	Article						cell proliferation; HBV; MAFG; MAFG-AS1; nonmuscle myosin IIA	LONG NONCODING RNA; CANCER; PHOSPHORYLATION; GENE; DNA	To identify hepatitis B virus (HBV)-related lncRNA(s), we previously examined the transcription profiles of the HBV-transgenic cell line HepG2-4D14 and parental HepG2 cells by RNA deep sequencing and identified 38 upregulated long noncoding RNAs (lncRNAs). In the present study, the lncRNA MAFG-AS1 is investigated in detail because its gene is located adjacent to the MAFG gene, which is an important transcription factor involved in cell proliferation. The level of MAFG-AS1 is significantly higher in HCC tissue than in nontumor tissues. TCGA data show that the expression level of MAFG-AS1 is negatively correlated with survival of HCC patients. GEO cohort data show that compared with healthy tissues, the expression level of MAFG-AS1 is significantly higher in HBV-infected liver tissues. Real-time PCR and luciferase reporter assay data show that HBx can enhance the transcription of MAFG-AS1. Gain-of-function and loss-of-function experiments indicate that MAFG-AS1 promotes proliferation, migration, and invasion of HCC cells. Tumor formation assay results demonstrate that knockdown of MAFG-AS1 significantly inhibits cell proliferation in nude mice. Furthermore, MAFG-AS1 enhances the transcription of adjacent MAFG via E2F1. Additionally, MAFG-AS1 interacts with three subunits (MYH9, MYL12B, and MYL6) of nonmuscle myosin IIA (NM IIA). Knockdown of MAFG-AS1 inhibits ATPase activity of MYH9, interaction of NM IIA subunits, and cell cycle progression. Thus, the lncRNA MAFG-AS1 is upregulated by HBV and promotes proliferation and migration of HCC cells. Our findings suggest that MAFG-AS1 is a potential oncogene that may contribute to HBV-related HCC development.	[Zhang, Fang; Li, Yong; Gan, Lipeng; Tong, Xiaomei; Qi, Dandan; Wang, Qihui; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Zhang, Fang; Li, Yong; Gan, Lipeng; Ye, Xin] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [81772989, 31900143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81772989 and 31900143	Atanasovska B, 2017, HEPATOLOGY, V66, P794, DOI 10.1002/hep.29034; Chen JA, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0947-9; Cui SS, 2018, BIOCHEM BIOPH RES CO, V506, P251, DOI 10.1016/j.bbrc.2018.10.112; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Gao WW, 2020, HEPATOLOGY, V71, P1678, DOI 10.1002/hep.30947; Gao Y, 2017, HEPATOLOGY, V66, P1413, DOI 10.1002/hep.29316; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Huang PB, 2020, ONCOGENE, V39, P3774, DOI 10.1038/s41388-020-1254-z; Komatsu S, 2007, MOL BIOL CELL, V18, P5081, DOI 10.1091/mbc.E06-12-1076; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Liu NN, 2018, HEPATOLOGY, V68, P2130, DOI 10.1002/hep.30098; Liu PY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12971-3; Newell-Litwa KA, 2015, DIS MODEL MECH, V8, P1495, DOI 10.1242/dmm.022103; Nguyen MH, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00046-19; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ouyang H, 2019, EXP THER MED, V18, P2547, DOI 10.3892/etm.2019.7850; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pei HL, 2018, CANCER RES, V78, P4563, DOI 10.1158/0008-5472.CAN-18-0988; Qin G, 2020, HEPATOLOGY, V71, P112, DOI 10.1002/hep.30793; Revill PA, 2020, NAT REV GASTRO HEPAT, V17, P618, DOI 10.1038/s41575-020-0296-6; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Salerno D, 2020, GUT, V69, P2016, DOI 10.1136/gutjnl-2019-319637; Singer RA, 2019, CELL METAB, V30, P1091, DOI 10.1016/j.cmet.2019.09.013; Sui Y, 2019, EUR J PHARMACOL, V859, DOI 10.1016/j.ejphar.2019.172465; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Sun TT, 2016, CANCER DISCOV, V6, P784, DOI 10.1158/2159-8290.CD-15-0921; Tang J, 2019, NAT COMMUN, V1, DOI DOI 10.1038/S41467-019-11447-824; Tong S., 2016, J HEPATOL, V64, pS4; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang M, 2019, CELL DEATH DIFFER, V26, P2329, DOI 10.1038/s41418-019-0304-y; Wang YQ, 2017, P NATL ACAD SCI USA, V114, P474, DOI 10.1073/pnas.1619917114; Wong CM, 2018, NAT REV GASTRO HEPAT, V15, P137, DOI 10.1038/nrgastro.2017.169	35	9	9	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21529	10.1096/fj.202002374R	http://dx.doi.org/10.1096/fj.202002374R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813778				2022-12-28	WOS:000645260100106
J	Zhang, YJ; Masters, L; Wang, YH; Wu, LY; Pei, YX; Guo, BQ; Parissenti, A; Lees, SJ; Wang, R; Yang, GD				Zhang, Yanjie; Masters, Laura; Wang, Yuehong; Wu, Lingyun; Pei, Yanxi; Guo, Baoqing; Parissenti, Amadeo; Lees, Simon J.; Wang, Rui; Yang, Guangdong			Cystathionine gamma-lyase/H2S signaling facilitates myogenesis under aging and injury condition	FASEB JOURNAL			English	Article						aging; cystathionine gamma-lyase; H2S; MEF2c; myogenesis; S-sulfhydration	ENDOGENOUS HYDROGEN-SULFIDE; GAMMA-LYASE; S-SULFHYDRATION; LIFE-SPAN; MYOBLAST DIFFERENTIATION; DIETARY RESTRICTION; H2S; CYSTEINE; REGULATOR; INCREASES	Hydrogen sulfide (H2S) can be endogenously produced and belongs to the class of signaling molecules known as gasotransmitters. Cystathionine gamma-lyase (CSE)-derived H2S is implicated in the regulation of cell differentiation and the aging process, but the involvements of the CSE/H2S system in myogenesis upon aging and injury have not been explored. In this study, we demonstrated that CSE acts as a major H2S-generating enzyme in skeletal muscles and is significantly down-regulated in aged skeletal muscles in mice. CSE deficiency exacerbated the age-dependent sarcopenia and cardiotoxin-induced injury/regeneration in mouse skeletal muscle, possibly attributed to inefficient myogenesis. In contrast, supplement of NaHS (an H2S donor) induced the expressions of myogenic genes and promoted muscle regeneration in mice. In vitro, incubation of myoblast cells (C2C12) with H2S promoted myogenesis, as evidenced by the inhibition of cell cycle progression and migration, altered expressions of myogenic markers, elongation of myoblasts, and formation of multinucleated myotubes. Myogenesis was also found to upregulate CSE expression, while blockage of CSE/H2S signaling resulted in a suppression of myogenesis. Mechanically, H2S significantly induced the heterodimer formation between MEF2c and MRF4 and promoted the binding of MEF2c/MRF4 to myogenin promoter. MEF2c was S-sulfhydrated at both cysteine 361 and 420 in the C-terminal transactivation domain, and blockage of MEF2c S-sulfhydration abolished the stimulatory role of H2S on MEF2c/MRF4 heterodimer formation. These findings support an essential role for H2S in maintaining myogenesis, presenting it as a potential candidate for the prevention of age-related sarcopenia and treatment of muscle injury.	[Zhang, Yanjie; Masters, Laura; Wang, Yuehong; Guo, Baoqing; Parissenti, Amadeo; Yang, Guangdong] Laurentian Univ, Dept Chem & Biochem, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada; [Zhang, Yanjie; Masters, Laura; Wang, Yuehong; Wu, Lingyun; Yang, Guangdong] Laurentian Univ, Cardiovasc & Metab Res Unit, Sudbury, ON, Canada; [Wu, Lingyun] Laurentian Univ, Sch Human Kinet, Sudbury, ON, Canada; [Wu, Lingyun; Guo, Baoqing; Parissenti, Amadeo] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Pei, Yanxi] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China; [Lees, Simon J.] Northern Ontario Sch Med, Thunder Bay, ON, Canada; [Wang, Rui] York Univ, Dept Biol, Toronto, ON, Canada	Laurentian University; Laurentian University; Laurentian University; Health Sciences North; Northern Ontario School of Medicine; Shanxi University; Northern Ontario School of Medicine; York University - Canada	Yang, GD (corresponding author), Laurentian Univ, Dept Chem & Biochem, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada.	gyang2@laurentian.ca	Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620; Yang, Guangdong/0000-0003-3575-7786	Natural Sciences and Engineering Research Council of Canada [04051]; Heart and Stroke Foundation of Canada [G-18-0022098]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: 04051; Heart and Stroke Foundation of Canada, Grant/Award Number: G-18-0022098	Baghdadi MB, 2018, CELL STEM CELL, V23, P859, DOI 10.1016/j.stem.2018.09.017; Bitar MS, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6825452; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brunet A, 2014, J GERONTOL A-BIOL, V69, pS17, DOI 10.1093/gerona/glu042; Byun SK, 2017, MOL CELLS, V40, P667, DOI 10.14348/molcells.2017.0116; Chen YH, 2005, CHEST, V128, P3205, DOI 10.1378/chest.128.5.3205; Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008; Ding J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155349; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Droge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Gao XH, 2020, MOL CELL PROTEOMICS, V19, P852, DOI 10.1074/mcp.RA119.001910; Guo BQ, 2003, BREAST CANCER RES TR, V82, P125, DOI 10.1023/B:BREA.0000003969.21267.81; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Iciek M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150147; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Islam KN, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001986; Jin S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/758358; Ju YJ, 2015, BBA-GEN SUBJECTS, V1850, P2293, DOI 10.1016/j.bbagen.2015.08.003; Keller K, 2019, WIEN MED WOCHENSCHR, V169, P157, DOI 10.1007/s10354-018-0618-2; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Lands LC, 1999, J APPL PHYSIOL, V87, P1381, DOI 10.1152/jappl.1999.87.4.1381; Leslie M, 2008, SCIENCE, V320, P1155, DOI 10.1126/science.320.5880.1155; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Longchamp A, 2018, CELL, V173, P117, DOI 10.1016/j.cell.2018.03.001; Lu FP, 2020, J CELL MOL MED, V24, P9362, DOI 10.1111/jcmm.15587; Lu ZH, 2019, REJUV RES, V22, P513, DOI 10.1089/rej.2018.2166; Majumder A, 2018, AM J PHYSIOL-CELL PH, V315, pC609, DOI 10.1152/ajpcell.00147.2018; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Matei IV, 2017, REGEN MED, V12, P125, DOI 10.2217/rme-2016-0142; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagpure BV, 2015, HANDB EXP PHARMACOL, V230, P193, DOI 10.1007/978-3-319-18144-8_10; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Ohtsubo H, 2017, INT J BIOCHEM CELL B, V85, P91, DOI 10.1016/j.biocel.2017.02.005; Okamoto S, 2014, CELL REP, V8, P217, DOI 10.1016/j.celrep.2014.06.005; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Parsanathan R, 2019, ARCH BIOCHEM BIOPHYS, V672, DOI 10.1016/j.abb.2019.07.019; Parsanathan R, 2018, FREE RADICAL RES, V52, P288, DOI 10.1080/10715762.2018.1431626; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Perridon BW, 2016, AGING-US, V8, P2264, DOI 10.18632/aging.101026; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Qabazard B, 2015, HANDB EXP PHARMACOL, V230, P269, DOI 10.1007/978-3-319-18144-8_14; Qabazard B, 2014, ANTIOXID REDOX SIGN, V20, P2621, DOI 10.1089/ars.2013.5448; Rizvi SI, 2008, REJUV RES, V11, P661, DOI 10.1089/rej.2007.0652; Sen N, 2017, J MOL BIOL, V429, P543, DOI 10.1016/j.jmb.2016.12.015; Sen U, 2012, AM J PHYSIOL-CELL PH, V303, pC41, DOI 10.1152/ajpcell.00398.2011; Shaposhnikov M, 2018, AGING-US, V10, P3260, DOI 10.18632/aging.101630; Shaposhnikov MV, 2021, BIOGERONTOLOGY, V22, P197, DOI 10.1007/s10522-021-09911-4; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Sinha-Hikim I, 2013, J GERONTOL A-BIOL, V68, P749, DOI 10.1093/gerona/gls334; Stokes E, 2018, LIFE SCI, V213, P116, DOI 10.1016/j.lfs.2018.10.031; Szczesny B, 2014, NITRIC OXIDE-BIOL CH, V41, P120, DOI 10.1016/j.niox.2014.04.008; Vellecco V, 2020, BRIT J PHARMACOL, V177, P810, DOI 10.1111/bph.14700; Vellecco V, 2018, BRIT J PHARMACOL, V175, P3090, DOI 10.1111/bph.14358; Wang PP, 2017, ANTIOXID REDOX SIGN, V27, P931, DOI 10.1089/ars.2016.6875; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang RX, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9752698; Wang WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30292; Wang XJ, 2017, GENE, V629, P68, DOI 10.1016/j.gene.2017.07.062; Wang YH, 2020, NITRIC OXIDE-BIOL CH, V103, P9, DOI 10.1016/j.niox.2020.07.002; Wetzel MD, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1753-7; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2018, BBA-MOL CELL BIOL L, V1863, P165, DOI 10.1016/j.bbalip.2017.11.008; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2012, J MOL CELL CARDIOL, V52, P677, DOI 10.1016/j.yjmcc.2011.12.004; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Yang R, 2020, EXP BIOL MED, V245, P1280, DOI 10.1177/1535370220931038; Zhang YJ, 2020, ANTIOXID REDOX SIGN, V32, P583, DOI 10.1089/ars.2019.7824; Zhao KX, 2014, EMBO REP, V15, P792, DOI 10.1002/embr.201338213; Zhao KX, 2014, FRONT BIOSCI-LANDMRK, V19, P1355, DOI 10.2741/4286; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zivanovic J, 2019, CELL METAB, V30, P1152, DOI 10.1016/j.cmet.2019.10.007	79	9	9	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21511	10.1096/fj.202002675R	http://dx.doi.org/10.1096/fj.202002675R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826201				2022-12-28	WOS:000645260100010
J	Menko, AS; DeDreu, J; Logan, CM; Paulson, H; Levin, AV; Walker, JL				Menko, A. Sue; DeDreu, JodiRae; Logan, Caitlin M.; Paulson, Heather; Levin, Alex V.; Walker, Janice L.			Resident immune cells of the avascular lens: Mediators of the injury and fibrotic response of the lens	FASEB JOURNAL			English	Article						fibrosis; injury; lens; resident immune cells; wound healing	POSTERIOR CAPSULE; TISSUE; PHAGOCYTOSIS; MACROPHAGES; MONOCYTES; CATARACT; ANTIGEN; REPAIR; CD14; DIFFERENTIATION	Tissues typically harbor subpopulations of resident immune cells that function as rapid responders to injury and whose activation leads to induction of an adaptive immune response, playing important roles in repair and protection. Since the lens is an avascular tissue, it was presumed that it was absent of resident immune cells. Our studies now show that resident immune cells are a shared feature of the human, mouse, and chicken lens epithelium. These resident immune cells function as immediate responders to injury and rapidly populate the wound edge following mock cataract surgery to function as leader cells. Many of these resident immune cells also express MHCII providing them with antigen presenting ability to engage an adaptive immune response. We provide evidence that during development immune cells migrate on the ciliary zonules and localize among the equatorial epithelial cells of the lens adjacent to where the ciliary zonules associate with the lens capsule. These findings suggest that the vasculature-rich ciliary body is a source of lens resident immune cells. We identified a major role for these cells as rapid responders to wounding, quickly populating each wound were they can function as leaders of lens tissue repair. Our findings also show that lens resident immune cells are progenitors of myofibroblasts, which characteristically appear in response to lens cataract surgery injury, and therefore, are likely agents of lens pathologies to impair vision like fibrosis.	[Menko, A. Sue; DeDreu, JodiRae; Logan, Caitlin M.; Paulson, Heather; Walker, Janice L.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Room 571 JAH, Philadelphia, PA 19107 USA; [Menko, A. Sue; Levin, Alex V.; Walker, Janice L.] Thomas Jefferson Univ, Dept Ophthalmol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Levin, Alex V.] Wills Eye Hosp & Res Inst, Philadelphia, PA USA; [Logan, Caitlin M.] Stanford Univ, Mary M & Sash A Spencer Ctr Vision Res, Byers Eye Inst, Palo Alto, CA 94304 USA; [Levin, Alex V.] Univ Rochester, Med Ctr, Flaum Eye Inst, Rochester, NY 14642 USA; [Levin, Alex V.] Univ Rochester, Med Ctr, Golisano Childrens Hosp, Rochester, NY 14642 USA	Jefferson University; Jefferson University; Jefferson University; Stanford University; University of Rochester; University of Rochester	Walker, JL (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Room 571 JAH, Philadelphia, PA 19107 USA.	Janice.Walker@jefferson.edu		Menko, A. Sue/0000-0002-7514-4696	HHS \ NIH \ National Eye Institute (NEI) [EY02615, EY021784]	HHS \ NIH \ National Eye Institute (NEI)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY02615 and EY021784	Ancuta P, 2000, EUR J IMMUNOL, V30, P1872, DOI 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Ardain A, 2020, IMMUNOLOGY, V159, P245, DOI 10.1111/imm.13143; Beebe DC, 2008, SEMIN CELL DEV BIOL, V19, P125, DOI 10.1016/j.semcdb.2007.08.014; Bleaken BM, 2016, MOL BIOL CELL, V27, P451, DOI 10.1091/mbc.E15-09-0615; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Blum-Hareuveni T, 2017, AM J OPHTHALMOL, V177, P139, DOI 10.1016/j.ajo.2017.02.023; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; Caputa G, 2019, NAT IMMUNOL, V20, P793, DOI 10.1038/s41590-019-0407-0; Chang JL, 2019, J CELL BIOL, V218, P2456, DOI 10.1083/jcb.201903066; CUADROS MA, 1991, CELL TISSUE RES, V266, P117, DOI 10.1007/BF00678718; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dawson CA, 2020, NAT CELL BIOL, V22, P546, DOI 10.1038/s41556-020-0505-0; De Maria A, 2017, INVEST OPHTH VIS SCI, V58, P573, DOI 10.1167/iovs.16-20866; DeDreu J, 2020, FASEB J, V34, P9316, DOI 10.1096/fj.202000289R; Eom DS, 2017, SCIENCE, V355, P1317, DOI 10.1126/science.aal2745; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fisus AD, 2020, EYE, V34, P256, DOI 10.1038/s41433-019-0723-5; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; HAYNES BF, 1989, IMMUNOL TODAY, V10, P423, DOI 10.1016/0167-5699(89)90040-6; Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hu W, 2013, J LEUKOCYTE BIOL, V94, P409, DOI 10.1189/jlb.0413207; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jancevski M, 2010, DISCOV MED, V9, P51; Jensen AA, 2002, OPHTHALMOLOGY, V109, P324, DOI 10.1016/S0161-6420(01)00950-2; Jiang J, 2018, INVEST OPHTH VIS SCI, V59, P4986, DOI 10.1167/iovs.18-25067; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Lang RA, 1997, CELL DEATH DIFFER, V4, P12, DOI 10.1038/sj.cdd.4400211; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lim JJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00191; Liu FM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16158-z; Llop SM, 2018, SEMIN OPHTHALMOL, V33, P64, DOI 10.1080/08820538.2017.1353815; Logan CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16456-5; Lu JL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01173; Lu WL, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/8160256; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; McLeod DS, 2012, INVEST OPHTH VIS SCI, V53, P7912, DOI 10.1167/iovs.12-10140; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Negahban Kambiz, 2002, Curr Opin Ophthalmol, V13, P419, DOI 10.1097/00055735-200212000-00013; Niederkorn J Y, 1990, Adv Immunol, V48, P191, DOI 10.1016/S0065-2776(08)60755-5; Nishitani K, 2006, EXP EYE RES, V83, P223, DOI 10.1016/j.exer.2005.12.008; Obrosova IG, 2010, DIABETES-METAB RES, V26, P172, DOI 10.1002/dmrr.1075; Oishi Y, 2018, INT IMMUNOL, V30, P511, DOI 10.1093/intimm/dxy054; Pakshir P, 2020, J CELL SCI, V133, DOI 10.1242/jcs.227900; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Raj Shetal M, 2007, Int J Biomed Sci, V3, P237; Richmond JM, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015339; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rocher M, 2020, EYE, V34, P232, DOI 10.1038/s41433-019-0684-8; SAIKA S, 1992, JPN J OPHTHALMOL, V36, P184; Saika S, 1997, J CATARACT REFR SURG, V23, P787, DOI 10.1016/S0886-3350(97)80292-1; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Shu DY, 2017, PROG RETIN EYE RES, V60, P44, DOI 10.1016/j.preteyeres.2017.08.001; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; TODD RF, 1981, J IMMUNOL, V126, P1435; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; UENOYAMA K, 1990, J CATARACT REFR SURG, V16, P465, DOI 10.1016/S0886-3350(13)80800-0; Ursell PG, 2020, EYE, V34, P960, DOI 10.1038/s41433-019-0630-9; Walker JL, 2018, MOL BIOL CELL, V29, P1555, DOI 10.1091/mbc.E17-06-0364; Walker JL, 2007, INVEST OPHTH VIS SCI, V48, P2214, DOI 10.1167/iovs.06-1059; Walker JL, 2015, JOVE-J VIS EXP, DOI 10.3791/52886; Walker JL, 2010, P NATL ACAD SCI USA, V107, P13730, DOI 10.1073/pnas.0910382107; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu YF, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135121; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015	76	10	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21341	10.1096/fj.202002200R	http://dx.doi.org/10.1096/fj.202002200R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710665	Green Published			2022-12-28	WOS:000635216100097
J	Wang, ZZ; Li, K; Maskey, AR; Huang, WH; Toutov, AA; Yang, N; Srivastava, K; Geliebter, J; Tiwari, R; Miao, MS; Li, XM				Wang, Zhen-Zhen; Li, Kun; Maskey, Anish R.; Huang, Weihua; Toutov, Anton A.; Yang, Nan; Srivastava, Kamal; Geliebter, Jan; Tiwari, Raj; Miao, Mingsan; Li, Xiu-Min			A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study	FASEB JOURNAL			English	Article						anti-viral; apoptosis; berberine; computational modeling; COVID-19 and SARS	RESPIRATORY SYNDROME CORONAVIRUS; NF-KAPPA-B; CELL-CYCLE ARREST; CYTOKINE STORM; CYCLOOXYGENASE ACTIVITY; SIGNALING PATHWAYS; ANTIVIRAL ACTIVITY; INHIBITOR BINDING; INDUCED APOPTOSIS; NATURAL-PRODUCT	The novel coronavirus disease, COVID-19, has grown into a global pandemic and a major public health threat since its breakout in December 2019. To date, no specific therapeutic drug or vaccine for treating COVID-19 and SARS has been FDA approved. Previous studies suggest that berberine, an isoquinoline alkaloid, has shown various biological activities that may help against COVID-19 and SARS, including antiviral, anti-allergy and inflammation, hepatoprotection against drug- and infection-induced liver injury, as well as reducing oxidative stress. In particular, berberine has a wide range of antiviral activities such as anti-influenza, anti-hepatitis C, anti-cytomegalovirus, and anti-alphavirus. As an ingredient recommended in guidelines issued by the China National Health Commission for COVID-19 to be combined with other therapy, berberine is a promising orally administered therapeutic candidate against SARS-CoV and SARS-CoV-2. The current study comprehensively evaluates the potential therapeutic mechanisms of berberine in preventing and treating COVID-19 and SARS using computational modeling, including target mining, gene ontology enrichment, pathway analyses, protein-protein interaction analysis, and in silico molecular docking. An orally available immunotherapeutic-berberine nanomedicine, named NIT-X, has been developed by our group and has shown significantly increased oral bioavailability of berberine, increased IFN-gamma production by CD8+ T cells, and inhibition of mast cell histamine release in vivo, suggesting a protective immune response. We further validated the inhibition of replication of SARS-CoV-2 in lung epithelial cells line in vitro (Calu3 cells) by berberine. Moreover, the expression of targets including ACE2, TMPRSS2, IL-1 alpha, IL-8, IL-6, and CCL-2 in SARS-CoV-2 infected Calu3 cells were significantly suppressed by NIT-X. By supporting protective immunity while inhibiting pro-inflammatory cytokines; inhibiting viral infection and replication; inducing apoptosis; and protecting against tissue damage, berberine is a promising candidate in preventing and treating COVID-19 and SARS. Given the high oral bioavailability and safety of berberine nanomedicine, the current study may lead to the development of berberine as an orally, active therapeutic against COVID-19 and SARS.	[Wang, Zhen-Zhen; Miao, Mingsan] Henan Univ Chinese Med, Acad Chinese Med Sci, Zhengzhou, Peoples R China; [Wang, Zhen-Zhen; Maskey, Anish R.; Yang, Nan; Srivastava, Kamal; Geliebter, Jan; Tiwari, Raj; Li, Xiu-Min] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Li, Kun] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Huang, Weihua] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Toutov, Anton A.] Fuzionaire Inc, The Woodlands, TX USA; [Yang, Nan; Srivastava, Kamal] Gen Nutraceut Technol, Elmsford, NY USA; [Geliebter, Jan; Tiwari, Raj; Li, Xiu-Min] New York Med Coll, Sch Med, Dept Otolaryngol, Valhalla, NY 10595 USA	Henan University of Traditional Chinese Medicine; New York Medical College; University of Iowa; New York Medical College; New York Medical College	Li, XM (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	XiuMin_Li@NYMC.edu	li, xiu/GXV-1745-2022	Huang, Weihua/0000-0003-1176-3719; Wang, Zhenzhen/0000-0001-6961-4367	Henan University of Chinese Medicine [CTIM-01-2019]; Scientific Research Foundation [KYQD 2019-05]; Henan Province Scientific and Technological Project [202102310472]	Henan University of Chinese Medicine; Scientific Research Foundation; Henan Province Scientific and Technological Project	This research was founded by Henan University of Chinese Medicine, visiting fellowship grant to ZZW (CTIM-01-2019), Scientific Research Foundation (KYQD 2019-05), and Henan Province Scientific and Technological Project (NO. 202102310472). Study of Integrative Medicine for Immunology and Wellness, New York Medical College.	Afrin LB, 2020, INT J INFECT DIS, V100, P327, DOI 10.1016/j.ijid.2020.09.016; Alter P, 2001, CARDIOVASC PATHOL, V10, P229, DOI 10.1016/S1054-8807(01)00077-1; Amin M, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12984; [Anonymous], 2000, Altern Med Rev, V5, P175; [Anonymous], 2020, CORRECTION LANCET IN, DOI [10.1016/S1473-3099(20)30144-4, DOI 10.1016/S1473-3099(20)30144-4]; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Aviv A, 2020, FASEB J, V34, P7247, DOI 10.1096/fj.202001025; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blake JF, 2014, BIOORG MED CHEM LETT, V24, P2635, DOI 10.1016/j.bmcl.2014.04.068; Botwina P, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030344; Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carvalho-Silva D, 2019, NUCLEIC ACIDS RES, V47, pD1056, DOI 10.1093/nar/gky1133; Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chen XW, 2012, SCI WORLD J, DOI 10.1100/2012/708292; Chen XY, 2018, MOL MED REP, V18, P4468, DOI 10.3892/mmr.2018.9476; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Conti P, 2020, J BIOL REG HOMEOS AG, V34, P1629, DOI 10.23812/20-2EDIT; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Coskun M, 2011, CLIN CHIM ACTA, V412, P513, DOI 10.1016/j.cca.2010.12.020; Criado PR, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14068; Daina A, 2019, NUCLEIC ACIDS RES, V47, pW357, DOI 10.1093/nar/gkz382; DassaultSystemesBIOVIAD, 2020, DISCOVERY STUDIO, V2020; Davis AP, 2019, NUCLEIC ACIDS RES, V47, pD948, DOI 10.1093/nar/gky868; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Eleftheriou P, 2020, MOLECULES, V25, DOI 10.3390/molecules25112529; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fujikura D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072065; Fukuda K, 1999, PLANTA MED, V65, P381, DOI 10.1055/s-2006-960795; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Garner TP, 2016, MOL CELL, V63, P485, DOI 10.1016/j.molcel.2016.06.010; Germoush MO, 2014, J CANCER RES CLIN, V140, P1103, DOI 10.1007/s00432-014-1665-8; Gil C, 2020, J MED CHEM, V63, P12359, DOI 10.1021/acs.jmedchem.0c00606; Hansbro PM, 2017, IMMUNOL REV, V278, P41, DOI 10.1111/imr.12543; Hao G, 2015, XENOBIOTICA, V45, P1024, DOI 10.3109/00498254.2015.1034223; Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hinks TSC, 2016, J ALLERGY CLIN IMMUN, V138, P61, DOI 10.1016/j.jaci.2015.11.020; Ho YT, 2009, ANTICANCER RES, V29, P4063; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L., 2020, MEDRXIV 2020 2020031; Hui DSC, 2003, RESPIROLOGY, V8, pS20, DOI 10.1046/j.1440-1843.2003.00520.x; Hung TC, 2019, PHYTOMEDICINE, V53, P62, DOI 10.1016/j.phymed.2018.09.025; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033; Kim TS, 2003, IMMUNOLOGY, V109, P407, DOI 10.1046/j.1365-2567.2003.01673.x; Kimura H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00276; Kindrachuk J, 2015, ANTIMICROB AGENTS CH, V59, P1088, DOI 10.1128/AAC.03659-14; Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1789, DOI 10.1002/jmv.25900; Laurencikiene J, 2001, J IMMUNOL, V167, P3257, DOI 10.4049/jimmunol.167.6.3257; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee CH, 2004, J IMMUNOL, V172, P7841, DOI 10.4049/jimmunol.172.12.7841; Lee CH, 2007, PHARMACOL RES, V56, P193, DOI 10.1016/j.phrs.2007.06.003; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li FN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020327; Li Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/289264; Lin CC, 2006, ANTICANCER RES, V26, P1097; Lin JP, 2006, WORLD J GASTROENTERO, V12, P21, DOI 10.3748/wjg.v12.i1.21; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Lingeswaran M, 2020, INDIAN J CLIN BIOCHE, V35, P260, DOI 10.1007/s12291-020-00897-3; Liu CS, 2016, FITOTERAPIA, V109, P274, DOI 10.1016/j.fitote.2016.02.001; Liu H, 2020, J LEUKOCYTE BIOL, V108, P253, DOI 10.1002/JLB.3MA0320-358RR; Liu M, 2007, FASEB J, V21, P1586, DOI 10.1096/fj.06-6589com; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Liu YF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2503703; Luganini A, 2019, ANTIVIR RES, V164, P52, DOI 10.1016/j.antiviral.2019.02.006; Mahmoud MA, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2039897; Malone RW., 2020, RES SQ; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Marshall HD, 2011, J VIROL, V85, P5929, DOI 10.1128/JVI.02516-10; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Elizalde MM, 2018, VIROLOGY, V513, P160, DOI 10.1016/j.virol.2017.10.016; Mirhadi E, 2018, BIOMED PHARMACOTHER, V104, P465, DOI 10.1016/j.biopha.2018.05.067; Mizutani T, 2006, FEMS IMMUNOL MED MIC, V46, P236, DOI 10.1111/j.1574-695X.2005.00028.x; Mizutani T, 2004, BIOCHEM BIOPH RES CO, V319, P1228, DOI 10.1016/j.bbrc.2004.05.107; Mosaddeghi P., 2020, PREPRINTS; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Narkhede RR, 2020, NAT PRODUCT BIOPROSP, V10, P297, DOI 10.1007/s13659-020-00253-1; Nienhold R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18854-2; Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010; Oczypok EA, 2017, PAEDIATR RESPIR REV, V23, P40, DOI 10.1016/j.prrv.2017.03.012; Pinero J, 2020, NUCLEIC ACIDS RES, V48, pD845, DOI 10.1093/nar/gkz1021; Pizzorno A, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104878; Polley S, 2016, CELL REP, V17, P1907, DOI 10.1016/j.celrep.2016.10.067; Pyeon D, 2000, J VIROL, V74, P5740, DOI 10.1128/JVI.74.12.5740-5745.2000; Qin X, 2010, J IMMUNOL, V185, P1855, DOI 10.4049/jimmunol.0903853; Qiu YY, 2017, MOL CELL ENDOCRINOL, V443, P89, DOI 10.1016/j.mce.2017.01.009; Raaben M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-55; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Rojas A, 2020, INFLAMM RES, V69, P641, DOI 10.1007/s00011-020-01353-x; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Rott D, 2003, J AM COLL CARDIOL, V41, P1812, DOI 10.1016/S0735-1097(03)00304-8; Russell B, 2020, ECANCERMEDICALSCIENC, V14, P1, DOI 10.3332/ecancer.2020.1022; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Safran M, 2002, BIOINFORMATICS, V18, P1542, DOI 10.1093/bioinformatics/18.11.1542; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sharif PM, 2020, CYTOKINE, V130, DOI 10.1016/j.cyto.2020.155066; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Sun J, 2020, LIVER INT, V40, P1278, DOI 10.1111/liv.14470; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tai CJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040908; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thio CLP, 2019, J ALLERGY CLIN IMMUN, V144, P682, DOI 10.1016/j.jaci.2019.03.008; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; Venkataraman T, 2017, ANTIVIR RES, V143, P142, DOI 10.1016/j.antiviral.2017.03.022; Rosa SGV, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.40; Walsh MJ, 2004, HEPATOLOGY, V39, P1230, DOI 10.1002/hep.20179; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang HQ, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0674-4; Wang JX, 2016, ONCOTARGET, V7, P76076, DOI 10.18632/oncotarget.12589; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang Q, 2012, INVEST OPHTH VIS SCI, V53, P2395, DOI 10.1167/iovs.11-8982; Wang YX, 2020, NUCLEIC ACIDS RES, V48, pD1031, DOI 10.1093/nar/gkz981; Warowicka A, 2020, ARCH VIROL, V165, P1935, DOI 10.1007/s00705-020-04706-3; Wen CY, 2020, NEUROTOX RES, V38, P59, DOI 10.1007/s12640-020-00178-0; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiu SY, 2020, J MED CHEM, V63, P12256, DOI 10.1021/acs.jmedchem.0c00502; Xu LL, 2018, EUR J PHARMACOL, V819, P161, DOI 10.1016/j.ejphar.2017.11.013; Yan FG, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110142; Yan TT, 2020, FASEB J, V34, P6017, DOI 10.1096/fj.202000782; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343; Yan YQ, 2018, PHYTOTHER RES, V32, P2560, DOI 10.1002/ptr.6196; Yang IW, 1996, N-S ARCH PHARMACOL, V354, P102; Yang N, 2017, INT IMMUNOPHARMACOL, V45, P120, DOI 10.1016/j.intimp.2017.01.009; Yang N, 2014, ANN ALLERG ASTHMA IM, V113, P556, DOI 10.1016/j.anai.2014.07.021; Yang Y, 2020, INT J BIOL SCI, V16, P1708, DOI 10.7150/ijbs.45538; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yazdi S, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00032; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Yip NKY, 2013, ONCOL REP, V30, P1107, DOI 10.3892/or.2013.2543; Yu CS, 2006, FASEB J, V20, pA1131; Yu H., 2017, Patent No. [2017/056822, 2017056822]; Yue Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0917-y; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang J, 2014, INT J MOL MED, V33, P1209, DOI 10.3892/ijmm.2014.1695; Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393; Zhang X, 2007, VIROLOGY, V365, P324, DOI 10.1016/j.virol.2007.04.009; Zhao HY, 2006, J MED CHEM, V49, P4455, DOI 10.1021/jm060465l; Zhou H, 2017, BIOMED PHARMACOTHER, V89, P864, DOI 10.1016/j.biopha.2017.03.003; Zhou HY, 2000, J PHARMACOL EXP THER, V294, P822	166	18	18	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21360	10.1096/fj.202001792R	http://dx.doi.org/10.1096/fj.202001792R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749932	Green Published			2022-12-28	WOS:000635216100017
J	Zemljic-Harpf, AE; Hoe, LES; Schilling, JM; Zuniga-Hertz, JP; Nguyen, A; Vaishnav, YJ; Belza, GJ; Budiono, BP; Patel, PM; Head, BP; Dillmann, WH; Mahata, SK; Peart, JN; Roth, DM; Headrick, JP; Patel, HH				Zemljic-Harpf, Alice E.; Hoe, Louise E. See; Schilling, Jan M.; Zuniga-Hertz, Juan P.; Nguyen, Alexander; Vaishnav, Yash J.; Belza, Gianna J.; Budiono, Boris P.; Patel, Piyush M.; Head, Brian P.; Dillmann, Wolfgang H.; Mahata, Sushil K.; Peart, Jason N.; Roth, David M.; Headrick, John P.; Patel, Hemal H.			Morphine induces physiological, structural, and molecular benefits in the diabetic myocardium	FASEB JOURNAL			English	Article						cardioprotection; diabetic cardiomyopathy; ischemia&#8208; reperfusion injury; mitochondria; opioid receptors		The obesity epidemic has increased type II diabetes mellitus (T2DM) across developed countries. Cardiac T2DM risks include ischemic heart disease, heart failure with preserved ejection fraction, intolerance to ischemia-reperfusion (I-R) injury, and refractoriness to cardioprotection. While opioids are cardioprotective, T2DM causes opioid receptor signaling dysfunction. We tested the hypothesis that sustained opioid receptor stimulus may overcome diabetes mellitus-induced cardiac dysfunction via membrane/mitochondrial-dependent protection. In a murine T2DM model, we investigated effects of morphine on cardiac function, I-R tolerance, ultrastructure, subcellular cholesterol expression, mitochondrial protein abundance, and mitochondrial function. T2DM induced 25% weight gain, hyperglycemia, glucose intolerance, cardiac hypertrophy, moderate cardiac depression, exaggerated postischemic myocardial dysfunction, abnormalities in mitochondrial respiration, ultrastructure and Ca2+-induced swelling, and cell death were all evident. Morphine administration for 5 days: (1) improved glucose homeostasis; (2) reversed cardiac depression; (3) enhanced I-R tolerance; (4) restored mitochondrial ultrastructure; (5) improved mitochondrial function; (6) upregulated Stat3 protein; and (7) preserved membrane cholesterol homeostasis. These data show that morphine treatment restores contractile function, ischemic tolerance, mitochondrial structure and function, and membrane dynamics in type II diabetic hearts. These findings suggest potential translational value for short-term, but high-dose morphine administration in diabetic patients undergoing or recovering from acute ischemic cardiovascular events.	[Zemljic-Harpf, Alice E.; Schilling, Jan M.; Zuniga-Hertz, Juan P.; Nguyen, Alexander; Vaishnav, Yash J.; Belza, Gianna J.; Patel, Piyush M.; Head, Brian P.; Dillmann, Wolfgang H.; Mahata, Sushil K.; Roth, David M.; Patel, Hemal H.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Zemljic-Harpf, Alice E.; Schilling, Jan M.; Zuniga-Hertz, Juan P.; Nguyen, Alexander; Vaishnav, Yash J.; Belza, Gianna J.; Patel, Piyush M.; Head, Brian P.; Roth, David M.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Hoe, Louise E. See] Univ Queensland, Dept Fac Med, Brisbane, Qld, Australia; [Hoe, Louise E. See] Prince Charles Hosp, Crit Care Res Grp, Brisbane, Qld, Australia; [Budiono, Boris P.; Peart, Jason N.; Headrick, John P.] Griffith Univ, Heart Fdn Res Ctr, Griffith Hlth Inst, Southport, Qld, Australia; [Dillmann, Wolfgang H.; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Queensland; Prince Charles Hospital; Griffith University; Menzies Health Institute Queensland; University of California System; University of California San Diego	Patel, HH (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.; Headrick, JP (corresponding author), Griffith Univ, Heart Fdn Res Ctr, Southport, Qld 4222, Australia.; Patel, HH (corresponding author), Univ Calif San Diego, San Diego, CA 92161 USA.	j.headrick@griffith.edu.au; hepatel@ucsd.edu	Hertz, Juan Pablo Zúñiga/J-3588-2019; Hoe, Louise E See/C-6650-2017	Hertz, Juan Pablo Zúñiga/0000-0002-8679-3456; Hoe, Louise E See/0000-0003-0553-205X; Zemljic-Harpf, Alice/0000-0002-5604-9343	National Institutes of Health, USA [HL091071, HL107200]; VA Merit grant [BX001963, BX000783]; VA Research Career Scientist Award [BX005229]; National Health and Medical Research Council of Australia [481922]; National Heart Foundation of Australia; Australian Research Council; QLD state government fellowship	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant; VA Research Career Scientist Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council(Australian Research Council); QLD state government fellowship	This study was supported by grants from the National Institutes of Health, USA (HL091071, HL107200), a VA Merit grant (BX001963 and BX000783), VA Research Career Scientist Award (BX005229), and the National Health and Medical Research Council of Australia (481922). L.S. was supported by a scholarship from the National Heart Foundation of Australia. J.N.P. was supported by a Future Fellowship from the Australian Research Council. J.P.H. was supported by a QLD state government fellowship.	Akita Y, 2007, AM J PHYSIOL-HEART C, V292, pH2051, DOI 10.1152/ajpheart.01102.2006; Ashton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072278; Balakumar P, 2012, CELL SIGNAL, V24, P53, DOI 10.1016/j.cellsig.2011.09.007; Barnes AS, 2011, TEX HEART I J, V38, P142; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bolling SF, 1997, ANN THORAC SURG, V64, P623, DOI 10.1016/S0003-4975(97)00631-0; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Budiono BP, 2012, AM J PHYSIOL-REG I, V302, pR1091, DOI 10.1152/ajpregu.00406.2011; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Ferenczi S, 2010, NEUROCHEM INT, V57, P323, DOI 10.1016/j.neuint.2010.06.011; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; Fryer RM, 2000, J PHARMACOL EXP THER, V294, P451; Gateau-Roesch O, 2006, CARDIOVASC RES, V70, P264, DOI 10.1016/j.cardiores.2006.02.024; Ghosh S, 2001, J AM COLL CARDIOL, V37, P711, DOI 10.1016/S0735-1097(00)01161-X; Gilbert ER, 2011, EXP DIAB RES, V2011; Gross ER, 2007, DIABETES, V56, P127, DOI 10.2337/db06-0907; Guo YR, 2013, MOL CELL PROTEOMICS, V12, P3744, DOI 10.1074/mcp.M113.027441; Hafstad AD, 2013, DIABETES, V62, P2287, DOI 10.2337/db12-1580; Harhous Z, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00150; Hoe LES, 2014, AM J PHYSIOL-HEART C, V307, pH895, DOI 10.1152/ajpheart.00081.2014; KATZ RJ, 1982, ANN NY ACAD SCI, V398, P291, DOI 10.1111/j.1749-6632.1982.tb39501.x; Lee TM, 2003, J CLIN ENDOCR METAB, V88, P531, DOI 10.1210/jc.2002-020904; Lei SQ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9836302; LEVINE AS, 1988, PHARMACOL BIOCHEM BE, V29, P495, DOI 10.1016/0091-3057(88)90010-X; Mammucari C, 2011, BIOFACTORS, V37, P219, DOI 10.1002/biof.160; Marso SP, 2007, AM J CARDIOL, V100, P206, DOI 10.1016/j.amjcard.2007.02.080; Medford HM, 2013, AM J PHYSIOL-HEART C, V305, pH114, DOI 10.1152/ajpheart.00135.2013; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Miki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-67; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Ng M, 2014, LANCET, V384, P746; Nunes JM, 2019, THROMB RES, V178, P91, DOI 10.1016/j.thromres.2019.04.005; Obame FN, 2008, J PHARMACOL EXP THER, V326, P252, DOI 10.1124/jpet.108.138008; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohsawa M, 1998, J PHARMACOL EXP THER, V286, P780; Olianas MC, 2012, MOL PHARMACOL, V81, P154, DOI 10.1124/mol.111.075267; Opie L., 2004, FUELS AEROBIC ANAERO; Oxberry SG, 2013, J PALLIAT MED, V16, P250, DOI 10.1089/jpm.2012.0270; Panneerselvam M, 2013, MOL NUTR FOOD RES, V57, P1007, DOI 10.1002/mnfr.201300026; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Peart JN, 2007, J MOL CELL CARDIOL, V42, P972, DOI 10.1016/j.yjmcc.2007.02.011; Peart JN, 2006, AM J PHYSIOL-HEART C, V291, pH1746, DOI 10.1152/ajpheart.00233.2006; Peart JN, 2011, J PHARMACOL EXP THER, V336, P274, DOI 10.1124/jpet.110.172593; Peart JN, 2004, EXP GERONTOL, V39, P1021, DOI 10.1016/j.exger.2004.03.038; Qi JS, 2004, DIABETOLOGIA, V47, P214, DOI 10.1007/s00125-003-1288-0; RUSCHHAUPT DG, 1983, J AM COLL CARDIOL, V2, P77, DOI 10.1016/S0735-1097(83)80379-9; Sack MN, 2009, J MOL CELL CARDIOL, V46, P842, DOI 10.1016/j.yjmcc.2009.02.001; Schilling JM, 2015, BRIT J PHARMACOL, V172, P2114, DOI 10.1111/bph.13009; Schultz JE, 1998, CIRCULATION, V97, P1282, DOI 10.1161/01.CIR.97.13.1282; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874; Smallwood N, 2015, INTERN MED J, V45, P898, DOI 10.1111/imj.12857; Sood A, 2001, ENDOCR RES, V27, P215, DOI 10.1081/ERC-100107182; Su CF, 2004, HORM METAB RES, V36, P571, DOI 10.1055/s-2004-825763; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tomai F, 1999, CIRCULATION, V100, P559, DOI 10.1161/01.CIR.100.5.559; Van der Mieren G, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-36; Viola R, 2008, SUPPORT CARE CANCER, V16, P329, DOI 10.1007/s00520-007-0389-6; Wang JW, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2019.116942; Wen T, 2009, MOL ENDOCRINOL, V23, P671, DOI 10.1210/me.2008-0345; Xenopoulos NP, 1998, J AM COLL CARDIOL, V31, p65A, DOI 10.1016/S0735-1097(97)83991-5; Yamagishi T, 2010, HEART VESSELS, V25, P417, DOI 10.1007/s00380-009-1222-6; Zatta AJ, 2008, AM J PHYSIOL-HEART C, V294, pH1444, DOI 10.1152/ajpheart.01279.2006; Zemljic-Harpf AE., 2021, FASEB J, V35; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	73	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21407	10.1096/fj.201903233R	http://dx.doi.org/10.1096/fj.201903233R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583084				2022-12-28	WOS:000629576700030
J	Hanke-Gogokhia, C; Lehmann, GL; Benedicto, I; de la Fuente-Ortega, E; Arshavsky, VY; Schreiner, R; Rodriguez-Boulan, E				Hanke-Gogokhia, Christin; Lehmann, Guillermo L.; Benedicto, Ignacio; de la Fuente-Ortega, Erwin; Arshavsky, Vadim Y.; Schreiner, Ryan; Rodriguez-Boulan, Enrique			Apical CLC-2 in retinal pigment epithelium is crucial for survival of the outer retina	FASEB JOURNAL			English	Article						CLC-2; photoreceptor degeneration; RPE; subretinal space	TISSUE-SPECIFIC POLARITY; MONOCARBOXYLATE TRANSPORTERS; CHLORIDE CHANNEL; PHOTORECEPTOR DEGENERATION; PLASMA-MEMBRANE; RPE CELLS; EXPRESSION; MUTATION; HYPERPOLARIZATION; MECHANISMS	Knockout of the chloride channel protein 2 (CLC-2; CLCN2) results in fast progressing blindness in mice. Retinal Pigment Epithelium (RPE) and photoreceptors undergo, in parallel, rapid, and profound morphological changes and degeneration. Immunohistochemistry and electron microscopy of the outer retina and electroretinography of the CLC-2 KO mouse demonstrated normal morphology at postnatal day 2, followed by drastic changes in RPE and photoreceptor morphology and loss of vision during the first postnatal month. To investigate whether the RPE or the photoreceptors are the primary cause of the degeneration, we injected lentiviruses carrying HA-tagged CLC-2 with an RPE-specific promotor in the subretinal space of CLC-2-KO mice at the time of eye opening. As expected, CLC-2-HA was expressed exclusively in RPE; strikingly, this procedure rescued the degeneration of both RPE and photoreceptors. Light response in transduced eyes was also recovered. Only a fraction of RPE was transduced with the lentivirus; however, the entire RPE monolayer appears healthy, even the RPE cells not expressing the CLC-2-HA. Surprisingly, in contrast with previous physiological observations that postulate that CLC-2 has a basolateral localization in RPE, our immunofluorescence experiments demonstrated CLC-2 has an apical distribution, facing the subretinal space and the photoreceptor outer segments. Our findings suggest that CLC-2 does not play the postulated role in fluid transport at the basolateral membrane. Rather, they suggest that CLC-2 performs a critical homeostatic role in the subretinal compartment involving a chloride regulatory mechanism that is critical for the survival of both RPE and photoreceptors.	[Hanke-Gogokhia, Christin] Yale Univ, Dept Ophthalmol, New Haven, CT USA; [Lehmann, Guillermo L.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Benedicto, Ignacio] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain; [de la Fuente-Ortega, Erwin] Univ Catolica Norte, Fac Med, Dept Ciencias Biomed, Coquimbo, Chile; [Arshavsky, Vadim Y.] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Schreiner, Ryan] Weill Cornell Med, Div Regenerat Med, Ansary Stern Cell Inst Dept Med, New York, NY USA; [Rodriguez-Boulan, Enrique] Weill Cornell Med, Dept Ophthalmol, Margaret Dyson Vis Res Inst, New York, NY USA	Yale University; Regeneron; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Catolica del Norte; Duke University; Cornell University; Cornell University	Schreiner, R; Rodriguez-Boulan, E (corresponding author), 1300 York Ave, New York, NY 10065 USA.	rps2001@med.cornell.edu; boulan@med.cornell.edu	de la Fuente Ortega, Erwin/S-6513-2019	de la Fuente Ortega, Erwin/0000-0001-8757-571X; Rodriguez-Boulan, Enrique/0000-0003-2033-6233; Schreiner, Ryan/0000-0002-7457-6606	HHS | NIH | National Eye Institute (NEI) [EY08538]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM34107]; New York State Stem Cell Science (NYSTEM) [C32596GG]; Comunidad de Madrid [2017-T1/BMD-5247]; MINECO | Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovacion (MICINN); Weill Cornell Medicine [EY005722]	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New York State Stem Cell Science (NYSTEM); Comunidad de Madrid(Comunidad de Madrid); MINECO | Instituto de Salud Carlos III (ISCIII)(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Weill Cornell Medicine	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY08538; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM34107; New York State Stem Cell Science (NYSTEM), Grant/Award Number: C32596GG; Comunidad de Madrid, Grant/Award Number: 2017-T1/BMD--5247; MINECO | Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovacion (MICINN); Weill Cornell Medicine, Grant/Award Number: EY005722	Arreola J, 2003, J PHYSIOL-LONDON, V547, P197, DOI 10.1113/jphysiol.2002.028373; BIALEK S, 1995, J PHYSIOL-LONDON, V484, P53, DOI 10.1113/jphysiol.1995.sp020647; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Caceres PS, 2020, CURR OPIN CELL BIOL, V62, P37, DOI 10.1016/j.ceb.2019.08.001; Caceres PS, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a027847; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; de la Fuente-Ortega E, 2015, MOL BIOL CELL, V26, P1728, DOI 10.1091/mbc.E15-01-0047; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Edwards MM, 2010, INVEST OPHTH VIS SCI, V51, P3264, DOI 10.1167/iovs.09-4887; Engevik AC, 2021, CELL MOL GASTROENTER, V12, P59, DOI 10.1016/j.jcmgh.2021.01.022; German OL, 2008, J NEUROSCI RES, V86, P3503, DOI 10.1002/jnr.21813; Goppner C, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016031; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hamann S, 2002, INT REV CYTOL, V215, P395; Han JYS, 2020, FASEB J, V34, P5401, DOI 10.1096/fj.201902961R; Hu JG, 1996, EXP EYE RES, V62, P443, DOI 10.1006/exer.1996.0049; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jablonski MM, 2000, J NEUROSCI, V20, P7149; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2005, J AM SOC NEPHROL, V16, P1549, DOI 10.1681/ASN.2005020207; KENNEDY BG, 1990, AM J PHYSIOL, V259, pC29, DOI 10.1152/ajpcell.1990.259.1.C29; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Lehmann GL, 2014, EXP EYE RES, V126, P5, DOI 10.1016/j.exer.2014.04.021; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lobato-Alvarez JA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00450; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; MILLER SS, 1990, J PHYSIOL-LONDON, V424, P283, DOI 10.1113/jphysiol.1990.sp018067; Nasonkin IO, 2013, DEVELOPMENT, V140, P1330, DOI 10.1242/dev.086603; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Pena-Muzenmayer G, 2005, J CELL SCI, V118, P4243, DOI 10.1242/jcs.02525; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Qiao XX, 2003, VISION RES, V43, P859, DOI 10.1016/S0042-6989(02)00393-0; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Singh RK, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00179; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P13087, DOI 10.1073/pnas.1906421116; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Venkatesh A., 2013, Curr Protoc Microbiol, V28, DOI 10.1002/9780471729259.mc14d04s28; Wang HW, 2017, MOL MED REP, V16, P11, DOI 10.3892/mmr.2017.6600; Zhang KJ, 2014, PROTEIN CELL, V5, P48, DOI 10.1007/s13238-013-0011-2	50	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21689	10.1096/fj.202100349R	http://dx.doi.org/10.1096/fj.202100349R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085737	Green Published, hybrid			2022-12-28	WOS:000667814100060
J	Bozelli, JC; Yune, J; Takahashi, D; Sakane, F; Epand, RM				Bozelli, Jose Carlos; Yune, Jenny; Takahashi, Daisuke; Sakane, Fumio; Epand, Richard M.			Membrane morphology determines diacylglycerol kinase alpha substrate acyl chain specificity	FASEB JOURNAL			English	Article						acyl chain specificity; cancer; diacylglycerol kinase alpha; immunological synapse; immunotherapy; membrane shape; negative curvature; regulation of enzyme by membrane	ARACHIDONOYL SPECIFICITY; CELL; MODULATION; ACTIVATION; ISOFORMS; METABOLISM; CHECKPOINT; EXPRESSION; SECRETION; APOPTOSIS	Diacylglycerol kinases catalyze the ATP-dependent phosphorylation of diacylglycerol (DAG) to produce phosphatidic acid (PA). In humans, the alpha isoform (DGK alpha) has emerged as a potential target in the treatment of cancer due to its anti-tumor and pro-immune responses. However, its mechanism of action at a molecular level is not fully understood. In this work, a systematic investigation of the role played by the membrane in the regulation of the enzymatic properties of human DGK alpha is presented. By using a cell-free system with purified DGK alpha and model membranes of variable physical and chemical properties, it is shown that membrane physical properties determine human DGK alpha substrate acyl chain specificity. In model membranes with a flat morphology; DGK alpha presents high enzymatic activity, but it is not able to differentiate DAG molecular species. Furthermore, DGK alpha enzymatic properties are insensitive to membrane intrinsic curvature. However, in the presence of model membranes with altered morphology, specifically the presence of physically curved membrane structures, DGK alpha bears substrate acyl chain specificity for palmitic acid-containing DAG. The present results identify changes in membrane morphology as one possible mechanism for the depletion of specific pools of DAG as well as the production of specific pools of PA by DGK alpha, adding an extra layer of regulation on the interconversion of these two potent lipid-signaling molecules. It is proposed that the interplay between membrane physical (shape) and chemical (lipid composition) properties guarantee a fine-tuned signal transduction system dependent on the levels and molecular species of DAG and PA.	[Bozelli, Jose Carlos; Yune, Jenny; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hlth Sci Ctr, Hamilton, ON, Canada; [Takahashi, Daisuke] Kyushu Univ, Dept Pharmaceut Hlth Care & Sci, Fukuoka, Japan; [Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Kyushu University; Chiba University	Bozelli, JC; Epand, RM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	bozellj@mcmaster.ca; epand@mcmaster.ca	Sakane, Fumio/H-2693-2017	Sakane, Fumio/0000-0003-0857-0377; Bozelli Jr, Jose Carlos/0000-0001-9533-0886	Canadian Natural Sciences and Engineering Research Council [RGPIN-2018-05585]; JSPS KAKENHI [JP19K06527, 20H03205]	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Canadian Natural Sciences and Engineering Research Council, Grant/Award Number: RGPIN-2018-05585; JSPS KAKENHI, Grant/Award Number: JP19K06527, JP and 20H03205	Acker M, 2014, PERSPECT SCI, V1, P56, DOI 10.1016/j.pisc.2013.12.001; Almena M, 2011, TRENDS BIOCHEM SCI, V36, P593, DOI 10.1016/j.tibs.2011.06.005; Alonso R, 2011, CELL DEATH DIFFER, V18, P1161, DOI 10.1038/cdd.2010.184; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Andrada E, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7714; Antonny B, 2015, TRENDS CELL BIOL, V25, P427, DOI 10.1016/j.tcb.2015.03.004; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bacchiocchi R, 2005, BLOOD, V106, P2175, DOI 10.1182/blood-2005-01-0316; Basanez G, 1996, BIOPHYS J, V70, P2299, DOI 10.1016/S0006-3495(96)79795-3; Bozelli JC, 2020, J MOL BIOL, V432, P5124, DOI 10.1016/j.jmb.2020.03.028; Bozelli JC, 2020, BIOPHYS CHEM, V265, DOI 10.1016/j.bpc.2020.106431; Bozelli JC, 2019, CHEM PHYS LIPIDS, V221, P24, DOI 10.1016/j.chemphyslip.2019.03.002; Bozelli JC, 2018, J BIOL CHEM, V293, P17780, DOI 10.1074/jbc.RA118.005293; Carlson ML, 2018, ELIFE, V7, DOI 10.7554/eLife.34085; Chauveau A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005287; Choi S, 2011, J IMMUNOL, V187, P805, DOI 10.4049/jimmunol.1003314; Dominguez CL, 2013, CANCER DISCOV, V3, P782, DOI 10.1158/2159-8290.CD-12-0215; Epand RM, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00112; Epand RM, 2015, BBA-BIOMEMBRANES, V1848, P220, DOI 10.1016/j.bbamem.2014.05.004; Epand RM, 2004, BIOCHEMISTRY-US, V43, P14778, DOI 10.1021/bi0484724; Fanani ML, 2004, BIOCHEMISTRY-US, V43, P14767, DOI 10.1021/bi049145z; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Jones DR, 2002, FASEB J, V16, P595, DOI 10.1096/fj.01-0762fje; Kimura T, 2016, PROG LIPID RES, V62, P75, DOI 10.1016/j.plipres.2016.02.001; Kollmitzer B, 2013, SOFT MATTER, V9, P10877, DOI 10.1039/c3sm51829a; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Merida Isabel, 2017, Advances in Biological Regulation, V63, P22, DOI 10.1016/j.jbior.2016.09.005; Merida I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0974; Milne SB, 2008, BIOCHEMISTRY-US, V47, P9372, DOI 10.1021/bi800492c; Murakami Y, 2020, BIOCHEM BIOPH RES CO, V525, P1054, DOI 10.1016/j.bbrc.2020.02.162; Noessner E, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00016; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Purow B, 2015, CLIN CANCER RES, V21, P5008, DOI 10.1158/1078-0432.CCR-15-0413; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shulga YV, 2011, J MOL BIOL, V409, P101, DOI 10.1016/j.jmb.2011.03.071; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Takahashi D, 2018, PEERJ, V6, DOI 10.7717/peerj.5449; Takeishi K, 2012, J HEPATOL, V57, P77, DOI 10.1016/j.jhep.2012.02.026; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Torres-Ayuso P, 2014, ONCOTARGET, V5, P9710, DOI 10.18632/oncotarget.2344; Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5; Ware TB, 2020, NAT CHEM BIOL, V16, P170, DOI 10.1038/s41589-019-0445-9; Yamada K, 1997, BIOCHEM J, V321, P59, DOI 10.1042/bj3210059; Yamaki A, 2019, J CELL BIOCHEM, V120, P10043, DOI 10.1002/jcb.28288; Yanagisawa K, 2007, BBA-MOL CELL BIOL L, V1771, P462, DOI 10.1016/j.bbalip.2006.12.008; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	49	5	5	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21602	10.1096/fj.202100264R	http://dx.doi.org/10.1096/fj.202100264R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33977628				2022-12-28	WOS:000655695900008
J	Dumont, AA; Dumont, L; Zhou, DL; Giguere, H; Pileggi, C; Harper, ME; Blondin, DP; Scott, MS; Auger-Messier, M				Dumont, Audrey-Ann; Dumont, Lauralyne; Zhou, Delong; Giguere, Hugo; Pileggi, Chantal; Harper, Mary-Ellen; Blondin, Denis P.; Scott, Michelle S.; Auger-Messier, Mannix			Cardiomyocyte-specific Srsf3 deletion reveals a mitochondrial regulatory role	FASEB JOURNAL			English	Article						cardiomyocyte; mitochondria; oxidative phosphorylation; respiratory chain complex I; Srsf3	HIGH-FAT DIET; HIPPOCAMPAL NEUROGENESIS; PREFRONTAL CORTEX; MATERNAL OBESITY; NMDA; GLUTAMATE; MEMORY; EXPRESSION; PREGNANCY; BEHAVIOR	Serine-rich splicing factor 3 (SRSF3) was recently reported as being necessary to preserve RNA stability via an mTOR mechanism in a cardiac mouse model in adulthood. Here, we demonstrate the link between Srsf3 and mitochondrial integrity in an embryonic cardiomyocyte-specific Srsf3 conditional knockout (cKO) mouse model. Fifteen-day-old Srsf3 cKO mice showed dramatically reduced (below 50%) survival and reduced the left ventricular systolic performance, and histological analysis of these hearts revealed a significant increase in cardiomyocyte size, confirming the severe remodeling induced by Srsf3 deletion. RNA-seq analysis of the hearts of 5-day-old Srsf3 cKO mice revealed early changes in expression levels and alternative splicing of several transcripts related to mitochondrial integrity and oxidative phosphorylation. Likewise, the levels of several protein complexes of the electron transport chain decreased, and mitochondrial complex I-driven respiration of permeabilized cardiac muscle fibers from the left ventricle was impaired. Furthermore, transmission electron microscopy analysis showed disordered mitochondrial length and cristae structure. Together with its indispensable role in the physiological maintenance of mouse hearts, these results highlight the previously unrecognized function of Srsf3 in regulating the mitochondrial integrity.	[Dumont, Audrey-Ann; Dumont, Lauralyne; Giguere, Hugo; Blondin, Denis P.; Auger-Messier, Mannix] Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Med,Serv Cardiol, Sherbrooke, PQ J1H 5N4, Canada; [Zhou, Delong] Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Sherbrooke, PQ, Canada; [Pileggi, Chantal; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Scott, Michelle S.] Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Biochim & Genom Fonct, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Ottawa; University of Sherbrooke	Auger-Messier, M (corresponding author), Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Med,Serv Cardiol, Sherbrooke, PQ J1H 5N4, Canada.	Mannix.Auger-Messier@USherbrooke.ca		Harper, Mary-Ellen/0000-0003-3864-5886; ZHOU, Delong/0000-0001-5397-3920; Auger-Messier, Mannix/0000-0001-8600-5440; Dumont, Lauralyne/0000-0002-7681-6212; Giguere, Hugo/0000-0001-7193-0051	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [301131, FDN143278]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: 301131 and FDN143278	Abbott KN, 2019, NEUROSCI BIOBEHAV R, V107, P399, DOI 10.1016/j.neubiorev.2019.08.010; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Ashwood P, 2008, J AUTISM DEV DISORD, V38, P169, DOI 10.1007/s10803-006-0353-1; Beilharz JE, 2015, NUTRIENTS, V7, P6719, DOI 10.3390/nu7085307; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boitard C, 2012, HIPPOCAMPUS, V22, P2095, DOI 10.1002/hipo.22032; Cadena-Burbano EV, 2019, NUTR NEUROSCI, V22, P98, DOI 10.1080/1028415X.2017.1354958; Carpita B, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3717215; Cercato MC, 2014, J PHYSIOL-PARIS, V108, P263, DOI 10.1016/j.jphysparis.2014.08.001; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chen BS, 2012, CELL REP, V2, P1120, DOI 10.1016/j.celrep.2012.09.024; Chin EH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174030; Choi CS, 2015, J NUTR BIOCHEM, V26, P1520, DOI 10.1016/j.jnutbio.2015.07.018; Cohen JFW, 2018, AM J PREV MED, V54, P727, DOI 10.1016/j.amepre.2018.02.020; Cordner ZA, 2019, EXP NEUROL, V318, P92, DOI 10.1016/j.expneurol.2019.04.018; DeCapo M, 2019, BIOL PSYCHIAT, V85, P122, DOI 10.1016/j.biopsych.2018.08.006; Desai RA, 2009, CNS SPECTRUMS, V14, P372, DOI 10.1017/S1092852900023026; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Edlow AG, 2017, PRENATAL DIAG, V37, P95, DOI 10.1002/pd.4932; Feyissa AM, 2009, PROG NEURO-PSYCHOPH, V33, P70, DOI 10.1016/j.pnpbp.2008.10.005; Flores-Barrera E, 2014, BIOL PSYCHIAT, V75, P508, DOI 10.1016/j.biopsych.2013.07.033; Forero DA, 2010, HUM MUTAT, V31, P1195, DOI 10.1002/humu.21344; Gao C, 2010, HIPPOCAMPUS, V20, P1072, DOI 10.1002/hipo.20705; Glendining KA, 2018, PSYCHONEUROENDOCRINO, V96, P132, DOI 10.1016/j.psyneuen.2018.06.015; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Hammerton G, 2014, INT J OBESITY, V38, P513, DOI 10.1038/ijo.2013.133; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Harraz Maged M, 2014, Mol Cell Ther, V2; Huang CC, 2011, J NEUROSCI, V31, P4194, DOI 10.1523/JNEUROSCI.5239-10.2011; Hunsberger JG, 2009, NEUROMOL MED, V11, P173, DOI 10.1007/s12017-009-8070-5; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; Kiyohara Chikako, 2009, Environmental Health and Preventive Medicine, V14, P71, DOI 10.1007/s12199-008-0073-6; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; de la Garza AL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030572; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; Marcondes LA, 2020, NEUROBIOL LEARN MEM, V168, DOI 10.1016/j.nlm.2019.107153; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mendes-da-Silva C, 2015, INT J DEV NEUROSCI, V40, P35, DOI 10.1016/j.ijdevneu.2014.11.005; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mitchell S, 2015, BEST PRACT RES CL OB, V29, P289, DOI 10.1016/j.bpobgyn.2014.10.002; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Moutin E, 2012, J CELL SCI, V125, P2030, DOI 10.1242/jcs.098160; Mucellini AB, 2019, BRAIN RES, V1708, P138, DOI 10.1016/j.brainres.2018.12.021; Naef L, 2013, STRESS, V16, P540, DOI 10.3109/10253890.2013.805321; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; Ogden CL., 2014, JAMA-J AM MED ASSOC, V312, p189; Page KC, 2014, AM J PHYSIOL-REG I, V306, pR527, DOI 10.1152/ajpregu.00319.2013; Panchenko PE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050948; Patterson PH, 2012, BRAIN BEHAV IMMUN, V26, P393, DOI 10.1016/j.bbi.2011.09.008; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Pilc A, 2008, BIOCHEM PHARMACOL, V75, P997, DOI 10.1016/j.bcp.2007.09.021; Qian Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00770; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Ray GT, 2009, MED CARE, V47, P105, DOI 10.1097/MLR.0b013e31817e18c0; Robb JL, 2017, BEHAV BRAIN RES, V326, P187, DOI 10.1016/j.bbr.2017.02.049; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Robinson M, 2013, J DEV ORIG HLTH DIS, V4, P42, DOI 10.1017/S2040174412000578; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Sarker G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53652-x; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sousa Fabio J, 2020, Brain Behav Immun Health, V5, P100075, DOI 10.1016/j.bbih.2020.100075; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Trujillo-Villarreal LA, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01157-x; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Baez MV, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5093048; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; Vuong B, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0859-9; Weible AP, 2009, J NEUROPHYSIOL, V102, P2055, DOI 10.1152/jn.00214.2009; WHO, 2014, OB OV; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Winther G, 2018, NEUROSCIENCE, V388, P87, DOI 10.1016/j.neuroscience.2018.07.014; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yasuda H, 2015, HIPPOCAMPUS, V25, P1274, DOI 10.1002/hipo.22435; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001; Zheng HH, 2016, MOL NEUROBIOL, V53, P1, DOI 10.1007/s12035-014-8981-5	93	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21544	10.1096/fj.202002293RR	http://dx.doi.org/10.1096/fj.202002293RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33819356	Green Submitted			2022-12-28	WOS:000645260100081
J	Eid, SA; Hinder, LM; Zhang, HY; Eksi, R; Nair, V; Eddy, S; Eichinger, F; Park, M; Saha, J; Berthier, CC; Jagadish, HV; Guan, YF; Pennathur, S; Hur, J; Kretzler, M; Feldman, EL; Brosius, FC				Eid, Stephanie A.; Hinder, Lucy M.; Zhang, Hongyu; Eksi, Ridvan; Nair, Viji; Eddy, Sean; Eichinger, Felix; Park, Meeyoung; Saha, Jharna; Berthier, Celine C.; Jagadish, Hosagrahar, V; Guan, Yuanfang; Pennathur, Subramaniam; Hur, Junguk; Kretzler, Matthias; Feldman, Eva L.; Brosius, Frank C.			Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects	FASEB JOURNAL			English	Article						diabetic kidney disease; diabetic peripheral neuropathy; genome-wide expression; RAS blockade; self-organizing map	NEPHROPATHY; PODOCYTE; DEFICIENCY; BIOLOGY; SYSTEM; CELLS	Diabetic kidney disease (DKD) and diabetic peripheral neuropathy (DPN) are two common diabetic complications. However, their pathogenesis remains elusive and current therapies are only modestly effective. We evaluated genome-wide expression to identify pathways involved in DKD and DPN progression in db/db eNOS-/- mice receiving renin-angiotensin-aldosterone system (RAS)-blocking drugs to mimic the current standard of care for DKD patients. Diabetes and eNOS deletion worsened DKD, which improved with RAS treatment. Diabetes also induced DPN, which was not affected by eNOS deletion or RAS blockade. Given the multiple factors affecting DKD and the graded differences in disease severity across mouse groups, an automatic data analysis method, SOM, or self-organizing map was used to elucidate glomerular transcriptional changes associated with DKD, whereas pairwise bioinformatic analysis was used for DPN. These analyses revealed that enhanced gene expression in several pro-inflammatory networks and reduced expression of development genes correlated with worsening DKD. Although RAS treatment ameliorated the nephropathy phenotype, it did not alter the more abnormal gene expression changes in kidney. Moreover, RAS exacerbated expression of genes related to inflammation and oxidant generation in peripheral nerves. The graded increase in inflammatory gene expression and decrease in development gene expression with DKD progression underline the potentially important role of these pathways in DKD pathogenesis. Since RAS blockers worsened this gene expression pattern in both DKD and DPN, it may partly explain the inadequate therapeutic efficacy of such blockers.	[Eid, Stephanie A.; Hinder, Lucy M.; Park, Meeyoung; Feldman, Eva L.] Univ Michigan, Dept Neurol, Sch Med, 5017 AATBSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Zhang, Hongyu; Nair, Viji; Eddy, Sean; Eichinger, Felix; Saha, Jharna; Berthier, Celine C.; Pennathur, Subramaniam; Kretzler, Matthias; Brosius, Frank C.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Eksi, Ridvan; Jagadish, Hosagrahar, V; Guan, Yuanfang; Kretzler, Matthias] Univ Michigan, Dept Computat Med & Biol, Sch Med, Ann Arbor, MI 48109 USA; [Pennathur, Subramaniam; Brosius, Frank C.] Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI 48109 USA; [Hur, Junguk] Univ North Dakota, Dept Biomed Sci, Grand Forks, ND USA; [Brosius, Frank C.] Univ Arizona, Dept Med, Tucson, AZ USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Dakota Grand Forks; University of Arizona	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Sch Med, 5017 AATBSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	efeldman@umich.edu			HHS | National Institutes of Health (NIH) [1DP3DK094292]; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R24082841, U2CDK110768]; Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research) [NNF14OC0011633]; Nathan and Rose Milstein Research Fund; Neuronetwork for Emerging Therapies at the University of Michigan; A. Alfred Taubman Medical Research Institute; University of Michigan O'Brien Kidney Translational Core Center [2P30DK081943]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Nathan and Rose Milstein Research Fund; Neuronetwork for Emerging Therapies at the University of Michigan; A. Alfred Taubman Medical Research Institute; University of Michigan O'Brien Kidney Translational Core Center	HHS | National Institutes of Health (NIH), Grant/Award Number: 1DP3DK094292; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: 1R24082841 and U2CDK110768; Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research), Grant/Award Number: NNF14OC0011633; The Nathan and Rose Milstein Research Fund; Neuronetwork for Emerging Therapies at the University of Michigan; the A. Alfred Taubman Medical Research Institute; University of Michigan O'Brien Kidney Translational Core Center, Grant/Award Number: 2P30DK081943	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azushima K, 2018, NAT REV NEPHROL, V14, P48, DOI 10.1038/nrneph.2017.142; Barutta F, 2015, ENDOCRINE, V48, P730, DOI 10.1007/s12020-014-0437-1; Bhatt LK, 2010, NEUROL SCI, V31, P705, DOI 10.1007/s10072-010-0243-3; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; Boini KM, 2014, BBA-MOL CELL RES, V1843, P836, DOI 10.1016/j.bbamcr.2014.01.033; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Callaghan BC, 2020, JAMA-J AM MED ASSOC, V324, P90, DOI 10.1001/jama.2020.0700; Callaghan BC, 2018, ANN CLIN TRANSL NEUR, V5, P397, DOI 10.1002/acn3.531; Chittka D, 2018, NEPHROL DIAL TRANSPL, V33, P1533, DOI 10.1093/ndt/gfx359; del Nogal M, 2012, APOPTOSIS, V17, P1261, DOI 10.1007/s10495-012-0769-3; Eid S, 2019, DIABETOLOGIA, V62, P1539, DOI 10.1007/s00125-019-4959-1; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Feldman EL, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0092-1; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Guo K, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00913-6; Gupta G, 2020, CHEM-BIOL INTERACT, V317, DOI 10.1016/j.cbi.2020.108975; Gurley SB, 2018, DIABETES, V67, P2096, DOI 10.2337/db17-1323; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Hinder LM, 2018, EXP NEUROL, V305, P33, DOI 10.1016/j.expneurol.2018.03.011; Hinder LM, 2017, J CELL MOL MED, V21, P2140, DOI 10.1111/jcmm.13136; Hinder LM, 2017, DIS MODEL MECH, V10, P717, DOI 10.1242/dmm.028530; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; Hur J, 2016, DIABETOLOGIA, V59, P1297, DOI 10.1007/s00125-016-3913-8; Hur J, 2015, DIABETES, V64, P3294, DOI 10.2337/db15-0133; Hur J, 2011, BRAIN, V134, P3222, DOI 10.1093/brain/awr228; Jiang GZ, 2016, KIDNEY INT, V89, P411, DOI 10.1016/j.kint.2015.09.001; Jurga AM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00048; Juster-Switlyk K., 2016, F1000RES, V5, P738, DOI [10.12688/f1000research.7898.1, DOI 10.12688/F1000RESEARCH.7898.1]; Kallenborn-Gerhardt W, 2014, PAIN, V155, P2161, DOI 10.1016/j.pain.2014.08.013; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Komorowsky CV, 2012, J CARDIOVASC TRANSL, V5, P491, DOI 10.1007/s12265-012-9382-7; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laboratory B., ANIMAL MODELS DIABET; Leoncini G, 2020, J NEPHROL, V33, P949, DOI 10.1007/s40620-020-00803-3; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Liu YF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00172; Maity S, 2020, J BIOL CHEM, V295, P14262, DOI 10.1074/jbc.RA120.014994; Manea SA, 2015, REDOX BIOL, V5, P358, DOI 10.1016/j.redox.2015.06.012; Matoba K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143393; McGregor BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36098-5; Mifsud SA, 2001, DIABETOLOGIA, V44, P878; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; O'Brien PD, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.042101; O'Brien PD, 2015, NEUROBIOL DIS, V73, P348, DOI 10.1016/j.nbd.2014.10.015; O'Brien PD, 2014, ILAR J, V54, P259, DOI 10.1093/ilar/ilt052; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Perlman AS, 2015, ANN CLIN LAB SCI, V45, P256; Roscioni SS, 2014, NAT REV NEPHROL, V10, P77, DOI 10.1038/nrneph.2013.251; Sanden SK, 2003, J AM SOC NEPHROL, V14, P2484, DOI 10.1097/01.ASN.0000089829.45296.7C; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Sas KM, 2018, J LIPID RES, V59, P173, DOI 10.1194/jlr.M077222; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shi Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67054-x; Shonesy BC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.002; Sun L, 2015, KIDNEY INT, V88, P662, DOI 10.1038/ki.2015.250; Takahashi T, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/590541; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Williams AS, 2017, DIABETES, V66, P325, DOI 10.2337/db16-0484; Wilson PC, 2019, P NATL ACAD SCI USA, V116, P19619, DOI 10.1073/pnas.1908706116; Zain M, 2014, PAK J PHARM SCI, V27, P1379; Zhang HY, 2008, AM J PHYSIOL-RENAL, V295, pF1071, DOI 10.1152/ajprenal.90208.2008; Zhang HY, 2017, KIDNEY INT, V92, P909, DOI 10.1016/j.kint.2017.03.027; Zhang HY, 2010, AM J PHYSIOL-RENAL, V299, pF91, DOI 10.1152/ajprenal.00021.2010; Zhang MZ, 2012, AM J PHYSIOL-RENAL, V302, pF433, DOI 10.1152/ajprenal.00292.2011; Zhang Z, 2008, P NATL ACAD SCI USA, V105, P15896, DOI 10.1073/pnas.0803751105; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zheng XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185250	73	4	5	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21467	10.1096/fj.202002387R	http://dx.doi.org/10.1096/fj.202002387R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788970	Green Published			2022-12-28	WOS:000645260100029
J	Huang, DD; Ding, QH; Chen, SB; Lu, SQ; Zhang, Y; Long, MA				Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian			E-selectin negatively regulates polymorphonuclear neutrophil transmigration through altered endothelial junction integrity	FASEB JOURNAL			English	Article						cytoskeletal remodeling; endothelial integrity; E-selectin; neutrophil; transmigration	ARP2/3 COMPLEX; CELL-ADHESION; LEUKOCYTE ADHESION; ACTIN; DYNAMICS; LAMELLIPODIA; CORTACTIN; MOLECULES; MIGRATION; PROTEINS	Transendothelial migration (TEM) of neutrophils under blood flow is critical in the inflammatory cascade. However, the role of endothelial plasticity in this process is not fully understood. Therefore, we used an in vitro model to test the dynamics of human polymorphonuclear neutrophil (PMN) TEM across lipopolysaccharide-treated human umbilical vein endothelial cell (HUVEC) monolayers. Interestingly, shRNA-E-selectin knockdown in HUVECs destabilized endothelial junctional integrity by reducing actin branching and increasing stress fiber at cell-cell junctions. This process is accomplished by downregulating the activation of cortactin and Arp2/3, which in turn alters the adhesive function of VE-cadherin, enhancing PMN transmigration. Meanwhile, redundant P-selectins possess overlapping functions in E-selectin-mediated neutrophil adhesion, and transmigration. These results demonstrate, to our knowledge, for the first time, that E-selectins negatively regulate neutrophil transmigration through alterations in endothelial plasticity. Furthermore, it improves our understanding of the mechanisms underlying actin remodeling, and junctional integrity, in endothelial cells mediating leukocyte TEM.	[Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Natl Micrograv Lab, Ctr Biomech & Bioengn,Key Lab Micrograv, Beijing 100190, Peoples R China; [Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing 100190, Peoples R China; [Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian] Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y; Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Natl Micrograv Lab, Ctr Biomech & Bioengn,Key Lab Micrograv, Beijing 100190, Peoples R China.; Zhang, Y; Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing 100190, Peoples R China.	zhangyan@imech.ac.cn; mlong@imech.ac.cn			National Natural Science Foundation of China (NSFC) [31627804, 91642203, 11772345, 91539119]; National Key Rsearch and Development Program of China [2016YFA0501601]; Chinese Academy of Sciences Strategic Priority Research Program [XDB22040101]; Frontier Science Key Project [QYZDJ--SSW--JSC018]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Rsearch and Development Program of China; Chinese Academy of Sciences Strategic Priority Research Program; Frontier Science Key Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31627804, 91642203, 11772345 and 91539119; National Key Rsearch and Development Program of China, Grant/Award Number: 2016YFA0501601; Chinese Academy of Sciences Strategic Priority Research Program, Grant/Award Number: XDB22040101; Frontier Science Key Project, Grant/Award Number: QYZDJ--SSW--JSC018	Abu Taha A, 2014, MOL BIOL CELL, V25, P245, DOI 10.1091/mbc.E13-07-0404; Alon R, 2017, TRENDS IMMUNOL, V38, P606; Belvitch P, 2017, PULM CIRC, V7, P200, DOI 10.1086/690307; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Brodt P, 1997, INT J CANCER, V71, P612, DOI 10.1002/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D; Dimchev G, 2017, MOL BIOL CELL, V28, P1311, DOI 10.1091/mbc.E16-05-0334; Eguiluz RCA, 2017, BIOMATERIALS, V140, P45, DOI 10.1016/j.biomaterials.2017.06.010; Gong YX, 2017, FASEB J, V31, P212, DOI 10.1096/fj.201600398RRR; Hayer A, 2016, NAT CELL BIOL, V18, P1311, DOI 10.1038/ncb3438; Hu J, 2019, BIOPHYS REP, V6, P9; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; Isac L, 2011, ANAL BIOANAL CHEM, V399, P2351, DOI 10.1007/s00216-010-3978-z; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Lorenzon P, 1998, J CELL BIOL, V142, P1381, DOI 10.1083/jcb.142.5.1381; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Martinelli R, 2014, J CELL SCI, V127, P3720, DOI 10.1242/jcs.148619; Martinelli R, 2013, J CELL BIOL, V201, P449, DOI 10.1083/jcb.201209077; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; McEver RP, 2010, ANN REV, P363; Milstone DS, 1998, MICROCIRCULATION-LON, V5, P153, DOI 10.1080/713773857; Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Neto F, 2018, ELIFE, V7, DOI 10.7554/eLife.31037; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Pesen D, 2005, BIOPHYS J, V88, P670, DOI 10.1529/biophysj.104.049965; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rajagopal V, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1407; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schnittler H, 2014, CELL TISSUE RES, V355, P529, DOI 10.1007/s00441-014-1856-2; Schnoor M, 2015, J IMMUNOL, V194, P3535, DOI 10.4049/jimmunol.1403250; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tilghman RW, 2002, FASEB J, V16, P1257, DOI 10.1096/fj.01-0969fje; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; van Buul JD, 2009, THROMB HAEMOSTASIS, V101, P649, DOI 10.1160/TH08-11-0714; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Xu YH, 2019, APL BIOENG, V3, DOI 10.1063/1.5045115; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445	51	2	2	8	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21521	10.1096/fj.202000662RR	http://dx.doi.org/10.1096/fj.202000662RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811691				2022-12-28	WOS:000645260100005
J	Ma, C; Teng, L; Lin, G; Guo, BB; Zhuo, R; Qian, XW; Guan, TC; Wu, RH; Liu, Y; Liu, M				Ma, Chao; Teng, Long; Lin, Ge; Guo, Beibei; Zhuo, Run; Qian, Xiaowei; Guan, Tuchen; Wu, Ronghua; Liu, Yan; Liu, Mei			L-leucine promotes axonal outgrowth and regeneration via mTOR activation	FASEB JOURNAL			English	Article						axonal outgrowth; CSPGs; L-Leucine; mTOR pathway; spinal cord injury	SPINAL-CORD; PTEN; SUPPLEMENTATION; SYSTEM; MICROTUBULES; LOCOMOTION; SURVIVAL; DELETION; 3-KINASE; PATHWAY	Discovering safe and effective drugs that promote neuron regeneration is an essential strategy for the recovery of central nervous system injuries. In this study, we found that L-leucine, an essential amino acid obtained from both supplements and food sources, could dramatically boost axonal outgrowth and regeneration. First, the effects of L-leucine on neurons were evaluated by cell apoptosis, survival, and death assays, and the results showed no changes in these processes after treatment. By live cell imaging, L-leucine was found to remarkably increase axonal length and growth velocity after axotomy. We also verified that L-leucine enhanced p-mTOR/p-S6K activation in neurons by testing with an mTOR inhibitor, rapamycin. Thereafter, we investigated the effects of L-leucine on the spinal cord injury in vivo. A mouse model of spinal cord hemi-section was established, and L-leucine was administered by tail intravenous injection. Basso mouse scale values revealed that L-leucine could improve functional recovery after injury. It was also notable that L-leucine treatment promoted axon growth across chondroitin sulfate proteoglycan (CSPG) areas. Furthermore, we used CSPGs as inhibitory environmental cues and clarified that L-leucine significantly enhanced axonal outgrowth and regeneration by promoting p-mTOR and p-S6K activation. Therefore, our study is the first to report that L-leucine promotes axonal regeneration in vitro and in vivo and could be candidate drug for axonal re-growth and nervous functional recovery.	[Ma, Chao; Teng, Long; Lin, Ge; Guo, Beibei; Zhuo, Run; Qian, Xiaowei; Guan, Tuchen; Wu, Ronghua; Liu, Yan; Liu, Mei] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Jiangsu, Peoples R China; [Ma, Chao; Teng, Long; Lin, Ge; Guo, Beibei; Zhuo, Run; Qian, Xiaowei; Guan, Tuchen; Wu, Ronghua; Liu, Yan; Liu, Mei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Liu, Y; Liu, M (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Jiangsu, Peoples R China.; Liu, Y; Liu, M (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong 226001, Jiangsu, Peoples R China.	liuyan@ntu.edu.cn; liumei@ntu.edu.cn	; Liu, Mei/H-9415-2018	ma, chao/0000-0001-9478-1810; Guan, Tuchen/0000-0001-5929-5489; Liu, Mei/0000-0003-1168-6119	National Major Project of Research and Development [2017YFA0104701]; National Natural Science Foundation of China [31970412, 32070725]; Natural Science Foundation of Jiangsu Province [BK20191446]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Major Project of Research and Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This study was supported by the National Major Project of Research and Development (2017YFA0104701), the National Natural Science Foundation of China (31970412, 32070725), Natural Science Foundation of Jiangsu Province (BK20191446), and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	de Moraes WMAM, 2015, NUTRIENTS, V7, P3751, DOI 10.3390/nu7053751; Anderson MA, 2018, NATURE, V561, P396, DOI 10.1038/s41586-018-0467-6; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Berry M, 2016, NEUROBIOL DIS, V85, P99, DOI 10.1016/j.nbd.2015.10.002; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Chen CH, 2016, EXP NEUROL, V278, P27, DOI 10.1016/j.expneurol.2016.01.023; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dhamija R, 2020, CLIN IMAG, V60, P180, DOI 10.1016/j.clinimag.2019.12.006; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Elghazi L, 2017, MOL METAB, V6, P560, DOI 10.1016/j.molmet.2017.03.010; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Hu ZL, 2017, MOL BIOL CELL, V28, P545, DOI 10.1091/mbc.E16-09-0628; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Ishizuka Y, 2008, J NEUROCHEM, V106, P934, DOI 10.1111/j.1471-4159.2008.05438.x; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu M, 2010, J NEUROSCI, V30, P14896, DOI 10.1523/JNEUROSCI.3739-10.2010; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Matamoros AJ, 2019, J NEUROSCI, V39, P2011, DOI 10.1523/JNEUROSCI.1888-18.2018; Morgan-Warren PJ, 2013, INVEST OPHTH VIS SCI, V54, P6903, DOI 10.1167/iovs.13-12803; Ohtake Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37152; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Pedroso JAB, 2015, NUTRIENTS, V7, P3914, DOI 10.3390/nu7053914; Pereira MG, 2014, NUTRIENTS, V6, P3981, DOI 10.3390/nu6103981; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Poulopoulos A, 2019, NATURE, V565, P356, DOI 10.1038/s41586-018-0847-y; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Teng L, 2020, BIOCHEM BIOPH RES CO, V534, P121; Tran AP, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113276; Wei XY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091075; Wu RH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01303; Yang T, 2016, NEUROPHARMACOLOGY, V110, P343, DOI 10.1016/j.neuropharm.2016.06.015; Yang T, 2020, FASEB J, V34, P15504, DOI 10.1096/fj.202001657RR; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571; Zanchi D, 2016, SCI REP-UK, V6, DOI 10.1038/srep35727; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	42	9	9	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21526	10.1096/fj.202001798RR	http://dx.doi.org/10.1096/fj.202001798RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813773				2022-12-28	WOS:000645260100107
J	Chen, X; Zhang, YH; Wang, QQ; Qin, YY; Yang, XY; Xing, ZC; Shen, YJ; Wu, HM; Qi, YT				Chen, Xu; Zhang, Yuhong; Wang, Qiqi; Qin, Yuanyuan; Yang, Xinyi; Xing, Zhengcao; Shen, Yajie; Wu, Hongmei; Qi, Yitao			The function of SUMOylation and its crucial roles in the development of neurological diseases	FASEB JOURNAL			English	Review						cancer therapy; channelopathy; neurological disease; SENP; SUMOylation	AMYLOID PRECURSOR PROTEIN; ALPHA-SYNUCLEIN AGGREGATION; NITRIC-OXIDE SYNTHASE; MOUSE MODEL; POSTTRANSLATIONAL MODIFICATIONS; POTASSIUM CHANNEL; SUMO MODIFICATION; TRANSCRIPTIONAL ACTIVATION; TYROSINE-HYDROXYLASE; TAU PHOSPHORYLATION	Neurological diseases are relatively complex diseases of a large system; however, the detailed mechanism of their pathogenesis has not been completely elucidated, and effective treatment methods are still lacking for some of the diseases. The SUMO (small ubiquitin-like modifier) modification is a dynamic and reversible process that is catalyzed by SUMO-specific E1, E2, and E3 ligases and reversed by a family of SENPs (SUMO/Sentrin-specific proteases). SUMOylation covalently conjugates numerous cellular proteins, and affects their cellular localization and biological activity in numerous cellular processes. A wide range of neuronal proteins have been identified as SUMO substrates, and the disruption of SUMOylation results in defects in synaptic plasticity, neuronal excitability, and neuronal stress responses. SUMOylation disorders cause many neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and Huntington's disease. By modulating the ion channel subunit, SUMOylation imbalance is responsible for the development of various channelopathies. The regulation of protein SUMOylation in neurons may provide a new strategy for the development of targeted therapeutic drugs for neurodegenerative diseases and channelopathies.	[Chen, Xu; Zhang, Yuhong; Wang, Qiqi; Qin, Yuanyuan; Yang, Xinyi; Xing, Zhengcao; Shen, Yajie; Wu, Hongmei; Qi, Yitao] Shaanxi Normal Univ, Minist Educ Med Resources & Nat Pharmaceut Chem, Natl Engn Lab Resource Developing Endangered Chin, Key Lab,Coll Life Sci, Xian 710119, Shaanxi, Peoples R China	Shaanxi Normal University	Wu, HM; Qi, YT (corresponding author), Shaanxi Normal Univ, Minist Educ Med Resources & Nat Pharmaceut Chem, Natl Engn Lab Resource Developing Endangered Chin, Key Lab,Coll Life Sci, Xian 710119, Shaanxi, Peoples R China.	hq8479@snnu.edu.cn; qiyitao@snnu.edu.cn	; Qi, Yitao/B-4220-2014	xu, chen/0000-0002-3777-0514; Qi, Yitao/0000-0003-4820-2659	National Natural Science Foundation of China (NSFC) [81671294, 81870241]; fundamental research funds for central universities [GK201903066]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); fundamental research funds for central universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671294 and 81870241; fundamental research funds for central universities, Grant/Award Number: GK201903066	Abeywardana T, 2015, BIOCHEMISTRY-US, V54, P959, DOI 10.1021/bi501512m; Akar CA, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-12; Archer Stephen L, 2006, Novartis Found Symp, V272, P157; Bardgett ME, 2011, NEUROBIOL LEARN MEM, V95, P64, DOI 10.1016/j.nlm.2010.10.008; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Benarroch EE, 2014, NAT REV NEUROL, V10, P396, DOI 10.1038/nrneurol.2014.88; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bido S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07181-0; Bleasel JM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-15; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Burre J, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024091; Cao J, 2017, ADV EXP MED BIOL, V1037, P203, DOI 10.1007/978-981-10-6583-5_13; Chang HM, 2020, PHYSIOL REV, V100, P1599, DOI 10.1152/physrev.00025.2019; Chen X, 2018, METHODS MOL BIOL, V1684, P63, DOI 10.1007/978-1-4939-7362-0_6; Cheng CF, 2016, J COMP NEUROL, V524, P846, DOI 10.1002/cne.23876; Chew LA, 2018, NEURONAL SIGNALING, V2; Chiou HYC, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-53; Cho SJ, 2015, J ALZHEIMERS DIS, V47, P639, DOI 10.3233/JAD-150103; Choi BR, 2013, NEUROSCIENCE, V253, P214, DOI 10.1016/j.neuroscience.2013.08.043; Chua HC, 2017, ADV PHARMACOL, V79, P1, DOI 10.1016/bs.apha.2017.03.003; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Citro S, 2013, J MOL CELL BIOL, V5, P416, DOI 10.1093/jmcb/mjt032; Clark J, 2009, ANTIOXID REDOX SIGN, V11, P509, DOI 10.1089/ARS.2008.2241; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Comes N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00283; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Davis RL, 2005, BRAIN RES REV, V49, P494, DOI 10.1016/j.brainresrev.2005.01.008; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Ding Wei-Guang, 2019, Cell Physiol Biochem, V52, P302, DOI 10.33594/000000022; Ding WG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092923; Dolgacheva LP, 2019, J BIOENERG BIOMEMBR, V51, P175, DOI 10.1007/s10863-019-09798-4; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Dustrude ET, 2016, P NATL ACAD SCI USA, V113, pE8443, DOI 10.1073/pnas.1610531113; Dustrude ET, 2013, J BIOL CHEM, V288, P24316, DOI 10.1074/jbc.M113.474924; Endres K, 2018, J INNATE IMMUN, V10, P172, DOI 10.1159/000488629; Silva MVF, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0524-y; Francois-Moutal L, 2018, PAIN, V159, P2115, DOI 10.1097/j.pain.0000000000001294; Gao JZ, 2019, CURR DRUG TARGETS, V20, P579, DOI 10.2174/1389450119666181022153942; Gardella E, 2019, EPILEPSIA, V60, pS77, DOI 10.1111/epi.16319; Geng L, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.118.007097; Ghosh H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13365; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Harrison LM, 2013, EXP CELL RES, V319, P2310, DOI 10.1016/j.yexcr.2013.03.033; Hasegawa M, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a024273; Hatano N, 2004, J BIOL CHEM, V279, P5450, DOI 10.1074/jbc.M302034200; Hattori N, 2004, LANCET, V364, P722, DOI 10.1016/S0140-6736(04)16901-8; Henley JM, 2018, TRENDS NEUROSCI, V41, P198, DOI 10.1016/j.tins.2018.02.004; Hoffmann C, 2021, CELL RES, V31, P245, DOI 10.1038/s41422-020-00440-2; Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034; Jenkins SM, 2000, BIOCHEM J, V345, P263, DOI 10.1042/0264-6021:3450263; Jesko H, 2019, ACTA NEUROBIOL EXP, V79, P276, DOI 10.21307/ane-2019-026; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; JOHNSON PF, 1993, MOL CELL BIOL, V13, P6919, DOI 10.1128/MCB.13.11.6919; Ju WN, 2013, CHANNELS, V7, P153, DOI 10.4161/chan.24224; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kang JH, 2012, BIOTECHNOL ADV, V30, P1662, DOI 10.1016/j.biotechadv.2012.07.004; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim June-Bum, 2014, Korean J Pediatr, V57, P1, DOI 10.3345/kjp.2014.57.1.1; Knock E, 2018, NEUROBIOL DIS, V110, P154, DOI 10.1016/j.nbd.2017.11.015; Kovalchuke L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47952-5; Kreir M, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172474; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; Kunadt M, 2015, ACTA NEUROPATHOL, V129, P695, DOI 10.1007/s00401-015-1408-1; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07190; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Leney AC, 2017, P NATL ACAD SCI USA, V114, pE7255, DOI 10.1073/pnas.1620529114; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Li YM, 2010, CANCER RES, V70, P646, DOI 10.1158/0008-5472.CAN-09-1924; Liu J, 2016, J MEMBRANE BIOL, V249, P449, DOI 10.1007/s00232-016-9885-2; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Lotankar S, 2017, NEUROSCI BULL, V33, P585, DOI 10.1007/s12264-017-0183-5; Luo HB, 2014, P NATL ACAD SCI USA, V111, P16586, DOI 10.1073/pnas.1417548111; Luo QC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00499-3; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marcelli S, 2017, MOL NEUROBIOL, V54, P6609, DOI 10.1007/s12035-016-0176-9; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Maruyama T, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00601; Mazdeh M, 2018, NEUROL SCI, V39, P1565, DOI 10.1007/s10072-018-3458-3; McColgan P, 2018, EUR J NEUROL, V25, P24, DOI 10.1111/ene.13413; Meyer RC, 1998, ANN NY ACAD SCI, V854, P307, DOI 10.1111/j.1749-6632.1998.tb09911.x; Michel S, 2012, J CELL PHYSIOL, V227, P2297, DOI 10.1002/jcp.23021; Min R, 2018, BRAIN PATHOL, V28, P372, DOI 10.1111/bpa.12602; Mischiati C, 2008, CURR PHARM DESIGN, V14, P2075, DOI 10.2174/138161208785294618; Myllykoski M, 2017, AMINO ACIDS, V49, P747, DOI 10.1007/s00726-016-2376-z; Nakka VP, 2020, NEUROCHEM RES, V45, P1975, DOI 10.1007/s11064-020-03066-3; Napolitano F, 2018, NEUROSCIENCE, V384, P419, DOI 10.1016/j.neuroscience.2018.05.027; Niki T, 2003, MOL CANCER RES, V1, P247; Nistico R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00063; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; O'Rourke JG, 2013, CELL REP, V4, P362, DOI 10.1016/j.celrep.2013.06.034; Ochaba J, 2016, NEURON, V90, P507, DOI 10.1016/j.neuron.2016.03.016; Ochoa-de la Paz L, 2019, EXPERT REV NEUROTHER, V19, P289, DOI 10.1080/14737175.2019.1593827; Oh Y, 2011, BRAIN RES, V1381, P78, DOI 10.1016/j.brainres.2011.01.039; Ohkuni K, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00379; Ortuno-Sahagun D, 2012, HIPPOCAMPUS, V22, P128, DOI 10.1002/hipo.20869; Pandey P, 2016, ONCOTARGET, V7, P19430, DOI 10.18632/oncotarget.7103; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Plant LD, 2005, CURR OPIN NEUROBIOL, V15, P326, DOI 10.1016/j.conb.2005.05.008; Ptacek LJ, 1997, NEUROMUSCULAR DISORD, V7, P250, DOI 10.1016/S0960-8966(97)00046-1; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Qi YT, 2014, NEURON, V83, P1159, DOI 10.1016/j.neuron.2014.07.042; Qi YT, 2014, J BIOL CHEM, V289, P3288, DOI 10.1074/jbc.M113.518282; Qu J, 2009, NEUROSCI LETT, V464, P209, DOI 10.1016/j.neulet.2009.08.048; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Ramberg V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-34; Ramos-Vicente D, 2018, ELIFE, V7, DOI 10.7554/eLife.35774; Rao M, 2016, NAT REV GASTRO HEPAT, V13, DOI 10.1038/nrgastro.2016.107; Reiss AB, 2018, REV NEUROSCIENCE, V29, P613, DOI 10.1515/revneuro-2017-0063; Riedel M, 2011, J MOL NEUROSCI, V43, P290, DOI 10.1007/s12031-010-9439-5; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Shao RJ, 2004, ENDOCRINOLOGY, V145, P384, DOI 10.1210/en.2003-0527; Sharma M, 2019, P NATL ACAD SCI USA, V116, P23760, DOI 10.1073/pnas.1912868116; Shepherd E, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012409.pub2; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Silveirinha V, 2013, J NEUROCHEM, V127, P580, DOI 10.1111/jnc.12347; Spiliopoulos K, 2009, J NEURAL TRANSM, V116, P417, DOI 10.1007/s00702-009-0199-8; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Straccia M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-156; Sun H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5980; Tabor GT, 2019, MOL CELL NEUROSCI, V98, P121, DOI 10.1016/j.mcn.2019.06.007; Takahashi K, 2008, NEUROSCI LETT, V441, P90, DOI 10.1016/j.neulet.2008.06.012; Tao CC, 2017, CELL DEATH DIFFER, V24, P597, DOI 10.1038/cdd.2016.161; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tong YA, 2011, J NEUROSCI, V31, P14794, DOI 10.1523/JNEUROSCI.2774-11.2011; Um JW, 2006, J NEUROSCI RES, V84, P1543, DOI 10.1002/jnr.21041; Varejao N, 2020, BIOCHEM SOC T, V48, P123, DOI 10.1042/BST20190357; Vijayakumaran S, 2015, BIOMOLECULES, V5, P1697, DOI 10.3390/biom5031697; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Wang LW, 2018, BBA-MOL CELL RES, V1865, P1698, DOI 10.1016/j.bbamcr.2018.07.004; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Weetman J, 2013, NEUROSCI LETT, V544, P119, DOI 10.1016/j.neulet.2013.03.057; Welch MA, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00144; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Wilson VG., 2005, SCI STKE SIGNAL TRAN, pE32; Wong MB, 2013, NEUROTOX RES, V23, P1, DOI 10.1007/s12640-012-9358-z; Wu HM, 2016, ADV PROTEIN CHEM STR, V103, P295, DOI 10.1016/bs.apcsb.2015.11.009; Ye QY, 2016, MOL NEUROBIOL, V53, P3756, DOI 10.1007/s12035-015-9299-7; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yu J, 2019, MOL NEUROBIOL, V56, P5241, DOI 10.1007/s12035-018-1445-6; Yun SM, 2013, NEUROBIOL AGING, V34, P650, DOI 10.1016/j.neurobiolaging.2012.08.005; Zhang JF, 2018, BRAIN RES BULL, V139, P21, DOI 10.1016/j.brainresbull.2018.02.004; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109; Zhao BY, 2021, J CELL PHYSIOL, V236, P3466, DOI 10.1002/jcp.30143; Zhao XL, 2018, MOL CELL, V71, P409, DOI 10.1016/j.molcel.2018.07.027; Zhong N, 2008, HUM MOL GENET, V17, P3357, DOI 10.1093/hmg/ddn230; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zondler L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184040	164	7	7	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21510	10.1096/fj.202002702R	http://dx.doi.org/10.1096/fj.202002702R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710677				2022-12-28	WOS:000635216100006
J	Kwon, PK; Kim, HM; Kang, B; Kim, SW; Hwang, SM; Im, SH; Roh, TY; Kim, KT				Kwon, Paul Kwangho; Kim, Hyo-Min; Kang, Byunghee; Kim, Sung Wook; Hwang, Sung-Min; Im, Sin-Hyeog; Roh, Tae-Young; Kim, Kyong-Tai			hnRNP K supports the maintenance of ROR gamma circadian rhythm through ERK signaling	FASEB JOURNAL			English	Article						circadian rhythm; hnRNP K; poly(C) motif; ROR&#947; transcription		Retinoic acid-related orphan receptor gamma (ROR gamma) maintains the circadian rhythms of its downstream genes. However, the mechanism behind the transcriptional activation of ROR gamma itself remains unclear. Here, we demonstrate that transcription of ROR gamma is activated by heterogeneous nuclear ribonucleoprotein K (hnRNP K) via the poly(C) motif within its proximal promoter. Interestingly, we confirmed the binding of endogenous hnRNP K within ROR gamma 1 and ROR gamma 2 promoter along with the recruitment of RNA polymerase 2 through chromatin immunoprecipitation (ChIP). Furthermore, an assay for transposase accessible chromatin (ATAC)-qPCR showed that hnRNP K induced higher chromatin accessibility within the ROR gamma 1 and ROR gamma 2 promoter. Then we found that the knockdown of hnRNP K lowers ROR gamma mRNA oscillation amplitude in both ROR gamma and ROR gamma-dependent metabolic genes. Moreover, we demonstrated that time-dependent extracellular signal-regulated kinase (ERK) activation controls mRNA oscillation of ROR gamma and ROR gamma-dependent metabolic genes through hnRNP K. Taken together, our results provide new insight into the regulation of ROR gamma by hnRNP K as a transcriptional activator, along with its physiological significance in metabolism.	[Kwon, Paul Kwangho; Im, Sin-Hyeog; Roh, Tae-Young; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Kim, Hyo-Min; Kang, Byunghee; Kim, Sung Wook; Hwang, Sung-Min; Im, Sin-Hyeog; Roh, Tae-Young; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea.	ktk@postech.ac.kr	Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Kim, Hyo-Min/0000-0002-2667-3719; Kim, Sung Wook/0000-0001-9572-4762; KIM, KYONG-TAI/0000-0001-7292-2627; Hwang, Sung-Min/0000-0002-4868-147X; Roh, Tae-Young/0000-0001-5833-0844	National Research Foundation (NRF) [2017M3C7A1023478, 2019R1A2C2009440]; Rural Development Administration [PJ01324801]; Ministry of Education [10Z20130012243]	National Research Foundation (NRF); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Education	National Research Foundation (NRF), Grant/Award Number: 2017M3C7A1023478 and 2019R1A2C2009440; Rural Development Administration, Grant/Award Number: PJ01324801; Ministry of Education, Grant/Award Number: 10Z20130012243	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Banerjee K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6769; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cai DM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12529-3; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Charroux B, 1999, MOL CELL BIOL, V19, P7846, DOI 10.1128/mcb.19.11.7846; Choi JH, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00371-18; Choi JH, 2018, EMBO J, V37, DOI 10.15252/embj.201695266; Coogan AN, 2003, J NEUROSCI, V23, P3085; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Fitzsimmons RL, 2012, J STEROID BIOCHEM, V130, P159, DOI 10.1016/j.jsbmb.2011.06.009; Goldsmith CS, 2013, ADV GENET, V84, P1, DOI 10.1016/B978-0-12-407703-4.00001-3; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hovemann BT, 2000, GENE, V245, P127, DOI 10.1016/S0378-1119(00)00027-5; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kim SH, 2015, J NEUROCHEM, V132, P642, DOI 10.1111/jnc.13027; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kwon PK, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00537-19; Kwon PK, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00101-19; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Lee HR, 2015, J PINEAL RES, V59, P518, DOI 10.1111/jpi.12284; Lee KH, 2014, NUCLEIC ACIDS RES, V42, P3590, DOI 10.1093/nar/gkt1379; Lee KH, 2013, MOL BIOL CELL, V24, P2248, DOI 10.1091/mbc.E12-12-0849; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Masri S, 2018, NAT MED, V24, P1795, DOI 10.1038/s41591-018-0271-8; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Miyazaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027168; Noh JY, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.153; Rutz S, 2016, CYTOKINE GROWTH F R, V30, P1, DOI 10.1016/j.cytogfr.2016.07.004; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Takeda Y, 2014, NUCLEIC ACIDS RES, V42, P10448, DOI 10.1093/nar/gku766; Takeda Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004331; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830	42	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21507	10.1096/fj.202002076R	http://dx.doi.org/10.1096/fj.202002076R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724572				2022-12-28	WOS:000635216100013
J	Welty, FK; Schulte, F; Alfaddagh, A; Elajami, TK; Bistrian, BR; Hardt, M				Welty, Francine K.; Schulte, Fabian; Alfaddagh, Abdulhamied; Elajami, Tarec K.; Bistrian, Bruce R.; Hardt, Markus			Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid plus resolvin E1) to leukotriene B-4	FASEB JOURNAL			English	Article						coronary plaque regression; inflammation; metabololipidomics; omega&#8208; 3 fatty acids; resolvins		Inflammation in arterial walls leads to coronary artery disease (CAD). We previously reported that a high omega-3 fatty index was associated with prevention of progression of coronary atherosclerosis, a disease of chronic inflammation in the arterial wall. However, the mechanism of such benefit is unclear. The two main omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are precursors of specialized pro-resolving lipid mediators (SPMs)-resolvins and maresins-which actively resolve chronic inflammation. To explore whether SPMs are associated with coronary plaque progression, levels of SPMs and proinflammatory mediators (leukotriene B-4 [LTB4] and prostaglandins) were measured using liquid chromatography-tandem mass spectrometry in 31 statin-treated patients with stable CAD randomized to either EPA and DHA, 3.36 g daily, or no EPA/DHA (control). Coronary plaque volume was measured by coronary computed tomographic angiography at baseline and at 30-month follow-up. Higher plasma levels of EPA+DHA were associated with significantly increased levels of two SPMs-resolvin E1 and maresin 1-and 18-hydroxy-eicosapentaenoic acid (HEPE), the precursor of resolvin E1. Those with low plasma EPA+DHA levels had a low (18-HEPE+resolvin E1)/LTB4 ratio and significant plaque progression. Those with high plasma EPA+DHA levels had either low (18-HEPE+resolvin E1)/LTB4 ratios with significant plaque progression or high (18-HEPE+resolvin E1)/LTB4 ratios with significant plaque regression. These findings suggest that an imbalance between pro-resolving and proinflammatory lipid mediators is associated with plaque progression and potentially mediates the beneficial effects of EPA and DHA in CAD patients.	[Welty, Francine K.; Alfaddagh, Abdulhamied; Elajami, Tarec K.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, SL 423,330 Brookline Ave, Boston, MA 02215 USA; [Schulte, Fabian; Hardt, Markus] Forsyth Inst, Cambridge, MA USA; [Schulte, Fabian; Hardt, Markus] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA; [Bistrian, Bruce R.] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Harvard University; Beth Israel Deaconess Medical Center	Welty, FK (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, SL 423,330 Brookline Ave, Boston, MA 02215 USA.	fwelty@bidmc.harvard.edu	Hardt, Markus/M-8569-2019	Hardt, Markus/0000-0002-2300-216X	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [P50 HL 083813, UL1 TR001102]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: P50 HL 083813 and UL1 TR001102	Alfaddagh A, 2019, ATHEROSCLEROSIS, V285, P153, DOI 10.1016/j.atherosclerosis.2019.04.213; Alfaddagh A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006981; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Artiach G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01327; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Bayturan O, 2010, J AM COLL CARDIOL, V55, P2736, DOI 10.1016/j.jacc.2010.01.050; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Carracedo M, 2019, CARDIOVASC RES, V115, P1557, DOI 10.1093/cvr/cvy316; Chatterjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113480; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Elajami TK, 2016, FASEB J, V30, P2792, DOI 10.1096/fj.201500155R; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Hauser TH, 2016, JAMA CARDIOL, V1, P413, DOI 10.1001/jamacardio.2016.0605; Khosa F, 2013, ATHEROSCLEROSIS, V226, P428, DOI 10.1016/j.atherosclerosis.2012.11.033; Laguna-Fernandez A, 2018, CIRCULATION, V138, P1693, DOI 10.1161/CIRCULATIONAHA.117.032801; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Norris PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36679-4; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Parashar K, 2020, FASEB J, V34, P7733, DOI 10.1096/fj.201902196R; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; Sampson UK, 2012, CURR ATHEROSCLER REP, V14, P1, DOI 10.1007/s11883-011-0219-7; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Yang Rong, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1426s95	43	17	17	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21448	10.1096/fj.202002471R	http://dx.doi.org/10.1096/fj.202002471R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749913	Green Accepted			2022-12-28	WOS:000635216100085
J	Yuan, QC; Gong, H; Du, M; Mao, XY				Yuan, Qi-chen; Gong, Han; Du, Min; Mao, Xue-ying			Supplementation of milk polar lipids to obese dams improves neurodevelopment and cognitive function in male offspring	FASEB JOURNAL			English	Article						cognitive function; insulin resistance; maternal obesity; neurodevelopment; polar lipids&#8208; enriched milk fat globule membrane		Milk contains about 4% fat globules with its surface covered by polar lipids. Despite the abundant consumption of dairy products, the biological effects of dietary milk polar lipids on metabolic health have only been sparsely examined. Maternal obesity results in neurodevelopmental disorders and cognitive impairment in offspring. Considering the importance of maternal nutrition, the effects of polar lipids-enriched milk fat globule membrane (MFGM-PL) supplementation to dams during pregnancy and lactation on neurodevelopment and its long-term programming effects on offspring cognition were examined. Female Sprague-Dawley rats consumed 8-week control diet (CON) or high-fat diet (HFD) to induce obesity before mating. Then, female rats were fed CON or HFD with or without the supplementation of 400 mg/kg body weight MFGM-PL during pregnancy and lactation. The offspring were fed 11-week HFD after weaning. MFGM-PL supplementation to obese dams suppressed body weight gain and hyperinsulinemia in both dams and offspring. Offspring born to obese dams displayed delayed neurological reflexes development, impaired neurogenesis before weaning, and cognitive impairment in adulthood, which were recovered by maternal MFGM-PL supplementation. Insulin resistance and aberrant brain-derived neurotrophic factor signaling were induced in the hippocampus of neonatal and adult offspring due to maternal and progeny HFD, but recovered by maternal MFGM-PL administration. This study demonstrates that maternal MFGM-PL supplementation can promote neurodevelopment and exert long-term effects against HFD-induced cognitive impairment in offspring via alleviating hippocampal insulin resistance. Hence, MFGM-PL is a promising ingredient for exerting beneficial programming effects on the brain health of offspring.	[Yuan, Qi-chen; Gong, Han; Mao, Xue-ying] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Key Lab Precis Nutr & Food Qual, Key Lab Funct Dairy,Minist Educ, Beijing, Peoples R China; [Yuan, Qi-chen; Gong, Han; Mao, Xue-ying] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	China Agricultural University; China Agricultural University; Washington State University	Mao, XY (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.	maoxueying@cau.edu.cn		Yuan, Qichen/0000-0001-9588-0968	National Natural Science Foundation of China [31871806]; Beijing Dairy Industry Innovation Team [BAIC06-2020]; National Key Research Development Program of China [2019YFC1605000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Dairy Industry Innovation Team; National Key Research Development Program of China	National Natural Science Foundation of China, Grant/Award Number: 31871806; Beijing Dairy Industry Innovation Team, Grant/Award Number: BAIC06-2020; National Key Research Development Program of China, Grant/Award Number: 2019YFC1605000	Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Brink LR, 2019, J NUTR BIOCHEM, V69, P163, DOI [10.1016/j.jnutbio.2019.03.013, 10.1016/j.jnutbio.2019.0]; Brink LR, 2018, J NUTR BIOCHEM, V58, P131, DOI 10.1016/j.jnutbio.2018.05.004; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; Puentes AD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092154; del Bas JM, 2015, INT J OBESITY, V39, P7, DOI 10.1038/ijo.2014.159; Derbyshire E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061731; Dewettinck K, 2008, INT DAIRY J, V18, P436, DOI 10.1016/j.idairyj.2007.10.014; Dutta-Roy AK, 2000, AM J CLIN NUTR, V71, p315S, DOI 10.1093/ajcn/71.1.315s; Edlow AG, 2017, PRENATAL DIAG, V37, P95, DOI 10.1002/pd.4932; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459; Graf AE, 2016, BRAIN BEHAV IMMUN, V58, P369, DOI 10.1016/j.bbi.2016.08.005; Hari S, 2015, BIOSCI BIOTECH BIOCH, V79, P1172, DOI 10.1080/09168451.2015.1012150; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Heni M, 2014, ACTA DIABETOL, V51, P679, DOI 10.1007/s00592-013-0546-y; Kamel AS, 2018, MOL NEUROBIOL, V55, P8188, DOI 10.1007/s12035-018-0966-3; Kern W, 2006, DIABETOLOGIA, V49, P2790, DOI 10.1007/s00125-006-0409-y; Lamothe S, 2008, J DAIRY RES, V75, P439, DOI 10.1017/S002202990800349X; Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Lemas DJ, 2016, AM J CLIN NUTR, V103, P1291, DOI 10.3945/ajcn.115.126375; Li TG, 2020, FASEB J, V34, P4619, DOI 10.1096/fj.201901867RRR; Liu HN, 2014, J NUTR, V144, P1903, DOI 10.3945/jn.114.199828; Mahizir D, 2016, MOL NUTR FOOD RES, V60, P8, DOI 10.1002/mnfr.201500289; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Mi YS, 2017, FASEB J, V31, P4998, DOI 10.1096/fj.201700400RR; Mitchell MD, 2012, PLACENTA, V33, P312, DOI 10.1016/j.placenta.2011.12.018; Motta-Teixeira LC, 2018, HORM BEHAV, V105, P146, DOI 10.1016/j.yhbeh.2018.08.006; Moukarzel S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33603-8; Norris T, 2021, J MATERN-FETAL NEO M, V34, P3313, DOI 10.1080/14767058.2019.1683539; Page KC, 2014, AM J PHYSIOL-REG I, V306, pR527, DOI 10.1152/ajpregu.00319.2013; Ribes-Navarro A, 2019, MOL NEUROBIOL, V56, P454, DOI 10.1007/s12035-018-1091-z; Sangusa G, 2018, MOL NEUROBIOL, V55, P6984, DOI 10.1007/s12035-017-0863-1; Schipper L, 2016, J NUTR, V146, P1155, DOI 10.3945/jn.115.224998; Schmitz L, 2018, PSYCHONEUROENDOCRINO, V89, P46, DOI 10.1016/j.psyneuen.2017.12.023; Sona C, 2018, NEUROBIOL DIS, V118, P94, DOI 10.1016/j.nbd.2018.07.002; TAKAMIZAWA K, 1986, BIOCHIM BIOPHYS ACTA, V879, P73; Tome-Carneiro J, 2018, MOL NEUROBIOL, V55, P7285, DOI 10.1007/s12035-018-0934-y; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Widen EM, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12481; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Yan ZH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700461; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yuan QC, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103435; Zhu C, 2018, EXP CELL RES, V368, P159, DOI 10.1016/j.yexcr.2018.04.019; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478	54	6	7	10	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21454	10.1096/fj.202001974RRR	http://dx.doi.org/10.1096/fj.202001974RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749945				2022-12-28	WOS:000635216100074
J	Avni, D; Harikumar, KB; Sanyal, AJ; Spiegel, S				Avni, Dorit; Harikumar, Kuzhuvelil B.; Sanyal, Arun J.; Spiegel, Sarah			Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNF alpha-dependent inflammation and apoptosis	FASEB JOURNAL			English	Article						acute liver failure; apoptosis; cytokines; sphingosine kinase		Acute liver failure (ALF) causes severe liver dysfunction that can lead to multi-organ failure and death. Previous studies suggest that sphingosine kinase 1 (SphK1) protects against hepatocyte injury, yet not much is still known about its involvement in ALF. This study examines the role of SphK1 in D-galactosamine (GalN)/lipopolysaccharide (LPS)-induced ALF, which is a well-established experimental mouse model that mimics the fulminant hepatitis. Here we report that deletion of SphK1, but not SphK2, dramatically decreased GalN/LPS-induced liver damage, hepatic apoptosis, serum alanine aminotransferase levels, and mortality rate compared to wild-type mice. Whereas GalN/LPS treatment-induced hepatic activation of NF-kappa B and JNK in wild-type and SphK2(-/-) mice, these signaling pathways were reduced in SphK1(-/-) mice. Moreover, repression of ALF in SphK1(-/-) mice correlated with decreased expression of the pro-inflammatory cytokine TNF alpha. Adoptive transfer experiments indicated that SphK1 in bone marrow-derived infiltrating immune cells but not in host liver-resident cells, contribute to the development of ALF. Interestingly, LPS-induced TNF alpha production was drastically suppressed in SphK1-deleted macrophages, whereas IL-10 expression was markedly enhanced, suggesting a switch to the anti-inflammatory phenotype. Finally, treatment with a specific SphK1 inhibitor ameliorated inflammation and protected mice from ALF. Our findings suggest that SphK1 regulates TNF alpha secretion from macrophages and inhibition or deletion of SphK1 mitigated ALF. Thus, a potent inhibitor of SphK1 could potentially be a therapeutic agent for fulminant hepatitis.	[Avni, Dorit; Harikumar, Kuzhuvelil B.; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Sch Med, Richmond, VA 23298 USA; [Avni, Dorit] Migal Galilee Technol Ctr, Galilee Res Inst, MIGAL Bldg,Tarshish St, Qiryat Shemona, Israel; [Harikumar, Kuzhuvelil B.] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India	Virginia Commonwealth University; Virginia Commonwealth University; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Avni, D; Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA.	dorita@migal.org.il; sarah.spiegel@vcuhealth.org		Avni, Dorit/0000-0002-0444-881X	National Institutes of Health [RO1GM043880]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RO1GM043880 (to SS)	Ali M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.451; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; ATILLASOY E, 1995, ANNU REV MED, V46, P181; Avni D., 2021, FASEB J, V35; Avni D, 2010, IMMUNOLOGY, V129, P375, DOI 10.1111/j.1365-2567.2009.03188.x; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Chan G, 2009, LIVER TRANSPLANT, V15, P1696, DOI 10.1002/lt.21931; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Coldewey SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27594; Dong XT, 2019, EXP THER MED, V17, P3835, DOI 10.3892/etm.2019.7450; Guillot A, 2019, HEPATOL COMMUN, V3, P730, DOI 10.1002/hep4.1356; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019; Tunon MJ, 2009, WORLD J GASTROENTERO, V15, P3086, DOI 10.3748/wjg.15.3086; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Kaneko T, 2006, BIOCHEM BIOPH RES CO, V345, P85, DOI 10.1016/j.bbrc.2006.04.067; Kleuser B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030722; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Lei YC, 2015, WORLD J GASTROENTERO, V21, P13438, DOI 10.3748/wjg.v21.i48.13438; Lei YC, 2015, WORLD J GASTROENTERO, V21, P13055, DOI 10.3748/wjg.v21.i46.13055; LEIST M, 1995, AM J PATHOL, V146, P1220; Li LJ, 2020, CELL DEATH DIFFER, V27, P1924, DOI 10.1038/s41418-019-0471-x; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu Y, 2013, J PATHOL, V230, P365, DOI 10.1002/path.4194; Louis H, 1997, HEPATOLOGY, V25, P1382, DOI 10.1002/hep.510250614; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Megidish T, 1998, J BIOL CHEM, V273, P21834, DOI 10.1074/jbc.273.34.21834; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Mucke VT, 2020, HEPATOL COMMUN, V4, P1477, DOI 10.1002/hep4.1561; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nakama T, 2001, HEPATOLOGY, V33, P1441, DOI 10.1053/jhep.2001.24561; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Nowatari T, 2015, HEPATOL RES, V45, P1136, DOI 10.1111/hepr.12446; Olleros ML, 2010, J HEPATOL, V53, P1059, DOI 10.1016/j.jhep.2010.05.029; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Park WJ, 2020, MOL CELLS, V43, P419, DOI 10.14348/molcells.2020.0054; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Porta C, 2015, SEMIN IMMUNOL, V27, P237, DOI 10.1016/j.smim.2015.10.003; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; ROLANDO N, 1990, HEPATOLOGY, V11, P49, DOI 10.1002/hep.1840110110; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Saliba F, 2013, J HEPATOL, V59, P6, DOI 10.1016/j.jhep.2013.04.001; Santucci L, 1996, GASTROENTEROLOGY, V111, P736, DOI 10.1053/gast.1996.v111.pm8780580; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Stravitz RT, 2019, LANCET, V394, P869, DOI 10.1016/S0140-6736(19)31894-X; Tian T, 2016, UNITED EUR GASTROENT, V4, P677, DOI 10.1177/2050640616637968; Wang K, 2010, LAB INVEST, V90, P257, DOI 10.1038/labinvest.2009.129; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Weigert A, 2019, BBA-MOL CELL BIOL L, V1864, P1235, DOI 10.1016/j.bbalip.2019.05.008; Winkler MS, 2019, J INTENSIVE CARE, V7, DOI 10.1186/s40560-019-0376-2; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13423; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	60	3	3	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21415	10.1096/fj.202002540R	http://dx.doi.org/10.1096/fj.202002540R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566377	Bronze, Green Accepted			2022-12-28	WOS:000629576700015
J	Feng, X; Wei, Z; Tao, X; Du, Y; Wu, J; Yu, YH; Yu, HD; Zhao, HB				Feng, Xuan; Wei, Zhi; Tao, Xiang; Du, Yan; Wu, Jing; Yu, Yinhua; Yu, Huandi; Zhao, Hongbo			PLAC8 promotes the autophagic activity and improves the growth priority of human trophoblast cells	FASEB JOURNAL			English	Article						autophagy; p53; PLAC8; proliferation; trophoblast		Autophagy plays an important role in the normal development and function of trophoblast cells and is precisely regulated during pregnancy. Dysregulated autophagy contributes to the abnormal proliferation of trophoblasts, which is closely related to the occurrence of pregnancy-related diseases. Placenta specific 8 (PLAC8, Onzin) is a multifaceted protein proven to promote autophagy and potentiate various tumor progression. Its role in trophoblasts remains elusive. In our present study, PLAC8 expression was detected in tissues of first-trimester placentas (n = 5), term placentas (n = 5), choriocarcinoma (n = 5), and placental site trophoblastic tumor (n = 5). PLAC8 expression was increased in gestational neoplasms compared with normal pregnancies. mCherry-EGFP-LC3B reporter and transmission electron microscopy confirmed PLAC8 promoted the autophagic flux of human trophoblast cells. Both gain-of-function and loss-of-function experiments demonstrated PLAC8-regulated autophagy-related genes, including ATG5, ATG12, and Beclin-1. In addition, our data showed that PLAC8 co-localized with p53 and promoted its degradation, and p53 re-expression partially abrogated the PLAC8-induced autophagy activity. Furthermore, the overexpression of PLAC8 promoted cell viability and proliferation, acting as a protective mechanism of trophoblasts against the cytotoxicity of etoposide (VP-16). Such a phenomenon was effectively abrogated by autophagy inhibitors 3-methyladenine (3-MA) and chloroquine (CQ). In conclusion, PLAC8-induced autophagy to promote the proliferation of trophoblasts. This study provided insights into the mechanism of PLAC8-induced autophagy in trophoblasts, which is significant for a wide range of gestational diseases and may contribute to developing novel treatment strategies for trophoblastic diseases.	[Feng, Xuan; Wei, Zhi; Tao, Xiang; Du, Yan; Wu, Jing; Yu, Yinhua; Yu, Huandi; Zhao, Hongbo] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, 128 Shenyang Rd, Shanghai 200011, Peoples R China; [Feng, Xuan; Wei, Zhi; Tao, Xiang; Du, Yan; Wu, Jing; Yu, Yinhua; Yu, Huandi; Zhao, Hongbo] Fudan Univ, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai, Peoples R China	Fudan University; Fudan University	Yu, HD; Zhao, HB (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, 128 Shenyang Rd, Shanghai 200011, Peoples R China.	yuhuandi1019@gmail.com; zhaohongbo01@sina.com	Wang, Jin/GYA-2019-2022; Du, Yan/AAD-5510-2020; wang, jing/GVT-8700-2022; Wu, Jing/GZK-5063-2022	Du, Yan/0000-0001-5413-7836; zhi, WEI/0000-0002-8971-045X	National Natural Science Foundation of China [81971394, 81571457]; Shanghai Pujiang Program [15PJ1400900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was funded by the National Natural Science Foundation of China [grant number: 81971394, 81571457], the Shanghai Pujiang Program [grant number: 15PJ1400900]	Abd Rahman R, 2018, J MATERN-FETAL NEO M, V31, P525, DOI 10.1080/14767058.2017.1289511; Al-Bari MAA, 2020, ANN NY ACAD SCI, V1467, P3, DOI 10.1111/nyas.14305; Avagliano L, 2015, REPROD SCI, V22, P838, DOI 10.1177/1933719114565036; Cha HH, 2014, REPROD SCI, V21, P612, DOI 10.1177/1933719113508816; Chang WL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.148932; Crocker IP, 2003, AM J PATHOL, V162, P637, DOI 10.1016/S0002-9440(10)63857-6; Du Y, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0572-5; DUNCAN DA, 1989, HUM PATHOL, V20, P370, DOI 10.1016/0046-8177(89)90047-6; Feng X, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00937; Gauster M, 2018, CELL MOL LIFE SCI, V75, P1839, DOI 10.1007/s00018-017-2695-6; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; Gong Jin-Sung, 2014, Clin Exp Reprod Med, V41, P97, DOI 10.5653/cerm.2014.41.3.97; Huang ML, 2020, J CELL MOL MED, V24, P7778, DOI 10.1111/jcmm.15409; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Jackson WT, 2013, AUTOPHAGY, V9, P1905, DOI 10.4161/auto.26819; Jia YL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0580-3; Kaistha BP, 2016, CANCER RES, V76, P96, DOI 10.1158/0008-5472.CAN-15-0216; Kinsey C, 2014, CELL REP, V7, P1143, DOI 10.1016/j.celrep.2014.03.061; Kolluru V, 2017, CANCER LETT, V408, P121, DOI 10.1016/j.canlet.2017.08.023; Lacroix MC, 2002, PLACENTA, V23, pS87, DOI 10.1053/plac.2002.0811; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Li CX, 2014, J CLIN INVEST, V124, P2172, DOI 10.1172/JCI71103; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; Manu KA, 2019, CANCERS, V11, DOI 10.3390/cancers11081112; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2020, CURR OPIN CELL BIOL, V63, P1, DOI 10.1016/j.ceb.2019.12.001; Nakashima A, 2017, J REPROD IMMUNOL, V123, P17, DOI 10.1016/j.jri.2017.08.006; Nakashima A, 2017, J OBSTET GYNAECOL RE, V43, P633, DOI 10.1111/jog.13292; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Oh Soo-Young, 2017, Obstet Gynecol Sci, V60, P241, DOI 10.5468/ogs.2017.60.3.241; Ravanan P, 2017, LIFE SCI, V188, P53, DOI 10.1016/j.lfs.2017.08.029; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Saito S, 2013, PLACENTA, V34, pS79, DOI 10.1016/j.placenta.2012.11.026; Saito S, 2014, J REPROD IMMUNOL, V101, P80, DOI 10.1016/j.jri.2013.06.002; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Shen Y, 2015, EXP CELL RES, V334, P207, DOI 10.1016/j.yexcr.2015.04.010; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Tamargo-Gomez I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123812; Tang JJ, 2015, CANCER LETT, V363, P101, DOI 10.1016/j.canlet.2015.04.014; Wani WY, 2015, LAB INVEST, V95, P14, DOI 10.1038/labinvest.2014.131; Wargasetia TL, 2015, INT J REPROD BIOMED, V13, P413; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	45	7	8	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21351	10.1096/fj.202002075RR	http://dx.doi.org/10.1096/fj.202002075RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570788	Bronze			2022-12-28	WOS:000629576700044
J	Sakai, S; Watanabe, S; Komine, O; Sobue, A; Yamanaka, K				Sakai, Shohei; Watanabe, Seiji; Komine, Okiru; Sobue, Akira; Yamanaka, Koji			Novel reporters of mitochondria-associated membranes (MAM), MAMtrackers, demonstrate MAM disruption as a common pathological feature in amyotrophic lateral sclerosis	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis (ALS); ER-mitochondria contact; mitochondria-associated membrane (MAM); organelle; sigma-1 receptor (Sig1R)	ER; ALS; INTERFACE; AGONIST; DAMAGE; FUS	The mitochondria-associated membrane (MAM) is a functional subdomain of the endoplasmic reticulum membrane that tethers to the mitochondrial outer membrane and is essential for cellular homeostasis. A defect in MAM is involved in various neurological diseases, including amyotrophic lateral sclerosis (ALS). Recently, we and others reported that MAM was disrupted in the models expressing several ALS-linked genes, including SOD1, SIGMAR1, VAPB, TARDBP, and FUS, suggesting that MAM disruption is deeply involved in the pathomechanism of ALS. However, it is still uncertain whether MAM disruption is a common pathology in ALS, mainly due to the absence of a simple, quantitative tool for monitoring the status of MAM. In this study, to examine the effects of various ALS-causative genes on MAM, we created the following two novel MAM reporters: MAMtracker-Luc and MAMtracker-Green. The MAMtrackers could detect MAM disruption caused by suppression of SIGMAR1 or the overexpression of ALS-linked mutant SOD1 in living cells. Moreover, the MAMtrackers have an advantage in their ability to monitor reversible changes in the MAM status induced by nutritional conditions. We used the MAMtrackers with an expression plasmid library of ALS-causative genes and noted that 76% (16/21) of the genes altered MAM integrity. Our results suggest that MAM disruption is a common pathological feature in ALS. Furthermore, we anticipate our MAMtrackers, which are suitable for high-throughput assays, to be valuable tools to understand MAM dynamics.	[Sakai, Shohei; Watanabe, Seiji; Komine, Okiru; Sobue, Akira; Yamanaka, Koji] Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan; [Sakai, Shohei; Watanabe, Seiji; Komine, Okiru; Sobue, Akira; Yamanaka, Koji] Nagoya Univ, Dept Neurosci & Pathobiol, Grad Sch Med, Nagoya, Aichi, Japan; [Sobue, Akira] Nagoya Univ, Med Interact Res & Acad Ind Collaborat Ctr, Res Inst Environm Med, Nagoya, Aichi, Japan; [Yamanaka, Koji] Nagoya Univ, Inst Glyco Core Res iGCORE, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Watanabe, S; Yamanaka, K (corresponding author), Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan.	swtnb@riem.nagoya-u.ac.jp; koji.yamanaka@riem.nagoya-u.ac.jp	Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Watanabe, Seiji/0000-0001-8038-7919	Japan Agency for Medical Research and Development (AMED) [21ek0109426h0002]; Uehara Memorial Foundation; Public Foundation of Chubu Science and Technology Center	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); Public Foundation of Chubu Science and Technology Center	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 21ek0109426h0002; Uehara Memorial Foundation; the Public Foundation of Chubu Science and Technology Center	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Alam Muhammad S, 2018, Curr Protoc Immunol, V123, pe58, DOI 10.1002/cpim.58; Alford SC, 2012, ACS SYNTH BIOL, V1, P569, DOI 10.1021/sb300050j; [Anonymous], SCI REP UK; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Chami M, 2008, MOL CELL, V32, P641, DOI 10.1016/j.molcel.2008.11.014; Cieri D, 2018, CELL DEATH DIFFER, V25, P1131, DOI 10.1038/s41418-017-0033-z; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Gerbino V, 2020, NEURON, V106, P789, DOI 10.1016/j.neuron.2020.03.005; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hertlein V, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900600; Komine O, 2018, CELL DEATH DIFFER, V25, P2130, DOI 10.1038/s41418-018-0098-3; Lee S, 2018, MOL CELLS, V41, P1000, DOI 10.14348/molcells.2018.0438; Mancuso R, 2012, NEUROTHERAPEUTICS, V9, P814, DOI 10.1007/s13311-012-0140-y; Mejzini R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01310; Motohashi K, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0162-8; Naumann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02299-1; Ono Y, 2014, NEUROSCI LETT, V559, P174, DOI 10.1016/j.neulet.2013.12.005; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Sigal YM, 2018, SCIENCE, V361, P880, DOI 10.1126/science.aau1044; Stoica R, 2016, EMBO REP, V17, P1326, DOI 10.15252/embr.201541726; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Suzuki H, 2011, J NEUROCHEM, V119, P1099, DOI 10.1111/j.1471-4159.2011.07491.x; Tan YS, 2019, METHODS MOL BIOL, V1960, P85, DOI 10.1007/978-1-4939-9167-9_7; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Theurey P, 2016, J MOL CELL BIOL, V8, P129, DOI 10.1093/jmcb/mjw004; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Watanabe S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.459; Watanabe S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03116-2; Watanabe S, 2016, EMBO MOL MED, V8, P1421, DOI 10.15252/emmm.201606403; Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Xu DC, 2018, CELL, V174, P1477, DOI 10.1016/j.cell.2018.07.041; Yang ZY, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208686	41	6	6	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21688	10.1096/fj.202100137R	http://dx.doi.org/10.1096/fj.202100137R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143516				2022-12-28	WOS:000667814100050
J	Suresh, V; Mohanty, V; Avula, K; Ghosh, A; Singh, B; Reddy, RK; Parida, D; Suryawanshi, AR; Raghav, SK; Chattopadhyay, S; Prasad, P; Swain, RK; Dash, R; Parida, A; Syed, GH; Senapati, S				Suresh, Voddu; Mohanty, Varshasnata; Avula, Kiran; Ghosh, Arup; Singh, Bharati; Reddy, Rajendra Kumar; Parida, Deepti; Suryawanshi, Amol Ratnakar; Raghav, Sunil Kumar; Chattopadhyay, Soma; Prasad, Punit; Swain, Rajeeb Kumar; Dash, Rupesh; Parida, Ajay; Syed, Gulam Hussain; Senapati, Shantibhusan			Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity	FASEB JOURNAL			English	Article						COVID-19; differentially expressed proteins; lung proteome; mass spectrometry; Orbitrap; pulmonary surfactant; SARS-CoV-2	IMMUNE-RESPONSES; PROTEIN; SURFACTANT; SERUM; MODEL	Syrian golden hamsters (Mesocricetus auratus) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) manifests lung pathology. In this study, efforts were made to check the infectivity of a local SARS-CoV-2 isolate in a self-limiting and non-lethal hamster model and evaluate the differential expression of lung proteins during acute infection and convalescence. The findings of this study confirm the infectivity of this isolate in vivo. Analysis of clinical parameters and tissue samples show the pathophysiological manifestation of SARS-CoV-2 infection similar to that reported earlier in COVID-19 patients and hamsters infected with other isolates. However, diffuse alveolar damage (DAD), a common histopathological feature of human COVID-19 was only occasionally noticed. The lung-associated pathological changes were very prominent on the 4th day post-infection (dpi), mostly resolved by 14 dpi. Here, we carried out the quantitative proteomic analysis of the lung tissues from SARS-CoV-2-infected hamsters on day 4 and day 14 post-infection. This resulted in the identification of 1585 proteins of which 68 proteins were significantly altered between both the infected groups. Pathway analysis revealed complement and coagulation cascade, platelet activation, ferroptosis, and focal adhesion as the top enriched pathways. In addition, we also identified altered expression of two pulmonary surfactant-associated proteins (Sftpd and Sftpb), known for their protective role in lung function. Together, these findings will aid in understanding the mechanism(s) involved in SARS-CoV-2 pathogenesis and progression of the disease.	[Suresh, Voddu; Mohanty, Varshasnata; Avula, Kiran; Ghosh, Arup; Singh, Bharati; Reddy, Rajendra Kumar; Parida, Deepti; Suryawanshi, Amol Ratnakar; Raghav, Sunil Kumar; Chattopadhyay, Soma; Prasad, Punit; Swain, Rajeeb Kumar; Dash, Rupesh; Parida, Ajay; Syed, Gulam Hussain; Senapati, Shantibhusan] Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Odisha, India; [Suresh, Voddu; Avula, Kiran; Parida, Deepti] Reg Ctr Biotechnol, Faridabad, India; [Ghosh, Arup; Singh, Bharati] Kalinga Inst Ind Technol, Bhubaneswar, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Kalinga Institute of Industrial Technology (KIIT)	Syed, GH; Senapati, S (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Odisha, India.	gulamsyed@ils.res.in; senapati@ils.res.in		Ghosh, Arup/0000-0003-3259-0124; Syed, Gulam/0000-0001-8540-6162; MOHANTY, VARSHASNATA/0000-0002-1520-7974; Senapati, Shantibhusan/0000-0001-7108-8255; Suresh, Voddu/0000-0001-8533-9465	DBT-BIRAC, India [BT/CS0004/CS/02/20]	DBT-BIRAC, India	DBT-BIRAC, India, Grant/Award Number: BT/CS0004/CS/02/20	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2; Chan JFW, 2020, CLIN INFECT DIS, V71, P2139, DOI 10.1093/cid/ciaa644; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chen RC, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05672; Das S, 2014, MOL CANCER RES, V12, P1195, DOI 10.1158/1541-7786.MCR-14-0131; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Doyle IR, 1997, AM J RESP CRIT CARE, V156, P1217, DOI 10.1164/ajrccm.156.4.9603061; Edeas M, 2020, INT J INFECT DIS, V97, P303, DOI 10.1016/j.ijid.2020.05.110; Ehaideb SN, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03304-8; Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; Goldstein AL, 2015, EXPERT OPIN BIOL TH, V15, pS139, DOI 10.1517/14712598.2015.1011617; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; Gomez-Casado C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071730; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Hermjakob H, 2006, EXPERT REV PROTEOMIC, V3, P1, DOI 10.1586/14789450.3.1.1; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; Hou X, 2020, MOL CELL PROTEOMICS, V19, P1749, DOI 10.1074/mcp.RP120.002128; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Islam AMMK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76404-8; Ji HL, 2020, PHYSIOL REV, V100, P1065, DOI 10.1152/physrev.00013.2020; Ji YL, 2015, PLATELETS, V26, P138, DOI 10.3109/09537104.2014.888547; Kale K, 2020, AM J REPROD IMMUNOL, V83, DOI 10.1111/aji.13208; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kerget B, 2020, LUNG, V198, P777, DOI 10.1007/s00408-020-00393-8; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee ACY, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100121; Lee CY, 2021, CURR OPIN VIROL, V48, P73, DOI 10.1016/j.coviro.2021.03.009; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Leng L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00355-9; Li C, 2021, CLIN INFECT DIS, V73, pE719, DOI 10.1093/cid/ciab083; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; Li Yanchang, 2020, Urine (Amst), V2, P1, DOI 10.1016/j.urine.2021.02.001; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Matsumoto T, 2016, INT J CHRONIC OBSTR, V11, P2321, DOI 10.2147/COPD.S113707; McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1; Messner CB, 2020, CELL SYST, V11, P11, DOI 10.1016/j.cels.2020.05.012; Mi HY, 2021, NUCLEIC ACIDS RES, V49, pD394, DOI 10.1093/nar/gkaa1106; Middleton EA, 2016, PHYSIOL REV, V96, P1211, DOI 10.1152/physrev.00038.2015; Mohandas S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102054; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Nie X, 2021, CELL, V184, P775, DOI 10.1016/j.cell.2021.01.004; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Park J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-80120-8; Rogan PK, 2020, F1000RESEARCH, V9, P943, DOI [DOI 10.12688/F1000RESEARCH.25390.1, 10.12688/ f1000research.25390.1]; Rosenke Kyle, 2020, bioRxiv, DOI 10.1101/2020.09.25.314070; Sahin, 2020, 2005201420102558 MED, V2005; Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Suresh V, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.579330; Suresh V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51947-7; Surette AP, 2011, BLOOD, V118, P3172, DOI 10.1182/blood-2011-05-353482; Tostanoski LH, 2020, NAT MED, V26, P1694, DOI 10.1038/s41591-020-1070-6; Tresoldi I, 2020, J MED VIROL, V92, P1741, DOI 10.1002/jmv.25831; Vargas-Vargas M, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.72; Vinayagam S, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118431; Wang N, 2019, J IMMUNOL, V203, P1288, DOI 10.4049/jimmunol.1900427; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Wang YT, 2013, ARCH IMMUNOL THER EX, V61, P309, DOI 10.1007/s00005-013-0230-5; Weisel JW, 2017, SUBCELL BIOCHEM, V82, P405, DOI 10.1007/978-3-319-49674-0_13; Weiskirchen R, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01905; Wu M, 2020, P NATL ACAD SCI USA, V117, P28336, DOI 10.1073/pnas.2018030117; Xu M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.584310; Zeng HL, 2021, FEBS J, V288, P5190, DOI 10.1111/febs.15609	76	7	7	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21713	10.1096/fj.202100431R	http://dx.doi.org/10.1096/fj.202100431R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105201	Green Published, Green Submitted			2022-12-28	WOS:000667814100034
J	Dansako, H; Ueda, Y; Satoh, S; Kato, N				Dansako, Hiromichi; Ueda, Youki; Satoh, Shinya; Kato, Nobuyuki			Extracellular vesicles activate ATM-Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV-infected human hepatocytes	FASEB JOURNAL			English	Article						ATM&#8208; Chk2 signaling pathway; extracellular vesicles; hepatitis B virus; mitochondrial DNA	CANCER; INFLAMMATION; HEPATITIS; EXOSOMES; DAMAGE; CELLS	Hepatitis B virus (HBV) is a human hepatotropic pathogen causing hepatocellular carcinoma. We recently obtained HBV-susceptible immortalized human hepatocyte NKNT-3 by exogenously expressing NTCP and its derived cell clones, #28.3.8 and #28.3.25.13 exhibiting different levels of HBV susceptibility. In the present study, we showed that HBV infection activated the ATM-Chk2 signaling pathway in #28.3.25.13 cells but not in #28.3.8 cells. Both the cell culture supernatant and extracellular vesicles (EVs) derived from HBV-infected #28.3.25.13 cells also activated the ATM-Chk2 signaling pathway in naive #28.3.25.13 cells. Interestingly, EVs derived from HBV-infected #28.3.25.13 cells included higher level of mitochondrial DNA (mtDNA) than those from HBV-infected #28.3.8 cells. Based on our results, we propose the novel model that EVs mediate the activation of ATM-Chk2 signaling pathway by the intercellular transfer of mtDNA in HBV-infected human hepatocyte.	[Dansako, Hiromichi; Ueda, Youki; Satoh, Shinya; Kato, Nobuyuki] Okayama Univ, Dept Tumor Virol, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan	Okayama University	Dansako, H (corresponding author), Okayama Univ, Dept Tumor Virol, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	dansako@md.okayama-u.ac.jp	Dansako, Hiromichi/B-2025-2011	Dansako, Hiromichi/0000-0002-2353-3024	Japan Agency for Medical Research and Development (AMED) [JP20fk0310103, JP20fk0310107]; Wesco Foundation; Okayama Medical Foundation	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Wesco Foundation; Okayama Medical Foundation	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20fk0310103 and JP20fk0310107; Wesco Foundation; Okayama Medical Foundation	Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Alminana C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020979; Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Dansako H, 2019, FASEB BIOADV, V1, P67, DOI 10.1096/fba.1022; Dansako H, 2016, FEBS J, V283, P144, DOI 10.1111/febs.13563; Dansako H, 2014, VIROLOGY, V462, P166, DOI 10.1016/j.virol.2014.05.017; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; de Galarreta MR, 2017, NAT CELL BIOL, V19, P1008, DOI 10.1038/ncb3603; Desrochers LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11958; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Guenat D, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080211; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Honegger A, 2013, INT J CANCER, V133, P1631, DOI 10.1002/ijc.28164; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Imai H, 2018, BIOCHEM BIOPH RES CO, V504, P672, DOI 10.1016/j.bbrc.2018.08.195; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Koczor CA, 2009, J BIOL CHEM, V284, P36191, DOI 10.1074/jbc.M109.036020; Maekawa H, 2019, CELL REP, V29, P1261, DOI 10.1016/j.celrep.2019.09.050; Maybury BD, 2013, ANTICANCER RES, V33, P3543; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Takasugi M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15728; Torresi J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5916-6; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhang L, 2019, BBA-REV CANCER, V1871, P455, DOI 10.1016/j.bbcan.2019.04.004	36	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21680	10.1096/fj.202002678R	http://dx.doi.org/10.1096/fj.202002678R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042225				2022-12-28	WOS:000655695900057
J	Li, P; Liu, CL; Qian, L; Zheng, ZY; Li, CL; Lian, ZN; Liu, J; Zhang, ZM; Wang, L				Li, Peng; Liu, Chunlei; Qian, Lei; Zheng, Zhenyu; Li, Chenglong; Lian, Zhengnan; Liu, Jie; Zhang, Zhongmin; Wang, Liang			miR-10396b-3p inhibits mechanical stress-induced ligamentum flavum hypertrophy by targeting IL-11	FASEB JOURNAL			English	Article						ligamentum flavum hypertrophy; lumbar spinal stenosis; mechanical stress; miR&#8208; 10396b&#8208; 3p	LUMBAR SPINAL STENOSIS; FIBROSIS; REGULATOR; APOPTOSIS; CELLS	Ligamentum flavum hypertrophy (LFH) leads to lumbar spinal stenosis (LSS) caused by LF tissue inflammation and fibrosis. Emerging evidence has indicated that dysregulated microRNAs (miRNAs) have an important role in inflammation and fibrosis. Mechanical stress (MS) has been explored as an initiating step in LFH pathology progression; the inflammation-related miRNAs induced after mechanical stress have been implicated in fibrosis pathology. However, the pathophysiological mechanism of MS-miRNAs-LFH remains to be elucidated. Using miRNAs sequencing analysis and subsequent confirmation with qRT-PCR assays, we identified the decreased expression of miR-10396b-3p and increased expression of IL-11 (interleukin-11) as responses to the development of LSS in hypertrophied LF tissues. We also found that IL-11 is positively correlated with fibrosis indicators of collagen I and collagen III. The up-regulation of miR-10396b-3p significantly decreased the level of IL-11 expression, whereas miR-10396b-3p down-regulation increased IL-11 expression in vitro. Luciferase reporter assay indicates that IL-11 is a direct target of miR-10396b-3p. Furthermore, cyclic mechanical stress inhibits miR-10396b-3p and induces IL-11, collagen I, and collagen III in vitro. Our results showed that overexpression of miR-10396b-3p suppresses MS-induced LFH by inhibiting collagen I and III via the inhibition of IL-11. These data suggest that the MS-miR-10396b-3p-IL-11 axis plays a key role in the pathological progression of LFH.	[Li, Peng; Liu, Chunlei; Zheng, Zhenyu; Li, Chenglong; Lian, Zhengnan; Liu, Jie; Zhang, Zhongmin; Wang, Liang] Southern Med Univ, Acad Orthoped, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China; [Qian, Lei] Southern Med Univ, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Peoples R China; [Zhang, Zhongmin] Southern Med Univ, Nanfang Hosp, Div Spine Surg, Dept Orthopad, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, ZM; Wang, L (corresponding author), Southern Med Univ, Acad Orthoped, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.	nfzzm@163.com; liang091@aliyun.com		Li, Peng/0000-0002-5027-5526	National Natural Science Foundation of China [81874013, 81702199, 31801012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81874013, 81702199, and 31801012).	Bagnato G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0125-2016; Chang ML, 2017, J CELL PHYSIOL, V232, P3762, DOI 10.1002/jcp.25856; Chao YH, 2012, CONNECT TISSUE RES, V53, P422, DOI 10.3109/03008207.2012.685132; Chen JW, 2016, J SPINAL CORD MED, V39, P450, DOI 10.1080/10790268.2016.1141470; Chen JW, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/786543; Cook SA, 2020, ANNU REV MED, V71, P263, DOI 10.1146/annurev-med-041818-011649; Fernandez-Ruiz I, 2018, NAT REV CARDIOL, V15, P1, DOI 10.1038/nrcardio.2017.197; Han TS, 2019, GASTROENTEROLOGY, V156, P1140, DOI 10.1053/j.gastro.2018.11.059; Hayashi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13360-w; Hur JW, 2015, NEUROSURGERY, V77, P274, DOI 10.1227/NEU.0000000000000755; Jezek J, 2020, SPINE J, V20, P1125, DOI 10.1016/j.spinee.2020.03.002; Kim YU, 2017, PAIN PHYSICIAN, V20, pE419; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Metcalfe RD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01424; Mori T, 2017, SPINE SURG RELAT RES, V1, P211, DOI 10.22603/ssrr.1.2017-0023; Nakamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085542; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Negahdaripour M, 2016, CYTOKINE GROWTH F R, V32, P41, DOI 10.1016/j.cytogfr.2016.06.002; Nguyen PM, 2019, GROWTH FACTORS, V37, P1, DOI 10.1080/08977194.2019.1620227; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Park JO, 2013, J SPINAL DISORD TECH, V26, pE6, DOI 10.1097/BSD.0b013e3182698501; Powers JC, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.119.006426; Sakai Y, 2017, J ORTHOP SCI, V22, P27, DOI 10.1016/j.jos.2016.08.007; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Shafaq N, 2012, J SPINAL DISORD TECH, V25, P107, DOI 10.1097/BSD.0b013e31820bb76e; Shojaati G, 2019, STEM CELL TRANSL MED, V8, P1192, DOI 10.1002/sctm.18-0297; Sidon E, 2019, J CELL BIOCHEM, V120, P11716, DOI 10.1002/jcb.28451; Stienen MN, 2019, SPINE J, V19, P1276, DOI 10.1016/j.spinee.2019.02.014; Sun C, 2020, FASEB J, V34, P9854, DOI 10.1096/fj.202000635R; Sun C, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171214; Sun C, 2017, BIOCHEM BIOPH RES CO, V490, P1106, DOI 10.1016/j.bbrc.2017.06.182; Wang J, 2015, CELL MOL LIFE SCI, V72, P2091, DOI 10.1007/s00018-015-1853-y; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xu YQ, 2016, SPINE, V41, P275, DOI 10.1097/BRS.0000000000001226; Yan B, 2018, CELL PHYSIOL BIOCHEM, V48, P293, DOI 10.1159/000491729; Ye S, 2019, J ORTHOP RES, V37, P2634, DOI 10.1002/jor.24425; Yuan J, 2018, THERANOSTICS, V8, P2565, DOI 10.7150/thno.22878; Zheng ZY, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00858	38	2	2	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21676	10.1096/fj.202100169RR	http://dx.doi.org/10.1096/fj.202100169RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042220				2022-12-28	WOS:000655695900067
J	Broatch, JR; O'Riordan, SF; Keske, MA; Betik, AC; Bishop, DJ; Halson, SL; Parker, L				Broatch, James R.; O'Riordan, Shane F.; Keske, Michelle A.; Betik, Andrew C.; Bishop, David J.; Halson, Shona L.; Parker, Lewan			Reduced post-exercise muscle microvascular perfusion with compression is offset by increased muscle oxygen extraction: Assessment by contrast-enhanced ultrasound	FASEB JOURNAL			English	Article						capillary-myocyte interface; ergogenic; microvasculature; NIRS; sprint-interval exercise	PRESERVED EJECTION FRACTION; BLOOD-FLOW RESPONSES; SKELETAL-MUSCLE; EXERCISE INTOLERANCE; LOWER-LIMB; PHYSIOLOGICAL-RESPONSES; EXTERNAL COMPRESSION; PROTEIN-SYNTHESIS; HEART-FAILURE; INSULIN	The microvasculature is important for both health and exercise tolerance in a range of populations. However, methodological limitations have meant changes in microvascular blood flow are rarely assessed in humans during interventions designed to affect skeletal muscle blood flow such as the wearing of compression garments. The aim of this study is, for the first time, to use contrast-enhanced ultrasound to directly measure the effects of compression on muscle microvascular blood flow alongside measures of femoral artery blood flow and muscle oxygenation following intense exercise in healthy adults. It was hypothesized that both muscle microvascular and femoral artery blood flows would be augmented with compression garments as compared with a control condition. Ten recreationally active participants completed two repeated-sprint exercise sessions, with and without lower-limb compression tights. Muscle microvascular blood flow, femoral arterial blood flow (2D and Doppler ultrasound), muscle oxygenation (near-infrared spectroscopy), cycling performance, and venous blood samples were measured/taken throughout exercise and the 1-hour post-exercise recovery period. Compared with control, compression reduced muscle microvascular blood volume and attenuated the exercise-induced increase in microvascular velocity and flow immediately after exercise and 1 hour post-exercise. Compression increased femoral artery diameter and augmented the exercise-induced increase in femoral arterial blood flow during exercise. Markers of blood oxygen extraction in muscle were increased with compression during and after exercise. Compression had no effect on blood lactate, glucose, or exercise performance. We provide new evidence that lower-limb compression attenuates the exercise-induced increase in skeletal muscle microvascular blood flow following exercise, despite a divergent increase in femoral artery blood flow. Decreased muscle microvascular perfusion is offset by increased muscle oxygen extraction, a potential mechanism allowing for the maintenance of exercise performance.	[Broatch, James R.; O'Riordan, Shane F.; Bishop, David J.] Victoria Univ, Inst Hlth & Sport IHES, POB 14428, Melbourne, Vic 8001, Australia; [Broatch, James R.; O'Riordan, Shane F.] Australia Inst Sport, Canberra, ACT, Australia; [Keske, Michelle A.; Betik, Andrew C.; Parker, Lewan] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr IPAN, Geelong, Vic, Australia; [Halson, Shona L.] Australian Catholic Univ, Sch Behav & Hlth Sci, Melbourne, Vic, Australia	Victoria University; Australian Institute of Sport; Deakin University; Australian Catholic University	Broatch, JR (corresponding author), Victoria Univ, Inst Hlth & Sport IHES, POB 14428, Melbourne, Vic 8001, Australia.	james.broatch@vu.edu.au	Broatch, James R/N-9488-2018; Bishop, David John/X-9826-2019; Broatch, James R/AAC-3628-2019	Broatch, James R/0000-0002-0082-3168; Bishop, David John/0000-0002-6956-9188; Broatch, James R/0000-0002-0082-3168; Keske, Michelle/0000-0003-4214-7628; O'Riordan, Shane/0000-0002-1022-4492; Parker, Lewan/0000-0002-5372-1851	Deakin University; National Heart Foundation Early Career Fellowship [APP1157930]; compression garment manufacturer 2XU (Australia); Victoria University; NHMRC	Deakin University; National Heart Foundation Early Career Fellowship; compression garment manufacturer 2XU (Australia); Victoria University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by Deakin University and Victoria University. LP was supported by a NHMRC & National Heart Foundation Early Career Fellowship (APP1157930). JRB, SLH, and DJB received a research grant from compression garment manufacturer 2XU (Australia), which also supported JRB. 2XU had no input in study design, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the article for publication	Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Bangsbo J, 1998, ACTA PHYSIOL SCAND, V162, P305, DOI 10.1046/j.1365-201X.1998.0331e.x; Barrett EJ, 2012, DIABETES, V61, P2661, DOI 10.2337/db12-0271; Barstow TJ, 2019, J APPL PHYSIOL, V126, P1360; Betik AC, 2021, MED SCI SPORT EXER, V53, P375, DOI 10.1249/MSS.0000000000002463; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bochmann RP, 2005, J APPL PHYSIOL, V99, P2337, DOI 10.1152/japplphysiol.00965.2004; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broatch JR, 2018, INT J SPORT PHYSIOL, V13, P882, DOI 10.1123/ijspp.2017-0638; Broatch JR, 2014, MED SCI SPORT EXER, V46, P2139, DOI 10.1249/MSS.0000000000000348; Brophy-Williams N, 2015, J SPORT SCI, V33, P1403, DOI 10.1080/02640414.2014.990489; Brown F, 2017, SPORTS MED, V47, P2245, DOI 10.1007/s40279-017-0728-9; Buchheit M, 2011, EUR J APPL PHYSIOL, V111, P293, DOI 10.1007/s00421-010-1654-9; Clark MG, 2000, ACTA PHYSIOL SCAND, V168, P519, DOI 10.1046/j.1365-201x.2000.00704.x; CLARK MG, 1995, AM J PHYSIOL, V268, pE79; Cocks M, 2016, J PHYSIOL-LONDON, V594, P2307, DOI 10.1113/jphysiol.2014.285254; Coggins M, 2001, DIABETES, V50, P2682, DOI 10.2337/diabetes.50.12.2682; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; CUI WJ, 1991, P SOC PHOTO-OPT INS, V1431, P180, DOI 10.1117/12.44189; Dhakal BP, 2015, CIRC-HEART FAIL, V8, P286, DOI 10.1161/CIRCHEARTFAILURE.114.001825; DORA KA, 1994, J APPL PHYSIOL, V77, P277, DOI 10.1152/jappl.1994.77.1.277; Durham WJ, 2010, FASEB J, V24, P4117, DOI 10.1096/fj.09-150177; Engel FA, 2016, SPORTS MED, P461939; FAULKNER JA, 1977, MED SCI SPORT EXER, V9, P148; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Fujita S, 2006, AM J PHYSIOL-ENDOC M, V291, pE745, DOI 10.1152/ajpendo.00271.2005; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Green DJ, 2017, PHYSIOL REV, V97, P495, DOI 10.1152/physrev.00014.2016; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Hellsten Y, 2016, COMPR PHYSIOL, V6, P1, DOI 10.1002/cphy.c140080; Hopker J, 2010, INT J SPORTS MED, V31, P731, DOI 10.1055/s-0030-1261968; Ilkka H, 2011, AM J PHYSIOL-HEART C, V300, pH1510, DOI 10.1152/ajpheart.00996.2010; Joyner MJ, 2015, PHYSIOL REV, V95, P549, DOI 10.1152/physrev.00035.2013; Kerherve HA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00247; Keske MA, 2017, CLIN EXP PHARMACOL P, V44, P143, DOI 10.1111/1440-1681.12688; Keske MA, 2016, J PHYSIOL-LONDON, V594, P2223, DOI 10.1113/jphysiol.2014.283549; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457, DOI 10.1113/jphysiol.1919.sp001844; Kundi Rishi, 2017, J Vasc Endovasc Surg, V2; Laughlin M H, 1988, Adv Exp Med Biol, V227, P87; LAWRENCE D, 1980, BRIT J SURG, V67, P119, DOI 10.1002/bjs.1800670214; Lee DCW, 2020, INT J SPORTS MED, V41, P3, DOI 10.1055/a-0970-5399; Lee DCW, 2018, J SCI MED SPORT, V21, P1062, DOI 10.1016/j.jsams.2017.12.004; Lindner JR, 2008, JACC-CARDIOVASC IMAG, V1, P343, DOI 10.1016/j.jcmg.2008.04.001; Liu R, 2008, ADV THER, V25, P465, DOI 10.1007/s12325-008-0058-2; Mayrovitz HN, 1998, CLIN PHYSIOL, V18, P117; Mayrovitz HN, 1997, CLIN PHYSIOL, V17, P105, DOI 10.1046/j.1365-2281.1997.01616.x; McCormick A, 2015, SPORTS MED, V45, P997, DOI 10.1007/s40279-015-0319-6; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; Menetrier A, 2015, J SPORT MED PHYS FIT, V55, P258; Mitchell CJ, 2015, J APPL PHYSIOL, V118, P495, DOI 10.1152/japplphysiol.00609.2014; Parker L, 2021, J PHYSIOL-LONDON, V599, P83, DOI 10.1113/JP280651; Parker L, 2020, AM J PHYSIOL-ENDOC M, V318, pE1014, DOI 10.1152/ajpendo.00540.2019; Rattigan S, 1996, AM J PHYSIOL-ENDOC M, V271, pE96, DOI 10.1152/ajpendo.1996.271.1.E96; Rendell M, 1998, CLIN PHYSIOL, V18, P426, DOI 10.1046/j.1365-2281.1998.00108.x; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Roseguini BT, 2019, MUSCLE AND EXERCISE PHYSIOLOGY, P379, DOI 10.1016/B978-0-12-814593-7.00017-7; Russell RD, 2018, AM J PHYSIOL-ENDOC M, V315, pE307, DOI 10.1152/ajpendo.00448.2017; Russell RD, 2017, DIABETES CARE, V40, P1256, DOI 10.2337/dc16-2750; Sacre JW, 2015, JACC-CARDIOVASC IMAG, V8, P913, DOI 10.1016/j.jcmg.2014.12.033; Saltin B, 1998, ACTA PHYSIOL SCAND, V162, P421, DOI 10.1046/j.1365-201X.1998.0293e.x; Samendinger S, 2019, J SPORT HEALTH SCI, V8, P289, DOI 10.1016/j.jshs.2018.08.003; SEGAL SS, 1995, MED SCI SPORT EXER, V27, P1158; Shen W, 2000, ACTA PHYSIOL SCAND, V168, P675, DOI 10.1046/j.1365-201x.2000.00719.x; Sjoberg KA, 2017, DIABETES, V66, P1501, DOI 10.2337/db16-1327; Sperlich B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060923; St-Pierre P, 2012, DIABETES OBES METAB, V14, P753, DOI 10.1111/j.1463-1326.2012.01598.x; Staub D, 2013, VASA, V42, P17, DOI 10.1024/0301-1526/a000244; Timmerman KL, 2010, DIABETES, V59, P2764, DOI 10.2337/db10-0415; Upadhya B, 2015, J GERIATR CARDIOL, V12, P294, DOI 10.11909/j.issn.1671-5411.2015.03.013; Vaile J, 2016, J SPINAL CORD MED, V39, P206, DOI 10.1179/2045772314Y.0000000287; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Vercruyssen F, 2014, EUR J SPORT SCI, V14, P144, DOI 10.1080/17461391.2012.730062; Vincent MA, 2002, DIABETES, V51, P42, DOI 10.2337/diabetes.51.1.42; Vincent MA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1191, DOI 10.1152/ajpendo.00497.2005; WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772; Womack L, 2009, J AM COLL CARDIOL, V53, P2175, DOI 10.1016/j.jacc.2009.02.042; Zonios G, 2001, J INVEST DERMATOL, V117, P1452, DOI 10.1046/j.0022-202x.2001.01577.x	79	5	5	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21499	10.1096/fj.202002205RR	http://dx.doi.org/10.1096/fj.202002205RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811697	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000645260100099
J	Chongchai, A; Waramit, S; Suwan, K; Al-Bahrani, M; Udomruk, S; Phitak, T; Kongtawelert, P; Pothacharoen, P; Hajitou, A				Chongchai, Aitthiphon; Waramit, Sajee; Suwan, Keittisak; Al-Bahrani, Mariam; Udomruk, Sasimol; Phitak, Thanyaluck; Kongtawelert, Prachya; Pothacharoen, Peraphan; Hajitou, Amin			Bacteriophage-mediated therapy of chondrosarcoma by selective delivery of the tumor necrosis factor alpha (TNF alpha) gene	FASEB JOURNAL			English	Article						chondrosarcoma; integrins alpha v beta 3 and alpha v beta 5 apoptosis; phage-based particle; targeted gene therapy; tumor necrosis factor alpha (TNF alpha)	TARGETED DELIVERY; CANCER; VASCULATURE; PHAGE; DEATH	Chondrosarcoma is a cartilage-forming bone tumor, well known for intrinsic resistance to chemotherapy and radiotherapy. We have designed a targeted chondrosarcoma gene therapy using a bacteriophage (phage) particle to deliver therapeutic genes. Phage has no tropism for mammalian cells, allowing engineered phage to be targeted to specific cell surface receptors in cancer. We modified the phage capsid to display the RGD4C ligand on the pIII minor coat proteins to specifically bind to alpha v beta 3 or alpha v beta 5 integrin receptors. The endosomal escape peptide, H5WYG, was also displayed on recombinant pVIII major coat proteins to enhance gene delivery. Finally, a human tumor necrosis factor alpha (TNF alpha) therapeutic transgene expression cassette was incorporated into the phage genome. First, we found that human chondrosarcoma cells (SW1353) have high expression of alpha v beta 3, alpha v beta 5 integrin receptors, and both TNF alpha receptors. Targeted particle encoding a luciferase reporter gene efficiently and selectively mediated gene delivery to these cells. When SW1353 cells were treated with the targeted particle encoding a TNF alpha transgene, significant cell killing was evident and was associated with high expression of TNF alpha and apoptosis-related genes. In vivo, mice with established human chondrosarcoma showed suppression of tumors upon repetitive intravenous administrations of the targeted phage. These data show that our phage-based particle is a promising, selective, and efficient tool for targeted chondrosarcoma therapy.	[Chongchai, Aitthiphon; Udomruk, Sasimol; Phitak, Thanyaluck; Kongtawelert, Prachya; Pothacharoen, Peraphan] Chiang Mai Univ, Fac Med, Thailand Excellence Ctr Tissue Engn & Stem Cells, Dept Biochem, Chiang Mai, Thailand; [Chongchai, Aitthiphon; Waramit, Sajee; Suwan, Keittisak; Al-Bahrani, Mariam; Hajitou, Amin] Imperial Coll London, Fac Med, Dept Brain Sci, Canc Phage Therapy Grp, London, England	Chiang Mai University; Imperial College London	Hajitou, A (corresponding author), Imperial Coll London, Fac Med, Dept Brain Sci, Canc Phage Therapy, Hammersmith Hosp Campus,Burlington Danes Bldg, London W12 0NN, England.	a.hajitou@imperial.ac.uk	Pothacharoen, Peraphan/GZG-6521-2022	Pothacharoen, Peraphan/0000-0002-8560-553X; Hajitou, Amin/0000-0003-1119-5686; Suwan, Keittisak/0000-0001-6542-5841	The Royal Golden Jubilee PhD Program [PHD/0189/2557]; Newton-TRF [351404776]; UK Department of Business, Energy and Industrial Strategy (BEIS); Royal Golden Jubilee (RGJ) PhD program; UK Medical [G0701159]	The Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF)); Newton-TRF; UK Department of Business, Energy and Industrial Strategy (BEIS); Royal Golden Jubilee (RGJ) PhD program; UK Medical	This research was funded by The Royal Golden Jubilee PhD Program, grant No. PHD/0189/2557, a PhD Placement for Scholars 2017/18 grant, ID 351404776, under the Newton--TRF PhD Scholarship partnership. The grant is funded by the UK Department of Business, Energy and Industrial Strategy (BEIS) and the Royal Golden Jubilee (RGJ) PhD program and delivered by the British Council. For further information, please visit www.newtonfund. ac.uk, Phage Cancer Therapy Group, Department of Brain Sciences, Faculty of Medicine, Imperial College London, United Kingdom, The Graduate School of Chiang Mai University and Thailand Excellence Center for Tissue Engineering and Stem Cells. This study was also supported by a grant G0701159 of the UK Medical	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Asavarut P, 2014, LANCET INFECT DIS, V14, P686, DOI [10.1016/S1473-3099(14)70867-9, DOI 10.1016/S1473-3099(14)70867-9]; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ayen A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071930; Chow Warren A, 2018, F1000Res, V7, DOI 10.12688/f1000research.15953.1; Dobroff AS, 2016, P NATL ACAD SCI USA, V113, P12780, DOI 10.1073/pnas.1615288113; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Hajitou A, 2007, NAT PROTOC, V2, P523, DOI 10.1038/nprot.2007.51; Hemminki A, 2001, MOL THER, V4, P223, DOI 10.1006/mthe.2001.0446; Jiang YP, 2017, CELL DEATH DIFFER, V24, P660, DOI 10.1038/cdd.2016.162; Josephs SF, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1611-7; Kamimura K, 2020, CANCERS, V12, DOI 10.3390/cancers12020472; Kia A, 2012, MOL CANCER THER, V11, P2566, DOI 10.1158/1535-7163.MCT-12-0587; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; Kwiatkowska Aneta, 2013, Cancers (Basel), V5, P1271, DOI 10.3390/cancers5041271; Lai TH, 2009, J CELL PHYSIOL, V218, P334, DOI 10.1002/jcp.21601; Libutti SK, 2019, CANCER GENE THER, V26, P345, DOI 10.1038/s41417-019-0121-y; Majhen D, 2009, VIRUS RES, V139, P64, DOI 10.1016/j.virusres.2008.10.004; Martinez-Reza I, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0398-9; Medler J, 2019, EXPERT OPIN THER TAR, V23, P295, DOI 10.1080/14728222.2019.1586886; Murphey MD, 2003, RADIOGRAPHICS, V23, P1245, DOI 10.1148/rg.235035134; Natsume A, 2008, CELL ADHES MIGR, V2, P186, DOI 10.4161/cam.2.3.6278; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Przystal JM, 2013, MOL ONCOL, V7, P55, DOI 10.1016/j.molonc.2012.08.001; Przystal JM, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201708492; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Smith TL, 2016, P NATL ACAD SCI USA, V113, P2466, DOI 10.1073/pnas.1525709113; Stoneham CA, 2012, J BIOL CHEM, V287, P35849, DOI 10.1074/jbc.M112.369389; Sun WM, 2019, DISCOV MED, V27, P45; Suwan K, 2019, P NATL ACAD SCI USA, V116, P18571, DOI 10.1073/pnas.1906653116; Tandle A, 2009, CANCER-AM CANCER SOC, V115, P128, DOI 10.1002/cncr.24001; Van Oosterom A T, 1990, Curr Opin Oncol, V2, P495; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00091; Wang Z, 2019, J CANCER, V10, P2457, DOI 10.7150/jca.30388; Ye CL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008049; Yuan Z, 2013, CANCER GENE THER, V20, P46, DOI 10.1038/cgt.2012.83	41	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21487	10.1096/fj.202002539R	http://dx.doi.org/10.1096/fj.202002539R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811705	Green Published, hybrid			2022-12-28	WOS:000645260100002
J	de Guia, RM; Hassing, AS; Ma, T; Plucinska, K; Holst, B; Gerhart-Hines, Z; Emanuelli, B; Treebak, JT				de Guia, Roldan Medina; Hassing, Anna S.; Ma, Tao; Plucinska, Kaja; Holst, Birgitte; Gerhart-Hines, Zach; Emanuelli, Brice; Treebak, Jonas T.			Ablation of Nampt in AgRP neurons leads to neurodegeneration and impairs fasting-and ghrelin-mediated food intake	FASEB JOURNAL			English	Article						AgRP; arcuate nucleus; NAD(+); NAMPT; neurodegeneration	NAD(+) DEPLETION; NEUROPEPTIDE-Y; INSULIN SENSITIVITY; ENERGY HOMEOSTASIS; NPY/AGRP NEURONS; ADULT MICE; CELL-DEATH; AGOUTI; PROTEIN; BIOSYNTHESIS	Agouti-related protein (AgRP) neurons in the arcuate nucleus of the hypothalamus regulates food intake and whole-body metabolism. NAD(+) regulates multiple cellular processes controlling energy metabolism. Yet, its role in hypothalamic AgRP neurons to control food intake is poorly understood. Here, we aimed to assess whether genetic deletion of nicotinamide phosphoribosyltransferase (Nampt), a rate-limiting enzyme in NAD(+) production, affects AgRP neuronal function to impact whole-body metabolism and food intake. Metabolic parameters during fed and fasted states, and upon systemic ghrelin and leptin administration were studied in AgRP-specific Nampt knockout (ARNKO) mice. We monitored neuropeptide expression levels and density of AgRP neurons in ARNKO mice from embryonic to adult age. NPY cells were used to determine effects of NAMPT inhibition on neuronal viability, energy status, and oxidative stress in vitro. In these cells, NAD(+) depletion reduced ATP levels, increased oxidative stress, and promoted cell death. Agrp expression in the hypothalamus of ARNKO mice gradually decreased after weaning due to progressive AgRP neuron degeneration. Adult ARNKO mice had normal glucose and insulin tolerance, but exhibited an elevated respiratory exchange ratio (RER) when fasted. Remarkably, fasting-induced food intake was unaffected in ARNKO mice when evaluated in metabolic cages, but fasting-and ghrelin-induced feeding and body weight gain decreased in ARNKO mice when evaluated outside metabolic cages. Collectively, deletion of Nampt in AgRP neurons causes progressive neurodegeneration and impairs fasting and ghrelin responses in a context-dependent manner. Our data highlight an essential role of Nampt in AgRP neuron function and viability.	[de Guia, Roldan Medina; Hassing, Anna S.; Ma, Tao; Plucinska, Kaja; Gerhart-Hines, Zach; Emanuelli, Brice; Treebak, Jonas T.] Univ Copenhagen, Fac Hlth & Med Sci, Integrat Metab & Environm Influences, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Holst, Birgitte] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [de Guia, Roldan Medina] Czech Acad Sci, Vvi, Inst Mol Genet, Czech Ctr Phenogen BIOCEV IMG, Prumyslova 595, Vestec 25250, Czech Republic	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Treebak, JT (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic Metab Res, Novo Nordisk Fdn, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	jttreebak@sund.ku.dk	de Guia, Roldan/AAL-8529-2020; Emanuelli, Brice/M-2097-2016; Treebak, Jonas Thue/B-4521-2017	de Guia, Roldan/0000-0002-4239-2407; Emanuelli, Brice/0000-0001-5795-5666; Treebak, Jonas Thue/0000-0003-1488-7012; Gerhart-Hines, Zachary/0000-0003-2981-4991; Hassing, Anna Skab/0000-0003-1650-8784; Plucinska, Kaja/0000-0002-2144-7712	Novo Nordisk Fonden (NNF) [NNF14OC0009315, NNF18CC0034900]; Sundhed og Sygdom, Det Frie Forskningsrad (FSS, DFF) [DFF 4004-00235, DFF 6110-00132]	Novo Nordisk Fonden (NNF); Sundhed og Sygdom, Det Frie Forskningsrad (FSS, DFF)	Novo Nordisk Fonden (NNF), Grant/Award Number: NNF14OC0009315 and NNF18CC0034900; Sundhed og Sygdom, Det Frie Forskningsrad (FSS, DFF), Grant/Award Number: DFF 4004-00235 and DFF 6110-00132	Agerholm M, 2018, AM J PHYSIOL-ENDOC M, V314, pE377, DOI 10.1152/ajpendo.00213.2017; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Cea M, 2013, AUTOPHAGY, V9, P410, DOI 10.4161/auto.22866; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Chi H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103082; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Corander MP, 2011, ENDOCRINOLOGY, V152, P1819, DOI 10.1210/en.2010-1450; Curley JP, 2009, DEV NEUROSCI-BASEL, V31, P318, DOI 10.1159/000216543; Dall M, 2018, MOL CELL ENDOCRINOL, V473, P245, DOI 10.1016/j.mce.2018.01.025; de Guia RM, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13437; Denis RGP, 2015, CELL METAB, V22, P646, DOI 10.1016/j.cmet.2015.07.011; Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8; Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; Kim ER, 2015, J NEUROSCI, V35, P10440, DOI 10.1523/JNEUROSCI.1110-15.2015; Lautrup S, 2019, CELL METAB, V30, P630, DOI 10.1016/j.cmet.2019.09.001; Li CH, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0438-1; Lin JB, 2016, CELL REP, V17, P69, DOI 10.1016/j.celrep.2016.08.073; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nielsen KN, 2018, MOL METAB, V11, P178, DOI 10.1016/j.molmet.2018.02.014; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Okur MN, 2020, NPJ AGING MECH DIS, V6, DOI 10.1038/s41514-019-0040-z; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Rasmussen S, 2011, J AM ASSOC LAB ANIM, V50, P479; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sasaki T, 2014, DIABETOLOGIA, V57, P819, DOI 10.1007/s00125-013-3140-5; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Steculorum SM, 2016, CELL, V165, P125, DOI 10.1016/j.cell.2016.02.044; Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917; Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027; Tan K, 2014, MOL METAB, V3, P694, DOI 10.1016/j.molmet.2014.07.002; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Wang XW, 2017, CELL REP, V20, P2184, DOI 10.1016/j.celrep.2017.08.022; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Wei CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00851-z; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yoon MJ, 2015, CELL METAB, V21, P706, DOI 10.1016/j.cmet.2015.04.002; Zhang L, 2012, DIABETES OBES METAB, V14, P727, DOI 10.1111/j.1463-1326.2012.01592.x; Zhao Y, 2015, STROKE, V46, P1966, DOI 10.1161/STROKEAHA.115.009216; Zhou MH, 2015, BRAIN, V138, P992, DOI 10.1093/brain/awv002	69	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21450	10.1096/fj.202002740R	http://dx.doi.org/10.1096/fj.202002740R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788980				2022-12-28	WOS:000645260100044
J	Ehinger, R; Kuret, A; Matt, L; Frank, N; Wild, K; Kabagema-Bilan, C; Bischof, H; Malli, R; Ruth, P; Bausch, AE; Lukowski, R				Ehinger, Rebekka; Kuret, Anna; Matt, Lucas; Frank, Nadine; Wild, Katharina; Kabagema-Bilan, Clement; Bischof, Helmut; Malli, Roland; Ruth, Peter; Bausch, Anne E.; Lukowski, Robert			Slack K+ channels attenuate NMDA-induced excitotoxic brain damage and neuronal cell death	FASEB JOURNAL			English	Article						BDNF; excitotoxicity; glutamate; Kcnt1; K(Na)1.1; neuroprotection; NMDA receptor; Slack; Slo2.2; TrkB	ACTIVATED POTASSIUM CHANNEL; CEREBELLAR GRANULE CELLS; MENTAL-RETARDATION PROTEIN; MIGRATING PARTIAL SEIZURES; METHYL-D-ASPARTATE; NA CHANNELS; AMPA RECEPTORS; NEUROTROPHIC FACTOR; IN-VITRO; GLUTAMATE NEUROTOXICITY	The neuronal Na+-activated K+ channel Slack (aka Slo2.2, K(Na)1.1, or Kcnt1) has been implicated in setting and maintaining the resting membrane potential and defining excitability and firing patterns, as well as in the generation of the slow afterhyperpolarization following bursts of action potentials. Slack activity increases significantly under conditions of high intracellular Na+ levels, suggesting this channel may exert important pathophysiological functions. To address these putative roles, we studied whether Slack K+ channels contribute to pathological changes and excitotoxic cell death caused by glutamatergic overstimulation of Ca2+-and Na+-permeable N-methyl-D-aspartic acid receptors (NMDAR). Slack-deficient (Slack KO) and wild-type (WT) mice were subjected to intrastriatal microinjections of the NMDAR agonist NMDA. NMDA-induced brain lesions were significantly increased in Slack KO vs WT mice, suggesting that the lack of Slack renders neurons particularly susceptible to excitotoxicity. Accordingly, excessive neuronal cell death was seen in Slack-deficient primary cerebellar granule cell (CGC) cultures exposed to glutamate and NMDA. Differences in neuronal survival between WT and Slack KO CGCs were largely abolished by the NMDAR antagonist MK-801, but not by NBQX, a potent and highly selective competitive antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type ionotropic glutamate receptors. Interestingly, NMDAR-evoked Ca2+ signals did not differ with regard to Slack genotype in CGCs. However, real-time monitoring of K+ following NMDAR activation revealed a significant contribution of this channel to the intracellular drop in K+. Finally, TrkB and TrkC neurotrophin receptor transcript levels were elevated in NMDA-exposed Slack-proficient CGCs, suggesting a mechanism by which this K+ channel contributes to the activation of the extracellular-signal-regulated kinase (Erk) pathway and thereby to neuroprotection. Combined, our findings suggest that Slack-dependent K+ signals oppose the NMDAR-mediated excitotoxic neuronal injury by promoting pro-survival signaling via the BDNF/TrkB and Erk axis.	[Ehinger, Rebekka; Kuret, Anna; Matt, Lucas; Frank, Nadine; Wild, Katharina; Kabagema-Bilan, Clement; Bischof, Helmut; Ruth, Peter; Bausch, Anne E.; Lukowski, Robert] Univ Tubingen, Inst Pharm, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany; [Malli, Roland] Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Graz, Austria	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Medical University of Graz	Lukowski, R (corresponding author), Univ Tubingen, Inst Pharm, Expt Pharmacol, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany.	robert.lukowski@uni-tuebingen.de		Matt, Lucas/0000-0003-3235-5140; Bischof, Helmut/0000-0003-2380-600X	Deutsche Forschungsgemeinschaft; Doktor Robert Pfleger--Stiftung; Landesgraduiertenforderung Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Doktor Robert Pfleger--Stiftung; Landesgraduiertenforderung Baden-Wurttemberg	Deutsche Forschungsgemeinschaft; Doktor Robert Pfleger--Stiftung; Landesgraduiertenforderung Baden-Wurttemberg	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Alim I, 2013, J NEUROSCI, V33, P17264, DOI 10.1523/JNEUROSCI.1729-13.2013; Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Ayata C, 1997, J NEUROSCI, V17, P6908; Babot Z, 2005, EUR J NEUROSCI, V21, P103, DOI 10.1111/j.1460-9568.2004.03848.x; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Bausch AE, 2018, NEUROSCIENCE, V384, P361, DOI 10.1016/j.neuroscience.2018.05.040; Bausch AE, 2015, LEARN MEMORY, V22, P323, DOI 10.1101/lm.037820.114; BEAL MF, 1992, J NEUROL SCI, V108, P80; Bentzen BH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00389; Berg AP, 2007, J NEUROSCI, V27, P8845, DOI 10.1523/JNEUROSCI.0551-07.2007; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Bischof H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01615-z; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brandoli C, 1998, J NEUROSCI, V18, P7953; Brown DR, 1999, MOL CELL NEUROSCI, V13, P379, DOI 10.1006/mcne.1999.0751; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Cebers G, 1997, BRAIN RES BULL, V43, P393, DOI 10.1016/S0361-9230(97)00025-7; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; DiGregorio DA, 2007, J NEUROSCI, V27, P8344, DOI 10.1523/JNEUROSCI.2399-07.2007; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dolga AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.30; Dolga AM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00196; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Evely KM, 2017, MOL PAIN, V13, P1, DOI 10.1177/1744806917714342; Finn R, 2010, J NEUROSCI RES, V88, P2648, DOI 10.1002/jnr.22433; Gao SB, 2008, ACTA PHARMACOL SIN, V29, P899, DOI 10.1111/j.1745-7254.2008.00842.x; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Grunnet M, 2001, NEUROPHARMACOLOGY, V40, P879, DOI 10.1016/S0028-3908(01)00028-4; Guglielmi L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00034; Gururaj S, 2017, CELL REP, V21, P926, DOI 10.1016/j.celrep.2017.09.088; Gururaj S, 2016, NEUROPHARMACOLOGY, V103, P279, DOI 10.1016/j.neuropharm.2015.12.016; HACK NJ, 1995, DEV BRAIN RES, V87, P55, DOI 10.1016/0165-3806(95)00054-H; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Han BH, 2000, NEUROBIOL DIS, V7, P38; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Ikegami A, 2004, INT REV NEUROBIOL, V62, P45, DOI 10.1016/S0074-7742(04)62002-2; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Jiang XY, 2003, ANN NY ACAD SCI, V993, P134, DOI 10.1111/j.1749-6632.2003.tb07522.x; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Judge Susan I V, 2007, Recent Pat CNS Drug Discov, V2, P200, DOI 10.2174/157488907782411765; Kaczmarek Leonard K, 2013, ISRN Neurosci, V2013; Kramer D, 2010, METHODS MOL BIOL, V633, P233, DOI 10.1007/978-1-59745-019-5_17; Lawson K, 2006, CURR PHARM DESIGN, V12, P459, DOI 10.2174/138161206775474477; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015601; Lu RR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010405; Lu RR, 2015, J NEUROSCI, V35, P1125, DOI 10.1523/JNEUROSCI.2423-14.2015; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Mandir AS, 2000, J NEUROSCI, V20, P8005; MANEV H, 1989, MOL PHARMACOL, V36, P106; Martinez-Espinosa PL, 2015, ELIFE, V4, DOI 10.7554/eLife.10013; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Milligan CJ, 2014, ANN NEUROL, V75, P581, DOI 10.1002/ana.24128; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Nanou E, 2007, EUR J NEUROSCI, V25, P445, DOI 10.1111/j.1460-9568.2006.05287.x; Nanou E, 2008, P NATL ACAD SCI USA, V105, P20941, DOI 10.1073/pnas.0806403106; Numakawa T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113650; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; OLNEY JW, 1989, J CHILD NEUROL, V4, P218, DOI 10.1177/088307388900400315; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Ortuno-Sahagun D, 2014, J MOL NEUROSCI, V52, P366, DOI 10.1007/s12031-013-0157-7; Perez-Capote K, 2004, GLIA, V45, P258, DOI 10.1002/glia.10329; Pryce KD, 2019, FASEB J, V33, P7315, DOI 10.1096/fj.201802454RR; Quraishi IH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60028-z; Reijntjes DOJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39119-z; Rizzi S, 2016, J COMP NEUROL, V524, P2093, DOI 10.1002/cne.23934; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Rose CR, 2002, NEUROSCIENTIST, V8, P532, DOI 10.1177/1073858402238512; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Schousboe A, 1981, Int Rev Neurobiol, V22, P1, DOI 10.1016/S0074-7742(08)60289-5; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Shen Y, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0269-2; Soltysinska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103402; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tejada MD, 2012, BIOCHEM BIOPH RES CO, V424, P208, DOI 10.1016/j.bbrc.2012.06.038; Uchino S, 2003, BIOCHEM BIOPH RES CO, V310, P1140, DOI 10.1016/j.bbrc.2003.09.133; Wallen P, 2007, J PHYSIOL-LONDON, V585, P75, DOI 10.1113/jphysiol.2007.138156; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; Wu SN, 2003, CURR MED CHEM, V10, P649, DOI 10.2174/0929867033457863; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yu SP, 1999, SCIENCE, V284, P336, DOI 10.1126/science.284.5412.336; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zhang JY, 2018, P NATL ACAD SCI USA, V115, pE9006, DOI 10.1073/pnas.1802567115; Zhang SC, 1996, ACTA NEUROPATHOL, V91, P385, DOI 10.1007/s004010050440; Zhang YL, 2012, J NEUROSCI, V32, P15318, DOI 10.1523/JNEUROSCI.2162-12.2012	104	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21568	10.1096/fj.202002308RR	http://dx.doi.org/10.1096/fj.202002308RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817875	hybrid			2022-12-28	WOS:000645260100055
J	Ge, Q; Hu, XX; Ma, N; Sun, MQ; Zhang, LY; Cai, ZL; Tan, RL; Lu, HX				Ge, Qian; Hu, Xiaoxuan; Ma, Ning; Sun, Meiqi; Zhang, Liyun; Cai, Zhenlu; Tan, Ruolan; Lu, Haixia			Maternal high-salt diet during pregnancy impairs synaptic plasticity and memory in offspring	FASEB JOURNAL			English	Article						high&#8208; salt diet; maternal; memory; offspring; synaptic plasticity	LONG-TERM-MEMORY; HIGH-FAT DIET; COGNITIVE IMPAIRMENT; INSULIN-RESISTANCE; OXIDATIVE STRESS; HIPPOCAMPAL; FETAL; MODEL; MICE; RESTRICTION	Excess salt intake harms the brain health and cognitive functions, but whether a maternal high-salt diet (HSD) affects the brain development and neural plasticity of offspring remains unclear. Here, using a range of behavioral tests, we reported that the offspring of maternal HSD subjects exhibited short- and long-term memory deficits, especially in spatial memory in adulthood. Moreover, impairments in synaptic transmission and plasticity in the hippocampus were observed in adult offspring by using in vivo electrophysiology. Consistently, the number of astrocytes but not neurons in the hippocampus of the offspring from the HSD group were significantly decreased, and ERK and AKT signaling pathways involved in neurodevelopment were highly activated only during juvenile. In addition, the expression of synaptic proteins decreased both in juvenile and adulthood, and this effect might be involved in synaptic dysfunction. Collectively, these data demonstrated that the maternal HSD might cause adult offspring synaptic dysfunction and memory loss. It is possibly due to the reduction of astrocytes in juvenile.	[Ge, Qian; Hu, Xiaoxuan; Ma, Ning; Sun, Meiqi; Zhang, Liyun; Cai, Zhenlu; Tan, Ruolan; Lu, Haixia] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Xian 710061, Shannxi, Peoples R China; [Hu, Xiaoxuan; Ma, Ning; Zhang, Liyun; Tan, Ruolan] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Human Anat & Histoembryol, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Lu, HX (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Xian 710061, Shannxi, Peoples R China.	hxl01@mail.xjtu.edu.cn			National Natural Science Foundation of China (NSFC) [81870981]; Fundamental Research Funds for the Central Universities [xzy012019082]; China Postdoctoral Science Foundation [2018M643674]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870981; Fundamental Research Funds for the Central Universities, Grant/Award Number: xzy012019082; China Postdoctoral Science Foundation, Grant/Award Number: 2018M643674	Andrade-Talavera Y, 2015, NEUROBIOL DIS, V82, P516, DOI 10.1016/j.nbd.2015.09.005; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Basu A, 2017, HORM BEHAV, V93, P18, DOI 10.1016/j.yhbeh.2017.04.001; Borge TC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016777; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Cai ZL, 2019, MOL CELL TOXICOL, V15, P391, DOI 10.1007/s13273-019-0042-8; Cipriano AC, 2016, HORM BEHAV, V81, P59, DOI 10.1016/j.yhbeh.2016.03.002; Cordner ZA, 2019, EXP NEUROL, V318, P92, DOI 10.1016/j.expneurol.2019.04.018; Edlow AG, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01335; Faraco G, 2019, NATURE, V574, P686, DOI 10.1038/s41586-019-1688-z; Fisch J, 2019, PHYSIOL BEHAV, V204, P162, DOI 10.1016/j.physbeh.2019.02.026; Fleming TP, 2015, REPROD FERT DEVELOP, V27, P684, DOI 10.1071/RD14455; Fusco S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12793-3; Ge Q, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700134; Gould JM, 2018, P NATL ACAD SCI USA, V115, pE7398, DOI 10.1073/pnas.1721876115; Govic A, 2014, HORM BEHAV, V66, P591, DOI 10.1016/j.yhbeh.2014.08.013; Gray C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09753; Grimes CA., 2020, BRIT J NUTR, V1, P53; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Janthalthin Y, 2017, PSYCHONEUROENDOCRINO, V83, P49, DOI 10.1016/j.psyneuen.2017.05.003; Jiang PF, 2015, EUR ARCH PSY CLIN N, V265, P497, DOI 10.1007/s00406-015-0588-y; Joseph A, 2017, J NEUROSCI, V37, P6778, DOI 10.1523/JNEUROSCI.0618-17.2017; Kendig MD, 2019, ASIA PAC J CLIN NUTR, V28, P6, DOI 10.6133/apjcn.201903_28(1).0002; Liu YZ, 2014, NEUROBIOL LEARN MEM, V114, P10, DOI 10.1016/j.nlm.2014.04.010; Mao CP, 2013, J ENDOCRINOL, V218, P61, DOI 10.1530/JOE-13-0139; Maruyama K, 2015, LIFE SCI, V136, P42, DOI 10.1016/j.lfs.2015.06.023; Mokler DJ, 2007, BRAIN RES, V1148, P226, DOI 10.1016/j.brainres.2007.02.031; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; O'Donnell M, 2020, EUR HEART J, V41, P3363, DOI 10.1093/eurheartj/ehaa586; Ogihara T, 2002, HYPERTENSION, V40, P83, DOI 10.1161/01.HYP.0000022880.45113.C9; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Penedo LA, 2009, EXP NEUROL, V217, P108, DOI 10.1016/j.expneurol.2009.01.021; Reynolds CM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12110; Rivera P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061829; Robb JL, 2017, BEHAV BRAIN RES, V326, P187, DOI 10.1016/j.bbr.2017.02.049; Sah SK, 2017, BIOCHEM BIOPH RES CO, V493, P731, DOI 10.1016/j.bbrc.2017.08.122; Skaper SD, 2017, CNS NEUROL DISORD-DR, V16, P220, DOI 10.2174/1871527316666170113120853; Soleimani E, 2016, FOOD CHEM TOXICOL, V96, P263, DOI 10.1016/j.fct.2016.07.009; Stocher DP, 2018, BRIT J NUTR, V119, P1003, DOI [10.1017/S0007114518000235, 10.1017/s0007114518000235]; Stogsdill JA, 2017, NATURE, V551, P192, DOI 10.1038/nature24638; Tay SH, 2012, ANIMAL, V6, P1803, DOI 10.1017/S1751731112000584; Wang YJ, 2018, J NUTR BIOCHEM, V56, P133, DOI 10.1016/j.jnutbio.2018.01.007; Wang ZJ, 2020, NEUROSCIENCE, V424, P24, DOI 10.1016/j.neuroscience.2019.10.050; Wimmer ME, 2012, NEUROBIOL AGING, V33, P2220, DOI 10.1016/j.neurobiolaging.2011.07.007; Woodcock EA, 2019, NEUROIMAGE, V186, P437, DOI 10.1016/j.neuroimage.2018.11.017; Wu XL, 2018, NEUROPHARMACOLOGY, V131, P351, DOI 10.1016/j.neuropharm.2018.01.003; Zhang XH, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-9; Zhao FL, 2019, NEUROSCIENCE, V411, P237, DOI 10.1016/j.neuroscience.2019.05.033	49	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21244	10.1096/fj.202001890R	http://dx.doi.org/10.1096/fj.202001890R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715195				2022-12-28	WOS:000635216100019
J	Kobayashi, K; Ashina, K; Derouiche, S; Hamabata, T; Nakamura, T; Nagata, N; Takenouchi, S; Tominaga, M; Murata, T				Kobayashi, Koji; Ashina, Kohei; Derouiche, Sandra; Hamabata, Taiki; Nakamura, Tatsuro; Nagata, Nanae; Takenouchi, Shinya; Tominaga, Makoto; Murata, Takahisa			5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid accelerates the healing of colitis by inhibiting transient receptor potential vanilloid 4-mediated signaling	FASEB JOURNAL			English	Article						eicosapentaenoic acid; inflammatory bowel disease; lipid mediator		5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid (5,6-DiHETE) is an eicosapentaenoic acid-derived lipid metabolite, which we previously detected in inflamed mouse colon. In this study, we investigated the pathophysiological roles of 5,6-DiHETE in murine colitis and its underlying mechanisms of action, focusing on the effects on transient receptor potential vanilloid (TRPV) channel activity. Oral administration of dextran sodium sulfate (DSS, 2%, for 4 days) caused colon inflammation, which peaked on day 7 and gradually declined by day 18. 5,6-DiHETE concentration in colon tissue was significantly increased during the healing phase of colitis (days 9 to 18). In vitro study showed that pretreatment with 5,6-DiHETE (0.1-1 mu M, 30 minutes) significantly inhibited endothelial barrier disruption induced by a TRPV4 agonist (GSK1016790A, 50 nM). Intracellular Ca2+ imaging also showed that pretreatment with 5,6-DiHETE (1 mu M, 10 minutes) reduced GSK1016790A-induced intracellular Ca2+ increase in HEK293T cells overexpressing TRPV4. In vivo, intraperitoneal administration of 5,6-DiHETE (50 mu g kg(-1) day(-1)) during the healing phase accelerated the recovery from DSS-induced colitis. Pathological studies showed that the administration of 5,6-DiHETE inhibited edema formation and leukocyte infiltration in inflamed colon tissue. In conclusion, we identified 5,6-DiHETE as a novel endogenous TRPV4 antagonist, and we also demonstrated that its administration promotes the healing of colitis by inhibiting inflammatory responses.	[Kobayashi, Koji; Ashina, Kohei; Hamabata, Taiki; Nakamura, Tatsuro; Nagata, Nanae; Takenouchi, Shinya; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Derouiche, Sandra; Tominaga, Makoto] Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Bunkyo Ku, 1-1 Yayoi, Tokyo 1138657, Japan.	amurata@g.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	Japan Society for the Promotion of Science [19K15975, 18K14603, 19K16603, 17H06252, 17H01509]; Takeda Science Foundation; Kobayashi Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation	Japan Society for the Promotion of Science, Grant/Award Number: 19K15975, 18K14603, 19K16603, 17H06252 and 17H01509; Takeda Science Foundation; Kobayashi Foundation	Almallah YZ, 1998, AM J GASTROENTEROL, V93, P804, DOI 10.1111/j.1572-0241.1998.229_a.x; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Derouiche S, 2018, FASEB J, V32, P1841, DOI 10.1096/fj.201700954R; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Fernandes ES, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/506450; Fichna J, 2012, NEUROGASTROENT MOTIL, V24, pe557, DOI 10.1111/j.1365-2982.2012.01999.x; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hamabata T, 2018, J LIPID RES, V59, P1864, DOI 10.1194/jlr.M085233; Hamabata T, 2018, J LIPID RES, V59, P586, DOI 10.1194/jlr.M079095; Hashimoto K, 2016, EXPERT OPIN THER TAR, V20, P1149, DOI 10.1080/14728222.2016.1226284; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kittaka H, 2017, PFLUG ARCH EUR J PHY, V469, P1313, DOI 10.1007/s00424-017-1998-7; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kruschewski M, 2001, DIGEST DIS SCI, V46, P2336, DOI 10.1023/A:1012334727509; Kusunoki Y, 2015, J GASTROEN HEPATOL, V30, P1618, DOI 10.1111/jgh.12966; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Lee TH, 2009, J ALLERGY CLIN IMMUN, V124, P417, DOI 10.1016/j.jaci.2009.04.020; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Matsumoto K, 2018, BRIT J PHARMACOL, V175, P84, DOI 10.1111/bph.14072; Navarini L, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0586-3; Phuong TTT, 2017, J PHYSIOL-LONDON, V595, P6869, DOI 10.1113/JP275052; Proudman SM, 2015, ANN RHEUM DIS, V74, P89, DOI 10.1136/annrheumdis-2013-204145; Qiu YE, 2018, PROSTAG OTH LIPID M, V136, P9, DOI 10.1016/j.prostaglandins.2018.03.004; RACHMILEWITZ D, 1989, GASTROENTEROLOGY, V97, P326, DOI 10.1016/0016-5085(89)90068-1; Scotland RS, 2004, CIRC RES, V95, P1027, DOI 10.1161/01.RES.0000148633.93110.24; Szitter I, 2010, J MOL NEUROSCI, V42, P80, DOI 10.1007/s12031-010-9366-5; Taberner FJ, 2015, BBA-BIOMEMBRANES, V1848, P1818, DOI 10.1016/j.bbamem.2015.03.022; Teitelbaum JE, 2001, J NUTR BIOCHEM, V12, P21, DOI 10.1016/S0955-2863(00)00141-8; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Utsumi D, 2018, J PHARMACOL SCI, V136, P121, DOI 10.1016/j.jphs.2017.12.012; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang YP, 2017, ATHEROSCLEROSIS, V260, P13, DOI 10.1016/j.atherosclerosis.2017.03.016; WEISS HJ, 1979, BLOOD, V53, P244; Yin J, 2016, AM J RESP CELL MOL, V54, P370, DOI 10.1165/rcmb.2014-0225OC; Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003	39	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21238	10.1096/fj.201903207RRR	http://dx.doi.org/10.1096/fj.201903207RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715198				2022-12-28	WOS:000635216100029
J	Li, DF; Li, FF; Meng, LL; Wei, HF; Zhang, QJ; Jiang, F; Chen, DN; Li, W; Tan, YQ; Li, JD				Li, Dengfeng; Li, Fangfang; Meng, Lanlan; Wei, Huafang; Zhang, Qianjun; Jiang, Fang; Chen, Dan-Na; Li, Wei; Tan, Yue-Qiu; Li, Jia-Da			RNF216 regulates meiosis and PKA stability in the testes	FASEB JOURNAL			English	Article						PKA; proteomics; RNF216; spermatogenesis		Spermatogenesis is a highly sophisticated process that comprises of mitosis, meiosis, and spermiogenesis. RNF216 (ring finger protein 216), an E3 ubiquitin ligase, has been reported to be essential for spermatogenesis and male fertility in mice. However, the stages affected by Rnf216 deficiency and its underlying molecular pathological mechanisms are still unknown. In this study, we generated Rnf216-deficient mice (Rnf216(-/-)) using CRISPR-Cas9 technology. Knockout of Rnf216 led to infertility in male but not female mice. Rnf216 knockout affected the prophase of meiosis I, as no genotypic difference was observed until 12 dpp (days postpartum). Rnf216(-/-) spermatocytes were incompletely arrested at the zygotene stage and underwent apoptosis at approximately the pachytene stage. The proportion of zygotene spermatocytes was significantly increased, whereas the proportion of pachytene spermatocytes was significantly decreased in Rnf216(-/-) testes. Nevertheless, there was no significantly genotypic difference in the number of diplotene spermatocytes. We further revealed that the PKA catalytic subunit beta (PRKACB) was significantly increased, which subsequently resulted in elevated PKA activity in testes from adult as well as 9 dpp Rnf216(-/-) mice. RNF216 interacts with PRKACB and promotes its degradation through the ubiquitin-lysosome pathway. Collectively, our results revealed an important role for RNF216 in regulation of meiosis and PKA stability in the testes.	[Li, Dengfeng; Li, Fangfang; Jiang, Fang; Li, Jia-Da] Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha, Peoples R China; [Li, Dengfeng; Li, Fangfang; Jiang, Fang; Li, Jia-Da] Cent South Univ, Hunan Key Lab Anim Models Human Dis, Changsha, Peoples R China; [Li, Dengfeng; Li, Fangfang; Jiang, Fang; Li, Jia-Da] Cent South Univ, Hunan Key Lab Med Genet, Changsha, Peoples R China; [Meng, Lanlan; Zhang, Qianjun; Tan, Yue-Qiu] Cent South Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, Changsha, Peoples R China; [Wei, Huafang; Li, Wei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Chen, Dan-Na] Changsha Med Univ, Dept Basic Med Sci, Changsha, Peoples R China; [Li, Jia-Da] Hunan Int Sci & Technol Cooperat Base Anim Models, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University; Chinese Academy of Sciences; Institute of Zoology, CAS; Changsha Medical University	Li, JD (corresponding author), Cent South Univ, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	lijiada@sklmg.edu.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Li, Jia-Da/0000-0002-4236-3518	National Natural Science Foundation of China (NSFC) [81770780, 81728013, 31972913]; Key Research and Development Programs from Hunan Province [2018DK2010, 2018DK2013]; Guangdong Key Project in 'Development of New Tools for Diagnosis and Treatment of Autism' [2018B030335001]; Strategic Priority Research Program of Central South University [ZLXD2017004]; National Science Fund for Distinguished Young Scholars [81925015]; Key Grant of Prevention and Treatment of Birth Defect from Hunan Province [2019SK1012]; Training Program for Excellent Young Innovators of Changsha [kq1802019]; Natural Science Foundation of Hunan Province [2018JJ3573]; Foundation of Education Bureau of Hunan Province [18A493]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Research and Development Programs from Hunan Province; Guangdong Key Project in 'Development of New Tools for Diagnosis and Treatment of Autism'; Strategic Priority Research Program of Central South University; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Grant of Prevention and Treatment of Birth Defect from Hunan Province; Training Program for Excellent Young Innovators of Changsha; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Foundation of Education Bureau of Hunan Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770780, 81728013 and 31972913; Key Research and Development Programs from Hunan Province, Grant/Award Number: 2018DK2010 and 2018DK2013; Guangdong Key Project in `Development of New Tools for Diagnosis and Treatment of Autism', Grant/Award Number: 2018B030335001; Strategic Priority Research Program of Central South University, Grant/Award Number: ZLXD2017004; National Science Fund for Distinguished Young Scholars, Grant/Award Number: 81925015; Key Grant of Prevention and Treatment of Birth Defect from Hunan Province, Grant/Award Number: 2019SK1012; Training Program for Excellent Young Innovators of Changsha, Grant/Award Number: kq1802019; Natural Science Foundation of Hunan Province, Grant/Award Number: 2018JJ3573; Foundation of Education Bureau of Hunan Province, Grant/Award Number: 18A493	Alavattam KG, 2016, CELL REP, V17, P1141, DOI 10.1016/j.celrep.2016.09.073; Alturki NA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0672-0; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Bonomi M, 2012, ASIAN J ANDROL, V14, P49, DOI 10.1038/aja.2011.68; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Burton KA, 2006, MOL ENDOCRINOL, V20, P2504, DOI 10.1210/me.2006-0060; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; da Cruz I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2618-1; Dickins RA, 2002, MOL CELL BIOL, V22, P2294, DOI 10.1128/MCB.22.7.2294-2303.2002; Dove KK, 2017, J MOL BIOL, V429, P3363, DOI 10.1016/j.jmb.2017.08.008; Evankovich J, 2020, AM J RESP CELL MOL, V62, P157, DOI 10.1165/rcmb.2018-0373OC; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Hillers Kenneth J, 2017, WormBook, V2017, P1, DOI 10.1895/wormbook.1.178.1; Huang XY, 2011, ASIAN J ANDROL, V13, P18, DOI 10.1038/aja.2010.71; Husain N, 2017, AGING CELL, V16, P281, DOI 10.1111/acel.12551; Jan SZ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160614; Kim SH, 2015, ENDOCRINOL METAB, V30, P456, DOI 10.3803/EnM.2015.30.4.456; Kumazoe M, 2017, J BIOL CHEM, V292, P4077, DOI 10.1074/jbc.M116.755959; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Meehan TF, 2017, NAT GENET, V49, P1231, DOI 10.1038/ng.3901; Melnick AF, 2019, BIOL REPROD, V100, P1132, DOI 10.1093/biolre/ioz006; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Seenivasan R, 2019, HUM MOL GENET, V28, P2862, DOI 10.1093/hmg/ddz098; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Spiller C, 2017, ANNU REV GENET, V51, P265, DOI 10.1146/annurev-genet-120215-035449; Walden H, 2018, NAT STRUCT MOL BIOL, V25, P440, DOI 10.1038/s41594-018-0063-3; Walker-Gray R, 2017, P NATL ACAD SCI USA, V114, P10414, DOI 10.1073/pnas.1701782114; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Wosnitzer Matthew, 2014, Spermatogenesis, V4, pe28218; Xu CF, 2014, AUTOPHAGY, V10, P2239, DOI 10.4161/15548627.2014.981792; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, P9681, DOI 10.1093/nar/gkw652; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	36	3	3	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21460	10.1096/fj.202002294RR	http://dx.doi.org/10.1096/fj.202002294RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724554				2022-12-28	WOS:000635216100094
J	Romana-Souza, B; Chen, L; Leonardo, TR; Chen, ZL; DiPietro, LA				Romana-Souza, Bruna; Chen, Lin; Leonardo, Trevor R.; Chen, Zhenlong; DiPietro, Luisa A.			Dermal fibroblast phagocytosis of apoptotic cells: A novel pathway for wound resolution	FASEB JOURNAL			English	Article						apoptosis; endothelial cell; fibroblasts; milk fat globule&#8208; EGF factor 8 protein; phagocytosis; wound healing		The effective clearance of apoptotic cells is an essential step in the resolution of healing wounds. In particular, blood vessel regression during wound resolution produces a significant number of apoptotic endothelial cells (ApoEC) that must be cleared. In considering the fate of ApoEC and the presence of fibroblasts during wound resolution, we hypothesized that fibroblasts might serve as phagocytes involved in endothelial cell removal. The current study investigated whether dermal fibroblasts engulf ApoEC, whether this uptake alters the phenotype of dermal fibroblasts, and the biological molecules involved. In both in vitro and in vivo studies, following ApoEC engulfment, fibroblasts acquired a pro-healing phenotype (increased cell migration, contractility, alpha-smooth muscle actin expression, and collagen deposition). In addition, fibroblast uptake of ApoEC was shown to be mediated in part by the milk fat globule-EGF factor 8 protein/integrin alpha(v)beta(5) pathway. Our study demonstrates a novel function of fibroblasts in the clearance of ApoEC and suggests that this capability has significant implications for tissue repair and fibrosis.	[Romana-Souza, Bruna] Univ Estado Rio De Janeiro, Tissue Repair Lab, 381 Marechal Rondon Ave, BR-20950003 Rio De Janeiro, RJ, Brazil; [Chen, Lin; DiPietro, Luisa A.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, 801 S Paulina St, Chicago, IL 60612 USA; [Leonardo, Trevor R.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL USA; [Chen, Zhenlong] Univ Illinois, Dept Anesthesiol, Chicago, IL USA	Universidade do Estado do Rio de Janeiro; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Romana-Souza, B (corresponding author), Univ Estado Rio De Janeiro, Tissue Repair Lab, 381 Marechal Rondon Ave, BR-20950003 Rio De Janeiro, RJ, Brazil.; DiPietro, LA (corresponding author), Univ Illinois, Ctr Wound Healing & Tissue Regenerat, 801 S Paulina St, Chicago, IL 60612 USA.	bruna.romana.souza@uerj.br; Ldipiet@uic.edu	Chen, Zhenlong/AAQ-9578-2021; Romana-Souza, Bruna/O-9104-2017	Romana-Souza, Bruna/0000-0001-5665-8694	National Institutes of Health [NIH R01 GM50875, F31 DE028747]; National Council of Research (CNPq) [203109/2018-0]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Institutes of Health grants: NIH R01 GM50875 (LAD) and F31 DE028747 (TRL). In addition, the authors thank National Council of Research (CNPq) for its support of BRS's postdoctoral scholarship (Number: 203109/2018-0)	Akasaka Y, 2000, LAB INVEST, V80, P345, DOI 10.1038/labinvest.3780039; Akasaka Y, 2001, WOUND REPAIR REGEN, V9, P501, DOI 10.1046/j.1524-475x.2001.00501.x; Arai S, 2018, SEMIN IMMUNOPATHOL, V40, P567, DOI 10.1007/s00281-018-0717-6; Barth ND, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01708; Brissette MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036368; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Coleman R, 2011, ACTA HISTOCHEM, V113, P231, DOI 10.1016/j.acthis.2010.02.002; Das A, 2016, J IMMUNOL, V196, P5089, DOI 10.4049/jimmunol.1502270; De Felice B, 2009, MOL CELL BIOCHEM, V327, P191, DOI 10.1007/s11010-009-0057-x; Dimmeler S, 2000, CIRC RES, V87, P434; DiPietro LA, 2016, J LEUKOCYTE BIOL, V100, P979, DOI 10.1189/jlb.4MR0316-102R; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Gurevich DB, 2018, EMBO J, V37, DOI 10.15252/embj.201797786; Han CZ, 2016, NATURE, V539, P570, DOI 10.1038/nature20141; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Laplante P, 2017, J INVEST DERMATOL, V137, P2005, DOI 10.1016/j.jid.2017.04.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Messadi DV, 1999, WOUND REPAIR REGEN, V7, P511, DOI 10.1046/j.1524-475X.1999.00511.x; Michalczyk ER, 2020, ADV WOUND CARE, V9, P1, DOI 10.1089/wound.2019.1019; Michalczyk ER, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29465-9; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nakaya M, 2017, J CLIN INVEST, V127, P383, DOI 10.1172/JCI83822; Ngo P, 2006, METH MOL B, V341, P103; Perez B, 2012, J BIOL CHEM, V287, P16029, DOI 10.1074/jbc.M112.340489; PIERARD GE, 1989, MATRIX, V9, P68, DOI 10.1016/S0934-8832(89)80021-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwegler M, 2015, BIOL CELL, V107, P372, DOI 10.1111/boc.201400090; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Uchiyama A, 2017, J DERMATOL SCI, V86, P187, DOI 10.1016/j.jdermsci.2017.02.285; Uchiyama A, 2015, J INVEST DERMATOL, V135, P1157, DOI 10.1038/jid.2014.515; Watson EC, 2017, CELL MOL LIFE SCI, V74, P4387, DOI 10.1007/s00018-017-2577-y; Wietecha MS, 2015, AM J PHYSIOL-HEART C, V309, pH812, DOI 10.1152/ajpheart.00153.2015; Wietecha MS, 2013, CURR TOP MICROBIOL, V367, P3, DOI 10.1007/82_2012_287; Wood W, 2000, DEVELOPMENT, V127, P5245; Yoon H, 2020, EXP EYE RES, V194, DOI 10.1016/j.exer.2020.108017; Zeng RJ, 2018, CELL TISSUE RES, V374, P217, DOI 10.1007/s00441-018-2830-1; Zhang MZ, 2017, AM J TRANSL RES, V9, P5548; Zomer HD, 2018, J DERMATOL SCI, V90, P3, DOI 10.1016/j.jdermsci.2017.12.009	45	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21443	10.1096/fj.202002078R	http://dx.doi.org/10.1096/fj.202002078R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749877	Green Accepted			2022-12-28	WOS:000635216100063
J	Xie, X; Chen, H; Zhang, LL; Chan, D; Hill, WG; Zeidel, ML; Yu, WQ				Xie, Xiang; Chen, Huan; Zhang, Lanlan; Chan, Daniel; Hill, Warren G.; Zeidel, Mark L.; Yu, Weiqun			Molecular mechanisms of voiding dysfunction in a novel mouse model of acute urinary retention	FASEB JOURNAL			English	Article						integrin signaling; lower urinary tract symptoms; purinergic signaling; smooth muscle contractility; urodynamics	INTEGRIN-LINKED KINASE; ACUTE OVERDISTENSION; SUBSEQUENT CATHETERIZATION; TRACT FUNCTION; ATP RELEASE; BLADDER; MATRIX; MICE; MECHANOSENSITIVITY; CONTRACTILITY	Acute urinary retention (AUR) is a common urological emergency and affects a significant patient population. The inability to eliminate urine may lead to permanent damage to the bladder's structure and functioning. However, we know little about the underlying molecular sequelae to the urine retention. To closely mirror the potential high pressures that patients with AUR could experience, we catheterized anesthetized female mice via the urethra and filled the bladder by pumping saline (25 mu L/min) into the bladder lumen to 50 cm or 80 cm water pressure. A water column with designated height (50 or 80 cm) was then adjusted to maintain constant pressure in the bladder lumen for 30 minutes. Functional and morphological evaluations were performed from 0 to 24 hours after AUR treatment. Mice exhibited incontinence and overactivity with diminished voiding pressure. Significant injury was confirmed which revealed bladders with disrupted urothelial barrier, edematous lamina propria, and distorted muscle bundles. Bladder smooth muscle (BSM) from pressure-treated mice have significantly diminished contraction force, suggesting that bladder voiding dysfunction can be attributed to impaired BSM contractility. Indeed, dysregulation of acetylcholine and purinergic signaling pathways were demonstrated, indicating that reduced efficacy of these pathways contributes to impaired BSM contractility. Finally, altered expression of beta 1-integrin and extracellular matrix mediated mechanotransduction pathways were detected, suggesting a profound remodeling process. These data demonstrated an easy to perform, quantifiable, and reproducible AUR mouse model, which mimics well the characteristics of human AUR patients, and our data generate new insights into the molecular mechanisms that occur following AUR.	[Xie, Xiang; Chen, Huan; Zhang, Lanlan; Hill, Warren G.; Zeidel, Mark L.; Yu, Weiqun] Beth Israel Deaconess Med Ctr, Dept Med, RN380B,99 Brookline Ave, Boston, MA 02215 USA; [Xie, Xiang; Chen, Huan; Zhang, Lanlan; Hill, Warren G.; Zeidel, Mark L.; Yu, Weiqun] Harvard Med Sch, Boston, MA 02115 USA; [Chan, Daniel] Brown Univ Harvard Summer Res Program Kidney Med, Providence, RI USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yu, WQ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, RN380B,99 Brookline Ave, Boston, MA 02215 USA.	wyu2@bidmc.harvard.edu		Chan, Daniel Y./0000-0002-7507-3218; Chen, Huan/0000-0002-6487-7923				Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Baldini G, 2009, ANESTHESIOLOGY, V110, P1139, DOI 10.1097/ALN.0b013e31819f7aea; Berggren T, 1998, UROL RES, V26, P325, DOI 10.1007/s002400050064; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Bross S, 1999, EUR UROL, V36, P354, DOI 10.1159/000019999; Carere M, 2018, CAN J EMERG MED, V20, P640, DOI 10.1017/cem.2017.408; Cathcart P, 2006, J UROLOGY, V176, P200, DOI 10.1016/S0022-5347(06)00509-X; Chen H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18167-4; Chen H, 2017, AM J PHYSIOL-RENAL, V313, pF1274, DOI 10.1152/ajprenal.00318.2017; CHEN MW, 1994, MOL CELL BIOCHEM, V132, P39, DOI 10.1007/BF00925673; Choong S, 2000, BJU INT, V85, P186, DOI 10.1046/j.1464-410x.2000.00409.x; Dubey D, 2001, BJU INT, V88, P178, DOI 10.1046/j.1464-410x.2001.02273.x; Dwivedi A, 2008, BASIC RES CARDIOL, V103, P244, DOI 10.1007/s00395-007-0693-9; Ens G, 2015, TRANSL ANDROL UROL, V4, P624, DOI 10.3978/j.issn.2223-4683.2015.09.04; Etafy MH, 2017, UROL ANNALS, V9, P339, DOI 10.4103/0974-7796.216320; Furuya K, 2005, J CELL SCI, V118, P3289, DOI 10.1242/jcs.02453; Hao Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122112; Ho B, 2008, AM J PATHOL, V173, P278, DOI 10.2353/ajpath.2008.071046; Horton ER, 2016, EXP CELL RES, V343, P7, DOI 10.1016/j.yexcr.2015.10.025; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; Kanasaki K, 2013, FASEB J, V27, P1950, DOI 10.1096/fj.12-223404; KATO K, 1988, J UROLOGY, V140, P880, DOI 10.1016/S0022-5347(17)41849-0; Khara S, 2019, BRIT J HOSP MED, V80, pC103, DOI 10.12968/hmed.2019.80.7.C103; KITADA S, 1989, J UROLOGY, V141, P166, DOI 10.1016/S0022-5347(17)40633-1; LASANEN LT, 1992, SCAND J UROL NEPHROL, V26, P253, DOI 10.3109/00365599209180878; LAWSON JD, 1952, J UROLOGY, V67, P951, DOI 10.1016/S0022-5347(17)68439-8; LAWSON JD, 1951, J UROLOGY, V66, P678, DOI 10.1016/S0022-5347(17)74397-2; Leppilahti M, 1999, UROL RES, V27, P272, DOI 10.1007/s002400050122; Leppilahti M, 1997, SCAND J UROL NEPHROL, V31, P517, DOI 10.3109/00365599709030654; Li WJ, 2011, APOPTOSIS, V16, P574, DOI 10.1007/s10495-011-0588-y; Mahavadi S, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13495; Oelke M, 2015, UROLOGY, V86, P654, DOI 10.1016/j.urology.2015.06.025; Ohmasa F, 2010, EUR J PHARMACOL, V635, P194, DOI 10.1016/j.ejphar.2010.02.052; Piraprez M., 2017, REV MED LIEGE, V72, p529; Rajandram R, 2016, AM J PHYSIOL-RENAL, V310, pF885, DOI 10.1152/ajprenal.00483.2015; Reitz A, 2004, EUR UROL, V46, P235, DOI 10.1016/j.eururo.2004.04.009; Saito M, 2001, J UROLOGY, V165, P1745, DOI 10.1016/S0022-5347(05)66406-3; Saito M, 2010, MOL CELL BIOCHEM, V333, P109, DOI 10.1007/s11010-009-0210-6; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Selius BA, 2008, AM FAM PHYSICIAN, V77, P643; Shimizu S, 2009, BJU INT, V104, P713, DOI 10.1111/j.1464-410X.2009.08471.x; Swartzberg K., 2017, CASE REP EMERG MED, V2017; Takahara N, 2014, AM J RESP CELL MOL, V51, P772, DOI 10.1165/rcmb.2014-0008OC; TAMMELA TLJ, 1993, J UROLOGY, V150, P1533, DOI 10.1016/S0022-5347(17)35836-6; TANAGHO E A, 1970, British Journal of Urology, V42, P175, DOI 10.1111/j.1464-410X.1970.tb10019.x; TAYLOR DE, 1963, LANCET, V2, P1033; Thomas K, 2005, BJU INT, V95, P72, DOI 10.1111/j.1464-410X.2004.05254.x; TONG YC, 1992, J UROLOGY, V148, P1347, DOI 10.1016/S0022-5347(17)36906-9; Upadhyay J, 2003, J UROLOGY, V169, P750, DOI 10.1016/S0022-5347(05)64007-4; Vecchione C, 2009, HYPERTENSION, V54, P1028, DOI 10.1161/HYPERTENSIONAHA.109.136572; Walker NF, 2016, NEUROUROL URODYNAM, V35, P866, DOI 10.1002/nau.22851; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Wu YD, 2016, AM J PHYSIOL-LUNG C, V311, pL893, DOI 10.1152/ajplung.00299.2016; Yu WQ, 2015, AM J PHYSIOL-RENAL, V309, pE864, DOI 10.1152/ajprenal.00175.2015; Yu WQ, 2014, FASEB J, V28, P5288, DOI 10.1096/fj.14-255885; Yu WQ, 2014, AM J PHYSIOL-RENAL, V306, pF1296, DOI 10.1152/ajprenal.00074.2014; Yu WQ, 2013, FASEB J, V27, P1895, DOI 10.1096/fj.12-219006	58	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21447	10.1096/fj.202002415R	http://dx.doi.org/10.1096/fj.202002415R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742688				2022-12-28	WOS:000635216100082
J	Hatayama, K; Chen, RH; Hanson, J; Teshigawara, K; Qiu, J; Santoso, A; Disdier, C; Nakada, S; Chen, XD; Nishibori, M; Lim, YP; Stonestreet, BS				Hatayama, Kazuki; Chen, Ray H.; Hanson, Jordan; Teshigawara, Kiyoshi; Qiu, Joseph; Santoso, Andre; Disdier, Clemence; Nakada, Sakura; Chen, Xiaodi; Nishibori, Masahiro; Lim, Yow-Pin; Stonestreet, Barbara S.			High-mobility group box-1 and inter-alpha inhibitor proteins: In vitro binding and co-localization in cerebral cortex after hypoxic-ischemic injury	FASEB JOURNAL			English	Article						brain injury; high&#8208; mobility group box 1; hypoxia&#8208; ischemia; inter&#8208; alpha inhibitor proteins; inter&#8208; alpha inhibitor proteins		The high-mobility group box-1 (HMGB1) protein is a transcription-regulating protein located in the nucleus. However, it serves as a damage-associated molecular pattern protein that activates immune cells and stimulates inflammatory cytokines to accentuate neuroinflammation after release from damaged cells. In contrast, Inter-alpha Inhibitor Proteins (IAIPs) are proteins with immunomodulatory effects including inhibition of pro-inflammatory cytokines. We have demonstrated that IAIPs exhibit neuroprotective properties in neonatal rats exposed to hypoxic-ischemic (HI) brain injury. In addition, previous studies have suggested that the light chain of IAIPs, bikunin, may exert its anti-inflammatory effects by inhibiting HMGB1 in a variety of different injury models in adult subjects. The objectives of the current study were to confirm whether HMGB1 is a target of IAIPs by investigating the potential binding characteristics of HMGB1 and IAIPs in vitro, and co-localization in vivo in cerebral cortices after exposure to HI injury. Solid-phase binding assays and surface plasmon resonance (SPR) were used to determine the physical binding characteristics between IAIPs and HMGB1. Cellular localizations of IAIPs-HMGB1 in neonatal rat cortex were visualized by double labeling with anti-IAIPs and anti-HMGB1 antibodies. Solid-phase binding and SPR demonstrated specific binding between IAIPs and HMGB1 in vitro. Cortical cytoplasmic and nuclear co-localization of IAIPs and HMGB1 were detected by immunofluorescent staining in control and rats immediately and 3 hours after HI. In conclusion, HMGB1 and IAIPs exhibit direct binding in vitro and co-localization in vivo in neonatal rats exposed to HI brain injury suggesting HMGB1 could be a target of IAIPs.	[Hatayama, Kazuki; Chen, Ray H.; Hanson, Jordan; Disdier, Clemence; Nakada, Sakura; Chen, Xiaodi; Stonestreet, Barbara S.] Brown Univ, Women & Infants Hosp Rhode Isl, Alpert Med Sch, Providence, RI 02905 USA; [Teshigawara, Kiyoshi; Nishibori, Masahiro] Okayama Univ, Grad Sch Med, Dept Pharmacol, Okayama, Japan; [Qiu, Joseph; Santoso, Andre; Lim, Yow-Pin] ProThera Biol Inc, Providence, RI USA; [Lim, Yow-Pin] Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02905 USA	Brown University; Women & Infants Hospital Rhode Island; Okayama University; Brown University	Stonestreet, BS (corresponding author), Brown Univ, Women & Infants Hosp Rhode Isl, Dept Pediat, Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	bstonestreet@wihri.org	Chen, Ray/GRJ-6736-2022; disdier, clemence/GWV-3085-2022	disdier, clemence/0000-0003-3107-3459; Chen, Xiaodi/0000-0002-1860-2814	NIH [1R21NS095130, 1R21NS096525, 2R01HD057100, 2R44 NS084575]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH (1R21NS095130, 1R21NS096525, 2R01HD057100, 2R44 NS084575).	Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Barrios-Anderson A, 2019, J NEUROPATH EXP NEUR, V78, P742, DOI 10.1093/jnen/nlz051; Bianchi ME, 2004, TRENDS CELL BIOL, V14, P287, DOI 10.1016/j.tcb.2004.04.004; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Chaaban H, 2015, BLOOD, V125, P2286, DOI 10.1182/blood-2014-06-582759; Chaaban H, 2010, J PEDIATR-US, V157, P757, DOI 10.1016/j.jpeds.2010.04.075; Chaaban H, 2009, J PEDIATR-US, V154, P620, DOI 10.1016/j.jpeds.2008.10.008; Chen HM, 2014, INT J CLIN EXP MED, V7, P1483; Chen XD, 2019, EXP NEUROL, V317, P244, DOI 10.1016/j.expneurol.2019.03.013; Chen XD, 2019, EXP NEUROL, V311, P1, DOI 10.1016/j.expneurol.2018.09.007; COWAN WM, 1979, SCI AM, V241, P112, DOI 10.1038/scientificamerican0979-112; Delsesto D, 2011, CONTRIB MICROBIOL, V17, P137, DOI 10.1159/000324030; Disdier C, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060101; Disdier C, 2018, INT J DEV NEUROSCI, V65, P54, DOI 10.1016/j.ijdevneu.2017.10.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Gaudet CM, 2016, BEHAV BRAIN RES, V302, P88, DOI 10.1016/j.bbr.2016.01.016; Gulke E, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418774254; Hatayama K., 2021, FASEB J, V35; Htwe SS, 2018, BLOOD ADV, V2, P1923, DOI 10.1182/bloodadvances.2018018986; Kim B, 2020, J NEUROSCI RES, V98, P869, DOI 10.1002/jnr.24565; Kim SW, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0747-x; Koga Y, 2010, NEUROL RES, V32, P925, DOI 10.1179/016164110X12645013515133; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Li XF, 2018, EXP NEUROL, V302, P68, DOI 10.1016/j.expneurol.2017.12.016; Lim Yow-Pin, 2013, R I Med J (2013), V96, P16; Lim YP, 2005, J CHROMATOGR A, V1065, P39, DOI 10.1016/j.chroma.2004.11.006; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Liu M, 2017, BIOMED PHARMACOTHER, V85, P412, DOI 10.1016/j.biopha.2016.11.044; Liu W, 2018, ONCOL LETT, V16, P4057, DOI 10.3892/ol.2018.9123; Logsdon AF, 2020, J CEREBR BLOOD F MET, V40, P1090, DOI 10.1177/0271678X19859465; Luo YP, 2017, INT J MOL MED, V39, P297, DOI 10.3892/ijmm.2016.2828; Magna M, 2016, CLIN THER, V38, P1029, DOI 10.1016/j.clinthera.2016.02.029; Nishibori M, 2019, J PHARMACOL SCI, V140, P94, DOI 10.1016/j.jphs.2019.04.006; Opal SM, 2011, SHOCK, V35, P42, DOI 10.1097/SHK.0b013e3181e83204; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rumajogee P, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00057; Sadowska GB, 2015, J CEREBR BLOOD F MET, V35, P1388, DOI 10.1038/jcbfm.2015.134; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shah BA, 2017, J PEDIATR-US, V180, P135, DOI 10.1016/j.jpeds.2016.09.016; Singh K, 2010, PEDIATR RES, V68, P242, DOI 10.1203/00006450-201011001-00474; Spasova MS, 2017, DEV NEUROBIOL, V77, P726, DOI 10.1002/dneu.22451; Spasova MS, 2014, EXP BIOL MED, V239, P724, DOI 10.1177/1535370213519195; Sun Nian-Kang, 2005, Chang Gung Med J, V28, P673; Takahashi HK, 2013, EUR J PHARMACOL, V701, P194, DOI 10.1016/j.ejphar.2012.11.058; Threlkeld SW, 2017, BRAIN BEHAV IMMUN, V64, P173, DOI 10.1016/j.bbi.2017.03.004; Threlkeld SW, 2014, EXP NEUROL, V261, P424, DOI 10.1016/j.expneurol.2014.07.012; Tian QY, 2014, METHODS MOL BIOL, V1155, P163, DOI 10.1007/978-1-4939-0669-7_14; Tong Y, 2014, INT J MED SCI, V11, P337, DOI 10.7150/ijms.7861; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Wang DL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030643; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang SY, 2015, GENET MOL RES, V14, P4344, DOI 10.4238/2015.April.30.7; Wang WK, 2017, EXP THER MED, V14, P2497, DOI 10.3892/etm.2017.4824; Wu RQ, 2004, CRIT CARE MED, V32, P1747, DOI 10.1097/01.CCM.0000132903.14121.0E; Xu B, 2020, BRAIN RES, V1726, DOI 10.1016/j.brainres.2019.146495; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Ye YZ, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00127; Zhang J, 2016, J NEUROPATH EXP NEUR, V75, P527, DOI 10.1093/jnen/nlw030; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458	69	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21399	10.1096/fj.202002109RR	http://dx.doi.org/10.1096/fj.202002109RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559227				2022-12-28	WOS:000629576700050
J	O'Donnell, L; Rebourcet, D; Dagley, LF; Sgaier, R; Infusini, G; O'Shaughnessy, PJ; Chalmel, F; Fietz, D; Weidner, W; Legrand, JMD; Hobbs, RM; McLachlan, RI; Webb, AI; Pilatz, A; Diemer, T; Smith, LB; Stanton, PG				O'Donnell, Liza; Rebourcet, Diane; Dagley, Laura F.; Sgaier, Raouda; Infusini, Giuseppe; O'Shaughnessy, Peter J.; Chalmel, Frederic; Fietz, Daniela; Weidner, Wolfgang; Legrand, Julien M. D.; Hobbs, Robin M.; McLachlan, Robert, I; Webb, Andrew, I; Pilatz, Adrian; Diemer, Thorsten; Smith, Lee B.; Stanton, Peter G.			Sperm proteins and cancer-testis antigens are released by the seminiferous tubules in mice and men	FASEB JOURNAL			English	Article						biomarker; cancer&#8208; testis antigen; interstitial fluid; sperm; testis	PLASMA PROTEOME DATABASE; REGULATORY T-CELLS; CANCER/TESTIS ANTIGENS; SERTOLI-CELLS; ANTISPERM ANTIBODIES; SAMPLE PREPARATION; MESSENGER-RNAS; EXPRESSION; MOUSE; IDENTIFICATION	Sperm develop from puberty in the seminiferous tubules, inside the blood-testis barrier to prevent their recognition as "non-self" by the immune system, and it is widely assumed that human sperm-specific proteins cannot access the circulatory or immune systems. Sperm-specific proteins aberrantly expressed in cancer, known as cancer-testis antigens (CTAs), are often pursued as cancer biomarkers and therapeutic targets based on the assumption they are neoantigens absent from the circulation in healthy men. Here, we identify a wide range of germ cell-derived and sperm-specific proteins, including multiple CTAs, that are selectively deposited by the Sertoli cells of the adult mouse and human seminiferous tubules into testicular interstitial fluid (TIF) that is "outside" the blood-testis barrier. From TIF, the proteins can access the circulatory- and immune systems. Disruption of spermatogenesis decreases the abundance of these proteins in mouse TIF, and a sperm-specific CTA is significantly decreased in TIF from infertile men, suggesting that exposure of certain CTAs to the immune system could depend on fertility status. The results provide a rationale for the development of blood-based tests useful in the management of male infertility and indicate CTA candidates for cancer immunotherapy and biomarker development that could show sex-specific and male-fertility-related responses.	[O'Donnell, Liza; Sgaier, Raouda; Legrand, Julien M. D.; Hobbs, Robin M.; McLachlan, Robert, I; Stanton, Peter G.] Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia; [O'Donnell, Liza; Sgaier, Raouda; Legrand, Julien M. D.; Hobbs, Robin M.; McLachlan, Robert, I; Stanton, Peter G.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [O'Donnell, Liza; Rebourcet, Diane; Smith, Lee B.] Univ Newcastle, Fac Sci, Callaghan, NSW, Australia; [Dagley, Laura F.; Infusini, Giuseppe; Webb, Andrew, I] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Dagley, Laura F.; Infusini, Giuseppe; Webb, Andrew, I] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Sgaier, Raouda; Weidner, Wolfgang; Pilatz, Adrian; Diemer, Thorsten] Justus Liebig Univ Giessen, Med Fac, Dept Urol Pediat Urol & Androl, UKGM GmbH, Giessen, Germany; [O'Shaughnessy, Peter J.; Chalmel, Frederic] Univ Rennes, Irset Inst Rech Sante Environm & Travail, UMR S 1085, INSERM,EHESP, Rennes, France; [Fietz, Daniela] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Smith, Lee B.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	Hudson Institute of Medical Research; Monash University; University of Newcastle; Walter & Eliza Hall Institute; University of Melbourne; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Justus Liebig University Giessen; University of Edinburgh	O'Donnell, L (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	Liza.ODonnell@hudson.org.au	Chalmel, Frédéric/L-5360-2018; Chalmel, Frédéric/AAM-1079-2021; Legrand, Julien/I-9365-2017	Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Legrand, Julien/0000-0001-5577-5645; Smith, Lee/0000-0002-4103-3074	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J015105/1]; Department of Health | National Health and Medical Research Council (NHMRC) [10099002]; Victorian State Government Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft (DFG); Medical Research Council Program Grant Award [MR/N002970/1]; Society for Endocrinology	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Medical Research Council Program Grant Award; Society for Endocrinology	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/J015105/1; Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: 10099002; Victorian State Government Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft (DFG); Medical Research Council Program Grant Award, Grant/Award Number: MR/N002970/1; Society for Endocrinology	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Barton G., 2018, PROTEUS R PACKAGE DO; Bates CA, 1997, BRIT J UROL, V80, P691, DOI 10.1046/j.1464-410X.1997.00379.x; Bergmann M, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P155, DOI 10.1007/978-3-540-78355-8_11; BREUCKER H, 1985, CELL TISSUE RES, V240, P303; Bruggeman JW, 2018, ONCOGENE, V37, P5694, DOI 10.1038/s41388-018-0357-2; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chen HL, 2017, MOL CELL ENDOCRINOL, V445, P65, DOI 10.1016/j.mce.2016.10.010; Chiriva-Internati M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-61; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dabaja AA, 2013, ASIAN J ANDROL, V15, P35, DOI 10.1038/aja.2012.141; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Djureinovic D, 2018, LUNG CANCER, V125, P157, DOI 10.1016/j.lungcan.2018.09.012; DYM M, 1974, AM J ANAT, V140, P1, DOI 10.1002/aja.1001400102; Fiedler SE, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105262; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Gjerstorff MF, 2015, ONCOTARGET, V6, P15772, DOI 10.18632/oncotarget.4694; Gordeeva O, 2018, SEMIN CANCER BIOL, V53, P75, DOI 10.1016/j.semcancer.2018.08.006; Hedger MP, 2011, J ANDROL, V32, P625, DOI 10.2164/jandrol.111.012989; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Itoh M, 1999, AM J REPROD IMMUNOL, V42, P321; Jagadish N, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078965; Jones PA, 2019, NAT REV CANCER, V19, P151, DOI 10.1038/s41568-019-0109-9; Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011; Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152; Li XY, 2018, FASEB J, V32, P1653, DOI 10.1096/fj.201700681R; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Luconi M, 2011, FRONT BIOSCI-LANDMRK, V16, P1315, DOI 10.2741/3791; Luo B, 2013, INT J CLIN EXP PATHO, V6, P2835; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; Marconi M, 2012, EUR UROL, V62, P713, DOI 10.1016/j.eururo.2012.03.004; Meinhardt A, 2018, J LEUKOCYTE BIOL, V104, P757, DOI 10.1002/JLB.3MR0318-086RR; Meinhardt A, 2011, MOL CELL ENDOCRINOL, V335, P60, DOI 10.1016/j.mce.2010.03.022; Mirandola L, 2015, ONCOTARGET, V6, P2812, DOI 10.18632/oncotarget.2802; Morales CR, 2002, DEV BIOL, V246, P480, DOI 10.1006/dbio.2002.0679; Mossadegh-Keller N, 2018, CELL IMMUNOL, V330, P120, DOI 10.1016/j.cellimm.2018.03.009; Mossadegh-Keller N, 2017, J EXP MED, V214, P2829, DOI 10.1084/jem.20170829; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Naito M, 2012, MED MOL MORPHOL, V45, P185, DOI 10.1007/s00795-012-0587-2; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Olesen IA, 2018, HUM REPROD, V33, P1963, DOI 10.1093/humrep/dey283; Osuru HP, 2014, MOL REPROD DEV, V81, P896, DOI 10.1002/mrd.22358; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Peterson C, 1999, MOL HUM REPROD, V5, P627, DOI 10.1093/molehr/5.7.627; Rebourcet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105687; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rival C, 2013, J REPROD IMMUNOL, V100, P66, DOI 10.1016/j.jri.2013.08.004; RUSSELL LD, 1987, GAMETE RES, V17, P43, DOI 10.1002/mrd.1120170106; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; Samy ET, 2006, IMMUNOL REV, V212, P170, DOI 10.1111/j.0105-2896.2006.00404.x; Schooten E, 2018, CANCER TREAT REV, V67, P54, DOI 10.1016/j.ctrv.2018.04.009; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHARPE RM, 1992, INT J ANDROL, V15, P201, DOI 10.1111/j.1365-2605.1992.tb01340.x; Shires K, 2018, CRIT REV ONCOL HEMAT, V132, P17, DOI 10.1016/j.critrevonc.2018.09.010; Sielaff M, 2017, J PROTEOME RES, V16, P4060, DOI 10.1021/acs.jproteome.7b00433; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith LB, 2015, ANDROLOGY-US, V3, P1035, DOI 10.1111/andr.12107; Soffientini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4357-3; Song MH, 2012, ONCOL REP, V28, P1792, DOI 10.3892/or.2012.2002; Stanton PG, 2016, SEMIN CELL DEV BIOL, V59, P166, DOI 10.1016/j.semcdb.2016.06.018; Stanton PG, 2016, PROTEOMICS, V16, P2391, DOI 10.1002/pmic.201600107; Suryavathi V, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.121095; Takahashi K, 2007, INT J ANDROL, V30, P21, DOI 10.1111/j.1365-2605.2006.00704.x; Thomas R, 2020, CANCER IMMUNOL IMMUN, V69, P449, DOI 10.1007/s00262-020-02480-4; Tung KSK, 2017, J CLIN INVEST, V127, P1046, DOI 10.1172/JCI89927; TUNG KSK, 1987, J IMMUNOL, V138, P752; TUNG KSK, 1975, CLIN EXP IMMUNOL, V20, P93; TURNER TT, 1984, ENDOCRINOLOGY, V115, P1925, DOI 10.1210/endo-115-5-1925; Ueda Shugo, 2018, Oncotarget, V9, P35997, DOI 10.18632/oncotarget.26323; Wang ZQ, 2004, CLIN CANCER RES, V10, P6544, DOI 10.1158/1078-0432.CCR-04-0911; Wheeler K, 2011, P NATL ACAD SCI USA, V108, P7511, DOI 10.1073/pnas.1017615108; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wosnitzer Matthew, 2014, Spermatogenesis, V4, pe28218; Xiao CY, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12786	83	10	10	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21397	10.1096/fj.202002484R	http://dx.doi.org/10.1096/fj.202002484R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565176	Green Published, hybrid			2022-12-28	WOS:000629576700047
J	Singh, R; Kang, A; Luo, XQ; Jeyanathan, M; Gillgrass, A; Afkhami, S; Xing, Z				Singh, Ramandeep; Kang, Alisha; Luo, Xiangqian; Jeyanathan, Mangalakumari; Gillgrass, Amy; Afkhami, Sam; Xing, Zhou			COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development	FASEB JOURNAL			English	Review						COVID-19; immunity; SARS-CoV-2; therapy; vaccines	RESPIRATORY SYNDROME CORONAVIRUS; SARS-COV-2 INFECTION; INACTIVATED VACCINE; IMMUNE-RESPONSES; BCG VACCINATION; CELL ENTRY; IN-VITRO; IMMUNOGENICITY; INTENSITY; TRIAL	The COVID-19 pandemic has unfolded to be the most challenging global health crisis in a century. In 11 months since its first emergence, according to WHO, the causative infectious agent SARS-CoV-2 has infected more than 100 million people and claimed more than 2.15 million lives worldwide. Moreover, the world has raced to understand the virus and natural immunity and to develop vaccines. Thus, within a short 11 months a number of highly promising COVID-19 vaccines were developed at an unprecedented speed and are now being deployed via emergency use authorization for immunization. Although a considerable number of review contributions are being published, all of them attempt to capture only a specific aspect of COVID-19 or its therapeutic approaches based on ever-expanding information. Here, we provide a comprehensive overview to conceptually thread together the latest information on global epidemiology and mitigation strategies, clinical features, viral pathogenesis and immune responses, and the current state of vaccine development.	[Singh, Ramandeep; Kang, Alisha; Luo, Xiangqian; Jeyanathan, Mangalakumari; Gillgrass, Amy; Afkhami, Sam; Xing, Zhou] McMaster Univ, McMaster Immunol Res Ctr, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Singh, Ramandeep; Kang, Alisha; Luo, Xiangqian; Jeyanathan, Mangalakumari; Gillgrass, Amy; Afkhami, Sam; Xing, Zhou] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada; [Luo, Xiangqian] Southern Med Univ, Shenzhen Hosp, Dept Pediat Otolaryngol, Shenzhen, Peoples R China	McMaster University; McMaster University; Southern Medical University - China	Xing, Z (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada.; Xing, Z (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada.	xingz@mcmaster.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Abassi Z, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01312; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], BBC NEWS; [Anonymous], REUTERS; [Anonymous], TORONTO SUN; [Anonymous], 2020, AM J PHYS MED REHAB, DOI DOI 10.1056/NEJMcp2009575; [Anonymous], BIOSPACE; [Anonymous], VACC PIP RSV COVID 1; [Anonymous], EUROPEAN PHARM REV; [Anonymous], SCI AM; [Anonymous], FOX NEWS; [Anonymous], FRANCE 24; [Anonymous], SIN COMM PHAS 3 CLIN; [Anonymous], BNN BLOOMBERG; [Anonymous], SCI DAILY; Aslan MM, 2022, J MATERN-FETAL NEO M, V35, P2876, DOI 10.1080/14767058.2020.1793318; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bayati A., 2020, BIORXIV, DOI [10.1101/2020.07.13.201509, DOI 10.1101/2020.07.13.201509]; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Blaising J, 2014, ANTIVIR RES, V107, P84, DOI 10.1016/j.antiviral.2014.04.006; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Bodro M, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000821; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Callaway E, 2021, NATURE, V589, P500, DOI 10.1038/d41586-021-00121-z; Cannalire R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165707; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; CBC News, CBC NEWS; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chang MC, 2020, AM J PHYS MED REHAB, V99, P583, DOI 10.1097/PHM.0000000000001471; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen C, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P567, DOI 10.3760/cma.j.cn112148-20200225-00123; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Ciarlo E, 2020, J INFECT DIS, V222, P1869, DOI 10.1093/infdis/jiz692; Cirulli ET, 2020, MEDRXIV, V2020, DOI [10.1101/2020.10.07.20208702, DOI 10.1101/2020.10.07.20208702, DOI 10.1001/jamaoto.2014.1675]; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Codo AC, 2020, CELL METAB, V32, P437, DOI 10.1016/j.cmet.2020.07.007; Colaneri M, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.05.009; Colaneri M, 2020, J HOSP INFECT, V105, P474, DOI 10.1016/j.jhin.2020.03.018; Cui PF, 2020, AM J OBSTET GYNECOL, V223, P131, DOI [10.1016/j.ajog.2020.04.038, 10.1101/2020.02.26.20028225]; Cyranoski D, 2020, NATURE, V588, P548, DOI 10.1038/d41586-020-03563-z; Davies NG., 2020, LANCET INFECT DIS, V3099, P2; Davis BH, 2013, CYTOM PART B-CLIN CY, V84, P286, DOI 10.1002/cyto.b.21105; de Bruin YB, 2020, SAFETY SCI, V128, DOI 10.1016/j.ssci.2020.104773; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; del Rio C, 2020, JAMA-J AM MED ASSOC, V324, P1723, DOI 10.1001/jama.2020.19719; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Dhochak N, 2020, INDIAN J PEDIATR, V87, P537, DOI 10.1007/s12098-020-03322-y; Di Domenico L, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01698-4; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; European Respiratory Society, COVID 19 PAT SUFF LO; FDA, IN VITR DIAGN EUAS; Fidel PL, 2020, MBIO, V11, DOI 10.1128/mBio.00907-20; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Fowler Z, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241954; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Gao WT, 2003, LANCET, V362, P1895, DOI 10.1016/S0140-6736(03)14962-8; Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Haffajee RL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006740; Hassan AO, 2020, CELL, V183, P169, DOI 10.1016/j.cell.2020.08.026; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Hernandez AV, 2020, ANN INTERN MED, V173, pW156, DOI 10.7326/L20-1257; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Hong XY, 2020, INT J INFECT DIS, V94, P78, DOI 10.1016/j.ijid.2020.03.058; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hsu J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4457; Hu Y, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104371; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Imperial College London, LANDM COR STUD TRAIL; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jeyanathan M, 2020, NAT REV IMMUNOL, V20, P615, DOI 10.1038/s41577-020-00434-6; Juan J, 2020, ULTRASOUND OBST GYN, V56, P15, DOI 10.1002/uog.22088; Ki M, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020007; Kim J, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.03.052; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kramer CK, 2020, CAN J PUBLIC HEALTH, V111, P636, DOI 10.17269/s41997-020-00405-3; L'Angiocola Paolo Diego, 2020, Acta Biomed, V91, P35, DOI 10.23750/abm.v91i2.9575; Lamirande EW, 2008, J VIROL, V82, P7721, DOI 10.1128/JVI.00304-08; Lao Wilson P, 2020, World J Otorhinolaryngol Head Neck Surg, V6, pS22, DOI 10.1016/j.wjorl.2020.04.001; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Li ZQ, 2020, FRONT MED-PRC, V14, P533, DOI 10.1007/s11684-020-0786-5; Lin JT, 2007, ANTIVIR THER, V12, P1107; Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549; Liu STH, 2020, NAT MED, V26, P1708, DOI 10.1038/s41591-020-1088-9; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Ma J, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108408; Machhi J, 2020, J NEUROIMMUNE PHARM, V15, P359, DOI 10.1007/s11481-020-09944-5; Madjunkov M, 2020, J OVARIAN RES, V13, DOI 10.1186/s13048-020-00737-1; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Marshall M, 2020, NATURE, V585, P339, DOI 10.1038/d41586-020-02598-6; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; McCombs A, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008388; Melo Géssyca Cavalcante de, 2020, Cad. Saúde Pública, V36, pe00087320, DOI 10.1590/0102-311x00087320; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Mitra P, 2020, AM J PHYSIOL-CELL PH, V319, pC500, DOI 10.1152/ajpcell.00260.2020; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moreno-Fierros L, 2020, EXPERT OPIN BIOL TH, V20, P831, DOI 10.1080/14712598.2020.1767062; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022; Mukherjee R, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00040-7; Netea MG, 2020, CELL, V181, P969, DOI 10.1016/j.cell.2020.04.042; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Neuwirth C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76392-9; Niedzwiedz CL, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01640-8; Nikolich-Zugich J, 2020, GEROSCIENCE, V42, P505, DOI 10.1007/s11357-020-00186-0; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Novavax Inc, PIP IS ROB NOV; Ozveri H, 2020, UROL CASE REP, V33, DOI 10.1016/j.eucr.2020.101349; Padoan A, 2020, CLIN CHIM ACTA, V507, P164, DOI 10.1016/j.cca.2020.04.026; Padron-Regalado E, 2020, INFECT DIS THER, V9, P255, DOI 10.1007/s40121-020-00300-x; Pak A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00241; Pan F, 2020, FERTIL STERIL, V113, P1135, DOI 10.1016/j.fertnstert.2020.04.024; Port JR., 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, DOI 10.1038/s41586-020-2608-y]; Qiu L, 2020, CLIN INFECT DIS, V71, P813, DOI 10.1093/cid/ciaa375; Rastrelli G, 2021, ANDROLOGY-US, V9, P88, DOI 10.1111/andr.12821; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314; Roper RL, 2009, EXPERT REV VACCINES, V8, P887, DOI [10.1586/erv.09.43, 10.1586/ERV.09.43]; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Salvatori G, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02392-y; Sanchez-Ramon S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02936; Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0; Schuler BA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140766; See RH, 2006, J GEN VIROL, V87, P641, DOI 10.1099/vir.0.81579-0; Sharif-Askari NS, 2020, MOL THER-METH CLIN D, V18, P1, DOI 10.1016/j.omtm.2020.05.013; Sheraton M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8192; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Shim BS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-65; Singh R, 2021, FASEB J, V35, DOI 10.1096/fj.202002662R; Torres-Roman JS, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101689; Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0; Stavem K, 2021, THORAX, V76, P405, DOI 10.1136/thoraxjnl-2020-216377; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Swerdlow DL, 2020, JAMA-J AM MED ASSOC, V323, P1129, DOI 10.1001/jama.2020.1960; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V41, P145, DOI DOI 10.1056/NEJMcp2009249; Thieme CJ, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100092; Thierry AR, 2020, CLIN SCI, V134, P1295, DOI 10.1042/CS20200531; Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; Ueki H, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00637-20; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Valdes G, 2006, PLACENTA, V27, P200, DOI 10.1016/j.placenta.2005.02.015; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Vandenberg O, 2021, NAT REV MICROBIOL, V19, P171, DOI 10.1038/s41579-020-00461-z; Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang J, 2020, J LEUKOCYTE BIOL, V108, P17, DOI 10.1002/JLB.3COVR0520-272R; Wang M., 2020, CELL RES, V30, P269, DOI [DOI 10.1038/s41422-020-0282-0, 10.1038/s41422-020-0282-0, 10.1038/s41422-020-0282-02020]; Wang QX, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00325; Wang ZP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040920; Ward H., 2020, MEDRXIV, DOI [10.1101/2020.10.26.20219725, DOI 10.1101/2020.10.26.20219725, 2020.10.26.20219725]; Weerahandi Himali, 2020, medRxiv, DOI 10.1101/2020.08.11.20172742; Wei YY, 2020, J INFECTION, V81, pE89, DOI 10.1016/j.jinf.2020.04.010; WHO, 2020, WHO EM US LIST IN VI; WHO, 2020, COR COVID 19 EV THEY; WHO, CLIN MAN COVID 19; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wood Emily, 2021, Chronic Dis Transl Med, V7, P14, DOI 10.1016/j.cdtm.2020.11.002; World Health Organization, WHO COR DIS COVID 19; Wunsch H, 2020, AM J RESP CRIT CARE, V202, P1, DOI 10.1164/rccm.202004-1385ED; Xia SL, 2020, JAMA-J AM MED ASSOC, V324, P951, DOI 10.1001/jama.2020.15543; Xing Z, 2020, J LEUKOCYTE BIOL, V108, P825, DOI 10.1002/JLB.4MR0220-446R; Xiong S, 2004, IMMUNOL LETT, V95, P139, DOI 10.1016/j.imlet.2004.06.014; Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363; Xu J, 2006, BIOL REPROD, V74, P410, DOI 10.1095/biolreprod.105.044776; Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yan J, 2020, MOL HUM REPROD, V26, P367, DOI 10.1093/molehr/gaaa030; Yang Y, 2020, J MED VIROL, V92, P536, DOI 10.1002/jmv.25720; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Yilla M, 2005, VIRUS RES, V107, P93, DOI 10.1016/j.virusres.2004.09.004; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zakhartchouk AN, 2005, J GEN VIROL, V86, P211, DOI 10.1099/vir.0.80530-0; Zeng WH, 2020, BIOCHEM BIOPH RES CO, V527, P618, DOI 10.1016/j.bbrc.2020.04.136; Zeng Z, 2020, HISTOPATHOLOGY, V77, P823, DOI 10.1111/his.14138; Zhang J, 2020, CLIN MICROBIOL INFEC, V26, P767, DOI 10.1016/j.cmi.2020.04.012; Zhang L, 2015, EXPERT REV VACCINES, V14, P1509, DOI 10.1586/14760584.2015.1081067; Zhang PX, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0084-5; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhanga CH, 2005, VACCINE, V23, P3196, DOI 10.1016/j.vaccine.2004.11.073; Zhao YM, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100463; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou RH, 2020, IMMUNITY, V53, P864, DOI 10.1016/j.immuni.2020.07.026; Zhou W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0127-9; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	227	44	44	6	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21409	10.1096/fj.202002662R	http://dx.doi.org/10.1096/fj.202002662R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33577115	Green Published			2022-12-28	WOS:000629576700032
J	Vinette, V; Aubry, I; Insull, H; Uetani, N; Hardy, S; Tremblay, ML				Vinette, Valerie; Aubry, Isabelle; Insull, Hayley; Uetani, Noriko; Hardy, Serge; Tremblay, Michel L.			Protein tyrosine phosphatome metabolic screen identifies TC-PTP as a positive regulator of cancer cell bioenergetics and mitochondrial dynamics	FASEB JOURNAL			English	Article						cancer; metabolism; mitochondria; protein tyrosine phosphatases; PTPN2; TC-PTP	OXIDATIVE-PHOSPHORYLATION; INCREASED EXPRESSION; NEGATIVE REGULATOR; UP-REGULATION; STAT3; KINASE; PTEN; SRC; INITIATION; SURVIVAL	Metabolic reprogramming occurs in cancer cells and is regulated partly by the opposing actions of tyrosine kinases and tyrosine phosphatases. Several members of the protein tyrosine phosphatase (PTP) superfamily have been linked to cancer as either pro-oncogenic or tumor-suppressive enzymes. In order to investigate which PTPs can modulate the metabolic state of cancer cells, we performed an shRNA screen of PTPs in HCT116 human colorectal cancer cells. Among the 72 PTPs efficiently targeted, 24 were found to regulate mitochondrial respiration, 8 as negative and 16 as positive regulators. Of the latter, we selected TC-PTP (PTPN2) for further characterization since inhibition of this PTP resulted in major functional defects in oxidative metabolism without affecting glycolytic flux. Transmission electron microscopy revealed an increase in the number of damaged mitochondria in TC-PTP-null cells, demonstrating the potential role of this PTP in regulating mitochondrial homeostasis. Downregulation of STAT3 by siRNA-mediated silencing partially rescued the mitochondrial respiration defect observed in TC-PTP-deficient cells, supporting the role of this signaling axis in regulating mitochondrial activity. In addition, mitochondrial stress prevented an increased expression of electron transport chain-related genes in cells with TC-PTP silencing, correlating with decreased ATP production, cellular proliferation, and migration. Our shRNA-based metabolic screen revealed that PTPs can serve as either positive or negative regulators of cancer cell metabolism. Taken together, our findings uncover a new role for TC-PTP as an activator of mitochondrial metabolism, validating this PTP as a key target for cancer therapeutics.	[Vinette, Valerie; Aubry, Isabelle; Insull, Hayley; Uetani, Noriko; Hardy, Serge; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Vinette, Valerie; Aubry, Isabelle; Insull, Hayley; Uetani, Noriko; Hardy, Serge; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Vinette, Valerie] Weill Cornell Med, 413 E 69th St, New York, NY 10044 USA	McGill University; McGill University; Cornell University	Tremblay, ML (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca		Tremblay, Michel L./0000-0002-0281-541X	Faculty of Medicine, McGill University (McGill Faculty of Medicine); Fondation Jean-Louis Levesque (Fondation J Louis Levesque); Terry Fox Foundation [TFF-116128]; Government of Canada | Canadian Institutes of Health Research (CIHR) [FDN-159923]	Faculty of Medicine, McGill University (McGill Faculty of Medicine); Fondation Jean-Louis Levesque (Fondation J Louis Levesque); Terry Fox Foundation; Government of Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Faculty of Medicine, McGill University (McGill Faculty of Medicine); Fondation Jean-Louis Levesque (Fondation J Louis Levesque); Terry Fox Foundation, Grant/Award Number: TFF-116128; Government of Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: FDN-159923	Alonso A, 2016, METHODS MOL BIOL, V1447, P1, DOI 10.1007/978-1-4939-3746-2_1; Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Bourke Lauren T, 2013, JAKSTAT, V2, pe25666, DOI 10.4161/jkst.25666; Boyle KA, 2018, J BIOL CHEM, V293, P14891, DOI 10.1074/jbc.RA117.001469; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chatelain EH, 2011, CELL MOL LIFE SCI, V68, P2603, DOI 10.1007/s00018-010-0573-6; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Daw CC, 2020, CELL, V183, P474, DOI 10.1016/j.cell.2020.08.049; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Deng JW, 2018, P NATL ACAD SCI USA, V115, pE9678, DOI 10.1073/pnas.1806655115; Denisenko TV, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00355; Fetalvero KM, 2013, MOL CELL BIOL, V33, P98, DOI 10.1128/MCB.01075-12; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang L, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1186-z; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Katkeviciute E, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140281; LaFleur MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09656-2; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Lim S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0089-3; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lu HQ, 2018, CANCER RES, V78, P4191, DOI 10.1158/0008-5472.CAN-18-0270; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; Macias E, 2014, J INVEST DERMATOL, V134, P1971, DOI 10.1038/jid.2014.68; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Meier JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2588; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moreno-Beltran B, 2017, P NATL ACAD SCI USA, V114, pE3041, DOI 10.1073/pnas.1618008114; Nemani N, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz6206; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Patra M, 2016, J CELL SCI, V129, P2841, DOI 10.1242/jcs.186247; Penafuerte C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1321185; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Poliakova M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0798-9; Robert F, 2014, P NATL ACAD SCI USA, V111, P13421, DOI 10.1073/pnas.1402650111; Rodriguez-Hernandez MA, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101510; Rosini P, 2004, J BIOL CHEM, V279, P14016, DOI 10.1074/jbc.M305356200; Russell S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15325-5; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Scharl M, 2012, INFLAMM BOWEL DIS, V18, P1287, DOI 10.1002/ibd.21891; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Simoncic PD, 2006, MOL CELL BIOL, V26, P4149, DOI 10.1128/MCB.01932-05; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sisler JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144444; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tronchere H, 2012, CLIN LIPIDOL, V7, P151, DOI 10.2217/CLP.12.7; Tsou RC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00192; Untereiner AA, 2017, BIOCHEM PHARMACOL, V136, P86, DOI 10.1016/j.bcp.2017.03.025; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Voet D., 2004, BIOCHEMISTRY-US, V3; Wallace L, 2016, TUMOR BIOL, V37, P12465, DOI 10.1007/s13277-016-5101-3; Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wei YJ, 2020, CANCER MANAG RES, V12, P2097, DOI 10.2147/CMAR.S240040; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zaytseva YY, 2015, ONCOTARGET, V6, P18891, DOI 10.18632/oncotarget.3783; Zheng BA, 2014, SCI WORLD J, DOI 10.1155/2014/703804; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5	75	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21708	10.1096/fj.202100207R	http://dx.doi.org/10.1096/fj.202100207R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34169549				2022-12-28	WOS:000667814100025
J	Zhang, YQ; Shen, WJ; Qiu, S; Yang, PL; Dempsey, G; Zhao, L; Zhou, Q; Hao, X; Dong, DC; Stahl, A; Kraemer, FB; Leung, LL; Morser, J				Zhang, Yiqiang; Shen, Wen-Jun; Qiu, Shuo; Yang, Pinglin; Dempsey, Garrett; Zhao, Lei; Zhou, Qin; Hao, Xiao; Dong, Dachuan; Stahl, Andreas; Kraemer, Fredric B.; Leung, Lawrence L.; Morser, John			Chemerin regulates formation and function of brown adipose tissue: Ablation results in increased insulin resistance with high fat challenge and aging	FASEB JOURNAL			English	Article						adipocytes; adipokines; chemerin; energy balance	WHITE; ADIPOGENESIS; ADIPOCYTES; COAGULATION; ACTIVATION; ADIPOKINE; PROTEIN; OBESITY; CELLS	Apart from its role in inflammation and immunity, chemerin is also involved in white adipocyte biology. To study the role of chemerin in adipocyte metabolism, we examined the function of chemerin in brown adipose tissue. Brown and white adipocyte precursors were differentiated into adipocytes in the presence of Chemerin siRNA. Chemerin-deficient (Chem(-/-)) mice were compared to wild-type mice when fed a high-fat diet. Chemerin is expressed during brown adipocyte differentiation and knock down of chemerin mRNA results in decreased brown adipocyte differentiation with reduced fatty acid uptake in brown adipocytes. Chem(-/-) mice are leaner than wild-type mice but gain more weight when challenged with high-fat diet feeding, resulting in a larger increase in fat deposition. Chem(-/-) mice develop insulin resistance when on a high-fat diet or due to age. Brown adipose depots in Chem(-/-) mice weigh more than in wild-type mice, but with decreased mitochondrial content and function. Compared to wild-type mice, male Chem(-/-) mice have decreased oxygen consumption, CO2 production, energy expenditure, and a lower respiratory exchange ratio. Additionally, body temperature of Chem(-/-) mice is lower than that of wild-type mice. These results revealed that chemerin is expressed during brown adipocyte differentiation and has a pivotal role in energy metabolism through brown adipose tissue thermogenesis.	[Zhang, Yiqiang; Shen, Wen-Jun; Qiu, Shuo; Yang, Pinglin; Hao, Xiao; Dong, Dachuan; Kraemer, Fredric B.] Stanford Univ, Dept Med, Div Endocrinol, Sch Med, Stanford, CA 94305 USA; [Zhang, Yiqiang; Shen, Wen-Jun; Qiu, Shuo; Yang, Pinglin; Zhao, Lei; Zhou, Qin; Hao, Xiao; Dong, Dachuan; Kraemer, Fredric B.; Leung, Lawrence L.; Morser, John] Vet Affairs Palo Alto Hlth Care Syst, Bldg 101-4A131,3801 Miranda Ave, Palo Alto, CA 94304 USA; [Zhang, Yiqiang] Changzhi Med Coll, Dept Biochem, Changzhi, Peoples R China; [Yang, Pinglin] Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 2, Xian, Peoples R China; [Dempsey, Garrett; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Zhao, Lei; Zhou, Qin; Leung, Lawrence L.; Morser, John] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA; [Hao, Xiao] Zhengzhou Univ, Dept Endocrinol, Affiliated Hosp 1, Med Coll, Zhengzhou, Peoples R China	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Changzhi Medical College; Xi'an Jiaotong University; University of California System; University of California Berkeley; Stanford University; Zhengzhou University	Shen, WJ; Morser, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Bldg 101-4A131,3801 Miranda Ave, Palo Alto, CA 94304 USA.	wen-jun@stanford.edu; jmorser@stanford.edu		Kraemer, Fredric/0000-0003-2468-7807	U.S. Department of Veterans Affairs (VA) [I01BX001959, I01BX000398]; SU | School of Medicine, Stanford University (Stanford University School of Medicine); HHS | National Institutes of Health (NIH) [P30DK116074]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); SU | School of Medicine, Stanford University (Stanford University School of Medicine); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX001959; SU | School of Medicine, Stanford University (Stanford University School of Medicine); U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX000398; HHS | National Institutes of Health (NIH), Grant/Award Number: P30DK116074	Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chang SS, 2016, OBESITY, V24, P1522, DOI 10.1002/oby.21534; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; De Henau O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164179; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Ge XM, 2018, BLOOD, V131, P353, DOI 10.1182/blood-2017-07-792580; Giordano A, 2014, EUR J ENDOCRINOL, V170, pR159, DOI 10.1530/EJE-13-0945; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; Lorincz H, 2014, CLIN ENDOCRINOL, V81, P370, DOI 10.1111/cen.12363; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Parlee SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051072; Rhee EJ, 2011, DIABETES METAB J, V35, P216, DOI 10.4093/dmj.2011.35.3.216; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Rourke JL, 2014, J ENDOCRINOL, V222, P201, DOI 10.1530/JOE-14-0069; SBARBATI A, 1991, INT J OBESITY, V15, P581; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shin HY, 2012, CLIN ENDOCRINOL, V77, P47, DOI 10.1111/j.1365-2265.2011.04217.x; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zhao L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202780; Zhao L, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1615-y; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	38	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21687	10.1096/fj.202100156R	http://dx.doi.org/10.1096/fj.202100156R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34089273	Green Accepted			2022-12-28	WOS:000667814100053
J	Guo, HL; Ni, MM; Xu, J; Chen, F; Yao, ZY; Yao, YQ; Liu, C; Du, QM				Guo, Hongli; Ni, Mingming; Xu, Jing; Chen, Feng; Yao, Zhaoying; Yao, Yiqin; Liu, Chao; Du, Qianming			Transcriptional enhancement of GBP-5 by BATF aggravates sepsis-associated liver injury via NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						acute liver injury; BATF; GBP-5; inflammation; NLRP3 inflammasome	INTERFERON-INDUCIBLE GTPASES; GUANYLATE-BINDING PROTEINS	Strong inflammatory response triggered by the activation of the innate immune system is one typical characteristic of sepsis-associated liver injury (SALI). Guanylate-binding protein 5 (GBP-5) is a component of cell-autonomous immunity and known to be associated with inflammation. Currently, whether GBP-5 participates in SALI and its roles in this disease are yet to be investigated. Using a lipopolysaccharide (LPS)-induced SALI mouse model, we found GBP-5 was highly expressed in LPS-treated mice, and its expression was tightly related to the serum concentrations of live injury markers and inflammatory cytokines, liver damage scores by H&E staining, and amounts of apoptotic hepatocytes by TUNEL staining. Moreover, GBP-5 overexpression was found to aggravate LPS-induced SALI by promoting the activation of NLR family pyrin domain containing 3 (NLRP3) inflammasome, then facilitated the production of pro-inflammatory cytokines, eventually induced hepatocyte cell death. Direct transcriptional activation of GBP-5 by basic leucine zipper ATF-like transcription factor (BATF) was identified and further validated. This study unveils a transcriptional upregulation of GBP-5 by interacting with BATF, which promotes the progression of LPS-induced SALI through NLRP3 inflammasome activation, and provides novel therapeutic insights for halting the progression of liver injury in various liver diseases.	[Guo, Hongli; Ni, Mingming; Xu, Jing; Chen, Feng] Nanjing Med Univ, Dept Pharm, Childrens Hosp, 72 Guanzhou Rd, Nanjing 210008, Peoples R China; [Du, Qianming] Nanjing Med Univ, Nanjing First Hosp, Gen Clin Res Ctr, 68 Changle Rd, Nanjing 210006, Peoples R China; [Liu, Chao] Nanjing Med Univ, Nanjing First Hosp, Dept Pharm, Nanjing, Peoples R China; [Yao, Zhaoying; Liu, Chao; Du, Qianming] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Nanjing, Peoples R China; [Yao, Yiqin] Xinjiang Med Univ, Coll Pharm, Urumqi, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; China Pharmaceutical University; Xinjiang Medical University	Guo, HL (corresponding author), Nanjing Med Univ, Dept Pharm, Childrens Hosp, 72 Guanzhou Rd, Nanjing 210008, Peoples R China.; Du, QM (corresponding author), Nanjing Med Univ, Nanjing First Hosp, Gen Clin Res Ctr, 68 Changle Rd, Nanjing 210006, Peoples R China.	guohongli@njmu.edu.cn; duqianming@njmu.edu.cn	Ming-ming, Ni/AAD-1301-2022	Ming-ming, Ni/0000-0003-3809-0614; Guo, Hongli/0000-0002-6660-8145	National Natural Science Foundation of China [81800530]; Natural Science Foundation of Jiangsu Province [BK20170149]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	National Natural Science Foundation of China, Grant/Award Number: 81800530; Natural Science Foundation of Jiangsu Province, Grant/Award Number: BK20170149	Alvisi G, 2020, J CLIN INVEST, V130, P3137, DOI 10.1172/JCI130426; Bian XB, 2019, J SCI FOOD AGR, V99, P3283, DOI 10.1002/jsfa.9541; Cerqueira DM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007519; Chen LY, 2019, DIGEST DIS SCI, V64, P773, DOI 10.1007/s10620-018-5392-x; Chen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044890; Cho HI, 2016, BRIT J PHARMACOL, V173, P980, DOI 10.1111/bph.13397; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; Fellenberg F, 2004, J INVEST DERMATOL, V122, P1510, DOI 10.1111/j.0022-202X.2004.22613.x; Finethy R, 2017, MBIO, V8, DOI 10.1128/mBio.01188-17; Fujiwara Y, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.59; Groslambert M, 2018, J INFLAMM RES, V11, P359, DOI 10.2147/JIR.S141220; Inzaugarat ME, 2019, HEPATOLOGY, V69, P845, DOI 10.1002/hep.30252; Jiang ZY, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/5871431; Jimenez-Castro MB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101131; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu EH, 2020, J BIOL REG HOMEOS AG, V34, P1719, DOI 10.23812/20-326-A; Liu LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121383; Liu Q, 2020, ACTA PHARMACOL SIN, V41, P771, DOI 10.1038/s41401-019-0335-4; Luan JY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02201; Meunier E, 2016, CELL MICROBIOL, V18, P168, DOI 10.1111/cmi.12546; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Punkenburg E, 2016, GUT, V65, P1139, DOI 10.1136/gutjnl-2014-308227; Sakai N, 2012, J GASTROEN HEPATOL, V27, P1609, DOI 10.1111/j.1440-1746.2012.07187.x; Shao BZ, 2019, INFLAMMATION, V42, P1147, DOI 10.1007/s10753-019-01008-y; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; 't Hart NA, 2004, AM J TRANSPLANT, V4, P1836, DOI 10.1111/j.1600-6143.2004.00580.x; Wang LY, 2018, CLIN EXP MED, V18, P263, DOI 10.1007/s10238-017-0480-3; Woznica EA, 2018, ADV CLIN EXP MED, V27, P547, DOI 10.17219/acem/68363; Yan J, 2014, INT REV IMMUNOL, V33, P498, DOI 10.3109/08830185.2014.889129; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	34	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21672	10.1096/fj.202100234R	http://dx.doi.org/10.1096/fj.202100234R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042221				2022-12-28	WOS:000655695900038
J	Park, YH; Woo, SJ; Chungu, K; Lee, SB; Shim, JH; Lee, HJ; Kim, I; Rengaraj, D; Song, CS; Suh, JY; Lim, JM; Han, JY				Park, Young Hyun; Woo, Seung Je; Chungu, Kelly; Lee, Su Bin; Shim, Ji Hyeon; Lee, Hong Jo; Kim, Iktae; Rengaraj, Deivendran; Song, Chang-Seon; Suh, Jeong-Yong; Lim, Jeong Mook; Han, Jae Yong			Asp149 and Asp152 in chicken and human ANP32A play an essential role in the interaction with influenza viral polymerase	FASEB JOURNAL			English	Article						ANP32A; host factor; influenza virus; precise genome editing; protein&#8208; protein interaction	GENOME; PROTEINS	The acidic nuclear phosphoprotein 32 family member A (ANP32A) is a cellular host factor that determines the host tropism of the viral polymerase (vPol) of avian influenza viruses (AIVs). Compared with human ANP32A (hANP32A), chicken ANP32A contains an additional 33 amino acid residues (176-208) duplicated from amino acid residues 149-175 (27 residues), suggesting that these residues could be involved in increasing vPol activity by strengthening interactions between ANP32A and vPol. However, the molecular interactions and functional roles of the 27 residues within hANP32A during AIV vPol activity remain unclear. Here, we examined the functional role of 27 residues of hANP32A based on comparisons with other human (h) ANP32 family members. It was notable that unlike hANP32A and hANP32B, hANP32C could not support vPol activity or replication of AIVs, despite the fact that hANP32C shares a higher sequence identity with hANP32A than hANP32B. Pairwise comparison between hANP32A and hANP32C revealed that Asp149 (D149) and Asp152 (D152) are involved in hydrogen bonding and electrostatic interactions, respectively, which support vPol activity. Mutation of these residues reduced the interaction between hANP32A and vPol. Finally, we demonstrated that precise substitution of the identified residues within chicken ANP32A via homology-directed repair using the CRISPR/Cas9 system resulted in a marked reduction of viral replication in chicken cells. These results increase our understanding of ANP32A function and may facilitate the development of AIV-resistant chickens via precise modification of residues within ANP32A.	[Park, Young Hyun; Woo, Seung Je; Chungu, Kelly; Lee, Su Bin; Shim, Ji Hyeon; Lee, Hong Jo; Kim, Iktae; Rengaraj, Deivendran; Suh, Jeong-Yong; Lim, Jeong Mook; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea; [Park, Young Hyun; Woo, Seung Je; Chungu, Kelly; Lee, Su Bin; Shim, Ji Hyeon; Lee, Hong Jo; Kim, Iktae; Rengaraj, Deivendran; Suh, Jeong-Yong; Lim, Jeong Mook; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Song, Chang-Seon] Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Konkuk University	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Rengaraj, Deivendran/C-5593-2015	Rengaraj, Deivendran/0000-0001-9274-9921	National Research Foundation of Korea (NRF) [2015R1A3A2033826]; BK21 FOUR Program of the Department of Agricultural Biotechnology, Seoul National University	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); BK21 FOUR Program of the Department of Agricultural Biotechnology, Seoul National University	National Research Foundation of Korea (NRF), Grant/Award Number: 2015R1A3A2033826; BK21 FOUR Program of the Department of Agricultural Biotechnology, Seoul National University	Baker SF, 2018, CELL REP, V24, P2581, DOI 10.1016/j.celrep.2018.08.012; Domingues P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11388-2; Domingues P, 2017, CELL REP, V20, P2538, DOI 10.1016/j.celrep.2017.08.061; GILLES H-J, 1974, European Journal of Toxicology and Environmental Hygiene, V7, P77; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0234-4; Hutchinson EC, 2013, VIRUSES-BASEL, V5, P2424, DOI 10.3390/v5102424; JACKSON DA, 1982, NATURE, V296, P366, DOI 10.1038/296366a0; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lee HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112245; Lee HJ, 2017, DEV COMP IMMUNOL, V77, P340, DOI 10.1016/j.dci.2017.09.006; Long JS, 2019, ELIFE, V8, DOI 10.7554/eLife.45066; Long JS, 2019, NAT REV MICROBIOL, V17, P67, DOI 10.1038/s41579-018-0115-z; Long JS, 2016, NATURE, V529, P101, DOI 10.1038/nature16474; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Park YH, 2020, J INFECT DIS, V221, P71, DOI 10.1093/infdis/jiz506; Reilly PT, 2014, BIOESSAYS, V36, P1062, DOI 10.1002/bies.201400058; Shinya K, 2009, J VIROL, V83, P13015, DOI 10.1128/JVI.01714-09; Sid H, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00456; Staller E, 2019, J VIROL, V93, DOI 10.1128/JVI.00217-19; Sugiyama K, 2015, ELIFE, V4, DOI 10.7554/eLife.08939; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; te Velthuis AJW, 2016, NAT REV MICROBIOL, V14, P479, DOI 10.1038/nrmicro.2016.87; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Wei XL, 2019, ARCH VIROL, V164, P787, DOI 10.1007/s00705-018-04139-z; Zhang HL, 2019, J VIROL, V93, DOI 10.1128/JVI.00174-19; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8	26	2	2	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21630	10.1096/fj.202002006RR	http://dx.doi.org/10.1096/fj.202002006RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33982347				2022-12-28	WOS:000655695900035
J	Wang, XL; Liu, D; Wang, Z; Cai, C; Jiang, H; Yu, GL				Wang, Xueliang; Liu, Di; Wang, Zhe; Cai, Chao; Jiang, Hao; Yu, Guangli			Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice	FASEB JOURNAL			English	Article						cecal microbiota; insulin signaling pathway; nonalcoholic fatty liver disease; oxidative stress; porphyran&#8208; derived oligosaccharides	FATTY LIVER-DISEASE; OXIDATIVE STRESS; INSULIN-RESISTANCE; GUT MICROBIOTA; ADIPOSE-TISSUE; LIPID-PEROXIDATION; ENERGY-METABOLISM; OBESITY; INFLAMMATION; FIBROSIS	Porphyran and its derivatives possess a variety of biological activities, such as ameliorations of oxidative stress, inflammation, hyperlipemia, and immune deficiencies. In this study, we evaluated the potential efficacy of porphyran-derived oligosaccharides from Porphyra yezoensis (PYOs) in alleviating nonalcoholic fatty liver disease (NAFLD) and preliminarily clarified the underlying mechanism. NAFLD was induced by a high-fat diet for six months in C57BL/6J mice, followed by treatment with PYOs (100 or 300 mg/kg/d) for another six weeks. We found that PYOs reduced hepatic oxidative stress in mice with NAFLD, which plays a critical role in the occurrence and development of NAFLD. In addition, PYOs could markedly decrease lipid accumulation in liver by activating the IRS-1/AKT/GSK-3 beta signaling pathway and the AMPK signaling pathway in mice with NAFLD. PYOs also apparently relieved the hepatic fibrosis induced by oxidative stress via downregulation of TGF-beta and its related proteins, so that liver injury was markedly alleviated. Furthermore, PYOs treatment relieved cecal microbiota dysbiosis (such as increasing the relative abundance of Akkermansia, while decreasing the Helicobacter abundance), which could alleviate oxidative stress, inflammation, and lipid metabolism, and protect the liver to a certain degree. In summary, PYOs treatment remarkably improved NAFLD via a specific molecular mechanism and reshaped the cecal microbiota.	[Wang, Xueliang; Liu, Di; Wang, Zhe; Cai, Chao; Jiang, Hao; Yu, Guangli] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Shandong Prov Key Lab Glycosci & Glycotechnol,Min, Qingdao 266003, Peoples R China; [Wang, Xueliang; Liu, Di; Wang, Zhe; Cai, Chao; Jiang, Hao; Yu, Guangli] Pilot Natl Lab Marine Sci & Technol Qingdao, Lab Marine Drugs & Bioproducts, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Jiang, H; Yu, GL (corresponding author), Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Shandong Prov Key Lab Glycosci & Glycotechnol,Min, Qingdao 266003, Peoples R China.	haojiang@ouc.edu.cn; haojiang@ouc.edu.cn			National Natural Science Foundation of China [81991522, 81402982, 21807094, 31670811]; National Science and Technology Major Project of China [2018ZX09735-004]; NSFC-Shandong Joint Fund for Marine Science Research Centers [U1606403]; Shandong Provincial Major Science and Technology Innovation Project [2018SDKJ0404]; Natural Science Foundation of Shandong Province [ZR2017BC007]; Taishan Scholar Climbing Project [TSPD20210304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; NSFC-Shandong Joint Fund for Marine Science Research Centers; Shandong Provincial Major Science and Technology Innovation Project; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Taishan Scholar Climbing Project	National Natural Science Foundation of China, Grant/Award Number: 81991522, 81402982, 21807094 and 31670811; National Science and Technology Major Project of China, Grant/Award Number: 2018ZX09735-004; NSFC-Shandong Joint Fund for Marine Science Research Centers, Grant/Award Number: U1606403; Shandong Provincial Major Science and Technology Innovation Project, Grant/Award Number: 2018SDKJ0404; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2017BC007; Taishan Scholar Climbing Project, Grant/Award Number: TSPD20210304	Abrams GA, 2004, HEPATOLOGY, V40, P475, DOI 10.1002/hep.20323; Al-Lahham R, 2016, MOL CELL ENDOCRINOL, V419, P1, DOI 10.1016/j.mce.2015.09.013; Arrese M, 2016, DIGEST DIS SCI, V61, P1294, DOI 10.1007/s10620-016-4049-x; Arslan N, 2014, WORLD J GASTROENTERO, V20, P16452, DOI 10.3748/wjg.v20.i44.16452; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAI CL, 1992, TOXICOLOGY, V75, P221; Baroni GS, 1998, HEPATOLOGY, V27, P720; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Bhatia S, 2013, INT J BIOL MACROMOL, V57, P50, DOI 10.1016/j.ijbiomac.2013.03.012; Boursier J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004559; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cao J, 2016, J APPL PHYCOL, V28, P1315, DOI 10.1007/s10811-015-0637-y; Castano-Rodriguez N, 2017, BEST PRACT RES CL GA, V31, P657, DOI 10.1016/j.bpg.2017.09.008; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494; Chen CX, 2017, APPL PHYSIOL NUTR ME, V42, P295, DOI 10.1139/apnm-2016-0499; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Choudhary NS, 2012, ANN HEPATOL, V11, P478, DOI 10.1016/S1665-2681(19)31461-9; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Drew L, 2017, NATURE, V550, pS101, DOI 10.1038/550S101a; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ferolla SM, 2014, NUTRIENTS, V6, P5583, DOI 10.3390/nu6125583; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Flores-Costa R, 2018, BRIT J PHARMACOL, V175, P953, DOI 10.1111/bph.14137; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Gong GP, 2018, PROCESS BIOCHEM, V74, P185, DOI 10.1016/j.procbio.2018.05.022; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Henriksen BS, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-29; HYDER MA, 2013, EUR J EXP BIOL, V3, P280; Isaka S, 2015, INT J BIOL MACROMOL, V74, P68, DOI 10.1016/j.ijbiomac.2014.11.043; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P943, DOI 10.1016/j.bbadis.2018.06.023; Jang BK, 2012, CLIN MOL HEPATOL, V18, P357, DOI 10.3350/cmh.2012.18.4.357; Jarrar MH, 2008, ALIMENT PHARM THER, V27, P412, DOI 10.1111/j.1365-2036.2007.03586.x; Jiao N, 2018, GUT, V67, P1881, DOI 10.1136/gutjnl-2017-314307; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; KRAL JG, 1993, METABOLISM, V42, P548, DOI 10.1016/0026-0495(93)90210-F; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; LeBlanc JG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0691-z; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li S, 2017, CARBOHYD POLYM, V173, P330, DOI 10.1016/j.carbpol.2017.05.063; Li Y, 2013, ENDOCRINE, V43, P376, DOI 10.1007/s12020-012-9761-5; Ling J R, 2018, Zhonghua Er Ke Za Zhi, V56, P850, DOI 10.3760/cma.j.issn.0578-1310.2018.11.011; Liu HL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091298; Liu YJ, 2018, MAR DRUGS, V16, DOI 10.3390/md16030082; Magrone T, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-31; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Miele L, 2013, CURR PHARM DESIGN, V19, P5314, DOI 10.2174/1381612811319290011; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030; Mota M, 2016, METABOLISM, V65, P1049, DOI 10.1016/j.metabol.2016.02.014; Musso G, 2012, HEPATOLOGY, V56, P933, DOI 10.1002/hep.25739; Natsume M, 1999, J LEUKOCYTE BIOL, V66, P601, DOI 10.1002/jlb.66.4.601; Nishikawa T, 2007, DIABETES RES CLIN PR, V77, pS161, DOI 10.1016/j.diabres.2007.01.071; Pan MH, 2014, MOL NUTR FOOD RES, V58, P147, DOI 10.1002/mnfr.201300522; Parola M, 1996, FREE RADICAL BIO MED, V20, P351, DOI 10.1016/0891-5849(96)02055-2; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; Perluigi M, 2012, ANTIOXID REDOX SIGN, V17, P1590, DOI 10.1089/ars.2011.4406; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Qian L, 2014, INT J BIOL MACROMOL, V68, P48, DOI 10.1016/j.ijbiomac.2014.04.004; Sahuri-Arisoylu M, 2016, INT J OBESITY, V40, P955, DOI 10.1038/ijo.2016.23; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Serviddio G, 2013, FREE RADICAL BIO MED, V65, P952, DOI 10.1016/j.freeradbiomed.2013.08.174; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Torres DM, 2012, CLIN GASTROENTEROL H, V10, P837, DOI 10.1016/j.cgh.2012.03.011; Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001; Wang XM, 2017, CARBOHYD POLYM, V174, P417, DOI 10.1016/j.carbpol.2017.06.040; Wang XL, 2020, CARBOHYD POLYM, V229, DOI 10.1016/j.carbpol.2019.115482; Wang XL, 2018, CARBOHYD POLYM, V195, P601, DOI 10.1016/j.carbpol.2018.05.003; Wang Y, 2016, EUR J PHARM SCI, V93, P123, DOI 10.1016/j.ejps.2016.08.017; Wieland A, 2015, ALIMENT PHARM THER, V42, P1051, DOI 10.1111/apt.13376; Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019; Yuan Y, 2019, FOOD CHEM TOXICOL, V125, P333, DOI 10.1016/j.fct.2019.01.007; Zhang TH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081055; Zhang X, 2021, GUT, V70, P761, DOI 10.1136/gutjnl-2019-319664; Zhang ZS, 2009, CARBOHYD POLYM, V78, P449, DOI 10.1016/j.carbpol.2009.04.026; Zheng YY, 2018, INT J BIOL MACROMOL, V112, P929, DOI 10.1016/j.ijbiomac.2018.02.072	86	6	6	6	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21458	10.1096/fj.202000763RRR	http://dx.doi.org/10.1096/fj.202000763RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33948987				2022-12-28	WOS:000655695900031
J	Yang, CC; Sung, PH; Chiang, JY; Chai, HT; Chen, CH; Chu, YC; Li, YC; Yip, HK				Yang, Chih-Chao; Sung, Pei-Hsun; Chiang, John Y.; Chai, Han-Tan; Chen, Chih-Hung; Chu, Yi-Ching; Li, Yi-Chen; Yip, Hon-Kan			Combined tacrolimus and melatonin effectively protected kidney against acute ischemia-reperfusion injury	FASEB JOURNAL			English	Article						acute kidney injury; inflammation; kidney ischemia-reperfusion; melatonin; oxidative stress; tacrolimus	CRITICALLY-ILL PATIENTS; MESENCHYMAL STEM-CELL; ACUTE-RENAL-FAILURE; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; HOSPITALIZED-PATIENTS; RIFLE CRITERIA; SEPSIS; CARE; THERAPY	Acute kidney injury (AKI) is commonly encountered and causes high mortality in hospitalized patients; however, effective therapies for AKI have still not been established. Accordingly, we performed a rodent model with acute renal ischemia-reperfusion (IR) and tested the hypothesis that combined tacrolimus and melatonin therapy could be superior to either one for protecting the kidney against IR injury. Adult-male SD rat (n = 30) were equally categorized into group 1 (receiving laparotomy only), group 2 (IR treated by 3.0 cc/normal-saline), group 3 [IR + tacrolimus/0.5 mg/kg by intravenous administration at 30 minutes and at days 1/2/3 after IR], group 4 (IR + melatonin/50 mg/kg by intra-peritoneal administration at 30 minutes and 25 mg/kg at days 1/2/3 after IR] and group 5 (IR + tacrolimus +melatonin). By day 3 after IR, the creatinine/BUN levels and ratio of urine protein to urine creatinine were highest in group 2, lowest in group 1 and significantly lower in group 5 than in groups 3/4 (all P < .0001), but they did not differ between the groups 3/4. The protein expressions of oxidative-stress (p47phox/NOX-1/NOX-2/NOX-4), upstream (TLR4/MAL/MyD88/TRAF6/ASK1/MKK4/MKK7/NF-kappa B) and downstream (IL-6/INF-gamma/MMP-9/IL-1ss) inflammatory signaling, MAPK-family-signaling cascades(ERK1/2, JNK/p38/c-JUN), apoptotic/autophagic (p53/caspase 3/mitochondrial-Bax, ratio of LC3B-II/LC3B-I), and mitochondrial-damaged (cyclophilin D/cytochrome C/DRP1) biomarkers, and the expressions of inflammatory-immune cells (F4/80, CD14/CD3/CD8) as well as the kidney injured score exhibited an identical pattern of creatinine level (all P < .0001). In conclusion, combined tacrolimus and melatonin therapy was better than either single one on protecting the kidney functional and anatomical integrity against IR injury through suppressing inflammation and the generation of oxidative stress.	[Yang, Chih-Chao] Kaohsiung Chang Gung Mem Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Yang, Chih-Chao; Sung, Pei-Hsun; Chai, Han-Tan; Chen, Chih-Hung; Chu, Yi-Ching; Li, Yi-Chen; Yip, Hon-Kan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Sung, Pei-Hsun; Chai, Han-Tan; Chu, Yi-Ching; Li, Yi-Chen; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, 123 Ta Pei Rd, Kaohsiung, Taiwan; [Sung, Pei-Hsun; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan; [Sung, Pei-Hsun; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan; [Chiang, John Y.] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan; [Chiang, John Y.] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Chen, Chih-Hung] Kaohsiung Chang Gung Mem Hosp, Div Gen Med, Dept Internal Med, Kaohsiung, Taiwan; [Yip, Hon-Kan] Asia Univ, Dept Nursing, Taichung, Taiwan; [Yip, Hon-Kan] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yip, Hon-Kan] Xiamen Chang Gung Hosp, Dept Internal Med, Div Cardiol, Xiamen, Peoples R China	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Li, YC; Yip, HK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, 123 Ta Pei Rd, Kaohsiung, Taiwan.	han.gung@msa.hinet.net; han.gung@msa.hinet.net		Sung, Pei-Hsun/0000-0002-1989-9752; Yip, Hon-Kan/0000-0002-6305-5717	Chang Gung Memorial Hospital, Chang Gung University [CMRPG8H0741]	Chang Gung Memorial Hospital, Chang Gung University(Chang Gung Memorial Hospital)	This study was supported by a program grant from Chang Gung Memorial Hospital, Chang Gung University (Grant number: CMRPG8H0741).	Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Chen HH, 2016, J PINEAL RES, V61, P52, DOI 10.1111/jpi.12326; Chen HH, 2014, J PINEAL RES, V57, P16, DOI 10.1111/jpi.12140; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Chen YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-270; Chen YT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt212; Clec'h C, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-31; Damman J, 2011, AM J TRANSPLANT, V11, P660, DOI 10.1111/j.1600-6143.2011.03475.x; Fernandez A, 2015, J PINEAL RES, V59, P292, DOI 10.1111/jpi.12264; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garcia JJ, 2014, J PINEAL RES, V56, P225, DOI 10.1111/jpi.12128; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Jin SA, 2016, TRANSPL P, V48, P199, DOI 10.1016/j.transproceed.2015.12.018; Jones SL, 2013, NEPHROL DIAL TRANSPL, V28, P1186, DOI 10.1093/ndt/gft015; Joslin J, 2015, CLIN MED, V15, P431, DOI 10.7861/clinmedicine.15-5-431; Kang JW, 2011, J PINEAL RES, V50, P403, DOI 10.1111/j.1600-079X.2011.00858.x; Kim MH, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0008-x; Li YJ, 2015, CELL PHYSIOL BIOCHEM, V37, P14, DOI 10.1159/000430329; Mesropian PD, 2016, NEPHROLOGY, V21, P729, DOI 10.1111/nep.12751; Moriyama T, 2016, J SURG RES, V201, P213, DOI 10.1016/j.jss.2015.10.036; Pickering JW, 2015, AM J KIDNEY DIS, V65, P283, DOI 10.1053/j.ajkd.2014.09.008; Rajapakse S, 2009, SAUDI J KIDNEY DIS T, V20, P553; RATYCH R E, 1986, Journal of Free Radicals in Biology and Medicine, V2, P311, DOI 10.1016/S0748-5514(86)80030-7; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Sheu JJ, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-82; Sun CK, 2017, AM J TRANSL RES, V9, P1543; Sun CK, 2015, J PINEAL RES, V58, P137, DOI 10.1111/jpi.12199; Sung PH, 2018, ONCOTARGET, V9, P3531, DOI 10.18632/oncotarget.23180; Sung PH., 2020, ACTA CARDIOL SIN, V39, P689; Tapper EB, 2016, AM J MED, V129, P461, DOI 10.1016/j.amjmed.2015.12.006; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; UK National Clinical Guideline Centre, 2013, ACUTE KIDNEY INJURY; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713; Yang CH, 2013, J ATHEROSCLER THROMB, V20, P9, DOI 10.5551/jat.14316; Yang JH, 2020, FASEB J, V34, P12324, DOI 10.1096/fj.202001252R; ZAGER RA, 1992, CIRC RES, V70, P20, DOI 10.1161/01.RES.70.1.20; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhao HY, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8219287	41	2	3	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21661	10.1096/fj.202100174R	http://dx.doi.org/10.1096/fj.202100174R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34029398	hybrid			2022-12-28	WOS:000655695900017
J	Degauque, N; Haziot, A; Brouard, S; Mooney, N				Degauque, Nicolas; Haziot, Alain; Brouard, Sophie; Mooney, Nuala			Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection	FASEB JOURNAL			English	Review						COVID-19; inflammation; immunomodulation	ACUTE RESPIRATORY SYNDROME; REGULATORY T-CELLS; SARS-CORONAVIRUS; IL-6; REPLICATION; RECEPTOR; PROTEIN; ACTIVATION; MIGRATION; MECHANISM	SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is an emerging respiratory pathogen that has rapidly spread in human populations. Severe forms of infection associate cytokine release syndrome and acute lung injury due to hyperinflammatory responses even though virus clearance is achieved. Key components of inflammation include immune cell recruitment in infected tissues, a step which is under the control of endothelial cells. Here, we review endothelial cell responses in inflammation and infection due to SARS-CoV-2 together with phenotypic and functional alterations of monocytes, T and B lymphocytes with which they interact. We surmise that endothelial cells function as an integrative and active platform for the various cells recruited, where fine tuning of immune responses takes place and which provides opportunities for therapeutic intervention.	[Degauque, Nicolas; Brouard, Sophie] Univ Nantes, INSERM, Ctr Rech Transplantat & Immunol, UMR1064, Nantes, France; [Degauque, Nicolas; Brouard, Sophie] CHU Nantes, Inst Transplantat Urol Nephrol ITUN, Nantes, France; [Degauque, Nicolas; Brouard, Sophie] CHU Nantes, Lab Immunol, Nantes, France; [Haziot, Alain; Mooney, Nuala] Inst Rech St Louis, INSERM, U976, 1 Ave Claude Vellefaux, F-75010 Paris, France; [Haziot, Alain; Mooney, Nuala] Univ Paris, Inst Rech St Louis, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Mooney, N (corresponding author), Inst Rech St Louis, INSERM, U976, 1 Ave Claude Vellefaux, F-75010 Paris, France.; Brouard, S (corresponding author), CHU Nantes, Hotel Dieu, Ctr Rech Transplantat & Immunol, UMR 1064, 30 Blvd Jean, F-44093 Nantes 01, France.	sophie.brouard@univ-nantes.fr	Degauque, Nicolas/R-4944-2017; Haziot, Alain/AAF-5507-2021	Degauque, Nicolas/0000-0003-2990-3513; Mooney, Nuala/0000-0002-3516-6882	Agence Nationale de la Recherche (ANR) [ANR-11-LABX-0016-01]; European Cooperation in Science and Technology (COST) [CA17138]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Cooperation in Science and Technology (COST)(European Cooperation in Science and Technology (COST))	Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-11-LABX-0016-01; European Cooperation in Science and Technology (COST), Grant/Award Number: CA17138	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Addetia A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02107-20; Akaberi D, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101734; Akerstrom S, 2005, J VIROL, V79, P1966, DOI 10.1128/JVI.79.3.1966-1969.2005; Alshukairi AN, 2016, EMERG INFECT DIS, V22, P1113, DOI 10.3201/eid2206.160010; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Bagate F, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00769-2; Bedin A-S., 2020, MONOCYTE CD 169 EXPR; Bermejo-Martin JF, 2020, CARDIOVASC RES, V116, pE132, DOI 10.1093/cvr/cvaa140; Biedermann BC, 1999, J IMMUNOL, V162, P7022; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bordi L, 2006, ARCH VIROL, V151, P369, DOI 10.1007/s00705-005-0632-8; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Burkhardt AM, 2014, J IMMUNOL, V193, P1468, DOI 10.4049/jimmunol.1400551; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Buzhdygan TP, 2020, NEUROBIOL DIS, V146, DOI [10.1016/j.nbd.2020.105131, 10.1101/2020.06.15.150912]; Carsetti R., 2020, DIFFERENT INNATE ADA; Chevrier S, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2020.100166; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Cross AR, 2019, KIDNEY INT, V96, P689, DOI 10.1016/j.kint.2019.04.023; Danilczyk U, 2006, CIRC RES, V98, P463, DOI 10.1161/01.RES.0000205761.22353.5f; Davey MP, 2006, MICROVASC RES, V71, P103, DOI 10.1016/j.mvr.2005.11.010; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dib H, 2012, PROTEOMICS, V12, P2547, DOI 10.1002/pmic.201200060; Gatheral T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042386; Gatti A, 2020, CYTOM PART A, V97, P887, DOI 10.1002/cyto.a.24188; Gorse GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1875, DOI 10.1128/CVI.00278-10; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Han Q, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.615972; Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266; Hirano T, 2021, INT IMMUNOL, V33, P127, DOI 10.1093/intimm/dxaa078; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang L, 2020, BLOOD SINGLE CELL IM, DOI 10.1101/2020.03.15.20033472; Huang W, 2020, CYTOM PART A, V97, P772, DOI 10.1002/cyto.a.24172; HUGHES CCW, 1990, J EXP MED, V171, P1453, DOI 10.1084/jem.171.5.1453; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jane-wit D, 2013, CIRCULATION, V128, P2504, DOI 10.1161/CIRCULATIONAHA.113.002972; Kahn R, 2021, J LEUKOCYTE BIOL, V109, P115, DOI 10.1002/JLB.5COVBCR0720-310RR; Kaneko N, 2020, CELL, V183, P143, DOI 10.1016/j.cell.2020.08.025; Krishnamachary B., 2020, POTENTIAL ROLE EXTRA; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Lion J, 2016, AM J TRANSPLANT, V16, P1408, DOI 10.1111/ajt.13644; Lion J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01761; Liu LF, 2020, CIRCULATION, V141, P464, DOI 10.1161/CIRCULATIONAHA.119.042501; Lomas-Neira J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03030; Mancuso P, 2020, J THROMB HAEMOST, V18, P2744, DOI 10.1111/jth.15044; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mazzoni A, 2020, J CLIN INVEST, V130, P4694, DOI [10.1172/JCI138554., 10.1172/JCI138554]; Merah-Mourah F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61022-1; Mesel-Lemoine M, 2012, J VIROL, V86, P7577, DOI 10.1128/JVI.00269-12; Minervina AA, 2021, ELIFE, V10, DOI 10.7554/eLife.63502; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Muller WA, 2016, IMMUNOL REV, V273, P61, DOI 10.1111/imr.12443; Neidleman J, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100081; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060; Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z; Padgett LE., 2020, INTERPLAY MONOCYTES; Palmieri EM, 2020, METABOLITES, V10, DOI 10.3390/metabo10110429; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rossaint J, 2013, J INNATE IMMUN, V5, P348, DOI 10.1159/000345943; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Sanchez-Cerrillo Ildefonso, 2020, medRxiv, DOI 10.1101/2020.05.13.20100925; Sattler A, 2020, J CLIN INVEST, V130, DOI 10.1172/JCI140965; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Schulte-Schrepping J., 2020, DTSCH COVID 19 OMICS; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Shibamiya A, 2009, BLOOD, V113, P714, DOI 10.1182/blood-2008-02-137901; Shin HS, 2019, CLIN INFECT DIS, V68, P984, DOI 10.1093/cid/ciy595; Smadja DM, 2020, ANGIOGENESIS, V23, P611, DOI 10.1007/s10456-020-09730-0; Song JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17240-2; Swedish Orphan Biovitrum, 2020, PHAS 2 3 RAND OP LAB; Taflin C, 2011, P NATL ACAD SCI USA, V108, P2891, DOI 10.1073/pnas.1011811108; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Thieme CJ, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100092; Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Van Mol P., 2020, INTERPLAY MONOCYTES; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wimmer RA, 2019, NATURE, V565, P505, DOI 10.1038/s41586-018-0858-8; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Xia S, 2020, CELL RES, V30, P343, DOI 10.1038/s41422-020-0305-x; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yang XH, 2007, COMPARATIVE MED, V57, P450; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Yilla M, 2005, VIRUS RES, V107, P93, DOI 10.1016/j.virusres.2004.09.004; Zegeye MM, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0268-4; Zhang HJ, 2020, AM J RESP CRIT CARE, V202, P219, DOI 10.1164/rccm.202003-0541OC; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	119	7	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21577	10.1096/fj.202100024R	http://dx.doi.org/10.1096/fj.202100024R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33831263	Green Published			2022-12-28	WOS:000645260100041
J	Fernandez, C; Burgos, A; Morales, D; Rosales-Rojas, R; Canelo, J; Vergara-Jaque, A; Vieira, GV; da Silva, RAA; Sales, KU; Conboy, MJ; Bae, EJ; Park, KS; Torres, VA; Garrido, M; Cerda, O; Conboy, IM; Caceres, M				Fernandez, Christian; Burgos, Andres; Morales, Diego; Rosales-Rojas, Roberto; Canelo, Javiera; Vergara-Jaque, Ariela; Vieira, Gabriel Viliod; Alves da Silva, Rodrigo Alberto; Sales, Katiuchia Uzzun; Conboy, Michael J.; Bae, Eun Ji; Park, Kang-Sik; Torres, Vicente A.; Garrido, Mauricio; Cerda, Oscar; Conboy, Irina M.; Caceres, Monica			TMPRSS11a is a novel age-altered, tissue specific regulator of migration and wound healing	FASEB JOURNAL			English	Article						aging; beta1 integrin; cell migration; RGD motif	MOLECULAR-DYNAMICS; SENESCENT CELLS; CRYSTAL-STRUCTURE; ECRG1; EXPRESSION; MOTILITY; ADHESION; PROTEIN; ARREST; CANCER	Aging is a gradual biological process characterized by a decrease in cellular and organism functions. Aging-related processes involve changes in the expression and activity of several proteins. Here, we identified the transmembrane protease serine 11a (TMPRSS11a) as a new age-specific protein that plays an important role in skin wound healing. TMPRSS11a levels increased with age in rodent and human skin and gingival samples. Strikingly, overexpression of TMPRSS11a decreased cell migration and spreading, and inducing cellular senescence. Mass spectrometry, bioinformatics, and functional analyses revealed that TMPRSS11a interacts with integrin beta(1) through an RGD sequence contained within the C-terminal domain and that this motif was relevant for cell migration. Moreover, TMPRSS11a was associated with cellular senescence, as shown by overexpression and downregulation experiments. In agreement with tissue-specific expression of TMPRSS11a, shRNA-mediated downregulation of this protein improved wound healing in the skin, but not in the skeletal muscle of old mice, where TMPRSS11a is undetectable. Collectively, these findings indicate that TMPRSS11a is a tissue-specific factor relevant for wound healing, which becomes elevated with aging, promoting cellular senescence and inhibiting cell migration and skin repair.	[Fernandez, Christian; Burgos, Andres; Morales, Diego; Canelo, Javiera; Cerda, Oscar; Caceres, Monica] Univ Chile, Fac Med, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago, Chile; [Rosales-Rojas, Roberto; Vergara-Jaque, Ariela] Univ Talca, Fac Engn, Ctr Bioinformat Simulat & Modeling CBSM, Talca, Chile; [Vergara-Jaque, Ariela; Cerda, Oscar; Caceres, Monica] Millennium Nucleus Ion Channel Associated Dis MiN, Santiago, Chile; [Vieira, Gabriel Viliod; Alves da Silva, Rodrigo Alberto; Sales, Katiuchia Uzzun] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Sao Paulo, Brazil; [Conboy, Michael J.; Conboy, Irina M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Conboy, Michael J.; Conboy, Irina M.] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Bae, Eun Ji; Park, Kang-Sik] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea; [Torres, Vicente A.] Univ Chile, Fac Dent, Adv Ctr Chron Dis ACCDiS, Inst Res Dent Sci, Santiago, Chile; [Garrido, Mauricio] Univ Chile, Fac Dent, Dept Conservat Dent, Santiago, Chile; [Cerda, Oscar; Caceres, Monica] Wound Repair Treatment & Hlth WoRTH Initiat, Santiago, Chile	Universidad de Chile; Universidad de Talca; Universidade de Sao Paulo; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Kyung Hee University; Universidad de Chile; Universidad de Chile	Caceres, M (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago, Chile.	monicacaceres@med.uchile.cl	sales, katiuchia u/J-4880-2012	Alberto Alves da Silva, Rodrigo/0000-0002-1032-0644; Torres, Vicente A/0000-0002-5973-7248; Fernandez, Christian/0000-0001-8157-5997; sales, katiuchia/0000-0002-3768-5790; Cerda, Oscar/0000-0003-2873-5722	FONDECYT Grant [1181263]; Iniciativa Cientifica Milenio of National Agency of Research and Development (ANID) (Chile)	FONDECYT Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio of National Agency of Research and Development (ANID) (Chile)	This research was funded by FONDECYT Grant 1181263 to MC. The Millennium Nucleus of Ion Channel--Associated Diseases (MiNICAD) is a Millennium Nucleus supported by the Iniciativa Cientifica Milenio of National Agency of Research and Development (ANID) (Chile)	Ballas CB, 2001, WOUND REPAIR REGEN, V9, P223, DOI 10.1046/j.1524-475x.2001.00223.x; Barbieri MA, 1996, ARCH BIOCHEM BIOPHYS, V326, P64, DOI 10.1006/abbi.1996.0047; Caceres M, 2014, J DENT RES, V93, P691, DOI 10.1177/0022034514533126; Caceres M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130540; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Cerda O, 2011, J BIOL CHEM, V286, P28738, DOI 10.1074/jbc.M111.251942; Chen Q, 2008, INT J BIOCHEM CELL B, V40, P2164, DOI 10.1016/j.biocel.2008.02.021; Demaria M, 2015, J INVEST DERMATOL, V135, P1722, DOI 10.1038/jid.2015.108; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kyrieleis OJP, 2007, FEBS J, V274, P2148, DOI 10.1111/j.1742-4658.2007.05756.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Moreno-Layseca P, 2019, NAT CELL BIOL, V21, P122, DOI 10.1038/s41556-018-0223-z; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Saldias MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184189; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708; Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012; Rasool S, 2013, ONKOLOGIE, V36, P213, DOI 10.1159/000349960; Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363; Rivas J, 2020, FASEB J, V34, P7847, DOI 10.1096/fj.201901195RRR; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwarze SR, 2001, ONCOGENE, V20, P8184, DOI 10.1038/sj.onc.1205049; Smith PC, 2015, J DENT RES, V94, P395, DOI 10.1177/0022034514563750; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Zhao NX, 2006, EXP BIOL MED, V231, P84; Zhao NX, 2004, J CELL BIOCHEM, V92, P65, DOI 10.1002/jcb.20025	44	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21597	10.1096/fj.202002253RRR	http://dx.doi.org/10.1096/fj.202002253RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33908663				2022-12-28	WOS:000645260100018
J	Nash, Y; Ganoth, A; Borenstein-Auerbach, N; Levy-Barazany, H; Goldsmith, G; Kopelevich, A; Pozyuchenko, K; Sakhneny, L; Lazdon, E; Blanga-Kanfi, S; Alhadeff, R; Benromano, T; Landsman, L; Tsfadia, Y; Frenkel, D				Nash, Yuval; Ganoth, Assaf; Borenstein-Auerbach, Nofit; Levy-Barazany, Hilit; Goldsmith, Guy; Kopelevich, Adi; Pozyuchenko, Katia; Sakhneny, Lina; Lazdon, Ekaterina; Blanga-Kanfi, Shani; Alhadeff, Raphael; Benromano, Tali; Landsman, Limor; Tsfadia, Yossi; Frenkel, Dan			From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment	FASEB JOURNAL			English	Article							WEB SERVER; T-CELLS; PROTEIN; PEPTIDE; DYNAMICS; BINDING; GENE; PROLIFERATION; RECOGNITION; PREVALENCE	Inhibition of insulin-degrading enzyme (IDE) is a possible target for treating diabetes. However, it has not yet evolved into a medical intervention, mainly because most developed inhibitors target the zinc in IDE's catalytic site, potentially causing toxicity to other essential metalloproteases. Since IDE is a cellular receptor for the varicella-zoster virus (VZV), we constructed a VZV-based inhibitor. We computationally characterized its interaction site with IDE showing that the peptide specifically binds inside IDE's central cavity, however, not in close proximity to the zinc ion. We confirmed the peptide's effective inhibition on IDE activity in vitro and showed its efficacy in ameliorating insulin-related defects in types 1 and 2 diabetes mouse models. In addition, we suggest that inhibition of IDE may ameliorate the pro-inflammatory profile of CD4(+) T-cells toward insulin. Together, we propose a potential role of a designed VZV-derived peptide to serve as a selectively-targeted and as an efficient diabetes therapy.	[Nash, Yuval; Borenstein-Auerbach, Nofit; Levy-Barazany, Hilit; Goldsmith, Guy; Kopelevich, Adi; Pozyuchenko, Katia; Lazdon, Ekaterina; Blanga-Kanfi, Shani; Benromano, Tali; Frenkel, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Neurobiol, Biochem & Biophys Sch,Dept Neurobiol, Tel Aviv, Israel; [Nash, Yuval; Frenkel, Dan] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Ganoth, Assaf] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Ganoth, Assaf] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel; [Sakhneny, Lina; Landsman, Limor] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel; [Alhadeff, Raphael] Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA; [Tsfadia, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Neurobiol Biochem & Biophys, Dept Biochem & Mol Biol, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Reichman University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University of Southern California; Tel Aviv University	Frenkel, D (corresponding author), George S Wise Fac Life Sci, Dept Neurobiol, Sherman Bldg,Room 424, IL-69978 Tel Aviv, Israel.	dfrenkel@tauex.tau.ac.il		Landsman, Limor/0000-0002-8974-1344	Colton Family Next Generation Technological institute [590046]; SAIA Fund Tel Aviv University [590117]	Colton Family Next Generation Technological institute; SAIA Fund Tel Aviv University	The Colton Family Next Generation Technological institute, Grant/Award Number: 590046; SAIA Fund Tel Aviv University, Grant/Award Number: 590117	Abdul-Hay SO, 2013, J MED CHEM, V56, P2246, DOI 10.1021/jm301280p; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Abraham M., 2014, GROMACS USER MANUAL, V5, P1; AFFHOLTER JA, 1990, BIOCHEMISTRY-US, V29, P7727, DOI 10.1021/bi00485a022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; AUTHIER F, 1994, J BIOL CHEM, V269, P3010; BACKER JM, 1990, J BIOL CHEM, V265, P14828; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bora RP, 2010, BIOCHEMISTRY-US, V49, P3947, DOI 10.1021/bi1002103; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chermak E, 2015, BIOINFORMATICS, V31, P1481, DOI 10.1093/bioinformatics/btu837; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Culina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088365; da Cruz CHB, 2014, J CHEM INF MODEL, V54, P1380, DOI 10.1021/ci400695m; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies M, 2004, INT J OBESITY, V28, pS14, DOI 10.1038/sj.ijo.0802745; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Deprez-Poulain R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9250; DIMITRIADIS GD, 1983, DIABETES CARE, V6, P374, DOI 10.2337/diacare.6.4.374; Dirice E, 2019, NAT METAB, V1, P509, DOI 10.1038/s42255-019-0061-8; DORER FE, 1974, CIRC RES, V34, P824, DOI 10.1161/01.RES.34.6.824; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Durham TB, 2015, J BIOL CHEM, V290, P20044, DOI 10.1074/jbc.M115.638205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fernandez-Diaz CM, 2019, AM J PHYSIOL-ENDOC M, V317, pE805, DOI 10.1152/ajpendo.00040.2019; Golan Y, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006503; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hess B, 1998, J COMPUT CHEM, P18; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; Jimenez-Garcia B, 2013, BIOINFORMATICS, V29, P1698, DOI 10.1093/bioinformatics/btt262; KAHN CR, 1986, NEW ENGL J MED, V315, P252, DOI 10.1056/NEJM198607243150410; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; LEE FS, 1993, J COMPUT CHEM, V14, P161, DOI 10.1002/jcc.540140205; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Levy-Barazany H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-120; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Li QX, 2007, J VIROL, V81, P8525, DOI 10.1128/JVI.00286-07; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Malhotra S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0572-6; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Mehta SN, 2010, ENDOCRIN METAB CLIN, V39, P573, DOI 10.1016/j.ecl.2010.05.002; Miners JS, 2008, J NEUROSCI METH, V169, P177, DOI 10.1016/j.jneumeth.2007.12.003; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SEMPLE JW, 1992, INT IMMUNOL, V4, P1161, DOI 10.1093/intimm/4.10.1161; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Shuto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136840; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sofer Y, 2021, ENDOCRINE, V71, P357, DOI 10.1007/s12020-020-02548-2; Son SM, 2016, AUTOPHAGY, V12, P784, DOI 10.1080/15548627.2016.1159375; Song ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133114; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tang WJ, 2016, TRENDS ENDOCRIN MET, V27, P24, DOI 10.1016/j.tem.2015.11.003; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tundo GR, 2016, FEBS J, V283, P3755, DOI 10.1111/febs.13841; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Vangone A, 2015, ELIFE, V4, DOI 10.7554/eLife.07454; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Yang D, 2018, J MED CHEM, V61, P8174, DOI 10.1021/acs.jmedchem.8b00418; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yang MY, 2017, CHEM REV, V117, P10377, DOI 10.1021/acs.chemrev.7b00100; Zeng C, 2012, J MOL MED, V90, P175, DOI 10.1007/s00109-011-0816-5; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZN, 2018, ELIFE, V7, DOI 10.7554/eLife.33572; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001	93	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21374	10.1096/fj.201901945R	http://dx.doi.org/10.1096/fj.201901945R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835493				2022-12-28	WOS:000645260100095
J	Zhong, BR; Zhou, GF; Song, L; Wen, QX; Deng, XJ; Ma, YL; Hu, LT; Chen, GJ				Zhong, Bi-Rou; Zhou, Gui-Feng; Song, Li; Wen, Qi-Xin; Deng, Xiao-Juan; Ma, Yuan-Lin; Hu, Li-Tian; Chen, Guo-Jun			TUFM is involved in Alzheimer's disease-like pathologies that are associated with ROS	FASEB JOURNAL			English	Article						apoptosis; BACE1 translation; beta-amyloid protein; RNA stability; ROS; Tau; TUFM	KAPPA-B; TRANSLATIONAL REGULATION; COGNITIVE DECLINE; BACE1; EXPRESSION; ELONGATION; INHIBITION; MUTATION; PROTEIN; BETA	Mitochondrial Tu translation elongation factor (TUFM or EF-Tu) is part of the mitochondrial translation machinery. It is reported that TUFM expression is reduced in the brain of Alzheimer's disease (AD), suggesting that TUFM might play a role in the pathophysiology. In this study, we found that TUFM protein level was decreased in the hippocampus and cortex especially in the aged APP/PS1 mice, an animal model of AD. In HEK cells that stably express full-length human amyloid-beta precursor protein (HEK-APP), TUFM knockdown or overexpression increased or reduced the protein levels of beta-amyloid protein (A beta) and beta-amyloid converting enzyme 1 (BACE1), respectively. TUFM-mediated reduction of BACE1 was attenuated by translation inhibitor cycloheximide (CHX) or alpha-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl] hydrazinylidene]-2-nitro-benzenepropanoic acid (4EGI1), and in cells overexpressing BACE1 constructs deleting the 5' untranslated region (5'UTR). TUFM silencing increased the half-life of BACE1 mRNA, suggesting that RNA stability was affected by TUFM. In support, transcription inhibitor Actinomycin D (ActD) and silencing of nuclear factor kappa B (NF kappa B) failed to abolish TUFM-mediated regulation of BACE1 protein and mRNA. We further found that the mitochondria-targeted antioxidant TEMPO diminished the effects of TUFM on BACE1, suggesting that reactive oxygen species (ROS) played an important role. Indeed, cellular ROS levels were affected by TUFM knockdown or overexpression, and TUFM-mediated regulation of apoptosis and Tau phosphorylation at selective sites was attenuated by TEMPO. Collectively, TUFM protein levels were decreased in APP/PS1 mice. TUFM is involved in AD pathology by regulating BACE1 translation, apoptosis, and Tau phosphorylation, in which ROS plays an important role.	[Zhong, Bi-Rou; Zhou, Gui-Feng; Song, Li; Wen, Qi-Xin; Deng, Xiao-Juan; Ma, Yuan-Lin; Hu, Li-Tian; Chen, Guo-Jun] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Hu, Li-Tian] Nanchong Cent Hosp, Dept Neurol, North Sichuan Med Coll, Clin Coll 2, Nanchong, Peoples R China	Chongqing Medical University; North Sichuan Medical University	Chen, GJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, 1 Youyi Rd, Chongqing 400016, Peoples R China.	woodchen2015@163.com		Chen, Guo-Jun/0000-0001-8148-9810	National Key R&D Program of China [2018YFC1314700]; NSFC [81971030]; Chongqing Science and Technology Commission [cstc2018jcyjAX0067]; Strategic Science & Technology Cooperation Project of North Sichuan Medical College; Nanchong Municipal Government [18SXHZ0184]; Scientific Research Development Project of North Sichuan Medical College [CBY17-A-ZD03]; Sichuan Provincial Health and Family Planning Commission [18PJ335]	National Key R&D Program of China; NSFC(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC); Strategic Science & Technology Cooperation Project of North Sichuan Medical College; Nanchong Municipal Government; Scientific Research Development Project of North Sichuan Medical College; Sichuan Provincial Health and Family Planning Commission	National Key R&D Program of China, Grant/Award Number: 2018YFC1314700; NSFC, Grant/Award Number: 81971030; Chongqing Science and Technology Commission, Grant/Award Number: cstc2018jcyjAX0067; The Strategic Science & Technology Cooperation Project of North Sichuan Medical College; Nanchong Municipal Government, Grant/Award Number: 18SXHZ0184; Scientific Research Development Project of North Sichuan Medical College, Grant/Award Number: CBY17-A-ZD03; Sichuan Provincial Health and Family Planning Commission, Grant/Award Number: 18PJ335	Bilkei-Gorzo A, 2014, PHARMACOL THERAPEUT, V142, P244, DOI 10.1016/j.pharmthera.2013.12.009; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Cieslik M, 2020, MOL NEUROBIOL, V57, P1374, DOI 10.1007/s12035-019-01819-y; Dai CL, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0341-7; Di Nottia M, 2017, BBA-MOL BASIS DIS, V1863, P961, DOI 10.1016/j.bbadis.2017.01.022; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; He K, 2016, CELL MOL LIFE SCI, V73, P2105, DOI 10.1007/s00018-015-2122-9; Hershkovitz T, 2019, J HUM GENET, V64, P589, DOI 10.1038/s10038-019-0592-6; Imbimbo BP, 2019, EXPERT OPIN INV DRUG, V28, P967, DOI 10.1080/13543784.2019.1683160; Jembrek MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/346783; Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6; Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543; Labno A, 2016, BBA-MOL CELL RES, V1863, P3125, DOI 10.1016/j.bbamcr.2016.09.023; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lindqvist L, 2009, FUTURE MED CHEM, V1, P1709, DOI 10.4155/FMC.09.122; May PC, 2015, J NEUROSCI, V35, P1199, DOI 10.1523/JNEUROSCI.4129-14.2015; Min Z, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00198; Mitsunaga M, 2007, WORLD J GASTROENTERO, V13, P692, DOI 10.3748/wjg.v13.i5.692; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Mondragon-Rodriguez S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/940603; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mori K, 2019, FEBS J, V286, P459, DOI 10.1111/febs.14671; Mostafavi S, 2018, NAT NEUROSCI, V21, P811, DOI 10.1038/s41593-018-0154-9; Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Nishimura T, 2015, CELL REP, V11, P1425, DOI 10.1016/j.celrep.2015.04.065; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; Ravet K, 2012, EMBO J, V31, P175, DOI 10.1038/emboj.2011.341; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Tang Y, 2018, EXP NEUROL, V305, P89, DOI 10.1016/j.expneurol.2018.04.003; Thangavelu B, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00915; Thiadens KAMH, 2015, BIOCHEM SOC T, V43, P343, DOI 10.1042/BST20150009; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; Valente L, 2009, BBA-MOL BASIS DIS, V1792, P791, DOI 10.1016/j.bbadis.2009.06.002; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; Wang J, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00918-y; Wang WZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00376-6; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang YP, 2004, CELL RES, V14, P467, DOI 10.1038/sj.cr.7290249; Weller Jason, 2018, F1000Res, V7, DOI 10.12688/f1000research.14506.1; Weng XY, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.12113; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wingo AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09613-z; Xiang XJ, 2019, EXP NEUROL, V318, P145, DOI 10.1016/j.expneurol.2019.05.006; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yang J, 2019, J MOL NEUROSCI, V69, P608, DOI 10.1007/s12031-019-01389-7; Yu Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04389-0; Zeng T, 2019, J CHEM NEUROANAT, V98, P87, DOI 10.1016/j.jchemneu.2019.04.001; Zhu BL, 2019, BRAIN, V142, P176, DOI 10.1093/brain/awy305; Zhu BL, 2016, J NEUROL SCI, V360, P30, DOI 10.1016/j.jns.2015.11.041; Zottel A, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920915302; Zuo L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/604658	62	2	2	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21445	10.1096/fj.202002461R	http://dx.doi.org/10.1096/fj.202002461R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774866				2022-12-28	WOS:000645260100059
J	Luo, NJ; Yue, F; Jia, ZH; Chen, JJ; Deng, Q; Zhao, YJ; Kuang, SH				Luo, Nanjian; Yue, Feng; Jia, Zhihao; Chen, Jingjuan; Deng, Qing; Zhao, Yongju; Kuang, Shihuan			Reduced electron transport chain complex I protein abundance and function in Mfn2-deficient myogenic progenitors lead to oxidative stress and mitochondria swelling	FASEB JOURNAL			English	Article						Mfn2; mitochondrion; myogenesis; myogenic progenitor cells; oxidative respiration	SKELETAL-MUSCLE; MITOFUSIN 2; INSULIN-RESISTANCE; SATELLITE CELLS; FIBER TYPES; STEM-CELLS; MFN2; FUSION; METABOLISM; EXPRESSION	Mitochondrial remodeling through fusion and fission is crucial for progenitor cell differentiation but its role in myogenesis is poorly understood. Here, we characterized the function of mitofusin 2 (Mfn2), a mitochondrial outer membrane protein critical for mitochondrial fusion, in muscle progenitor cells (myoblasts). Mfn2 expression is upregulated during myoblast differentiation in vitro and muscle regeneration in vivo. Targeted deletion of Mfn2 gene in myoblasts (Mfn2(MKO)) increases oxygen-consumption rates (OCR) associated with the maximal respiration and spare respiratory capacity, and increased levels of reactive oxygen species (ROS). Skeletal muscles of Mfn2(MKO) mice exhibit robust mitochondrial swelling with normal mitochondrial DNA content. Additionally, mitochondria isolated from Mfn2(MKO) muscles have reduced OCR at basal state and for complex I respiration, associated with decreased levels of complex I proteins NDUFB8 (NADH ubiquinone oxidoreductase subunit B8) and NDUFS3 (NADH ubiquinone oxidoreductase subunit S3). However, Mfn2(MKO) has no obvious effects on myoblast differentiation, muscle development and function, and muscle regeneration. These results demonstrate a novel role of Mfn2 in regulating mitochondrial complex I protein abundance and respiratory functions in myogenic progenitors and myofibers.	[Luo, Nanjian; Yue, Feng; Jia, Zhihao; Chen, Jingjuan; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, 2070 Creighton Hall Anim Sci,270 S Russell St, W Lafayette, IN 47907 USA; [Luo, Nanjian; Zhao, Yongju] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China; [Deng, Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Deng, Qing; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Deng, Qing; Kuang, Shihuan] Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Southwest University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, 2070 Creighton Hall Anim Sci,270 S Russell St, W Lafayette, IN 47907 USA.	skuang@purdue.edu		Kuang, Shihuan/0000-0001-9180-3180; Luo, Nanjian/0000-0002-4371-5378; Deng, Qing/0000-0002-9254-9951	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR071649]; U.S. Department of Agriculture (USDA) [NC1184]; China Scholarship Council (CSC) [201806990052]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R35GM119787]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); China Scholarship Council (CSC)(China Scholarship Council); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR071649; U.S. Department of Agriculture (USDA), Grant/Award Number: NC1184; China Scholarship Council (CSC), Grant/Award Number: 201806990052; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R35GM119787	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bell MR, 2019, J APPL PHYSIOL, V126, P341, DOI 10.1152/japplphysiol.00719.2018; Bhattacharya D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00480; Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Galindo MF, 2003, BRIT J PHARMACOL, V139, P797, DOI 10.1038/sj.bjp.0705309; Gouspillou G, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00446; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jia ZH, 2019, ELIFE, V8, DOI 10.7554/eLife.47097; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kawalec M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134162; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu XW, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0916-9; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Mahdaviani K, 2017, EMBO REP, V18, P1123, DOI 10.15252/embr.201643827; Mancini G, 2019, CELL REP, V26, P2849, DOI 10.1016/j.celrep.2019.02.039; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Nabben M, 2011, BBA-BIOENERGETICS, V1807, P1095, DOI 10.1016/j.bbabio.2011.04.003; Nie Q, 2014, MOL BIOL REP, V41, P6975, DOI 10.1007/s11033-014-3584-9; Olah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134227; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Pala F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212977; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Ryall JG, 2013, FEBS J, V280, P4004, DOI 10.1111/febs.12189; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Segales J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1208, DOI 10.1152/ajpendo.00546.2012; Seo BJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123893; Sheffield-Moore M, 2004, TRENDS ENDOCRIN MET, V15, P110, DOI 10.1016/j.tem.2004.02.009; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; Westerblad H, 2010, EXP CELL RES, V316, P3093, DOI 10.1016/j.yexcr.2010.05.019; Wilson JD, 2005, BIOPHYS J, V88, P2929, DOI 10.1529/biophysj.104.054528; Wolf C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101289; Wyckelsma VL, 2017, J PHYSIOL-LONDON, V595, P3345, DOI 10.1113/JP273950; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Zorzano A, 2009, APPL PHYSIOL NUTR ME, V34, P433, DOI 10.1139/H09-049; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	59	1	1	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21426	10.1096/fj.202002464R	http://dx.doi.org/10.1096/fj.202002464R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749882	Green Accepted			2022-12-28	WOS:000635216100060
J	Abdollahi, P; Vandsemb, EN; Elsaadi, S; Rost, LM; Yang, R; Hjort, MA; Andreassen, T; Misund, K; Slordahl, TS; Ro, TB; Sponaas, AM; Moestue, S; Bruheim, P; Borset, M				Abdollahi, Pegah; Vandsemb, Esten N.; Elsaadi, Samah; Rost, Lisa M.; Yang, Rui; Hjort, Magnus A.; Andreassen, Trygve; Misund, Kristine; Slordahl, Tobias S.; Ro, Torstein B.; Sponaas, Anne-Marit; Moestue, Siver; Bruheim, Per; Borset, Magne			Phosphatase of regenerating liver-3 regulates cancer cell metabolism in multiple myeloma	FASEB JOURNAL			English	Article						GLDC; glycine; serine; Warburg effect	ONE-CARBON METABOLISM; PRL-3 PHOSPHATASE; AMINO-ACIDS; GLYCINE; PROTEIN; EXPRESSION; SERINE; PROLIFERATION; METASTASIS; GLYCOLYSIS	Cancer cells often depend on microenvironment signals from molecules such as cytokines for proliferation and metabolic adaptations. PRL-3, a cytokine-induced oncogenic phosphatase, is highly expressed in multiple myeloma cells and associated with poor outcome in this cancer. We studied whether PRL-3 influences metabolism. Cells transduced to express PRL-3 had higher aerobic glycolytic rate, oxidative phosphorylation, and ATP production than the control cells. PRL-3 promoted glucose uptake and lactate excretion, enhanced the levels of proteins regulating glycolysis and enzymes in the serine/glycine synthesis pathway, a side branch of glycolysis. Moreover, mRNAs for these proteins correlated with PRL-3 expression in primary patient myeloma cells. Glycine decarboxylase (GLDC) was the most significantly induced metabolism gene. Forced GLDC downregulation partly counteracted PRL-3-induced aerobic glycolysis, indicating GLDC involvement in a PRL-3-driven Warburg effect. AMPK, HIF-1 alpha, and c-Myc, important metabolic regulators in cancer cells, were not mediators of PRL-3's metabolic effects. A phosphatase-dead PRL-3 mutant, C104S, promoted many of the metabolic changes induced by wild-type PRL-3, arguing that important metabolic effects of PRL-3 are independent of its phosphatase activity. Through this study, PRL-3 emerges as one of the key mediators of metabolic adaptations in multiple myeloma.	[Abdollahi, Pegah; Vandsemb, Esten N.; Elsaadi, Samah; Yang, Rui; Hjort, Magnus A.; Misund, Kristine; Slordahl, Tobias S.; Ro, Torstein B.; Sponaas, Anne-Marit; Moestue, Siver; Borset, Magne] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Clin & Mol Med, Trondheim, Norway; [Abdollahi, Pegah; Yang, Rui] St Olays Univ Hosp, Lab Clin, Trondheim, Norway; [Rost, Lisa M.; Bruheim, Per] Norwegian Univ Sci & Technol, Fac Nat Sci, Dept Biotechnol & Food Sci, Trondheim, Norway; [Hjort, Magnus A.; Ro, Torstein B.] St Olays Univ Hosp, Childrens Clin, Trondheim, Norway; [Andreassen, Trygve] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, MR Core Facil, Trondheim, Norway; [Misund, Kristine; Slordahl, Tobias S.] St Olays Univ Hosp, Clin Med, Trondheim, Norway; [Moestue, Siver] Nord Univ, Fac Hlth Sci, Dept Pharm, Bodo, Norway; [Borset, Magne] St Olays Univ Hosp, Dept Immunol & Transfus Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Nord University	Borset, M (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7491 Trondheim, Norway.	magne.borset@ntnu.no	Abdollahi, Pegah/GON-4184-2022; Borset, Magne/AAY-1713-2021; Abdollahi, pegah/AGW-4229-2022; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Elsaadi, Samah/0000-0002-5554-0771; Rost, Lisa Marie/0000-0003-3980-8667	NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway	NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway	NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway	Abdollahi P, 2017, MOL CANCER RES, V15, P69, DOI 10.1158/1541-7786.MCR-16-0212; Austdal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091923; Avet-Loiseau H, 2001, BLOOD, V98, P3082, DOI 10.1182/blood.V98.10.3082; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Bettum IJ, 2015, CANCER LETT, V366, P71, DOI 10.1016/j.canlet.2015.06.006; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Chong PSY, 2019, CANCER RES, V79, P4679, DOI 10.1158/0008-5472.CAN-19-0343; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Funato Y, 2020, DEV CELL, V55, P387, DOI 10.1016/j.devcel.2020.08.009; Funato Y, 2019, J BIOCHEM, V165, P219, DOI 10.1093/jb/mvy095; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Ganapathy-Kanniappan S, 2018, CRIT REV BIOCHEM MOL, V53, P667, DOI 10.1080/10409238.2018.1556578; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Gulerez I, 2016, EMBO REP, V17, P1890, DOI 10.15252/embr.201643393; Hardy S, 2019, P NATL ACAD SCI USA, V116, P2925, DOI 10.1073/pnas.1815361116; Hardy S, 2018, FEBS J, V285, P3886, DOI 10.1111/febs.14503; Hjort MA, 2018, ONCOTARGET, V9, P3549, DOI 10.18632/oncotarget.23186; Hjort MA, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0100-2; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kang PJ, 2019, METAB ENG, V53, P35, DOI 10.1016/j.ymben.2019.02.003; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; KLEIN B, 1989, BLOOD, V73, P517; Kozlov G, 2020, J BIOL CHEM, V295, P11682, DOI 10.1074/jbc.RA120.014464; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Li QL, 2020, P NATL ACAD SCI USA, V117, P20538, DOI 10.1073/pnas.2002964117; Liu YX, 2013, GUT, V62, P571, DOI 10.1136/gutjnl-2011-301059; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lujan P, 2016, J CELL SCI, V129, P4130, DOI 10.1242/jcs.190215; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park JE, 2013, EMBO MOL MED, V5, P1351, DOI 10.1002/emmm.201202183; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Qu S, 2014, CANCER-AM CANCER SOC, V120, P2130, DOI 10.1002/cncr.28668; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Slordahl TS, 2016, ONCOTARGET, V7, P27295, DOI 10.18632/oncotarget.8422; Sogaard Caroline Krogh, 2018, Oncotarget, V9, P32448, DOI 10.18632/oncotarget.25963; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vandsemb EN, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0830-z; WARBURG O, 1956, SCIENCE, V124, P269; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Woo CC, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00196; Wu SP, 2016, CLIN CANCER RES, V22, P4039, DOI 10.1158/1078-0432.CCR-15-2366; Xu HY, 2017, INT J ONCOL, V51, P1271, DOI 10.3892/ijo.2017.4090; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07132-x; Yang YY, 2018, CANCER MANAG RES, V10, P5071, DOI 10.2147/CMAR.S165344; Yang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169665; Zhang HZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00147-2; Zhang MM, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100766; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhou JB, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-72; Zhou JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019798	64	12	12	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21344	10.1096/fj.202001920RR	http://dx.doi.org/10.1096/fj.202001920RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566385	Green Published, hybrid			2022-12-28	WOS:000629576700009
J	Jia, XS; Li, MQ; Wang, JW; Ning, JQ; Zhao, K				Jia Xiaoshi; Li Maoquan; Wang Jiwei; Ning Jinqiu; Zhao Ke			SETD7 mediates the vascular invasion in articular cartilage and chondrocytes apoptosis in osteoarthriis	FASEB JOURNAL			English	Article						angiogenesis; chondrocyte apoptosis; osteoarthritis; oxygen tension; SETD7	RHEUMATOID-ARTHRITIS; NERVE GROWTH; IN-VITRO; HYPOXIA; ANGIOGENESIS; EXPRESSION; INFLAMMATION; MECHANISMS; REPRESSION; BONE	The pathological characteristics of osteoarthritis are cartilage matrix degradation, chondrocytes apoptosis, and low-grade inflammation of the joint. Recent studies have shown that blood vessels grow from the subchondral bone to the articular cartilage. However, the relationship among inflammation, angiogenesis, and chondrocyte apoptosis is still unclear. We found that chondrocytes could secrete chemokines and VEGF to promote the migration of vascular endothelial cells in response to TNF-alpha stimulation. The invasion of blood vessels leads to increased oxygen tension in the local environment, which increased the expression of SETD7 in chondrocytes by activating the JAK-STAT5 pathway. The bond of phosphorylated STAT5 and the specific locus in the promoter of SETD7 directly increased the transcription of SETD7. On the one hand, SETD7-regulated chemokine expression by forming a positive loop; on the other hand, SETD7-mediated chondrocyte apoptosis by inhibiting the nuclear localization of HIF-1 alpha. In this study, we discovered a novel function of chondrocytes as mediators of inflammation and angiogenesis. Our study demonstrates that SETD7 is a potential molecular target to prevent OA development and progression.	[Jia Xiaoshi; Li Maoquan; Ning Jinqiu; Zhao Ke] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510055, Guangdong, Peoples R China; [Jia Xiaoshi; Li Maoquan; Ning Jinqiu; Zhao Ke] Guangdong Prov Key Lab Stomatol, Guangzhou, Peoples R China; [Jia Xiaoshi; Li Maoquan; Ning Jinqiu; Zhao Ke] Guangdong Engn Res Ctr Technol & Mat Oral Reconst, Guangzhou, Peoples R China; [Wang Jiwei] Guangzhou Med Univ, Guangzhou Inst Oral Dis, Key Lab Oral Med, Stomatol Hosp, Guangzhou, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Zhao, K (corresponding author), Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510055, Guangdong, Peoples R China.	zhaoke@mail.sysu.edu.cn			National Natural Science Foundation of China [81901025, 81771110]; China Postdoctoral Science Foundation [2019M653232]; Guangdong Basic and Applied Basic Research Foundation [2019A1515011326]; Fundamental Research Funds for the Central Universities [19ykpy82]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Basic and Applied Basic Research Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China, Grant/Award Number: 81901025 and 81771110; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653232; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2019A1515011326; Fundamental Research Funds for the Central Universities, Grant/Award Number: 19ykpy82	Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Ashraf S, 2011, ANN RHEUM DIS, V70, P523, DOI 10.1136/ard.2010.137844; Barbero G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091060; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Bu HL, 2019, NEUROSCIENCE, V406, P62, DOI 10.1016/j.neuroscience.2019.02.025; Chang SH, 2019, NAT COMMUN, V10; Charlier E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122146; Domm C, 2000, ORTHOPADE, V29, P91; Fenwick SA, 1999, OSTEOARTHR CARTILAGE, V7, P441, DOI 10.1053/joca.1998.0238; Fernandez-Torres J, 2017, EUR REV MED PHARMACO, V21, P2800; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Greene MA, 2015, OSTEOARTHR CARTILAGE, V23, P1966, DOI 10.1016/j.joca.2015.01.008; Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314; Han LX, 2018, BONE, V117, P15, DOI 10.1016/j.bone.2018.08.017; Hayami T, 2003, J RHEUMATOL, V30, P2207; Hemker SL, 2016, PEDIATR NEPHROL, V31, P1571, DOI 10.1007/s00467-016-3333-5; Hu HY, 2013, ACTA PHARMACOL SIN, V34, P157, DOI 10.1038/aps.2012.161; Huang XB, 2019, J ORTHOP RES, V37, P84, DOI 10.1002/jor.24142; Jia XS, 2017, ACTA BIOMATER, V53, P495, DOI 10.1016/j.actbio.2017.02.025; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kean TJ, 2016, CONNECT TISSUE RES, V57, P319, DOI 10.1080/03008207.2016.1182996; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Liu QB, 2019, BIOCHEM BIOPH RES CO, V516, P22, DOI 10.1016/j.bbrc.2019.05.168; Liu Q, 2015, BBA-MOL CELL RES, V1853, P881, DOI 10.1016/j.bbamcr.2015.01.011; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Malemud CJ, 2018, THER ADV MUSCULOSKEL, V10, P117, DOI 10.1177/1759720X18776224; Mapp PI, 2012, NAT REV RHEUMATOL, V8, P390, DOI 10.1038/nrrheum.2012.80; Oppenheimer H, 2014, J BONE MINER RES, V29, P348, DOI 10.1002/jbmr.2052; Paleolog EM, 2009, INT J EXP PATHOL, V90, P249, DOI 10.1111/j.1365-2613.2009.00640.x; Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693; Pufe T, 2005, ANN ANAT, V187, P461, DOI 10.1016/j.aanat.2005.06.008; Reuther MS, 2012, LARYNGOSCOPE, V122, P2407, DOI 10.1002/lary.23478; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Song H., 2020, INT J MOL SCI, V21; Stegen S, 2019, NATURE, V565, P511, DOI 10.1038/s41586-019-0874-3; Walsh DA, 2010, RHEUMATOLOGY, V49, P1852, DOI 10.1093/rheumatology/keq188; Wu YY, 2019, INT IMMUNOPHARMACOL, V72, P459, DOI 10.1016/j.intimp.2019.04.043; Zhang CT, 2019, J BONE MINER RES, V34, P547, DOI 10.1002/jbmr.3610; Zhang FJ, 2015, JOINT BONE SPINE, V82, P144, DOI 10.1016/j.jbspin.2014.10.003; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zhu SP, 2019, CELL MOL LIFE SCI, V76, P4493, DOI 10.1007/s00018-019-03225-y	45	6	6	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21283	10.1096/fj.202000373RRRR	http://dx.doi.org/10.1096/fj.202000373RRRR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33617050	Bronze			2022-12-28	WOS:000629576700033
J	Lv, X; Chen, SF; Gao, F; Hu, BW; Wang, YK; Ni, SF; Kou, HW; Song, ZM; Qing, XC; Wang, SY; Liu, HJ; Shao, ZW				Lv, Xiao; Chen, Songfeng; Gao, Feng; Hu, Binwu; Wang, Yongkui; Ni, Shuangfei; Kou, Hongwei; Song, Zongmian; Qing, Xiangcheng; Wang, Shangyu; Liu, Hongjian; Shao, Zengwu			Resveratrol-enhanced SIRT1-mediated osteogenesis in porous endplates attenuates low back pain and anxiety behaviors	FASEB JOURNAL			English	Article						anxiety; low back pain; osteogenesis; porous endplates; resveratrol; SIRT1		Low back pain (LBP) is a major clinical problem that lacks effective treatments. The sensory innervation in porous vertebral endplates and anxiety contributes to spinal hyperalgesia. We hypothesized that SIRT1 activator resveratrol alleviates LBP and anxiety via promotion of osteogenesis in the porous endplates. The hyperalgesia and anxiety-related behaviors; sensory innervation, inflammation and porosity of endplates; and osteogenic/osteoclastic factors expression were measured following resveratrol treatment after lumbar spine instability (LSI) surgery. To explore whether resveratrol promotes endplates osteogenesis and thus alleviates LBP through activation of SIRT1 in the osteoprogenitor cells of endplates, SIRT1(OSX)(-/-) mice were employed. Additionally, the levels of inflammation markers, phosphorylation of cAMP response element-binding protein (pCREB), and brain-derived neurotrophic factor (BDNF) in hippocampus were evaluated. After 4 or 8 weeks LSI surgery, the mice suffered from hyperalgesia and anxiety, which were efficiently attenuated by resveratrol at 8 weeks. Resveratrol treatment-enhanced osteogenesis and decreased endplates porosities accompanied with the reduction of TNF alpha, IL-1 beta, and COX2 levels and CGRP+ nerve fibers innervation in porous endplates. Resveratrol-mediated endplates osteogenesis, decreased endplates porosities, and analgesic and antianxiety effects were abrogated in SIRT1(OSX)(-/-) mice. Furthermore, resveratrol relieved inflammation and increased pCREB and BDNF expression in the hippocampus after 8 weeks, which alleviate anxiety-related behaviors. This study provides that resveratrol-mediated porous endplates osteogenesis via the activation of SIRT1 markedly blocked sensory innervation and inflammation in endplates, therefore, alleviating LSI surgery-induced LBP and hippocampus-related anxiety.	[Lv, Xiao; Gao, Feng; Hu, Binwu; Qing, Xiangcheng; Wang, Shangyu; Shao, Zengwu] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan 430022, Peoples R China; [Chen, Songfeng; Wang, Yongkui; Ni, Shuangfei; Kou, Hongwei; Song, Zongmian; Liu, Hongjian] Zhengzhou Univ, Affiliated Hosp 1, Dept Orthopaed, Zhengzhou 450052, Peoples R China	Huazhong University of Science & Technology; Zhengzhou University	Shao, ZW (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan 430022, Peoples R China.; Liu, HJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Orthopaed, Zhengzhou 450052, Peoples R China.	fccliuhj@zzu.edu.cn; szwpro@163.com			NSFC \ Major Research Plan [91649204]; National Natural Science Foundation of China (NSFC) [81974352, 81902253]; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department) [192102310111, 192102310118]	NSFC \ Major Research Plan(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department)	NSFC vertical bar Major Research Plan, Grant/Award Number: 91649204; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974352 and 81902253; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department), Grant/Award Number: 192102310111 and 192102310118	Abe-Higuchi N, 2016, BIOL PSYCHIAT, V80, P815, DOI 10.1016/j.biopsych.2016.01.009; Almeida M, 2018, MED J AUSTRALIA, V208, P272, DOI 10.5694/mja17.01152; Antunes C, 2021, MOL PSYCHIATR, V26, P1445, DOI 10.1038/s41380-020-0695-7; Bailey JF, 2019, SPINE, V44, P1010, DOI 10.1097/BRS.0000000000003035; Beith ID, 2011, PAIN, V152, P1511, DOI 10.1016/j.pain.2011.02.033; Bekhbat M, 2019, BRAIN BEHAV IMMUN, V76, P248, DOI 10.1016/j.bbi.2018.12.005; Bertin E, 2021, MOL PSYCHIATR, V26, P629, DOI 10.1038/s41380-019-0641-8; Bian Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep27093; Brayda-Bruno M, 2018, EUR SPINE J, V27, P2854, DOI 10.1007/s00586-018-5787-6; Butowicz CM, 2020, PAIN MED, V21, P1068, DOI 10.1093/pm/pnz293; Calvo-Munoz I, 2018, CLIN J PAIN, V34, P468, DOI 10.1097/AJP.0000000000000558; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Chen SF, 2017, APOPTOSIS, V22, P626, DOI 10.1007/s10495-017-1358-2; Chen WK, 2020, FREE RADICAL BIO MED, V146, P92, DOI 10.1016/j.freeradbiomed.2019.10.412; Chen X, 2018, FREE RADICAL BIO MED, V126, P187, DOI 10.1016/j.freeradbiomed.2018.08.001; Chesnokova V, 2016, BRAIN BEHAV IMMUN, V58, P1, DOI 10.1016/j.bbi.2016.01.017; Clouet J, 2019, ADV DRUG DELIVER REV, V146, P306, DOI 10.1016/j.addr.2018.04.017; Belache FTC, 2018, J PHYSIOTHER, V64, P192, DOI 10.1016/j.jphys.2018.02.018; de Cossio LF, 2017, BRAIN BEHAV IMMUN, V64, P33, DOI 10.1016/j.bbi.2016.12.022; Dudli S, 2017, EUR SPINE J, V26, P1362, DOI 10.1007/s00586-017-4955-4; Dudli S, 2016, EUR SPINE J, V25, P3723, DOI 10.1007/s00586-016-4459-7; Fields AJ, 2014, SPINE J, V14, P513, DOI 10.1016/j.spinee.2013.06.075; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Frapin L, 2019, ADV DRUG DELIVER REV, V149, P49, DOI 10.1016/j.addr.2019.08.007; Garcia-Cosamalon J, 2010, J ANAT, V217, P1, DOI 10.1111/j.1469-7580.2010.01227.x; Hallegraeff JM, 2020, J PHYSIOTHER, V66, P39, DOI 10.1016/j.jphys.2019.11.011; Karth MM, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00298; Lee S, 2020, J ORTHOP RES, V38, P1238, DOI 10.1002/jor.24560; Li GW, 2018, NEUROPHARMACOLOGY, V133, P181, DOI 10.1016/j.neuropharm.2017.12.035; Liao ZW, 2019, THERANOSTICS, V9, P4084, DOI 10.7150/thno.33638; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Liu DX, 2014, BEHAV BRAIN RES, V264, P9, DOI 10.1016/j.bbr.2014.01.039; Liu L, 2020, FASEB J, V34, P3743, DOI 10.1096/fj.201900393RR; Lotz JC, 2013, GLOB SPINE J, V3, P153, DOI 10.1055/s-0033-1347298; Louvet L, 2020, BONE, V136, DOI 10.1016/j.bone.2020.115361; Lv X., 2021, FASEB J, V35, pE21414; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Ni SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13476-9; Noormohammadpour P, 2019, SPINE, V44, pE357, DOI 10.1097/BRS.0000000000002837; Pearson-Leary J, 2020, MOL PSYCHIATR, V25, P1068, DOI 10.1038/s41380-019-0380-x; Price RB, 2020, MOL PSYCHIATR, V25, P530, DOI 10.1038/s41380-019-0615-x; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Rodriguez AG, 2012, J ORTHOP RES, V30, P280, DOI 10.1002/jor.21513; Simula AS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57105-3; Sun W, 2018, METABOLISM, V88, P61, DOI 10.1016/j.metabol.2018.06.006; Tellegen AR, 2018, J CONTROL RELEASE, V286, P439, DOI 10.1016/j.jconrel.2018.08.019; Traeger AC, 2015, JAMA INTERN MED, V175, P733, DOI 10.1001/jamainternmed.2015.0217; Turk DC, 2015, J PAIN, V16, P1012, DOI 10.1016/j.jpain.2015.07.001; Wang H, 2019, J BONE MINER RES, V34, P1169, DOI 10.1002/jbmr.3677; Wang YL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1054-3; Wang Y, 2011, BONE, V48, P804, DOI 10.1016/j.bone.2010.12.005; Watanabe S, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0062-1; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9; Wuertz K, 2011, SPINE, V36, pE1373, DOI 10.1097/BRS.0b013e318221e655; Yuan YR, 2020, J PSYCHOPHARMACOL, V34, P726, DOI 10.1177/0269881120914221; Zanchi F, 2020, EUR RADIOL, V30, P2583, DOI 10.1007/s00330-019-06626-6; Zehra U, 2019, J ORTHOP RES, V37, P1080, DOI 10.1002/jor.24195; Zhang L, 2018, BIOMED PHARMACOTHER, V104, P300, DOI 10.1016/j.biopha.2018.05.030; Zhu LJ, 2020, BRIT J PHARMACOL, V177, P3674, DOI 10.1111/bph.15084; Zhu SA, 2019, J CLIN INVEST, V129, P1076, DOI 10.1172/JCI121561	61	1	1	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21414	10.1096/fj.202002524R	http://dx.doi.org/10.1096/fj.202002524R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583095	hybrid			2022-12-28	WOS:000629576700014
J	Monteiro, DA; Dole, NS; Campos, JL; Kaya, S; Schurman, CA; Belair, CD; Alliston, T				Monteiro, David A.; Dole, Neha S.; Campos, J. Luke; Kaya, Serra; Schurman, Charles A.; Belair, Cassandra D.; Alliston, Tamara			Fluid shear stress generates a unique signaling response by activating multiple TGF beta family type I receptors in osteocytes	FASEB JOURNAL			English	Article						mechanobiology; microfluidics; osteocytes; TGF-beta	MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION; LATENT TGF-BETA-1; EXPRESSION; STIMULATION; STIFFNESS; ENRICHR	Bone is a dynamic tissue that constantly adapts to changing mechanical demands. The transforming growth factor beta (TGF beta) signaling pathway plays several important roles in maintaining skeletal homeostasis by both coupling the bone-forming and bone-resorbing activities of osteoblasts and osteoclasts and by playing a causal role in the anabolic response of bone to applied loads. However, the extent to which the TGF beta signaling pathway in osteocytes is directly regulated by fluid shear stress (FSS) is unknown, despite work suggesting that fluid flow along canaliculi is a dominant physical cue sensed by osteocytes following bone compression. To investigate the effects of FSS on TGF beta signaling in osteocytes, we stimulated osteocytic OCY454 cells cultured within a microfluidic platform with FSS. We find that FSS rapidly upregulates Smad2/3 phosphorylation and TGF beta target gene expression, even in the absence of added TGF beta. Indeed, relative to treatment with TGF beta, FSS induced a larger increase in levels of pSmad2/3 and Serpine1 that persisted even in the presence of a TGF beta receptor type I inhibitor. Our results show that FSS stimulation rapidly induces phosphorylation of multiple TGF beta family R-Smads by stimulating multimerization and concurrently activating several TGF beta and BMP type I receptors, in a manner that requires the activity of the corresponding ligand. While the individual roles of the TGF beta and BMP signaling pathways in bone mechanotransduction remain unclear, these results implicate that FSS activates both pathways to generate a downstream response that differs from that achieved by either ligand alone.	[Monteiro, David A.; Dole, Neha S.; Campos, J. Luke; Kaya, Serra; Schurman, Charles A.; Alliston, Tamara] Univ Calif San Francisco, Dept Orthopaed Surg, 513 Parnassus Ave,S-1155, San Francisco, CA 94143 USA; [Monteiro, David A.; Schurman, Charles A.; Alliston, Tamara] UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA USA; [Belair, Cassandra D.; Alliston, Tamara] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Belair, Cassandra D.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alliston, T (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, 513 Parnassus Ave,S-1155, San Francisco, CA 94143 USA.	tamara.alliston@ucsf.edu	Kaya, Serra/J-8447-2019	Kaya, Serra/0000-0002-4979-3705; Schurman, Charles/0000-0002-5739-8481; Dole, Neha/0000-0003-4675-2649	National Science Foundation (NSF) [1636331]; HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR) [R01DE019284]; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21AR070403]; U.S. Department of Defense (DOD); National Institutes of Health	National Science Foundation (NSF)(National Science Foundation (NSF)); HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR); HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); U.S. Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Science Foundation (NSF), Grant/Award Number: 1636331; HHS vertical bar NIH vertical bar National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: R01DE019284; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R21AR070403; U.S. Department of Defense (DOD), Grant/Award Number: NDSEG Graduate Fellowship; National Institutes of Health	Albro MB, 2012, OSTEOARTHR CARTILAGE, V20, P1374, DOI 10.1016/j.joca.2012.07.006; Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; Baeyens N, 2016, J CELL BIOL, V214, P807, DOI 10.1083/jcb.201603106; Baeyens N, 2015, ELIFE, V4, DOI 10.7554/eLife.04645; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Budi EH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53490-x; Cabahug-Zuckerman P, 2018, J ORTHOP RES, V36, P642, DOI 10.1002/jor.23792; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Cook LM, 2019, ONCOGENE, V38, P6959, DOI 10.1038/s41388-019-0913-4; Davidson ENB, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; de Kroon LMG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dole NS, 2017, CELL REP, V21, P2585, DOI 10.1016/j.celrep.2017.10.115; Duan D, 2019, J BIOL CHEM, V294, P8490, DOI 10.1074/jbc.RA118.005763; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finnson KW, 2010, OSTEOARTHR CARTILAGE, V18, P1518, DOI 10.1016/j.joca.2010.09.002; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Govey PM, 2015, J BIOMECH, V48, P4327, DOI 10.1016/j.jbiomech.2015.10.045; Govey PM, 2014, J BIOMECH, V47, P1838, DOI 10.1016/j.jbiomech.2014.03.022; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Klingberg F, 2014, J CELL BIOL, V207, P283, DOI 10.1083/jcb.201402006; Kouzbari K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42302-x; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kunnen SJ, 2017, CELL MOL LIFE SCI, V74, P2283, DOI 10.1007/s00018-017-2460-x; Kutmon Martina, 2014, F1000Res, V3, P152, DOI 10.12688/f1000research.4254.2; Kwon SH, 2013, TISSUE ENG PT A, V19, P49, DOI [10.1089/ten.tea.2012.0245, 10.1089/ten.TEA.2012.0245]; Labour MN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35542; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Li J, 2012, J BIOMECH, V45, P247, DOI 10.1016/j.jbiomech.2011.10.037; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyons JS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan5748; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Moore Emily R, 2018, J Mol Biochem, V7, P48; Morrell AE, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0007-x; Nguyen J, 2020, BONE, V131, DOI 10.1016/j.bone.2019.115148; Nguyen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053813; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Rape AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9129; Rys JP, 2016, MATRIX BIOL, V52-54, P413, DOI 10.1016/j.matbio.2016.02.002; Rys JP, 2015, ELIFE, V4, DOI [10.7554/elife.09300, 10.7554/eLife.09300]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Stanley A, 2019, J BONE MINER RES, V34, P1894, DOI 10.1002/jbmr.3760; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Utsunomiya T, 2016, INVEST OPHTH VIS SCI, V57, P6382, DOI 10.1167/iovs.16-20638; Walshe TE, 2013, ARTERIOSCL THROM VAS, V33, P2608, DOI 10.1161/ATVBAHA.113.302161; Wang WG, 2019, P NATL ACAD SCI USA, V116, P15570, DOI 10.1073/pnas.1902927116; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Wittkowske C, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00087; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Xie YF, 2016, BONE, V93, P22, DOI 10.1016/j.bone.2016.09.008; Xu LCH, 2019, J ORTHOP RES, V37, P1681, DOI 10.1002/jor.24302; Yan ZD, 2018, CELL BIOL INT, V42, P1410, DOI 10.1002/cbin.11032; Zhou J, 2012, P NATL ACAD SCI USA, V109, P7770, DOI 10.1073/pnas.1205476109	67	10	10	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21263	10.1096/fj.202001998R	http://dx.doi.org/10.1096/fj.202001998R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570811	hybrid, Green Published			2022-12-28	WOS:000629576700005
J	Ren, ZJ; Lv, MM; Yu, Q; Bao, J; Lou, KX; Li, XJ				Ren, Zhaojun; Lv, Mengmeng; Yu, Qiao; Bao, Jun; Lou, Kexin; Li, Xiujuan			MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-kappa B axis to promote breast cancer progression	FASEB JOURNAL			English	Article						CYLD; extracellular vesicles; fibroblasts; highly metastatic breast cancer cells; miR&#8208; 370&#8208; 3p; NF&#8208; &#954; B	DOWN-REGULATION; EXPRESSION; GROWTH; PROLIFERATION; ANGIOGENESIS; METASTASIS; RESISTANCE; MIGRATION	Breast cancer is a malignancy arising in the mammary epithelial tissues. Recent studies have indicated the abundance of microRNAs (miRNAs) in extracellular vesicles (EVs), and their interactions have been illustrated to exert crucial roles in the cell-to-cell communication. The present study focused on investigating whether EV-delivered miR-370-3p affects breast cancer. Initially, the miR-370-3p expression pattern was examined in the cancer-associated fibroblasts (CAFs), normal fibroblasts (NFs), and cancerous cells-derived EVs. The relation of miR-370-3p to CYLD was assessed using luciferase activity assay. Afterwards, based on ectopic expression and depletion experiments in the MCF-7 breast cancer cells, we evaluated stemness, migration, invasion, and sphere formation ability, and EMT, accompanied with measurement on the expression patterns of pro-inflammatory factors and nuclear factor-kappa B (NF-kappa B) signaling-related genes. Finally, tumorigenesis and proliferation were analyzed in vivo using a nude mouse xenograft model. The in vitro experiments revealed that breast cancer cell-derived EVs promoted NF activation, while activated fibroblasts contributed to enhanced stemness, migration, invasion, as well as EMT of cancerous cells. In addition, EVs could transfer miR-370-3p from breast cancer cells to NFs, and EV-encapsulated miR-370-3p was also found to facilitate fibroblast activation. Mechanistically, EV-encapsulated miR-370-3p downregulated the expression of CYLD through binding to its 3 ' UTR and activated the NF-kappa B signaling pathway, thereby promoting the cellular functions in vitro and in vivo in breast cancer. Taken together, EVs secreted by breast cancer cells could carry miR-370-3p to aggravate breast cancer through downregulating CYLD expression and activating the NF-kappa B signaling pathway.	[Ren, Zhaojun; Lou, Kexin] Nanjing Med Univ, Dept Pathol, Jiangsu Canc Hosp, Nanjing, Peoples R China; [Ren, Zhaojun; Lv, Mengmeng; Yu, Qiao; Bao, Jun; Lou, Kexin; Li, Xiujuan] Nanjing Med Univ, Jiangsu Inst Canc Res, 42 Baziting, Nanjing 210009, Jiangsu, Peoples R China; [Ren, Zhaojun; Lv, Mengmeng; Yu, Qiao; Bao, Jun; Lou, Kexin; Li, Xiujuan] Nanjing Med Univ, Affiliated Canc Hosp, 42 Baziting, Nanjing 210009, Jiangsu, Peoples R China; [Lv, Mengmeng] Nanjing Med Univ, Jiangsu Canc Hosp, Dept Gynecol Oncol, Nanjing, Peoples R China; [Yu, Qiao; Li, Xiujuan] Nanjing Med Univ, Jiangsu Canc Hosp, Dept Gen Surg, 42 Baziting, Nanjing 210009, Jiangsu, Peoples R China; [Bao, Jun] Nanjing Med Univ, Jiangsu Canc Hosp, Dept Med Oncol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Li, XJ (corresponding author), Nanjing Med Univ, Jiangsu Inst Canc Res, 42 Baziting, Nanjing 210009, Jiangsu, Peoples R China.; Li, XJ (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, 42 Baziting, Nanjing 210009, Jiangsu, Peoples R China.; Li, XJ (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Dept Gen Surg, 42 Baziting, Nanjing 210009, Jiangsu, Peoples R China.	szlxj88@163.com	li, xiu/GXV-1745-2022		NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [81702612, 81702895]; Young Talent Program of Jiangsu Cancer Hospital [2017YQL-17]; Nanjing International Scientific and Technological Cooperation Foundation [201911036]	NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); Young Talent Program of Jiangsu Cancer Hospital; Nanjing International Scientific and Technological Cooperation Foundation	NSFC vertical bar National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81702612 & 81702895 and 81702895; Young Talent Program of Jiangsu Cancer Hospital, Grant/Award Number: 2017YQL-17; Nanjing International Scientific and Technological Cooperation Foundation, Grant/Award Number: 201911036	Anastasiadi Z, 2017, UPDATES SURG, V69, P313, DOI 10.1007/s13304-017-0424-1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Che SPY, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00261; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Curtis M, 2019, CELL METAB, V29, P141, DOI 10.1016/j.cmet.2018.08.007; Darwish NHE, 2019, MOLECULES, V24, DOI 10.3390/molecules24112103; Dorsam B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01358; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Hayashi M, 2014, BREAST CANCER RES TR, V143, P447, DOI 10.1007/s10549-013-2824-3; He LL, 2019, CANCER RES, V79, P4399, DOI 10.1158/0008-5472.CAN-19-0012; Huang L, 2019, DNA CELL BIOL, V38, P501, DOI 10.1089/dna.2018.4602; Huynh PT, 2016, INT J CANCER, V138, P1971, DOI 10.1002/ijc.29939; Ivey KN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a008144; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Krzysiek-Maczka G, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12653; Kwa M, 2017, NAT REV CLIN ONCOL, V14, P595, DOI 10.1038/nrclinonc.2017.74; Lahav TG, 2019, INT J CANCER, V145, P2521, DOI 10.1002/ijc.32521; Lehuede C, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-018-1088-6; Lynch MD, 2018, J CLIN INVEST, V128, P26, DOI 10.1172/JCI93555; Ma CB, 2019, MOL CELLS, V42, P628, DOI 10.14348/molcells.2019.0038; Rivero EM, 2017, CURR CANCER DRUG TAR, V17, P756, DOI 10.2174/1568009617666170330151415; Ni F, 2016, ONCOL LETT, V11, P1155, DOI 10.3892/ol.2015.3993; Orfanidou T, 2017, ANTICANCER RES, V37, P3493, DOI 10.21873/anticanres.11717; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Qi X, 2016, INT J BIOL SCI, V12, P836, DOI 10.7150/ijbs.14809; Sato Y, 2015, NAT STRUCT MOL BIOL, V22, P222, DOI 10.1038/nsmb.2970; Schulte J, 2012, HISTOCHEM CELL BIOL, V138, P847, DOI 10.1007/s00418-012-0998-0; Shen M, 2019, CANCER RES, V79, P3608, DOI 10.1158/0008-5472.CAN-18-4055; Sim J, 2015, J BREAST CANCER, V18, P323, DOI 10.4048/jbc.2015.18.4.323; Song HM, 2018, BMB REP, V51, P602, DOI 10.5483/BMBRep.2018.51.11.168; Szvicsek Z, 2019, CELL MOL LIFE SCI, V76, P2463, DOI 10.1007/s00018-019-03052-1; Tawara K, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0971-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang XF, 2018, CANCER RES, V78, P4586, DOI 10.1158/0008-5472.CAN-17-3841; Xiao B, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6068-4; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Zhang LM, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1722-9; Zhang X, 2019, J BUON, V24, P897; Zhao YL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317692264; Zhu J, 2017, GENE, V607, P23, DOI 10.1016/j.gene.2016.12.026	41	9	9	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21383	10.1096/fj.202001430RR	http://dx.doi.org/10.1096/fj.202001430RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33629796				2022-12-28	WOS:000629576700004
J	van Bodegraven, EJ; Sluijs, JA; Tan, AK; Robe, PAJT; Hol, EM				van Bodegraven, Emma J.; Sluijs, Jacqueline A.; Tan, A. Katherine; Robe, Pierre A. J. T.; Hol, Elly M.			New GFAP splice isoform (GFAP mu) differentially expressed in glioma translates into 21 kDa N-terminal GFAP protein	FASEB JOURNAL			English	Article						GFAP; glioma; alternative splicing; GFAP isoforms; intermediate filaments	FIBRILLARY ACIDIC PROTEIN; ALTERNATIVE CLEAVAGE; CELLS; POLYADENYLATION; TRANSCRIPTION; ASTROCYTES; FILAMENTS; IDENTIFICATION; INTERACTS; MOTILITY	The glial fibrillary acidic protein (GFAP) is a type III intermediate filament (IF) protein that is highly expressed in astrocytes, neural stem cells, and in gliomas. Gliomas are a heterogeneous group of primary brain tumors that arise from glia cells or neural stem cells and rely on accurate diagnosis for prognosis and treatment strategies. GFAP is differentially expressed between glioma subtypes and, therefore, often used as a diagnostic marker. However, GFAP is highly regulated by the process of alternative splicing; many different isoforms have been identified. Differential expression of GFAP isoforms between glioma subtypes suggests that GFAP isoform-specific analyses could benefit diagnostics. In this study we report on the differential expression of a new GFAP isoform between glioma subtypes, GFAP mu. A short GFAP transcript resulting from GFAP exon 2 skipping was detected by RNA sequencing of human glioma. We show that GFAP mu mRNA is expressed in healthy brain tissue, glioma cell lines, and primary glioma cells and that it translates into a similar to 21 kDa GFAP protein. 21 kDa GFAP protein was detected in the IF protein fraction isolated from human spinal cord as well. We further show that induced GFAFP mu expression disrupts the GFAP IF network. The characterization of this new GFAP isoform adds on to the numerous previously identified GFAP splice isoforms. It emphasizes the importance of studying the contribution of IF splice variants to specialized functions of the IF network and to glioma research.	[van Bodegraven, Emma J.; Sluijs, Jacqueline A.; Tan, A. Katherine; Hol, Elly M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr, Utrecht, Netherlands; [Tan, A. Katherine; Robe, Pierre A. J. T.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Bodegraven, EJ; Hol, EM (corresponding author), Univ Med Ctr Utrecht, Translat Neurosci, Brain Ctr Rudolf Magnus, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	e.m.hol-2@umcutrecht.nl	Hol, Elly M/F-1891-2013	Hol, Elly M/0000-0001-5604-2603; van Bodegraven, Emma J./0000-0002-3796-2516	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [865.09.003]; KWF Kankerbestrijding (Dutch Cancer Society) [KWF 10123]; TP Bohnenn fund	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); KWF Kankerbestrijding (Dutch Cancer Society); TP Bohnenn fund	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: 865.09.003; KWF Kankerbestrijding (Dutch Cancer Society), Grant/Award Number: KWF 10123; T&P Bohnenn fund	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Blechingberg J, 2007, NUCLEIC ACIDS RES, V35, P7636, DOI 10.1093/nar/gkm931; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Chen L, 2011, HUM MOL GENET, V20, P4422, DOI 10.1093/hmg/ddr370; CHEN WJ, 1994, J CELL SCI, V107, P2299; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Dunbar E, 2010, ADV ANAT PATHOL, V17, P187, DOI 10.1097/PAP.0b013e3181d98cd9; Dvinge H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0168-9; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Helman G, 2020, HUM MUTAT, V41, P1131, DOI 10.1002/humu.24008; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hol EM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a021642; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Jorgens DM, 2017, J CELL SCI, V130, P177, DOI 10.1242/jcs.190967; Kanski R, 2014, J CELL SCI, V127, P4368, DOI 10.1242/jcs.145912; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Moeton M, 2016, CELL MOL LIFE SCI, V73, P4101, DOI 10.1007/s00018-016-2239-5; Moeton M, 2014, FASEB J, V28, P2942, DOI 10.1096/fj.13-245837; Morris AR, 2012, CLIN CANCER RES, V18, P5256, DOI 10.1158/1078-0432.CCR-12-0543; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Perry Arie, 2016, Handb Clin Neurol, V134, P71, DOI 10.1016/B978-0-12-802997-8.00005-0; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Stassen OMJA, 2017, ONCOTARGET, V8, P88104, DOI 10.18632/oncotarget.21540; van Bodegraven EJ, 2019, FASEB J, V33, P12941, DOI 10.1096/fj.201900916R; van Bodegraven EJ, 2019, GLIA, V67, P1417, DOI 10.1002/glia.23594; van Strien ME, 2014, STEM CELL TRANSL MED, V3, P470, DOI 10.5966/sctm.2013-0038; VELASCO ME, 1980, CANCER, V45, P484, DOI 10.1002/1097-0142(19800201)45:3<484::AID-CNCR2820450312>3.0.CO;2-9; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P	41	3	3	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21389	10.1096/fj.202001767R	http://dx.doi.org/10.1096/fj.202001767R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583081	hybrid			2022-12-28	WOS:000629576700010
J	Luque, GM; Xu, XR; Romarowski, A; Gervasi, MG; Orta, G; De la Vega-Beltran, JL; Stival, C; Gilio, N; Dalotto-Moreno, T; Krapf, D; Visconti, PE; Krapf, D; Darszon, A; Buffone, MG				Luque, Guillermina M.; Xu, Xinran; Romarowski, Ana; Gervasi, Maria G.; Orta, Gerardo; De la Vega-Beltran, Jose L.; Stival, Cintia; Gilio, Nicolas; Dalotto-Moreno, Tomas; Krapf, Dario; Visconti, Pablo E.; Krapf, Diego; Darszon, Alberto; Buffone, Mariano G.			Cdc42 localized in the CatSper signaling complex regulates cAMP-dependent pathways in mouse sperm	FASEB JOURNAL			English	Article						calcium; capacitation; hyperactivation; sperm; super-resolution	TYROSINE PHOSPHORYLATION; ACTIN POLYMERIZATION; ION CHANNELS; RHO GTPASES; TRANSMEMBRANE PROTEIN; FERTILIZING-CAPACITY; ACROSOME REACTION; CA2+ CHANNEL; GUINEA-PIG; SPERMATOZOA	Sperm acquire the ability to fertilize in a process called capacitation and undergo hyperactivation, a change in the motility pattern, which depends on Ca2+ transport by CatSper channels. CatSper is essential for fertilization and it is subjected to a complex regulation that is not fully understood. Here, we report that similar to CatSper, Cdc42 distribution in the principal piece is confined to four linear domains and this localization is disrupted in CatSper1-null sperm. Cdc42 inhibition impaired CatSper activity and other Ca2+-dependent downstream events resulting in a severe compromise of the sperm fertilizing potential. We also demonstrate that Cdc42 is essential for CatSper function by modulating cAMP production by soluble adenylate cyclase (sAC), providing a new regulatory mechanism for the stimulation of CatSper by the cAMP-dependent pathway. These results reveal a broad mechanistic insight into the regulation of Ca2+ in mammalian sperm, a matter of critical importance in male infertility as well as in contraception.	[Luque, Guillermina M.; Romarowski, Ana; Gilio, Nicolas; Dalotto-Moreno, Tomas; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina; [Xu, Xinran; Krapf, Diego] Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA; [Romarowski, Ana; Gervasi, Maria G.; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Orta, Gerardo; De la Vega-Beltran, Jose L.; Darszon, Alberto] UNAM, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Stival, Cintia; Krapf, Dario] UNR, CONICET, Inst Biol Mol & Celular Rosario, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Colorado State University; University of Massachusetts System; University of Massachusetts Amherst; Universidad Nacional Autonoma de Mexico; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Buffone, MG (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	mgbuffone@ibyme.conicet.gov.ar	Luque, Guillermina/M-9237-2019	Luque, Guillermina/0000-0002-2745-8236; Gervasi, Maria Gracia/0000-0002-5468-2700; Darszon, Alberto/0000-0002-2502-0505	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2015-2294, 2015-3164, 2017-3047, 2018-1988]; Williams Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACyT - Mexico Fronteras 71); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM [PAPIIT/DGAPA IN205516]; UNAM/DGAPA; IGC; Rene Baron Foundation	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Williams Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACyT - Mexico Fronteras 71); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); UNAM/DGAPA(Universidad Nacional Autonoma de Mexico); IGC; Rene Baron Foundation	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2015-2294, 2015-3164, 2017-3047, 2018-1988), the Williams and Rene Baron Foundations, the Consejo Nacional de Ciencia y Tecnologia (CONACyT - Mexico Fronteras 71) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM (PAPIIT/DGAPA IN205516). Part of this work was performed, while AD was carrying out a sabbatical at the Instituto Gulbenkian de Ciencia (IGC) supported by UNAM/DGAPA and IGC	Alvau A, 2016, DEVELOPMENT, V143, P2325, DOI 10.1242/dev.136499; Angeles-Floriano T, 2016, MOL REPROD DEV, V83, P1015, DOI 10.1002/mrd.22736; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; Avidan N, 2003, EUR J HUM GENET, V11, P497, DOI 10.1038/sj.ejhg.5200991; Balbach M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.572735; Baltierrez-Hoyos R, 2012, REPRODUCTION, V144, P123, DOI 10.1530/REP-11-0433; Barratt CLR, 2012, EMBO J, V31, P1624, DOI 10.1038/emboj.2012.62; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Campagnola G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17721; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chapin RE, 2001, J ANDROL, V22, P1030; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen SR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.65; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Delgado-Buenrostro NL, 2005, MOL REPROD DEV, V70, P198, DOI 10.1002/mrd.20192; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; DEMOTT RP, 1992, BIOL REPROD, V46, P779, DOI 10.1095/biolreprod46.5.779; Dey S, 2020, FASEB J, V34, P1247, DOI 10.1096/fj.201902163R; Ducummon CC, 2006, ZYGOTE, V14, P249, DOI 10.1017/S0967199406003790; Ernesto JI, 2015, J CELL BIOL, V210, P1213, DOI 10.1083/jcb.201412041; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Fujita A, 2000, J CELL SCI, V113, P103; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gervasi MG, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215897; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Hwang JY, 2019, CELL, V177, P1480, DOI 10.1016/j.cell.2019.03.047; Izeddin I, 2012, OPT EXPRESS, V20, P4957, DOI 10.1364/OE.20.004957; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kirichok Y, 2011, MOL HUM REPROD, V17, P478, DOI 10.1093/molehr/gar044; Lishko PV, 2018, CURR OPIN PHYSIOL, V2, P109, DOI 10.1016/j.cophys.2018.02.004; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Liu T, 2010, FERTIL STERIL, V93, P1556, DOI 10.1016/j.fertnstert.2009.03.056; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Lopez-Gonzalez I, 2014, MOL HUM REPROD, V20, P619, DOI 10.1093/molehr/gau029; Luque GM, 2018, J CELL PHYSIOL, V233, P9685, DOI 10.1002/jcp.26883; Miller Melissa R, 2018, Cell Rep, V24, P2606, DOI 10.1016/j.celrep.2018.08.016; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Miller MR, 2015, CELL CALCIUM, V58, P105, DOI 10.1016/j.ceca.2014.10.009; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; Navarrete FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33589; Navarrete FA, 2015, J CELL PHYSIOL, V230, P1758, DOI 10.1002/jcp.24873; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Orta G, 2018, J BIOL CHEM, V293, P16830, DOI 10.1074/jbc.RA117.001566; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Peterson JR, 2006, CHEM BIOL, V13, P443, DOI 10.1016/j.chembiol.2006.02.009; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Razani B, 2001, J BIOL CHEM, V276, P38121; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Romarowski A, 2015, DEV BIOL, V405, P237, DOI 10.1016/j.ydbio.2015.07.008; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; STAUSS CR, 1995, BIOL REPROD, V53, P1280, DOI 10.1095/biolreprod53.6.1280; Stival C, 2018, J BIOL CHEM, V293, P9435, DOI 10.1074/jbc.RA118.002286; Suarez SS, 2003, CELL MOL BIOL, V49, P351; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; Torres-Flores V, 2011, HUM REPROD, V26, P2626, DOI 10.1093/humrep/der237; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Wang HK, 2009, BIOL REPROD, V81, P539, DOI 10.1095/biolreprod.109.077107; Wang T, 2020, J BIOL CHEM, V295, P13181, DOI 10.1074/jbc.RA120.013218; Wang XF, 2003, NAT CELL BIOL, V5, P902, DOI 10.1038/ncb1047; Weigel AV, 2011, P NATL ACAD SCI USA, V108, P6438, DOI 10.1073/pnas.1016325108; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107	78	3	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21723	10.1096/fj.202002773RR	http://dx.doi.org/10.1096/fj.202002773RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34224609	Green Published			2022-12-28	WOS:000678975300049
J	Wang, HM; Bu, SY; Tang, JJ; Li, Y; Liu, CH; Dong, JH				Wang, Hongmei; Bu, Siyuan; Tang, Jiajian; Li, Yi; Liu, Chunhua; Dong, Junhong			PTPN5 promotes follicle-stimulating hormone secretion through regulating intracellular calcium homeostasis	FASEB JOURNAL			English	Article						calcium channel; FSH secretion; GnRH; OVX; PTPN5	PROTEIN-TYROSINE-PHOSPHATASE; GENE-EXPRESSION; RECEPTOR; STEP; FSH; MECHANISMS; PHYSIOLOGY; RELEASE; ALPHA; LH	Protein tyrosine phosphatase non-receptor type 5 (PTPN5), also called striatal-enriched protein tyrosine phosphatase (STEP), is highly expressed in neurons of the basal ganglia, hippocampus, cortex, and related structures, also in the pituitary. Gonadotropins are the key regulator of the reproduction in mammals. In this study, PTPN5 is detected to express in murine pituitary in a developmental manner. Moreover, the expression of PTPN5 in the pituitary is heavily reduced after ovary removal. Follicle-stimulating hormone (FSH) secretion in gonadotropes is regulated by PTPN5 via binding GnRH to GnRH-R. Two parallel signaling pathways, Gs-protein kinase A (PKA)-PTPN5 and Gq-phospholipases C (PLC)-p38 MAPK-PTPN5, cooperatively regulate GnRH-induced FSH secretion. We also show that influx of Ca2+ activates the Ca2+-dependent phosphatase calcineurin, leading to the phosphorylation and activation of PTPN5. The intracellular release of Ca2+ is reduced via TC2153. In conclusion, blocking or knocking out of PTPN5 reduces the release of FSH in whole pituitary. Mechanically, PTPN5 regulates gonadotropes' function through regulating intracellular calcium homeostasis.	[Wang, Hongmei; Bu, Siyuan; Tang, Jiajian] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Peoples R China; [Li, Yi] Shandong First Med Univ, Shandong Prov Hosp, Dept Joint Surg, Jinan, Peoples R China; [Liu, Chunhua] Shandong First Med Univ, Dept Physiol, Tai An 271000, Shandong, Peoples R China; [Dong, Junhong] Weifang Med Univ, Sch Basic Med, Dept Biochem, Weifang 261021, Shandong, Peoples R China	Southeast University - China; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Weifang Medical University	Liu, CH (corresponding author), Shandong First Med Univ, Dept Physiol, Tai An 271000, Shandong, Peoples R China.; Dong, JH (corresponding author), Weifang Med Univ, Sch Basic Med, Dept Biochem, Weifang 261021, Shandong, Peoples R China.	chhliu@sdfmu.edu.cn; djh196@163.com	wang, hongmei/HGT-7374-2022	wang, hongmei/0000-0002-6975-9467	National Natural Science Foundation of China (NSFC) [81602327, 81700473]; Funds for Zhishan Young Scholars [2242021R41070]; National Key Research and Development Program of China [2017YFA0104303]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Funds for Zhishan Young Scholars; National Key Research and Development Program of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81602327 and 81700473; The Funds for Zhishan Young Scholars, Grant/Award Number: 2242021R41070; The National Key Research and Development Program of China, Grant/Award Number: 2017YFA0104303	Anderson RC, 2018, ENDOCR REV, V39, P911, DOI 10.1210/er.2018-00052; Auernhammer CJ, 2007, PITUITARY, V10, P1, DOI 10.1007/s11102-007-0001-6; Beck A, 2017, ENDOCRINOLOGY, V158, P887, DOI 10.1210/en.2016-1810; Belkacemi A, 2018, CELL REP, V22, P1339, DOI 10.1016/j.celrep.2018.01.010; Bosco F, 2018, MOL NEUROBIOL, V55, P8084, DOI 10.1007/s12035-018-0980-5; Casarini L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072270; Garcia-Campayo V, 2001, ENDOCRINOLOGY, V142, P5203, DOI 10.1210/en.142.12.5203; Goebel-Goody SM, 2012, PHARMACOL REV, V64, P65, DOI 10.1124/pr.110.003053; Gotz V, 2017, CELL CALCIUM, V67, P138, DOI 10.1016/j.ceca.2017.04.004; Holesh JE., 2021, STATPEARLS; Inada Masaki, 2011, Clin Calcium, V21, P164, DOI CliCa1102164170; Jonak CR, 2018, ENDOCRINOLOGY, V159, P1496, DOI 10.1210/en.2017-00844; Kamceva M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8136925; Karigo T, 2014, ENDOCRINOLOGY, V155, P536, DOI 10.1210/en.2013-1642; Kim HJ, 2011, J ENDOCRINOL, V210, P309, DOI 10.1530/JOE-11-0098; Kulikov AV, 2012, PSYCHOPHARMACOLOGY, V221, P469, DOI 10.1007/s00213-011-2594-8; Kulikova EA, 2018, NEUROSCIENCE, V394, P220, DOI 10.1016/j.neuroscience.2018.10.031; Kulikova E, 2017, CURR PROTEIN PEPT SC, V18, P1152, DOI 10.2174/1389203718666170710121532; La Vignera S, 2019, EUR REV MED PHARMACO, V23, P5994, DOI 10.26355/eurrev_201907_18346; Ligon B, 1998, J BIOL CHEM, V273, P13905, DOI 10.1074/jbc.273.22.13905; Lunenfeld B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00429; Morselli E, 2018, AM J PHYSIOL-ENDOC M, V315, pE7, DOI 10.1152/ajpendo.00473.2017; Mukherjee S, 2011, BIOCHEM J, V440, P115, DOI 10.1042/BJ20110240; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; Ohta T, 2010, BIOCHEM BIOPH RES CO, V394, P464, DOI 10.1016/j.bbrc.2010.01.036; Omiya T, 2018, BONE, V107, P18, DOI 10.1016/j.bone.2017.10.021; OYAMA T, 1995, NEUROSCIENCE, V69, P869, DOI 10.1016/0306-4522(95)00278-Q; Panagiotakos G, 2019, ELIFE, V8, DOI 10.7554/eLife.51037; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pelov I, 2012, PSYCHIAT GENET, V22, P168, DOI 10.1097/YPG.0b013e3283518586; Qiao S, 2016, ENDOCRINOLOGY, V157, P1082, DOI 10.1210/en.2015-1836; Quinn MA, 2018, CELL REP, V22, P2690, DOI 10.1016/j.celrep.2018.02.041; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Ramracheya R, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13852; Roper LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9645; Shacham S, 2001, VITAM HORM, V63, P63, DOI 10.1016/S0083-6729(01)63003-6; Shioda T, 1996, P NATL ACAD SCI USA, V93, P12298, DOI 10.1073/pnas.93.22.12298; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Simoni M, 2020, ANDROLOGY-US, V8, P535, DOI 10.1111/andr.12746; Song Y, 2016, J CLIN ENDOCR METAB, V101, P253, DOI 10.1210/jc.2015-2724; Stamatiades GA, 2018, MOL CELL ENDOCRINOL, V463, P131, DOI 10.1016/j.mce.2017.10.015; Taneja C, 2019, J MOL ENDOCRINOL, V63, pR73, DOI 10.1530/JME-19-0152; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; van den Brand AD, 2019, MOL CELL ENDOCRINOL, V496, DOI 10.1016/j.mce.2019.110520; Yang CH, 2012, J NEUROSCI, V32, P7550, DOI 10.1523/JNEUROSCI.5902-11.2012	48	0	0	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21756	10.1096/fj.202002752RR	http://dx.doi.org/10.1096/fj.202002752RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34270805				2022-12-28	WOS:000678975300007
J	Milicevic, N; Hakkari, OAH; Bagchi, U; Sandu, C; Jongejan, A; Moerland, PD; ten Brink, JB; Hicks, D; Bergen, AA; Felder-Schmittbuhl, MP				Milicevic, Nemanja; Hakkari, Ouafa Ait-Hmyed; Bagchi, Udita; Sandu, Cristina; Jongejan, Aldo; Moerland, Perry D.; ten Brink, Jacoline B.; Hicks, David; Bergen, Arthur A.; Felder-Schmittbuhl, Marie-Paule			Core circadian clock genes Per1 and Per2 regulate the rhythm in photoreceptor outer segment phagocytosis	FASEB JOURNAL			English	Article						circadian rhythm; clock gene; phagocytosis; photoreceptor; photoreceptor outer segment; retinal pigment epithelium	ARVICANTHIS-ANSORGEI; MAMMALIAN RETINA; ROD; EXPRESSION; ORGANIZATION; CELLS; MERTK; MPER2; COMPONENTS; MUTATIONS	Retinal photoreceptors undergo daily renewal of their distal outer segments, a process indispensable for maintaining retinal health. Photoreceptor outer segment (POS) phagocytosis occurs as a daily peak, roughly about 1 hour after light onset. However, the underlying cellular and molecular mechanisms which initiate this process are still unknown. Here we show that, under constant darkness, mice deficient for core circadian clock genes (Per1 and Per2) lack a daily peak in POS phagocytosis. By qPCR analysis, we found that core clock genes were rhythmic over 24 hours in both WT and Per1, Per2 double mutant whole retinas. More precise transcriptomics analysis of laser capture microdissected WT photoreceptors revealed no differentially expressed genes between time points preceding and during the peak of POS phagocytosis. In contrast, we found that microdissected WT retinal pigment epithelium (RPE) had a number of genes that were differentially expressed at the peak phagocytic time point compared to adjacent ones. We also found a number of differentially expressed genes in Per1, Per2 double mutant RPE compared to WT ones at the peak phagocytic time point. Finally, based on STRING analysis, we found a group of interacting genes that potentially drive POS phagocytosis in the RPE. This potential pathway consists of genes such as: Pacsin1, Syp, Camk2b, and Camk2d among others. Our findings indicate that Per1 and Per2 are necessary clock components for driving POS phagocytosis and suggest that this process is transcriptionally driven by the RPE.	[Milicevic, Nemanja; Bagchi, Udita; ten Brink, Jacoline B.; Bergen, Arthur A.] Univ Amsterdam, Dept Clin Genet, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Milicevic, Nemanja; Hakkari, Ouafa Ait-Hmyed; Bagchi, Udita; Sandu, Cristina; Hicks, David; Felder-Schmittbuhl, Marie-Paule] Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, 8 Allee Gen Rouvillois, F-67000 Strasbourg, France; [Jongejan, Aldo; Moerland, Perry D.] Amsterdam UMC, Dept Epidemiol & Data Sci, Bioinformat Lab, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Bergen, Arthur A.] Univ Amsterdam, Dept Ophthalmol, Amsterdam UMC, Amsterdam, Netherlands; [Bergen, Arthur A.] Netherlands Inst Neurosci NIN KNAW, Amsterdam, Netherlands	University of Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Bergen, AA (corresponding author), Univ Amsterdam, Dept Clin Genet, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Felder-Schmittbuhl, MP (corresponding author), Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, 8 Allee Gen Rouvillois, F-67000 Strasbourg, France.	aabergen@amsterdamumc.nl; feldermp@inci-cnrs.unistra.fr	Milićević, Nemanja/AAM-2103-2021; Moerland, Perry/AAG-1425-2020	Milićević, Nemanja/0000-0002-8062-7270; Moerland, Perry/0000-0002-2357-3659; Jongejan, Aldo/0000-0002-8948-2549; Felder-Schmittbuhl, Marie-Paule/0000-0003-3539-1243; Bergen, Arthur/0000-0002-6333-9576; BAGCHI, UDITA/0000-0001-7726-0319	NeuroTime Erasmus+ grant (European Union); Rotterdamse Stichting Blindenbelangen (Netherlands); Nelly Reef fund (Netherlands); Stichting voor Ooglijders (Netherlands); Stichting tot Verbetering van het Lot der Blinden (Netherlands); Retina France (France)	NeuroTime Erasmus+ grant (European Union); Rotterdamse Stichting Blindenbelangen (Netherlands)(Netherlands Government); Nelly Reef fund (Netherlands); Stichting voor Ooglijders (Netherlands); Stichting tot Verbetering van het Lot der Blinden (Netherlands); Retina France (France)	We thank Anneloor LMA ten Asbroek and Nguyen-Vy Vo for technical assistance. We thank Dr D. Sage, Dr S. Reibel and N. Lethenet from the Chronobiotron (UMS 3415) for animal care and Dr U. Albrecht (University of Freiburg) for the Per1<SUP>-/-</SUP>Per2<SUP>Brdm1</SUP> mice. This project has been funded with support from the NeuroTime Erasmus+ grant (European Union), Rotterdamse Stichting Blindenbelangen (Netherlands), Nelly Reef fund (Netherlands), Stichting voor Ooglijders (Netherlands), Stichting tot Verbetering van het Lot der Blinden (Netherlands), and Retina France (France).	Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baba K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05394-x; Baba K, 2010, MOL VIS, V16, P2605; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; Bobu C, 2006, INVEST OPHTH VIS SCI, V47, P3109, DOI 10.1167/iovs.05-1397; Bobu C, 2013, MOL VIS, V19, P1060; Bobu C, 2009, INVEST OPHTH VIS SCI, V50, P3495, DOI 10.1167/iovs.08-3145; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Daiger S. P., 1998, IOVS, V39, pS295; DeVera C., 2020, CIRCADIAN CLOCK RETI, DOI [10.1101/2020.12.02.408799, DOI 10.1101/2020.12.02.408799]; DeVera C, 2020, EXP EYE RES, V193, DOI 10.1016/j.exer.2020.107988; Esposito NJ, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.2.7; Farkas MH, 2014, AM J PATHOL, V184, P2641, DOI 10.1016/j.ajpath.2014.06.026; Felder-Schmittbuhl MP, 2018, INVEST OPHTH VIS SCI, V59, P4856, DOI 10.1167/iovs.18-24957; FISHER SK, 1983, INVEST OPHTH VIS SCI, V24, P844; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Goyal V, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.5.10; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Hiragaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106819; Ikarashi R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44175; Jaeger C, 2015, FASEB J, V29, P1493, DOI 10.1096/fj.14-261214; Johansson JK, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0681-1; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko GYP, 2020, EUR J NEUROSCI, V51, P194, DOI 10.1111/ejn.14185; Krigel A, 2010, MOL VIS, V16, P2873; Laurent V, 2017, EXP EYE RES, V165, P90, DOI 10.1016/j.exer.2017.09.007; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Law AL, 2015, J BIOL CHEM, V290, P4941, DOI 10.1074/jbc.M114.628297; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; Louer EMM, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.5.49; Louer EMM, 2020, EXP EYE RES, V193, DOI 10.1016/j.exer.2020.107985; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mazzoni F, 2019, METHODS MOL BIOL, V1834, P95, DOI 10.1007/978-1-4939-8669-9_7; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Milicevic N, 2020, EXP EYE RES, V190, DOI 10.1016/j.exer.2019.107861; Milicevic N, 2019, CHRONOBIOL INT, V36, P1592, DOI 10.1080/07420528.2019.1653317; Milicevic N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48203-3; Morioka E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00108; Muller C, 2014, CELL SIGNAL, V26, P968, DOI 10.1016/j.cellsig.2013.12.021; Muller C, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P47, DOI 10.1007/978-3-030-28384-1_3; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Sayols S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1276-2; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang Y, 2015, METAB BRAIN DIS, V30, P943, DOI 10.1007/s11011-015-9653-5; TERMAN JS, 1993, BRAIN RES, V605, P256; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Wilson T., 1995, P167; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105; Zhang DQ, 2005, BRAIN RES, V1050, P101, DOI 10.1016/j.brainres.2005.05.042; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	76	12	12	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21722	10.1096/fj.202100293RR	http://dx.doi.org/10.1096/fj.202100293RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160105	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000667814100061
J	Di Tomo, P; Alessio, N; Falone, S; Pietrangelo, L; Lanuti, P; Cordone, V; Santini, SJ; Di Pietrantonio, N; Marchisio, M; Protasi, F; Di Pietro, N; Formoso, G; Amicarelli, F; Galderisi, U; Pandolfi, A				Di Tomo, Pamela; Alessio, Nicola; Falone, Stefano; Pietrangelo, Laura; Lanuti, Paola; Cordone, Valeria; Santini, Silvano Junior; Di Pietrantonio, Nadia; Marchisio, Marco; Protasi, Feliciano; Di Pietro, Natalia; Formoso, Gloria; Amicarelli, Fernanda; Galderisi, Umberto; Pandolfi, Assunta			Endothelial cells from umbilical cord of women affected by gestational diabetes: A suitable in vitro model to study mechanisms of early vascular senescence in diabetes	FASEB JOURNAL			English	Article						endothelium; gestational diabetes; mitochondria; oxidative stress; senescence	NF-KAPPA-B; OXIDATIVE STRESS; HIGH-GLUCOSE; SUPEROXIDE-DISMUTASE; CELLULAR SENESCENCE; LIPID-PEROXIDATION; GENE-EXPRESSION; DYSFUNCTION; HYPERGLYCEMIA; MELLITUS	Human umbilical cord endothelial cells (HUVECs) obtained from women affected by gestational diabetes (GD-HUVECs) display durable pro-atherogenic modifications and might be considered a valid in vitro model for studying chronic hyperglycemia effects on early endothelial senescence. Here, we demonstrated that GD- compared to C-HUVECs (controls) exhibited oxidative stress, altered both mitochondrial membrane potential and antioxidant response, significant increase of senescent cells characterized by a reduced NAD-dependent deacetylase sirtuin-1 (SIRT1) activity together with an increase in cyclin-dependent kinase inhibitor-2A (P16), cyclin-dependent kinase inhibitor-1 (P21), and tumor protein p53 (P53) acetylation. This was associated with the p300 activation, and its silencing significantly reduced the GD-HUVECs increased protein levels of P300 and Ac-P53 thus indicating a persistent endothelial senescence via SIRT1/P300/P53/P21 pathway. Overall, our data suggest that GD-HUVECs can represent an "endothelial hyperglycemic memory" model to investigate in vitro the early endothelium senescence in cells chronically exposed to hyperglycemia in vivo.	[Di Tomo, Pamela; Di Pietrantonio, Nadia; Di Pietro, Natalia; Pandolfi, Assunta] Univ G dAnnunzio, Dept Med & Oral Sci & Biotechnol, Chieti, Italy; [Di Tomo, Pamela; Pietrangelo, Laura; Lanuti, Paola; Di Pietrantonio, Nadia; Marchisio, Marco; Protasi, Feliciano; Di Pietro, Natalia; Formoso, Gloria; Pandolfi, Assunta] Univ G dAnnunzio, Ctr Adv Studies & Technol CAST ex CeSI MeT, Chieti, Italy; [Alessio, Nicola; Galderisi, Umberto] Univ Campania L Vanvitelli, Dept Expt Med, Naples, Italy; [Falone, Stefano; Santini, Silvano Junior; Amicarelli, Fernanda] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Pietrangelo, Laura; Lanuti, Paola; Marchisio, Marco; Protasi, Feliciano; Formoso, Gloria] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Cordone, Valeria] Univ Ferrara, Dept Biomed & Specialist Surg Sci, Ferrara, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Universita della Campania Vanvitelli; University of L'Aquila; G d'Annunzio University of Chieti-Pescara; University of Ferrara	Pandolfi, A (corresponding author), Univ G dAnnunzio, Dept Med & Oral Sci & Biotechnol, Ctr Adv Studies & Technol CAST ex CeSIMeT, Room 421, I-66100 Chieti, Italy.	assunta.pandolfi@unich.it	Cordone, Valeria/HGB-2367-2022; Santini, Silvano Junior/L-6688-2019; Falone, Stefano/D-8692-2017	Cordone, Valeria/0000-0003-2791-8121; Santini, Silvano Junior/0000-0001-6577-5892; Falone, Stefano/0000-0002-5978-0545	POR FESR ABRUZZO 2014-2020 Asse I Determinazione (SANI) [39 DPG013/12222017]; Italian Telethon ONLUS Foundation [GGP19231]; Italian MIUR [2015ZZR4W3]; Italian Society of Nephrology (SIN) [10122016]	POR FESR ABRUZZO 2014-2020 Asse I Determinazione (SANI); Italian Telethon ONLUS Foundation(Fondazione Telethon); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Society of Nephrology (SIN)	This study was partially supported by grants from: POR FESR ABRUZZO 2014-2020 Asse I Determinazione (SANI, number: 39 DPG013/12222017) to Assunta Pandolfi; Italian Telethon ONLUS Foundation (GGP19231) and Italian MIUR (PRIN #2015ZZR4W3) to Feliciano Protasi; Italian Society of Nephrology (SIN, 10122016) to Natalia Di Pietro.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alessio N, 2017, NEOPLASIA, V19, P781, DOI 10.1016/j.neo.2017.06.005; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Angulo J, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101271; Aronson D, 2014, CARDIOL CLIN, V32, P439, DOI 10.1016/j.ccl.2014.04.001; Baskin SI., 2017, OXIDANTS ANTIOXIDANT, DOI [10.1201/9780203744673, DOI 10.1201/9780203744673]; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Bonfigli A, 2006, INT J BIOCHEM CELL B, V38, P2196, DOI 10.1016/j.biocel.2006.06.011; Capone V, 2018, BBA-MOL BASIS DIS, V1864, P3164, DOI 10.1016/j.bbadis.2018.07.003; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1729, DOI 10.1152/ajpheart.01103.2005; Chen YH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.04.29; Cheng XH, 2013, DIABETES, V62, P4088, DOI 10.2337/db13-0169; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Coco C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122949; Conti V, 2015, AGING CLIN EXP RES, V27, P547, DOI 10.1007/s40520-015-0357-9; Cossarizza A, 1996, EXP CELL RES, V222, P84, DOI 10.1006/excr.1996.0011; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281; Di Fulvio P, 2014, NUTR METAB CARDIOVAS, V24, P1337, DOI 10.1016/j.numecd.2014.06.005; Di Tomo P, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2925; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563; El Assar M, 2016, J PHYSIOL-LONDON, V594, P3045, DOI 10.1113/JP271836; Feng YH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00748; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gui J, 2016, PEDIATR RES, V79, P788, DOI 10.1038/pr.2015.269; HA HJ, 1994, KIDNEY INT, V46, P1620, DOI 10.1038/ki.1994.461; Hayashi T, 2014, P NATL ACAD SCI USA, V111, P1168, DOI 10.1073/pnas.1322153111; Herbert KJ, 2014, TOXICOL APPL PHARM, V277, P288, DOI 10.1016/j.taap.2014.04.001; Hill Michael D, 2014, Handb Clin Neurol, V126, P167, DOI 10.1016/B978-0-444-53480-4.00012-6; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Iskender H, 2017, BIOMED PHARMACOTHER, V90, P500, DOI 10.1016/j.biopha.2017.03.102; Jia GH, 2019, BBA-MOL BASIS DIS, V1865, P1802, DOI 10.1016/j.bbadis.2018.08.008; Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018; Ksiazek K, 2008, BIOCHEM BIOPH RES CO, V366, P793, DOI 10.1016/j.bbrc.2007.12.021; Kuki S, 2006, CIRC J, V70, P1076, DOI 10.1253/circj.70.1076; La Sala L, 2019, EUR J PREV CARDIOL, V26, P15, DOI 10.1177/2047487319878373; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manohar SM, 2013, J RES MED SCI, V18, P89; Marchetti C, 2004, HUM REPROD, V19, P2267, DOI 10.1093/humrep/deh416; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Masoud S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010197; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Morley JE, 2018, CLIN GERIATR MED, V34, pIX, DOI 10.1016/j.cger.2018.08.013; Nigro C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070749; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Ortega-Camarillo C, 2006, MOL CELL BIOCHEM, V281, P163, DOI 10.1007/s11010-006-0829-5; Ozuguz U, 2011, DIABETES RES CLIN PR, V94, P426, DOI 10.1016/j.diabres.2011.08.024; Palmer AK, 2019, DIABETOLOGIA, V62, P1835, DOI 10.1007/s00125-019-4934-x; Pandolfi A, 2007, GENES NUTR, V2, P195, DOI 10.1007/s12263-007-0050-5; Patel H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-142; Pluvinet R, 2008, BLOOD, V112, P3624, DOI 10.1182/blood-2008-03-143305; RAJESWARI P, 1991, J CELL PHYSIOL, V149, P100, DOI 10.1002/jcp.1041490113; Santini S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090346; Santos AN, 2017, MECH AGEING DEV, V166, P24, DOI 10.1016/j.mad.2017.07.009; Schisano B, 2011, DIABETOLOGIA, V54, P1219, DOI 10.1007/s00125-011-2049-0; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Sobrevia L, 2015, EXP PHYSIOL, V100, P231, DOI 10.1113/expphysiol.2014.082743; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ucci M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8184656; Villalobos-Labra R, 2019, PLACENTA, V86, P35, DOI 10.1016/j.placenta.2019.07.007; Wang XL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36911-1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xu WL, 2010, DIABETES, V59, P2928, DOI 10.2337/db10-0539; Yagi K, 1998, Methods Mol Biol, V108, P101; Yang JH, 2011, ARCH MED RES, V42, P354, DOI 10.1016/j.arcmed.2011.07.005; Yerra VG, 2013, REDOX BIOL, V1, P394, DOI 10.1016/j.redox.2013.07.005; Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598; Yiu KH, 2014, ARTERIOSCL THROM VAS, V34, P1136, DOI 10.1161/ATVBAHA.114.302192; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Yokoyama M, 2019, J MOL CELL CARDIOL, V129, P105, DOI 10.1016/j.yjmcc.2019.02.010; Yu YX, 2010, CHINESE MED J-PEKING, V123, P1915, DOI 10.3760/cma.j.issn.0366-6999.2010.14.016; Zhang EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143814; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	81	5	5	6	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21662	10.1096/fj.202002072RR	http://dx.doi.org/10.1096/fj.202002072RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046935				2022-12-28	WOS:000655695900013
J	Monasterio, BG; Jimenez-Rojo, N; Garcia-Arribas, AB; Riezman, H; Goni, FM; Alonso, A				Monasterio, Bingen G.; Jimenez-Rojo, Noemi; Garcia-Arribas, Aritz B.; Riezman, Howard; Goni, Felix M.; Alonso, Alicia			CHO/LY-B cell growth under limiting sphingolipid supply: Correlation between lipid composition and biophysical properties of sphingolipid-restricted cell membranes	FASEB JOURNAL			English	Article						AFM; CHO; Laurdan; lipidomics; LY-B; mass-spectroscopy; membrane fluidity; plasma membrane; sphingolipids; sphingomyelin	ATOMIC-FORCE MICROSCOPY; PLASMA-MEMBRANE; SERINE PALMITOYLTRANSFERASE; MODEL MEMBRANES; SPHINGOMYELIN; CHOLESTEROL; DOMAINS; CERAMIDE; PROTEIN; IDENTIFICATION	Sphingolipids (SL) are ubiquitous in mammalian cell membranes, yet there is little data on the behavior of cells under SL-restriction conditions. LY-B cells derive from a CHO linein whichserine palmitoyl transferase (SPT), thus de novo SL synthesis, is suppressed, while maintaining the capacity of taking up and metabolizing exogenous sphingoid bases from the culture medium. In this study, LY-B cells were adapted to grow in a fetal bovine serum (FBS)-deficient medium to avoid external uptake of lipids. The lowest FBS concentration that allowed LY-B cell growth, though at a slow rate, under our conditions was 0.04%, that is, 250-fold less than the standard (10%) concentration. Cells grown under limiting SL concentrations remained viable for at least 72 hours. Enriching with sphingomyelin the SL-deficient medium allowed the recovery of growth rates analogous to those of control LY-B cells. Studies including whole cells, plasma membrane preparations, and derived lipid vesicles were carried out. Laurdan fluorescence was recorded to measure membrane molecular order, showing a significant decrease in the rigidity of LY-B cells, not only in plasma membrane but also in whole cell lipid extract, as a result of SL limitation in the growth medium. Plasma membrane preparations and whole cell lipid extracts were also studied using atomic force microscopy in the force spectroscopy mode. Force measurements demonstrated that lower breakthrough forces were required to penetrate samples obtained from SL-poor LY-B cells than those obtained from control cells. Mass-spectroscopic analysis was also a helpful tool to understand the rearrangement undergone by the LY-B cell lipid metabolism. The most abundant SL in LY-B cells, sphingomyelin, decreased by about 85% as a result of SL limitation in the medium, the bioactive lipid ceramide and the ganglioside precursor hexosylceramide decreased similarly, together with cholesterol. Quantitative SL analysis showed that a 250-fold reduction in sphingolipid supply to LY-B cells led only to a sixfold decrease in membrane sphingolipids, underlining the resistance to changes in composition of these cells. Plasma membrane compositions exhibited similar changes, at least qualitatively, as the whole cells with SL restriction. A linear correlation was observed between the sphingomyelin concentration in the membranes, the degree of lipid order as measured by laurdan fluorescence, and membrane breakthrough forces assessed by atomic force microscopy. Smaller, though significant, changes were also detected in glycerophospholipids under SL-restriction conditions.	[Monasterio, Bingen G.; Garcia-Arribas, Aritz B.; Goni, Felix M.; Alonso, Alicia] Univ Basque Country, Inst Biofis CSIC, UPV EHU, Leioa 48940, Spain; [Monasterio, Bingen G.; Garcia-Arribas, Aritz B.; Goni, Felix M.; Alonso, Alicia] Univ Basque Country, Dept Bioquim, Leioa, Spain; [Jimenez-Rojo, Noemi; Riezman, Howard] Univ Geneva, Dept Biochem, NCCR Chem Biol, Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Geneva	Goni, FM (corresponding author), Univ Basque Country, Inst Biofis CSIC, UPV EHU, Leioa 48940, Spain.	felix.goni@ehu.es	Jiménez-Rojo, Noemi/AAM-2821-2020; Alonso, Alicia/E-5310-2012	Jiménez-Rojo, Noemi/0000-0001-6200-0434; Alonso, Alicia/0000-0002-2730-7470; Garcia Arribas, Aritz/0000-0003-1866-6647	Spanish Ministry of Economy [PGC2018-099857-B-I00]; Basque Government [IT1264-19, IT1270-19]; Swiss National Science Foundation [310030-184949]	Spanish Ministry of Economy(Spanish Government); Basque Government(Basque Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Spanish Ministry of Economy, Grant/ Award Number: PGC2018--099857--B--I00; Basque Government, Grant/Award Number: IT1264--19 and IT1270--19; Swiss National Science Foundation, Grant/Award Number: 310030--184949	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Agrawal H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25412; Ahyayauch H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25905-8; Alberts B., 1994, MOL BIOL CELL; Albi E., 2008, OPEN ENZYME INHIB J, V1, P72, DOI DOI 10.2174/1874940200801010072; Alonso A, 2018, ANNU REV BIOPHYS, V47, P633, DOI 10.1146/annurev-biophys-070317-033309; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bejaoui K, 2002, J CLIN INVEST, V110, P1301, DOI 10.1172/JCI200216450; Bezrukov L, 2009, ANAL BIOCHEM, V394, P171, DOI 10.1016/j.ab.2009.07.027; Bienias K, 2016, PHARMACOL REP, V68, P570, DOI 10.1016/j.pharep.2015.12.008; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; Bouvrais H, 2008, BIOPHYS CHEM, V137, P7, DOI 10.1016/j.bpc.2008.06.004; Busto JV, 2014, BIOPHYS J, V106, P621, DOI 10.1016/j.bpj.2013.12.021; Capasso S, 2017, EMBO J, V36, P1736, DOI 10.15252/embj.201696048; Carquin M, 2014, J LIPID RES, V55, P1331, DOI 10.1194/jlr.M048538; Carravilla P, 2015, LANGMUIR, V31, P2808, DOI 10.1021/la504251u; Chakraborty M, 2013, ADV EXP MED BIOL, V991, P1, DOI 10.1007/978-94-007-6331-9_1; Chiantia Salvatore, 2013, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-7091-1368-4_2; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; Dougherty AM, 2006, ORG LETT, V8, P649, DOI 10.1021/ol052839v; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; ESTEP TN, 1979, BIOCHEMISTRY-US, V18, P2112, DOI 10.1021/bi00577a042; FEINGOLD KR, 1991, CRIT REV THER DRUG, V8, P193; Frisz JF, 2013, J BIOL CHEM, V288, P16855, DOI 10.1074/jbc.M113.473207; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; FUJITA T, 1994, J ANTIBIOT, V47, P208, DOI 10.7164/antibiotics.47.208; Galisteo-Gonzalez F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56799-9; Garcia-Arribas AB, 2015, LANGMUIR, V31, P3135, DOI 10.1021/la504047n; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gerstle R, 2017, BIOPHYS J, V112, p519A, DOI 10.1016/j.bpj.2016.11.2808; Goni FM, 2019, CHEM PHYS LIPIDS, V218, P34, DOI 10.1016/j.chemphyslip.2018.11.006; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Gonzalez-Ramirez EJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50020-7; Guan XL, 2010, METHOD ENZYMOL, V470, P369, DOI 10.1016/S0076-6879(10)70015-X; Guri Y, 2017, CANCER CELL, V32, P807, DOI 10.1016/j.ccell.2017.11.011; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; HOLLERAN WM, 1991, J LIPID RES, V32, P1151; Huang SH, 2019, ANAL CHEM, V91, P1501, DOI 10.1021/acs.analchem.8b04593; Jimenez-Rojo N, 2020, CURR BIOL, V30, P3775, DOI 10.1016/j.cub.2020.07.059; Keyvanloo A, 2018, BIOPHYS J, V114, P1344, DOI 10.1016/j.bpj.2018.01.024; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; KOVANEN PT, 1975, J LIPID RES, V16, P211; Krasnowska EK, 1998, BIOPHYS J, V74, P1984, DOI 10.1016/S0006-3495(98)77905-6; Li H, 2014, PHARMAZIE, V69, P187, DOI 10.1691/ph.2014.3835; Li ZQ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0214-1; Luberto C, 2002, NEUROCHEM RES, V27, P609, DOI 10.1023/A:1020267831851; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Manni MM, 2015, BBA-BIOMEMBRANES, V1848, P797, DOI 10.1016/j.bbamem.2014.11.028; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Miklosz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085547; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; Monasterio BG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072643; Monasterio BG, 2017, LANGMUIR, V33, P8181, DOI 10.1021/acs.langmuir.7b01552; Montes LR, 2010, METHODS MOL BIOL, V606, P105, DOI 10.1007/978-1-60761-447-0_9; Murakoshi M, 2006, JARO-J ASSOC RES OTO, V7, P267, DOI 10.1007/s10162-006-0041-z; Nakamura H, 2015, J CELL BIOCHEM, V116, P1898, DOI 10.1002/jcb.25145; Nicovich PR, 2018, BIOPHYS J, V114, P2855, DOI 10.1016/j.bpj.2018.04.050; Nieto FL, 2008, J BIOL CHEM, V283, P25682, DOI 10.1074/jbc.M804437200; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; Santuz A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21018-4; Schmidt CF., 1977, J PHYS SOC JPN, V42, P719; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shchelokovskyy P, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025004; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Skinkle AD, 2020, BIOPHYS J, V118, P1292, DOI 10.1016/j.bpj.2019.12.040; Smith WS, 2017, BBA-BIOMEMBRANES, V1859, P993, DOI 10.1016/j.bbamem.2017.02.013; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; Szeliova D, 2020, METAB ENG, V61, P288, DOI 10.1016/j.ymben.2020.06.002; Tristram-Nagle S, 2010, J MOL BIOL, V402, P139, DOI 10.1016/j.jmb.2010.07.026; van Meer G, 2003, PHILOS T ROY SOC B, V358, P869, DOI 10.1098/rstb.2003.1266; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Varela ARP, 2017, PHYS CHEM CHEM PHYS, V19, P340, DOI 10.1039/c6cp07227e; Veiga-da-Cunha M, 2012, J BIOL CHEM, V287, P7246, DOI 10.1074/jbc.M111.323485; Yasuda T, 2016, BIOPHYS J, V110, P431, DOI 10.1016/j.bpj.2015.11.3515; Ziesemer S, 2019, TOXINS, V11, DOI 10.3390/toxins11020126; Ziulkoski AL, 2001, BIOCHEM BIOPH RES CO, V281, P971, DOI 10.1006/bbrc.2001.4440	80	3	3	5	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21657	10.1096/fj.202001879RR	http://dx.doi.org/10.1096/fj.202001879RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34010474	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000655695900024
J	Cai, J; Qiong, G; Li, CJ; Sun, LL; Luo, YH; Yuan, SH; Gonzalez, FJ; Xu, J				Cai, Jie; Qiong, Gu; Li, Chanjuan; Sun, Lulu; Luo, Yuhong; Yuan, Shengheng; Gonzalez, Frank J.; Xu, Jun			Manassantin B attenuates obesity by inhibiting adipogenesis and lipogenesis in an AMPK dependent manner	FASEB JOURNAL			English	Article						adipogenesis; AMPK; lipogenesis; manassantin B; obesity	ACTIVATED PROTEIN-KINASE; SAURURUS-CHINENSIS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; FATTY-ACID; LIGNANS; COA; ATHEROSCLEROSIS; METABOLISM; MODELS	Saururus chinensis (S chinensis) has been used as an herb to treat edema, jaundice, and gonorrhea. Manassantin B (MNSB), a dineolignan isolated from S chinensis, was identified as a potent adipogenesis/lipogenesis inhibitor (IC50 = 9.3 nM). To explore the underlying mechanism, both adipogenesis and lipogenesis were measured in differentiated 3T3-L1 preadipocytes, murine primary preadipocytes and adipose tissue explants upon MNSB treatment. Key regulators of adipogenesis/lipogenesis were downregulated by MNSB treatment, mainly resulting from increased phosphorylation of AMPK which was identified as a vital regulator of adipogenesis and lipogenesis. Moreover, MNSB did not increase AMPK phosphorylation in 3T3-L1 cells transfected with Prkaa1 (encoding protein kinase AMP-activated catalytic subunit alpha 1) siRNA or adipose tissue explants isolated from adipose-specific Prkaa1-disrupted mice (Prkaa1(Delta ad)). In diet-induced obese C57BL/6N mice, MNSB displayed preventive and therapeutic effects on obesity accompanied by decreased adipocyte size. MNSB was also found to increase AMPK phosphorylation both in subcutaneous white adipose tissue and brown adipose tissue in vivo. These findings suggest that MNSB can be a new therapeutic agent for the prevention and treatment of obesity and other related metabolic disorders.	[Cai, Jie; Qiong, Gu; Li, Chanjuan; Yuan, Shengheng; Xu, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, 132 East Circle Univ City, Guangzhou 510006, Peoples R China; [Cai, Jie; Sun, Lulu; Luo, Yuhong; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA	Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xu, J (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, 132 East Circle Univ City, Guangzhou 510006, Peoples R China.; Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov; junxu@biochemomes.com	LUO, YUHONG/GPW-8361-2022	Sun, Lulu/0000-0001-8876-5099; Cai, Jie/0000-0002-4224-1721	National Natural Science Foundation of China [81573310]; Science and Technology Program of Guangzhou [201604020109]; National Cancer Institute Intramural Research Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou; National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Natural Science Foundation of China (No. 81573310), the Science and Technology Program of Guangzhou (201604020109), and the National Cancer Institute Intramural Research Program	Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014; Choi HN, 2013, FASEB J, P27; Chow YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38129; Cui H, 2014, J NAT PROD, V77, P100, DOI 10.1021/np400757k; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hwang BY, 2003, PHYTOCHEMISTRY, V64, P765, DOI 10.1016/S0031-9422(03)00391-1; Hwang Ji-Yeon, 2007, Nutr Res Pract, V1, P100, DOI 10.4162/nrp.2007.1.2.100; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Joo HJ, 2006, FOOD SCI BIOTECHNOL, V15, P413; Jung YW, 2019, ARCH PHARM RES, V42, P332, DOI 10.1007/s12272-018-1093-4; Kahn CR, 2019, J CLIN INVEST, V129, P3990, DOI 10.1172/JCI129187; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; KIM J, 2012, FASEB J, P26; Kim SJ, 2009, BIOCHEM BIOPH RES CO, V389, P437, DOI 10.1016/j.bbrc.2009.08.161; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Kwon DY, 2015, J MED CHEM, V58, P7659, DOI 10.1021/acs.jmedchem.5b01220; Lai K, 2013, ACS CHEM BIOL, V8, P257, DOI 10.1021/cb300495e; Lang LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099584; Li J, 2018, METHODS MOL BIOL, V1773, P167, DOI 10.1007/978-1-4939-7799-4_14; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu ZJ, 2014, ONCOL REP, V32, P659, DOI 10.3892/or.2014.3244; Ma YB, 2017, J BIOL CHEM, V292, P20989, DOI 10.1074/jbc.M117.812925; Muller S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43624-6; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Seo CS, 2008, J NAT PROD, V71, P1771, DOI 10.1021/np8002723; Seo CS, 2009, PHYTOTHER RES, V23, P1531, DOI 10.1002/ptr.2791; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Steinbeck KS, 2018, NAT REV ENDOCRINOL, V14, P331, DOI 10.1038/s41574-018-0002-8; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Wang EC, 1996, HETEROCYCLES, V43, P969, DOI 10.3987/COM-95-7370; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Yang QY, 2016, CELL METAB, V24, P542, DOI 10.1016/j.cmet.2016.08.010; Yu H, 2018, METHODS MOL BIOL, V1773, P273, DOI 10.1007/978-1-4939-7799-4_21; Yun YR, 2007, J MED FOOD, V10, P316, DOI 10.1089/jmf.2006.149; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zeng XY, 2012, BIOCHEM PHARMACOL, V84, P830, DOI 10.1016/j.bcp.2012.07.003; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhou YP, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0268-9	51	1	1	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21496	10.1096/fj.202002126RR	http://dx.doi.org/10.1096/fj.202002126RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33904622				2022-12-28	WOS:000645260100101
J	Gutierrez, J; Gonzalez, D; Escalona-Rivano, R; Takahashi, C; Brandan, E				Gutierrez, Jaime; Gonzalez, David; Escalona-Rivano, Rodrigo; Takahashi, Chiaki; Brandan, Enrique			Reduced RECK levels accelerate skeletal muscle differentiation, improve muscle regeneration, and decrease fibrosis	FASEB JOURNAL			English	Article						MMP; muscle fibrosis; RECK; regeneration; skeletal muscle differentiation	ACTIVATED PROTEIN-KINASE; MMP-REGULATOR RECK; MATRIX METALLOPROTEINASES; SATELLITE CELL; MYOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; STEM-CELLS; DYSTROPHIC MUSCLE; GENE-EXPRESSION; UP-REGULATION	The muscle regeneration process requires a properly assembled extracellular matrix (ECM). Its homeostasis depends on the activity of different matrix-metalloproteinases (MMPs). The reversion-inducing-cysteine-rich protein with kazal motifs (RECK) is a membrane-anchored protein that negatively regulates the activity of different MMPs. However, the role of RECK in the process of skeletal muscle differentiation, regeneration, and fibrosis has not been elucidated. Here, we show that during skeletal muscle differentiation of C2C12 myoblasts and in satellite cells on isolated muscle fibers, RECK is transiently up regulated. C2C12 myoblasts with reduced RECK levels are more prone to enter the differentiation program, showing an accelerated differentiation process. Notch-1 signaling was reduced, while p38 and AKT signaling were augmented in myoblasts with decreased RECK levels. Overexpression of RECK restores the normal differentiation process but diminished the ability to form myotubes. Transient up-regulation of RECK occurs during skeletal muscle regeneration, which was accelerated in RECK-deficient mice (Reck +/-). RECK, MMPs and ECM proteins augmented in chronically damaged WT muscle, a model of muscle fibrosis. In this model, RECK +/- mice showed diminished fibrosis compared to WT. These results strongly suggest that RECK is acting as a potential myogenic repressor during muscle formation and regeneration, emerging as a new player in these processes, and as a potential target to treat individuals with the muscle-wasting disease.	[Gutierrez, Jaime; Escalona-Rivano, Rodrigo] Univ San Sebastian, Hlth Sci Fac, Sch Med Technol, Cellular Signaling & Differentiat Lab CSDL, Santiago, Chile; [Gutierrez, Jaime; Gonzalez, David; Brandan, Enrique] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol, Santiago 8330025, Chile; [Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Canc & Stem Cell Res Program, Oncol & Mol Biol, Kanazawa, Ishikawa, Japan; [Brandan, Enrique] Fdn Ciencia & Vida, Santiago, Chile	Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Kanazawa University	Gutierrez, J; Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol, Santiago 8330025, Chile.	jaime.gutierrez@uss.cl; ebrandan@bio.puc.cl			Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1190144]; Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) [AFB170005]; FONDECYT [11110010, 1180935, CONICYT-79090027]; CONICYT	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1190144 and Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) AFB170005 to EB. FONDECYT 11110010, 1180935, and CONICYT-79090027 to JG. DG held a CONICYT PhD fellowship. Funding sources had no role in the design of the study, collection, analysis, and interpretation of data, writing of the report, nor in the decision to submit the article for publication	Alameddine Hala S, 2016, J Neuromuscul Dis, V3, P455; Barnes BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1501, DOI 10.1152/ajpcell.00217.2009; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bersini S, 2018, ADV DRUG DELIVER REV, V129, P64, DOI 10.1016/j.addr.2018.02.009; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Cabrera D, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-6; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chandana EPS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-84; Chen X, 1999, MOL CELL BIOL, V19, P4695; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Chin JR, 1997, DEVELOPMENT, V124, P1519; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Contreras O, 2019, J CELL SCI, V132, DOI 10.1242/jcs.232157; Contreras O, 2016, CELL TISSUE RES, V364, P647, DOI 10.1007/s00441-015-2343-0; COUCH CB, 1983, CELL, V32, P257, DOI 10.1016/0092-8674(83)90516-0; Danisovic L, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120253; Darabi R, 2008, STEM CELL REV, V4, P217, DOI 10.1007/s12015-008-9023-3; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; Demestre M, 2005, NEUROPATH APPL NEURO, V31, P545, DOI 10.1111/j.1365-2990.2005.00676.x; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; Fiore D, 2016, STEM CELL RES, V17, P161, DOI 10.1016/j.scr.2016.06.007; Fujimaki S, 2018, STEM CELLS, V36, P278, DOI 10.1002/stem.2743; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-54; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Morales MG, 2013, CELL TISSUE RES, V353, P173, DOI 10.1007/s00441-013-1642-6; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Gonzalez D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177649; Gutierrez J, 2017, PLACENTA, V59, P19, DOI 10.1016/j.placenta.2017.09.004; Gutierrez J, 2016, CURR VASC PHARMACOL, V14, P106, DOI 10.2174/1570161113666151014130746; Gutierrez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135005; Hong KJ, 2014, J CELL PHYSIOL, V229, P191, DOI 10.1002/jcp.24434; Jaiswal N, 2019, MOL METAB, V28, P1, DOI 10.1016/j.molmet.2019.08.001; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Acuna MJ, 2014, HUM MOL GENET, V23, P1237, DOI 10.1093/hmg/ddt514; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; Karalaki M, 2009, IN VIVO, V23, P779; Kawashima S, 2008, J NEUROCHEM, V104, P376, DOI 10.1111/j.1471-4159.2007.04977.x; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Kherif S, 1998, NEUROPATH APPL NEURO, V24, P309; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Khurana A, 2002, MOL CELL BIOCHEM, V238, P27, DOI 10.1023/A:1019957602038; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Larrain J, 1998, J BIOL CHEM, V273, P32288, DOI 10.1074/jbc.273.48.32288; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Li HP, 2019, ISCIENCE, V19, P559, DOI 10.1016/j.isci.2019.08.009; Li YQ, 2000, CELL SIGNAL, V12, P751, DOI 10.1016/S0898-6568(00)00120-0; Li Y, 2011, J NEUROSCI, V31, P13191, DOI 10.1523/JNEUROSCI.2953-11.2011; Liu JM, 2008, AM J PHYSIOL-CELL PH, V294, pC627, DOI 10.1152/ajpcell.00329.2007; Lluri G, 2005, MUSCLE NERVE, V32, P492, DOI 10.1002/mus.20383; Mahdy MAA, 2019, CELL TISSUE RES, V375, P575, DOI 10.1007/s00441-018-2955-2; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Mizuno S, 2015, J BIOL CHEM, V290, P28456, DOI 10.1074/jbc.M115.653477; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Mullooly M, 2016, CANCER BIOL THER, V17, P870, DOI 10.1080/15384047.2016.1177684; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mummidi S, 2019, J CELL PHYSIOL, V234, P22242, DOI 10.1002/jcp.28792; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Nowak E, 2018, CELL BIOL INT, V42, P373, DOI 10.1002/cbin.10914; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Perdiguero E, 2007, CELL CYCLE, V6, P1298, DOI 10.4161/cc.6.11.4315; Pessina Patrizia, 2014, Skelet Muscle, V4, P7, DOI 10.1186/2044-5040-4-7; Pichavant Christophe, 2011, PLoS Curr, V3, pRRN1275, DOI 10.1371/currents.RRN1275; Rayagiri SS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03425-3; Rebolledo DL, 2019, MATRIX BIOL, V82, P20, DOI 10.1016/j.matbio.2019.01.002; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Smith LR, 2018, MATRIX BIOL, V68-69, P602, DOI 10.1016/j.matbio.2018.01.014; Snyman C, 2015, J MUSCLE RES CELL M, V36, P215, DOI 10.1007/s10974-015-9414-4; Son DJ, 2017, THERANOSTICS, V7, P2186, DOI 10.7150/thno.18407; TEDESCO D, 1995, J VIROL, V69, P6947, DOI 10.1128/JVI.69.11.6947-6957.1995; Valle-Tenney R, 2020, MATRIX BIOL, V87, P48, DOI 10.1016/j.matbio.2019.09.003; Vallon M, 2018, CELL REP, V25, P339, DOI 10.1016/j.celrep.2018.09.045; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yokoyama S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176376; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zimowska M, 2008, INT J DEV BIOL, V52, P307, DOI 10.1387/ijdb.072331mz	111	1	1	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21503	10.1096/fj.202001646RR	http://dx.doi.org/10.1096/fj.202001646RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811686				2022-12-28	WOS:000645260100028
J	Jiang, J; Zhu, JH; Liu, Q; Zhang, TT; Wen, JK; Xia, JH; Deng, YQ				Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Xia, Jianhong; Deng, Yiqun			Role of DNA methylation-related chromatin remodeling in aryl hydrocarbon receptor-dependent regulation of T-2 toxin highly inducible Cytochrome P450 1A4 gene	FASEB JOURNAL			English	Article						AhR; chromatin remodeling; CYP1A4; DNA methylation; T-2 toxin	CYP1A1 PROMOTER; HISTONE; METABOLISM; DEOXYNIVALENOL; TRICHOTHECENES; TRANSCRIPTION; COACTIVATOR; PATHWAYS; PROTEINS; ENZYME	Mycotoxins are toxic secondary metabolites produced by food-contaminating fungi, which lead to global epigenetic changes and cause toxicity to both farm animals and humans. However, whether mycotoxins induce gene-specific epigenetic alterations associated with inducible downstream gene expression is unclear as are the underlying regulatory mechanisms. Here, we found that T-2 toxin and its deacetylated metabolites but not deoxynivalenol (DON) or other representative mycotoxins highly induced the expression of cytochrome P450 1A4 (CYP1A4) in both Leghorn male hepatoma (LMH) cells and chicken primary hepatocytes, and this effect was related to the regulation of both aryl hydrocarbon receptor (AhR) and DNA methylation. We used methylation-sensitive restriction enzyme digestion-qPCR (MSRE-qPCR) and chromatin immunoprecipitation (ChIP) assays and found that the binding of DNA methyltransferase 1 (DNMT1) and histone deacetylase 2 (HDAC2) to highly methylated CpG island 3-2 at the enhancer of CYP1A4 was accompanied by the recruitment of the repressive histone modification marker H3K27me3, inducing a silent state. In turn, T-2 toxin stimulation enriched the binding of AhR to demethylated CpG island 3-2, which facilitated p300 and H3K9ac recruitment and ultimately generated an activated chromatin structure at the enhancer by increasing the active histone modification markers, including H3K4me3, H3K27ac, and H3K14ac. Interestingly, T-2 toxin-induced AhR activation also facilitated RNA polymerase II binding to CpG island 2, which may form a transcriptionally active chromatin structure at the promoter and ultimately transactivate CYP1A4. Our findings provide novel insights into the epigenetic regulation of T-2 toxin-induced gene expression.	[Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Deng, Yiqun] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China; [Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Deng, Yiqun] South China Agr Univ, Guangdong Lab Lingnan Modern Agr, Guangzhou, Peoples R China; [Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Deng, Yiqun] South China Agr Univ, Key Lab Zoonosis, Minist Agr & Rural Affairs, Guangzhou, Peoples R China; [Xia, Jianhong] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China	South China Agricultural University; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Deng, YQ (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China.	yqdeng@scau.edu.cn	wen, jikai/AAV-9818-2021; Deng, Yiqun/K-7709-2013	wen, jikai/0000-0002-4010-4416; Deng, Yiqun/0000-0002-6838-3779	Natural Science Foundation of Guangdong Province [2016A030313166, 2018A030313001]; National Natural Science Foundation of China [U1901207]; National Natural Science Foundation of Guangdong Province [U1901207]; Science and Technology Program of Guangzhou [201804020067]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou	the Natural Science Foundation of Guangdong Province, Grant/Award Number: 2018A030313001; the Joint Fund of National Natural Science Foundation of China and Guangdong Province, Grant/Award Number: U1901207; the Natural Science Foundation of Guangdong Province, Grant/Award Number: 2016A030313166; the Science and Technology Program of Guangzhou, Grant/Award Number: 201804020067	Amenya HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34989; Anttila S, 2003, CANCER RES, V63, P8623; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Dai CS, 2019, ARCH TOXICOL, V93, P3041, DOI 10.1007/s00204-019-02577-5; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gannon M, 2000, TOXICOL APPL PHARM, V164, P24, DOI 10.1006/taap.1999.8864; Han J, 2016, TOXICOL APPL PHARM, V300, P70, DOI 10.1016/j.taap.2016.03.006; Huang DY, 2019, FOOD CHEM TOXICOL, V123, P595, DOI 10.1016/j.fct.2018.10.059; Kikuchi Y, 2003, J BIOCHEM, V134, P83, DOI 10.1093/jb/mvg115; Ko M, 2015, IMMUNOL REV, V263, P6, DOI 10.1111/imr.12239; Kobayashi A, 1997, J BIOCHEM, V122, P703; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruber P, 2011, TOXICOLOGY, V284, P34, DOI 10.1016/j.tox.2011.03.012; Liu AM, 2019, TOXICOLOGY, V425, DOI 10.1016/j.tox.2019.152246; Liu AM, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110661; Liu Q, 2019, BIOCHEM PHARMACOL, V168, P319, DOI 10.1016/j.bcp.2019.07.023; Liu XL, 2017, TOXICOLOGY, V392, P81, DOI 10.1016/j.tox.2017.10.013; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MORGAN JE, 1992, P NATL ACAD SCI USA, V89, P11622, DOI 10.1073/pnas.89.23.11622; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; OKINO ST, 1995, MOL CELL BIOL, V15, P3714; Okino ST, 2006, CANCER RES, V66, P7420, DOI 10.1158/0008-5472.CAN-06-0504; PICARDO M, 1982, COMP BIOCHEM PHYS B, V71, P689, DOI 10.1016/0305-0491(82)90482-5; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; Santes-Palacios R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5341081; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Shang SF, 2013, INT J MOL SCI, V14, P10809, DOI 10.3390/ijms140610809; Sun Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44305-0; Taylor RT, 2009, TOXICOL SCI, V107, P1, DOI 10.1093/toxsci/kfn217; Wang X, 2012, TOXICOL SCI, V127, P412, DOI 10.1093/toxsci/kfs106; Wu QH, 2014, ARCH TOXICOL, V88, P1309, DOI 10.1007/s00204-014-1280-0; Wu QH, 2020, ARCH TOXICOL, V94, P3645, DOI 10.1007/s00204-020-02899-9; Wu QH, 2017, ARCH TOXICOL, V91, P3737, DOI 10.1007/s00204-017-2118-3; Yang X, 2020, J AGR FOOD CHEM, V68, P727, DOI 10.1021/acs.jafc.9b07880; Ye WC, 2019, TOXICOL LETT, V315, P77, DOI 10.1016/j.toxlet.2019.08.021; Zhang Y, 2017, THERIOGENOLOGY, V103, P110, DOI 10.1016/j.theriogenology.2017.07.052	42	0	0	5	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21469	10.1096/fj.202002570RR	http://dx.doi.org/10.1096/fj.202002570RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788981				2022-12-28	WOS:000645260100026
J	Li, ZK; Wang-Heaton, H; Cartwright, BM; Makinwa, Y; Hilton, BA; Musich, PR; Shkriabai, N; Kvaratskhelia, M; Guan, SH; Chen, Q; Yu, XC; Zou, Y				Li, Zhengke; Wang-Heaton, Hui; Cartwright, Brian M.; Makinwa, Yetunde; Hilton, Benjamin A.; Musich, Phillip R.; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Guan, Shengheng; Chen, Qian; Yu, Xiaochun; Zou, Yue			ATR prevents Ca2+ overload-induced necrotic cell death through phosphorylation-mediated inactivation of PARP1 without DNA damage signaling	FASEB JOURNAL			English	Article						ATR; Ca2+ overload; necrosis; PARP1; PARP1 phosphorylation	MITOCHONDRIAL PERMEABILITY TRANSITION; NUCLEOTIDE EXCISION-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-MECHANISMS; PROGRAMMED NECROSIS; ESSENTIAL KINASE; APOPTOSIS; CALCIUM; CHECKPOINT; ACTIVATION	Hyperactivation of PARP1 is known to be a major cause of necrotic cell death by depleting NAD(+)/ATP pools during Ca2+ overload which is associated with many ischemic diseases. However, little is known about how PARP1 hyperactivity is regulated during calcium overload. In this study we show that ATR kinase, well known for its role in DNA damage responses, suppresses ionomycin, glutamate, or quinolinic acid-induced necrotic death of cells including SH-SY5Y neuronal cells. We found that the inhibition of necrosis requires the kinase activity of ATR. Specifically, ATR binds to and phosphorylates PARP1 at Ser179 after the ionophore treatments. This site-specific phosphorylation inactivates PARP1, inhibiting ionophore-induced necrosis. Strikingly, all of this occurs in the absence of detectable DNA damage and signaling up to 8 hours after ionophore treatment. Furthermore, little AIF was released from mitochondria/cytoplasm for nuclear import, supporting the necrotic type of cell death in the early period of the treatments. Our results reveal a novel ATR-mediated anti-necrotic mechanism in the cellular stress response to calcium influx without DNA damage signaling.	[Li, Zhengke; Wang-Heaton, Hui; Cartwright, Brian M.; Hilton, Benjamin A.; Musich, Phillip R.; Zou, Yue] East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA; [Makinwa, Yetunde; Zou, Yue] Univ Toledo, Dept Canc Biol, Coll Med, Toledo, OH 43614 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA; [Guan, Shengheng] Univ Calif San Francisco, Dept Pharmaceut Chem & Mass Spectrometry Facil, San Francisco, CA USA; [Chen, Qian; Yu, Xiaochun] City Hope Natl Med Ctr, Dept Canc Genet & Epigenet, Duarte, CA USA	East Tennessee State University; University System of Ohio; University of Toledo; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; City of Hope	Li, ZK; Zou, Y (corresponding author), East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA.; Zou, Y (corresponding author), Univ Toledo, Dept Canc Biol, Coll Med, Toledo, OH 43614 USA.	LIZ01@mail.etsu.edu; yue.zou@utoledo.edu			National Institutes of Health [R01CA219342, R01CA86927, R15GM112168]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01CA219342, R01CA86927 and R15GM112168	Alcock RF, 2012, HEART, V98, P792, DOI 10.1136/heartjnl-2011-301577; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Auclair Y, 2009, CELL CYCLE, V8, P1865, DOI 10.4161/cc.8.12.8800; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P1; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Budker V, 2006, BIOPOLYMERS, V83, P646, DOI 10.1002/bip.20602; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cho YS, 2010, MOL CELLS, V29, P327, DOI 10.1007/s10059-010-0066-3; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Douglas DL, 2014, J CELL SCI, V127, P4134, DOI 10.1242/jcs.128009; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Francis RJ, 2013, J LEUKOCYTE BIOL, V93, P95, DOI 10.1189/jlb.0412212; Gagne JP, 2012, SCIENCE, V336, P678, DOI 10.1126/science.1221870; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han SI, 2008, BMB REP, V41, P1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Heffernan TP, 2009, J INVEST DERMATOL, V129, P1805, DOI 10.1038/jid.2008.435; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hsu PC, 2019, ONCOGENE, V38, P1166, DOI 10.1038/s41388-018-0506-7; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kedar PS, 2008, DNA REPAIR, V7, P1787, DOI 10.1016/j.dnarep.2008.07.006; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Kim D, 2018, NUCLEIC ACIDS RES, V46, P8311, DOI 10.1093/nar/gky625; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kitsis RN, 2010, P NATL ACAD SCI USA, V107, P9031, DOI 10.1073/pnas.1003827107; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Li GY, 2010, BIOMED ENVIRON SCI, V23, P371, DOI 10.1016/S0895-3988(10)60078-5; Li ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068297; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Liu QH, 2000, GENE DEV, V14, P1448; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; Monassier JP, 2008, ARCH CARDIOVASC DIS, V101, P491, DOI 10.1016/j.acvd.2008.06.014; Muller GJ, 2004, BRAIN PATHOL, V14, P415; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Park S, 2015, ANAT CELL BIOL, V48, P66, DOI 10.5115/acb.2015.48.1.66; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; PATEL R, 1989, J CELL SCI, P129; Phengchat R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38281; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Saldivar JC, 2018, SCIENCE, V361, P806, DOI 10.1126/science.aap9346; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Strom CE, 2012, BIOMOLECULES, V2, P635, DOI 10.3390/biom2040635; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Visvanathan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067689; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang PM, 2007, CHEM RES TOXICOL, V20, P406, DOI 10.1021/tx060144c; Yelamos J, 2011, AM J CANCER RES, V1, P328; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang FJ, 2014, TOXICOL SCI, V140, P118, DOI 10.1093/toxsci/kfu073; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	101	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21373	10.1096/fj.202001636RRR	http://dx.doi.org/10.1096/fj.202001636RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811702	Green Published, hybrid			2022-12-28	WOS:000645260100096
J	Perazza, LR; Mitchell, PL; Lizotte, F; Jensen, BAH; St-Pierre, P; Trottier, J; Barbier, O; Mathieu, P; Geraldes, PM; Marette, A				Perazza, Lais R.; Mitchell, Patricia L.; Lizotte, Farah; Jensen, Benjamin A. H.; St-Pierre, Philippe; Trottier, Jocelyn; Barbier, Olivier; Mathieu, Patrick; Geraldes, Pedro M.; Marette, Andre			Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice	FASEB JOURNAL			English	Article						CVD; diabetic nephropathy; end-stage renal disease; omega-3 fatty acids; protectin DX	LEFT-VENTRICULAR HYPERTROPHY; POLYUNSATURATED FATTY-ACIDS; GROWTH-FACTOR-II; CARDIOVASCULAR-DISEASE; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; LIPID MEDIATORS; KIDNEY-DISEASE; BLOOD-PRESSURE; OMEGA-3-FATTY-ACIDS	Diabetic nephropathy (DN) remains the major cause of end-stage renal disease (ESRD). We used high-fat/high-sucrose (HFHS)-fed LDLr-/- /ApoB(100/100) mice with transgenic overexpression of IGFII in pancreatic beta-cells (LRKOB100/IGFII) as a model of ESRD to test whether dietary long chain omega-3 polyunsaturated fatty acids LC omega 3FA-rich fish oil (FO) could prevent ESRD development. We further evaluated the potential of docosahexaenoic acid (DHA)-derived pro-resolving lipid mediators, 17-hydroxy-DHA (17-HDHA) and Protectin DX (PDX), to reverse established ESRD damage. HFHS-fed vehicle-treated LRKOB100/IGFII mice developed severe kidney dysfunction leading to ESRD, as revealed by advanced glomerular fibrosis and mesangial expansion along with reduced percent survival. The kidney failure outcome was associated with cardiac dysfunction, revealed by reduced heart rate and prolonged diastolic and systolic time. Dietary FO prevented kidney damage, lean mass loss, cardiac dysfunction, and death. 17-HDHA reduced podocyte foot process effacement while PDX treatment alleviated kidney fibrosis and mesangial expansion as compared to vehicle treatment. Only PDX therapy was effective at preserving the heart function and survival rate. These results show that dietary LC omega 3FA intake can prevent ESRD and cardiac dysfunction in LRKOB100/IGFII diabetic mice. Our data further reveals that PDX can protect against renal failure and cardiac dysfunction, offering a potential new therapeutic strategy against ESRD.	[Perazza, Lais R.; Mitchell, Patricia L.; Jensen, Benjamin A. H.; St-Pierre, Philippe; Mathieu, Patrick; Marette, Andre] Laval Univ, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Perazza, Lais R.; Mitchell, Patricia L.; St-Pierre, Philippe; Marette, Andre] Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Lizotte, Farah; Geraldes, Pedro M.] Univ Sherbrook, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Jensen, Benjamin A. H.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Human Genom & Metagen Metab, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Trottier, Jocelyn; Barbier, Olivier] Laval Univ, CHU Quebec, Res Ctr, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute; Laval University; Novo Nordisk Foundation; University of Copenhagen; Laval University	Marette, A (corresponding author), Laval Univ, Quebec Heart & Lung Inst, Fac Med, Dept Med, Quebec City, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	; Jensen, Benjamin/M-4661-2014	Marette, Andre/0000-0003-3950-5973; Mitchell, Patricia/0000-0002-0773-1047; Barbier, Olivier/0000-0002-3067-1134; Jensen, Benjamin/0000-0001-6991-0828	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC); Diabetes Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Diabetes Canada	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC); Diabetes Canada	Abbate M, 1998, J AM SOC NEPHROL, V9, P1213; Berl T, 2006, CLIN J AM SOC NEPHRO, V1, P8, DOI 10.2215/CJN.00730805; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Cabo J, 2012, BRIT J NUTR, V107, pS195, DOI 10.1017/S0007114512001584; Casanova MA, 2017, J AM SOC HYPERTENS, V11, P10, DOI 10.1016/j.jash.2016.10.004; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; Chou HH, 2012, NEPHRON CLIN PRACT, V121, pC30, DOI 10.1159/000341929; Dalla Vestra M, 2001, J NEPHROL, V14, pS51; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; de Boer IH, 2019, JAMA-J AM MED ASSOC, V322, P1899, DOI 10.1001/jama.2019.17380; DECATERINA R, 1993, KIDNEY INT, V44, P843, DOI 10.1038/ki.1993.320; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; EBIHARA I, 1993, J AM SOC NEPHROL, V3, P1387; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; El-Sherif N, 2011, CARDIOL J, V18, P233; Elajami TK, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004740; FLOEGE J, 1991, KIDNEY INT, V40, P477, DOI 10.1038/ki.1991.235; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forclaz A, 2003, HYPERTENSION, V41, P31, DOI 10.1161/01.HYP.0000047512.58862.A9; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26428; Garman JH, 2009, AM J PHYSIOL-RENAL, V296, pF306, DOI 10.1152/ajprenal.90326.2008; GULER HP, 1988, P NATL ACAD SCI USA, V85, P4889, DOI 10.1073/pnas.85.13.4889; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ilyas Z, 2017, REV ENDOCR METAB DIS, V18, P21, DOI 10.1007/s11154-017-9422-3; KERJASCHKI D, 1994, KIDNEY INT, V45, P300, DOI 10.1038/ki.1994.39; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Le Quang K, 2014, ARTERIOSCL THROM VAS, V34, P2283, DOI 10.1161/ATVBAHA.114.304205; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Lee CC, 2012, CURR ATHEROSCLER REP, V14, P535, DOI 10.1007/s11883-012-0279-3; Lee CC, 2010, DIABETES CARE, V33, P1454, DOI 10.2337/dc09-2245; Lee GSL, 1998, KIDNEY INT, V53, P1389, DOI 10.1046/j.1523-1755.1998.00871.x; Li GB, 2017, J LIPID RES, V58, P1080, DOI [10.1194/jlr.M072587, 10.1194/jlr.m072587]; Losi MA, 2010, NEPHROL DIAL TRANSPL, V25, P1950, DOI 10.1093/ndt/gfp747; Marcello T, 2016, CIRCULATION, V133, P518, DOI 10.1161/CIRCULATIONAHA.115.018713; Meeus F, 2000, KIDNEY INT, V58, pS140, DOI 10.1046/j.1523-1755.2000.07618.x; Micakovic T, 2018, KIDNEY INT, V94, P937, DOI 10.1016/j.kint.2018.06.006; Middleton JP, 2010, KIDNEY INT, V77, P753, DOI 10.1038/ki.2010.19; Miller ER, 2009, AM J CLIN NUTR, V89, P1937, DOI 10.3945/ajcn.2008.26867; Miller PE, 2014, AM J HYPERTENS, V27, P885, DOI 10.1093/ajh/hpu024; Montford JR, 2017, J AM SOC NEPHROL, V28, P3155, DOI 10.1681/ASN.2016121344; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pighin D, 2003, J NUTR, V133, P4095, DOI 10.1093/jn/133.12.4095; Powell DW, 2013, LIFE SCI, V93, P257, DOI 10.1016/j.lfs.2013.06.016; pubmeddev al G-IC- et, 2019, PREVALENCE PROTEIN E; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Robinson BM, 2016, LANCET, V388, P294, DOI 10.1016/S0140-6736(16)30448-2; ROGERS SA, 1991, J CELL BIOL, V113, P1447, DOI 10.1083/jcb.113.6.1447; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; Rozenbaum Z, 2019, INT J CARDIOL, V277, P147, DOI 10.1016/j.ijcard.2018.08.008; Saran R, 2018, AM J KIDNEY DIS, V71, pS1, DOI 10.1053/j.ajkd.2018.01.002; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Srinivasan M, 2010, AM J PHYSIOL-ENDOC M, V299, pE910, DOI 10.1152/ajpendo.00339.2010; Svensson J, 2007, J ENDOCRINOL, V193, P359, DOI 10.1677/JOE-07-0024; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Vallon V, 2011, COMPR PHYSIOL, V1, P1175, DOI 10.1002/cphy.c100049; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; WOLF E, 1994, ENDOCRINOLOGY, V135, P1877, DOI 10.1210/en.135.5.1877; Xia HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00103-0	71	3	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21559	10.1096/fj.202100073R	http://dx.doi.org/10.1096/fj.202100073R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835594				2022-12-28	WOS:000645260100075
J	Senefeld, JW; Shepherd, JRA; Baker, SE; Joyner, MJ				Senefeld, Jonathon W.; Shepherd, John R. A.; Baker, Sarah E.; Joyner, Michael J.			Sex-based limits to running speed in the human, horse and dog: The role of sexual dimorphisms	FASEB JOURNAL			English	Article						comparative physiology; endurance performance; performance prediction; physiological determinants; sex differences	ENDURANCE EXERCISE PERFORMANCE; SPLENIC CONTRACTION; GENDER-DIFFERENCES; MUSCLE; WOMEN; MEN; ECONOMY; CONSUMPTION; PHYSIOLOGY; RESPONSES	Elite performing men continue to record faster record times in running events compared to women. These sex-based differences in running speed and endurance in humans are expected based on sexual dimorphisms that contribute to differences in the determinants of aerobic performance. Comparatively, the sexual dimorphisms contributing to sex-based differences in elite aerobic performance are not ubiquitous across other species that compete in running events. The purpose of this review is to offer a framework and model for ongoing discussions of the physiological determinants and ultimately limits of physical performance. The records for average running speed of champion athletes were delineated by sex for thoroughbred horses, greyhound dogs, and humans. Male and female performances within each of these species are being optimized by training, nutrition, and financial incentives, and are approaching a performance maximum. For horses and greyhounds breeding also plays a role. Analysis of athletic records shows that there is a sex-related difference of similar to 10% or more in elite athletic performance for humans; however, the upper limit of performance does not appear to be different between sexes for thoroughbred horses and greyhound dogs. In the context of the nil sex differences in running performance in thoroughbreds and greyhounds, we discuss the physiological role of sexual dimorphisms on sex-specific limits to running performance. We highlight that studies on both human and animal performance in athletic events stimulate critical physiological questions and drive novel research.	[Senefeld, Jonathon W.; Shepherd, John R. A.; Baker, Sarah E.; Joyner, Michael J.] Mayo Clin, Dept Anesthesiol & Perioperat Med, 200 First St SW, Rochester, MN 55905 USA; [Shepherd, John R. A.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA	Mayo Clinic; Medical College of Wisconsin	Joyner, MJ (corresponding author), Mayo Clin, Dept Anesthesiol & Perioperat Med, 200 First St SW, Rochester, MN 55905 USA.	joyner.michael@mayo.edu		Baker, Sarah/0000-0001-9647-7660	National Heart, Lung, and Blood Institute (NHLBI) [5R35HL139854, 1F32HL154320]; National Institute on Aging [U54 AG044170]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Chad Wiggins, Dr. Stephen Klassen, Dr. Martin Husen, and Mr. Kevin Webb for intellectual discussions and feedback on earlier versions of the manuscript. This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) grant 5R35HL139854 (to MJJ) and grant 1F32HL154320 (to JWS), and National Institute on Aging grant U54 AG044170 (to SEB).	Armstrong RB, 1985, J APPL PHYSIOL, V73, P2274; ASTRAND PO, 1964, J APPL PHYSIOL, V19, P268, DOI 10.1152/jappl.1964.19.2.268; Bakovic D, 2005, CLIN EXP PHARMACOL P, V32, P944, DOI 10.1111/j.1440-1681.2005.04289.x; Bower MA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1644; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; Costa AM, 2012, SPORTS MED, V42, P449, DOI 10.2165/11650560-000000000-00000; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; Entin P, 2007, PHYSIOLOGY, V4, P135; Fletcher JR, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.178; Gagnon CM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0684; GUILHERME João Paulo Limongi França, 2014, Rev. bras. educ. fís. esporte, V28, P177, DOI 10.1590/S1807-55092014000100177; Guth LM, 2013, CURR OPIN PEDIATR, V25, P653, DOI 10.1097/MOP.0b013e3283659087; Handelsman DJ, 2018, ENDOCR REV, V39, P803, DOI 10.1210/er.2018-00020; Harper J., 2015, J SPORT CULT IDENTIT, V6, P1, DOI [DOI 10.18848/2381-6678/CGP/V06I01/54079, 10.18848/2381-6678/CGP/v06i01/54079]; Haugen T, 2018, INT J SPORT PHYSIOL, V13, P678, DOI 10.1123/ijspp.2017-0441; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; HELGERUD J, 1990, EUR J APPL PHYSIOL O, V61, P433, DOI 10.1007/BF00236064; Hilton EN, 2021, SPORTS MED, V51, P199, DOI 10.1007/s40279-020-01389-3; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Howden EJ, 2015, J APPL PHYSIOL, V119, P37, DOI 10.1152/japplphysiol.00092.2015; Hunter SK, 2015, J APPL PHYSIOL, V118, P1321, DOI 10.1152/japplphysiol.00852.2014; Ingham SA, 2008, MED SCI SPORT EXER, V40, P345, DOI 10.1249/mss.0b013e31815a83dc; Jeon Y, 2019, J EXERC REHABIL, V15, P537, DOI 10.12965/jer.1938336.168; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Joyner MJ, 2020, J APPL PHYSIOL, V128, P1065, DOI 10.1152/japplphysiol.00793.2019; Joyner MJ, 2019, SPORTS MED, V49, P199, DOI 10.1007/s40279-019-01164-z; Joyner MJ, 2017, J PHYSIOL-LONDON, V595, P2949, DOI 10.1113/JP272268; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Joyner MJ, 1985, J APPL PHYSIOL, V2011, P275; Keenan KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191504; Kim J, 2018, P NATL ACAD SCI USA, V115, pE7212, DOI 10.1073/pnas.1800455115; Kipp S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00079; Kubo K, 2003, EUR J APPL PHYSIOL, V88, P520, DOI 10.1007/s00421-002-0744-8; Lauderdale M A, 1999, Equine Vet J Suppl, P586; Liebenberg L, 2008, J HUM EVOL, V55, P1156, DOI 10.1016/j.jhevol.2008.07.004; LONGHURST JC, 1986, AM J PHYSIOL, V251, pH502, DOI 10.1152/ajpheart.1986.251.3.H502; Lund RJ, 1995, J S AFR VET ASSOC, V66, P239; McKeever K H, 2006, Equine Vet J Suppl, P233; Miller VM, 2015, J WOMENS HEALTH, V24, P969, DOI 10.1089/jwh.2015.5498; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Pate RR, 2007, SPORTS MED, V37, P294, DOI 10.2165/00007256-200737040-00006; Porter MM, 2002, J APPL PHYSIOL, V92, P1451, DOI 10.1152/japplphysiol.00744.2001; Roberts TA, 2020, BR J SPORTS MED; Rooney MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205664; Schagatay E, 2020, EUR J APPL PHYSIOL, V120, P2693, DOI 10.1007/s00421-020-04471-w; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Senefeld J, 2016, SCAND J MED SCI SPOR, V26, P17, DOI 10.1111/sms.12412; Senefeld JW, 2020, JAMA-J AM MED ASSOC, V324, P99, DOI 10.1001/jama.2020.5655; Senefeld JW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225724; Shave Rob, 2017, Vet Sci, V4, DOI 10.3390/vetsci4010009; Staaden R., 1984, THESIS; Thibault V, 2010, J SPORT SCI MED, V9, P214; Trachsel DS, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0846-x; VAHLQUIST B, 1950, BLOOD, V5, P874, DOI 10.1182/blood.V5.9.874.874; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; Wiik A, 2020, J CLIN ENDOCR METAB, V105, pE805, DOI 10.1210/clinem/dgz247; Yilmaz DC, 2013, INDIAN J MED RES, V137, P1111; Young LE, 2003, EXP PHYSIOL, V88, P659, DOI 10.1113/eph8802615; Zaldivar-Lopez S, 2011, VET CLIN PATH, V40, P414, DOI 10.1111/j.1939-165X.2011.00360.x	65	2	2	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21562	10.1096/fj.202100161R	http://dx.doi.org/10.1096/fj.202100161R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913189	Green Accepted			2022-12-28	WOS:000645260100069
J	Chang, YM; Menges, S; Westhof, A; Kleinschmidt-Doerr, K; Brenneis, C; Pitsillides, AA				Chang, Yu-Mei; Menges, Stephanie; Westhof, Andreas; Kleinschmidt-Doerr, Kerstin; Brenneis, Christian; Pitsillides, Andrew A.			Systematic analysis reveals that colony housing aligns gait profiles and strengthens link between histological and micro-CT bone markers in rat models of osteoarthritis	FASEB JOURNAL			English	Article						colony housing; gait; histology; micro&#8208; CT; osteoarthritis	RODENT MODELS; PAIN; RECOMMENDATIONS; ASSESSMENTS; STRESS	Osteoarthritis (OA) etiopathogenesis is complex with strong environmental/lifestyle determinants that, in laboratory animals, extend to social context and stress levels. This study seeks to identify whether colony housing of rats exerts a social impact on locomotion behaviors to influence alignment between symptomatic (gait) and structural (bone micro-CT measures, cartilage morphometry, and histology) OA outcome measures. Rats were randomly allocated to conventional (type IV; n = 48) or rat colony cage (RCC; n = 30) housing, further randomized to OA surgical models (ACLT + tMx, MMT or DMM) or no surgery (control), and maintained for 19 weeks during which multiple gait recordings were made. Standard histological grading and bone micro-CT data were collected at necropsy. Principal component analysis was used to summarize the variation in gait, micro-CT or histology. Linear mixed effects model or two-way ANOVA was employed to evaluate the impact of the housing system, surgery and time on gait, or micro-CT and histology components Analyses reveal that RCC exaggerates trends in gait change via a combined effect of the housing system and surgery. Intriguingly, RCC-housed nonoperated control rats showed similar gait changes to rats subjected to surgery; the latter exhibited significant structural joint changes in both systems. Stronger correlation between histological and micro-CT bone changes were found in medial and lateral tibia joint compartments of rats housed in RCC system. This study has established that rat social housing exaggerates outcomes in traditional histological measures of OA, generates stronger links between histology and micro-CT bone changes and removes gait differences as a variable in their etiology.	[Chang, Yu-Mei; Pitsillides, Andrew A.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Menges, Stephanie; Westhof, Andreas; Kleinschmidt-Doerr, Kerstin; Brenneis, Christian] Merck Healthcare KGaA, Darmstadt, Germany	University of London; University of London Royal Veterinary College	Chang, YM (corresponding author), Royal Vet Coll, 4 Royal Coll St, London NW1 0TU, England.	ychang@rvc.ac.uk						Adebayo OO, 2017, OSTEOARTHR CARTILAGE, V25, P2108, DOI 10.1016/j.joca.2017.08.016; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; BERMAN D, 1982, PAIN, V13, P307, DOI 10.1016/0304-3959(82)90020-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bove SE, 2006, OSTEOARTHR CARTILAGE, V14, P1041, DOI 10.1016/j.joca.2006.05.001; Brenneis C, 2020, Osteoarthr Cartil Open, V2, P100100, DOI 10.1016/j.ocarto.2020.100100; Brenneis C, 2017, J AM ASSOC LAB ANIM, V56, P18; Burr DB, 2004, J RHEUMATOL, V31, P77; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; HUSKISSON EC, 1995, J RHEUMATOL, V22, P1941; Huzard D, 2015, PHYSIOL BEHAV, V151, P238, DOI 10.1016/j.physbeh.2015.07.018; Jacobs BY, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0456-x; Javaheri B, 2017, BONE, V103, P308, DOI 10.1016/j.bone.2017.07.028; Kraus VB, 2010, OSTEOARTHR CARTILAGE, V18, pS35, DOI 10.1016/j.joca.2010.04.015; Lakes EH, 2016, OSTEOARTHR CARTILAGE, V24, P1837, DOI 10.1016/j.joca.2016.03.008; Liu X, 2013, BRAIN RES, V1502, P71, DOI 10.1016/j.brainres.2013.01.044; Lorenz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105858; Malfait AM, 2013, OSTEOARTHR CARTILAGE, V21, P1316, DOI 10.1016/j.joca.2013.06.003; Malfait AM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0747-6; Martin Loren J, 2014, Curr Top Behav Neurosci, V20, P233, DOI 10.1007/7854_2014_287; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Ohtori S, 2013, YONSEI MED J, V54, P1253, DOI 10.3349/ymj.2013.54.5.1253; Patterson-Kane EG, 2002, ANIM WELFARE, V11, P327; Poulet B, 2015, OSTEOARTHR CARTILAGE, V23, P940, DOI 10.1016/j.joca.2015.01.012; Salvarrey-Strati A, 2008, ILAR J, V49, pE23; Santangelo KS, 2014, ARTHRITIS, DOI 10.1155/2014/503519; Shu CC, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-2117-2; Suri P, 2012, PM&R, V4, pS10, DOI 10.1016/j.pmrj.2012.01.007; TenBroek EM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0921-5; U.S. Department of Health and Human Services Food and Drug Administration, 2018, OSTEOARTHRITIS STRUC; van der Kraan PM, 2017, OSTEOARTHR CARTILAGE, V25, P369, DOI 10.1016/j.joca.2016.09.005	32	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21451	10.1096/fj.202002009R	http://dx.doi.org/10.1096/fj.202002009R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33683776	hybrid			2022-12-28	WOS:000635216100081
J	Le Garf, S; Sibille, B; Mothe-Satney, I; Eininger, C; Fauque, P; Murdaca, J; Chinetti, G; Neels, JG; Rousseau, AS				Le Garf, Sebastien; Sibille, Brigitte; Mothe-Satney, Isabelle; Eininger, Cyril; Fauque, Philippe; Murdaca, Joseph; Chinetti, Giulia; Neels, Jaap G.; Rousseau, Anne-Sophie			Alpha-lipoic acid supplementation increases the efficacy of exercise- and diet-induced obesity treatment and induces immunometabolic changes in female mice and women	FASEB JOURNAL			English	Article						antioxidant; diet; exercise; immunometabolism; inflammation; regulatory T cells; T lymphocyte; translational study	REGULATORY T-CELLS; VISCERAL ADIPOSE-TISSUE; OXIDATIVE STRESS; UNIQUE POPULATION; ACTIVATION; TREG; FAT; INFLAMMATION; ASSOCIATION; METABOLISM	The decrease in the regulatory T cells (Tregs) population is highly involved in adipose tissue inflammation and insulin resistance in obesity. Tregs depend on fatty acids via beta-oxidation for immunosuppressive function adapting their antioxidant systems to allow survival to oxidative stress. In this study, we have hypothesized that a dietary supplementation with alpha-lipoic acid (ALA), a powerful antioxidant, would improve immunometabolism when added to the classical strategy of obesity treatment. First, we showed by in vitro experiments that ALA favors the polarization of mice CD4 + T cells toward Tregs. Next, we have carried out a translational study where female obese mice and women were supplemented with ALA or vehicle/placebo (mice: 2.5 g(ALA)/kg(food); 6 weeks(;) women: 600 mg(ALA)/day, 8 weeks) while following a protocol including regular exercise and a change in diet. Fatty acid oxidation potential and activity of nuclear erythroid-related factor 2 (NRF2) of mouse secondary lymphoid tissues were improved by ALA supplementation. ALA reduced visceral adipose tissue (VAT) mass and preserved Tregs in VAT in mice. In women, ALA supplementation induced significant metabolic changes of circulating CD4 + T cells including increased oxidative capacity and fatty acid oxidation, ameliorated their redox status, and improved the reduction of visceral fat mass. While appropriate biological markers are still required to be used in clinics to judge the effectiveness of long-term obesity treatment, further studies in female mice and women are needed to determine whether these immunometabolic changes would reduce VAT mass-associated risk for secondary health issues arising from obesity.	[Le Garf, Sebastien; Sibille, Brigitte; Mothe-Satney, Isabelle; Murdaca, Joseph; Neels, Jaap G.; Rousseau, Anne-Sophie] Univ Cote dAzur, INSERM, C3M, Nice, France; [Eininger, Cyril; Fauque, Philippe] Polyclin Oxford, Cannes, France; [Chinetti, Giulia] Univ Cote dAzur, CHU Nice, INSERM, C3M, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Rousseau, AS (corresponding author), Univ Cote dAzur, Mediterranean Ctr Mol Med C3M, Team 9 Metab Challenges Immune Cells Obes Diabet, INSERM,U1065, Batiment Univ Archimed 151 Route Ginestiere, F-06204 Nice 3, France.	Anne-Sophie.ROUSSEAU@univ-cotedazur.fr	Neels, Jaap G/F-5534-2010; Sibille, Brigitte/Q-8240-2016; MOTHE-SATNEY, ISABELLE/Q-6377-2016; chinetti, giulia/Q-6901-2016	Neels, Jaap G/0000-0002-5900-8395; Sibille, Brigitte/0000-0001-6806-0454; MOTHE-SATNEY, ISABELLE/0000-0002-2693-8385; Anne-Sophie, Rousseau/0000-0002-7672-0237; Le Garf, Sebastien/0000-0001-7253-0121; chinetti, giulia/0000-0001-8048-8138	Agence Francaise de Lutte contre le Dopage (AFLD) [201700016]; Institut National de la Sante et de la Recherche Medicale (Inserm)	Agence Francaise de Lutte contre le Dopage (AFLD); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Agence Francaise de Lutte contre le Dopage (AFLD), Grant/Award Number: 201700016; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ahnstedt H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00659; Anderson EK, 2013, DIABETES, V62, P3180, DOI 10.2337/db12-1076; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bjorkman F, 2016, EUR J APPL PHYSIOL, V116, P1627, DOI 10.1007/s00421-016-3412-0; Blackburn GL., 2002, EATING DISORDERS OBE, V2nd ed, P484; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chen XF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1580967; Christensen P, 2018, DIABETES OBES METAB, V20, P2840, DOI 10.1111/dom.13466; Cluxton D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00115; Cui J, 2016, FREE RADICAL RES, V50, P1106, DOI 10.1080/10715762.2016.1210140; Deiuliis JA, 2011, LIPIDS, V46, P1021, DOI 10.1007/s11745-011-3603-8; Deng T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15725; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; Huang KC, 2004, OBES RES, V12, P840, DOI 10.1038/oby.2004.101; Ishikawa A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230885; Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225; Klaus S, 2012, GENES NUTR, V7, P369, DOI 10.1007/s12263-011-0260-8; Le Garf S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205182; Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Maj T, 2017, NAT IMMUNOL, V18, P1332, DOI 10.1038/ni.3868; Maurovich-Horvat P, 2007, INT J OBESITY, V31, P500, DOI 10.1038/sj.ijo.0803454; McCarty MF, 2009, MED HYPOTHESES, V72, P29, DOI 10.1016/j.mehy.2008.07.043; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Namazi N, 2018, CLIN NUTR, V37, P419, DOI 10.1016/j.clnu.2017.06.002; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; Panda S., 2013, BIO-PROTOCOL, V3, pe323, DOI DOI 10.21769/BIOPROTOC.323; Patwardhan RS, 2020, FREE RADICAL RES, V54, P947, DOI 10.1080/10715762.2020.1745202; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Piening BD, 2018, CELL SYST, V6, P157, DOI 10.1016/j.cels.2017.12.013; Rahimlou M, 2019, CLIN NUTR ESPEN, V32, P16, DOI 10.1016/j.clnesp.2019.03.015; Rochette L, 2013, MOL NUTR FOOD RES, V57, P114, DOI 10.1002/mnfr.201200608; Rousseau AS, 2016, FASEB J, V30, P1287, DOI 10.1096/fj.15-280453; Sen CK, 1997, FREE RADICAL BIO MED, V22, P1241, DOI 10.1016/S0891-5849(96)00552-7; Sena CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092706; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02716; Sireesh D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22913-6; Pereira LMS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00605; SUZUKI YJ, 1992, BIOCHEM BIOPH RES CO, V189, P1709, DOI 10.1016/0006-291X(92)90275-P; Tyrrell DJ, 2015, EXP GERONTOL, V70, P84, DOI 10.1016/j.exger.2015.07.015; Vasanthakumar A, 2020, NATURE, V579, P581, DOI 10.1038/s41586-020-2040-3; Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087; Wang KC, 2013, CLIN SCI, V125, P329, DOI 10.1042/CS20120560; Wirth A, 1998, OBES RES, V6, P393, DOI 10.1002/j.1550-8528.1998.tb00370.x; Yadav V, 2010, MULT SCLER J, V16, P387, DOI 10.1177/1352458509359722; Zeng Q, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02075; Zhang Q, 2018, J CELL MOL MED, V22, P4335, DOI 10.1111/jcmm.13723; Zou JH, 2018, CELL MOL IMMUNOL, V15, P630, DOI 10.1038/cmi.2017.36	55	4	5	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21312	10.1096/fj.202001817RR	http://dx.doi.org/10.1096/fj.202001817RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742689				2022-12-28	WOS:000635216100055
J	Rohwer, N; Chiu, CY; Huang, D; Smyl, C; Rothe, M; Rund, KM; Schebb, NH; Kuhn, H; Weylandt, KH				Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Rothe, Michael; Rund, Katharina M.; Helge Schebb, Nils; Kuhn, Hartmut; Weylandt, Karsten-Henrich			Omega-3 fatty acids protect from colitis via an Alox15-derived eicosanoid	FASEB JOURNAL			English	Article						lipid peroxidation; lipoxygenases; eicosanoids; inflammatory bowel disease		An increased omega-3 polyunsaturated fatty acid (n-3 PUFA) tissue status can lead to a significant formation of anti-inflammatory lipid mediators and effective reduction in inflammation and tissue injury in murine colitis. Arachidonic acid lipoxygenases (ALOX) have been implicated in the pathogenesis of inflammatory bowel disease as well as in the formation of pro- and anti-inflammatory lipid mediators. To explore the role of Alox15 in the protective response found in fat1 transgenic mice with endogenously increased n-3 PUFA tissue status fat1 transgenic mice were crossed with Alox15-deficient animals and challenged in the dextran sulfate sodium (DSS)- and the 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis model. Transgenic fat1 mice rich in endogenous n-3 PUFAs were protected from colitis. However, additional systemic inactivation of the Alox15 gene counteracted this protective effect. To explore the molecular basis for this effect Alox15 lipid metabolites derived from n-3 PUFA were analyzed in the different mice. Alox15 deficiency suppressed the formation of n-3 PUFA-derived 15-hydroxy eicosapentaenoic acid (15-HEPE). In contrast, treating mice with intraperitoneal injections of 15S-HEPE protected wild-type mice from DSS- and TNBS-induced colitis. These data suggest that the anti-colitis effect of increased n-3 PUFA in the transgenic fat1 mouse model is mediated in part via Alox15-derived 15-HEPE formation.	[Rohwer, Nadine; Weylandt, Karsten-Henrich] Brandenburg Med Sch Theodor Fontane, Ruppin Gen Hosp, Dept Gastroenterol Metab & Oncol, Div Med, Neuruppin, Germany; [Rohwer, Nadine; Weylandt, Karsten-Henrich] Theodor Fontane & Univ Potsdam, Brandenburg Med Sch, Joint Fac Brandenburg Univ Technol Cottbus Senfte, Fac Hlth Sci Brandenburg, Potsdam, Germany; [Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Weylandt, Karsten-Henrich] Charite Univ Med Berlin, Dept Hepatol Gastroenterol & Metab, Div Med, Berlin, Germany; [Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Kuhn, Hartmut; Weylandt, Karsten-Henrich] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Kuhn, Hartmut; Weylandt, Karsten-Henrich] Berlin Inst Hlth, Berlin, Germany; [Rohwer, Nadine] German Inst Human Nutr, Dept Mol Toxicol, Potsdam, Nuthetal, Germany; [Rothe, Michael] Lipidomix GmbH, Berlin, Germany; [Rund, Katharina M.; Helge Schebb, Nils] Univ Wuppertal, Fac Math & Nat Sci, Chair Food Chem, Wuppertal, Germany; [Kuhn, Hartmut] Charite Univ Med Berlin, Inst Biochem, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Wuppertal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Weylandt, KH (corresponding author), Brandenburg Med Sch, Ruppin Gen Hosp, Dept Gastroenterol Metab & Oncol, Div Med, Neuruppin, Germany.	karsten.weylandt@mhb-fontane.de		Schebb, Nils Helge/0000-0003-1299-6629; Rohwer, Nadine/0000-0001-6170-1327	Deutsche Forschungsgemeinschaft (DFG) [WE2908/11-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: KU961/11-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: KU961/13-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: WE2908/11-1	Ackermann JA, 2017, BBA-MOL CELL BIOL L, V1862, P371, DOI 10.1016/j.bbalip.2016.07.014; Adel S, 2016, P NATL ACAD SCI USA, V113, pE4266, DOI 10.1073/pnas.1604029113; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; COOPER HS, 1993, LAB INVEST, V69, P238; Coras R, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1527-0; FREIREMOAR J, 1995, BBA-LIPID LIPID MET, V1254, P112, DOI 10.1016/0005-2760(94)00199-9; Gil A, 2002, BIOMED PHARMACOTHER, V56, P388, DOI 10.1016/S0753-3322(02)00256-1; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Goto Y, 2015, CURR OPIN RHEUMATOL, V27, P388, DOI 10.1097/BOR.0000000000000192; Graham TO, 2002, GASTROENTEROL CLIN N, V31, P203, DOI 10.1016/S0889-8553(01)00022-X; Gu MQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101351; Huang CH, 2015, CLIN NUTR, V34, P1018, DOI 10.1016/j.clnu.2014.11.008; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kroschwald S, 2018, BBA-MOL CELL BIOL L, V1863, P866, DOI 10.1016/j.bbalip.2018.04.019; KUHN H, 1990, J BIOL CHEM, V265, P18351; Kuhn H, 2018, PROG LIPID RES, V72, P55, DOI 10.1016/j.plipres.2018.09.002; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kutzner L, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158806; Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001; Lewis JD, 2017, GASTROENTEROLOGY, V152, P398, DOI 10.1053/j.gastro.2016.10.019; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Mazzon E, 2006, SHOCK, V25, P377, DOI 10.1097/01.shk.0000209530.30564.22; Nguyen DH, 2011, BRIT J PHARMACOL, V162, P1119, DOI 10.1111/j.1476-5381.2010.01117.x; Ostermann AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184470; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Pochard C, 2016, GASTROENTEROLOGY, V150, P168, DOI 10.1053/j.gastro.2015.09.038; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; Rossi A, 2019, PHARMACOL RES, V139, P182, DOI 10.1016/j.phrs.2018.11.024; Rund KM, 2018, ANAL CHIM ACTA, V1037, P63, DOI 10.1016/j.aca.2017.11.002; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; SIGAL E, 1990, J BIOL CHEM, V265, P5113; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yum HW, 2017, BIOCHEM BIOPH RES CO, V487, P847, DOI 10.1016/j.bbrc.2017.04.140	47	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21491	10.1096/fj.202002340RR	http://dx.doi.org/10.1096/fj.202002340RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710695	Green Published			2022-12-28	WOS:000635216100033
J	Xu, LW; Gou, X; Yang, JY; Jiang, R; Jiang, X; Chen, GG; Liu, ZM				Xu, Lin-Wan; Gou, Xi; Yang, Jun-Yan; Jiang, Rong; Jiang, Xue; Chen, George G.; Liu, Zhi-Min			Methylation of ER beta 5 '-untranslated region attenuates its inhibitory effect on ER alpha gene transcription and promotes the initiation and progression of papillary thyroid cancer	FASEB JOURNAL			English	Article						5&#8242; &#8208; untranslated region; ER&#945; mRNA (A&#8208; 1); ER&#946; mRNA (0N&#8208; 1)		Normal thyroid tissue displays a prevalent expression of ER beta than ER alpha, which drastically turns upside down in the initiation and progression of papillary thyroid cancer (PTC). The underlying molecular mechanism of this phenomenon remains unclear. Here, we demonstrated that ER alpha and ER beta were coexpressed in human thyroid tissues and cells. ER alpha mRNA (A-1) and ER beta mRNA (0N-1), transcribed from Promoter A of ER alpha gene and Promoter 0N of ER beta gene, respectively, were the major mRNA isoforms which mainly contributed to total ER alpha mRNA and total ER beta mRNA in human thyroid-derived cell lines and tissues. The expression levels of ER alpha mRNA (A-1) and total ER alpha mRNA were gradually increased, and those of ER beta mRNA (0N-1) and total ER beta mRNA were decreased by degree in the initiation and progression of PTC. No aberrant DNA methylation of ER alpha 5 '-untranslated region was involved in its up-regulation; however, aberrant DNA methylation in Promoter 0N and Exon 0N of ER beta gene was found to be involved in its down-regulation in the initiation and progression of PTC. ER beta can repress ER alpha gene transcription via recruitment of NCoR and displacement of RNA polymerase II at the Sp1 site in ER alpha Promoter A-specific region in thyroid-derived cells. It is suggested that DNA methylation of CpG islands in Promoter 0N and Exon 0N of ER beta gene leads to a decreased ER beta gene expression, which attenuates its inhibitory effect on ER alpha gene transcription and results in an increased ER alpha gene expression, cell proliferation, initiation, and progression of PTC.	[Xu, Lin-Wan; Gou, Xi; Yang, Jun-Yan; Jiang, Rong; Jiang, Xue; Liu, Zhi-Min] Chongqing Med Univ, Coll Basic Med, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China; [Chen, George G.] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Peoples R China	Chongqing Medical University; Chinese University of Hong Kong; Prince of Wales Hospital	Liu, ZM (corresponding author), Chongqing Med Univ, Coll Basic Med, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	liuzm9999@aliyun.com			National Natural Science Foundation of China [81272937]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81272937	Ahn HY, 2015, CLIN ENDOCRINOL, V82, P300, DOI 10.1111/cen.12486; Al-Nakhle H, 2013, INT J ONCOL, V43, P2039, DOI 10.3892/ijo.2013.2112; Barreto-Andrade JN, 2018, INT J MED SCI, V15, P1320, DOI 10.7150/ijms.26774; Bartella V, 2012, BREAST CANCER RES TR, V134, P569, DOI 10.1007/s10549-012-2090-9; Bie LH, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-018-3678-8; Bossard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044787; Bouras E, 2019, GENE, V710, P333, DOI 10.1016/j.gene.2019.06.023; de Dieuleveult M, 2018, EPIGENETICS INSIGHTS, V11, DOI 10.1177/2516865718811117; deGraffenried LA, 2004, BREAST CANCER RES TR, V85, P111, DOI 10.1023/B:BREA.0000025398.93829.78; deGraffenried LA, 2002, J STEROID BIOCHEM, V82, P7, DOI 10.1016/S0960-0760(02)00151-6; Medina-Jaime AD, 2014, ASIAN PAC J CANCER P, V15, P3041, DOI 10.7314/APJCP.2014.15.7.3041; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Flouriot G, 1998, MOL ENDOCRINOL, V12, P1939, DOI 10.1210/me.12.12.1939; Greaves E, 2013, HUM REPROD, V28, P2490, DOI 10.1093/humrep/det235; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hirata S, 2001, J STEROID BIOCHEM, V78, P33, DOI 10.1016/S0960-0760(01)00071-1; Huang YH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-383; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Inoue A, 2002, J PHARMACOL TOX MET, V47, P129, DOI 10.1016/S1056-8719(02)00221-6; Jia M, 2015, BEST PRACT RES CL EN, V29, P557, DOI 10.1016/j.beem.2015.04.008; Kohler F, 2020, J INVEST DERMATOL, V140, P38, DOI 10.1016/j.jid.2019.05.011; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kurata A, 2019, MED HYPOTHESES, V122, P5, DOI 10.1016/j.mehy.2018.10.008; Lee J, 2007, ARCH BIOCHEM BIOPHYS, V461, P200, DOI 10.1016/j.abb.2006.12.030; Liu J, 2014, PATHOL RES PRACT, V210, P830, DOI 10.1016/j.prp.2014.09.002; Liyanage C, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040148; Maekawa R, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0489-1; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; MENASCE LP, 1993, GENOMICS, V17, P263, DOI 10.1006/geno.1993.1320; Mo XM, 2016, MOL CELL ENDOCRINOL, V431, P71, DOI 10.1016/j.mce.2016.05.010; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Nadal-Serrano M, 2012, J CELL BIOCHEM, V113, P3178, DOI 10.1002/jcb.24192; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Osborne CK, 2001, CLIN CANCER RES, V7, p4338S; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Przybylik-Mazurek E, 2012, GYNECOL ENDOCRINOL, V28, P150, DOI 10.3109/09513590.2011.563909; Qiu YB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37648-7; Rahbari R, 2010, FUTURE ONCOL, V6, P1771, DOI 10.2217/FON.10.127; Reid G, 2002, CELL MOL LIFE SCI, V59, P821, DOI 10.1007/s00018-002-8470-2; Rice LW, 2010, GYNECOL ONCOL, V118, P202, DOI 10.1016/j.ygyno.2010.03.014; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Rody A, 2005, ENDOCR-RELAT CANCER, V12, P903, DOI 10.1677/erc.1.01088; Schonfeld SJ, 2011, CANCER EPIDEMIOL, V35, pE85, DOI 10.1016/j.canep.2011.05.009; Seah MKY, 2018, CURR TOP DEV BIOL, V128, P203, DOI 10.1016/bs.ctdb.2017.10.011; Shenker NS, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1335-5; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Su CW, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2016-0; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Sungwalee W, 2013, ASIAN PAC J CANCER P, V14, P5153, DOI 10.7314/APJCP.2013.14.9.5153; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; Suzuki F, 2008, CANCER SCI, V99, P2365, DOI 10.1111/j.1349-7006.2008.00988.x; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Teneng I, 2015, ONCOGENE, V34, P621, DOI 10.1038/onc.2013.580; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yi JW, 2017, ANN SURG ONCOL, V24, P3754, DOI 10.1245/s10434-017-5780-z; Zannoni GF, 2013, HUM PATHOL, V44, P1047, DOI 10.1016/j.humpath.2012.09.007; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	62	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21516	10.1096/fj.202001467R	http://dx.doi.org/10.1096/fj.202001467R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710697				2022-12-28	WOS:000635216100028
J	Kandasamy, K; Tan, LG; Johana, NB; Tan, YW; Foo, W; Yeo, JSL; Ravikumar, V; Ginhoux, F; Choolani, M; Chan, JKY; Mattar, CNZ				Kandasamy, Karthikeyan; Tan, Lay Geok; Johana, Nuryanti B.; Tan, Yi Wan; Foo, Wanling; Yeo, Julie S. L.; Ravikumar, Vikashini; Ginhoux, Florent; Choolani, Mahesh; Chan, Jerry K. Y.; Mattar, Citra N. Z.			Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation	FASEB JOURNAL			English	Article						bone marrow cells; fetal therapy; hematopoietic stem and progenitor cells; intrauterine transplantation; maternal donor cells; paternal donor cells; semi&#8208; allogenic donor cells	BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; REGULATORY T-CELLS; PRENATAL TOLERANCE INDUCTION; VERSUS-HOST-DISEASE; CANINE MODEL; CHIMERISM; DELETION; ANTIGENS; MHC	Successful intrauterine hematopoietic cell transplantation (IUT) for congenital hemoglobinopathies is hampered by maternal alloresponsiveness. We investigate these interactions in semi-allogenic murine IUT. E14 fetuses (B6 females x BALB/c males) were each treated with 5E+6 maternal (B6) or paternal (BALB/c) bone marrow cells and serially monitored for chimerism (>1% engraftment), trafficked maternal immune cells, and immune responsiveness to donor cells. A total of 41.0% of maternal IUT recipients (mIUT) were chimeras (mean donor chimerism 3.0 +/- 1.3%) versus 75.0% of paternal IUT recipients (pIUT, 3.6 +/- 1.1%). Chimeras showed higher maternal microchimerism of CD4, CD8, and CD19 than non-chimeras. These maternal cells showed minimal responsiveness to B6 or BALB/c stimulation. To interrogate tolerance, mIUT were injected postnatally with 5E+6 B6 cells/pup; pIUT received BALB/c cells. IUT-treated pups showed no changes in trafficked maternal or fetal immune cell levels compared to controls. Donor-specific IgM and IgG were expressed by 1%-3% of recipients. mIUT splenocytes showed greater proliferation of regulatory T cells (Treg) upon BALB/c stimulation, while B6 stimulation upregulated the pro-inflammatory cytokines more than BALB/c. pIUT splenocytes produced identical Treg and cytokine responses to BALB/c and B6 cells, with higher Treg activity and lower pro-inflammatory cytokine expression upon exposure to BALB/c. In contrast, naive fetal splenocytes demonstrated greater alloresponsiveness to BALB/c compared to B6 cells. Thus pIUT, associated with increased maternal cell trafficking, modulates fetal Treg, and cytokine responsiveness to donor cells more efficiently than mIUT, resulting in improved engraftment. Paternal donor cells may be considered alternatively to maternal donor cells for intrauterine and postnatal transplantation to induce tolerance and maintain engraftment.	[Kandasamy, Karthikeyan; Tan, Lay Geok; Foo, Wanling; Ravikumar, Vikashini; Choolani, Mahesh; Mattar, Citra N. Z.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 119228, Singapore; [Tan, Lay Geok; Choolani, Mahesh; Mattar, Citra N. Z.] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Obstet & Gynaecol, Singapore, Singapore; [Johana, Nuryanti B.; Tan, Yi Wan; Yeo, Julie S. L.; Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Mattar, CNZ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 119228, Singapore.	citramattar@nus.edu.sg		Mattar, Citra Nurfarah/0000-0003-0068-6957; Kandasamy, Karthikeyan/0000-0001-8335-8953	MOH \ National Medical Research Council (NMRC) [NMRC/TA/0003/2012, NMRC/CSA-INV/0012/2016]	MOH \ National Medical Research Council (NMRC)(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	MOH vertical bar National Medical Research Council (NMRC), Grant/Award Number: NMRC/TA/0003/2012 and NMRC/CSA-INV/0012/2016	Alhajjat AM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00051; Araki M, 2010, J IMMUNOL, V185, P7739, DOI 10.4049/jimmunol.1001226; Ashizuka S, 2006, EXP HEMATOL, V34, P359, DOI 10.1016/j.exphem.2005.11.011; Benichou G, 1999, J IMMUNOL, V162, P352; Blakemore K, 2004, AM J OBSTET GYNECOL, V190, P960, DOI 10.1016/j.ajog.2004.01.014; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Bracamonte-Baran W, 2015, BIOMED J, V38, P39, DOI 10.4103/2319-4170.143498; Burlingham William J, 2012, Chimerism, V3, P29, DOI 10.4161/chim.21668; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chen JC, 2008, EXP HEMATOL, V36, P1236, DOI 10.1016/j.exphem.2008.04.012; Chou SH, 2013, CELL TRANSPLANT, V22, P711, DOI 10.3727/096368912X655172; Derderian SC, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00278; Dighe NM, 2018, EXP HEMATOL, V62, P45, DOI 10.1016/j.exphem.2018.03.006; Durkin ET, 2008, BLOOD, V112, P5245, DOI 10.1182/blood-2007-12-128116; Dutta P, 2011, AM J TRANSPLANT, V11, P1296, DOI 10.1111/j.1600-6143.2011.03484.x; Dutta Partha, 2011, Chimerism, V2, P78, DOI 10.4161/chim.2.3.18083; Dutta Partha, 2010, Chimerism, V1, P2, DOI 10.4161/chim.1.1.12667; Dutta P, 2009, BLOOD, V114, P3578, DOI 10.1182/blood-2009-03-213561; Dutta P, 2009, CURR OPIN ORGAN TRAN, V14, P439, DOI 10.1097/MOT.0b013e32832d6683; Fehr T, 2008, J IMMUNOL, V181, P4371, DOI 10.4049/jimmunol.181.6.4371; FLAKE AW, 1993, CRIT REV ONCOL HEMAT, V15, P35, DOI 10.1016/1040-8428(93)90019-Z; Fowler DH., 2019, IMMUNE BIOL ALLOGENE, P195; Frascoli M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan2263; Gotherstrom C, 2014, STEM CELL TRANSL MED, V3, P255, DOI 10.5966/sctm.2013-0090; Hayashi S, 2003, EXP HEMATOL, V31, P176, DOI 10.1016/S0301-472X(02)01024-X; Hayashi S, 2002, BLOOD, V100, P804, DOI 10.1182/blood-2002-01-0016; JACOBY RO, 1969, AM J VET RES, V30, P1503; Kandasamy K., 2021, FASEB J, V35; Karnon J, 1999, CLIN LAB HAEMATOL, V21, P377, DOI 10.1046/j.1365-2257.1999.00262.x; Kim HB, 1998, J SURG RES, V77, P1, DOI 10.1006/jsre.1997.5255; Kim HB, 1999, J PEDIATR SURG, V34, P726, DOI 10.1016/S0022-3468(99)90364-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz J, 2004, BLOOD, V103, P4336, DOI 10.1182/blood-2003-08-2642; Lee PW, 2005, TRANSPLANTATION, V79, P1084, DOI 10.1097/01.TP.0000161247.61727.67; Lee PW, 2005, EXP HEMATOL, V33, P371, DOI 10.1016/j.exphem.2004.12.002; Lin JX, 2019, ANNU REV IMMUNOL, V37, P295, DOI 10.1146/annurev-immunol-042718-041447; Liu LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031300; Masouridi-Levrat S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00362; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P683, DOI 10.1016/j.bpobgyn.2012.06.005; Mattar CNZ, 2019, FETAL DIAGN THER, V46, P175, DOI 10.1159/000493791; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Merianos D, 2008, BIOL BLOOD MARROW TR, V14, P729, DOI 10.1016/j.bbmt.2008.02.012; Merianos DJ, 2009, J CLIN INVEST, V119, P2590, DOI 10.1172/JCI38979; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Nijagal A, 2013, BLOOD, V121, P4595, DOI 10.1182/blood-2012-10-463174; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Nowlan B, 2020, HAEMATOLOGICA, V105, P71, DOI 10.3324/haematol.2018.212910; Peng B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0152-y; Peranteau WH, 2002, BLOOD, V100, P2225, DOI 10.1182/blood-2002-01-0166; Peranteau WH, 2007, BLOOD, V109, P1331, DOI 10.1182/blood-2006-04-018606; Peranteau WH, 2006, BLOOD, V108, P4268, DOI 10.1182/blood-2006-04-018986; Peranteau WH, 2015, BLOOD, V126, P1245, DOI 10.1182/blood-2015-03-636803; Peranteau WH, 2009, BIOL BLOOD MARROW TR, V15, P293, DOI 10.1016/j.bbmt.2008.11.034; Petersen SM, 2007, FETAL DIAGN THER, V22, P175, DOI 10.1159/000098711; Petersen SM, 2013, FETAL DIAGN THER, V33, P116, DOI 10.1159/000346211; Richter M, 2017, HEMATOL ONCOL CLIN N, V31, P771, DOI 10.1016/j.hoc.2017.06.001; Riley JS, 2020, BLOOD ADV, V4, P1102, DOI 10.1182/bloodadvances.2019001208; Stern M, 2008, BLOOD, V112, P2990, DOI 10.1182/blood-2008-01-135285; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Tiblad E, 2008, BEST PRACT RES CL OB, V22, P189, DOI 10.1016/j.bpobgyn.2007.07.007; Tilburgs T, 2013, AM J REPROD IMMUNOL, V69, P395, DOI 10.1111/aji.12094; van Rood JJ, 2002, BLOOD, V99, P1572, DOI 10.1182/blood.V99.5.1572; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Vrecenak JD, 2018, BIOL BLOOD MARROW TR, V24, P1795, DOI 10.1016/j.bbmt.2018.05.020; Vrecenak JD, 2014, BLOOD, V124, P1987, DOI 10.1182/blood-2013-11-537571; Wegorzewska M, 2014, J IMMUNOL, V192, P1938, DOI 10.4049/jimmunol.1302403; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	69	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21413	10.1096/fj.202002185RR	http://dx.doi.org/10.1096/fj.202002185RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570785	hybrid			2022-12-28	WOS:000629576700027
J	Zeng, HL; Yang, Q; Yuan, PH; Wang, X; Cheng, LM				Zeng, Hao-Long; Yang, Qing; Yuan, Peihong; Wang, Xu; Cheng, Liming			Associations of essential and toxic metals/metalloids in whole blood with both disease severity and mortality in patients with COVID-19	FASEB JOURNAL			English	Article						COVID-19; metals; metalloids; mortality; severity; whole blood	HEAVY-METALS; EXPOSURE; INFECTION; CHROMIUM; SYSTEM; HEALTH; COPPER; ZINC; DNA	The variations and dynamics of essential and toxic metal(loid)s in patients with COVID-19 may associate with the progression and fatal outcome of the disease, which still remains to investigate. In the present study, a retrospective analysis was performed in a cohort of 306 confirmed COVID-19 patients admitted to Tongji hospital (Wuhan, China) from February 10 to March 15, 2020. Whole blood levels of essential and/or toxic metal(loid)s were analyzed, including magnesium, calcium, chromium, manganese, iron, copper, zinc, arsenic, cadmium, mercury, thallium, and lead according to the disease severity and outcome. Compared to the non-severe COVID-19 patients, severe cases showed significant higher levels of whole blood calcium, chromium, and copper, but lower levels of magnesium, manganese, iron, zinc, arsenic, thallium, and lead. These differences were further found consistently across the clinical course since the disease onset by longitudinal analysis. Among the severe patients, chromium and cadmium were higher in the deceased group compared to the recovered group, while arsenic was lower. Whole blood iron, age, and sex were determined to be independent factors associated with the disease severity, while chromium, cadmium, and the comorbidity of cardiovascular disease were determined to be independent factors associated with the mortality. These results suggest that variations of whole blood metal(loid)s may be associated with the severe illness and fatal outcome of COVID-19, which could be persistently monitored and would be helpful in the evaluation of the dynamic changes in patients with COVID-19.	[Zeng, Hao-Long; Yuan, Peihong; Wang, Xu; Cheng, Liming] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan 430030, Peoples R China; [Yang, Qing] Wuhan Polytech Univ, Inst Food Sci & Engn, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan Polytechnic University	Cheng, LM (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan 430030, Peoples R China.		Xiao, Hu/GMX-0258-2022		National Natural Science Foundation of China [31600666]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (31600666).	Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Bolondi G, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00323-2; Bortey-Sam N, 2018, ENVIRON POLLUT, V235, P163, DOI 10.1016/j.envpol.2017.12.005; Briffa J, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04691; Calder PC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041181; Cannas D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072074; Cappellini F, 2020, CLIN CHEM LAB MED, V58, pE171, DOI 10.1515/cclm-2020-0611; Cernat RI, 2011, INT J TUBERC LUNG D, V15, P1239, DOI 10.5588/ijtld.10.0445; Doboszewska U, 2020, BRIT J PHARMACOL, V177, P4887, DOI 10.1111/bph.15199; Edeas M, 2020, INT J INFECT DIS, V97, P303, DOI 10.1016/j.ijid.2020.05.110; Flem B, 2015, APPL GEOCHEM, V59, P211, DOI 10.1016/j.apgeochem.2015.01.016; Gombart AF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010236; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Iddir M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061562; Ilback NG, 2008, J TRACE ELEM MED BIO, V22, P120, DOI 10.1016/j.jtemb.2007.12.001; Iotti S, 2020, MAGNESIUM RES, V33, P21, DOI 10.1684/mrh.2020.0465; Lewicki S, 2014, ANN AGR ENV MED, V21, P331, DOI 10.5604/1232-1966.1108599; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Maier JA, 2021, SEMIN CELL DEV BIOL, V115, P37, DOI 10.1016/j.semcdb.2020.11.002; Malavolta M, 2015, MECH AGEING DEV, V151, P93, DOI 10.1016/j.mad.2015.01.004; Marazuela M, 2020, REV ENDOCR METAB DIS, V21, P495, DOI 10.1007/s11154-020-09569-2; Monti MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163313; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; National Health Commission of the People's Republic of China and National Administration of Traditional Chinese Medicine, 2020, DIAGN TREATM SCHEM N; Rahman MT, 2021, BIOL TRACE ELEM RES, V199, P550, DOI 10.1007/s12011-020-02194-9; Razzaque MS, 2020, TOHOKU J EXP MED, V251, P175, DOI 10.1620/tjem.251.175; Rehman K, 2018, J CELL BIOCHEM, V119, P157, DOI 10.1002/jcb.26234; Rhee SY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-9; Sanna A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010068; Sarzi-Puttini P, 2020, CLIN EXP RHEUMATOL, V38, P337, DOI 10.55563/clinexprheumatol/xcdary; Shrivastava R, 2002, FEMS IMMUNOL MED MIC, V34, P1, DOI 10.1111/j.1574-695X.2002.tb00596.x; Singh AK, 2020, DIABETES OBES METAB, V22, P1915, DOI 10.1111/dom.14124; Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1; Sun SY, 2020, CLIN CHIM ACTA, V507, P174, DOI 10.1016/j.cca.2020.04.024; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; Tsatsakis A, 2020, FOOD CHEM TOXICOL, V141, DOI 10.1016/j.fct.2020.111418; Valera P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141262; Valera P, 2014, ENVIRON GEOCHEM HLTH, V36, P79, DOI 10.1007/s10653-013-9520-4; Wallace TC, 2020, J AM COLL NUTR, V39, P685, DOI 10.1080/07315724.2020.1785971; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Wessels I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121286; Xu XH, 2017, ENVIRON POLLUT, V220, P1121, DOI 10.1016/j.envpol.2016.11.023; Xu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074288; Zeng HL, 2021, FASEB J, V35, DOI 10.1096/fj.202002346RR; Zeng HL, 2019, BIOL TRACE ELEM RES, V189, P344, DOI 10.1007/s12011-018-1486-8; Zhao K, 2020, OPEN FORUM INFECT DI, V7, DOI [10.1093/ofid/ofaa250, 10.1093/ofid/ofaa750]; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou Q, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3801639; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	50	32	32	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21392	10.1096/fj.202002346RR	http://dx.doi.org/10.1096/fj.202002346RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33577131	Green Published			2022-12-28	WOS:000629576700041
J	Montgomery, J; Richardson, WJ; Marsh, S; Rhett, JM; Bustos, F; Degen, K; Ghatnekar, GS; Grek, CL; Jourdan, LJ; Holmes, JW; Gourdie, RG				Montgomery, Jade; Richardson, William J.; Marsh, Spencer; Rhett, J. Matthew; Bustos, Francis; Degen, Katherine; Ghatnekar, Gautam S.; Grek, Christina L.; Jourdan, L. Jane; Holmes, Jeffrey W.; Gourdie, Robert G.			The connexin 43 carboxyl terminal mimetic peptide alpha CT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin	FASEB JOURNAL			English	Article						clinical trial; computational model; Cx43; peptide therapeutic; scar mitigation; skin	FIBROBLAST MIGRATION; CELL-MIGRATION; ORIENTATION; TISSUE; PHOSPHORYLATION; EXPRESSION; REDUCTION; KINASE; CX43; MECHANISMS	Phase II clinical trials have reported that acute treatment of surgical skin wounds with the therapeutic peptide alpha Connexin Carboxy-Terminus 1 (alpha CT1) improves cutaneous scar appearance by 47% 9-month postsurgery. While Cx43 and ZO-1 have been identified as molecular targets of alpha CT1, the mode-of-action of the peptide in scar mitigation at cellular and tissue levels remains to be further characterized. Scar histoarchitecture in alpha CT1 and vehicle-control treated skin wounds within the same patient were compared using biopsies from a Phase I clinical trial at 29-day postwounding. The sole effect on scar structure of a range of epidermal and dermal variables examined was that alpha CT1-treated scars had less alignment of collagen fibers relative to control wounds-a characteristic that resembles unwounded skin. The with-in subject effect of alpha CT1 on scar collagen order observed in Phase I testing in humans was recapitulated in Sprague-Dawley rats and the IAF hairless guinea pig. Transient increase in histologic collagen density in response to alpha CT1 was also observed in both animal models. Mouse NIH 3T3 fibroblasts and primary human dermal fibroblasts treated with alpha CT1 in vitro showed more rapid closure in scratch wound assays, with individual cells showing decreased directionality in movement. An agent-based computational model parameterized with fibroblast motility data predicted collagen alignments in simulated scars consistent with that observed experimentally in human and the animal models. In conclusion, alpha CT1 prompts decreased directionality of fibroblast movement and the generation of a 3D collagen matrix postwounding that is similar to unwounded skin-changes that correlate with long-term improvement in scar appearance.	[Montgomery, Jade; Marsh, Spencer; Bustos, Francis; Degen, Katherine; Jourdan, L. Jane; Gourdie, Robert G.] Virginia Tech Carilion, Ctr Vasc & Heart Res, Fralin Biomed Res Inst, Roanoke, VA USA; [Montgomery, Jade; Degen, Katherine; Gourdie, Robert G.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Richardson, William J.] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Rhett, J. Matthew] Med Univ South Carolina, Hollings Canc Ctr, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Bustos, Francis; Gourdie, Robert G.] Virginia Tech Carilion, Sch Med, Roanoke, VA USA; [Ghatnekar, Gautam S.; Grek, Christina L.] FirstString Res Inc, Mt Pleasant, SC USA; [Holmes, Jeffrey W.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Montgomery, Jade] Univ Geneva, Dept Pathol & Immunol, Fac Med, CH-1211 Geneva, Switzerland	Virginia Polytechnic Institute & State University; Clemson University; Medical University of South Carolina; University of Virginia; University of Geneva	Gourdie, RG (corresponding author), Virginia Tech Carilion, Fralin Biomed Res Inst, Ctr Vasc & Heart Res, 2 Riverside Circle, Roanoke, VA 24016 USA.	gourdier@vtc.vt.edu			National Institutes of Health (NIH) [HL56728, HL141855]; NIH P20 grant [GM121342, HL075639]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH P20 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) R01 grants HL56728 and HL141855 (for RGG), NIH P20 grant GM121342 (for WJR), HL075639 (for JWH)	[Anonymous], 2002, GARDNER DLT DEF PATH, P359; [Anonymous], 2014, MATL 2014A MATL 2014A; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BOLOGNIA JL, 1990, PIGM CELL RES, V3, P150, DOI 10.1111/j.1600-0749.1990.tb00280.x; Bush JA, 2011, WOUND REPAIR REGEN, V19, pS32, DOI 10.1111/j.1524-475X.2010.00607.x; Chen CH, 2015, AM J PHYSIOL-CELL PH, V309, pC600, DOI 10.1152/ajpcell.00155.2015; Chittoria Ravi Kumar, 2013, J Cutan Aesthet Surg, V6, P12, DOI 10.4103/0974-2077.110090; Churko JM, 2012, EXP DERMATOL, V21, P612, DOI 10.1111/j.1600-0625.2012.01532.x; Cogliati B, 2015, J DERMATOL SCI, V79, P50, DOI 10.1016/j.jdermsci.2015.03.019; Corr DT, 2009, WOUND REPAIR REGEN, V17, P250, DOI 10.1111/j.1524-475X.2009.00463.x; Correa-Gallegos D, 2019, NATURE, V576, P287, DOI 10.1038/s41586-019-1794-y; Dallon JC, 1999, J THEOR BIOL, V199, P449, DOI 10.1006/jtbi.1999.0971; Ehrlich H. Paul, 1996, Wound Repair and Regeneration, V4, P203, DOI 10.1046/j.1524-475X.1996.40206.x; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Fang QQ, 2017, CURR PHARM DESIGN, V23, P2268, DOI 10.2174/1381612822666161025144434; Ferguson MWJ, 2009, LANCET, V373, P1264, DOI 10.1016/S0140-6736(09)60322-6; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fomovsky GM, 2010, AM J PHYSIOL-HEART C, V298, pH221, DOI 10.1152/ajpheart.00495.2009; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205; GOLIGER JA, 1995, MOL BIOL CELL, V6, P1491, DOI 10.1091/mbc.6.11.1491; Grek CL, 2017, J INVEST DERMATOL, V137, P620, DOI 10.1016/j.jid.2016.11.006; Gurtner GC, 2011, ANN SURG, V254, P217, DOI 10.1097/SLA.0b013e318220b159; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Jiang JB, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012385; Kanapathy M, 2018, BRIT J SURG, V105, P59, DOI 10.1002/bjs.10653; Kandyba EE, 2008, J INVEST DERMATOL, V128, P1039, DOI 10.1038/sj.jid.5701125; Karppinen Sanna-Maria, 2019, F1000Res, V8, DOI 10.12688/f1000research.18293.1; Laird DW, 2018, NAT REV DRUG DISCOV, V17, P905, DOI 10.1038/nrd.2018.138; LAUFER M, 1974, BRIT J EXP PATHOL, V55, P233; Lim AF, 2014, PLAST RECONSTR SURG, V133, P398, DOI 10.1097/01.prs.0000436526.64046.d0; LINARES HA, 1974, J INVEST DERMATOL, V62, P514, DOI 10.1111/1523-1747.ep12681048; Lorraine C, 2015, BIOCHEM SOC T, V43, P482, DOI 10.1042/BST20150034; Lu YB, 2018, J BONE MINER RES, V33, P1166, DOI 10.1002/jbmr.3409; Marquez-Rosado L, 2012, J CELL SCI, V125, P695, DOI 10.1242/jcs.084400; MathWorks, 2005, NORM 2 D CROSS NORMX NORM 2 D CROSS NORMX; McDougall S, 2006, PHILOS T R SOC A, V364, P1385, DOI [10.1098/rsta.2006.1773, 10.1098/rsta.2000.1773]; MELLES GRJ, 1995, BRIT J OPHTHALMOL, V79, P760, DOI 10.1136/bjo.79.8.760; Montgomery J, 2019, BUILDING BETTER SCAR; Montgomery J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061778; Morel S, 2016, CARDIOVASC RES, V109, P385, DOI 10.1093/cvr/cvw004; O'Quinn MP, 2011, CIRC RES, V108, P704, DOI 10.1161/CIRCRESAHA.110.235747; OACU.OIR.NIH, NAT I HLTH OFF INTR NAT I HLTH OFF INTR; Ongstad EL, 2013, ADV WOUND CARE, V2, P55, DOI 10.1089/wound.2011.0341; Peng GL, 2019, FACIAL PLAST SURG CL, V27, P513, DOI 10.1016/j.fsc.2019.07.013; Plotnikov SV, 2013, CURR OPIN CELL BIOL, V25, P619, DOI 10.1016/j.ceb.2013.06.003; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Qiu C, 2003, CURR BIOL, V13, P1697, DOI 10.1016/j.cub.2003.09.007; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Richardson WJ, 2018, BIOMECH MODEL MECHAN, V17, P1569, DOI 10.1007/s10237-018-1044-5; Richardson WJ, 2016, BIOPHYS J, V110, P2266, DOI 10.1016/j.bpj.2016.04.014; Rid R, 2005, CELL MOTIL CYTOSKEL, V61, P161, DOI 10.1002/cm.20076; Rose J, 2015, LANCET GLOB HEALTH, V3, pS13, DOI 10.1016/S2214-109X(15)70087-2; Rouillard AD, 2012, J PHYSIOL-LONDON, V590, P4585, DOI 10.1113/jphysiol.2012.229484; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Sutcliffe JES, 2015, BRIT J DERMATOL, V173, P1205, DOI 10.1111/bjd.14064; Tarzemany R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115524; Thevenin AF, 2017, MOL BIOL CELL, V28, P3595, DOI 10.1091/mbc.E16-07-0496; Tziotzios C, 2012, J AM ACAD DERMATOL, V66, P13, DOI 10.1016/j.jaad.2011.08.035; Verhaegen PD, 2012, WOUND REPAIR REGEN, V20, P658, DOI 10.1111/j.1524-475X.2012.00827.x; Verhaegen PDHM, 2012, J MICROSC-OXFORD, V245, P82, DOI 10.1111/j.1365-2818.2011.03547.x; Wen HA, 2009, INT WOUND J, V6, P149, DOI 10.1111/j.1742-481X.2009.00591.x; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485	65	7	7	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21762	10.1096/fj.202001881R	http://dx.doi.org/10.1096/fj.202001881R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34246197	Green Accepted, Green Submitted			2022-12-28	WOS:000678975300043
J	de ten Ryen, SV; Warnier, G; Gnimassou, O; Belhaj, MR; Benoit, N; Naslain, D; Brook, MS; Smith, K; Wilkinson, DJ; Nielens, H; Atherton, PJ; Francaux, M; Deldicque, L				van Doorslaer de ten Ryen, Sophie; Warnier, Geoffrey; Gnimassou, Olouyomi; Belhaj, Mehdi R.; Benoit, Nicolas; Naslain, Damien; Brook, Matthew S.; Smith, Kenneth; Wilkinson, Daniel J.; Nielens, Henri; Atherton, Philip J.; Francaux, Marc; Deldicque, Louise			Higher strength gain after hypoxic vs normoxic resistance training despite no changes in muscle thickness and fractional protein synthetic rate	FASEB JOURNAL			English	Article						deuterium; hypoxia; muscle thickness; myogenesis; protein synthesis	ACUTE ENVIRONMENTAL HYPOXIA; SATELLITE CELL; HYPERTROPHY; EXERCISE; MYOGENESIS; ADAPTATIONS; INTERVAL; POWER; REST	Acute hypoxia has previously been suggested to potentiate resistance training-induced hypertrophy by activating satellite cell-dependent myogenesis rather than an improvement in protein balance in human. Here, we tested this hypothesis after a 4-week hypoxic vs normoxic resistance training protocol. For that purpose, 19 physically active male subjects were recruited to perform 6 sets of 10 repetitions of a one-leg knee extension exercise at 80% 1-RM 3 times/week for 4 weeks in normoxia (FiO(2): 0.21; n = 9) or in hypoxia (FiO(2): 0.135, n = 10). Blood and skeletal muscle samples were taken before and after the training period. Muscle fractional protein synthetic rate was measured over the whole period by deuterium incorporation into the protein pool and muscle thickness by ultrasound. At the end of the training protocol, the strength gain was higher in the hypoxic vs the normoxic group despite no changes in muscle thickness and in the fractional protein synthetic rate. Only early myogenesis, as assessed by higher MyoD and Myf5 mRNA levels, appeared to be enhanced by hypoxia compared to normoxia. No effects were found on myosin heavy chain expression, markers of oxidative metabolism and lactate transport in the skeletal muscle. Though the present study failed to unravel clearly the mechanisms by which hypoxic resistance training is particularly potent to increase muscle strength, it is important message to keep in mind that this training strategy could be effective for all athletes looking at developing and optimizing their maximal muscle strength.	[van Doorslaer de ten Ryen, Sophie; Warnier, Geoffrey; Gnimassou, Olouyomi; Belhaj, Mehdi R.; Benoit, Nicolas; Naslain, Damien; Francaux, Marc; Deldicque, Louise] UCLouvain, Inst Neurosci, Pl Pierre Coubertin,1 L08 10 01, B-1348 Lovain La Neuve, Belgium; [Brook, Matthew S.; Smith, Kenneth; Wilkinson, Daniel J.; Atherton, Philip J.] Univ Nottingham, Sch Med, Nottingham Biomed Res Ctr BRC, MRC ARUK Ctr Musculoskeletal Ageing Res, Nottingham, England; [Brook, Matthew S.; Smith, Kenneth; Wilkinson, Daniel J.; Atherton, Philip J.] Univ Nottingham, Sch Med, Nottingham Biomed Res Ctr BRC, Natl Inst Hlth Res, Nottingham, England; [Nielens, Henri] UCLouvain, Clin Univ St Luc, Brussels, Belgium; [Gnimassou, Olouyomi] Univ Hubert Koutoukou Maga, Ctr Natl Hosp, Clin Univ Med Phys & Readaptat, Cotonou, Benin; [Belhaj, Mehdi R.] Australian Catholic Univ, Mary MacKillop Inst Hlth, Exercise & Nutr Res Program, Melbourne, Vic, Australia	University of Nottingham; University of Nottingham; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Australian Catholic University	Deldicque, L (corresponding author), UCLouvain, Inst Neurosci, Pl Pierre Coubertin,1 L08 10 01, B-1348 Lovain La Neuve, Belgium.	louise.deldicque@uclouvain.be	Warnier, Geoffrey/AEK-2389-2022	Warnier, Geoffrey/0000-0002-2438-0875	Fonds National de la Recherche Scientifique [J.0050.16]; Sports Ministry of the Brussels-Wallonia Federation; Centre d'Aide a la Performance Sportive	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Sports Ministry of the Brussels-Wallonia Federation; Centre d'Aide a la Performance Sportive	Fonds National de la Recherche Scientifique, Grant/Award Number: J.0050.16; Sports Ministry of the Brussels-Wallonia Federation and the Centre d'Aide a la Performance Sportive	Bazgir B, 2017, CELL J, V18, P473; Britto FA, 2020, FASEB J, V34, P1885, DOI 10.1096/fj.201902244R; Brocherie F, 2015, EUR J APPL PHYSIOL, V115, P891, DOI 10.1007/s00421-014-3070-z; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; D'Hulst G, 2013, ACTA PHYSIOL, V208, P251, DOI 10.1111/apha.12086; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-00000; Etheridge T, 2011, AM J PHYSIOL-ENDOC M, V301, pE697, DOI 10.1152/ajpendo.00276.2011; Feriche B, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0078-z; Francaux M., 2013, CELL MOL EXERC PHYSL, V2, pE5; Friedmann B, 2003, PFLUG ARCH EUR J PHY, V446, P742, DOI 10.1007/s00424-003-1133-9; Gnimassou O, 2018, FASEB J, V32, P5272, DOI 10.1096/fj.201800049RR; Ho JY, 2014, J STRENGTH COND RES, V28, P935, DOI 10.1519/JSC.0000000000000289; Inness MWH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00502; Joanisse S, 2015, AM J PHYSIOL-REG I, V309, pR1101, DOI 10.1152/ajpregu.00249.2015; Joanisse S, 2013, FASEB J, V27, P4596, DOI 10.1096/fj.13-229799; Kon M, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12033; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Kurobe K, 2015, CLIN PHYSIOL FUNCT I, V35, P197, DOI 10.1111/cpf.12147; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Mancinelli R, 2011, J BIOL REG HOMEOS AG, V25, P635; Manimmanakorn A, 2013, EUR J APPL PHYSIOL, V113, P1767, DOI 10.1007/s00421-013-2605-z; Masschelein E, 2014, FASEB J, V28, P1022, DOI 10.1096/fj.13-239863; Mitchell CJ, 2015, J APPL PHYSIOL, V118, P495, DOI 10.1152/japplphysiol.00609.2014; MORITANI T, 1993, J BIOMECH, V26, P95, DOI 10.1016/0021-9290(93)90082-P; Muller W, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-095641; Nguyen DD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00604; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359; Paddon-Jones D, 2001, EUR J APPL PHYSIOL, V85, P466, DOI 10.1007/s004210100467; Puype J, 2013, MED SCI SPORT EXER, V45, P2166, DOI 10.1249/MSS.0b013e31829734ae; Ramos-Campo DJ, 2018, EUR J SPORT SCI, V18, P92, DOI 10.1080/17461391.2017.1388850; Richardson RS, 2001, J APPL PHYSIOL, V91, P2679, DOI 10.1152/jappl.2001.91.6.2679; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Scott BR, 2015, SPORTS MED, V45, P313, DOI 10.1007/s40279-014-0288-1; Shamim B, 2018, SPORTS MED, V48, P1329, DOI 10.1007/s40279-018-0883-7; Shepstone TN, 2005, J APPL PHYSIOL, V98, P1768, DOI 10.1152/japplphysiol.01027.2004; Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilkinson DJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12433; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Yasuda T, 2016, ONCOTARGET, V7, P33595, DOI 10.18632/oncotarget.9564	44	1	1	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21773	10.1096/fj.202100654RR	http://dx.doi.org/10.1096/fj.202100654RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324735				2022-12-28	WOS:000678975300031
J	Yang, YD; Yang, YQ; Chan, K; Couture, JF				Yang, Yidai; Yang, Yaqing; Chan, Kin; Couture, Jean-Francois			Analyzing the impact of CFP1 mutational landscape on epigenetic signaling	FASEB JOURNAL			English	Review						cancer; CFP1; epigenetics	CXXC FINGER PROTEIN-1; CPG-BINDING-PROTEIN; GENOMIC CYTOSINE METHYLATION; HISTONE H3K4 METHYLASES; MEIOTIC RECOMBINATION; PHD FINGER; METHYLTRANSFERASE ACTIVITY; DNA METHYLTRANSFERASE; CHROMATIN-STRUCTURE; COMPASS FAMILY	CXXC Zinc finger protein 1 (CFP1) is a multitasking protein playing essential roles during various developmental processes. Its ability to interact with several proteins contribute to several epigenetic events. Here, we review CFP1's functions and its impact on DNA methylation and the post-translational modification of histone proteins such as lysine acetylation and methylation. We will also discuss the potential role of CFP1 in carcinogenesis and the impact of the mutations identified in patients suffering from various cancers.	[Yang, Yidai; Yang, Yaqing; Chan, Kin; Couture, Jean-Francois] Univ Ottawa, Ottawa Inst Syst Biol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada; [Yang, Yidai; Couture, Jean-Francois] Univ Ottawa, Res Ctr Syst & Personalized Pharmacol, Shanghai Inst Mat Med, Ottawa, ON, Canada; [Yang, Yidai; Yang, Yaqing; Chan, Kin; Couture, Jean-Francois] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Couture, JF (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	jean-francois.couture@uottawa.ca		Couture, Jean-Francois/0000-0003-0385-4450	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [PJT-148869]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT-148869	Acquaviva L, 2013, EPIGENETICS-US, V8, P355, DOI 10.4161/epi.24295; Acquaviva L, 2013, SCIENCE, V339, P215, DOI 10.1126/science.1225739; Adam C, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007223; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Angelina C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17192-6; Arndt K, 2018, BLOOD, V131, P1311, DOI 10.1182/blood-2017-09-806844; Avdic V, 2011, FASEB J, V25, P960, DOI 10.1096/fj.10-171959; Baker CL, 2014, GENOME RES, V24, P724, DOI 10.1101/gr.170167.113; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baylin SB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019505; Begum S, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1511209; Belousov Iu B, 1987, Kardiologiia, V27, P100; Beurton F, 2019, NUCLEIC ACIDS RES, V47, P11164, DOI 10.1093/nar/gkz880; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Branford S, 2018, BLOOD, V132, P948, DOI 10.1182/blood-2018-02-832253; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Brown DA, 2017, CELL REP, V20, P2313, DOI 10.1016/j.celrep.2017.08.030; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Buratowski S, 2010, COLD SH Q B, V75, P95, DOI 10.1101/sqb.2010.75.036; Butler JS, 2009, DNA CELL BIOL, V28, P223, DOI 10.1089/dna.2009.0854; Butler JS, 2008, DNA CELL BIOL, V27, P533, DOI 10.1089/dna.2007.0714; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Cao WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11687; Carlone DL, 2001, MOL CELL BIOL, V21, P7601, DOI 10.1128/MCB.21.22.7601-7606.2001; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; Chen D, 2019, MOL MED REP, V19, P1587, DOI 10.3892/mmr.2019.9832; Cheng XD, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018747; Cheray M, 2014, EPIGENOMICS-UK, V6, P267, DOI [10.2217/epi.14.18, 10.2217/EPI.14.18]; Choi YJ, 2014, HUM PATHOL, V45, P1674, DOI 10.1016/j.humpath.2014.04.013; Chun KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113745; Clouaire T, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0451-x; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Couture JF, 2013, EPIGENETICS-US, V8, P349, DOI 10.4161/epi.24177; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Diagouraga B, 2018, MOL CELL, V69, P853, DOI 10.1016/j.molcel.2018.01.033; Garcia-Sanz P, 2017, INT J CANCER, V140, P1551, DOI 10.1002/ijc.30573; Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; He C, 2019, BIOCHEM J, V476, P1957, DOI 10.1042/BCJ20190091; Higgs MR, 2018, MOL CELL, V71, P25, DOI 10.1016/j.molcel.2018.05.018; Hui ZY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01885; Imai Y, 2017, CHROMOSOMA, V126, P681, DOI 10.1007/s00412-017-0631-z; Jacob Y, 2014, SCIENCE, V343, P1249, DOI 10.1126/science.1248357; Jiang Y, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.183764; Kim SS, 2020, BREAST CANCER RES TR, V180, P45, DOI 10.1007/s10549-019-05517-0; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kumar A, 2018, GENE, V674, P31, DOI 10.1016/j.gene.2018.06.063; Kwon M, 2020, NUCLEIC ACIDS RES, V48, P5442, DOI 10.1093/nar/gkaa317; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Lewis R, 2019, NEOPLASIA, V21, P505, DOI 10.1016/j.neo.2019.03.012; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li TM, 2016, MOL THER, V24, P261, DOI 10.1038/mt.2015.208; Li YX, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026831; Liu K, 2020, J MOL BIOL, V432, P1674, DOI 10.1016/j.jmb.2019.09.025; Local A, 2018, NAT GENET, V50, P73, DOI 10.1038/s41588-017-0015-6; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Mahadevan J, 2016, GENE, V594, P1, DOI 10.1016/j.gene.2016.08.048; Mai T, 2013, J IMMUNOL, V191, P1895, DOI 10.4049/jimmunol.1300922; Michieletto D, 2018, NUCLEIC ACIDS RES, V46, P83, DOI 10.1093/nar/gkx1200; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Parvanov ED, 2017, MOL BIOL CELL, V28, P488, DOI 10.1091/mbc.E16-09-0686; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Qu QH, 2018, CELL, V174, P1117, DOI 10.1016/j.cell.2018.07.020; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rickels R, 2017, NAT GENET, V49, P1647, DOI 10.1038/ng.3965; Salz T, 2015, MOL CANCER RES, V13, P461, DOI 10.1158/1541-7786.MCR-14-0389; Salz T, 2014, CANCER RES, V74, P775, DOI 10.1158/0008-5472.CAN-13-1400; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sha QQ, 2021, NUCLEIC ACIDS RES, V49, P2569, DOI 10.1093/nar/gkab107; Sha QQ, 2020, CELL MOL LIFE SCI, V77, P2997, DOI 10.1007/s00018-019-03322-y; Sha QQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05930-x; Shah KK, 2019, EXP CELL RES, V382, DOI 10.1016/j.yexcr.2019.06.030; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Soares LM, 2017, MOL CELL, V68, P773, DOI 10.1016/j.molcel.2017.10.013; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Sun JY, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0946-3; Sze CC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4764; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Tate CM, 2010, FEBS J, V277, P210, DOI 10.1111/j.1742-4658.2009.07475.x; Tencer AH, 2017, STRUCTURE, V25, P1530, DOI 10.1016/j.str.2017.08.009; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tian H, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007657; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wang L, 2019, MOL CELL, V76, P646, DOI 10.1016/j.molcel.2019.08.019; Wu JG, 2020, MOL ONCOL, V14, P1397, DOI 10.1002/1878-0261.12689; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang PH, 2019, INT J CANCER, V145, P2986, DOI 10.1002/ijc.32334; Yang YD, 2020, NUCLEIC ACIDS RES, V48, P421, DOI 10.1093/nar/gkz1037; Young SRL, 2007, DNA CELL BIOL, V26, P80, DOI 10.1089/dna.2006.0535; Young SRL, 2006, J BIOL CHEM, V281, P37034, DOI 10.1074/jbc.M604546200; Yu C, 2017, CELL REP, V20, P1161, DOI 10.1016/j.celrep.2017.07.011; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235	107	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21790	10.1096/fj.202100427R	http://dx.doi.org/10.1096/fj.202100427R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320252				2022-12-28	WOS:000678975300023
J	Cui, W; Chen, J; Yu, F; Liu, WH; He, ML				Cui, Wei; Chen, Jing; Yu, Feng; Liu, Wenhong; He, Maolin			GYY4137 protected the integrity of the blood-brain barrier via activation of the Nrf2/ARE pathway in mice with sepsis	FASEB JOURNAL			English	Article						blood-brain barrier; GYY4137; Nrf2; ARE pathway; sepsis-associated encephalopathy	NEURON-SPECIFIC ENOLASE; HYDROGEN-SULFIDE; NITRIC-OXIDE; IMPROVES; INJURY; EXPRESSION; INJECTION; APOPTOSIS	Injury to the blood-brain barrier (BBB) plays a vital role in sepsis-associated encephalopathy (SAE), which is one of the most common complications of sepsis. GYY4137, a new synthetic compound of hydrogen sulfide (H2S), has extensive biological benefits. In this study, we focused on the protective effects of GYY4137 on the BBB in septic mice and the underlying mechanisms. The results suggested that whether administrated at the same time or 3 hours after LPS injection, GYY4137 both significantly alleviated the clinical symptoms and the long-term prognosis. Besides, GYY4137 improved the pathological abnormalities of septic mice. Moreover, the degradation of tight junctions in the BBB was considerably inhibited by GYY4137. In addition, GYY4137 significantly attenuated inflammation and apoptosis in the brain. Furthermore, GYY4137 activated the Nrf2/ARE pathway through the sulfhydrylation of Keap1 and inhibited oxidative stress. ML385, the specific inhibitor of Nrf2, significantly reversed the protective effects of GYY4137 in sepsis mice. In conclusion, this study indicated that through the sulfhydrylation of Keap1, GYY4137 activated the Nrf2/ARE pathway and exerted anti-inflammatory, anti-apoptotic and antioxidant effects in septic mice that consequently protected the integrity of the BBB and improved the clinical outcome of sepsis. Our findings suggest that GYY4137 might be a promising agent for the treatment of SAE.	[Cui, Wei; Chen, Jing; Yu, Feng; Liu, Wenhong; He, Maolin] Capital Med Univ, Beijing Shijitan Hosp, Dept Neurol, 10 Tieyi St, Beijing, Peoples R China	Capital Medical University	Cui, W (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Dept Neurol, 10 Tieyi St, Beijing, Peoples R China.	cuiwei3352@bjsjth.cn			Capital Medical University (CMU) [2016-q13]	Capital Medical University (CMU)	Capital Medical University (CMU), Grant/Award Number: 2016-q13	Ahmad A, 2016, SHOCK, V46, P183, DOI 10.1097/SHK.0000000000000589; Al-Obaidi MMJ, 2018, CELL MOL NEUROBIOL, V38, P1349, DOI 10.1007/s10571-018-0609-2; Alkharfy KM, 2015, LIFE SCI, V143, P131, DOI 10.1016/j.lfs.2015.08.007; Anderson BJ, 2016, J CRIT CARE, V36, P18, DOI 10.1016/j.jcrc.2016.06.012; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Chen SW, 2015, INFLAMM RES, V64, P789, DOI 10.1007/s00011-015-0862-5; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Chung HY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030703; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Erikson K, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03101-3; Feng W, 2015, J MED CHEM, V58, P6456, DOI 10.1021/acs.jmedchem.5b00848; Gemici B, 2015, METHOD ENZYMOL, V555, P169, DOI 10.1016/bs.mie.2014.11.034; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; Grambow E, 2014, PLATELETS, V25, P166, DOI 10.3109/09537104.2013.786823; Haileselassie B, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1689-8; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jiang LJ, 2021, INFLAMM RES, V70, P205, DOI 10.1007/s00011-020-01415-0; Jin XZ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.573422; Kadl A, 2007, SHOCK, V28, P582, DOI 10.1097/shk.0b013e31804d41dd; Kamisaki Y, 1997, BBA-MOL BASIS DIS, V1362, P24, DOI 10.1016/S0925-4439(97)00052-5; Kaur G, 2006, TOXICOLOGY, V226, P152, DOI 10.1016/j.tox.2006.06.018; Kutz JL, 2015, J PHYSIOL-LONDON, V593, P2121, DOI 10.1113/JP270054; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Li HB, 2018, CELL PHYSIOL BIOCHEM, V47, P994, DOI 10.1159/000490166; Liu XN, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7161592; Luppi F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-140; Magierowski M, 2015, MOLECULES, V20, P9099, DOI 10.3390/molecules20059099; Marquez-Velasco R, 2011, INFLAMM RES, V60, P947, DOI 10.1007/s00011-011-0355-0; Mills-Davies N, 2017, ACTA CRYSTALLOGR D, V73, P9, DOI 10.1107/S2059798316019525; Mosevoll KA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00691; Nath N, 2019, J CELL PHYSIOL, V234, P3007, DOI 10.1002/jcp.27120; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Ogawa Y, 2016, ELIFE, V5, DOI 10.7554/eLife.21055; Qiu YB, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01500-2; Quan N, 1998, BRAIN RES, V802, P189, DOI 10.1016/S0006-8993(98)00402-8; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rivera S, 2019, CELL MOL LIFE SCI, V76, P3051, DOI 10.1007/s00018-019-03172-8; Rose P, 2015, METHOD ENZYMOL, V554, P143, DOI 10.1016/bs.mie.2014.11.014; Sarker S, 2018, ECOTOX ENVIRON SAFE, V151, P132, DOI 10.1016/j.ecoenv.2018.01.004; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Singh A, 2016, ACS CHEM BIOL, V11, P3214, DOI 10.1021/acschembio.6b00651; Sonneville R, 2017, INTENS CARE MED, V43, P1075, DOI 10.1007/s00134-017-4807-z; Torun AN, 2009, CLIN ENDOCRINOL, V70, P469, DOI 10.1111/j.1365-2265.2008.03348.x; Troletti CD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1294-2; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang Y, 2019, NEUROSCI LETT, V711, DOI 10.1016/j.neulet.2019.134387; Wang Y, 2016, NEUROCHEM RES, V41, P659, DOI 10.1007/s11064-015-1731-x; Wang YM, 2016, J NEUROL SCI, V368, P223, DOI 10.1016/j.jns.2016.07.010; Xiao F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05062-2; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	54	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21710	10.1096/fj.202100074R	http://dx.doi.org/10.1096/fj.202100074R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143548				2022-12-28	WOS:000667814100030
J	Garcia-Gonzalez, L; Paumier, JM; Louis, L; Pilat, D; Bernard, A; Stephan, D; Jullien, N; Checler, F; Nivet, E; Khrestchatisky, M; Baranger, K; Rivera, S				Garcia-Gonzalez, Laura; Paumier, Jean-Michel; Louis, Laurence; Pilat, Dominika; Bernard, Anne; Stephan, Delphine; Jullien, Nicolas; Checler, Frederic; Nivet, Emmanuel; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago			MT5-MMP controls APP and beta-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid beta precursor protein; endosome; metalloproteinase; proteasome; secretase	AMYLOID PRECURSOR PROTEIN; C-TERMINAL FRAGMENT; MATRIX-METALLOPROTEINASE; BETA-PROTEIN; A-BETA; MEMBRANE; IDENTIFICATION; C99; INHIBITORS; BRAIN	We previously discovered the implication of membrane-type 5-matrix metalloproteinase (MT5-MMP) in Alzheimer's disease (AD) pathogenesis. Here, we shed new light on pathogenic mechanisms by which MT5-MMP controls the processing of amyloid precursor protein (APP) and the fate of amyloid beta peptide (A beta) as well as its precursor C99, and C83. We found in human embryonic kidney cells (HEK) carrying the APP Swedish familial mutation (HEKswe) that deleting the C-terminal non-catalytic domains of MT5-MMP hampered its ability to process APP and release the soluble 95 kDa form (sAPP95). Catalytically inactive MT5-MMP variants increased the levels of A beta and promoted APP/C99 sorting in the endolysosomal system, likely through interactions of the proteinase C-terminal portion with C99. Most interestingly, the deletion of the C-terminal domain of MT5-MMP caused a strong degradation of C99 by the proteasome and prevented A beta accumulation. These discoveries reveal new control of MT5-MMP over APP by proteolytic and non-proteolytic mechanisms driven by the C-terminal domains of the proteinase. The targeting of these non-catalytic domains of MT5-MMP could, therefore, provide new insights into the therapeutic regulation of APP-related pathology in AD.	[Garcia-Gonzalez, Laura; Paumier, Jean-Michel; Louis, Laurence; Pilat, Dominika; Bernard, Anne; Stephan, Delphine; Jullien, Nicolas; Nivet, Emmanuel; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago] Aix Marseille Univ, Inst Neurophysiopathol, INP, CNRS, Marseille, France; [Checler, Frederic] CNRS UCA, IPMC, UMR 7275, Labex DistAlz, Valbonne, France; [Paumier, Jean-Michel] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Northwestern University; Feinberg School of Medicine	Baranger, K; Rivera, S (corresponding author), Aix Marseille Univ, Inst Neuropathophysiol INP, UMR 7051, CNRS, Campus Timone,27 Bld Jean Moulin, F-13005 Marseille, France.	kevin.baranger@univ-amu.fr; santiago.rivera@univ-amu.fr	Jullien, Nicolas/O-1947-2015; Checler, Frederic/C-1241-2009	Jullien, Nicolas/0000-0001-8273-2106; Pilat, Dominika/0000-0001-8533-3514; /0000-0001-8875-1877; Checler, Frederic/0000-0003-2098-1750	CNRS; Aix-Marseille Universite; French National Research Agency (ANR); CoEN; Fondation Plan Alzheimer; France Alzheimer; Vaincre l'Alzheimer; Fonds Europeens de Developpement Regional; La fondation NRJ-Institut de France; Fondation pour la Recherche Medicale [FDT201904008423, FDT202001011017]; Conseil General des Alpes Maritimes; LABEX DISTALZ; A*Midex foundation [ANR-17-EURE-0029]; French National Research Agency	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; French National Research Agency (ANR)(French National Research Agency (ANR)); CoEN; Fondation Plan Alzheimer; France Alzheimer; Vaincre l'Alzheimer; Fonds Europeens de Developpement Regional(European Commission); La fondation NRJ-Institut de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); LABEX DISTALZ; A*Midex foundation(French National Research Agency (ANR)); French National Research Agency(French National Research Agency (ANR))	CNRS; Aix--Marseille Universite; French National Research Agency (ANR); CoEN; Fondation Plan Alzheimer; France Alzheimer; Vaincre l'Alzheimer; Fonds Europeens de Developpement Regional; La fondation NRJ--Institut de France; Fondation pour la Recherche Medicale, Grant/Award Number: FDT201904008423 and FDT202001011017; Conseil General des Alpes Maritimes; LABEX DISTALZ; A*Midex foundation, Grant/Award Number: ANR--17--EURE--0029; French National Research Agency	Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Baranger K, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00163; Baranger K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0633-4; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; Baranger K, 2014, PROG BRAIN RES, V214, P313, DOI 10.1016/B978-0-444-63486-3.00014-1; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bourgeois A, 2018, NEUROBIOL AGING, V71, P21, DOI 10.1016/j.neurobiolaging.2018.06.038; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chen AC, 2015, J CELL BIOL, V211, P1157, DOI 10.1083/jcb.201502001; Dive V, 2005, INT J CANCER, V113, P775, DOI 10.1002/ijc.20459; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Evrard C, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00435; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Garcia-Gonzalez L, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00244; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Gueye Y, 2011, GLIA, V59, P750, DOI 10.1002/glia.21146; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Jaworski DM, 2000, BRAIN RES, V860, P174, DOI 10.1016/S0006-8993(00)02035-7; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Kwart D, 2019, NEURON, V104, P256, DOI 10.1016/j.neuron.2019.07.010; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lauritzen L, 2019, CURR ALZHEIMER RES, V16, P453, DOI 10.2174/1567205016666190325092841; Letronne F, 2016, EBIOMEDICINE, V9, P278, DOI 10.1016/j.ebiom.2016.06.002; Llano E, 1999, CANCER RES, V59, P2570; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; NEVE RL, 1992, P NATL ACAD SCI USA, V89, P3448, DOI 10.1073/pnas.89.8.3448; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Ould-Yahoui A, 2013, CELL TRANSPLANT, V22, P993, DOI 10.3727/096368912X657468; Paumier JM, 2019, FASEB J, V33, P2910, DOI 10.1096/fj.201801076R; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Pera M, 2017, EMBO J, V36, P3356, DOI 10.15252/embj.201796797; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Pulina MV, 2020, ALZHEIMERS DEMENT, V16, P273, DOI 10.1016/j.jalz.2019.09.002; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Rivera S, 2019, CELL MOL LIFE SCI, V76, P3167, DOI 10.1007/s00018-019-03178-2; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Sander H, 2019, ANAL BIOCHEM, V575, P44, DOI 10.1016/j.ab.2019.03.010; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Tan JZA, 2019, J BIOL CHEM, V294, P1618, DOI 10.1074/jbc.RA118.005222; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Wang X, 2001, J BIOL CHEM, V276, P35953, DOI 10.1074/jbc.M103680200; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Zipfel P, 2020, J MED CHEM, V63, P10705, DOI 10.1021/acs.jmedchem.0c00352	57	3	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21727	10.1096/fj.202100593R	http://dx.doi.org/10.1096/fj.202100593R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34117802	Green Submitted, Green Published			2022-12-28	WOS:000667814100065
J	Su, ZY; Li, YJ; Lv, H; Cui, XY; Liu, M; Wang, ZY; Zhang, Y; Zhen, JH; Tang, W; Wang, XJ; Yi, F				Su, Zeyu; Li, Yujia; Lv, Hang; Cui, Xiaoyang; Liu, Min; Wang, Ziying; Zhang, Yan; Zhen, Junhui; Tang, Wei; Wang, Xiaojie; Yi, Fan			CLEC14A protects against podocyte injury in mice with adriamycin nephropathy	FASEB JOURNAL			English	Article						C-type lectin receptors; EGR1 signaling; focal segmental glomerular sclerosis; HMGB1; podocyte	HMGB1; RECEPTOR; ACTIVATION; EXPRESSION; ANGIOGENESIS; PATHOGENESIS; INFLAMMATION; PROGRANULIN; TARGET; CELLS	Podocyte injury is a major determinant of focal segmental glomerular sclerosis (FSGS) and the identification of potential therapeutic targets for preventing podocyte injury has clinical importance for the treatment of FSGS. CLEC14A is a single-pass transmembrane glycoprotein belonging to the vascular expressed C-type lectin family. CLEC14A is found to be expressed in vascular endothelial cells during embryogenesis and is also implicated in tumor angiogenesis. However, the current understanding of the biological functions of CLEC14A in podocyte is very limited. In this study, we found that CLEC14A was expressed in podocyte and protected against podocyte injury in mice with Adriamycin (ADR)-induced FSGS. First, we observed that CLEC14A was downregulated in mice with ADR nephropathy and renal biopsies from individuals with FSGS and other forms of podocytopathies. Moreover, CLEC14A deficiency exacerbated podocyte injury and proteinuria in mice with ADR nephropathy accompanied by enhanced inflammatory cell infiltration and inflammatory responses. In vitro, overexpression of CLEC14A in podocyte had pleiotropic protective actions, including anti-inflammatory and anti-apoptosis effects. Mechanistically, CLEC14A inhibited high-mobility group box 1 protein (HMGB1) release, at least in part by directly binding HMGB1, and suppressed HMGB1-mediated signaling, including NF-kappa B signaling and early growth response protein 1 (EGR1) signaling. Taken together, our findings provide new insights into the pivotal role of CLEC14A in maintaining podocyte function, indicating that CLEC14A may be an innovative therapeutic target in FSGS.	[Su, Zeyu; Li, Yujia; Lv, Hang; Cui, Xiaoyang; Liu, Min; Wang, Ziying; Zhang, Yan; Tang, Wei; Wang, Xiaojie; Yi, Fan] Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Zhen, Junhui] Shandong Univ, Sch Basic Med Sci, Dept Pathol, Jinan, Peoples R China	Shandong University; Shandong University	Wang, XJ; Yi, F (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	wangxiaojie@sdu.edu.cn; fanyi@sdu.edu.cn	Tang, Wei/A-6254-2016	Tang, Wei/0000-0002-4573-3502	National Nature Science Foundation of China [82090024, 91949202, 81800645, 81873614, 81770726]; Shandong Provincial Natural Science Foundation, China [ZR2019ZD40, ZR2019MH041]; Key Technology Research and Development Program of Shandong, China [2017GSF218095]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Key Technology Research and Development Program of Shandong, China	This study was supported by the National Nature Science Foundation of China (82090024 to FY, 91949202 to FY, 81800645 to ML, 81873614 to ZW, 81770726 to YZ); Shandong Provincial Natural Science Foundation, China (ZR2019ZD40 to FY, ZR2019MH041 to ZW); the Key Technology Research and Development Program of Shandong, China (2017GSF218095 to YZ).	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Brown GD, 2018, NAT REV IMMUNOL, V18, P374, DOI 10.1038/s41577-018-0004-8; Chen QJ, 2016, ACTA PHARM SIN B, V6, P183, DOI 10.1016/j.apsb.2016.02.004; Chen XC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26637-5; Dumitriu IE, 2005, EUR J IMMUNOL, V35, P2184, DOI 10.1002/eji.200526066; Feng D, 2018, AM J PHYSIOL-RENAL, V314, pF921, DOI 10.1152/ajprenal.00641.2017; Fu Y, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.019; Fu Y, 2017, HYPERTENSION, V69, P259, DOI 10.1161/HYPERTENSIONAHA.116.08154; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hayashi Y, 2018, BIOCHEM BIOPH RES CO, V495, P634, DOI 10.1016/j.bbrc.2017.11.079; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Inoue K, 2019, J CLIN INVEST, V129, P1295, DOI 10.1172/JCI124030; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11118-y; Jefferson JA, 2014, ADV CHRONIC KIDNEY D, V21, P408, DOI 10.1053/j.ackd.2014.05.009; Jin J, 2019, J DIABETES, V11, P826, DOI 10.1111/1753-0407.12914; Khan KA, 2019, FEBS J, V286, P3299, DOI 10.1111/febs.14985; Kim Y, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1727-6; Lee S, 2017, J CLIN INVEST, V127, P457, DOI 10.1172/JCI85145; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Lim BJ, 2016, J PATHOL TRANSL MED, V50, P405, DOI 10.4132/jptm.2016.09.21; Liu M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00498-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lv B, 2009, THROMB HAEMOSTASIS, V102, P352, DOI 10.1160/TH08-11-0759; Mallipattu SK, 2015, J CLIN INVEST, V125, P1347, DOI 10.1172/JCI77084; Noy PJ, 2015, ONCOGENE, V34, P5821, DOI 10.1038/onc.2015.34; Okabe M, 2019, AM J PHYSIOL-RENAL, V316, pF241, DOI 10.1152/ajprenal.00115.2018; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Priya SK, 2017, INT J CLIN ONCOL, V22, P107, DOI 10.1007/s10147-016-1033-6; Pulskens WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085775; Shang J, 2015, FREE RADICAL BIO MED, V79, P217, DOI 10.1016/j.freeradbiomed.2014.12.013; SUKHATME VP, 1992, KIDNEY INT, V41, P550, DOI 10.1038/ki.1992.79; Tan RJ, 2015, J AM SOC NEPHROL, V26, P2447, DOI 10.1681/ASN.2014060613; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Wang XJ, 2014, KIDNEY INT, V86, P712, DOI 10.1038/ki.2014.111; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wen YM, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00098; Wu C, 2019, EXP CLIN ENDOCR DIAB, V127, P630, DOI 10.1055/s-0044-101601; Yamada K, 2001, KIDNEY INT, V59, P137, DOI 10.1046/j.1523-1755.2001.00474.x; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yu RC, 2016, KIDNEY BLOOD PRESS R, V41, P55, DOI 10.1159/000368547; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102	46	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21711	10.1096/fj.202100283R	http://dx.doi.org/10.1096/fj.202100283R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34107098				2022-12-28	WOS:000667814100040
J	Zindel, D; Mensat, P; Vol, C; Homayed, Z; Charrier-Savournin, F; Trinquet, E; Baneres, JL; Pin, JP; Pannequin, J; Roux, T; Dupuis, E; Prezeau, L				Zindel, Diana; Mensat, Patrick; Vol, Claire; Homayed, Zeinab; Charrier-Savournin, Fabienne; Trinquet, Eric; Baneres, Jean-Louis; Pin, Jean-Philippe; Pannequin, Julie; Roux, Thomas; Dupuis, Elodie; Prezeau, Laurent			G protein-coupled receptors can control the Hippo/YAP pathway through Gq signaling	FASEB JOURNAL			English	Article						cellular signaling; constitutive activity; inverse agonist; Ghrelin receptor; Hippo pathway	PROMOTES CELL-PROLIFERATION; GHRELIN RECEPTOR; YAP PATHWAY; INVERSE AGONISM; UVEAL MELANOMA; TAZ; YAP/TAZ; GROWTH; CANCER; ACTIVATION	The Hippo pathway is an evolutionarily conserved kinase cascade involved in the control of tissue homeostasis, cellular differentiation, proliferation, and organ size, and is regulated by cell-cell contact, apical cell polarity, and mechanical signals. Miss-regulation of this pathway can lead to cancer. The Hippo pathway acts through the inhibition of the transcriptional coactivators YAP and TAZ through phosphorylation. Among the various signaling mechanisms controlling the hippo pathway, activation of G12/13 by G protein-coupled receptors (GPCR) recently emerged. Here we show that a GPCR, the ghrelin receptor, that activates several types of G proteins, including G12/13, Gi/o, and Gq, can activate YAP through Gq/11 exclusively, independently of G12/13. We revealed that a strong basal YAP activation results from the high constitutive activity of this receptor, which can be further increased upon agonist activation. Thus, acting on ghrelin receptor allowed to modulate up-and-down YAP activity, as activating the receptor increased YAP activity and blocking constitutive activity reduced YAP activity. Our results demonstrate that GPCRs can be used as molecular switches to finely up- or down-regulate YAP activity through a pure Gq pathway.	[Zindel, Diana; Vol, Claire; Homayed, Zeinab; Pin, Jean-Philippe; Pannequin, Julie; Prezeau, Laurent] Univ Montpellier, Inst Genom Fonct IGF, INSERM, CNRS, 141 Rue Cardonille, F-34094 Montpellier 5, France; [Mensat, Patrick; Charrier-Savournin, Fabienne; Trinquet, Eric; Roux, Thomas; Dupuis, Elodie] Perkin Elmer Cisbio, Codolet, France; [Baneres, Jean-Louis] Univ Montpellier, Inst Biomol Max Mousseron, CNRS, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Prezeau, L (corresponding author), Univ Montpellier, Inst Genom Fonct IGF, INSERM, CNRS, 141 Rue Cardonille, F-34094 Montpellier 5, France.	laurent.prezeau@igf.cnrs.fr		homayed, Zeinab/0000-0003-4361-3969; Baneres, jean-louis/0000-0001-7078-1285	Labex EpiGenMed, an << Investissements d'avenir >> program of the French government [ANR-10-LABX-12-01]; Fondation Recherche Medicale [FRM DEQ20170336747]; EIDOS Collaborative team IGF-Cisbio (Codolet, France); Region Occitanie (France)	Labex EpiGenMed, an << Investissements d'avenir >> program of the French government(French National Research Agency (ANR)); Fondation Recherche Medicale; EIDOS Collaborative team IGF-Cisbio (Codolet, France); Region Occitanie (France)	This work was supported by the Labex EpiGenMed, an << Investissements d'avenir >> program of the French government (reference ANR-10-LABX-12-01) to JPP, the Fondation Recherche Medicale (FRM DEQ20170336747) to JPP, and by the EIDOS Collaborative team IGF-Cisbio (Codolet, France). DZ was supported by a Grant from the Region Occitanie (France)	Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Currow D, 2017, ANN ONCOL, V28, P1949, DOI 10.1093/annonc/mdx192; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Davenport AP, 2005, PHARMACOL REV, V57, P541, DOI 10.1124/pr.57.4.1; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Els S, 2012, J MED CHEM, V55, P7437, DOI 10.1021/jm300414b; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Feng X, 2016, J BIOL CHEM, V291, P18947, DOI 10.1074/jbc.M116.739722; Finch-Edmondson ML, 2015, J BIOL CHEM, V290, P27928, DOI 10.1074/jbc.M115.692285; Gong R, 2015, CELL RES, V25, P985, DOI 10.1038/cr.2015.88; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hot B, 2017, CELL SIGNAL, V32, P93, DOI 10.1016/j.cellsig.2017.01.023; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020; Koo JH, 2018, CELL METAB, V28, P196, DOI 10.1016/j.cmet.2018.07.010; Lee JH, 2014, FEBS LETT, V588, P4708, DOI 10.1016/j.febslet.2014.10.044; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lin TC, 2015, J PATHOL, V237, P50, DOI 10.1002/path.4552; Liu HR, 2018, ONCOL REP, V40, P16, DOI 10.3892/or.2018.6423; Luo JQ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050426; M'Kadmi C, 2019, J MED CHEM, V62, P965, DOI 10.1021/acs.jmedchem.8b01644; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mo JS, 2017, BMB REP, V50, P71, DOI 10.5483/BMBRep.2017.50.2.199; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Nallet-Staub F, 2014, J INVEST DERMATOL, V134, P123, DOI 10.1038/jid.2013.319; Northrup R, 2013, SUPPORT CARE CANCER, V21, P2409, DOI 10.1007/s00520-013-1800-0; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Soleyman-Jahi S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01014; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wang J, 2016, J BIOL CHEM, V291, P17988, DOI 10.1074/jbc.M115.711275; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang Q, 2018, CELL PHYSIOL BIOCHEM, V50, P1698, DOI 10.1159/000494789; Waseem T, 2008, PEPTIDES, V29, P1369, DOI 10.1016/j.peptides.2008.03.020; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109575; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573; Zhu HY, 2015, INT J BIOL SCI, V11, P1181, DOI 10.7150/ijbs.12500; Zindel D, 2019, METHODS MOL BIOL, V1893, P153, DOI 10.1007/978-1-4939-8910-2_13	66	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21668	10.1096/fj.202002159R	http://dx.doi.org/10.1096/fj.202002159R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34114695	Green Submitted			2022-12-28	WOS:000667814100014
J	Huang, LP; Ma, YL; Chen, L; Chang, J; Zhong, M; Wang, ZJ; Sun, Y; Chen, X; Sun, F; Xiao, L; Chen, JI; Lai, YJ; Yan, CM; Yue, XJ				Huang, Liping; Ma, Yanlin; Chen, Lu; Chang, Jiang; Zhong, Mei; Wang, Zhijian; Sun, Ying; Chen, Xia; Sun, Fei; Xiao, Lu; Chen, Jianing; Lai, Yingjun; Yan, Chuming; Yue, Xiaojing			Maternal RND3/RhoE deficiency impairs placental mitochondrial function in preeclampsia by modulating the PPAR gamma-UCP2 cascade	FASEB JOURNAL			English	Article						mitochondrion; oxidative stress; PPAR gamma; preeclampsia; Rnd3	ACTIVATED RECEPTOR-GAMMA; OXIDATIVE STRESS; PPAR-GAMMA; UNCOUPLING PROTEIN-2; THERAPEUTIC TARGET; GENETIC DELETION; UP-REGULATION; TROPHOBLAST; RND3; PATHOPHYSIOLOGY	Preeclampsia (PE) is a life-threatening disease of pregnant women associated with severe hypertension, proteinuria, or multi-organ injuries. Mitochondrial-mediated placental oxidative stress plays a key role in the pathogenesis of PE. However, the underlying mechanism remains to be revealed. Here, we identify Rnd3, a small Rho GTPase, regulating placental mitochondrial reactive oxygen species (ROS). We showed that Rnd3 is down-regulated in primary trophoblasts isolated from PE patients. Loss of Rnd3 in trophoblasts resulted in excessive ROS generation, cell apoptosis, mitochondrial injury, and proton leakage from the respiratory chain. Moreover, Rnd3 overexpression partially rescues the mitochondrial defects and oxidative stress in human PE primary trophoblasts. Rnd3 physically interacts with the peroxisome proliferators-activated receptor gamma (PPAR gamma) and promotes the PPAR gamma-mitochondrial uncoupling protein 2 (UCP2) cascade. Forced expression of PPAR gamma rescues deficiency of Rnd3-mediated mitochondrial dysfunction. We conclude that Rnd3 acts as a novel protective factor in placental mitochondria through PPAR gamma-UCP2 signaling and highlight that downregulation of Rnd3 is a potential factor involved in PE pathogenesis.	[Huang, Liping; Chen, Lu; Zhong, Mei; Wang, Zhijian; Chen, Xia; Sun, Fei; Xiao, Lu; Chen, Jianing; Lai, Yingjun; Yan, Chuming; Yue, Xiaojing] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1023 South Shatai Rd, Guangzhou 510515, Peoples R China; [Ma, Yanlin] Hainan Med Univ, Hainan Prov Key Lab Human Reprod Med & Genet Res, Reprod Med Ctr, Affiliated Hosp 1, Haikou, Hainan, Peoples R China; [Chang, Jiang] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Sun, Ying] Southern Med Univ, Dept Obstet & Gynecol, Affiliated Shenzhen Matern & Child Healthcare Hos, Shenzhen, Peoples R China	Southern Medical University - China; Hainan Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Southern Medical University - China	Yue, XJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1023 South Shatai Rd, Guangzhou 510515, Peoples R China.	yuexj1986@163.com	WANG, JINGYI/GSJ-1241-2022; Ma, Yanlin/CAH-2185-2022; wang, jie/GRS-0942-2022	Ma, Yanlin/0000-0001-9668-0204; 	Major Science and Technology Program of Hainan Province [ZDKJ2017007]; National Natural Science Foundation of China [81771609, 81601317, 81960283, 81971415]; Natural Science Foundation of Guangdong Province [2017A030313584, 2019A1515010290, 2019A1515010019]; Special Fund for Cooperative Innovation and Platform Environment Construction [2015B050501006]; Outstanding Youth Development Scheme of Nanfang Hospital Southern Medical University [2018J010]	Major Science and Technology Program of Hainan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Special Fund for Cooperative Innovation and Platform Environment Construction; Outstanding Youth Development Scheme of Nanfang Hospital Southern Medical University	This study was supported by the following funding sources: the Major Science and Technology Program of Hainan Province (ZDKJ2017007), the National Natural Science Foundation of China (81771609, 81601317, 81960283, and 81971415), the Natural Science Foundation of Guangdong Province (2017A030313584, 2019A1515010290 and 2019A1515010019), the Special Fund for Cooperative Innovation and Platform Environment Construction (2015B050501006), the Outstanding Youth Development Scheme of Nanfang Hospital Southern Medical University (2018J010)	Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019; Collett GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030453; Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023; D'Souza V, 2016, CLIN EXP HYPERTENS, V38, P225, DOI 10.3109/10641963.2015.1081226; Dai Y, 2019, CIRCULATION, V139, P1185, DOI 10.1161/CIRCULATIONAHA.118.033700; Fang YN, 2018, EUR REV MED PHARMACO, V22, P6583, DOI 10.26355/eurrev_201810_16132; Hladunewich M, 2007, CLIN J AM SOC NEPHRO, V2, P543, DOI 10.2215/CJN.03761106; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jie W, 2016, COMPR PHYSIOL, V6, P169, DOI 10.1002/cphy.c150018; Kohan-Ghadr HR, 2019, BIOL REPROD, V100, P479, DOI 10.1093/biolre/ioy186; Lin X, 2013, P NATL ACAD SCI USA, V110, P8236, DOI 10.1073/pnas.1219995110; Liu BH, 2015, CANCER MED-US, V4, P1404, DOI 10.1002/cam4.484; McCarthy FP, 2011, HYPERTENSION, V58, P280, DOI 10.1161/HYPERTENSIONAHA.111.172627; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Moses E, 2012, Pregnancy Hypertens, V2, P219, DOI 10.1016/j.preghy.2012.04.078; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276; Salgado SS, 2011, JCPSP-J COLL PHYSICI, V21, P482, DOI 08.2011/JCPSP.482486; Juan-Reyes SS, 2020, ARCH BIOCHEM BIOPHYS, V681, DOI 10.1016/j.abb.2020.108255; Sanchez-Aranguren LC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00372; Saso J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094698; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; Shi ZJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078533, 10.1371/journal.pone.0064351]; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902; Vishnyakova PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32410; Waite LL, 2000, J CLIN ENDOCR METAB, V85, P3808, DOI 10.1210/jc.85.10.3808; Waite LL, 2005, J CLIN ENDOCR METAB, V90, P620, DOI 10.1210/jc.2004-0849; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Xu YT, 2018, MOL THER-NUCL ACIDS, V12, P195, DOI 10.1016/j.omtn.2018.05.007; Xu YT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.503; Yang XS, 2015, CIRC RES, V116, pE1, DOI 10.1161/CIRCRESAHA.116.304940; Yiallourides M, 2009, REPRODUCTION, V138, P601, DOI 10.1530/REP-09-0043; Yue X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.235; Yue XJ, 2018, PLACENTA, V62, P43, DOI 10.1016/j.placenta.2017.12.009; Yue XJ, 2016, HYPERTENSION, V67, P597, DOI 10.1161/HYPERTENSIONAHA.115.06412	39	2	2	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21555	10.1096/fj.202002639RRR	http://dx.doi.org/10.1096/fj.202002639RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046947	Green Submitted			2022-12-28	WOS:000655695900068
J	Khan, A; Ni, WM; Lopez-Giraldez, F; Kluger, MS; Pober, JS; Pierce, RW				Khan, Alamzeb; Ni, Weiming; Lopez-Giraldez, Francesc; Kluger, Martin S.; Pober, Jordan S.; Pierce, Richard W.			Tumor necrosis factor-induced ArhGEF10 selectively activates RhoB contributing to human microvascular endothelial cell tight junction disruption	FASEB JOURNAL			English	Article						capillary leak; inflammation; permeability; Rho guanine nucleotide&#8208; exchange factor; transendothelial electrical resistance; vascular dysfunction	NUCLEOTIDE EXCHANGE FACTOR; EXPRESSION; GTPASES; KINASE; MECHANISM; ADHESION; PATHWAY; GAPS; GEFS	Capillary endothelial cells (ECs) maintain a semi-permeable barrier between the blood and tissue by forming inter-EC tight junctions (TJs), regulating selective transport of fluid and solutes. Overwhelming inflammation, as occurs in sepsis, disrupts these TJs, leading to leakage of fluid, proteins, and small molecules into the tissues. Mechanistically, disruption of capillary barrier function is mediated by small Rho-GTPases, such as RhoA, -B, and -C, which are activated by guanine nucleotide exchange factors (GEFs) and disrupted by GTPase-activating factors (GAPs). We previously reported that a mutation in a specific RhoB GAP (p190BRhoGAP) underlays a hereditary capillary leak syndrome. Tumor necrosis factor (TNF) treatment disrupts TJs in cultured human microvascular ECs, a model of capillary leak. This response requires new gene transcription and involves increased RhoB activation. However, the specific GEF that activates RhoB in capillary ECs remains unknown. Transcriptional profiling of cultured tight junction-forming human dermal microvascular endothelial cells (HDMECs) revealed that 17 GEFs were significantly induced by TNF. The function of each candidate GEF was assessed by short interfering RNA depletion and trans-endothelial electrical resistance screening. Knockown of ArhGEF10 reduced the TNF-induced loss of barrier which was phenocopied by RhoB or dual ArhGEF10/RhoB knockdown. ArhGEF10 knockdown also reduced the extent of TNF-induced RhoB activation and disruption at tight junctions. In a cell-free assay, immunoisolated ArhGEF10 selectively catalyzed nucleotide exchange to activate RhoB, but not RhoA or RhoC. We conclude ArhGEF10 is a TNF-induced RhoB-selective GEF that mediates TJ disruption and barrier loss in human capillary endothelial cells.	[Khan, Alamzeb; Ni, Weiming; Pierce, Richard W.] Yale Univ, Dept Pediat, Yale Sch Med, New Haven, CT 06520 USA; [Lopez-Giraldez, Francesc] Yale Univ, Yale Sch Med, Dept Genet, New Haven, CT USA; [Kluger, Martin S.; Pober, Jordan S.] Yale Univ, Yale Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Yale University; Yale University	Pierce, RW (corresponding author), Pediat Crit Care Med, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	Richard.pierce@yale.edu	López-Giráldez, Francesc/A-5251-2011	López-Giráldez, Francesc/0000-0001-7476-9822; Pierce, Richard/0000-0001-5941-8805	Charles H. Hood Foundation; NIH/NHLBI [5 T32 HL 7974-19, 1K08HL136898-01A1]; NIH/NICHD [K12HD047349]; NIH [1S10OD018521-01]	Charles H. Hood Foundation; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been supported by grants from the Charles H. Hood Foundation, NIH/NHLBI 1K08HL136898-01A1, NIH/NICHD K12HD047349, NIH/NHLBI 5 T32 HL 7974-19, NIH 1S10OD018521-01	Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Aepfelbacher M, 1997, ARTERIOSCL THROM VAS, V17, P1623, DOI 10.1161/01.ATV.17.9.1623; Aoki T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-56; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cerutti C, 2017, EXP CELL RES, V358, P31, DOI 10.1016/j.yexcr.2017.06.003; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Clark PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120075; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Kluger MS, 2002, J IMMUNOL, V168, P2091, DOI 10.4049/jimmunol.168.5.2091; Kluger MS, 1997, J IMMUNOL, V158, P887; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Loosli Felix, 2013, Small GTPases, V4, P242, DOI 10.4161/sgtp.27061; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marcos-Ramiro B, 2016, J CELL BIOL, V213, P385, DOI 10.1083/jcb.201504038; Mohl M, 2006, N-S ARCH PHARMACOL, V373, P333, DOI 10.1007/s00210-006-0083-0; Ngok SP, 2013, J CELL SCI, V126, P3271, DOI 10.1242/jcs.123869; Pathak Ritu, 2013, Small GTPases, V4, P174, DOI 10.4161/sgtp.24616; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pierce RW, 2017, J EXP MED, V214, P3497, DOI 10.1084/jem.20162143; Pierce RW, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0355; Reinhard NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25502; Riedlinger T, 2019, FASEB J, V33, P4188, DOI 10.1096/fj.201801638R; Rodriguez PL, 2007, CELL SIGNAL, V19, P2361, DOI 10.1016/j.cellsig.2007.07.021; Scott DW, 2016, MOL BIOL CELL, V27, P1420, DOI 10.1091/mbc.E15-12-0833; Shibata S, 2016, J CELL SCI, V129, P3620, DOI 10.1242/jcs.186817; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Vega Francisco M, 2018, Small GTPases, V9, P384, DOI 10.1080/21541248.2016.1253528; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yuan SY., 2010, REGULATION ENDOTHELI; Zaritsky A, 2017, J CELL BIOL, V216, P1543, DOI 10.1083/jcb.201609095	40	5	5	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21627	10.1096/fj.202002783RR	http://dx.doi.org/10.1096/fj.202002783RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33948992	Green Accepted			2022-12-28	WOS:000655695900044
J	Das, H; Sarkar, S; Paidi, RK; Biswas, SC				Das, Hrishita; Sarkar, Sukanya; Paidi, Ramesh K.; Biswas, Subhas C.			Subtle genomic DNA damage induces intraneuronal production of amyloid-beta (1-42) by increasing beta-secretase activity	FASEB JOURNAL			English	Article						amyloid-beta; DNA damage; BACE1; PERK; eIF2 alpha 0; 5xFAD; MFN2	UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; A-BETA; ENDOPLASMIC-RETICULUM; GAMMA-SECRETASE; INTRACELLULAR ACCUMULATION; MITOCHONDRIAL DYNAMICS; PRECURSOR PROTEIN; ALZHEIMERS; NEURONS	Aberrant accumulation of amyloid-beta (A beta) in brain is the major trigger for pathogenesis in Alzheimer's disease (AD). It is imperative to understand how A beta attains such toxic levels in the brain parenchyma. We detected that a subtle and tolerable amount of DNA damage, related to aging, increased intraneuronal A beta(1-42) production both in cultured neuron and in cortex of rodent brain. Strikingly, we also observed elevated levels of mitochondrial fusion and of its major driver protein, MFN2. Hyperfusion of mitochondria may be seen as an adaptive stress response resulting from the induction of ER stress since we detected the activation of both PERK and IRE1a arms of unfolded protein response of ER stress. We found increased phosphorylation of PERK substrate eukaryotic initiation factor 2 alpha (eIF2 alpha), and upregulation of the downstream effector proteins, ATF4 and CHOP. Concomitantly, increased XBP1 level, the direct effecter protein of IRE-1 alpha, was observed. Reports suggest that eIF2 alpha phosphorylation can increase BACE1 activity, the rate limiting enzyme in A beta production. Here, we show that inhibiting PERK, decreased A beta(1-42) level while direct BACE1 inhibition, reduced the mitochondrial fusion. We found increased MFN2 expression in young 5xFAD mice when A beta plaques and neurodegeneration were absent. Thus, our study indicates that mild DNA damage leads to increased A beta(1-42) production almost as a consequence of an initial ER stress-directed protective mitochondrial fusion in brain. We propose that an age-related subtle genomic DNA damage may trigger enhanced intraneuronal A beta(1-42) production in an apparently healthy neuron way before the appearance of clinical symptoms in AD.	[Das, Hrishita; Sarkar, Sukanya; Paidi, Ramesh K.; Biswas, Subhas C.] CSIR Indian Inst Chem Biol, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Biswas, SC (corresponding author), CSIR Indian Inst Chem Biol, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	biswassc@gmail.com	Paidi, Ramesh Kumar/HHC-0353-2022	Paidi, Ramesh Kumar/0000-0003-3340-8056	SERB [EEQ/2018/000997]	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	SERB Projects, Grant/Award Number: EEQ/2018/000997	Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Bradley-Whitman MA, 2014, J NEUROCHEM, V128, P294; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Cheng SY, 2004, TOXICOL LETT, V146, P139, DOI 10.1016/j.toxlet.2003.09.009; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Strooper B, 2012, EMBO J, V31, P4095, DOI 10.1038/emboj.2012.279; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hegde ML, 2011, J ALZHEIMERS DIS, V24, P183, DOI 10.3233/JAD-2011-110281; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin SM, 2008, CELL DEATH DIFFER, V15, P1375, DOI 10.1038/cdd.2008.49; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuo LJ, 2008, IN VIVO, V22, P305; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manchon JFM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25705; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Misonou H, 2000, BIOCHEMISTRY-US, V39, P6951, DOI 10.1021/bi000169p; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pan L, 2014, J MOL BIOL, V426, P3376, DOI 10.1016/j.jmb.2014.08.001; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Patil S, 2006, NEUROSCI LETT, V406, P55, DOI 10.1016/j.neulet.2006.07.015; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Wang DB, 2013, J NEUROSCI, V33, P1357, DOI 10.1523/JNEUROSCI.3365-12.2013; Wang J, 2015, J ALZHEIMERS DIS, V43, P465, DOI 10.3233/JAD-140078; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343	62	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21569	10.1096/fj.202001676RR	http://dx.doi.org/10.1096/fj.202001676RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864420				2022-12-28	WOS:000645260100057
J	Okui, M; Murakami, T; Sun, H; Ikeshita, C; Kanamura, N; Taruno, A				Okui, Motoki; Murakami, Tatsuro; Sun, Hongxin; Ikeshita, Chiaki; Kanamura, Narisato; Taruno, Akiyuki			Posttranslational regulation of CALHM1/3 channel: N-linked glycosylation and S-palmitoylation	FASEB JOURNAL			English	Article						acylation; ATP; gustation; patch clamp	SURFACE EXPRESSION; ION-CHANNEL; IDENTIFICATION; SUBUNIT; STABILITY; SITES	Among calcium homeostasis modulator (CALHM) family members, CALHM1 and 3 together form a voltage-gated large-pore ion channel called CALHM1/3. CALHM1/3 plays an essential role in taste perception by mediating neurotransmitter release at channel synapses of taste bud cells. However, it is poorly understood how CALHM1/3 is regulated. Biochemical analyses of the two subunits following site-directed mutagenesis and pharmacological treatments established that both CALHM1 and 3 were N-glycosylated at single Asn residues in their second extracellular loops. Biochemical and electrophysiological studies revealed that N-glycan acquisition on CALHM1 and 3, respectively, controls the biosynthesis and gating kinetics of the CALHM1/3 channel. Furthermore, failure in subsequent remodeling of N-glycans decelerated the gating kinetics. Thus, the acquisition of N-glycans on both subunits and their remodeling differentially contribute to the functional expression of CALHM1/3. Meanwhile, metabolic labeling and acyl-biotin exchange assays combined with genetic modification demonstrated that CALHM3 was reversibly palmitoylated at three intracellular Cys residues. Screening of the DHHC protein acyltransferases identified DHHC3 and 15 as CALHM3 palmitoylating enzymes. The palmitoylation-deficient mutant CALHM3 showed a normal degradation rate and interaction with CALHM1. However, the same mutation markedly attenuated the channel activity but not surface localization of CALHM1/3, suggesting that CALHM3 palmitoylation is a critical determinant of CALHM1/3 activity but not its formation or forward trafficking. Overall, this study characterized N-glycosylation and S-palmitoylation of CALHM1/3 subunits and clarified their differential contributions to its functional expression, providing insights into the fine control of the CALHM1/3 channel and associated physiological processes.	[Okui, Motoki; Murakami, Tatsuro; Sun, Hongxin; Ikeshita, Chiaki; Taruno, Akiyuki] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, 465 Kajiicho Kamigyo Ward, Kyoto 6028566, Japan; [Okui, Motoki; Kanamura, Narisato] Kyoto Prefectural Univ Med, Dept Dent Med, Kyoto, Japan; [Taruno, Akiyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Japan Science & Technology Agency (JST)	Taruno, A (corresponding author), Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, 465 Kajiicho Kamigyo Ward, Kyoto 6028566, Japan.	taruno@koto.kpu-m.ac.jp			JST [JPMJPR1886]; JSPS [16K15181, 19H03819, 20K21505, 20H04908]; Salt Science Research Foundation [18C2, 19C2, 20C2]	JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Salt Science Research Foundation	JST, Grant/Award Number: JPMJPR1886; JSPS, Grant/Award Number: 16K15181, 19H03819, 20K21505 and 20H04908; Salt Science Research Foundation, Grant/Award Number: 18C2, 19C2 and 20C2	Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Choi W, 2019, NATURE, V576, P163, DOI 10.1038/s41586-019-1781-3; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Demura K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8105; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Drozdzyk K, 2020, ELIFE, V9, DOI 10.7554/eLife.55853; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Hofherr A, 2014, J BIOL CHEM, V289, P14854, DOI 10.1074/jbc.M114.562264; Jun M, 2018, MOL PSYCHIATR, V23, P883, DOI 10.1038/mp.2017.229; Kashio M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39593-5; Lichnerova K, 2015, J BIOL CHEM, V290, P18379, DOI 10.1074/jbc.M115.656546; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Ma ZM, 2018, NEURON, V98, P547, DOI 10.1016/j.neuron.2018.03.043; Ma ZM, 2016, PFLUG ARCH EUR J PHY, V468, P395, DOI 10.1007/s00424-015-1757-6; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; Nomura K, 2020, NEURON, V106, P816, DOI 10.1016/j.neuron.2020.03.006; Ren Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8161; Romanov RA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1815; Sclafani A, 2018, AM J PHYSIOL-REG I, V315, pR576, DOI 10.1152/ajpregu.00015.2018; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Suzuki M, 2015, MOL BIOL CELL, V26, P2333, DOI 10.1091/mbc.E14-11-1504; Syam N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00052; Syrjanen JL, 2020, NAT STRUCT MOL BIOL, V27, P150, DOI 10.1038/s41594-019-0369-9; Taruno A, 2021, PFLUG ARCH EUR J PHY, V473, P3, DOI 10.1007/s00424-020-02464-4; Taruno A, 2017, J PHYSIOL-LONDON, V595, P6121, DOI 10.1113/JP274164; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Thayer DA, 2016, J PHYSIOL-LONDON, V594, P6701, DOI 10.1113/JP272394; Tordoff MG, 2014, CHEM SENSES, V39, P515, DOI 10.1093/chemse/bju020; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Weiss N, 2013, PFLUG ARCH EUR J PHY, V465, P1159, DOI 10.1007/s00424-013-1259-3; Yang WX, 2020, PROTEIN SCI, V29, P1803, DOI 10.1002/pro.3904; Yokoi N, 2016, J NEUROSCI, V36, P6431, DOI 10.1523/JNEUROSCI.0419-16.2016	39	1	1	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21527	10.1096/fj.202002632R	http://dx.doi.org/10.1096/fj.202002632R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788965				2022-12-28	WOS:000645260100108
J	Sato, T; Ishiwatari, C; Kaneko, YK; Ishikawa, Y; Kimura, Y; Watanabe, N; Aoshima, I; Matsuda, Y; Nakayama, T; Chiba, R; Fujinuki, T; Iwata, K; Lu, Q; Usuki, T; Sakane, F; Ishikawa, T				Sato, Taiji; Ishiwatari, Chihiro; Kaneko, Yukiko K.; Ishikawa, Yoko; Kimura, Yuki; Watanabe, Naoya; Aoshima, Ikumi; Matsuda, Yukari; Nakayama, Takahiro; Chiba, Rina; Fujinuki, Takahiro; Iwata, Kai; Lu, Qiang; Usuki, Takako; Sakane, Fumio; Ishikawa, Tomohisa			Diacylglycerol kinase delta functions as a proliferation suppressor in pancreatic beta-cells	FASEB JOURNAL			English	Article						diacylglycerol kinase delta; pancreatic beta-cell; proliferation; beta-cell mass	INSULIN-SECRETION; NUCLEAR DIACYLGLYCEROL; POSSIBLE INVOLVEMENT; SWISS 3T3-CELLS; PLASMA-MEMBRANE; ADULT-MOUSE; FATTY-ACID; PROTEIN; EXPRESSION; GLUCOSE	Although an aberrant reduction in pancreatic beta-cell mass contributes to the pathogenesis of diabetes, the mechanism underlying the regulation of beta-cell mass is poorly understood. Here, we show that diacylglycerol kinase delta (DGK delta) is a key enzyme in the regulation of beta-cell mass. DGK delta expression was detected in the nucleus of beta-cells. We developed beta-cell-specific DGK delta knockout (beta DGK delta KO) mice, which showed lower blood glucose, higher plasma insulin levels, and better glucose tolerance compared to control mice. Moreover, an increased number of small islets and Ki-67-positive islet cells, as well as elevated cyclin B1 expression in the islets, were detected in the pancreas of beta DGK delta KO mice. DGK delta knockdown in the beta-cell line MIN6 induced significant increases in bromodeoxyuridine (BrdU) incorporation and cyclin B1 expression. Finally, we confirmed that streptozotocin-induced hyperglycemia and beta-cell loss were alleviated in beta DGK delta KO mice. Thus, suppressing the expression or enzymatic activity of DGK delta that functions as a suppressor of beta-cell proliferation could be a novel therapeutic approach to increase beta-cell mass for the treatment of diabetes.	[Sato, Taiji; Ishiwatari, Chihiro; Kaneko, Yukiko K.; Ishikawa, Yoko; Kimura, Yuki; Watanabe, Naoya; Aoshima, Ikumi; Matsuda, Yukari; Nakayama, Takahiro; Chiba, Rina; Fujinuki, Takahiro; Ishikawa, Tomohisa] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacol, Shizuoka, Japan; [Iwata, Kai; Lu, Qiang; Usuki, Takako; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan	University of Shizuoka; Chiba University	Kaneko, YK (corresponding author), Univ Shizuoka, Dept Pharmacol, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	ykaneko@u-shizuoka-ken.ac.jp	Sakane, Fumio/H-2693-2017; Kaneko, Yukiko/AAV-2701-2021	Sakane, Fumio/0000-0003-0857-0377; Kaneko, Yukiko/0000-0002-5930-5349	University of Shizuoka; Japan Society for the Promotion of Science JSPS KAKENHI [26750336, 17K01857, 20K11512, 15K12705, 17H02175]; Takeda Science Foundation; Suzuken Memorial Foundation	University of Shizuoka; Japan Society for the Promotion of Science JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation	This study was supported by grants for the research projects from the University of Shizuoka. This study was also supported in part by Grants-in-Aid for Young Scientists (YKK, 26750336) and Scientific Research (YKK, 17K01857, 20K11512, TI, 15K12705, 17H02175) from the Japan Society for the Promotion of Science JSPS KAKENHI Grant and grants from Takeda Science Foundation and Suzuken Memorial Foundation	Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Baldanzi Gianluca, 2014, Advances in Biological Regulation, V55, P39, DOI 10.1016/j.jbior.2014.02.001; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bonner-Weir S, 1989, DIABETES, V38, P49; Bonner-Weir S., 2000, TRENDS ENDOCRIN MET, V11, P375; Bonner-Weir Susan, 2012, Rev Diabet Stud, V9, P407, DOI 10.1900/RDS.2012.9.407; Briaud I, 2001, DIABETES, V50, P315; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Daniel P, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.21; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Eizirik DL, 2018, NAT REV ENDOCRINOL, V14, P629, DOI 10.1038/s41574-018-0101-6; Evangelisti C, 2006, EUR J HISTOCHEM, V50, P9; Evangelisti C, 2007, FASEB J, V21, P3297, DOI 10.1096/fj.07-8336com; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; Jiang LQ, 2016, AM J PHYSIOL-ENDOC M, V310, pE51, DOI 10.1152/ajpendo.00209.2015; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kaneko YK, 2015, BIOL PHARM BULL, V38, P669, DOI 10.1248/bpb.b15-00060; Kaneko YK, 2013, ENDOCRINOLOGY, V154, P4089, DOI 10.1210/en.2013-1356; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Los AP, 2006, J BIOL CHEM, V281, P858, DOI 10.1074/jbc.M502693200; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Martelli AM, 2000, CANCER RES, V60, P815; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakayama Y, 2013, INT REV CEL MOL BIO, V305, P303, DOI 10.1016/B978-0-12-407695-2.00007-X; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Razavi R, 2015, DIABETES, V64, P1311, DOI 10.2337/db14-0070; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Takeuchi M, 2012, BBA-MOL CELL RES, V1823, P2210, DOI 10.1016/j.bbamcr.2012.08.019; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Togashi Y, 2014, ENDOCRINOLOGY, V155, P1643, DOI 10.1210/en.2013-1796; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Turban S, 2018, FEBS LETT, V585, P269; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Usuki T, 2016, BRAIN RES, V1648, P193, DOI 10.1016/j.brainres.2016.07.017; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; Wrede CE, 2003, J MOL ENDOCRINOL, V30, P271, DOI 10.1677/jme.0.0300271; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	54	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21420	10.1096/fj.202001279RR	http://dx.doi.org/10.1096/fj.202001279RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774855	hybrid			2022-12-28	WOS:000645260100085
J	Yu, YT; Xiao, LJ; Ren, ZY; Zhu, GY; Wang, WW; Jia, YT; Peng, A; Wang, XY				Yu, Yanting; Xiao, Leijuan; Ren, Zhiyun; Zhu, Gangyi; Wang, Weiwan; Jia, Yutao; Peng, Ai; Wang, Xiaoyan			Glucose-induced decrease of cystathionine beta-synthase mediates renal injuries	FASEB JOURNAL			English	Article						cystathionine beta-synthase; diabetic kidney disease; glucose; hydrogen sulfide; proteasome; ubiquitination	UBIQUITIN PROTEASOME SYSTEM; HYDROGEN-SULFIDE; HOMOCYSTEINE; EXPRESSION; PROTECTS; DISEASE; ENZYMES; STRESS; LEVEL	Exogenous hydrogen sulfide (H2S) protects kidneys from diabetic injuries in animal models. In order to explore the role of endogenous H2S in diabetic nephropathy, we determined the renal H2S producing enzymes in vivo and in vitro. In diabetic mice, H2S levels in blood and kidney were decreased while cystathionine beta-synthase (CBS), mainly located in mouse renal proximal convoluted tubules (PCT), was reduced selectively. In cultured mouse PCT cells treated with high glucose, CBS protein and activity was reduced while ubiquitinated CBS was increased, which was abolished by a proteasome inhibitor MG132 at 1 hour; high glucose drove CBS colocalized with proteasome 26S subunit ATPase6, indicating an involvement of ubiquitination proteasome degradation. At 48 hours, high glucose also selectively decreased CBS protein, concentration-dependently, but increased the ubiquitination of CBS; silence of CBS by siRNA increased nitrotyrosine, a marker for protein oxidative injury. Nitrotyrosine was also increased by high glucose treatments. The increases of nitrotyrosine either by cbs-siRNA or by glucose were restored by GYY4137, indicating that the H2S donor may protect kidney from oxidative injury induced by CBS deficiency. In diabetic kidneys, ubiquitinated CBS and nitrotyrosine were increased but restored by GYY4137. The treatment also ameliorated albuminuria and renal morphologic changes in diabetic mice. Our findings suggest that high glucose induces reduction of renal CBS protein and activity in vivo and in vitro that is critical to the pathogenesis of diabetic kidney disease.	[Yu, Yanting; Xiao, Leijuan; Jia, Yutao; Wang, Xiaoyan] Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Dept Nephrol, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China; [Yu, Yanting; Ren, Zhiyun; Zhu, Gangyi; Wang, Weiwan; Wang, Xiaoyan] Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Core Lab, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China; [Peng, Ai] Nanjing Med Univ, Affiliated Shanghai Clin Med Coll 10, Dept Nephrol & Rheumatol, 301 Yan Chang Middle Rd, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, XY (corresponding author), Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Dept Nephrol, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China.; Wang, XY (corresponding author), Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Core Lab, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China.; Peng, A (corresponding author), Nanjing Med Univ, Affiliated Shanghai Clin Med Coll 10, Dept Nephrol & Rheumatol, 301 Yan Chang Middle Rd, Nanjing, Peoples R China.	pengai@tongji.edu.cn; Xiaoyan.wang@benqmedicalcenter.com	Wang, Xiaoyan/GOK-1663-2022	Wang, Xiaoyan/0000-0001-7406-5008; Yu, Yanting/0000-0002-1631-2928	Natural Science Foundation of China [81900650, 81970605]; Natural Science Foundation of Jiangsu Province [BK20190128]; Nanjing Science and Technology Development Foundation [201715065]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Nanjing Science and Technology Development Foundation	This work was supported by grants from the Natural Science Foundation of China (81900650 and 81970605), Natural Science Foundation of Jiangsu Province (BK20190128), and Nanjing Science and Technology Development Foundation (201715065).	Beeken M, 2014, J AM SOC NEPHROL, V25, P2511, DOI 10.1681/ASN.2013050522; Beltowski J, 2019, METHODS MOL BIOL, V2007, P1, DOI 10.1007/978-1-4939-9528-8_1; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Chen H, 2015, CURR ALZHEIMER RES, V12, P88, DOI 10.2174/1567205012666141218144035; Dai YN, 2016, J CLIN BIOCHEM NUTR, V58, P76, DOI 10.3164/jcbn.15-54; Diao ZY, 2017, FREE RADICAL BIO MED, V106, P80, DOI 10.1016/j.freeradbiomed.2017.02.021; Elbassuoni EA, 2020, J CELL PHYSIOL, V235, P5223, DOI 10.1002/jcp.29403; Feliers D, 2016, ANTIOXID REDOX SIGN, V25, P720, DOI 10.1089/ars.2015.6596; FRIEDMAN P A, 1991, Journal of the American Society of Nephrology, V2, P737; Goru SK, 2017, PHARMACOL RES, V120, P170, DOI 10.1016/j.phrs.2017.03.024; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Holwerda KM, 2014, J AM SOC NEPHROL, V25, P717, DOI 10.1681/ASN.2013030291; Huang CW, 2015, HANDB EXP PHARMACOL, V230, P3, DOI 10.1007/978-3-319-18144-8_1; Kasinath BS, 2018, BIOCHEM PHARMACOL, V149, P29, DOI 10.1016/j.bcp.2017.12.005; Lee HJ, 2017, J BIOL CHEM, V292, P5665, DOI 10.1074/jbc.M116.766758; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Liu M, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13630; Lu DZ, 2018, INT J BIOL MACROMOL, V117, P1211, DOI 10.1016/j.ijbiomac.2018.06.039; Luo RF, 2019, FASEB J, V33, P469, DOI 10.1096/fj.201800436R; Pushpakumar S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38467-6; Sardina F, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000799; Sjakste T, 2016, MOL GENET GENOMICS, V291, P891, DOI 10.1007/s00438-015-1153-0; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Sun HJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24152857; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Wallace JL, 2018, ANTIOXID REDOX SIGN, V28, P1533, DOI 10.1089/ars.2017.7068; Wang T, 2001, AM J PHYSIOL-RENAL, V281, pF288, DOI 10.1152/ajprenal.2001.281.2.F288; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Yuan XN, 2017, KIDNEY BLOOD PRESS R, V42, P428, DOI 10.1159/000479295; Yuan YQ, 2018, BRAIN BEHAV IMMUN, V67, P77, DOI 10.1016/j.bbi.2017.07.159; Zhang HX, 2016, CELL PHYSIOL BIOCHEM, V40, P1603, DOI 10.1159/000453210; Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593; Zientara-Rytter K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010040; Zuhra K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080828	37	4	4	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21576	10.1096/fj.202002696RR	http://dx.doi.org/10.1096/fj.202002696RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864412				2022-12-28	WOS:000645260100050
J	Benny, PA; Al-Akwaa, FM; Dirkx, C; Schlueter, RJ; Wolfgruber, TK; Chern, IY; Hoops, S; Knights, D; Garmire, LX				Benny, Paula A.; Al-Akwaa, Fadhl M.; Dirkx, Corbin; Schlueter, Ryan J.; Wolfgruber, Thomas K.; Chern, Ingrid Y.; Hoops, Suzie; Knights, Dan; Garmire, Lana X.			Placentas delivered by pre-pregnant obese women have reduced abundance and diversity in the microbiome	FASEB JOURNAL			English	Article						Microbiome; Obesity; Placenta; Pregnancy; 16S sequencing	GUT MICROBIOME; TERM; PRETERM; SEQUENCES; MEMBRANES; SAMPLES; MODE; GENE; TOOL	Maternal pre-pregnancy obesity may have an impact on both maternal and fetal health. We examined the microbiome recovered from placentas in a multi-ethnic maternal pre-pregnant obesity cohort, through an optimized microbiome protocol to enrich low bacterial biomass samples. We found that the microbiomes recovered from the placentas of obese pre-pregnant mothers are less abundant and less diverse when compared to those from mothers of normal pre-pregnancy weight. Microbiome richness also decreases from the maternal side to the fetal side, demonstrating heterogeneity by geolocation within the placenta. In summary, our study shows that the microbiomes recovered from the placentas are associated with pre-pregnancy obesity. Importance Maternal pre-pregnancy obesity may have an impact on both maternal and fetal health. The placenta is an important organ at the interface of the mother and fetus, and supplies nutrients to the fetus. We report that the microbiomes enriched from the placentas of obese pre-pregnant mothers are less abundant and less diverse when compared to those from mothers of normal pre-pregnancy weight. More over, the microbiomes also vary by geolocation within the placenta.	[Benny, Paula A.; Wolfgruber, Thomas K.] Univ Hawaii, Ctr Canc, Dept Epidemiol, Honolulu, HI 96822 USA; [Al-Akwaa, Fadhl M.; Garmire, Lana X.] Univ Michigan, Dept Computat Med & Bioinformat, North Campus Res Complex, Ann Arbor, MI 48109 USA; [Dirkx, Corbin] Univ Minnesota Twin Cities, Univ Minnesota, Genom Ctr, Minneapolis, MN USA; [Schlueter, Ryan J.; Chern, Ingrid Y.] Univ Hawaii, Dept Obstet & Gynaecol, Honolulu, HI 96822 USA; [Hoops, Suzie; Knights, Dan] Univ Minnesota, Coll Biol Sci, BioTechnol Inst, Minneapolis, MN USA; [Hoops, Suzie; Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Schlueter, Ryan J.] Atlanta Perinatal Associates, Atlanta, GA USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Hawaii System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Garmire, LX (corresponding author), Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, NCRC, Room 3366,Bldg 520,1600 Huron Pkwy, Ann Arbor, MI 48105 USA.	lgarmire@med.umich.edu	Hoops, Susan L/AGF-1383-2022	Hoops, Susan/0000-0001-5273-5795	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [K01ES025434]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [P20 COBRE GM103457]; HHS | NIH | U.S. National Library of Medicine (NLM) [R01 LM012373]; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD084633]	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHS | NIH | U.S. National Library of Medicine (NLM); HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: K01ES025434; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20 COBRE GM103457; HHS | NIH | U.S. National Library of Medicine (NLM), Grant/Award Number: R01 LM012373; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01 HD084633	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Antony KM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.041; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Chu DM, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0330-z; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Doyle RM, 2014, PLACENTA, V35, P1099, DOI 10.1016/j.placenta.2014.10.007; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leiby JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0575-4; Li X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01882; Liu YY, 2019, FERTIL STERIL, V112, P707, DOI 10.1016/j.fertnstert.2019.05.015; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.044; Parnell LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11514-4; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rogers GB, 2013, J CLIN MICROBIOL, V51, P4029, DOI 10.1128/JCM.02164-13; Seferovic MD, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.04.036; Stanislawski MA, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0091-8; Thoendel M, 2016, J MICROBIOL METH, V127, P141, DOI 10.1016/j.mimet.2016.05.022; Walker RW, 2017, PEDIATR OBES, V12, P3, DOI 10.1111/ijpo.12217; Wu YJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4458; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315	36	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21524	10.1096/fj.202002184RR	http://dx.doi.org/10.1096/fj.202002184RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742690	Green Published			2022-12-28	WOS:000635216100039
J	Narapareddy, L; Rhon-Calderon, EA; Vrooman, LA; Baeza, J; Nguyen, DK; Mesaros, C; Lan, YM; Garcia, BA; Schultz, RM; Bartolomei, MS				Narapareddy, Laren; Rhon-Calderon, Eric A.; Vrooman, Lisa A.; Baeza, Josue; Nguyen, Duy K.; Mesaros, Clementina; Lan, Yemin; Garcia, Benjamin A.; Schultz, Richard M.; Bartolomei, Marisa S.			Sex-specific effects of in vitro fertilization on adult metabolic outcomes and hepatic transcriptome and proteome in mouse	FASEB JOURNAL			English	Article						assisted reproductive technologies; developmental origins of health and disease; long&#8208; term health; metabolic outcomes; sex&#8208; specific	ASSISTED REPRODUCTIVE TECHNOLOGIES; ELEMENT-BINDING PROTEIN-1C; DEVELOPMENTAL ORIGINS; VASCULAR DYSFUNCTION; INSULIN-RESISTANCE; MASS-SPECTROMETRY; HEALTH OUTCOMES; GENE-EXPRESSION; MESSENGER-RNA; LIVER	Although in vitro fertilization (IVF) is associated with adverse perinatal outcomes, there is increasing concern about the long-term and sex-specific health implications. Augmenting our IVF mouse model to longitudinally investigate metabolic outcomes in offspring from optimal neonatal litter sizes, we found sex-specific metabolic outcomes in IVF offspring. IVF-conceived females had higher body weight and cholesterol levels compared to naturally conceived females, whereas IVF-conceived males had higher levels of triglycerides and insulin, and increased body fat composition. Through adult liver transcriptomics and proteomics, we identified sexually dimorphic dysregulation of the sterol regulatory element-binding protein (SREBP) pathways that are associated with the sex-specific phenotypes. We also found that global loss of DNA methylation in placenta was linked to higher cholesterol levels in IVF-conceived females. Our findings indicate that IVF procedures have long-lasting sex-specific effects on metabolic health of offspring and lay the foundation to utilize the placenta as a predictor of long-term outcomes.	[Narapareddy, Laren] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Narapareddy, Laren; Rhon-Calderon, Eric A.; Vrooman, Lisa A.; Nguyen, Duy K.; Lan, Yemin; Bartolomei, Marisa S.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Epigenet Inst, 9-122 Smilow Ctr Translat Res,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Baeza, Josue; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Mesaros, Clementina; Bartolomei, Marisa S.] Univ Penn, Ctr Excellence Environm Toxicol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schultz, Richard M.] Univ Penn, Dept Biol, Sch Arts & Sci, Philadelphia, PA 19104 USA	Emory University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Bartolomei, MS (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Epigenet Inst, 9-122 Smilow Ctr Translat Res,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	bartolom@pennmedicine.upenn.edu		Bartolomei, Marisa/0000-0001-9410-5222	National Institutes of Child Health and Human Development [HD092266, HD068157]; National Institute of General Medical Sciences [GM110174]; National Institute of Nursing Research [T32NR007100]; Ruth L. Kirshstein National Service Award Individual Postdoctoral Fellowship [HD089623]; National Institute of Environmental Health Sciences [P30-ES013508]	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Ruth L. Kirshstein National Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the National Institutes of Child Health and Human Development HD092266 and HD068157 (MSB), the National Institute of General Medical Sciences GM110174 (BAG), the National Institute of Nursing Research T32NR007100 (LN), Ruth L. Kirshstein National Service Award Individual Postdoctoral Fellowship HD089623 (LAV), and the National Institute of Environmental Health Sciences P30-ES013508 (Center for Excellence in Environmental Toxicology).	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calle A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100743; Carbon S., 2018, **DATA OBJECT**, DOI [10.5281/ZENODO.3873405, DOI 10.5281/ZENODO.3873405]; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen M, 2017, J DEV ORIG HLTH DIS, V8, P388, DOI 10.1017/S2040174417000228; Chen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113155; Chen MX, 2014, DIABETES, V63, P3189, DOI 10.2337/db14-0103; Chen SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10596; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Collier AC, 2009, J STEROID BIOCHEM, V116, P21, DOI 10.1016/j.jsbmb.2009.04.005; de Waal E, 2015, HUM MOL GENET, V24, P6975, DOI 10.1093/hmg/ddv400; de Waal E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114785; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Erion KA, 2017, CURR OBES REP, V6, P178, DOI 10.1007/s13679-017-0261-z; European Society of Human Reproduction and Embryology, 2020, ART FACT SHEET; Feuer SK, 2014, ENDOCRINOLOGY, V155, P4554, DOI 10.1210/en.2014-1465; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Fortier AL, 2014, MOL CELL ENDOCRINOL, V388, P51, DOI 10.1016/j.mce.2014.03.003; Garcia-Calzon S, 2018, J CLIN ENDOCR METAB, V103, P4395, DOI 10.1210/jc.2018-00423; Gessulat S, 2019, NAT METHODS, V16, P509, DOI 10.1038/s41592-019-0426-7; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hart R, 2013, HUM REPROD UPDATE, V19, P232, DOI 10.1093/humupd/dms062; Hattori H, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0623-3; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Intapad S, 2014, PHYSIOLOGY, V29, P122, DOI 10.1152/physiol.00045.2013; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luke B, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.10.003; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Meng Y, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0194-5; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Miles HL, 2007, J CLIN ENDOCR METAB, V92, P3441, DOI 10.1210/jc.2006-2465; Moro E, 2003, METABOLISM, V52, P616, DOI 10.1053/meta.2003.50102; Nagy A., 2014, MANIPULATING MOUSE E, V4 th, P604; Nesteruk M, 2014, FUNCT INTEGR GENOMIC, V14, P245, DOI 10.1007/s10142-013-0342-3; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Parra-Vargas M, 2020, CELL METAB, V32, P334, DOI 10.1016/j.cmet.2020.07.014; Pino LK, 2020, MOL CELL PROTEOMICS, V19, P1088, DOI 10.1074/mcp.P119.001913; Pontesilli M, 2015, REPROD BIOMED ONLINE, V30, P258, DOI 10.1016/j.rbmo.2014.11.006; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rexhaj E, 2015, AM J PHYSIOL-HEART C, V309, pH1151, DOI 10.1152/ajpheart.00621.2014; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; Sang J, 2019, BRIT J NUTR, V122, P1062, DOI 10.1017/S0007114519001740; Schieve LA, 2007, MATERN CHILD HLTH J, V11, P517, DOI 10.1007/s10995-007-0202-7; Scott KA, 2010, BIOL REPROD, V83, P220, DOI 10.1095/biolreprod.109.082826; Searle BC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15346-1; Searle BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07454-w; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Stern JE, 2018, J ASSIST REPROD GEN, V35, P1585, DOI 10.1007/s10815-018-1238-x; Sui LL, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.124248; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037; Vrooman LA, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186551; Vrooman LA, 2017, REPROD TOXICOL, V68, P72, DOI 10.1016/j.reprotox.2016.07.015; Wang WR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24813-1; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Whidden L, 2016, HUM MOL GENET, V25, P4649, DOI 10.1093/hmg/ddw293; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100	71	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21523	10.1096/fj.202002744R	http://dx.doi.org/10.1096/fj.202002744R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734487	Green Accepted			2022-12-28	WOS:000635216100041
J	Tantengco, OAG; Richardson, LS; Medina, PMB; Han, A; Menon, R				Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Medina, Paul Mark B.; Han, Arum; Menon, Ramkumar			Organ-on-chip of the cervical epithelial layer: A platform to study normal and pathological cellular remodeling of the cervix	FASEB JOURNAL			English	Article						cervix; cervical ripening; epithelial&#8208; to&#8208; mesenchymal transition; organ&#8208; on&#8208; a&#8208; chip; pregnancy; preterm birth	TUMOR-NECROSIS-FACTOR; PRETERM; PREGNANCY; TERM; PARTURITION; INFECTION; DYNAMICS	Damage to the cervical epithelial layer due to infection and inflammation is associated with preterm birth. However, the individual and/or collective roles of cervical epithelial layers in maintaining cervical integrity remain unclear during infection/inflammation. To determine the intercellular interactions, we developed an organ-on-chip of the cervical epithelial layer (CE-OOC) composed of two co-culture chambers connected by microchannels, recapitulating the ectocervical and endocervical epithelial layers. Further, we tested the interactions between cells from each distinct region and their contributions in maintaining cervical integrity in response to LPS and TNF alpha stimulations. The co-culture of ectocervical and endocervical cells facilitated cellular migration of both epithelial cells inside the microchannels. Compared to untreated controls, both LPS and TNF alpha increased apoptosis, necrosis, and senescence as well as increased pro-inflammatory cytokine productions by cervical epithelial cells. In summary, the CE-OOC established an in vitro model that can recapitulate the ectocervical and the endocervical epithelial regions of the cervix. The established CE-OOC may become a powerful tool in obstetrics and gynecology research such as in studying cervical remodeling during pregnancy and parturition and the dynamics of cervical epithelial cells in benign and malignant pathology in the cervix.	[Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Menon, Ramkumar] Univ Texas Med Branch Galveston, Div Maternal Fetal Med & Perinatal Res, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA; [Tantengco, Ourlad Alzeus G.; Medina, Paul Mark B.] Univ Philippines Manila, Dept Biochem & Mol Biol, Coll Med, Manila, Philippines; [Richardson, Lauren S.; Han, Arum] Texas A&M Univ, Dept Elect & Comp Engn, Dept Biomed Engn, College Stn, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of the Philippines System; University of the Philippines Manila; Texas A&M University System; Texas A&M University College Station	Menon, R (corresponding author), Univ Texas Med Branch Galveston, Div Maternal Fetal Med & Perinatal Res, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	ra2menon@utmb.edu	Han, Arum/C-7078-2013; Tantengco, Ourlad Alzeus/L-4740-2019	Han, Arum/0000-0002-9223-8301; Tantengco, Ourlad Alzeus/0000-0002-4535-8837; Menon, Ramkumar/0000-0001-9213-6105; Richardson, Lauren/0000-0001-8392-2833; Medina, Paul Mark/0000-0001-6116-1818	Philippine Council for Health Research and Development, Department of Science and Technology, Republic of the Philippines; National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) of the United States [T32 ES026568]; NIH/NICHD [1R01HD100729-01]	Philippine Council for Health Research and Development, Department of Science and Technology, Republic of the Philippines; National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) of the United States; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	O Tantengco is an MD-PhD trainee in the MD -PhD in Molecular Medicine Program, supported by the Philippine Council for Health Research and Development, Department of Science and Technology, Republic of the Philippines, and administered through the University of the Philippines Manila. L Richardson is a postdoctoral fellow in the Regulatory Science in Environmental Health and Toxicology Training Grant (T32 ES026568), supported by the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) of the United States, administered through Texas A&M University. This study was supported by 1R01HD100729-01 (NIH/NICHD) [R Menon and A Han]).	Anton L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02181; Anton L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03217-7; Battaglia Rachel A, 2018, F1000Res, V7, DOI 10.12688/f1000research.15967.1; Blander JM, 2016, FEBS J, V283, P2720, DOI 10.1111/febs.13771; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bonney EA, 2013, AM J REPROD IMMUNOL, V69, P567, DOI 10.1111/aji.12102; Dixon CL, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12790; Grossmann H, 2020, REPROD TOXICOL, V95, P29, DOI 10.1016/j.reprotox.2020.04.074; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Huh J., 2018, US Patent App., Patent No. [15/769,387, 15769387]; Jin J, 2018, PLACENTA, V67, P15, DOI 10.1016/j.placenta.2018.05.008; Lavenus SB, 2020, J BIOL CHEM, V295, P6700, DOI 10.1074/jbc.RA119.011537; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Maymon E, 1999, AM J OBSTET GYNECOL, V181, P1142, DOI 10.1016/S0002-9378(99)70097-9; Mcgee D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188645; Nallasamy S, 2017, SEMIN REPROD MED, V35, P190, DOI 10.1055/s-0037-1599091; Niepel M, 2019, CELL SYST, V9, P35, DOI 10.1016/j.cels.2019.06.005; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Nott J.P., 2016, T RES ANAT, V2, P1, DOI DOI 10.1016/j.tria.2016.02.001; Pavlidis I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14089-y; Payne KJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101840; Potter NT., 1992, J MATERNAL FETAL MED, V1, P142; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Richardson L, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00715; Richardson L, 2020, REPROD SCI, V27, P1562, DOI 10.1007/s43032-020-00184-9; Richardson L, 2019, FASEB J, V33, P8945, DOI 10.1096/fj.201900020RR; Richardson LS, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay1486; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1576, DOI 10.1016/0002-9378(92)91636-O; ROMERO R, 1988, AM J OBSTET GYNECOL, V158, P1044, DOI 10.1016/0002-9378(88)90216-5; Ruder B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081887; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Sosa-Hernandez JE, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9100536; Stouffer RL, 2017, ILAR J, V58, P281, DOI 10.1093/ilar/ilx027; Tantengco OAG, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13370; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Velez DR, 2008, HUM REPROD, V23, P1902, DOI 10.1093/humrep/den170; Vink J, 2017, SEMIN PERINATOL, V41, P427, DOI 10.1053/j.semperi.2017.07.014; Vink J, 2016, SEMIN FETAL NEONAT M, V21, P106, DOI 10.1016/j.siny.2015.12.009; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Yellon SM, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03156; Yellon SM, 2017, BIOL REPROD, V96, P13, DOI 10.1095/biolreprod.116.142844	43	14	14	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21463	10.1096/fj.202002590RRR	http://dx.doi.org/10.1096/fj.202002590RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33689188	Green Accepted			2022-12-28	WOS:000635216100095
J	Shen, H; He, YC; Wang, N; Fritch, MR; Li, XY; Lin, H; Tuan, RS				Shen, He; He, Yuchen; Wang, Ning; Fritch, Madalyn R.; Li, Xinyu; Lin, Hang; Tuan, Rocky S.			Enhancing the potential of aged human articular chondrocytes for high-quality cartilage regeneration	FASEB JOURNAL			English	Article						cell shape; cellular rejuvenation; chondrocytes; ERK1; 2; RhoA; suspension cell culture	SENESCENT CELLS; ACTIN CYTOSKELETON; PROTEIN-KINASE; N-CADHERIN; OSTEOARTHRITIS; DIFFERENTIATION; CHONDROGENESIS; IMPLANTATION; MORPHOLOGY; PHENOTYPE	Autologous chondrocyte implantation (ACI) is a regenerative procedure used to treat focal articular cartilage defects in knee joints. However, age has been considered as a limiting factor and ACI is not recommended for patients older than 40-50 years of age. One reason for this may be due to the reduced capacity of aged chondrocytes in generating new cartilage. Currently, the underlying mechanism contributing to aging-associated functional decline in chondrocytes is not clear and no proven approach exists to reverse chondrocyte aging. Given that chondrocytes in healthy hyaline cartilage typically display a spherical shape, believed to be essential for chondrocyte phenotype stability, we hypothesize that maintaining aged chondrocytes in a suspension culture that forces the cells to adopt a round morphology may help to "rejuvenate" them to a younger state, thus, leading to enhanced cartilage regeneration. Chondrocytes isolated from aged donors displayed reduced proliferation potential and impaired capacity in generating hyaline cartilage, compared to cells isolated from young donors, indicated by increased hypertrophy and cellular senescence. To test our hypothesis, the "old" chondrocytes were seeded as a suspension onto an agarose-based substratum, where they maintained a round morphology. After the 3-day suspension culture, aged chondrocytes displayed enhanced replicative capacity, compared to those grown adherent to tissue culture plastic. Moreover, chondrocytes subjected to suspension culture formed new cartilage in vitro with higher quality and quantity, with enhanced cartilage matrix deposition, concomitant with lower levels of hypertrophy and cellular senescence markers. Mechanistic analysis suggested the involvement of the RhoA and ERK1/2 signaling pathways in the "rejuvenation" process. In summary, our study presents a robust and straightforward method to enhance the function of aged human chondrocytes, which can be conveniently used to generate a large number of high-quality chondrocytes for ACI application in the elderly.	[Shen, He; He, Yuchen; Wang, Ning; Fritch, Madalyn R.; Li, Xinyu; Lin, Hang; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15261 USA; [Lin, Hang; Tuan, Rocky S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Sch Med, Pittsburgh, PA USA; [Lin, Hang; Tuan, Rocky S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Tuan, Rocky S.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong	Lin, H (corresponding author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15261 USA.; Tuan, RS (corresponding author), Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China.	hal46@pitt.edu; tuanr@cuhk.edu.hk	Lin, Hang/AFO-8482-2022; Lin, Hang/D-3003-2012	Lin, Hang/0000-0002-0781-6630; Tuan, Rocky/0000-0001-6067-6705	National Institutes of Health [R21AG056819, P30AG024827, UL1TR001857]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R21AG056819, P30AG024827 and UL1TR001857	Appleton CTG, 2010, LAB INVEST, V90, P20, DOI 10.1038/labinvest.2009.111; ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0; Ashraf S, 2016, OSTEOARTHR CARTILAGE, V24, P196, DOI 10.1016/j.joca.2015.07.008; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110; Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208; Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x; Bobacz K, 2004, ANN RHEUM DIS, V63, P1618, DOI 10.1136/ard.2002.002162; Bobick BE, 2010, J CELL PHYSIOL, V224, P178, DOI 10.1002/jcp.22120; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chen ZJ, 2015, J BONE MINER RES, V30, P765, DOI 10.1002/jbmr.2409; Coricor G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38616; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Djouad F, 2009, TISSUE ENG PT A, V15, P2825, DOI [10.1089/ten.tea.2008.0663, 10.1089/ten.TEA.2008.0663]; DOMINICE J, 1987, MECH AGEING DEV, V37, P231, DOI 10.1016/0047-6374(86)90040-0; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gegg C, 2020, TISSUE ENG PT A, V26, P130, DOI [10.1089/ten.TEA.2019.0068, 10.1089/ten.tea.2019.0068]; Giannoni P, 2005, OSTEOARTHR CARTILAGE, V13, P589, DOI 10.1016/j.joca.2005.02.015; Hall AC, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0837-6; Haudenschild Dominik R., 2009, Molecular & Cellular Biomechanics, V6, P135; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; JACENKO O, 1995, DEV DYNAM, V202, P27, DOI 10.1002/aja.1002020104; Jeon OH, 2018, J CLIN INVEST, V128, P1229, DOI 10.1172/JCI95147; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Jha SK, 2017, BBA-MOL BASIS DIS, V1863, P1132, DOI 10.1016/j.bbadis.2016.06.015; Jones Deryk G, 2007, Instr Course Lect, V56, P429; Karim A, 2018, J ANAT, V232, P686, DOI 10.1111/joa.12768; Kim MJ, 2012, BIOCHEM BIOPH RES CO, V418, P500, DOI 10.1016/j.bbrc.2012.01.053; Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Liu YW, 2019, BIOMATERIALS, V218, DOI 10.1016/j.biomaterials.2019.119336; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parreno J, 2018, J ORTHOP RES, V36, P2392, DOI 10.1002/jor.23896; Rosenberger RE, 2008, AM J SPORT MED, V36, P2336, DOI 10.1177/0363546508322888; Rottmar M, 2014, EXP CELL RES, V320, P175, DOI 10.1016/j.yexcr.2013.11.004; Sasazaki Y, 2008, RHEUMATOLOGY, V47, P1641, DOI 10.1093/rheumatology/ken341; Sessa A, 2019, JBJS ESSENT SURG TEC, V9, DOI 10.2106/JBJS.ST.18.00089; Shen H, 2018, J MATER CHEM B, V6, P908, DOI 10.1039/c7tb02172k; Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0; Singh P, 2019, ANN NY ACAD SCI, V1442, P17, DOI 10.1111/nyas.13930; Smeriglio P, 2015, JOVE-J VIS EXP, DOI 10.3791/53085; Solursh M., 1984, CARTILAGE DEV DIFFER, V2, P121; Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106; Tran-Khanh N, 2010, CONNECT TISSUE RES, V51, P216, DOI 10.3109/03008200903281683; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; van der Kraan PA, 2008, AGEING RES REV, V7, P106, DOI 10.1016/j.arr.2007.10.001; Vavken P, 2010, OSTEOARTHR CARTILAGE, V18, P857, DOI 10.1016/j.joca.2010.03.005; Verbruggen G, 2000, OSTEOARTHR CARTILAGE, V8, P170, DOI 10.1053/joca.1999.0287; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115; Zhou HW, 2004, RHEUMATOLOGY, V43, P555, DOI 10.1093/rheumatology/keh127	57	3	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21410	10.1096/fj.202002386R	http://dx.doi.org/10.1096/fj.202002386R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33617078	Green Accepted			2022-12-28	WOS:000629576700023
J	Chung, I; Kim, SA; Kim, S; Lee, JO; Park, CY; Lee, J; Kang, J; Lee, JY; Seo, I; Lee, HJ; Han, JA; Kang, MJ; Lim, E; Kim, SJ; Wu, SW; Oh, JY; Chung, JH; Kim, EK; Kim, HS; Shin, MJ				Chung, InHyeok; Kim, Shin Ae; Kim, Seolsong; Lee, Jung Ok; Park, Clara Yongjoo; Lee, Juhee; Kang, Jun; Lee, Jin Young; Seo, Ilhyeok; Lee, Hye Jeong; Han, Jeong Ah; Kang, Min Ju; Lim, Eunice; Kim, Su Jin; Wu, Sang Woo; Oh, Joo Yeon; Chung, Ji Hyung; Kim, Eun-Kyoung; Kim, Hyeon Soo; Shin, Min-Jeong			Biglycan reduces body weight by regulating food intake in mice and improves glucose metabolism through AMPK/AKT dual pathways in skeletal muscle	FASEB JOURNAL			English	Article						AKT; AMPK; biglycan; food intake; glucose uptake; obesity	PROTEIN-KINASE; INSULIN-RESISTANCE; TOLL-LIKE; EXPRESSION; EXERCISE; DECORIN; PROTEOGLYCANS; HEALTH; CONTRACTION; NEURONS	While biglycan (BGN) is suggested to direct diverse signaling cascades, the effects of soluble BGN as a ligand on metabolic traits have not been studied. Herein, we tested the effects of BGN on obesity in high-fat diet (HFD)-induced obese animals and glucose metabolism, with the underlying mechanism responsible for observed effects in vitro. Our results showed that BGN administration (1 mg/kg body weight, intraperitoneally) significantly prevented HFD-induced obesity, and this was mainly attributed to reduced food intake. Also, intracerebroventricular injection of BGN reduced food intake and body weight. The underlying mechanism includes modulation of neuropeptides gene expression involved in appetite in the hypothalamus in vitro and in vivo. In addition, BGN regulates glucose metabolism as shown by improved glucose tolerance in mice as well as AMPK/AKT dual pathway-driven enhanced glucose uptake and GLUT4 translocation in L6 myoblast cells. In conclusion, our results suggest BGN as a potential therapeutic target to treat risk factors for metabolic diseases.	[Chung, InHyeok; Lee, Juhee; Lee, Jin Young; Shin, Min-Jeong] Korea Univ, Interdisciplinary Program Precis Publ Hlth, Seoul 02841, South Korea; [Kim, Shin Ae; Lee, Jung Ok; Seo, Ilhyeok; Lee, Hye Jeong; Han, Jeong Ah; Kang, Min Ju; Kim, Su Jin; Wu, Sang Woo; Oh, Joo Yeon; Kim, Hyeon Soo] Korea Univ, Dept Anat, Coll Med, Seoul 02841, South Korea; [Kim, Seolsong; Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu, South Korea; [Park, Clara Yongjoo] Chonnam Natl Univ, Dept Food & Nutr, Gwangju, South Korea; [Kang, Jun; Chung, Ji Hyung] CHA Univ, Dept Biotechnol, Gyeonggi Do, South Korea; [Lim, Eunice] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Neurometabol Res Ctr, Daegu, South Korea; [Shin, Min-Jeong] Korea Univ, Sch Biosyst & Biomed Sci, Coll Hlth Sci, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Chonnam National University; Pochon Cha University; University of Michigan System; University of Michigan; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Korea University	Shin, MJ (corresponding author), Korea Univ, Interdisciplinary Program Precis Publ Hlth, Seoul 02841, South Korea.; Kim, HS (corresponding author), Korea Univ, Dept Anat, Coll Med, Seoul 02841, South Korea.	anatomykim@korea.ac.kr; mjshin@korea.ac.kr		Lee, Juhee/0000-0002-3223-734X	NRF - Ministry of Science and ICT [NRF-2020R1A2C2005580, NRF-2020R1A2B5B02001468]	NRF - Ministry of Science and ICT	This study was supported by the Basic Science Research Program through the NRF funded by the Ministry of Science and ICT (NRF-2020R1A2C2005580 & NRF-2020R1A2B5B02001468)	Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Carter S, 2019, PFLUG ARCH EUR J PHY, V471, P413, DOI 10.1007/s00424-018-2210-4; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chanmee T, 2016, J BIOL CHEM, V291, P24105, DOI 10.1074/jbc.M116.751263; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; ERIKSSON H, 1992, J INTERN MED, V232, P389, DOI 10.1111/j.1365-2796.1992.tb00604.x; FISHER LW, 1983, J BIOL CHEM, V258, P6588; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hogemann B, 1997, PATHOL RES PRACT, V193, P747; Huang GR, 2012, TRENDS ENDOCRIN MET, V23, P16, DOI 10.1016/j.tem.2011.09.006; Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jeon Y, 2016, BIOCHEM BIOPH RES CO, V470, P818, DOI 10.1016/j.bbrc.2016.01.115; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Kim JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep18825; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Kwak SY, 2020, METABOLISM, V105, DOI 10.1016/j.metabol.2020.154171; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Matsuura T, 2001, MATRIX BIOL, V20, P367, DOI 10.1016/S0945-053X(01)00142-1; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; O'Neill HM, 2013, DIABETES METAB J, V37, P1, DOI 10.4093/dmj.2013.37.1.1; Ojima K, 2014, EUPA OPEN PROTEOM, V5, DOI DOI 10.1016/J.EUPR0T.2014.08.001; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; ROUGHLEY PJ, 1994, MATRIX BIOL, V14, P51, DOI 10.1016/0945-053X(94)90029-9; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Smushkin Galina, 2010, Medicine (Abingdon), V38, P597; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Ying Z, 2018, BBA-MOL BASIS DIS, V1864, P3679, DOI 10.1016/j.bbadis.2018.10.002	48	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21794	10.1096/fj.202002039RR	http://dx.doi.org/10.1096/fj.202002039RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314059	Green Published			2022-12-28	WOS:000678975300003
J	Kurano, M; Kobayashi, T; Sakai, E; Tsukamoto, K; Yatomi, Y				Kurano, Makoto; Kobayashi, Tamaki; Sakai, Eri; Tsukamoto, Kazuhisa; Yatomi, Yutaka			Lysophosphatidylinositol, especially albumin-bound form, induces inflammatory cytokines in macrophages	FASEB JOURNAL			English	Article						inflammation; lipoproteins; lysophosphatidylinositol; macrophage	SPHINGOSINE 1-PHOSPHATE; INSULIN-SECRETION; APOLIPOPROTEIN M; RECEPTOR GPR55; LYSOPHOSPHOLIPIDS; AGONIST; PROTEIN; IDENTIFICATION; INVOLVEMENT; ACTIVATION	Lysophosphatidylinositol (LPI) is a glycero-lysophospholipid and a natural agonist against GPR55. The roles of the LPI/GPR55 axis in the pathogenesis of inflammation have been controversial. In the present study, we attempted to elucidate the roles of the LPI/GPR55 axis in inflammation, especially the secretion of inflammatory cytokines, IL-6 and TNF-alpha from macrophages. We treated RAW264.7 cells and mouse peritoneal macrophages (MPMs) with LPI and observed that LPI induced the secretion of IL-6 and TNF-alpha from these cells, as well as the phosphorylation of p38. These responses were inhibited by treatment with CID16020046 (CID), an antagonist against GPR55, or SB202190, an inhibitor of p38 cascade or knockdown of GPR55 with siRNA. Treatment with CID or ML-193, another antagonist against GPR55, attenuated the elevation of inflammatory cytokines in the plasma or tissue of db/db mice and in a septic mouse model induced using lipopolysaccharide, suggesting contributions to the improvement of insulin resistance and protection against organ injuries by treatment with CID or ML-193, respectively. In human subjects, although the serum LPI levels were not different, the levels of LPI in the lipoprotein fractions were lower and the levels in the lipoprotein-depleted fractions were higher in subjects with diabetes. LPI bound to albumin induced the secretion of IL-6 and TNF-alpha from RAW264.7 cells to a greater degree than LPI bound to LDL or HDL. These results suggest that LPI, especially the albumin-bound form, induced inflammatory cytokines depending on the GPR55/p38 pathway, which might contribute to the pathogenesis of obesity-induced inflammation and acute inflammation.	[Kurano, Makoto; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Kurano, Makoto; Kobayashi, Tamaki; Sakai, Eri; Yatomi, Yutaka] Univ Tokyo Hosp, Dept Clin Lab, Tokyo, Japan; [Tsukamoto, Kazuhisa] Teikyo Univ, Dept Internal Med, Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; Teikyo University	Kurano, M; Yatomi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurano-tky@umin.ac.jp; kurano-tky@umin.ac.jp		Yatomi, Yutaka/0000-0003-1719-4297	JSPS KAKENHI [16H06236, 20H03573]; Japan Heart Foundation; MSD Life Science Foundation; Public Interest Incorporated Foundation; Takeda Science Foundation; AMED;  [15H05906]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Heart Foundation; MSD Life Science Foundation; Public Interest Incorporated Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); AMED; 	JSPS KAKENHI, Grant/Award Number: 16H06236 and 20H03573; Japan Heart Foundation; MSD Life Science Foundation, Public Interest Incorporated Foundation; Takeda Science Foundation; AMED; Grant-in--Aid for Scientific Research on Innovative Areas, Grant/Award Number: 15H05906	Alhouayek M, 2018, TRENDS PHARMACOL SCI, V39, P586, DOI 10.1016/j.tips.2018.02.011; AlSuleimani YM, 2015, BRIT J PHARMACOL, V172, P3043, DOI 10.1111/bph.13107; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Bjursell M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167965; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Deliu E, 2015, MOL PHARMACOL, V88, P265, DOI 10.1124/mol.115.099333; Emoto S, 2017, J LIPID RES, V58, P763, DOI 10.1194/jlr.P072090; FALASCA M, 1995, ONCOGENE, V10, P2113; Fondevila MF, 2021, HEPATOLOGY, V73, P606, DOI 10.1002/hep.31290; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Harada K, 2017, J BIOL CHEM, V292, P10855, DOI 10.1074/jbc.M117.788653; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kobayashi T, 2021, J ATHEROSCLER THROMB, V28, P730, DOI 10.5551/jat.55699; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Kurano M, 2019, BIOCHEM J, V476, P3565, DOI 10.1042/BCJ20190498; Kurano M, 2019, FREE RADICAL RES, V53, P892, DOI 10.1080/10715762.2019.1641603; Kurano M, 2019, FASEB J, V33, P5181, DOI 10.1096/fj.201801748R; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; Kurano M, 2018, J ATHEROSCLER THROMB, V25, P16, DOI 10.5551/jat.RV17010; Kurano M, 2017, ARTERIOSCL THROM VAS, V37, P506, DOI 10.1161/ATVBAHA.116.308692; Kurano M, 2017, J LIPID RES, V58, P433, DOI 10.1194/jlr.P071803; Kurano M, 2015, ARTERIOSCL THROM VAS, V35, P463, DOI 10.1161/ATVBAHA.114.304748; Kurano M, 2014, BBA-MOL CELL BIOL L, V1841, P1217, DOI 10.1016/j.bbalip.2014.05.002; Kurano M, 2011, J ATHEROSCLER THROMB, V18, P373, DOI 10.5551/jat.6999; Lin XH, 2011, NEUROGASTROENT MOTIL, V23, P862, DOI 10.1111/j.1365-2982.2011.01742.x; Liu B, 2016, DIABETES OBES METAB, V18, P1263, DOI 10.1111/dom.12780; Lu YH, 2016, DIABETOLOGIA, V59, P2349, DOI 10.1007/s00125-016-4069-2; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Masquelier J, 2018, BBA-MOL CELL BIOL L, V1863, P1458, DOI 10.1016/j.bbalip.2018.09.003; Meadows A, 2016, INT J OBESITY, V40, P417, DOI 10.1038/ijo.2015.209; METZ SA, 1988, BIOCHIM BIOPHYS ACTA, V968, P239, DOI 10.1016/0167-4889(88)90013-4; Minamihata T, 2020, INFLAMMATION, V43, P1971, DOI 10.1007/s10753-020-01271-4; Morita Y, 2019, LIPIDS, V54, P487, DOI 10.1002/lipd.12175; Munawar N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00136; Nishikawa M, 2015, J ATHEROSCLER THROMB, V22, P518, DOI 10.5551/jat.25650; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Reustle A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123761; Schicho R, 2011, INFLAMM BOWEL DIS, V17, P1651, DOI 10.1002/ibd.21538; Sisay S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076907; Stancic A, 2015, NEUROGASTROENT MOTIL, V27, P1432, DOI 10.1111/nmo.12639; SUZUKI E, 1992, DIABETES RES CLIN PR, V18, P153, DOI 10.1016/0168-8227(92)90140-M; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yatomi Y, 2018, P JPN ACAD B-PHYS, V94, P373, DOI 10.2183/pjab.94.025	49	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21673	10.1096/fj.202100245R	http://dx.doi.org/10.1096/fj.202100245R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042213				2022-12-28	WOS:000655695900034
J	Larson-Casey, JL; Gu, LL; Davis, D; Cai, GQ; Ding, Q; He, C; Carter, AB				Larson-Casey, Jennifer L.; Gu, Linlin; Davis, Dana; Cai, Guo-Qiang; Ding, Qiang; He, Chao; Carter, A. Brent			Post-translational regulation of PGC-1 alpha modulates fibrotic repair	FASEB JOURNAL			English	Article						mitochondrial biogenesis; monocyte&#8208; derived macrophages; PGC&#8208; 1&#945; pulmonary fibrosis	ACTIVATED-RECEPTOR-GAMMA; IDIOPATHIC PULMONARY-FIBROSIS; P38 MAP KINASE; MITOCHONDRIAL BIOGENESIS; ALTERNATIVE ACTIVATION; APOPTOSIS RESISTANCE; TRANSCRIPTION FACTOR; KIDNEY FIBROSIS; GENE-EXPRESSION; MACROPHAGES	Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease associated with mitochondrial oxidative stress. Mitochondrial reactive oxygen species (mtROS) are important for cell homeostasis by regulating mitochondrial dynamics. Here, we show that IPF BAL cells exhibited increased mitochondrial biogenesis that is, in part, due to increased nuclear expression of peroxisome proliferator-activated receptor-gamma (PPAR gamma) coactivator (PGC)-1 alpha. Increased PPARGC1A mRNA expression directly correlated with reduced pulmonary function in IPF subjects. Oxidant-mediated activation of the p38 MAPK via Akt1 regulated PGC-1 alpha activation to increase mitochondrial biogenesis in monocyte-derived macrophages. Demonstrating the importance of PGC-1 alpha in fibrotic repair, mice harboring a conditional deletion of Ppargc1a in monocyte-derived macrophages or mice administered a chemical inhibitor of mitochondrial division had reduced biogenesis and increased apoptosis, and the mice were protected from pulmonary fibrosis. These observations suggest that Akt1-mediated regulation of PGC-1 alpha maintains mitochondrial homeostasis in monocyte-derived macrophages to induce apoptosis resistance, which contributes to the pathogenesis of pulmonary fibrosis.	[Larson-Casey, Jennifer L.; Gu, Linlin; Davis, Dana; He, Chao; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA; [Cai, Guo-Qiang; Ding, Qiang] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Mol & Translat Biomed, Birmingham, AL USA; [Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA.	bcarter1@uab.edu		Larson-Casey, Jennifer L./0000-0001-7238-7986	HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS) [2R01ES015981-14, P42 ES027723]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [P01 HL114470-7]; U.S. Department of Veterans Affairs (VA) [1 I01 CX001715-01]; Parker Foundation; American Lung Association (Lung Association) [RG-507440]	HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Parker Foundation; American Lung Association (Lung Association)	HHS vertical bar NIH vertical bar National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: 2R01ES015981-14 and P42 ES027723; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: P01 HL114470-7; U.S. Department of Veterans Affairs (VA), Grant/Award Number: 1 I01 CX001715-01; Parker Foundation; American Lung Association (Lung Association), Grant/ Award Number: RG-507440	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Alzaid F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88689; [Anonymous], 2015, AM CANC SOC CANC FAC; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bauer Yasmina, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00074-2016; Besse-Patin A, 2019, P NATL ACAD SCI USA, V116, P4285, DOI 10.1073/pnas.1815150116; Breunig C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.364; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Carter KB, 2000, J BIOL CHEM, V275, P27858; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Eschbach J, 2013, HUM MOL GENET, V22, P3477, DOI 10.1093/hmg/ddt202; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gu LL, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101307; Gu LL, 2017, FASEB J, V31, P3072, DOI 10.1096/fj.201601371R; Han L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.30; Han SH, 2017, J AM SOC NEPHROL, V28, P3312, DOI 10.1681/ASN.2017020130; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; He C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126551; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hughes R, 2015, CANCER RES, V75, P3479, DOI 10.1158/0008-5472.CAN-14-3587; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Hutchinson John P, 2014, Ann Am Thorac Soc, V11, P1176, DOI 10.1513/AnnalsATS.201404-145OC; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Larson-Casey JL, 2019, J CLIN INVEST, V129, P4962, DOI [10.1172/JCl127959, 10.1172/JCI127959]; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mannam P, 2014, AM J PHYSIOL-LUNG C, V306, pL604, DOI 10.1152/ajplung.00272.2013; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Richards TJ, 2012, AM J RESP CRIT CARE, V185, P67, DOI 10.1164/rccm.201101-0058OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Shearn AIU, 2012, ARTERIOSCL THROM VAS, V32, P1142, DOI 10.1161/ATVBAHA.111.239111; Sheikh AQ, 2018, CELL REP, V23, P1152, DOI 10.1016/j.celrep.2018.03.043; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yu GY, 2018, NAT MED, V24, P39, DOI 10.1038/nm.4447; Zhang LW, 2018, MOL MED REP, V17, P4490, DOI 10.3892/mmr.2018.8433; Zhao C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.69	77	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21675	10.1096/fj.202100339R	http://dx.doi.org/10.1096/fj.202100339R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34038004	hybrid, Green Published			2022-12-28	WOS:000655695900064
J	Nemerovsky, L; Bar-Joseph, H; Eldar-Boock, A; Miller, I; Ben-Ami, I; Shalgi, R				Nemerovsky, Luba; Bar-Joseph, Hadas; Eldar-Boock, Anat; Miller, Irit; Ben-Ami, Ido; Shalgi, Ruth			Pigment epithelium-derived factor negates oxidative stress in mouse oocytes	FASEB JOURNAL			English	Article						ATP; oocyte maturation; oxidative stress; PEDF	FACTOR PEDF; IMPACT; MITOCHONDRIA; COMPETENCE; DYNAMICS; OBESITY; CELLS; WOMEN; OVARY; IVF	Molecular changes, caused by various environmental factors, affect the quality and developmental potential of oocytes. Oxidative stress (OS) is a major factor involved in various gynecologic disorders and/or in aging. Recent studies suggest that elevated reactive oxygen species (ROS) hamper oocyte quality and future embryonic development. Pigment epithelium-derived factor (PEDF) is a pleiotropic protein, known for its antiangiogenic, anti-inflammatory, and antioxidative properties. Our previous findings demonstrate the antioxidative role of rPEDF in maintaining granulosa cell viability. In the current study, we examined the ability of PEDF to negate the adverse impact of OS on oocytes. Maturation rate of oocytes exposed to OS was significantly lower than that of control oocytes. The number of mtDNA copies in OS-exposed oocytes was significantly higher than in control oocytes (>3 times), whereas ATP concentration was significantly lower. Oocytes exposed to OS demonstrated impaired chromosome arrangement at the metaphase plate. PEDF significantly improved maturation rate of untreated OS-exposed oocytes. Moreover, mtDNA copy number, ATP concentration, and chromosome arrangement at the metaphase plate in rPEDF-treated OS-exposed oocytes were restored to the level of control oocytes. Our findings demonstrate that OS hampers the ability of oocytes to undergo proper in vitro maturation. The energetic balance of OS-exposed oocyte is characterized by excessive mtDNA replication and reduced ATP concentration; it hampers the ability of oocytes to perform high fidelity chromosome segregation. PEDF alleviates this damage, improves the rate of oocyte maturation, and preserves mtDNA level and ATP content, thus enabling oocytes to form proper metaphase plate and improve oocyte competence.	[Nemerovsky, Luba; Miller, Irit; Shalgi, Ruth] Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Bar-Joseph, Hadas; Eldar-Boock, Anat] Tel Aviv Univ, TMCR Unit, Sackler Fac Med, Tel Aviv, Israel; [Ben-Ami, Ido] Hebrew Univ Med Sch Jerusalem, IVF & Infertil Unit, Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Shalgi, R (corresponding author), Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	shalgir@tauex.tau.ac.il		Bar-Joseph, Hadas/0000-0001-7280-230X; Miller, Irit/0000-0002-7710-3732	Israel Ministry of Health [3--15140]	Israel Ministry of Health	This work was partially supported by a grant from the Israel Ministry of Health (No. 3--15140 to I.B--A and R.S)	Agarwal A, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-126; Atiken RJ., 2020, REPRODUCTION, V159, pR189; Babayev E, 2015, CURR OPIN OBSTET GYN, V27, P175, DOI 10.1097/GCO.0000000000000164; Bar-Joseph H, 2020, REPROD BIOMED ONLINE, V41, P335, DOI 10.1016/j.rbmo.2020.03.024; Bar-Joseph H, 2014, FERTIL STERIL, V102, P891, DOI 10.1016/j.fertnstert.2014.06.012; Becerra SP., 2012, J BIOMED BIOTECHNOL, V2012, P1; Belkacemi L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-015-0278-7; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Boudoures AL, 2017, DEV BIOL, V426, P126, DOI 10.1016/j.ydbio.2017.04.005; Broughton DE, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.01.017; Cecchino GN, 2018, REPROD BIOMED ONLINE, V36, P686, DOI 10.1016/j.rbmo.2018.02.007; Chaudhary GR, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0504-2; Chuderland D, 2014, REPRODUCTION, V148, pR53, DOI 10.1530/REP-14-0251; Chuderland D, 2013, HUM REPROD, V28, P1626, DOI 10.1093/humrep/det027; Chuderland D, 2013, J CLIN ENDOCR METAB, V98, pE258, DOI 10.1210/jc.2012-3037; Chuderland D, 2013, MOL HUM REPROD, V19, P72, DOI 10.1093/molehr/gas046; Conti M, 2018, HUM REPROD UPDATE, V24, P245, DOI 10.1093/humupd/dmx040; Goud PT, 2014, FERTIL STERIL, V102, P151, DOI 10.1016/j.fertnstert.2014.03.053; Haas J, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0367-5; Holt JE, 2010, DEVELOPMENT, V137, P1297, DOI 10.1242/dev.047555; Jones KT, 2012, EXP CELL RES, V318, P1394, DOI 10.1016/j.yexcr.2012.02.012; Kampfer C, 2014, LIFE SCI, V97, P129, DOI 10.1016/j.lfs.2013.12.007; Keefe D, 2015, FERTIL STERIL, V103, P317, DOI 10.1016/j.fertnstert.2014.12.115; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Levi M, 2010, REPRODUCTION, V140, P827, DOI 10.1530/REP-10-0312; Li XH, 2019, LIFE SCI, V216, P129, DOI 10.1016/j.lfs.2018.11.015; Franco-Chuaire ML, 2015, IRAN J BASIC MED SCI, V18, P837; Liu XM, 2016, ONCOTARGET, V7, P1155, DOI 10.18632/oncotarget.6713; Lord T, 2013, REPRODUCTION, V146, pR217, DOI 10.1530/REP-13-0111; Lu JY, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0391-5; May-Panloup P, 2019, HUM REPROD, V34, P1313, DOI 10.1093/humrep/dez054; Mihalas BP., 2017, SCI REP-UK, V7, P1; Miller I, 2020, J ENDOCRINOL, V245, P291, DOI 10.1530/JOE-19-0603; Miller I, 2016, J CLIN ENDOCR METAB, V101, P4699, DOI 10.1210/jc.2016-1744; Minkevich NI, 2010, ACTA NATURAE, V2, P62, DOI 10.32607/20758251-2010-2-3-62-71; Mogessie B, 2018, ANNU REV CELL DEV BI, V34, P381, DOI 10.1146/annurev-cellbio-100616-060553; Palomba S, 2017, TRENDS ENDOCRIN MET, V28, P186, DOI 10.1016/j.tem.2016.11.008; Pasquariello R, 2019, BIOL REPROD, V100, P971, DOI 10.1093/biolre/ioy248; Penfield L, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201908179; Pizzino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8416763; Pomerantz Y, 2013, REPROD FERT DEVELOP, V25, P484, DOI 10.1071/RD12242; Prasad S, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0253-4; Rienzi L, 2012, HUM REPROD, V27, P2, DOI 10.1093/humrep/des200; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schatten H, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-111; Silber M, 2020, J ENDOCRINOL, V244, P297, DOI 10.1530/JOE-19-0297; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; Smits RM, 2018, FERTIL STERIL, V110, P578, DOI 10.1016/j.fertnstert.2018.05.028; Takehara I, 2020, MOL HUM REPROD, V26, P567, DOI 10.1093/molehr/gaaa040; Tamura H, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-5; Tsao YP, 2006, LIFE SCI, V79, P545, DOI 10.1016/j.lfs.2006.01.041; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wang JJ, 2008, AM J PHYSIOL-RENAL, V294, pF1166, DOI 10.1152/ajprenal.00375.2007; Yamagishi S, 2005, CELL TISSUE RES, V320, P437, DOI 10.1007/s00441-005-1094-8; Yu YS, 2010, J CELL PHYSIOL, V224, P672, DOI 10.1002/jcp.22171	56	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21637	10.1096/fj.202002443RR	http://dx.doi.org/10.1096/fj.202002443RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33948995				2022-12-28	WOS:000655695900060
J	Ryl, M; Urbasik, A; Gierke, K; Babai, N; Joachimsthaler, A; Feigenspan, A; Frischknecht, R; Stallwitz, N; Fejtova, A; Kremers, J; von Wittgenstein, J; Brandstatter, JH				Ryl, Miriam; Urbasik, Alexander; Gierke, Kaspar; Babai, Norbert; Joachimsthaler, Anneka; Feigenspan, Andreas; Frischknecht, Renato; Stallwitz, Nina; Fejtova, Anna; Kremers, Jan; von Wittgenstein, Julia; Brandstaetter, Johann Helmut			Genetic disruption of bassoon in two mutant mouse lines causes divergent retinal phenotypes	FASEB JOURNAL			English	Article						active zone; bassoon; photoreceptor; photoreceptor death; ribbon synapse	CYTOMATRIX PROTEIN BASSOON; RIBBON SYNAPSES; ACTIVE ZONE; SYNAPTIC-TRANSMISSION; CA2+ CHANNELS; ROD; PLASTICITY; RELEASE; RIBEYE; CELLS	Bassoon (BSN) is a presynaptic cytomatrix protein ubiquitously present at chemical synapses of the central nervous system, where it regulates synaptic vesicle replenishment and organizes voltage-gated Ca2+ channels. In sensory photoreceptor synapses, BSN additionally plays a decisive role in anchoring the synaptic ribbon, a presynaptic organelle and functional extension of the active zone, to the presynaptic membrane. In this study, we functionally and structurally analyzed two mutant mouse lines with a genetic disruption of Bsn-Bsn(gt) and Bsn(ko)-using electrophysiology and high-resolution microscopy. In both Bsn mutant mouse lines, full-length BSN was abolished, and photoreceptor synaptic function was similarly impaired, yet synapse structure was more severely affected in Bsn(gt/gt) than in Bsn(ko/ko) photoreceptors. The synaptic defects in Bsn(gt/gt) retina coincide with remodeling of the outer retina-rod bipolar and horizontal cell sprouting, formation of ectopic ribbon synaptic sites-and death of cone photoreceptors, processes that did not occur in Bsn(ko/ko) retina. An analysis of Bsn(gt/ko) hybrid mice revealed that the divergent retinal phenotypes of Bsn(gt/gt) and Bsn(ko/ko) mice can be attributed to the expression of the Bsn(gt) allele, which triggers cone photoreceptor death and neurite sprouting in the outer retina. These findings shed new light on the existing Bsn mutant mouse models and might help to understand mechanisms that drive photoreceptor death.	[Ryl, Miriam; Urbasik, Alexander; Gierke, Kaspar; Babai, Norbert; Feigenspan, Andreas; Frischknecht, Renato; von Wittgenstein, Julia; Brandstaetter, Johann Helmut] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Anim Physiol, Staudtstr 5, D-91058 Erlangen, Germany; [Joachimsthaler, Anneka; Stallwitz, Nina; Kremers, Jan] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Fejtova, Anna] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Psychiat & Psychotherapy, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Brandstatter, JH (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Anim Physiol, Staudtstr 5, D-91058 Erlangen, Germany.	johann.helmut.brandstaetter@fau.de	Fejtova, Anna/AAZ-1024-2020	Fejtova, Anna/0000-0002-1815-4409	Deutsche Forschungsgemeinschaft (DFG) [270949263]; DFG [GRK2162/1, FE1335/3, GRK 2162]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft (DFG) Grant 270949263; DFG GRK2162/1 and 2 to J.H.B. and DFG FE1335/3 to A.Fej. M.R. and A.U. are graduate students, and J.H.B. and A.Fej. are principal investigators of the DFG research training group GRK 2162 "Neurodevelopment and Vulnerability of the Central Nervous System"	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Annamneedi A, 2018, BRAIN STRUCT FUNCT, V223, P3423, DOI 10.1007/s00429-018-1692-3; Babai N, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13241; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Davydova D, 2014, NEURON, V82, P181, DOI 10.1016/j.neuron.2014.02.012; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Dieck ST, 2012, J NEUROSCI, V32, P12192, DOI 10.1523/JNEUROSCI.0752-12.2012; Feigenspan A, 2017, JOVE-J VIS EXP, DOI 10.3791/55173; Feigenspan A, 2015, EUR J NEUROSCI, V42, P2615, DOI 10.1111/ejn.13016; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hagiwara A, 2018, J CELL BIOL, V217, P3993, DOI 10.1083/jcb.201704076; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Jing ZZ, 2013, J NEUROSCI, V33, P4456, DOI 10.1523/JNEUROSCI.3491-12.2013; Joachimsthaler A, 2017, VISION, V1, DOI [10.3390/vision1040023, DOI 10.3390/VISI0]; Kerov V, 2018, J NEUROSCI, V38, P6145, DOI 10.1523/JNEUROSCI.3818-16.2018; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lagnado L, 2015, ANNU REV VIS SCI, V1, P235, DOI 10.1146/annurev-vision-082114-035709; Maddox JW, 2020, ELIFE, V9, DOI 10.7554/eLife.62184; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Maxeiner S, 2016, EMBO J, V35, P1098, DOI 10.15252/embj.201592701; Moser T, 2020, PHYSIOL REV, V100, P103, DOI 10.1152/physrev.00026.2018; Muller TM, 2019, J NEUROSCI, V39, P2606, DOI 10.1523/JNEUROSCI.2038-18.2019; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Raven MA, 2008, J COMP NEUROL, V506, P745, DOI 10.1002/cne.21526; Regus-Leidig H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086769; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Schattling B, 2019, NAT NEUROSCI, V22, P887, DOI 10.1038/s41593-019-0385-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schulz AM, 2014, EMBO J, V33, P512, DOI 10.1002/embj.201385887; Specht D, 2007, EUR J NEUROSCI, V26, P2506, DOI 10.1111/j.1460-9568.2007.05886.x; Wang YC, 2017, NEURON, V93, P1359, DOI 10.1016/j.neuron.2017.02.021	46	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21520	10.1096/fj.202001962R	http://dx.doi.org/10.1096/fj.202001962R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811381	hybrid, Green Published			2022-12-28	WOS:000645260100003
J	Tholen, LE; Bos, C; Jansen, PWTC; Venselaar, H; Vermeulen, M; Hoenderop, JGJ; de Baaij, JHF				Tholen, Lotte E.; Bos, Caro; Jansen, Pascal W. T. C.; Venselaar, Hanka; Vermeulen, Michiel; Hoenderop, Joost G. J.; de Baaij, Jeroen H. F.			Bifunctional protein PCBD2 operates as a co-factor for hepatocyte nuclear factor 1 beta and modulates gene transcription	FASEB JOURNAL			English	Article						hepatocyte nuclear factor 1&#946; pterin&#8208; 4a&#8208; carbinolamine dehydratase 2; transcription co&#8208; factor		Hepatocyte nuclear factor 1 beta (HNF1 beta) is an essential transcription factor in development of the kidney, liver, and pancreas. HNF1 beta-mediated transcription of target genes is dependent on the cell type and the development stage. Nevertheless, the regulation of HNF1 beta function by enhancers and co-factors that allow this cell-specific transcription is largely unknown. To map the HNF1 beta interactome we performed mass spectrometry in a mouse kidney inner medullary collecting duct cell line. Pterin-4a-carbinolamine dehydratase 2 (PCBD2) was identified as a novel interaction partner of HNF1 beta. PCBD2 and its close homolog PCBD1 shuttle between the cytoplasm and nucleus to exert their enzymatic and transcriptional activities. Although both PCBD proteins share high sequence identity (48% and 88% in HNF1 recognition helix), their tissue expression patterns are unique. PCBD1 is most abundant in kidney and liver while PCBD2 is also abundant in lung, spleen, and adipose tissue. Using immunolocalization studies and biochemical analysis we show that in presence of HNF1 beta the nuclear localization of PCBD1 and PCBD2 increases significantly. Promoter luciferase assays demonstrate that co-factors PCBD1 and PCBD2 differentially regulate the ability of HNF1 beta to activate the promoters of transcriptional targets important in renal electrolyte homeostasis. Deleting the N-terminal sequence of PCBD2, not found in PCBD1, diminished the differential effects of the co-factors on HNF1 beta activity. All together these results indicate that PCBD1 and PCBD2 can exert different effects on HNF1 beta-mediated transcription. Future studies should confirm whether these unique co-factor activities also apply to HNF1 beta-target genes involved in additional processes besides ion transport in the kidney.	[Tholen, Lotte E.; Bos, Caro; Hoenderop, Joost G. J.; de Baaij, Jeroen H. F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Jansen, Pascal W. T. C.; Vermeulen, Michiel] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci,Oncode Inst, Nijmegen, Netherlands; [Venselaar, Hanka] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Radboud Inst Mol Life Sci, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	de Baaij, JHF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	jeroen.debaaij@radboudumc.nl	de Baaij, Jeroen/P-5704-2015; Vermeulen, Michiel/C-8883-2013; Bos, Caro/V-2390-2017	de Baaij, Jeroen/0000-0003-2372-8486; Vermeulen, Michiel/0000-0003-0836-6894; Bos, Caro/0000-0001-5016-9435; Tholen, Lotte/0000-0003-2838-8636	Nierstichting (Dutch Kidney Foundation) [17OKG07]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [Veni 016.186.012, Vici 016.130.668]; KWF Kankerbestrijding (Dutch Cancer Society)	Nierstichting (Dutch Kidney Foundation); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); KWF Kankerbestrijding (Dutch Cancer Society)	Nierstichting (Dutch Kidney Foundation), Grant/Award Number: 17OKG07; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: Veni 016.186.012 and Vici 016.130.668; KWF Kankerbestrijding (Dutch Cancer Society)	Aboudehen K, 2017, J AM SOC NEPHROL, V28, P2887, DOI 10.1681/ASN.2016101095; Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Adam M, 2017, DEVELOPMENT, V144, P3625, DOI 10.1242/dev.151142; Barbacci E, 2004, HUM MOL GENET, V13, P3139, DOI 10.1093/hmg/ddh338; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Bueno R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010612; Choi YH, 2013, AM J PHYSIOL-RENAL, V305, pF100, DOI 10.1152/ajprenal.00582.2012; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; CITRON BA, 1993, AM J HUM GENET, V53, P768; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Desgrange A, 2017, DEVELOPMENT, V144, P4704, DOI 10.1242/dev.154336; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Ferre S, 2014, J AM SOC NEPHROL, V25, P574, DOI 10.1681/ASN.2013040337; Ferre S, 2011, BIOCHEM BIOPH RES CO, V404, P284, DOI 10.1016/j.bbrc.2010.11.108; FICNER R, 1995, EMBO J, V14, P2034, DOI 10.1002/j.1460-2075.1995.tb07195.x; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469; Kazgan N, 2014, GASTROENTEROLOGY, V146, P1006, DOI 10.1053/j.gastro.2013.12.029; Kompatscher A, 2018, AM J PHYSIOL-RENAL, V315, pF27, DOI 10.1152/ajprenal.00601.2017; Kompatscher A, 2017, KIDNEY INT, V92, P1145, DOI 10.1016/j.kint.2017.03.034; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Limbutara K, 2020, J AM SOC NEPHROL, V31, P1255, DOI 10.1681/ASN.2020010071; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Meyer AH, 2002, J NEUROSCI, V22, P7055; Morris JA, 2019, NAT GENET, V51, P258, DOI 10.1038/s41588-018-0302-x; Muto Y., 2020, SINGLE CELL TRANSCRI, DOI [10.1101/2020.06.14.151167, DOI 10.1101/2020.06.14.151167]; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rho H, 2010, BIOCHEMISTRY-US, V49, P10187, DOI 10.1021/bi1015056; Rose RB, 2004, BIOCHEMISTRY-US, V43, P7345, DOI 10.1021/bi049620t; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; Simaite D, 2014, DIABETES, V63, P3557, DOI 10.2337/db13-1784; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Thony B, 1998, AM J HUM GENET, V62, P1302, DOI 10.1086/301887; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; Verhave JC, 2016, J AM SOC NEPHROL, V27, P345, DOI 10.1681/ASN.2015050544; Von Strandmann EP, 2000, MECH DEVELOP, V91, P53, DOI 10.1016/S0925-4773(99)00269-5; VONSTRANDMANN EP, 1995, DEVELOPMENT, V121, P1217; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang DL, 2015, J BIOL CHEM, V290, P4319, DOI 10.1074/jbc.M114.616870; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Zhang DL, 2019, EUR REV MED PHARMACO, V23, P2417, DOI 10.26355/eurrev_201903_17388	51	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21366	10.1096/fj.202002022R	http://dx.doi.org/10.1096/fj.202002022R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749890	Green Published			2022-12-28	WOS:000635216100018
J	Vohwinkel, CU; Coit, EJ; Burns, N; Elajaili, H; Hernandez-Saavedra, D; Yuan, XY; Eckle, T; Nozik, E; Tuder, RM; Eltzschig, HK				Vohwinkel, Christine U.; Coit, Ethan J.; Burns, Nana; Elajaili, Hanan; Hernandez-Saavedra, Daniel; Yuan, Xiaoyi; Eckle, Tobias; Nozik, Eva; Tuder, Rubin M.; Eltzschig, Holger K.			Targeting alveolar-specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury	FASEB JOURNAL			English	Article						ALI; alveolar epithelium; ARDS; HIF; inflammation; mechanical ventilation; SDHA; succinate	A2B ADENOSINE RECEPTOR; HYPOXIA; RESOLUTION; LINKS; HIF; METABOLISM; INHIBITION; PROTECTION; CONTRIBUTE; ITACONATE	Acute lung injury (ALI) is an inflammatory lung disease, which manifests itself in patients as acute respiratory distress syndrome (ARDS). Previous studies have implicated alveolar-epithelial succinate in ALI protection. Therefore, we hypothesized that targeting alveolar succinate dehydrogenase SDH A would result in elevated succinate levels and concomitant lung protection. Wild-type (WT) mice or transgenic mice with targeted alveolar-epithelial Sdha or hypoxia-inducible transcription factor Hif1a deletion were exposed to ALI induced by mechanical ventilation. Succinate metabolism was assessed in alveolar-epithelial via mass spectrometry as well as redox measurements and evaluation of lung injury. In WT mice, ALI induced by mechanical ventilation decreased SDHA activity and increased succinate in alveolar-epithelial. In vitro, cell-permeable succinate decreased epithelial inflammation during stretch injury. Mice with inducible alveolar-epithelial Sdha deletion (Sdha(loxp/loxp) SPC-CreER mice) revealed reduced lung inflammation, improved alveolar barrier function, and attenuated histologic injury. Consistent with a functional role of succinate to stabilize HIF, Sdha(loxp/loxp) SPC-CreER experienced enhanced Hif1a levels during hypoxia or ALI. Conversely, Hif1a(loxp/loxp) SPC-CreER showed increased inflammation with ALI induced by mechanical ventilation. Finally, wild-type mice treated with intra-tracheal dimethlysuccinate were protected during ALI. These data suggest that targeting alveolar-epithelial SDHA dampens ALI via succinate-mediated stabilization of HIF1A. Translational extensions of our studies implicate succinate treatment in attenuating alveolar inflammation in patients suffering from ARDS.	[Vohwinkel, Christine U.; Coit, Ethan J.; Burns, Nana; Elajaili, Hanan; Nozik, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Vohwinkel, Christine U.; Coit, Ethan J.; Burns, Nana; Elajaili, Hanan; Nozik, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA; [Hernandez-Saavedra, Daniel; Tuder, Rubin M.] Univ Colorado, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Yuan, Xiaoyi; Eltzschig, Holger K.] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, Houston, TX 77030 USA; [Eckle, Tobias] Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Health Science Center Houston; University of Colorado System; University of Colorado Anschutz Medical Campus	Vohwinkel, CU (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Vohwinkel, CU (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	Christine.Vohwinkel@cuanschutz.edu	Hernandez-Saavedra, Daniel/AGO-1286-2022	Vohwinkel, Christine/0000-0001-8959-157X	HHS | NIH | National Institute of Child Health and Human Development (NICHD) [K12HD068372]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [K08HL130586, R01HL133900, R01HL154720]; Parker B Francis Foundation; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK122796, R01DK109574]; DOD | Defense Advanced Research Projects Agency (DARPA) [W81XWH2110032]	HHS | NIH | National Institute of Child Health and Human Development (NICHD); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Parker B Francis Foundation; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DOD | Defense Advanced Research Projects Agency (DARPA)	HHS | NIH | National Institute of Child Health and Human Development (NICHD), Grant/Award Number: K12HD068372; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K08HL130586; Parker B Francis Foundation, Grant/Award Number: Parker B Francis Fellowship; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL133900; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK122796; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK109574; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL154720; DOD | Defense Advanced Research Projects Agency (DARPA), Grant/Award Number: W81XWH2110032	Al Rasheed MRH, 2018, ARCH PATHOL LAB MED, V142, P1564, DOI 10.5858/arpa.2017-0285-RS; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; Bowser JL, 2017, J APPL PHYSIOL, V123, P1303, DOI 10.1152/japplphysiol.00101.2017; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chen JN, 2021, FREE RADICAL BIO MED, V162, P582, DOI 10.1016/j.freeradbiomed.2020.11.017; Chen N, 2019, NEW ENGL J MED, V381, P1011, DOI 10.1056/NEJMoa1901713; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Eckle T, 2008, AM J PHYSIOL-LUNG C, V295, pL718, DOI 10.1152/ajplung.90298.2008; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Elajaili HB, 2019, JOVE-J VIS EXP, DOI 10.3791/58461; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gudernatsch V, 2020, IMMUNOTARGETS THER, V9, P31, DOI 10.2147/ITT.S243238; Gui YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046076; Haase VH, 2019, NEPHROL DIAL TRANSPL, V34, P90, DOI 10.1093/ndt/gfy055; Hanidziar D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61489-y; Hernandez-Saavedra D, 2017, ADV EXP MED BIOL, V967, P57, DOI 10.1007/978-3-319-63245-2_5; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hoegl S, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13648; Hoegl S, 2015, J IMMUNOL, V195, P1815, DOI 10.4049/jimmunol.1401957; Hoffman O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172116; Huang XJ, 2019, AM J PATHOL, V189, P1664, DOI 10.1016/j.ajpath.2019.04.014; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lee JW, 2020, ANESTHESIOLOGY, V132, P763, DOI 10.1097/ALN.0000000000003037; Lee JW, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0235-1; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li MY, 2020, SHOCK, V53, P208, DOI 10.1097/SHK.0000000000001347; Li Y, 2018, FREE RADICAL BIO MED, V126, P1, DOI 10.1016/j.freeradbiomed.2018.07.009; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda M, 1990, Nihon Kyobu Shikkan Gakkai Zasshi, V28, P135; Mamary AJ, 2011, CLIN MED INSIGHTS-CI, V5, P17, DOI 10.4137/CCRPM.S6649; McClendon J, 2017, AM J PATHOL, V187, P1772, DOI 10.1016/j.ajpath.2017.04.012; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; MONTANER JSG, 1986, J CLIN INVEST, V77, P1786, DOI 10.1172/JCI112503; Murphy MP, 2018, CELL, V174, P780, DOI 10.1016/j.cell.2018.07.030; Nemkov T, 2019, METHODS MOL BIOL, V1978, P13, DOI 10.1007/978-1-4939-9236-2_2; Neudecker V, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5360; Nowak-Machen M, 2013, AM J RESP CELL MOL, V48, P601, DOI 10.1165/rcmb.2012-0180OC; Nunns Geoffrey R, 2022, Ann Surg, V276, pe944, DOI 10.1097/SLA.0000000000004644; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rawlins EL, 2012, AM J RESP CELL MOL, V46, P269, DOI 10.1165/rcmb.2011-0372PS; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Shah D, 2019, FASEB J, V33, P13617, DOI 10.1096/fj.201901123R; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Tojo K, 2018, FASEB J, V32, P2258, DOI 10.1096/fj.201700888R; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Vohwinkel CU, 2017, AM J RESP CELL MOL, V57, P589, DOI 10.1165/rcmb.2016-0358OC; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Williams GW, 2021, ANESTHESIOLOGY, V134, P270, DOI 10.1097/ALN.0000000000003571; Yuan XY, 2018, ANESTH ANALG, V126, P308, DOI 10.1213/ANE.0000000000002288; Zhang YH, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8327486; Zhao CQ, 2020, EMERG MICROBES INFEC, V9, P691, DOI 10.1080/22221751.2020.1742585	85	7	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21468	10.1096/fj.202002778R	http://dx.doi.org/10.1096/fj.202002778R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33687752	Green Published			2022-12-28	WOS:000635216100015
J	Rossi, M; Rana, I; Buonuomo, PS; Battafarano, G; Mariani, E; D'Agostini, M; Porzio, O; De Martino, V; Minisola, S; Macchiaiolo, M; De Vito, R; Vecchio, D; Gonfiantini, MV; Jenkner, A; Bartuli, A; Del Fattore, A				Rossi, Michela; Rana, Ippolita; Buonuomo, Paola Sabrina; Battafarano, Giulia; Mariani, Eda; D'Agostini, Matteo; Porzio, Ottavia; De Martino, Viviana; Minisola, Salvatore; Macchiaiolo, Marina; De Vito, Rita; Vecchio, Davide; Gonfiantini, Michaela Veronika; Jenkner, Alessandro; Bartuli, Andrea; Del Fattore, Andrea			Dysregulated miRNAs in bone cells of patients with Gorham-Stout disease	FASEB JOURNAL			English	Article						Gorham&#8208; Stout disease; miRNA; osteoblast; osteoclast	MASSIVE OSTEOLYSIS; OSTEOGENIC DIFFERENTIATION; DISAPPEARING BONE; MICRORNAS; LYMPHANGIOGENESIS; MECHANISM; REGULATORS; SERUM	Gorham-Stout disease (GSD) is a very rare disease characterized by increased bone erosion with angiomatous proliferation. The mechanisms underlying this disorder have not been deeply investigated. Due to its rarity, no guidelines are currently available for treatment and management of GSD. We recently evaluated the cellular alterations of the bone remodeling in patients showing that osteoclast precursors displayed increased ability to differentiate into osteoclasts and that affected osteoclasts resorb bone more actively than control cells. Moreover, osteoblasts isolated from a patient showed a defective ability to form mineralized nodules. In this paper, we investigated the molecular pathways involved in the cellular defects of GSD bone cells. For this study, we recruited nine patients and performed miRNome analysis of bone cells. Between the 178 miRNAs robustly expressed in GSD osteoclasts, significant modulation of three miRNAs (miR-1246, miR-1-3p, and miR-137-3p) involved in the regulation of osteoclast formation and activity or in the angiomatous proliferation was found in patients' cells. Interestingly, miR-1246 was also up-regulated in serum exosomes from patients. Analysis of miRNAs from patient osteoblasts suggested alteration of miR-204a-5p, miR-615-3p and miR-378a-3p regulating osteoblast function and differentiation. The resulting miRNA pattern may help to understand better the mechanisms involved in GSD and to identify new potential therapeutic targets for this rare disease.	[Rossi, Michela; Battafarano, Giulia; Del Fattore, Andrea] Bambino Gesu Pediat Hosp, IRCCS, Bone Physiopathol Res Unit, Genet & Rare Dis Res Div, Viale San Paolo 15, I-00146 Rome, Italy; [Rana, Ippolita; Buonuomo, Paola Sabrina; Macchiaiolo, Marina; Vecchio, Davide; Gonfiantini, Michaela Veronika; Bartuli, Andrea] Bambino Gesu Pediat Hosp, Rare Dis & Med Genet Unit, IRCCS, Rome, Italy; [Mariani, Eda] Bambino Gesu Pediat Hosp, IRCCS, Res Labs, Rome, Italy; [D'Agostini, Matteo; Porzio, Ottavia] Bambino Gesu Pediat Hosp, IRCCS, Clin Lab, Rome, Italy; [Porzio, Ottavia] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy; [De Martino, Viviana; Minisola, Salvatore] Sapienza Univ, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy; [De Vito, Rita] Bambino Gesu Pediat Hosp, IRCCS, Dept Histopathol, Rome, Italy; [Jenkner, Alessandro] Bambino Gesu Pediat Hosp, IRCCS, Div Immunol & Infect Dis, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Rome Tor Vergata; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Del Fattore, A (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Bone Physiopathol Res Unit, Genet & Rare Dis Res Div, Viale San Paolo 15, I-00146 Rome, Italy.	andrea.delfattore@opbg.net	Rossi, Michela/AAI-1642-2019; Vecchio, Davide/K-8166-2016; MARIANI, EDA/GNH-4218-2022; Battafarano, Giulia/N-8048-2013; macchiaiolo, marina/HGU-2371-2022; De Martino, Viviana/ABA-3813-2021	Vecchio, Davide/0000-0003-2907-3206; MARIANI, EDA/0000-0002-5119-0022; De Martino, Viviana/0000-0002-7034-7718; ROSSI, MICHELA/0000-0002-6844-6469; Battafarano, Giulia/0000-0002-9297-5184	University of Pennsylvania [MDBR-17-116-GLA/GSD59]; Italian Ministry of Health	University of Pennsylvania; Italian Ministry of Health(Ministry of Health, Italy)	University of Pennsylvania, Grant/Award Number: #MDBR-17-116-GLA/GSD59; Italian Ministry of Health	[Anonymous], 1838, BOSTON MED SURG J; Bhagirath D, 2018, CANCER RES, V78, P1833, DOI 10.1158/0008-5472.CAN-17-2069; Brodszki N, 2011, ACTA PAEDIATR, V100, P1448, DOI 10.1111/j.1651-2227.2011.02361.x; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Colucci S, 2006, J BONE MINER RES, V21, P207, DOI 10.1359/JBMR.051019; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; de Vries TJ, 2005, J CELL BIOCHEM, V94, P954, DOI 10.1002/jcb.20326; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Devlin RD, 1996, J CLIN ENDOCR METAB, V81, P1893, DOI 10.1210/jc.81.5.1893; DICKSON GR, 1990, BONE, V11, P205, DOI 10.1016/8756-3282(90)90215-K; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Eghbali-Fatourechi G, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0109-y; Feng L, 2020, MOL THER-NUCL ACIDS, V21, P1017, DOI 10.1016/j.omtn.2020.07.018; Feng QY, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180453; Garcia V, 2016, COLOMB MEDICA, V47, P213; GORHAM LW, 1955, J BONE JOINT SURG AM, V37, P985, DOI 10.2106/00004623-195537050-00008; GORHAM LW, 1954, AM J MED, V17, P674, DOI 10.1016/0002-9343(54)90027-3; Hagendoorn J, 2006, NAT CLIN PRACT ONCOL, V3, P693, DOI 10.1038/ncponc0660; Hammer F, 2005, J BONE MINER RES, V20, P350, DOI 10.1359/JBMR.041113; Harvey NL, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-15; HEFFEZ L, 1983, ORAL SURG ORAL MED O, V55, P331, DOI 10.1016/0030-4220(83)90185-8; Heyd R, 2011, INT J RADIAT ONCOL, V81, pE179, DOI 10.1016/j.ijrobp.2011.01.006; HEYDEN G, 1977, J BONE JOINT SURG AM, V59, P57, DOI 10.2106/00004623-197759010-00009; Hopman SMJ, 2012, AM J MED GENET A, V158A, P1719, DOI 10.1002/ajmg.a.35406; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Kar UP, 2017, J BIOSCIENCES, V42, P333, DOI 10.1007/s12038-017-9680-y; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu Y, 2016, CLIN RHEUMATOL, V35, P813, DOI 10.1007/s10067-014-2780-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00375; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Mahmoudi E, 2017, MOL PSYCHIATR, V22, P44, DOI 10.1038/mp.2016.150; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mishima Y, 2007, CELL, V129, P247, DOI 10.1016/j.cell.2007.04.008; Mo Andrew Z, 2018, JBJS Case Connect, V8, pe70, DOI 10.2106/JBJS.CC.17.00287; Narayanan A, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116676; Rossi M, 2020, BONE, V130, DOI 10.1016/j.bone.2019.115068; Ruggieri P, 2011, SKELETAL RADIOL, V40, P1391, DOI 10.1007/s00256-010-1051-9; Sakha S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38750; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang Y., 2018, BIOSCIENCE REP, V38; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005; Yin JC, 2017, CELL BIOL INT, V41, P779, DOI 10.1002/cbin.10780; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhang ZY, 2019, HEMATOL ONCOL, V37, P409, DOI 10.1002/hon.2639; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu YZ, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07125-4; Zou X, 2020, GENE, V722, DOI 10.1016/j.gene.2019.144104; Zou YW, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017814	49	4	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21424	10.1096/fj.202001904RR	http://dx.doi.org/10.1096/fj.202001904RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33609323				2022-12-28	WOS:000629576700013
J	Wang, Y; Takeshita, H; Yamamoto, K; Huang, YB; Wang, C; Nakajima, T; Nozato, Y; Fujimoto, T; Yokoyama, S; Hongyo, K; Nakagami, F; Akasaka, H; Takami, Y; Takeya, Y; Sugimoto, K; Rakugi, H				Wang, Yu; Takeshita, Hikari; Yamamoto, Koichi; Huang, Yibin; Wang, Cheng; Nakajima, Tsuneo; Nozato, Yoichi; Fujimoto, Taku; Yokoyama, Serina; Hongyo, Kazuhiro; Nakagami, Futoshi; Akasaka, Hiroshi; Takami, Yoichi; Takeya, Yasushi; Sugimoto, Ken; Rakugi, Hiromi			A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice	FASEB JOURNAL			English	Article						angiotensin II; angiotensin-converting enzyme 2; ARB; COVID-19; SARS-CoV-2	MYOCARDIAL-INFARCTION; RECEPTOR BLOCKADE; ACE2 ACTIVITY; EXPRESSION; INHIBITION; RAT; HYPERTENSION; DYSFUNCTION; COVID-19; TMPRSS2	In the early phase of the Coronavirus disease 2019 (COVID-19) pandemic, it was postulated that the renin-angiotensin-system inhibitors (RASi) increase the infection risk. This was primarily based on numerous reports, which stated that the RASi could increase the organ Angiotensin-converting enzyme 2 (ACE2), the receptor of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in rodents. RASi can theoretically antagonize the potential influence of angiotensin II (Ang II) on ACE2. However, while Ang II decreases the ACE2 levels in cultured cells, there is little evidence that supports this phenomenon in living animals. In this study, we tested whether Ang II or Ang II combined with its antagonist would alter the ACE2 and other molecules associated with the infection of SARS-CoV-2. Male C57BL6/J mice were administered vehicle, Ang II (400 ng/kg/min), or Ang II with losartan (10 mg/kg/min) for 2 weeks. ACE2 knockout mice were used as a negative control for the ACE2 assay. We found that both Ang II, which elevated blood pressure by 30 mm Hg, and Ang II with losartan, had no effect on the expression or protein activity of ACE2 in the lung, left ventricle, kidney, and ileum. Likewise, these interventions had no effect on the expression of Transmembrane Protease Serine 2 (TMPRSS2) and Furin, proteases that facilitate the virus-cell fusion, and the expression or activity of Tumor Necrosis Factor alpha-Convertase (TACE) that cleaves cell-surface ACE2. Collectively, physiological concentrations of Ang II do not modulate the molecules associated with SARS-CoV-2 infection. These results support the recent observational studies suggesting that the use of RASi is not a risk factor for COVID-19.	[Wang, Yu; Takeshita, Hikari; Yamamoto, Koichi; Huang, Yibin; Wang, Cheng; Nakajima, Tsuneo; Nozato, Yoichi; Fujimoto, Taku; Yokoyama, Serina; Hongyo, Kazuhiro; Nakagami, Futoshi; Akasaka, Hiroshi; Takami, Yoichi; Takeya, Yasushi; Sugimoto, Ken; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Yamamoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kyamamoto@geriat.med.osaka-u.ac.jp	Takeshita, Hikari/L-9812-2014	Yamamoto, Koichi/0000-0003-0107-9315	JSPS KAKENHI [J550703552];  [JP 20H03576]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by a Grant-in-Aid for Scientific Research (No. J550703552) and by JSPS KAKENHI Grant Number JP 20H03576	Agata J, 2006, HYPERTENS RES, V29, P865, DOI 10.1291/hypres.29.865; Brown JD, 2020, LANCET RESP MED, V8, pE28, DOI 10.1016/S2213-2600(20)30158-2; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Gallagher PE, 2006, AM J PHYSIOL-CELL PH, V290, pC420, DOI 10.1152/ajpcell.00409.2004; Gao C, 2020, EUR HEART J, V41, P2058, DOI 10.1093/eurheartj/ehaa433; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gonzalez AA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01212; Gowrisankar YV, 2016, J NEUROCHEM, V138, P74, DOI 10.1111/jnc.13641; Han SX, 2010, TOXICOL APPL PHARM, V245, P100, DOI 10.1016/j.taap.2010.02.009; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; HUANG H, 1989, CLIN EXP HYPERTENS A, V11, P1535, DOI 10.3109/10641968909038181; Igase M, 2005, AM J PHYSIOL-HEART C, V289, pH1013, DOI 10.1152/ajpheart.00068.2005; Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a; Iwanami J, 2014, HYPERTENS RES, V37, P616, DOI 10.1038/hr.2014.49; Jessup JA, 2006, AM J PHYSIOL-HEART C, V291, pH2166, DOI 10.1152/ajpheart.00061.2006; Jin HY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042432, 10.1371/journal.pone.0038502]; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Karram T, 2005, AM J PHYSIOL-HEART C, V289, pH1351, DOI 10.1152/ajpheart.01186.2004; Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762; Li YC, 2015, SHOCK, V43, P395, DOI 10.1097/SHK.0000000000000302; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Marvar PJ, 2014, BIOL PSYCHIAT, V75, P864, DOI 10.1016/j.biopsych.2013.08.024; Matsuzawa Y, 2020, HYPERTENS RES, V43, P1257, DOI 10.1038/s41440-020-00535-8; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; Oller J, 2015, MOL CELL BIOL, V35, P3409, DOI 10.1128/MCB.00494-15; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Pedersen KB, 2011, AM J PHYSIOL-REG I, V301, pR1293, DOI 10.1152/ajpregu.00339.2011; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Schulz A, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-37; Shibata S, 2020, HYPERTENS RES, V43, P1028, DOI 10.1038/s41440-020-0515-0; Soler MJ, 2009, AM J PHYSIOL-RENAL, V296, pF398, DOI 10.1152/ajprenal.90488.2008; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Takeda Y, 2007, AM J HYPERTENS, V20, P1119, DOI 10.1016/j.amjhyper.2007.05.008; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Velkoska E, 2010, CLIN SCI, V118, P269, DOI 10.1042/CS20090318; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wang YJ, 2020, J HEPATOL, V73, P807, DOI 10.1016/j.jhep.2020.05.002; Wang Y, 2021, FASEB J, V35, DOI 10.1096/fj.202100016R; Wosten-van Asperen RM, 2011, J PATHOL, V225, P618, DOI 10.1002/path.2987; Wu CQ, 2020, HYPERTENSION, V76, pE29, DOI 10.1161/HYPERTENSIONAHA.120.15782; Wysocki J, 2015, AM J HYPERTENS, V28, P1418, DOI 10.1093/ajh/hpv054; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Zhang YH, 2015, J RENIN-ANGIO-ALDO S, V16, P292, DOI 10.1177/1470320314542829; Zhong JC, 2011, REGUL PEPTIDES, V166, P90, DOI 10.1016/j.regpep.2010.09.005; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55550-8	56	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21419	10.1096/fj.202100016R	http://dx.doi.org/10.1096/fj.202100016R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566370	Green Published			2022-12-28	WOS:000629576700018
J	Martin, M; Salleron, L; Peyret, V; Geysels, RC; Darrouzet, E; Lindenthal, S; Barquero, CEB; Masini-Repiso, AM; Pourcher, T; Nicola, JP				Martin, Mariano; Salleron, Lisa; Peyret, Victoria; Geysels, Romina Celeste; Darrouzet, Elisabeth; Lindenthal, Sabine; Bernal Barquero, Carlos Eduardo; Masini-Repiso, Ana Maria; Pourcher, Thierry; Nicola, Juan Pablo			The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane	FASEB JOURNAL			English	Article						dyshormonogenic congenital hypothyroidism; iodide transport defect; sodium; iodide symporter (NIS); PDZ-binding motif; PDZ domain-containing protein SCRIB	NA+/I-SYMPORTER; IODIDE TRANSPORTER; BINDING MOTIF; MUTATION; MECHANISM; DOMAIN; TRAFFICKING; PHYSIOLOGY; REVEALS; COMPLEX	The sodium/iodide symporter (NIS) expresses at the basolateral plasma membrane of the thyroid follicular cell and mediates iodide accumulation required for normal thyroid hormonogenesis. Loss-of-function NIS variants cause congenital hypothyroidism due to impaired iodide accumulation in thyroid follicular cells underscoring the significance of NIS for thyroid physiology. Here we report novel findings derived from the thorough characterization of the nonsense NIS mutant p.R636* NIS-leading to a truncated protein missing the last eight amino acids-identified in twins with congenital hypothyroidism. R636* NIS is severely mislocalized into intracellular vesicular compartments due to the lack of a conserved carboxy-terminal type 1 PDZ-binding motif. As a result, R636* NIS is barely targeted to the plasma membrane and therefore iodide transport is reduced. Deletion of the PDZ-binding motif causes NIS accumulation into late endosomes and lysosomes. Using PDZ domain arrays, we revealed that the PDZ-domain containing protein SCRIB binds to the carboxy-terminus of NIS by a PDZ-PDZ interaction. Furthermore, in CRISPR/Cas9-based SCRIB deficient cells, NIS expression at the basolateral plasma membrane is compromised, leading to NIS localization into intracellular vesicular compartments. We conclude that the PDZ-binding motif is a plasma membrane retention signal that participates in the polarized expression of NIS by selectively interacting with the PDZ-domain containing protein SCRIB, thus retaining the transporter at the basolateral plasma membrane. Our data provide insights into the molecular mechanisms that regulate NIS expression at the plasma membrane, a topic of great interest in the thyroid cancer field considering the relevance of NIS-mediated radioactive iodide therapy for differentiated thyroid carcinoma.	[Martin, Mariano; Peyret, Victoria; Geysels, Romina Celeste; Bernal Barquero, Carlos Eduardo; Masini-Repiso, Ana Maria; Nicola, Juan Pablo] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Medina Allende S-N,Cuidad Univ,X5000HUA, Cordoba, Argentina; [Martin, Mariano; Peyret, Victoria; Geysels, Romina Celeste; Bernal Barquero, Carlos Eduardo; Masini-Repiso, Ana Maria; Nicola, Juan Pablo] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Bioquim Clin & Inmunol CIBICI, Cordoba, Argentina; [Salleron, Lisa; Darrouzet, Elisabeth; Lindenthal, Sabine; Pourcher, Thierry] Univ Cote dAzur, Inst Sci Vivant Freder Joliot, Commissariat Energie Atom & Energies Alternat, Direct Rech Fondamentale,Fac Med,Transporteurs Im, Nice, France; [Darrouzet, Elisabeth] Univ Grenoble Apes, Ctr Natl Rech Sci, Lab Chim & Biol Metaux, Inst Rech Interdisciplinaire Grenoble,Commissaria, Grenoble, France	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CEA; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Nicola, JP (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Medina Allende S-N,Cuidad Univ,X5000HUA, Cordoba, Argentina.	juan.nicola@unc.edu.ar		Bernal Barquero, Carlos Eduardo/0000-0001-7166-2210; Martin, Mariano/0000-0002-9518-2630	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2014-0726, PICT-2015-3839, PICT-2015-3705, PICT-2018-1596, PICT-2019-1772]; PRIODAC research program - Institute of Nuclear Safety and Radiation Protection of the French National Research Agency [ANR-11-RSNR-0019-01]; Secretaria de Ciencia y Tecnologia - Universidad Nacional de Cordoba [30820150100222CB, 33620180100772CB]; Instituto Nacional del Cancer - Ministerio de Salud y Desarrollo Social; Thyroid Cancer Survivors' Association; Latin American Thyroid Society	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica; PRIODAC research program - Institute of Nuclear Safety and Radiation Protection of the French National Research Agency; Secretaria de Ciencia y Tecnologia - Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Instituto Nacional del Cancer - Ministerio de Salud y Desarrollo Social; Thyroid Cancer Survivors' Association; Latin American Thyroid Society	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas, Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2014-0726, PICT-2015-3839, PICT-2015-3705, PICT-2018-1596, and PICT-2019-1772 to JPN), Secretaria de Ciencia y Tecnologia --Universidad Nacional de Cordoba (30820150100222CB and 33620180100772CB to JPN), Instituto Nacional del Cancer - Ministerio de Salud y Desarrollo Social, Thyroid Cancer Survivors' Association, and Latin American Thyroid Society. This study was also supported by PRIODAC research program funded by the Institute of Nuclear Safety and Radiation Protection of the French National Research Agency (contract number ANR-11-RSNR-0019-01).	Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Darrouzet E, 2016, BIOCHEM J, V473, P919, DOI 10.1042/BJ20151086; Dayem M, 2008, J ENDOCRINOL, V197, P95, DOI 10.1677/JOE-07-0455; De la Vieja A, 2021, CANCERS, V13, DOI 10.3390/cancers13050995; Montesinos MD, 2016, MOL CELL ENDOCRINOL, V420, P105, DOI 10.1016/j.mce.2015.11.020; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Feng F, 2018, CANCER RES, V78, P6121, DOI 10.1158/0008-5472.CAN-18-1954; Fletcher A, 2020, CANCER RES, V80, P102, DOI 10.1158/0008-5472.CAN-19-1957; Geysels RC, 2021, THYROID, V31, P299, DOI 10.1089/thy.2020.0208; Gujral TS, 2013, CHEM BIOL, V20, P816, DOI 10.1016/j.chembiol.2013.04.021; Harris BZ, 2001, J CELL SCI, V114, P3219; HERZLINGER DA, 1982, J CELL BIOL, V93, P269, DOI 10.1083/jcb.93.2.269; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Ivarsson Y, 2014, P NATL ACAD SCI USA, V111, P2542, DOI 10.1073/pnas.1312296111; Kalay E, 2005, J MOL MED, V83, P1025, DOI 10.1007/s00109-005-0719-4; Kumar M, 2020, NUCLEIC ACIDS RES, V48, pD296, DOI 10.1093/nar/gkz1030; Lacoste C, 2012, CANCER RES, V72, P5505, DOI 10.1158/0008-5472.CAN-12-0516; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li WJ, 2013, FASEB J, V27, P3229, DOI 10.1096/fj.13-229138; Makretskaya N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204323; Martin M, 2021, J CLIN ENDOCR METAB, V106, P1867, DOI 10.1210/clinem/dgab283; Martin M, 2019, THYROID, V29, P1023, DOI 10.1089/thy.2019.0046; Martin M, 2019, J ENDOCR SOC, V3, P222, DOI 10.1210/js.2018-00100; Martin M, 2019, ENDOCRINOLOGY, V160, P156, DOI 10.1210/en.2018-00603; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Nicola JP., 2016, J ANAL ONCOL, V5, P75; Nicola JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4948; Nicola JP, 2015, J CLIN ENDOCR METAB, V100, pE1353, DOI 10.1210/jc.2015-1824; Nicola JP, 2009, AM J PHYSIOL-CELL PH, V296, pC654, DOI 10.1152/ajpcell.00509.2008; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Nicola JP, 2015, ENDOCRINOLOGY, V156, P4741, DOI 10.1210/en.2015-1192; Nicola JP, 2015, VITAM HORM, V98, P1, DOI 10.1016/bs.vh.2014.12.002; Nicola JP, 2011, J CLIN ENDOCR METAB, V96, pE1100, DOI 10.1210/jc.2011-0349; Park J, 2014, J AM SOC NEPHROL, V25, P726, DOI 10.1681/ASN.2013040438; Paroder V, 2013, J CELL SCI, V126, P3305, DOI 10.1242/jcs.120246; Paroder-Belenitsky M, 2011, P NATL ACAD SCI USA, V108, P17933, DOI 10.1073/pnas.1108278108; Peinetti N, 2018, ENDOCRINOLOGY, V159, P945, DOI 10.1210/en.2017-00718; Peyret V, 2018, MOL CANCER RES, V16, P833, DOI 10.1158/1541-7786.MCR-17-0433; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ravera S, 2017, ANNU REV PHYSIOL, V79, P261, DOI 10.1146/annurev-physiol-022516-034125; Reyna-Neyra A, 2021, THYROID, V31, P1272, DOI 10.1089/thy.2020.0931; Rossich LE, 2016, MOL CELL ENDOCRINOL, V437, P292, DOI 10.1016/j.mce.2016.08.036; Santoni MJ, 2020, ONCOGENE, V39, P7019, DOI 10.1038/s41388-020-01478-7; Shy D, 2013, BBA-MOL CELL RES, V1833, P886, DOI 10.1016/j.bbamcr.2012.10.026; Smith VE, 2009, J CELL SCI, V122, P3393, DOI 10.1242/jcs.045427; Sundell GN, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178129; Tavares C, 2018, ENDOCR CONNECT, V7, P78, DOI 10.1530/EC-17-0302; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Wang HJ, 2020, MOL MED REP, V22, P297, DOI 10.3892/mmr.2020.11078; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360	56	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21681	10.1096/fj.202100303R	http://dx.doi.org/10.1096/fj.202100303R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34196428				2022-12-28	WOS:000678975300010
J	Bordoni, L; Petracci, I; Pelikant-Malecka, I; Radulska, A; Piangerelli, M; Samulak, JJ; Lewicki, L; Kalinowski, L; Gabbianelli, R; Olek, RA				Bordoni, Laura; Petracci, Irene; Pelikant-Malecka, Iwona; Radulska, Adriana; Piangerelli, Marco; Samulak, Joanna J.; Lewicki, Lukasz; Kalinowski, Leszek; Gabbianelli, Rosita; Olek, Robert A.			Mitochondrial DNA copy number and trimethylamine levels in the blood: New insights on cardiovascular disease biomarkers	FASEB JOURNAL			English	Article						biomarkers; cardiovascular disease; hypertension; mitochondrial DNA; sex; TMAO	PERIPHERAL-BLOOD; OXIDATIVE STRESS; L-CARNITINE; RISK; ATHEROSCLEROSIS; DYSFUNCTION; METABOLISM; HEALTH; DAMAGE; CELLS	Among cardiovascular disease (CVD) biomarkers, the mitochondrial DNA copy number (mtDNAcn) is a promising candidate. A growing attention has been also dedicated to trimethylamine-N-oxide (TMAO), an oxidative derivative of the gut metabolite trimethylamine (TMA). With the aim to identify biomarkers predictive of CVD, we investigated TMA, TMAO, and mtDNAcn in a population of 389 coronary artery disease (CAD) patients and 151 healthy controls, in association with established risk factors for CVD (sex, age, hypertension, smoking, diabetes, glomerular filtration rate [GFR]) and troponin, an established marker of CAD. MtDNAcn was significantly lower in CAD patients; it correlates with GFR and TMA, but not with TMAO. A biomarker including mtDNAcn, sex, and hypertension (but neither TMA nor TMAO) emerged as a good predictor of CAD. Our findings support the mtDNAcn as a promising plastic biomarker, useful to monitor the exposure to risk factors and the efficacy of preventive interventions for a personalized CAD risk reduction.	[Bordoni, Laura; Gabbianelli, Rosita] Univ Camerino, Sch Pharm, Unit Mol Biol & Nutrigen, Camerino, Italy; [Petracci, Irene] Univ Camerino, Sch Adv Studies, Camerino, Italy; [Pelikant-Malecka, Iwona; Radulska, Adriana; Kalinowski, Leszek] Med Univ Gdansk, Div Med Lab Diagnost, Gdansk, Poland; [Pelikant-Malecka, Iwona; Radulska, Adriana; Kalinowski, Leszek] Tiobanking & Biomol Resources Res Infrastruct Pol, Gdansk, Poland; [Piangerelli, Marco] Univ Camerino, Sch Sci & Technol, Comp Sci Div, Camerino, Italy; [Piangerelli, Marco] Univ Camerino, Sch Sci & Technol, Math Div, Camerino, Italy; [Samulak, Joanna J.] Gdansk Univ Phys Educ & Sport, Doctoral Sch, Gdansk, Poland; [Lewicki, Lukasz] Pomeranian Hosp, Kashubian Ctr Heart & Vasc Dis, Dept Cardiol & Angiol, Wejherowo, Poland; [Kalinowski, Leszek] Gdansk Univ Technol, Dept Mech Mat & Struct, Gdansk, Poland; [Olek, Robert A.] Poznan Univ Phys Educ, Dept Athlet Strength & Conditioning, Poznan, Poland	University of Camerino; University of Camerino; Fahrenheit Universities; Medical University Gdansk; University of Camerino; University of Camerino; Gdansk University of Physical Education & Sport; Fahrenheit Universities; Gdansk University of Technology	Bordoni, L (corresponding author), Univ Camerino, Unit Mol Biol, Sch Pharm, I-62032 Camerino, Italy.	laura.bordoni@unicam.it	Olek, Robert/CAI-7765-2022; Olek, Robert A/H-7206-2019; Bordoni, Laura/T-7092-2017; Piangerelli, Marco/H-2658-2018; Kalinowski, Leszek/N-3076-2019	Olek, Robert A/0000-0002-3714-7386; Bordoni, Laura/0000-0001-6968-1164; Petracci, Irene/0000-0003-2433-7516; Gabbianelli, Rosita/0000-0003-0037-7740; , IWONA/0000-0002-4780-8256; Piangerelli, Marco/0000-0002-8545-3740; Kalinowski, Leszek/0000-0001-7270-1592	Ministry of Science and Higher Education, Poland [FPA000033];  [DIR/WK/2017/01]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); 	Funding for reagents were provided by Prof. Rosita Gabbianelli (FPA000033), and Ministry of Science and Higher Education, Poland, grant no. DIR/WK/2017/01	Bai Y, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00482-x; Bito R, 2005, AM J PHYSIOL-CELL PH, V289, pC531, DOI 10.1152/ajpcell.00431.2004; Bordoni L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75633-1; Bordoni L, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080764; Bordoni L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031047; Calderon Jose L Martin, 2015, Pract Lab Med, V1, P42, DOI 10.1016/j.plabm.2015.03.006; Carugno M, 2012, ENVIRON HEALTH PERSP, V120, P210, DOI 10.1289/ehp.1103979; Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004; Cayci T, 2012, J ASSIST REPROD GEN, V29, P855, DOI 10.1007/s10815-012-9803-1; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chen ML, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006347; Cioffi F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040323; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins HL, 2016, ATHEROSCLEROSIS, V244, P29, DOI 10.1016/j.atherosclerosis.2015.10.108; Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; Eirin A, 2017, AM J HYPERTENS, V30, P1112, DOI 10.1093/ajh/hpx103; Eirin A, 2016, HYPERTENSION, V68, P401, DOI 10.1161/HYPERTENSIONAHA.116.07849; ERA S, 1995, BBA-PROTEIN STRUCT M, V1247, P12, DOI 10.1016/0167-4838(94)00166-E; Fazzini F, 2021, J INTERN MED, V290, P190, DOI 10.1111/joim.13242; Fazzini F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33684-5; Flint AC, 2019, NEW ENGL J MED, V381, P243, DOI 10.1056/NEJMoa1803180; Fuchs FD, 2020, HYPERTENSION, V75, P285, DOI 10.1161/HYPERTENSIONAHA.119.14240; Garg P, 2017, INTERN EMERG MED, V12, P147, DOI 10.1007/s11739-017-1612-1; Guo YD, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010596; Haghikia A, 2018, ARTERIOSCL THROM VAS, V38, P2225, DOI 10.1161/ATVBAHA.118.311023; Hang D, 2018, EUR J EPIDEMIOL, V33, P485, DOI 10.1007/s10654-018-0382-z; Hernandez-Rios R, 2013, EXP CLIN ENDOCR DIAB, V121, P535, DOI 10.1055/s-0033-1349144; Hoff J, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0566-5; Hou LF, 2013, PART FIBRE TOXICOL, V10, DOI [10.1186/1743-8977-10-17, 10.1186/1743-8977-10-47]; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Huang CH, 2011, J ATHEROSCLER THROMB, V18, P867, DOI 10.5551/jat.8698; Jaworska K, 2019, CARDIOVASC RES, V115, P1948, DOI 10.1093/cvr/cvz231; Jaworska K, 2019, TOXINS, V11, DOI 10.3390/toxins11090490; Kanitsoraphan Chanavuth, 2018, Curr Nutr Rep, V7, P207, DOI 10.1007/s13668-018-0252-z; Khan SS, 2018, JAMA CARDIOL, V3, P280, DOI 10.1001/jamacardio.2018.0022; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koller A, 2020, J INTERN MED, V287, P569, DOI 10.1111/joim.13027; Landfald Bjarne, 2017, Microbial Ecology in Health and Disease, V28, P1327309, DOI 10.1080/16512235.2017.1327309; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Lei L, 2017, J HUM HYPERTENS, V31, P585, DOI 10.1038/jhh.2017.30; Leon BM, 2015, WORLD J DIABETES, V6, P1246, DOI 10.4239/wjd.v6.i13.1246; Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Makrecka-Kuka M, 2017, TOXICOL LETT, V267, P32, DOI 10.1016/j.toxlet.2016.12.017; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Mancini A, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03566-7; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9; Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Olek RA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6247169; Picard M, 2013, DIABETES, V62, P672, DOI 10.2337/db12-1203; Prestes PR, 2017, J HUM HYPERTENS, V31, P761, DOI 10.1038/jhh.2017.73; Qiu CF, 2013, CLIN LAB, V59, P655, DOI 10.7754/Clin.Lab.2012.120227; Rahmani-Kukia N, 2020, BIOORG CHEM, V105, DOI 10.1016/j.bioorg.2020.104429; Restini CBA, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105273; Revesz D, 2018, J CLIN ENDOCR METAB, V103, P148, DOI 10.1210/jc.2017-01625; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Samulak JJ, 2019, ANN NUTR METAB, V74, P11, DOI 10.1159/000495037; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider J, 2018, CHEM RES TOXICOL, V31, P447, DOI 10.1021/acs.chemrestox.7b00329; Seldin MM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002767; Senthong V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002816; Silva FSG, 2016, CURR PHARM DESIGN, V22, P5698, DOI 10.2174/1381612822666160822150243; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661; Torres, 2018, INT J MOL BIOL OPEN, V3, P117; Vallance HD, 2018, MOL GENET METAB REP, V15, P130, DOI 10.1016/j.ymgmr.2018.04.005; Velasquez MT, 2016, TOXINS, V8, DOI 10.3390/toxins8110326; Wang J, 2017, J GERIATR CARDIOL, V14, P135, DOI 10.11909/j.issn.1671-5411.2017.02.008; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wei RP, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018776; Whitaker RM, 2015, KIDNEY INT, V88, P1336, DOI 10.1038/ki.2015.240; Wong J, 2009, DIABETOLOGIA, V52, P1953, DOI 10.1007/s00125-009-1424-6; Xu FX, 2012, DIABETIC MED, V29, pE47, DOI 10.1111/j.1464-5491.2011.03565.x; Yin J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002699; Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271; Yue P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206003; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	85	10	11	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21694	10.1096/fj.202100056R	http://dx.doi.org/10.1096/fj.202100056R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165220	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000667814100070
J	Chen, SW; Liu, T; Bu, DF; Zhu, J; Wang, X; Pan, YS; Liu, YC; Lu, ZJ; Wang, PY				Chen, Shanwen; Liu, Tao; Bu, Dingfang; Zhu, Jing; Wang, Xin; Pan, Yisheng; Liu, Yucun; Lu, Zhi John; Wang, Pengyuan			Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer	FASEB JOURNAL			English	Article						CfDNA; colorectal cancer; liver metastasis; methylight; methylome; TCHH	DNA; PLASMA	Methylation of circulating free DNA (CfDNA) has emerged as an efficient marker of tumor screening and prognostics. However, no efficient methylation marker has been developed for monitoring liver metastasis (LM) in colorectal cancer (CRC). Utilizing methylome profiling and bisulfite sequencing polymerase chain reaction of paired primary and LM sites, significantly increased methylation of TCHH was identified in the process of LM in CRC in the present study. Methylight analysis of TCHH methylation in CfDNA displayed a promisingly discriminative power between CRC with and without LM. Besides, significant coefficient of TCHH methylation and LM tumor volume was also validated. Together, these results indicated the potential of TCHH methylation in CfDNA as a monitoring marker of LM in CRC.	[Chen, Shanwen; Liu, Tao; Zhu, Jing; Wang, Xin; Pan, Yisheng; Liu, Yucun; Wang, Pengyuan] Peking Univ First Hosp, Div Gen Surg, Beijing, Peoples R China; [Bu, Dingfang] Peking Univ First Hosp, Cent Lab, Beijing, Peoples R China; [Lu, Zhi John] Tsinghua Univ, Ctr Synthet & Syst Biol, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China	Peking University; Tsinghua University	Wang, PY (corresponding author), Peking Univ First Hosp, Div Gen Surg, Beijing, Peoples R China.	wangpengyuan2014@126.com		Pan, Yisheng/0000-0002-8924-2342; Wang, Pengyuan/0000-0003-3884-0227	National Natural Science Foundation of China [81902384, 81770522]; Interdisciplinary Clinical Research Project of Peking University First Hospital, Scientific Research Seed Fund of Peking University First Hospital [2019SF01]; National Science and Technology Major Project of China [2018ZX10723204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Interdisciplinary Clinical Research Project of Peking University First Hospital, Scientific Research Seed Fund of Peking University First Hospital; National Science and Technology Major Project of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81902384, No. 81770522), Interdisciplinary Clinical Research Project of Peking University First Hospital, Scientific Research Seed Fund of Peking University First Hospital (No. 2019SF01) and National Science and Technology Major Project of China (2018ZX10723204).	Ansa BE, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020022; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bhangu JS, 2018, ANN SURG, V268, P894, DOI 10.1097/SLA.0000000000002901; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Chan KCA, 2013, P NATL ACAD SCI USA, V110, P18761, DOI 10.1073/pnas.1313995110; Chen SW, 2019, J CROHNS COLITIS, V13, P1067, DOI 10.1093/ecco-jcc/jjz027; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Fan JW, 2011, CLIN CANCER RES, V17, P2908, DOI 10.1158/1078-0432.CCR-10-2552; Filip S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155255; Gai WX, 2018, CLIN CHEM, V64, P1239, DOI 10.1373/clinchem.2018.290304; Gruosso T, 2019, J CLIN INVEST, V129, P1785, DOI 10.1172/JCI96313; Hao XK, 2017, P NATL ACAD SCI USA, V114, P7414, DOI 10.1073/pnas.1703577114; Lamb YN, 2017, MOL DIAGN THER, V21, P225, DOI 10.1007/s40291-017-0259-y; Luo HY, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax7533; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Nordlund J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r105; Orjuela S, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06777-6; Petrova A, 2016, STEM CELLS DEV, V25, P1366, DOI 10.1089/scd.2016.0156; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh A, 2020, INT J CANCER, V147, P1740, DOI 10.1002/ijc.32984; Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Xie H, 2021, ANN SURG ONCOL, V28, P1845, DOI 10.1245/s10434-020-09002-7; Zaimi I, 2018, EPIGENETICS-US, V13, P1056, DOI 10.1080/15592294.2018.1530008; Zhou WD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw967	29	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21720	10.1096/fj.202100266R	http://dx.doi.org/10.1096/fj.202100266R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110642				2022-12-28	WOS:000667814100052
J	Ehlers, L; Kuppe, A; Damerau, A; Wilantri, S; Kirchner, M; Mertins, P; Strehl, C; Buttgereit, F; Gaber, T				Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Kirchner, Marieluise; Mertins, Philipp; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo			Surface AMP deaminase 2 as a novel regulator modifying extracellular adenine nucleotide metabolism	FASEB JOURNAL			English	Article						adenosine; inflammation; nucleotidases; purines; rheumatoid arthritis; RRIDs	NUCLEOSIDE TRANSPORTER FAMILY; A(3) ADENOSINE RECEPTOR; T-CELLS; ATP RELEASE; AMPHITROPIC PROTEINS; ADENYLATE DEAMINASE; IL-1-BETA RELEASE; RAT-BRAIN; INOSINE; CD73	Adenine nucleotides represent crucial immunomodulators in the extracellular environment. The ectonucleotidases CD39 and CD73 are responsible for the sequential catabolism of ATP to adenosine via AMP, thus promoting an anti-inflammatory milieu induced by the "adenosine halo". AMPD2 intracellularly mediates AMP deamination to IMP, thereby both enhancing the degradation of inflammatory ATP and reducing the formation of anti-inflammatory adenosine. Here, we show that this enzyme is expressed on the surface of human immune cells and its predominance may modify inflammatory states by altering the extracellular milieu. Surface AMPD2 (eAMPD2) expression on monocytes was verified by immunoblot, surface biotinylation, mass spectrometry, and immunofluorescence microscopy. Flow cytometry revealed enhanced monocytic eAMPD2 expression after TLR stimulation. PBMCs from patients with rheumatoid arthritis displayed significantly higher levels of eAMPD2 expression compared with healthy controls. Furthermore, the product of AMPD2-IMP-exerted anti-inflammatory effects, while the levels of extracellular adenosine were not impaired by an increased eAMPD2 expression. In summary, our study identifies eAMPD2 as a novel regulator of the extracellular ATP-adenosine balance adding to the immunomodulatory CD39-CD73 system.	[Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany; [Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany; [Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany; [Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Deutsch Rheuma Forschungszentrum DRFZ, Inst Leibniz Assoc, Berlin, Germany; [Kirchner, Marieluise; Mertins, Philipp] Berlin Inst Hlth BIH, BIH Core Unit Prote, Berlin, Germany; [Kirchner, Marieluise; Mertins, Philipp] Max Delbruck Ctr Mol Med MDC, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ehlers, L (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany.; Ehlers, L (corresponding author), Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.; Ehlers, L (corresponding author), Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany.; Ehlers, L (corresponding author), Berlin Inst Hlth BIH, Charitepl 1, D-10117 Berlin, Germany.	lisa.ehlers@charite.de		Damerau, Alexandra/0000-0001-6651-2963; Ehlers, Lisa/0000-0001-8737-001X; Buttgereit, Frank/0000-0003-2534-550X; Kirchner, Marieluise/0000-0002-7049-534X	Horizon Pharma plc. [112517]; Studienstiftung des deutschen Volkes (Alexandra Damerau); Deutsche Forschungsgemeinschaft [353142848]	Horizon Pharma plc.; Studienstiftung des deutschen Volkes (Alexandra Damerau); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge funding provided by an unrestricted grant from Horizon Pharma plc. (112517). This work was supported by grants from Horizon Pharma plc. (112517) for LE, Studienstiftung des deutschen Volkes (Alexandra Damerau) for AD, and Deutsche Forschungsgemeinschaft (353142848) for TG.	Akhtari M, 2018, CLIN RHEUMATOL, V37, P1589, DOI 10.1007/s10067-018-4055-9; Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; Allard D, 2019, IMMUNOL LETT, V205, P31, DOI 10.1016/j.imlet.2018.05.001; Antonio L, 2017, DRUG DISCOV TODAY, V22, P1686, DOI 10.1016/j.drudis.2017.06.005; Antonioli L, 2019, IMMUNOL LETT, V205, P9, DOI 10.1016/j.imlet.2018.04.006; Antonioli L, 2014, DRUG DISCOV TODAY, V19, P1051, DOI 10.1016/j.drudis.2014.02.010; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Antonioli L, 2012, CURR DRUG TARGETS, V13, P842, DOI 10.2174/138945012800564095; ATKINSON DE, 1966, ANNU REV BIOCHEM, V35, P85, DOI 10.1146/annurev.bi.35.070166.000505; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Ballard P L, 1979, Monogr Endocrinol, V12, P25; BAUMANN G, 1975, J CLIN ENDOCR METAB, V40, P462, DOI 10.1210/jcem-40-3-462; Bavaresco L, 2007, J NEURO-ONCOL, V84, P1, DOI 10.1007/s11060-007-9342-2; Bedoui Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205023; Binkley Philip F, 2004, Congest Heart Fail, V10, P274, DOI 10.1111/j.1527-5299.2004.02017.x; Blay J, 1997, CANCER RES, V57, P2602; Borkowski T, 2010, NUCLEOS NUCLEOT NUCL, V29, P449, DOI 10.1080/15257771003741364; Bossennec M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111859; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; Burnstock G, 2014, PURINERG SIGNAL, V10, P529, DOI 10.1007/s11302-014-9427-2; Cai XY, 2016, ONCOL LETT, V12, P4080, DOI 10.3892/ol.2016.5189; Cai XY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004989; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; CHAPMAN AG, 1973, J BIOL CHEM, V248, P8309; Chen J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00504; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Cronstein BN, 2017, NAT REV RHEUMATOL, V13, P41, DOI 10.1038/nrrheum.2016.178; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; CUENDA A, 1994, BBA-BIOMEMBRANES, V1194, P35, DOI 10.1016/0005-2736(94)90200-3; Mora-Garcia MD, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1057-8; Dong RP, 1996, J IMMUNOL, V156, P1349; DORNAND J, 1985, P SOC EXP BIOL MED, V179, P448; Dou L, 2018, CLIN IMMUNOL, V188, P67, DOI 10.1016/j.clim.2017.12.006; DUNKLEY CR, 1966, J CELL PHYSIOL, V68, P241, DOI 10.1002/jcp.1040680305; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Endo W, 2014, MOD RHEUMATOL, V24, P844, DOI 10.3109/14397595.2013.864225; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferretti E, 2019, IMMUNOL LETT, V205, P25, DOI 10.1016/j.imlet.2018.03.007; Figueiro F, 2016, PURINERG SIGNAL, V12, P303, DOI 10.1007/s11302-016-9505-8; Figueiro F, 2014, ANTICANCER RES, V34, P1837; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Finn JD., 2015, ANN RHEUM DIS, V74, pA86; Fishman P, 2016, CLIN RHEUMATOL, V35, P2359, DOI 10.1007/s10067-016-3202-4; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Frasson AP, 2017, PURINERG SIGNAL, V13, P569, DOI 10.1007/s11302-017-9584-1; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gordon-Smith SB, 2015, ARTHRITIS RHEUMATOL, V67, P545, DOI 10.1002/art.38959; Gorini S, 2013, AM J BLOOD RES, V3, P14; Gourdin N, 2018, CANCER RES, V78, P3604, DOI 10.1158/0008-5472.CAN-17-2405; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Guinzberg R, 2006, AM J PHYSIOL-ENDOC M, V290, pE940, DOI 10.1152/ajpendo.00173.2005; Guo GQ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1739-5; Hausler SFM, 2014, AM J TRANSL RES, V6, P129; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hasko G, 1996, J IMMUNOL, V157, P4634; Herrath J, 2014, EUR J IMMUNOL, V44, P2979, DOI 10.1002/eji.201344140; Horenstein AL, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26246; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Jacobson KA, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00124; Jiang T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4073-7; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Johnson TA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00098; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabisch S, 2004, AKTUEL RHEUMATOL, V29, P197, DOI 10.1055/s-2004-813426; Kekesi V, 2002, CLIN SCI, V103, p198S, DOI 10.1042/CS103S198S; Keller RCA, 2014, J BIOSCIENCES, V39, P771, DOI 10.1007/s12038-014-9479-z; KLEMENS MR, 1990, BIOCHEM BIOPH RES CO, V172, P1371, DOI 10.1016/0006-291X(90)91601-N; Lapa FD, 2012, PURINERG SIGNAL, V8, P693, DOI 10.1007/s11302-012-9299-2; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; LEVRAUX V, 1993, LIFE SCI, V52, P1917, DOI 10.1016/0024-3205(93)90632-D; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; LOWENSTEIN JM, 1972, PHYSIOL REV, V52, P382, DOI 10.1152/physrev.1972.52.2.382; Lu YM, 2019, ANN HEMATOL, V98, P1845, DOI 10.1007/s00277-019-03716-9; Luo YY, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0240-5; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; MANERY JF, 1968, CAN J PHYSIOL PHARM, V46, P537, DOI 10.1139/y68-078; Marton A, 2001, INT J MOL MED, V8, P617; McWhinney CD, 1996, EUR J PHARMACOL, V310, P209, DOI 10.1016/0014-2999(96)00272-5; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Monguio-Tortajada M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01577; Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Muls NGV, 2015, MULT SCLER J, V21, P1533, DOI 10.1177/1352458514567215; OGASAWARA N, 1987, HUM GENET, V75, P15; Ohradanova-Repic A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00852; Ohta M, 2013, ARTERIOSCL THROM VAS, V33, P629, DOI 10.1161/ATVBAHA.112.300600; Parzych K, 2017, FASEB J, V31, P2439, DOI 10.1096/fj.201600256; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; PETERSON RE, 1957, J CLIN INVEST, V36, P1301, DOI 10.1172/JCI103528; PIPOLY GM, 1979, J CLIN INVEST, V63, P1066, DOI 10.1172/JCI109376; Pulte ED, 2007, THROMB RES, V121, P309, DOI 10.1016/j.thromres.2007.04.008; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Quarona V, 2015, ANN NY ACAD SCI, V1335, P10, DOI 10.1111/nyas.12485; RAO SN, 1968, BIOCHIM BIOPHYS ACTA, V151, P651, DOI 10.1016/0005-2744(68)90012-0; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; SABINA RL, 1984, J CLIN INVEST, V73, P720, DOI 10.1172/JCI111265; Sabina RL, 2000, PHARMACOL THERAPEUT, V87, P279, DOI 10.1016/S0163-7258(00)00040-1; Sales-Campos H, 2017, IMMUNOLOGY, V150, P115, DOI 10.1111/imm.12672; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saze Z, 2013, BLOOD, V122, P9, DOI 10.1182/blood-2013-02-482406; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schuler PJ, 2014, CLIN EXP IMMUNOL, V177, P531, DOI 10.1111/cei.12354; Shinohara Y, 2018, BIOCHEM BIOPH RES CO, V498, P764, DOI 10.1016/j.bbrc.2018.03.055; Silva-Vilches C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02581; Silverman MH, 2008, J RHEUMATOL, V35, P41; Sims B, 1999, J BIOL CHEM, V274, P25701, DOI 10.1074/jbc.274.36.25701; Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Strehl C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01744; Sun WC, 2007, AM J VET RES, V68, P649, DOI 10.2460/ajvr.68.6.649; Sun XF, 2009, AM J PHYSIOL-GASTR L, V297, pG306, DOI 10.1152/ajpgi.90703.2008; Szabo C, 1998, BRIT J PHARMACOL, V125, P379, DOI 10.1038/sj.bjp.0702040; Taylor PC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040515; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Viegas TX, 2000, J CLIN PHARMACOL, V40, P410, DOI 10.1177/00912700022008991; Walscheid K, 2018, CLIN IMMUNOL, V190, P84, DOI 10.1016/j.clim.2017.09.014; WEBEL ML, 1974, J LAB CLIN MED, V83, P383; WEILMALHERBE H, 1975, J NEUROCHEM, V24, P801; Welihinda AA, 2018, CELL SIGNAL, V42, P227, DOI 10.1016/j.cellsig.2017.11.002; Welihinda AA, 2016, CELL SIGNAL, V28, P552, DOI 10.1016/j.cellsig.2016.02.010; Wessels JAM, 2006, ARTHRITIS RHEUM, V54, P2830, DOI 10.1002/art.22032; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yago T, 2015, J IMMUNOL, V195, P3880, DOI 10.4049/jimmunol.1500775; Yan K, 2018, BRIT J DERMATOL, V179, P896, DOI 10.1111/bjd.16560; Young A, 2016, CANCER CELL, V30, P391, DOI 10.1016/j.ccell.2016.06.025; Yu N, 2012, INFLAMMATION, V35, P1773, DOI 10.1007/s10753-012-9496-8; Zanin RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031205; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	149	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21684	10.1096/fj.202002658RR	http://dx.doi.org/10.1096/fj.202002658RR			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34159634	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000667814100047
J	Graf, F; Horn, P; Ho, AD; Boutros, M; Maercker, C				Graf, Fabian; Horn, Patrick; Ho, Anthony D.; Boutros, Michael; Maercker, Christian			The extracellular matrix proteins type I collagen, type III collagen, fibronectin, and laminin 421 stimulate migration of cancer cells	FASEB JOURNAL			English	Article						cancer cell migration; extracellular matrix proteins	MESENCHYMAL STEM-CELLS; STROMAL CELLS; STEM/PROGENITOR CELLS; METASTATIC NICHE; TUMOR-GROWTH; ADHESION; INVASION; CHEMOTAXIS; RECEPTORS; INTEGRIN	For metastasis formation, individual cells from a primary tumor must migrate toward other tissues. The aim of this study was to determine if mesenchymal stromal cells (MSCs) from human bone marrow are able to emit signals that induce this migratory activity in cancer cells. We separated the supernatant of MSCs derived from human bone marrow by size-exclusion and ion-exchange chromatography and have subsequently studied the migratory behavior of the prostate cancer cell line PC3 and the breast cancer cell line MDA-MB-231 toward the respective fractions in a transwell migration assay. We identified the extracellular matrix (ECM) proteins type I collagen, type III collagen, fibronectin, and laminin 421 as potential drivers of cancer cell migration. These results could be reproduced using the corresponding isolated or recombinant ECM proteins. Knockdown of the gene encoding beta 1 integrin, an important cell surface receptor for fibronectin, has led to inhibition of cancer cell migration. This supports the hypothesis that beta 1 integrin signaling represents an initial event that leads to metastasis, and that signaling is triggered by binding of integrin heterodimers to ECM molecules. Further characterization of signaling factors and their respective receptors will have implications for anticancer drug development.	[Graf, Fabian; Boutros, Michael; Maercker, Christian] German Canc Res Ctr, Div Signaling & Funct Genom, Neuenheimer Feld 580, D-69120 Heidelberg, Germany; [Graf, Fabian; Maercker, Christian] Mannheim Univ Appl Sci, Dept Biotechnol, Mannheim, Germany; [Horn, Patrick; Ho, Anthony D.] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Boutros, Michael] Heidelberg Univ, Med Fac, Dept Cell & Mol Biol, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Maercker, C (corresponding author), German Canc Res Ctr, Div Signaling & Funct Genom, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	christian.maercker@gmail.com			State of Baden-Wuerttemberg; Albert and Anneliese Konanz Foundation	State of Baden-Wuerttemberg; Albert and Anneliese Konanz Foundation	State of Baden-Wuerttemberg; Albert and Anneliese Konanz Foundation	Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Chen Hong-Chen, 2004, V294, P15; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Fidler IJ, 2008, LANCET ONCOL, V9, P808, DOI 10.1016/S1470-2045(08)70201-8; Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80; Fu Guanyuan, 2012, Methods Mol Biol, V757, P81, DOI 10.1007/978-1-61779-166-6_7; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Ho C S, 2003, Clin Biochem Rev, V24, P3; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang EH, 2009, J SURG RES, V155, P231, DOI 10.1016/j.jss.2008.06.044; Hullinger TG, 1998, PROSTATE, V36, P14, DOI 10.1002/(SICI)1097-0045(19980615)36:1<14::AID-PROS3>3.0.CO;2-B; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Ishikawa T, 2014, MATRIX BIOL, V38, P69, DOI 10.1016/j.matbio.2014.06.002; Joshi R, 2020, MOL CANCER RES, V18, P27, DOI 10.1158/1541-7786.MCR-19-0442; Joshi R, 2017, CELL ADHES MIGR, V11, P305, DOI 10.1080/19336918.2016.1212139; Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Korenchuk S, 2001, IN VIVO, V15, P163; Kulawig R, 2013, INT J BIOCHEM CELL B, V45, P1410, DOI 10.1016/j.biocel.2013.04.016; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Nabha SM, 2008, INT J CANCER, V122, P2482, DOI 10.1002/ijc.23431; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nishimori H, 2012, J BIOL CHEM, V287, P20037, DOI 10.1074/jbc.M112.353094; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pouliot N, 2013, CELL ADHES MIGR, V7, P142, DOI 10.4161/cam.22125; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Ridge SM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0597-8; Saito N, 2009, PIGM CELL MELANOMA R, V22, P601, DOI 10.1111/j.1755-148X.2009.00590.x; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Siler U, 2000, BLOOD, V96, P4194; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Sottnik JL, 2013, CLIN EXP METASTAS, V30, P569, DOI 10.1007/s10585-012-9561-6; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; Uphoff Cord C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb2804s106; van der Horst G, 2011, NEOPLASIA, V13, P516, DOI 10.1593/neo.11122; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Verfaillie CM, 1998, BLOOD, V92, P2609, DOI 10.1182/blood.V92.8.2609; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu T, 2020, MOL BIOL REP, V47, P3937, DOI 10.1007/s11033-020-05487-3; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	56	7	7	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21692	10.1096/fj.202002558RR	http://dx.doi.org/10.1096/fj.202002558RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118087				2022-12-28	WOS:000667814100072
J	Nichols, AEC; Muscat, SN; Miller, SE; Green, LJ; Richards, MS; Loiselle, AE				Nichols, Anne E. C.; Muscat, Samantha N.; Miller, Sarah E.; Green, Luke J.; Richards, Michael S.; Loiselle, Alayna E.			Impact of isolation method on cellular activation and presence of specific tendon cell subpopulations during in vitro culture	FASEB JOURNAL			English	Article						cell culture; fibroblast activation; lineage; tendon	BICEPS TENDON; DIFFERENTIATION; MYOFIBROBLAST; FIBROBLASTS; EXPRESSION; TENOCYTES	Tendon injuries are common and heal poorly, due in part to a lack of understanding of fundamental tendon cell biology. A major impediment to the study of tendon cells is the absence of robust, well-characterized in vitro models. Unlike other tissue systems, current tendon cell models do not account for how differences in isolation methodology may affect the activation state of tendon cells or the presence of various tendon cell subpopulations. The objective of this study was to characterize how common isolation methods affect the behavior, fate, and lineage composition of tendon cell cultures. Tendon cells isolated by explant exhibited reduced proliferative capacity, decreased expression of tendon marker genes, and increased expression of genes associated with fibroblast activation compared to digested cells. Consistently, explanted cells also displayed an increased propensity to differentiate to myofibroblasts compared to digested cells. Explanted cultures from multiple different tendons were substantially enriched for the presence of scleraxis-lineage (Scx-lin+) cells compared to digested cultures, while the overall percentage of S100a4-lineage (S100a4-lin+) cells was dependent on both isolation method and tendon of origin. Neither isolation methods preserved the ratios of Scx-lin+ or S100a4-lin+ to non-lineage cells seen in tendons in vivo. Combined, these data indicate that further refinement of in vitro cultures models is required in order to more accurately understand the effects of various stimuli on tendon cell behavior. Statement of clinical significance: The development of informed in vitro tendon cell models will facilitate enhanced screening of potential therapeutic candidates to improve tendon healing.	[Nichols, Anne E. C.; Muscat, Samantha N.; Loiselle, Alayna E.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA; [Miller, Sarah E.; Green, Luke J.; Richards, Michael S.] Rochester Inst Technol, Dept Biomed Engn, Rochester, NY 14623 USA	University of Rochester; Rochester Institute of Technology	Loiselle, AE (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, 601 Elmwood Ave,Box 665, Rochester, NY 14642 USA.	Alayna_Loiselle@urmc.rochester.edu		Loiselle, Alayna/0000-0002-7548-6653	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01AR068386, R01AR073169, T32AR076950, P30AR069655]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: K01AR068386; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR073169; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: T32AR076950; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: P30AR069655	Ackerman JE, 2019, ELIFE, V8, DOI 10.7554/eLife.45342; BANES AJ, 1988, J ORTHOP RES, V6, P83, DOI 10.1002/jor.1100060111; BernardBeaubois K, 1997, CELL BIOL TOXICOL, V13, P103, DOI 10.1023/B:CBTO.0000010395.51944.2a; Best KT, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abb7209; Best KT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47461-5; Best KT, 2019, FASEB J, V33, P8578, DOI 10.1096/fj.201900130RR; Buxton AN, 2011, TISSUE ENG PT A, V17, P371, DOI [10.1089/ten.tea.2009.0839, 10.1089/ten.TEA.2009.0839]; Chang YJ, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00027; Dakin SG, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1218-4; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; De Micheli AJ, 2020, AM J PHYSIOL-CELL PH, V319, pC885, DOI 10.1152/ajpcell.00372.2020; Disser NP, 2020, J PHYSIOL-LONDON, V598, P1537, DOI 10.1113/JP279646; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Evrova O, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020458; Hecht N, 2019, OSTEOARTHR CARTILAGE, V27, P1208, DOI 10.1016/j.joca.2019.04.010; HERRMANN H, 1980, EUR J BIOCHEM, V105, P63, DOI 10.1111/j.1432-1033.1980.tb04474.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Jo CH, 2019, TISSUE ENG REGEN MED, V16, P151, DOI 10.1007/s13770-019-00182-2; Kendal AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70786-5; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Li P, 2000, J IMMUNOL, V164, P5990, DOI 10.4049/jimmunol.164.11.5990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzocca AD, 2012, KNEE SURG SPORT TR A, V20, P1666, DOI 10.1007/s00167-011-1711-x; Nichols AEC, 2019, TRANSL RES, V209, P156, DOI 10.1016/j.trsl.2019.02.002; Nichols AEC, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0166-z; Pauly S, 2010, EUR CELLS MATER, V20, P84, DOI 10.22203/eCM.v020a08; Pietschmann MF, 2014, ARCH MED SCI, V10, P587, DOI 10.5114/aoms.2014.43752; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Smith CO, 2021, STEM CELLS DEV, V30, P149, DOI 10.1089/scd.2020.0141; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tan GK, 2020, ELIFE, V9, DOI 10.7554/eLife.52695; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; Teicher Beverly A, 2019, Oncotarget, V10, P993, DOI 10.18632/oncotarget.26590; van Vijven M, 2021, J ORTHOP RES, V39, P1561, DOI 10.1002/jor.24761; Wagenhauser MU, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-140; Wu YF, 2020, STEM CELLS DEV, V29, P1016, DOI 10.1089/scd.2020.0036; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061424; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JH, 2011, AM J PATHOL, V178, P382, DOI 10.1016/j.ajpath.2010.11.017	45	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21733	10.1096/fj.202100405R	http://dx.doi.org/10.1096/fj.202100405R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160846	Green Submitted, Green Accepted			2022-12-28	WOS:000667814100084
J	Adebayo, M; Singh, S; Singh, AP; Dasgupta, S				Adebayo, Mary; Singh, Seema; Singh, Ajay Pratap; Dasgupta, Santanu			Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis	FASEB JOURNAL			English	Review						diseases; dynamics; fission; fusion; mitochondria	DYNAMIN-RELATED PROTEIN-1; STRESS-INDUCED PHOSPHORYLATION; DOMINANT OPTIC ATROPHY; MITOFUSIN 2; SPORADIC PARKINSONS; OPA1 DEFICIENCY; MOUSE MODEL; DRP1; DISEASE; MUTATIONS	Mitochondria are highly dynamic, maternally inherited cytoplasmic organelles, which fulfill cellular energy demand through the oxidative phosphorylation system. Besides, they play an active role in calcium and damage-associated molecular patterns signaling, amino acid, and lipid metabolism, and apoptosis. Thus, the maintenance of mitochondrial integrity and homeostasis is extremely critical, which is achieved through continual fusion and fission. Mitochondrial fusion allows the transfer of gene products between mitochondria for optimal functioning, especially under metabolic and environmental stress. On the other hand, fission is crucial for mitochondrial division and quality control. The imbalance between these two processes is associated with various ailments such as cancer, neurodegenerative and cardiovascular diseases. This review discusses the molecular mechanisms that control mitochondrial fusion and fission and how the disruption of mitochondrial dynamics manifests into various disease conditions.	[Adebayo, Mary; Singh, Seema; Singh, Ajay Pratap; Dasgupta, Santanu] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA; [Adebayo, Mary; Singh, Seema; Singh, Ajay Pratap; Dasgupta, Santanu] Univ S Alabama, Dept Pathol, Coll Med, Mobile, AL USA; [Singh, Seema; Singh, Ajay Pratap; Dasgupta, Santanu] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL USA	University of South Alabama; University of South Alabama; University of South Alabama	Singh, AP; Dasgupta, S (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Pathol, Coll Med,Canc Biol Program, 1660 Springhill Ave, Mobile, AL 36604 USA.	asingh@health.southalabama.edu; dasgupta@southalabama.edu	Haastrup, Mary/GWC-8199-2022	Singh, Ajay/0000-0003-3492-6330; Haastrup, MD, Mary/0000-0001-6953-1449; DASGUPTA, SANTANU/0000-0002-1499-0039	HHS | National Institutes of Health (NIH) [CA185490, CA224306, CA204801, CA231925]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: CA185490, CA224306, CA204801 and CA231925	Archibald JM, 2015, CURR BIOL, V25, pR911, DOI 10.1016/j.cub.2015.07.055; Arduino DM, 2012, HUM MOL GENET, V21, P4680, DOI 10.1093/hmg/dds309; Arduino DM, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/767230; Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bannerman P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167573; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Bertholet AM, 2016, NEUROBIOL DIS, V90, P3, DOI 10.1016/j.nbd.2015.10.011; Bombelli F, 2014, JAMA NEUROL, V71, P1036, DOI 10.1001/jamaneurol.2014.629; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chakrabarti R, 2018, J CELL BIOL, V217, P251, DOI 10.1083/jcb.201709111; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1083-y; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cheng CT, 2016, CANCER RES, V76, P5006, DOI 10.1158/0008-5472.CAN-15-2921; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Esteves AR, 2014, BBA-MOL BASIS DIS, V1842, P7, DOI 10.1016/j.bbadis.2013.10.003; Esteves AR, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.005.2009; Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e; Ferre M, 2015, HUM MUTAT, V36, P20, DOI 10.1002/humu.22703; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Ge YF, 2020, ELIFE, V9, DOI 10.7554/eLife.50973; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Huang CY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1019-6; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Huang X, 2020, ACS OMEGA, V5, P23413, DOI 10.1021/acsomega.0c03143; Humphries BA, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01301-x; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Javadov S, 2011, BASIC RES CARDIOL, V106, P99, DOI 10.1007/s00395-010-0122-3; Kamerkar SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07543-w; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Kannan A, 2016, CLIN CANCER RES, V22, P3348, DOI 10.1158/1078-0432.CCR-15-2456; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321; Lenaers G, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-46; Li M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010121; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Liang CL, 2007, EXP NEUROL, V203, P370, DOI 10.1016/j.expneurol.2006.08.015; Ma YW, 2020, AM J CANCER RES, V10, P1278; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Machiela E, 2020, FASEB J, V34, P8475, DOI 10.1096/fj.201903235R; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Maycotte P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698391; Mottie S, 2018, J CELL BIOL, V217, P507, DOI 10.1083/jcb.201611194; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Patrushev MV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1457, DOI 10.1134/S0006297915110061; Prudent J, 2015, MOL CELL, V59, P941, DOI 10.1016/j.molcel.2015.08.001; Pyakurel A, 2015, MOL CELL, V58, P244, DOI 10.1016/j.molcel.2015.02.021; Qi YB, 2016, J CELL BIOL, V215, P621, DOI 10.1083/jcb.201609019; Qian W, 2013, EXPERT OPIN THER TAR, V17, P997, DOI 10.1517/14728222.2013.823160; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020; Rehklau K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.448; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011; Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13; Santos D, 2015, MOL NEUROBIOL, V52, P573, DOI 10.1007/s12035-014-8893-4; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Srinivasan S, 2017, BBA-BIOENERGETICS, V1858, P602, DOI 10.1016/j.bbabio.2017.01.004; Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Vasquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Wan YY, 2014, ONCOL REP, V32, P619, DOI 10.3892/or.2014.3235; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Yu MF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126915; Zhang Z, 2020, BRIT J CANCER, V122, P209, DOI 10.1038/s41416-019-0658-4; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	102	36	37	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21620	10.1096/fj.202100067R	http://dx.doi.org/10.1096/fj.202100067R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34048084	Green Accepted			2022-12-28	WOS:000655695900052
J	Harmsen, JF; van Polanen, N; van Weeghel, M; Wefers, J; Hoeks, J; Vaz, FM; Pras-Raves, ML; van Kampen, AHC; Schaart, G; van Moorsel, D; Hansen, J; Hesselink, MKC; Houtkooper, RH; Schrauwen, P				Harmsen, Jan-Frieder; van Polanen, Nynke; van Weeghel, Michel; Wefers, Jakob; Hoeks, Joris; Vaz, Frederic M.; Pras-Raves, Mia L.; van Kampen, Antoine H. C.; Schaart, Gert; van Moorsel, Dirk; Hansen, Jan; Hesselink, Matthijs K. C.; Houtkooper, Riekelt H.; Schrauwen, Patrick			Circadian misalignment disturbs the skeletal muscle lipidome in healthy young men	FASEB JOURNAL			English	Article						circadian clock; human skeletal muscle; insulin resistance; lipidomics; lipid droplet; shift work	INSULIN-RESISTANCE; DROPLET SIZE; CARDIOLIPIN; SENSITIVITY; SECRETION; PARADOX; ACID	Circadian misalignment, as seen in shift work, is associated with an increased risk to develop type 2 diabetes. In an experimental setting, we recently showed that a rapid day-night shift for 3 consecutive nights leads to misalignment of the core molecular clock, induction of the PPAR pathway, and insulin resistance in skeletal muscle of young, healthy men. Here, we investigated if circadian misalignment affects the skeletal muscle lipidome and intramyocellular lipid droplet characteristics, explaining the misalignment-induced insulin resistance. Fourteen healthy men underwent one aligned and one circadian misalignment period, both consisting of similar to 3.5 days. In the misaligned condition, day and night were rapidly shifted by 12 hours leading to opposite eating, sleep, and activity times compared with the aligned condition. For each condition, two muscle biopsies were taken from the m. vastus lateralis in the morning and evening and subjected to semi-targeted lipidomics and confocal microscopy analysis. We found that only 2% of detected lipids were different between morning and evening in the aligned condition, whereas 12% displayed a morning-evening difference upon misalignment. Triacylglycerols, in particular species of a carbon length >= 55, were the most abundant lipid species changed upon misalignment. Cardiolipins were decreased upon misalignment, whereas phosphatidylcholines consistently followed the same morning-evening pattern, suggesting regulation by the circadian clock. Cholesteryl esters adjusted to the shifted behavior. Lipid droplet characteristics remained unaltered upon misalignment. Together, these findings show that simulated shift work disturbs the skeletal muscle lipidome, which may contribute to misalignment-induced insulin resistance.	[Harmsen, Jan-Frieder; van Polanen, Nynke; Wefers, Jakob; Hoeks, Joris; Schaart, Gert; Hansen, Jan; Hesselink, Matthijs K. C.; Schrauwen, Patrick] Maastricht Univ Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Nutr & Movement Sci, Maastricht, Netherlands; [van Weeghel, Michel; Vaz, Frederic M.; Pras-Raves, Mia L.; Houtkooper, Riekelt H.] Univ Amsterdam, Lab Genet Metab Dis, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam Cardiovasc Sci,Amsterdam UMC, Amsterdam, Netherlands; [van Weeghel, Michel; Vaz, Frederic M.; Pras-Raves, Mia L.] Univ Amsterdam, Amsterdam Univ Med Ctr, Core Facil Metabol, Amsterdam, Netherlands; [Pras-Raves, Mia L.; van Kampen, Antoine H. C.] Univ Amsterdam, Bioinformat Lab, Dept Epidemiol & Data Sci, Amsterdam UMC, Amsterdam, Netherlands; [van Moorsel, Dirk] Maastricht Univ Med Ctr, Div Endocrinol, Dept Internal Med, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; University of Amsterdam; University of Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC)	Houtkooper, RH (corresponding author), Amsterdam UMC, Lab Genet Metab Dis, Locat AMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Schrauwen, P (corresponding author), Maastricht Univ Med Ctr, Dept Nutr & Movement Sci, POB 616, NL-6200 MD Maastricht, Netherlands.	r.h.houtkooper@amsterdamumc.nl; p.schrauwen@maastrichtuniversity.nl	Harmsen, Jan-Frieder/ABE-6103-2020; Houtkooper, Riekelt/P-5001-2019	Harmsen, Jan-Frieder/0000-0002-0962-8633; Hoeks, Joris/0000-0002-0265-0870; Houtkooper, Riekelt/0000-0001-9961-0842; Vaz, Frederic/0000-0002-9048-1041	Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation [CVON2014-02]; Netherlands Organization for Scientific Research [022.003.011, TOP 40-00812-98-14047]; School of Nutrition and Translational Research in Metabolism (NUTRIM) Netherlands Organization for Scientific Research (NWO) Graduate Programme; VIDI grant from ZonMw [91715305]	Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); School of Nutrition and Translational Research in Metabolism (NUTRIM) Netherlands Organization for Scientific Research (NWO) Graduate Programme(Netherlands Organization for Scientific Research (NWO)); VIDI grant from ZonMw	We acknowledge the support from the Netherlands Cardiovascular Research Initiative: an initiative with the support of the Dutch Heart Foundation (CVON2014-02 ENERGISE); this work is partly financed by the Netherlands Organization for Scientific Research (TOP 40-00812-98-14047 to PS); J. Hansen is supported by the School of Nutrition and Translational Research in Metabolism (NUTRIM) Netherlands Organization for Scientific Research (NWO) Graduate Programme, which is financially supported by Netherlands Organization for Scientific Research Grant 022.003.011; work in the Houtkooper group is financially supported by a VIDI grant from ZonMw (no. 91715305). The remaining authors declare no conflicts of interest.	Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Covington JD, 2017, OBESITY, V25, P2079, DOI 10.1002/oby.21980; Daemen S, 2018, MOL METAB, V17, P71, DOI 10.1016/j.molmet.2018.08.004; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Gemmink A, 2017, BBA-MOL CELL BIOL L, V1862, P1242, DOI 10.1016/j.bbalip.2017.07.010; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Grimaldi D, 2016, HYPERTENSION, V68, P243, DOI 10.1161/HYPERTENSIONAHA.115.06847; Gutierrez-Monreal MA, 2020, OBESITY, V28, pS46, DOI 10.1002/oby.22826; Held NM, 2020, MOL METAB, V37, DOI 10.1016/j.molmet.2020.100989; Herzog K, 2016, J LIPID RES, V57, P1447, DOI 10.1194/jlr.M067470; Hodge BA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0039-5; Hommelberg PPH, 2009, AM J PHYSIOL-ENDOC M, V296, pE114, DOI 10.1152/ajpendo.00436.2007; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Koshy A, 2019, FASEB J, V33, P6789, DOI 10.1096/fj.201801889R; Loizides-Mangold U, 2017, P NATL ACAD SCI USA, V114, pE8565, DOI 10.1073/pnas.1705821114; Machann J, 2011, MAGN RESON MATER PHY, V24, P29, DOI 10.1007/s10334-010-0233-8; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Nielsen J, 2017, AM J PHYSIOL-ENDOC M, V313, pE721, DOI 10.1152/ajpendo.00062.2017; Saad A, 2012, DIABETES, V61, P2691, DOI 10.2337/db11-1478; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Sulli G, 2018, TRENDS PHARMACOL SCI, V39, P812, DOI 10.1016/j.tips.2018.07.003; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	25	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21611	10.1096/fj.202100143R	http://dx.doi.org/10.1096/fj.202100143R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33977623				2022-12-28	WOS:000655695900027
J	Lefevre, C; Chartoire, D; Ferraz, JC; Verdier, T; Pinteur, C; Chanon, S; Pesenti, S; Vieille-Marchiset, A; Genestier, L; Vidal, H; Mey, A				Lefevre, Camille; Chartoire, Dimitri; Ferraz, Jose Candido; Verdier, Thomas; Pinteur, Claudie; Chanon, Stephanie; Pesenti, Sandra; Vieille-Marchiset, Aurelie; Genestier, Laurent; Vidal, Hubert; Mey, Anne			Obesity activates immunomodulating properties of mesenchymal stem cells in adipose tissue with differences between localizations	FASEB JOURNAL			English	Article						adipose tissue; immune regulation-immunometabolism; low-grade inflammation; mesenchymal stem cells; obesity	INSULIN-RESISTANCE; INDUCED INFLAMMATION; T-CELLS; FAT; ADIPOCYTES; KEY; ADIPOGENESIS; SUPPRESSION; EXPRESSION; ADIPOKINES	Mesenchymal stem cells from healthy adipose tissue are adipocytes progenitors with immunosuppressive potential that are used for years in cell therapy. Whether adipose stem cells (ASC) may prevent inflammation in early obesity is not known. To address this question, we performed a kinetic study of high-fat (HF) diet induced obesity in mice to follow the immune regulating functions of adipose stem cells (ASC) isolated from the subcutaneous (SAT) and the visceral adipose tissue (VAT). Our results show that, early in obesity and before inflammation was detected, HF diet durably and differently activated ASC from SAT and VAT. Subcutaneous ASC from HF-fed mice strongly inhibited the proliferation of activated T lymphocytes, whereas visceral ASC selectively inhibited TNF alpha expression by macrophages and simultaneously released higher concentrations of IL6. These depot specific differences may contribute to the low-grade inflammation that develops with obesity in VAT while inflammation in SAT is delayed. The mechanisms involved differ from those already described for naive cells activation with inflammatory cytokines and probably engaged metabolic activation. These results evidence that adipose stem cells are metabolic sensors acquiring an obesity-primed immunocompetent state in answer to depot-specific intrinsic features with overnutrition, placing these cells ahead of inflammation in the local dialog with immune cells.	[Lefevre, Camille; Verdier, Thomas; Pinteur, Claudie; Chanon, Stephanie; Pesenti, Sandra; Vieille-Marchiset, Aurelie; Vidal, Hubert; Mey, Anne] Univ Claude Bernard Lyon 1, Univ Lyon, CarMeN Lab, INSERM,INRAE 1397,INSA Lyon,U1060, Oullins, France; [Lefevre, Camille; Verdier, Thomas; Pinteur, Claudie; Chanon, Stephanie; Pesenti, Sandra; Vieille-Marchiset, Aurelie; Vidal, Hubert; Mey, Anne] Hop Lyon Sud, Hosp Civils Lyon, Fac Med, Oullins, France; [Chartoire, Dimitri; Genestier, Laurent] Univ Claude Bernard Lyon I, Fac Med Lyon Sud, Equipe Labellisee Ligue Canc, CRCL,INSERM,CNRS,Ctr Leon Berard,U1052,UMR5286, Oullins, France; [Ferraz, Jose Candido] Fed Univ Pernambuco UFPE, Dept Phys Educ & Sports Sci, CAV, Vitoria De Santo Antao, Brazil	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Universidade Federal de Pernambuco	Mey, A (corresponding author), Hop Lyon Sud, CarMeN Lab, INSERM, U1060, Batiment CENS ELI 2D,165 Chemin Grand Revoyet, F-69921 Oullins, France.	anne.mey@inrae.fr	Vidal, Hubert/M-6674-2017; Carmen, Team1/Y-7382-2019; GENESTIER, Laurent/H-6443-2016	Vidal, Hubert/0000-0002-9467-0317; Carmen, Team1/0000-0003-4234-1746; MEY, Anne/0000-0002-2643-5702; Lefevre, Camille/0000-0002-8508-7437; Chanon, Stephanie/0000-0001-6930-6671; Pesenti, Sandra/0000-0003-4037-208X; Lab, Carmen/0000-0002-5935-3236; GENESTIER, Laurent/0000-0002-0527-4583	INRA-CIRAD: Glofoods programme; INSERM [INSERM U1060-INRA 1397]; University Lyon I [INSERM U1060-INRA 1397]; INRA [INSERM U1060-INRA 1397]; French Ministry of Higher Education and Research; Institute Carnot/CALYM; La Ligue Nationale Contre le Cancer (LNCC)-Equipe Labellisee LIGUE contre le Cancer; CAPES-COFECUB program	INRA-CIRAD: Glofoods programme; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Lyon I; INRA; French Ministry of Higher Education and Research; Institute Carnot/CALYM; La Ligue Nationale Contre le Cancer (LNCC)-Equipe Labellisee LIGUE contre le Cancer; CAPES-COFECUB program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by a grant from INRA-CIRAD: Glofoods programme and from recurrent funding from INSERM, University Lyon I and INRA to the CarMeN laboratory (INSERM U1060-INRA 1397). Camille Lefevre was supported by a PhD fellowship from the French Ministry of Higher Education and Research. Laurent Genestier was supported by The Institute Carnot/CALYM and La Ligue Nationale Contre le Cancer (LNCC)-Equipe Labellisee LIGUE contre le Cancer. Jose Candido Ferraz was supported by the CAPES-COFECUB program. The study funders were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report	Alligier M, 2013, J CLIN ENDOCR METAB, V98, P802, DOI 10.1210/jc.2012-3289; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Baptista LS, 2015, WORLD J STEM CELLS, V7, P165, DOI 10.4252/wjsc.v7.i1.165; Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.3.CO;2-7; Bluher M, 2016, CLIN SCI, V130, P1603, DOI 10.1042/CS20160005; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caussy C, 2020, OBESITY, V28, P1175, DOI 10.1002/oby.22842; Chatzigeorgiou A, 2012, DIABETOLOGIA, V55, P2583, DOI 10.1007/s00125-012-2607-0; Chinnadurai R, 2014, J IMMUNOL, V192, P1491, DOI 10.4049/jimmunol.1301828; De Girolamo L, 2013, INT J IMMUNOPATH PH, V26, P11, DOI 10.1177/03946320130260S103; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Duan YH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02649; Eljaafari A, 2015, DIABETES, V64, P2477, DOI 10.2337/db15-0162; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Han MS, 2020, P NATL ACAD SCI USA, V117, P2751, DOI 10.1073/pnas.1920004117; Harbrecht BG, 1997, J LEUKOCYTE BIOL, V61, P712, DOI 10.1002/jlb.61.6.712; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kaundal U, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1403-0; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kulshrestha H, 2018, DIABETES METAB SYND, V12, P543, DOI 10.1016/j.dsx.2018.03.019; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n; Lefevre C, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/9323864; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nasef A, 2007, GENE EXPRESSION, V13, P217; Nishimura S, 2013, CELL METAB, V18, P759, DOI 10.1016/j.cmet.2013.09.017; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Serena C, 2016, STEM CELLS, V34, P2559, DOI 10.1002/stem.2429; Serrano R, 2009, AM J PHYSIOL-REG I, V297, pR1563, DOI 10.1152/ajpregu.00093.2009; Shang QW, 2015, STEM CELLS DEV, V24, P2052, DOI 10.1089/scd.2014.0557; Shirjang S, 2017, CELL IMMUNOL, V315, P1, DOI 10.1016/j.cellimm.2016.12.005; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Stolarczyk E, 2017, CURR OPIN PHARMACOL, V37, P35, DOI 10.1016/j.coph.2017.08.006; Vernon RG, 2001, DOMEST ANIM ENDOCRIN, V21, P197, DOI 10.1016/S0739-7240(01)00121-7; Wang Q, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02509; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008	50	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21650	10.1096/fj.202002046RR	http://dx.doi.org/10.1096/fj.202002046RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33993539				2022-12-28	WOS:000655695900003
J	Wang, FF; Xiao, F; Du, LJ; Niu, YG; Yin, HR; Zhou, ZH; Jiang, XX; Jiang, HZ; Yuan, FX; Liu, K; Chen, SH; Duan, SZ; Guo, FF				Wang, Fenfen; Xiao, Fei; Du, Linjuan; Niu, Yuguo; Yin, Hanrui; Zhou, Ziheng; Jiang, Xiaoxue; Jiang, Haizhou; Yuan, Feixiang; Liu, Kan; Chen, Shanghai; Duan, Shengzhong; Guo, Feifan			Activation of GCN2 in macrophages promotes white adipose tissue browning and lipolysis under leucine deprivation	FASEB JOURNAL			English	Article						GCN2; leucine deprivation; lipolysis; macrophage; white adipose tissue browning	CATECHOLAMINE-INDUCED LIPOLYSIS; ALTERNATIVE ACTIVATION; SKELETAL-MUSCLE; OBESITY; STRESS; PROLIFERATION; ADIPOCYTES; RESISTANCE; ABLATION; LEPTIN	We have previously shown that leucine deprivation stimulates browning and lipolysis in white adipose tissue (WAT), which helps to treat obesity. Adipose tissue macrophages (ATMs) significantly influence WAT browning and lipolysis. However, it is unclear whether ATMs are involved in leucine deprivation-induced browning and lipolysis in WAT; the associated signals remain to be elucidated. Here, we investigated the role of ATMs and the possible mechanisms involved in WAT browning and lipolysis under leucine-deprivation conditions. In this study, macrophages were depleted in mice by injecting clodronate-liposomes (CLOD) into subcutaneous white adipose tissues. Then, mice lacking general control nonderepressible 2 kinase (GCN2), which is a sensor of amino acid starvation, specifically in Lyz2-expressing cells, were generated to investigate the changes in leucine deprivation-induced WAT browning and lipolysis. We found leucine deprivation decreased the accumulation and changed the polarization of ATMs. Ablation of macrophages by CLOD impaired WAT browning and lipolysis under leucine-deprivation conditions. Mechanistically, leucine deprivation activated GCN2 signals in macrophages. Myeloid-specific abrogation of GCN2 in mice blocked leucine deprivation-induced browning and lipolysis in WAT. Further analyses revealed that GCN2 activation in macrophages reduced the expression of monoamine oxidase A (MAOA), resulting in increased norepinephrine (NE) secretion from macrophages to adipocytes, and this resulted in enhanced WAT browning and lipolysis. Moreover, the injection of CL316,243, a beta 3-adrenergic receptor agonist, and inhibition of MAOA effectively increased the level of NE, leading to the enhancement of browning and lipolysis of WAT in myeloid GCN2 knockout mice under leucine deprivation. Collectively, our results demonstrate a novel function of GCN2 signals in macrophages, that is, regulating WAT browning and lipolysis under leucine deprivation. Our study provides important hints for possible treatment for obesity.	[Wang, Fenfen; Xiao, Fei; Niu, Yuguo; Yin, Hanrui; Zhou, Ziheng; Jiang, Xiaoxue; Jiang, Haizhou; Yuan, Feixiang; Liu, Kan; Chen, Shanghai; Guo, Feifan] Chinese Acad Sci, CAS Key Lab Nutr Metab & Food Safety, Innovat Ctr Intervent Chron Dis & Promot Hlth, Shanghai Inst Nutr & Hlth,Univ Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Du, Linjuan; Duan, Shengzhong] Shanghai Jiao Tong Univ Sch Med, Shanghai Ninth Peoples Hosp Res Ctr, Shanghai, Peoples R China; [Guo, Feifan] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Guo, FF (corresponding author), Chinese Acad Sci, CAS Key Lab Nutr Metab & Food Safety, Innovat Ctr Intervent Chron Dis & Promot Hlth, Shanghai Inst Nutr & Hlth,Univ Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	ffguo@sibs.ac.cn	Du, Linjuan/GZL-3707-2022		National Key R&D Program of China [2018YFA0800600]; National Natural Science Foundation [91957207, 31830044, 81970742, 81870592, 81770852, 81970731, 82000764]; CAS Interdisciplinary Innovation Team, Novo Nordisk-Chinese Academy of Sciences Research Fund [NNCAS-2008-10]	National Key R&D Program of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); CAS Interdisciplinary Innovation Team, Novo Nordisk-Chinese Academy of Sciences Research Fund	The National Key R&D Program of China, Grant/Award Number: 2018YFA0800600; The National Natural Science Foundation, Grant/Award Number: 91957207,31830044, 81970742,81870592,81770852,81970731,82000764; CAS Interdisciplinary Innovation Team, Novo Nordisk-Chinese Academy of Sciences Research Fund, Grant/Award Number: NNCAS-2008-10	Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Apovian Caroline M, 2016, Am J Manag Care, V22, ps176; Arnold AC, 2017, J CLIN ENDOCR METAB, V102, P10, DOI 10.1210/jc.2016-3274; Brunner JS, 2020, NAT METAB, DOI 10.1038/s42255-020-00311-5; Bu Y, 2018, DIABETES, V67, P1761, DOI 10.2337/db17-1201; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Cheng Y, 2010, DIABETES, V59, P17, DOI 10.2337/db09-0929; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; COUSIN B, 1992, J CELL SCI, V103, P931; Dever TE, 2005, MOL CELL, V18, P141, DOI 10.1016/j.molcel.2005.03.023; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Feng J, 2018, CELL MOL IMMUNOL, V15, P493, DOI 10.1038/cmi.2016.71; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Halaby MJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax8189; Hu JM, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0017; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Jocken JWE, 2008, PHYSIOL BEHAV, V94, P219, DOI 10.1016/j.physbeh.2008.01.002; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Keiran N, 2019, NAT IMMUNOL, V20, P581, DOI 10.1038/s41590-019-0372-7; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Liu HY, 2014, MOL CELL BIOL, V34, P428, DOI 10.1128/MCB.00946-13; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marie LS, 2003, ENDOCRINOLOGY, V144, P4427, DOI 10.1210/en.2003-0561; Mullins GR, 2014, P NATL ACAD SCI USA, V111, P17450, DOI 10.1073/pnas.1410530111; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Ravishankar B, 2015, P NATL ACAD SCI USA, V112, P10774, DOI 10.1073/pnas.1504276112; Shan B, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00301-7; Shan B, 2017, NAT IMMUNOL, V18, P519, DOI 10.1038/ni.3709; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yuan FX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16662-2; Zheng CX, 2015, P NATL ACAD SCI USA, V112, pE7239, DOI 10.1073/pnas.1500396113; Zhou QL, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00153-17; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	45	2	2	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21652	10.1096/fj.202100061RR	http://dx.doi.org/10.1096/fj.202100061RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34004054				2022-12-28	WOS:000655695900002
J	Hanna, AD; Lee, CS; Babcock, L; Wang, H; Recio, J; Hamilton, SL				Hanna, Amy D.; Lee, Chang Seok; Babcock, Lyle; Wang, Hui; Recio, Joseph; Hamilton, Susan L.			Pathological mechanisms of vacuolar aggregate myopathy arising from a Casq1 mutation	FASEB JOURNAL			English	Article						calsequestrin; EC coupling; ER stress; myopathy; sarcoplasmic reticulum	SARCOPLASMIC-RETICULUM CONNECTION; INCLUSION-BODY MYOSITIS; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE; PROTEASOME INHIBITION; PROTEIN-SYNTHESIS; ER-STRESS; CALSEQUESTRIN; CA2+; CALCIUM	Mice with a mutation (D244G, DG) in calsequestrin 1 (CASQ1), analogous to a human mutation in CASQ1 associated with a delayed onset human myopathy (vacuolar aggregate myopathy), display a progressive myopathy characterized by decreased activity, decreased ability of fast twitch muscles to generate force and low body weight after one year of age. The DG mutation causes CASQ1 to partially dissociate from the junctional sarcoplasmic reticulum (SR) and accumulate in the endoplasmic reticulum (ER). Decreased junctional CASQ1 reduces SR Ca2+ release. Muscles from older DG mice display ER stress, ER expansion, increased mTOR signaling, inadequate clearance of aggregated proteins by the proteasomes, and elevation of protein aggregates and lysosomes. This study suggests that the myopathy associated with the D244G mutation in CASQ1 is driven by CASQ1 mislocalization, reduced SR Ca2+ release, CASQ1 misfolding/aggregation and ER stress. The subsequent maladaptive increase in protein synthesis and decreased protein aggregate clearance are likely to contribute to disease progression.	[Hanna, Amy D.; Lee, Chang Seok; Babcock, Lyle; Wang, Hui; Recio, Joseph; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA	Baylor College of Medicine	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA.	susanh@bcm.edu	Wang, Hui J./AAT-7096-2020	Wang, Hui J./0000-0003-2654-0243; Hanna, Amy/0000-0001-6418-6666	Muscular Dystrophy Association (MDA) [548809]; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [NIH AR072475, NIH AR053349]; HHS | National Institutes of Health (NIH) [T32HL007676]	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Muscular Dystrophy Association (MDA), Grant/Award Number: 548809; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: NIH AR072475 and NIH AR053349; HHS | National Institutes of Health (NIH), Grant/Award Number: T32HL007676	An H, 2019, MOL CELL, V74, P891, DOI 10.1016/j.molcel.2019.03.034; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; Babcock LW, 2011, J GEN PHYSIOL; Beard NA, 2009, EUR BIOPHYS J BIOPHY, V39, P27, DOI 10.1007/s00249-009-0449-6; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bohm J, 2018, ACTA NEUROPATHOL, V135, P149, DOI 10.1007/s00401-017-1775-x; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Di Blasi C, 2015, J MED GENET, V52, P617, DOI 10.1136/jmedgenet-2014-102882; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X; Fuqua JD, 2019, FASEB J, V33, P11735, DOI 10.1096/fj.201900766R; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; Goebel HH, 2000, MOL GENET METAB, V71, P267, DOI 10.1006/mgme.2000.3064; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Guo A, 2012, J BIOL CHEM, V287, P16670, DOI 10.1074/jbc.M112.340927; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Houle TD, 2006, EXP CELL RES, V312, P4150, DOI 10.1016/j.yexcr.2006.09.010; Hwang JW, 2018, TRENDS BIOCHEM SCI, V43, P593, DOI 10.1016/j.tibs.2018.06.005; Kaakinen M, 2008, EXP CELL RES, V314, P237, DOI 10.1016/j.yexcr.2007.10.009; Kaisto T, 2003, EXP CELL RES, V289, P47, DOI 10.1016/S0014-4827(03)00231-3; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Lamboley CR, 2013, J PHYSIOL-LONDON, V591, P6053, DOI 10.1113/jphysiol.2013.265900; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Lavorato M, 2017, MICROS TODAY, V25, P40; Lee CS, 2014, J BIOL CHEM, V289, P25556, DOI 10.1074/jbc.M114.586289; Lee CY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15502; Lewis KM, 2015, J BIOL CHEM, V290, P28665, DOI 10.1074/jbc.M115.686261; Manno C, 2017, P NATL ACAD SCI USA, V114, pE638, DOI 10.1073/pnas.1620265114; McFarland TP, 2010, J MOL CELL CARDIOL, V49, P556, DOI 10.1016/j.yjmcc.2010.05.012; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michelucci A, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.202012617; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Rossi D, 2008, TRAFFIC, V9, P1044, DOI 10.1111/j.1600-0854.2008.00717.x; Rossi D, 2014, HUM MUTAT, V35, P1163, DOI 10.1002/humu.22631; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Samant RS, 2018, NATURE, V563, P407, DOI 10.1038/s41586-018-0678-x; Sanchez EJ, 2012, J BIOL CHEM, V287, P3042, DOI 10.1074/jbc.M111.326363; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Semplicini C, 2018, NEUROLOGY, V91, pE1629, DOI 10.1212/WNL.0000000000006387; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026; Tomelleri G, 2006, BRAIN, V129, P2085, DOI 10.1093/brain/awl128; VILLA A, 1993, EXP CELL RES, V209, P140, DOI 10.1006/excr.1993.1294; VOLPE P, 1992, P NATL ACAD SCI USA, V89, P6142, DOI 10.1073/pnas.89.13.6142; Wang HY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17937-4; Wang LM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11349; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Xiao YJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12271; Yoshida I, 2006, NEUROCHEM INT, V48, P696, DOI 10.1016/j.neuint.2005.12.012; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zito E, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101232	71	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21349	10.1096/fj.202001653RR	http://dx.doi.org/10.1096/fj.202001653RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33786938	Green Accepted			2022-12-28	WOS:000645260100030
J	Marsh, SA; Park, C; Redgrave, RE; Singh, E; Draganova, L; Boag, SE; Spray, L; Ali, S; Spyridopoulos, I; Arthur, HM				Marsh, Sarah A.; Park, Catherine; Redgrave, Rachael E.; Singh, Esha; Draganova, Lilia; Boag, Stephen E.; Spray, Luke; Ali, Simi; Spyridopoulos, Ioakim; Arthur, Helen M.			Rapid fall in circulating non-classical monocytes in ST elevation myocardial infarction patients correlates with cardiac injury	FASEB JOURNAL			English	Article						animal models; coronary circulation; monocytes; myocardial infarction	SPINAL-CORD; LEUCINE SUPPLEMENTATION; PTEN; SYSTEM; ACTIVATION; REGENERATION; MICROTUBULES; LOCOMOTION; SURVIVAL; DELETION	Myocardial infarction leads to a rapid innate immune response that is ultimately required for repair of damaged heart tissue. We therefore examined circulating monocyte dynamics immediately after reperfusion of the culprit coronary vessel in STEMI patients to determine whether this correlated with level of cardiac injury. A mouse model of cardiac ischemia/reperfusion injury was subsequently used to establish the degree of monocyte margination to the coronary vasculature that could potentially contribute to the drop in circulating monocytes. We retrospectively analyzed blood samples from 51 STEMI patients to assess the number of non-classical (NC), classical, and intermediate monocytes immediately following primary percutaneous coronary intervention. Classical and intermediate monocytes showed minimal change. On the other hand, circulating numbers of NC monocytes fell by approximately 50% at 90 minutes post-reperfusion. This rapid decrease in NC monocytes was greatest in patients with the largest infarct size (P < .05) and correlated inversely with left ventricular function (r = 0.41, P = .04). The early fall in NC monocytes post-reperfusion was confirmed in a second prospective study of 13 STEMI patients. Furthermore, in a mouse cardiac ischemia model, there was significant monocyte adhesion to coronary vessel endothelium at 2 hours post-reperfusion pointing to a specific and rapid vessel margination response to cardiac injury. In conclusion, rapid depletion of NC monocytes from the circulation in STEMI patients following coronary artery reperfusion correlates with the level of acute cardiac injury and involves rapid margination to the coronary vasculature.	[Marsh, Sarah A.; Redgrave, Rachael E.; Singh, Esha; Arthur, Helen M.] Newcastle Univ, Biosci Inst, Ctr Life, Newcastle NE1 3BZ, England; [Park, Catherine; Draganova, Lilia; Boag, Stephen E.; Spyridopoulos, Ioakim] Newcastle Univ, Ctr Life, Translat & Clin Res Inst, Newcastle NE1 3BZ, England; [Spray, Luke] Freeman Rd Hosp, Cardiol Dept, Newcastle, England; [Ali, Simi] Translat & Clin Res Inst, Leech Bldg, Newcastle, England	Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital	Arthur, HM (corresponding author), Newcastle Univ, Biosci Inst, Ctr Life, Newcastle NE1 3BZ, England.; Spyridopoulos, I (corresponding author), Newcastle Univ, Ctr Life, Translat & Clin Res Inst, Newcastle NE1 3BZ, England.	ioakim.spyridopoulos@ncl.ac.uk; helen.arthur@ncl.ac.uk			British Heart Foundation [PG/18/25/33587, FS/15/77/31823, FS/12/31/29533]; MRC DiMeN studentship award	British Heart Foundation(British Heart Foundation); MRC DiMeN studentship award	This work was supported by British Heart Foundation awards PG/18/25/33587, FS/15/77/31823, and FS/12/31/29533. SAM was supported by an MRC DiMeN studentship award	de Moraes WMAM, 2015, NUTRIENTS, V7, P3751, DOI 10.3390/nu7053751; Anderson MA, 2018, NATURE, V561, P396, DOI 10.1038/s41586-018-0467-6; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Berry M, 2016, NEUROBIOL DIS, V85, P99, DOI 10.1016/j.nbd.2015.10.002; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Chen CH, 2016, EXP NEUROL, V278, P27, DOI 10.1016/j.expneurol.2016.01.023; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dhamija R, 2020, CLIN IMAG, V60, P180, DOI 10.1016/j.clinimag.2019.12.006; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Elghazi L, 2017, MOL METAB, V6, P560, DOI 10.1016/j.molmet.2017.03.010; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Hu ZL, 2017, MOL BIOL CELL, V28, P545, DOI 10.1091/mbc.E16-09-0628; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Ishizuka Y, 2008, J NEUROCHEM, V106, P934, DOI 10.1111/j.1471-4159.2008.05438.x; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu M, 2010, J NEUROSCI, V30, P14896, DOI 10.1523/JNEUROSCI.3739-10.2010; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Matamoros AJ, 2019, J NEUROSCI, V39, P2011, DOI 10.1523/JNEUROSCI.1888-18.2018; Morgan-Warren PJ, 2013, INVEST OPHTH VIS SCI, V54, P6903, DOI 10.1167/iovs.13-12803; Ohtake Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37152; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Pedroso JAB, 2015, NUTRIENTS, V7, P3914, DOI 10.3390/nu7053914; Pereira MG, 2014, NUTRIENTS, V6, P3981, DOI 10.3390/nu6103981; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Poulopoulos A, 2019, NATURE, V565, P356, DOI 10.1038/s41586-018-0847-y; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Teng L, 2021, BIOCHEM BIOPH RES CO, V534, P121, DOI 10.1016/j.bbrc.2020.11.120; Tran AP, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113276; Wei XY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091075; Wu RH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01303; Yang T, 2016, NEUROPHARMACOLOGY, V110, P343, DOI 10.1016/j.neuropharm.2016.06.015; Yang T, 2020, FASEB J, V34, P15504, DOI 10.1096/fj.202001657RR; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571; Zanchi D, 2016, SCI REP-UK, V6, DOI 10.1038/srep35727; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	42	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21604	10.1096/fj.202100240R	http://dx.doi.org/10.1096/fj.202100240R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913566	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000645260100109
J	Tan, F; Rui, XQ; Xiang, X; Yu, ZR; Al-Rubeai, M				Tan, Fei; Rui, Xiaoqing; Xiang, Xue; Yu, Zuoren; Al-Rubeai, Mohamed			Multimodal treatment combining cold atmospheric plasma and acidic fibroblast growth factor for multi-tissue regeneration	FASEB JOURNAL			English	Article						angiogenesis; atmospheric plasma; cell attachment; cell differentiation; cell migration; cell proliferation; cold plasma; EA.hy926; FGF; L-929; neurogenesis; neurite; nonthermal plasma; osteogenesis; PC-12; plasma-activated medium; plasma medicine; Saos-2; wound healing	ESTROGEN-RECEPTOR-ALPHA; OVIDUCTAL TRANSPORT; FACTOR-I; CELL; PROTEIN; EXPRESSION; ESTRADIOL; PROLIFERATION; HYDROSALPINX; DISRUPTION	Cold atmospheric plasma (CAP) is an emerging technology for biomedical applications, exemplified by its antimicrobial and antineoplastic potentials. On the contrary, acidic fibroblast growth factor (aFGF) has been a long-standing potent mitogen for cells from various origins. In this study, we are the first to develop a multimodal treatment combining the aforementioned physicochemical and pharmacological treatments and investigated their individual and combined effects on wound healing, angiogenesis, neurogenesis, and osteogenesis. This work was performed at the tissue, cellular, protein, and gene levels, using histochemical staining, flow cytometry, ELISA, and PCR, respectively. Depending on the type of target tissue, various combinations of aforementioned methods were used. The results showed that the enhancement on would healing and angiogenesis by CAP and aFGF were synergistic. The former was manifested by increased murine fibroblast proliferation and reduced cutaneous tissue inflammation, whereas the latter by upregulated proangiogenic markers in vivo, for example, CD31, VEGF, and TGF-beta, and downregulated antiangiogenic proteins in vitro, for example, angiostatin and angiopoietin-2, respectively. In addition, aFGF outperformed CAP during neurogenesis, which was evidenced by superior neurite outgrowth, while CAP exceeded aFGF in osteogenesis which was demonstrated by more substantial bone nodule formation. These novel findings not only support the fact that CAP and aFGF are both multipotent agents during tissue regeneration, but also highlight the potential of our multimodal treatment combining the individual advantages of CAP and aFGF. The versatile administration route, that is, topical and/or systemic, might further broaden its applications.	[Tan, Fei; Rui, Xiaoqing] Shanghai East Hosp, Dept ORL HNS, Shanghai, Peoples R China; [Tan, Fei; Yu, Zuoren] Tongji Univ, Sch Med, Shanghai, Peoples R China; [Tan, Fei] Royal Coll Surgeons England, London, England; [Xiang, Xue; Yu, Zuoren] Shanghai East Hosp, Res Ctr Translat Med, Shanghai, Peoples R China; [Al-Rubeai, Mohamed] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland	Tongji University; Royal College of Surgeons of England; University College Dublin	Tan, F (corresponding author), Shanghai East Hosp, Dept ORL HNS, Shanghai, Peoples R China.	iatrologist@163.com		Tan, Fei/0000-0003-1010-0163	Fundamental Research Funds for the Central Universities; Shanghai Pujiang Program [19PJ1408800]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work is sponsored by the Fundamental Research Funds for the Central Universities. It is also sponsored by Shanghai Pujiang Program (project no. 19PJ1408800).	Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Alminana C, 2017, REPRODUCTION, V154, P253, DOI 10.1530/REP-17-0054; Barton BE, 2020, REPRODUCTION, V159, pR125, DOI 10.1530/REP-19-0189; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Beyler SA, 1997, HUM REPROD, V12, P2724, DOI 10.1093/humrep/12.12.2724; Bonilla AQS, 2011, MOL CELL ENDOCRINOL, V332, P170, DOI 10.1016/j.mce.2010.10.009; Borel F, 2018, P NATL ACAD SCI USA, V115, P2788, DOI 10.1073/pnas.1713689115; BRENNER RM, 1969, FERTIL STERIL, V20, P599; Chronopoulou E, 2015, HUM REPROD UPDATE, V21, P39, DOI 10.1093/humupd/dmu040; Croxatto H.B., 1991, ARCH BIOL MED EXP, V24, P403; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Diao HL, 2010, FERTIL STERIL, V94, P2808, DOI 10.1016/j.fertnstert.2010.06.034; DOHERTY AS, 1994, MOL REPROD DEV, V37, P21, DOI 10.1002/mrd.1080370104; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Ford MJ., 2020, OVIDUCT EPITHELIAL C, DOI [10.1101/2020.08.21.261016, DOI 10.1101/2020.08.21.261016]; FREEMAN DA, 1992, J REPROD FERTIL, V95, P535, DOI 10.1530/jrf.0.0950535; Harris EA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218280; HARVEY MB, 1992, MECH DEVELOP, V38, P169, DOI 10.1016/0925-4773(92)90050-T; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2019, J BIOL CHEM, V294, P9746, DOI 10.1074/jbc.RA119.008759; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hong SH, 2004, MOL CELLS, V17, P477; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; LAMPRON C, 1995, DEVELOPMENT, V121, P539; Lee KF, 2006, ENDOCRINOLOGY, V147, P79, DOI 10.1210/en.2005-0596; Lee YL, 2004, J BIOL CHEM, V279, P12763, DOI 10.1074/jbc.M311160200; Li S, 2017, FASEB J, V31, P1595, DOI 10.1096/fj.201601128R; Li S, 2017, J ENDOCRINOL, V232, pR1, DOI [10.1530/JOE-16-0302, 10.1530/joe-16-0302]; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; McInnes L, UMAP UNIFORM MANIFOL; Mukherjee T, 1996, FERTIL STERIL, V66, P851, DOI 10.1016/S0015-0282(16)58652-X; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Orihuela PA, 2003, BIOL REPROD, V68, P1225, DOI 10.1095/biolreprod.102.011395; Orihuela PA, 2001, BIOL REPROD, V65, P1238, DOI 10.1095/biolreprod65.4.1238; Orostica ML, 2014, REPRODUCTION, V148, P285, DOI 10.1530/REP-14-0128; ORTIZ ME, 1989, BIOL REPROD, V41, P381, DOI 10.1095/biolreprod41.3.381; ORTIZ ME, 1986, BIOL REPROD, V34, P777, DOI 10.1095/biolreprod34.4.777; Ozmen B, 2007, REPROD BIOMED ONLINE, V14, P235, DOI 10.1016/S1472-6483(10)60792-4; Pillai VV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188105; Polanski K, 2020, BIOINFORMATICS, V36, P964, DOI 10.1093/bioinformatics/btz625; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; Reuquen P, 2015, REPRODUCTION, V150, P331, DOI 10.1530/REP-15-0137; Saraiya M, 1998, AM J OBSTET GYNECOL, V178, P493, DOI 10.1016/S0002-9378(98)70427-2; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Stuart T., 2019, CELL, V177, P1888, DOI [DOI 10.1016/j.cell.2019.05.031, DOI 10.1016/J.CELL.2019.05.031]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tibbetts TA, 1998, BIOL REPROD, V59, P1143, DOI 10.1095/biolreprod59.5.1143; Velazquez MA, 2012, THERIOGENOLOGY, V78, P517, DOI 10.1016/j.theriogenology.2012.02.034; Velazquez MA, 2009, REPRODUCTION, V137, P161, DOI 10.1530/REP-08-0362; WEBER JA, 1991, BIOL REPROD, V45, P540, DOI 10.1095/biolreprod45.4.540; WEBER JA, 1991, BIOL REPROD, V45, P544, DOI 10.1095/biolreprod45.4.544; Winuthayanon W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07728-1; Winuthayanon W, 2015, ELIFE, V4, DOI 10.7554/eLife.10453; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Wolf A., SCANPY TUTORIALS; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	59	4	4	4	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21442	10.1096/fj.202002611R	http://dx.doi.org/10.1096/fj.202002611R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774850				2022-12-28	WOS:000645260100071
J	Tang, M; Chen, Y; Li, BR; Sugimoto, H; Yang, SJ; Yang, CQ; LeBleu, VS; McAndrews, KM; Kalluri, R				Tang, Min; Chen, Yang; Li, Bingrui; Sugimoto, Hikaru; Yang, Sujuan; Yang, Changqing; LeBleu, Valerie S.; McAndrews, Kathleen M.; Kalluri, Raghu			Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis	FASEB JOURNAL			English	Article						engineered exosomes; liver fibrosis; mesenchymal stromal cells; STAT3	HEPATIC STELLATE CELLS; EXTRACELLULAR VESICLES; SIGNAL TRANSDUCER; TRANSCRIPTION 3; ACTIVATION; DELIVERY; MECHANISMS; SIRNA; BETA	Hepatic fibrosis is a wound healing response that results in excessive extracellular matrix (ECM) accumulation in response to chronic hepatic injury. Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor associated with the pathogenesis of liver fibrosis. Though a promising potential therapeutic target, there are no specific drug candidates for STAT3. Exosomes are extracellular vesicles generated by all cell types with a capacity to efficiently enter cells across different biological barriers. Here, we utilize exosomes as delivery conduit to specifically target STAT3 in liver fibrosis. Exosomes derived from clinical grade fibroblast-like mesenchymal stem cells (MSCs) were engineered to carry siRNA or antisense oligonucleotide (ASO) targeting STAT3 (iExo(siRNA-STAT3) or iExo(mASO-STAT3)). Compared to scrambled siRNA control, siRNA-STAT3, or ASO-STAT3, iExo(siRNA-STAT3) or iExomASO-STAT(3) showed enhanced STAT3 targeting efficiency. iExo(siRNA-STAT3) or iExo(mASO-STAT3) treatments suppressed STAT3 levels and ECM deposition in established liver fibrosis in mice, and significantly improved liver function. iExo(mASO-Stat3) restored liver function more efficiently when compared to iExo(siRNA-STAT3). Our results identify a novel anti-fibrotic approach for direct targeting of STAT3 with exosomes with immediate translational potential.	[Tang, Min; Chen, Yang; Li, Bingrui; Sugimoto, Hikaru; Yang, Sujuan; LeBleu, Valerie S.; McAndrews, Kathleen M.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Yang, Changqing] Tongji Univ, Tongji Hosp, Sch Med, Div Gastroenterol, Shanghai, Peoples R China; [Yang, Changqing] Tongji Univ, Tongji Hosp, Sch Med, Inst Digest Dis, Shanghai, Peoples R China; [LeBleu, Valerie S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Kalluri, Raghu] Rice Univ, Dept Bioengn, Houston, TX USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tongji University; Tongji University; Northwestern University; Feinberg School of Medicine; Rice University; Baylor College of Medicine	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1906, 1881 East Rd,4SCR5-1180, Houston, TX 77054 USA.	rkalluri@mdanderson.org	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; McAndrews, Kathleen/0000-0002-4092-4991	MD Anderson Cancer Center	MD Anderson Cancer Center	MD Anderson Cancer Center, Grant/Award Number: N/A	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Bartneck Matthias, 2014, Hepatobiliary Surg Nutr, V3, P364, DOI 10.3978/j.issn.2304-3881.2014.11.02; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beebe JD, 2018, PHARMACOL THERAPEUT, V191, P74, DOI 10.1016/j.pharmthera.2018.06.006; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Breitkopf K, 2005, GUT, V54, P673, DOI 10.1136/gut.2004.042911; Busatto S, 2019, BIOMED MICRODEVICES, V21, DOI 10.1007/s10544-019-0396-7; Chakraborty D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01236-6; Choi S, 2019, BIOCHEM BIOPH RES CO, V513, P49, DOI 10.1016/j.bbrc.2019.03.156; Gong XH, 2014, CELL PHYSIOL BIOCHEM, V33, P97, DOI 10.1159/000356653; He WW, 2019, ONCOL LETT, V17, P5608, DOI 10.3892/ol.2019.10236; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krishna Murli, 2017, Clin Liver Dis (Hoboken), V10, P53, DOI 10.1002/cld.653; Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026; LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lou GH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1512-5; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00243; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y; Ogiso H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162183; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Su TH, 2015, P NATL ACAD SCI USA, V112, P7243, DOI 10.1073/pnas.1507499112; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Xiang DM, 2018, GUT, V67, P1704, DOI 10.1136/gutjnl-2016-313392; Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004; Zhai XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49287-7; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240	47	18	18	13	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21557	10.1096/fj.202002777RR	http://dx.doi.org/10.1096/fj.202002777RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855751				2022-12-28	WOS:000645260100072
J	Xiao, CY; Sun, ZB; Gao, JX; Bai, YX; Zhang, C; Pang, BY; Qiao, HJ; Fu, M; Dang, EL; Wang, G				Xiao, Chunying; Sun, Zhongbin; Gao, Jixin; Bai, Yaxing; Zhang, Chen; Pang, Bingyu; Qiao, Hongjiang; Fu, Meng; Dang, Erle; Wang, Gang			Enhanced phenotype of calcipotriol-induced atopic dermatitis in filaggrin-deficient mice	FASEB JOURNAL			English	Article						atopic dermatitis; emollient; filaggrin; inflammation; skin barrier	THYMIC STROMAL LYMPHOPOIETIN; BARRIER; MOISTURIZERS; PATHOGENESIS; EXPRESSION; EMOLLIENTS; CYTOKINES; EFFICACY; TRIGGER; CELLS	Impaired function of filaggrin (FLG) is a major predisposing factor for atopic dermatitis (AD). Several studies on FLG-deficient (Flg(-/-)) mice have indicated an essential role for FLG in the skin barrier and the development of AD, but none of the studies have described the characteristics on Flg(-/-) mice with calcipotriol (CPT)-induced atopic dermatitis, which restricts the comprehensive understanding of functions of FLG. The present study sought to generate Flg(-/-) mice and applied CPT to produce AD-like dermatitis for in vivo analysis of the FLG functions. CPT was applied on the skin of Flg(-/-) mice to establish the AD-like dermatitis mouse model. The lesion inflammation was evaluated by gross ear thickness, histopathology, immunofluorescence, and cytokine production. Also, mucopolysaccharide polysulfate (MPS) and ceramide were used to observe the therapeutic function in this model. The results showed that the inflammation of CPT-induced dermatitis in Flg(-/-) mice was more severer than that of wild-type (WT) mice, as evident by the increased level of gross appearance, ear thickness, inflammatory cell infiltration (mast cells and CD3(+) T cells), and inflammatory cytokine expression (interleukin (IL)-4, IL-6, IL-13, and thymic stromal lymphopoietin (TSLP)). The emollients MPS and ceramide partially restored the epidermal function and alleviated the skin inflammation in Flg(-/-) mice with CPT-induced AD--like dermatitis. The current study demonstrated that skin barrier protein FLG is critical in the pathogenesis of AD. Also, the AD mouse model induced by CPT in Flg(-/-) mice could be utilized to search for drug targets in AD.	[Xiao, Chunying; Sun, Zhongbin; Gao, Jixin; Bai, Yaxing; Zhang, Chen; Pang, Bingyu; Qiao, Hongjiang; Fu, Meng; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Dang, EL; Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China.	dangerle@fmmu.edu.cn; wanggangxjyy@163.com	fu, meng/GZG-3120-2022; Wang, Gang/H-6710-2019	Xiao, Chunying/0000-0002-3847-715X	National Natural Science Foundation of China [81803125, 81903192]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81803125 and 81903192	Bagherani N, 2016, DERMATOL THER, V29, P69, DOI 10.1111/dth.12244; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; DALE BA, 1985, ANN NY ACAD SCI, V455, P330, DOI 10.1111/j.1749-6632.1985.tb50420.x; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hart VA, 2017, BRIT J DERMATOL, V176, P553, DOI 10.1111/bjd.15184; Hayama K, 2015, AUSTRALAS J DERMATOL, V56, P36, DOI 10.1111/ajd.12179; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li QY, 2020, J DERMATOL SCI, V97, P2, DOI 10.1016/j.jdermsci.2019.12.002; Malik K, 2017, DERMATOL CLIN, V35, P317, DOI 10.1016/j.det.2017.02.006; Man G, 2015, J INVEST DERMATOL, V135, P1184, DOI 10.1038/jid.2014.486; Orfali RL, 2017, GIORN ITAL DERMAT V, V152, P140, DOI 10.23736/S0392-0488.16.05533-4; Otsuka A, 2017, IMMUNOL REV, V278, P246, DOI 10.1111/imr.12545; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Proksch E, 2008, SKIN PHARMACOL PHYS, V21, P75, DOI 10.1159/000112957; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schwartz C, 2019, ALLERGY, V74, P1920, DOI 10.1111/all.13801; Schwartz C, 2016, J ALLERGY CLIN IMMUN, V138, P1443, DOI 10.1016/j.jaci.2016.04.031; Sekiguchi K, 2018, JPN J CLIN ONCOL, V48, P450, DOI 10.1093/jjco/hyy045; Sekiguchi K, 2015, JPN J CLIN ONCOL, V45, P1146, DOI 10.1093/jjco/hyv155; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; Watanabe S, 2017, CLIN COSMET INV DERM, V10, P353, DOI 10.2147/CCID.S140796; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Yang G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082867; Yao Y, 2019, EXP DERMATOL, V28, P956, DOI 10.1111/exd.13985	30	3	3	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21574	10.1096/fj.202002709R	http://dx.doi.org/10.1096/fj.202002709R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855746				2022-12-28	WOS:000645260100052
J	Berg, NK; Li, JW; Kim, B; Mills, T; Pei, GS; Zhao, ZM; Li, XY; Zhang, X; Ruan, W; Eltzschig, HK; Yuan, XY				Berg, Nathaniel K.; Li, Jiwen; Kim, Boyun; Mills, Tingting; Pei, Guangsheng; Zhao, Zhongming; Li, Xiangyun; Zhang, Xu; Ruan, Wei; Eltzschig, Holger K.; Yuan, Xiaoyi			Hypoxia-inducible factor-dependent induction of myeloid-derived netrin-1 attenuates natural killer cell infiltration during endotoxin-induced lung injury	FASEB JOURNAL			English	Article						lung inflammation; netrin&#8208; 1; natural killer cells	NF-KAPPA-B; INHIBITS LEUKOCYTE MIGRATION; ISCHEMIA-REPERFUSION INJURY; PRO-RESOLVING MEDIATORS; NK CELLS; PULMONARY INFLAMMATION; MACROPHAGE RETENTION; INSULIN-RESISTANCE; KIDNEY INJURY; IN-VITRO	Sepsis and sepsis-associated lung inflammation significantly contribute to the morbidity and mortality of critical illness. Here, we examined the hypothesis that neuronal guidance proteins could orchestrate inflammatory events during endotoxin-induced lung injury. Through a targeted array, we identified netrin-1 as the top upregulated neuronal guidance protein in macrophages treated with lipopolysaccharide (LPS). Furthermore, we found that netrin-1 is highly enriched in infiltrating myeloid cells, particularly in macrophages during LPS-induced lung injury. Transcriptional studies implicate hypoxia-inducible factor HIF-1 alpha in the transcriptional induction of netrin-1 during LPS treatment. Subsequently, the deletion of netrin-1 in the myeloid compartment (Ntn1(loxp/loxp) LysM Cre) resulted in exaggerated mortality and lung inflammation. Surprisingly, further studies revealed enhanced natural killer cells (NK cells) infiltration in Ntn1(loxp/loxp) LysM Cre mice, and neutralization of NK cell chemoattractant chemokine (C-C motif) ligand 2 (CCL2) reversed the exaggerated lung inflammation. Together, these studies provide functional insight into myeloid cell-derived netrin-1 in controlling lung inflammation through the modulation of CCL2-dependent infiltration of NK cells.	[Berg, Nathaniel K.; Li, Jiwen; Kim, Boyun; Mills, Tingting; Li, Xiangyun; Ruan, Wei; Eltzschig, Holger K.; Yuan, Xiaoyi] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, 6431 Fannin St, Houston, TX 77030 USA; [Li, Jiwen] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Cardiac Surg, Hangzhou, Peoples R China; [Pei, Guangsheng; Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Sch Biomed Informat, Houston, TX 77030 USA; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Li, Xiangyun] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Zhang, Xu] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Zhang, Xu] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX 77030 USA; [Ruan, Wei] Cent South Univ, Second Xiangya Hosp, Dept Anesthesiol, Changsha, Peoples R China	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Zhejiang University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Tianjin Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Central South University	Yuan, XY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, 6431 Fannin St, Houston, TX 77030 USA.	lijiwen@zju.edu.cn; Holger.Eltzschig@uth.tmc.edu; Xiaoyi.Yuan@uth.tmc.edu		Pei, Guangsheng/0000-0003-1804-7598; Ruan, Wei/0000-0002-2718-7923; Mills, Tingting/0000-0002-6041-4788; Berg, Nathaniel/0000-0002-2568-2867; Li, Jiwen/0000-0002-8595-860X	HHS | National Institutes of Health (NIH) [T32GM120011]; American Thoracic Society (ATS); American Heart Association (AHA) [19CDA34660279]; American Lung Association (Lung Association) [CA622265]; UTHealth | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (CCTS, UTHealth) [1UL1TR003167-01]; Parker B. Francis Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT) [CPRIT RP180734]; National Institutes of Health [R01HL154720, R01DK122796, R01DK109574, R01HL133900]; Department of Defense [W81XWH2110032]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society (ATS); American Heart Association (AHA)(American Heart Association); American Lung Association (Lung Association); UTHealth | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (CCTS, UTHealth); Parker B. Francis Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	HHS | National Institutes of Health (NIH), Grant/Award Number: T32GM120011; American Thoracic Society (ATS); American Heart Association (AHA), Grant/Award Number: 19CDA34660279; American Lung Association (Lung Association), Grant/Award Number: CA622265; UTHealth | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (CCTS, UTHealth), Grant/Award Number: 1UL1TR003167-01; Parker B. Francis Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/Award Number: CPRIT RP180734; National Institutes of Health, Grant/Award Number: R01HL154720, R01DK122796, R01DK109574 and R01HL133900; Department of Defense, Grant number: W81XWH2110032	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Abdulnour REE, 2018, J LEUKOCYTE BIOL, V103, P919, DOI 10.1002/JLB.3A0617-252RR; Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; Aherne CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24957; Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhavani S, 2015, ANN AM THORAC SOC, V12, pS164, DOI 10.1513/AnnalsATS.201503-115AW; Bin JM, 2015, CELL REP, V12, P1099, DOI 10.1016/j.celrep.2015.07.028; Brunet I, 2014, J CLIN INVEST, V124, P3230, DOI 10.1172/JCI75181; Carlin LE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00781; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colgan SP, 2020, P NATL ACAD SCI USA, V117, P10621, DOI 10.1073/pnas.2005652117; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duvall MG, 2017, MOL ASPECTS MED, V58, P44, DOI 10.1016/j.mam.2017.04.003; Ehrentraut H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032416; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Gianchecchi E, 2018, AUTOIMMUN REV, V17, P142, DOI 10.1016/j.autrev.2017.11.018; Granja T, 2014, MUCOSAL IMMUNOL, V7, P879, DOI 10.1038/mi.2013.104; Hadi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07495-1; Hammer Q, 2018, NAT IMMUNOL, V19, P800, DOI 10.1038/s41590-018-0163-6; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hoegl S, 2017, J LEUKOCYTE BIOL, V101, P471, DOI 10.1189/jlb.3A0516-227R; Hong MJ, 2018, MUCOSAL IMMUNOL, V11, P894, DOI 10.1038/mi.2017.93; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Kohler D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14958-x; Konig K, 2016, CRIT CARE MED, V44, pE625, DOI 10.1097/CCM.0000000000001609; Konig K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032145; Korner A, 2018, CELL DEATH DIFFER, V25, P421, DOI 10.1038/cdd.2017.177; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kominsky DJ, 2011, J IMMUNOL, V186, P6505, DOI 10.4049/jimmunol.1002805; Koscso B, 2013, J LEUKOCYTE BIOL, V94, P1309, DOI 10.1189/jlb.0113043; Koscso B, 2013, PURINERG SIGNAL, V9, P427, DOI 10.1007/s11302-013-9362-7; Krishnamoorthy N, 2018, PHYSIOL REV, V98, P1335, DOI 10.1152/physrev.00026.2017; Le TTT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01633; Lee LK, 2020, ANESTH ANALG, V131, P1471, DOI 10.1213/ANE.0000000000005146; Li FA, 2012, J VIROL, V86, P2251, DOI 10.1128/JVI.06209-11; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lu W, 2015, NAT IMMUNOL, V16, P1185, DOI 10.1038/ni.3292; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; MacManus CF, 2011, FASEB J, V25, P1856, DOI 10.1096/fj.10-170316; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Martin M., 2011, EMBNETJ, V17, p10; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Mediero A, 2016, FASEB J, V30, P3835, DOI 10.1096/fj.201600615R; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Millien Valentine Ongeri, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS277, DOI 10.1513/AnnalsATS.201403-105AW; Mirakaj V, 2017, TRENDS IMMUNOL, V38, P444, DOI 10.1016/j.it.2017.03.007; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Mirakaj V, 2012, FASEB J, V26, P1549, DOI 10.1096/fj.11-200063; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Movassagh H, 2017, J IMMUNOL, V198, P1023, DOI 10.4049/jimmunol.1601093; Mutz C, 2010, CRIT CARE, V14, DOI 10.1186/cc9301; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Ngamsri KC, 2010, J IMMUNOL, V185, P4374, DOI 10.4049/jimmunol.1000433; Okamoto M, 2002, BLOOD, V99, P1289, DOI 10.1182/blood.V99.4.1289; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Ramkhelawon B, 2013, ARTERIOSCL THROM VAS, V33, P1180, DOI 10.1161/ATVBAHA.112.301008; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Ryan HE, 2000, CANCER RES, V60, P4010; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schlegel M, 2019, J CLIN INVEST, V129, P2165, DOI 10.1172/JCI128681; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sham HP, 2018, J IMMUNOL, V200, P2757, DOI 10.4049/jimmunol.1602090; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shen H, 2013, J IMMUNOL, V191, P2857, DOI 10.4049/jimmunol.1301539; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Shimasaki N, 2020, NAT REV DRUG DISCOV, V19, P200, DOI 10.1038/s41573-019-0052-1; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Taylor L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160685; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Varadarajan SG, 2017, NEURON, V94, P790, DOI 10.1016/j.neuron.2017.03.007; Victorino F, 2015, J IMMUNOL, V195, P4973, DOI 10.4049/jimmunol.1500651; Wang J, 2014, J IMMUNOL, V193, P1133, DOI 10.4049/jimmunol.1303303; Watanabe S, 2019, J CLIN INVEST, V129, P2619, DOI 10.1172/JCI124615; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yang YL, 2008, RESP PHYSIOL NEUROBI, V160, P99, DOI 10.1016/j.resp.2007.09.011; Yuan XY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124317; Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang YY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24506-9	109	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21334	10.1096/fj.202002407R	http://dx.doi.org/10.1096/fj.202002407R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715200	hybrid, Green Published			2022-12-28	WOS:000635216100079
J	Kumari, A; Shriwas, O; Sisodiya, S; Santra, MK; Guchhait, SK; Dash, R; Panda, D				Kumari, Anuradha; Shriwas, Omprakash; Sisodiya, Shailendra; Santra, Manas K.; Guchhait, Sankar K.; Dash, Rupesh; Panda, Dulal			Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of beta-catenin: Evidence of inhibition of Wnt/beta-catenin signaling as an important antitumor mechanism of microtubule-targeting agents	FASEB JOURNAL			English	Article						apoptosis; cell cycle; microtubule-targeting agents; oral squamous cell carcinoma; Wnt/beta-catenin signaling		An aberrant accumulation of nuclear beta-catenin is closely associated with the augmentation of cancer malignancy. In this work, we report that several microtubule-targeting agents (MTAs) such as vinblastine, taxol, and C12 (combretastatin-2-aminoimidazole analog) inhibit VvUt/beta-catenin sienaline in oral squamous cell carcinoma (OSCC). We showed that the inhibition of microtuhule dynamics by MTAs decreased the level of beta-catenin by increasing Axin and adenomatous polyposis coli levels and reducing the level of dishevelled. Furthermore, MTAs strongly reduced the localization of beta-catenin in the nucleus. The reduction in the level of nuclear beta-catenin was neither due to the degradation of beta-catenin in the nucleus nor due to an increase in the export of nuclear beta-catenin from the nucleus. A motor protein kinesin-2 was found to assist the nuclear transportation of beta-catenin. Interestingly, Wnt/beta-catenin signaling antagonist treatment synergized with MTAs and the activators of Wnt/beta-catenin signaling antagonized with the MTAs. C12 potently suppressed the growth of 4-Nitroquinoline 1-oxide-induced OSCC in the tongue of C57 black 6 mice and also abrogated Wnt/beta-catenin signaling pathway in the tumor. Our results provide evidence that the decrease in Wnt/beta-catenin signaling is an important antitumor effect of MTAs and the combined use of MTAs with Wnt/beta-catenin signaling antagonists could be a promising strategy for cancer chemotherapy.	[Kumari, Anuradha; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Shriwas, Omprakash; Dash, Rupesh] Inst Life Sci, Bhubaneswar, India; [Sisodiya, Shailendra; Guchhait, Sankar K.] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Mohali, Punjab, India; [Santra, Manas K.] Natl Ctr Cell Sci, Pune, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	panda@iitb.ac.in		Kumari, Anuradha/0000-0003-1829-8215	JC Bose National Fellowship [JCB/2019/000016]; Department of Science and Technology, Government of India	JC Bose National Fellowship; Department of Science and Technology, Government of India(Department of Science & Technology (India))	The work is supported by JC Bose National Fellowship (JCB/2019/000016) from the Department of Science and Technology, Government of India to DP.	Birajdar Smita Shrishail, 2014, J Oral Maxillofac Pathol, V18, P169, DOI 10.4103/0973-029X.140729; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71; Chaudhary V, 2016, J MED CHEM, V59, P3439, DOI 10.1021/acs.jmedchem.6b00101; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Fischer MM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700090; Follet J, 2012, BRIT J CANCER, V106, P685, DOI 10.1038/bjc.2012.6; Frenzel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027988; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hongo H, 2012, BIOCHEM BIOPH RES CO, V426, P94, DOI 10.1016/j.bbrc.2012.08.042; Huang JQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40716; Huang YS, 2015, BIOCHEM J, V466, P499, DOI 10.1042/BJ20141143; Inoue T, 2005, FEBS LETT, V579, P4978, DOI 10.1016/j.febslet.2005.08.006; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kalele K, 2015, J CLIN DIAGN RES, V9, pZJ1, DOI 10.7860/JCDR/2015/13644.6416; Kan W, 2020, ELIFE, V9, DOI 10.7554/eLife.55015; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kendziorra E, 2011, CARCINOGENESIS, V32, P1824, DOI 10.1093/carcin/bgr222; Khan AH, 2016, PHARMACOGENOMICS J, V16, P164, DOI 10.1038/tpj.2015.50; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kumari A, 2019, BIOCHEM PHARMACOL, V170, DOI 10.1016/j.bcp.2019.113663; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee BE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12054-7; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liang YJ, 2020, CELL TISSUE RES, V381, P527, DOI 10.1007/s00441-020-03220-x; Ling YH, 2001, MOL PHARMACOL, V59, P593, DOI 10.1124/mol.59.3.593; Vuong LT, 2014, DEVELOPMENT, V141, P3222, DOI 10.1242/dev.106229; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Liu ST, 2016, AIMS MOL SCI, V3, P597, DOI 10.3934/molsci.2016.4.597; Lucas FR, 1998, J CELL SCI, V111, P1351; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mohammed MK, 2016, GENES DIS, V3, P11, DOI 10.1016/j.gendis.2015.12.004; Odajima T, 2005, HUM PATHOL, V36, P234, DOI 10.1016/j.humpath.2004.12.009; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Shi J, 2017, ENDOCR-RELAT CANCER, V24, pT83, DOI 10.1530/ERC-17-0003; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SU LK, 1995, CANCER RES, V55, P2972; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vuong LT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07605-z; Wu CW, 2004, WORLD J GASTROENTERO, V10, P3240, DOI 10.3748/wjg.v10.i22.3240; Xu YS, 2018, ARTIF CELL NANOMED B, V46, P192, DOI 10.1080/21691401.2018.1453827; Yu XM, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1031-4; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang K, 2017, ONCOTARGET, V8, P115803, DOI 10.18632/oncotarget.23253; Zhang K, 2015, CELL PROLIFERAT, V48, P249, DOI 10.1111/cpr.12161; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	52	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21539	10.1096/fj.202002594R	http://dx.doi.org/10.1096/fj.202002594R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742719				2022-12-28	WOS:000635216100048
J	Marquant, Q; Laubreton, D; Drajac, C; Mathieu, E; Bouguyon, E; Noordine, ML; Remot, A; Riffault, S; Thomas, M; Descamps, D				Marquant, Quentin; Laubreton, Daphne; Drajac, Carole; Mathieu, Elliot; Bouguyon, Edwige; Noordine, Marie-Louise; Remot, Aude; Riffault, Sabine; Thomas, Muriel; Descamps, Delphyne			The microbiota plays a critical role in the reactivity of lung immune components to innate ligands	FASEB JOURNAL			English	Article						alveolar macrophages; germ&#8208; free; innate immune memory; lung explants; microbiota; respiratory syncytial virus		The gut microbiota contributes to shaping efficient and safe immune defenses in the gut. However, little is known about the role of the gut and/or lung microbiota in the education of pulmonary innate immune responses. Here, we tested whether the endogenous microbiota in general can modulate the reactivity of pulmonary tissue to pathogen stimuli by comparing the response of specific-pathogen-free (SPF) and germ-free (GF) mice. Thus, we observed earlier and greater inflammation in the pulmonary compartment of GF mice than that of SPF mice after intranasal instillation to lipopolysaccharide (LPS), a component of Gram-negative bacteria. Toll-like receptor 4 (TLR4) was more abundantly expressed in the lungs of GF mice than those of SPF mice at steady state, which could predispose the innate immunity of GF mice to strongly react to the environmental stimuli. Lung explants were stimulated with different TLR agonists or infected with the human airways pathogen, respiratory syncytial virus (RSV), resulting in greater inflammation under almost all conditions for the GF explants. Finally, alveolar macrophages (AM) from GF mice presented a higher innate immune response upon RSV infection than those of SPF mice. Overall, these data suggest that the presence of microbiota in SPF mice induced a process of innate immune tolerance in the lungs by a mechanism which remains to be elucidated. Our study represents a step forward to establishing the link between the microbiota and the immune reactivity of the lungs.	[Marquant, Quentin; Laubreton, Daphne; Drajac, Carole; Bouguyon, Edwige; Riffault, Sabine; Descamps, Delphyne] Univ Paris Saclay, INRAE, UVSQ, VIM, Jouy En Josas, France; [Mathieu, Elliot; Noordine, Marie-Louise; Thomas, Muriel] Univ Paris Saclay, INRAE, Micalis, Jouy En Josas, France; [Remot, Aude] Univ Tours, INRAE, ISP, Tours, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Tours	Descamps, D (corresponding author), UVSQ, INRAE, Virol & Immunol Mol, F-78350 Jouy En Josas, France.	delphyne.descamps@inrae.fr	thomas, muriel/HDO-3887-2022; Laubreton, Daphne/GRT-0001-2022	Descamps, Delphyne/0000-0002-4883-6910	Agence Nationale de la Recherche (ANR) [ANR-13-BSV3-0016]; Ile-de-France Regional Council | Domaine d'Interet Majeur OneHealth; Fondation Air Liquide	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ile-de-France Regional Council | Domaine d'Interet Majeur OneHealth; Fondation Air Liquide	Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-13-BSV3-0016; Ile-de-France Regional Council | Domaine d'Interet Majeur OneHealth; Fondation Air Liquide	Al Nabhani Z, 2020, MUCOSAL IMMUNOL, V13, P183, DOI 10.1038/s41385-020-0257-y; Dang AT, 2019, MUCOSAL IMMUNOL, V12, P843, DOI 10.1038/s41385-019-0160-6; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bigot J, 2020, J INFECT DIS, V221, P1000, DOI 10.1093/infdis/jiz569; Boraschi D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00799; Caballero MT, 2015, J CLIN INVEST, V125, P571, DOI 10.1172/JCI75183; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Francois A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24687; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825; Hamon MA, 2016, SEMIN IMMUNOL, V28, P351, DOI 10.1016/j.smim.2016.05.003; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee SK, 2005, BIOCHEM BIOPH RES CO, V337, P457, DOI 10.1016/j.bbrc.2005.09.071; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Makris S, 2016, J INNATE IMMUN, V8, P452, DOI 10.1159/000446824; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marzec J, 2019, PHYSIOL GENOMICS, V51, P630, DOI 10.1152/physiolgenomics.00101.2019; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; Mathieu E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01168; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Pulvirenti G, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00393; Rameix-Welti MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6104; Remot A, 2017, ISME J, V11, P1061, DOI 10.1038/ismej.2016.181; Sencio V, 2020, CELL REP, V30, P2934, DOI 10.1016/j.celrep.2020.02.013; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Takiishi T, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1373208; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Xiang M, 2010, MOL MED, V16, P69, DOI 10.2119/molmed.2009.00097	42	5	5	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21348	10.1096/fj.202002338R	http://dx.doi.org/10.1096/fj.202002338R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715218	Green Submitted, hybrid			2022-12-28	WOS:000635216100014
J	Yu, Y; Yang, WJ; Bilotta, AJ; Zhao, XJ; Cong, YZ; Li, YQ				Yu, Yu; Yang, Wenjing; Bilotta, Anthony J.; Zhao, Xiaojing; Cong, Yingzi; Li, Yanqing			L-lactate promotes intestinal epithelial cell migration to inhibit colitis	FASEB JOURNAL			English	Article						ATP; IEC; intestinal homeostasis; L&#8208; lactate; migration	BARRIER FUNCTION; GUT MICROBIOTA; RHO-GTPASES; IN-VITRO; TURNOVER; RESTITUTION; ORGANIZATION; PERSISTENCE; ACTIVATION; RESPONSES	Lactate, one of the most common primary metabolites of bacteria and human cells, has been shown to play essential roles in the regulation of inflammatory diseases, including inflammatory bowel diseases. However, whether and how host-derived lactate affects intestinal epithelial homeostasis is still not completely understood. Here, we investigated how L-lactate, mainly produced by host cells, regulates intestinal epithelial cell (IEC) migration to promote intestinal wound healing. Using video microscopy and tracking individual cells, we found that L-lactate enhanced IEC migration in direction persistence and speed. Mechanistically, L-lactate promoted IEC mitochondrial ATP production. The mitochondrial ATP synthase inhibitor, oligomycin, significantly decreased IEC persistence and speed, which inhibited cell migration induced by L-lactate. Furthermore, administering mice with L-lactate suppressed colitis induced by dextran sulfate sodium. In conclusion, our study demonstrates that host-derived L-lactate promotes IEC mitochondrial ATP production to drive cell migration, promoting intestinal wound healing to alleviate intestinal inflammation.	[Yu, Yu; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Cheeloo Coll Med, Jinan, Peoples R China; [Yu, Yu; Yang, Wenjing; Bilotta, Anthony J.; Zhao, Xiaojing; Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, 107 Wenhuaxi Rd, Jinan 250012, Peoples R China.	liyanqing@sdu.edu.cn	Yang, Wenjing/AAE-5924-2021	Yang, Wenjing/0000-0003-1541-1892; Cong, Yingzi/0000-0003-4167-7395; Li, Yanqing/0000-0003-0575-0399				Angajala A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01605; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Bilotta AJ, 2021, CELL MOL GASTROENTER, V11, P1023, DOI 10.1016/j.jcmgh.2020.11.011; Bressan C, 2020, ELIFE, V9, DOI 10.7554/eLife.56006; Brooks GA, 2007, SPORTS MED, V37, P341, DOI 10.2165/00007256-200737040-00017; Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008; Campeau JL, 2012, INFECT IMMUN, V80, P2632, DOI 10.1128/IAI.00288-12; Certo M, 2020, WIRES SYST BIOL MED, V12, DOI 10.1002/wsbm.1474; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Daw CC, 2020, CELL, V183, P474, DOI 10.1016/j.cell.2020.08.049; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Dodard G, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107855; Ellmerer M, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/390975; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Finley LWS, 2019, NATURE, V571, P39, DOI 10.1038/d41586-019-01934-9; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gal N, 2013, RHEOL ACTA, V52, P425, DOI 10.1007/s00397-013-0694-6; Goetze K, 2011, INT J ONCOL, V39, P453, DOI 10.3892/ijo.2011.1055; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Han SY, 2018, INT J MOL MED, V42, P1644, DOI 10.3892/ijmm.2018.3733; Han TY, 2013, CELL ADHES MIGR, V7, P395, DOI 10.4161/cam.26345; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Iraporda C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00651; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Krndija D, 2019, SCIENCE, V365, P705, DOI 10.1126/science.aau3429; Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598; Lee, 2019, BIORXIV, DOI [10.1101/827998, DOI 10.1101/827998]; Lee YS, 2018, CELL HOST MICROBE, V24, P833, DOI 10.1016/j.chom.2018.11.002; Lei XJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225380; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; Marelli-Berg FM, 2018, J LEUKOCYTE BIOL, V104, P285, DOI 10.1002/JLB.1MR1117-472R; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pohanka M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3419034; Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0; Pucino V, 2019, CELL METAB, V30, P1055, DOI 10.1016/j.cmet.2019.10.004; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ramio-Lluch L, 2014, REPROD FERT DEVELOP, V26, P883, DOI 10.1071/RD13145; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Schaks M, 2019, ESSAYS BIOCHEM, V63, P483, DOI 10.1042/EBC20190015; Sittipo P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215296; Song JY, 2018, P NATL ACAD SCI USA, V115, P2850, DOI 10.1073/pnas.1801697115; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; VONJAGOW G, 1980, ANGEW CHEM INT EDIT, V19, P659, DOI 10.1002/anie.198006593; Watson Joanna R, 2017, Small GTPases, V8, P237, DOI 10.1080/21541248.2016.1215657; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404; Wortel IM., 2020, BIORXIV, DOI [10.1101/338459, DOI 10.1101/338459]; Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197; Zanotelli MR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12155-z	64	3	3	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21554	10.1096/fj.202100095R	http://dx.doi.org/10.1096/fj.202100095R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742715				2022-12-28	WOS:000635216100053
J	Elder, CT; Filiberto, AC; Su, G; Ladd, Z; Leroy, V; Pruitt, EY; Lu, GY; Jiang, ZH; Sharma, AK; Upchurch, GR				Elder, Craig T.; Filiberto, Amanda C.; Su, Gang; Ladd, Zachary; Leroy, Victoria; Pruitt, Eric Y.; Lu, Guanyi; Jiang, Zhihua; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.			Maresin 1 activates LGR6 signaling to inhibit smooth muscle cell activation and attenuate murine abdominal aortic aneurysm formation	FASEB JOURNAL			English	Article						aorta; aneurysm; efferocytosis; macrophage; maresin; smooth muscle cells; transforming growth factor beta 2	TGF-BETA; APOPTOTIC CELLS; LIPID MEDIATORS; INFLAMMATION; RESOLUTION; RECEPTOR; PROTEOLYSIS; PROTECTS	The specialized pro-resolving lipid mediator maresin 1 (MaR1) is involved in the resolution phase of tissue inflammation. It was hypothesized that exogenous administration of MaR1 would attenuate abdominal aortic aneurysm (AAA) growth in a cytokine-dependent manner via LGR6 receptor signaling and macrophage-dependent efferocytosis of smooth muscle cells (SMCs). AAAs were induced in C57BL/6 wild-type (WT) mice and smooth muscle cell specific TGF-beta 2 receptor knockout (SMC-TGF beta r2(-/-)) mice using a topical elastase AAA model. MaR1 treatment significantly attenuated AAA growth as well as increased aortic SMC alpha-actin and TGF-beta 2 expressions in WT mice, but not SMC-TGF beta r2(-/-) mice, compared to vehicle-treated mice. In vivo inhibition of LGR6 receptors obliterated MaR1-dependent protection in AAA formation and SMC alpha-actin expression. Furthermore, MaR1 upregulated macrophage-dependent efferocytosis of apoptotic SMCs in murine aortic tissue during AAA formation. In vitro studies demonstrate that MaR1-LGR6 interaction upregulates TGF-beta 2 expression and decreases MMP2 activity during crosstalk of macrophage-apoptotic SMCs. In summary, these results demonstrate that MaR1 activates LGR6 receptors to upregulate macrophage-dependent efferocytosis, increases TGF-beta expression, preserves aortic wall remodeling and attenuate AAA formation. Therefore, this study demonstrates the potential of MaR1-LGR6-mediated mitigation of vascular remodeling through increased efferocytosis of apoptotic SMCs via TGF-beta 2 to attenuate AAA formation.	[Elder, Craig T.; Filiberto, Amanda C.; Su, Gang; Ladd, Zachary; Leroy, Victoria; Pruitt, Eric Y.; Lu, Guanyi; Jiang, Zhihua; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.] Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Upchurch, GR (corresponding author), Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA.	gib.upchurch@surgery.ufl.edu		Ladd, Zachary/0000-0001-8146-1076; Sharma, Ashish/0000-0002-1234-6039	NIH [R01 HL153341]; American College of Surgeons Resident Research Scholarship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Resident Research Scholarship	NIH, Grant/Award Number: R01 HL153341; American College of Surgeons Resident Research Scholarship	Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Angelov SN, 2017, ARTERIOSCL THROM VAS, V37, P2102, DOI 10.1161/ATVBAHA.117.309401; [Anonymous], UNDERLYING CAUSE DEA; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Chen PY, 2020, CELL STEM CELL, V26, P542, DOI 10.1016/j.stem.2020.02.013; Chiang N, 2019, J CLIN INVEST, V129, P5294, DOI 10.1172/JCI129448; Cullen JM, 2019, J VASC SURG, V70, P252, DOI 10.1016/j.jvs.2018.09.057; Dale MA, 2015, ARTERIOSCL THROM VAS, V35, P1746, DOI 10.1161/ATVBAHA.115.305269; Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fashandi AZ., 2017, SURGERY; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; Gong J, 2014, BRIT J PHARMACOL, V171, P3539, DOI 10.1111/bph.12714; HARRIS LM, 1991, J VASC SURG, V14, P812, DOI 10.1067/mva.1991.33494; Kojima Y, 2018, CIRCULATION, V137, P750, DOI 10.1161/CIRCULATIONAHA.117.030389; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Laser A, 2012, J SURG RES, V178, P1038, DOI 10.1016/j.jss.2012.04.073; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; LopezCandales A, 1997, AM J PATHOL, V150, P993; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Meher AK, 2018, ARTERIOSCL THROM VAS, V38, P843, DOI 10.1161/ATVBAHA.117.309897; Nelson JW, 2014, AM J PHYSIOL-CELL PH, V306, pC178, DOI 10.1152/ajpcell.00284.2013; NEWMAN KM, 1994, CIRCULATION, V90, P224; Petri MH, 2018, JACC-BASIC TRANSL SC, V3, P719, DOI 10.1016/j.jacbts.2018.08.005; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Rowe VL, 2000, J VASC SURG, V31, P567; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shah PK, 1997, CIRCULATION, V96, P2115; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Spinosa M, 2018, J VASC SURG, V68, p93S, DOI 10.1016/j.jvs.2018.05.253; Spinosa M, 2018, FASEB J, V32, P6038, DOI 10.1096/fj.201701138RR; Sun QC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9634803; Thompson RW, 1997, CORONARY ARTERY DIS, V8, P623, DOI 10.1097/00019501-199710000-00005; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Yang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35444	46	9	9	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21780	10.1096/fj.202100484R	http://dx.doi.org/10.1096/fj.202100484R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320253	Green Accepted			2022-12-28	WOS:000678975300036
J	Le Coq, J; Navajas, PL; Martin, BR; Alfonso, C; Lietha, D				Le Coq, Johanne; Lopez Navajas, Pilar; Rodrigo Martin, Barbara; Alfonso, Carlos; Lietha, Daniel			A new layer of phosphoinositide-mediated allosteric regulation uncovered for SHIP2	FASEB JOURNAL			English	Article						allosteric regulation; enzyme kinetics; lipid phosphatase; phosphinositides; SHIP2	PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATASE SHIP2; PROTEIN; CANCER; EXPRESSION; RECEPTOR; ACTIVATION; INHIBIT; BINDING	The Src homology 2 containing inositol 5-phosphatase 2 (SHIP2) is a large multidomain enzyme that catalyzes the dephosphorylation of the phospholipid phosphatidylinositol 3,4,5-triphosphate (PI(3,4,5)P-3) to form PI(3,4)P-2. PI(3,4,5)P-3 is a key lipid second messenger controlling the recruitment of signaling proteins to the plasma membrane, thereby regulating a plethora of cellular events, including proliferation, growth, apoptosis, and cytoskeletal rearrangements. SHIP2, alongside PI3K and PTEN, regulates PI(3,4,5)P-3 levels at the plasma membrane and has been heavily implicated in serious diseases such as cancer and type 2 diabetes; however, many aspects of its regulation mechanism remain elusive. We recently reported an activating effect of the SHIP2 C2 domain and here we describe an additional layer of regulation via the pleckstrin homology-related (PHR) domain. We show a phosphoinositide-induced transition to a high activity state of the enzyme that increases phosphatase activity up to 10-15 fold. We further show that PI(3,4)P-2 directly interacts with the PHR domain to trigger this allosteric activation. Modeling of the PHR-phosphatase-C2 region of SHIP2 on the membrane suggests no major inter-domain interactions with the PHR domain, but close contacts between the two linkers offer a possible path of allosteric communication. Together, our data show that the PHR domain acts as an allosteric module regulating the catalytic activity of SHIP2 in response to specific phosphoinositide levels in the cell membrane.	[Le Coq, Johanne] Spanish Natl Canc Res Ctr CNIO, Struct Biol Programme, Madrid, Spain; [Lopez Navajas, Pilar; Rodrigo Martin, Barbara; Alfonso, Carlos; Lietha, Daniel] CSIC, Ctr Invest Biol Margarita Salas, Struct & Chem Biol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Lietha, D (corresponding author), CSIC, Ctr Invest Biol Margarita Salas, Struct & Chem Biol, Madrid, Spain.	daniel.lietha@cib.csic.es	Alfonso, Carlos/K-1316-2014; Lietha, Daniel/L-8041-2014; Lietha, Daniel/AAD-1952-2022	Alfonso, Carlos/0000-0001-7165-4800; Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486	Ministerio de Ciencia, Innovacion y Universidades (MCIU) [RTI2018-099318-B-I00]; Ministerio de Ciencia e Innovacion (MICINN) [PID2019-104544GB-I00]	Ministerio de Ciencia, Innovacion y Universidades (MCIU)(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Ministerio de Ciencia, Innovacion y Universidades (MCIU), Grant/Award Number: RTI2018-099318-B-I00; Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: PID2019-104544GB-I00	[Anonymous], PYMOL MOL GRAPHICS S; Balzano D, 2015, J BIOL CHEM, V290, P24975, DOI 10.1074/jbc.M115.651570; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Brauer H, 2012, CELL SIGNAL, V24, P2095, DOI 10.1016/j.cellsig.2012.07.017; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fu MY, 2013, INT J CLIN EXP PATHO, V6, P2185; Giuriato S, 2002, BIOCHEM BIOPH RES CO, V296, P106, DOI 10.1016/S0006-291X(02)00787-8; Gozzelino L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00360; Hamilton MJ, 2011, EXP HEMATOL, V39, P2, DOI 10.1016/j.exphem.2010.11.002; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hawkins PT, 2016, BIOCHEM SOC T, V44, P307, DOI 10.1042/BST20150248; Hoekstra E, 2016, ONCOTARGET, V7, P73525, DOI 10.18632/oncotarget.12321; Kaisaki PJ, 2004, DIABETES, V53, P1900, DOI 10.2337/diabetes.53.7.1900; Kato K, 2012, MOL BIOL CELL, V23, P2593, DOI 10.1091/mbc.E11-11-0958; Kerr WG, 2020, BIOCHEM SOC T, V48, P291, DOI 10.1042/BST20190775; Kuruma S, 2014, WORLD J GASTROENTERO, V20, P17456, DOI 10.3748/wjg.v20.i46.17456; Le Coq J, 2017, ELIFE, V6, DOI 10.7554/eLife.26640; Le Coq J, 2016, PROTEIN J, V35, P225, DOI 10.1007/s10930-016-9665-y; Lee HN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51914-2; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lo TCT, 2009, LEUKEMIA RES, V33, P1562, DOI 10.1016/j.leukres.2009.04.032; Lopez-Suarez A, 2019, METABOLISM, V92, P136, DOI 10.1016/j.metabol.2018.10.013; Luo JM, 2003, LEUKEMIA, V17, P1, DOI 10.1038/sj.leu.2402725; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Ming-Lum A, 2012, FASEB J, V26, P3163, DOI 10.1096/fj.11-201475; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Pauls SD, 2017, EUR J IMMUNOL, V47, P932, DOI 10.1002/eji.201646795; Pesesse X, 2006, ADV ENZYME REGUL, V46, P142, DOI 10.1016/j.advenzreg.2006.01.013; Pirruccello M, 2012, TRENDS BIOCHEM SCI, V37, P134, DOI 10.1016/j.tibs.2012.01.002; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Prasad NK, 2008, TUMOR BIOL, V29, P330, DOI 10.1159/000172970; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Schink KO, 2016, ANNU REV CELL DEV BI, V32, P143, DOI 10.1146/annurev-cellbio-111315-125349; Sherwood AR, 2013, ANAL BIOCHEM, V435, P54, DOI 10.1016/j.ab.2012.10.044; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Srivastava N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00288; Stelea SD, 2002, BIOPHYS J, V83, P2259, DOI 10.1016/S0006-3495(02)73986-6; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Suwa A, 2010, EXPERT OPIN THER TAR, V14, P727, DOI 10.1517/14728222.2010.492780; Taylor V, 2000, MOL CELL BIOL, V20, P6860, DOI 10.1128/MCB.20.18.6860-6871.2000; Viernes DR, 2014, MED RES REV, V34, P795, DOI 10.1002/med.21305; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang YB, 2018, J BIOL CHEM, V293, P6230, DOI 10.1074/jbc.R117.000582; Yip SC, 2008, BIOCHEM J, V411, P441, DOI 10.1042/BJ20071179; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhou H, 2021, PROTEIN EXPRES PURIF, V180, DOI 10.1016/j.pep.2021.105821; Zhou XJ, 2011, ARCH MED RES, V42, P589, DOI 10.1016/j.arcmed.2011.10.012	53	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21815	10.1096/fj.202100561R	http://dx.doi.org/10.1096/fj.202100561R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314064	Green Published			2022-12-28	WOS:000678975300027
J	Pereira, MF; Amaral, IM; Lopes, C; Leitao, C; Madeira, D; Lopes, JP; Goncalves, FQ; Canas, PM; Cunha, RA; Agostinho, P				Pereira, Marlene F.; Amaral, Ines M.; Lopes, Catia; Leitao, Catarina; Madeira, Daniela; Lopes, Joao P.; Goncalves, Francisco Q.; Canas, Paula M.; Cunha, Rodrigo A.; Agostinho, Paula			L-alpha-aminoadipate causes astrocyte pathology with negative impact on mouse hippocampal synaptic plasticity and memory	FASEB JOURNAL			English	Article						astrocyte; hippocampus; L-alpha-aminoadipate; memory; synaptic plasticity	LONG-TERM POTENTIATION; ADENOSINE A(2A) RECEPTORS; D-SERINE; GLUTAMATE TRANSPORTER; CULTURED ASTROCYTES; PREFRONTAL CORTEX; OXIDATIVE STRESS; AMINO-ACIDS; RELEASE; RECOGNITION	Increasing evidence shows that astrocytes, by releasing and uptaking neuroactive molecules, regulate synaptic plasticity, considered the neurophysiological basis of memory. This study investigated the impact of L-alpha-aminoadipate (L-AA) on astrocytes which sense and respond to stimuli at the synaptic level and modulate hippocampal long-term potentiation (LTP) and memory. L-AA selectivity toward astrocytes was proposed in the early 70's and further tested in different systems. Although it has been used for impairing the astrocytic function, its effects appear to be variable in different brain regions. To test the effects of L-AA in the hippocampus of male C57Bl/6 mice we performed two different treatments (ex vivo and in vivo) and took advantage of other compounds that were reported to affect astrocytes. L-AA superfusion did not affect the basal synaptic transmission but decreased LTP magnitude. Likewise, trifluoroacetate and dihydrokainate decreased LTP magnitude and occluded the effect of L-AA on synaptic plasticity, confirming L-AA selectivity. L-AA superfusion altered astrocyte morphology, increasing the length and complexity of their processes. In vivo, L-AA intracerebroventricular injection not only reduced the astrocytic markers but also LTP magnitude and impaired hippocampal-dependent memory in mice. Interestingly, D-serine administration recovered hippocampal LTP reduction triggered by L-AA (2 h exposure in hippocampal slices), whereas in mice injected with L-AA, the superfusion of D-serine did not fully rescue LTP magnitude. Overall, these data show that both L-AA treatments affect astrocytes differently, astrocytic activation or loss, with similar negative outcomes on hippocampal LTP, implying that opposite astrocytic adaptive alterations are equally detrimental for synaptic plasticity.	[Pereira, Marlene F.; Amaral, Ines M.; Lopes, Catia; Leitao, Catarina; Madeira, Daniela; Lopes, Joao P.; Goncalves, Francisco Q.; Canas, Paula M.; Cunha, Rodrigo A.; Agostinho, Paula] CNC, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Madeira, Daniela; Cunha, Rodrigo A.; Agostinho, Paula] Univ Coimbra, FMUC, Fac Med, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Agostinho, P (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Rua Larga,Polo FMUC,1St Floor, P-3004504 Coimbra, Portugal.; Agostinho, P (corresponding author), Univ Coimbra, Fac Med, Rua Larga,Polo FMUC,1St Floor, P-3004504 Coimbra, Portugal.	pagostinho@fmed.uc.pt	Pereira, Marlene/AFM-9564-2022; Madeira, Daniela/GWZ-4268-2022; Lopes, Joao P/A-2332-2017; Agostinho, Paula/F-3748-2010; Cunha, Rodrigo A/E-7475-2015; Leitão, Catarina/GMW-5355-2022	Pereira, Marlene/0000-0002-8890-2994; Madeira, Daniela/0000-0002-6027-5407; Lopes, Joao P/0000-0002-5122-1802; Agostinho, Paula/0000-0001-5523-4945; Cunha, Rodrigo A/0000-0003-2550-6422; Leitão, Catarina/0000-0003-1262-0453	European Regional Development Fund (ERDF) through the COMPETE 2020; Portuguese National Funds (FCT) [PTDC/NEU-NMC/4154/2014-POCI-01-0145-FEDER-016684, PTDC/MED-NEU/31274/2017]; European Regional Development Fund (ERDF) [CENTRO-01-0246-FEDER-000010]	European Regional Development Fund (ERDF) through the COMPETE 2020; Portuguese National Funds (FCT); European Regional Development Fund (ERDF)(European Commission)	This work was financially supported by the European Regional Development Fund (ERDF) through the COMPETE 2020 and Portuguese National Funds (FCT, PTDC/NEU--NMC/4154/2014--POCI-01--0145--FEDER--016684 and PTDC/MED--NEU/31274/2017) and by European Regional Development Fund (ERDF, CENTRO--01--0246--FEDER--000010)	Adamsky A, 2018, CELL, V174, P59, DOI 10.1016/j.cell.2018.05.002; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Bernardinelli Y, 2008, BRAIN RES, V1240, P47, DOI 10.1016/j.brainres.2008.09.014; Brown DR, 1998, J NEUROCYTOL, V27, P109, DOI 10.1023/A:1006947322342; Canas PM, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-18.2018; Choi M, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0253-z; Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724; da Silva SV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11915; Darcet F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00136; David J, 2019, BEHAV BRAIN RES, V362, P90, DOI 10.1016/j.bbr.2019.01.015; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746; Derouiche A, 2002, J PHYSIOLOGY-PARIS, V96, P177, DOI 10.1016/S0928-4257(02)00004-9; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Fellin T, 2006, J BIOL CHEM, V281, P4274, DOI 10.1074/jbc.M510679200; Fonnum F, 1997, GLIA, V21, P106; George J, 2015, GLIA, V63, P1636, DOI 10.1002/glia.22833; Goncalves FQ, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104570; Guerra-Gomes S, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00427; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Han HL, 2015, PHARMACOL BIOCHEM BE, V133, P51, DOI 10.1016/j.pbb.2015.03.017; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; HUCK S, 1984, J NEUROSCI, V4, P2650; Ivanov AD, 2019, NEUROSCI LETT, V689, P21, DOI 10.1016/j.neulet.2018.05.039; Kaster MP, 2015, P NATL ACAD SCI USA, V112, P7833, DOI 10.1073/pnas.1423088112; Katagiri H, 2001, EUR J NEUROSCI, V14, P547, DOI 10.1046/j.0953-816x.2001.01664.x; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112; Lima A, 2014, MOL PSYCHIATR, V19, P834, DOI 10.1038/mp.2013.182; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Masuoka T, 2019, NEUROPHARMACOLOGY, V151, P64, DOI 10.1016/j.neuropharm.2019.03.036; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; Matos M, 2012, GLIA, V60, P702, DOI 10.1002/glia.22290; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; MCBEAN GJ, 1994, BRIT J PHARMACOL, V113, P536, DOI 10.1111/j.1476-5381.1994.tb17022.x; Miller RF, 2004, GLIA, V47, P275, DOI 10.1002/glia.20073; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; Ota Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/185463; Padmashri R, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/938023; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Papouin T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0154; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; PAULSEN RE, 1987, J NEUROCHEM, V48, P1377, DOI 10.1111/j.1471-4159.1987.tb05674.x; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Robin LM, 2018, NEURON, V98, P935, DOI 10.1016/j.neuron.2018.04.034; Rodrigues DI, 2014, J ALZHEIMERS DIS, V40, P981, DOI 10.3233/JAD-132030; Rodrigues RJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00148; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schousboe A, 2004, NEUROCHEM INT, V45, P521, DOI 10.1016/j.neuint.2003.11.001; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Simoes AP, 2016, NEUROPSYCHOPHARMACOL, V41, P2862, DOI 10.1038/npp.2016.98; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sullivan SJ, 2010, J NEUROCHEM, V115, P1681, DOI 10.1111/j.1471-4159.2010.07077.x; Sun CQ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00280; TAKADA M, 1986, HISTOL HISTOPATHOL, V1, P271; Tavares G, 2017, BRAIN STRUCT FUNCT, V222, P1989, DOI 10.1007/s00429-016-1316-8; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Verkhratsky A, 2016, EMBO J, V35, P239, DOI 10.15252/embj.201592705; Verkhratsky A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0595; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Wolosker H, 2016, TRENDS NEUROSCI, V39, P712, DOI 10.1016/j.tins.2016.09.007	77	2	2	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21726	10.1096/fj.202100336R	http://dx.doi.org/10.1096/fj.202100336R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34196433				2022-12-28	WOS:000678975300040
J	Xu, DC; Wu, JW; Chen, JH; Jiang, LL; Chen, J; Bao, WH; Chen, X; Yang, QQ; Zhang, XL; Yao, LY; Su, HB; Liu, JB				Xu, Dacai; Wu, Jiawen; Chen, Jinghong; Jiang, Liling; Chen, Juan; Bao, Wenhao; Chen, Xin; Yang, Qianqian; Zhang, Xiaolan; Yao, Leyi; Su, Huabo; Liu, Jinbao			Cullin 2-RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability	FASEB JOURNAL			English	Article						coagulation; deubiquitinase; neddylation; ubiquitin	THERAPEUTIC TARGETING ANTITHROMBIN; HEMOPHILIA-A; CANCER; COAGULATION; DEGRADATION; INHIBITORS; ENZYME	Hemophilia A and B are congenital bleeding disorders caused by a deficiency in pro-coagulant factor VIII or IX that is treated by downregulation of antithrombin. However, the molecular mechanisms that regulate antithrombin expression remain poorly understood. Here, we identified Cullin 2 and USP2 (ubiquitin-specific peptidase-2) as novel regulators of antithrombin expression that act by modulating antithrombin ubiquitination. Inhibition of the proteasome caused accumulation of antithrombin and its ubiquitinated forms in HepG2 and SMMC7721 cells. Notably, inhibition of neddylation with MLN4924 suppressed both ubiquitination and degradation of antithrombin, which is recapitulated by silencing of the neddylation enzymes, NAE1, UBA3, and UBE2M, with small interfering RNA (siRNA). We identified Cullin 2 as the interaction partner of antithrombin, and siRNA-mediated Cullin 2 knockdown reduced antithrombin ubiquitination and increased antithrombin protein. We further found that USP2 interacted with antithrombin and regulated antithrombin expression, showing that overexpression of USP2 inhibits the ubiquitination and proteasomal clearance of antithrombin, whereas pharmacological inhibition or siRNA-mediated knockdown of USP2 downregulates antithrombin. Collectively, these results suggest that Cullin 2 E3 ubiquitin ligase and USP2 coordinately regulate antithrombin ubiquitination and degradation. Thus, targeting Cullin 2 and USP2 could be a potential strategy for treatment of hemophilia.	[Xu, Dacai; Wu, Jiawen; Chen, Jinghong; Jiang, Liling; Chen, Juan; Bao, Wenhao; Chen, Xin; Yang, Qianqian; Zhang, Xiaolan; Yao, Leyi; Liu, Jinbao] Guangzhou Med Univ, Affiliated Canc Hosp, Sch Basic Med Sci, State Key Lab Resp Dis,Guangzhou Municipal & Guan, Guangzhou, Peoples R China; [Su, Huabo] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University System of Georgia; Augusta University	Liu, JB (corresponding author), Guangzhou Med Univ, Sch Basic Med Sci, Key Lab Prot Modificat & Degradat, Guangzhou 511436, Guangdong, Peoples R China.	jliu@gzhmu.edu.cn		Xu, Dacai/0000-0002-2566-7077; Su, Huabo/0000-0002-8475-2685; CHEN, XIN/0000-0003-3668-4830	National Funds for developing local Colleges and Universities [B16056001]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2018B030312001]; Science and Technology Program of Guangzhou [201604020001]; Innovative Academic Team of Guangzhou Education System [1201610014]; Department of the Education Guangdong [2017KCXTD027]; National Natural Science Foundation of China (NSFC) [81900365]	National Funds for developing local Colleges and Universities; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou; Innovative Academic Team of Guangzhou Education System; Department of the Education Guangdong; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Funds for developing local Colleges and Universities, Grant/Award Number: B16056001; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2018B030312001; Science and Technology Program of Guangzhou, Grant/Award Number: 201604020001; Innovative Academic Team of Guangzhou Education System, Grant/Award Number: 1201610014; Research Team of the Department of the Education Guangdong, Grant/Award Number: 2017KCXTD027; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81900365	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; CHAN TK, 1981, THROMB HAEMOSTASIS, V46, P504; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Chen X, 2017, EUR J PHARMACOL, V815, P147, DOI 10.1016/j.ejphar.2017.09.003; Colombo M, 2010, CHEMMEDCHEM, V5, P552, DOI 10.1002/cmdc.200900409; Davis MI, 2016, J BIOL CHEM, V291, P24628, DOI 10.1074/jbc.M116.738567; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Hermanns T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03148-5; Hernandez-Espinosa D, 2008, LAB INVEST, V88, P306, DOI 10.1038/labinvest.3700717; Liao H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009183; Liao YN, 2018, ONCOGENE, V37, P1896, DOI 10.1038/s41388-017-0069-z; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Machin N, 2018, J BLOOD MED, V9, P135, DOI 10.2147/JBM.S159297; Mammen EF., 1998, SEMIN THROMB HEMOST, V24, p19; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Palta S, 2014, INDIAN J ANAESTH, V58, P515, DOI 10.4103/0019-5049.144643; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang SW, 2016, ONCOTARGET, V7, P46707, DOI 10.18632/oncotarget.8732; Xu JF, 2015, MOL CELL PROTEOMICS, V14, P499, DOI 10.1074/mcp.M114.045211; Zhang SZ, 2020, ADV EXP MED BIOL, V1217, P261, DOI 10.1007/978-981-15-1025-0_16; Zhu HQ, 2017, INT J BIOL SCI, V13, P1489, DOI 10.7150/ijbs.21637	28	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21800	10.1096/fj.202001146RR	http://dx.doi.org/10.1096/fj.202001146RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324733	Green Accepted, hybrid			2022-12-28	WOS:000678975300048
J	Agbleke, AA; Seeber, A; Broker, TR				Agbleke, Andrews Akwasi; Seeber, Andrew; Broker, Thomas R.			The 2021 FASEB Virtual Catalyst Conference on Imaging Cells to Organisms for Basic Science and Medical Research, April 14, 2021	FASEB JOURNAL			English	Editorial Material									[Agbleke, Andrews Akwasi] Harvard Univ, Harvard Ctr Biol Imaging, Cambridge, MA 02138 USA; [Agbleke, Andrews Akwasi] Sena Inst Technol, Penyi, Ghana; [Seeber, Andrew] Harvard Univ, Ctr Adv Imaging, Cambridge, MA 02138 USA; [Broker, Thomas R.] Univ Alabama Birmingham, Dept Biochem & Mol Biol, Birmingham, AL USA	Harvard University; Harvard University; University of Alabama System; University of Alabama Birmingham	Agbleke, AA (corresponding author), Harvard Univ, Harvard Ctr Biol Imaging, Cambridge, MA 02138 USA.	agbleke@fas.harvard.edu			New England Biolabs (Ipswich, MA, USA); ThermoFisher Scientific (Waltham, MA, USA); Addgene (Watertown, MA, USA)	New England Biolabs (Ipswich, MA, USA); ThermoFisher Scientific (Waltham, MA, USA); Addgene (Watertown, MA, USA)	The authors thank FASEB for its exceptional role of leading the effort to bring its conference programs to a broader global audience, especially to researchers on the African Continent. The authors thank sponsors of the SIT African Seminar Series, notably New England Biolabs (Ipswich, MA, USA), ThermoFisher Scientific (Waltham, MA, USA), and Addgene (Watertown, MA, USA). The authors also thank the speakers for participating in the SIT/FASEB virtual conference with Focus on Africa.		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21749	10.1096/fj.202100970	http://dx.doi.org/10.1096/fj.202100970			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143494				2022-12-28	WOS:000667814100021
J	Hamdani, E; Popek, M; Frontczak-Baniewicz, M; Utheim, TP; Albrecht, J; Zielinska, M; Chaudhry, FA				Hamdani, El Hassan; Popek, Mariusz; Frontczak-Baniewicz, Malgorzata; Utheim, Tor Paaske; Albrecht, Jan; Zielinska, Magdalena; Chaudhry, Farrukh Abbas			Perturbation of astroglial Slc38 glutamine transporters by NH4 (+) contributes to neurophysiologic manifestations in acute liver failure	FASEB JOURNAL			English	Article						hepatic encephalopathy; NH4; (+); Slc38; Slc38a3; SNAT3	SWELLING-INDUCED CHANGES; BLOOD-BRAIN-BARRIER; SYSTEM-N; GLIAL-CELLS; HEPATIC-ENCEPHALOPATHY; ELECTROPHYSIOLOGICAL PROPERTIES; CULTURED ASTROCYTES; AMINO-ACIDS; AMMONIA; EXPRESSION	Ammonia is considered the main pathogenic toxin in hepatic encephalopathy (HE). However, the molecular mechanisms involved have been disputed. As altered glutamatergic and GABAergic neurotransmission has been reported in HE, we investigated whether four members of the solute carrier 38 (Slc38) family of amino acid transporters-involved in the replenishment of glutamate and GABA-contribute to ammonia neurotoxicity in HE. We show that ammonium ion exerts multiple actions on the Slc38 transporters: It competes with glutamine for the binding to the system N transporters Slc38a3 and Slc38a5, consequently inhibiting bidirectional astroglial glutamine transport. It also competes with H+, Na+, and K+ for uncoupled permeation through the same transporters, which may perturb astroglial intracellular pH, membrane potential, and K+-buffering. Knockdown of Slc38a3 in mice results in cerebral cortical edema and disrupted neurotransmitter synthesis mimicking events contributing to HE development. Finally, in a mouse model of acute liver failure (ALF), we demonstrate the downregulation of Slc38a3 protein, impeded astroglial glutamine release, and cytotoxic edema. Altogether, we demonstrate contribution of Slc38 transporters to the ammonia-induced impairment of glutamine recycling between astrocytes and neurons, a phenomenon underlying acute ammonia neurotoxicity in the setting of ALF.	[Hamdani, El Hassan; Chaudhry, Farrukh Abbas] Univ Oslo UiO, Dept Mol Med, Oslo, Norway; [Hamdani, El Hassan] Oslo Metropolitan Univ, Inst Behav Sci, Oslo, Norway; [Popek, Mariusz; Albrecht, Jan; Zielinska, Magdalena] Mossakowski Med Res Inst PAS, Neurotoxicol Dept, Warsaw, Poland; [Frontczak-Baniewicz, Malgorzata] Mossakowski Med Res Inst PAS, Electron Microscopy Platform, Warsaw, Poland; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Tor Paaske; Chaudhry, Farrukh Abbas] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway	University of Oslo; Oslo Metropolitan University (OsloMet); Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; University of Oslo; University of Oslo	Zielinska, M (corresponding author), Mossakowski Med Res Inst PAS, Neurotoxicol Dept, Warsaw, Poland.; Chaudhry, FA (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, POB 1110, N-0317 Oslo, Norway.	mzielinska@imdik.pan.pl; f.a.chaudhry@medisin.uio.no	Zielińska, Magdalena/S-6624-2019	Zielińska, Magdalena/0000-0001-7388-3092; Chaudhry, Farrukh Abbas/0000-0002-2039-9667; Popek, Mariusz/0000-0003-4394-3394	National Centre for Research (NCBiR) Polish Norwegian Research Program [Pol-Nor/196190/23/2013]; South-Eastern Norway Regional Health Authority [21561/2017052]; UiO:Life Science	National Centre for Research (NCBiR) Polish Norwegian Research Program; South-Eastern Norway Regional Health Authority; UiO:Life Science	The National Centre for Research (NCBiR) Polish Norwegian Research Program, Grant/Award Number: Pol-Nor/196190/23/2013; South-Eastern Norway Regional Health Authority, Grant/Award Number: ID 21561/2017052; UiO:Life Science	Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004; Baird FE, 2004, J PHYSIOL-LONDON, V559, P367, DOI 10.1113/jphysiol.2003.060293; Bhatia V, 2006, GUT, V55, P98, DOI 10.1136/gut.2004.061754; Boulland JL, 2003, GLIA, V41, P260, DOI 10.1002/glia.10188; Boulland JL, 2002, EUR J NEUROSCI, V15, P1615, DOI 10.1046/j.1460-9568.2002.01995.x; Broer A, 2002, J PHYSIOL-LONDON, V539, P3, DOI 10.1013/jphysiol.2001.013303; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; Chang ML, 2007, J ANAT, V210, P54, DOI 10.1111/j.1469-7580.2006.00671.x; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Cittolin-Santos GF, 2019, NEUROSCIENCE, V401, P117, DOI 10.1016/j.neuroscience.2018.12.032; Cooper AJL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020016; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; Dolgodilina E, 2016, J CEREBR BLOOD F MET, V36, P1929, DOI 10.1177/0271678X15609331; Ennis SR, 1998, J NEUROCHEM, V71, P2565; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Fleischer W, 2017, EXP NEUROL, V290, P41, DOI 10.1016/j.expneurol.2017.01.003; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Hakvoort TBM, 2017, HEPATOLOGY, V65, P281, DOI 10.1002/hep.28852; Hamdani E, 2012, GLIA, V60, P1671, DOI 10.1002/glia.22386; HILGIER W, 1994, J NEUROCHEM, V62, P197; Hilgier W, 1999, J NEUROSCI RES, V56, P76, DOI 10.1002/(SICI)1097-4547(19990401)56:1<76::AID-JNR10>3.0.CO;2-Y; Jenstad M, 2009, CEREB CORTEX, V19, P1092, DOI 10.1093/cercor/bhn151; KIMELBERG HK, 1990, BRAIN RES, V529, P255, DOI 10.1016/0006-8993(90)90835-Y; KIMELBERG HK, 1990, BRAIN RES, V529, P262, DOI 10.1016/0006-8993(90)90836-Z; Kosenko EA, 2014, CNS NEUROL DISORD-DR, V13, P1089, DOI 10.2174/1871527313666140806155929; Lee WJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1101, DOI 10.1152/ajpcell.1998.274.4.C1101; Leke R, 2011, J NEUROCHEM, V117, P824, DOI 10.1111/j.1471-4159.2011.07244.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Malaguarnera M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00132; MANS AM, 1994, J NEUROCHEM, V63, P1829; Marcaggi P, 2004, EUR J NEUROSCI, V19, P966, DOI 10.1111/j.0953-816X.2004.03165.x; Marcaggi P, 2001, PROG NEUROBIOL, V64, P157, DOI 10.1016/S0301-0082(00)00043-5; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455; Menchini RJ, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.107789; Niranjan-Azadi Ashwini M, 2016, Ann Transplant, V21, P479; Nissen-Meyer LSH, 2011, J NEUROSCI, V31, P6565, DOI 10.1523/JNEUROSCI.3694-10.2011; Popek M, 2020, NEUROSCIENCE, V446, P124, DOI 10.1016/j.neuroscience.2020.08.019; Popek M, 2018, MOL NEUROBIOL, V55, P1244, DOI 10.1007/s12035-016-0367-4; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Qureshi T, 2019, CEREB CORTEX, V29, P5166, DOI 10.1093/cercor/bhz055; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Scott TR, 2013, WORLD J GASTROENTERO, V19, P9240, DOI 10.3748/wjg.v19.i48.9240; Solbu TT, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.001.2010; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Umapathy NS, 2008, INVEST OPHTH VIS SCI, V49, P5151, DOI 10.1167/iovs.08-2245; WillardMack CL, 1996, NEUROSCIENCE, V71, P589, DOI 10.1016/0306-4522(95)00462-9; Zielinska M, 2016, J NEUROCHEM, V136, P329, DOI 10.1111/jnc.13376	60	8	8	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21588	10.1096/fj.202001712RR	http://dx.doi.org/10.1096/fj.202001712RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34169573	Green Published, hybrid			2022-12-28	WOS:000667814100002
J	Yao, XQ; Liu, ZY; Chen, JY; Huang, ZC; Liu, JH; Sun, BH; Zhu, QA; Ding, RT; Chen, JT				Yao, Xin-Qiang; Liu, Zhong-Yuan; Chen, Jia-Ying; Huang, Zu-Cheng; Liu, Jun-Hao; Sun, Bai-Hui; Zhu, Qing-An; Ding, Ruo-Ting; Chen, Jian-Ting			Proteomics and bioinformatics reveal insights into neuroinflammation in the acute to subacute phases in rat models of spinal cord contusion injury	FASEB JOURNAL			English	Article						lipid metabolism; lysosomes; neuroinflammation; proteomics; spinal cord injury	INFLAMMATORY RESPONSE; COMPLEMENT; ACTIVATION; CLEARANCE; MICROGLIA; PATHWAYS; PACKAGE; CNS	Neuroinflammation is recognized as a hallmark of spinal cord injury (SCI). Although neuroinflammation is an important pathogenic factor that leads to secondary injuries after SCI, neuroprotective anti-inflammatory treatments remain ineffective in the management of SCI. Moreover, the molecular signatures involved in the pathophysiological changes that occur during the course of SCI remain ambiguous. The current study investigated the proteins and pathways involved in C5 spinal cord hemi-contusion injury using a rat model by means of 4-D label-free proteomic analysis. Furthermore, two Gene Expression Omnibus (GEO) transcriptomic datasets, Western blot assays, and immunofluorescent staining were used to validate the expression levels and localization of dysregulated proteins. The present study observed that the rat models of SCI were associated with the enrichment of proteins related to the complement and coagulation cascades, cholesterol metabolism, and lysosome pathway throughout the acute and subacute phases of injury. Intriguingly, the current study also observed that 75 genes were significantly altered in both the GEO datasets, including ANXA1, C1QC, CTSZ, GM2A, GPNMB, and PYCARD. Further temporal clustering analysis revealed that the continuously upregulated protein cluster was associated with immune response, lipid regulation, lysosome pathway, and myeloid cells. Additionally, five proteins were further validated by means of Western blot assays and the immunofluorescent staining showed that these proteins coexisted with the F4/80+ reactive microglia and infiltrating macrophages. In conclusion, the proteomic data pertaining to the current study indicate the notable proteins and pathways that may be novel therapeutic targets for the treatment of SCI.	[Yao, Xin-Qiang; Liu, Zhong-Yuan; Huang, Zu-Cheng; Liu, Jun-Hao; Zhu, Qing-An; Ding, Ruo-Ting; Chen, Jian-Ting] Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Spine Surg, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Jia-Ying] Southern Med Univ, Nanfang Hosp, Dept Comprehens Med Treatment Ward, Guangzhou, Peoples R China; [Liu, Jun-Hao] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Dept Orthopaed,Div Spine Surg, Guangzhou, Peoples R China; [Sun, Bai-Hui] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; South China University of Technology; Southern Medical University - China	Ding, RT; Chen, JT (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Spine Surg, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	ding_ruoting@163.com; chenjt@smu.edu.cn			Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) [2017B010110012]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2021A1515011228]; Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality) [20211A011008]; National Natural Science Foundation of China (NSFC) [81902217, 81701921]	Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province), Grant/Award Number: 2017B010110012; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2021A1515011228; Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality), Grant/Award Number: 20211A011008; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81902217 and 81701921	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Allan ERO, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0874-x; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Brekk OR, 2020, P NATL ACAD SCI USA, V117, P27646, DOI 10.1073/pnas.2003021117; Cantuti-Castelvetri L, 2018, SCIENCE, V359, P684, DOI 10.1126/science.aan4183; Cheng XX, 2018, EXP NEUROL, V299, P97, DOI 10.1016/j.expneurol.2017.10.014; Ding H, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117235; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gabande-Rodriguez E, 2019, EMBO J, V38, DOI 10.15252/embj.201899553; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang ZC, 2018, NEUROSCI LETT, V664, P116, DOI 10.1016/j.neulet.2017.11.019; Kobayakawa K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5086; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lee JD, 2019, SEMIN IMMUNOL, V45, DOI 10.1016/j.smim.2019.101340; Liu ZY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01751-2; Mallah K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02021; Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1; Milich LM, 2019, ACTA NEUROPATHOL, V137, P785, DOI 10.1007/s00401-019-01992-3; Nakanishi H, 2020, NEURAL REGEN RES, V15, P25, DOI 10.4103/1673-5374.264444; Natrajan MS, 2015, BRAIN, V138, P3581, DOI 10.1093/brain/awv289; Norris GT, 2018, J EXP MED, V215, P1789, DOI 10.1084/jem.20172244; Peterson SL, 2015, J NEUROSCI, V35, P4332, DOI 10.1523/JNEUROSCI.4473-12.2015; Peterson SL, 2014, EXP NEUROL, V258, P35, DOI 10.1016/j.expneurol.2014.04.028; Pislar A, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.575453; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Squair JW, 2018, ELIFE, V7, DOI 10.7554/eLife.39188; Steward O, 2017, EXP NEUROL, V287, P374, DOI 10.1016/j.expneurol.2016.06.029; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Tran AP, 2021, NEURAL REGEN RES, V16, P26, DOI 10.4103/1673-5374.286948; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Yong HYF, 2019, CELL MOL IMMUNOL, V16, P540, DOI 10.1038/s41423-019-0223-3; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang XF, 2018, NAT PROTOC, V13, P530, DOI 10.1038/nprot.2017.147; Zhou T, 2019, NAT NEUROSCI, V22, P421, DOI 10.1038/s41593-018-0324-9; Zhou X, 2020, NAT NEUROSCI, V23, P337, DOI 10.1038/s41593-020-0597-7; Zhu Y, 2017, J NEUROSCI, V37, P2362, DOI 10.1523/JNEUROSCI.2751-16.2017	41	10	10	6	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21735	10.1096/fj.202100081RR	http://dx.doi.org/10.1096/fj.202100081RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143440				2022-12-28	WOS:000667814100082
J	Markworth, JF; Sugg, KB; Sarver, DC; Maddipati, KR; Brooks, SV				Markworth, James F.; Sugg, Kristoffer B.; Sarver, Dylan C.; Maddipati, Krishna Rao; Brooks, Susan V.			Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse	FASEB JOURNAL			English	Article						eicosanoid; inflammation; lipid mediator; mass spectrometry; resolution; tendon	ANTIINFLAMMATORY MEDICATION; MACROPHAGES ACCUMULATE; DOCOSAHEXAENOIC ACID; COLLAGEN-SYNTHESIS; REPETITIVE MOTION; PATELLAR TENDON; SKELETAL-MUSCLE; THROMBOXANE A2; SUBSTANCE-P; HUMAN-BLOOD	Tendon inflammation has been implicated in both adaptive connective tissue remodeling and overuse-induced tendinopathy. Lipid mediators control both the initiation and resolution of inflammation, but their roles within tendon are largely unknown. Here, we profiled local shifts in intratendinous lipid mediators via liquid chromatography-tandem mass spectrometry in response to synergist ablation-induced plantaris tendon overuse. Sixty-four individual lipid mediators were detected in homogenates of plantaris tendons from ambulatory control rats. This included many bioactive metabolites of the cyclooxygenase (COX), lipoxygenase (LOX), and epoxygenase (CYP) pathways. Synergist ablation induced a robust inflammatory response at day 3 post-surgery characterized by epitenon infiltration of polymorphonuclear leukocytes and monocytes/macrophages (M phi), heightened expression of inflammation-related genes, and increased intratendinous concentrations of the pro-inflammatory eicosanoids thromboxane B-2 and prostaglandin E-2. By day 7, M phi became the predominant myeloid cell type in tendon and there were further delayed increases in other COX metabolites including prostaglandins D-2, F-2 alpha, and I-2. Specialized pro-resolving mediators including protectin D1, resolvin D2 and D6, as well as related pathway markers of D-resolvins (17-hydroxy-docosahexaenoic acid), E-resolvins (18-hydroxy-eicosapentaenoic acid), and lipoxins (15-hydroxy-eicosatetraenoic acid) were also increased locally in response to tendon overuse, as were anti-inflammatory fatty acid epoxides of the CYP pathway (eg, epoxy-eicosatrienoic acids). Nevertheless, intratendinous prostaglandins remained markedly increased even following 28 days of tendon overuse together with a lingering M phi presence. These data reveal a delayed and prolonged local inflammatory response to tendon overuse characterized by an overwhelming predominance of pro-inflammatory eicosanoids and a relative lack of specialized pro-resolving lipid mediators.	[Markworth, James F.; Brooks, Susan V.] Univ Michigan, Dept Mol & Integrat Physiol, 2029 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Markworth, James F.; Sugg, Kristoffer B.; Sarver, Dylan C.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Sugg, Kristoffer B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Sarver, Dylan C.] Johns Hopkins Univ, Dept Cellular & Mol Physiol, Baltimore, MD USA; [Maddipati, Krishna Rao] Wayne State Univ, Dept Pathol, Lipid Core Facil, Detroit, MI 48202 USA; [Brooks, Susan V.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Wayne State University; University of Michigan System; University of Michigan	Brooks, SV (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, 2029 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	svbrooks@umich.edu	Maddipati, Krishna Rao/G-1859-2011	Maddipati, Krishna Rao/0000-0003-1445-791X; Markworth, James/0000-0002-5348-1464	Glenn Foundation for Medical Research Post-Doctoral Fellowship in Aging Research; University of Michigan Department of Orthopedic Surgery; National Institutes of Health (NIH) [R01 (AG050676), PO1 (AG051442), P30 (AR069620), S10 (RR027926)]	Glenn Foundation for Medical Research Post-Doctoral Fellowship in Aging Research; University of Michigan Department of Orthopedic Surgery(University of Michigan System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Glenn Foundation for Medical Research Post-Doctoral Fellowship in Aging Research (JFM), the University of Michigan Department of Orthopedic Surgery, and the National Institutes of Health (NIH) under the awards R01 (AG050676) (SVB), PO1 (AG051442) (SVB), P30 (AR069620) (SVB), and S10 (RR027926) (KRM).	Abat F, 2017, J Exp Orthop, V4, P18, DOI 10.1186/s40634-017-0092-6; Abate M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2723; Ali A E, 1980, Adv Prostaglandin Thromboxane Res, V6, P533; ALMEKINDERS LC, 1993, MED SCI SPORT EXER, V25, P603; ALMEKINDERS LC, 1995, AM J SPORT MED, V23, P119, DOI 10.1177/036354659502300120; Andersson G, 2011, BRIT J SPORT MED, V45, P1017, DOI 10.1136/bjsm.2010.082750; Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; BACKMAN C, 1990, J ORTHOPAED RES, V8, P541, DOI 10.1002/jor.1100080410; Barbe MF, 2008, J ORTHOP RES, V26, P1320, DOI 10.1002/jor.20674; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Bergqvist F, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1855-5; BRYANT RW, 1978, J BIOL CHEM, V253, P8134; Chbinou N, 2004, AM J PHYSIOL-REG I, V286, pR952, DOI 10.1152/ajpregu.00536.2003; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Christensen B, 2011, J APPL PHYSIOL, V110, P137, DOI 10.1152/japplphysiol.00942.2010; Christie WW, 2020, ESSAYS BIOCHEM, V64, P401, DOI 10.1042/EBC20190082; Dakin SG, 2019, AM J PATHOL, V189, P2258, DOI 10.1016/j.ajpath.2019.07.011; Dakin SG, 2019, FASEB J, V33, P8043, DOI 10.1096/fj.201900196R; Dakin SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11188-y; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Dakin SG, 2014, VET IMMUNOL IMMUNOP, V158, P121, DOI 10.1016/j.vetimm.2014.01.007; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048978; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; Dalli J, 2019, BRIT J PHARMACOL, V176, P1024, DOI 10.1111/bph.14336; Dalli J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01400; ENWEMEKA CS, 1989, PHYS THER, V69, P816, DOI 10.1093/ptj/69.10.816; Fedorczyk JM, 2010, J ORTHOP RES, V28, P298, DOI 10.1002/jor.20984; Fenwick SA, 2002, ARTHRITIS RES, V4, P252, DOI 10.1186/ar416; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Giannakis N, 2019, NAT IMMUNOL, V20, P626, DOI 10.1038/s41590-019-0356-7; Gilroy DW, 2019, BRIT J PHARMACOL, V176, P1009, DOI 10.1111/bph.14587; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GOLDBERG AL, 1967, AM J PHYSIOL, V213, P1193, DOI 10.1152/ajplegacy.1967.213.5.1193; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; HONDA H, 1990, IMMUNOLOGY, V70, P272; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; HUMES JL, 1977, NATURE, V269, P149, DOI 10.1038/269149a0; Jomaa G, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-3094-y; KANG H J, 1990, Yonsei Medical Journal, V31, P264; Kawamura S, 2005, J ORTHOP RES, V23, P1425, DOI 10.1016/j.orthres.2005.01.014; Khan KM, 2002, BRIT MED J, V324, P626, DOI 10.1136/bmj.324.7338.626; Kietrys DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046954; Kongsgaard M, 2007, ACTA PHYSIOL, V191, P111, DOI 10.1111/j.1748-1716.2007.01714.x; KURLAND JI, 1978, J EXP MED, V147, P952, DOI 10.1084/jem.147.3.952; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Langberg H, 2003, J PHYSIOL-LONDON, V551, P683, DOI 10.1113/jphysiol.2003.046094; Lehner C, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.041384; Leuti A, 2020, ADV DRUG DELIVER REV, V159, P133, DOI 10.1016/j.addr.2020.06.028; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Maddipati KR, 2014, FASEB J, V28, P4835, DOI 10.1096/fj.14-254383; Markworth JF, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137713; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Markworth JF., 2020, LIPIDOMIC PROFILING, DOI [10.1101/2020.11.05.370056, DOI 10.1101/2020.11.05.370056]; Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; McArthur S, 2020, J CLIN INVEST, V130, P1156, DOI 10.1172/JCI124635; MCLENNAN IS, 1991, J ANAT, V178, P243; Messner K, 1999, CELLS TISSUES ORGANS, V165, P30, DOI 10.1159/000016671; Mosca MJ, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2017-000332; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Nieman DC, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.00121; Nieman DC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213676; Norris PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36679-4; Pingel J, 2013, SCAND J MED SCI SPOR, V23, pE353, DOI 10.1111/sms.12089; Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750; Pouliot M, 1998, FASEB J, V12, P1109, DOI 10.1096/fasebj.12.12.1109; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Sansbury BE, 2020, P NATL ACAD SCI USA, V117, P14354, DOI 10.1073/pnas.1918163117; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2011, FASEB J, V25, P1441, DOI 10.1096/fj.11-0502ufm; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SERHAN CN, 1986, P NATL ACAD SCI USA, V83, P1983, DOI 10.1073/pnas.83.7.1983; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SERHAN CN, 1986, J BIOL CHEM, V261, P6340; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Signini EF, 2020, METABOLITES, V10, DOI 10.3390/metabo10060264; Stanford KI, 2018, CELL METAB, V27, P1111, DOI 10.1016/j.cmet.2018.03.020; Su B, 2013, J APPL PHYSIOL, V115, P892, DOI 10.1152/japplphysiol.00053.2013; SVENSSON J, 1976, ACTA PHYSIOL SCAND, V98, P285, DOI 10.1111/j.1748-1716.1976.tb10313.x; Thorpe CT, 2016, ADV EXP MED BIOL, V920, P3, DOI 10.1007/978-3-319-33943-6_1; Trappe TA, 2008, AM J PHYSIOL-REG I, V294, pR192, DOI 10.1152/ajpregu.00669.2007; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Vella L, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14108; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Wang YJ, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12650; WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922; Werner M, 2019, FASEB J, V33, P6140, DOI 10.1096/fj.201802509R; WILLIAMS TJ, 1979, BRIT J PHARMACOL, V65, P517, DOI 10.1111/j.1476-5381.1979.tb07860.x; WOJCIAK B, 1993, CLIN EXP IMMUNOL, V93, P108; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Zhang JY, 2014, J ORTHOP TRANSL, V2, P75, DOI 10.1016/j.jot.2014.01.001; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067303; Zhang JY, 2010, J ORTHOP RES, V28, P1178, DOI 10.1002/jor.21123; Zhang MJ, 2016, CIRCULATION, V134, P666, DOI 10.1161/CIRCULATIONAHA.116.021894; Zhao GY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222369; ZUCALI JR, 1986, J CLIN INVEST, V77, P1857, DOI 10.1172/JCI112512; Zurier R B, 1975, Inflammation, V1, P93, DOI 10.1007/BF00918062	103	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21655	10.1096/fj.202100078R	http://dx.doi.org/10.1096/fj.202100078R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042218	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000655695900026
J	Zhu, ZS; Wu, XL; Li, Q; Zhang, JQ; Yu, S; Shen, QY; Zhou, Z; Pan, Q; Yue, W; Qin, DZ; Zhang, Y; Zhao, WX; Zhang, R; Peng, S; Li, N; Zhang, SQ; Lei, AM; Miao, YL; Liu, ZH; Chen, XQ; Wang, HY; Liao, MZ; Hua, JL				Zhu, Zhenshuo; Wu, Xiaolong; Li, Qun; Zhang, Juqing; Yu, Shuai; Shen, Qiaoyan; Zhou, Zhe; Pan, Qin; Yue, Wei; Qin, Dezhe; Zhang, Ying; Zhao, Wenxu; Zhang, Rui; Peng, Sha; Li, Na; Zhang, Shiqiang; Lei, Anmin; Miao, Yi-Liang; Liu, Zhonghua; Chen, Xingqi; Wang, Huayan; Liao, Mingzhi; Hua, Jinlian			Histone demethylase complexes KDM3A and KDM3B cooperate with OCT4/SOX2 to define a pluripotency gene regulatory network	FASEB JOURNAL			English	Article						histone demethylase complexes; KDM3A; 3B; pluripotency	STEM-LIKE CELLS; TRANSCRIPTION FACTORS; SELF-RENEWAL; GENERATION; OCT4; ACTIVATION; CHROMATIN; SOX2; ESTABLISHMENT; ANNOTATION	The pluripotency gene regulatory network of porcine induced pluripotent stem cells(piPSCs), especially in epigenetics, remains elusive. To determine the biological function of epigenetics, we cultured piPSCs in different culture conditions. We found that activation of pluripotent gene- and pluripotency-related pathways requires the erasure of H3K9 methylation modification which was further influenced by mouse embryonic fibroblast (MEF) served feeder. By dissecting the dynamic change of H3K9 methylation during loss of pluripotency, we demonstrated that the H3K9 demethylases KDM3A and KDM3B regulated global H3K9me2/me3 level and that their co-depletion led to the collapse of the pluripotency gene regulatory network. Immunoprecipitation-mass spectrometry (IP-MS) provided evidence that KDM3A and KDM3B formed a complex to perform H3K9 demethylation. The genome-wide regulation analysis revealed that OCT4 (O) and SOX2 (S), the core pluripotency transcriptional activators, maintained the pluripotent state of piPSCs depending on the H3K9 hypomethylation. Further investigation revealed that O/S cooperating with histone demethylase complex containing KDM3A and KDM3B promoted pluripotency genes expression to maintain the pluripotent state of piPSCs. Together, these data offer a unique insight into the epigenetic pluripotency network of piPSCs.	[Zhu, Zhenshuo; Wu, Xiaolong; Zhang, Juqing; Yu, Shuai; Shen, Qiaoyan; Zhou, Zhe; Pan, Qin; Yue, Wei; Qin, Dezhe; Zhang, Ying; Zhao, Wenxu; Zhang, Rui; Peng, Sha; Li, Na; Zhang, Shiqiang; Lei, Anmin; Wang, Huayan; Hua, Jinlian] Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, 3rd Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China; [Li, Qun; Liao, Mingzhi] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Miao, Yi-Liang] Huazhong Agr Univ, Inst Stem Cell & Regenerat Biol, Coll Anim Sci & Vet Med, Wuhan, Peoples R China; [Liu, Zhonghua] North East Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin, Peoples R China; [Chen, Xingqi] Karolinska Inst, Dept Cell & Mol Biol, Solna, Sweden	Northwest A&F University - China; Northwest A&F University - China; Huazhong Agricultural University; Karolinska Institutet	Hua, JL (corresponding author), Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, 3rd Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.; Liao, MZ (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	liaomz@nwsuaf.edu.cn; jinlianhua@nwsuaf.edu.cn		LEI, An-min/0000-0002-5066-8709; chen, xingqi/0000-0002-5657-2839; Li, Qun/0000-0002-7194-7504	Program of National Natural Science Foundation of China [32072806, 62072377]; National Key Research and Development Program of China Stem Cell and Translational Research [2016YFA0100203]; Program of Shaanxi Province Science and Technology Innovation Team [2019TD-036]; China Postdoctoral Science Foundation National Natural Science Foundation of China [32002246]; Fundamental research funds for the central Universities, NWSUAF [Z1090219146, Z102022004]	Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China Stem Cell and Translational Research; Program of Shaanxi Province Science and Technology Innovation Team; China Postdoctoral Science Foundation National Natural Science Foundation of China; Fundamental research funds for the central Universities, NWSUAF(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Program of National Natural Science Foundation of China (32072806, 62072377); The National Key Research and Development Program of China Stem Cell and Translational Research (Grant No.2016YFA0100203), Program of Shaanxi Province Science and Technology Innovation Team (2019TD--036), the China Postdoctoral Science Foundation National Natural Science Foundation of China (32002246), Fundamental research funds for the central Universities, NWSUAF (Z1090219146, Z102022004).	Abdelalim EM, 2014, STEM CELLS DEV, V23, P2687, DOI 10.1089/scd.2014.0297; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cha HJ, 2018, REPROD DOMEST ANIM, V53, P176, DOI 10.1111/rda.13088; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Choi HW, 2016, STEM CELL REP, V7, P911, DOI 10.1016/j.stemcr.2016.09.012; Choi KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158046; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Criqui M, 2020, ELIFE, V9, DOI 10.7554/eLife.47333; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2016, ANNU REV ANIM BIOSCI, V4, P223, DOI 10.1146/annurev-animal-021815-111202; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fang L, 2016, STEM CELLS, V34, P565, DOI 10.1002/stem.2250; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Hou DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25838; Huang B, 2019, ISCIENCE, V21, P375, DOI 10.1016/j.isci.2019.10.041; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Kuroki S, 2018, STEM CELL REP, V10, P1340, DOI 10.1016/j.stemcr.2018.02.002; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Li DW, 2017, CELL STEM CELL, V21, P819, DOI 10.1016/j.stem.2017.10.012; Li J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15146; Li N, 2019, CELL DEATH DIFFER, V26, P2115, DOI 10.1038/s41418-019-0280-2; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173047; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Liu ZL, 2015, INT J BIOL SCI, V11, P494, DOI 10.7150/ijbs.11849; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Ma KY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00033; Ma YY, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0015-4; Malik V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11054-7; Mao J, 2017, STEM CELL REP, V8, P11, DOI 10.1016/j.stemcr.2016.11.013; Narayan S, 2017, CELL REP, V20, P1585, DOI 10.1016/j.celrep.2017.07.071; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Prather RS, 2013, NAT BIOTECHNOL, V31, P122, DOI 10.1038/nbt.2490; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramos-Ibeas P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08387-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarac H, 2020, ONCOGENE, V39, P2187, DOI 10.1038/s41388-019-1116-8; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tran KA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7188; Veerapandian V, 2018, STEM CELL REP, V11, P593, DOI 10.1016/j.stemcr.2018.07.002; Walters Eric M, 2013, Mo Med, V110, P212; Wang HY, 2019, NUCLEIC ACIDS RES, V47, P2349, DOI 10.1093/nar/gky1317; Wang JY, 2013, STEM CELL REV REP, V9, P700, DOI 10.1007/s12015-013-9439-2; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wei YD, 2021, ZOOL RES, V42, P14, DOI 10.24272/j.issn.2095-8137.2020.186; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Xiao F, 2017, STEM CELL REP, V9, P927, DOI 10.1016/j.stemcr.2017.07.013; Xue BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151737; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu N, 2007, MOL CELL BIOL, V27, P8859, DOI 10.1128/MCB.01724-07; Zhu ZS, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12932	69	8	9	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21664	10.1096/fj.202100230R	http://dx.doi.org/10.1096/fj.202100230R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042215				2022-12-28	WOS:000655695900051
J	Alderfer, L; Russo, E; Archilla, A; Coe, B; Hanjaya-Putra, D				Alderfer, Laura; Russo, Elizabeth; Archilla, Adriana; Coe, Brian; Hanjaya-Putra, Donny			Matrix stiffness primes lymphatic tube formation directed by vascular endothelial growth factor-C	FASEB JOURNAL			English	Article						hyaluronic acid; lymphatic networks; matrix stiffness; mechanoregulation; VEGF-C	NUCLEOTIDE EXCISION-REPAIR; MITOCHONDRIAL PERMEABILITY TRANSITION; NECROTIC CELL-DEATH; DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-MECHANISMS; PROGRAMMED NECROSIS; ESSENTIAL KINASE; ATR KINASE; S PHASE	Dysfunction of the lymphatic system is associated with a wide range of disease phenotypes. The restoration of dysfunctional lymphatic vessels has been hypothesized as an innovative method to rescue healthy phenotypes in diseased states including neurological conditions, metabolic syndromes, and cardiovascular disease. Compared to the vascular system, little is known about the molecular regulation that controls lymphatic tube morphogenesis. Using synthetic hyaluronic acid (HA) hydrogels as a chemically and mechanically tunable system to preserve lymphatic endothelial cell (LECs) phenotypes, we demonstrate that low matrix elasticity primes lymphatic cord-like structure (CLS) formation directed by a high concentration of vascular endothelial growth factor-C (VEGF-C). Decreasing the substrate stiffness results in the upregulation of key lymphatic markers, including PROX-1, lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), and VEGFR-3. Consequently, higher levels of VEGFR-3 enable stimulation of LECs with VEGF-C which is required to both activate matrix metalloproteinases (MMPs) and facilitate LEC migration. Both of these steps are critical in establishing CLS formation in vitro. With decreases in substrate elasticity, we observe increased MMP expression and increased cellular elongation, as well as formation of intracellular vacuoles, which can further merge into coalescent vacuoles. RNAi studies demonstrate that MMP-14 is required to enable CLS formation and that LECs sense matrix stiffness through YAP/TAZ mechanosensors leading to the activation of their downstream target genes. Collectively, we show that by tuning both the matrix stiffness and VEGF-C concentration, the signaling pathways of CLS formation can be regulated in a synthetic matrix, resulting in lymphatic networks which will be useful for the study of lymphatic biology and future approaches in tissue regeneration.	[Alderfer, Laura; Hanjaya-Putra, Donny] Univ Notre Dame, Bioengn Grad Program, Notre Dame, IN USA; [Russo, Elizabeth; Coe, Brian; Hanjaya-Putra, Donny] Univ Notre Dame, Aerosp & Mech Engn, 141 Multidisciplinary Res Bldg, Notre Dame, IN 46556 USA; [Archilla, Adriana; Hanjaya-Putra, Donny] Univ Notre Dame, Notre Dame Nanosci & Technol NDnano, Notre Dame, IN USA; [Hanjaya-Putra, Donny] Univ Notre Dame, Chem & Biomol Engn, Notre Dame, IN USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Notre Dame	Hanjaya-Putra, D (corresponding author), Univ Notre Dame, Aerosp & Mech Engn, 141 Multidisciplinary Res Bldg, Notre Dame, IN 46556 USA.	dputra1@nd.edu		HanjayaPutra, Donny/0000-0002-5403-544X	American Heart Association (AHA) [19-CDA-34630012]; American Cancer Society (ACS) [IRG-17-182-04]; Walther Cancer Foundation (WCF) [0180.01]; HHS \ NIH \ National Center for Advancing Translational Sciences (NCATS) [ULITR001108]	American Heart Association (AHA)(American Heart Association); American Cancer Society (ACS)(American Cancer Society); Walther Cancer Foundation (WCF); HHS \ NIH \ National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	American Heart Association (AHA), Grant/Award Number: 19-CDA-34630012; American Cancer Society (ACS), Grant/Award Number: IRG-17-182-04; Walther Cancer Foundation (WCF): 0180.01; HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Grant/Award Number: ULITR001108	Alcock RF, 2012, HEART, V98, P792, DOI 10.1136/heartjnl-2011-301577; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Auclair Y, 2009, CELL CYCLE, V8, P1865, DOI 10.4161/cc.8.12.8800; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P1; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Budker V, 2006, BIOPOLYMERS, V83, P646, DOI 10.1002/bip.20602; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cho YS, 2010, MOL CELLS, V29, P327, DOI 10.1007/s10059-010-0066-3; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Douglas DL, 2014, J CELL SCI, V127, P4134, DOI 10.1242/jcs.128009; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Francis RJ, 2013, J LEUKOCYTE BIOL, V93, P95, DOI 10.1189/jlb.0412212; Gagne JP, 2012, SCIENCE, V336, P678, DOI 10.1126/science.1221870; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han SI, 2008, BMB REP, V41, P1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Heffernan TP, 2009, J INVEST DERMATOL, V129, P1805, DOI 10.1038/jid.2008.435; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hsu PC, 2019, ONCOGENE, V38, P1166, DOI 10.1038/s41388-018-0506-7; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kedar PS, 2008, DNA REPAIR, V7, P1787, DOI 10.1016/j.dnarep.2008.07.006; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Kim D, 2018, NUCLEIC ACIDS RES, V46, P8311, DOI 10.1093/nar/gky625; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kitsis RN, 2010, P NATL ACAD SCI USA, V107, P9031, DOI 10.1073/pnas.1003827107; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Li GY, 2010, BIOMED ENVIRON SCI, V23, P371, DOI 10.1016/S0895-3988(10)60078-5; Li ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068297; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Liu QH, 2000, GENE DEV, V14, P1448; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; Monassier JP, 2008, ARCH CARDIOVASC DIS, V101, P491, DOI 10.1016/j.acvd.2008.06.014; Muller GJ, 2004, BRAIN PATHOL, V14, P415; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Park S, 2015, ANAT CELL BIOL, V48, P66, DOI 10.5115/acb.2015.48.1.66; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; PATEL R, 1989, J CELL SCI, P129; Phengchat R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38281; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Saldivar JC, 2018, SCIENCE, V361, P806, DOI 10.1126/science.aap9346; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Strom CE, 2012, BIOMOLECULES, V2, P635, DOI 10.3390/biom2040635; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Visvanathan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067689; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang PM, 2007, CHEM RES TOXICOL, V20, P406, DOI 10.1021/tx060144c; Yelamos J, 2011, AM J CANCER RES, V1, P328; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang FJ, 2014, TOXICOL SCI, V140, P118, DOI 10.1093/toxsci/kfu073; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	101	8	8	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21498	10.1096/fj.202002426RR	http://dx.doi.org/10.1096/fj.202002426RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774872	Green Accepted			2022-12-28	WOS:000645260100098
J	Caputo, M; Kurhe, Y; Kumari, S; Cansby, E; Amrutkar, M; Scandalis, E; Booten, SL; Stahlman, M; Boren, J; Marschall, HU; Aghajan, M; Mahlapuu, M				Caputo, Mara; Kurhe, Yeshwant; Kumari, Sima; Cansby, Emmelie; Amrutkar, Manoj; Scandalis, Eli; Booten, Sheri L.; Stahlman, Marcus; Boren, Jan; Marschall, Hanns-Ulrich; Aghajan, Mariam; Mahlapuu, Margit			Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease	FASEB JOURNAL			English	Article						antisense oligonucleotide treatment; fibrosis; inflammation; nonalcoholic fatty liver disease; oxidative stress; steatosis	HEPATIC STEATOSIS; INSULIN-RESISTANCE; MOLECULAR-MECHANISMS; AMERICAN ASSOCIATION; STK25; STEATOHEPATITIS; VARIANT; PHOSPHORYLATION; SUSCEPTIBILITY; PROGRESSION	Nonalcoholic fatty liver disease (NAFLD) is emerging as a leading cause of chronic liver disease worldwide. Despite intensive nonclinical and clinical research in this field, no specific pharmacological therapy is currently approved to treat NAFLD, which has been recognized as one of the major unmet medical needs of the 21st century. Our recent studies have identified STE20-type kinase MST3, which localizes to intracellular lipid droplets, as a critical regulator of ectopic fat accumulation in human hepatocytes. Here, we explored whether treatment with Mst3-targeting antisense oligonucleotides (ASOs) can promote hepatic lipid clearance and mitigate NAFLD progression in mice in the context of obesity. We found that administration of Mst3-targeting ASOs in mice effectively ameliorated the full spectrum of high-fat diet-induced NAFLD including liver steatosis, inflammation, fibrosis, and hepatocellular damage. Mechanistically, Mst3 ASOs suppressed lipogenic gene expression, as well as acetyl-CoA carboxylase (ACC) protein abundance, and substantially reduced lipotoxicity-mediated oxidative and endoplasmic reticulum stress in the livers of obese mice. Furthermore, we found that MST3 protein levels correlated positively with the severity of NAFLD in human liver biopsies. In summary, this study provides the first in vivo evidence that antagonizing MST3 signaling is sufficient to mitigate NAFLD progression in conditions of excess dietary fuels and warrants future investigations to assess whether MST3 inhibitors may provide a new strategy for the treatment of patients with NAFLD.	[Caputo, Mara; Kurhe, Yeshwant; Kumari, Sima; Cansby, Emmelie; Mahlapuu, Margit] Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden; [Caputo, Mara; Kurhe, Yeshwant; Kumari, Sima; Cansby, Emmelie; Stahlman, Marcus; Boren, Jan; Marschall, Hanns-Ulrich; Mahlapuu, Margit] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Amrutkar, Manoj] Univ Oslo, Inst Clin Med, Dept Hepatopancreatobiliary Surg, Oslo, Norway; [Scandalis, Eli; Booten, Sheri L.; Aghajan, Mariam] Ionis Pharmaceut, Carlsbad, CA USA; [Stahlman, Marcus; Boren, Jan; Marschall, Hanns-Ulrich] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Oslo; Ionis Pharmaceuticals, Inc.; University of Gothenburg	Mahlapuu, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden.	Margit.Mahlapuu@gu.se	; AMRUTKAR, MANOJ/I-4975-2014	Mahlapuu, Margit/0000-0001-8740-8874; AMRUTKAR, MANOJ/0000-0002-1868-0249	Swedish Research Council; European Foundation for the Study of Diabetes/Novo Nordisk Programme for Diabetes Research in Europe; West Sweden Avtal om Lakarutbildning och Forskning (ALF) Program; Novo Nordisk Foundation; Swedish Heart--Lung Foundation; Torsten Soderbergs Foundation; Swedish Diabetes Foundation; Royal Society of Arts and Sciences in Gothenburg; A. Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; F. Neubergh Foundation; Prof. N. Svartz Foundation; L. and J. Gronberg Foundation; W. and M. Lundgren Foundation; I--B. and A. Lundbergs Research Foundation; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Foundation for the Study of Diabetes/Novo Nordisk Programme for Diabetes Research in Europe; West Sweden Avtal om Lakarutbildning och Forskning (ALF) Program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Heart--Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderbergs Foundation; Swedish Diabetes Foundation; Royal Society of Arts and Sciences in Gothenburg; A. Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; F. Neubergh Foundation; Prof. N. Svartz Foundation; L. and J. Gronberg Foundation; W. and M. Lundgren Foundation; I--B. and A. Lundbergs Research Foundation; Swedish Cancer Society(Swedish Cancer Society)	Swedish Research Council; European Foundation for the Study of Diabetes/Novo Nordisk Programme for Diabetes Research in Europe; West Sweden Avtal om Lakarutbildning och Forskning (ALF) Program; Novo Nordisk Foundation; Swedish Heart--Lung Foundation; Torsten Soderbergs Foundation; Swedish Diabetes Foundation; Royal Society of Arts and Sciences in Gothenburg; A. Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; F. Neubergh Foundation; Prof. N. Svartz Foundation; L. and J. Gronberg Foundation; W. and M. Lundgren Foundation; I--B. and A. Lundbergs Research Foundation; the Swedish Cancer Society	Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Abul-Husn NS, 2018, NEW ENGL J MED, V378, P1096, DOI 10.1056/NEJMoa1712191; Aghajan M, 2019, JCI INSIGHT, P4; Amrutkar M, 2016, FASEB J, V30, P3628, DOI 10.1096/fj.201600562R; Amrutkar M, 2016, DIABETOLOGIA, V59, P341, DOI 10.1007/s00125-015-3801-7; Amrutkar M, 2015, DIABETES, V64, P2791, DOI 10.2337/db15-0060; Amrutkar M, 2015, FASEB J, V29, P1564, DOI 10.1096/fj.14-264937; Andersson L, 2017, INT J BIOCHEM CELL B, V91, P9, DOI 10.1016/j.biocel.2017.07.021; Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bruschi FV, 2017, HEPATOLOGY, V65, P1875, DOI 10.1002/hep.29041; Cansby E, 2019, FASEB J, V33, P9974, DOI 10.1096/fj.201900356RR; Cansby E, 2019, CELL MOL GASTROENTER, V7, P597, DOI 10.1016/j.jcmgh.2018.12.004; Carrer M, 2020, AM J RESP CELL MOL, V63, P46, DOI 10.1165/rcmb.2019-0257OC; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004; Crooke ST, 2017, NUCLEIC ACID THER, V27, P70, DOI 10.1089/nat.2016.0656; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gao YS, 2020, ACTA PHARMACOL SIN, V41, P336, DOI 10.1038/s41401-019-0310-0; Gapp B, 2020, HEPATOL COMMUN, V4, P109, DOI 10.1002/hep4.1443; Gluchowski NL, 2019, HEPATOLOGY, V70, P1972, DOI 10.1002/hep.30765; Hall Z, 2017, HEPATOLOGY, V65, P1165, DOI 10.1002/hep.28953; Hong D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5272; Hung GN, 2013, NUCLEIC ACID THER, V23, P369, DOI 10.1089/nat.2013.0443; Iglesias C, 2017, DIABETOLOGIA, V60, P2453, DOI 10.1007/s00125-017-4433-x; Kazankov K, 2019, NAT REV GASTRO HEPAT, V16, P145, DOI 10.1038/s41575-018-0082-x; Kim CW, 2017, CELL METAB, V26, P394, DOI 10.1016/j.cmet.2017.07.009; Kisseleva T, 2019, CELL METAB, V30, P850, DOI 10.1016/j.cmet.2019.10.010; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020; Lawitz EJ, 2018, CLIN GASTROENTEROL H, V16, P1983, DOI 10.1016/j.cgh.2018.04.042; Lofgren L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27688; Loomba R, 2018, GASTROENTEROLOGY, V155, P1463, DOI 10.1053/j.gastro.2018.07.027; Matsumoto M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228212; McLaren DG, 2018, CELL METAB, V27, P1236, DOI 10.1016/j.cmet.2018.04.004; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Nerstedt A, 2010, DIABETOLOGIA, V53, P2406, DOI 10.1007/s00125-010-1856-z; Nerstedt A, 2020, J LIPID RES, V61, P178, DOI 10.1194/jlr.RA119000316; Nunez-Duran E, 2018, HEPATOL COMMUN, V2, P69, DOI 10.1002/hep4.1128; Peter A, 2014, DIABETOLOGIA, V57, P2103, DOI 10.1007/s00125-014-3310-0; Quistorff B, 1990, Methods Mol Biol, V5, P151, DOI 10.1385/0-89603-150-0:151; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Ross SJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5253; Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8; Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Seth PP, 2009, J MED CHEM, V52, P10, DOI 10.1021/jm801294h; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tang J, 2014, J NEUROSCI, V34, P7425, DOI 10.1523/JNEUROSCI.5449-13.2014; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Xie L, 2012, J HEPATOL, V57, P1076, DOI 10.1016/j.jhep.2012.07.002; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	61	5	5	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21567	10.1096/fj.202002671RR	http://dx.doi.org/10.1096/fj.202002671RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33891332	Green Published			2022-12-28	WOS:000645260100060
J	Khatri, V; Kalyanasundaram, R				Khatri, Vishal; Kalyanasundaram, Ramaswamy			Therapeutic implications of inflammasome in inflammatory bowel disease	FASEB JOURNAL			English	Review						Crohn's disease; inflammasome; inflammatory bowel disease; NLRP3; ulcerative colitis	GROWTH-FACTOR-II; POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; CARDIOVASCULAR-DISEASE; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; LIPID MEDIATORS; TRANSGENIC MICE; BLOOD-PRESSURE; KIDNEY	Inflammatory bowel disease (IBD) remains a persistent health problem with a global burden surging over 6.8 million cases currently. Clinical pathology of IBD is complicated; however, hyperactive inflammatory and immune responses in the gut is shown to be one of the persistent causes of the disease. Human gut inflammasome, the activator of innate immune system is believed to be a primary underlying cause for the pathology and is largely associated with the progression of IBD. To manage IBD, there is a need to fully understand the role of inflammasome activation in IBD. Since inflammasome potentially play a significant role in IBD, systemic modulation of inflammasome may provide an effective therapeutic and clinical approach to control IBD symptoms. In this review, we have focused on this association between IBD and gut inflammasome, and recent advances in the research and therapeutic strategies for IBD. We have discussed inflammasomes and their components, outcomes from the experimental animals and human studies, inflammasome inhibitors, and developments in the inflammasome-targeted therapies for IBD.	[Khatri, Vishal; Kalyanasundaram, Ramaswamy] Univ Illinois, Coll Med, Dept Biomed Sci, 1601 Parkview Ave, Rockford, IL 61107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Khatri, V (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, 1601 Parkview Ave, Rockford, IL 61107 USA.	vkkhatr4@uic.edu	Khatri, Vishal/AAG-4080-2020	Khatri, Vishal/0000-0002-5154-6260	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [RO1AI116441]; Blazer foundation of Rockford [344524]	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID); Blazer foundation of Rockford	HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: RO1AI116441; Blazer foundation of Rockford, Grant/Award Number: 344524	Abbate M, 1998, J AM SOC NEPHROL, V9, P1213; [Anonymous], NEW ENGL J MED, DOI [10.1056/NEJMoa032566?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov, DOI 10.1056/NEJMOA032566?URL_VER=Z39.88-2003&RFR_ID=ORI%3ARID%3ACROSSREF.ORG&RFR_DAT=CR_PUB%3DWWW.NCBI.NLM.NIH.GOV]; [Anonymous], HDB OF DIABETES, V4th; Berl T, 2006, CLIN J AM SOC NEPHRO, V1, P8, DOI 10.2215/CJN.00730805; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Cabo J, 2012, BRIT J NUTR, V107, pS195, DOI 10.1017/S0007114512001584; Casanova MA, 2017, J AM SOC HYPERTENS, V11, P10, DOI 10.1016/j.jash.2016.10.004; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; Chou HH, 2012, NEPHRON CLIN PRACT, V121, pC30, DOI 10.1159/000341929; Dalla Vestra M, 2001, J NEPHROL, V14, pS51; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; de Boer IH, 2019, JAMA-J AM MED ASSOC, V322, P1899, DOI 10.1001/jama.2019.17380; DECATERINA R, 1993, KIDNEY INT, V44, P843, DOI 10.1038/ki.1993.320; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; EBIHARA I, 1993, J AM SOC NEPHROL, V3, P1387; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; El-Sherif N, 2011, CARDIOL J, V18, P233; Elajami TK, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004740; FLOEGE J, 1991, KIDNEY INT, V40, P477, DOI 10.1038/ki.1991.235; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forclaz A, 2003, HYPERTENSION, V41, P31, DOI 10.1161/01.HYP.0000047512.58862.A9; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26428; Garman JH, 2009, AM J PHYSIOL-RENAL, V296, pF306, DOI 10.1152/ajprenal.90326.2008; GULER HP, 1988, P NATL ACAD SCI USA, V85, P4889, DOI 10.1073/pnas.85.13.4889; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ilyas Z, 2017, REV ENDOCR METAB DIS, V18, P21, DOI 10.1007/s11154-017-9422-3; KERJASCHKI D, 1994, KIDNEY INT, V45, P300, DOI 10.1038/ki.1994.39; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Le Quang K, 2014, ARTERIOSCL THROM VAS, V34, P2283, DOI 10.1161/ATVBAHA.114.304205; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Lee CC, 2012, CURR ATHEROSCLER REP, V14, P535, DOI 10.1007/s11883-012-0279-3; Lee CC, 2010, DIABETES CARE, V33, P1454, DOI 10.2337/dc09-2245; Lee GSL, 1998, KIDNEY INT, V53, P1389, DOI 10.1046/j.1523-1755.1998.00871.x; Li GB, 2017, J LIPID RES, V58, P1080, DOI [10.1194/jlr.M072587, 10.1194/jlr.m072587]; Losi MA, 2010, NEPHROL DIAL TRANSPL, V25, P1950, DOI 10.1093/ndt/gfp747; Meeus F, 2000, KIDNEY INT, V58, pS140, DOI 10.1046/j.1523-1755.2000.07618.x; Micakovic T, 2018, KIDNEY INT, V94, P937, DOI 10.1016/j.kint.2018.06.006; Middleton JP, 2010, KIDNEY INT, V77, P753, DOI 10.1038/ki.2010.19; Miller ER, 2009, AM J CLIN NUTR, V89, P1937, DOI 10.3945/ajcn.2008.26867; Miller PE, 2014, AM J HYPERTENS, V27, P885, DOI 10.1093/ajh/hpu024; Montford JR, 2017, J AM SOC NEPHROL, V28, P3155, DOI 10.1681/ASN.2016121344; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pighin D, 2003, J NUTR, V133, P4095, DOI 10.1093/jn/133.12.4095; Powell DW, 2013, LIFE SCI, V93, P257, DOI 10.1016/j.lfs.2013.06.016; pubmeddev al G-IC et, PREVALENCE PROTEIN E; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Robinson BM, 2016, LANCET, V388, P294, DOI 10.1016/S0140-6736(16)30448-2; ROGERS SA, 1991, J CELL BIOL, V113, P1447, DOI 10.1083/jcb.113.6.1447; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; Rozenbaum Z, 2019, INT J CARDIOL, V277, P147, DOI 10.1016/j.ijcard.2018.08.008; Saran Rajiv, 2019, Am J Kidney Dis, V73, pA7, DOI 10.1053/j.ajkd.2019.01.001; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Srinivasan M, 2010, AM J PHYSIOL-ENDOC M, V299, pE910, DOI 10.1152/ajpendo.00339.2010; Svensson J, 2007, J ENDOCRINOL, V193, P359, DOI 10.1677/JOE-07-0024; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Tonelli M, 2016, CIRCULATION, V133, P518, DOI 10.1161/CIRCULATIONAHA.115.018713; Vallon V, 2011, COMPR PHYSIOL, V1, P1175, DOI 10.1002/cphy.c100049; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; WOLF E, 1994, ENDOCRINOLOGY, V135, P1877, DOI 10.1210/en.135.5.1877; Xia HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00103-0	74	14	14	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21439	10.1096/fj.202002622R	http://dx.doi.org/10.1096/fj.202002622R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774860	Green Accepted			2022-12-28	WOS:000645260100076
J	Parial, R; Li, H; Li, J; Archacki, S; Yang, ZC; Wang, IZ; Chen, QY; Xu, CQ; Wang, QK				Parial, Ramendu; Li, Hui; Li, Jia; Archacki, Stephen; Yang, Zhongcheng; Wang, Isabel Z.; Chen, Qiuyun; Xu, Chengqi; Wang, Qing K.			Role of epigenetic m(6)A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling	FASEB JOURNAL			English	Article						mettl3; m6A methylation; PHLPP2; mTOR-AKT; vascular development; zebrafish	GENE-EXPRESSION; MESSENGER-RNA; ENDOTHELIAL-CELL; DIFFERENTIATION; IDENTIFICATION; SPECIFICATION; ANGIOGENESIS; MATURATION; ADTRP; AKT1	N-6-methyladenosine (m6A) methylation is the most prevalent RNA modification, and it emerges as an important regulatory mechanism of gene expression involved in many cellular and biological processes. However, the role of m6A methylation in vascular development is not clear. The m(6)A RNA methylation is regulated by dynamic interplay among methyltransferases, binding proteins, and demethylases. Mettl3 is a member of the mettl3-mettl14 methyltransferase complex, referred to as writers that catalyze m(6)A RNA methylation. Here, we used CRISPR-Cas9 genome editing to develop two lines of knockout (KO) zebrafish for mettl3. Heterozygous mettl(3+/-) KO embryos show defective vascular development, which is directly visible in fli-EGFP and flk-EGFP zebrafish. Alkaline phosphatase staining and whole mount in situ hybridization with cdh5, and flk markers demonstrated defective development of intersegmental vessels (ISVs), subintestinal vessels (SIVs), interconnecting vessels (ICVs) and dorsal longitudinal anastomotic vessels (DLAV) in both heterozygous mettl(3+/-) and homozygous mettl(3-/-) KO zebrafish embryos. Similar phenotypes were observed in zebrafish embryos with morpholino knockdown (KD) of mettl3; however, the vascular defects were rescued fully by overexpression of constitutively active AKT1. KD of METTL3 in human endothelial cells inhibited cell proliferation, migration, and capillary tube formation. Mechanistically, mettl3 KO and KD significantly reduced the levels of m(6)A RNA methylation, and AKT phosphorylation (S473) by an increase in the expression of phosphatase enzyme PHLPP2 and reduction in the phosphorylation of mTOR (S2481), a member of the phosphatidylinositol 3-kinase-related kinase family of protein kinases. These data suggest that m(6)A RNA methylation regulates vascular development via PHLPP2/mTOR--AKT signaling.	[Parial, Ramendu; Li, Hui; Li, Jia; Yang, Zhongcheng; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan, Peoples R China; [Parial, Ramendu; Li, Hui; Li, Jia; Yang, Zhongcheng; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Peoples R China; [Archacki, Stephen; Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA; [Archacki, Stephen; Chen, Qiuyun; Wang, Qing K.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH USA; [Wang, Isabel Z.] Stanford Univ, Symbol Syst Program, Stanford, CA USA; [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Stanford University; Case Western Reserve University	Xu, CQ; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan, Peoples R China.; Xu, CQ; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Peoples R China.; Chen, QY; Wang, QK (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA.	chenq_2003@yahoo.com; cqxu@hust.edu.cn; qingwang118@qq.com		Wang, Qing Kenneth/0000-0002-2235-6572; Wang, Isabel/0000-0002-2209-308X; Li, Jia/0000-0001-7132-2574; Xu, Chengqi/0000-0002-4269-6830	China National Natural Science Foundation [81630002, 31430047]; Hubei Province Natural Science Program Innovative Team [2017CFA014]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hubei Province Natural Science Program Innovative Team	China National Natural Science Foundation, Grant/Award Number: 81630002 and 31430047; Hubei Province Natural Science Program Innovative Team, Grant/Award Number: 2017CFA014	Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Coots RA, 2017, MOL CELL, V68, P504, DOI 10.1016/j.molcel.2017.10.002; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dorn LE, 2019, CIRCULATION, V139, P533, DOI 10.1161/CIRCULATIONAHA.118.036146; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gu Y, 2021, PLACENTA, V103, P43, DOI 10.1016/j.placenta.2020.10.016; Hsu PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1336-6; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu J, 2018, NAT CELL BIOL, V20, P1074, DOI 10.1038/s41556-018-0174-4; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998; Luo CY, 2017, BBA-MOL BASIS DIS, V1863, P1640, DOI 10.1016/j.bbadis.2017.03.010; Luo CY, 2016, PHYSIOL GENOMICS, V48, P554, DOI 10.1152/physiolgenomics.00028.2016; Lv JH, 2018, CELL RES, V28, P249, DOI 10.1038/cr.2017.143; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ozkurede U, 2019, J MOL ENDOCRINOL, V63, P123, DOI 10.1530/JME-19-0021; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Tian C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030551; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tobia C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01092; Vejnar CE, 2016, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot086850, DOI 10.1101/PDB.PR0T086850]; Wang Qing K., 2005, Lymphatic Research and Biology, V3, P226, DOI 10.1089/lrb.2005.3.226; Wang XJ, 2018, FEBS J, V285, P4071, DOI 10.1111/febs.14653; Xia H, 2018, GENETICS, V208, P729, DOI 10.1534/genetics.117.300574; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yao MD, 2020, MOL THER, V28, P2191, DOI 10.1016/j.ymthe.2020.07.022; Yao YF, 2019, DIABETES, V68, P1635, DOI 10.2337/db18-1178; Yao YF, 2019, PULM PHARMACOL THER, V55, P38, DOI 10.1016/j.pupt.2019.01.007; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883	36	7	7	8	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21465	10.1096/fj.202000516RR	http://dx.doi.org/10.1096/fj.202000516RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788967				2022-12-28	WOS:000645260100037
J	Sarin, HV; Pirinen, E; Pietilainen, KH; Isola, V; Hakkinen, K; Perola, M; Hulmi, JJ				Sarin, Heikki V.; Pirinen, Eija; Pietilainen, Kirsi H.; Isola, Ville; Hakkinen, Keijo; Perola, Markus; Hulmi, Juha J.			Mitochondrial bioenergetic pathways in blood leukocyte transcriptome decrease after intensive weight loss but are rescued following weight regain in female physique athletes	FASEB JOURNAL			English	Article						diet; exercise; leukocytes; oxidative phosphorylation; ribosomes		Prolonged periods of energy deficit leading to weight loss induce metabolic adaptations resulting in reduced energy expenditure, but the mechanisms for energy conservation are incompletely understood. We examined 42 healthy athletic females (age 27.5 +/- 4.0 years, body mass index 23.4 +/- 1.7 kg/m(2)) who volunteered into either a group dieting for physique competition (n = 25) or a control group (n = 17). The diet group substantially reduced their energy intake and moderately increased exercise levels to induce loss of fat mass that was regained during a voluntary weight regain period. The control group maintained their typical lifestyle habits and body mass as instructed. From the diet group, fasting blood samples were drawn at baseline (PRE), after 4- to 5-month weight loss (PRE-MID), and after 4- to 5-month weight regain (MID-POST) as well as from the control group at similar intervals. Blood was analyzed to determine leukocyte transcriptome by RNA-Sequencing and serum metabolome by nuclear magnetic resonance (NMR) platform. The intensive weight loss period induced several metabolic adaptations, including a prominent suppression of transcriptomic signature for mitochondrial OXPHOS and ribosome biogenesis. The upstream regulator analysis suggested that this reprogramming of cellular energy metabolism may be mediated via AMPK/PGC1-alpha signaling and mTOR/eIF2 signaling-dependent pathways. Our findings show for the first time that prolonged energy deprivation induced modulation of mitochondrial metabolism can be observed through minimally invasive measures of leukocyte transcriptome and serum metabolome at systemic level, suggesting that adaptation to energy deficit is broader in humans than previously thought.	[Sarin, Heikki V.; Perola, Markus] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Genom & Biobank Unit, Helsinki, Finland; [Sarin, Heikki V.; Pirinen, Eija; Perola, Markus] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Obes Res Unit, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Helsinki Univ Hosp, Abdominal Ctr, Obes Ctr,Endocrinol, Helsinki, Finland; [Isola, Ville; Hakkinen, Keijo; Hulmi, Juha J.] Univ Jyvaskyla, Neuromuscular Res Ctr, Fac Sport & Hlth Sci, POB 35, FI-40014 Jyvaskyla, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Jyvaskyla	Hulmi, JJ (corresponding author), Univ Jyvaskyla, Neuromuscular Res Ctr, Fac Sport & Hlth Sci, POB 35, FI-40014 Jyvaskyla, Finland.; Sarin, HV (corresponding author), Natl Inst Hlth & Welf THL, Dept Publ Hlth Solut, Genom & Biomarkers Unit, POB 30,Mannerheimintie 166, FIN-00271 Helsinki, Finland.	heikki.sarin@thl.fi; juha.hulmi@jyu.fi			Academy of Finland (Suomen Akatemia) [269517, 286359, 275922, 314383, 266286]; Academy of Finland, Centre of Excellence in Research on Mitochondria, Metabolism and Disease [272376]; Novo Nordisk Foundation Center for Basic Metabolic Research [NNF16OC0020866, NNF17OC0027232, NNF10OC1013354]; Orionin Tutkimussaatio (Orion Research Foundation); European Union's FP7 programme [HZ2020 633589]; Yrjo Jahnsson Foundation; Suomen Laaketieteen Saatio (Finnish Medical Foundation); Finnish Diabetes Research Foundation; Signe ja Ane Gyllenbergin Saatio (Signe and Ane Gyllenberg Foundation); Sigrid Juselius Foundation; Helsinki University Hospital Research Funds; Helsingin Yliopisto ja Jyvaskylan yliopisto (University of Helsinki and Jyvaskyla); Juho Vainion Saatio	Academy of Finland (Suomen Akatemia)(Academy of Finland); Academy of Finland, Centre of Excellence in Research on Mitochondria, Metabolism and Disease(Academy of Finland); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Orionin Tutkimussaatio (Orion Research Foundation); European Union's FP7 programme; Yrjo Jahnsson Foundation; Suomen Laaketieteen Saatio (Finnish Medical Foundation); Finnish Diabetes Research Foundation; Signe ja Ane Gyllenbergin Saatio (Signe and Ane Gyllenberg Foundation); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital Research Funds; Helsingin Yliopisto ja Jyvaskylan yliopisto (University of Helsinki and Jyvaskyla); Juho Vainion Saatio	Academy of Finland (Suomen Akatemia), Grant/Award Number: 269517, 286359, 275922, 314383 and 266286; Academy of Finland, Centre of Excellence in Research on Mitochondria, Metabolism and Disease, Grant/Award Number: 272376; Novo Nordisk Foundation Center for Basic Metabolic Research, Grant/Award Number: NNF16OC0020866, NNF17OC0027232 and NNF10OC1013354; Juho Vainion Saatio; Orionin Tutkimussaatio (Orion Research Foundation); The European Union's FP7 programme, Grant/Award Number: HZ2020 633589 (Ageing with Elegans); Yrjo Jahnsson Foundation; Suomen Laaketieteen Saatio (Finnish Medical Foundation); Finnish Diabetes Research Foundation; Signe ja Ane Gyllenbergin Saatio (Signe and Ane Gyllenberg Foundation); Sigrid Juselius Foundation; Helsinki University Hospital Research Funds; Government Research Funds; Helsingin Yliopisto ja Jyvaskylan yliopisto (University of Helsinki and Jyvaskyla)	Ackerman KE, 2019, BRIT J SPORT MED, V53, P628, DOI 10.1136/bjsports-2017-098958; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Camps SGJA, 2013, AM J CLIN NUTR, V97, P990, DOI 10.3945/ajcn.112.050310; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310; Hulmi JJ, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00689; Huovinen HT, 2015, J STRENGTH COND RES, V29, P29, DOI 10.1519/JSC.0000000000000619; Iraki J, 2019, SPORTS, V7, DOI 10.3390/sports7070154; Jokinen R, 2018, INT J OBESITY, V42, P817, DOI 10.1038/ijo.2017.299; Kitada M, 2013, BBA-GEN SUBJECTS, V1830, P4820, DOI 10.1016/j.bbagen.2013.06.014; Kohane IS, 2012, BIOINFORMATICS, V28, P538, DOI 10.1093/bioinformatics/btr713; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Loucks AB, 2007, SPORTS MED, V37, P348, DOI 10.2165/00007256-200737040-00019; Ma EH, 2017, CURR OPIN IMMUNOL, V46, P45, DOI 10.1016/j.coi.2017.04.004; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Melin AK, 2019, INT J SPORT NUTR EXE, V29, P152, DOI 10.1123/ijsnem.2018-0201; Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x; Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; Ranhotra HS, 2010, INDIAN J BIOCHEM BIO, V47, P272; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Sarin HV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40107-6; Sarin HV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00907; Simpson RJ, 2020, EXERC IMMUNOL REV, V26, P8; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Sparks LM, 2017, J CLIN ENDOCR METAB, V102, P111, DOI 10.1210/jc.2016-3211; Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007; Topf U, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226258; Trexler ET, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-7; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; WEIGLE DS, 1988, METABOLISM, V37, P930, DOI 10.1016/0026-0495(88)90149-7; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Weyer C, 2000, AM J CLIN NUTR, V72, P946; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Zhao Y, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0648-1	46	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21484	10.1096/fj.202002029R	http://dx.doi.org/10.1096/fj.202002029R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710692	Green Published			2022-12-28	WOS:000635216100026
J	Wu, K; Tao, GQ; Xu, T; An, YY; Yu, XY; Wang, Y; Wang, SC; Guo, W; Ma, L				Wu, Kun; Tao, Guoquan; Xu, Ting; An, Yuanyuan; Yu, Xiangyou; Wang, Yi; Wang, Shaochuang; Guo, Wen; Ma, Long			Downregulation of miR-497-5p prevents liver ischemia-reperfusion injury in association with MED1/TIMP-2 axis and the NF-kappa B pathway	FASEB JOURNAL			English	Article						liver ischemia&#8208; reperfusion injury; mediator complex subunit 1; microRNA&#8208; 497&#8208; 5p; nuclear factor kappa&#8208; B; tissue inhibitor of metalloproteinases 2		Liver ischemia-reperfusion (I/R) injury is a common clinical pathological phenomenon, which is accompanied by the occurrence in liver transplantation. However, the underlying mechanism is not yet fully understood. MicroRNAs (miRNAs) play an important role in liver I/R injury. Therefore, the study of miRNAs function will contribute a new biological marker diagnosis of liver I/R injury. This study aims to evaluate effects of miR-497-5p in liver I/R injury in mice. The related regulatory factors of miR-497-5p in liver I/R injury were predicted by bioinformatics analysis. Vascular occlusion was performed to establish the liver I/R injury animal models. Hypoxia/reoxygenation (H/R) was performed to establish the in vitro models. Hematoxylin-eosin (HE) staining was conducted to assess liver injury. The inflammatory factors were evaluated by enzyme-linked immunosorbent assay (ELISA). Flow cytometry was adopted to assess the cell apoptosis. The expression of miR-497b-5p was increased in liver I/R injury. Knockdown of miR-497b-5p inhibited the production of inflammatory factors and cell apoptosis. Overexpression of mediator complex subunit 1 (MED1) and tissue inhibitor of metalloproteinase 2 (TIMP2) inhibited cell apoptosis to alleviate liver I/R injury. miR-497b-5p could activate the nuclear factor kappa-B (NF-kappa B) pathway by inhibiting the MED1/TIMP-2 axis to promote liver I/R injury. This study may provide a new strategy for the treatment of liver I/R injury.	[Wu, Kun; Tao, Guoquan] Nanjing Med Univ, Dept Gen Surg, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China; [Xu, Ting] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China; [Xu, Ting] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China; [An, Yuanyuan] Xinjiang Med Univ, Affiliated Hosp 1, Dept VIP Med, Urumqi, Peoples R China; [Yu, Xiangyou; Wang, Yi; Guo, Wen; Ma, Long] Xinjiang Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Urumqi, Peoples R China; [Wang, Shaochuang] Nanjing Med Univ, Dept Hepatobiliary Surg, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Nanjing Medical University	Ma, L (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Urumqi, Peoples R China.	malong8617@163.com	guo, wenjia/GXF-5510-2022		National Natural Science Foundation of China [81960356]; Innovative Talents Project of Huai'an First People's Hospital (The Affiliated Huai'an); Science and Technology Development Fund of Nanjing Medical University [NMUB2018155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Talents Project of Huai'an First People's Hospital (The Affiliated Huai'an); Science and Technology Development Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (No. 81960356); the Innovative Talents Project of Huai'an First People's Hospital (The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University); and Science and Technology Development Fund of Nanjing Medical University (No. NMUB2018155)	Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Balzano T, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01746-z; Bi CL, 2020, CELL SIGNAL, V70, DOI 10.1016/j.cellsig.2020.109569; Drusco A, 2017, ADV CANCER RES, V135, P1, DOI 10.1016/bs.acr.2017.06.005; Du YC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3765898; Fan WX, 2019, CLIN CHEM LAB MED, V57, P567, DOI 10.1515/cclm-2018-0776; Feng L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190654; Gatla HR, 2014, METHODS MOL BIOL, V1172, P271, DOI 10.1007/978-1-4939-0928-5_25; Hirao H, 2020, FREE RADICAL BIO MED, V157, P75, DOI 10.1016/j.freeradbiomed.2020.02.012; Hua SY, 2019, INT IMMUNOPHARMACOL, V68, P145, DOI 10.1016/j.intimp.2019.01.002; Jiang H, 2013, PROG NEURO-PSYCHOPH, V47, P33, DOI 10.1016/j.pnpbp.2013.07.009; Jimenez-Castro MB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101131; Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999; Kim HJ, 2012, CANCER LETT, V321, P195, DOI 10.1016/j.canlet.2012.02.009; Koh WU, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235899; Lee EJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-116; Li G, 2019, J CELL BIOCHEM, V120, P10587, DOI 10.1002/jcb.28345; Li SP, 2019, INFLAMMATION, V42, P2139, DOI 10.1007/s10753-019-01078-y; Li YK, 2017, TRANSPLANTATION, V101, P1600, DOI 10.1097/TP.0000000000001765; Li YF, 2020, CARDIOVASC ENG TECHN, V11, P219, DOI 10.1007/s13239-019-00452-z; Ma JH, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz300; Nichols TC, 2004, DRUG NEWS PERSPECT, V17, P99, DOI 10.1358/dnp.2004.17.2.829042; Padrissa-Altes S, 2010, AM J TRANSPLANT, V10, P1167, DOI 10.1111/j.1600-6143.2010.03092.x; Ramachandran S, 2012, TRANSPL IMMUNOL, V26, P201, DOI 10.1016/j.trim.2012.01.001; Wang WL, 2020, INFLAMMATION, V43, P2119, DOI 10.1007/s10753-020-01279-w; Wu YM, 2016, BIOMED PHARMACOTHER, V84, P1126, DOI 10.1016/j.biopha.2016.10.024; Xia HY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1079129; Yang WL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051302; Yu C, 2020, J CELL BIOCHEM, V121, P1934, DOI 10.1002/jcb.29428; Zhang Y, 2019, J CELL PHYSIOL, V234, P16367, DOI 10.1002/jcp.28305; Zhou XD, 2020, FASEB J, V34, P3224, DOI 10.1096/fj.201901718RR	31	4	4	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21180	10.1096/fj.202001029R	http://dx.doi.org/10.1096/fj.202001029R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715222				2022-12-28	WOS:000635216100087
J	Jiang, CL; Chen, YF; Lin, FJ				Jiang, Chung-Lin; Chen, Ying-Fang; Lin, Fu-Jung			Apolipoprotein E deficiency activates thermogenesis of white adipose tissues in mice through enhancing beta-hydroxybutyrate production from precursor cells	FASEB JOURNAL			English	Article						apolipoprotein E; browning; white adipose tissue; beta-hydroxybutyrate	GENE-EXPRESSION; ADIPOCYTE PROGENITORS; LDL RECEPTOR; FATTY-ACIDS; BROWN; CD36; HYPERCHOLESTEROLEMIA; DIFFERENTIATION; IDENTIFICATION; ACCUMULATION	White adipose tissue (WAT) has the capacity to undergo a white-to-beige phenotypic switch, known as browning, in response to stimuli such as cold. However, the mechanism underlying beige adipocyte formation is largely unknown. Apolipoprotein E (ApoE) is highly induced in WAT and has been implicated in lipid metabolism. Here, we show that ApoE deficiency in mice increased oxygen consumption and thermogenesis and enhanced adipose browning pattern in inguinal WAT (iWAT), with associated characteristics such as increased Ucp1 and Ppar. expression. At the cellular level, ApoE deficient beige adipocytes had increased glucose uptake and higher mitochondrial respiration than wild-type cells. Mechanistically, we showed that ApoE deficient iWAT and primary adipose precursor cells activated the thermogenic genes program by stimulating the production of ketone body beta-hydroxybutyrate (beta HB), a novel adipose browning promoting factor. This was accompanied by increased expression of genes involved in ketogenesis and could be compromised by the treatment for ketogenesis inhibitors. Consistently, ApoE deficient mice show higher serum beta HB level than wild-type mice in the fed state and during cold exposure. Our results further demonstrate that the increased beta HB production in ApoE deficient adipose precursor cells could be attributed, at least in part, to enhanced Cd36 expression and CD36-mediated fatty acid utilization. Our findings uncover a previously uncharacterized role for ApoE in energy homeostasis via its cell-autonomous action in WAT.	[Jiang, Chung-Lin; Chen, Ying-Fang; Lin, Fu-Jung] Natl Taiwan Univ, Dept Biochem Sci & Technol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Lin, Fu-Jung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University	Lin, FJ (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	fujlin@ntu.edu.tw		Jiang, Chung-Lin/0000-0001-8293-2984; LIN, FU-JUNG/0000-0003-4065-0983	Ministry of Science and Technology, Taiwan (MOST) [MOST 107--2320--B--002--004--MY3]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 107--2320--B--002--004--MY3	Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Christiaens V, 2012, BBA-GEN SUBJECTS, V1820, P949, DOI 10.1016/j.bbagen.2012.04.001; Cinti S, 2018, TRENDS ENDOCRIN MET, V29, P651, DOI 10.1016/j.tem.2018.05.007; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; El-Lebedy D, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0329-1; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Gao H, 2017, STEM CELLS, V35, P1799, DOI 10.1002/stem.2635; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Grabacka MM, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00005; Huang ZH, 2015, J LIPID RES, V56, P215, DOI 10.1194/jlr.M050567; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040; Jones NS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010063; Lee CC, 2019, MOL CELL, V76, P500, DOI 10.1016/j.molcel.2019.07.026; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x; Merat S, 1999, ARTERIOSCL THROM VAS, V19, P1223, DOI 10.1161/01.ATV.19.5.1223; Morroni M, 2004, P NATL ACAD SCI USA, V101, P16801, DOI 10.1073/pnas.0407647101; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nonaka Y, 2016, J OLEO SCI, V65, P693, DOI 10.5650/jos.ess16069; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Takagi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18944; Torres-Perez E, 2016, ATHEROSCLEROSIS, V245, P35, DOI 10.1016/j.atherosclerosis.2015.11.029; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang WS, 2019, CELL METAB, V30, P174, DOI 10.1016/j.cmet.2019.05.005; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; Zhang HF, 2020, NAT CELL BIOL, V22, P18, DOI 10.1038/s41556-019-0440-0; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhuang QS, 2017, ONCOTARGET, V8, P55915, DOI 10.18632/oncotarget.19115	51	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21760	10.1096/fj.202100298RR	http://dx.doi.org/10.1096/fj.202100298RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34309918				2022-12-28	WOS:000678975300011
J	Mishra, R; Nawas, AF; Mendelson, CR				Mishra, Ritu; Nawas, Afshan Fathima; Mendelson, Carole R.			Role of NRF2 in immune modulator expression in developing lung	FASEB JOURNAL			English	Article						development; fetal lung; immune modulators; NRF2; oxygen tension; SP-A	SURFACTANT-PROTEIN-A; ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT RESPONSE ELEMENT; II CELL-DIFFERENTIATION; GENE-EXPRESSION; CYCLIC-AMP; HEME OXYGENASE-1; EPITHELIAL-CELL; FUNCTIONAL POLYMORPHISMS	After birth, the alveolar epithelium is exposed to environmental pathogens and high O-2 tensions. The alveolar type II cells may protect this epithelium through surfactant production. Surfactant protein, SP-A, an immune modulator, is developmentally upregulated in fetal lung with surfactant phospholipid synthesis. Herein, we observed that the redox-regulated transcription factor, NRF2, and co-regulated C/EBP beta and PPAR gamma, were markedly induced during cAMP-mediated differentiation of cultured human fetal lung (HFL) epithelial cells. This occurred with enhanced expression of immune modulators, SP-A, TDO2, AhR, and NQO1. Like SP-A, cAMP induction of NRF2 was prevented when cells were exposed to hypoxia. NRF2 knockdown inhibited induction of C/EBP beta, PPAR gamma, and immune modulators. Binding of endogenous NRF2 to promoters of SP-A and other immune modulator genes increased during HFL cell differentiation. In mouse fetal lung (MFL), a developmental increase in Nrf2, SP-A, Tdo2, Ahr, and Nqo1 and decrease in Keap1 occurred from 14.5 to 18.5 dpc. Developmental induction of Nrf2 in MFL was associated with increased nuclear localization of NF-kappa B p65, a decline in p38 MAPK phosphorylation, increase in the MAPK phosphatase, DUSP1, induction of the histone acetylase, CBP, and decline in the histone deacetylase, HDAC4. Thus, together with surfactant production, type II cells protect the alveolar epithelium through increased expression of NRF2 and immune modulators to prevent inflammation and oxidative stress. Our findings further suggest that lung cancer cells have usurped this developmental pathway to promote immune tolerance and enhance survival.	[Mishra, Ritu; Nawas, Afshan Fathima; Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, North Texas March Dimes Birth Defects Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, North Texas March Dimes Birth Defects Ctr, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, North Texas March Dimes Birth Defects Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carole.mendelson@utsouthwestern.edu	Nawas, Afshan Fathima/AAH-4726-2020	Nawas, Afshan Fathima/0000-0001-5606-9603; Mendelson, Carole Ruth/0000-0003-1696-9791	HHS | National Institutes of Health (NIH) [R01-HL050022]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: R01-HL050022	ACARREGUI MJ, 1993, AM J PHYSIOL, V264, pL465, DOI 10.1152/ajplung.1993.264.5.L465; Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; Ambalavanan N, 2008, AM J PHYSIOL-LUNG C, V295, pL86, DOI 10.1152/ajplung.00534.2007; Benlhabib H, 2015, J BIOL CHEM, V290, P22409, DOI 10.1074/jbc.M114.636068; Benlhabib H, 2011, MOL CELL BIOL, V31, P1949, DOI 10.1128/MCB.01063-10; Best SA, 2018, CELL CYCLE, V17, P1696, DOI 10.1080/15384101.2018.1496756; Best SA, 2018, CELL METAB, V27, P935, DOI 10.1016/j.cmet.2018.02.006; Bhattacharya S, 2014, AM J PHYSIOL-LUNG C, V307, pL516, DOI 10.1152/ajplung.00200.2014; BOGGARAM V, 1988, J BIOL CHEM, V263, P2939; Brinker KG, 2003, AM J PHYSIOL-LUNG C, V284, pL232, DOI 10.1152/ajplung.00187.2002; CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Cheong JE, 2018, TRENDS PHARMACOL SCI, V39, P307, DOI 10.1016/j.tips.2017.11.007; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; Cho HY, 2015, FREE RADICAL BIO MED, V88, P362, DOI 10.1016/j.freeradbiomed.2015.06.012; Cho HY, 2015, ANTIOXID REDOX SIGN, V22, P325, DOI 10.1089/ars.2014.5942; Cho HY, 2014, AM J RESP CELL MOL, V50, P844, DOI 10.1165/rcmb.2014-0116PS; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; deMello DE, 1997, AM J RESP CELL MOL, V16, P568, DOI 10.1165/ajrcmb.16.5.9160839; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Esser C, 2016, METHODS MOL BIOL, V1371, P239, DOI 10.1007/978-1-4939-3139-2_16; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Garufi A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030348; Guo W, 2016, MOL CELL BIOL, V36, P2141, DOI 10.1128/MCB.00096-16; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Hsu YL, 2016, ONCOTARGET, V7, P27584, DOI 10.18632/oncotarget.8488; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Iannitti RG, 2013, AM J RESP CRIT CARE, V187, P609, DOI 10.1164/rccm.201207-1346OC; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Islam KN, 2002, MOL ENDOCRINOL, V16, P1428, DOI 10.1210/me.16.6.1428; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jaronen M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00521; Jiang WW, 2004, J PHARMACOL EXP THER, V310, P512, DOI 10.1124/jpet.103.059766; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kim BR, 2018, BIOCHEM BIOPH RES CO, V497, P1149, DOI 10.1016/j.bbrc.2017.01.107; Kurinna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6099; Li JX, 1998, J BIOL CHEM, V273, P4592, DOI 10.1074/jbc.273.8.4592; Liu DY, 2009, MOL ENDOCRINOL, V23, P772, DOI 10.1210/me.2008-0282; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; MENDELSON CR, 1986, J BIOL CHEM, V261, P9938; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Mishra R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00037-18; Mukherjee S, 2012, J IMMUNOL, V188, P4376, DOI 10.4049/jimmunol.1101775; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nam ST, 2016, J MICROBIOL BIOTECHN, V26, P1446, DOI 10.4014/jmb.1603.03041; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155; Oerlecke I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054261; Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Pastva AM, 2011, J IMMUNOL, V186, P2842, DOI 10.4049/jimmunol.0904190; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Platten M, 2012, ONCOIMMUNOLOGY, V1, P395, DOI 10.4161/onci.19071; Polvani S, 2012, PPAR RES, V2012, DOI 10.1155/2012/641087; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Reddy NM, 2011, AM J RESP CELL MOL, V45, P1161, DOI 10.1165/rcmb.2011-0144OC; Rennie MY, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140681; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shivanna B, 2013, TOXICOL APPL PHARM, V267, P209, DOI 10.1016/j.taap.2013.01.003; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Takahashi N, 2020, MOL CELL, V80, DOI 10.1016/j.molcel.2020.10.010; Tamatam CM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75834-8; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Wang B, 2012, FREE RADICAL BIO MED, V52, P928, DOI 10.1016/j.freeradbiomed.2011.12.006; Wang HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136703; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Xu Y, 2009, AM J PHYSIOL-LUNG C, V297, pL286, DOI 10.1152/ajplung.00094.2009; Ye MX, 2018, CLIN CANCER RES, V24, P1227, DOI 10.1158/1078-0432.CCR-17-0396; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhou L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0710-y; Zimta AA, 2019, CANCERS, V11, DOI 10.3390/cancers11111755	91	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21758	10.1096/fj.202100129RR	http://dx.doi.org/10.1096/fj.202100129RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34245611	Green Accepted			2022-12-28	WOS:000678975300001
J	Fang, H; Shao, S; Xue, K; Yuan, X; Qiao, P; Zhang, JY; Cao, TY; Luo, YX; Bai, XC; Li, WJ; Li, CX; Qiao, HJ; Dang, EL; Wang, G				Fang, Hui; Shao, Shuai; Xue, Ke; Yuan, Xu; Qiao, Pei; Zhang, Jieyu; Cao, Tianyu; Luo, Yixin; Bai, Xiaocui; Li, Wenjing; Li, Caixia; Qiao, Hongjiang; Dang, Erle; Wang, Gang			Neutrophil extracellular traps contribute to immune dysregulation in bullous pemphigoid via inducing B-cell differentiation and antibody production	FASEB JOURNAL			English	Article						autoantibody; autoimmunity; B cell; bullous pemphigoid; neutrophil extracellular traps	MITOCHONDRIAL-DNA; ELASTASE; AUTOANTIBODIES; DEGRADATION; RELEASE; COLLAGEN; INNATE; NETS	Bullous pemphigoid (BP), an autoimmune skin disease, is characterized by autoantibodies against hemidesmosomal proteins in the skin and mucous membranes. Neutrophils infiltrate BP skin lesions, however, their role in immune dysregulation remains unclear. We investigated whether BP involves aberrant neutrophil extracellular traps (NETs) formation in skin lesions and circulation; and examined the triggers and deleterious immuno-inflammatory consequences. In the present study, we found that circulating NET-related biomarker levels increased in serum and blister fluid of BP patients and significantly correlated with disease severity. Additionally, circulating neutrophils from BP patients displayed enhanced spontaneous NETs formation than healthy controls. In vitro, BP180-NC16A immune complexes-induced NETosis in neutrophils from BP patients, which was abrogated by Fc gamma receptor and/or NADPH pathway blockade. Furthermore, the elevated levels of NETs from BP patients boosted autoantibody production by inducing B-cell differentiation into plasma cells, mediated by MAPK P38 cascade activation. Together, our findings provide strong evidence that NETs are involved in a pathogenic loop, causing excessive differentiation of B cells and promotion of autoantibody production. Hence, targeting aberrant neutrophil responses will provide novel potential targets for the treatment of BP.	[Fang, Hui; Shao, Shuai; Xue, Ke; Yuan, Xu; Qiao, Pei; Zhang, Jieyu; Cao, Tianyu; Luo, Yixin; Bai, Xiaocui; Li, Wenjing; Li, Caixia; Qiao, Hongjiang; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China	Air Force Military Medical University	Dang, EL; Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China.	dangerle@fmmu.edu.cn; wanggangxjyy@163.com	Fang, Hui/GSN-9002-2022; Wang, Gang/H-6710-2019	Fang, Hui/0000-0002-3081-5863; 	National Natural Science Foundation of China [81672692, 81703125, 81703116, 81703119, 81903208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank our patients and healthy volunteers for their enthusiastic participation. The authors also thank Meihong Yu, Na Li, Yi Wang, and Qiaozhen Lin for their assistance with the immunofluorescence staining. This work was supported by grants from the National Natural Science Foundation of China (grant numbers 81672692, 81703125, 81703116, 81703119, and 81903208).	An ZJ, 2019, CELL CYCLE, V18, P2928, DOI 10.1080/15384101.2019.1662678; Bagci IS, 2017, AUTOIMMUN REV, V16, P445, DOI 10.1016/j.autrev.2017.03.010; Barnado A, 2016, J LEUKOCYTE BIOL, V99, P265, DOI 10.1189/jlb.5BT0615-234R; Bodano A, 2006, RHEUMATOLOGY, V45, P819, DOI 10.1093/rheumatology/kel019; Boeltz S, 2019, CELL DEATH DIFFER, V26, P395, DOI 10.1038/s41418-018-0261-x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brumann M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/749175; Cervantes-Luevano KE, 2018, J ALLERGY CLIN IMMUN, V142, P1605, DOI 10.1016/j.jaci.2017.11.063; Chiriac MT, 2007, J PATHOL, V212, P56, DOI 10.1002/path.2157; Costa S, 2019, IMMUNOLOGY, V156, P23, DOI 10.1111/imm.13005; D'Auria L, 2000, EXP DERMATOL, V9, P131, DOI 10.1034/j.1600-0625.2000.009002131.x; de Graauw E, 2018, ALLERGY, V73, P1119, DOI 10.1111/all.13376; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gestermann N, 2018, J IMMUNOL, V200, P3364, DOI 10.4049/jimmunol.1700778; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; Giusti D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00701; Grund LZ, 2017, AUTOIMMUNITY, V50, P86, DOI 10.1080/08916934.2016.1261834; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Heimbach L, 2011, J BIOL CHEM, V286, P15003, DOI 10.1074/jbc.M111.221036; Hu SCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31119; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kowalski EH, 2019, AUTOIMMUN REV, V18, P526, DOI 10.1016/j.autrev.2019.03.009; Lambert S, 2019, J INVEST DERMATOL, V139, P1245, DOI 10.1016/j.jid.2018.11.021; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Le Joncour A, 2019, ANN RHEUM DIS, V78, P1274, DOI 10.1136/annrheumdis-2018-214335; Lin L, 2012, MATRIX BIOL, V31, P38, DOI 10.1016/j.matbio.2011.09.003; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; Liu Z, 2000, J CLIN INVEST, V105, P113, DOI 10.1172/JCI3693; Liu Z, 2008, J AUTOIMMUN, V31, P331, DOI 10.1016/j.jaut.2008.08.009; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Maugeri N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao3089; Mistry P, 2018, ANN RHEUM DIS, V77, P1825, DOI 10.1136/annrheumdis-2018-213746; Nelson KC, 2006, J CLIN INVEST, V116, P2892, DOI 10.1172/JCI17891; Nishie W, 2014, J DERMATOL SCI, V73, P179, DOI 10.1016/j.jdermsci.2013.12.001; O'Neil LJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091325; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pruchniak MP, 2019, AUTOIMMUNITY, V52, P126, DOI 10.1080/08916934.2019.1631812; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Shao S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00746; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Soderberg D, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00256; Wright HL, 2017, J LEUKOCYTE BIOL, V101, P599, DOI 10.1189/jlb.5A0116-022R; Yoo DG, 2014, IMMUNOL LETT, V160, P186, DOI 10.1016/j.imlet.2014.03.003; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	50	2	2	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21746	10.1096/fj.202100145R	http://dx.doi.org/10.1096/fj.202100145R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34151465				2022-12-28	WOS:000667814100012
J	Hall, RJ; O'Loughlin, J; Billington, CK; Thakker, D; Hall, IP; Sayers, I				Hall, Robert J.; O'Loughlin, Jonathan; Billington, Charlotte K.; Thakker, Dhruma; Hall, Ian P.; Sayers, Ian			Functional genomics of GPR126 in airway smooth muscle and bronchial epithelial cells	FASEB JOURNAL			English	Article						COPD; cell biology; genomics	PROTEIN-COUPLED RECEPTOR; ADOLESCENT IDIOPATHIC SCOLIOSIS; OBSTRUCTIVE PULMONARY-DISEASE; ADHESION-GPCRS; SCHWANN-CELLS; GENE; ACTIVATION; EXPRESSION; DOMAIN; MYELINATION	GPR126 is an adhesion G protein-coupled receptor which lies on chromosome 6q24. Genetic variants in this region are reproducibly associated with lung function and COPD in genome wide association studies (GWAS). The aims of this study were to define the role of GPR126 in the human lung and in pulmonary disease and identify possible casual variants. Online tools (GTEx and LDlink) identified SNPs which may have effects on GPR126 function/ expression, including missense variant Ser123Gly and an intronic variant that shows eQTL effects on GPR126 expression. GPR126 signaling via cAMP-mediated pathways was identified in human structural airway cells when activated with the tethered agonist, stachel. RNA-seq was used to identify downstream genes/ pathways affected by stachel-mediated GPR126 activation in human airway smooth muscle cells. We identified similar to 350 differentially expressed genes at 4 and 24 hours post stimulation with similar to 20% overlap. We identified that genes regulated by GPR126 activation include IL33, CTGF, and SERPINE1, which already have known roles in lung biology. Pathways altered by GPR126 included those involved in cell cycle progression and cell proliferation. Here, we suggest a role for GPR126 in airway remodeling.	[Hall, Robert J.; O'Loughlin, Jonathan; Billington, Charlotte K.; Thakker, Dhruma; Hall, Ian P.; Sayers, Ian] Univ Nottingham, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Biodiscovery Inst,Div Resp Med, Nottingham NG7 2RD, England	University of Nottingham	Hall, RJ (corresponding author), Univ Nottingham, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Biodiscovery Inst,Div Resp Med, Nottingham NG7 2RD, England.	robert.hall@nottingham.ac.uk		Sayers, Ian/0000-0001-5601-5410; Hall, Robert/0000-0001-9114-7144	Hermes Fellowship University of Nottingham [2016-2017]; British Lung Foundation (BLF) [PPRG15-5]; RCUK | Medical Research Council (MRC) [G1000861]; NIHR Senior Investigator award; Centre of Membrane Proteins and Receptors (COMPARE)	Hermes Fellowship University of Nottingham; British Lung Foundation (BLF); RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Senior Investigator award; Centre of Membrane Proteins and Receptors (COMPARE)	Hermes Fellowship University of Nottingham, Grant/Award Number: 2016-2017; British Lung Foundation (BLF), Grant/Award Number: Grant PPRG15-5; RCUK | Medical Research Council (MRC), Grant/Award Number: G1000861; NIHR Senior Investigator award; The Centre of Membrane Proteins and Receptors (COMPARE)	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Artigas MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9658; Billington CK, 2001, AM J RESP CELL MOL, V24, P633, DOI 10.1165/ajrcmb.24.5.4215; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Carvalho-Silva D, 2019, NUCLEIC ACIDS RES, V47, pD1056, DOI 10.1093/nar/gky1133; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Chang GW, 2003, FEBS LETT, V547, P145, DOI 10.1016/S0014-5793(03)00695-1; Cui HX, 2014, J BIOL CHEM, V289, P34871, DOI 10.1074/jbc.M114.571000; Demberg LM, 2017, J BIOL CHEM, V292, P4383, DOI 10.1074/jbc.M116.763656; Francis SMS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-88; Geng FS, 2013, DEVELOPMENT, V140, P4362, DOI 10.1242/dev.098061; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Glenn TD, 2013, DEVELOPMENT, V140, P3167, DOI 10.1242/dev.093401; Gorr MW, 2020, BRIT J PHARMACOL, V177, P3505, DOI 10.1111/bph.15074; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Hu H, 2010, TOHOKU J EXP MED, V222, P291, DOI 10.1620/tjem.222.291; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang YY, 2010, RESPIROLOGY, V15, P939, DOI 10.1111/j.1440-1843.2010.01799.x; Kheirallah AK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3628-3; Kim WJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/206937; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; Kou I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29011-7; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Leon K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14040-1; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Lin CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104746; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Miller S, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0410-z; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Morrow JD, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1032-z; Musa G, 2019, ANN NY ACAD SCI, V1456, P96, DOI 10.1111/nyas.14135; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Panettieri RA, 2008, AM J RESP CRIT CARE, V177, P248, DOI 10.1164/rccm.200708-1217PP; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Qin XD, 2017, SPINE, V42, pE1098, DOI 10.1097/BRS.0000000000002123; Raivo K., 2019, PHEATMAP PRETTY HEAT; Rayner RE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36735-z; Shang J, 2015, BIOCHEM CELL BIOL, V93, P359, DOI 10.1139/bcb-2014-0163; Shrine N, 2019, NAT GENET, V51, P481, DOI 10.1038/s41588-018-0321-7; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terzikhan N, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00647-2018; To M, 2013, CHEST, V144, P515, DOI 10.1378/chest.12-2381; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vosa U., 2018, 447367 BIORXIV; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xia J, 2015, AM J PHYSIOL-LUNG C, V308, pL619, DOI 10.1152/ajplung.00305.2014; Xu EJ, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4678969; Xu JF, 2015, GENOMICS, V105, P101, DOI 10.1016/j.ygeno.2014.11.009; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	65	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21300	10.1096/fj.202002073R	http://dx.doi.org/10.1096/fj.202002073R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165809	Green Published, hybrid			2022-12-28	WOS:000667814100007
J	Leverrier-Penna, S; Michel, A; Lecante, LL; Costet, N; Suglia, A; Desdoits-Lethimonier, C; Boulay, H; Viel, R; Chemouny, JM; Becker, E; Lavoue, V; Rolland, AD; Dejucq-Rainsford, N; Vigneau, C; Mazaud-Guittot, S				Leverrier-Penna, Sabrina; Michel, Alain; Lecante, Laetitia L.; Costet, Nathalie; Suglia, Antonio; Desdoits-Lethimonier, Christele; Boulay, Hugoline; Viel, Roselyne; Chemouny, Jonathan M.; Becker, Emmanuelle; Lavoue, Vincent; Rolland, Antoine D.; Dejucq-Rainsford, Nathalie; Vigneau, Cecile; Mazaud-Guittot, Severine			Exposure of human fetal kidneys to mild analgesics interferes with early nephrogenesis	FASEB JOURNAL			English	Article						acetaminophen; fetal kidney; nephrogenesis; NSAIDs; prostaglandins	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTE-RENAL-FAILURE; LOW-BIRTH-WEIGHT; TUBULAR INJURY; NEPHRON NUMBER; ACETAMINOPHEN; PARACETAMOL; IBUPROFEN; RECEPTOR; ASPIRIN	Acetaminophen, aspirin, and ibuprofen are mild analgesics commonly used by pregnant women, the sole current recommendation being to avoid ibuprofen from the fifth month of gestation. The nephrotoxicity of these three analgesics is well documented in adults, as is their interference with prostaglandins biosynthesis. Here we investigated the effect of these analgesics on human first trimester kidneys ex vivo. We first evaluated prostaglandins biosynthesis functionality by performing a wide screening of prostaglandin expression patterns in first trimester human kidneys. We demonstrated that prostaglandins biosynthesis machinery is functional during early nephrogenesis. Human fetal kidney explants aged 7-12 developmental weeks were exposed ex vivo to ibuprofen, aspirin or acetaminophen for 7 days, and analyzed by histology, immunohistochemistry, and flow cytometry. This study has revealed that these analgesics induced a spectrum of abnormalities within early developing structures, ranging from cell death to a decline in differentiating glomeruli density. These results warrant caution for the use of these medicines during the first trimester of pregnancy.	[Leverrier-Penna, Sabrina; Lecante, Laetitia L.; Costet, Nathalie; Suglia, Antonio; Desdoits-Lethimonier, Christele; Becker, Emmanuelle; Rolland, Antoine D.; Dejucq-Rainsford, Nathalie; Vigneau, Cecile; Mazaud-Guittot, Severine] Univ Rennes, Irset Inst Rech Sante Environm & Travail, UMR S 1085, EHESP,INSERM, Rennes, France; [Michel, Alain; Boulay, Hugoline; Chemouny, Jonathan M.; Vigneau, Cecile] Univ Rennes, CHU Rennes, INSERM, EHESP,Irset Inst Rech Sante Environm & Travail,UM, Rennes, France; [Viel, Roselyne] Univ Rennes 1, CNRS, Inserm UMS Biosit, Core Facil H2P2, Rennes, France; [Lavoue, Vincent] CHU Rennes, Serv Gynecol & Obstet, Rennes, France; [Leverrier-Penna, Sabrina] Univ Poitiers, Stem, CNRS, ERL7003, Poitiers, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; CHU Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Vigneau, C; Mazaud-Guittot, S (corresponding author), CHU Pontchaillou, Serv Nephrol, F-35033 Rennes 9, France.	Cecile.VIGNEAU@chu-rennes.fr; severine.mazaud@univ-rennes1.fr	Mazaud-Guittot, Severine/I-4694-2015; ROLLAND, Antoine D/B-2611-2012	Mazaud-Guittot, Severine/0000-0003-0566-4124; ROLLAND, Antoine D/0000-0002-9758-4406; Desdoits-Lethimonier, Christele/0000-0003-4232-2107; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690; Lecante, Laetitia/0000-0002-3185-7803	Inserm, University of Rennes 1, EHESP-School of Public Health; Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM) [HAP-2014-073]; Agence Nationale de la Recherche [ANR-15-CE34-0001-01]; French Society of Nephrology	Inserm, University of Rennes 1, EHESP-School of Public Health; Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM)(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Society of Nephrology	We thank the entire staff of the Obstetrics and Gynecology Department of the Rennes Sud Hospital (Rennes, France), along with the participating women, without whom this study would have been impossible. We thank Pauline Le Faouder from the MetaToul-Lipidomique core facility (I2MC, Inserm 1048, Toulouse, France), MetaboHUB-ANR-11-INBS-0010 for prostaglandin measurements. Thanks to the staff at the Biosit histopathology platform (Biogenouest, Universite de Rennes 1, Rennes, France). We are grateful to Isabelle Coiffec for help with organ collection, and to Juliana Berland for American editing. This study was funded by Inserm, University of Rennes 1, EHESP-School of Public Health. SLP was a recipient of a stipend from the Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM; HAP-2014-073), LL from the Agence Nationale de la Recherche (ANR-15-CE34-0001-01) and AM from The French Society of Nephrology.	Abe K, 2003, BIRTH DEFECTS RES A, V67, P911, DOI 10.1002/bdra.10130; Akinola O, 2003, Niger Postgrad Med J, V10, P46; Akiyama K, 2013, PATHOL INT, V63, P37, DOI 10.1111/pin.12031; Aminoshariae A, 2015, J ENDODONT, V41, P588, DOI 10.1016/j.joen.2015.01.024; Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Andersson S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15840; Azzarello J, 2008, J HISTOCHEM CYTOCHEM, V56, P853, DOI 10.1369/jhc.2008.951384; BLAKELY P, 1995, J AM SOC NEPHROL, V6, P48; BRANDON RA, 1986, CEPHALALGIA, V6, P19, DOI 10.1046/j.1468-2982.1986.0601019.x; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; BRIERE N, 1991, BIOCHEM CELL BIOL, V69, P256, DOI 10.1139/o91-039; Brune K, 2015, J PAIN RES, V8, P105, DOI 10.2147/JPR.S75160; Bueters RRG, 2015, BIRTH DEFECTS RES B, V104, P218, DOI 10.1002/bdrb.21161; Carmody JB, 2013, PEDIATRICS, V131, P1168, DOI 10.1542/peds.2013-0009; Cataldi L, 2005, ARCH DIS CHILD-FETAL, V90, pF514, DOI 10.1136/adc.2004.060434; Cuzzolin L, 2001, DRUG SAFETY, V24, P9, DOI 10.2165/00002018-200124010-00002; Daniel S, 2012, J RHEUMATOL, V39, P2163, DOI 10.3899/jrheum.120453; Deleage C, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-017-0387-9; Drukker Alfred, 2002, Paediatr Child Health, V7, P538; Duncan K, 2012, IUBMB LIFE, V64, P636, DOI 10.1002/iub.1035; Ericson A, 2001, REPROD TOXICOL, V15, P371, DOI 10.1016/S0890-6238(01)00137-X; Espiridiao S, 2002, Clin Exp Obstet Gynecol, V29, P37; Eyers S, 2011, CLIN EXP ALLERGY, V41, P482, DOI 10.1111/j.1365-2222.2010.03691.x; Fored CM, 2001, NEW ENGL J MED, V345, P1801, DOI 10.1056/NEJMoa010323; Frances F, 2007, CLIN CHIM ACTA, V386, P53, DOI 10.1016/j.cca.2007.07.020; Frolich S, 2012, AM J PHYSIOL-RENAL, V303, pF209, DOI 10.1152/ajprenal.00418.2011; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; GOVINDARAJAN S, 1987, HEPATOLOGY, V7, P654, DOI 10.1002/hep.1840070407; Guignard JP, 2005, ARCH PEDIATRIE, V12, P726, DOI 10.1016/j.arcped.2005.04.060; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Hinz B, 2012, ANN RHEUM DIS, V71, P20, DOI 10.1136/ard.2011.200087; Hochane M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000152; Hodgin JB, 2009, CLIN J AM SOC NEPHRO, V4, P71, DOI 10.2215/CJN.01700408; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; KALLSTROM E, 1988, J INT MED RES, V16, P44; KARTTUNEN P, 1990, INT J CLIN PHARM TH, V28, P251; Kent AL, 2007, PEDIATR RES, V62, P307, DOI 10.1203/PDR.0b013e318123f6e3; Khan KNM, 2001, PEDIATR DEVEL PATHOL, V4, P461, DOI 10.1007/s10024001-0041-2; Klein T., 2015, MEDIAT INFLAMM, V2015; Komhoff M, 1997, AM J PHYSIOL-RENAL, V272, pF460, DOI 10.1152/ajprenal.1997.272.4.F460; Komhoff M, 2000, KIDNEY INT, V57, P414; Komhoff M, 1998, KIDNEY INT, V54, P1899, DOI 10.1046/j.1523-1755.1998.00213.x; Kristensen DM, 2016, NAT REV ENDOCRINOL, V12, P381, DOI 10.1038/nrendo.2016.55; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Leverrier-Penna S, 2018, HUM REPROD, V33, P482, DOI 10.1093/humrep/dex383; LEVY G, 1981, ARCH INTERN MED, V141, P279, DOI 10.1001/archinte.141.3.279; Lindstrom NO, 2018, DEV CELL, V45, P651, DOI 10.1016/j.devcel.2018.05.010; Lorz C, 2004, J AM SOC NEPHROL, V15, P380, DOI 10.1097/01.ASN.0000111289.91206.B0; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Mazaud-Guittot S, 2013, J CLIN ENDOCR METAB, V98, pE1757, DOI 10.1210/jc.2013-2531; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Naga Rani M A, 1989, J Indian Med Assoc, V87, P182; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Olliges A, 2011, BRIT J PHARMACOL, V163, P927, DOI 10.1111/j.1476-5381.2011.01313.x; Rainsford K. D., 2009, Inflammopharmacology, V17, P275, DOI 10.1007/s10787-009-0016-x; RAYBURN W, 1986, AM J OBSTET GYNECOL, V155, P1353, DOI 10.1016/0002-9378(86)90173-0; REGAZZI BM, 1986, INT J CLIN PHARM RES, V6, P469; Roberts E, 2016, ANN RHEUM DIS, V75, P552, DOI 10.1136/annrheumdis-2014-206914; Sales KJ, 2003, PROSTAG OTH LIPID M, V71, P97, DOI 10.1016/S1098-8823(03)00050-9; Slattery P, 2016, AM J PHYSIOL-RENAL, V310, pF1113, DOI 10.1152/ajprenal.00430.2015; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Therland KL, 2004, J AM SOC NEPHROL, V15, P1189, DOI 10.1097/01.ASN.0000124673.79934.24; Thiele K, 2013, J REPROD IMMUNOL, V97, P128, DOI 10.1016/j.jri.2012.10.014; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; van den Driesche S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4097; Vieira LD, 2008, FUND CLIN PHARMACOL, V22, P379, DOI 10.1111/j.1472-8206.2008.00604.x; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Welham Simon J M, 2017, World J Nephrol, V6, P21, DOI 10.5527/wjn.v6.i1.21; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Yamamoto E, 2011, J TOXICOL PATHOL, V24, P257, DOI 10.1293/tox.24.257	76	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21718	10.1096/fj.202100050R	http://dx.doi.org/10.1096/fj.202100050R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105801				2022-12-28	WOS:000667814100041
J	Okutsu, M; Yamada, M; Tokizawa, K; Marui, S; Suzuki, K; Lira, VA; Nagashima, K				Okutsu, Mitsuharu; Yamada, Mami; Tokizawa, Ken; Marui, Shuri; Suzuki, Katsuhiko; Lira, Vitor A.; Nagashima, Kei			Regular exercise stimulates endothelium autophagy via IL-1 signaling in ApoE deficient mice	FASEB JOURNAL			English	Article						atherosclerosis; autophagy; cholesterol; exercise; inflammation; interleukine-1	ATHEROSCLEROSIS; MECHANISMS; ATHEROGENESIS; CHOLESTEROL; MACROPHAGES; ADAPTATION; LESIONS; FAT	Regular exercise maintains arterial endothelial cell homeostasis and protects the arteries from vascular disease, such as peripheral artery disease and atherosclerosis. Autophagy, which is a cellular process that degrades misfolded or aggregate proteins and damaged organelles, plays an important role in maintaining organ and cellular homeostasis. However, it is unknown whether regular exercise stimulates autophagy in aorta endothelial cells of mice prone to atherosclerosis independently of their circulating lipid profile. Here, we observed that 16 weeks of voluntary exercise reduced high-fat diet-induced atherosclerotic plaque formation in the aortic root of ApoE deficient mice, and that this protection occurred without changes in circulating triglycerides, total cholesterol, and lipoproteins. Immunofluorescence analysis indicated that voluntary exercise increased levels of the autophagy protein LC3 in aortic endothelial cells. Interestingly, human umbilical vein endothelial cells (HUVECs) exposed to serum from voluntarily exercised mice displayed significantly increased LC3-I and LC3-II protein levels. Analysis of circulating cytokines demonstrated that voluntary exercise caused changes directly relevant to IL-1 signaling (ie, decreased interleukin-1 receptor antagonist [IL-1ra] while also increasing IL-1 alpha). HUVECs exposed to IL-1 alpha and IL-1 beta recombinant protein significantly increased LC3 mRNA expression, LC3-I and LC3-II protein levels, and autophagy flux. Collectively, these results suggest that regular exercise protects arteries from ApoE deficient mice against atherosclerosis at least in part by stimulating endothelial cell autophagy via enhanced IL-1 signaling.	[Okutsu, Mitsuharu; Yamada, Mami] Nagoya City Univ, Grad Sch Sci, Nagoya, Aichi, Japan; [Tokizawa, Ken] Natl Inst Occupat Safety & Hlth, Tokyo, Japan; [Marui, Shuri; Nagashima, Kei] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan; [Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Lira, Vitor A.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Dept Hlth & Human Physiol, Iowa City, IA USA	Nagoya City University; Waseda University; Waseda University; University of Iowa	Okutsu, M (corresponding author), Nagoya City Univ, Grad Sch Sci, Mizuho Ku, Yamanohata 1,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	okutsu@nsc.nagoya-cu.ac.jp		Lira, Vitor A./0000-0002-3162-3804	MEXT \ Japan Society for the Promotion of Science (JSPS) [16K13019, 18H03153, 21H03326, 20J15551]; Meiji Yasuda Life Foundation of Health and Welfare; Kao Foundation for Health and Science	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); Kao Foundation for Health and Science	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K13019, 18H03153, 21H03326 and 20J15551; The Meiji Yasuda Life Foundation of Health and Welfare; The Kao Foundation for Health and Science	Ajijola OA, 2009, ANTIOXID REDOX SIGN, V11, P15, DOI 10.1089/ars.2008.2092; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Antunes BMM, 2016, CURR CARDIOL REV, V12, P47, DOI 10.2174/1573403X12666160126115317; Basterfield L, 2009, INT J OBESITY, V33, P212, DOI 10.1038/ijo.2008.253; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cesar L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017263; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Green DJ, 2017, PHYSIOL REV, V97, P495, DOI 10.1152/physrev.00014.2016; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li Y, 2020, OBES RES CLIN PRACT, V14, P264, DOI 10.1016/j.orcp.2020.04.008; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Matsushima Y, 2001, J Atheroscler Thromb, V8, P71; Matsushima Y, 1999, MAMM GENOME, V10, P352, DOI 10.1007/s003359901000; Menon P, 2015, METHODS MOL BIOL, V1339, P131, DOI 10.1007/978-1-4939-2929-0_9; Missiou A, 2010, CIRC RES, V107, P757, DOI 10.1161/CIRCRESAHA.110.219295; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Muscella A, 2020, AM J PHYSIOL-HEART C, V319, pH76, DOI 10.1152/ajpheart.00708.2019; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Okutsu M, 2008, BRAIN BEHAV IMMUN, V22, P1066, DOI 10.1016/j.bbi.2008.03.006; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Okutsu M, 2014, ATHEROSCLEROSIS, V232, P414, DOI 10.1016/j.atherosclerosis.2013.11.076; Pellegrin M, 2007, ATHEROSCLEROSIS, V190, P35, DOI 10.1016/j.atherosclerosis.2006.02.001; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SLYPER AH, 1994, JAMA-J AM MED ASSOC, V272, P305, DOI 10.1001/jama.272.4.305; Smith DD, 2010, J PHYSIOL PHARMACOL, V61, P309; Tanaka G, 2015, BIOCHEM BIOPH RES CO, V466, P512, DOI 10.1016/j.bbrc.2015.09.061; Usui S, 2002, J LIPID RES, V43, P805; Vieira VJ, 2009, CYTOKINE, V46, P339, DOI 10.1016/j.cyto.2009.03.006; Vion AC, 2017, P NATL ACAD SCI USA, V114, pE8675, DOI 10.1073/pnas.1702223114; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yamada M, 2019, AM J PHYSIOL-REG I, V317, pR770, DOI 10.1152/ajpregu.00155.2019; Yamada M, 2019, FASEB J, V33, P8022, DOI 10.1096/fj.201900133R; Zhang CB, 2013, AM J PHYSIOL-ENDOC M, V305, pE530, DOI 10.1152/ajpendo.00640.2012; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	43	5	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21698	10.1096/fj.202002790RR	http://dx.doi.org/10.1096/fj.202002790RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085350				2022-12-28	WOS:000667814100076
J	Sirica, AE				Sirica, Alphonse E.			The 2021 FASEB Virtual Catalyst Conference on Cholangiocarcinoma: Molecular Drivers, Microenvironment, and Precision Medicine, April 7, 2021	FASEB JOURNAL			English	Editorial Material									[Sirica, Alphonse E.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA	Virginia Commonwealth University	Sirica, AE (corresponding author), Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA.	alphonse.sirica@vcuhealth.org							0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21670	10.1096/fj.202100745	http://dx.doi.org/10.1096/fj.202100745			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34169576	Bronze			2022-12-28	WOS:000667814100027
J	Marcinek, P; Haag, F; Geithe, C; Krautwurst, D				Marcinek, Patrick; Haag, Franziska; Geithe, Christiane; Krautwurst, Dietmar			An evolutionary conserved olfactory receptor for foodborne and semiochemical alkylpyrazines	FASEB JOURNAL			English	Article						chemical ecology; chemosensory evolution; odorant receptor; olfaction	KEY AROMA COMPOUNDS; HUMAN ODORANT RECEPTOR; BEHAVIORAL-RESPONSES; FUNCTIONAL EXPRESSION; ALARM PHEROMONE; INNATE THREAT; FOOD ODORANT; CD-1 MICE; MOUSE; FEAR	Molecular recognition is a fundamental principle in biological systems. The olfactory detection of both food and predators via ecological relevant odorant cues are abilities of eminent evolutionary significance for many species. Pyrazines are such volatile cues, some of which act as both human-centered key food odorants (KFOs) and semiochemicals. A pyrazine-selective odorant receptor has been elusive. Here we screened 2,3,5-trimethylpyrazine, a KFO and semiochemical, and 2,5-dihydro-2,4,5-trimethylthiazoline, an innate fear-associated non-KFO, against 616 human odorant receptor variants, in a cell-based luminescence assay. OR5K1 emerged as sole responding receptor. Tested against a comprehensive collection of 178 KFOs, we newly identified 18 pyrazines and (2R/2S)-4-methoxy-2,5-dimethylfuran-3(2H)-one as agonists. Notably, OR5K1 orthologs in mouse and domesticated species displayed a human-like, potency-ranked activation pattern of pyrazines, suggesting a domestication-led co-evolution of OR5K1 and its orthologs. In summary, OR5K1 is a specialized olfactory receptor across mammals for the detection of pyrazine-based key food odors and semiochemicals.	[Marcinek, Patrick; Haag, Franziska; Geithe, Christiane; Krautwurst, Dietmar] Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany; [Marcinek, Patrick] Hamilton Germany GmbH, Grafelfing, Germany; [Geithe, Christiane] Brandenburg Univ Technol Cottbus Senftenberg, Senftenberg, Germany	Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich; Brandenburg University of Technology Cottbus	Krautwurst, D (corresponding author), Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany.	d.krautwurst.leibniz-lsb@tum.de		Haag, Franziska/0000-0003-4210-0475; Marcinek, Patrick/0000-0003-4003-9308; Geithe, Christiane/0000-0002-7302-8851	Altria Client Services Inc, Richmond, VA, USA; MARS Inc, McLean, VA, USA	Altria Client Services Inc, Richmond, VA, USA; MARS Inc, McLean, VA, USA	We thank Tim Frey, Sandra Hoffmann, and Julia Bauer for expert technical assistance. FH has been supported partially by a collaboration project with Altria Client Services Inc, Richmond, VA, USA. CG has been supported partially by a collaboration project with MARS Inc, McLean, VA, USA.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Alberto FJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03206-y; Anson JR, 2013, OECOLOGIA, V171, P367, DOI 10.1007/s00442-012-2424-7; Apfelbach R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00263; Ayers LW, 2013, BEHAV BRAIN RES, V253, P54, DOI 10.1016/j.bbr.2013.06.034; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Bautze V, 2012, CHEM SENSES, V37, P479, DOI 10.1093/chemse/bjr130; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; Bohman B, 2014, NEW PHYTOL, V203, P939, DOI 10.1111/nph.12800; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buttery RG, 1999, J AGR FOOD CHEM, V47, P4353, DOI 10.1021/jf990140w; Chamaille-Jammes S, 2014, OECOLOGIA, V174, P1151, DOI 10.1007/s00442-013-2843-0; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dewan A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05129-0; Dunkel A, 2014, ANGEW CHEM INT EDIT, V53, P7124, DOI 10.1002/anie.201309508; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Geithe C, 2017, CELL MOL LIFE SCI, V74, P4209, DOI 10.1007/s00018-017-2576-z; Geithe C, 2017, CHEM SENSES, V42, P181, DOI 10.1093/chemse/bjw117; Geithe C, 2015, J AGR FOOD CHEM, V63, P9410, DOI 10.1021/acs.jafc.5b01884; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Guan D, 2014, J AGR FOOD CHEM, V62, P11924, DOI 10.1021/jf505191s; Hellwig M, 2014, ANGEW CHEM INT EDIT, V53, P10316, DOI 10.1002/anie.201308808; Henning C, 2016, GLYCOCONJUGATE J, V33, P499, DOI 10.1007/s10719-016-9694-y; Horio N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07940-1; Hunter P, 2018, EMBO REP, V19, P201, DOI 10.15252/embr.201745664; Inlamea OF, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008081; Jiang Y, 2015, CURR OPIN NEUROBIOL, V34, P54, DOI 10.1016/j.conb.2015.01.014; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KOSUGE T, 1962, NATURE, V193, P776, DOI 10.1038/193776a0; Krautwurst Dietmar, 2013, Methods Mol Biol, V1003, P85, DOI 10.1007/978-1-62703-377-0_6; Kreissl J., 2019, LEIBNIZ LSB TUM ODOR; Kriventseva EV, 2019, NUCLEIC ACIDS RES, V47, pD807, DOI 10.1093/nar/gky1053; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larson G, 2014, ANNU REV ECOL EVOL S, V45, P115, DOI 10.1146/annurev-ecolsys-110512-135813; Laska M, 2009, J EXP ZOOL PART A, V311A, P278, DOI 10.1002/jez.527; LAW JH, 1971, ANNU REV BIOCHEM, V40, P533, DOI 10.1146/annurev.bi.40.070171.002533; Li F, 2013, J NEUROSCI, V33, P7975, DOI 10.1523/JNEUROSCI.5563-12.2013; Li JY, 2015, J NEUROCHEM, V134, P47, DOI 10.1111/jnc.13095; Li YY, 2018, MOLECULES, V23, DOI 10.3390/molecules23071661; Lindstrom L, 2001, P ROY SOC B-BIOL SCI, V268, P159, DOI 10.1098/rspb.2000.1344; Llaneza L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093015; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Man O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000682; Masanetz C, 1998, FLAVOUR FRAG J, V13, P115, DOI [10.1002/(SICI)1099-1026(199803/04)13:2&lt;115::AID-FFJ706&gt;3.0.CO;2-6, 10.1002/(SICI)1099-1026(199803/04)13:2<115::AID-FFJ706>3.3.CO;2-Y]; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Moine F, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0479-y; Muller R, 2010, APPL MICROBIOL BIOT, V85, P1315, DOI 10.1007/s00253-009-2362-4; Neta ERD, 2008, J FOOD SCI, V73, pC632, DOI 10.1111/j.1750-3841.2008.00948.x; Nielsen BL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00226; Niimura Yoshihito, 2009, Human Genomics, V4, P107; Noe Franziska, 2017, Journal of Biological Methods, V4, pe82, DOI 10.14440/jbm.2017.207; Noe Franziska, 2017, Journal of Biological Methods, V4, pe81, DOI 10.14440/jbm.2017.206; Noe F, 2017, CHEM SENSES, V42, P195, DOI 10.1093/chemse/bjw118; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Osada K, 2017, J CHEM ECOL, V43, P263, DOI 10.1007/s10886-017-0822-3; Osada K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00363; Osada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061753; Paudel Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1449-9; Pickett JA, 2014, BIOCHEM SOC T, V42, P846, DOI 10.1042/BST20140134; Rampin O, 2018, CHEM SENSES, V43, P105, DOI 10.1093/chemse/bjx075; REGNIER FE, 1971, BIOL REPROD, V4, P309, DOI 10.1093/biolreprod/4.3.309; Rosen JB, 2008, NEUROSCI BIOBEHAV R, V32, P1267, DOI 10.1016/j.neubiorev.2008.05.006; Rosen JB, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00292; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sahlen E, 2016, ECOL EVOL, V6, P791, DOI 10.1002/ece3.1866; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16011; Saraiva LR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0396; Saraiva LR, 2016, P NATL ACAD SCI USA, V113, pE3300, DOI 10.1073/pnas.1605973113; Sbarbati A, 2006, CELLS TISSUES ORGANS, V183, P206, DOI 10.1159/000096511; Schieberle P., 2011, CHEM FUNCTIONAL PROP, P413; Schleidt Wolfgang, 2003, Evolution and Cognition, V9, P57; Schweizer RM, 2016, MOL ECOL, V25, P357, DOI 10.1111/mec.13467; Seyfried C, 2019, J AGR FOOD CHEM, V67, P5827, DOI 10.1021/acs.jafc.8b06183; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Sievert T, 2016, CHEM SENSES, V41, P399, DOI 10.1093/chemse/bjw015; Silva EA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20953-6; Son S, 2020, GENES GENOM, V42, P1107, DOI 10.1007/s13258-020-00978-w; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Sullivan AP, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0065; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28; Wagner J, 2017, J AGR FOOD CHEM, V65, P132, DOI 10.1021/acs.jafc.6b04499; Wagner J, 2016, J AGR FOOD CHEM, V64, P8388, DOI 10.1021/acs.jafc.6b03676; Wagner R, 1999, Z LEBENSM UNTERS F A, V208, P308, DOI 10.1007/s002170050422; Wang YB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04324-3; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wyatt TD, 2017, CURR BIOL, V27, pR739, DOI 10.1016/j.cub.2017.06.039; Zhang K, 2020, ANIM GENET, V51, P637, DOI 10.1111/age.12974	95	5	5	8	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21638	10.1096/fj.202100224R	http://dx.doi.org/10.1096/fj.202100224R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34047404	hybrid			2022-12-28	WOS:000655695900061
J	Zhou, HM; Ti, Y; Wang, H; Shang, YY; Liu, YP; Ni, XN; Wang, D; Wang, ZH; Zhang, W; Zhong, M				Zhou, Hui-Min; Ti, Yun; Wang, Hui; Shang, Yuan-Yuan; Liu, Ya-Peng; Ni, Xiao-Ning; Wang, Di; Wang, Zhi-Hao; Zhang, Wei; Zhong, Ming			Cell death-inducing DFFA-like effector C/CIDEC gene silencing alleviates diabetic cardiomyopathy via upregulating AMPKa phosphorylation	FASEB JOURNAL			English	Article						AMP-activated protein kinase alpha; cell death-inducing DFFA-like effector C; diabetic cardiomyopathy; fibrosis; insulin resistance	CARDIAC-FUNCTION; ADIPOSE-TISSUE; PROTEIN-KINASE; GROWTH-FACTOR; CIDEC/FSP27; CONTRIBUTES; ADIPOCYTES; ACTIVATION; EXPRESSION; OXIDATION	Cell death-inducing DFFA-like effector C (CIDEC) is responsible for metabolic disturbance and insulin resistance, which are considered to be important triggers in the development of diabetic cardiomyopathy (DCM). To investigate whether CIDEC plays a critical role in DCM, DCM rat model was induced by a high-fat diet and a single injection of low-dose streptozotocin (27.5 mg/kg). DCM rats showed severe metabolic disturbance, insulin resistance, myocardial hypertrophy, interstitial fibrosis, ectopic lipid deposition, inflammation and cardiac dysfunction, accompanied by CIDEC elevation. With CIDEC gene silencing, the above pathophysiological characteristics were significantly ameliorated accompanied by significant improvements in cardiac function in DCM rats. Enhanced AMP-activated protein kinase (AMPK) alpha activation was involved in the underlying pathophysiological molecular mechanisms. To further explore the underlying mechanisms that CIDEC facilitated collagen syntheses in vitro, insulin-resistant cardiac fibroblast (CF) model was induced by high glucose (15.5 mmol/L) and high insulin (10(4) mu U/mL). We observed that insulin-resistant stimulation dramatically raised CIDEC expression and promoted CIDEC nuclear translocation in CFs. Meanwhile, AMPK alpha 2 was observed to distribute almost completely inside CF nucleus. The results further proved that CIDEC biochemically interacted and co-localized with AMPK alpha 2 rather than AMPK alpha 1 in CF nucleus, which provided a novel mechanism of CIDEC in promoting collagen syntheses. This study suggested that CIDEC gene silencing alleviates DCM via AMPK alpha signaling both in vivo and in vitro, implicating CIDEC may be a promising target for treatment of human DCM.	[Zhou, Hui-Min; Ti, Yun; Wang, Hui; Shang, Yuan-Yuan; Liu, Ya-Peng; Ni, Xiao-Ning; Wang, Di; Wang, Zhi-Hao; Zhang, Wei; Zhong, Ming] Chinese Natl Hlth Commiss, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Zhou, Hui-Min; Ti, Yun; Wang, Hui; Shang, Yuan-Yuan; Liu, Ya-Peng; Ni, Xiao-Ning; Wang, Di; Wang, Zhi-Hao; Zhang, Wei; Zhong, Ming] Shandong Univ, Chinese Acad Med Sci, Qilu Hosp,Cheeloo Coll Med,Dept Cardiol, State & Shandong Prov Joint Key Lab Translat Card, Jinan, Peoples R China; [Wang, Hui] Shandong Univ, Second Hosp, Cheeloo Coll Med, Dept Geriatr Med, Jinan, Peoples R China; [Wang, Zhi-Hao] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Geriatr Med, Jinan, Peoples R China; [Wang, Zhi-Hao] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Shandong Key Lab Cardiovasc Prote, Jinan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Shandong University; Shandong University; Shandong University; Shandong University	Zhong, M (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Cardiol, 107 Wen Hua Xi Rd, Jinan, Peoples R China.	zhongming2sdu@163.com			National Natural Science Foundation of China [81300168, 81900332, 81600633, 81670441]; Natural Science Foundation of Shandong Province [ZR2019QH010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	National Natural Science Foundation of China, Grant/Award Number: 81300168, 81900332, 81600633 and 81670441; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2019QH010	Athithtan L, 2019, WORLD J DIABETES, V10, P490, DOI 10.4239/wjd.v10.i10.490; Chen RF, 2018, BRIT J PHARMACOL, V175, P1217, DOI 10.1111/bph.13753; Christensen B, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0327-z; Daskalopoulos EP, 2016, J MOL CELL CARDIOL, V91, P188, DOI 10.1016/j.yjmcc.2016.01.001; Ding WY, 2012, INT J BIOCHEM CELL B, V44, P1031, DOI 10.1016/j.biocel.2012.03.013; Gao H, 2015, ARCH BIOCHEM BIOPHYS, V565, P76, DOI 10.1016/j.abb.2014.11.009; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Hu XY, 2017, COMPR PHYSIOL, V7, P693, DOI 10.1002/cphy.c160021; Jia GH, 2018, DIABETOLOGIA, V61, P21, DOI 10.1007/s00125-017-4390-4; Langhi C, 2017, J LIPID RES, V58, P81, DOI 10.1194/jlr.M069799; Mendez R, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2602; Meng LP, 2018, MOL MED REP, V17, P6887, DOI 10.3892/mmr.2018.8688; Mishra Paras K, 2017, Front Endocrinol (Lausanne), V8, P72, DOI 10.3389/fendo.2017.00072; Moreno-Navarrete JM, 2014, INT J OBESITY, V38, P865, DOI 10.1038/ijo.2013.171; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Quan DJ, 2018, MOL MED REP, V18, P5520, DOI 10.3892/mmr.2018.9566; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sharma AX, 2018, CELL REP, V22, P1760, DOI 10.1016/j.celrep.2018.01.065; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Tan XR, 2016, OBESITY, V24, P1070, DOI 10.1002/oby.21436; Tan Y, 2020, NAT REV CARDIOL, V17, P585, DOI 10.1038/s41569-020-0339-2; Ti Y, 2011, DIABETES, V60, P2963, DOI 10.2337/db11-0549; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tong MM, 2019, CIRC RES, V124, P1360, DOI 10.1161/CIRCRESAHA.118.314607; Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711; Wang ZQ, 2010, INT J OBESITY, V34, P1355, DOI 10.1038/ijo.2010.77; Xu YQ, 2015, BBA-GEN SUBJECTS, V1850, P2552, DOI 10.1016/j.bbagen.2015.09.008; Yang H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0307-5; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36	31	6	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21504	10.1096/fj.202002562R	http://dx.doi.org/10.1096/fj.202002562R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913563	hybrid			2022-12-28	WOS:000645260100032
J	Mayere, C; Neirijnck, Y; Sararols, P; Rands, CM; Stevant, I; Kuhne, F; Chassot, AA; Chaboissier, MC; Dermitzakis, ET; Nef, S				Mayere, Chloe; Neirijnck, Yasmine; Sararols, Pauline; Rands, Chris M.; Stevant, Isabelle; Kuhne, Francoise; Chassot, Anne-Amandine; Chaboissier, Marie-Christine; Dermitzakis, Emmanouil T.; Nef, Serge			Single-cell transcriptomics reveal temporal dynamics of critical regulators of germ cell fate during mouse sex determination	FASEB JOURNAL			English	Article						development; gene regulatory network; germ cells; gonocytes; meiosis; oocytes; ovary; prospermatogonia; RNA splicing; sex determination; single&#8208; cell RNA&#8208; sequencing (scRNA&#8208; seq); testis	BONE MORPHOGENETIC PROTEIN; INTRON RETENTION PROGRAM; GENE-EXPRESSION; MEIOTIC INITIATION; MESSENGER-RNA; DNA DEMETHYLATION; GENOMIC ANALYSIS; MITOTIC ARREST; ENTER MEIOSIS; DIFFERENTIATION	Despite the importance of germ cell (GC) differentiation for sexual reproduction, the gene networks underlying their fate remain unclear. Here, we comprehensively characterize the gene expression dynamics during sex determination based on single-cell RNA sequencing of 14 914 XX and XY mouse GCs between embryonic days (E) 9.0 and 16.5. We found that XX and XY GCs diverge transcriptionally as early as E11.5 with upregulation of genes downstream of the bone morphogenic protein (BMP) and nodal/Activin pathways in XY and XX GCs, respectively. We also identified a sex-specific upregulation of genes associated with negative regulation of mRNA processing and an increase in intron retention consistent with a reduction in mRNA splicing in XY testicular GCs by E13.5. Using computational gene regulation network inference analysis, we identified sex-specific, sequential waves of putative key regulator genes during GC differentiation and revealed that the meiotic genes are regulated by positive and negative master modules acting in an antagonistic fashion. Finally, we found that rare adrenal GCs enter meiosis similarly to ovarian GCs but display altered expression of master genes controlling the female and male genetic programs, indicating that the somatic environment is important for GC function. Our data are available on a web platform and provide a molecular roadmap of GC sex determination at single-cell resolution, which will serve as a valuable resource for future studies of gonad development, function, and disease.	[Mayere, Chloe; Neirijnck, Yasmine; Sararols, Pauline; Rands, Chris M.; Stevant, Isabelle; Kuhne, Francoise; Dermitzakis, Emmanouil T.; Nef, Serge] Univ Geneva, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland; [Mayere, Chloe; Stevant, Isabelle; Dermitzakis, Emmanouil T.; Nef, Serge] Univ Geneva, Inst Genet & Genom Geneva, iGE3, Geneva, Switzerland; [Neirijnck, Yasmine; Chassot, Anne-Amandine; Chaboissier, Marie-Christine] Univ Cote Azur, CNRS, INSERM, IBV, Nice, France	University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Nef, S (corresponding author), Univ Geneva, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Serge.Nef@unige.ch	Chassot, Anne-Amandine/O-2102-2016; CHABOISSIER, Marie-Christine/F-6166-2019; CHABOISSIER, Marie-Christine/AAZ-5905-2021	Chassot, Anne-Amandine/0000-0003-1242-9456; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Nef, Serge/0000-0001-5462-0676; Neirijnck, Yasmine/0000-0001-7236-8451; Dermitzakis, Emmanouil/0000-0002-9302-6490; MAYERE, Chloe/0000-0002-9254-4886; Rands, Christopher/0000-0002-8222-9364; Stevant, Isabelle/0000-0002-0193-2526	Swiss National Science Foundation [31003A_173070]; Departement de l'Instruction Publique of the State of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Departement de l'Instruction Publique of the State of Geneva	This work was supported by grants from the Swiss National Science Foundation (grant 31003A_173070) and by the Departement de l'Instruction Publique of the State of Geneva (to SN)	Adams IR, 2002, DEVELOPMENT, V129, P1155; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Boehm E, 2017, NUCLEIC ACIDS RES, V45, P6135, DOI 10.1093/nar/gkx164; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1261; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; CHEE L F, 1989, Journal of Forensic Sciences, V34, P708; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Darde TA, 2019, BIOINFORMATICS, V35, P3133, DOI 10.1093/bioinformatics/btz047; Darde TA, 2015, NUCLEIC ACIDS RES, V43, pW109, DOI 10.1093/nar/gkv345; Edwards CR, 2016, BLOOD, V127, pE24, DOI 10.1182/blood-2016-01-692764; EVANS EP, 1977, NATURE, V267, P430, DOI 10.1038/267430a0; Galvin KE, 2010, J BIOL CHEM, V285, P19747, DOI 10.1074/jbc.M109.077347; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Heeren AM, 2016, BIOL OPEN, V5, P185, DOI 10.1242/bio.013847; Hill PWS, 2018, NATURE, V555, P392, DOI 10.1038/nature25964; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Ishiguro K, 2020, DEV CELL, V52, P429, DOI 10.1016/j.devcel.2020.01.010; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jourdain AA, 2017, NUCLEIC ACIDS RES, V45, P10941, DOI 10.1093/nar/gkx772; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lebrigand K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17800-6; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; Licatalosi DD, 2016, ADV EXP MED BIOL, V907, P123, DOI 10.1007/978-3-319-29073-7_6; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; MCLAREN A, 1983, DIFFERENTIATION, V23, pS93; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Miyauchi H, 2017, EMBO J, V36, P3100, DOI 10.15252/embj.201796875; Moerman T, 2019, BIOINFORMATICS, V35, P2159, DOI 10.1093/bioinformatics/bty916; Molyneaux KA, 2004, GENE EXPR PATTERNS, V4, P167, DOI 10.1016/j.modgep.2003.09.002; MOTOKURA T, 1992, J BIOL CHEM, V267, P20412; Myers M, 2011, BIOL REPROD, V85, P1175, DOI 10.1095/biolreprod.111.091728; Nagaoka SI, 2020, SCIENCE, V367, P1089, DOI 10.1126/science.aaw4115; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Naro C, 2017, DEV CELL, V41, P82, DOI 10.1016/j.devcel.2017.03.003; Nilsson EE, 2014, REPRODUCTION, V147, P865, DOI 10.1530/REP-14-0005; Niu WB, 2020, P NATL ACAD SCI USA, V117, P20015, DOI 10.1073/pnas.2005570117; Pentek J, 2009, GENESIS, V47, P261, DOI 10.1002/dvg.20486; Pimentel H, 2016, NUCLEIC ACIDS RES, V44, P838, DOI 10.1093/nar/gkv1168; Prados J., 2018, SINGLE CELL TRANSCRI; Pushpa Kumari, 2017, Results Probl Cell Differ, V59, P175, DOI 10.1007/978-3-319-44820-6_6; Rolland AD, 2008, ADV EXP MED BIOL, V636, P16, DOI 10.1007/978-0-387-09597-4_2; Rolland AD, 2011, BIOL REPROD, V84, P790, DOI 10.1095/biolreprod.110.088443; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Soh YQS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005531; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller C, 2019, CURR TOP DEV BIOL, V134, P253, DOI 10.1016/bs.ctdb.2019.01.011; Spiller CM, 2012, INT J DEV BIOL, V56, P779, DOI 10.1387/ijdb.120142pk; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Stevant I, 2019, CELL REP, V26, P3272, DOI 10.1016/j.celrep.2019.02.069; Sudo S, 2004, J BIOL CHEM, V279, P23134, DOI 10.1074/jbc.M402376200; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Sugino Hiromu, 1997, Journal of Medical Investigation, V44, P1; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Teichmann SA., 2018, FAST BATCH ALIGNMENT; Teo CH, 2010, J MACH LEARN RES, V11, P311; Thijssen R., 2020, COMPREHENSIVE CHARAC; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584; Vanhoutteghem A, 2014, DEVELOPMENT, V141, P4298, DOI 10.1242/dev.112888; Vernet N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1139; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wang AHJ, 2017, MOL CELL, V68, P398, DOI 10.1016/j.molcel.2017.09.016; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Wu J, 2017, BRIT J CANCER, V117, P675, DOI 10.1038/bjc.2017.204; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2006, BIOL REPROD, V74, P978, DOI 10.1095/biolreprod.105.050286; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; ZAMBONI L, 1983, J EXP ZOOL, V228, P173, DOI 10.1002/jez.1402280204; Zou C, 2021, CELL MOL LIFE SCI, V78, P117, DOI 10.1007/s00018-020-03593-w	99	15	15	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21452	10.1096/fj.202002420R	http://dx.doi.org/10.1096/fj.202002420R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749946	Green Published, Green Submitted			2022-12-28	WOS:000635216100080
J	Saito, K; Mori, M; Kambara, N; Ohta, Y				Saito, Koji; Mori, Mamiko; Kambara, Norito; Ohta, Yasutaka			FilGAP, a GAP protein for Rac, regulates front-rear polarity and tumor cell migration through the ECM	FASEB JOURNAL			English	Article						Arf6; breast cancer; ECM; PIP3; Rho GTPase		Migrating tumor cells are characterized by a sustained front-rear asymmetry, with a front enriched in filamentous actin, which is induced by Rho small GTPase Rac. Regulation of Rac activity by its regulators should be required for effective motility. Here, we show that FilGAP, a GTPase-activating protein (GAP) for Rac, controls front-rear polarity and contributes to maintain effective tumor cell migration through the extracellular matrix (ECM). Overexpression of FilGAP in breast cancer cells induced polarized morphology and led to increased migration speed in collagen matrices, while depletion of FilGAP impaired the cell polarity and migration. FilGAP localizes to the cell front through its pleckstrin-homology (PH) domain in a phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent manner and appears to inactivate Rac at its site. We found that the affinity of PH domain to PIP3 is critically involved in the maintenance of cell polarity. Moreover, small GTPase ADP-ribosylation factor 6 (Arf6), which binds to the FilGAP PH domain, also regulates FilGAP-mediated cell polarity and migration of breast cancer cells. We propose that FilGAP regulates front-rear polarity through its PIP3 and Arf6 binding in tumor cell migration through the ECM.	[Saito, Koji; Mori, Mamiko; Kambara, Norito; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa, Japan	Kitasato University	Saito, K; Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	k-saito@kitasato-u.ac.jp; yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22700885, 22570192]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 22700885 and 22570192	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Campa Carlo C, 2015, Small GTPases, V6, P71, DOI 10.4161/21541248.2014.989789; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; Costa C, 2011, BLOOD, V118, P1099, DOI 10.1182/blood-2010-12-324756; Dai XP, 2018, MED SCI MONITOR, V24, P8669, DOI 10.12659/MSM.911394; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Feng M, 2014, J CLIN INVEST, V124, P5291, DOI 10.1172/JCI76711; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fritz Rafael Dominik, 2016, F1000Res, V5, DOI 10.12688/f1000research.7370.1; Graziano BR, 2017, J CELL BIOL, V216, P2515, DOI 10.1083/jcb.201604113; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Halet G, 2005, BIOL CELL, V97, P501; Hara A, 2016, CANCER MED-US, V5, P3412, DOI 10.1002/cam4.937; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ishihara S, 2013, FEBS LETT, V587, P732, DOI 10.1016/j.febslet.2013.01.055; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lien EC, 2017, CURR OPIN CELL BIOL, V45, P62, DOI 10.1016/j.ceb.2017.02.007; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Morishita Y, 2015, J BIOL CHEM, V290, P26328, DOI 10.1074/jbc.M115.666875; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nishi T, 2015, CANCER MED-US, V4, P808, DOI 10.1002/cam4.423; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pan SL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0707-6; Pandya P, 2017, MOL ONCOL, V11, P5, DOI 10.1002/1878-0261.12019; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Remorino A, 2017, CELL REP, V21, P1922, DOI 10.1016/j.celrep.2017.10.069; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Saito K, 2015, CYTOSKELETON, V72, P146, DOI 10.1002/cm.21211; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Sun Z, 2017, CANCER SCI, V108, P61, DOI 10.1111/cas.13118; Takagi K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030804; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Uehara S, 2017, ANTICANCER RES, V37, P4837, DOI 10.21873/anticanres.11891; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wang L, 2017, MOL BIOSYST, V13, P2564, DOI 10.1039/c7mb00406k; Xu GS, 2016, ONCOTARGET, V7, P51829, DOI 10.18632/oncotarget.10386; Yamada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146593; Yamazaki D, 2013, MOL BIOL CELL, V24, P3393, DOI 10.1091/mbc.E13-04-0178	68	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21508	10.1096/fj.202002155R	http://dx.doi.org/10.1096/fj.202002155R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710706				2022-12-28	WOS:000635216100012
J	Shi, FF; Feng, XZ				Shi, Feifei; Feng, Xizeng			Decabromodiphenyl ethane exposure damaged the asymmetric division of mouse oocytes by inhibiting the inactivation of cyclin-dependent kinase 1	FASEB JOURNAL			English	Article						asymmetric division; blastocyst; cyclin&#8208; dependent kinase 1; decabromodiphenyl ethane; oocyte	BROMINATED FLAME RETARDANTS; POLYBROMINATED DIPHENYL ETHERS; ADVERSE PREGNANCY OUTCOMES; SPINDLE MIGRATION; ENVIRONMENTAL EXPOSURES; DIETARY EXPOSURE; CAR DUST; LEGACY; PBDES; AIR	Decabromodiphenyl ethane (DBDPE) is a new brominated flame retardant and is widely added to flammable materials to prevent fire. Because it has been continuously detected in a variety of organisms and humans, it is important to reveal the biological toxicity of DBDPE. However, the influence of DBDPE for female reproduction is unclear. In this study, we investigated whether and how DBDPE exposure affects oocyte development. Female mice as a model were orally exposed to DBDPE by 0, 0.05, 0.5, 5, 50 mu g/kg bw/day for 30 days (0.05 mu g/kg bw/day is close to the environmental exposure concentration). We found that exposure of mice to DBDPE did not affect the first polar body extrusion (PBE) of oocytes. Strikingly, however, asymmetric division of oocytes was markedly impaired in 5 and 50 mu g/kg bw/day DBDPE exposed group, which resulted in oocytes with larger polar bodies (PBs). Then, we further explored and found that DBDPE exposure inhibited the spindle migration and membrane protrusion in oocytes during anaphase of meiosis I (anaphase I), thereby impairing asymmetric division. Additionally, we found that DBDPE exposure suppressed the inactivation of cyclin-dependent kinase 1 (Cdk1), resulting in the decrease of cytoplasmic formin2 (FMN2)-mediated F-actin polymerization in oocytes at the onset of anaphase I. Simultaneously, DBDPE exposure damaged the structural integrity of the spindle and the perpendicular relationship between spindle and cortex. These together led to the failure of spindle migration and membrane protrusion required for oocytes asymmetric division. Finally, DBDPE exposure injured the development of blastocysts, leading to blastocyst apoptosis.	[Shi, Feifei; Feng, Xizeng] Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, Minist Educ,State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University	Feng, XZ (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, Minist Educ,State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	xzfeng@nankai.edu.cn			National Natural Science Foundation of China (NSFC) [U1613220,61633012]; National Key R&D Program of China [2019YFB1309704]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: U1613220,61633012; National Key R&D Program of China, Grant/Award Number: 2019YFB1309704	Adhikari D, 2016, CELL RES, V26, P1212, DOI 10.1038/cr.2016.119; Al-Omran LS, 2018, CHEMOSPHERE, V193, P1105, DOI 10.1016/j.chemosphere.2017.11.147; Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Besis A, 2017, ENVIRON POLLUT, V230, P871, DOI 10.1016/j.envpol.2017.07.032; Bu QW, 2019, ENVIRON INT, V122, P159, DOI 10.1016/j.envint.2018.11.005; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Chen T, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105179; de la Torre A, 2018, SCI TOTAL ENVIRON, V630, P154, DOI 10.1016/j.scitotenv.2018.02.199; Duan X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14068-3; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Feng X., ECOTOX ENVIRON SAFE, V207; He MJ, 2012, SCI TOTAL ENVIRON, V419, P109, DOI 10.1016/j.scitotenv.2011.12.035; Hu GC, 2010, J ENVIRON SCI, V22, P1833, DOI 10.1016/S1001-0742(09)60328-4; Jing L, 2019, CHEMOSPHERE, V223, P675, DOI 10.1016/j.chemosphere.2019.02.115; Kalachova K, 2012, SCI TOTAL ENVIRON, V441, P182, DOI 10.1016/j.scitotenv.2012.09.061; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; McGrath TJ, 2018, ENVIRON INT, V113, P191, DOI 10.1016/j.envint.2018.01.026; McGrath TJ, 2017, ENVIRON POLLUT, V230, P741, DOI 10.1016/j.envpol.2017.07.009; Moller A, 2011, ENVIRON POLLUT, V159, P1577, DOI 10.1016/j.envpol.2011.02.054; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Shen KH, 2019, ENVIRON POLLUT, V250, P79, DOI 10.1016/j.envpol.2019.03.090; Shi ZX, 2016, ENVIRON INT, V96, P82, DOI 10.1016/j.envint.2016.09.005; Silbergeld EK, 2005, AM J OBSTET GYNECOL, V192, pS11, DOI 10.1016/j.ajog.2004.06.117; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; Sun RB, 2018, BIOMED ENVIRON SCI, V31, P12, DOI 10.3967/bes2018.002; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; Sun YM, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135783; Svitkina Tatyana, 2018, Cold Spring Harb Perspect Biol, V10, DOI 10.1101/cshperspect.a018267; Tao F, 2016, ENVIRON SCI TECHNOL, V50, P13052, DOI 10.1021/acs.est.6b02816; Tay JH, 2018, ENVIRON INT, V115, P285, DOI 10.1016/j.envint.2018.03.038; Venkatesan AK, 2014, WATER RES, V55, P133, DOI 10.1016/j.watres.2014.02.021; Wang FX, 2010, ENVIRON SCI TECHNOL, V44, P5655, DOI 10.1021/es101158e; Wang XC, 2019, ENVIRON SCI TECHNOL, V53, P8437, DOI 10.1021/acs.est.9b02831; Wei Z, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17088-6; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06510-9; Xie BT, 2018, CELL RES, V28, P462, DOI 10.1038/s41422-018-0009-7; Zhang K, 2015, REPROD FERT DEVELOP, V27, P880, DOI 10.1071/RD14441; Zhang SZ, 2020, CHEMOSPHERE, V245, DOI 10.1016/j.chemosphere.2019.125679; Zhou CX, 2019, J CELL SCI, V132, DOI 10.1242/jcs.233379	44	5	6	5	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21449	10.1096/fj.202002585R	http://dx.doi.org/10.1096/fj.202002585R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724544				2022-12-28	WOS:000635216100084
J	Wang, XZ; Liu, ZY; Sun, JJ; Song, X; Bian, MX; Wang, FK; Yan, F; Yu, ZY				Wang, Xinzhao; Liu, Zhaoyun; Sun, Jujie; Song, Xiang; Bian, Mengxue; Wang, Fukai; Yan, Feng; Yu, Zhiyong			Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer	FASEB JOURNAL			English	Article						breast cancer; lymphangiogenesis; metastasis; Nox4	C-INDUCED LYMPHANGIOGENESIS; LYMPH-NODE METASTASIS; NOX4; CELLS; BEVACIZUMAB; EXPRESSION; GENERATION; INDUCTION; PROGNOSIS; DENSITY	Lymphangiogenesis is thought to contribute to promote tumor cells to enter lymphatic vessels and plant at a secondary site. Endothelial cells are the cornerstone of the generation of new lymphatic vessels. NADPH oxidase 4 (Nox4) is the most abundant one of NADPH oxidases in endothelial cells and the most studied one in relevance with cancer. Our purpose is to analyze the relationship between Nox4 and lymphangiogenesis and find out whether the newborn lymphatic vessels lead to cancer metastasis. We first explored the expression of Nox4 in lymphatic endothelial cells of primary invasive breast tumors and human normal mammary glands using GEO databases and found that Nox4 was upregulated in primary invasive breast tumors samples. In addition, its high expression correlated with lymph node metastasis in breast cancer patients. Nox4 could increase the tube formation and lymphatic vessel sprouting in a three-dimensional setting. In vivo, inhibition of Nox4 in 4T1 tumor-bearing mice could significantly decrease the tumor lymphangiogenesis and metastasis. Nox4 may increase tumor lymphangiogenesis via ROS/ERK/CCL21 pathway and attract CCR7-positive breast cancer cells to entry lymphatic vessels and distant organs. In conclusion, our results show that Nox4 is a factor that promotes lymphangiogenesis and is a potential target of antitumor metastasis.	[Wang, Xinzhao; Liu, Zhaoyun] Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R China; [Wang, Xinzhao; Liu, Zhaoyun; Sun, Jujie; Song, Xiang; Bian, Mengxue; Wang, Fukai; Yu, Zhiyong] Shandong First Med Univ, Shandong Canc Hosp & Inst, Breast Canc Ctr, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China; [Wang, Xinzhao; Liu, Zhaoyun; Sun, Jujie; Song, Xiang; Bian, Mengxue; Wang, Fukai; Yu, Zhiyong] Shandong Acad Med Sci, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China; [Yan, Feng] Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Emergency Med, Jinan 250012, Shandong, Peoples R China; [Yan, Feng] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Jinan, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong University	Yu, ZY (corresponding author), Shandong First Med Univ, Shandong Canc Hosp & Inst, Breast Canc Ctr, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.; Yu, ZY (corresponding author), Shandong Acad Med Sci, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.; Yan, F (corresponding author), Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Emergency Med, Jinan 250012, Shandong, Peoples R China.	yanfeng@sdu.edu.cn; drzhiyongyu@aliyun.com		Yan, Feng/0000-0002-2756-3167	Natural Science Foundation of Shandong Province [ZR2017PH055, ZR2019MH109, ZR2016HB11]; National Natural Science Foundation of China [81601721]; Key Research and Development Program of Shandong Province [2018GSF118089]; Medical and Health Development Plan of Shandong Province [2016WS0556]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shandong Province; Medical and Health Development Plan of Shandong Province	Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2017PH055, ZR2019MH109 and ZR2016HB11; National Natural Science Foundation of China, Grant/Award Number: 81601721; Key Research and Development Program of Shandong Province, Grant/Award Number: 2018GSF118089; Medical and Health Development Plan of Shandong Province, Grant/Award Number: 2016WS0556	Bonner MY, 2012, CELL MOL LIFE SCI, V69, P2435, DOI 10.1007/s00018-012-1017-2; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chen YH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120497; Du SC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0953-7; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Gregg JL, 2014, CANCER RES, V74, P3501, DOI 10.1158/0008-5472.CAN-13-2979; Guo SH, 2015, J DRUG TARGET, V23, P888, DOI 10.3109/1061186X.2015.1036276; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lala PK, 2018, CANCER METAST REV, V37, P369, DOI 10.1007/s10555-018-9734-0; Lee E, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.2; Li XY, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101373; Lin HY, 2017, INT IMMUNOPHARMACOL, V51, P124, DOI 10.1016/j.intimp.2017.07.018; Lin XL, 2017, ONCOTARGET, V8, P33586, DOI 10.18632/oncotarget.16829; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Nagahashi M, 2010, WORLD J GASTROENTERO, V16, P4003, DOI 10.3748/wjg.v16.i32.4003; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Nathanson SD, 2000, ARCH SURG-CHICAGO, V135, P586, DOI 10.1001/archsurg.135.5.586; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Shimada K, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-22; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Srour MK, 2020, BREAST J, V26, P904, DOI 10.1111/tbj.13684; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tang CT, 2018, CELL SIGNAL, V46, P52, DOI 10.1016/j.cellsig.2018.02.007; Tutunea-Fatan E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0306-4; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; WEIDNER N, 1995, AM J PATHOL, V147, P9; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Zhang B, 2013, BIOCHEM PHARMACOL, V86, P253, DOI 10.1016/j.bcp.2013.05.011; Zhang CX, 2014, ONCOTARGET, V5, P4392, DOI 10.18632/oncotarget.2025	36	9	9	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21531	10.1096/fj.202002533R	http://dx.doi.org/10.1096/fj.202002533R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769605				2022-12-28	WOS:000635216100034
J	Zhang, SK; Liu, BH; Wang, WJ; Lv, LY; Gao, DQ; Chai, M; Li, MS; Wu, ZH; Zhu, YP; Ma, J; Leng, L				Zhang, Shikun; Liu, Binghui; Wang, Wenjuan; Lv, Luye; Gao, Dunqin; Chai, Mi; Li, Mansheng; Wu, Zhihong; Zhu, Yunping; Ma, Jie; Leng, Ling			The "Matrisome" reveals the characterization of skin keloid microenvironment	FASEB JOURNAL			English	Article						biomatrix scaffold; extracellular matrix; keloid; matrisome; skin		Keloids are fibroproliferative dermal tumors of unknown origin that are characterized by the overabundant accumulation of extracellular matrix (ECM) components. The mechanism of keloid formation has remained unclear because of a poor understanding of its molecular basis. In this study, the dermal ECM components of keloids were identified and the pathological features of keloid formation were characterized using large-scale quantitative proteomic analyses of decellularized keloid biomatrix scaffolds. We identified a total of 267 dermal core ECM and ECM-associated proteins that were differentially expressed between patients with keloids and healthy controls. Skin mechanical properties and biological processes including protease activity, wound healing, and adhesion were disordered in keloids. The integrated network analysis of the upregulated ECM proteins revealed multiple signaling pathways involved in these processes that may lead to keloid formation. Our findings may improve the scientific basis of keloid treatment and provide new ideas for the establishment of keloid models.	[Zhang, Shikun; Gao, Dunqin; Wu, Zhihong; Leng, Ling] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Translat Med Ctr, Stem Cell & Regenerat Med Lab,Dept Med Sci,Res Ct, Beijing, Peoples R China; [Zhang, Shikun] Inst Hlth Serv & Transfus Med, Dept Stem Cell & Regenerat Med Lab, Beijing, Peoples R China; [Liu, Binghui; Li, Mansheng; Zhu, Yunping; Ma, Jie] Beijing Inst Life Om, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Wang, Wenjuan] Chinese Peoples Liberat Army Gen Hosp, Dept Dermatol, Beijing, Peoples R China; [Lv, Luye] Inst NBC Def, Beijing, Peoples R China; [Chai, Mi] Chinese Peoples Liberat Army Gen Hosp, Dept Plast & Reconstruct Surg, Beijing, Peoples R China; [Zhu, Yunping] Anhui Med Univ, Basic Med Sch, Hefei, Anhui, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Anhui Medical University	Ma, J (corresponding author), Beijing Inst Life Om, Natl Ctr Prot Sci Beijing, 38 Life Sci Pk Rd, Beijing 102206, Peoples R China.; Leng, L (corresponding author), Peking Union Med Coll Hosp, Dept Med Sci, Res Ctr, Stem Cell & Regenerat Med Lab, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.	majie@ncpsb.org.cn; lengling@pumch.cn	leng, ling/GQH-2273-2022; Li, Mansheng/AAA-7127-2022; wu, zhi/GXH-3041-2022	Li, Mansheng/0000-0002-0778-0965; Ma, Jie/0000-0002-8934-922X; Leng, Ling/0000-0002-6519-012X	National Key Research and Development Program of China [2016YFB0201702, 2016YFC0901701]	National Key Research and Development Program of China	the National Key Research and Development Program of China, Grant/Award Number: 2016YFB0201702 and 2016YFC0901701	Al-Attar A, 2006, PLAST RECONSTR SURG, V117, P286, DOI 10.1097/01.prs.0000195073.73580.46; Amadeu TP, 2004, WOUND REPAIR REGEN, V12, P169, DOI 10.1111/j.1067-1927.2004.012209.x; Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Andrews JP, 2016, MATRIX BIOL, V51, P37, DOI 10.1016/j.matbio.2016.01.013; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badr G, 2012, J NUTR BIOCHEM, V23, P1640, DOI 10.1016/j.jnutbio.2011.11.006; Bagabir RA, 2011, J INVEST DERMATOL, V131, P2128, DOI 10.1038/jid.2011.163; Bijnen M, 2018, GUT, V67, P1317, DOI 10.1136/gutjnl-2016-313654; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; Chua AWC, 2011, J DERMATOL SCI, V64, P199, DOI 10.1016/j.jdermsci.2011.09.008; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fernandes RJ, 2007, MATRIX BIOL, V26, P597, DOI 10.1016/j.matbio.2007.06.007; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200; Gragnani A, 2010, ARCH DERMATOL RES, V302, P1, DOI 10.1007/s00403-009-0983-1; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Inui S, 2011, AM J PATHOL, V179, P1951, DOI 10.1016/j.ajpath.2011.06.034; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jiao H, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00885; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang JS, 2008, ZOOL SCI, V25, P912, DOI 10.2108/zsj.25.912; Kang N, 2006, J PLAST RECONSTR AES, V59, P693, DOI 10.1016/j.bjps.2005.11.022; Kirkness MWH, 2019, CURR OPIN CHEM BIOL, V53, P98, DOI 10.1016/j.cbpa.2019.08.001; Li HW, 2013, JAMA FACIAL PLAST SU, V15, P448, DOI 10.1001/jamafacial.2013.1211; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02422; Liu CJ, 2003, SCAND J PLAST RECONS, V37, P321, DOI 10.1080/02844310310004677; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Ma LJ, 2014, BURNS TRAUMA, V2, DOI 10.4103/2321-3868.130191; Maccarana M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184028; MARTIN GR, 1984, CIBA F SYMP, V108, P197; Muncie JM, 2018, CURR TOP DEV BIOL, V130, P1, DOI 10.1016/bs.ctdb.2018.02.002; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Rasi K, 2010, CIRC RES, V107, P1241, DOI 10.1161/CIRCRESAHA.110.222133; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sayani K, 2000, HISTOPATHOLOGY, V36, P262; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih Barbara, 2010, Eplasty, V10, pe24; Shmoilov AM, 2006, J DRUG DELIV SCI TEC, V16, P285, DOI 10.1016/S1773-2247(06)50052-8; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Son ED, 2005, J INVEST DERMATOL, V124, P1149, DOI 10.1111/j.0022-202X.2005.23736.x; Suarez E, 2015, ARCH DERMATOL RES, V307, P115, DOI 10.1007/s00403-014-1512-4; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tan JL, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0016-6; Tredget EE, 2014, SURG CLIN N AM, V94, P793, DOI 10.1016/j.suc.2014.05.005; Ulrich D, 2010, J PLAST RECONSTR AES, V63, P1015, DOI 10.1016/j.bjps.2009.04.021; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Wang WJ, 2020, BIOCHEM BIOPH RES CO, V524, P567, DOI 10.1016/j.bbrc.2020.01.131; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xia W, 2006, AM J PHYSIOL-REG I, V290, pR501, DOI 10.1152/ajpregu.00472.2005; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485	65	3	3	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21237	10.1096/fj.202001660RR	http://dx.doi.org/10.1096/fj.202001660RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715180				2022-12-28	WOS:000635216100031
J	Velingkaar, N; Mezhnina, V; Poe, A; Kondratov, RV				Velingkaar, Nikkhil; Mezhnina, Volha; Poe, Allan; Kondratov, Roman, V			Two-meal caloric restriction induces 12-hour rhythms and improves glucose homeostasis	FASEB JOURNAL			English	Article						aging; metabolism; diet; circadian rhythms; gene expression; glucose homeostasis; 12&#8208; hour rhythms	PERIPHERAL CIRCADIAN CLOCKS; MTOR SIGNALING PATHWAY; DIETARY RESTRICTION; FOOD-INTAKE; LIFE-SPAN; METABOLISM; LIVER; TIME; GROWTH; MICE	Glucose metabolism is tightly regulated and disrupting glucose homeostasis is a hallmark of many diseases. Caloric restriction (CR), periodic fasting, and circadian rhythms are interlinked with glucose metabolism. Here, we directly investigated if CR depends on periodic fasting and circadian rhythms to improve glucose metabolism. CR was implemented as two-meals per day (2M-CR), provided at 12-hour intervals, and compared with one meal per day CR, mealtime (MT), and ad libitum (AL) feeding. The 2M-CR impacted the circadian rhythms in blood glucose, metabolic signaling, circadian clock, and glucose metabolism gene expression. 2M-CR significantly reduced around the clock blood glucose and improved glucose tolerance. Twenty-four-hour rhythms in mTOR signaling and gene expression observed under AL, MT, and CR, became 12-hour rhythms in 2M-CR. The 12-hour rhythms in behavior, gene expression, and signaling persisted in fasted mice, implicating some internal regulation. The study highlights that the reduction in caloric intake rather than meal frequency and duration of fasting is essential for metabolic reprograming and improvement in glucose metabolism and provides evidence on food-entrained molecular pacemaker, which can be uncoupled from the light-entrained circadian clock and rhythms.	[Velingkaar, Nikkhil; Mezhnina, Volha; Poe, Allan; Kondratov, Roman, V] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Velingkaar, Nikkhil; Mezhnina, Volha; Poe, Allan; Kondratov, Roman, V] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Velingkaar, N; Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.; Velingkaar, N; Kondratov, RV (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.	n.velingkaar@vikes.csuohio.edu; r.kondratov@csuohio.edu	Velingkaar, Nikkhil/ABC-8132-2020	Velingkaar, Nikkhil/0000-0003-1571-0833; Mezhnina, Volha/0000-0001-9634-0410	NIA NIH HHS [R01 AG039547] Funding Source: Medline; NIH HHS [S10 OD025252] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Aguilar-Arnal L, 2015, P NATL ACAD SCI USA, V112, P6863, DOI 10.1073/pnas.1411264111; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao R, 2013, NEURON, V79, P712, DOI 10.1016/j.neuron.2013.06.026; Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chavan R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10580; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Greenwell BJ, 2019, CELL REP, V27, P649, DOI 10.1016/j.celrep.2019.03.064; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamming DW, 2011, CELL METAB, V13, P617, DOI 10.1016/j.cmet.2011.05.006; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mitchell SJ, 2019, CELL METAB, V29, P221, DOI 10.1016/j.cmet.2018.08.011; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mukherji A, 2015, P NATL ACAD SCI USA, V112, pE6683, DOI 10.1073/pnas.1519735112; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Patel SA, 2016, FASEB J, V30, P1634, DOI 10.1096/fj.15-282475; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Ray S, 2020, SCIENCE, V367, P800, DOI 10.1126/science.aaw7365; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Solovev I, 2019, BIOGERONTOLOGY, V20, P159, DOI 10.1007/s10522-018-9784-2; Sutton EF, 2018, CELL METAB, V27, P1212, DOI 10.1016/j.cmet.2018.04.010; Taormina G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/308690; Tognini P, 2017, CELL METAB, V26, P523, DOI 10.1016/j.cmet.2017.08.015; Tulsian R, 2018, AGING-US, V10, P1640, DOI 10.18632/aging.101498; Ulgherait M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15617-x; Velingkaar N, 2020, AGING CELL, V19, DOI 10.1111/acel.13138; Wu R, 2019, CELL METAB, V29, P653, DOI 10.1016/j.cmet.2018.11.006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	54	1	1	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21342	10.1096/fj.202002470R	http://dx.doi.org/10.1096/fj.202002470R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33543540	hybrid, Green Published			2022-12-28	WOS:000647789600033
J	Li, MD; Sun, FR; Qian, JF; Chen, LT; Li, DJ; Wang, SC; Du, MR				Li, Mengdie; Sun, Fengrun; Qian, Jinfeng; Chen, Lanting; Li, Dajin; Wang, Songcun; Du, Meirong			Tim-3/CTLA-4 pathways regulate decidual immune cells-extravillous trophoblasts interaction by IL-4 and IL-10	FASEB JOURNAL			English	Article						CTLA-4; decidual immune cells; extravillous trophoblasts; maternal-fetal crosstalk; Tim-3	MATERNAL-FETAL TOLERANCE; T-CELLS; INVASION; PREGNANCY; PD-1	To obtain a successful pregnancy, the establishment of maternal-fetal tolerance and successful placentation are required to be established. Disruption of this immune balance and/or inadequate placental perfusion is believed to be associated with a lot of pregnancy-related complications, such as recurrent spontaneous abortion, pre-eclampsia, and fetal intrauterine growth restriction. Extravillous trophoblasts (EVTs) have the unique ability to instruct decidual immune cells (DICs) to develop a regulatory phenotype for fetal tolerance. Utilizing immortalized human first trimester extravillous trophoblast cells and primary EVTs, we found that DICs promote EVT function and placental development. We have previously shown that checkpoints T-cell immunoglobulin mucin-3 (Tim-3) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are important for DIC function. In the present study, we showed that blockade of Tim-3 and CTLA-4 pathways leaded to the abnormal DICs-EVTs interaction, poor placental development, and increased fetal loss. Treatment with IL-4 and IL-10 could rescue the adverse effects of targeting Tim-3 and CTLA-4 on the pregnancy outcome. Hence, the reproductive safety must be a criterion considered in the assessment of immuno-therapeutic agents. In addition, IL-4 and IL-10 may represent novel therapeutic strategies to prevent pregnancy loss induced by checkpoint inhibition.	[Li, Mengdie; Sun, Fengrun; Qian, Jinfeng; Chen, Lanting; Li, Dajin; Wang, Songcun; Du, Meirong] Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol,Hosp Obstet & Gynecol, Key Lab Reprod Regulat NPFPC,SIPPR,IRD,Shanghai K, Shanghai, Peoples R China	Fudan University	Wang, SC; Du, MR (corresponding author), Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol, NHC Key Lab Reprod Regulat,Hosp Obstet & Gynecol, 1326 Pingliang Rd, Shanghai 200080, Peoples R China.	songcunwang@fudan.edu.cn; mrdu@fudan.edu.cn		Wang, Songcun/0000-0001-6484-4358	National Nature Science Foundation of China [81630036, 91542116, 31570920, 31700799]; National Key R&D Program of China [2017YFC1001403, 2017YFC1001404]; Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine; Ferring Pharmaceuticals; Chinese Academy of Sciences [FIRMX200504]; Innovation-oriented Science and Technology Grant from NPFPC Key Laboratory of Reproduction Regulation [CX2017-2]; Training Program for Young Talents of Shanghai Health System [2018YQ07]; Shanghai Chenguang Program [18CG09]; Development Fund of Shanghai Talents [2018110]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine(Ferring Pharmaceuticals); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Chinese Academy of Sciences(Chinese Academy of Sciences); Innovation-oriented Science and Technology Grant from NPFPC Key Laboratory of Reproduction Regulation; Training Program for Young Talents of Shanghai Health System; Shanghai Chenguang Program; Development Fund of Shanghai Talents	National Nature Science Foundation of China, Grant/Award Number: 81630036, 91542116, 31570920 and 31700799; National Key R&D Program of China, Grant/Award Number: 2017YFC1001403 and 2017YFC1001404; The Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine; Ferring Pharmaceuticals; Chinese Academy of Sciences, Grant/Award Number: FIRMX200504; Innovation-oriented Science and Technology Grant from NPFPC Key Laboratory of Reproduction Regulation, Grant/Award Number: CX2017-2; Training Program for Young Talents of Shanghai Health System, Grant/Award Number: 2018YQ07; Shanghai Chenguang Program, Grant/Award Number: 18CG09; Development Fund of Shanghai Talents, Grant/Award Number: 2018110	Al-Khan A, 2013, PLACENTA, V34, pS11, DOI 10.1016/j.placenta.2012.11.018; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bucheit AD, 2020, MELANOMA RES, V30, P423, DOI 10.1097/CMR.0000000000000657; Du MR, 2014, J IMMUNOL, V192, P1502, DOI 10.4049/jimmunol.1203425; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kudo M, 2017, ONCOLOGY-BASEL, V93, P147, DOI 10.1159/000481245; Lash GE, 2006, FASEB J, V20, P2512, DOI 10.1096/fj.06-6616com; Li YH, 2016, CELL MOL IMMUNOL, V13, P73, DOI 10.1038/cmi.2014.126; Li YH, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4323; Lissauer D, 2015, EUR J IMMUNOL, V45, P2858, DOI 10.1002/eji.201445404; Liu S, 2017, J REPROD IMMUNOL, V124, P44, DOI 10.1016/j.jri.2017.10.045; Ma C, 2021, MOL CELL BIOCHEM, V476, P2989, DOI 10.1007/s11010-021-04137-x; Matthiesen L, 2012, AM J REPROD IMMUNOL, V67, P334, DOI 10.1111/j.1600-0897.2012.01121.x; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Qiu YQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002984; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Sasso E, 2018, MABS-AUSTIN, V10, P1060, DOI 10.1080/19420862.2018.1496772; Solano ME, 2019, BEST PRACT RES CL OB, V60, P3, DOI 10.1016/j.bpobgyn.2019.05.009; Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536; Wang SC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1642-x; Wang SC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1251-0; Wang SC, 2016, HUM REPROD, V31, P700, DOI 10.1093/humrep/dew019; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112; Zhang H, 2013, HUM REPROD, V28, P2350, DOI 10.1093/humrep/det258; Zhou GY, 2017, GASTROENTEROLOGY, V153, P1107, DOI 10.1053/j.gastro.2017.06.017	27	5	5	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21754	10.1096/fj.202100142R	http://dx.doi.org/10.1096/fj.202100142R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34191338				2022-12-28	WOS:000678975300006
J	Li, Y; Dong, JL; Xiao, HW; Wang, B; Chen, ZY; Zhang, SQ; Jin, YX; Li, YL; Fan, SJ; Cui, M				Li, Yuan; Dong, Jiali; Xiao, Huiwen; Wang, Bin; Chen, Zhiyuan; Zhang, Shuqin; Jin, Yuxiao; Li, Yiliang; Fan, Saijun; Cui, Ming			Caloric restriction alleviates radiation injuries in a sex-dependent fashion	FASEB JOURNAL			English	Article						caloric restriction; intestinal microbiota; radiation injury; sex-specific	DIETARY RESTRICTION; DIMORPHISM; CANCER; MECHANISMS; PROTECTS; LIVER	Safe and effective regimens are still needed given the risk of radiation toxicity from iatrogenic irradiation. The gut microbiota plays an important role in radiation damage. Diet has emerged as a key determinant of the intestinal microbiome signature and function. In this report, we investigated whether a 30% caloric restriction (CR) diet may ameliorate radiation enteritis and hematopoietic toxicity. Experimental mice were either fed ad libitum (AL) or subjected to CR preconditioning for 10 days and then exposed to total body irradiation (TBI) or total abdominal irradiation (TAI). Gross examinations showed that short-term CR pretreatment restored hematogenic organs and improved the intestinal architecture in both male and female mice. Intriguingly, CR preconditioning mitigated radiation-induced systemic and enteric inflammation in female mice, while gut barrier function improved in irradiated males. 16S rRNA high-throughput sequencing showed that the frequency of pro-inflammatory microbes, including Helicobacter and Desulfovibrionaceae, was reduced in female mice after 10 days of CR preconditioning, while an enrichment of short-chain fatty acid (SCFA)-producing bacteria, such as Faecalibaculum, Clostridiales, and Lactobacillus, was observed in males. Using fecal microbiota transplantation (FMT) or antibiotic administration to alter the gut microbiota counteracted the short-term CR-elicited radiation tolerance of both male and female mice, further indicating that the radioprotection of a 30% CR diet depends on altering the gut microbiota. Together, our findings provide new insights into CR in clinical applications and indicate that a short-term CR diet prior to radiation modulates sex-specific gut microbiota configurations, protecting male and female mice against the side effects caused by radiation challenge.	[Li, Yuan; Dong, Jiali; Wang, Bin; Chen, Zhiyuan; Zhang, Shuqin; Li, Yiliang; Fan, Saijun; Cui, Ming] Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin 300192, Peoples R China; [Xiao, Huiwen] Nankai Univ, Dept Microbiol, Coll Life Sci, Tianjin, Peoples R China; [Jin, Yuxiao] Soochow Univ, Dept Gen Surg, Affiliated Hosp 2, Suzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College; Nankai University; Soochow University - China	Fan, SJ; Cui, M (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin 300192, Peoples R China.	fansaijun@irm-cams.ac.cn; cuiming0403@bjmu.edu.cn			Science Foundation for Distinguished Young Scholars of Tianjin [20JCJQJC00100]; Natural Science Foundation of China [82003399, 81872555, 81730086]	Science Foundation for Distinguished Young Scholars of Tianjin; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Science Foundation for Distinguished Young Scholars of Tianjin, Grant/Award Number: 20JCJQJC00100; Natural Science Foundation of China, Grant/Award Number: 82003399, 81872555 and 81730086	Bae MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32225; Baruch EN, 2021, SCIENCE, V371, P602, DOI 10.1126/science.abb5920; Bonilla MD, 2019, INT J RADIAT ONCOL, V105, P537, DOI 10.1016/j.ijrobp.2019.06.2533; Brandhorst S, 2017, AGEING RES REV, V39, P68, DOI 10.1016/j.arr.2017.02.001; Caffa I, 2020, NATURE, V583, P620, DOI 10.1038/s41586-020-2502-7; Cai YP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61851-0; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Cho YE, 2021, HEPATOLOGY, V73, P2180, DOI 10.1002/hep.30652; Collins N, 2019, CELL, V178, P1088, DOI 10.1016/j.cell.2019.07.049; Conforti F, 2019, JNCI-J NATL CANCER I, V111, P772, DOI 10.1093/jnci/djz094; Conforti F, 2018, LANCET ONCOL, V19, P737, DOI 10.1016/S1470-2045(18)30261-4; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Cui M, 2019, ADV SCI, V6, DOI 10.1002/advs.201901048; Cui M, 2017, EMBO MOL MED, V9, P448, DOI 10.15252/emmm.201606932; D'Abbondanza M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092748; Diaz-Ruiz A, 2019, J GERONTOL A-BIOL, V74, P155, DOI 10.1093/gerona/gly112; Downer S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2482; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Gerdts E, 2019, NAT MED, V25, P1657, DOI 10.1038/s41591-019-0643-8; Gibbs VK, 2018, J GERONTOL A-BIOL, V73, P157, DOI 10.1093/gerona/glx127; Greenhill Claire, 2016, Nat Rev Endocrinol, V12, P496, DOI 10.1038/nrendo.2016.112; Guo H, 2020, SCIENCE, V370, P549, DOI 10.1126/science.aay9097; Guo TZ, 2019, PAIN, V160, P2013, DOI 10.1097/j.pain.0000000000001592; Hauer-Jensen M, 2014, NAT REV GASTRO HEPAT, V11, P470, DOI 10.1038/nrgastro.2014.46; Hines M, 2020, J NEUROSCI, V40, P37, DOI 10.1523/JNEUROSCI.0750-19.2019; Honjoh S, 2017, CELL REP, V21, P3646, DOI 10.1016/j.celrep.2017.11.108; Jairam V, 2019, JAMA ONCOL, V5, P1028, DOI 10.1001/jamaoncol.2019.0086; Jia FP, 2020, LIVER CANCER, V9, P529, DOI 10.1159/000508308; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Kamran MZ, 2016, MED RES REV, V36, P461, DOI 10.1002/med.21386; Kelly CJ, 2013, MUCOSAL IMMUNOL, V6, P1110, DOI 10.1038/mi.2013.6; Kitzman DW, 2016, JAMA-J AM MED ASSOC, V315, P36, DOI 10.1001/jama.2015.17346; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kopeina GS, 2017, BBA-REV CANCER, V1867, P29, DOI 10.1016/j.bbcan.2016.11.002; Kraus WE, 2019, LANCET DIABETES ENDO, V7, P673, DOI 10.1016/S2213-8587(19)30151-2; Kumagai T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101405; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Liu T, 2019, MBIO, V10, DOI 10.1128/mBio.02903-18; Lu LN, 2020, JPEN-PARENTER ENTER, V44, P1308, DOI 10.1002/jpen.1744; Maggi A, 2018, MOL METAB, V15, P3, DOI 10.1016/j.molmet.2018.02.012; Mutoh E, 2011, OBES RES CLIN PRACT, V5, pE119, DOI 10.1016/j.orcp.2010.12.006; Naghshi S, 2020, BMJ-BRIT MED J, V370, DOI [10.1136/bmj.m2412, 10.1136bmj.m2412]; Perry RJ, 2018, CELL METAB, V27, P210, DOI 10.1016/j.cmet.2017.10.004; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Ploeger JM, 2017, CANCER PREV RES, V10, P660, DOI 10.1158/1940-6207.CAPR-17-0174; Schoenberg MH, 2016, VISC MED, V32, P199, DOI 10.1159/000446492; Tonneau M, 2021, CANCER RADIOTHER, V25, P283, DOI 10.1016/j.canrad.2020.08.047; Tonneau M, 2021, RADIOTHER ONCOL, V156, P1, DOI 10.1016/j.radonc.2020.10.033; Tye H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06125-0; Viennois E, 2019, CELL MOL GASTROENTER, V8, P61, DOI 10.1016/j.jcmgh.2019.02.008; Wang P, 2020, INT J OBESITY, V44, P213, DOI 10.1038/s41366-019-0332-1; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Wu MN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092809; Zhao RZ, 2020, NATURE, V577, P416, DOI 10.1038/s41586-019-1873-0; Zheng XJ, 2018, FRONT MED-PRC, V12, P634, DOI 10.1007/s11684-018-0670-8; Zhu YZ, 2019, CANCER LETT, V466, P35, DOI 10.1016/j.canlet.2019.08.017	57	1	1	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21787	10.1096/fj.202100351RR	http://dx.doi.org/10.1096/fj.202100351RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320242				2022-12-28	WOS:000678975300017
J	Ramshekar, A; Wang, HB; Kunz, E; Pappas, C; Hageman, GS; Chaqour, B; Sacks, DB; Hartnett, ME				Ramshekar, Aniket; Wang, Haibo; Kunz, Eric; Pappas, Christian; Hageman, Gregory S.; Chaqour, Brahim; Sacks, David B.; Hartnett, M. Elizabeth			Active Rap1-mediated inhibition of choroidal neovascularization requires interactions with IQGAP1 in choroidal endothelial cells	FASEB JOURNAL			English	Article						choroidal neovascularization; IQGAP1; Rac1GTP; Rap1GTP; vascular endothelial growth factor	RHO-FAMILY GTPASES; MACULAR DEGENERATION; NADPH OXIDASE; GROWTH-FACTOR; COMPLEMENT ACTIVATION; ROS GENERATION; RAP1; ANGIOGENESIS; RANIBIZUMAB; MIGRATION	Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness. The pathophysiology involves activation of choroidal endothelial cells (CECs) to transmigrate the retinal pigment epithelial (RPE) monolayer and form choroidal neovascularization (CNV) in the neural retina. The multidomain GTPase binding protein, IQGAP1, binds active Rac1 and sustains activation of CECs, thereby enabling migration associated with vision-threatening CNV. IQGAP1 also binds the GTPase, Rap1, which when activated reduces Rac1 activation in CECs and CNV. In this study, we tested the hypothesis that active Rap1 binding to IQGAP1 is necessary and sufficient to reduce Rac1 activation in CECs, and CNV. We found that pharmacologic activation of Rap1 or adenoviral transduction of constitutively active Rap1a reduced VEGF-mediated Rac1 activation, migration, and tube formation in CECs. Following pharmacologic activation of Rap1, VEGF-mediated Rac1 activation was reduced in CECs transfected with an IQGAP1 construct that increased active Rap1-IQGAP1 binding but not in CECs transfected with an IQGAP1 construct lacking the Rap1 binding domain. Specific knockout of IQGAP1 in endothelial cells reduced laser-induced CNV and Rac1 activation in CNV lesions, but pharmacologic activation of Rap1 did not further reduce CNV compared to littermate controls. Taken together, our findings provide evidence that active Rap1 binding to the IQ domain of IQGAP1 is sufficient to interfere with active Rac1-mediated CEC activation and CNV formation.	[Ramshekar, Aniket; Wang, Haibo; Kunz, Eric; Pappas, Christian; Hageman, Gregory S.; Hartnett, M. Elizabeth] Univ Utah, John A Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA; [Pappas, Christian; Hageman, Gregory S.] Univ Utah, Steele Ctr Translat Med, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Chaqour, Brahim] Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY USA; [Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; National Institutes of Health (NIH) - USA	Hartnett, ME (corresponding author), Univ Utah, John A Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	ME.Hartnett@hsc.utah.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324	HHS | NIH | National Eye Institute (NEI) [P30EY014800, R01EY024998, R01EY015130, R01EY017011]; Research to Prevent Blindness (RPB)	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: P30EY014800; Research to Prevent Blindness (RPB); HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY024998; HHS | National Institutes of Health (NIH); HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY015130; HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY017011	Awasthi A, 2010, J EXP MED, V207, P1923, DOI 10.1084/jem.20100040; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Bretz CA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20520-z; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cao SJ, 2016, BRIT J OPHTHALMOL, V100, P713, DOI 10.1136/bjophthalmol-2015-307213; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Cruz-Gonzalez F, 2014, GRAEF ARCH CLIN EXP, V252, P469, DOI 10.1007/s00417-014-2585-7; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Garvin S, 2003, CANCER RES, V63, P8742; Gillies MC, 2015, OPHTHALMOLOGY, V122, P1837, DOI 10.1016/j.ophtha.2015.05.010; Goitre L, 2014, METHODS MOL BIOL, V1120, P1, DOI 10.1007/978-1-62703-791-4_1; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gu LP, 2010, EXP EYE RES, V91, P433, DOI 10.1016/j.exer.2010.06.019; Haller JA, 2013, OPHTHALMOLOGY, V120, pS3, DOI 10.1016/j.ophtha.2013.01.057; Hartnett ME, 1996, OPHTHALMOLOGY, V103, P58, DOI 10.1016/S0161-6420(96)30731-8; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071808; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Joussen AM, 2009, DTSCH ARZTEBL INT, V106, P312, DOI 10.3238/arztebl.2009.0312; Keenan TDL, 2015, INVEST OPHTH VIS SCI, V56, P4870, DOI 10.1167/iovs.15-17009; Lakshmikanthan S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207605; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lee S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01585-8; Li JJ, 2018, CURR EYE RES, V43, P934, DOI 10.1080/02713683.2018.1454477; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Malarkannan S, 2012, J IMMUNOL, V188, P2057, DOI 10.4049/jimmunol.1102439; Monaghan-Benson E, 2010, AM J PATHOL, V177, P2091, DOI 10.2353/ajpath.2010.090878; Namkoong S, 2009, CELL SIGNAL, V21, P906, DOI 10.1016/j.cellsig.2009.01.038; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Nowak-Sliwinska P, 2018, ANGIOGENESIS, V21, P425, DOI 10.1007/s10456-018-9613-x; Otsuji T, 2013, CLIN OPHTHALMOL, V7, P1487, DOI 10.2147/OPTH.S46317; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Prokofyeva E, 2012, OPHTHALMIC RES, V47, P171, DOI 10.1159/000329603; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Seddon JM, 2015, INVEST OPHTH VIS SCI, V56, P2192, DOI 10.1167/iovs.14-15841; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Solomon SD, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub4; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stevens TS, 1997, ARCH OPHTHALMOL-CHIC, V115, P345, DOI 10.1001/archopht.1997.01100150347006; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Toomey CB, 2015, P NATL ACAD SCI USA, V112, pE3040, DOI 10.1073/pnas.1424391112; Wang HB, 2020, ANGIOGENESIS, V23, P685, DOI 10.1007/s10456-020-09740-y; Wang HB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52163-z; Wang HB, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.56; Wang HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157748; Wang HB, 2015, AM J PATHOL, V185, P3316, DOI 10.1016/j.ajpath.2015.08.017; Wang HB, 2014, FASEB J, V28, P265, DOI 10.1096/fj.13-240028; Wittchen ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073070; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Zouache MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78059-x	59	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21642	10.1096/fj.202100112R	http://dx.doi.org/10.1096/fj.202100112R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34166557	Green Accepted			2022-12-28	WOS:000667814100055
J	Archambault, AS; Zaid, Y; Rakotoarivelo, V; Turcotte, C; Dore, E; Dubuc, I; Martin, C; Flamand, O; Amar, Y; Cheikh, A; Fares, H; El Hassani, A; Tijani, Y; Cote, A; Laviolette, M; Boilard, E; Flamand, L; Flamand, N				Archambault, Anne-Sophie; Zaid, Younes; Rakotoarivelo, Volatiana; Turcotte, Caroline; Dore, Etienne; Dubuc, Isabelle; Martin, Cyril; Flamand, Olivier; Amar, Youssef; Cheikh, Amine; Fares, Hakima; El Hassani, Amine; Tijani, Youssef; Cote, Andreanne; Laviolette, Michel; Boilard, Eric; Flamand, Louis; Flamand, Nicolas			High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients	FASEB JOURNAL			English	Article						COVID-19; docosanoids; eicosanoids; eoxins; specialized pro-resolving mediators; thromboxane	BRONCHOALVEOLAR LAVAGE FLUID; PHOSPHOLIPASE A(2); LEUKOTRIENE BIOSYNTHESIS; HUMAN NEUTROPHILS; ARACHIDONIC-ACID; LIPID MEDIATORS; GROUP X; RELEASE; CELLS; INHIBITION	Severe acute respiratory syndrome coronavirus 2 is responsible for coronavirus disease 2019 (COVID-19). While COVID-19 is often benign, a subset of patients develops severe multilobar pneumonia that can progress to an acute respiratory distress syndrome. There is no cure for severe COVID-19 and few treatments significantly improved clinical outcome. Dexamethasone and possibly aspirin, which directly/indirectly target the biosynthesis/effects of numerous lipid mediators are among those options. Our objective was to define if severe COVID-19 patients were characterized by increased bioactive lipids modulating lung inflammation. A targeted lipidomic analysis of bronchoalveolar lavages (BALs) by tandem mass spectrometry was done on 25 healthy controls and 33 COVID-19 patients requiring mechanical ventilation. BALs from severe COVID-19 patients were characterized by increased fatty acids and inflammatory lipid mediators. There was a predominance of thromboxane and prostaglandins. Leukotrienes were also increased, notably LTB4, LTE4, and eoxin E-4. Monohydroxylated 15-lipoxygenase metabolites derived from linoleate, arachidonate, eicosapentaenoate, and docosahexaenoate were also increased. Finally yet importantly, specialized pro-resolving mediators, notably lipoxin A(4) and the D-series resolvins, were also increased, underscoring that the lipid mediator storm occurring in severe COVID-19 involves pro- and anti-inflammatory lipids. Our data unmask the lipid mediator storm occurring in the lungs of patients afflicted with severe COVID-19. We discuss which clinically available drugs could be helpful at modulating the lipidome we observed in the hope of minimizing the deleterious effects of pro-inflammatory lipids and enhancing the effects of anti-inflammatory and/or pro-resolving lipid mediators.	[Archambault, Anne-Sophie; Rakotoarivelo, Volatiana; Turcotte, Caroline; Martin, Cyril; Cote, Andreanne; Laviolette, Michel; Flamand, Nicolas] Univ Laval, Dept Med, Fac Med, Ctr Rech,Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin Ste Foy,Off A3140, Quebec City, PQ G1V 4G5, Canada; [Archambault, Anne-Sophie; Rakotoarivelo, Volatiana; Turcotte, Caroline; Martin, Cyril; Flamand, Nicolas] Univ Laval, Canada Excellence Res Chair Microbiome Endocannab, Quebec City, PQ, Canada; [Zaid, Younes] Mohammed V Univ, Dept Biol, Fac Sci, Rabat, Morocco; [Zaid, Younes; Cheikh, Amine; Fares, Hakima; El Hassani, Amine] Abulcasis Univ Hlth Sci, Cheikh Zaid Hosp, Rabat, Morocco; [Dore, Etienne; Dubuc, Isabelle; Flamand, Olivier; Boilard, Eric; Flamand, Louis] Univ Laval, Ctr Rech, Ctr Hosp Univ Quebec, 2705 Laurier Blvd,Off T1-64, Quebec City, PQ G1V 4G2, Canada; [Dore, Etienne; Boilard, Eric] Univ Laval, Ctr Rech Arthrite, Quebec City, PQ, Canada; [Amar, Youssef] Moroccan Fdn Adv Sci Innovat & Res MAScIR, Rabat, Morocco; [Tijani, Youssef] Mohammed VI Univ Hlth Sci, Fac Med, Casablanca, Morocco; [Boilard, Eric; Flamand, Louis] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada	Laval University; Laval University; Mohammed V University in Rabat; Laval University; Laval University; Moroccan Foundation for Advanced Science Innovation & Research (MASCIR); Mohammed VI University of Health Sciences (UM6SS); Laval University	Flamand, N (corresponding author), Univ Laval, Dept Med, Fac Med, Ctr Rech,Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin Ste Foy,Off A3140, Quebec City, PQ G1V 4G5, Canada.; Flamand, L (corresponding author), Univ Laval, Ctr Rech, Ctr Hosp Univ Quebec, 2705 Laurier Blvd,Off T1-64, Quebec City, PQ G1V 4G2, Canada.	Louis.Flamand@crchudequebec.ulaval.ca; Nicolas.Flamand@criucpq.ulaval.ca	Zaid, Younes/AAU-4035-2021; Flamand, Nicolas/H-5823-2019; Cheikh, Amine/AAU-6916-2021	Zaid, Younes/0000-0001-8750-9106; Flamand, Nicolas/0000-0001-5944-7200; Cheikh, Amine/0000-0002-5602-3004; Flamand, Louis/0000-0001-5010-4586; Archambault, Anne-Sophie/0000-0001-7243-7445	Cheikh Zaid Foundation; Canadian New Frontier Research Fund [NFRN-2019-00004]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds de Recherche du Quebec en Sante (FRQS)	Cheikh Zaid Foundation; Canadian New Frontier Research Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec en Sante (FRQS)	Cheikh Zaid Foundation; Canadian New Frontier Research Fund, Grant/Award Number: NFRN-2019-00004; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds de Recherche du Quebec en Sante (FRQS)	Abdulnour REE, 2018, AM J RESP CRIT CARE, V197, P1575, DOI 10.1164/rccm.201712-2530OC; Amigues I, 2020, EXPERT REV CLIN IMMU, V16, P1185, DOI 10.1080/1744666X.2021.1847084; Andreakos E, 2021, ALLERGY, V76, P626, DOI 10.1111/all.14595; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Arbibe L, 1998, J CLIN INVEST, V102, P1152, DOI 10.1172/JCI3236; Archambault AS, 2019, J LEUKOCYTE BIOL, V105, P1131, DOI 10.1002/JLB.MA0718-306R; Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]; Brunnstrom A, 2015, PROSTAG OTH LIPID M, V121, P83, DOI 10.1016/j.prostaglandins.2015.04.010; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chang JE, 2014, J ALLERGY CLIN IMMUN, V133, P899, DOI 10.1016/j.jaci.2013.09.020; Chow JH, 2021, ANESTH ANALG, V132, P930, DOI 10.1213/ANE.0000000000005292; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Damiani S, 2021, J PATHOL, V253, P31, DOI 10.1002/path.5549; Del Valle D.M., 2020, NAT MED, V26, P1636, DOI DOI 10.1038/s41591-020-1051-9; Duchaine C., 2020, CLIN MICROBIOL REV, V34; Flamand N, 2004, BRIT J PHARMACOL, V141, P552, DOI 10.1038/sj.bjp.0705654; Flamand N, 2000, AM J RESP CRIT CARE, V161, pS88, DOI 10.1164/ajrccm.161.supplement_1.ltta-18; FONTEH AN, 1993, J IMMUNOL, V151, P339; Funk CD, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01214; Gupta A., 2020, J MOL GENET MED INT, DOI 10.37421/jmgm.32020.37414.3745; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Herrero R, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00337-9; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hottz ED, 2020, BLOOD, V136, P1330, DOI 10.1182/blood.2020007252; Hu BY, 2021, J MED VIROL, V93, P250, DOI 10.1002/jmv.26232; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214; Medeiros A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/327568; Merzon E, 2021, FEBS J, V288, P5179, DOI 10.1111/febs.15784; MITCHELL JA, 1994, BRIT J PHARMACOL, V113, P1008, DOI 10.1111/j.1476-5381.1994.tb17093.x; Murakami M, 2003, J BIOL CHEM, V278, P10657, DOI 10.1074/jbc.M211325200; Panigrahy D, 2020, CANCER METAST REV, V39, P1, DOI [10.1007/s10555-020-09862-1, 10.1007/s10555-020-09889-4]; Portincasa P, 2020, EUR J INTERN MED, V77, P18, DOI 10.1016/j.ejim.2020.05.035; Rubin EJ, 2021, NEW ENGL J MED, V384, P1564, DOI 10.1056/NEJMe2103108; Schwarz B, 2020, J IMMUNOL; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Sonti R, 2020, J INTENSIVE CARE MED; Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708; Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021; Turcotte C, 2019, J LEUKOCYTE BIOL, V106, P1337, DOI 10.1002/JLB.3A0919-049RRR; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Weber S, 2021, GUT, V70, P1925, DOI [10.1136/gutjnl-2020-323800, 10.1136/gutjnl-2020-]; Wu F, 2020, NATURE, V580, pE7; Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363; Yang J, 2012, FREE RADICAL BIO MED, V53, P160, DOI 10.1016/j.freeradbiomed.2012.05.001; Zaid Y, 2021, BLOOD ADV, V5, P635, DOI 10.1182/bloodadvances.2020003513; Zaid Y, 2020, CIRC RES, V127, P1404, DOI 10.1161/CIRCRESAHA.120.317703; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777	55	43	45	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21666	10.1096/fj.202100540R	http://dx.doi.org/10.1096/fj.202100540R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34033145	Green Submitted, Green Published			2022-12-28	WOS:000655695900047
J	Robinson, LJ; Soboloff, J; Tourkova, IL; Larrouture, QC; Witt, MR; Gross, S; Hooper, R; Samakai, E; Worley, PF; Barnett, JB; Blair, HC				Robinson, Lisa J.; Soboloff, Jonathan; Tourkova, Irina L.; Larrouture, Quitterie C.; Witt, Michelle R.; Gross, Scott; Hooper, Robert; Samakai, Elsie; Worley, Paul F.; Barnett, John B.; Blair, Harry C.			The function of the calcium channel Orai1 in osteoclast development	FASEB JOURNAL			English	Article						bone; mononuclear cells; Orai1 calcium channel; Orai1(fl/fl)-LysMcre; osteoclast	OSTEOBLAST DIFFERENTIATION; BONE-RESORPTION; STIM; ROLES; MICE; DEFICIENCY; ACTIVATION; EXPRESSION; PROTEIN; ENTRY	To determine the intrinsic role of Orai1 in osteoclast development, Orai1-floxed mice were bred with LysMcre mice to delete Orai1 from the myeloid lineage. PCR, in situ labelling and Western analysis showed Orai1 deletion in myeloid-lineage cells, including osteoclasts, as expected. Surprisingly, bone resorption was maintained in vivo, despite loss of multinucleated osteoclasts; instead, a large number of mononuclear cells bearing tartrate resistant acid phosphatase were observed on cell surfaces. An in vitro resorption assay confirmed that RANKL-treated Orai1 null cells, also TRAP-positive but mononuclear, degraded matrix, albeit at a reduced rate compared to wild type osteoclasts. This shows that mononuclear osteoclasts can degrade bone, albeit less efficiently. Further unexpected findings included that Orai1(fl/fl)-LysMcre vertebrae showed slightly reduced bone density in 16-week-old mice, despite Orai1 deletion only in myeloid cells; however, this mild difference resolved with age. In summary, in vitro analysis showed a severe defect in osteoclast multinucleation in Orai1 negative mononuclear cells, consistent with prior studies using less targeted strategies, but with evidence of resorption in vivo and unexpected secondary effects on bone formation leaving bone mass largely unaffected.	[Robinson, Lisa J.; Witt, Michelle R.] West Virginia Univ, Sch Med, Dept Pathol Anat & Lab Med, Morgantown, WV 26506 USA; [Robinson, Lisa J.; Witt, Michelle R.; Barnett, John B.] West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Inst Canc, Morgantown, WV 26506 USA; [Soboloff, Jonathan; Gross, Scott; Hooper, Robert; Samakai, Elsie] Temple Univ, Fels Canc Inst Personalized Med, Dept Med Genet & Mol Biochem, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Tourkova, Irina L.; Larrouture, Quitterie C.; Blair, Harry C.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Tourkova, Irina L.; Larrouture, Quitterie C.; Blair, Harry C.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Tourkova, Irina L.; Larrouture, Quitterie C.; Blair, Harry C.] Pittsburgh VA Med Ctr, Pittsburgh, PA 15261 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	West Virginia University; West Virginia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University	Barnett, JB (corresponding author), West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Inst Canc, Morgantown, WV 26506 USA.; Blair, HC (corresponding author), Pittsburgh VA Med Ctr, Pittsburgh, PA 15261 USA.; Blair, HC (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15261 USA.	jbarnett@hsc.wvu.edu; hcblair@pitt.edu		Witt, Michelle/0000-0001-9483-8346; Barnett, John/0000-0001-6547-2381	U.S. Department of Veterans Affairs (VA) [BX002490]; HHS | National Institutes of Health (NIH) [AR065407]; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR076146]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM104942]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	U.S. Department of Veterans Affairs (VA), Grant/Award Number: BX002490; HHS | National Institutes of Health (NIH), Grant/Award Number: AR065407; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR076146; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM104942	Ahuja M, 2017, CELL METAB, V25, P635, DOI 10.1016/j.cmet.2017.02.007; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Blair HC, 2016, LAB INVEST, V96, P763, DOI 10.1038/labinvest.2016.51; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Boraschi-Diaz I, 2016, CYTOTECHNOLOGY, V68, P105, DOI 10.1007/s10616-014-9759-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cheng Z., 2020, J BONE MINER RES, V35, p143; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Doroudi M, 2015, J STEROID BIOCHEM, V147, P81, DOI 10.1016/j.jsbmb.2014.11.002; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hwang SY, 2012, CELL CALCIUM, V52, P488, DOI 10.1016/j.ceca.2012.10.001; Hwang SY, 2012, FASEB J, V26, P1484, DOI 10.1096/fj.11-194399; KAHN AJ, 1978, SCIENCE, V199, P988, DOI 10.1126/science.622581; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Kim HJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050705; Lo Iacono N, 2012, J BONE MINER RES, V27, P2501, DOI 10.1002/jbmr.1712; Mookerjee-Basu J, 2020, EMBO REP, V21, DOI 10.15252/embr.201948904; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; Robinson LJ, 2019, CELL CALCIUM, V81, P51, DOI 10.1016/j.ceca.2019.06.001; Robinson LJ, 2012, LAB INVEST, V92, P1071, DOI 10.1038/labinvest.2012.72; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Tourkova IL, 2019, LAB INVEST, V99, P1850, DOI 10.1038/s41374-019-0311-0; Waddell LA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02246; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Witwicka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128275; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xi G, 2019, J CELL PHYSIOL, V234, P23232, DOI 10.1002/jcp.28890; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Zhou YD, 2011, J CELL PHYSIOL, V226, P1082, DOI 10.1002/jcp.22423	38	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21653	10.1096/fj.202001921RR	http://dx.doi.org/10.1096/fj.202001921RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34009685	Green Accepted			2022-12-28	WOS:000655695900032
J	Chen, XY; He, XY; Guo, Y; Liu, LH; Li, H; Tan, JF; Feng, WD; Guan, HY; Cao, XP; Xiao, HP; Li, YB				Chen, Xueying; He, Xiaoying; Guo, Yan; Liu, Liehua; Li, Hai; Tan, Jinfu; Feng, Weidong; Guan, Hongyu; Cao, Xiaopei; Xiao, Haipeng; Li, Yanbing			Glucose-dependent insulinotropic polypeptide modifies adipose plasticity and promotes beige adipogenesis of human omental adipose-derived stem cells	FASEB JOURNAL			English	Article						cellular research; drug mechanism; energy regulation; GIP; obesity therapy	ADIPOCYTE DIFFERENTIATION; FAT-CELL; TISSUE; OBESITY; WHITE; BROWN; EXPANSION; GIP; PROLIFERATION; MECHANISMS	The adipocyte precursors (APs) located in white adipose tissue (WAT) are functionally significant in adipose plasticity and browning. Modifying adipogenesis or WAT browning targeted on APs is a promising mechanism for anti-obesity drug. We herein explored the in vitro actions and mechanisms of glucose-dependent insulinotropic polypeptide (GIP), a gut-derived peptide, in human adipose-derived mesenchymal stem cells (hADSCs) isolated from omentum. The hADSCs were cotreated with 100 nM GIP with or without equimolar concentration of GIP3-42 (a GIP receptor antagonist), and subsequently examined in vitro. CCK-8, EdU incorporation, and flow cytometry assays were used to assess cellular proliferation. Annexin V FTIC/PI double stain, TUNEL staining, and Western blot were applied for apoptosis evaluation. Adipogenesis was reflected by Western blot, real-time PCR, Oil Red O staining, mitochondrial staining, and mitochondrial DNA analysis. Results showed that GIP promoted proliferation and inhibited apoptosis of hADSCs via pleiotropic effects. Besides, GIP facilitated de novo beige adipogenesis, by accelerating mitotic clonal expansion (MCE), upregulating core adipogenic regulators (C/EBP alpha and PPAR gamma), augmenting beige-related genes (UCP1, PGC1 alpha, and PRDM16), increasing mitochondrial content and improving beige adipocyte functionalities. Above all, our study expands knowledge on the mechanisms of GIP modifying adipogenesis especially in inducing beige adipogenesis, and thus provides a theoretical support for clinical usage of GIP on obesity treatment.	[Chen, Xueying; He, Xiaoying; Guo, Yan; Liu, Liehua; Li, Hai; Guan, Hongyu; Cao, Xiaopei; Xiao, Haipeng; Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China; [Chen, Xueying; He, Xiaoying; Guo, Yan; Liu, Liehua; Li, Hai; Guan, Hongyu; Cao, Xiaopei; Xiao, Haipeng; Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Diabet Ctr, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China; [Tan, Jinfu; Feng, Weidong] Sun Yat Sen Univ, Ctr Gastrointestinal Surg, Affiliated Hosp 1, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China.; Li, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Diabet Ctr, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China.	liyb@mail.sysu.edu.cn	li, yan/GTI-4638-2022		State Key Research and Development Program of China [2018YFC1314100]; National Natural Science Foundation of China [81870557, 81572623, 81572624, 81800716]; Key Field Research and Development Program of Guangdong Province, China [2019B020230001]; Natural Science Foundation of Guangdong Province, China [2016A030310169]; Guangdong Basic and Applied Basic Research Foundation [2019A1515012046, 2019A1515011248]; Medicine Technology Foundation of Guangdong Province [201811393557793]; Sun Yat-sen University Outstanding Graduate Innovation Development Project [19ykyjs09]	State Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Field Research and Development Program of Guangdong Province, China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangdong Basic and Applied Basic Research Foundation; Medicine Technology Foundation of Guangdong Province; Sun Yat-sen University Outstanding Graduate Innovation Development Project	State Key Research and Development Program of China, Grant/Award Number: 2018YFC1314100; National Natural Science Foundation of China, Grant/Award Number: 81870557, 81572623, 81572624 and 81800716; Key Field Research and Development Program of Guangdong Province, China, Grant/Award Number: 2019B020230001; Natural Science Foundation of Guangdong Province, China, Grant/Award Number: 2016A030310169; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2019A1515012046 and 2019A1515011248; Medicine Technology Foundation of Guangdong Province, Grant/Award Number: 201811393557793; Sun Yat--sen University Outstanding Graduate Innovation Development Project, Grant/Award Number: 19ykyjs09	Beaudry JL, 2019, MOL METAB, V28, P14; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cefalu WT, 2019, DIABETES CARE, V42, pS90, DOI 10.2337/dc19-S009; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Coskun T, 2018, MOL METAB, V18, P3, DOI 10.1016/j.molmet.2018.09.009; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Frias JP, 2018, LANCET, V392, P2180, DOI 10.1016/S0140-6736(18)32260-8; Goedecke JH, 2011, J CLIN ENDOCR METAB, V96, pE2029, DOI 10.1210/jc.2011-1576; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Ha J, 2015, MOL ASPECTS MED, V46, P46, DOI 10.1016/j.mam.2015.08.002; He XY, 2018, INT J OBESITY, V42, P1051, DOI 10.1038/s41366-018-0024-2; Inoue N, 2008, J BIOL CHEM, V283, P21220, DOI 10.1074/jbc.M801824200; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Kim SM, 2014, CELL METAB, V20, P1049, DOI 10.1016/j.cmet.2014.10.010; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Liang WW, 2015, ONCOTARGET, V6, P31780, DOI 10.18632/oncotarget.5566; Lopez-Mejia IC, 2018, CELL MOL LIFE SCI, V75, P975, DOI 10.1007/s00018-017-2668-9; Louwen F, 2018, OBES REV, V19, P888, DOI 10.1111/obr.12679; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; McIntosh CHS, 2012, J DIABETES INVEST, V3, P96, DOI 10.1111/j.2040-1124.2012.00196.x; Moisan A, 2015, NAT CELL BIOL, V17, P57, DOI 10.1038/ncb3075; Montanari T, 2017, OBES REV, V18, P495, DOI 10.1111/obr.12520; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Ng SYA, 2014, EXPERT OPIN BIOL TH, V14, P1215, DOI 10.1517/14712598.2014.925870; Panina YA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01656; Perez LM, 2016, OBESITY, V24, P661, DOI 10.1002/oby.21405; Preston KJ, 2019, FASEB J, V33, P11993, DOI 10.1096/fj.201802637RR; Quang MDX, 2013, CYTOM PART A, V83, P933, DOI 10.1002/cyto.a.22333; Rose F, 2019, EXPERT OPIN DRUG DIS, V14, P1151, DOI 10.1080/17460441.2019.1646243; Rui LY, 2017, COMPR PHYSIOL, V7, P1281, DOI 10.1002/cphy.c170001; Sarantopoulos CN, 2018, STEM CELL REV REP, V14, P27, DOI 10.1007/s12015-017-9774-9; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schrover IM, 2018, EUR J PREV CARDIOL, V25, P1548, DOI 10.1177/2047487318790722; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Silva KR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0029-x; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srivastava G, 2018, NAT REV ENDOCRINOL, V14, P12, DOI 10.1038/nrendo.2017.122; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Verma MK, 2018, EXPERT OPIN THER TAR, V22, P615, DOI 10.1080/14728222.2018.1487952; Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weaver RE, 2008, INT J OBESITY, V32, P1705, DOI 10.1038/ijo.2008.148; Wilkins HM, 2016, J NEUROCHEM, V137, P76, DOI 10.1111/jnc.13545; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhang Y, 2018, J CLIN INVEST, V128, P4898, DOI 10.1172/JCI98353; Zhang Z, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110970	53	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21534	10.1096/fj.201903253R	http://dx.doi.org/10.1096/fj.201903253R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817830				2022-12-28	WOS:000645260100089
J	Fang, ZF; Yi, F; Peng, Y; Zhang, JF; Zhang, LT; Deng, Z; Chen, FG; Li, CH; He, YW; Huang, CQ; Zhang, QL; Lai, KF; Xie, JX				Fang, Zhangfu; Yi, Fang; Peng, Yang; Zhang, Junfeng (Jim); Zhang, Liting; Deng, Zheng; Chen, Fagui; Li, Chenhui; He, Yaowei; Huang, Chuqin; Zhang, Qingling; Lai, Kefang; Xie, Jiaxing			Inhibition of TRPA1 reduces airway inflammation and hyperresponsiveness in mice with allergic rhinitis	FASEB JOURNAL			English	Article						airway inflammation; allergic rhinitis; asthma; TRPA1; vagal sensory neurons	SPLICING FACTOR SRSF3; MESSENGER-RNA; MITOCHONDRIAL DYNAMICS; SKELETAL-MUSCLE; GENE-EXPRESSION; HEART; CARDIOMYOPATHY; TRANSLATION; PROTEINS; HYPERTROPHY	This study was conducted to investigate whether a transient receptor potential ankyrin 1 (TRPA1) antagonist (HC-030031) can reduce airway inflammation and hyperresponsiveness in a murine allergic rhinitis (AR) model. BALB/c mice were sensitized and challenged by ovalbumin (OVA) to induce AR. HC-030031 or vehicle was administrated to mice via intraperitoneal injection prior to OVA challenges. Nose-scratching events, histopathologic alterations of the airways, and bronchial hyperresponsiveness (BHR) were assessed. Differential cells and proinflammatory cytokines in the nasal lavage (NAL) and bronchoalveolar lavage (BAL) fluid were measured. Expressions of TRPA1 in nasal mucosa were examined by immunohistochemistry. TRPA1-expressing vagal neurons were labeled by immunofluorescent staining. HC-030031-treated AR mice had markedly reduced type-2 inflammation in nasal mucosa and ameliorated-nose-scratching events than AR mice received vehicle. HC-030031 treatment also dramatically reduced leucocyte numbers and IL-8 level in the BAL fluid, inhibited lower airway remodeling and fibrosis, and nearly abolished BHR. HC-0300031 treatment significantly inhibited the upregulated number of TRPA1 expressing nasal epithelial cells and TRPA1 expressing sensory neurons, leading to downregulation of SP in both upper and lower airways. Targeting TRPA1 may represent a promising strategy for treating AR and AR-related asthma.	[Fang, Zhangfu; Yi, Fang; Peng, Yang; Zhang, Junfeng (Jim); Zhang, Liting; Deng, Zheng; He, Yaowei; Huang, Chuqin; Lai, Kefang] Guangzhou Med Univ, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China; [Zhang, Junfeng (Jim)] Duke Univ, Nicholas Sch Environm, Global Hlth Inst, Durham, NC 27708 USA; [Chen, Fagui] Shantou Cent Hosp, Dept Resp Med, Shantou, Peoples R China; [Li, Chenhui] Shenzhen Peoples Hosp, Dept Resp & Crit Care Med, Shenzhen, Peoples R China; [Zhang, Qingling; Xie, Jiaxing] Guangzhou Med Univ, Affiliated Hosp 1, Dept Allergy & Clin Immunol,Guangzhou Inst Resp H, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Duke University; Jinan University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Lai, KF; Xie, JX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou Inst Resp Hlth, 151 Yanjiang Rd, Guangzhou 510120, Peoples R China.	klai@163.com; jiaxingxie@126.com	Fang, Zhangfu/GVU-6797-2022; Xie, Jiaxing/B-5795-2012	Deng, Zheng/0000-0002-2203-6384; Zhang, Junfeng/0000-0003-3759-6672; Xie, Jiaxing/0000-0001-6462-6676	National Natural Science Foundation of China (NSFC) [81100028, 81270151, 82000024]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81100028, 81270151 and 82000024	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ajiro M, 2016, NUCLEIC ACIDS RES, V44, P1854, DOI 10.1093/nar/gkv1500; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Arimura T, 2011, HUM MUTAT, V32, P1481, DOI 10.1002/humu.21603; Beqqali A, 2018, Biophys Rev, V10, P1061, DOI 10.1007/s12551-018-0439-y; Boengler K, 2006, J MOL CELL CARDIOL, V41, P426, DOI 10.1016/j.yjmcc.2006.05.015; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0; Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031; Boucher L, 2001, RNA, V7, P1693; Boutej H, 2017, CELL REP, V21, P3220, DOI 10.1016/j.celrep.2017.11.058; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Carlson SM, 2017, J BIOL CHEM, V292, P13381, DOI 10.1074/jbc.M117.784371; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Chen J, 1998, DEVELOPMENT, V125, P1943; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Datta K, 2005, MOL BIOL CELL, V16, P954, DOI 10.1091/mbc.E04-07-0622; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; de Groot NE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64667-0; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorn GW, 2020, J MOL CELL CARDIOL, V142, P146, DOI 10.1016/j.yjmcc.2020.04.016; Dumont AA, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.118557; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fang X, 2017, J CLIN INVEST, V127, P3189, DOI 10.1172/JCI94310; Feng Y, 2009, DEV CELL, V16, P528, DOI 10.1016/j.devcel.2009.02.009; FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gao C, 2016, J CLIN INVEST, V126, P195, DOI 10.1172/JCI84015; Gao G, 2011, CIRCULATION, V124, P1124, DOI 10.1161/CIRCULATIONAHA.111.044495; Garrido-Martin D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006360; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Han H, 2017, MOL CELL, V65, P539, DOI 10.1016/j.molcel.2017.01.011; He XL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0422-1; Hoshino A, 2014, CIRC-HEART FAIL, V7, P500, DOI 10.1161/CIRCHEARTFAILURE.113.001062; Howard JM, 2015, WIRES RNA, V6, P93, DOI 10.1002/wrna.1260; Jeong S, 2017, MOL CELLS, V40, P1, DOI 10.14348/molcells.2017.2319; Jia R, 2010, INT J BIOL SCI, V6, P806; Kaizuka T, 2016, MOL CELL BIOL, V36, P585, DOI 10.1128/MCB.01005-15; Kanaan GN, 2018, REDOX BIOL, V14, P509, DOI 10.1016/j.redox.2017.10.019; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim HK, 2018, PFLUG ARCH EUR J PHY, V470, P995, DOI 10.1007/s00424-018-2136-x; Kim J, 2014, CELL DEATH DIFFER, V21, P481, DOI 10.1038/cdd.2013.171; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kotani T, 2013, NUCLEIC ACIDS RES, V41, P3713, DOI 10.1093/nar/gkt079; Kumar D, 2019, J CLIN INVEST, V129, P4477, DOI 10.1172/JCI127374; Kurokawa K, 2014, ONCOGENE, V33, P1407, DOI 10.1038/onc.2013.86; Lara-Pezzi E, 2013, J CARDIOVASC TRANSL, V6, P945, DOI 10.1007/s12265-013-9482-z; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lee HC, 2012, CLIN GENET, V81, P394, DOI 10.1111/j.1399-0004.2011.01659.x; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liu J, 2019, PROTEIN CELL, V10, P405, DOI 10.1007/s13238-018-0578-8; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lupu I., 2019, THESIS U OXFORD; Martin OJ, 2014, CIRC RES, V114, P626, DOI 10.1161/CIRCRESAHA.114.302562; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mirtschink P, 2015, NATURE, V522, P444, DOI 10.1038/nature14508; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Opie LH., 1997, HEART PHYSL CELL CIR; Ortiz-Sanchez P, 2019, CIRC RES, V125, P170, DOI 10.1161/CIRCRESAHA.118.314515; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Piquereau J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00959; Pircher H, 2015, J BIOL CHEM, V290, P6755, DOI 10.1074/jbc.M114.609305; Rawcliffe DFR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165453; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Sabbah HN, 2016, CIRC-HEART FAIL, V9, P1, DOI 10.1161/CIRCHEARTFAILURE.115.002206; SABBAH HN, 1992, J MOL CELL CARDIOL, V24, P1333, DOI 10.1016/0022-2828(92)93098-5; Sanchez-Diaz M, 2020, TRENDS ENDOCRIN MET, V31, P308, DOI 10.1016/j.tem.2020.01.006; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Semmler AL, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0121-9; Sen S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2342; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Simon MT, 2017, MITOCHONDRION, V34, P84, DOI 10.1016/j.mito.2017.02.004; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song X, 2019, CANCER RES, V79, P5288, DOI 10.1158/0008-5472.CAN-19-1504; Stepanov V, 1997, AM J PHYSIOL-CELL PH, V273, pC1397, DOI 10.1152/ajpcell.1997.273.4.C1397; Stopp S, 2017, P NATL ACAD SCI USA, V114, P8029, DOI 10.1073/pnas.1703406114; Tahrir FG, 2017, J CELL PHYSIOL, V232, P797, DOI 10.1002/jcp.25476; Tang K, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004346; Tapial J, 2017, GENOME RES, V27, P1759, DOI 10.1101/gr.220962.117; Tunster SJ, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0154-6; Tyrakis PA, 2017, CELL REP, V21, P1036, DOI 10.1016/j.celrep.2017.09.092; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35520; Wang RX, 2018, INT J MOL MED, V41, P311, DOI 10.3892/ijmm.2017.3234; Wei CL, 2015, CELL REP, V10, P1521, DOI 10.1016/j.celrep.2015.02.013; Weiss AKH, 2018, BIOCHEM SOC T, V46, P295, DOI 10.1042/BST20170518; Whitcomb J, 2020, IUBMB LIFE, V72, P53, DOI 10.1002/iub.2163; Wong J, 2012, J NEUROCHEM, V123, P159, DOI 10.1111/j.1471-4159.2012.07873.x; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang JW, 2014, DEV CELL, V31, P87, DOI 10.1016/j.devcel.2014.08.025; Ye JQ, 2015, P NATL ACAD SCI USA, V112, pE3020, DOI 10.1073/pnas.1508461112; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	112	2	2	4	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21428	10.1096/fj.201902627R	http://dx.doi.org/10.1096/fj.201902627R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774861				2022-12-28	WOS:000645260100082
J	Martinez-Chacon, G; Yatkin, E; Polari, L; Dinc, DD; Peuhu, E; Hartiala, P; Saarinen, N; Makela, S				Martinez-Chacon, Gabriela; Yatkin, Emrah; Polari, Lauri; Dinc, Defne Deniz; Peuhu, Emilia; Hartiala, Pauliina; Saarinen, Niina; Makela, Sari			CC chemokine ligand 2 (CCL2) stimulates aromatase gene expression in mammary adipose tissue	FASEB JOURNAL			English	Article						aromatase regulation; breast adipose tissue; CYP19A1; inflammation; obesity	MONOCYTE CHEMOATTRACTANT PROTEIN-1; POLYMERASE-CHAIN-REACTION; BREAST-CANCER; CYTOCHROME-P450 TRANSCRIPTS; CORTISOL METABOLISM; SIGNALING PATHWAYS; STROMAL CELLS; OBESE WOMEN; WEIGHT-GAIN; CYP19 GENE	Obesity is a risk factor for postmenopausal breast cancer. Obesity-related inflammation upregulates aromatase expression, the rate-limiting enzyme for estrogen synthesis, in breast adipose tissue (BAT), increasing estrogen production and cancer risk. The regulation of aromatase gene (CYP19A1) in BAT is complex, and the mechanisms linking obesity and aromatase dysregulation are not fully understood. An obesity-associated factor that could regulate aromatase is the CC chemokine ligand (CCL) 2, a pro-inflammatory factor that also activates signaling pathways implicated in CYP19A1 transcription. By using human primary breast adipose stromal cells (ASCs) and aromatase reporter (hARO-Luc) mouse mammary adipose explants, we demonstrated that CCL2 enhances the glucocorticoid-mediated CYP19A1 transcription. The potential mechanism involves the activation of PI.4 via ERK1/2 pathway. We also showed that CCL2 contributes to the pro-inflammatory milieu and aromatase expression in obesity, evidenced by increased expression of CCL2 and CYP19A1 in mammary tissues from obese hARO-Luc mice, and subcutaneous adipose tissue from obese women. In summary, our results indicate that postmenopausal obesity may promote CCL2 production in BAT, leading to exacerbation of the menopause-related inflammatory state and further stimulation of local aromatase and estrogens. These results provide new insights into the regulation of aromatase and may aid in finding approaches to prevent breast cancer.	[Martinez-Chacon, Gabriela; Yatkin, Emrah; Polari, Lauri; Saarinen, Niina; Makela, Sari] Univ Turku, Funct Foods Forum, Turku, Finland; [Martinez-Chacon, Gabriela; Yatkin, Emrah; Polari, Lauri; Dinc, Defne Deniz; Peuhu, Emilia; Hartiala, Pauliina; Saarinen, Niina; Makela, Sari] Univ Turku, Inst Biomed, 20014 Turun Yliopisto, Turku, Finland; [Yatkin, Emrah] Univ Turku, Cent Anim Lab, Turku, Finland; [Polari, Lauri] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Turku, Finland; [Dinc, Defne Deniz; Peuhu, Emilia] Univ Turku, FICAN West Canc Res Lab, Turku, Finland; [Dinc, Defne Deniz; Peuhu, Emilia] Turku Univ Hosp, Turku, Finland; [Dinc, Defne Deniz; Peuhu, Emilia] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Dinc, Defne Deniz; Peuhu, Emilia] Abo Akad Univ, Turku, Finland; [Hartiala, Pauliina] Turku Univ Hosp TYS, Dept Plast & Gen Surg, Turku, Finland; [Saarinen, Niina; Makela, Sari] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland	University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Turku	Makela, S (corresponding author), Univ Turku, Inst Biomed, 20014 Turun Yliopisto, Turku, Finland.	sari.makela@utu.fi		Hartiala, Pauliina/0000-0002-7606-7813; Dinc, Defne D./0000-0002-7578-129X; Makela, Sari/0000-0002-8698-4076; Martinez-Chacon, Gabriela/0000-0002-1387-8715	University of Turku Graduated School (UTUGS) [2014-2017]; Finnish Bioeconomic Cluster, the BioRefine Program of Finnish Funding Agency for Technology and Innovation [605/11]; University of Turku Foundation [10-2139, 080526]; Jalmari and Rauha Ahokas Foundation [2018]; Turku University Hospital [2019]; Academy of Finland [264153, 323096, 328892]; Suomen Kulttuurirahasto [2018-2019]	University of Turku Graduated School (UTUGS); Finnish Bioeconomic Cluster, the BioRefine Program of Finnish Funding Agency for Technology and Innovation; University of Turku Foundation; Jalmari and Rauha Ahokas Foundation; Turku University Hospital; Academy of Finland(Academy of Finland); Suomen Kulttuurirahasto	University of Turku Graduated School (UTUGS), Grant/Award Number: 2014-2017; Finnish Bioeconomic Cluster, the BioRefine Program of Finnish Funding Agency for Technology and Innovation, Grant/Award Number: 605/11; University of Turku Foundation, Grant/Award Number: 10--2139 and 080526; Jalmari and Rauha Ahokas Foundation, Grant/Award Number: 2018; The State Research Funding of the Turku University Hospital, Grant/Award Number: 2019; Academy of Finland, Grant/Award Number: 264153, 323096 and 328892; Suomen Kulttuurirahasto, Grant/Award Number: 2018--2019	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; An J, 2017, ONCOTARGET, V8, P39230, DOI 10.18632/oncotarget.16837; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Basurto L, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.05.013; Bezemer ID, 2005, CANCER CAUSE CONTROL, V16, P561, DOI 10.1007/s10552-004-7472-9; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Brown KA, 2017, J CLIN ENDOCR METAB, V102, P1692, DOI 10.1210/jc.2016-3606; Brown KA, 2014, J MAMMARY GLAND BIOL, V19, P183, DOI 10.1007/s10911-014-9321-0; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P428, DOI 10.1210/jc.78.2.428; Bulun SE, 2007, J STEROID BIOCHEM, V106, P81, DOI 10.1016/j.jsbmb.2007.05.027; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Burkhard K, 2010, METHODS MOL BIOL, V661, P107, DOI 10.1007/978-1-60761-795-2_6; Chen D, 2012, MOL CELL ENDOCRINOL, V355, P114, DOI 10.1016/j.mce.2012.01.027; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dutta P, 2018, BREAST CANCER RES TR, V170, P477, DOI 10.1007/s10549-018-4760-8; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; Han R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27810-6; Hao QY, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00589-8; Hetemaki N, 2017, J CLIN ENDOCR METAB, V102, P4588, DOI 10.1210/jc.2017-01474; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Ignacio RMC, 2016, IMMUNE NETW, V16, P189, DOI 10.4110/in.2016.16.3.189; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; Iyengar NM, 2015, CANCER PREV RES, V8, P349, DOI 10.1158/1940-6207.CAPR-14-0243; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kulendran M, 2009, ANTICANCER RES, V29, P1095; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; Lim SY, 2016, ONCOTARGET, V7, P28697, DOI 10.18632/oncotarget.7376; Lubowicka E, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2124390; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Martinez-Chacon G, 2018, FASEB J, V32, P3361, DOI 10.1096/fj.201700938RRR; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P1327, DOI 10.1210/jc.87.3.1327; McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Nascimento-Sales M, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13271; NEWTON CJ, 1986, J STEROID BIOCHEM, V24, P1033, DOI 10.1016/0022-4731(86)90356-0; Park KS, 2009, CLIN CHIM ACTA, V403, P92, DOI 10.1016/j.cca.2009.01.025; Peuhu E, 2017, EMBO J, V36, P165, DOI 10.15252/embj.201694387; Polari L, 2015, MOL CELL ENDOCRINOL, V412, P123, DOI 10.1016/j.mce.2015.06.002; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rice S, 2012, FERTIL STERIL, V97, P1460, DOI 10.1016/j.fertnstert.2012.03.008; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 1997, RECENT PROG HORM RES, V52, P185; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Stingl J, 2005, HUMANA PRESS, P249; Strauss L, 2013, FASEB J, V27, P1342, DOI 10.1096/fj.12-219048; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Svensson S, 2015, CLIN CANCER RES, V21, P3794, DOI 10.1158/1078-0432.CCR-15-0204; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Thijssen JHH., 1976, CONSENSUS MENOPAUSE, P25; To SQ, 2015, J STEROID BIOCHEM, V145, P179, DOI 10.1016/j.jsbmb.2014.05.004; To SQ, 2013, BIOCHEM BIOPH RES CO, V433, P96, DOI 10.1016/j.bbrc.2013.02.058; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; Vrieling A, 2010, BREAST CANCER RES TR, V123, P641, DOI 10.1007/s10549-010-1116-4; Westerbacka J, 2008, AM J PHYSIOL-ENDOC M, V294, pE841, DOI 10.1152/ajpendo.00653.2006; Zhao Y, 1997, J STEROID BIOCHEM, V61, P203, DOI 10.1016/S0960-0760(97)80013-1; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350	73	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21536	10.1096/fj.201902485RRR	http://dx.doi.org/10.1096/fj.201902485RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33913559	Green Published, hybrid			2022-12-28	WOS:000645260100087
J	Harris, BRE; Zhang, Y; Tao, JX; Shen, RH; Zhao, XQ; Cleary, MP; Wang, T; Yang, DQ				Harris, Benjamin R. E.; Zhang, Ye; Tao, Jianxin; Shen, Renhui; Zhao, Xiaoqian; Cleary, Margot P.; Wang, Tong; Yang, Da-Qing			ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt	FASEB JOURNAL			English	Article						ATM; Akt; glucose uptake; GLUT1; KU-55933		Enhanced glucose uptake is coupled with elevated aerobic glycolysis (the Warburg effect) in cancer cells and is closely correlated with increased tumor aggressiveness and poor prognosis. We previously discovered that ATM, a protein kinase deficient in Ataxia-tclangiectasia (A-T) disease, is an insulin-responsive protein that participates in insulin-mediated glucose uptake in muscle cells by stimulating glucose transporter 4 (GLUT4) translocation. However, the role of ATM in glucose uptake and tumorigenesis of cancer cells is unclear. In the present study, we found that aggressive breast and prostate cancer cell lines with overactivated Akt activity exhibit enhanced glucose uptake and GLUT1 translocation upon insulin treatment, and KU-55933, a specific inhibitor of ATM, inhibits insulin-mediated glucose uptake by blocking translocation of GLUT1 to the cell surface. KU-55933 also inhibits aerobic glycolysis and ATP production in these cells. Moreover, KU-55933 induces apoptosis and inhibits motility of cancer cells by inhibiting glucose uptake. Our results showed that while high concentration of glucose and insulin promote the expression of a mesenchymal biomarker (vimentin) in these cancer cells, KU-55933 strongly inhibits its expression as well as epithelial to mesenchymal transition. The roles of ATM in stimulating glucose uptake, glycolysis, motility, and proliferation of cancer cells were demonstrated by knocking-down ATM in these cells. KU-55933 treatment also inhibits tumor growth and metastasis in vivo in mouse mammary tumors through inhibition of GLUT1 translocation and vimentin expression. These results suggest that ATM acts as a promoter of tumorigenesis in cancer cells with over- activated Akt, and KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake and glycolysis in these cancer cells, which may lead to the use of KU-55933 and its analogs as new preventive or therapeutic agents against cancer.	[Harris, Benjamin R. E.; Zhang, Ye; Tao, Jianxin; Shen, Renhui; Cleary, Margot P.; Yang, Da-Qing] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Zhang, Ye; Wang, Tong] Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Tao, Jianxin; Shen, Renhui; Zhao, Xiaoqian; Wang, Tong] Nanjing Med Univ, Nanjing, Peoples R China; [Cleary, Margot P.; Yang, Da-Qing] Univ Minnesota, Mason Canc Ctr, 801 16th Ave NE, Minneapolis, MN 55455 USA	University of Minnesota System; Jiangnan University; Nanjing Medical University; University of Minnesota System; University of Minnesota Twin Cities	Yang, DQ (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.; Wang, T (corresponding author), Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China.; Yang, DQ (corresponding author), Univ Minnesota, Mason Canc Ctr, 801 16th Ave NE, Minneapolis, MN 55455 USA.	aanti@163.com; dyang@umn.edu		Tao, Jianxin/0000-0001-5417-213X; Harris, Benjamin/0000-0003-1459-1473	National Cancer Institute of National Institute of Health [1R01CA157012-01A1]; University of Minnesota [GIA]; National Natural Science Foundation of China;  [NSFC]	National Cancer Institute of National Institute of Health; University of Minnesota(University of Minnesota System); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	Margot P. Cleary, Grant/Award Number: 1R01CA157012-01A1; DAQING YANG, Grant/Award Number: GIA; Ye Zhang, Grant/Award Number: NSFC; National Cancer Institute of National Institute of Health, Grant/Award Number: 1R01CA157012-01A1; The University of Minnesota, Grant/Award Number: GIA; National Natural Science Foundation of China	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andrisse S, 2014, REDOX BIOL, V2, P764, DOI 10.1016/j.redox.2014.03.004; Andrisse S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066027; Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Chen CT, 2012, MOL CANCER THER, V11, P2212, DOI 10.1158/1535-7163.MCT-12-0180; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Ching JK, 2013, APPL PHYSIOL NUTR ME, V38, P589, DOI 10.1139/apnm-2012-0175; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Ferretti AC, 2016, ONCOTARGET, V7, P17815, DOI 10.18632/oncotarget.7404; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Grossmann Michael E, 2015, Curr Pharmacol Rep, V1, P312; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Halaby MJ, 2013, BIOCHEM BIOPH RES CO, V435, P708, DOI 10.1016/j.bbrc.2013.05.047; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoffman K, 1996, CANCER CHEMOTH PHARM, V37, P254; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Jang SM, 2012, J BREAST CANCER, V15, P172, DOI 10.4048/jbc.2012.15.2.172; Kang XW, 2015, CELL PHYSIOL BIOCHEM, V35, P1008, DOI 10.1159/000373928; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Krohn NG, 2014, G3-GENES GENOM GENET, V4, P49, DOI 10.1534/g3.113.008607; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Leighl NB, 2008, BREAST CANCER RES TR, V108, P87, DOI 10.1007/s10549-007-9584-x; Li DD, 2015, MOL MED REP, V12, P8148, DOI 10.3892/mmr.2015.4445; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matsuura K, 2016, INT REV CEL MOL BIO, V327, P43, DOI 10.1016/bs.ircmb.2016.06.006; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Santos JM, 2020, NUTR CANCER, V72, P734, DOI 10.1080/01635581.2019.1654527; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Stagni V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7886; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Ueda S, 2008, JPN J CLIN ONCOL, V38, P250, DOI 10.1093/jjco/hyn019; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Yang DQ, 2016, FEBS LETT, V590, P3179, DOI 10.1002/1873-3468.12360; Yang DQ, 2011, DRUG DISCOV TODAY, V16, P332, DOI 10.1016/j.drudis.2011.02.001; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zelenko Z, 2016, ENDOCR-RELAT CANCER, V23, P747, DOI 10.1530/ERC-16-0142; Zielinska HA, 2018, CANCER LETT, V419, P187, DOI 10.1016/j.canlet.2018.01.028	47	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21264	10.1096/fj.202001415RR	http://dx.doi.org/10.1096/fj.202001415RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715230				2022-12-28	WOS:000635216100047
J	Jaufmann, J; Franke, FC; Sperlich, A; Blumendeller, C; Kloos, I; Schneider, B; Sasaki, D; Janssen, KP; Beer-Hammer, S				Jaufmann, Jennifer; Franke, Fabian Christoph; Sperlich, Andreas; Blumendeller, Carolin; Kloos, Isabel; Schneider, Barbara; Sasaki, Daisuke; Janssen, Klaus-Peter; Beer-Hammer, Sandra			The emerging and diverse roles of the SLy/SASH1-protein family in health and disease Overview of three multifunctional proteins	FASEB JOURNAL			English	Review						adaptor proteins; apoptosis; cancer; cell biology; immune regulation; intracellular signaling; SLy/ SASH1-protein family	TUMOR-SUPPRESSOR GENE; CELL-PROLIFERATION; DOWN-SYNDROME; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; ADAPTIVE IMMUNITY; SASH1 INTERACTS; SH3 DOMAINS; EXPRESSION; ACTIVATION	Intracellular adaptor proteins arc indispensable for the transduction of receptor-derived signals, as they recruit and connect essential downstream effectors. The SLy/ SASH1-adaptor family comprises three highly homologous proteins, all of them sharing conserved structural motifs. The initial characterization of the first member SLy1/SASH3 (SH3 protein expressed in lymphocytes 1) in 2001 was rapidly followed by identification of SLy2/HACS1 (hematopoictic adaptor containing SH3 and SAM domains 1) and SASH1/SLy3 (SAM and SH3 domain containing 1). Based on their pronounced sequence similarity, they were subsequently classified as one family of intracellular scaffold proteins. Despite their obvious homology, the three SLy/SASH1-members fundamentally differ with regard to their expression and function in intracellular signaling. On the contrary, growing evidence clearly demonstrates an important role of all three proteins in human health and disease. In this review, we systematically summarize what is known about the SLy/SASH1-adaptors in the field of molecular cell biology and immunology. To this end, we recapitulate current research about SLy1/SASH3, SLy2/HACS1, and SASH1/SLy3, with an emphasis on their similarities and differences.	[Jaufmann, Jennifer; Blumendeller, Carolin; Kloos, Isabel; Schneider, Barbara; Beer-Hammer, Sandra] Univ Tubingen, Inst Expt & Clin Pharmacol & Pharmacogenom, Dept Pharmacol Expt Therapy & Toxicol, Tubingen, Germany; [Jaufmann, Jennifer; Blumendeller, Carolin; Kloos, Isabel; Schneider, Barbara; Beer-Hammer, Sandra] Univ Tubingen, ICePhA, Tubingen, Germany; [Franke, Fabian Christoph; Sperlich, Andreas; Sasaki, Daisuke; Janssen, Klaus-Peter] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Ismaninger Str 22, D-81765 Munich, Germany; [Sasaki, Daisuke] Nitto Boseki Co Ltd, Gen Res Inst, Med SC New Technol Strategy Off, Tokyo, Japan	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Technical University of Munich	Janssen, KP (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Ismaninger Str 22, D-81765 Munich, Germany.; Beer-Hammer, S (corresponding author), Eberhard Karls Univ Tubingen, Dept Pharmacol Expt Therapy & Toxicol, D-72074 Tubingen, Germany.	klaus-peter.janssen@tum.de; sandra.beer-hammer@uni-tuebingen.de			Deutsche Forschungsgemeinschaft (DFG) [BE2813/1-2]; Jurgen Manchot Stiftung (Jurgen Manchot Foundation)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Jurgen Manchot Stiftung (Jurgen Manchot Foundation)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: BE2813/1-2; Jurgen Manchot Stiftung (Jurgen Manchot Foundation)	Acevedo CM, 2002, CANCER-AM CANCER SOC, V94, P793, DOI 10.1002/cncr.10275; Alcock HE, 2003, GENE CHROMOSOME CANC, V37, P369, DOI 10.1002/gcc.10201; Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Amend SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127828; [Anonymous], **DATA OBJECT**; Araki Y, 2020, PIGM CELL MELANOMA R, DOI 10.1111/pcmr.12930; Arefanian S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238543; Astoul E, 2003, J BIOL CHEM, V278, P9267, DOI 10.1074/jbc.M211252200; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Barghorn A, 2001, AM J PATHOL, V158, P1903, DOI 10.1016/S0002-9440(10)64658-5; Bat-Erdene A, 2019, BRIT J HAEMATOL, V185, P969, DOI 10.1111/bjh.15673; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Beer S, 2005, MOL CELL BIOL, V25, P9646, DOI 10.1128/MCB.25.21.9646-9660.2005; Beer S, 2001, BBA-GENE STRUCT EXPR, V1520, P89, DOI 10.1016/S0167-4781(01)00242-1; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Brandt S, 2010, INT J BIOCHEM CELL B, V42, P1472, DOI 10.1016/j.biocel.2010.05.004; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Burgess JT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75625-1; Burgess JT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.364; Burgess JT, 2016, ONCOTARGET, V7, P72807, DOI 10.18632/oncotarget.12020; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chen EG, 2012, TUMOR BIOL, V33, P1393, DOI 10.1007/s13277-012-0387-2; Chen H, 2016, MOL MED REP, V13, P3613, DOI 10.3892/mmr.2016.4946; Chen SZ, 2020, ONCOTARGETS THER, V13, P4617, DOI 10.2147/OTT.S234667; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Cohen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025558; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Cotte C, 2017, VACCINE, V35, P3520, DOI 10.1016/j.vaccine.2017.05.039; Coulombe P, 2019, CELL REP, V27, P1769, DOI 10.1016/j.celrep.2019.04.039; Courcet JB, 2015, EUR J HUM GENET, V23, P957, DOI 10.1038/ejhg.2014.213; Cui HZ, 2020, INT J BIOL SCI, V16, P1264, DOI 10.7150/ijbs.38415; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Dauphinee SM, 2013, J IMMUNOL, V191, P892, DOI 10.4049/jimmunol.1200583; De Hingh YCM, 2005, J PEDIATR-US, V147, P744, DOI 10.1016/j.jpeds.2005.07.022; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Eckschlager T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071414; Emslie D, 2008, J EXP MED, V205, P409, DOI 10.1084/jem.20072049; Englund A, 2013, AM J MED GENET A, V161A, P642, DOI 10.1002/ajmg.a.35706; Fang Q, 2018, ONCOTARGET, V9, P2475, DOI 10.18632/oncotarget.23504; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Franke FC, 2020, INT J CANCER, V147, P1715, DOI 10.1002/ijc.32955; Franke FC, 2019, CELL MOL GASTROENTER, V7, P33, DOI 10.1016/j.jcmgh.2018.08.007; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hong CW, 2012, SEMIN IMMUNOL, V24, P151, DOI 10.1016/j.smim.2012.02.002; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Janssen K., 2014, ATLAS GENET CYTOGENE, V18, p236; Jaufmann J, 2019, J HEMATOL MULT MYELO, V4, P1019; Jaufmann J, 2021, IMMUN INFLAMM DIS, V9, P533, DOI 10.1002/iid3.413; Jaufmann J, 2020, IMMUN INFLAMM DIS, V8, P736, DOI 10.1002/iid3.365; Jin Y, 2020, INT J BIOCHEM CELL B, V127, DOI 10.1016/j.biocel.2020.105846; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanda M, 2016, ONCOL LETT, V12, P4708, DOI 10.3892/ol.2016.5233; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kay BK, 2012, FEBS LETT, V586, P2606, DOI 10.1016/j.febslet.2012.05.025; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kusters MAA, 2009, CLIN EXP IMMUNOL, V156, P189, DOI 10.1111/j.1365-2249.2009.03890.x; Kwan JJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01397-z; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li XQ, 2020, EPIGENOMICS-UK, V12, P893, DOI 10.2217/epi-2020-0060; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Lin SY, 2013, J BUON, V18, P891; Lin SY, 2012, MOL MED REP, V6, P1243, DOI 10.3892/mmr.2012.1099; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Martini M, 2011, INT J BIOCHEM CELL B, V43, P1630, DOI 10.1016/j.biocel.2011.07.012; Meng QB, 2013, MOL CELL BIOCHEM, V373, P201, DOI 10.1007/s11010-012-1491-8; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Ni IBP, 2012, HEMATOL REP, V4, P60, DOI 10.4081/hr.2012.e19; Nitsche U, 2012, ANN SURG, V256, P763, DOI 10.1097/SLA.0b013e318272de87; Noll JE, 2014, NEOPLASIA, V16, P572, DOI 10.1016/j.neo.2014.07.002; Norian LA, 2000, SEMIN IMMUNOL, V12, P43; Pan J, 2016, INT J CLIN EXP PATHO, V9, P750; Pang MY, 2011, J CELL BIOCHEM, V112, P2138, DOI 10.1002/jcb.23135; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peng L, 2014, J BUON, V19, P1041; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rajkumar SV, 2016, AM J HEMATOL, V91, P720, DOI 10.1002/ajh.24402; RAMESH N, 1995, CLIN IMMUNOL IMMUNOP, V76, pS208, DOI 10.1016/S0090-1229(95)90252-X; Reis B, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-38; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Rolink AG, 2004, IMMUNOL REV, V197, P41, DOI 10.1111/j.0105-2896.2004.0101.x; Schall D, 2015, EUR J IMMUNOL, V45, P3087, DOI 10.1002/eji.201545609; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Scheikl T, 2009, MOL IMMUNOL, V46, P969, DOI 10.1016/j.molimm.2008.09.023; Schmitt F, 2015, EUR J IMMUNOL, V45, P60, DOI 10.1002/eji.201444882; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shellman YG, 2015, J INVEST DERMATOL, V135, P3192, DOI 10.1038/jid.2015.292; Shridhar V, 1999, ONCOGENE, V18, P3913, DOI 10.1038/sj.onc.1202756; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sperlich A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4940-2; Srikantan V, 1999, INT J CANCER, V84, P331, DOI 10.1002/(SICI)1097-0215(19990621)84:3<331::AID-IJC23>3.0.CO;2-J; Stubblefield K, 2017, EXP CELL RES, V359, P384, DOI 10.1016/j.yexcr.2017.08.022; Sueoka S, 2015, ANN SURG ONCOL, V22, pS1453, DOI 10.1245/s10434-015-4524-1; Sun DW, 2015, INT J CLIN EXP PATHO, V8, P12276; Tao W, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00613; Trzcinski K, 2005, INFECT IMMUN, V73, P7043, DOI 10.1128/IAI.73.10.7043-7046.2005; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; Uchida T, 2001, BIOCHEM BIOPH RES CO, V288, P137, DOI 10.1006/bbrc.2001.5722; UGAZIO AG, 1990, AM J MED GENET, P204; Verdugo RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050888; Viiri KM, 2009, MOL CELL BIOL, V29, P342, DOI 10.1128/MCB.01213-08; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; von Holleben M, 2011, J BIOL CHEM, V286, P13489, DOI 10.1074/jbc.M110.155184; Wan M, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP2395, 10.1289/ehp2395]; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Wang JB, 2017, ACTA DERM-VENEREOL, V97, P530, DOI 10.2340/00015555-2575; Watanabe T, 2011, CLIN COLORECTAL CANC, V10, P134, DOI 10.1016/j.clcc.2011.03.011; Weidmann H, 2015, ATHEROSCLEROSIS, V242, P571, DOI 10.1016/j.atherosclerosis.2015.08.013; Wu DJ, 2019, PATHOL RES PRACT, V215, P115, DOI 10.1016/j.prp.2018.10.012; Xu ZX, 2020, INT J MOL MED, V46, P1118, DOI 10.3892/ijmm.2020.4652; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yang L, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/383046; Yang L, 2012, TUMOR BIOL, V33, P2255, DOI 10.1007/s13277-012-0487-z; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhang J, 2016, CLIN GENET, V90, P372, DOI 10.1111/cge.12728; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhang YM, 1997, GENE CHROMOSOME CANC, V18, P310, DOI 10.1002/(SICI)1098-2264(199704)18:4<310::AID-GCC10>3.0.CO;2-K; Zhong WL, 2019, INDIAN J DERMATOL VE, V85, DOI 10.4103/ijdvl.IJDVL_360_17; Zhou DA, 2017, J CELL MOL MED, V21, P2465, DOI 10.1111/jcmm.13168; Zhou DA, 2017, J CELL MOL MED, V21, P802, DOI 10.1111/jcmm.13022; Zhou DA, 2013, CELL SIGNAL, V25, P1526, DOI 10.1016/j.cellsig.2012.12.025; Zhou MM, 1995, PROG BIOPHYS MOL BIO, V64, P221, DOI 10.1016/S0079-6107(96)00005-3; Zhou N, 2018, HUM PATHOL, V74, P83, DOI 10.1016/j.humpath.2018.01.008; Zhu YX, 2019, J CELL MOL MED, V23, P93, DOI 10.1111/jcmm.13887; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816; Zong W, 2016, ONCOL RES, V24, P17, DOI 10.3727/096504016X14570992647203	140	4	4	5	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21470	10.1096/fj.202002495R	http://dx.doi.org/10.1096/fj.202002495R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710696				2022-12-28	WOS:000635216100001
J	Lindsay, A; Holm, J; Razzoli, M; Bartolomucci, A; Ervasti, JM; Lowe, DA				Lindsay, Angus; Holm, John; Razzoli, Maria; Bartolomucci, Alessandro; Ervasti, James M.; Lowe, Dawn A.			Some dystrophy phenotypes of dystrophin-deficient mdx mice are exacerbated by mild, repetitive daily stress	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; Dystrophin; fibrosis; hypothalamic&#8208; pituitary&#8208; adrenal axis; skeletal muscle		Psychosocial stressors can cause physical inactivity, cardiac damage, and hypotension-induced death in the mdx mouse model of Duchenne muscular dystrophy (DMD). Because repeated exposure to mild stress can lead to habituation in wild-type mice, we investigated the response of mdx mice to a mild, daily stress to determine whether habituation occurred. Male mdx mice were exposed to a 30-sec scruff restraint daily for 12 weeks. Scruff restraint induced immediate physical inactivity that persisted for at least 60 minutes, and this inactivity response was just as robust after 12 weeks as it was after one day. Physical inactivity in the mdx mice was not associated with acute skeletal muscle contractile dysfunction. However, skeletal muscle of mdx mice that were repeatedly stressed had slow-twitch and tetanic relaxation times and trended toward high passive stiffness, possibly due to a small but significant increase in muscle fibrosis. Elevated urinary corticosterone secretion, adrenal hypertrophy, and a larger adrenal cortex indicating chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis were measured in 12-week stressed mdx mice relative to those unstressed. However, pharmacological inhibition of the HPA axis did not affect scruff-induced physical inactivity and acute corticosterone injection did not recapitulate the scruff-induced phenotype, suggesting the HPA axis is not the driver of physical inactivity. Our results indicate that the response of mdx mice to an acute mild stress is non-habituating and that when that stressor is repeated daily for weeks, it is sufficient to exacerbate some phenotypes associated with dystrophinopathy in mdx mice.	[Lindsay, Angus; Lowe, Dawn A.] Univ Minnesota, Dept Rehabil Med, Minneapolis, MN USA; [Lindsay, Angus; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Lindsay, Angus] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia; [Holm, John] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Razzoli, Maria; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Deakin University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lowe, DA (corresponding author), Univ Minnesota, Dept Rehabil Med, Div Rehabil Sci & Phys Therapy, Minneapolis, MN 55455 USA.	lowex017@umn.edu		Lowe, Dawn/0000-0002-5784-9289; Lindsay, Angus/0000-0002-5195-1901	UM | Lillehei Heart Institute, University of Minnesota (LHI, UM); HHS | National Institutes of Health (NIH) [R01 AR042423, R01 AR049899]; Muscular Dystrophy Association (MDA) [349549]; Summer's Wish Foundation; Greg Marzolf Jr. Foundation	UM | Lillehei Heart Institute, University of Minnesota (LHI, UM); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Summer's Wish Foundation; Greg Marzolf Jr. Foundation	UM | Lillehei Heart Institute, University of Minnesota (LHI, UM); HHS | National Institutes of Health (NIH), Grant/Award Number: R01 AR042423 and R01 AR049899; Muscular Dystrophy Association (MDA), Grant/Award Number: 349549; Summer's Wish Foundation; Greg Marzolf Jr. Foundation, Grant/Award Number: Research Grant	Aupy P, 2020, MOL THER-METH CLIN D, V17, P1037, DOI 10.1016/j.omtm.2020.04.025; Belanto JJ, 2016, HUM MOL GENET, V25, P4951, DOI 10.1093/hmg/ddw318; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; Bonnefont-Rousselot D, 2002, REDOX REP, V7, P145, DOI 10.1179/135100002125000389; Chaussenot R, 2015, NEUROBIOL LEARN MEM, V124, P111, DOI 10.1016/j.nlm.2015.07.006; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Johansen IB, 2011, J EXP BIOL, V214, P1313, DOI 10.1242/jeb.053058; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Lindsay A, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-0221-2; Lindsay A, 2019, FEBS J, V286, P2562, DOI 10.1111/febs.14831; Lindsay A, 2014, PTERIDINES, V25, P53, DOI 10.1515/pteridines-2014-0003; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Moran AL, 2005, EXP GERONTOL, V40, P966, DOI 10.1016/j.exger.2005.09.005; Nelson DM, 2018, HUM MOL GENET, V27, P2090, DOI 10.1093/hmg/ddy113; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Razzoli M, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102700; Rorabaugh BR, 2020, STRESS, V23, P125, DOI 10.1080/10253890.2019.1641081; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Salaria S, 2006, NEUROBIOL DIS, V23, P630, DOI 10.1016/j.nbd.2006.05.003; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Smith ELP, 2002, BRAIN BEHAV IMMUN, V16, P140, DOI 10.1006/brbi.2001.0629; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Strakova J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31753-3; Swiderski K, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-1; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Vaillend C, 2017, HUM MOL GENET, V26, P1041, DOI 10.1093/hmg/ddx013; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yamamoto K, 2010, NEUROMUSCULAR DISORD, V20, P505, DOI 10.1016/j.nmd.2010.05.006	36	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21489	10.1096/fj.202002500R	http://dx.doi.org/10.1096/fj.202002500R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734502				2022-12-28	WOS:000635216100020
J	Mayer, KA; Smole, U; Zhu, C; Derdak, S; Minervina, AA; Salnikova, M; Witzeneder, N; Christamentl, A; Boucheron, N; Waidhofer-Sollner, P; Trauner, M; Hoermann, G; Schmetterer, KG; Mamedov, IZ; Bilban, M; Ellmeier, W; Pickl, WF; Gualdoni, GA; Zlabinger, GJ				Mayer, Katharina A.; Smole, Ursula; Zhu, Ci; Derdak, Sophia; Minervina, Anastasia A.; Salnikova, Maria; Witzeneder, Nadine; Christamentl, Anna; Boucheron, Nicole; Waidhofer-Sollner, Petra; Trauner, Michael; Hoermann, Gregor; Schmetterer, Klaus G.; Mamedov, Ilgar Z.; Bilban, Martin; Ellmeier, Wilfried; Pickl, Winfried F.; Gualdoni, Guido A.; Zlabinger, Gerhard J.			The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells	FASEB JOURNAL			English	Article						AMPK; cellular metabolism; T cell; translation		The importance of cellular metabolic adaptation in inducing robust T cell responses is well established. However, the mechanism by which T cells link information regarding nutrient supply to clonal expansion and effector function is still enigmatic. Herein, we report that the metabolic sensor adenosine monophosphate-activated protein kinase (AMPK) is a critical link between cellular energy demand and translational activity and, thus, orchestrates optimal expansion of T cells in vivo. AMPK deficiency did not affect T cell fate decision, activation, or T effector cell generation; however, the magnitude of T cell responses in murine in vivo models of T cell activation was markedly reduced. This impairment was global, as all T helper cell subsets were similarly sensitive to loss of AMPK which resulted in reduced T cell accumulation in peripheral organs and reduced disease severity in pathophysiologically as diverse models as T cell transfer colitis and allergic airway inflammation. T cell receptor repertoire analysis confirmed similar clonotype frequencies in different lymphoid organs, thereby supporting the concept of a quantitative impairment in clonal expansion rather than a skewed qualitative immune response. In line with these findings, in-depth metabolic analysis revealed a decrease in T cell oxidative metabolism, and gene set enrichment analysis indicated a major reduction in ribosomal biogenesis and mRNA translation in AMPK-deficient T cells. We, thus, provide evidence that through its interference with these delicate processes, AMPK orchestrates the quantitative, but not the qualitative, manifestation of primary T cell responses in vivo.	[Mayer, Katharina A.; Smole, Ursula; Zhu, Ci; Christamentl, Anna; Boucheron, Nicole; Waidhofer-Sollner, Petra; Ellmeier, Wilfried; Pickl, Winfried F.; Zlabinger, Gerhard J.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria; [Zhu, Ci; Trauner, Michael] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Hans Popper Lab Mol Hepatol, Vienna, Austria; [Derdak, Sophia; Bilban, Martin] Med Univ Vienna, Core Facil, Vienna, Austria; [Minervina, Anastasia A.; Salnikova, Maria; Mamedov, Ilgar Z.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Genom Adapt Immun, Moscow, Russia; [Witzeneder, Nadine; Hoermann, Gregor; Schmetterer, Klaus G.; Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Witzeneder, Nadine] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Hoermann, Gregor] MLL Munich Leukemia Lab, Munich, Germany; [Mamedov, Ilgar Z.] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Gualdoni, Guido A.] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Medical University of Vienna; Medical University of Vienna; MLL Munich Leukemia Laboratory; Masaryk University Brno; Medical University of Vienna	Zlabinger, GJ (corresponding author), Med Univ Vienna, Inst Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	gerhard.zlabinger@meduniwien.ac.at	Mamedov, Ilgar Z/H-9559-2014; Hoermann, Gregor/B-8832-2016	Mamedov, Ilgar Z/0000-0002-3992-9285; Trauner, Michael/0000-0002-1275-6425; Boucheron, Nicole/0000-0002-4979-8311; Pickl, Winfried F./0000-0003-0430-4952; Mayer, Katharina/0000-0003-2495-790X; Hoermann, Gregor/0000-0002-7374-4380	Austrian Science Fund (FWF) [DK-W1248, SFB-F4609]; Doctoral Program "Inflammation and Immunity" [DK-IAI W1212]; Russian Foundation for Basic Research (RFBR) [18-29-09132-mk]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Doctoral Program "Inflammation and Immunity"; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	US and WFP were supported by grants DK-W1248 and SFB-F4609, respectively, from the Austrian Science Fund (FWF). CZ was supported by the Doctoral Program "Inflammation and Immunity" (DK-IAI W1212 to MT). IZM received funding from the Russian Foundation for Basic Research (RFBR, grant 18-29-09132-mk)	Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bouladoux Nicolas, 2017, Curr Protoc Immunol, V119, DOI 10.1002/cpim.34; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chiche J, 2019, CELL METAB, V29, P1243, DOI 10.1016/j.cmet.2019.02.002; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eri R, 2012, METHODS MOL BIOL, V844, P261, DOI 10.1007/978-1-61779-527-5_19; Gualdoni GA, 2018, P NATL ACAD SCI USA, V115, pE7158, DOI 10.1073/pnas.1800525115; Gualdoni GA, 2016, FASEB J, V30, P3800, DOI 10.1096/fj.201600522R; Guma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140452; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2015, CLIN CANCER RES, V21, P3836, DOI 10.1158/1078-0432.CCR-14-3300; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Kang KY, 2013, INT IMMUNOPHARMACOL, V16, P85, DOI 10.1016/j.intimp.2013.03.020; Katzman SD, 2011, CYTOKINE, V56, P116, DOI 10.1016/j.cyto.2011.07.005; Kumase F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147279; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Rao EY, 2016, ONCOTARGET, V7, P33783, DOI 10.18632/oncotarget.9277; Rao EY, 2015, ONCOTARGET, V6, P7944, DOI 10.18632/oncotarget.3501; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Ron-Harel N, 2019, CELL REP, V28, P3011, DOI 10.1016/j.celrep.2019.08.034; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smole U, 2020, NAT IMMUNOL, V21, P756, DOI 10.1038/s41590-020-0698-1; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Wei J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00247; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Yoo HS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.45; Zeng H, 2017, CURR OPIN IMMUNOL, V46, P103, DOI 10.1016/j.coi.2017.04.005; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	61	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21217	10.1096/fj.202001763RR	http://dx.doi.org/10.1096/fj.202001763RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715236	Green Published, hybrid			2022-12-28	WOS:000635216100102
J	Viswanathan, P; Sharma, Y; Jaber, FL; Tchaikovskaya, T; Gupta, S				Viswanathan, Preeti; Sharma, Yogeshwar; Jaber, Fadi-Luc; Tchaikovskaya, Tatyana; Gupta, Sanjeev			Transplanted hepatocytes rescue mice in acetaminophen-induced acute liver failure through paracrine signals for hepatic ATM and STAT3 pathways	FASEB JOURNAL			English	Article						cell therapy; DNA damage response; granulocyte colony&#8208; stimulating factor; inflammation; liver sinusoidal endothelial cells		Acute liver failure constitutes a devastating condition that needs novel cell and molecular therapies. To elicit synergisms in cell types of therapeutic interest, we studied hepatocytes and liver sinusoidal endothelial in mice with acetaminophen-induced acute liver failure. The context of regenerative signals was examined by transplants in peritoneal cavity because it possesses considerable capacity and allows soluble signals to enter the systemic circulation. Whereas transplanted hepatocytes and liver sinusoidal endothelial cells engrafted in peritoneal cavity, only the former could rescue mice in liver failure by improving injury outcomes, activating hepatic DNA damage repair, and inducing liver regeneration. The cytokines secreted by donor hepatocytes or liver sinusoidal endothelial cells differed and in hepatocytes from mice undergoing acetaminophen toxicity major cytokines were even rendered deficient (eg, G-CSF, VEGF, and others). Significantly, recapitulating hepatotoxicity-related DNA damage response in cultured cells identified impairments in ATM and JAK/STAT3 intersections since replacing cytokines produced less from injured hepatocytes restored these pathways to avoid acetaminophen hepatotoxicity. Similarly, hepatocyte transplantation in acute liver failure restored ATM and JAK/STAT3 pathways to advance DNA damage/repair and liver regeneration. The unexpected identification of novel hepatic G-CSF receptor expression following injury allowed paradigmatic studies of G-CSF supplementation to confirm the centrality of this paracrine ATM and STAT3 intersection. Remarkably, DNA damage/repair and hepatic regeneration directed by G-CSF concerned rebalancing of regulatory gene networks overseeing inflammation, metabolism, and cell viability. We conclude that healthy donor hepatocytes offer templates for generating specialized cell types to replace metabolic functions and regenerative factors in liver failure.	[Viswanathan, Preeti] Albert Einstein Coll Med, Dept Pediat, Childrens Hosp Montefiore, Div Pediat Gastroenterol, Bronx, NY 10467 USA; [Viswanathan, Preeti; Sharma, Yogeshwar; Jaber, Fadi-Luc; Tchaikovskaya, Tatyana; Gupta, Sanjeev] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Ullmann Bldg,Room 625,1300 Morris Pk Ave, Bronx, NY 10461 USA; [Sharma, Yogeshwar; Jaber, Fadi-Luc; Tchaikovskaya, Tatyana; Gupta, Sanjeev] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Diabet Ctr, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Fle Inst Diabet & Metab, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Irwin S & Sylvia Chanin Inst Canc Res, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gupta, S (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Ullmann Bldg,Room 625,1300 Morris Pk Ave, Bronx, NY 10461 USA.	sanjeev.gupta@einsteinmed.org	Viswanathan, Preeti/ABA-9925-2021		NIH [R01-DK071111, P30-DK41296]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH grants R01-DK071111 and P30-DK41296	Bahde R, 2014, HEPATOLOGY, V59, P1107, DOI 10.1002/hep.26766; Bandi S, 2019, DIFFERENTIATION, V105, P54, DOI 10.1016/j.diff.2019.01.005; Bandi S, 2014, ASSAY DRUG DEV TECHN, V12, P272, DOI 10.1089/adt.2014.571; Bandi S, 2012, J CELL SCI, V125, P1274, DOI 10.1242/jcs.095372; Bandi S, 2011, AM J PATHOL, V178, P161, DOI 10.1016/j.ajpath.2010.11.001; Barcena C, 2015, J HEPATOL, V63, P670, DOI 10.1016/j.jhep.2015.04.013; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Benten D, 2018, LAB INVEST, V98, P525, DOI 10.1038/s41374-017-0010-7; Cao ZW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8710; Dold C, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.21; Du Z, 2015, CELL PROLIFERAT, V48, P293, DOI 10.1111/cpr.12186; Dumbuya JS, 2020, BRAIN RES, V1739, DOI 10.1016/j.brainres.2020.146817; Enami Y, 2012, HEPATOLOGY, V55, P1182, DOI 10.1002/hep.24735; Enami Y, 2009, GASTROENTEROLOGY, V136, P2356, DOI 10.1053/j.gastro.2009.03.003; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Follenzi A, 2012, BLOOD, V119, P5532, DOI 10.1182/blood-2011-07-367680; Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040; Freedman Deborah A, 2007, Novartis Found Symp, V283, P207; Gupta P, 2020, CYTOKINE, V127, DOI 10.1016/j.cyto.2019.154946; Gupta S, 2000, J PATHOL, V190, P203; Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213; Huang W, 2019, ONCOGENE, V38, P6818, DOI 10.1038/s41388-019-0925-0; Jaber FL, 2021, AM J PATHOL, V191, P79, DOI 10.1016/j.ajpath.2020.09.014; Jaber FL, 2017, METHODS MOL BIOL, V1506, P161, DOI 10.1007/978-1-4939-6506-9_11; Kakabadze Z, 2018, HEPATOLOGY, V67, P1956, DOI 10.1002/hep.29713; Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379; Lee WM, 2017, J HEPATOL, V67, P1324, DOI 10.1016/j.jhep.2017.07.005; Lu S, 2005, HUM MOL GENET, V14, P3019, DOI 10.1093/hmg/ddi333; Mehta HM, 2015, J IMMUNOL, V195, P1341, DOI 10.4049/jimmunol.1500861; Meng FY, 2012, HEPATOLOGY, V55, P209, DOI 10.1002/hep.24673; Merlin S, 2016, AM J PATHOL, V186, P539, DOI 10.1016/j.ajpath.2015.11.002; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Olgasi C, 2018, STEM CELL REP, V11, P1391, DOI 10.1016/j.stemcr.2018.10.012; Rajvanshi P, 1996, HEPATOLOGY, V23, P482; Remot A, 2016, EUR J IMMUNOL, V46, P874, DOI 10.1002/eji.201545929; Rowell DL, 1997, AM J PHYSIOL-GASTR L, V273, pG322, DOI 10.1152/ajpgi.1997.273.2.G322; Steuerwald NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081974; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Viswanathan P, 2020, EXP MOL PATHOL, V113, DOI 10.1016/j.yexmp.2020.104369; Viswanathan P, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12445; Viswanathan P, 2016, J HEPATOL, V65, P1171, DOI 10.1016/j.jhep.2016.07.008; Viswanathan P, 2014, HEPATOLOGY, V60, P1378, DOI 10.1002/hep.27232; Woolbright BL, 2017, J HEPATOL, V66, P836, DOI 10.1016/j.jhep.2016.11.017; Wu YM, 2008, HEPATOLOGY, V47, P279, DOI 10.1002/hep.21937; Yadav N, 2019, HUM GENE THER, V30, P365, DOI 10.1089/hum.2018.166; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	49	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21471	10.1096/fj.202002421R	http://dx.doi.org/10.1096/fj.202002421R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33683737				2022-12-28	WOS:000635216100008
J	Wu, Y; Peng, SS; Finnell, RH; Zheng, YF				Wu, Yu; Peng, Sisi; Finnell, Richard H.; Zheng, Yufang			Organoids as a new model system to study neural tube defects	FASEB JOURNAL			English	Review						neural tube; NTDs; organoid		The neural tube is the first critically important structure that develops in the embryo. It serves as the primordium of the central nervous system; therefore, the proper formation of the neural tube is essential to the developing organism. Neural tube defects (NTDs) are severe congenital defects caused by failed neural tube closure during early embryogenesis. The pathogenesis of NTDs is complicated and still not fully understood even after decades of research. While it is an ethically impossible proposition to investigate the in vivo formation process of the neural tube in human embryos, a newly developed technology involving the creation of neural tube organoids serves as an excellent model system with which to study human neural tube formation and the occurrence of NTDs. Herein we reviewed the recent literature on the process of neural tube formation, the progress of NTDs investigations, and particularly the exciting potential to use neural tube organoids to model the cellular and molecular mechanisms underlying the etiology of NTDs.	[Wu, Yu; Peng, Sisi; Zheng, Yufang] Fudan Univ, Sch Life Sci, Dept Cellular & Dev Biol, Shanghai, Peoples R China; [Wu, Yu; Peng, Sisi; Zheng, Yufang] Fudan Univ, Inst Obstet & Gynecol, Obstet & Gynecol Hosp, Shanghai, Peoples R China; [Finnell, Richard H.] Baylor Coll Med, Ctr Precis Environm Hlth, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Finnell, Richard H.] Baylor Coll Med, Ctr Precis Environm Hlth, Dept Mol & Human Genet, Houston, TX 77030 USA; [Finnell, Richard H.] Baylor Coll Med, Dept Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA	Fudan University; Fudan University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zheng, YF (corresponding author), Fudan Univ, Inst Dev Biol & Mol Med, Rm 312,Jiangwan Campus,2005 Songhu Rd, Shanghai 200485, Peoples R China.	zhengyf@fudan.edu.cn	Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624	National Natural Science Foundation of China (NSFC) [81870894]; National Key Research and Development Program of China [2018YFA0800303]; Innovation Program of Shanghai Municipal Education Commission [2019-01-07-00-07-E00041]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870894; National Key Research and Development Program of China, Grant/Award Number: 2018YFA0800303; Innovation Program of Shanghai Municipal Education Commission, Grant/Award Number: 2019-01-07-00-07-E00041	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Avagliano L, 2019, BIRTH DEFECTS RES, V111, P1455, DOI 10.1002/bdr2.1380; Baumholtz AI, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00664; Benedum CM, 2015, AM J EPIDEMIOL, V182, P675, DOI 10.1093/aje/kwv126; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen ZZ, 2018, CELL RES, V28, P1039, DOI 10.1038/s41422-018-0061-3; Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; COCKROFT DL, 1988, TERATOLOGY, V38, P281, DOI 10.1002/tera.1420380312; Copp AJ, 2013, LANCET NEUROL, V12, P799, DOI 10.1016/S1474-4422(13)70110-8; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Demers CJ, 2016, DEVELOPMENT, V143, P1884, DOI 10.1242/dev.126847; Deshwar AR, 2020, CLIN GENET, V98, P299, DOI 10.1111/cge.13804; Duval N, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.175430; Eibach S, 2020, J KOREAN NEUROSURG S, V63, P327, DOI 10.3340/jkns.2020.0018; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Fattah A.R.A., 2020, ACTUATION ENHANCES P, DOI [10.1101/2020.09.22.308411, DOI 10.1101/2020.09.22.308411]; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Gamero-Estevez E, 2018, REPROD TOXICOL, V81, P155, DOI 10.1016/j.reprotox.2018.08.008; Garne E, 2012, BIRTH DEFECTS RES A, V94, P134, DOI 10.1002/bdra.22886; Goetzinger KR, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.100; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Gustavsson P, 2007, EUR J MED GENET, V50, P237, DOI 10.1016/j.ejmg.2007.01.004; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Harris MJ, 2010, BIRTH DEFECTS RES A, V88, P653, DOI 10.1002/bdra.20676; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Liu JF, 2016, BIRTH DEFECTS RES A, V106, P267, DOI 10.1002/bdra.23486; Liu SL, 2019, PAEDIATR PERINAT EP, V33, P145, DOI 10.1111/ppe.12543; Manojlovic Z, 2014, MECH DEVELOP, V132, P28, DOI 10.1016/j.mod.2014.02.001; Massarwa R, 2013, DEVELOPMENT, V140, P226, DOI 10.1242/dev.085001; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Medveczky E, 2004, PHARMACOEPIDEM DR S, V13, P443, DOI 10.1002/pds.900; Meinhardt A, 2014, STEM CELL REP, V3, P987, DOI 10.1016/j.stemcr.2014.09.020; Nikolopoulou E, 2017, DEVELOPMENT, V144, P552, DOI 10.1242/dev.145904; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; O'Rahilly R, 2002, TERATOLOGY, V65, P162, DOI 10.1002/tera.10007; Ogura T, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162214; Pai YJ, 2012, BIRTH DEFECTS RES A, V94, P817, DOI 10.1002/bdra.23072; Park SE, 2019, SCIENCE, V364, P960, DOI 10.1126/science.aaw7894; Ranga A, 2016, P NATL ACAD SCI USA, V113, pE6831, DOI 10.1073/pnas.1603529113; Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021; Richards DJ, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-020-0539-4; Rifes P, 2020, NAT BIOTECHNOL, V38, P1265, DOI 10.1038/s41587-020-0525-0; Runnels LW, 2020, DEV DYNAM, V249, P912, DOI 10.1002/dvdy.182; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Sedykh I, 2018, DEV DYNAM, V247, P650, DOI 10.1002/dvdy.24613; Sharon N, 2011, STEM CELLS, V29, P600, DOI 10.1002/stem.621; Stamm DS, 2006, BIRTH DEFECTS RES A, V76, P499, DOI 10.1002/bdra.20272; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Veenvliet JV, 2020, SCIENCE, V370, P1291, DOI 10.1126/science.aba4937; Waller DK, 2018, BIRTH DEFECTS RES, V110, P342, DOI 10.1002/bdr2.1147; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang SN, 2020, TRANSL STROKE RES, V11, P983, DOI 10.1007/s12975-019-00773-0; Wei J, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2020.105542; Yao Y, 2020, CELL STEM CELL, V26, P17, DOI 10.1016/j.stem.2019.10.010; Zaganjor I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151586; Zheng Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5933; Zohn IE, 2020, ADV EXP MED BIOL, V1236, P39, DOI 10.1007/978-981-15-2389-2_2	73	6	9	5	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21545	10.1096/fj.202002348R	http://dx.doi.org/10.1096/fj.202002348R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33729606	Green Accepted, hybrid			2022-12-28	WOS:000635216100059
J	Zhang, H; Wu, ZP; Yang, LJ; Zhang, Z; Chen, H; Ren, J				Zhang, Hui; Wu, Zhongping; Yang, Lijuan; Zhang, Zhen; Chen, Hao; Ren, Jun			Novel mutations in the Myo5a gene cause a dilute coat color phenotype in mice	FASEB JOURNAL			English	Article						coat color dilution; mice; microsatellite variation; molecular mechanism; Myo5a	TRANSCRIPTION FACTOR-BINDING; OPEN-ACCESS DATABASE; TANDEM REPEATS; GLOBULAR TAIL; MYOSIN V; INTRON; INSIGHTS; JASPAR; MLPH; MICROSATELLITE	C57BL/6 laboratory mice usually show black coat color. We observed a dilute (gray) coat color phenotype in progenies of two C57BL/6 mice. This phenotype is inherited in an autosomal recessive mode. To uncover the molecular mechanism underlying this naturally occurring phenotypic variation, we performed whole-genome sequencing (25x) on 10 offspring of the two founder mice. The whole-genome DNA sequencing and additional RNA-Seq data reveal that Myo5a is the gene responsible for the coat color dilution in C57BL/6 mice, and novel mutations in the Myo5a gene are likely causal. We further performed reverse transcription-quantitative PCR, and showed increased expression of truncated Myo5a transcripts encoding dysfunctional proteins and decreased expression of Myo5a full-length transcripts encoding functional proteins in mutant individuals. The decrease in full-length messenger RNA abundance was accompanied by reduced Myo5a protein level and deficient melanosome transport, a potential mechanistic link between the Myo5a mutations and the dilute color phenotype. This study not only advances our understanding of the molecular mechanisms of pigmentation in mice, but also provides a typical case of deciphering the molecular basis of phenotypic variation in mice by genomic analyses and subsequent functional work.	[Zhang, Hui; Yang, Lijuan; Ren, Jun] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Peoples R China; [Wu, Zhongping] Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Guangzhou, Peoples R China; [Zhang, Zhen] Guilin Med Univ, Coll Biotechnol, Guilin, Peoples R China; [Chen, Hao] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China	South China Agricultural University; Zhongkai University of Agriculture & Engineering; Guilin Medical University; Jiangxi Science & Technology Normal University	Zhang, H; Ren, J (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Peoples R China.	zhanghui520627@hotmail.com; junren@scau.edu.cn	chen, hao/HGA-8980-2022	chen, hao/0000-0002-5210-8924; zhang, hui/0000-0003-0468-3526	Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry; National Natural Science Foundation of China [31525023]	Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry; National Natural Science Foundation of China: 31525023.	Albanese V, 2001, HUM MOL GENET, V10, P1785, DOI 10.1093/hmg/10.17.1785; Bauer A, 2018, ANIM GENET, V49, P94, DOI 10.1111/age.12632; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; Cirera S, 2013, GENE, V527, P48, DOI 10.1016/j.gene.2013.05.047; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Furutani Y, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00027; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Haerry TE, 1996, P NATL ACAD SCI USA, V93, P13884, DOI 10.1073/pnas.93.24.13884; Harper MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053239; Hill M, 2010, PHARMACOGENOMICS J, V10, P442, DOI 10.1038/tpj.2009.66; Hofreiter M, 2010, CELL MOL LIFE SCI, V67, P2591, DOI 10.1007/s00018-010-0333-7; Hou LM, 2019, P NATL ACAD SCI USA, V116, P14583, DOI 10.1073/pnas.1904324116; Hugo H, 2006, GENE CHROMOSOME CANC, V45, P1143, DOI 10.1002/gcc.20378; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liakath-Ali K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4540; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Schwartz AM, 2017, GENE, V602, P50, DOI 10.1016/j.gene.2016.11.032; Sharma VK, 2007, PHYSIOL GENOMICS, V31, P96, DOI 10.1152/physiolgenomics.00183.2006; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Vaez M, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-7; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilkins JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-141; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 1997, J CELL SCI, V110, P847; Wu ZP, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00218; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Zhang WB, 2016, J BIOL CHEM, V291, P13571, DOI 10.1074/jbc.M116.724328	48	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21261	10.1096/fj.201903141RR	http://dx.doi.org/10.1096/fj.201903141RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715225				2022-12-28	WOS:000635216100042
J	Gao, JL; Weaver, JD; Tuo, JS; Wang, LQ; Siwicki, M; Despres, D; Lizak, M; Schneider, EH; Kovacs, W; Maminishkis, A; Chen, KQ; Yoshimura, T; Wang, JM; Chan, CC; Murphy, PM				Gao, Ji-Liang; Weaver, Joseph D.; Tuo, Jingsheng; Wang, Long Q.; Siwicki, Marie; Despres, Daryl; Lizak, Martin; Schneider, Erich H.; Kovacs, William; Maminishkis, Arvydas; Chen, Keqiang; Yoshimura, Teizo; Wang, Ji Ming; Chan, Chi Chao; Murphy, Philip M.			Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation	FASEB JOURNAL			English	Article						cataract; chemoattractant receptor; eye; formyl peptide; G protein; knockout mouse	FIBER CELL-DIFFERENTIATION; FORMYL PEPTIDE RECEPTORS; LENS EPITHELIUM; HOST-DEFENSE; PROTEINS; GROWTH; PAX6	Cataracts are a common consequence of aging; however, pathogenesis remains poorly understood. Here, we observed that after 3 months of age mice lacking the G protein-coupled leukocyte chemotactic receptor Fpr1 (N-formyl peptide receptor 1) began to develop bilateral posterior subcapsular cataracts that progressed to lens rupture and severe degeneration, without evidence of either systemic or local ocular infection or inflammation. Consistent with this, Fpr1 was detected in both mouse and human lens in primary lens epithelial cells (LECs), the only cell type present in the lens; however, expression was confined to subcapsular LECs located along the anterior hemispheric surface. To maximize translucency, LECs at the equator proliferate and migrate posteriorly, then differentiate into lens fiber cells by nonclassical apoptotic signaling, which results in loss of nuclei and other organelles, including mitochondria which are a rich source of endogenous N-formyl peptides. In this regard, denucleation and posterior migration of LECs were abnormal in lenses from Fpr1(-/-) mice, and direct stimulation of LECs with the prototypic N-formyl peptide agonist fMLF promoted apoptosis. Thus, Fpr1 is repurposed beyond its immunoregulatory role in leukocytes to protect against cataract formation and lens degeneration during aging.	[Gao, Ji-Liang; Weaver, Joseph D.; Wang, Long Q.; Siwicki, Marie; Schneider, Erich H.; Kovacs, William; Murphy, Philip M.] NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Room 11N113, Bethesda, MD 20892 USA; [Tuo, Jingsheng; Chan, Chi Chao] NEI, Lab Immunol, NIH, Bethesda, MD 20892 USA; [Despres, Daryl; Lizak, Martin] NIH, Mouse Imaging Facil, Bldg 10, Bethesda, MD 20892 USA; [Maminishkis, Arvydas] NEI, Sect Epithelial & Retinal Physiol & Dis, NIH, Bethesda, MD 20892 USA; [Chen, Keqiang; Wang, Ji Ming] Natl Canc Inst Frederick, Ctr Canc Res, Lab Canc & Immunometab, Frederick, MD USA; [Yoshimura, Teizo] Okayama Univ, Dept Pathol & Expt Med, Okayama, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Okayama University	Murphy, PM (corresponding author), NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Room 11N113, Bethesda, MD 20892 USA.	pmm@nih.gov						Aliancy J.F., 1995, WEBVISION ORG RETINA; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; Dahm R, 1999, OPHTHALMIC RES, V31, P163, DOI 10.1159/000055530; de Paulis A, 2009, J IMMUNOL, V183, P3761, DOI 10.4049/jimmunol.0900863; ESHAGHIAN J, 1980, ARCH OPHTHALMOL-CHIC, V98, P134, DOI 10.1001/archopht.1980.01020030136016; Gao JL, 2011, BEHAV GENET, V41, P724, DOI 10.1007/s10519-011-9467-0; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; GREINER JV, 1979, ARCH OPHTHALMOL-CHIC, V97, P135, DOI 10.1001/archopht.1979.01020010069017; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P1874; Lee CM, 2017, CURR OPIN OPHTHALMOL, V28, P98, DOI 10.1097/ICU.0000000000000340; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Martinez G, 2010, INT J BIOCHEM CELL B, V42, P1945, DOI 10.1016/j.biocel.2010.09.012; Minogue PJ, 2017, INVEST OPHTH VIS SCI, V58, P4366, DOI 10.1167/iovs.17-21684; Muta M, 2002, GENES CELLS, V7, P791, DOI 10.1046/j.1365-2443.2002.00560.x; NAKAMURA T, 1995, P NATL ACAD SCI USA, V92, P6142, DOI 10.1073/pnas.92.13.6142; Nicolas-Leveque C, 1999, INVEST OPHTH VIS SCI, V40, P1812; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Reddan JR, 1999, EXP EYE RES, V68, P117, DOI 10.1006/exer.1998.0606; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Schneider EH, 2012, J BIOL CHEM, V287, P40779, DOI 10.1074/jbc.M112.411181; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; STREETEN BW, 1978, ARCH OPHTHALMOL-CHIC, V96, P1653, DOI 10.1001/archopht.1978.03910060279020; Thompson J, 2015, PRIMARY CARE, V42, P409, DOI 10.1016/j.pop.2015.05.012; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Wiley LA, 2011, DIS MODEL MECH, V4, P484, DOI 10.1242/dmm.006593; WORGUL BV, 1976, ARCH OPHTHALMOL-CHIC, V94, P996, DOI 10.1001/archopht.1976.03910030506013; Wormstone IM, 2011, PHILOS T R SOC B, V366, P1190, DOI 10.1098/rstb.2010.0377; Wormstone IM, 2002, EXP EYE RES, V74, P337, DOI 10.1006/exer.2001.1153; Wride MA, 1999, DEV BIOL, V213, P142, DOI 10.1006/dbio.1999.9375; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang MH, 2020, J IMMUNOL, V204, P2464, DOI 10.4049/jimmunol.1900430; Zhang XG, 2011, INVEST OPHTH VIS SCI, V52, P3160, DOI 10.1167/iovs.10-5156	43	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21315	10.1096/fj.202002135R	http://dx.doi.org/10.1096/fj.202002135R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33538366				2022-12-28	WOS:000647789600053
J	Tian, QY; Fan, XF; Ma, JS; Li, DT; Han, YJ; Yin, XH; Wang, H; Huang, TT; Wang, ZL; Shentu, YP; Xue, F; Du, CK; Wang, YY; Mao, SZ; Fan, JM; Gong, YS				Tian, Qiuyun; Fan, Xiaofang; Ma, Jianshe; Li, Dantong; Han, Yujiao; Yin, Xianghong; Wang, Hui; Huang, Tingting; Wang, Zhenglu; Shentu, Yangping; Xue, Feng; Du, Congkuo; Wang, Yongyu; Mao, Sunzhong; Fan, Junming; Gong, Yongsheng			Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice	FASEB JOURNAL			English	Article						hypoxia; pulmonary hypertension; STAT3; vascular remodeling; VGLL4	SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; TUMOR-SUPPRESSOR; SIRT1 PROTECTS; PROLIFERATION; CANCER; METHYLATION; INHIBITION; INDUCTION; STAT3	Pulmonary hypertension (PH), a rare but deadly cardiopulmonary disorder, is characterized by extensive remodeling of pulmonary arteries resulting from enhancement of pulmonary artery smooth muscle cell proliferation and suppressed apoptosis; however, the underlying pathophysiological mechanisms remain largely unknown. Recently, epigenetics has gained increasing prominence in the development of PH. We aimed to investigate the role of vestigial-like family member 4 (VGLL4) in chronic normobaric hypoxia (CNH)-induced PH and to address whether it is associated with epigenetic regulation. The rodent model of PH was established by CNH treatment (10% O-2, 23 hours/day). Western blot, quantitative reverse transcription polymerase chain reaction, immunofluorescence, immunoprecipitation, and adeno-associated virus tests were performed to explore the potential mechanisms involved in CNH-induced PH in mice. VGLL4 expression was upregulated and correlated with CNH in PH mouse lung tissues in a time-dependent manner. VGLL4 colocalized with alpha-smooth muscle actin in cultured pulmonary arterial smooth muscle cells (PASMCs), and VGLL4 immunoactivity was increased in PASMCs following hypoxia exposure in vitro. VGLL4 knockdown attenuated CNH-induced PH and pulmonary artery remodeling by blunting signal transducer and activator of transcription 3 (STAT3) signaling; conversely, VGLL4 overexpression exacerbated the development of PH. CNH enhanced the acetylation of VGLL4 and increased the interaction of ac-H3K9/VGLL4 and ac-H3K9/STAT3 in the lung tissues, and levels of ac-H3K9, p-STAT3/STAT3, and proliferation-associated protein levels were markedly up-regulated, whereas apoptosis-related protein levels were significantly downregulated, in the lung tissues of mice with CNH-induced PH. Notably, abrogation of VGLL4 acetylation reversed CNH-induced PH and pulmonary artery remodeling and suppressed STAT3 signaling. Finally, STAT3 knockdown alleviated CNH-induced PH. In conclusion, VGLL4 acetylation upregulation could contribute to CNH-induced PH and pulmonary artery remodeling via STAT3 signaling, and abrogation of VGLL4 acetylation reversed CNH-induced PH. Pharmacological or genetic deletion of VGLL4 might be a potential target for therapeutic interventions in CNH-induced PH.	[Tian, Qiuyun; Fan, Xiaofang; Ma, Jianshe; Li, Dantong; Han, Yujiao; Yin, Xianghong; Wang, Hui; Huang, Tingting; Xue, Feng; Du, Congkuo; Wang, Yongyu; Mao, Sunzhong; Fan, Junming; Gong, Yongsheng] Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Zhenglu] Wenzhou Med Univ, Renji Coll, Wenzhou, Peoples R China; [Shentu, Yangping] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Fan, JM; Gong, YS (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China.	fjmelite@163.com; fxbwzmc@126.com	huang, ting/GRR-3141-2022		Zhejiang Provincial Natural Science Foundation of China [LY20H010001, LY18H010007, LY17H010007]; National Natural Science Foundation of China [81900403, 31900685]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LY20H010001, LY18H010007 and LY17H010007; National Natural Science Foundation of China, Grant/Award Number: 81900403 and 31900685	Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Bertero T, 2016, J CLIN INVEST, V126, P3313, DOI 10.1172/JCI86387; Bertero T, 2015, CELL REP, V13, P1016, DOI 10.1016/j.celrep.2015.09.049; Boucherat O, 2017, PULM CIRC, V7, P285, DOI 10.1177/2045893217701438; Cai ZY, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0068-3; Chelladurai P, 2021, BRIT J PHARMACOL, V178, P54, DOI 10.1111/bph.14932; Chen B, 2014, AM J PHYSIOL-LUNG C, V307, pL317, DOI 10.1152/ajplung.00285.2013; Chen F, 2016, FREE RADICAL BIO MED, V99, P167, DOI 10.1016/j.freeradbiomed.2016.08.003; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Courboulin A, 2012, EUR RESPIR J, V40, P618, DOI 10.1183/09031936.00084211; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Dieffenbach PB, 2017, AM J PHYSIOL-LUNG C, V313, pL628, DOI 10.1152/ajplung.00173.2017; Ding MG, 2015, J CARDIOVASC PHARM, V65, P562, DOI 10.1097/FJC.0000000000000224; Fan JM, 2020, INT J BIOL SCI, V16, P515, DOI 10.7150/ijbs.34517; Fan JM, 2018, NEUROSCIENCE, V381, P22, DOI 10.1016/j.neuroscience.2018.04.013; Fan JM, 2016, HIGH ALT MED BIOL, V17, P43, DOI 10.1089/ham.2015.0086; Fang L, 2018, CANCER CELL, V34, P103, DOI 10.1016/j.ccell.2018.06.002; Gamen E, 2016, EUR RESPIR J, V48, P903, DOI 10.1183/13993003.01714-2015; Ghosh S, 2016, AM J PHYSIOL-LUNG C, V310, pL1199, DOI 10.1152/ajplung.00092.2016; Guignabert C, 2013, EUR RESPIR REV, V22, P543, DOI 10.1183/09059180.00007513; He JL, 2018, BRIT J PHARMACOL, V175, P1354, DOI 10.1111/bph.13806; Jiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14058; Kim J, 2017, J CLIN INVEST, V127, P3447, DOI 10.1172/JCI93825; Li N, 2015, AM J CANCER RES, V5, P1158; Lin ZQ, 2016, DEV CELL, V39, P466, DOI 10.1016/j.devcel.2016.09.005; Mao B, 2014, ONCOGENE, V33, P1468, DOI 10.1038/onc.2013.88; Mao SZ, 2014, PULM PHARMACOL THER, V27, P1, DOI 10.1016/j.pupt.2013.06.004; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Neto F, 2018, ELIFE, V7, DOI 10.7554/eLife.31037; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Paffett ML, 2012, VASC PHARMACOL, V56, P64, DOI 10.1016/j.vph.2011.11.002; Paulin R, 2011, CIRCULATION, V123, P1205, DOI 10.1161/CIRCULATIONAHA.110.963314; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Samanta S, 2017, BBA-MOL BASIS DIS, V1863, P518, DOI 10.1016/j.bbadis.2016.11.030; Shen H, 2020, CIRCULATION, V142, P1190, DOI 10.1161/CIRCULATIONAHA.120.048191; Song HM, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0338-8; Stenmark KR, 2018, CARDIOVASC RES, V114, P551, DOI 10.1093/cvr/cvy004; Tian QY, 2020, TOXICOL APPL PHARM, V408, DOI 10.1016/j.taap.2020.115261; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Wang Y, 2018, PHYSIOL GENOMICS, V50, P313, DOI 10.1152/physiolgenomics.00069.2017; Wu AL, 2019, EMBO J, V38, DOI 10.15252/embj.201899506; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yu W, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007977; Yuan WC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07394-5; Zhang EC, 2016, AM J CANCER RES, V6, P2901; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176; Zurlo G, 2018, J HYPERTENS, V36, P1164, DOI 10.1097/HJH.0000000000001676	50	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21822	10.1096/fj.202002650RR	http://dx.doi.org/10.1096/fj.202002650RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314061				2022-12-28	WOS:000678975300021
J	Bi, ZJ; Zhang, SS; Meng, YY; Feng, Y; Wang, YS; Wang, EK; Pan, XX; Zhu, RX; Fan, HT; Pang, SH; Zhu, LX; Yuan, JY				Bi, Zijuan; Zhang, Shisheng; Meng, Yangyang; Feng, Ya; Wang, Yinshu; Wang, Enkang; Pan, Xiangxue; Zhu, Ruixin; Fan, Haiting; Pang, Shuhua; Zhu, Lixin; Yuan, Jianye			Female serotonin transporter-knockout rat: A potential model of irritable bowel syndrome	FASEB JOURNAL			English	Article						5-HT receptors; dopamine transporter; irritable bowel syndrome; serotonin transporter; visceral hypersensitivity	FUNCTIONAL GASTROINTESTINAL DISORDERS; VISCERAL HYPERSENSITIVITY; RECEPTORS CONTRIBUTE; REUPTAKE INHIBITORS; 5-HT7 RECEPTOR; MESSENGER-RNA; 5-HYDROXYTRYPTAMINE; EXPRESSION; PREDOMINANT; DOPAMINE	Irritable bowel syndrome (IBS) is a common functional gastrointestinal disease. Although visceral hypersensitivity (VH) and disturbed gastrointestinal motility are typical pathophysiological features of IBS, the pathological mechanisms underlying this disease remain unclear. Serotonin system abnormalities are considered to play an important role in the pathomechanisms of IBS. Here, we hypothesize that similar alterations, including VH and colonic motility, induced by serotonin transporter (SERT) knockout result from altered serotonin signaling. We sought to determine the molecular mechanism underlying VH and colonic dysmotility induced by SERT knockout. We found that female SERT (slc6a4)-knockout (KO; ie, slc6a4(-/-)) rats exhibited lower pain pressure thresholds (PPTs) than wild-type (WT; ie, slc6a4(+/+)) rats in response to colorectal distension (CRD). Significantly increased fecal pellet output and reduced concentration of serum tryptophan were observed in the female SERT KO rats. The concentrations of 5-hydroxytryptamine (5-HT) in platelet-rich plasma (PRP) and serum in SERT KO rats were lower than those in WT rats, but the numbers of enterochromaffin cells (ECs) and the concentrations of 5-HT in colon of SERT KO rats were higher than those of WT rats. Finally, increased expression levels of 5-HT1B receptors, 5-HT2C receptors, 5-HT3A receptors, 5-HT3B receptors, 5-HT6 receptors, 5-HT7 receptors, and glycosylated dopamine transporters (DATs) were found in the female SERT KO rats. We concluded that alterations in the serotonin system induced by the knockout of slc6a4 might result in VH and accelerated gastrointestinal motility in female SERT KO rats, which can be used as an animal model of IBS.	[Bi, Zijuan; Meng, Yangyang; Feng, Ya; Wang, Yinshu; Wang, Enkang; Zhu, Lixin; Yuan, Jianye] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China; [Zhang, Shisheng; Zhu, Ruixin] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Zhang, Shisheng] Univ Sydney, Fac Engn & IT, Sch AMME, Sydney, NSW, Australia; [Pan, Xiangxue] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai, Peoples R China; [Fan, Haiting] Shanghai Univ Tradit Chinese Med, Lab Anim Ctr, Shanghai, Peoples R China; [Pang, Shuhua] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Clin Lab, Shanghai, Peoples R China; [Zhu, Lixin] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Inst Gastroenterol, Dept Colorectal Surg, Guangzhou, Peoples R China	Shanghai University of Traditional Chinese Medicine; Tongji University; University of Sydney; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Sun Yat Sen University	Zhu, LX; Yuan, JY (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China.; Zhu, LX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Inst Gastroenterol, Dept Colorectal Surg, Guangzhou, Peoples R China.	zhulx6@mail.sysu.edu.cn; yuanjianye@hotmail.com	Zhu, Ruixin/CAJ-1106-2022; , 金石为开/AFU-9737-2022; Yuan, Jianye/L-7858-2018	Yuan, Jianye/0000-0003-3728-2083; Zhu, Lixin/0000-0001-7904-1769; Zhang, Shisheng/0000-0002-1612-0694	National Natural Science Foundation of China [81473630, 81874391]; Xinglin Young Talent Program [RC-2017-02-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinglin Young Talent Program	This study has been carried out under the auspices of the National Natural Science Foundation of China (No. 81473630; 81874391), Xinglin Scholar, Xinglin Young Talent Program (No. RC-2017-02-07). We would like to thank: two reviewers and the journal editors, who have provided constructive comments; Dr Xuhui Bao from Duke University Medical Center for his useful suggestions on English editing.	Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Pineda-Farias JB, 2017, PHARMACOL REP, V69, P916, DOI 10.1016/j.pharep.2017.04.001; Camilleri M, 2004, GUT, V53, P1396, DOI 10.1136/gut.2004.039826; Camilleri M, 2007, GASTROENTEROLOGY, V132, P17, DOI 10.1053/j.gastro.2006.11.020; Cervantes-Duran C, 2013, NEUROSCIENCE, V252, P396, DOI 10.1016/j.neuroscience.2013.08.022; Ceuleers H, 2016, WORLD J GASTROENTERO, V22, P10275, DOI 10.3748/wjg.v22.i47.10275; Clarke G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00090; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Cui XF, 2014, WORLD J GASTROENTERO, V20, P13521, DOI 10.3748/wjg.v20.i37.13521; Delvaux M, 1998, ALIMENT PHARM THER, V12, P849, DOI 10.1046/j.1365-2036.1998.00375.x; DEVANE CL, 1995, HUM PSYCHOPHARM CLIN, V10, pS185, DOI 10.1002/hup.470100907; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1262, DOI 10.1053/j.gastro.2016.02.032; Efimova EV, 2016, J NEUROGENET, V30, P5, DOI 10.3109/01677063.2016.1144751; EGLEN RM, 1995, TRENDS PHARMACOL SCI, V16, P391, DOI 10.1016/S0165-6147(00)89081-1; El-Ayache N, 2019, AM J PHYSIOL-GASTR L, V316, pG132, DOI 10.1152/ajpgi.00131.2018; El-Salhy M, 2020, NEUROPEPTIDES, V79, DOI 10.1016/j.npep.2019.101973; Enck P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.14; Foley S, 2011, GASTROENTEROLOGY, V140, P1434, DOI 10.1053/j.gastro.2011.01.052; FoxxOrenstein AE, 1996, GASTROENTEROLOGY, V111, P1281, DOI 10.1053/gast.1996.v111.pm8898642; Franke L, 2010, J GASTROENTEROL, V45, P389, DOI 10.1007/s00535-009-0167-y; Galligan JJ, 2013, NEUROGASTROENT MOTIL, V25, pe373, DOI 10.1111/nmo.12133; Gellynck E, 2013, EXP BRAIN RES, V230, P555, DOI 10.1007/s00221-013-3694-y; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Haffmans PMJ, 1996, INT CLIN PSYCHOPHARM, V11, P157, DOI 10.1097/00004850-199609000-00002; Hagino Y, 2011, CURR NEUROPHARMACOL, V9, P91, DOI 10.2174/157015911795017254; Hegde SS, 1996, FASEB J, V10, P1398, DOI 10.1096/fasebj.10.12.8903510; Hong S, 2009, GUT, V58, P202, DOI 10.1136/gut.2008.157594; Houghton LA, 2009, ALIMENT PHARM THER, V30, P919, DOI 10.1111/j.1365-2036.2009.04121.x; Huot P, 2016, J PHARMACOL EXP THER, V357, P562, DOI 10.1124/jpet.116.232371; Jin DC, 2016, WORLD J GASTROENTERO, V22, P8137, DOI 10.3748/wjg.v22.i36.8137; Jin ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08953-4; Katsumata R, 2017, INTERNAL MED, V56, P993, DOI 10.2169/internalmedicine.56.7674; Kerckhoffs APM, 2012, AM J PHYSIOL-GASTR L, V302, pG1053, DOI 10.1152/ajpgi.00153.2011; Krasaelap A, 2017, PEDIATR ANN, V46, pE120, DOI 10.3928/19382359-20170213-01; Kumar S, 2012, J GASTROINTEST LIVER, V21, P31; Lanfumey L, 2004, CNS NEUROL DISORD-DR, V3, P1, DOI 10.2174/1568007043482570; LEATHWOOD PD, 1987, P NUTR SOC, V46, P143, DOI 10.1079/PNS19870018; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Liu MY, 2017, CHINESE MED J-PEKING, V130, P2219, DOI 10.4103/0366-6999.213966; Lovell RM, 2012, AM J GASTROENTEROL, V107, P1793, DOI 10.1038/ajg.2012.336; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Montanez S, 2014, NEUROCHEM INT, V73, P127, DOI 10.1016/j.neuint.2013.11.004; Nakajima K, 2009, EUR J PAIN, V13, P441, DOI 10.1016/j.ejpain.2008.06.007; Nelson DL, 2004, CNS NEUROL DISORD-DR, V3, P53, DOI 10.2174/1568007043482606; Nikiforuk A, 2015, CNS DRUGS, V29, P265, DOI 10.1007/s40263-015-0236-0; Nishijima H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00575; Nongonierma AB, 2015, FOOD FUNCT, V6, P2115, DOI [10.1039/c5fo00407a, 10.1039/C5FO00407A]; Oliver KH, 2016, J BIOL CHEM, V291, P20210, DOI 10.1074/jbc.M116.736983; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Prusator DK, 2016, NEUROGASTROENT MOTIL, V28, P1876, DOI 10.1111/nmo.12891; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Serrats J, 2004, SYNAPSE, V51, P102, DOI 10.1002/syn.10287; Shang JJ, 2013, WORLD J GASTROENTERO, V19, P8071, DOI 10.3748/wjg.v19.i44.8071; Shi HL, 2015, WORLD J GASTROENTERO, V21, P4852, DOI 10.3748/wjg.v21.i16.4852; Sobczak M, 2014, EUR J PHARMACOL, V736, P63, DOI 10.1016/j.ejphar.2014.04.038; Spigset O, 1999, DRUG SAFETY, V20, P277, DOI 10.2165/00002018-199920030-00007; Sun JH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0863-5; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Thumshirn M, 2000, ALIMENT PHARM THERAP, V14, P869; Tonini M, 2005, GASTROENTEROLOGY, V129, P1557, DOI 10.1053/j.gastro.2005.08.005; Wang YM, 2012, NEUROGASTROENT MOTIL, V24, P560, DOI 10.1111/j.1365-2982.2012.01902.x; Wang YS, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01082; Woolley ML, 2004, CNS NEUROL DISORD-DR, V3, P59, DOI 10.2174/1568007043482561; Xie C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127815; Xu GZ, 2020, NEUROPHARMACOLOGY, V165, DOI 10.1016/j.neuropharm.2019.107926; Yan C, 2012, BRAZ J MED BIOL RES, V45, P948, DOI 10.1590/S0100-879X2012007500122; Yu YB, 2010, NEUROCHEM RES, V35, P797, DOI 10.1007/s11064-010-0137-z; Zheng YP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172846; Zhu YB, 2018, GENE, V679, P133, DOI 10.1016/j.gene.2018.08.059; Zou BC, 2007, CHINESE MED J-PEKING, V120, P2069, DOI 10.1097/00029330-200712010-00002	71	4	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21701	10.1096/fj.202000007RRR	http://dx.doi.org/10.1096/fj.202000007RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143529				2022-12-28	WOS:000667814100015
J	Cruces-Solis, H; Babaev, O; Ali, H; Chatain, CP; Mykytiuk, V; Balekoglu, N; Wenger, S; Krueger-Burg, D				Cruces-Solis, Hugo; Babaev, Olga; Ali, Heba; Piletti Chatain, Carolina; Mykytiuk, Vasyl; Balekoglu, Nursen; Wenger, Sally; Krueger-Burg, Dilja			Altered theta and beta oscillatory synchrony in a genetic mouse model of pathological anxiety	FASEB JOURNAL			English	Article						coherence; conditional; Cre; fear; GABA; neuroligin2; NL2	MEDIAL PREFRONTAL CORTEX; INHIBITORY SYNAPSES; GAMMA-OSCILLATIONS; HIPPOCAMPAL THETA; AMYGDALA CIRCUITS; NEUROLIGIN-2; FEAR; DYSFUNCTION; DEPRESSION; PATTERNS	While the neural circuits mediating normal, adaptive defensive behaviors have been extensively studied, substantially less is currently known about the network mechanisms by which aberrant, pathological anxiety is encoded in the brain. Here we investigate in mice how deletion of Neuroligin-2 (Nlgn2), an inhibitory synapse-specific adhesion protein that has been associated with pathological anxiety and other psychiatric disorders, alters the communication between key brain regions involved in mediating defensive behaviors. To this end, we performed multi-site simultaneous local field potential (LFP) recordings from the basolateral amygdala (BLA), centromedial amygdala (CeM), bed nucleus of the stria terminalis (BNST), prefrontal cortex (mPFC) and ventral hippocampus (vHPC) in an open field paradigm. We found that LFP power in the vHPC was profoundly increased and was accompanied by an abnormal modulation of the synchrony of theta frequency oscillations particularly in the vHPC-mPFC-BLA circuit. Moreover, deletion of Nlgn2 increased beta and gamma frequency synchrony across the network, and this increase was associated with increased center avoidance. Local deletion of Nlgn2 in the vHPC and BLA revealed that they encode distinct aspects of this avoidance phenotype, with vHPC linked to immobility and BLA linked to a reduction in exploratory activity. Together, our data demonstrate that alterations in long-range functional connectivity link synaptic inhibition to abnormal defensive behaviors, and that both exaggerated activation of normal defensive circuits and recruitment of fundamentally distinct mechanisms contribute to this phenotype. Nlgn2 knockout mice therefore represent a highly relevant model to study the role of inhibitory synaptic transmission in the circuits underlying anxiety disorders.	[Cruces-Solis, Hugo; Babaev, Olga; Ali, Heba; Piletti Chatain, Carolina; Mykytiuk, Vasyl; Balekoglu, Nursen; Wenger, Sally; Krueger-Burg, Dilja] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany; [Babaev, Olga; Ali, Heba; Piletti Chatain, Carolina; Mykytiuk, Vasyl] Univ Gottingen, Gottingen Grad Sch Neurosci Biophys & Mol Biosci, Gottingen, Germany; [Krueger-Burg, Dilja] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Von Siebold Str 5, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Krueger-Burg, D (corresponding author), Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Von Siebold Str 5, D-37075 Gottingen, Germany.	dilja.krueger-burg@med.uni-goettingen.de		Mykytiuk, Vasyl/0000-0001-9495-2093; Krueger-Burg, Dilja/0000-0001-5597-6287	Brain and Behavior Research Foundation (BBRF); Minerva Foundation (Minerva Stiftung); European Commission (EC)	Brain and Behavior Research Foundation (BBRF); Minerva Foundation (Minerva Stiftung); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre)	Brain and Behavior Research Foundation (BBRF); Minerva Foundation (Minerva Stiftung); European Commission (EC)	Adhikari A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00112; Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Ali H, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abd8379; Amilhon B, 2015, NEURON, V86, P1277, DOI 10.1016/j.neuron.2015.05.027; Babaev O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07762-1; Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8; Babaev O, 2016, NEUROPHARMACOLOGY, V100, P56, DOI 10.1016/j.neuropharm.2015.06.016; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Bocchio M, 2017, NEURON, V94, P731, DOI 10.1016/j.neuron.2017.03.022; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Chen G, 2017, NEURON, V96, P1403, DOI 10.1016/j.neuron.2017.11.033; Craske MG, 2016, LANCET, V388, P3048, DOI 10.1016/S0140-6736(16)30381-6; Engin E, 2018, TRENDS PHARMACOL SCI, V39, P710, DOI 10.1016/j.tips.2018.04.003; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Grundemann J, 2019, SCIENCE, V364, P254, DOI 10.1126/science.aav8736; Haegens S, 2011, P NATL ACAD SCI USA, V108, P10708, DOI 10.1073/pnas.1107297108; Hammer M, 2015, CELL REP, V13, P516, DOI 10.1016/j.celrep.2015.09.011; Harris AZ, 2015, ANNU REV NEUROSCI, V38, P171, DOI 10.1146/annurev-neuro-071714-034111; Heshmati M, 2018, P NATL ACAD SCI USA, V115, P1111, DOI 10.1073/pnas.1719014115; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kirkby LA, 2018, CELL, V175, P1688, DOI 10.1016/j.cell.2018.10.005; Korotkova T, 2018, NEUROSCI BIOBEHAV R, V85, P65, DOI 10.1016/j.neubiorev.2017.09.004; Krueger-Burg D, 2017, CURR OPIN NEUROBIOL, V45, P66, DOI 10.1016/j.conb.2017.04.003; Lebow MA, 2016, MOL PSYCHIATR, V21, P450, DOI 10.1038/mp.2016.1; Lee SC, 2017, NEURON, V96, P81, DOI 10.1016/j.neuron.2017.09.002; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Liang J, 2015, MOL PSYCHIATR, V20, P850, DOI 10.1038/mp.2015.31; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lopes G, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00007; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mathalon DH, 2015, JAMA PSYCHIAT, V72, P840, DOI 10.1001/jamapsychiatry.2015.0483; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Osoegawa K, 2000, GENOME RES, V10, P116; Padilla-Coreano N, 2019, NEURON, V104, P601, DOI 10.1016/j.neuron.2019.08.006; Padilla-Coreano N, 2016, NEURON, V89, P857, DOI 10.1016/j.neuron.2016.01.011; Parente DJ, 2017, AM J MED GENET A, V173, P213, DOI 10.1002/ajmg.a.37977; Parnaudeau S, 2013, NEURON, V77, P1151, DOI 10.1016/j.neuron.2013.01.038; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Putman P, 2010, BIOL PSYCHOL, V83, P73, DOI 10.1016/j.biopsycho.2009.10.008; Shillington A, 2021, J AUTISM DEV DISORD, V51, P371, DOI 10.1007/s10803-020-04531-2; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Troyano-Rodriguez E, 2019, BIOL PSYCHIAT, V85, P1046, DOI 10.1016/j.biopsych.2019.01.022; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Xu J, 2019, NEUROSCI BIOBEHAV R, V96, P21, DOI 10.1016/j.neubiorev.2018.11.005	66	1	1	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21585	10.1096/fj.202002028RR	http://dx.doi.org/10.1096/fj.202002028RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	33960026	hybrid			2022-12-28	WOS:000655695900012
J	Huang, YM; Xu, XX; Arvan, P; Liu, M				Huang, Yumeng; Xu, Xiaoxi; Arvan, Peter; Liu, Ming			Deficient endoplasmic reticulum translocon-associated protein complex limits the biosynthesis of proinsulin and insulin	FASEB JOURNAL			English	Article						diabetes; insulin secretion; pancreatic beta cell; preproinsulin; translocation	TRAP; CONTRIBUTES	The conserved endoplasmic reticulum (ER) membrane protein TRAP alpha (translocon-associated protein, also known as signal sequence receptor 1, SSR1) has been reported to play a critical but unclear role in insulin biosynthesis. TRAP alpha/SSR1 is one component of a four-protein complex including TRAP beta/SSR2, TRAP gamma/SSR3, and TRAP delta/SSR4. The TRAP complex topologically has a small exposure on the cytosolic side of the ER via its TRAP gamma/SSR3 subunit, whereas TRAP beta/SSR2 and TRAP delta/SSR4 function along with TRAP alpha/SSR1 largely on the luminal side of the ER membrane. Here, we have examined pancreatic beta-cells with deficient expression of either TRAP beta/SSR2 or TRAP delta/SSR4, which does not perturb mRNA expression levels of other TRAP subunits, or insulin mRNA. However, deficient protein expression of TRAP beta/SSR2 and, to a lesser degree, TRAPd/SSR4, diminishes the protein levels of other TRAP subunits, concomitant with deficient steady-state levels of proinsulin and insulin. Deficient TRAP beta/SSR2 or TRAP delta/SSR4 is not associated with any apparent defect of exocytotic mechanism but rather by a decreased abundance of the proinsulin and insulin that accompanies glucose-stimulated secretion. Amino acid pulse labeling directly establishes that much of the steady-state deficiency of intracellular proinsulin can be accounted for by diminished proinsulin biosynthesis, observed in a pulse-labeling as short as 5 minutes. The proinsulin and insulin levels in TRAP beta/SSR2 or TRAP delta/SSR4 null mutant beta-cells are notably recovered upon re-expression of the missing TRAP subunit, accompanying a rebound of proinsulin biosynthesis. Remarkably, overexpression of TRAP alpha/SSR1 can also suppress defects in beta-cells with diminished expression of TRAP beta/SSR2, strongly suggesting that TRAP beta/SSR2 is needed to support TRAP alpha/SSR1 function.	[Huang, Yumeng; Xu, Xiaoxi; Liu, Ming] Tianjin Med Univ, Gen Hosp, Dept Endocrinol & Metab, Tianjin, Peoples R China; [Huang, Yumeng; Xu, Xiaoxi; Arvan, Peter; Liu, Ming] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA	Tianjin Medical University; University of Michigan System; University of Michigan	Arvan, P; Liu, M (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA.	parvan@umich.edu; mingliu@tmu.edu.cn						Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; Dittner-Moormann S., 2020, J MED GENET; Nguyen D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06188-z; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Gemmer M, 2020, J CELL SCI, V133, DOI 10.1242/jcs.231340; Guo H, 2018, J BIOL CHEM, V293, P1899, DOI 10.1074/jbc.RA117.000922; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; HOLTHUIS JCM, 1995, BIOCHEM J, V312, P205, DOI 10.1042/bj3120205; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Kriegler T, 2020, J MOL BIOL, V432, DOI 10.1016/j.jmb.2020.10.028; Lang S, 2019, SUBCELL BIOCHEM, V93, P83, DOI 10.1007/978-3-030-28151-9_4; Li X., 2019, SCI ADV, V5, P1; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2018, DIABETES OBES METAB, V20, P28, DOI 10.1111/dom.13378; Losfeld ME, 2014, HUM MOL GENET, V23, P1602, DOI 10.1093/hmg/ddt550; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933; Ng BG, 2019, J INHERIT METAB DIS, V42, P993, DOI 10.1002/jimd.12091; Pfeffer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14516; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211; Yamaguchi J, 2006, J BIOL CHEM, V281, P27063, DOI 10.1074/jbc.M606809200	25	4	4	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21515	10.1096/fj.202002774R	http://dx.doi.org/10.1096/fj.202002774R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811688	Green Accepted, Green Published			2022-12-28	WOS:000645260100013
J	Castro, J; Maddern, J; Grundy, L; Manavis, J; Harrington, AM; Schober, G; Brierley, SM				Castro, Joel; Maddern, Jessica; Grundy, Luke; Manavis, Jim; Harrington, Andrea M.; Schober, Gudrun; Brierley, Stuart M.			A mouse model of endometriosis that displays vaginal, colon, cutaneous, and bladder sensory comorbidities	FASEB JOURNAL			English	Article						bladder dysfunction; colonic hypersensitivity; cutaneous mechanical and thermal hypersensitivity; endometriotic lesions; vaginal hypersensitivity		Endometriosis is a painful inflammatory disorder affecting similar to 10% of women of reproductive age. Although chronic pelvic pain (CPP) remains the main symptom of endometriosis patients, adequate treatments for CPP are lacking. Animal models that recapitulate the features and symptoms experienced by women with endometriosis are essential for investigating the etiology of endometriosis, as well as developing new treatments. In this study, we used an autologous mouse model of endometriosis to examine a combination of disease features and symptoms including: a 10 week time course of endometriotic lesion development; the chronic inflammatory environment and development of neuroangiogenesis within lesions; sensory hypersensitivity and altered pain responses to vaginal, colon, bladder, and skin stimulation in conscious animals; and spontaneous animal behavior. We found significant increases in lesion size from week 6 post-transplant. Lesions displayed endometrial glands, stroma, and underwent neuroangiogenesis. Additionally, peritoneal fluid of mice with endometriosis contained known inflammatory mediators and angiogenic factors. Compared to Sham, mice with endometriosis displayed: enhanced sensitivity to pain evoked by (i) vaginal and (ii) colorectal distension, (iii) altered bladder function and increased sensitivity to cutaneous (iv) thermal and (v) mechanical stimuli. The development of endometriosis had no effect on spontaneous behavior. This study describes a comprehensive characterization of a mouse model of endometriosis, recapitulating the clinical features and symptoms experienced by women with endometriosis. Moreover, it delivers the groundwork to investigate the etiology of endometriosis and provides a platform for the development of therapeutical interventions to manage endometriosis-associated CPP.	[Castro, Joel; Maddern, Jessica; Grundy, Luke; Harrington, Andrea M.; Schober, Gudrun; Brierley, Stuart M.] Flinders Univ S Australia, Flinders Hlth & Med Res Inst FHMRI, Coll Med & Publ Hlth, Visceral Pain Res Grp, Bedford Pk, SA, Australia; [Castro, Joel; Maddern, Jessica; Grundy, Luke; Harrington, Andrea M.; Schober, Gudrun; Brierley, Stuart M.] South Australian Hlth & Med Res Inst SAHMRI, Lifelong Hlth Theme, Hopwood Ctr Neurobiol, Adelaide, SA 5000, Australia; [Manavis, Jim] Univ Adelaide Adelaide, Fac Hlth & Med Sci, Sch Med, Adelaide, SA, Australia; [Brierley, Stuart M.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Adelaide	Castro, J (corresponding author), South Australian Hlth & Med Res Inst SAHMRI, Lifelong Hlth Theme, Hopwood Ctr Neurobiol, Adelaide, SA 5000, Australia.	joel.castro@sahmri.com		Harrington, Andrea/0000-0002-1562-4137; Grundy, Luke/0000-0002-3900-7141; Castro, Joel/0000-0002-5781-2224; Brierley, Stuart/0000-0002-2527-2905	National Health and Medical Research Council (NHMRC) [APP1181448, APP1126378, 1139366, 1140297]; The Hospital Research Foundation (THRF) [SAPhD000242018]; Australian Research Council (ARC) Discovery Early Career Research [DE130100223, DP180101395]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); The Hospital Research Foundation (THRF); Australian Research Council (ARC) Discovery Early Career Research(Australian Research Council)	National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1181448, APP1126378, #1139366 and #1140297; The Hospital Research Foundation (THRF), Grant/Award Number: SAPhD000242018; Australian Research Council (ARC) Discovery Early Career Research, Grant/Award Number: DE130100223 and DP180101395	Abbott J, 2004, FERTIL STERIL, V82, P878, DOI 10.1016/j.fertnstert.2004.03.046; Adamson GD, 2010, J ENDOMETR PELVIC PA, V2, P3, DOI 10.1177/228402651000200102; Allen C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub3; Asante A, 2011, ANNU REV PHYSIOL, V73, P163, DOI 10.1146/annurev-physiol-012110-142158; Bajaj P, 2003, J PAIN, V4, P372, DOI 10.1016/S1526-5900(03)00720-X; Bakacak M, 2015, TURK J OBSTET GYNECO, V12, P125, DOI 10.4274/tjod.71601; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Barcz E, 2000, Med Sci Monit, V6, P1042; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bedaiwy MA, 2002, HUM REPROD, V17, P426, DOI 10.1093/humrep/17.2.426; Berkley KJ, 2007, PAIN, V132, pS150, DOI 10.1016/j.pain.2007.09.022; Berkley KJ, 2001, NEUROSCI LETT, V306, P185, DOI 10.1016/S0304-3940(01)01906-1; Braun KM, 2014, SEMIN PEDIATR SURG, V23, P336, DOI 10.1053/j.sempedsurg.2014.06.004; Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub4; Bruner-Tran KL, 2018, CURR WOMENS HEALTH R, V14, P173, DOI 10.2174/1573404813666170921162041; Burns KA, 2018, ENDOCRINOLOGY, V159, P103, DOI 10.1210/en.2017-00562; Burns KA, 2012, ENDOCRINOLOGY, V153, P3960, DOI 10.1210/en.2012-1294; Busacca M, 2006, J MINIM INVAS GYN, V13, P49, DOI 10.1016/j.jmig.2005.10.002; Carstens BB, 2016, ANGEW CHEM INT EDIT, V55, P4692, DOI 10.1002/anie.201600297; Cason AM, 2003, HORM BEHAV, V44, P123, DOI 10.1016/S0018-506X(03)00121-1; Castro J, 2021, PAIN, V162, P227, DOI 10.1097/j.pain.0000000000002036; Castro J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131712; Castro J, 2018, BRIT J PHARMACOL, V175, P2384, DOI 10.1111/bph.14115; Castro J, 2017, GASTROENTEROLOGY, V152, pS204, DOI 10.1016/S0016-5085(17)30989-7; Chung Maurice K, 2005, JSLS, V9, P25; Chung Maurice K, 2002, JSLS, V6, P311; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; Dmitrieva N, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00158; Exacoustos C, 2014, BEST PRACT RES CL OB, V28, P655, DOI 10.1016/j.bpobgyn.2014.04.010; Falcone T, 2018, OBSTET GYNECOL, V131, P557, DOI 10.1097/AOG.0000000000002469; Finnie GS, 2017, J COMP PATHOL, V156, P389, DOI 10.1016/j.jcpa.2017.03.001; Ge P, 2019, PAIN, V160, P2566, DOI 10.1097/j.pain.0000000000001657; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Grundy L, 2020, AM J PHYSIOL-RENAL, V318, pF298, DOI 10.1152/ajprenal.00435.2019; Grundy L, 2019, ANNU REV PHYSIOL, V81, P261, DOI 10.1146/annurev-physiol-020518-114525; Grundy L, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121841; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Harrington AM, 2012, J COMP NEUROL, V520, P2241, DOI 10.1002/cne.23042; Herington JL, 2011, FERTIL STERIL, V95, P1295, DOI 10.1016/j.fertnstert.2010.09.017; Hill WG, 2018, AM J PHYSIOL-RENAL, V315, pF1422, DOI 10.1152/ajprenal.00350.2018; Howard FM, 2000, J AM ASSOC GYN LAP, V7, P477, DOI 10.1016/S1074-3804(05)60360-X; Inserra MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42810; Jarrell J, 2015, J OBSTET GYNAECOL CA, V37, P628, DOI 10.1016/S1701-2163(15)30201-2; Jess T, 2012, GUT, V61, P1279, DOI 10.1136/gutjnl-2011-301095; Jimenez-Vargas NN, 2018, P NATL ACAD SCI USA, V115, pE7438, DOI 10.1073/pnas.1721891115; Kajitani T, 2013, ENDOCR J, V60, P1155; Kim NY, 2011, EUR J OBSTET GYN R B, V154, P85, DOI 10.1016/j.ejogrb.2010.08.008; Laux-Biehlmann A, 2015, TRENDS PHARMACOL SCI, V36, P270, DOI 10.1016/j.tips.2015.03.004; Li T, 2018, BIOL REPROD, V99, P349, DOI 10.1093/biolre/ioy035; Liang YC, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0441-z; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; McAllister SL, 2016, MOL CELL ENDOCRINOL, V437, P120, DOI 10.1016/j.mce.2016.08.017; McAllister SL, 2009, PAIN, V147, P255, DOI 10.1016/j.pain.2009.09.022; McKinnon B, 2012, FERTIL STERIL, V97, P373, DOI 10.1016/j.fertnstert.2011.11.011; Mechsner S, 2009, FERTIL STERIL, V92, P1856, DOI 10.1016/j.fertnstert.2008.09.006; MOEN MH, 1992, ACTA OBSTET GYN SCAN, V71, P337, DOI 10.3109/00016349209021069; Morotti M, 2017, EUR J OBSTET GYN R B, V209, P8, DOI 10.1016/j.ejogrb.2016.07.497; Morotti M, 2014, HUM REPROD UPDATE, V20, P717, DOI 10.1093/humupd/dmu021; Morrison TC, 2006, FERTIL STERIL, V86, P1067, DOI 10.1016/j.fertnstert.2006.03.026; Nagabukuro H, 2007, PAIN, V132, pS96, DOI 10.1016/j.pain.2007.04.039; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Nijs J, 2011, MANUAL THER, V16, P413, DOI 10.1016/j.math.2011.04.005; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Pelch KE, 2012, JOVE-J VIS EXP, DOI 10.3791/3396; Prodromidou A, 2018, J INVEST SURG, V31, P275, DOI 10.1080/08941939.2017.1317374; Rogers PAW, 2017, REPROD SCI, V24, P202, DOI 10.1177/1933719116654991; RYAN IP, 1995, FERTIL STERIL, V63, P929, DOI 10.1016/S0015-0282(16)57506-2; Salvatierra J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121000; Scholl B, 2009, GYNECOL ENDOCRINOL, V25, P701, DOI 10.3109/09513590903159680; Schomacker ML, 2018, EUR J OBSTET GYN R B, V231, P65, DOI 10.1016/j.ejogrb.2018.10.023; Shakiba K, 2008, OBSTET GYNECOL, V111, P1285, DOI 10.1097/AOG.0b013e3181758ec6; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Slater H, 2015, PAIN, V156, P2468, DOI 10.1097/j.pain.0000000000000317; Somigliana E, 1999, HUM REPROD, V14, P2944, DOI 10.1093/humrep/14.12.2944; Stilley JAW, 2009, BIOL REPROD, V80, P649, DOI 10.1095/biolreprod.108.073411; Stocks MM, 2017, REPROD SCI, V24, P1121, DOI 10.1177/1933719117698584; Surrey ES, 2018, J WOMENS HEALTH, V27, P1114, DOI 10.1089/jwh.2017.6432; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; Tirlapur SA, 2013, INT J SURG, V11, P233, DOI 10.1016/j.ijsu.2013.02.003; Tokushige N, 2006, HUM REPROD, V21, P3001, DOI 10.1093/humrep/del260; Vercellini P, 2007, HUM REPROD, V22, P266, DOI 10.1093/humrep/del339; VERNON MW, 1985, FERTIL STERIL, V44, P684; Vincent K, 2011, PAIN, V152, P1966, DOI 10.1016/j.pain.2011.03.029; Wieser F, 2002, BJOG-INT J OBSTET GY, V109, P1298, DOI 10.1046/j.1471-0528.2002.01087.x; Yildirim G, 2009, J TURK-GER GYNECOL A, V10, P199; Zhang GH, 2008, AM J PHYSIOL-REG I, V294, pR162, DOI 10.1152/ajpregu.00649.2007	88	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21430	10.1096/fj.202002441R	http://dx.doi.org/10.1096/fj.202002441R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749885				2022-12-28	WOS:000635216100057
J	Chen, JQ; Sun, JR; Hu, YF; Wan, XL; Wang, YW; Gao, M; Liang, J; Liu, T; Sun, XD				Chen, Jieqiong; Sun, Junran; Hu, Yifan; Wan, Xiaoling; Wang, Yuwei; Gao, Min; Liang, Jian; Liu, Te; Sun, Xiaodong			MicroRNA-191-5p ameliorates amyloid-beta(1-40)-mediated retinal pigment epithelium cell injury by suppressing the NLRP3 inflammasome pathway	FASEB JOURNAL			English	Article						A beta; C/EBP beta; miR-191-5P; NLRP3; retinal pigment epithelium		Amyloid beta (A beta) is a crucial component of drusen, the hallmark of the early stage of age-related macular degeneration (AMD), and can cause retinal pigment epithelium (RPE) cell damage through activation of the inflammatory response. MicroRNAs play a critical role in inflammation. However, the mechanism underlying the effect of microRNAs on the NLRP3 inflammasome induced by A beta remains poorly understood. In the present study, we demonstrated that A beta(1-)(40) -mediated RPE damage by inducing a decrease in endogenous miR-191-5p expression. This led to the upregulation of its target gene, C/EBP beta, C/EBP beta acts as a transcription factor for NLRP3, promotes its transcription, and upregulates the downstream inflammatory factors Caspase-1 and IL-1 beta. Correspondingly, overexpression of miR-191-5p alleviated RPE cell injury by suppressing inflammation. The present study elucidates a novel transcriptional regulatory mechanism of the NLRP3 inflammasome. Our findings suggest an anti-inflammatory effect of miR-191-5p in A beta(1-40)-induced RPE impairment, shedding light on novel preventive or therapeutic approaches for AMD-associated RPE impairment.	[Chen, Jieqiong; Sun, Junran; Hu, Yifan; Wan, Xiaoling; Wang, Yuwei; Gao, Min; Liang, Jian; Sun, Xiaodong] Shanghai Gen Hosp, Dept Ophthalmol,Shanghai Engn Ctr Precise Diag &, Shanghai First Peoples Hosp,Shanghai Engn Ctr Vis, Natl Clin Res Ctr Eye Dis,Shanghai Key Lab Ocular, Shanghai, Peoples R China; [Chen, Jieqiong; Hu, Yifan; Wang, Yuwei; Gao, Min; Sun, Xiaodong] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Liu, Te] Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, 365 South Xiangyang Rd, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Liu, T (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, 365 South Xiangyang Rd, Shanghai 200031, Peoples R China.; Sun, XD (corresponding author), Shanghai Gen Hosp, Natl Clin Res Ctr Eye Dis, Shanghai Key Lab Ocular Fundus Dis, Shanghai Engn Ctr Visual Sci & Photomed,Shanghai, 100 Haining Rd, Shanghai 200080, Peoples R China.	0721160004@mail.tongji.edu.cn; xdsun@sjtu.edu.cn			National Natural Science Foundation of China [81730026, 81700843]; National Key RD Program [2017YFA0105301]; Science and Technology Commission of Shanghai Municipality [17411953000]; Shanghai Sailing Program [19YF1439600, 19YF1439200, BJ-LM2018001J]; National Key R&D Program of China [2016YFC0904800, 2019YFC0840607]; National Science and Technology Major Project of China [2017ZX09304010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD Program; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Sailing Program; National Key R&D Program of China; National Science and Technology Major Project of China	National Natural Science Foundation of China, Grant/Award Number: 81730026 and 81700843; National Key R&D Program, Grant/Award Number: 2017YFA0105301; Science and Technology Commission of Shanghai Municipality, Grant/Award Number: 17411953000; Shanghai Sailing Program, Grant/Award Number: 19YF1439600 and 19YF1439200; Bethune-Langmu, Grant/Award Number: BJ-LM2018001J; National Key R&D Program of China, Grant/Award Number: 2016YFC0904800 and 2019YFC0840607; National Science and Technology Major Project of China, Grant/Award Number: 2017ZX09304010	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Calvente CJ, 2019, J CLIN INVEST, V129, P4091, DOI 10.1172/JCI122258; Chen J, 2018, J GENE MED, V20, DOI 10.1002/jgm.3014; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao JY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1062-3; Gilam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12868; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Ha YJ, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.47; Hong Y, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.05.054; HOOD DC, 1990, INVEST OPHTH VIS SCI, V31, P2070; Huang PR, 2017, INVEST OPHTH VIS SCI, V58, P1726, DOI 10.1167/iovs.16-20043; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Ji SY, 2014, BIOCHEM BIOPH RES CO, V451, P329, DOI 10.1016/j.bbrc.2014.07.130; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Karali M, 2016, NUCLEIC ACIDS RES, V44, P1525, DOI 10.1093/nar/gkw039; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kutty RK, 2010, MOL VIS, V16, P1475; La Rosa F, 2019, J ALZHEIMERS DIS, V72, P401, DOI 10.3233/JAD-181259; Lei CY, 2017, NEUROSCIENCE, V360, P48, DOI 10.1016/j.neuroscience.2017.07.053; Li FL, 2019, EXP THER MED, V18, P1175, DOI 10.3892/etm.2019.7668; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Liu RT, 2013, INVEST OPHTH VIS SCI, V54, P2225, DOI 10.1167/iovs.12-10849; Luciunaite A, 2020, J NEUROCHEM, V155, P650, DOI 10.1111/jnc.14945; McCulloch DL, 2019, DOC OPHTHALMOL, V138, P205, DOI 10.1007/s10633-019-09685-8; Morquette B, 2019, BRAIN, V142, P2979, DOI 10.1093/brain/awz245; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Nakanishi A, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0085-6; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Samuels IS, 2015, J NEUROPHYSIOL, V113, P1085, DOI 10.1152/jn.00761.2014; Shang P, 2018, JOVE-J VIS EXP, DOI 10.3791/56997; Sun JR, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.502; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tejera D, 2019, EMBO J, V38, DOI 10.15252/embj.2018101064; Teodori L, 2019, MECH AGEING DEV, V182, DOI 10.1016/j.mad.2019.111127; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Vistbakka J, 2018, ACTA NEUROL SCAND, V138, P130, DOI 10.1111/ane.12921; Wang K, 2017, EXP CELL RES, V357, P335, DOI 10.1016/j.yexcr.2017.05.030; Wang K, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21887; Wilkins HM, 2017, BRAIN RES BULL, V133, P71, DOI 10.1016/j.brainresbull.2016.08.009; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wu JH, 2012, OPHTHALMIC RES, V47, P195, DOI 10.1159/000331992; Yang HY, 2016, IMMUNITY, V45, P83, DOI 10.1016/j.immuni.2016.06.022; Yu SS, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1861-7; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang XF, 2015, ONCOTARGET, V6, P4144, DOI 10.18632/oncotarget.2864; Zhao T, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0337-1	60	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21184	10.1096/fj.202000645RR	http://dx.doi.org/10.1096/fj.202000645RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715208				2022-12-28	WOS:000635216100086
J	Sanchez-Cardenas, C; Romarowski, A; Orta, G; De la Vega-Beltran, JL; Martin-Hidalgo, D; Hernandez-Cruz, A; Visconti, PE; Darszon, A				Sanchez-Cardenas, Claudia; Romarowski, Ana; Orta, Gerardo; De la Vega-Beltran, Jose Luis; Martin-Hidalgo, David; Hernandez-Cruz, Arturo; Visconti, Pablo E.; Darszon, Alberto			Starvation induces an increase in intracellular calcium and potentiates the progesterone-induced mouse sperm acrosome reaction	FASEB JOURNAL			English	Article						acrosome reaction; CatSper; intracellular calcium; mice sperm; progesterone; starving		We have recently reported two different methodologies that improve sperm functionality. The first method involved transient exposure to the Ca2+ ionophore A(23187), and the second required sperm incubation in the absence of energy nutrients (starvation). Both methods were associated with an initial loss of motility followed by a rescue step involving ionophore removal or addition of energy metabolites, respectively. In this work, we show that starvation is accompanied by an increase in intracellular Ca2+ ([Ca2+](i)). Additionally, the starved cells acquire a significantly enhanced capacity to undergo a progesterone-induced acrosome reaction. Electrophysiological measurements show that CatSper channel remains active in starvation conditions. However, the increase in [Ca2+](i) was also observed in sperm from CatSper null mice. Upon starvation, addition of energy nutrients reversed the effects on [Ca2+](i) and decreased the effect of progesterone on the acrosome reaction to control levels. These data indicate that both methods have common molecular features.	[Sanchez-Cardenas, Claudia; Orta, Gerardo; De la Vega-Beltran, Jose Luis; Darszon, Alberto] UNAM, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico; [Romarowski, Ana; Martin-Hidalgo, David; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Hernandez-Cruz, Arturo] Univ Nacl Autonoma Mexico, Dept Neurociencia Cognit, Inst Fisiol Celular, Ciudad Univ, Mexico City, DF, Mexico; [Hernandez-Cruz, Arturo] Univ Nacl Autonoma Mexico, Lab Nacl Canalopatias, Inst Fisiol Celular, Ciudad Univ, Mexico City, DF, Mexico; [Martin-Hidalgo, David] Univ Extremadura, Res Grp Intracellular Signalling & Technol Reprod, Res Inst INBIO GC, Caceres, Spain	Universidad Nacional Autonoma de Mexico; University of Massachusetts System; University of Massachusetts Amherst; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad de Extremadura	Visconti, PE (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.; Darszon, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico.	pvisconti@vasci.umass.edu; darszon@ibt.unam.mx	; Martin Hidalgo, David/I-2840-2015	Darszon, Alberto/0000-0002-2502-0505; Martin Hidalgo, David/0000-0002-6787-0006	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD-038082, HD-088571]; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico) [314839, Fronteras 71]; UNAM Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM) [IN200919, IG200119]; Fondo Social Europeo [PO14005]	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: HD-038082, HD-088571; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico), Grant/Award Number: 314839 and Fronteras 71; UNAM Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM), Grant/Award Number: IN200919 and IG200119; Fondo Social Europeo, Grant/Award Number: PO14005	BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Balbach M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.572735; Balbach M, 2020, BIOL REPROD, V103, P791, DOI 10.1093/biolre/ioaa114; Beltran C, 2016, ADV ANAT EMBRYOL CEL, V220, P35, DOI 10.1007/978-3-319-30567-7_3; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chavez JC, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00366; Conine CC, 2018, DEV CELL, V46, P470, DOI 10.1016/j.devcel.2018.06.024; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Gervasi MG, 2016, MOL REPROD DEV, V83, P860, DOI 10.1002/mrd.22663; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; Hidalgo DM, 2020, MOL REPROD DEV, V87, P1037, DOI 10.1002/mrd.23421; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jung YH, 2017, CELL REP, V18, P1366, DOI 10.1016/j.celrep.2017.01.034; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Luque GM, 2018, J CELL PHYSIOL, V233, P9685, DOI 10.1002/jcp.26883; MEIZEL S, 1991, MOL CELL ENDOCRINOL, V77, pR1, DOI 10.1016/0303-7207(91)90080-C; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Navarrete FA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00262; Navarrete FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33589; Navarrete FA, 2015, J CELL PHYSIOL, V230, P1758, DOI 10.1002/jcp.24873; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Orta G, 2018, J BIOL CHEM, V293, P16830, DOI 10.1074/jbc.RA117.001566; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rohatgi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098760; Romarowski A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136085; Sakai H, 2013, J PHYSIOL-LONDON, V591, P5851, DOI 10.1113/jphysiol.2013.263558; Sanchez-Cardenas C, 2018, BIOL REPROD, V99, P1010, DOI 10.1093/biolre/ioy132; Sanchez-Cardenas C, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119768; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Tateno H, 2013, P NATL ACAD SCI USA, V110, P18543, DOI 10.1073/pnas.1317113110; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Yanagimachi R., 1994, PHYSL REPROD NEW YOR, P317	43	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21528	10.1096/fj.202100122R	http://dx.doi.org/10.1096/fj.202100122R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742713	Green Accepted			2022-12-28	WOS:000635216100037
J	Shi, XY; Miao, YL; Zhang, KM; Gong, S; Xiong, B				Shi, Xiaoyan; Miao, Yilong; Zhang, Kemei; Gong, Shuai; Xiong, Bo			Ethylene glycol butyl ether deteriorates oocyte quality via impairing mitochondrial function	FASEB JOURNAL			English	Article						EGBE; fertilization ability; meiotic competency; mitochondrial function; oocyte quality		Ethylene glycol butyl ether (EGBE) is a ubiquitous environmental pollutant that is commonly used in maquillage, industrial, and household products. EGBE has been shown to cause blood toxicity, carcinogenicity, and organ malformations. However, little is known about the impact of EGBE on the female reproductive system, especially oocyte quality. Here, we reported that EGBE influenced oocyte quality by showing the disturbed oocyte meiotic capacity, fertilization potential, and early embryonic development competency. Specifically, EGBE exposure impaired spindle/chromosome structure, microtubule stability, and actin polymerization to result in the oocyte maturation arrest and aneuploidy. In addition, EGBE exposure compromised the dynamics of cortical granules and their component ovastacin, leading to the failure of sperm binding and fertilization. Last, single-cell transcriptome analysis revealed that EGBE-induced oocyte deterioration was caused by mitochondrial dysfunction, which led to the accumulation of ROS and occurrence of apoptosis. Altogether, our study illustrates that mitochondrial dysfunction and redox perturbation is the major cause of the poor quality of oocytes exposed to EGBE.	[Shi, Xiaoyan; Miao, Yilong; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China; [Zhang, Kemei] Ningbo First Hosp, Reprod Med Ctr, Ningbo, Peoples R China; [Gong, Shuai] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Nanjing Agricultural University; Shandong Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China.	xiongbo@njau.edu.cn			National Key Research and Development Program of China [2018YFC1003802]; China Postdoctoral Science Foundation [2019M651849]; Medical and Health Science and Technology Plan Project [2018KY675]	National Key Research and Development Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical and Health Science and Technology Plan Project	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1003802; China Postdoctoral Science Foundation, Grant/Award Number: 2019M651849; Medical and Health Science and Technology Plan Project, Grant/Award Number: 2018KY675	Adedara IA, 2010, HUM EXP TOXICOL, V29, P801, DOI 10.1177/0960327109360115; Ambroso JL, 1998, TERATOLOGY, V58, P231, DOI 10.1002/(SICI)1096-9926(199812)58:6<231::AID-TERA4>3.0.CO;2-X; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x; BARBEE SJ, 1984, ENVIRON HEALTH PERSP, V57, P157, DOI 10.2307/3429912; Beranger R, 2017, ENVIRON HEALTH PERSP, V125, P684, DOI 10.1289/EHP39; Blajszczak C, 2017, TOXICOLOGY, V391, P84, DOI 10.1016/j.tox.2017.07.013; BROWNING RG, 1994, HUM EXP TOXICOL, V13, P325, DOI 10.1177/096032719401300508; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Cai M, 2015, CURR EYE RES, V40, P822, DOI 10.3109/02713683.2014.959607; CHEEVER KL, 1984, ENVIRON HEALTH PERSP, V57, P241, DOI 10.2307/3429922; Cordier S, 1997, EPIDEMIOLOGY, V8, P355, DOI 10.1097/00001648-199707000-00002; Cui ZK, 2019, J CELL PHYSIOL, V234, P20111, DOI 10.1002/jcp.28611; Dai XX, 2017, HUM REPROD, V32, P598, DOI 10.1093/humrep/dew362; Dayan C, 2014, BIRTH DEFECTS RES B, V101, P254, DOI 10.1002/bdrb.21108; Fastier A, 2005, TOXICOL LETT, V156, P59, DOI 10.1016/j.toxlet.2003.09.019; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Fort DJ, 2018, J APPL TOXICOL, V38, P628, DOI 10.1002/jat.3567; GHANAYEM BI, 1987, TOXICOL APPL PHARM, V91, P222, DOI 10.1016/0041-008X(87)90103-7; Gift JS, 2005, TOXICOL LETT, V156, P163, DOI 10.1016/j.toxlet.2003.08.014; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; Green T, 2002, TOXICOLOGY, V180, P257, DOI 10.1016/S0300-483X(02)00402-X; GROOTEGOED JA, 1984, BIOCHIM BIOPHYS ACTA, V767, P248, DOI 10.1016/0005-2728(84)90194-4; HARDIN BD, 1984, ENVIRON HEALTH PERSP, V57, P69, DOI 10.1289/ehp.845769; HEINDEL JJ, 1990, FUND APPL TOXICOL, V15, P683, DOI 10.1016/0272-0590(90)90185-M; Johanson G, 2000, CRIT REV TOXICOL, V30, P307, DOI 10.1080/10408440091159220; Kang J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/896751; KENNEDY CH, 1993, FUND APPL TOXICOL, V21, P486, DOI 10.1006/faat.1993.1124; Kops GJPL, 2020, CURR BIOL, V30, pR589, DOI 10.1016/j.cub.2020.02.021; LAMB JC, 1984, ENVIRON HEALTH PERSP, V57, P85, DOI 10.2307/3429902; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Maldonado G, 2003, INT ARCH OCC ENV HEA, V76, P405, DOI 10.1007/s00420-003-0441-x; Miao YL, 2018, FASEB J, V32, P1328, DOI 10.1096/fj.201700908R; Miao YL, 2018, HUM REPROD, V33, P116, DOI 10.1093/humrep/dex331; Multigner L, 2005, TOXICOL LETT, V156, P29, DOI 10.1016/j.toxlet.2003.12.077; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Sehenrich N, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP2094; Sperlingova I, 2010, ANAL BIOANAL CHEM, V397, P433, DOI 10.1007/s00216-009-3148-3; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; TYL RW, 1984, ENVIRON HEALTH PERSP, V57, P47, DOI 10.2307/3429899; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; Welsch F, 2005, TOXICOL LETT, V156, P13, DOI 10.1016/j.toxlet.2003.08.010; Weng SP, 2010, REPROD TOXICOL, V29, P452, DOI 10.1016/j.reprotox.2010.03.009; Xiong B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006580; Zhang MQ, 2019, FREE RADICAL BIO MED, V143, P84, DOI 10.1016/j.freeradbiomed.2019.08.002; Zhang MQ, 2018, FASEB J, V32, P342, DOI 10.1096/fj.201700514R; Zhou CY, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113194; Zhou CY, 2019, AGING-US, V11, P4706, DOI 10.18632/aging.102084	48	2	2	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21280	10.1096/fj.202002157R	http://dx.doi.org/10.1096/fj.202002157R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710673				2022-12-28	WOS:000635216100061
J	Kim, CW; Oh, ET; Park, HJ				Kim, Chan Woo; Oh, Eun-Taex; Park, Heon Joo			A strategy to prevent atherosclerosis via TNF receptor regulation	FASEB JOURNAL			English	Article						atherosclerosis; brusatol; inflammation; TNFR1; TNF&#8208; &#945	ENDOTHELIAL DYSFUNCTION; BRUSATOL; INHIBITION; MECHANISMS; INFLAMMATION; DISEASE; CELLS; CHEMORESISTANCE; DEGRADATION; EXPRESSION	Atherosclerosis is a chronic inflammatory disease of the arterial wall. It has been known that development of atherosclerosis is closely related to activation of tumor necrosis factor alpha (TNF-alpha). The objective of this study was to elucidate the effects of TNF-alpha blockade with brusatol on endothelial activation under pro-atherosclerotic conditions. To this end, we examined the effects of brusatol on TNF-alpha-induced intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression in human aortic endothelial cells (HAECs) using western blot and THP-1 adhesion assays. Brusatol induced a decrease in TNF-alpha-induced ICAM-1 and VCAM-1 expression through inhibiting TNFR1 expression, leading to suppression of endothelial inflammation independently of the NRF2 (nuclear factor erythroid 2-related factor 2) pathway. The mechanism underlying brusatol-induced TNF receptor 1 (TNFR1) inhibition was investigated with the aid of protein synthesis, co-immunoprecipitation, and cytokine arrays. Notably, brusatol inhibited TNFR1 protein synthesis and suppressed both the canonical nuclear factor kappa-light-chain-enhancer of activated B cell (NF-kappa B) signaling pathway and TNF-alpha-induced cytokine secretion. We further tested the functional effect of brusatol on atherosclerosis development in vivo using two different atherosclerosis mouse models, specifically, acute partial carotid ligation and conventional chronic high-fat diet-fed mouse models. Administration of brusatol led to significant suppression of atherosclerosis development in both mouse models. Our finding that brusatol prevents atherosclerosis via inhibition of TNFR1 protein synthesis supports the potential of downregulation of cell surface TNFR1 as an effective therapeutic approach to inhibit development of atherosclerosis.	[Kim, Chan Woo; Park, Heon Joo] Inha Univ, Coll Med, Dept Microbiol, Inha Ro 100, Incheon 22212, South Korea; [Kim, Chan Woo] Osong Med Innovat Fdn, Lab Anim Ctr, Dept Preclin Trial, Cheongju, South Korea; [Oh, Eun-Taex; Park, Heon Joo] Inha Univ, Coll Med, Hypoxia Related Dis Res Ctr, Incheon, South Korea; [Oh, Eun-Taex] Inha Univ, Coll Med, Dept Biomed Sci, Incheon, South Korea	Inha University; Osong Medical Innovation Foundation; Inha University; Inha University	Park, HJ (corresponding author), Inha Univ, Coll Med, Dept Microbiol, Inha Ro 100, Incheon 22212, South Korea.	park001@inha.ac.kr			National Research Foundation of Korea (NRF) [NRF-2014R1A5A2009392, NRF-2015M2B2B1068623]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2018R1D1A1B07047058, NRF-2019R1A2C1008142, NRF2020R1A2C2101772]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2014R1A5A2009392 and NRF-2015M2B2B1068623; the Basic Science Research Program through the National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1D1A1B07047058, NRF-2019R1A2C1008142 and NRF2020R1A2C2101772	Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Conti P, 2015, CENT EUR J IMMUNOL, V40, P380, DOI 10.5114/ceji.2015.54603; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; FEINGOLD KR, 1989, ENDOCRINOLOGY, V124, P2336, DOI 10.1210/endo-124-5-2336; Feingold KR, 1996, J LIPID RES, V37, P223; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; HALL IH, 1983, J PHARM SCI, V72, P1282, DOI 10.1002/jps.2600721111; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harder B, 2017, MOL CARCINOGEN, V56, P1493, DOI 10.1002/mc.22609; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Linden F, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00455; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Oh ET, 2017, THERANOSTICS, V7, P3415, DOI 10.7150/thno.20861; Oh ET, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13593; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Olayanju A, 2015, FREE RADICAL BIO MED, V78, P202, DOI 10.1016/j.freeradbiomed.2014.11.003; Raggi P, 2018, ATHEROSCLEROSIS, V276, P98, DOI 10.1016/j.atherosclerosis.2018.07.014; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Ridker PM, 2014, EUR HEART J, V35, P540, DOI 10.1093/eurheartj/eht398; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Sun XH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070997; Tang WB, 2014, J MED CHEM, V57, P7600, DOI 10.1021/jm5007534; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Vartanian S, 2016, MOL CELL PROTEOMICS, V15, P1220, DOI 10.1074/mcp.M115.055509; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Xanthoulea S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006113; Zhang LS, 2007, ARTERIOSCL THROM VAS, V27, P1087, DOI 10.1161/01.ATV.0000261548.49790.63	41	8	8	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21391	10.1096/fj.202000764R	http://dx.doi.org/10.1096/fj.202000764R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565155	Bronze			2022-12-28	WOS:000629576700040
J	Kim, HJ; Kim, E; Lee, H; Jung, JW; Kim, JE; Pack, CG; Lee, JW				Kim, Hye-Jin; Kim, Eunmi; Lee, Haesong; Jung, Jae Woo; Kim, Ji Eon; Pack, Chan-Gi; Lee, Jung Weon			SLAC2B-dependent microtubule acetylation regulates extracellular matrix-mediated intracellular TM4SF5 traffic to the plasma membranes	FASEB JOURNAL			English	Article						cell migration; fibronectin; SLAC2B; tubulin acetylation; vesicle traffic		Transmembrane 4 L six family member 5 (TM4SF5) translocates intracellularly and promotes cell migration, but how subcellular TM4SF5 traffic is regulated to guide cellular migration is unknown. We investigated the influences of the extracellular environment and intracellular signaling on the TM4SF5 traffic with regard to migration directionality. Cell adhesion to fibronectin (FN) but not poly-l-lysine enhanced the traffic velocity and straightness of the TM4SF5(WT) (but not palmitoylation-deficient mutant TM4SF5Pal-) toward the leading edges, depending on tubulin acetylation. Acetylated-microtubules in SLAC2B-positive cells reached mostly the juxtanuclear regions, but reached-out toward the leading edges upon SLAC2B suppression. TM4SF5 expression caused SLAC2B not to be localized at the leading edges. TM4SF5 colocalization with HDAC6 depended on paxillin expression. The trimeric complex consisting of TM4SF5, HDAC6, and SLAC2B might, thus, be enriched at the perinuclear cytosols toward the leading edges. More TM4SF5(WT) translocation to the leading edges was possible when acetylated-microtubules reached the frontal edges following HDAC6 inhibition by paxillin presumably at new cell-FN adhesions, leading to persistent cell migration. Collectively, this study revealed that cell-FN adhesion and microtubule acetylation could control intracellular traffic of TM4SF5 vesicles to the leading edges via coordinated actions of paxillin, SLAC2B, and HDAC6, leading to TM4SF5-dependent cell migration.	[Kim, Hye-Jin; Kim, Eunmi; Lee, Haesong; Kim, Ji Eon; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Dept Pharm, Seoul, South Korea; [Jung, Jae Woo; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Pack, Chan-Gi] Univ Ulsan, Asan Med Ctr, Asan Inst Life Sci, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center	Lee, JW (corresponding author), Seoul Natl Univ, Dept Pharm, Coll Pharm, Seoul 08826, South Korea.	jwl@snu.ac.kr		Lee, Jung Weon/0000-0003-2722-8200; Jung, Jae Woo/0000-0001-7178-7400	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2020R1I1A1A01070020, NRF-2018M3A9C8020027, 2020R1A2C3008993]; Tumor Microenvironment GCRC [2011-0030001]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Tumor Microenvironment GCRC	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2020R1I1A1A01070020 to EMK and NRF-2018M3A9C8020027 and 2020R1A2C3008993 to JWL), the Tumor Microenvironment GCRC (2011-0030001) to JWL.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Atilgan E, 2005, BIOPHYS J, V89, P3589, DOI 10.1529/biophysj.105.065383; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Caswell PT, 2018, TRENDS CELL BIOL, V28, P823, DOI 10.1016/j.tcb.2018.06.003; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Dubois F, 2017, MOL BIOL CELL, V28, P3815, DOI 10.1091/mbc.E17-08-0488; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ibata N, 2020, BIOPHYS J, V119, P2063, DOI 10.1016/j.bpj.2020.09.037; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Jung JW, 2019, CELL METAB, V29, P1306, DOI 10.1016/j.cmet.2019.03.005; Jung O, 2013, BBA-MOL CELL RES, V1833, P629, DOI 10.1016/j.bbamcr.2012.11.026; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102817; Kasai N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20146-1; Kim H-J., 2021, FASEB J, V35, P21369; Kim HJ, 2017, FASEB J, V31, P1461, DOI 10.1096/fj.201600944RR; Kim S, 2018, CANCER LETT, V438, P219, DOI 10.1016/j.canlet.2018.09.009; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Lee D, 2015, HEPATOLOGY, V61, P1978, DOI 10.1002/hep.27721; Lee JW, 2015, INT REV CEL MOL BIO, V319, P141, DOI 10.1016/bs.ircmb.2015.06.004; Lopez-Colome AM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0418-y; McGrath JA, 2012, AM J HUM GENET, V91, P1115, DOI 10.1016/j.ajhg.2012.10.012; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Ryu J, 2021, J PATHOL, V253, P55, DOI 10.1002/path.5548; Scales TME, 2011, CURR OPIN CELL BIOL, V23, P562, DOI 10.1016/j.ceb.2011.05.008; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Ustinova K, 2020, J BIOL CHEM, V295, P2614, DOI 10.1074/jbc.RA119.011243; Watanabe S, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202006010; Wloga D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102207; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100	40	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21369	10.1096/fj.202002138RR	http://dx.doi.org/10.1096/fj.202002138RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33554392				2022-12-28	WOS:000629576700037
J	Lu, AP; Guo, P; Pan, HY; Tseng, C; Sinha, KM; Yang, F; Scibetta, A; Cui, Y; Huard, M; Zhong, L; Ravuri, S; Huard, J				Lu, Aiping; Guo, Ping; Pan, Haiying; Tseng, Chieh; Sinha, Krishna M.; Yang, Fan; Scibetta, Alex; Cui, Yan; Huard, Matthieu; Zhong, Ling; Ravuri, Sudheer; Huard, Johnny			Enhancement of myogenic potential of muscle progenitor cells and muscle healing during pregnancy	FASEB JOURNAL			English	Article						circulating factors; heterochronic parabiosis; myogenic differentiation; skeletal muscle injury	SKELETAL-MUSCLE; STEM-CELLS; SATELLITE-CELL; REGENERATIVE CAPACITY; CLINICAL-IMPLICATIONS; GROWTH-HORMONE; TISSUE-REPAIR; FETAL CELLS; ACTIVATION; IMPROVE	The decline of muscle regenerative potential with age has been attributed to a diminished responsiveness of muscle progenitor cells (MPCs). Heterochronic parabiosis has been used as a model to study the effects of aging on stem cells and their niches. These studies have demonstrated that, by exposing old mice to a young systemic environment, aged progenitor cells can be rejuvenated. One interesting idea is that pregnancy represents a unique biological model of a naturally shared circulatory system between developing and mature organisms. To test this hypothesis, we evaluated the muscle regeneration potential of pregnant mice using a cardiotoxin (CTX) injury mouse model. Our results indicate that the pregnant mice demonstrate accelerated muscle healing compared to nonpregnant control mice following muscle injury based on improved muscle histology, superior muscle regeneration, and a reduction in inflammation and necrosis. Additionally, we found that MPCs isolated from pregnant mice display a significant improvement of myogenic differentiation capacity in vitro and muscle regeneration in vivo when compared to the MPCs from nonpregnant mice. Furthermore, MPCs from nonpregnant mice display enhanced myogenic capacity when cultured in the presence of serum obtained from pregnant mice. Our proteomics data from these studies provides potential therapeutic targets to enhance the myogenic potential of progenitor cells and muscle repair.	[Lu, Aiping; Guo, Ping; Scibetta, Alex; Huard, Matthieu; Ravuri, Sudheer] Steadman Philippon Res Inst, Vail, CO USA; [Pan, Haiying; Tseng, Chieh; Sinha, Krishna M.; Cui, Yan; Zhong, Ling; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, Dept Orthopaed Surg, Houston, TX 77030 USA; [Yang, Fan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Traumat Surg, Wuhan, Peoples R China	Steadman Philippon Research Institute; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology	Lu, AP; Huard, J (corresponding author), Steadman Philippon Res Inst SPRI, Ctr Regenerat Sports Med, Vail, CO 81657 USA.	alu@sprivail.org; jhuard@sprivail.org			National Institutes of Health (NIH) [R21 AR073509-01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS broken vertical bar National Institutes of Health (NIH), Grant/Award Number: R21 AR073509-01	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beiner J M, 2001, J Am Acad Orthop Surg, V9, P227; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Bernardi H, 2011, AM J PHYSIOL-CELL PH, V300, pC1122, DOI 10.1152/ajpcell.00214.2010; Best T M, 2000, Phys Med Rehabil Clin N Am, V11, P251; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cao BH, 2003, NAT CELL BIOL, V5, P640, DOI 10.1038/ncb1008; Chan WFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045592; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2012, CELL CYCLE, V11, P2260, DOI 10.4161/cc.20437; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Delos D, 2013, SPORTS HEALTH, V5, P346, DOI 10.1177/1941738113480934; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89, DOI 10.1152/ajpendo.1990.259.1.E89; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dohar JE, 1998, ARCH OTOLARYNGOL, V124, P25, DOI 10.1001/archotol.124.1.25; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FLORINI JR, 1993, ADV EXP MED BIOL, V343, P319; Fu X, 2015, CELL MOL LIFE SCI, V72, P1663, DOI 10.1007/s00018-014-1819-5; Garrett WE, 1996, AM J SPORT MED, V24, pS2, DOI 10.1177/036354659602406S02; GARRETT WE, 1984, J HAND SURG-AM, V9A, P683, DOI 10.1016/S0363-5023(84)80014-3; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gielchinsky Y, 2010, GENE DEV, V24, P543, DOI 10.1101/gad.563110; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Huard J, 2015, CELLS TISSUES ORGANS, V202, P227, DOI 10.1159/000443926; JARVINEN MJ, 1993, SPORTS MED, V15, P78; Jeanty C, 2014, CURR OPIN PEDIATR, V26, P377, DOI 10.1097/MOP.0000000000000087; Jones AE, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0038-6; Kara RJ, 2012, CIRC RES, V110, P82, DOI 10.1161/CIRCRESAHA.111.249037; Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2; Kasemkijwattana C, 2000, CLIN ORTHOP RELAT R, P272; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Kong WY, 2008, EXP CELL RES, V314, P1529, DOI 10.1016/j.yexcr.2008.01.022; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; Kuroda R, 2006, ARTHRITIS RHEUM-US, V54, P433, DOI 10.1002/art.21632; Lapaire O, 2007, J MATERN-FETAL NEO M, V20, P1, DOI 10.1080/14767050601144834; Laumonier Thomas, 2016, J Exp Orthop, V3, P15, DOI 10.1186/s40634-016-0051-7; Lavasani M, 2006, HUM GENE THER, V17, P180, DOI 10.1089/hum.2006.17.180; Lavasani Mitra, 2013, Methods Mol Biol, V976, P53, DOI 10.1007/978-1-62703-317-6_5; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LEVINOVITZ A, 1992, MOL ENDOCRINOL, V6, P1227, DOI 10.1210/me.6.8.1227; Li Y, 2005, ANN NY ACAD SCI, V1041, P395, DOI 10.1196/annals.1282.060; Li Y, 2005, PHYSICIAN SPORTSMED, V33, P44, DOI 10.3810/psm.2005.05.91; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lippert T. H., 1996, Clinical and Experimental Obstetrics and Gynecology, V23, P65; Lu AP, 2012, MOL THER, V20, P661, DOI 10.1038/mt.2011.261; MAGRI KA, 1991, ADV EXP MED BIOL, V293, P57; Mahmood Uzma, 2014, Chimerism, V5, P40; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mansurov N, 2018, J TISSUE ENG REGEN M, V12, pE1164, DOI 10.1002/term.2451; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; Michaeli TF, 2015, AGING CELL, V14, P698, DOI 10.1111/acel.12286; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mu XD, 2015, HUM MOL GENET, V24, P2923, DOI 10.1093/hmg/ddv055; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Murphy MM, 2014, STEM CELL REP, V3, P475, DOI 10.1016/j.stemcr.2014.06.019; Murphy T, 2015, AGEING RES REV, V19, P53, DOI 10.1016/j.arr.2014.11.004; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nassar D, 2012, FASEB J, V26, P149, DOI 10.1096/fj.11-180695; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Nijagal A, 2013, SEMIN PEDIATR SURG, V22, P62, DOI 10.1053/j.sempedsurg.2012.10.011; Ota S, 2011, AM J SPORT MED, V39, P1912, DOI 10.1177/0363546511415239; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Rudolf A, 2016, CELL REP, V15, P1277, DOI 10.1016/j.celrep.2016.04.022; Semsarian C, 1999, BIOCHEM J, V339, P443, DOI 10.1042/0264-6021:3390443; Seppanen EJ, 2012, STEM CELLS DEV, V21, P2809, DOI 10.1089/scd.2012.0047; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; Tamaki T, 2008, STEM CELLS DEV, V17, P653, DOI 10.1089/scd.2008.0070; Tiidus PM, 2003, EXERC SPORT SCI REV, V31, P40, DOI 10.1097/00003677-200301000-00008; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Velders M, 2013, SPORTS MED, V43, P1089, DOI 10.1007/s40279-013-0081-6; Vella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029226; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yablonka-Reuveni Z, 2011, J HISTOCHEM CYTOCHEM, V59, P1041, DOI 10.1369/0022155411426780; Yamakawa H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051830; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zeng XX, 2010, STEM CELLS DEV, V19, P1819, DOI 10.1089/scd.2010.0046; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zhou Y, 2017, TISSUE ENG PART C-ME, V23, P1012, DOI [10.1089/ten.tec.2017.0216, 10.1089/ten.TEC.2017.0216]; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008	103	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21378	10.1096/fj.202001914R	http://dx.doi.org/10.1096/fj.202001914R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565161	Bronze			2022-12-28	WOS:000629576700024
J	Song, TT; Guan, X; Wang, X; Qu, SS; Zhang, SW; Hui, WT; Men, LH; Chen, X				Song, Tongtong; Guan, Xin; Wang, Xuan; Qu, Shanshan; Zhang, Siwei; Hui, Wenting; Men, Lihui; Chen, Xia			Dynamic modulation of gut microbiota improves post-myocardial infarct tissue repair in rats via butyric acid-mediated histone deacetylase inhibition	FASEB JOURNAL			English	Article						butyric acid; HDAC; microbiome; myocardial infarction	MYOCARDIAL-INFARCTION; INTESTINAL MICROBIOTA; FIBROBLASTS	The complex and dynamic population of gut microbiota exerts a marked influence on the host during homeostasis and disease. Imbalance of gut microbiota metabolites may lead to cardiac dysfunction in patients with heart failure, which is related to myocardial infarction(MI) severity. However, the role of gut microbiota in the repair process after MI has rarely been reported. To explore the role of gut microbiota in MI repair and its underlying mechanism, we mixed antibiotics in drinking water to interfere with gut microbiota in rats. Hematoxylin and eosin staining, Sirius red staining, western blotting, and immunohistochemistry were used to detect tissue repair and fibrosis. We found that the expressions of alpha-smooth muscle actin, collagen, and histone deacetylase (HDAC) activities were significantly increased. We detected gut microbiota at different time points after MI using 16S ribosomal RNA sequencing and detected that Prevotellaceae, Clostridiaceae, and Lachnospiraceae were significantly altered among the butyric acid producers. We administered sodium butyrate via drinking water and discovered that sodium butyrate reduced HDAC activities and adverse repair. Therefore, we speculated that gut microbiota influences the acetylation level and tissue repair process after MI by affecting butyric acid production.	[Song, Tongtong; Guan, Xin; Wang, Xuan; Qu, Shanshan; Zhang, Siwei; Hui, Wenting; Men, Lihui; Chen, Xia] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China	Jilin University	Chen, X (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China.	TongtongSong2018@163.com; chenxjluedu@163.com	chen, xia/GXM-5435-2022		National Natural Science Foundation of China (NSFC) [81570253]; Health and Family Planning Commission of Jilin Province [2015Z040]; Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department) [20180101168JC]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Jilin Province; Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570253; Health and Family Planning Commission of Jilin Province, Grant/Award Number: 2015Z040; Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department), Grant/Award Number: 20180101168JC	Ahmadmehrabi S, 2017, CURR OPIN CARDIOL, V32, P761, DOI 10.1097/HCO.0000000000000445; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ascher S, 2018, EUR J IMMUNOL, V48, P564, DOI 10.1002/eji.201646879; Bultman SJ, 2018, NAT MICROBIOL, V3, P1332, DOI 10.1038/s41564-018-0299-z; Cahill TJ, 2017, NAT REV DRUG DISCOV, V16, P699, DOI 10.1038/nrd.2017.106; Chistiakov DA, 2016, EXP MOL PATHOL, V101, P231, DOI 10.1016/j.yexmp.2016.09.002; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P484, DOI 10.1016/j.ijmm.2013.06.008; Esquivel-Elizondo S, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00051-17; Fernandes MR, 2017, MICROB DRUG RESIST, V23, P56, DOI 10.1089/mdr.2015.0320; Harada N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23001; Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002; Heiss CN, 2018, J INNATE IMMUN, V10, P163, DOI 10.1159/000481519; Janssen AWF, 2015, FASEB J, V29, P3111, DOI 10.1096/fj.14-269514; Jia QJ, 2019, J CELL MOL MED, V23, P2314, DOI 10.1111/jcmm.14164; Jneid H, 2017, J AM COLL CARDIOL, V70, P2048, DOI 10.1016/j.jacc.2017.06.032; Karbach SH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003698; Kiouptsi K, 2019, BIOL OPEN, V8, DOI 10.1242/bio.038851; Kowalski K, 2019, J NEUROGASTROENTEROL, V25, P48, DOI 10.5056/jnm18087; Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921; Lau K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080859; Li ZP, 2015, MICROB ECOL, V69, P307, DOI 10.1007/s00248-014-0497-z; Lippi G, 2017, SEMIN THROMB HEMOST, V43, P609, DOI 10.1055/s-0036-1597903; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Miller PE, 2019, AM J CARDIOL, V124, P1140, DOI 10.1016/j.amjcard.2019.06.029; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nural-Guvener H, 2015, INT J MOL SCI, V16, P11482, DOI 10.3390/ijms160511482; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Song TT, 2021, FASEB J, V35, DOI 10.1096/fj.201903129RRR; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Talmor-Barkan Y, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2017-0014; Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510; Ueki T, 2014, MBIO, V5, DOI 10.1128/mBio.01636-14; Vahed SZ, 2018, PHARMACOL RES, V129, P308, DOI 10.1016/j.phrs.2017.11.008; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Lam V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160840; Yang T, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13256; Yuille S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201073; Zabell Allyson, 2017, Curr Treat Options Cardiovasc Med, V19, P27, DOI 10.1007/s11936-017-0528-4	44	9	9	11	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21385	10.1096/fj.201903129RRR	http://dx.doi.org/10.1096/fj.201903129RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565193	Bronze			2022-12-28	WOS:000629576700006
J	Valent, AM; Choi, H; Kolahi, KS; Thornburg, KL				Valent, Amy M.; Choi, Haeri; Kolahi, Kevin S.; Thornburg, Kent L.			Hyperglycemia and gestational diabetes suppress placental glycolysis and mitochondrial function and alter lipid processing	FASEB JOURNAL			English	Article						BODIPY; cytotrophoblast; gestational diabetes; hyperglycemia; lipids; metabolism; mitochondria; mitochondrial respiration; placenta; syncytiotrophoblast	GLUCOSE-TRANSPORT; IN-VITRO; OXYGEN-CONSUMPTION; FATTY-ACIDS; WOMEN; EXPRESSION; OBESITY; CYTOTROPHOBLASTS; DIFFERENTIATION; ACCUMULATION	The degree that maternal glycemia affects placental metabolism of trophoblast cell types [cytotrophoblast (CTB) and syncytiotrophoblast (SCT)] in pregnant persons with gestational diabetes mellitus (GDM) is unknown. We tested the hypotheses that (a) hyperglycemia suppresses the metabolic rates of CTB and SCT; and (b) low placental metabolic activity from GDM placentas is due to decreased oxygen consumption of CTB. Trophoblast cells isolated from GDM and non-GDM term placentas were cultured for 8-hour (CTB) and following syncytialization at 72-hour (SCT) in 5 mM of glucose or 25 mM of glucose. Oxygen consumption rates, glycolysis, ATP levels, and lipid droplet morphometries were determined in CTB and SCT. In CTB from GDM placentas compared to control CTB: (a) oxidative phosphorylation was decreased by 44% (41.8 vs 74.2 pmol O-2/min/100 ng DNA, P = .002); (b) ATP content was 39% lower (1.1 x 10(-7) vs 1.8 x 10(-7) nM/ng DNA, P = .046); and (c) lipid droplets were two times larger (31.0 vs 14.4 mu m(2)/cell, P < .001) and 1.7 times more numerous (13.5 vs 7.9 lipid droplets/cell, P < .001). Hyperglycemia suppressed CTB glycolysis by 55%-60% (mean difference 20.4 [GDM, P = .008] and 15.4 [non-GDM, P = .029] mpH/min/100 ng DNA). GDM SCT was not metabolically different from non-GDM SCT. However, GDM SCT had significantly decreased expression of genes associated with differentiation including hCG, GCM1, and syncytin-1. We conclude that suppressed metabolic activity by the GDM placenta is attributable to metabolic dysfunction of CTB, not SCT. Critical placental hormone expression and secretion are decreased in GDM trophoblasts.	[Valent, Amy M.; Choi, Haeri] Oregon Hlth & Sci Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, 3181 Sw Sam Jackson Pk Rd,Mail Locat L-458, Portland, OR 97239 USA; [Choi, Haeri; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, Portland, OR 97239 USA; [Kolahi, Kevin S.; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Valent, AM (corresponding author), Oregon Hlth & Sci Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, 3181 Sw Sam Jackson Pk Rd,Mail Locat L-458, Portland, OR 97239 USA.	valent@ohsu.edu		Valent, Amy/0000-0003-3832-2024	NIH [5 K12 HD085809-03, 1 R21 HD090529-01, 5 F30 HD084095-04]; M. Lowell Edwards Endowment	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. Lowell Edwards Endowment	Amy M. Valent: NIH 5 K12 HD085809-03. Haeri Choi: NIH 1 R21 HD090529-01. Kevin Kolahi: NIH 5 F30 HD084095-04. Kent L. Thornburg: NIH 1 R21 HD090529-01; M. Lowell Edwards Endowment	Aas V, 2004, DIABETOLOGIA, V47, P1452, DOI 10.1007/s00125-004-1465-9; Aas V, 2011, BBA-MOL BASIS DIS, V1812, P94, DOI 10.1016/j.bbadis.2010.09.014; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Araujo JR, 2013, J NUTR BIOCHEM, V24, P1741, DOI 10.1016/j.jnutbio.2013.03.003; Barbour LA, 2018, OBESITY, V26, P1347, DOI 10.1002/oby.22246; BOIME I, 1982, BIOL REPROD, V26, P73, DOI 10.1095/biolreprod26.1.73; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Calabuig-Navarro V, 2017, ENDOCRINOLOGY, V158, P2543, DOI 10.1210/en.2017-00152; Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Couch SC, 1998, J DIABETES COMPLICAT, V12, P1, DOI 10.1016/S1056-8727(97)00007-X; Cunningham P, 2009, J NUTR, V139, P636, DOI 10.3945/jn.108.098608; Debieve F, 2000, MOL HUM REPROD, V6, P743, DOI 10.1093/molehr/6.8.743; Deputy NP, 2018, MMWR-MORBID MORTAL W, V67, P1201, DOI 10.15585/mmwr.mm6743a2; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; DOUGLAS GC, 1990, J CELL SCI, V96, P131; Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514; Farabi SS., 2017, AM DIAB ASS 77 SCI S; Friedman JE, 2015, DIABETES CARE, V38, P1402, DOI 10.2337/dc15-0628; Guilbert LJ, 2002, PLACENTA, V23, P175, DOI 10.1053/plac.2001.0756; Hahn T, 1998, FASEB J, V12, P1221, DOI 10.1096/fasebj.12.12.1221; Hammoud NM, 2018, DIABETOLOGIA, V61, P1037, DOI 10.1007/s00125-018-4584-4; Harmon KA, 2011, DIABETES CARE, V34, P2198, DOI 10.2337/dc11-0723; Hauguel-de Mouzon S, 2001, PLACENTA, V22, P619, DOI 10.1053/plac.2001.0698; HAY WW, 1995, PLACENTA, V16, P19, DOI 10.1016/0143-4004(95)90078-0; Haythorne E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10189-x; Hulme CH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50626-x; Illsley NP, 2000, CLIN OBSTET GYNECOL, V43, P116, DOI 10.1097/00003081-200003000-00012; Jansson T, 1999, AM J OBSTET GYNECOL, V180, P163, DOI 10.1016/S0002-9378(99)70169-9; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kolahi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153522; Kolahi KS, 2018, PLACENTA, V72-73, P1, DOI 10.1016/j.placenta.2018.07.014; Kolahi KS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42941; Lee IK, 2014, DIABETES METAB J, V38, P181, DOI 10.4093/dmj.2014.38.3.181; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Meyer B, 1996, AUST NZ J OBSTET GYN, V36, P255, DOI 10.1111/j.1479-828X.1996.tb02705.x; Muralimanoharan S, 2016, CLIN SCI, V130, P931, DOI 10.1042/CS20160076; Napso T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01091; Nguyen TB, 2017, DEV CELL, V42, P9, DOI 10.1016/j.devcel.2017.06.003; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Ryckman KK, 2015, BJOG-INT J OBSTET GY, V122, P643, DOI 10.1111/1471-0528.13261; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Segura MT, 2017, PLACENTA, V57, P144, DOI 10.1016/j.placenta.2017.07.001; SILVERMAN BL, 1991, DIABETES, V40, P121, DOI 10.2337/diab.40.2.S121; Stirm L, 2018, J CLIN ENDOCR METAB, V103, P3299, DOI 10.1210/jc.2018-00397; Visiedo F, 2015, REPROD SCI, V22, P798, DOI 10.1177/1933719114561558; Visiedo F, 2013, AM J PHYSIOL-ENDOC M, V305, pE205, DOI 10.1152/ajpendo.00032.2013; Wang Y, 2019, J CLIN ENDOCR METAB, V104, P4178, DOI 10.1210/jc.2019-00166	51	8	9	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21423	10.1096/fj.202000326RR	http://dx.doi.org/10.1096/fj.202000326RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33605480	Green Accepted			2022-12-28	WOS:000629576700012
J	Ziogas, A; Sajib, MS; Lim, JH; Alves, TC; Das, A; Witt, A; Hagag, E; Androulaki, N; Grossklaus, S; Gerlach, M; Noll, T; Grinenko, T; Mirtschink, P; Hajishengallis, G; Chavakis, T; Mikelis, CM; Sprott, D				Ziogas, Athanasios; Sajib, Md Sanaullah; Lim, Jong-Hyung; Alves, Tiago C.; Das, Anupam; Witt, Anke; Hagag, Eman; Androulaki, Nikolais; Grossklaus, Sylvia; Gerlach, Michael; Noll, Thomas; Grinenko, Tatyana; Mirtschink, Peter; Hajishengallis, George; Chavakis, Triantafyllos; Mikelis, Constantinos M.; Sprott, David			Glycolysis is integral to histamine-induced endothelial hyperpermeability	FASEB JOURNAL			English	Article								Histamine-induced vascular leakage is a core process of allergic pathologies, including anaphylaxis. Here, we show that glycolysis is integral to histamine-induced endothelial barrier disruption and hyperpermeability. Histamine rapidly enhanced glycolysis in endothelial cells via a pathway that involved histamine receptor 1 and phospholipase C beta signaling. Consistently, partial inhibition of glycolysis with 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) prevented histamine-induced hyperpermeability in human microvascular endothelial cells, by abolishing the histamine-induced actomyosin contraction, focal adherens junction formation, and endothelial barrier disruption. Pharmacologic blockade of glycolysis with 3PO in mice reduced histamine-induced vascular hyperpermeability, prevented vascular leakage in passive cutaneous anaphylaxis and protected from systemic anaphylaxis. In conclusion, we elucidated the role of glycolysis in histamine-induced disruption of endothelial barrier integrity. Our data thereby point to endothelial glycolysis as a novel therapeutic target for human pathologies related to excessive vascular leakage, such as systemic anaphylaxis.	[Ziogas, Athanasios; Alves, Tiago C.; Witt, Anke; Hagag, Eman; Androulaki, Nikolais; Grossklaus, Sylvia; Grinenko, Tatyana; Mirtschink, Peter; Chavakis, Triantafyllos; Sprott, David] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Dresden, Germany; [Ziogas, Athanasios; Alves, Tiago C.; Witt, Anke; Hagag, Eman; Androulaki, Nikolais; Grossklaus, Sylvia; Grinenko, Tatyana; Mirtschink, Peter; Chavakis, Triantafyllos; Sprott, David] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dresden, Germany; [Sajib, Md Sanaullah; Mikelis, Constantinos M.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA; [Lim, Jong-Hyung; Hajishengallis, George] Univ Penn, Penn Dent Med, Lab Innate Immun & Inflammat, Dept Basic & Translat Sci, Philadelphia, PA 19104 USA; [Das, Anupam; Noll, Thomas] Tech Univ Dresden, Dept Physiol, Fac Med Carl Gustav Carus, Dresden, Germany; [Gerlach, Michael] Tech Univ Dresden, Fac Med Carl Gustav Carus, Core Facil Cellular Imaging CFCI, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Pennsylvania; Technische Universitat Dresden; Technische Universitat Dresden	Sprott, D (corresponding author), Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Dresden, Germany.; Sprott, D (corresponding author), Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dresden, Germany.; Mikelis, CM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA.	Constantinos.Mikelis@ttuhsc.edu; David.Sprott@uniklinikum-dresden.de	Mikelis, Constantinos/AGF-9423-2022	Sajib, Md Sanaullah/0000-0002-8182-1681; Gerlach, Michael/0000-0002-6831-751X	Deutsche Forschungsgemeinschaft [TR-SFB 127]; NIH/NIDCR [DE026152]; TTUHSC Office of Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); TTUHSC Office of Research	Deutsche Forschungsgemeinschaft, Grant/Award Number: TR-SFB 127; NIH/NIDCR, Grant/Award Number: DE026152; TTUHSC Office of Research	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Cao YP, 2019, P NATL ACAD SCI USA, V116, P13394, DOI 10.1073/pnas.1821401116; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; De Bisschop MB, 2012, CURR OPIN CRIT CARE, V18, P308, DOI 10.1097/MCC.0b013e3283557a63; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Diaz-Coranguez M, 2017, VISION RES, V139, P123, DOI 10.1016/j.visres.2017.05.009; Eelen G, 2018, PHYSIOL REV, V98, P3, DOI 10.1152/physrev.00001.2017; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Kim B, 2018, J CLIN INVEST, V128, P4543, DOI 10.1172/JCI120912; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Lamprecht DA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12393; Lu CM, 2010, P NATL ACAD SCI USA, V107, P18967, DOI 10.1073/pnas.1008816107; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mesquida M, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.5.32; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Noll T, 1999, J EXP MED, V189, P1373, DOI 10.1084/jem.189.9.1373; Ogola B, 2018, AM J PHYSIOL-CELL PH, V314, pC554, DOI 10.1152/ajpcell.00152.2017; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Park-Windhol C, 2016, ANNU REV PATHOL-MECH, V11, P251, DOI 10.1146/annurev-pathol-012615-044506; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rautava S, 2005, J ALLERGY CLIN IMMUN, V116, P31, DOI 10.1016/j.jaci.2005.02.010; Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023; Rice CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07505-2; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Tomita Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041188; Turner PJ, 2017, J ALLER CL IMM-PRACT, V5, P1169, DOI 10.1016/j.jaip.2017.06.031; Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang LN, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104292; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; WHITE MV, 1990, J ALLERGY CLIN IMMUN, V86, P599, DOI 10.1016/S0091-6749(05)80223-4; Xu YM, 2014, ARTERIOSCL THROM VAS, V34, P1231, DOI 10.1161/ATVBAHA.113.303041; Yarbro JR, 2019, MECH AGEING DEV, V183, DOI 10.1016/j.mad.2019.111146; Ziogas A., 2021, FASEB J, V35; Ziogas A, 2020, J IMMUNOL, V204, P1214, DOI 10.4049/jimmunol.1900746	52	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21425	10.1096/fj.202001634R	http://dx.doi.org/10.1096/fj.202001634R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566443	hybrid, Green Accepted			2022-12-28	WOS:000629576700051
